<SEC-DOCUMENT>0000105770-21-000008.txt : 20210223
<SEC-HEADER>0000105770-21-000008.hdr.sgml : 20210223
<ACCEPTANCE-DATETIME>20210223164923
ACCESSION NUMBER:		0000105770-21-000008
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		132
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210223
DATE AS OF CHANGE:		20210223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		21666371

	BUSINESS ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>wst-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:a80a1d85-d222-4f41-ba9f-844636cf1f8b,g:17422749-133e-4fe3-9091-dc8e0f45c575,d:c7db5523d9d74649b8592a121b55d512--><html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:wst="http://www.westpharma.com/20201231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>wst-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV80LTEtMS0xLTA_7258f3e3-53b5-4b67-92da-4d2b6d6143d2">0000105770</ix:nonNumeric><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV85LTEtMS0xLTA_49cb21ae-a3fc-48d6-baa4-20d2f5a4e357">2020</ix:nonNumeric><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV8xMC0xLTEtMS0w_cb06743d-c29d-4051-92c0-ec4f9f0a9260">FY</ix:nonNumeric><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV8xMS0xLTEtMS0w_592e0796-d00b-453d-8e1f-043064b678a9">false</ix:nonNumeric><ix:nonNumeric contextRef="if44a63268f854be99514777e8639749e_D20170101-20171231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMi0wLTEtMS0w_9af21823-f8b7-4576-99a8-b548961451d6">us-gaap:AccountingStandardsUpdate201409Member</ix:nonNumeric><ix:nonNumeric contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMC0xLTEtMTIxNTk_023aae83-1a7a-4eef-830d-157299dbe663">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDIvZnJhZzo2N2FmMzZkZGNjMjg0ZGViODZhMjgzNzZhODljYzhmZC90ZXh0cmVnaW9uOjY3YWYzNmRkY2MyODRkZWI4NmEyODM3NmE4OWNjOGZkXzYwNDczMTM5NTMxNDQ_45133a60-5b19-454b-98c6-745f7c68c0ae">0.25</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="wst-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="id2b3afcd93c148b5a5a8c3bf86ada02c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i821435e98b7349719699f23a9fabd11f_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iac1e5371f0134eb9995482f7560ead18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0230c88584154e91a07b322788cd39a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89754d8eff0a4a21b0723157da2cda70_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eb7e11a1b0044108c665a9e8425b3d8_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieff9a042b0cb4730aae3ec835e713476_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6198c5c042db47db99a2b2ffabc3425f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ec1277012249aaaba2bbc8e69b9dc1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if44a63268f854be99514777e8639749e_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia863152d72be424e95b4eccddadd94e2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a5e4a6111d54b648e0349ce16e32a15_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89a2d506efbe4e4abf499bcddf045827_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb45a33c02564935aa8568f277f49d7b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2eb6236c6ef4de2b1b88eb4b6d0f67f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide2eaf9f89f64fc3b8edf54395816f7a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc36a7c52d664ddd9d308b197d911005_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a2b0616539540d2afdbb1aef826ba8e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2860bdad8e4c5f80b333c36791f4e5_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840b6e15466f480a85b720e9d8dd1aa9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7db531a64e249498d81ca1360119f0c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9f256a412b4a58b1583e63cb3d853b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93b62e40fb3459c8fa7a41ab3cd4a0a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i505c1698fd5746dda4e419a17470e15e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82e08973cd064954b4b8f835bc97cd66_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd079bb091934d528c33b541a4ccce8e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c744ccf1da46369f9ffda6a48eaeb7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i953aa2443d1a4326b4f15164b962ef7f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cd9ef6885cb4483a826dc5519bf65fb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3839e393aceb4fd0834689e157654cf3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0b9a4c775c4c6d99c01d89bdb05da3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ce2e61c66d64a13aa94d7b58161681e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6986700a9d62490d965d3d1f40d2a0ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55957b9eba4c467ba3e5b0bba2e29a4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46a9cd662cd140e6a0bf37cf6471e2d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f5468dc7ce54d57819464e399e6c5bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45120a724f04b6dbac9726ee336f7ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if961352725c24b75a3c9007e9847415b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief5c5adaa64e42959e00816c3bf6c2b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d47931a6e3740b480deaae11058a69d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e2e771b55940c7ab603ef0b73ffe0d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia62094f562004390b81aa8036d7b155e_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf9d37b38c2447e990845dc75ad10954_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ab15527d47f4aa9a1633dab43f58d65_I20130630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie910eb49306b47f19aade26345fa3e40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i20906f3f318b4a2cba7c15716696f1dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i923c8a6896e54de69ca69cbbcaea99ec_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id367f23378974623b9859df2596c8183_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff18b4560ebb4519988e5000afc9573e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0748450e4b47baad0f75ab4d3d1e44_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d22ca205d074fadb933b7fd00da1f1c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3e7a414c18f47b2b7c9f8868c4db4a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aa616b221f246a086f3ff77b50744fd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i018928bacb95446581fa8dd22ce885b4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2940c5a94a5545e9b92428881a4b24ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b52db3c7d824219b44bf0415c21dd9b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife59a6f7e63848cfbf9db3761a806465_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i314b3eadc19f481a9a5cefedb7076b5d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c8bb5e908445ac94163109d6f187fe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80d6874e9d04c2c969ac30de82af315_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695ca37571594a2f90e91281811f3f60_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca2c0bc504f46c09b0f5349f5d4babc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b1d30e86ad0440eae32d35a5c10f6cf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icebffe8ea45e44b7ac1fb37ca2ab6e4e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i045d57ee128a4dfbab51df17a738c76d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05f318a8522b4df3a88ab126fbe483fd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacdb2fa885c04d209366d073597b6e65_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286700d9c43745be93c8819dcc7cbe24_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id754473ec64a4fc7bf5cd626c8c7f917_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id933de360a3a4f38a4f172632d39f380_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib979385c7bde4ce2b05dee2c7e29ab4e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f265678664c4854ba64c2adc9a8a208_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0b1fc94713546ad8ea568bae5635986_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9ade024d2944ee28eb78ee61e0a8c28_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8a3f92e87547398e250cd6e50d2471_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a8e9607c46467ea4f32c403fb194c4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3c3a0fd2c284cc5b42da67050e9f64e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e55590c051146b6bb265c367a817a3b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5338787af4fd49bb99c35be9bb0ef3b9_D20200101-20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73877135951c49808f223e59689acc98_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i797e7706a95c4087904100b08ffda29a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43893472b07f462daa1936e31dd6e050_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dc331021b39487eae7d8020f2a6bbb9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac82b7c5e944f5e9ef69d0cc9b23961_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b9f3baa155749da88ba56d5f039aae7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib84fd26354a144cea716d068af99f852_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac0052e9268404c8537a172e384ec54_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i623144efe05d406b97fe87c5de9251ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22f0862b68a74914864a578b3eccdf30_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i238e2384b1ff420ebcc2252db6a22803_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c646a3c66bd4b32b179638b0f4f3410_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a501f1bfd934f5986193d345963b2c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b6725930a324da584fa5818f87a7c19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0813f85e68a04705a535a614e3d8d1aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74e88843a60b49ff82c73cb0b8167faf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b9182def7704d2e8b4c70f42352b523_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fb2ab515f964445a7edbb1dcb815cb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c5e7423241f495ea2428efc693f1c2c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8af390c674040738b060151f2548d1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72fa20c7d6fe45dd9143b6334b282969_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e509ff0f5b945d2a61627e10cf74c19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be748d3389b4043bbf41058de1b56a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:WestCompanyMexicoSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3f00119f82f45ffaaf450f7f33b594d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:AluplastSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic55755bcb9b447d0bcdb031080c38641_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaTapSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca87fb6336b4470ae7aa7facb3cb9dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaRubberSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief5faa8076a2458484658e4551e6e62a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:IWPharmaGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa409a36165643678fa489cb0bfba317_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eb5c5ab7e624c9cb50fc001dee5e2ef_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8e22ea7f9ce44e9bab1f731e0385e4c_I20191101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if35f246fd3544635b81e8a42dbd0deae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife9245eb0c4a4874b266ec836a4fdc4f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10b64636eec7496ab4fe500fe0014523_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d80b77bc4ac4259a6a16b2462cb3040_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8da13621281d4304b07876e3311d46e7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfe51fd72fce4c61b52e43766f31dd16_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie604f66c47674b3483e91758ca61fca3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3bd440b2a0d4e18b3b9208a2c52f423_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4310b97395d143c894afeb7bfaa7db95_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dbef396511e4f7d99df2d1f6bf9ea78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8653a82cd240399911d2be8d12b1c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d40747cb76f4017801fff732122769f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d1e9f54b0d4246bce9c1710ee63360_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SouthKoreaDistributorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f82da0975740ea962df3a9317d294c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff44052635f445ae955fe9e5585b43a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6e9699cda854495a74995b636566af6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id22d02338f104289981b9d9ff7b017ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11d276e7e42d4f86a942aeb848b531f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i675a7006751b46918799584d6d648565_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aca41366c9f474c9c65cbd82020f94d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id040728146984679be5dc82bedb6dd6b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie61c5d576f4c47feb0147ea226ccf081_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SouthKoreaDistributorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id71719218e6a4641a583e3045ba927ad_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SouthKoreaDistributorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f18ec1636d4475a790dad18e1921a7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fd969a8862944cda67258a0d270f5df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf89ae5341df4d38abf9f74b7c69e08b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f4f2eff7da48748127b29635896464_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6bb6da4755b453bac747d67b20ec2c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d56da838e884589a4b9b27e4dba56bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d8b84cad2c648c3aac2a92756cb752e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36499f4c892042c99421485b861d8b26_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i053014645cf54e15bc7d157e3bd317fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a0baa710cca4e74ba3a4ba6d1ff9627_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib790285c47534a188d7b8a25e56a0757_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79870e1d300248c4b2045f7b6b99751d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dadaa6cfa6a402590d0baa08c3b3ff0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9276b28f1b2f476a8f79b186a11cf9cc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d9aaaa15fea43d5b98afa0705388896_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie84290cd198b4597b8a2abee7084ce4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77bf362efbe64c2ea5409f4177fc61b9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib153aa539cbc4b36bc036f9670da7976_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cdb2635fb0940748713a05a2e05ede6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0818ca18d1c04be49b0664009bcbaa77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0acb2d0db3f94443812b8dad4134f99f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5c6bd09e604af9b7086fafcc87e380_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40b38bc3ea1249599a6fddd5077007ca_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>wst:tranche</xbrli:measure></xbrli:unit><xbrli:context id="if9b19f87e2fa4bd7b7446c6d36467a3b_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05b210f28044eacb815b7c56280e7a8_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a8d1afadc494e8ca3807d39357fab2c_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1fdf8a78aa34446888179eb44e2ba9f_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe9b14827ba48db9e2a32e413c46681_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac32389974424652ba8a1cd7cfffab8c_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54a356e860a44f0a5c4f4291d81c943_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59aded202b8249ceaaa3c323b8b6ee44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85263fd85aef48eeb384af58612ce47d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sgd"><xbrli:measure>iso4217:SGD</xbrli:measure></xbrli:unit><xbrli:context id="id2df6627be904a9aaf00483f12940dc4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i252de83d670e4d1ba875a6c0d2fdd702_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee03ed217f4413f827d72745983e40f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i897b04b0d4e34a368ecdaa5308ccf498_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i531ab9f165fe49a0afa50abe554696f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i5aed1c49d23b4bc8983a2bb4f02182d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieabc497ed7d9444b85e9cce201865f83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01129bb47aaf431d90ed2cb429db9b45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04c2cfc044364719874b1386740f71fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb1615ceaf2a499986cb01691d97764e_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i139517c5b19c4c238b0b6d76659ca642_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff56989b09342d4bf86220442ddc67e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="bbl"><xbrli:measure>utr:bbl</xbrli:measure></xbrli:unit><xbrli:context id="iba0a8733971342b896a7d0f4d587b143_D20171101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfdda46fe61740e6a80e78c142d7da03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerBbl"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>wst:bbl</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i75443478f88f440a974d749223372bba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d779650ed364fd08c026185a18a616f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia766950276184bbc849712d05a16b8c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia815265990ad4f3abe0d627f15f293cb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f263abf32a8469dadba8af24398c81e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9848d3f7103145a283f6dfcbf2d72655_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic495cc68ba6b4b1694f7a3fd4db93012_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16739f8659e14555937d0e778a704f20_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13810f93490c470abbbb7b177ad2c70e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e5247f6308b4858a3772e7407bec118_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f77a45ab1ee47a3ada5f6fcca04c84e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic12ff4fafcd445b084b889fe3305c91c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9154515da1a548fea6cda75ecab6d22c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c3a44d90234809a59a5c72a954a186_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00c3d38891a437c9731668076f93583_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa425d5cda7449f4a965d518a8498929_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98f2ce6380048b498942fe656d21ed9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d44d9b0abe64e9c8fd7b8070ad808e7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i910293864a4644e2bed118d404b0a767_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie74cfeda5713466fb73b2c27fca500a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29005ee8df5b4ec39d6cdb0828b7dcb1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94f10a3f9bbb4fff966da3ea80caf6b3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id20703276ec2492ebfbc9c45c8e0ac7e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7734ad779fa1491187a73582966992ee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45ec217f28a14172945a28df8210d239_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9237b0939d04baab3100c204058459f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0c2886a63984bbfacf71552235bd450_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09837e92679f4dce8b31c888e3564350_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ce83038c2641929269fa9febd355c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i512334ec39334b2c92eadce7653de2b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cf21d4ddd1a4397b60f40f3bd3f765a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf35b6e1c0b46a8bb43590b974f7cf2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8053738038f04d46be3849707bcbbdea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icba0cd37398843499f9cfbbcc1d88190_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4124f16416b429fa6225456655a8660_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea7dadd6e8e4893929788b5e7b6e3f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b77a899950e419aa8380f233b32847f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideda06631bc243b6a3ad62cd4484d60c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifed7924e91c448cc906ea5c40bdcfde4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e10d28fc0cc413fa59ffcb836fd2a62_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdc1f55bdfaa4f77bc2d00ee21f69a3d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253a14ec94054a06b279f6ab052a1335_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047657ac51d94d94bcf8cfad62457a39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dd2da93f35e4130a407403f3b757235_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16fa19e29e634aeab2eb9224f0b45b18_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i724fe533a83d433eae9b42977e2f7b50_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c7a7f771134445a80565de94c28062f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id048dc02c0b2469fbea105614ae2e480_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bde75d952ad42e98d7390be88bb1df2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60ffcae4b075439ca55b2069a4fd47f1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c78a5b1b01444c69b59c15f8578421c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4cb3f26d5954c919726e7cb7785fd7d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0568fea18da421bbd3bca7960cc204a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1207be39ba114326a769b349741e01cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dbc3b28347940649422a5aabfb3dc04_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a4e354d29304999b66d6671f79f5028_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccc55ae3f38944cb8ac2a8bf2c81c4b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:SalesProjectionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4447f5127f674e7f8698a17c77e3f3b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:SalesProjectionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie942ed6d0ed647738c0b530564afcfc5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:SalesProjectionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7f2ccbcf7004f9783ca3beb8c271c99_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulFDAApprovalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196249d46fc346f1a73485f5ad2fbf3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulFDAApprovalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e3b441cdb5d4c2da4292cead5f46a91_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulExecutionOfAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09071b9fb2a14ad282d0cfdd020d47c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulExecutionOfAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib058c9e2b3e74454af000898cd0285bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id84b7326bff74d6ebd4702280f7944cb_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73f46e104061488a90e0e2d284629010_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i658cc38b8a3b41eda1a5d4e62559ac50_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51bfe342f5e747da8972ffeb014b1e1f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id681882b891d45d7b8705f79a7375de1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7365acbeffa54ca3967c4b060d8a6454_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad1f1467c6694df4a0d7fc8661e6b67c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i394755247a4245c5b34c032dd17977d5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i896e20ef243241948a91a08bcb36aada_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8565969bde54458fb11c038691603413_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8143f0aa268c43be9cb5a90dc5b80fc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93df88f97024c308142319431bb90a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1754a699316c449f8f1f4261e2891243_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14e414bd78984a40bfeb308b44cb7247_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75da7f02f5094418a3c0f650caaf45e6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib29ca945bd3c4f2e8e97e9cb0dd524b6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fadb2a71cac4c68a8087322aebf7865_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b53436536584f99949ba6e260846ce6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d102ffa7174cdf958957e889097fa6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd49877ac6e94e8ba65f322b6db5e98d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e981e6b5c1c4a0a96533e1a52c52939_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcddbacbafaa4e1a88fe1be38aec0244_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b56de45b3d044729f17a76e52cedbc9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58338c0d70074d60967ae84164421b21_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08616f88160948b48f5aaa6efbddcba4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idddb809162cb4f63a286d585b789e694_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d603594868f40508e7fe929d734564a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4526e48ffa5a4038b2bf9bfff300abac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6835ccab784849ca91ebb01f7d09ae9c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbed69520f7a44dfaa08f657cc8f4421_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c545e42bb914c0c88935ba87d94b5fb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d8d0c816eaf4dfca6437e6e6a59e325_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d543f5f46e4f9a93d41fac73ca8d9b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6d567413c754bd2bced1765c543f431_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96c87fad149e472cb246ab4b33e1c09e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f2ed4fc5d284253859a0c77c2b51762_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie536733ecf0f49159c3492b03170fa5e_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94b75e19c564babaabe3bbd0f85500a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf9f594c3975439797d9bcdaebc0d887_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa7ad396fdcd47809883f36d39da738a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if03468ad1c7345619b7c14865b28e6f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4df90090669487784ddadbfee1e8f77_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5509bc461133464cbdfc6fefe5088ba4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a997b8a25584ec488869d0d3049d1c0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ffc58869ae424aa7cbc9aaf84a2dd4_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c4540b26bb74a9a969cecf57c787621_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i417b7c21dd1b47b8b40d34cc70053be2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibae2919783b045ffaef7c87dc7aa860f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plan"><xbrli:measure>wst:plan</xbrli:measure></xbrli:unit><xbrli:context id="icd5b02eced6f45d7a117b354e107f82b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92f1d4eb98744d9bc103ffc68dd371b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69fd39a6d2c54a91b93d39724d4934c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic09e3fbc0235485daae5c0994ee55f63_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2f8c2dff1fb47aa8d3c65c340678d15_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796caa67ee0e45cfb059041a1e2187bb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if13e4b6d592a42489a6f499eb9fbfd39_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i876e963861bb446cbb82e6c637fae2f2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1478cc28dfaa4d7f889e3ee1528d58c4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386c37780a184cefb9928ebfdfedcfe7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbb0433c970748fa8ef413c8bd5370f7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dd3d667f6f24bf5bc61589ce38acb11_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c2c88135cd14a78813b05c34e34ca53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fc2f2f3b70d4f728400db29e64a3f7e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba56c58d773f48009254ee34458305df_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a02b0a604014333900498c1cfd05c7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81cac794d7894db3846aa546dee94d08_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib040619d3008485c9326df9c3dbf6e37_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8190a671d354cd382c8d1942d0777c4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id23ad1f4c66d488cb8092ac2514b826f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4075113bb61471da80f2c6ac352be97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2afddaa78ba4eb9a300b205038274cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e90da744d994db1aa27a052c7ea5372_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cc77fb8f01142a38ee0cb161ae8c1cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a86b5e8a2be41a4881009bd7646cbc1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8f7729b95c446d88cb96cfb7b67b5c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5eafccc5cbf45f3b2b2941de558f722_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i135ba46e2e694c4bbc75dbd5e31ab210_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if288e4886a22444a9cb6096fee75382e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f757014e0945a5bf6bc2c5b4dc7249_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5749a3d72efc471787a5d2c8be39e567_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i702b7d354d8f47ca9dce932abfe26468_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b55367d0664406584e5bef4f962b96b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id543109bbee84ce08728e7c8c83af280_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5187136b2ee4ca79301744704a7d717_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa0d5d817d5451f853f49d5e75d6d4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f4c146b4a9e4cc9ad5a9fb7c2736c33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11cf3bf12dcb4f7b89f6fa466bd6f61b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36f034759b184fafb0766fc3e84b1c36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87e6d40f72d74559bf0873f01c9b4e42_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094b2113e7f547cd90c587fc0372659e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1999229824e84c8d9ca34567aec0c908_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d0ab8218d949d2a659ec046d80a1bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie419e0a44aaf4d3eb5ee9c6b334f68ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa24c422d8c0405099e0de09723d85d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c91cc19e464254ad91d8affa894f9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4add538dc55426e88cd3a2c21336362_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60088b670a5d4762b599e56d5c4144e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19a7aa0c01fe487d95b11f1de2d144ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f5c08c9be044322af60b2edf7b438f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f71fa6b7014a0d9856ddccecd5f63e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8341c7060458474a822a8b5d2048ad64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd0101c2ca4488b94dba592a0fb3f19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d50bf5e175c440783b2b9c219b372c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266aa4fc9a0a43728336bfdd4f5d2243_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44f001b391204e3ca8e6364079ecc773_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i709ce196777d43518c28b2c94fdcce0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied72e1adf5634108a0178f0d097f1efb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98071b96fe31436b9c3b419eee7e32f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7cda47cc19b4bf19d6b5dbe554f69ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050e371f0fc64570a8371b4ee1d6bfd2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if951953d16294cdcbc6e8bb801ad899a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib50dc684425d41089759a744a6bfe976_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc2f1128dce6466cac75150836fb94ec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i494430ec845b43fea48e416c8601f31b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if60b7e3f1fcf4c8b9a2d92a956688b64_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd9cfb636098475aa47d5bd1a223dd8a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0308ba03d22245b7b8e1dfe8f84611d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf18620d1a2e439b9d01b280d170a058_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3082f2f2d81a4f0883e8d344e51d25b3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb54b4a5ace54151917b1754f3a19fa8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0a5df83d0b47c1b25e912b720d4e01_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08860c9461ea45b79e3605f7916ca562_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idad97ef7bc454cc2becb3891d672bea5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9c0729d942243dcb1acd45b7a4b2302_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd693c0a25a2479690b679e348d38eb8_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3279f29cb3d44ad398fdc8d0e4645742_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2db454712df547c7ab009dafbba594fd_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84165f2d4d454d8183ee94793f21eb44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c10b1ae682d4560b9e68e567ee78779_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9edfa646c3214875a75bd7a3a78ed53a_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f0c156b11b44bf9bb5fc1e2d121ddfb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9174797bed448da4f42a9ab90c7fe8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd22d3c670e54cfa9c8332dd9e2049f9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i011bfe673ee54bfcb6f9c6983b446443_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i810c968a3f8644c38105ee05c0745630_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b33dcfc3132453a9eaf1f23d1e28a46_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99ea9955e84d40b0977aa384c11038ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e32d9c6ce54b18abbf607406fce66b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5ec7fb1237e40e185af54faa36233cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic176204c3afa46c5bf47f585a3fda12b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1051c2e627924a1084b2ece63cb73f04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceed54e3fc2843188a6afef50414dfb5_D20180201-20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia296001215624e7b9dab9ac52000b1bd_I20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie24ddffb97cc4456a1f560750a4db57a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50f424d813e44fc58d59312550371a32_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e15367dd044052a08c353d17ed4488_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70f0a5d05a354c9ab3ed46523d85026b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eae9458001042abbe77ec865b769cdf_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd7f955de895424dbdb1f1a1c3db9fc2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb988feb4be406a9f663fd322648742_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85908bb4116442599a19d848f1076448_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32f79a77bed344a6981d9eff588ca896_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f5f1f9c46284f9b908b58203e0fdd95_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6629a2a3e6da4a748d04ed957a6ed07d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193830303b9d4d0193b328737f36c6c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i274376d36fa54890b82f08d6ed48bbee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27d7dd7dc1104b2593a44cdf7974d37f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62905753722c4190871f9b11bf5dd843_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed2f680acea47a38a544ddfae0bede5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb482e22f9f489f99c206b7e374b961_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4ca23e5869c48d8b6e8710608fcbbdd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5aa17d4bf34a9381a6369cd9b7643e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i124cb2fa8c124903a808a37113465670_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9daa8394ea5c4fff8c0bf665f388fdf8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cd1fba210414204826670f7b9718de1_D20170101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i595e0d99768d4fddb665c130376a4241_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia79ee42fd3854b1094384535405e880c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7054c41751544f6b384cd99197b808f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff77fa642e814b6b8597126f28871557_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie86aa1917b504d79b444ef1639528a31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib485a2f5d6d34d779c1f358e30597b6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>wst:segment</xbrli:measure></xbrli:unit><xbrli:context id="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i774d0f0cab54416082070e38f9410ff3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd2ce98d3354cb59bc39ace8c778f47_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f2732fdbddd435f8a75ce6550a1311f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccc9431b0b454feab552857b416ea0ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d4d146be594713a85bdeb50230ab00_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf861532e0d24915b8be512c7b015ea5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6859fd0c19984b50987f791266a4b2e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icac6e86e417f4406a08009e46537f51c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8b305543904c68b1b271d9387d71fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f8027821a434a1689f83110fca51907_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d0dacf1c0841d5a307f3bfc32d20da_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e114810392f4404aea674dae1f5b2f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6699e8acb7d14b0ca42ade817a9f705f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d2ac6a7f541499ea8ccf5a4208ace40_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2805175e4f14fc5b6d7559c8e6d0bea_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieca17c3296344ba29f4960a8397d1ba5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ed92857acc241a2bf581f09e87478ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib123a778d0474f6ab51dda0673a420c3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id32983fbf1724e6ea83c4fa95b8a050f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0588f0020ff4e1380042e497db31675_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f4c8efe73a94954b43ffa84714f22f9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id394f2aaf20a4f5a8065aac88dd87877_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9018f7f2975643e0a3f04da690ae1d48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia76813d2bec64911becdf36778a96555_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e63f25aee7c40ba95eaeefc7de3649d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i991655d17a3740aa8576ef108e472601_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieddac01d5e554b06879611717faa28f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81778baca03545dea6b871ec4c6c9f4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb14a0610fac4aad8769dddc489dbe8e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461ab78f5c0648c6b759cfad0b1be277_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i415eb61f5a0546a8871238557c61e7a0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ced6416e1114dbb92b4432c973d7b0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i416bd58eeeb14e2fb2be821ef3871bd3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1438eab01bf433fbc35a309da3262d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b7677acdc9401e83ce68aef09e830c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie10fea7610d24805934edfad68c8e75b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ccb8142a6fd48a197381524a3af0e94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a0e7149a4524df1af74160af660cd5f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a866adcce645a4a119d06e29948d8b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35257ff2d24b4eb0b102a172b964a457_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cda55f4b25b43e7b343a66c73455087_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i543690089e2d4cd78c08099fc3cabbd8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i719b99d7c88542fa96519a7e6ee06942_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d8b5816ea284568a1893e7fcb6f3fd7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26980b6c24b44caaac3a924b44a1e9e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fe7bd6c2ccf4155b6958ffbe633b8b2_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1ea59d55ee44d4ab3fe01dfb28f7c7e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fd2fec9ee1f4945b5522f7f39694676_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc2b6d65de7432a8a9361729083f9c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd68a9b944eb48d7acb4f4672ce330e2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5d2c8af23c24659a9310a2a892a4f62_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idec6d3b519f94b4fa556d9176df56073_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82896f6ac3984e04b4105c6005e58772_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67679e92fa7e4c908452f2ce5a3f225e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882a8d63ebbb4201a759ff4643894e63_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71aaf080ab884248b5379505dab9cfc7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if820fa9d156f4d8abd00df5a22472ff0_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i742f81f943014659ab25279911503298_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906d2c0507c14130885513cc846a85fc_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c0f9eef8a8d405ba0c12024d16f0191_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic7db5523d9d74649b8592a121b55d512_1"></div><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Washington, D.C.&#160;&#160;20549</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGJmMjQ2N2RkZTJhNDY2Nzk2MDNhNmFkZjgxYTNjZTEvdGFibGVyYW5nZTo0YmYyNDY3ZGRlMmE0NjY3OTYwM2E2YWRmODFhM2NlMV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjo0NGM0NWFiYjVkYWM0ODFjYThlNGQ0YjE0ZmU3MzljOV85_68c1870c-f749-4ee1-8758-46072b0e87c1">10-K</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Mark One)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MDZlZTA5ODk0YjhlNDg1ZWFiOTYzYWVhNzM4YWQwYTkvdGFibGVyYW5nZTowNmVlMDk4OTRiOGU0ODVlYWI5NjNhZWE3MzhhZDBhOV8wLTAtMS0xLTA_85ec3c2f-94bb-470c-8d24-a80bd6650cea">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the fiscal year ended <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4Njc2_dbd4f4de-edf0-4a6d-a859-8a065dde70b5"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4Njc2_a448b017-0cfd-4b72-8f5b-364c51b4cd00">December 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">or</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6ZTdhZDViZDM5MDkwNDEyYTg1Y2UxMzBhMDYwYjYzMWQvdGFibGVyYW5nZTplN2FkNWJkMzkwOTA0MTJhODVjZTEzMGEwNjBiNjMxZF8wLTAtMS0xLTA_569e11bf-dd55-44c4-a2e6-16bf108293b8">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8xMjk_a958e568-7437-4558-82ff-cb8e4839fe9f">1-8036</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6OGM4Y2U4NmM1ZWE3NDUwZDk3NGExNjg3MjlkZjJhMjMvdGFibGVyYW5nZTo4YzhjZTg2YzVlYTc0NTBkOTc0YTE2ODcyOWRmMmEyM18wLTAtMS0xLTAvdGV4dHJlZ2lvbjpiZDk0MWRhMWFhMzM0ZTVjYmRmNjIyZjBjZTI5YTA2M181_388abd33-aea7-4757-9bc9-304ae9efd202">WEST PHARMACEUTICAL SERVICES, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:48.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8wLTAtMS0xLTA_efe85c34-639d-4a5e-b2bb-0ab725cdad6f">Pennsylvania</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8wLTEtMS0xLTA_a2e427c2-0716-462d-b847-e102c448806a">23-1210010</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjozYjExNGQxNjI2YTg0NTlhYThiMjg2ODQ2ZDU3ZDc5Zl80_7bc1c93b-5683-44e2-bfc3-67aac9aa12ef">530 Herman O. West Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjozYjExNGQxNjI2YTg0NTlhYThiMjg2ODQ2ZDU3ZDc5Zl84_5ebde6f4-3416-4c09-830c-baa239c1dc5c">Exton</ix:nonNumeric>, <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjozYjExNGQxNjI2YTg0NTlhYThiMjg2ODQ2ZDU3ZDc5Zl8xMg_fa9199c7-64fc-4db5-9776-7243d91d046b">PA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTEtMS0xLTA_32cd47a8-ffe8-4941-909b-f6cc8302762f">19341-0645</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8xODk_fb946234-0e2d-4da6-8162-a025c7bfef3b">610</ix:nonNumeric>-<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8xOTI_1f5f15a4-3704-4020-8de8-9d0cc484a3d6">594-2900</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.958%"><tr><td style="width:1.0%"></td><td style="width:42.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6YTk2MWZiOTI4NjcwNDYzOWIzOTI5MWYwYjcyOWE0NGQvdGFibGVyYW5nZTphOTYxZmI5Mjg2NzA0NjM5YjM5MjkxZjBiNzI5YTQ0ZF8xLTAtMS0xLTA_1b13323e-d537-40be-8b55-3287b6a266f0">Common Stock, par value $.25 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6YTk2MWZiOTI4NjcwNDYzOWIzOTI5MWYwYjcyOWE0NGQvdGFibGVyYW5nZTphOTYxZmI5Mjg2NzA0NjM5YjM5MjkxZjBiNzI5YTQ0ZF8xLTEtMS0xLTA_a455e474-7ef2-48a0-a663-cc4f02180ff6">WST</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6YTk2MWZiOTI4NjcwNDYzOWIzOTI5MWYwYjcyOWE0NGQvdGFibGVyYW5nZTphOTYxZmI5Mjg2NzA0NjM5YjM5MjkxZjBiNzI5YTQ0ZF8xLTItMS0xLTA_ccc49c6d-5271-47db-8e4f-3bda9334c370">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act:   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">None</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzQ4_c99cad24-2ad4-4cdb-87d2-4616777307f5">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160;&#160;&#160;Yes &#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4Njc5_f7d14242-ebce-47fe-8e5e-31b5431660a7">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzUw_3b0092c1-2bc6-4708-b3d2-e1c8caa1f84c">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzUx_532fb7c9-f9ff-42d7-8266-9f795ce76cab">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.113%"><tr><td style="width:1.0%"></td><td style="width:21.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MTZjMTRiZjY4YzRjNGI2NTlkMmI4OTgxM2E4NzFjNGEvdGFibGVyYW5nZToxNmMxNGJmNjhjNGM0YjY1OWQyYjg5ODEzYTg3MWM0YV8wLTAtMS0xLTA_52d61c24-4ca5-4efc-98c7-8c824bc7d261">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MTZjMTRiZjY4YzRjNGI2NTlkMmI4OTgxM2E4NzFjNGEvdGFibGVyYW5nZToxNmMxNGJmNjhjNGM0YjY1OWQyYjg5ODEzYTg3MWM0YV8xLTQtMS0xLTA_e7c94544-3c78-4311-a2f9-e06513fbf000">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MTZjMTRiZjY4YzRjNGI2NTlkMmI4OTgxM2E4NzFjNGEvdGFibGVyYW5nZToxNmMxNGJmNjhjNGM0YjY1OWQyYjg5ODEzYTg3MWM0YV8yLTQtMS0xLTA_ca2f2b64-4e33-4a08-9710-26fbd89bf24a">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU3NDk4_fd51e32f-45c9-4f58-a581-ef69276fc294">&#9745;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;&#160;&#160;&#160;Yes&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzUy_943d26bc-134b-4a1e-b439-af6048be8089">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 30, 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="id2b3afcd93c148b5a5a8c3bf86ada02c_I20200630" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4NjYx_6c4bdd1f-1248-48e5-bada-c52b0ab170d1">16,742,194,934</ix:nonFraction> based on the closing price as reported on the New York Stock Exchange.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of January 27, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i821435e98b7349719699f23a9fabd11f_I20210127" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4NjY5_5fc214b3-c1aa-4715-88d7-988b58d0bfa8">74,103,026</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:center"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU3NTM3_3b42ea75-9c41-4489-8338-79828f366562" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.261%"><tr><td style="width:1.0%"></td><td style="width:68.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Parts Into Which Incorporated</span></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proxy Statement for the Annual Meeting of Shareholders to be held May 4, 2021.</span></td><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Part III</span></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_2215"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_7"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_13">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_13">BUSINESS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_16">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_16">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_16">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_19">ITEM 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_19">UNRESOLVED STAFF COMMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_19">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_22">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_22">PROPERTIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_22">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_25">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_25">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_25">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_28">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_28">MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_28">20</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_31">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_31">20</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_34">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_37">ITEM 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_37">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_37">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_40">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_40">SELECTED FINANCIAL DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_40">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_43">ITEM 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_43">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_43">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_52">ITEM 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_52">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_52">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_55">ITEM 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_55">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_55">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_172">ITEM 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_172">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_172">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_175">ITEM 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_175">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_175">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_178">ITEM 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_178">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_178">88</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_181">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_184">ITEM 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_184">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_184">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_187">ITEM 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_187">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_187">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_190">ITEM 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_190">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_190">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_193">ITEM 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_193">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_193">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_196">ITEM 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_196">PRINCIPAL ACCOUNT</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_196">ANT</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_196"> FEES AND SERVICES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_196">90</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_199">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_202">ITEM 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_202">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_202">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ic7db5523d9d74649b8592a121b55d512_205">ITEM 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_205">FORM 10-K SUMMARY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_205">91</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_208">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_208">92</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_211">EXHIBIT INDEX</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_211">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_211">1</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, or the context otherwise requires, references in this report to &#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; and &#8220;West&#8221; refer to West Pharmaceutical Services, Inc. and its majority-owned subsidiaries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All trademarks and registered trademarks used in this report are our property, either directly or indirectly through our subsidiaries, unless noted otherwise. Daikyo Crystal Zenith</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Crystal Zenith&#8221;) is a registered trademark of Daikyo Seiko, Ltd. (&#8220;Daikyo&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this report, references to &#8220;Notes&#8221; refer to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K (&#8220;Form 10-K&#8221;), unless otherwise indicated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information in this Form 10-K is current as of February&#160;23, 2021, unless otherwise specified. </span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_13"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.  BUSINESS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our packaging products include stoppers and seals for injectable packaging systems, which are designed to help ensure drug compatibility and stability with active drug products, while also supporting operational efficiency for customers. This product portfolio also includes syringe and cartridge components, including custom solutions for the specific needs of injectable drug applications, as well as administration systems that can enhance the safe delivery of drugs through advanced reconstitution, mixing and transfer technologies. We also provide films, coatings, washing, vision inspection and sterilization processes and services to enhance the quality of packaging components and mitigate the risk of contamination and compatibility issues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment&#8217;s product portfolio also includes drug containment solutions, including Crystal Zenith, a cyclic olefin polymer, in the form of vials, syringes and cartridges. These products can&#160;provide a&#160;high-quality solution to glass incompatibility issues and can stand up to cold storage environments, while reducing the risk of breakage that exists with glass. In addition, we offer a variety of self-injection devices, designed to address the need to provide at-home delivery of injectable therapies. These devices are patient-centric technologies that are easy-to-use and can be combined with connected health technologies that have the potential to increase adherence. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our Proprietary Products product portfolio, we provide our customers with a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. Offering the combination of primary packaging components, containment solutions, and drug delivery devices, as well as a broad range of integrated services, helps to position us as a leader in the integrated containment and delivery of injectable medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This reportable segment has manufacturing facilities in North and South America, Europe, and Asia Pacific, with affiliated companies in Mexico and Japan. Please refer to Item 2, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_22">Properties</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. These products include a variety of custom contract-manufacturing and assembly solutions, which use such technologies as multi-component molding, in-mold labeling, ultrasonic welding, clean room molding and device assembly. We manufacture customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have vast expertise in product design and development, including in-house mold design, process design and validation and high-speed automated assemblies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This reportable segment has manufacturing operations in North America and Europe. Please refer to Item 2, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_22">Properties</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant operations outside of the United States (&#8220;U.S.&#8221;), which are managed through the same business segments as our U.S. operations &#8211; Proprietary Products and Contract-Manufactured Products. Sales outside of the U.S. accounted for 54.6% of our consolidated net sales in 2020. Please refer to Item 2, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_22">Properties</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the general business processes are similar to the domestic business, international operations are exposed to additional risks. These risks include currency fluctuations relative to the U.S. Dollar (&#8220;USD&#8221;), multiple tax jurisdictions and, particularly in South America, Israel and the Middle East, uncertain or changing regulatory regimes, or political and social issues, that could destabilize local markets and affect the demand for our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion of our international operations, the risks associated with our international operations, and our attempt to minimize some of these risks in Part I, Item 1A, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_16">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Part II, Item 7, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part II, Item 7A, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_52">Quantitative and Qualitative Disclosures About Market Risk</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the captions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_127">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw Materials</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use three basic raw materials in the manufacture of our products: elastomers, aluminum and plastic. Elastomers include both synthetic and natural materials. We currently have access to adequate supplies of these raw materials to meet our production needs through agreements with suppliers.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ a supply chain management strategy in our business segments, which involves purchasing from integrated suppliers that control their own sources of supply. Due to regulatory control over our production processes, sole source availability, and the cost and time involved in qualifying suppliers, we rely on single-source suppliers for many critical raw materials. We generally purchase certain raw materials in the open market. This strategy increases the risk that our supply chain may be interrupted in the event of a supplier production or distribution problem. These risks are managed, when and where possible, by selecting suppliers with multiple manufacturing sites, rigorous quality control systems, surplus inventory levels and other methods of maintaining supply in case of an interruption in production or distribution.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property, including patents, trademarks, copyrights, and trade secrets, is important to our business. We own or license intellectual property rights, including know-how and issued patents and pending patent applications in the U.S. and in other countries, that relate to various aspects of our products. In 2020, more than 290 patents were issued to West across the globe. Some key value-added and proprietary products and processes are exclusively licensed from Daikyo. Our intellectual property rights help protect our products and are critical to the growth of our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to carry significant amounts of inventory to meet customer requirements. In addition, some of our supply agreements require us to purchase inventory in bulk orders, which increases inventory levels but decreases the risk of supply interruption. For a more detailed discussion of working capital, please refer to the discussion in Part II, Item 7, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resource</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The design, development, manufacturing, marketing and labeling of certain of our products and our customers&#8217; products that incorporate our products are subject to regulation by governmental authorities in the U.S., Europe and other countries, including the U.S. Food and Drug Administration (&#8220;FDA&#8221;), the European Medicines Agency and the National Medical Products Administration (China). Regulatory authorities, including regulatory review and oversight, can impact the time and cost associated with the development and continued availability of our products, and they have the authority to take various administrative and legal actions against West, such as product recalls. There were no required material capital expenditures for adherence to our government-led regulatory standards in our facilities in 2020 outside the normal course of business and there are currently no needed or planned material expenditures for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">West is also subject to various federal and state laws, and laws outside the United States, concerning fraud and abuse, global anti-corruption, and export control. With the recent increased regulations, we remain committed as a company to comply with all laws and regulations applicable to our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Regulations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various national, state and local provisions regulating the discharge of materials into the environment or otherwise relating to the protection of the environment. Our compliance with these laws and regulations has not had a material impact on our financial position, results of operations or cash flows. There were no required material capital expenditures for environmental controls in our facilities in 2020 and there are currently no needed or planned material expenditures for 2021.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Proprietary Products customers primarily include many of the major biologic, generic, and pharmaceutical drug companies in the world, which incorporate our components and other offerings into their injectable products for distribution to the point of care and ultimate end-user - the patient.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Contract-Manufactured Products customers include many of the world&#8217;s largest pharmaceutical, diagnostic, and medical device companies. Contract-Manufactured Products components generally are incorporated into our customers&#8217; manufacturing lines for further processing or assembly.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and services are sold and distributed primarily through our own sales force and distribution network, with limited use of contract sales agents and regional distributors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ten largest customers accounted for 42.0% of our consolidated net sales in 2020, but none of these customers individually accounted for more than 10% of consolidated net sales. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_94">Revenue</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 19, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_163">Segment Information</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on our consolidated net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our range of proprietary technologies, we compete with several companies across our Proprietary Products product lines. Competition for these components is based primarily on product design and performance, quality, regulatory, and scientific expertise, along with total cost.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there are a number of competitors supplying medical devices and medical device components, including a number of pharmaceutical manufacturers who are also potential customers of our medical devices and components. We compete in this market on the basis of our reputation for quality and reliability in engineering and project management, as well as our knowledge of, and experience in, compliance with regulatory requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have specialized knowledge of container closure components, which is integral to developing delivery systems. With our range of proprietary technologies, we compete with new and established companies in the area of drug delivery devices, including suppliers of prefillable syringes, auto-injectors, safety needles, and other proprietary systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to differentiate ourselves from our competition by serving as an integrated drug containment and delivery systems global supplier that can provide pre-approval primary packaging support and engineering development, analytical lab services and integrated solutions, regulatory expertise, and after-sale technical support. Customers also appreciate the global scope of our manufacturing capability and our ability to produce many products at multiple sites.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Contract-Manufactured Products business operates in very competitive markets for its products. The competition varies from smaller regional companies to large global assembly manufacturers. Given the cost pressures they face, many of our customers look to reduce costs by sourcing from low-cost locations. We seek to differentiate ourselves by leveraging our global capabilities and by employing new technologies such as high-speed automated assembly, insert-molding, multi-shot precision molding, and expertise with multiple-piece closure systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain our own research-scale production facilities and laboratories for developing new products and offer contract engineering design and development services to assist customers with new product development. Our quality control, regulatory and laboratory testing capabilities are used to ensure compliance with applicable manufacturing and regulatory standards for primary and secondary pharmaceutical packaging components and delivery systems.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial development of our new products and services for medical and pharmaceutical applications commonly requires several years. New products that we develop may require separate approval as medical devices, and products that are intended to be used in the packaging and delivery of pharmaceutical products are subject to both customer acceptance of our products and regulatory approval of the customer&#8217;s products following our development period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to pursue innovative strategic platforms in prefillable syringes, injectable containers, advanced injection, and safety and administration systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to seek new innovative opportunities for acquisition, licensing, partnering or development of products, services and technologies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Ca</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">pital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our People</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we employed approximately 9,200 people, excluding contractors and temporary workers, in our operations throughout the world. During 2020, West hired approximately 1,900 new team members and experienced an attrition rate of 15.1%. The following table presents the approximate percentage of our employees by region: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the following table presents the approximate percentage of our employees by business unit: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and Marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digital &amp; Technology (D&amp;T)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; Development</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had the following global gender demographics: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Men</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Women</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Global Employees</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37%</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity and Inclusion</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We actively foster an inclusive and collaborative culture for our team members where different views and perspectives are welcomed and valued. We are convinced that this approach brings forth innovation, learning and growth for our team members on a global basis. The Chief Executive Officer ("CEO") and the executive team members review diversity and inclusion objectives throughout the year to ensure continuous focus and improvement. As of December 31, 2020, three out of the ten members of West's Leadership Team are women, with five out of the ten members being women and/or people of color.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Training, Compliance and Talent Development</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We strongly encourage our team members to engage in continuous learning, and we provide development opportunities and build talent from within. We are proud to offer resources like our tuition reimbursement program and our online learning catalog, with approximately 1,300 courses available. We centrally manage and organize on-the-job training, instructor-led trainings and online trainings in many different languages and topics through our one global Learning Management System, where we tracked approximately 33,500 training completions during 2020 from our team members around the globe. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our team members live the values of our ethical culture. They are responsible for adhering to our core values as they work together to support our mission to improve patient lives. West&#8217;s Code of Business Conduct, available in multiple languages on westpharma.com, provides guidance to our team members on appropriate conduct. Every team member is required to undergo Code of Business Conduct and respect in the workplace training annually. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our focus on talent acquisition, performance management, resource planning and leadership assessment are strongly aligned with our diversity and inclusion strategies. We understand that diversity leads to greater innovation, more opportunities, better access to talent and stronger business performance</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">West is committed to providing fair and competitive compensation and benefits programs to attract, retain and reward high-performing team members at all levels. We offer a comprehensive total rewards program to support the health, financial and home-life needs of our team members. Total Rewards at West are defined as the value of the Compensation and Benefits programs offered to employees, which aim to reflect the value of the job and the contribution of the individual, while linking employees&#8217; performance to business and personal results. Based on country of employment, West may provide health care and retirement savings programs as well as paid time off, flexible work schedules, a Global Employee Assistance Program and an Employee Stock Purchase Program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health, Safety and Wellness </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The health and safety of our team members has always been both a top priority and a cultural value. West's commitment to the safety of our teams starts at the top and is driven throughout our business by every level of management and by every team member across the globe. In 2020, West formed a Health, Safety, and Environment ("HSE") Executive Council consisting of C-suite and executive operations leaders to monitor and guide our HSE process. West&#8217;s global HSE team is also a critical component in leading the safety efforts at our sites. Each manufacturing location has dedicated and trained HSE professionals, responsible for general safety oversight at the site. Our Recordable Injury Rate in 2020 was 0.94 per 100 employees. Our HSE focus can also be seen in our proactive global response to the novel coronavirus ("COVID-19") pandemic which includes training and active screening of employees for COVID-19 illness; enhanced gowning and cleaning protocols at all locations; mask requirements for all employees, vendors and contractors; eliminating all non-critical international and domestic business travel; requiring administrative and support personnel to work-from-home; modifying production operations to facilitate social distancing; and regular communications regarding COVID-19 protocols, precautions and information for both on and off the job use. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.westpharma.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) are available on our website under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - SEC Filings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caption as soon as reasonably practical after we electronically file the material with, or furnish it to, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). These filings are also available to the public over the Internet at the SEC&#8217;s website, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Part II of this Form 10-K, we incorporate by reference certain information from parts of other documents filed with the SEC and from our Proxy Statement for the 2021 Annual Meeting of Shareholders (&#8220;2021 Proxy Statement&#8221;), which will be filed with the SEC within 120 days following the end of our 2020 fiscal year. Our 2021 Proxy Statement will be available on our website on or about March 25, 2021, under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Annual Reports &amp; Proxy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about our corporate governance, including our Corporate Governance Principles and Code of Business Conduct, as well as information about our Directors, Board Committees, Committee Charters, and instructions on how to contact the Board, is available on our website under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Corporate Governance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">heading. We intend to make any required disclosures regarding any amendments of our Code of Business Conduct or waivers granted to any of our directors or executive officers under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Code of Business Conduct </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on our website. Information relating to the West Pharmaceutical Services Dividend Reinvestment Plan is also available on our website under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors - Transfer Agent/Dividend Reinvestment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caption. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on our website does not constitute part of this document.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will provide any of the foregoing information without charge upon written request to our Corporate Secretary, West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_16"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.  RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The statements in this section describe material risks to our business and should be considered carefully. In addition, these statements constitute our cautionary statements under the Private Securities Litigation Reform Act of 1995. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our disclosure and analysis in this Form 10-K contains some forward-looking statements that are based on management&#8217;s beliefs and assumptions, current expectations, estimates and forecasts. We also provide forward-looking statements in other materials we release to the public as well as oral forward-looking statements. Such statements give our current expectations or forecasts of future events. They do not relate strictly to historical or current facts. We have attempted, wherever possible, to identify forward-looking statements by using words such as &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;anticipate&#8221; and other words and phrases of similar meaning. In particular, these include statements relating to future actions, business plans and prospects, new products, future performance or results of current or anticipated products, sales efforts, expenses, interest rates, foreign-exchange rates, economic effects, the outcome of contingencies, such as legal proceedings, and financial results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Many of the factors that will determine our future results are beyond our ability to control or predict. Achievement of future results is subject to known or unknown risks or uncertainties, including, without limitation, the risks set forth below. Therefore, actual results could differ materially from past results and those expressed or implied in any forward-looking statement. You should bear this in mind as you consider forward-looking statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless required by applicable securities law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. We also refer you to further disclosures we make on related subjects in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K to the SEC.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Global and Economic Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Our results of operations and financial condition may be adversely affected by the COVID-19 pandemic and other public health epidemics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations and financial condition may be adversely affected if the progression of the COVID-19 pandemic interferes with our ability, or that of our employees, contractors, suppliers, customers and other business partners, to carry out and deliver on business obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 may have an adverse effect on our operations, supply chains and distribution systems. Known potential impacts are illness in our workforce as well as a reduction in access to raw materials for production and access to transportation of product. There could be other unknown and unforeseeable impacts. These impacts have increased and may continue to increase our expenses, including costs associated with preventive and precautionary measures that we, companies with which we conduct business and governments are taking. Government measures include actions that restrict or prohibit travel, which in turn may impact our operations by limiting our employees&#8217; ability to come to work, or the employees of companies upon which our supply chain depends. The impacts of the pandemic and the aforesaid measures taken by other companies and governments may cause us to experience significant and unpredictable reductions or increases in demand for certain of our products. This is especially possible in the event customers re-prioritize their needs due to the changing environment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to manage these COVID-19 related risks, their ultimate impact on the Company will be determined by factors beyond our knowledge or control, including the duration of COVID-19 and further actions taken to control its spread and mitigate its public health effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unauthorized access to our or our customers&#8217; information and systems could negatively impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systems and networks, as well as those of our customers, suppliers, service providers, and banks, have and may in the future become the target of cyberattacks or information security breaches which, in turn, could result in the unauthorized release and misuse of confidential or proprietary information about our company, our employees or our customers, as well as disrupt our operations or damage our facilities or those of third parties. Additionally, our systems are subject to regulation to preserve the privacy of certain data held on those systems. We maintain an extensive network of technical security controls, policy enforcement mechanisms and monitoring systems, in order to address these threats. While these measures are designed to prevent, detect and respond to unauthorized activity in our systems, certain types of attacks could result in financial or information losses and/or reputational harm. If we cannot comply with regulations or prevent the unauthorized access, release and/or corruption of our or our customers&#8217; confidential, classified or personally identifiable information, our reputation could be damaged, and/or we could face financial losses. We may also be required to incur additional costs to modify or enhance our systems, or to try to prevent or remediate any such attacks. Modifying or enhancing our systems may result in unanticipated or prolonged disruption events, which could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our operating results may be adversely affected by unfavorable economic and market conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current uncertainty in the global economy, including the effects of recession or slow economic growth in the U.S., Europe, and emerging markets in Asia and South America, may negatively affect our operating results. Examples of the effects of these global economic challenges include: our suppliers&#8217; and our customers&#8217; inability to access the credit markets at commercially reasonable rates; reduction in sales due to customers decreasing their inventories in the near-term or long-term or due to liquidity difficulties; reduction in sales due to shortages of materials we purchase from our suppliers; reduction in research and development efforts and expenditures by our customers; our inability to hedge our currency and raw material risks sufficiently or at commercially reasonable prices; insolvency of suppliers or customers; inflationary pressures on our supplies or our products; and increased expenses due to growing global taxation of corporate profits or revenues or changes in, or expirations of, a country&#8217;s tax laws or regulations. Our operating results in one or more geographic regions may also be affected by uncertain or changing economic conditions within that region. If economic and market conditions in the U.S. or Europe, or in emerging markets, weaken further, we may experience material adverse impacts on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in foreign currency exchange rates could have a material adverse effect on our business and/or results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to foreign currency exchange rate fluctuations. Sales outside of the U.S. accounted for 54.6% of our consolidated net sales in 2020 and we anticipate that sales from international operations will continue to represent a significant portion of our total sales in the future. In addition, many of our manufacturing facilities and suppliers are located outside of the U.S. Further, we intend to continue our expansion into emerging and/or faster-growing markets outside of the U.S. in the future. Virtually all of our international sales, assets and related operating costs and expenses are earned, valued or incurred in the currency of the local country, primarily the Euro, the Singapore Dollar (&#8220;SGD&#8221;), and the Danish Krone. In addition, we are exposed to Japanese Yen (&#8220;Yen&#8221;), as we maintain a 49% ownership interest in, and we purchase finished goods and other materials from, Daikyo. We are also exposed to currencies in emerging market countries, such as the Chinese Yuan, the Indian Rupee, the South Korean Won, and various South American currencies. Our consolidated financial statements are presented in USD, and, therefore, we must translate the reported values of our foreign assets, liabilities, revenues, and expenses into USD, which can result in significant fluctuations in the amount of those assets, liabilities, revenues, or expenses. The exchange rates between these foreign currencies and USD in recent years have fluctuated significantly and may continue to do so in the future. Increases or decreases in the value of USD compared to these foreign currencies may negatively affect the value of these items in our consolidated financial statements, which could have a material adverse effect on our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to translation risks, we incur currency transaction risk when we or one of our subsidiaries enters into a purchase or sales transaction in a currency other than that entity&#8217;s local currency. In order to reduce our exposure to fluctuations in certain exchange rates, we have entered, and expect to continue to enter, into hedging arrangements, including the use of financial derivatives. There can be no certainty that we will be able to enter into or maintain hedges of these currency risks, or that our hedges will be effective, which could have a significant effect on our financial condition and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are exposed to credit risk on accounts receivable and certain prepayments made in the normal course of business. This risk is heightened during periods when economic conditions worsen.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial majority of our outstanding trade receivables are not covered by collateral or credit insurance. In addition, we have made prepayments associated with insurance premiums and other advances in the normal course of business. While we have procedures to monitor and limit exposure to credit risk on trade receivables and other current assets, there can be no assurance such procedures will effectively limit our credit risk and avoid losses, which could have a material adverse effect on our financial condition and operating results.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">LIBOR reform may adversely affect our financial condition, results of operations and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our variable-rate debt, which includes our senior unsecured, multi-currency revolving credit facility agreement dated as of March 28, 2019 (the &#8220;Credit Agreement&#8221;), and its accompanying Incremental Facility Amendment dated as of December 30, 2019 (the &#8220;Term Loan&#8221;), currently use the London Interbank Offered Rate ("LIBOR") as a benchmark for establishing the interest rate. LIBOR is the subject of recent national, international and other regulatory guidance and proposals for reform. In July 2017, the U.K. Financial Conduct Authority (the "FCA"), which regulates LIBOR, announced that the FCA will no longer persuade or compel banks to submit rates for the calculation of LIBOR after 2021. Such announcement indicates that the continuation of LIBOR on the current basis cannot and will not be guaranteed after 2021. If the method for calculation of LIBOR changes, if LIBOR is no longer available or if lenders have increased costs due to changes in LIBOR, we may suffer from potential increases in interest rates on our variable-rate debt, which could have a material adverse effect on our financial condition, results of operations and cash flows. Further, we may need to amend our Credit Agreement and Term Loan in connection with the replacement of LIBOR with the new standard that is established. We will continue to monitor the proposals for reform relating to LIBOR.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">No assurance can be given that we will continue to pay or declare dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically paid dividends. However, there can be no assurance that we will pay or declare dividends in the future. The actual declaration and payment of future dividends, the amount of any such dividends, and the establishment of record and payment dates, if any, are subject to determination by our Board of Directors each quarter after its review of our then-current strategy, applicable debt covenants and financial performance and position, among other things. Our declaration and payment of future dividends is subject to risks and uncertainties, including: deterioration of our financial performance or position; inability to declare a dividend in compliance with applicable laws or debt covenants; an increase in our cash needs or decrease in available cash; and the business judgment of the Board of Directors that a declaration of a dividend is not in our best interest.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Industry Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our sales and profitability are largely dependent on the sale of drug products delivered by injection and the packaging of drug products. If the drug products developed by our customers in the future use another delivery system or are reconfigured to require less frequent dosing, our sales and profitability could suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends to a substantial extent on customers&#8217; continued sales and development of products that are delivered by injection. If (i) our customers fail to continue to sell, develop and deploy injectable products; (ii) our customers reconfigure their drug product or develop new drug products requiring less frequent dosing; or (iii) we are unable to develop new products that assist in the delivery of drugs by alternative methods, our sales and profitability may suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to provide comparative value advantages, timely fulfill customer orders, or resist pricing pressure, we will have to reduce our prices, which may reduce our profit margins. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with several companies across our major product lines. Because of the special nature of these products, competition is based primarily on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost-control programs across their operations. Companies often compete on the basis of price. We aim to differentiate ourselves from our competition by being a &#8220;full-service, value-added&#8221; global supplier that is able to provide pre-sale compatibility studies, engineering support, and other services and sophisticated post-sale technical support on a global basis. However, we face continued pricing pressure from our customers and competitors. If we are unable to resist or offset the effects of continued pricing pressure through our value-added services, improved operating efficiencies and reduced expenditures, or if we have to reduce our prices, our sales and profitability may suffer. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation in the pharmaceutical and healthcare industries could adversely affect our future revenues and operating income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pharmaceutical and healthcare industries continue to experience a significant amount of consolidation. As a result of this consolidation, competition to provide goods and services to customers has increased. In addition, group purchasing organizations and integrated health delivery networks have served to concentrate purchasing decisions for some customers, which has placed pricing pressure on suppliers. Further consolidation within the industries we serve could exert additional pressure on the prices of our products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The medical technology industry is very competitive and customer demands and/or new products in the marketplace could cause a reduction in demand. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology industry is subject to rapid technological changes, and we face significant competition across our product lines and in each market in which our products are sold. We face this competition from a wide range of companies, including large medical device companies, some of which have greater financial and marketing resources than we do. We also face competition from firms that are more specialized than we are with respect to particular markets. In some instances, competitors, including pharmaceutical companies, also offer, or are attempting to develop, alternative therapies for diseases that may be delivered via their own, or without, a medical device. The development of new or improved products, processes or technologies by other companies (such as needle-free injection technology) may reduce customer demand for our products or render some of our products or proposed products obsolete or less competitive. In addition, any failure or inability to meet increased customer quality expectations could cause a reduction in demand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Business and Operational Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruption in our manufacturing facilities could have a material adverse effect on our ability to make and sell products and have a negative impact on our reputation, performance or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have manufacturing sites throughout the world. In some instances, however, the manufacturing of certain product lines is concentrated in one or only a few of our plants. The functioning of our manufacturing and distribution assets and systems could be disrupted for reasons either within or beyond our control, including, without limitation: extreme weather or longer-term climatic changes; natural disasters; pandemic; war; accidental damage; disruption to the supply of material or services; product quality and safety issues; systems failure; workforce actions; or environmental matters. There is a risk that incident management systems in place may prove inadequate and that any disruption may materially adversely affect our ability to make and sell products and, therefore, materially adversely affect our reputation, performance or financial condition. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our international sales and operations are subject to risks and uncertainties that vary by country and which could have a material adverse effect on our business and/or results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in most of the major pharmaceutical markets in the world. Our international operations and our ability to implement our overall business strategy (including our plan to continue expanding into emerging and/or faster-growing markets outside of the U.S.) are subject to risks and uncertainties that can vary by country, and include: transportation delays and interruptions; political and economic instability and disruptions, including the United Kingdom&#8217;s withdrawal from the European Union; imposition of duties and tariffs; import and export controls; the risks of divergent business expectations or cultural incompatibility inherent in establishing and maintaining operations in foreign countries; difficulties in staffing and managing multi-national operations; labor strikes and/or disputes; and potentially adverse tax consequences. Limitations on our ability to enforce legal rights and remedies with third parties or our joint venture partners outside of the U.S. could also create exposure. In addition, we may not be able to operate in compliance with foreign laws and regulations, or comply with applicable customs, currency exchange control regulations, transfer pricing regulations or any other laws or regulations to which we may be subject, in the event that these laws or regulations change. Any of these events could have an adverse effect on our international operations in the future by reducing the demand for our products or decreasing the prices at which we can sell our products, or otherwise have an adverse effect on our financial condition, results of operations and cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruptions in the supply of key raw materials could adversely impact our operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally purchase our raw materials and supplies required for the production of our products in the open market. For reasons of quality assurance, sole source availability or cost effectiveness, many components and raw materials are available and/or purchased only from a single supplier. Due to the stringent regulations and requirements of the FDA and other regulatory authorities regarding the manufacture of our products and the availability of such raw materials, we may not be able to quickly establish additional or replacement sources for these components or raw materials or do so without excessive cost. As a result, a reduction or interruption in supply, or an inability to secure alternative sources of raw materials or components, could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw material and energy prices have a significant impact on our profitability. If raw material and/or energy prices increase, and we cannot pass those price increases on to our customers, our profitability and financial condition may suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use three basic raw materials in the manufacture of our products: elastomers (which include synthetic and natural material), aluminum and plastic. In addition, our manufacturing facilities consume a wide variety of energy products to fuel, heat and cool our operations. Supply and demand factors, which are beyond our control, generally affect the price of our raw materials and utility costs. If we are unable to pass along increased raw material prices and energy costs to our customers, our profitability, and thus our financial condition, may be adversely affected. The prices of many of these raw materials and utilities are cyclical and volatile. For example, the prices of certain commodities, particularly petroleum-based raw materials, have in the recent past exhibited rapid changes, affecting the cost of synthetic elastomers and plastic. While we generally attempt to pass along increased costs to our customers in the form of sales price increases, historically there has been a time delay between raw material and/or energy price increases and our ability to increase the prices of our products. In some circumstances, we may not be able to increase the prices of our products due to competitive pressure and other factors.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not timely or successful in new-product innovation or the development and commercialization of proprietary multi-component systems, our future revenues and operating income could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth partly depends on new-product innovation and the development and commercialization of proprietary multi-component systems for injectable drug administration and other healthcare applications. Product development and commercialization is inherently uncertain and is subject to a number of factors outside of our control, including any necessary regulatory approvals and commercial acceptance for the products. The ultimate timing and successful commercialization of new products and systems requires substantial evaluations of the functional, operational, clinical, and economic viability of our products. In addition, the timely and adequate availability of filling capacity is essential to both conducting definitive stability trials and the timing of commercialization of customers&#8217; products in Crystal Zenith vials, syringes and cartridges. Delays, interruptions or failures in developing and commercializing new-product innovations or proprietary multi-component systems could adversely affect future revenues and operating income. In addition, adverse conditions may also result in future charges to recognize impairment in the carrying value of our goodwill and other intangible assets, which could have a material adverse effect on our financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not succeed in finding and completing acquisitions or other strategic transactions, which could have an adverse effect on our business and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically engaged in acquisition activity, and we may in the future engage in acquisitions or other strategic transactions, such as joint ventures or investments in other entities. We may be unable to identify suitable targets, opportunistic or otherwise, for acquisitions or other strategic transactions in the future. If we identify a suitable candidate, our ability to successfully implement the strategic transaction would depend on a variety of factors, including our ability to obtain financing on acceptable terms and to comply with the restrictions contained in our debt agreements. Strategic transactions involve risks, including those associated with integrating the operations or maintaining the operations as separate (as applicable), financial reporting, disparate technologies, and personnel of acquired companies, joint ventures or related companies; managing geographically dispersed operations or other strategic investments; the diversion of management&#8217;s attention from other business concerns; the inherent risks in entering markets or lines of business in which we have either limited or no direct experience; the potential loss of key employees, customers and strategic partners of acquired companies, joint ventures or companies in which we may make strategic investments; and potentially other unknown risks. We may not successfully integrate any businesses or technologies we may acquire or strategically develop in the future and may not achieve anticipated revenue and cost benefits relating to any such strategic transactions. Strategic transactions may be expensive, time consuming and may strain our resources. Strategic transactions may not be accretive to our earnings and may negatively impact our results of operations as a result of, among other things, the incurrence of debt, one-time write-offs of goodwill, additional carrying costs of patent or trademark portfolios, and amortization expenses of other intangible assets. In addition, strategic transactions that we may pursue could result in dilutive issuances of equity securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product defects could adversely affect the results of our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design, manufacture and marketing of pharmaceutical packaging and medical devices involve certain inherent risks. Manufacturing or design defects, unanticipated use of our products, or inadequate disclosure of risks relating to the use of our products can lead to injury or other adverse events. These events could lead to recalls or safety alerts relating to our products (either voluntary or required by the FDA or similar governmental authorities in other countries), and could result, in certain cases, in the removal of a product from the market. A recall could result in significant costs, as well as negative publicity and damage to our reputation that could reduce demand for our products. Personal injuries relating to the use of our products can also result in product liability claims being brought against us. In some circumstances, such adverse events could also cause delays in new product approvals. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_94">Revenue</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the discussion of the voluntary recall of our Vial2Bag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product line.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A loss of key personnel or highly skilled employees could disrupt our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends, in large part, on our ability to retain key employees, including our executive officers and individuals in technical, marketing, sales, and research positions. Competition for experienced employees, particularly for persons with specialized skills, can be intense. Our ability to recruit such talent will depend on a number of factors, including compensation and benefits, work location and work environment. If we cannot effectively recruit and retain qualified executives and employees, our business could be adversely affected. Although we believe that we will be able to attract and retain talented personnel and replace key personnel should the need arise, our inability to do so on a timely basis could disrupt the operations of the unit affected or our overall operations. In addition, because of the complex nature of many of our products and programs, we are generally dependent on an educated and highly skilled engineering staff and workforce. Our operations could be disrupted by a shortage of available skilled employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Our results of operations and earnings may not meet guidance or expectations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide public guidance on our expected results of operations for future periods. This guidance is comprised of forward-looking statements subject to risks and uncertainties, including the risks and uncertainties described in this Form 10-K and in our other public filings and public statements, and is based on assumptions we make at the time we provide such guidance. Our guidance may not always be accurate. If, in the future, our results of operations for a particular period do not meet our guidance or the expectations of investment analysts, or if we reduce our guidance for future periods, the market price of our common stock could decline significantly. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with our obligations under our distributorship or license agreements with Daikyo or the agreements are terminated early or not renewed, we could lose license rights and access to certain product and technology that are important to our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key value-added and proprietary products and processes are licensed from our affiliate, Daikyo, including but not limited to, Crystal Zenith, FluroTec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and B2-coating technologies. Our rights to these products and processes are licensed pursuant to agreements that expire in 2027. However, if the agreements are terminated early or not renewed, our business could be adversely impacted. Please refer to Note 7, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_109">Affiliated Companies</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information relating to the increase in our ownership interest in Daikyo in 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Legal and Regulatory Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to regulation by governments around the world, and if these regulations are not complied with, existing and future operations may be curtailed, and we could be subject to liability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design, development, manufacturing, marketing and labeling of certain of our products and our customers&#8217; products that incorporate our products are subject to regulation by governmental authorities in the U.S., Europe and other countries, including the FDA, the European Medicines Agency and the National Medical Products Administration (China). Complying with governmental regulation can be costly and can result in required modification or withdrawal of existing products and a substantial delay in the introduction of new products. Failure to comply with applicable regulatory requirements or failure to obtain regulatory approval for a new product could result in expenses and actions that could adversely affect our business and financial performance. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products that incorporate our technologies and medical devices that we produce are subject to regulations and extensive approval or clearance processes, which make the timing and success of new-product commercialization difficult to predict.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining and maintaining FDA and other required regulatory approvals is expensive and time-consuming. Historically, most medical devices that incorporate our technologies and medical devices that we produce have been subject to the FDA&#8217;s 510(k) marketing approval process, which typically lasts from six to nine months. Supplemental or full pre-market approval reviews require a significantly longer period, delaying commercialization. Changes in regulation on a global scale must be monitored and actions taken to ensure ongoing compliance. Pharmaceutical products that incorporate our technologies and medical devices that we produce are subject to the FDA&#8217;s New Drug Application process, which typically takes a number of years to complete. Additionally, biotechnology products that incorporate our technologies and medical devices that we produce are subject to the FDA&#8217;s Biologics License Application process, which also typically takes a number of years to complete. Outside of the U.S., sales of medical devices and pharmaceutical or biotechnology products are subject to international regulatory requirements that vary from country to country. The time required to obtain approval for sale internationally may be longer or shorter than that required for FDA approval. There is no certainty that any regulatory approval may be obtained or maintained indefinitely, and our ability to launch products to the market and maintain market presence is not guaranteed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in the regulation of drug products and devices may increase competitive pressure and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An effect of the governmental regulation of our medical devices and our customers&#8217; drug products, devices, and manufacturing processes is that compliance with regulations makes it difficult to change components and devices produced by one supplier with those from another supplier, due to the large amount of data and information that customers must generate to demonstrate that the components and devices are equivalent and pose no additional risk to the patient. The regulation of our medical devices and our customers&#8217; products that incorporate our components and devices has increased over time. If the applicable regulations were to be modified in a way that reduced the level of data and information needed to prove equivalency for a change from one supplier&#8217;s components or devices to those made by another, it is likely that the competitive pressure would increase and adversely affect our sales and profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not successful in protecting our intellectual property rights, our ability to compete may be affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patents, trademarks and other intellectual property are important to our business. We rely on patent, trademark, copyright, trade secret, and other intellectual property laws, as well as nondisclosure and confidentiality agreements and other methods, to protect our proprietary products, information, technologies and processes. We also have obligations with respect to the non-use and non-disclosure of third-party intellectual property. We may need to engage in litigation or similar activities to enforce our intellectual property rights, to protect our trade secrets or to determine the validity and scope of proprietary rights of others. Any such litigation could require us to expend significant resources and divert the efforts and attention of our management and other personnel from our business operations. There can be no assurance that the steps we will take to prevent misappropriation, infringement or other violation of our intellectual property or the intellectual property of others will be successful. In addition, effective patent, trademark, copyright, and trade secret protection may be unavailable or limited for some of our proprietary products in some countries. Failure to protect our intellectual property or successfully invalidate or defend against intellectual property protections of third parties could harm our business and results of operations. In addition, if relevant and effective patent protection is not available or has expired, we may not be able to prevent competitors from independently developing products and services similar or duplicative to ours. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant developments in U.S. policies could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in U.S. social, political, regulatory, and economic conditions, or in laws and policies governing foreign trade, manufacturing, development, immigration, and investment, could have an adverse effect on our financial condition, results of operations and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Our operations must comply with environmental statutes and regulations, and any failure to comply could result in extensive costs which would harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture of some of our products has involved, and may continue to involve, the use, transportation, storage, and disposal of hazardous or toxic materials and is subject to various environmental protection and occupational health and safety laws and regulations in the countries in which we operate. This has exposed us in the past, and could expose us in the future, to risks of accidental contamination and events of non-compliance with environmental laws. Any such occurrences could result in regulatory enforcement or personal injury and property damage claims or could lead to a shutdown of some of our operations, which could have an adverse effect on our business and results of operations. We currently incur costs to comply with environmental laws and regulations and these costs may become more significant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthcare reform may adversely affect our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the U.S. or international healthcare systems could result in reduced demand for our products, as our sales depend, in part, on the extent to which pharmaceutical companies and healthcare providers and facilities are reimbursed by government authorities, private insurers and other third-party payers for the costs of our products. The coverage policies and reimbursement levels of third-party payers, which can vary among public and private sources, may affect which products customers purchase and the prices they are willing to pay for these products in a particular jurisdiction. Legislative or administrative reforms to reimbursement systems in the U.S. or abroad (for example, those under consideration in France, Germany, Italy and the United Kingdom) could significantly reduce reimbursement for our customers&#8217; products, which could in turn reduce the demand for our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, in the coming years, additional changes could be made to global governmental healthcare programs that could significantly impact the success of our products. We will continue to evaluate healthcare reform, as well as trends and changes that may be encouraged by healthcare legislation globally and that may potentially impact our business over time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The uncertain effects of climate change and potential climate change legislation could lead to business interruption, significantly increased costs and/or other adverse consequences to our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Climate change and potential climate change legislation may present risks to our operations, including business interruption, significantly increased costs and/or other adverse consequences to our business. Some of the potential impacts of climate change to our business include physical risks to our facilities, water and energy supply limitations or interruptions, disruptions to our supply chain and impairment of other resources. In addition, if legislation or regulations are enacted or promulgated in the U.S., Europe or Asia or any other jurisdictions in which we do business that limit or reduce allowable greenhouse gas emissions and other emissions, such restrictions could have a significant effect on our operating and financial decisions, including those involving capital expenditures to reduce emissions, and our results of operations. Our manufacturing operations may not be able to operate as planned if we are not able to comply with new legal and regulatory legislation around climate change, or it may become too costly to operate in a profitable manner. Additionally, suppliers&#8217; added expenses could be passed on to us in the form of higher prices and we may not be able to pass on such expenses to our customers through price increases. </span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM IB.  UNRESOLVED STAFF COMMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the filing of this Form 10-K, there were no unresolved comments from the Staff of the SEC.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.  PROPERTIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located at 530 Herman O. West Drive, Exton, Pennsylvania.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our facilities by segment and geographic region. All facilities shown are owned except where otherwise noted.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Type of Facility/ Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Manufacturing:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States of America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix, AZ (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scottsdale, AZ (1) (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tempe, AZ (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Petersburg, FL (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Rapids, MI </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kinston, NC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kearney, NE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jersey Shore, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Williamsport, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products and Contract Manufactured Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">South America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 1.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sao Paulo</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 1.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Horsens</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Austell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Le Nouvion</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Le Vaudreuil</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eschweiler (1) (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stolberg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waterford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Manufactured Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kovin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qingpu</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sri City</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jurong (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mold-and-Die Tool Shop: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States of America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upper Darby, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Type of Facility/ Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Segment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bodmin (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Analytical Laboratory:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States of America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exton, PA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Technology Center:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bangalore (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products, Contract Manufactured Products</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This manufacturing facility is also used for research and development activities.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This facility is leased in whole or in part.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Proprietary Products reportable segment leases facilities located in Scottsdale, AZ, Germany, and Israel for research and development, as well as other activities. Sales offices in various locations are leased under contractual arrangements.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_25"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.  LEGAL PROCEEDINGS </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.  MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The executive officers of the Company are set forth in this table. Generally, executive officers are elected by the Board of Directors annually at the regular meeting of the Board of Directors following the Annual Meeting of Shareholders. Additionally, executive officers may be elected upon hire or due to a promotion.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Position</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silji Abraham</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technology Officer since December 2020. Senior Vice President, Chief Digital and Transformation Officer from February 2018 to December 2020. Prior to joining West, he most recently served as Executive Vice President and Chief Information Officer of MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt, Germany. Prior to this role, he served as Chief Information Officer at Sigma-Aldrich Corporation, a leading life science and technology company, and worked in various leadership roles at Invensys Operations Management, ArvinMeritor and Chrysler Group.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Birkett</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer since June 2018. In addition, Treasurer from June 2018 to December 2019 and Principal Accounting Officer from October 2019 to April 2020. Prior to joining West, he spent more than 20 years at Merit Medical Systems, Inc., a leading manufacturer of disposable medical devices, where he served in a number of senior global leadership roles, including Chief Financial Officer and Treasurer, Controller for Europe, Middle East and Africa (EMEA) and Vice President of International Finance.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annette F. Favorite</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Human Resources Officer since October 2015. Prior to joining West, she spent more than 25 years at IBM Corporation, an information technology services company, in a number of strategic and global human resources roles, including Vice President, Global Talent Management, Vice President of Human Resources for Worldwide Software Sales, and Human Resources Leader for the company&#8217;s Southwest European Region, based out of Spain.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric M. Green</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer since April 2015 and President since December 2015. Prior to joining West, he was Executive Vice President and President of the Research Markets business unit at Sigma-Aldrich Corporation from 2013 to 2015. From 2009 to 2013, he served as Vice President and Managing Director, International, where he was responsible for Asia Pacific and Latin America, and prior thereto, held various commercial and operational roles.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quintin J. Lai</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Development, Strategy and Investor Relations since January 2016. Prior to joining West, he was Vice President of Investor Relations and Corporate Strategy at Sigma-Aldrich Corporation from 2012 to 2015. From 2002 to 2012, he was at Robert W. Baird &amp; Company, where he held various roles, including Managing Director and Senior Equity Research Analyst of the Life Science Tools and Diagnostic sector and Associate Director of Equity Research. </span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kimberly Banks MacKay</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel and Corporate Secretary since December 2020. Prior to joining West, from April 2019 to November 2020, she served as Senior Vice President, General Counsel and Corporate Secretary at the Segal Group in New York, a privately held firm specializing in employee benefits and investment consulting. Prior to Segal, she served for over 15 years in a variety of Legal leadership roles for Novartis, a global healthcare company, including Head of U.S. Legal for Novartis Business Service. </span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David A. Montecalvo</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Operations and Supply Chain Officer since February 2019. Senior Vice President, Global Operations and Supply Chain from September 2016 until February 2019. Prior to joining West, he served in a number of senior leadership roles at Medtronic plc, a medical device company, including Vice President, Contract Manufacturing Operations, for the company&#8217;s Restorative Therapies Group, Vice President, Business Operations Integration, where he was responsible for directing and leading the global operations integration of Covidien plc into Medtronic, and Vice President, Product Development and Operations for Medtronic Cardiovascular. Prior thereto, he held senior operations and product development roles at Urologix, Inc. and LecTec Corporation.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chad R. Winters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer and Corporate Controller since May 2020. Vice President and Corporate Controller since October 2019. Prior to joining West, he served as Senior Vice President of Finance &amp; Accounting and Controller of Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company. Prior to Amneal, he held roles of increasing responsibility at the Chemours Company, UGI Corporation, and PricewaterhouseCoopers LLP. </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_34"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;WST.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;27, 2021, we had 718 shareholders of record, which excludes beneficial owners whose shares were held by brokerage firms, depositaries and other institutional firms in &#8220;street names&#8221; for their customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock paid a quarterly dividend of $0.15 per share in each of the first three quarters of 2019; $0.16 per share in the fourth quarter of 2019 and each of the first three quarters of 2020; and $0.17 per share in the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. During the year ended December 31, 2020, we purchased 761,500 shares of our common stock under the now completed program at a cost of $115.5&#160;million, or an average price of $151.65 per share. During the three months ended December&#160;31, 2020, there were no purchases of our common stock made by us or any of our &#8220;affiliated purchasers&#8221; as defined in Rule 10b-18(a)(3) under the Exchange Act. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we announced a share repurchase program for calendar-year 2021 authorizing the repurchase of up to 631,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2021.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following performance graph compares the cumulative total return to holders of our common stock with the cumulative total return of the following Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) indices, for the five years ended December 31, 2020: 500, 500 Health Care Index, and MidCap 400 Index. The performance graph does not necessarily reflect management's opinion that such indices are an appropriate measure of the relative performance of the stock involved, and is not intended to forecast or be indicative of possible future performance of the Company&#8217;s common stock. Due to the increase in our market capitalization, we have decided to replace the S&amp;P MidCap 400 Index with the S&amp;P 500 Health Care Index for comparison purposes, which will be used going forward.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative total return to shareholders is measured by dividing total dividends (assuming dividend reinvestment) plus the per-share price change for the period by the share price at the beginning of the period. The Company&#8217;s cumulative shareholder return is based on an investment of $100 on December 31, 2015 and is compared to the cumulative total return of the S&amp;P indices mentioned above over the period with a like amount invested.</span></div><div style="text-align:center"><img src="wst-20201231_g1.jpg" alt="wst-20201231_g1.jpg" style="height:400px;margin-bottom:5pt;vertical-align:text-bottom;width:400px"/></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.  SELECTED FINANCIAL DATA</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIVE-YEAR SUMMARY</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUMMARY OF OPERATIONS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales (1)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,717.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,599.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,509.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating profit &#8224;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic (2)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted (3)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">YEAR-END FINANCIAL POSITION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">439.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">610.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">400.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,978.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,862.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,716.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total invested capital:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,854.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,573.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,117.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total invested capital</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,109.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,830.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,592.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,476.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,346.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PERFORMANCE MEASUREMENTS (4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross margin (a)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating profitability (b) &#8224;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate (5)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return on invested capital (c) &#8224;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net debt-to-total invested capital (d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">367.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock price range</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$305-124.53</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$152.12-93.08</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.09-82.74</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$103.36-77.97</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$86.50-53.88</span></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Results for reporting periods beginning after January 1, 2018 are presented under Accounting Standards Codification ("ASC") 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards in effect for those periods.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Based on weighted average common shares outstanding.</span></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Based on weighted average shares, assuming dilution.</span></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) Performance measurements represent indicators commonly used in the financial community. Certain of the following performance measures are not in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are included as management uses them in evaluating our results of operations and believes that this information provides users with a valuable insight into our overall performance and financial position.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Net sales minus cost of goods and services sold, including applicable depreciation and amortization, divided by net sales.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Operating profit divided by net sales.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Operating profit multiplied by one minus the effective tax rate divided by average total invested capital. </span></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Net debt (total debt less cash and cash equivalents) divided by total invested capital less cash and cash equivalents.</span></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) As a result of the Tax Cuts and Jobs Act (the &#8220;2017 Tax Act&#8221;), the federal statutory rate was reduced from 35.0% to 21.0% effective for tax years beginning after December 31, 2017. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_157">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion of the 2017 Tax Act.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;   Reflects our adoption of the guidance issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) regarding the presentation of net periodic pension and postretirement benefit cost (net benefit cost).</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion is intended to further the reader&#8217;s understanding of the consolidated financial condition and results of operations of our Company. It should be read in conjunction with our consolidated financial statements and the accompanying footnotes included in Part II, Item 8 of this Form 10-K. These historical financial statements may not be indicative of our future performance. This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks discussed in Part I, Item 1A of this Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-U.S. GAAP Financial Measures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of aiding the comparison of our year-over-year results, we may refer to net sales and other financial results excluding the effects of changes in foreign currency exchange rates. Organic net sales exclude the impact from acquisitions and/or divestitures and translate the current-period reported sales of subsidiaries whose functional currency is other than USD at the applicable foreign exchange rates in effect during the comparable prior-year period. We may also refer to adjusted consolidated operating profit and adjusted consolidated operating profit margin, which exclude the effects of unallocated items. The unallocated items are not representative of ongoing operations, and generally include restructuring and related charges, certain asset impairments, and other specifically-identified income or expense items. The re-measured results excluding effects from currency translation, the impact from acquisitions and/or divestitures, and excluding the effects of unallocated items are not in conformity with U.S. GAAP and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are incorporated in our discussion and analysis as management uses them in evaluating our results of operations and believes that this information provides users with a valuable insight into our overall performance and financial position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and additional medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. We also maintain collaborations to share technologies and market products with affiliates in Japan and Mexico.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020 Financial Performance Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following tables present a reconciliation from U.S. GAAP to non-U.S. GAAP financial measures: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020 GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020 adjusted amounts (non-U.S. GAAP)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During 2020, we recorded a tax benefit of $20.8&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019 GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on restructuring-related sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Recovery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax law Changes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019 adjusted amounts (non-U.S. GAAP)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During 2019, we recorded a tax benefit of $10.3&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2018 GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on restructuring-related sale of assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax law Changes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2018 adjusted amounts (non-U.S. GAAP)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.81&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During 2018, we recorded a tax benefit of $14.3&#160;million associated with stock-based compensation.  </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)  The Company recorded a pension settlement charge within other nonoperating (income) expense, as it determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plan exceeded the threshold for settlement accounting.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)  The Company recorded $0.6&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. Additionally, the company recorded $3.1&#160;million of amortization expense in association with an acquisition of increased ownership interest in Daikyo.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)  The Company recorded a net tax recovery related to previously-paid international excise taxes, following a favorable court ruling.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)  The Company recorded a net tax benefit in December&#160;31, 2019 and December&#160;31, 2018 of $0.3 million and $2.5&#160;million, respectively, due to the impact of federal law changes enacted during the respective years. </span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_46"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items for which further information can be found above in the reconciliation from U.S. GAAP to non-U.S. GAAP financial measures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Percentages in the following tables and throughout this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section may reflect rounding adjustments.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales, consolidated and by reportable segment:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:35.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020/2019</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019/2018</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales increased by $307.0 million, or 16.7%, in 2020, including a favorable foreign currency translation impact of $5.7 million. Excluding foreign currency translation effects, as well as incremental sales of $1.2 million from the acquisition of our distributor in South Korea in 2019, consolidated net sales increased by $300.1 million, or 16.3%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products net sales increased by $250.0 million, or 17.9%, in 2020, including a favorable foreign currency translation impact of $2.2 million. Excluding foreign currency translation effects, as well as $1.2 million of incremental sales in 2020 from the acquisition of our distributor in South Korea in 2019, net sales increased by $246.6 million, or 17.6%, primarily due to growth in our high-value product offerings, including our FluroTec-coated components, Westar&#174; components, Daikyo&#174; and NovaPure&#174; components, Daikyo Crystal Zenith&#174; products, and our self-injection delivery platforms, all of which included approximately $99 million in COVID-19 related activity for vaccines, antiviral treatments and treatment of underlying COVID-19 symptoms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Contract-Manufactured Products net sales increased by $57.1 million, or 12.9%, in 2020, including a favorable foreign currency translation impact of $3.5 million. Excluding foreign currency translation effects, net sales increased by $53.5 million, or 12.1%, due to an increase in the sale of healthcare-related injection and diagnostic devices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales increased by $122.5 million, or 7.1%, in 2019, including an unfavorable foreign currency translation impact of $52.2&#160;million. Excluding foreign currency translation effects, as well as incremental sales of $3.3&#160;million from the acquisition of our distributor in South Korea in 2019, consolidated net sales increased by $171.4 million or 10.0%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Proprietary Products net sales increased by $90.0 million, or 6.9%, in 2019, including an unfavorable foreign currency translation impact of $43.1&#160;million. Excluding foreign currency translation effects, as well as incremental sales of $3.3&#160;million from the acquisition of our distributor in South Korea in 2019, net sales increased by $129.8&#160;million, or 9.9%, primarily due to growth in our high-value product offerings, including our Daikyo components, our ready-to-use seals, stoppers, and plungers, our NovaPure&#174; components and Crystal Zenith products, and our self-injection systems and FluroTec-coated components.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Contract-Manufactured Products net sales increased by $32.4 million, or 7.9%, in 2019, including an unfavorable foreign currency translation impact of $9.1&#160;million. Excluding foreign currency translation effects, net sales increased by $41.5&#160;million, or 10.1%, due to an increase in the sale of healthcare-related injection and diagnostic devices. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents gross profit and related gross margins, consolidated and by reportable segment:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020/2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated gross profit increased by $162.1 million, or 26.8%, in 2020, including a favorable foreign currency translation impact of $1.0 million. Consolidated gross profit margin increased by 2.9 margin points in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Proprietary Products gross profit increased by $141.8 million, or 26.2%, in 2020, including a favorable foreign currency translation impact of $0.3 million. Proprietary Products gross profit margin increased by 2.8 margin points in 2020, due to a favorable mix of products sold, production efficiencies, and sales price increases, partially offset by increased overhead costs including compensation costs and COVID-19 related expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products gross profit increased by $20.1 million, or 30.7%, in 2020, including a favorable foreign currency translation impact of $0.7 million. Contract-Manufactured Products gross profit margin increased by 2.4 margin points in 2020, due to a favorable mix of products sold and production efficiencies, partially offset by increased overhead costs including compensation costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated gross profit increased by $60.3 million, or 11.1%, in 2019, including an unfavorable foreign currency translation impact of $15.7 million. Consolidated gross profit margin increased by 1.1 margin points in 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Proprietary Products gross profit increased by $55.0 million, or 11.3%, in 2019, including an unfavorable foreign currency translation impact of $14.3 million. Proprietary Products gross profit margin increased by 1.5 margin points in 2019, due to a favorable mix of products sold, production efficiencies, and sales price increases, partially offset by increased overhead costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Contract-Manufactured Products gross profit increased by $5.5 million, or 9.2%, in 2019, including an unfavorable foreign currency translation impact of $1.4&#160;million. Contract-Manufactured Products gross profit margin increased by 0.1 margin points in 2019, due to production efficiencies and lower material costs, partially offset by increased overhead costs and an unfavorable mix of products sold. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents consolidated R&amp;D costs:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020/2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019/2018</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated R&amp;D costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated R&amp;D costs increased by $8.0 million, or 20.6%, in 2020, as compared to 2019. Efforts remain focused on the continued investment in self-injection systems development, fluid transfer admixture devices, elastomeric packaging components, and formulation development. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated R&amp;D costs decreased by $1.4 million, or 3.5%, in 2019, primarily due to an increase in customer-funded R&amp;D projects via customer development agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the R&amp;D costs incurred during 2020, 2019 and 2018 related to Proprietary Products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative (&#8220;SG&amp;A&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents SG&amp;A costs, consolidated and by reportable segment and corporate and unallocated items:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020/2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated SG&amp;A costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">SG&amp;A as a % of net sales</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated SG&amp;A costs increased by $29.3 million, or 10.7%, in 2020 with no foreign currency translation impact.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products SG&amp;A costs increased by $7.6 million, or 4.0%, in 2020, primarily due to an increase in compensation costs, partially offset by a reduction in travel expenses and incremental costs incurred in 2019 associated with our voluntary recall. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products SG&amp;A costs decreased by $0.7 million, or 4.3%, in 2020, due to a reduction in travel expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated items &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate SG&amp;A costs increased by $22.4 million, or 33.6%, in 2020, primarily due to increases in stock-based compensation costs, incentive compensation costs and an increase in consulting service costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated SG&amp;A costs increased by $9.8 million, or 3.7%, in 2019, including the impact of foreign currency translation, which decreased SG&amp;A costs by $0.3 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products SG&amp;A costs increased by $4.9 million, or 2.6%, in 2019, primarily due to an increase in compensation costs, incremental costs associated with our voluntary recall and the acquisition of our distributor in South Korea in 2019, partially offset by ongoing cost control measures. Foreign currency translation decreased Proprietary Products SG&amp;A costs by $0.3 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products SG&amp;A costs decreased by $0.3 million, or 1.8%, in 2019, due to ongoing cost control measures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated items &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate SG&amp;A costs increased by $5.2 million, or 8.5%, in 2019, primarily due to increases in stock-based compensation costs and incentive compensation costs, partially offset by a decrease in U.S. pension costs due to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting) and ongoing cost control measures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Expense (Income)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents other expense and income items, consolidated and by reportable segment and corporate and unallocated items:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:61.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense (Income)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated other expense (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense and income items, consisting of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, development and licensing income, contingent consideration, and miscellaneous income and charges, are generally recorded within segment results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated other expense (income) changed by $14.5 million in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products other expense (income) changed by $5.3 million in 2020, primarily due to an increase in the fixed asset impairments recorded, partially offset by a decrease in the SmartDose contingent consideration charge. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_133">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of this item.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Contract-Manufactured Products other expense (income) changed by $1.3 million in 2020 as compared to 2019, primarily due to an increase in foreign exchange transaction losses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated items &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and unallocated items changed by $7.9 million in 2020. During 2020, we recorded $4.6&#160;million in restructuring and related charges and a $2.5&#160;million impairment charge related to a cost investment. We expect that our 2020 restructuring plan will provide annualized savings </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the range of $3.5&#160;million to $4.5&#160;million. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, offsetting the $4.9&#160;million restructuring and related charge and $1.0&#160;million charge as a result of the continued devaluation of Argentina&#8217;s currency, the Company recorded a $1.9&#160;million gain on the sale of fixed assets as a result of our 2018 restructuring plan and recognized a tax recovery of $4.7 million related to previously-paid international excise taxes, following a favorable court ruling. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated other expense (income) changed by $4.4 million in 2019.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products other expense (income) decreased by $4.3 million in 2019, primarily due to increased contingent consideration costs. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_133">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of this item.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Contract-Manufactured Products other expense (income) changed by $1.0 million in 2019, primarily due to a decrease in gains on the sale of fixed assets during 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated items &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and unallocated items changed by $9.7 million in 2019. During 2019, we recorded $4.9&#160;million in restructuring and related charges, a $1.9&#160;million gain on the sale of fixed assets as a result of our restructuring plan, and a charge of $1.0&#160;million as a result of the continued devaluation of Argentina&#8217;s currency. In addition, during 2019, we recognized a tax recovery of $4.7 million related to previously-paid international excise taxes, following a favorable court ruling. Please refer to Note 16, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_151">Other Expense (Income)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of these items.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Profit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents operating profit and adjusted operating profit, consolidated and by reportable segment, corporate and unallocated items:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020/2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted consolidated operating profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted consolidated operating profit margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating profit margin</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating profit increased by $110.3 million, or 37.2%, in 2020, including a favorable foreign currency translation impact of $0.8 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Proprietary Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Proprietary Products operating profit increased by $120.9 million, or 38.6%, in 2020, including a favorable foreign currency translation impact of $0.2 million, due to the factors described above, most notably the sales increase in our high-value product offerings, inclusive of COVID-19 related activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Contract-Manufactured Products operating profit increased by $19.5 million, or 39.7%, in 2020, including a favorable foreign currency translation impact of $0.6 million, due to the factors described above, most notably the sales increase in our products with a more favorable gross profit margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Corporate costs increased by $19.8 million, or 29.9%, in 2020, which decreased operating profit, due to the factors described above most notably an increase in stock-based compensation costs and incentive compensation costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unallocated items &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to the 2020 Financial Performance Summary section above and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense (Income) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section for details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the unallocated items, our adjusted consolidated operating profit margin increased by 3.3 margin points in 2020.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating profit increased by $56.3 million, or 23.4%, in 2019, including a favorable foreign currency translation impact of $0.6 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Proprietary Products operating profit increased by $47.2 million, or 17.7%, in 2019, including a favorable foreign currency translation impact of $0.6&#160;million, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Contract-Manufactured Products operating profit increased by $4.8 million, or 10.8%, in 2019, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate costs increased by $5.0 million, or 8.2%, in 2019, which decreased operating profit, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unallocated items &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense (Income) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section for details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the unallocated items, our adjusted consolidated operating profit margin increased by 1.6 margin points in 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents interest expense, net, by significant component:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020/2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, increased by $2.1 million, or 44.7%, in 2020, due to a decrease in interest income in 2020 resulting from lower interest rates compared to the prior year, partially offset by an increase in capitalized interest due to an increase in capital expenditures in 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, decreased by $1.6 million, or 25.4%, in 2019, due to an increase in interest income in 2019 resulting from higher interest rates on our deposit accounts and higher average cash and cash equivalents balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Nonoperating (Income) Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other nonoperating (income) expense changed by $1.3&#160;million in 2020, primarily due to a decrease in the interest cost component of our net periodic benefit expense, partially offset by an increase in pension settlement charges. A pension settlement charge of $3.7 million was recorded in 2020, as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other nonoperating (income) expense changed by $6.8 million in 2019, primarily due to a decrease in the expected return on pension plan assets and a pension settlement charge of $3.5&#160;million recorded in 2019, as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $72.5 million, $59.0 million, and $41.4 million for the years 2020, 2019, and 2018, respectively, and the effective tax rate was 18.1%, 20.2%, and 17.2%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we recorded a tax benefit of $20.8&#160;million associated with stock-based compensation, an increase from the tax benefit of $10.3 million associated with stock-based compensation in 2019, and incurred less tax on international operations versus the prior year, which both contributed to the effective tax rate decline from 20.2% in 2019 to 18.1% in 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recorded a net tax benefit of $0.3 million due to the impact of federal law changes enacted during the year, as well as a tax benefit of $10.3 million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, we recorded a net tax benefit of $2.5 million for the estimated impact of the 2017 Tax Act and a tax benefit of $14.3 million associated with stock-based compensation. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_157">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of the 2017 Tax Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_157">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our income taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity in Net Income of Affiliated Companies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in net income of affiliated companies represents the contribution to earnings from our 25% ownership interest in Daikyo, which increased to 49% during the fourth quarter of 2019, and our 49% ownership interest in five companies majority-owned by a long-time partner located in Mexico. Please refer to Note 7, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_109">Affiliated Companies</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion. Equity in net income of affiliated companies was $17.4 million, $8.9 million, and $7.6 million for the years 2020, 2019, and 2018, respectively. Equity in net income of affiliated companies increased by $8.5 million, or 95.5%, in 2020, primarily due to favorable operating results at Daikyo and the Mexico affiliates and increase in ownership of Daikyo starting in the fourth quarter of 2019. Equity in net income of affiliated companies increased by $1.3 million, or 17.1%, in 2019, primarily due to favorable operating results at Daikyo.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flow data for the years ended December&#160;31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:61.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Provided by Operating Activities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities increased by $105.3 million in 2020, primarily due to improved operating results and changes in assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities increased by $78.6&#160;million in 2019, primarily due to improved operating results and changes in assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Used in Investing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities decreased by $48.5 million in 2020, primarily due to 2019 investing activities that did not recur in 2020, such as our increase in Daikyo ownership and the acquisition of our South Korea distributor in 2019. These reductions in investing activities were offset in 2020 by an increase in capital expenditures to support our increased customer demands. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities increased by $127.2&#160;million in 2019, primarily due to the increase in our ownership interest in Daikyo, an increase in capital expenditures, and the acquisition of our distributor in South Korea in 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Used in Financing Activities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2020 compared to 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities increased by $100.3 million in 2020, primarily due an increase in purchases under our share repurchases program and given 2019 included new long-term borrowings while no such new borrowings occurred in 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2019 compared to 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities decreased by $43.9&#160;million in 2019, primarily due to borrowings of $90.0 million under our Term Loan, partially offset by net repayments of our outstanding long-term borrowings under our Credit Facility and increases in purchases under our share repurchases programs and dividend payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents selected liquidity and capital measures as of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:69.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working Capital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include all instruments that have maturities of ninety days or less when purchased. Working capital is defined as current assets less current liabilities.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our cash and cash equivalents balance at December&#160;31, 2020 consisted of cash held in depository accounts with banks around the world and cash invested in high-quality, short-term investments. The cash and cash equivalents balance at December&#160;31, 2020 included $293.5 million of cash held by subsidiaries within the U.S. and $322.0 million of cash held by subsidiaries outside of the U.S. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $345.6&#160;million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working capital -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Working capital at December&#160;31, 2020 increased by $153.2 million, or 21.4%, as compared to December&#160;31, 2019, including an increase of $3.2&#160;million due to foreign currency translation. Excluding the impact of currency exchange rates, cash and cash equivalents, accounts receivable, inventories, and total current liabilities increased by $156.0 million, $52.5&#160;million, $73.7&#160;million, and $119.1&#160;million, respectively. The increase in accounts receivable was due to increased sales activity. The increase in inventories that occurred in the period was to ensure we have sufficient inventory on hand to support the needs of our customers. The increase in total current liabilities was primarily due to increases in accounts payable, accrued salaries, wages and benefits, accrued expenses, and income taxes payable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and credit facilities -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The $2.1 million decrease in total debt at December&#160;31, 2020, as compared to December&#160;31, 2019, resulted from debt repayments under our Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of liquidity include our Credit Facility. At December&#160;31, 2020, we had no outstanding borrowings under the Credit Facility. At December&#160;31, 2020, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.5 million, was $297.5 million. We do not expect any significant limitations on our ability to access this source of funds. Please refer to Note 10,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_121">Debt</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our Credit Facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2020, we were in compliance with all of our debt covenants, and we expect to continue to be in compliance with the terms of these agreements throughout 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that cash on hand and cash generated from operations, together with availability under our Credit Facility, will be adequate to address our foreseeable liquidity needs based on our current expectations of our business operations, capital expenditures and scheduled payments of debt obligations.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contractual Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our commitments and contractual obligations at December&#160;31, 2020. These obligations are not expected to have a material impact on liquidity.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments Due By Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1 year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 - 3 years<br/>(through 2023)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years<br/>(through 2025)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">More than 5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (excluding unamortized debt issuance costs)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on debt and cross-currency swap </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contractual obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Our business creates a need to enter into various commitments with suppliers, including for the purchase of raw materials and finished goods. In accordance with U.S. GAAP, these purchase obligations are not reflected in the accompanying consolidated balance sheets. These purchase commitments do not exceed our projected requirements and are in the normal course of business.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For fixed-rate long-term debt, interest was based on principal amounts and fixed coupon rates at year-end. Future interest payments on variable-rate debt were calculated using principal amounts and the applicable ending interest rate at year-end. Interest on floating-rate derivative instruments was based on notional amounts and floating interest rates contractually obligated at year-end.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents acquisition-related contingencies. In connection with certain business acquisitions, we agreed to make payments to the sellers if and when certain operating milestones are achieved, such as sales and operating income targets. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This table does not include obligations pertaining to pension and postretirement benefits because the actual amount and timing of future contributions may vary significantly depending upon plan asset performance, benefit payments, and other factors. In 2021, we expect to contribute $3.6&#160;million to pension plans, of which $2.9&#160;million is for international plans. In addition, we expect to contribute $0.7&#160;million for other retirement benefits in 2021. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_145">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for estimated benefit payments over the next ten years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves for uncertain tax positions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The table above does not include $10.4 million of total gross unrecognized tax benefits as of December&#160;31, 2020. Due to the high degree of uncertainty regarding the timing of potential cash flows, we cannot reasonably estimate the settlement periods for amounts which may be paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Letters of credit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We have letters of credit totaling $2.5 million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.0 million at December&#160;31, 2020, of which $0.9 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OFF-BALANCE SHEET ARRANGEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had no off-balance sheet financing arrangements other than unconditional purchase obligations incurred in the ordinary course of business and outstanding letters of credit related to various insurance programs.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis addresses consolidated financial statements that are prepared in accordance with U.S. GAAP. The application of these principles requires management to make estimates and assumptions, some of which are subjective and complex, that affect the amounts reported in the consolidated financial statements. We believe the following accounting policies and estimates are critical to understanding and evaluating our results of operations and financial position: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC Topic 606 (&#8220;ASC 606&#8221;). Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. As of December&#160;31, 2020, there was $4.7 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $3.8 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets and liabilities result from transactions with revenue recorded primarily over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet in other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Considerable management judgment is necessary to estimate fair value. Amounts and assumptions used in our goodwill impairment test, such as future sales, future cash flows and long-term growth rates, are consistent with internal projections and operating plans. Amounts and assumptions used in our goodwill impairment test are also largely dependent on the continued sale of drug products delivered by injection and the packaging of drug products, as well as our timeliness and success in new-product innovation or the development and commercialization of proprietary multi-component systems. Changes in the estimate of fair value, including the estimate of future cash flows, could have a material impact on our future results of operations and financial position. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We maintain funded and unfunded defined benefit pension plans in the U.S. and a number of other countries that cover employees who meet eligibility requirements. In addition, we sponsor postretirement benefit plans which provide healthcare benefits for eligible employees who retire or become disabled. Postretirement benefit plans are limited to only those active employees who met the eligibility requirements as of January 1, 2017. The measurement of annual cost and obligations under these defined benefit pension and postretirement plans are subject to a number of assumptions, which are specific for each of our U.S. and foreign plans. The assumptions, which are reviewed at least annually, are relevant to both the plan assets (where applicable) and the obligation for benefits that will ultimately be provided to our employees. Two of the most critical assumptions in determining pension expense are the discount rate and expected long-term rate of return on plan assets. Other assumptions reflect demographic factors such as retirement age, rates of compensation increases, mortality and turnover and are evaluated periodically and updated to reflect our actual experience. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. One of the most critical assumptions in determining retiree mental plan expense is the discount rate. Under U.S. GAAP, differences between actual and expected results are generally accumulated in other comprehensive income (loss) as actuarial gains or losses and subsequently amortized into earnings over future periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in key assumptions could have a material impact on our future results of operations and financial position. We estimate that every 25-basis point reduction in our long-term rate of return assumption would increase pension expense by $0.6&#160;million, and every 25-basis point reduction in our discount rate would decrease pension expense by $0.1&#160;million. A decrease in the discount rate increases the present value of benefit obligations. Our net pension underfunded balance at December&#160;31, 2020 was $40.8 million, compared to $43.8 million at December&#160;31, 2019. Our underfunded balance for other postretirement benefits was $6.1 million at December&#160;31, 2020, compared to $6.6 million at December&#160;31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We estimate income taxes payable based upon current domestic and international tax legislation. In addition, deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and country level. Changes in tax legislation, business plans and other factors may affect the ultimate recoverability of tax assets or final tax payments, which could result in adjustments to tax expense in the period such change is determined.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When accounting for uncertainty in income taxes recognized in our financial statements, we apply a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 1, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_85">Basis of Presentation and Summary of Significant Accounting Policies</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 2, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_88">New Accounting Standards</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our consolidated financial statements for additional information on our significant accounting policies, recently adopted accounting standards, and accounting standards issued but not yet adopted.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. These risk factors can impact our results of operations, cash flows and financial position. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales outside of the U.S. accounted for 54.6% of our consolidated net sales in 2020. Virtually all of these sales and related operating costs are denominated in the currency of the local country and translated into USD for consolidated reporting purposes. Although the majority of the assets and liabilities of these subsidiaries are denominated in the functional currency of the subsidiary, they may also hold assets or liabilities denominated in other currencies. These items may give rise to foreign currency transaction gains and losses. As a result, our results of operations and financial position are exposed to changing currency exchange rates. We periodically use forward exchange contracts to hedge certain transactions or to manage month-end balance sheet exposures on cross-currency intercompany loans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2020 and December&#160;31, 2019, the total amount of these forward exchange contracts were SGD 601.5 million and $13.4 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2020, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Euro</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,194.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as a cumulative translation adjustment in accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a five-year floating-to-floating forward-starting cross-currency swap (the &#8220;cross-currency swap&#8221;) for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;9.6&#160;billion ($87.8&#160;million) as of December&#160;31, 2020. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Interest Rate Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of our normal borrowing activities, we have long-term debt with both fixed and variable interest rates. Long-term debt consists of our Term Loan and Series A, B and C notes. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate risk-sensitive instruments (excluding unamortized debt issuance costs): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Debt:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar denominated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average interest rate - variable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar denominated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$42.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$53.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$73.0</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$168.0</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$180.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average interest rate - fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.82%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dollar denominated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average interest rate - variable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. In recent years, raw material costs have fluctuated due to crude oil price fluctuations. We expect this volatility to continue and will continue to pursue pricing and hedging strategies, and ongoing cost control initiatives, to offset the effects on gross profit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through December 2020, we purchased several series of call options for a total of 472,477 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the loss recorded in cost of goods and services sold related to these options was $0.2 million. During 2019, the loss recorded in cost of goods and services sold related to these options was $0.4&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had outstanding contracts to purchase 141,734 barrels of crude oil from January 2021 to June 2022, at a weighted-average strike price of $59.14 per barrel.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2020, 2019 and 2018 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share data)</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.669%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMS0yLTEtMS0w_cb2a202d-10e8-4a39-bdd2-3397c7b6b1c6">2,146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMS00LTEtMS0w_e55ed845-79fb-456f-bf41-223a9f5cb9d2">1,839.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMS02LTEtMS0w_79f90d20-e5d2-493b-81c7-864e1295fde7">1,717.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMi0yLTEtMS0w_d7045f78-49e1-4934-8347-a2422f952a7b">1,379.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMi00LTEtMS0w_7d3fc790-2cc0-47dd-a52d-9a64ac739c27">1,234.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMi02LTEtMS0w_c4e55e17-6ae8-4178-b2a7-22648873f5db">1,172.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMy0yLTEtMS0w_c2441dfa-f2f2-46ee-bf92-afdafc0a1e36">767.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMy00LTEtMS0w_9907b28a-6f95-47ce-9420-2d20dfff1f4c">605.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMy02LTEtMS0w_8904883a-7efb-42cc-aa40-1a887a1cf9ce">545.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNC0yLTEtMS0w_ffc3f40d-5e28-4d36-8bde-b925b7fa5ffe">46.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNC00LTEtMS0w_1fd95241-4d01-4e70-a9eb-7d891d91e23a">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNC02LTEtMS0w_c493aa88-ade8-401f-86b8-e10aeaa36189">40.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNS0yLTEtMS0w_cd675cc7-6011-4640-9ca2-7a12d666dade">302.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNS00LTEtMS0w_69005be3-3573-41e8-9e77-3d5601ac7373">272.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNS02LTEtMS0w_7107eb5d-5a0b-4391-a409-349d4eb1d6e1">262.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) (Note 16)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNi0yLTEtMS0w_2ad26949-db25-485d-81a3-c912841ec367">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNi00LTEtMS0w_813efe4c-1d37-4299-8d25-68e8be626974">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNi02LTEtMS0w_8e2c77de-d11f-4dea-a633-f836194f8b50">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNy0yLTEtMS0w_32792673-c256-4dfb-9315-19bd694dba35">406.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNy00LTEtMS0w_6f78d9ea-519e-46da-9494-b99068851c20">296.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNy02LTEtMS0w_269702ce-c5fe-4a56-927f-a8deaf2bb00b">240.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOC0yLTEtMS0w_f76843d0-cc8f-43a0-9262-10c744ce82f0">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOC00LTEtMS0w_59f898b2-7da8-4c38-bad7-8bf61eaabda1">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOC02LTEtMS0w_e5b359fb-470b-496c-a2f8-de371930ef34">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOS0yLTEtMS0w_c0d0fba9-4dd5-41fe-998a-3ab4e06d0f51">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOS00LTEtMS0w_925a1cb9-d5e0-4ae5-b6a9-9fc8c424aca2">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOS02LTEtMS0w_537b69cf-a55e-4422-ae10-066df619b594">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other nonoperating (income) expense </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTAtMi0xLTEtMA_fc01c7e9-a4eb-43b2-bb3c-f167ac55f7d7">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTAtNC0xLTEtMA_71975b1f-47ff-418a-aa50-0e1e44128dc7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTAtNi0xLTEtMA_9e6bdff4-8652-4ae3-a618-f3db5cca38dd">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTEtMi0xLTEtMA_ff4b699e-bf2d-488f-a935-1ec19ed93d4e">401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTEtNC0xLTEtMA_bb4b8d37-1313-4744-9f10-32d414df3150">291.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTEtNi0xLTEtMA_177235c9-4470-4b13-bc6d-651e3ece5d2c">240.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTItMi0xLTEtMA_1570d4b0-6820-4cb5-8806-4a91c0cb6952">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTItNC0xLTEtMA_0d432a29-2d14-442f-acf1-e1fe5a4c3236">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTItNi0xLTEtMA_1bc9a894-b4e2-4a4f-bc27-0b5680dfffd7">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net income of affiliated companies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTMtMi0xLTEtMA_70f347f2-a1fc-469a-8a20-72d97a470491">17.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTMtNC0xLTEtMA_5fb081c2-3408-40e0-9478-1c1e5e1450ba">8.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTMtNi0xLTEtMA_81e77cb5-e568-45a2-b6eb-d0b013a665f6">7.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTQtMi0xLTEtMA_92f151ab-6ec2-433e-93c6-4f655d666b0f">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTQtNC0xLTEtMA_7ce66629-869e-4932-b8ae-4de86dff0b73">241.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTQtNi0xLTEtMA_dec68d9e-fea2-4974-8dc8-320bfb3bb050">206.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTctMi0xLTEtMA_dd0fb535-4b8d-49dd-956d-68d04f97143f">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTctNC0xLTEtMA_28d63c43-e577-4d6b-8072-7b744a355b2d">3.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTctNi0xLTEtMA_30c701d3-6cfd-4941-950d-a940b2320186">2.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTgtMi0xLTEtMA_3db70476-0775-4ce2-a07c-e3ec2a51320e">4.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTgtNC0xLTEtMA_f004d35f-99e1-4de4-ae83-e98b9dad5d9d">3.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTgtNi0xLTEtMA_877867f7-a965-4712-86fe-da1efa29ca4f">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjEtMi0xLTEtMA_bcf7daa5-bde4-4c10-b01c-79d3a5250f8b">73.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjEtNC0xLTEtMA_f5d5a3f5-b2a8-4453-9bf5-e2c548f55bfc">74.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjEtNi0xLTEtMA_beb7167a-0175-4e1c-856d-fb3ea1f8941a">73.9</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjItMi0xLTEtMA_f1290544-5b9b-4bca-a460-920c4439866a">75.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjItNC0xLTEtMA_8ee49628-c110-4776-8586-6231dc174f62">75.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjItNi0xLTEtMA_c8a49c8d-ac28-491d-8095-cbfd45077545">75.4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2020, 2019 and 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:62.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMS0xLTEtMS0w_dcf82920-1f86-458c-8231-b00061a07601">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMS0zLTEtMS0w_e91ddc06-cefd-4e1f-ad6a-e52ba98f0a70">241.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMS01LTEtMS0w_958ea339-4c26-4f00-82eb-2cdd73458aed">206.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMy0xLTEtMS0w_594c6090-1920-4bd5-877c-977f5ad58cb0">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMy0zLTEtMS0w_46b4a2cf-c7d3-449d-9a1e-d75ce02e5404">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMy01LTEtMS0w_3b7bd28c-7cd3-4db1-b3a5-ca3160a9c36d">39.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost arising during period, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0wLTEtMS0wL3RleHRyZWdpb246YjBiNzY4YTk1ZDYxNDFhMTg1OTE2OGNiODBkMGFjMjhfMTA5OTUxMTYyNzg0MA_a7897bed-2cdb-4551-9c59-bd5adb3f599f"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0wLTEtMS0wL3RleHRyZWdpb246YjBiNzY4YTk1ZDYxNDFhMTg1OTE2OGNiODBkMGFjMjhfMTA5OTUxMTYyNzg0MA_a7c1a8b0-a5f8-4a1c-821a-1745b622fa56"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0wLTEtMS0wL3RleHRyZWdpb246YjBiNzY4YTk1ZDYxNDFhMTg1OTE2OGNiODBkMGFjMjhfMTA5OTUxMTYyNzg0MA_f2b42922-d0df-428b-9226-841e568b84e9">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0xLTEtMS0w_13806dd4-e67c-4a68-a140-1742ddf4a4ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0zLTEtMS0w_e76484b4-10b2-4888-a813-6c4efe55d34d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS01LTEtMS0w_ea835769-da8a-4f9e-b602-03af3fe7305d">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZTE1ZGUyZDNkNDFmNDI4ZGE2NGFiZmIwNDhhNDU4MzJfMTA5OTUxMTYyNzg2OA_fb65e4ef-839a-4683-8ee2-646ee1b0762b">0.7</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZTE1ZGUyZDNkNDFmNDI4ZGE2NGFiZmIwNDhhNDU4MzJfMTA5OTUxMTYyNzg3OA_6f420e0d-ad93-4a59-ad0e-d8c1fb2fc5c9">0.3</ix:nonFraction>), and $(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZTE1ZGUyZDNkNDFmNDI4ZGE2NGFiZmIwNDhhNDU4MzJfMTA5OTUxMTYyNzg4Nw_2536eb33-6f6e-4502-a72a-8fb6127fde3b">0.2</ix:nonFraction>)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0xLTEtMS0w_b7aaff2e-db8c-486a-b030-8c4892484295">2.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0zLTEtMS0w_db8f9183-8245-4c41-a08a-dabf0169dc32">1.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi01LTEtMS0w_10f992c5-9444-4cfe-9b86-cc0aa723334b">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement effects arising during period, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0wLTEtMS0wL3RleHRyZWdpb246MDVmYzg2OTNkODIxNGM0MGFkMzEwYjY0NWVhYTQ0MjJfMTA5OTUxMTYyNzg1Ng_56969252-92a1-47eb-9fb9-41e3ad8b2a76">0.9</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0wLTEtMS0wL3RleHRyZWdpb246MDVmYzg2OTNkODIxNGM0MGFkMzEwYjY0NWVhYTQ0MjJfMTA5OTUxMTYyNzg2Mw_4d15f420-b9bc-460d-96b4-63873f544c0d">0.8</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0wLTEtMS0wL3RleHRyZWdpb246MDVmYzg2OTNkODIxNGM0MGFkMzEwYjY0NWVhYTQ0MjJfMTA5OTUxMTYyNzg2Nw_35c213a0-13b8-4354-aa83-0a9e61ae393f">0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0xLTEtMS0w_4b0acec1-de8d-4dab-a734-fc1190531568">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0zLTEtMS0w_54db89ec-3e9c-4bcc-a6ac-c1cc2c44697a">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy01LTEtMS0w_3fbf2b50-7316-421d-b28a-8f0c9bd3e24a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amortization of actuarial (gain) loss, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0wLTEtMS0wL3RleHRyZWdpb246NTg0MzQwZjU4ZTY5NGE5NWFiNDc4NzJmMzI3NWVjMWFfMTA5OTUxMTYyNzg1OA_22955790-67c7-412a-89b4-d3b740d1564c">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0wLTEtMS0wL3RleHRyZWdpb246NTg0MzQwZjU4ZTY5NGE5NWFiNDc4NzJmMzI3NWVjMWFfMTA5OTUxMTYyNzg2Mw_849bd26b-e007-4be3-bbe6-ebc5b8de9c16">0</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0wLTEtMS0wL3RleHRyZWdpb246NTg0MzQwZjU4ZTY5NGE5NWFiNDc4NzJmMzI3NWVjMWFfMTA5OTUxMTYyNzg3MQ_ca89749c-4829-419a-b066-3629475c7e31">0.3</ix:nonFraction></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0xLTEtMS0w_ed4234ea-ba90-4c8d-a760-0e2f26a4a484">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0zLTEtMS0w_89698db5-0288-457d-a1a8-4918f2341eb1">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC01LTEtMS0w_92bb6a6d-a285-45a9-bbcc-c9bf22802c03">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amortization of prior service credit, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0wLTEtMS0wL3RleHRyZWdpb246OTJkNWRjMjAzNDlhNDRlOTk5NWFlMTRjYzBlYzlmNWNfMTA5OTUxMTYyNzg2Mg_b7d5e68a-f078-447c-8c92-373b7939d598">0.1</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0wLTEtMS0wL3RleHRyZWdpb246OTJkNWRjMjAzNDlhNDRlOTk5NWFlMTRjYzBlYzlmNWNfMTA5OTUxMTYyNzg3MQ_b68199f7-a934-433d-817b-d00cbebfe51c">0.1</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0wLTEtMS0wL3RleHRyZWdpb246OTJkNWRjMjAzNDlhNDRlOTk5NWFlMTRjYzBlYzlmNWNfMTA5OTUxMTYyNzg4MA_9ecc0ab4-be19-48c7-b2bd-ab4ef692b82a">0.5</ix:nonFraction>).</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0xLTEtMS0w_fee2fdba-3559-460d-a725-576f165c7621">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0zLTEtMS0w_e2ed4e8b-b0b2-4131-9ed8-e9d1f703f69b">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS01LTEtMS0w_d0851ac3-372b-4c3d-94b1-36fc3733ea34">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmRkNzg2MjgyODU0NDQ5OWFiODc0MGI3Njk5ZTRiMmZiXzEwOTk1MTE2Mjc4NTM_81077cfb-6624-4044-8c55-ea4307d42a45">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmRkNzg2MjgyODU0NDQ5OWFiODc0MGI3Njk5ZTRiMmZiXzEwOTk1MTE2Mjc4NjI_41aadf84-c9a8-40e9-b68f-b667b88685ca">0</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmRkNzg2MjgyODU0NDQ5OWFiODc0MGI3Njk5ZTRiMmZiXzEwOTk1MTE2Mjc4NzM_a96c4347-0b30-41e9-9d17-214454bc8901">0.1</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMS0xLTEtMA_172e8ea2-b276-4dde-b954-4b5d7578358c">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMy0xLTEtMA_6f5898a4-0a52-43bb-8a6e-6d612ab01655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtNS0xLTEtMA_e6b50469-35c1-4057-82bd-30dc9cbc80e8">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) gain on derivatives, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjkxYzBiMWY2MTFiNDQzMTNiMDM5NjkxZWRhNmFmMjU5XzEwOTk1MTE2Mjc4NDg_191d4fd0-4e71-4240-b866-bf778b17678f">0.6</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjkxYzBiMWY2MTFiNDQzMTNiMDM5NjkxZWRhNmFmMjU5XzEwOTk1MTE2Mjc4NTM_9dba184a-5f7b-4631-9466-16e79839e02c">0.2</ix:nonFraction>), and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjkxYzBiMWY2MTFiNDQzMTNiMDM5NjkxZWRhNmFmMjU5XzEwOTk1MTE2Mjc4NjI_f308a816-705e-4bd9-974d-d8f3c2714d16">1.5</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMS0xLTEtMA_b43ef9fc-d6f3-400c-83ad-23565c775269">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMy0xLTEtMA_3e32dc98-a897-432a-9da2-93adf2b085eb">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItNS0xLTEtMA_14e70443-0caf-4b53-83b4-4d807ba80ac6">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTMtMS0xLTEtMA_1709b09f-6742-4067-afb6-c8d3d8896c40">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTMtMy0xLTEtMA_e892fe11-7625-468c-920f-68bc054c1e72">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTMtNS0xLTEtMA_2d34c263-71de-47ca-a0da-6b00ac646d0b">36.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTQtMS0xLTEtMA_34bbe18a-ccaa-4f4a-9577-9f955852a853">385.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTQtMy0xLTEtMA_1b3bdff7-1a3c-487f-9651-7e4a5adad544">246.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTQtNS0xLTEtMA_1f5346a4-59d5-4b09-a460-d54ea2cf3f7a">170.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries at December&#160;31, 2020 and 2019 </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:72.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMy0xLTEtMS0w_7cb793f6-e006-4daf-922f-b7aa96f269dc">615.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMy0zLTEtMS0w_708f04df-9bef-46b1-89da-37079c44caa0">439.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNC0xLTEtMS0w_4936abe1-8167-45ad-a213-abe975277376">385.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNC0zLTEtMS0w_a49134d3-f952-4eda-96f3-df785704b0b9">319.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNS0xLTEtMS0w_199c8c3b-26e9-42c4-82a2-2aca05cf635a">321.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNS0zLTEtMS0w_45dd7f14-4cfa-4be2-bb21-86572e32e6f5">235.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNi0xLTEtMS0w_710820d9-d20c-47a0-a0c7-b5e42fba977e">51.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNi0zLTEtMS0w_4fab8049-b7c9-46f6-8ca0-c81004585846">64.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNy0xLTEtMS0w_c518c1c9-14c1-4083-8fc8-9ce6a55e9840">1,373.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNy0zLTEtMS0w_c64511bd-6bd5-4a8b-b41e-b5c2b4689778">1,058.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOC0xLTEtMS0w_ecaf1131-4a8e-4a79-a7f2-b0d527648123">2,035.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOC0zLTEtMS0w_b702c863-78a5-46df-9d83-9d267ee33bdb">1,820.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOS0xLTEtMS0w_2d96cd96-dce5-4233-9a0a-bbab97042677">1,092.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOS0zLTEtMS0w_9657b21f-c62f-4fa4-8805-5f7c17e22c61">980.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTAtMS0xLTEtMA_6e4c9110-6359-4c06-8b73-3ff0e971aaf1">943.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTAtMy0xLTEtMA_8e503746-708b-4be0-8237-8bf3fabe9827">839.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTEtMS0xLTEtMA_b4dfa837-6b9c-4735-81a8-a20b602e6821">68.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTEtMy0xLTEtMA_e5ad112d-3d79-4a2c-81ec-7a76ddea3c62">70.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Investments in affiliated companies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTItMS0xLTEtMA_2a58a0ad-4c8a-4f46-b215-1c457d496478">214.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTItMy0xLTEtMA_b6b0371c-bde1-4c8f-80d3-25c0bec5ddb8">192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTMtMS0xLTEtMA_a03a45ec-2c6b-4f9d-b30f-c7589a80a594">111.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTMtMy0xLTEtMA_13b1887e-0e89-4175-bd74-8c58818a2171">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMS0xLTEtMjUxNw_728aaa57-418a-435c-ac30-f487fc950542">30.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMy0xLTEtMjUxNw_60ca09bc-596a-41d1-abc4-c610b91625b0">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMS0xLTEtMA_7aa65e28-48fd-43f5-a7ce-70d471fb87be">16.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMy0xLTEtMA_ec106c5d-214d-4452-8bbb-ba3ab0da7ff2">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTYtMS0xLTEtMA_533f776b-aec8-42da-b331-2ebe6ec82739">12.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTYtMy0xLTEtMA_acd63721-0d6a-43ca-87a5-76294c1c94d7">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTctMS0xLTEtMA_e980d1b8-0703-48d5-89ae-a5fae2dacabc">23.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTctMy0xLTEtMA_71b1c9ad-528a-4f09-98d4-0e931ab2f05a">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTgtMS0xLTEtMA_e2bd7181-57f6-40a9-8fdc-24ac18659efc">2,793.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTgtMy0xLTEtMA_39a0b0ff-65a3-46e7-90b2-e959261ead43">2,341.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Notes payable and other current debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjItMS0xLTEtMA_0d60f02f-23c6-477c-ab96-fbd8fe70fd71">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjItMy0xLTEtMA_01af71df-d37c-4c66-8738-a1e2960a1812">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjMtMS0xLTEtMA_c86675a8-5ff3-47f8-b3e1-b1458b709460">213.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjMtMy0xLTEtMA_d5d8a2a7-7ade-4de3-8de6-be27d4eb0c0e">156.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjQtMS0xLTEtMA_c6c5000a-31af-4812-b546-b633c266a853">2.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjQtMy0xLTEtMA_2f28d451-9c14-40d5-b1d2-6e7bdf194ed9">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued salaries, wages and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjUtMS0xLTEtMA_b06ca1a6-a498-45b6-90c6-eb94a60825c6">106.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjUtMy0xLTEtMA_538b98e6-d52a-4b04-ad9a-c42a2bff2d78">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjYtMS0xLTEtMA_9bfe9a15-ef12-48a5-afd2-3ace43ddb255">26.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjYtMy0xLTEtMA_c8ee0f00-b319-4f00-b1c8-93534aaaaf66">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjctMS0xLTEtMA_22307bc0-0af9-415d-85da-7e39426002b4">10.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjctMy0xLTEtMA_50c0613e-d0c8-4309-a5e9-94931c0da60c">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjgtMS0xLTEtMA_f6b085cd-8652-47cf-a7ec-f226705910b0">143.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjgtMy0xLTEtMA_b9709493-0514-40ef-b251-1e13cab3106c">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjktMS0xLTEtMA_949d7f73-8154-48e0-997b-3d091b62ea1c">503.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjktMy0xLTEtMA_c06718e3-c043-47ca-ac83-9d4381e9211a">341.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzAtMS0xLTEtMA_c93bd5ab-1225-4457-b5f8-377d9b69fb96">252.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzAtMy0xLTEtMA_06c3f907-ed74-4423-bdd0-980fd5e2f9c1">255.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzEtMS0xLTEtMA_ce768d06-f82c-43f5-8c8e-bb25c892283c">10.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzEtMy0xLTEtMA_87a306c1-d34f-4c2b-a776-7c75da4ed2a6">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzItMS0xLTEtMA_4822794a-eece-4cbb-9032-66e2e6d998a4">57.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzItMy0xLTEtMA_4d3cd1a8-db5d-4b13-9449-fc1c9b86d5ee">52.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzMtMS0xLTEtMA_e55fd01f-f37c-4fd6-8d03-666e57201a62">60.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzMtMy0xLTEtMA_850e6185-030d-4244-a472-ee0224b7008c">62.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred compensation benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMS0xLTEtMTExNTc_f37b1694-a322-43ee-85fb-d87f3c5e1469">22.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMy0xLTEtMTExNTc_96ff953e-7a52-4a97-8c31-52e7a959344a">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMS0xLTEtMA_e4179ccc-eab4-49e5-9fd8-5d8a12a15257">31.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMy0xLTEtMA_acf58ec6-5d0d-4c86-b18c-6d5d5a1b894e">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzUtMS0xLTEtMA_75a6ff67-25ed-4c00-9fad-71f8be4d78d8">939.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzUtMy0xLTEtMA_2383bacf-f0e9-4550-a9ca-5ac0a358f1e8">768.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzctMS0xLTEtMA_0f1b9b06-acc8-4093-ae9a-22986eecb247"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzctMy0xLTEtMA_957aee56-e037-4ca0-9559-092a874a819b"></ix:nonFraction></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock, <ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDU_170b4497-351a-4dba-9be1-727323918385"><ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDU_a760c3b6-2511-4e5b-998d-8630ae064dd6">3.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_17c0a4fe-b740-4a17-af76-806abdbcaf78"><ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_7a2153b3-5ed7-4445-92df-a1c71c210b8d"><ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_c65a4a1e-752b-43f3-b5b3-312a5d379d20"><ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_ef461f6e-6d3b-445f-aa3b-9d5bf2f53db0">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding in 2020 and 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMS0xLTEtMA_f82220d1-74e0-4801-8ea7-ffd218d3fb19">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMy0xLTEtMA_4a95e934-1d1b-486e-8bb4-6d698c793bbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTI_387dfce9-9efd-4b3e-a83f-5dd928b846ac"><ix:nonFraction unitRef="usdPerShare" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTI_40c1acca-fa27-4412-b4ca-81bd9bdf1249">0.25</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTk_34bfb519-ab24-42bd-981b-74389b9a0d78"><ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTk_fdb61460-a6d1-4633-b3fd-c67c77145404">200</ix:nonFraction></ix:nonFraction> million shares authorized; shares issued: <ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwNzg_0e36929e-888b-41ea-a70a-2793e42a310e">75.3</ix:nonFraction> million in 2020 and 2019; shares outstanding: <ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwNjg_4832aadc-3e32-4f97-a39d-03e099c92da4">74.0</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwODU_72ca55cb-1c3f-4b82-8085-76df7ca64b17">74.1</ix:nonFraction> million in 2020 and 2019</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMS0xLTEtMA_106f3287-34c0-4f60-860c-eab3b93216bf">18.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMy0xLTEtMA_c8ae3c57-4ce9-4d2d-8126-2f2d5a45eb0b">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDItMS0xLTEtMA_5f5c1fdf-c0b3-4c97-a056-79396f2e71e9">267.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDItMy0xLTEtMA_f241a6a3-8b0c-426a-8920-ed56d991d02a">272.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDMtMS0xLTEtMA_e549bcec-a886-46c4-a2ce-b65a464216a8">1,846.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDMtMy0xLTEtMA_9f8cd481-d5cb-4aac-9e95-3e2d03a6a606">1,549.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDQtMS0xLTEtMA_4fa56968-0099-4475-8b58-4a0de76dd07c">110.6</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDQtMy0xLTEtMA_1bc453fa-af39-4730-8ea7-402c0ca1c97f">149.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3N2ZhOTFkNDU2NjQyYzlhOTRlOWYxYjQxNDI2M2Y0XzEwOTk1MTE2Mjc4OTQ_05a29a35-398b-49fa-a6d3-83778b3b387b">1.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3N2ZhOTFkNDU2NjQyYzlhOTRlOWYxYjQxNDI2M2Y0XzEwOTk1MTE2Mjc4ODk_570284d1-f0d9-40ee-9151-cb2bb6ba93e1">1.2</ix:nonFraction> million shares in 2020 and 2019)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMS0xLTEtMA_d66eed42-8732-426d-ba59-ad752e2a39c8">167.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMy0xLTEtMA_39780fde-9280-4fcd-98dc-42170b6cbd64">118.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDYtMS0xLTEtMA_01627902-d3ee-4449-8c62-ccd69371007a">1,854.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDYtMy0xLTEtMA_bd433c33-b30c-48ae-ac5d-1619ffc6be30">1,573.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDctMS0xLTEtMA_e01f6bd3-9bbe-4bb0-8597-ef468f48bfe3">2,793.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDctMy0xLTEtMA_e322a6a0-43bc-487d-b9ab-72ad98fb1e5b">2,341.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_73"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENT OF EQUITY</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2020, 2019 and 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:31.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in Excess of Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89754d8eff0a4a21b0723157da2cda70_I20171231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xLTEtMS0w_09b56a54-f784-41f4-bf2d-8063456e3ccb">75.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89754d8eff0a4a21b0723157da2cda70_I20171231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0zLTEtMS0w_6fc5e1ec-1d43-4abe-8d99-4f11141eb373">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eb7e11a1b0044108c665a9e8425b3d8_I20171231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS01LTEtMS0w_d8ee150e-0141-476d-9b6b-7a335b8b79b5">309.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieff9a042b0cb4730aae3ec835e713476_I20171231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS03LTEtMS0w_a87d2e03-6ba1-4227-889a-9e3e60565d8f">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieff9a042b0cb4730aae3ec835e713476_I20171231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS05LTEtMS0w_50d2cce6-023a-4b6a-aa65-7224829c1ad2">109.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6198c5c042db47db99a2b2ffabc3425f_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xMS0xLTEtMA_25e379f1-e626-4aac-b070-61994226010c">1,178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ec1277012249aaaba2bbc8e69b9dc1_I20171231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xMy0xLTEtMA_81f13940-eb09-4fe2-87cc-2c8eb11f6b94">117.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xNS0xLTEtMA_ecb515c5-f5af-4a98-8ad3-189a3dc96a0e">1,279.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMi0wLTEtMS0w_9af21823-f8b7-4576-99a8-b548961451d6">Effect of modified retrospective application of a new accounting standard</span></span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia863152d72be424e95b4eccddadd94e2_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMi0xMS0xLTEtMA_f0e9421a-7719-4182-b214-f6ecce985611">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5e4a6111d54b648e0349ce16e32a15_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMi0xNS0xLTEtMA_4f9521fb-8655-4413-ab39-f4946f721a59">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a2d506efbe4e4abf499bcddf045827_D20180101-20181231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMy0xMS0xLTEtMA_8b17a134-1da8-4326-8a0f-526e5f21ba18">206.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMy0xNS0xLTEtMA_83b09a85-0a0b-4894-ab5c-2ece7475599a">206.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb45a33c02564935aa8568f277f49d7b_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC0xLTEtMS0w_82f33ebe-a823-42a7-897e-b8a8b9965bf8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2eb6236c6ef4de2b1b88eb4b6d0f67f_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC01LTEtMS0w_d7341ec7-964e-4d40-8cc8-5c4b53fa42a4">27.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC03LTEtMS0w_4ca6ad20-ac6d-4e06-a629-9d042a8963f5">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC05LTEtMS0w_a3954d5c-3b39-47f9-ada1-ba55f3bf3f40">76.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC0xNS0xLTEtMA_af1822d9-c225-4e4a-a9fa-808f05f9c996">48.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNS03LTEtMS0w_12ee4af0-a547-4cca-9b74-4eca437d9f98">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNS05LTEtMS0w_be13ecd4-ed94-48f5-bae0-6f82d5d19b09">70.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNS0xNS0xLTEtMA_c624c22d-5069-4b55-8d62-8f39527785ef">70.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNy0wLTEtMS0wL3RleHRyZWdpb246MTMxYjVkMzliNTNmNGZkZmI2NDZhYWU5MDRkNmI2YjhfMTA5OTUxMTYyNzgyMQ_a111758c-0932-4fb2-b30b-79fa20d83408">0.58</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89a2d506efbe4e4abf499bcddf045827_D20180101-20181231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNy0xMS0xLTEtMA_af53e0c0-69df-485b-a6b3-be8ef7575b90">43.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNy0xNS0xLTEtMA_c729f4c1-fd6d-472d-9ef4-6123677b373e">43.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide2eaf9f89f64fc3b8edf54395816f7a_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfOS0xMy0xLTEtMA_1b391cf2-dd48-4467-b56f-bf1684eb50b1">36.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfOS0xNS0xLTEtMA_5f3d8a32-3590-433d-8be8-b3ec9a8e2d75">36.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc36a7c52d664ddd9d308b197d911005_I20181231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMS0xLTEtMA_7f7f932a-aced-4e8a-a823-b990bd490beb">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc36a7c52d664ddd9d308b197d911005_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMy0xLTEtMA_5c13b7b8-7d33-4286-a004-e55162d33873">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2b0616539540d2afdbb1aef826ba8e_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtNS0xLTEtMA_a505f389-fa86-4e4e-82f7-826bbd27d862">282.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d2860bdad8e4c5f80b333c36791f4e5_I20181231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtNy0xLTEtMA_7a4e9a38-ffc0-4c57-8fce-6eecd7b5f83a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d2860bdad8e4c5f80b333c36791f4e5_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtOS0xLTEtMA_5d9936a6-4b7e-4b2b-aebd-e364be377fc7">103.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840b6e15466f480a85b720e9d8dd1aa9_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMTEtMS0xLTA_9c76b38c-74f5-470f-9e62-c5251136b50d">1,353.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7db531a64e249498d81ca1360119f0c_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMTMtMS0xLTA_d66e2f1d-2eef-411e-a676-bf3b53583dce">154.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMTUtMS0xLTA_b3ed766e-dc1d-4706-a594-b1d41a5af67a">1,396.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9f256a412b4a58b1583e63cb3d853b_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTItMTEtMS0xLTA_016fb6a6-7955-4ed9-ab19-957b5aa0f401">241.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTItMTUtMS0xLTA_0d49303c-bf6e-4b2a-8980-4fc7a8ee28b0">241.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib93b62e40fb3459c8fa7a41ab3cd4a0a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtNS0xLTEtMA_0f8edc25-ec20-405d-8cb3-c83218f6056d">11.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtNy0xLTEtMA_7650ccde-06d5-4584-908f-c61c1da11f4a">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtOS0xLTEtMA_07bd21f7-889f-40ca-92aa-b6d87f5dd7dc">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtMTUtMS0xLTA_d5e5e098-5e71-42e5-a39b-208d749cea43">54.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTUtNy0xLTEtMA_799dd224-790c-4acf-a2a9-28bacd426541">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTUtOS0xLTEtMA_e2a05715-936d-4613-9a68-ab8ceeefb22c">83.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTUtMTUtMS0xLTA_6d25b042-22db-4d81-94d0-a8937d3ddd52">83.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investment in affiliated companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93b62e40fb3459c8fa7a41ab3cd4a0a_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTYtNS0xLTEtMA_8e7fdfb2-86cb-476f-b051-289d5170a7d4">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTYtOS0xLTEtMA_3696b5a9-ab77-4ef6-a303-64c4ab5c9ee1">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTYtMTUtMS0xLTA_86768429-f2f1-4e97-9430-b462c0fbddd1">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmZhNWMzZjQ1YjMwNjRhYzU5ZjZjMzNkZmJkODI0YjcwXzEwOTk1MTE2Mjc4MjE_42c3a4f5-98d7-4e09-9e24-035a21279ad1">0.62</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c9f256a412b4a58b1583e63cb3d853b_D20190101-20191231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTctMTEtMS0xLTA_48415c97-4ae1-4341-922c-b619543c4e5d">45.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTctMTUtMS0xLTA_78bc16f5-2822-4c98-8e70-93991c72bbaf">45.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i505c1698fd5746dda4e419a17470e15e_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTktMTMtMS0xLTA_20ca8807-1ec0-46d5-b5ef-9a823d46d4f3">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTktMTUtMS0xLTA_b2ab10d2-cd7b-45ab-a106-538282604626">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82e08973cd064954b4b8f835bc97cd66_I20191231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMS0xLTEtMA_1b457e50-b6cd-465e-8b70-e08b3cb16c19">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e08973cd064954b4b8f835bc97cd66_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMy0xLTEtMA_829d4045-fc9a-42cd-87f9-e7b5cbb9eb72">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd079bb091934d528c33b541a4ccce8e_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtNS0xLTEtMA_85f62449-285b-4943-8e43-160cc60e6341">272.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57c744ccf1da46369f9ffda6a48eaeb7_I20191231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtNy0xLTEtMA_89b95f9c-ba5f-4695-a590-42b8960a1ed4">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57c744ccf1da46369f9ffda6a48eaeb7_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtOS0xLTEtMA_db9dd3bd-f291-4777-abcb-fc958b39f5ba">118.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i953aa2443d1a4326b4f15164b962ef7f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTEtMS0xLTA_aac890c0-4083-41ef-8764-10b9a689618a">1,549.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cd9ef6885cb4483a826dc5519bf65fb_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTMtMS0xLTA_7168ab0d-19e5-4a10-a448-0637fce028c1">149.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTUtMS0xLTA_a193acda-f169-4f19-aaec-3700501975f3">1,573.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMC0xLTEtMTIxNTk_023aae83-1a7a-4eef-830d-157299dbe663">Effect of modified retrospective application of a new accounting standard (see Note 2)</span></span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3839e393aceb4fd0834689e157654cf3_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjEtMTEtMS0xLTExNzMw_9ab07d7e-c180-40fc-9eac-2ece2df98e76">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e0b9a4c775c4c6d99c01d89bdb05da3_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTUtMS0xLTExODcz_3a6558af-1829-4359-a7a7-a0929839c03d">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ce2e61c66d64a13aa94d7b58161681e_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjItMTEtMS0xLTA_2197e7a6-c00d-43cf-97f5-5498c6fa42d4">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjItMTUtMS0xLTA_03a00320-7a37-4758-b6c1-afcb638cc4ba">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6986700a9d62490d965d3d1f40d2a0ec_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtNS0xLTEtMA_b3f50848-2317-4cd3-90ff-093c54a45848">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtNy0xLTEtMA_cec9050f-5a70-4a25-8a99-5de23d3eedf0">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtOS0xLTEtMA_71f98af5-5ed7-4462-89ef-22c024492d76">65.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtMTUtMS0xLTA_4d9e9015-29d3-4b78-be4f-840d163e6da7">60.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjUtNy0xLTEtMA_c7209d26-8bed-4088-9201-c7106fb0c9cb">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjUtOS0xLTEtMA_935cdc5b-44ff-437c-9482-fc4ef9f81859">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjUtMTUtMS0xLTA_80ee017d-cce8-433a-b302-932a8041cb3a">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjctMC0xLTEtMjU1MC90ZXh0cmVnaW9uOjk0YmMxODhkZGY1MTQ3Y2NiMWZiYmVhZWYzZTU3ZTI2XzEwOTk1MTE2Mjc4MjE_d5ad5f22-f581-48c3-a956-dc85eeadeaf0">0.66</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ce2e61c66d64a13aa94d7b58161681e_D20200101-20201231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjctMTEtMS0xLTA_f4fd3d3a-d419-4e2c-826e-a9925f71a5cb">48.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjctMTUtMS0xLTA_f4dee45c-ea21-4df7-9a30-370993c82bc0">48.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55957b9eba4c467ba3e5b0bba2e29a4b_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjktMTMtMS0xLTA_501c3745-1da5-43bb-9414-87806e5320e2">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjktMTUtMS0xLTA_7150513e-f906-4471-8c6f-45dfd407fbda">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46a9cd662cd140e6a0bf37cf6471e2d5_I20201231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMS0xLTEtMA_1a795daa-de2b-4470-b6f3-4cd156062cf3">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a9cd662cd140e6a0bf37cf6471e2d5_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMy0xLTEtMA_5dde83a9-3f31-4e85-ab26-4f8b3b22b666">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5468dc7ce54d57819464e399e6c5bb_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtNS0xLTEtMA_309b7284-ac81-4915-80e1-2b56942be6a4">267.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie45120a724f04b6dbac9726ee336f7ee_I20201231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtNy0xLTEtMA_8e6f46bc-b0b5-4415-b157-fb91233a96cb">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie45120a724f04b6dbac9726ee336f7ee_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtOS0xLTEtMA_2108f967-f05c-45ae-842e-f015b74de0a8">167.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if961352725c24b75a3c9007e9847415b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMTEtMS0xLTA_96b21071-0991-485d-b817-1968db8d077a">1,846.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief5c5adaa64e42959e00816c3bf6c2b3_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMTMtMS0xLTA_ed73d935-aead-4a1c-986e-f1776edbf55c">110.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMTUtMS0xLTA_d031d8dc-2d87-4ded-b2af-7cc22d0dce8c">1,854.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_79"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2020, 2019 and 2018</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:64.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMi0xLTEtMS0w_88ba288e-e04f-4b5a-8349-c45f5a1e7607">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMi0zLTEtMS0w_d64497dc-58b9-487c-9cba-7739efefe7e6">241.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMi01LTEtMS0w_c470f792-e85f-46e5-9b19-c80eb885d29e">206.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNC0xLTEtMS0w_972d54ed-6591-47b5-8a64-38b545c0e2d0">104.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNC0zLTEtMS0w_d36a4c7e-247c-4dde-83ee-748dd08ed6c2">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNC01LTEtMS0w_a7691ae1-da6f-4ade-acec-18efd49a159b">101.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNS0xLTEtMS0w_bd99d634-59f4-4f31-b13d-9a3a10ba1bce">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNS0zLTEtMS0w_c66a069e-1016-4ac3-a9d9-fe23d118efb5">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNS01LTEtMS0w_dc6bf331-6cbc-4f71-9f0d-555723b247f9">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNi0xLTEtMS0w_b1e9813d-ed21-4ca2-a9ba-e032cac18e7a">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNi0zLTEtMS0w_d0fec537-f595-4a6e-a960-5b174e59e337">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNi01LTEtMS0w_91142263-d89e-4709-91d6-a67ff6503e51">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNy0xLTEtMS0w_13277aff-1a62-4603-a3b6-52841e9327ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNy0zLTEtMS0w_3164d6a1-2535-4187-a0f9-ae6824ff0395">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNy01LTEtMS0w_d8a87fb6-b019-45f4-aa41-f6d9b5f72fde">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfOC0xLTEtMS0w_bf3c804c-9da4-427c-97c3-d3a76b100518">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfOC0zLTEtMS0w_81ca8c4d-9c0d-47a7-9a0e-60e9a859aa78">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfOC01LTEtMS0w_261df1df-fd9e-423b-b2c8-2f13b063aca0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration payments in excess of acquisition-date liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTAtMS0xLTEtMA_0f42b43c-2620-4e73-bbc0-07688320b00f">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTAtMy0xLTEtMA_6c2a9c7e-b32b-4d7b-90b7-f373187f4187">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTAtNS0xLTEtMA_1c258c09-bccf-487c-a798-5a006c9a3a27">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTEtMS0xLTEtMA_242b1305-9218-4504-bae9-ef329469c1d7">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTEtMy0xLTEtMA_f2c2de87-1a25-4170-a456-a66a3a602c98">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTEtNS0xLTEtMA_5967e8d4-44ef-46c1-a82c-8c42e1aa1f19">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTItMS0xLTEtMA_1884dca6-ebb1-4297-a1a6-074ba2ea5bb2">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTItMy0xLTEtMA_fc5eae97-9a4e-4303-b2fe-2f0f47ae3b1f">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTItNS0xLTEtMA_cbdec2f4-a4f6-40c5-8ab5-8d47dbeb1c0d">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and other retirement plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="wst:PensionAndOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTMtMS0xLTEtMA_534e52d5-458d-48ef-98ca-4bcd9413e3c4">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="wst:PensionAndOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTMtMy0xLTEtMA_fe0cc653-f09c-45a5-91a7-291dcdc2d270">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="wst:PensionAndOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTMtNS0xLTEtMA_242a7dd3-77d7-4581-9a87-cdfa6f6ef8fa">7.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in undistributed earnings of affiliates, net of dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTQtMS0xLTEtMA_f2c71a08-dcac-4a46-850e-ba4325871516">15.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTQtMy0xLTEtMA_6405396b-eb12-4207-b3d6-d3ac8d755f61">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTQtNS0xLTEtMA_2e570eaa-b905-423f-a22b-72ab3a231e3a">5.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTYtMS0xLTEtMA_7b1d7a5a-0571-48cd-86a9-ef68df75119c">46.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTYtMy0xLTEtMA_bff7abf4-c966-4dd9-9aff-4e9304b46cb3">33.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTYtNS0xLTEtMA_92d36c79-8742-400a-808e-68b602dbb003">43.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTctMS0xLTEtMA_98b29e50-f48b-43f4-840f-ea44a0475d51">73.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTctMy0xLTEtMA_2597bce4-b34e-4fe9-975f-e3beeaf57118">18.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTctNS0xLTEtMA_29e3d9f7-0067-46e6-a833-88bf671c82cd">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decrease (increase) in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTgtMS0xLTEtMA_20b29a18-2cd7-438a-8672-8f1c745da5b2">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTgtMy0xLTEtMA_fbf7343c-1c73-4032-b35c-8c36ef0be53e">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTgtNS0xLTEtMA_6b34dfd7-ae94-4d5c-8b22-7e8ff63d8e57">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTktMS0xLTEtMA_9df252e6-5c9d-4a99-824d-dd938555ec68">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTktMy0xLTEtMA_e8895c54-89d7-4252-8a9f-978b5c608eeb">25.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTktNS0xLTEtMA_a2e8e01c-6f43-45a5-9b31-d1d0dba05fdf">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in other assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjAtMS0xLTEtMA_0532c63f-6f7b-48aa-9cb9-d4fce3eff371">67.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjAtMy0xLTEtMA_af2b0766-568a-445c-8e17-ea88a3e308b1">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjAtNS0xLTEtMA_97103eb9-f598-4b4c-a782-047715a193ac">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjEtMS0xLTEtMA_7606f1ec-7045-4aa6-aafe-34203ed1fec6">472.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjEtMy0xLTEtMA_54e6624c-7095-4b39-bf4f-02d3adfb04ff">367.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjEtNS0xLTEtMA_0ba3339c-5bae-4c92-8bca-dbdf875904fe">288.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjMtMS0xLTEtMA_25008827-f729-45a7-a840-9a9795634524">174.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjMtMy0xLTEtMA_fde2e8c6-0546-4f8f-8b79-1ef057addc3c">126.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjMtNS0xLTEtMA_fed68eae-1fe9-41ec-acff-14b329cd8bbe">104.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of investment in affiliated companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjQtMS0xLTEtMA_374df669-0744-443e-84c2-b0e3b5c9924f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjQtMy0xLTEtMA_e5930859-3536-458d-91ae-51e697f36c12">85.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjQtNS0xLTEtMA_2f7266c1-b820-4675-b819-09d2ed02d3fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjUtMS0xLTEtMA_63e88734-2f98-4e73-a6bb-103fde92d6ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjUtMy0xLTEtMA_a6c5a1e7-c57f-4713-99e5-aa8300450505">18.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjUtNS0xLTEtMA_4e3a6766-b51d-49b1-af9b-ed0eebba8ada">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjktMS0xLTEtMA_e5356d8e-a5d3-4295-a254-22286962e2c2">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjktMy0xLTEtMA_0ddb96b2-659b-43e6-b347-8b1e109ab1f6">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjktNS0xLTEtMA_08badb66-d6dd-47fd-bb18-ab3fd24c5c79">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzAtMS0xLTEtMA_31a6c1c4-0659-4bd4-8b7c-9fa1ec6b616e">179.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzAtMy0xLTEtMA_65ee64e2-fc7f-4e85-b946-a6df2f4283c0">228.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzAtNS0xLTEtMA_10694e3d-abbd-47ce-b2e0-d90f10d476f2">100.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Borrowings under revolving credit agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzItMS0xLTEtMA_e458e7ff-f5a5-490d-856c-4ff140f42d35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzItMy0xLTEtMA_b9e0b8c5-589d-4719-b218-a0e3f8de45a5">108.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzItNS0xLTEtMA_57aeb3a5-fcda-45e3-8fdd-a1b2b701efe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments under revolving credit agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzMtMS0xLTEtMA_1bde671c-9f99-46e3-aca2-4e3a1c0a65ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzMtMy0xLTEtMA_d5337025-7403-4f3a-9298-1b09cf7265c4">136.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzMtNS0xLTEtMA_1a54c928-9aa2-453d-a7ab-65c991ed19ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzQtMS0xLTEtMA_6634db1c-db91-4d80-8736-19f91bf21b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzQtMy0xLTEtMA_8d3af33c-18b0-4e1e-8202-0a3909ae401c">90.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzQtNS0xLTEtMA_61dcbfb4-6750-467c-a383-e4e157ac3b1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzUtMS0xLTEtMA_784e3634-ef24-471c-a670-a223be6e6953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzUtMy0xLTEtMA_37e21e2e-07a0-4592-aef5-51d7d79a851d">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzUtNS0xLTEtMA_ede3a6c8-6aa4-40ca-8f71-255fb204d1f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzYtMS0xLTEtMA_cc4aad47-358f-481d-bfdb-dd6627b7a70e">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzYtMy0xLTEtMA_da6ec662-2475-4d0d-a7dd-434d29cb2ace">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzYtNS0xLTEtMA_ecd7a0b7-b09d-49a6-a8c2-d7cf8d3f6b39">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzctMS0xLTEtMA_fe583dd1-0c36-4e80-8f57-65f0e579ed86">48.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzctMy0xLTEtMA_3a918a5e-e556-4d5d-bfcc-a41415beee83">45.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzctNS0xLTEtMA_13810a58-abab-493d-ba28-f23f5c4d95d5">42.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from stock-based compensation awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzktMS0xLTEtMA_c3eac46a-088d-447a-b5b0-48711adfba95">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzktMy0xLTEtMA_60201ab8-adf7-454f-aa70-91e6f3f45b0e">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzktNS0xLTEtMA_7739d487-cb0d-4d16-ad29-cfc88e21e70b">27.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDAtMS0xLTEtMA_06a20497-97a7-4b4e-aa02-4b98c9481a2d">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDAtMy0xLTEtMA_2a6ec1c0-77e1-415f-8192-e926b1beb45f">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDAtNS0xLTEtMA_a06e6832-d6d7-4f92-b0d2-bd3f6fa31250">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares purchased under share repurchase programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDEtMS0xLTEtMA_a3dd445a-e29a-4cd7-be21-bf995db06e4f">115.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDEtMy0xLTEtMA_8c18d2d1-d85b-4861-95b8-968d332cc812">83.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDEtNS0xLTEtMA_9c2689ee-fe34-464b-acbe-968ddfa232da">70.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDItMS0xLTEtMA_b805ff03-7076-4ad7-8f32-90ca78dad729">137.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDItMy0xLTEtMA_a9dc677a-ca59-4892-8d1a-ab7f1c915d35">36.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDItNS0xLTEtMA_e253fb07-4c92-49da-b9bf-ee86ff63d8d0">80.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rates on cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDMtMS0xLTEtMA_6a2018d9-0b0d-446d-9549-d9009754f89b">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDMtMy0xLTEtMA_247b3f93-0e4f-4918-9b9d-7406bee7810a">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDMtNS0xLTEtMA_63c98a20-2e6f-44d8-a0b1-1d4e1273f9ac">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDQtMS0xLTEtMA_50fa294f-6151-4263-945e-690653fc1197">176.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDQtMy0xLTEtMA_870a1624-3f01-4223-bd65-9d455db83ee9">101.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDQtNS0xLTEtMA_a6b9d058-b55c-4dba-93a0-9aa07ffb3dee">101.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, including cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDUtMS0xLTEtMA_6bd1e9df-ba4e-43b3-a9a4-7795abe2723a">439.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDUtMy0xLTEtMA_d65b6a97-984d-40c6-ae3f-c3c6aa0598e5">337.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDUtNS0xLTEtMA_be7d126b-9fff-481c-aeab-dc9952754405">235.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, including cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDYtMS0xLTEtMA_ad536554-2a13-4c55-b0a8-4978b598aa43">615.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDYtMy0xLTEtMA_603a0626-56a7-46fb-9731-6222abc8feb5">439.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDYtNS0xLTEtMA_5dc6ca6e-ec00-44a9-a39f-0cbbdc1fd3f6">337.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid, net of amounts capitalized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDktMS0xLTEtMA_d15cc9cb-0d24-43cf-ad6e-ca486166d98d">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDktMy0xLTEtMA_6a452fd2-e05d-4a75-ac45-6fa4cd554c04">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDktNS0xLTEtMA_430999e7-f8fb-40d9-b044-01f1d7be4be2">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTAtMS0xLTEtMA_a67bd389-d070-41ee-8dc8-b20e39e23213">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTAtMy0xLTEtMA_5eceb28b-fad0-413f-b707-08716ccef935">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTAtNS0xLTEtMA_1dc710ac-d12c-44c6-a9bb-cd72333cb131">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTEtMS0xLTEtMA_52f38a39-e898-4deb-930f-bd3eec8b520e">31.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTEtMy0xLTEtMA_69e49a7b-430a-4604-9c8a-254caddb6a9a">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTEtNS0xLTEtMA_6a451780-c860-4e99-ba8b-5ca8c6a0e1e1">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared, not paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTItMS0xLTEtMA_de003504-2d70-458f-9dc7-6c1bf14d8a70">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTItMy0xLTEtMA_47924429-c88a-4065-9cbc-14926283e6aa">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTItNS0xLTEtMA_0f109280-5f57-4388-9c03-a82305714154">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of investment in affiliated companies, treasury stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTMtMS0xLTEtMA_f9ba654a-1205-468b-a5cb-afecedf54785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTMtMy0xLTEtMA_908481bb-86e4-410b-97d7-c1b3073f8021">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTMtNS0xLTEtMA_8e3130b1-b66a-41ee-b721-8a927fbf0cce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMTQ_8b090077-154e-4c6d-b34f-d260b0c18e7e" continuedAt="i8f2129e5ae6d4c039f3288fb0c8557c8" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8f2129e5ae6d4c039f3288fb0c8557c8" continuedAt="i99f3c3b73f03478a962ad392996fbe49"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfODc5NjA5MzA0MjE5OQ_19075acc-c1ef-491a-888a-7737cb3a6803" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, we acquired the business of our distributor in South Korea for $<ix:nonFraction unitRef="usd" contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMzU4_1ea70ada-c53b-47e9-9006-47137d29e5c9">18.9</ix:nonFraction>&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $<ix:nonFraction unitRef="usd" contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTA4_eb5bf97d-7c4d-4aa3-8bff-fd958afcc35d">4.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTEy_aa9a6790-6e9b-4e60-8e1f-ae26d29de5ed">0.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTE2_e9e2257c-f7e7-4b17-b899-e4d61c743094">2.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTIz_77382e97-cb9e-4052-9c9b-1d93fcb96233">11.2</ix:nonFraction>&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West has been actively monitoring the novel coronavirus (&#8220;COVID-19&#8221;) situation and its impact globally. Our production facilities continued to operate during the year as they had prior to the COVID-19 pandemic, other than for enhanced safety measures intended to prevent the spread of the virus and higher levels of production at certain plant locations to meet additional customer demand. The remote working arrangements and travel restrictions imposed by various governments had limited impact on our ability to maintain operations during the year, as our manufacturing operations have generally been exempted from stay-at-home orders.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNjM_23c87f52-e42b-4bfe-ab78-2d87545311c6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNjQ_58afbfa6-bf59-42fb-9f7e-27f70a215c85" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMTU_91ccca20-8a5e-44bc-9d40-c62432594580" continuedAt="iaa1ba63f1ed746df8cf2cea80fdcf320" escape="true">Accounts Receivable:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaa1ba63f1ed746df8cf2cea80fdcf320"> Our accounts receivable balance was net of an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTU4MQ_0576c7d9-d3ab-4cf1-9521-d231d3ba08cc">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTU4OA_aad4a34e-15d7-4223-8213-1b95ec591c4a">0.5</ix:nonFraction> million at December&#160;31, 2020 and 2019, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMzM_a356043c-1171-4671-8a47-2ddfddae0b69" continuedAt="iaacd6247e3004fb784b2375b5b0193ff" escape="true">Inventories:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaacd6247e3004fb784b2375b5b0193ff"> Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value.</ix:continuation> <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5NTI_66251ea8-24ce-4df9-b19f-b451036b937c" continuedAt="ib171c51e3bac4854a806a1472d4391b4" escape="true">The following is a summary of inventories at December 31:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="ib171c51e3bac4854a806a1472d4391b4"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:68.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.875%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMS0xLTEtMS0w_0e119cfb-113c-4f0c-a6a8-178d9221a77b">133.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMS0zLTEtMS0w_20ea8ede-575b-4a42-9146-ce50704ec75a">100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMi0xLTEtMS0w_0d6f09fb-d0fd-4830-87f9-b625bb9791fe">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMi0zLTEtMS0w_242a7931-2bf4-4abe-beec-611064c65e95">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMy0xLTEtMS0w_ca5e2236-0148-4b29-a6bf-d28bd9f5c625">132.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMy0zLTEtMS0w_cfd2a31e-0fe3-4688-b99e-13f1944b8c5d">97.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfNC0xLTEtMS0w_cd162456-9303-4acb-a590-ba04d117ec00">321.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfNC0zLTEtMS0w_9fcdf5e5-2cec-4d58-9ab3-3072313132aa">235.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMjU_fd78cdab-ed79-44c9-bd99-e15d8018b3ba" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i99f3c3b73f03478a962ad392996fbe49" continuedAt="i4378c4f79d9b483ab8cc3770663e9011"><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5NTk_4530790f-5cbc-4e87-88e2-d5130eaeead8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2020. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_106">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5NTY_b1535aeb-6d25-4a30-b049-6a4254bb47bd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDA_5e64ef2c-1839-42e0-a696-7f94caeee30b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of <ix:nonNumeric contextRef="i1d47931a6e3740b480deaae11058a69d_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTg3MA_737b9113-f9d3-4973-bf7e-3151d3b76a9b">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i37e2e771b55940c7ab603ef0b73ffe0d_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTg3Ng_68f6a60b-5fc6-45d7-bd4e-6214d39148b3">25</ix:nonNumeric> years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5MTA_558b905b-0e3f-4bc2-a966-94789e89b3b7" continuedAt="ida18647cfc46414ca3d1a8446799808d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_145">Benefit Plans</a></span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ida18647cfc46414ca3d1a8446799808d">, for a more detailed discussion of our pension and other retirement plans.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4378c4f79d9b483ab8cc3770663e9011" continuedAt="if3d23804b8984050a2cd6a54a0f9c225"><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMDU_71d4e05f-135f-4d98-9d37-a2f45edbe5b0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5MTQ_e095172a-8f22-4980-9623-cbbaff14ec54" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5ODM_336c65c6-f5d8-4965-9e46-360e34b78d48" continuedAt="i67fef98a2dd5413c81035900f9913ded" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification ("ASC") 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_94">Revenue</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_94">,</a></span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i67fef98a2dd5413c81035900f9913ded"> for additional information.</ix:continuation> </span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5Mjc_a56feb1f-fc49-46ab-868b-93ed7c175960" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMTc_0786a9ec-e206-4f73-a728-0729d4a75f0e" continuedAt="if3787d91bed74499a34790a8fb5b75cf" escape="true">Research and Development</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if3787d91bed74499a34790a8fb5b75cf">: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:EnvironmentalCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDQ_6b0c307c-e260-4db1-b538-0741d99fdaab" continuedAt="id650f24197004f829e5a6de5fe4e197b" escape="true">Environmental Remediation and Compliance Costs</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id650f24197004f829e5a6de5fe4e197b">: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.</ix:continuation> </span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDY_5833c396-9947-4cff-ad42-81ee37ea118b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if3d23804b8984050a2cd6a54a0f9c225"><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5ODA_68351bbb-b52f-4aab-9228-f30a3d713aa2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_157">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDc_0b7fb27f-a6ee-4172-8fd9-12fae547cbd0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_139">Stock-Based Compensation</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a more detailed discussion of our stock-based compensation plans.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMjI_da662ccb-dd02-473d-a0da-9eae460b85be" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84OC9mcmFnOjU5ZmZjZTE1YTkwNTRlYTZhYzhjZWM2MjE3M2QxMzhjL3RleHRyZWdpb246NTlmZmNlMTVhOTA1NGVhNmFjOGNlYzYyMTczZDEzOGNfNjk5NQ_76927d1d-3976-4f48-97f1-4224a6178881" continuedAt="i056cffd0c1bf4c36ad21e9f5692e4603" escape="true">New Accounting Standards</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i056cffd0c1bf4c36ad21e9f5692e4603"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84OC9mcmFnOjU5ZmZjZTE1YTkwNTRlYTZhYzhjZWM2MjE3M2QxMzhjL3RleHRyZWdpb246NTlmZmNlMTVhOTA1NGVhNmFjOGNlYzYyMTczZDEzOGNfOTg5NTYwNDY3MTQwMQ_5a50e562-69e8-4ccb-bd48-70fb495e2a78" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 and by clarifying and amending existing ASC Topic 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We early adopted this guidance, which did not have a material impact to our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the FASB issued guidance which clarifies and improves areas related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance and the respective disclosure updates are reflected in our financial statements, which did not have a material impact.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020. The adoption did not have a material impact on our financial statements. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_133">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under the previous guidance, an entity reflected credit losses on financial assets measured on an amortized cost basis only when it was probable that losses had incurred, generally considering only past events and current conditions when determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a modified retrospective basis, to the accounts receivable and contract asset balances as of January 1, 2020. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. The effect of the adoption on the financial statement line items of accounts receivable and contract assets was not material as of January 1, 2020. As a result of our adoption, we recorded a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="ia62094f562004390b81aa8036d7b155e_I20200101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84OC9mcmFnOjU5ZmZjZTE1YTkwNTRlYTZhYzhjZWM2MjE3M2QxMzhjL3RleHRyZWdpb246NTlmZmNlMTVhOTA1NGVhNmFjOGNlYzYyMTczZDEzOGNfNDk0NzgwMjMzODcyOQ_20fa8cb4-55e5-4446-8d4d-a790f2891f46">0.1</ix:nonFraction>&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2020, to reflect the incremental estimated lifetime expected credit losses on the accounts receivable balance as of January 1, 2020. We have not presented the amortized cost basis within each credit quality indicator by year of origination as all of our accounts receivable are due within one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluat</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ng</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the impact to our financial statements, the transition, and disclosure requirements of this guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODU5OQ_d9596ac8-9507-4ab4-a3f1-00cbb76abaff" continuedAt="i885bf97cc8d04458994cac410150a34c" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i885bf97cc8d04458994cac410150a34c" continuedAt="ie619847ee682494cadcabcf6ca0f3fd6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of ASC 606</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, we adopted ASC 606, on a modified retrospective basis, applied to those contracts which were not completed as of January 1, 2018. As a result of our adoption, we recorded a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="idf9d37b38c2447e990845dc75ad10954_I20180101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMjY5_d8b3aae1-89dc-486d-ae04-d3ff1866ece5">11.4</ix:nonFraction>&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2018, to reflect a change in the timing of revenue recognition under ASC 606, from point in time to over time, on our Contract-Manufactured Products product sales, certain Proprietary Products product sales, development and tooling agreements, as well as an acceleration on a portion of the remaining unearned income from a nonrefundable customer payment.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie619847ee682494cadcabcf6ca0f3fd6" continuedAt="ib941bbf83e2848dfb254f281292cb0a7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $<ix:nonFraction unitRef="usd" contextRef="i7ab15527d47f4aa9a1633dab43f58d65_I20130630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzU1NA_547bf445-603c-4d3c-b861-d584ba766970">20.0</ix:nonFraction> million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="ie910eb49306b47f19aade26345fa3e40_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzcwNA_832cebe9-991e-49a8-b286-017b97788d16">4.7</ix:nonFraction> million of unearned income related to this payment, of which $<ix:nonFraction unitRef="usd" contextRef="ie910eb49306b47f19aade26345fa3e40_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzc2MA_020a35a8-43fa-4334-9138-5298ddfcb918">0.9</ix:nonFraction> million was included in other current liabilities and $<ix:nonFraction unitRef="usd" contextRef="ie910eb49306b47f19aade26345fa3e40_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzgwOQ_24969347-50c6-4b5c-8b22-5f88a3c68c1c">3.8</ix:nonFraction> million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib941bbf83e2848dfb254f281292cb0a7" continuedAt="ib2b3bc073b924608acbcaad6ac14a145"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODYwMg_8f4fde8c-8385-43ec-8e68-35a836ac82c8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i20906f3f318b4a2cba7c15716696f1dc_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMS0xLTEtMS0w_b046b843-fc7f-494f-b715-5e5c7304bf41">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i923c8a6896e54de69ca69cbbcaea99ec_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMS0zLTEtMS0w_1f5d2724-0c32-4b6a-821d-2dd4cb59ec68">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id367f23378974623b9859df2596c8183_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMS01LTEtMS0yNjMz_62d87707-d7f1-4d41-8788-79404bd0ba4e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff18b4560ebb4519988e5000afc9573e_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMi0xLTEtMS0w_de3ff0f5-b11b-44f8-bf05-d0618c0ba814">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd0748450e4b47baad0f75ab4d3d1e44_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMi0zLTEtMS0w_817ec41f-5320-46ed-84b7-dbab6dde47e9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d22ca205d074fadb933b7fd00da1f1c_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMi01LTEtMS0yNjM2_34ea1666-0b29-4850-a28f-e0ccbbe28fd8">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3e7a414c18f47b2b7c9f8868c4db4a5_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMy0xLTEtMS0w_0d3095cd-a728-4062-9dc3-2ed2aab8ceb0">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9aa616b221f246a086f3ff77b50744fd_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMy0zLTEtMS0w_5ec54909-273c-4dbb-a427-4ee12a97a272">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i018928bacb95446581fa8dd22ce885b4_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMy01LTEtMS0yNjM5_bc247c25-c024-472d-a2e6-02202501451d">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2940c5a94a5545e9b92428881a4b24ae_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNC0xLTEtMS0w_7b9a267f-f3a3-4ce0-b0ac-988cb97983c8">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b52db3c7d824219b44bf0415c21dd9b_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNC0zLTEtMS0w_4f472fce-f62a-4ea5-ab3c-e3ba178a3286">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife59a6f7e63848cfbf9db3761a806465_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNC01LTEtMS0yNjM5_4a45c336-5394-4d4e-9dad-d7bdf113dab5">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNS0xLTEtMS0w_2d3660f6-b990-494c-87de-402bbc4316d5">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNS0zLTEtMS0w_8dcd3cd6-45f8-414d-acac-566c37e9a7b1">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNS01LTEtMS0yNjQz_658bc5d6-7c12-41c5-b4a5-0adc410fc6fb">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i314b3eadc19f481a9a5cefedb7076b5d_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMS0xLTEtMS0w_98a8d9d9-6821-4a45-8840-b258dc6b14ef">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5c8bb5e908445ac94163109d6f187fe_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMS0zLTEtMS0w_c14ced34-ceec-454e-9d24-6a5f2480a09b">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic80d6874e9d04c2c969ac30de82af315_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMS01LTEtMS0yNjcz_932f227d-8b1d-4a05-9e6a-e4aa19b08514">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i695ca37571594a2f90e91281811f3f60_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMi0xLTEtMS0w_42dec7b8-1c69-4fdc-b63b-5d2b2aa7f8ea">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ca2c0bc504f46c09b0f5349f5d4babc_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMi0zLTEtMS0w_632bcbc9-f020-4e91-84d5-fe9faff0d92f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9b1d30e86ad0440eae32d35a5c10f6cf_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMi01LTEtMS0yNjcz_73d62b81-e457-4a11-abe2-27699412d3c8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icebffe8ea45e44b7ac1fb37ca2ab6e4e_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMy0xLTEtMS0w_2ff7deee-a1d4-4a81-80b0-eb68e341229c">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i045d57ee128a4dfbab51df17a738c76d_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMy0zLTEtMS0w_29757465-5407-45e5-856d-6ebb1886e738">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05f318a8522b4df3a88ab126fbe483fd_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMy01LTEtMS0yNjcz_b30854a9-91d4-4865-8931-1f0ce1ffcb7f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacdb2fa885c04d209366d073597b6e65_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNC0xLTEtMS0w_7b0afdfe-fce0-4e4f-90c0-cdc4bc6ae55f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i286700d9c43745be93c8819dcc7cbe24_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNC0zLTEtMS0w_7f3dd64f-409e-4ab9-a090-f70a9f6078af">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id754473ec64a4fc7bf5cd626c8c7f917_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNC01LTEtMS0yNjcz_5fe55953-8740-4c60-ae9c-9e14a3163ff7">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNS0xLTEtMS0w_0e73bc86-df52-4303-8dc4-7dcc72951b83">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNS0zLTEtMS0w_46e73c6e-e774-42f5-893f-68e776cc8e34">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNS01LTEtMS0yNjcz_b891521d-85d0-438e-bfa8-cc793f297761">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.712%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id933de360a3a4f38a4f172632d39f380_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMS0xLTEtMS0w_ba338729-ce76-423b-8b7a-f6608d16866a">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib979385c7bde4ce2b05dee2c7e29ab4e_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMS0zLTEtMS0w_ffc0b82d-b64a-43b4-8694-327470d7229b">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f265678664c4854ba64c2adc9a8a208_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMS00LTEtMS0yNjYy_9cdf3ea1-ec76-45a7-9372-2cd516dd8f00">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0b1fc94713546ad8ea568bae5635986_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMi0xLTEtMS0w_74c56172-1782-4a94-99d0-e1f1ba7a27df">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9ade024d2944ee28eb78ee61e0a8c28_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMi0zLTEtMS0w_ac2c50c1-1489-403f-adb5-64032dc089c1">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b8a3f92e87547398e250cd6e50d2471_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMi00LTEtMS0yNjYy_4048f509-cd00-47f2-8ac1-d0b9043820fb">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5a8e9607c46467ea4f32c403fb194c4_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMy0xLTEtMS0w_12f907d3-c0d9-4923-aca7-3eb3333b63c1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3c3a0fd2c284cc5b42da67050e9f64e_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMy0zLTEtMS0w_53276bfa-c571-4047-97e7-7382b69cd8ef">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e55590c051146b6bb265c367a817a3b_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMy00LTEtMS0yNjYy_e6aacdb7-b2e7-4d7e-bf51-32ba4fcbcc14">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfNC0xLTEtMS0w_301f4b82-fcd2-4b4b-9288-e37edaf76db4">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfNC0zLTEtMS0w_ff6c6f23-c6df-42a7-93e1-6afce4d8dd35">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfNC00LTEtMS0yNjYy_ba5396f6-363a-408b-96df-3175babf7ecd">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets and liabilities result from transactions with revenue primarily recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet within other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib2b3bc073b924608acbcaad6ac14a145"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODYwMw_a1137de1-334a-45ab-8c8e-0941009a6327" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:83.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2019</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfMS0xLTEtMS0w_95a92a28-5303-4ce3-9289-11e51bc4dc39">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfMi0xLTEtMS0w_abae4c3d-6cff-44dc-bf1c-eac7848ff0ed">10.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="wst:ContractWithCustomerAssetIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfMy0xLTEtMS0w_33af6758-93d9-46c4-95fd-21c1dea25c41">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2019</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfNS0xLTEtMS0w_02863d5b-1ce5-4a95-8751-8160efaf7bb8">34.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfNi0xLTEtMS0w_97d5cdef-62e7-4b19-9b4d-d97f05468f96">57.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - (increase) decrease</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfNy0xLTEtMS0w_b742f054-9613-4ac1-b8da-90beb35726b2">22.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has entered into new capacity reservation agreements, which include the receipt of up-front cash and therefore caused an increase in the deferred income account balance. The Company expects revenue related to the capacity reservation agreements to be recognized over the next <ix:nonNumeric contextRef="i1d47931a6e3740b480deaae11058a69d_D20200101-20201231" format="ixt-sec:duryear" name="wst:ContractWithCustomerLiabilityRecognitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODc5NjA5MzAzMzE4MQ_2f876d70-0555-41ac-9eb0-518d89539f37">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i37e2e771b55940c7ab603ef0b73ffe0d_D20200101-20201231" format="ixt-sec:duryear" name="wst:ContractWithCustomerLiabilityRecognitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODc5NjA5MzAzMzE3OQ_2d2c953d-43b9-448e-b90c-611806e5e0a4">2</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in deferred income during 2020 was primarily due to additional cash payments of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzAzMg_58298525-0388-449c-bf9c-72b55609caaa">100.3</ix:nonFraction>&#160;million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzAzNg_938a6717-8475-4d0c-97fb-2062d3f95ec7">83.9</ix:nonFraction>&#160;million, including $<ix:nonFraction unitRef="usd" contextRef="i5338787af4fd49bb99c35be9bb0ef3b9_D20200101-20200101" decimals="-5" format="ixt:numdotdecimal" name="wst:ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzA0MA_42f7140f-8861-4c85-a515-8d4e2f5ac294">26.9</ix:nonFraction>&#160;million of revenue that was included in deferred income at the beginning of the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain Financing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of December&#160;31, 2020 and 2019, we derecognized accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzA4OQ_5f6adc25-d384-448b-a103-6963d31b75cc">14.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzA3OQ_52043b67-d48b-45bb-93f7-a4161431aa75">10.1</ix:nonFraction>&#160;million, respectively, under these agreements. Discount fees related to the sale of such accounts receivable on our consolidated income statements for 2020 and 2019 were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voluntary Recall</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 24, 2019, we issued a voluntary recall of our Vial2Bag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $<ix:nonFraction unitRef="usd" contextRef="i73877135951c49808f223e59689acc98_D20181001-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:ProvisionForProductReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODE1NQ_465540ba-aa3a-4c10-a0eb-370f0b40caa7">11.3</ix:nonFraction> million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During 2019, we recorded a net provision of $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:ProvisionForProductReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODM5NA_100bee03-3b0c-4dba-a9c7-e849dde3cd97">5.4</ix:nonFraction>&#160;million for inventory returns from our customers and related in-house inventory, partially offset by a reduction in our pro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vision for product returns. On October 21, 2020 we received market clearance from the FDA for our Vial2BagAdvanced</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0mm Admixture Device and continue to work to get the products back on the market.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMTQ0Mg_c680a0a4-e838-4ec1-b02c-484f6ccd8f63" continuedAt="i58b12cb0c20947fbbfc605aec8cc0d43" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="i58b12cb0c20947fbbfc605aec8cc0d43"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMTQzOA_0d2576a5-cf8b-4469-915d-293d19f986b1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMS0xLTEtMS0w_015da4c3-5ba6-4d63-ac8d-f76a2bff1315">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMS0zLTEtMS0w_376bbe9a-a28b-4828-a24d-678ce14e8bf1">241.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMS01LTEtMS0w_1b7a02c4-4502-4784-8271-09c81b3c94a2">206.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMi0xLTEtMS0w_3cb2c2d6-8728-42e6-a735-f046d9b10a42">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMi0zLTEtMS0w_d64ba62d-c65b-404c-9401-ac1317f50811">74.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMi01LTEtMS0w_6fc130c4-cf73-4764-9ab7-43be9a701068">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMy0xLTEtMS0w_e4292bdf-a31b-4c0a-aea3-1fef95df87a5">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMy0zLTEtMS0w_967a826a-17ae-4f33-ae65-f55ebab1a081">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMy01LTEtMS0w_c6d565e1-8d08-40d1-9c1b-aff88d782bab">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfNS0xLTEtMS0w_0f90d11d-26d2-4e5f-81f0-525a4303c726">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfNS0zLTEtMS0w_41426d26-9c43-4ff3-8301-a995165fecbb">75.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfNS01LTEtMS0w_3833acab-8344-4d7e-8019-33dec8df31bc">75.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, there were <ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMjE2_2ad41dbe-c808-4cc9-8f72-ee1d4953bf3c">0.0</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMjIw_04011746-790d-4cea-b69c-b5c7d80babb2">0.1</ix:nonFraction> million, and <ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMjI4_03b8cf95-8175-410b-be3f-d1d39f8b5dd4">0.4</ix:nonFraction> million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to <ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMTA1Ng_ae86f099-397d-44ca-a1ac-a419d2446ac3">848,000</ix:nonFraction> shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. There were <ix:nonFraction unitRef="shares" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjEwMw_868eccde-370c-4bef-8c89-84e71e2a0034">no</ix:nonFraction> shares purchased during the three months ended December 31, 2020. During the year ended December 31, 2020, we purchased <ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA2Ng_42b5dd8c-b117-4946-81f5-ac3108c1f637">761,500</ix:nonFraction> shares of our common stock under the now completed program at a cost of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA3NQ_14fb3c2e-dce1-4d2c-9a2a-2a2988368395">115.5</ix:nonFraction>&#160;million, or an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="INF" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA5MQ_a1688507-ba1b-42a5-86a8-2bd445df08f5">151.65</ix:nonFraction> per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, we announced a share repurchase program for calendar-year 2021 authorizing the repurchase of up to <ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA1Nw_3aa96091-7c30-4048-a265-de6713bd7c53">631,000</ix:nonFraction> shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2021.</span></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:  <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2Xzg3OTYwOTMwMjM0MTA_884e81e7-152e-4232-a493-957ea08a4852" continuedAt="i565c71a625c944f2803e5cdeb2e67e6e" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i565c71a625c944f2803e5cdeb2e67e6e"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzEwNjM_88086b87-b786-42ef-877b-19ac3c054aa8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected useful lives (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i797e7706a95c4087904100b08ffda29a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzEtMy0xLTEtMA_c3baa2d4-4c2c-4682-9e41-436a0b58e8b8">24.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43893472b07f462daa1936e31dd6e050_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzEtNS0xLTEtMA_7e25c2bc-1702-4498-ac6b-503652df2616">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7dc331021b39487eae7d8020f2a6bbb9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItMS0xLTEtNTkxMS90ZXh0cmVnaW9uOjY1NDk4MTRkZGQ4NDQxZmU4ODVmZWZiOGE2YmM4ZjlkXzEwOTk1MTE2Mjc3ODc_758ba0ad-65fc-4a1b-a286-222f599ec627">15</ix:nonNumeric>-<ix:nonNumeric contextRef="ifac82b7c5e944f5e9ef69d0cc9b23961_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItMS0xLTEtNTkxMS90ZXh0cmVnaW9uOjY1NDk4MTRkZGQ4NDQxZmU4ODVmZWZiOGE2YmM4ZjlkXzEwOTk1MTE2Mjc3OTI_a9d09d07-c63b-4b47-b503-a29d68db3b69">35</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b9f3baa155749da88ba56d5f039aae7_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItMy0xLTEtMA_5b7dedab-ce50-4275-aa59-ac2488682977">618.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84fd26354a144cea716d068af99f852_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItNS0xLTEtMA_f72dda4a-7baa-459e-95cf-91c4b1ecad9d">572.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieac0052e9268404c8537a172e384ec54_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtMS0xLTEtNTkxNC90ZXh0cmVnaW9uOmM5ZjYyZDA0MjY5YjRkMmZiNmVmOWMwYzk3MjVjN2I5XzEwOTk1MTE2Mjc3ODU_0d56e508-f34a-46bb-bdfd-2bdfd6c33bd7">5</ix:nonNumeric>-<ix:nonNumeric contextRef="i623144efe05d406b97fe87c5de9251ae_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtMS0xLTEtNTkxNC90ZXh0cmVnaW9uOmM5ZjYyZDA0MjY5YjRkMmZiNmVmOWMwYzk3MjVjN2I5XzEwOTk1MTE2Mjc3OTA_351e97b0-7bb2-4379-9f03-e8f011518c11">12</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22f0862b68a74914864a578b3eccdf30_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtMy0xLTEtMA_52567968-6e3b-4775-bc13-3ac46058e111">911.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i238e2384b1ff420ebcc2252db6a22803_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtNS0xLTEtMA_b48fe0a2-af3c-424a-ab6f-a5eb7f9d096d">817.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds and dies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c646a3c66bd4b32b179638b0f4f3410_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtMS0xLTEtNTkxNy90ZXh0cmVnaW9uOjQ1NzU5Y2YyNmU0ODRkYjZhODFhMTgxZGYxYjI1ZjhiXzEwOTk1MTE2Mjc3ODQ_24bb7b45-8fa5-45b0-b4c2-6b36e4b6a5de">4</ix:nonNumeric>-<ix:nonNumeric contextRef="i9a501f1bfd934f5986193d345963b2c0_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtMS0xLTEtNTkxNy90ZXh0cmVnaW9uOjQ1NzU5Y2YyNmU0ODRkYjZhODFhMTgxZGYxYjI1ZjhiXzEwOTk1MTE2Mjc3ODg_cb0136f6-ea6a-449c-977d-37c63b43e42a">7</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6725930a324da584fa5818f87a7c19_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtMy0xLTEtMA_2c11f0dd-3ac3-4ff0-beb8-b4979aa2dfad">131.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0813f85e68a04705a535a614e3d8d1aa_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtNS0xLTEtMA_380e2fd5-6578-4905-9b3f-a5b013bbed52">123.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i74e88843a60b49ff82c73cb0b8167faf_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtMS0xLTEtNTkyMC90ZXh0cmVnaW9uOmZhMDkyZGYzYWIyNTRjYzViYjAwMjJhNjdkZjgzMjA3XzEwOTk1MTE2Mjc3ODU_487f3736-c586-4019-be86-2a97639db463">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i6b9182def7704d2e8b4c70f42352b523_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtMS0xLTEtNTkyMC90ZXh0cmVnaW9uOmZhMDkyZGYzYWIyNTRjYzViYjAwMjJhNjdkZjgzMjA3XzEwOTk1MTE2Mjc3ODk_04515077-cff2-411f-bf9c-2236f4851687">10</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb2ab515f964445a7edbb1dcb815cb7_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtMy0xLTEtMA_c9015722-22aa-402d-8434-65eab5043f0f">157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5e7423241f495ea2428efc693f1c2c_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtNS0xLTEtMA_50ea26d8-5de2-45c8-9c30-9174acf95ecb">155.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8af390c674040738b060151f2548d1e_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzYtMy0xLTEtMA_77ccb991-bc31-409a-bae2-87b7eecd9015">192.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fa20c7d6fe45dd9143b6334b282969_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzYtNS0xLTEtMA_8fa40194-a108-4891-8ffe-4b97f3e78401">128.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzctMy0xLTEtMA_b974160c-b387-4eb2-96f6-828d5ff2f591">2,035.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzctNS0xLTEtMA_391e0f28-5ad4-49d9-bc52-858d3dfc485b">1,820.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzIwOA_737de742-e481-4a62-b6b6-ed44d8f38fc7">104.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzIxMg_a8aae951-8046-491d-82ca-eb24efb67de7">100.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzIxOQ_71eb93c7-ce8e-404f-8761-890a837811c2">101.7</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzYzNg_c8afaa3b-a2fa-4b04-ae78-f78bcf8b2a84">1.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzY0MA_c8918be6-9d1b-40cb-9881-c28aa1433e6a">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzY0Nw_1145cfe6-c339-4ba7-90e6-f5b9cc207d1f">0.9</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019 and 2018, as part of our 2018 restructuring plan, we recorded within other expense (income) $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzEwOTk1MTE2Mjg4NDI_c6fb317f-3df0-4249-a04d-988e6daa6dd6">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzEwOTk1MTE2Mjg4NDY_a8cb9897-c2f5-4caa-af46-76475c9a2148">2.2</ix:nonFraction>&#160;million, respectively, for non-cash asset write-downs associated with the discontinued use of certain equipment. During 2019 and 2018, as part of our restructuring plans, we recorded within other expense (income) $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2Xzk4NQ_42a80a05-e8e2-4dbc-9a7e-18cbf2ccaf08">1.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2Xzk5Mg_d2bd995e-638f-48fc-9936-984e8dc6caaf">1.1</ix:nonFraction>&#160;million, respectively, for gains on the sale of fixed assets.</span></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:  <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTU_061400db-b451-45d7-ade3-07d41e629fa9" continuedAt="i2db603268c4344c8a84ee113229bf468" escape="true">Leases</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2db603268c4344c8a84ee113229bf468" continuedAt="if9cd3e48037b46558dd949af41fd2885"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of ASC 842</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of December&#160;31, 2020, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases provide us with an option, exercisable at our sole discretion, to terminate the lease or extend the lease term for <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:durwordsen" name="wst:LesseeOperatingLeaseOptionToTerminateTerm" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzc0MA_ca0da83c-e1b3-48c6-b920-98b56ad676c2">one year</ix:nonNumeric> or more. We had <ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:FinanceLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzc1Ng_4e548ac4-1fac-40f2-92a4-c00f1d004279"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:FinanceLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzc1Ng_efc6e348-60e1-4634-a499-c8e35771a256">no</ix:nonFraction></ix:nonFraction> finance leases as of December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTg_827f4584-8b2b-4f7e-8612-9f83fb62cd14" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzEtMS0xLTEtMA_15dd81a2-6451-4ad4-8e89-bae80d4c301c">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzEtMy0xLTEtMjkxMA_0304e832-f01e-415c-bd55-b2e204fcbe34">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzItMS0xLTEtMA_ac58b885-8ad1-4680-9a78-bd4b67aee18f">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzItMy0xLTEtMjkxMA_de59820e-5c4e-4002-b47c-927ab24c14ae">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzMtMS0xLTEtMA_b0705851-494f-4a59-a128-813437551d9a">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzMtMy0xLTEtMjkxMA_4b851532-d071-4af2-9380-72feccd8682c">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzQtMS0xLTEtMA_2e388ab0-f269-40ae-acf0-8750f75245fb">17.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzQtMy0xLTEtMjkxMA_64ddf3e6-26c7-4447-bc2b-47fdaf8e7d2c">17.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if9cd3e48037b46558dd949af41fd2885"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense for 2018 was $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzM5Mzc_b9eea502-9933-4d1a-8081-8df9008d44a1">14.5</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTk_c3e12da1-bd66-434a-ab01-bd2536ac35d0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzItMS0xLTEtMA_8d6bcc8b-4d35-4342-b931-ed6b5b875542">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzItMy0xLTEtMjkwNA_e3babba0-6333-4281-b462-18cc8274105c">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzQtMS0xLTEtMA_2ff45578-1497-423e-8e23-e067214c9876">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzQtMy0xLTEtMjkwNw_1653a02a-d821-4f0e-af01-ccbc9ff640e7">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, the weighted average remaining lease term for operating leases was <ix:nonNumeric contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxNTE_5dc9110d-b018-4e04-9847-8c4e915e3777">11.1</ix:nonNumeric> years and <ix:nonNumeric contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxODE_57bbd37b-deae-47d3-af97-58a21778af65">11.7</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxNTU_241af146-7213-4fd2-b728-45c51f009920">3.68</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxODU_82689cc2-6953-47db-9227-b7a93ec5721b">3.76</ix:nonFraction>%, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTM_cf6c0710-1515-41ac-b7a8-a626b2047032" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzItMS0xLTEtMA_46544d54-aaba-45f1-bc01-dd8186ae69e7">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzMtMS0xLTEtMA_3acfe051-69df-4c79-95eb-344022245ed3">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzQtMS0xLTEtMA_9cc6a8c3-d43d-40e1-a493-80218f8b74ed">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzUtMS0xLTEtMA_6d678577-d72a-4278-9f8a-3776bfb1a039">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzYtMS0xLTEtMA_0d316e6e-a0ea-478a-924c-c4eb53c8f9a4">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzctMS0xLTEtMA_78d5bad7-1569-4aed-9a5b-14d0d2bbe7c1">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzgtMS0xLTEtMA_5e1bda98-0774-4681-9a71-63b1fd0c67c1">85.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzktMS0xLTEtMA_58391b69-219a-4bee-8c1e-0eba67ea1b62">14.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzEwLTEtMS0xLTA_c74b2e61-bc46-42a2-9a80-cda5f34a67c2">70.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to adopt practical expedients around the combination of lease and non-lease components and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of <ix:nonNumeric contextRef="i1e509ff0f5b945d2a61627e10cf74c19_I20201231" format="ixt-sec:durmonth" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUxMzY_d16cad19-16fc-4bb8-8ff8-a0eccc07aa1c">12</ix:nonNumeric> months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_109"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7:  <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzIwNTY_f9cdf328-7f1b-42e5-9168-b667248c8046" continuedAt="iee393fe07df0495fa6a194d71020094e" escape="true">Affiliated Companies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iee393fe07df0495fa6a194d71020094e"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzIwNjM_f4d1a895-3183-446e-b0d3-128affb32deb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the following affiliated companies were accounted for under the equity method:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3be748d3389b4043bbf41058de1b56a6_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzEtMi0xLTEtMA_f4f5461b-c07b-4958-b1a2-cf7bdf479ccc">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aluplast S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3f00119f82f45ffaaf450f7f33b594d_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzItMi0xLTEtMA_590f19c5-e4b5-4d5a-a1d0-85c09c922259">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic55755bcb9b447d0bcdb031080c38641_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzMtMi0xLTEtMA_f3a2680e-a66c-4196-b687-4b62e9640152">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idca87fb6336b4470ae7aa7facb3cb9dc_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzQtMi0xLTEtMA_f63b22d1-cb6f-4426-8ae0-7c767d50cd61">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I&amp;W Pharma Group LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief5faa8076a2458484658e4551e6e62a_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzUtMi0xLTEtMA_489c8dfa-c923-4d42-8535-336f33a3bf14">49</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daikyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa409a36165643678fa489cb0bfba317_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzYtMi0xLTEtMA_38a1404a-1150-4d53-bc43-582f312d6242">49</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2019, in connection with the amendment of certain commercial agreements with Daikyo, we increased our ownership interest from <ix:nonFraction unitRef="number" contextRef="i7eb5c5ab7e624c9cb50fc001dee5e2ef_I20191031" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzI2Ng_106f8d88-c239-4f75-963d-17d8c234e50e">25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ic8e22ea7f9ce44e9bab1f731e0385e4c_I20191101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzI3Mg_f1cefa6b-430c-4d67-9013-cdb28080de8c">49</ix:nonFraction>% in Daikyo in exchange for $<ix:nonFraction unitRef="usd" contextRef="i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzMwMQ_12a85cf4-5323-4bca-8276-53fcccfba150">85.1</ix:nonFraction>&#160;million in cash and $<ix:nonFraction unitRef="usd" contextRef="i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzMxNg_f662b19b-692c-4be5-92f8-4e5861b10989">4.9</ix:nonFraction>&#160;million in shares of our treasury stock to certain stockholders of Daikyo.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unremitted income of affiliated companies included in consolidated retained earnings amounted to $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzU5Ng_c2d35588-d7ed-436b-88d7-0c147e755f5b">98.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzYwMA_f26f7925-4eed-4d2c-b1bd-0d34c2445aa7">82.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzYwNw_38c77537-f939-44fb-9899-b591bbea62cf">75.8</ix:nonFraction> million at December&#160;31, 2020, 2019 and 2018, respectively. Dividends received from affiliated companies were $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzY5Mg_832f4353-5c6d-4d8e-941c-fdef797e34d3">1.6</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzcwMg_cedfcd20-efa8-4c0d-9e94-02903f8af7a0">2.2</ix:nonFraction> million in 2019 and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzcxNQ_fbaa87bd-c248-4492-8498-3c56a2751137">1.7</ix:nonFraction> million in 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity in net unrealized gains of Daikyo&#8217;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $<ix:nonFraction unitRef="usd" contextRef="ifa409a36165643678fa489cb0bfba317_I20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzkwOA_24b1b141-6035-4458-8b05-62132a97a09c">0.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="if35f246fd3544635b81e8a42dbd0deae_I20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzkxMg_34aa5ec6-912e-4622-8fb9-e8e1bb170e66">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife9245eb0c4a4874b266ec836a4fdc4f_I20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzkxOQ_06fefc81-63c9-4e0e-86d4-0d206248d259">0.4</ix:nonFraction> million at December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases from, and royalty payments made to, affiliates totaled $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwMjU_e72d2c40-557e-46b5-a654-f963d6a38501">143.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwMjk_57a074b9-5ad2-4cc9-8475-d6335553ede8">115.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwMzY_5666abd8-9230-4f2e-8c80-c1d75d762f05">86.3</ix:nonFraction> million, respectively, in 2020, 2019 and 2018, of which $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwODE_96fe10c1-3731-4af4-9853-a7bfa65c8928">33.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwODg_2b4da9d9-1dd1-4bfb-a22d-85e5f457cb42">20.8</ix:nonFraction> million was due and payable as of December&#160;31, 2020 and 2019, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:SalesToEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzMDk_1e0cf3e6-20be-4458-9b42-a3783b6cf1b1">9.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:SalesToEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzMTM_b9a95393-699b-445e-9480-7615375d2f11">9.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:SalesToEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzMjA_cd71ec3b-5e72-4c66-bd78-489f7ef52096">9.6</ix:nonFraction> million, respectively, in 2020, 2019 and 2018, of which $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzNjU_2a445dbe-2bf5-4451-9f45-66a266e5e96a">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzNzI_77a6262d-96a2-4e37-a69d-cfb58954de6d">1.9</ix:nonFraction> million was receivable as of December&#160;31, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzE1NTk_ed617f56-ea69-408e-b48b-d3a76cc18a01">201.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzE1NjY_3da011f7-4add-4a04-8791-79adbbf2f6ae">179.3</ix:nonFraction> million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzE3MTU_612bd491-50d0-42ca-82ae-47ec0a226ea8">12.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwOTk1MTE2Mjk4OTI_55ee5eee-29a2-44f0-ad19-425a1993e209">13.4</ix:nonFraction> million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:  <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzExMTU_0256b49f-83f6-4d8b-9495-eb4eab11b19e" continuedAt="i7b7cbf24974c485f88f561c1cd1901bc" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7b7cbf24974c485f88f561c1cd1901bc" continuedAt="ie7c4ad96feb54f8a9484737a6ef6e940"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTc_8210dee4-83b0-45cf-924f-dbc59d15f11b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b64636eec7496ab4fe500fe0014523_I20181231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzEtMS0xLTEtMA_da774c8a-b579-4855-b1a5-aad8aceb2c4e">76.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80b77bc4ac4259a6a16b2462cb3040_I20181231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzEtMy0xLTEtMA_492a08d1-99c5-4bc3-a4bc-3f6e43ff4d04">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzEtNS0xLTEtMA_43b5e315-f2ce-4371-ba3b-5e0aa901791e">105.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill recorded due to acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da13621281d4304b07876e3311d46e7_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzItMS0xLTEtMA_fab9de13-1b6f-4999-a516-c26c95940f88">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe51fd72fce4c61b52e43766f31dd16_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzItMy0xLTEtMA_fa7b4bf1-146b-4f86-8903-1eda9a60477d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzItNS0xLTEtNTcyMg_dd6344de-eeb0-49be-802d-34be2020170d">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8da13621281d4304b07876e3311d46e7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzMtMS0xLTEtMA_00ab10ae-6f02-494f-ad46-4200f68a09f8">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe51fd72fce4c61b52e43766f31dd16_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzMtMy0xLTEtMA_6a75e079-257a-424f-b11b-72c14d35b98b">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzMtNS0xLTEtMA_3bb7494e-0d05-4067-94c7-e369330c32c5">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie604f66c47674b3483e91758ca61fca3_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzQtMS0xLTEtMA_c06d5a32-19e0-4929-b025-32d02c21f7bd">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3bd440b2a0d4e18b3b9208a2c52f423_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzQtMy0xLTEtMA_bf6db2e7-4da5-45f4-be54-48a23fb7f6bc">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzQtNS0xLTEtMA_9603085a-5c91-4fe6-8971-23941597f366">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4310b97395d143c894afeb7bfaa7db95_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzYtMS0xLTEtMA_93d9a60c-3453-433f-9a09-e53faac3eb3a">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbef396511e4f7d99df2d1f6bf9ea78_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzYtMy0xLTEtMA_b6ec7f94-70ec-4cbb-ba60-28cf1aae223f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzYtNS0xLTEtMA_ab9a0f1a-f26c-4def-a70a-6568649238cb">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8653a82cd240399911d2be8d12b1c9_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzctMS0xLTEtMA_e1877e0f-2891-47cc-8bc5-acbaa57d55cd">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d40747cb76f4017801fff732122769f_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzctMy0xLTEtMA_9971b8a4-49c5-498f-8b45-ff2849471cc3">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzctNS0xLTEtMA_b606d837-ba50-4be0-b66e-21f4a6a12a49">111.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="ib0d1e9f54b0d4246bce9c1710ee63360_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzI2Ng_0c1a1d7a-127a-4330-890e-59f9c11ad82e">2.6</ix:nonFraction>&#160;million. The goodwill was recorded within our Proprietary Products reportable segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had <ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzYwNDczMTM5NTM5MTE_4e743792-8990-4e24-890d-235ae6597897">no</ix:nonFraction> accumulated goodwill impairment losses.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzExMDA_067ca9db-aee8-4463-9768-41c6d7bb5fe8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licensing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItMS0xLTEtMA_dbc9f868-632a-4ef6-afd8-d12c9dc8a145">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItMy0xLTEtMA_3f29435d-4a09-477e-8089-5f549c975d9d">17.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItNS0xLTEtMA_5f654622-9a22-4031-9244-4881bb4eff5b">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f82da0975740ea962df3a9317d294c_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItNy0xLTEtMA_bf365a5a-e364-4f6f-9893-23a86a095f2b">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f82da0975740ea962df3a9317d294c_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItOS0xLTEtMA_03542255-9da7-4a5e-acb6-2191120c84d8">16.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f82da0975740ea962df3a9317d294c_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItMTEtMS0xLTA_ef2ef103-7098-4e25-ac54-44c82b807c0c">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44052635f445ae955fe9e5585b43a6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtMS0xLTEtMA_4b5fd4f0-1a12-4e08-8722-1412e6068165">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44052635f445ae955fe9e5585b43a6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtMy0xLTEtMA_2e56aa9c-ae41-4c7b-bceb-2b487709f740">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44052635f445ae955fe9e5585b43a6_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtNS0xLTEtMA_19ece3cb-acdf-4d9e-bb70-448da8261ac7">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e9699cda854495a74995b636566af6_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtNy0xLTEtMA_f0993605-a7ef-46d1-a7bf-60eff38d97f5">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6e9699cda854495a74995b636566af6_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtOS0xLTEtMA_b9dc4d85-2653-4778-8663-186a47e7846b">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e9699cda854495a74995b636566af6_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtMTEtMS0xLTA_feea1739-43a1-4c9e-a5ad-89160ae9289e">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtMS0xLTEtMA_846d2fb0-3aac-4ae8-bc0c-a398689c28fd">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtMy0xLTEtMA_f3801fc9-04fc-47b7-a2e6-92449565702e">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtNS0xLTEtMA_ff70466d-8b4f-49e4-bda0-103248c3b7e7">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22d02338f104289981b9d9ff7b017ce_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtNy0xLTEtMA_fc189c86-6ea2-4545-9363-c91a8e369274">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id22d02338f104289981b9d9ff7b017ce_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtOS0xLTEtMA_d5c74001-78dc-48f6-a0f0-c606da09d872">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22d02338f104289981b9d9ff7b017ce_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtMTEtMS0xLTA_a2fccac9-76a5-4e31-b14b-ebede1cf5edc">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d276e7e42d4f86a942aeb848b531f3_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtMS0xLTEtMA_1ef6804e-49ae-4cc9-8b60-35eeb53e4985">40.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11d276e7e42d4f86a942aeb848b531f3_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtMy0xLTEtMA_99a8dd5e-5dfb-43ed-bf3e-b44803b49f0a">23.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d276e7e42d4f86a942aeb848b531f3_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtNS0xLTEtMA_7ebfc947-573b-4a2a-a208-50ba362ff2e1">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i675a7006751b46918799584d6d648565_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtNy0xLTEtMA_703b51fb-cc78-4d69-89ca-5dac8454de94">40.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i675a7006751b46918799584d6d648565_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtOS0xLTEtMA_5e3db3f7-ab68-4eeb-bd7d-79ef4b36f851">21.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i675a7006751b46918799584d6d648565_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtMTEtMS0xLTA_c37df9eb-a4fb-4399-bfdc-4a149e0ce926">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aca41366c9f474c9c65cbd82020f94d_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtMS0xLTEtMA_3a37650c-4021-4b60-92fc-5da28ec4b43a">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aca41366c9f474c9c65cbd82020f94d_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtMy0xLTEtMA_5bdc42f9-3a0d-4dd8-9e68-a0cb992c0f75">7.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aca41366c9f474c9c65cbd82020f94d_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtNS0xLTEtMA_1c4eceb1-fcae-4d35-93f1-75c19f1b4904">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id040728146984679be5dc82bedb6dd6b_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtNy0xLTEtMA_b1aa5068-749c-4e23-80b5-089b5c72810c">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id040728146984679be5dc82bedb6dd6b_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtOS0xLTEtMA_edd0cdad-230b-418b-ae36-7457bae24551">7.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id040728146984679be5dc82bedb6dd6b_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtMTEtMS0xLTA_1f082c06-bcee-4066-bbb3-27b46c091c2b">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctMS0xLTEtMA_f75ecb86-6c9a-4459-8a6a-33caf2b953ec">83.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctMy0xLTEtMA_602eb19c-cf13-471d-ac33-daa213510ff5">52.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctNS0xLTEtMA_9289e050-464d-4c9b-b7a8-e21c60acc6be">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctNy0xLTEtMA_c3bd9ddd-aba7-4409-9283-96f6c2a157ab">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctOS0xLTEtMA_78bcfdd6-69d9-438a-abb9-b9cabc7d3393">48.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctMTEtMS0xLTA_07b337ce-2b61-4baa-b60e-b46700a735d0">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the acquisition of our South Korean distributor in April 2019, we recorded a customer relationships intangible asset of $<ix:nonFraction unitRef="usd" contextRef="ie61c5d576f4c47feb0147ea226ccf081_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzY2MQ_b4ba6f24-70b4-4592-b097-d0d436256d21">11.2</ix:nonFraction>&#160;million, which is being amortized over <ix:nonNumeric contextRef="id71719218e6a4641a583e3045ba927ad_D20190401-20190430" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzYwNDczMTM5NTQwODg_f1351d0b-b8c3-45a5-88dd-313748cb2d13">ten years</ix:nonNumeric>. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie7c4ad96feb54f8a9484737a6ef6e940">The cost basis of intangible assets includes a foreign currency translation gain of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzc5MA_2f704d32-5800-4616-b0a7-265b640d863d">1.3</ix:nonFraction> million and a foreign currency translation loss of $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzgzNA_0710735f-09f7-415a-a297-0aa76e63e773">0.3</ix:nonFraction> million for the years ended December&#160;31, 2020 and 2019, respectively. Amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzk0MQ_e5ef343e-720f-4b98-9bdb-15d591ca93e4">4.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzk0NQ_01b50bfa-572a-4be3-8900-0546e9efa412">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzk1Mg_1f8112eb-240b-4247-811e-bde3519a506e">2.7</ix:nonFraction> million, respectively. Estimated annual amortization expense for the next five years is as follows: 2021 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg4OTc_a0982705-955b-498d-aa4e-37de692628b5">3.8</ix:nonFraction>&#160;million, 2022 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MDE_9766c7fe-5693-488b-a326-1ba13aff2bb7">3.8</ix:nonFraction>&#160;million, 2023 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MDU_4226c81b-ae8a-4498-94c1-fada1fac703d">3.7</ix:nonFraction>&#160;million, 2024 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MDk_53219b69-80c4-4e24-8e75-e17ff3c5ff73">3.6</ix:nonFraction>&#160;million and 2025 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MTM_3030229e-db37-4b9e-8883-1bd9ddf109ce">3.4</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:  <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90ZXh0cmVnaW9uOjI4ZTQyZjEyZTUxYTQ2ZDE5ZWY5ZmFkMDViMDBiOGI1XzExOA_503a588e-a4b2-44e9-b41f-ef0baa24c97a" continuedAt="ieeaf92f7ebb24b0785a50151332204ec" escape="true">Other Current Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ieeaf92f7ebb24b0785a50151332204ec"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities as of December 31 included the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90ZXh0cmVnaW9uOjI4ZTQyZjEyZTUxYTQ2ZDE5ZWY5ZmFkMDViMDBiOGI1XzExNA_a95d953a-aa63-47fb-820c-7ac89fd9fd3e" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEtMS0xLTEtMA_b8869f46-261b-43b9-9837-e3cc349846ae">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEtMy0xLTEtMA_66a5ed4a-812d-46e3-be69-07ac4a2cc2ca">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzItMS0xLTEtMA_c8a83d97-540f-43bf-96d9-11c5a639659d">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzItMy0xLTEtMA_ef2ab29c-51f5-473d-b34e-05ab0597c095">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzMtMS0xLTEtMA_4dfe3966-8628-4200-bb20-2ee49b686c0a">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzMtMy0xLTEtMA_e9dae2e1-bd3f-4a28-a17f-3fe2cfadaa0a">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzQtMS0xLTEtMA_8dfa934b-b74f-454f-9f47-9f39e8f10f55">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzQtMy0xLTEtMA_fc01ee3d-e7ee-49e0-b4b6-737477a0fec0">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzUtMS0xLTEtMA_0f1e23f2-7985-4f83-abae-53f269cd7fa7">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzUtMy0xLTEtMA_92d1c0d7-7701-4110-9bbc-0b527f021bfb">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzYtMS0xLTEtMA_16d88deb-93c8-4b33-88b0-104d077e2554">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzYtMy0xLTEtMA_c9bf4a23-bb90-49de-935a-2a525790b0c2">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzctMS0xLTEtMA_7248ed60-29b4-4a3c-ab98-0f6fdaad1aa4">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzctMy0xLTEtMA_e39173c3-5a33-4c62-ad8c-e78694a1c797">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzgtMS0xLTEtMA_39e71a2d-0441-4d7e-83d8-4cc689f645d4">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzgtMy0xLTEtMA_3f106b8f-bf5c-4f2a-83df-60d4a4e101d0">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMS0xLTEtMTA1MzM_9c682fe1-9fa9-4472-a22d-699f7570c4b9">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMy0xLTEtMTA1MzY_01a9cb53-0238-44bf-83d2-f50c3d074046">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMS0xLTEtMA_571b040d-29b4-4b19-8231-4cc3f0e87258">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMy0xLTEtMA_9f4d7d8e-c3f8-43eb-b75c-f21ea4c3a9cd">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEwLTEtMS0xLTA_45fbe08a-09c4-4c1c-9173-345bdbc1840d">143.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEwLTMtMS0xLTA_7ab128db-73c4-4a26-8187-16363363a8e8">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUxNzI_203b043c-279f-4593-95e5-24c2c3f2708d" continuedAt="i4ac151cbe2d5405abcbb39e71bdc1318" escape="true">Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4ac151cbe2d5405abcbb39e71bdc1318" continuedAt="i2d53ea4e3588419da22a61277212fba9"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUxNzM_68666dca-a98d-434f-8ba3-2679fb35de1b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (<ix:nonFraction unitRef="number" contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzgtMC0xLTEtMC90ZXh0cmVnaW9uOjVmYWRjNzAwMTkyNzRlNWM4YWYwYzIyZGNmMzM5NWY3XzEwOTk1MTE2Mjc4MjU_be5b5424-346b-461c-a3f5-46a4f9f36ee6">1.13</ix:nonFraction>%)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzgtMS0xLTEtMA_86a72f48-44a2-4a61-b3a6-cccdab1fb0f7">87.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f18ec1636d4475a790dad18e1921a7_I20191231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzgtMy0xLTEtMA_b5558c97-d434-4def-bfcc-ad47a015adf2">90.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A notes, due July 5, 2022 (<ix:nonFraction unitRef="number" contextRef="i4fd969a8862944cda67258a0d270f5df_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzktMC0xLTEtMC90ZXh0cmVnaW9uOjkyNzIwOWEzODE3MDQ0Yjk5MzJiMjExYjc5NmU3MmY1XzEwOTk1MTE2Mjc4MjU_dcd23989-1a4d-4634-8c93-313c6d5e5fbe">3.67</ix:nonFraction>%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd969a8862944cda67258a0d270f5df_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzktMS0xLTEtMA_5d186424-f01e-4f93-9f5a-220ad0240c45">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf89ae5341df4d38abf9f74b7c69e08b_I20191231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzktMy0xLTEtMA_a181afbb-46e5-4b4f-a96a-a3f4113fe06d">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (<ix:nonFraction unitRef="number" contextRef="ic8f4f2eff7da48748127b29635896464_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo1NmI2ZTJlNjc5Mzk0ODRkODg2YmE4OGMxODY4M2FjOF8xMDk5NTExNjI3ODI1_074555c0-50d0-46ec-a57f-708053aeacb0">3.82</ix:nonFraction>%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8f4f2eff7da48748127b29635896464_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEwLTEtMS0xLTA_a3fb99fd-753d-46a9-9583-394310629b0c">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6bb6da4755b453bac747d67b20ec2c5_I20191231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEwLTMtMS0xLTA_e569b3b9-14b3-4b05-a1a3-913b5073bfde">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (<ix:nonFraction unitRef="number" contextRef="i3d56da838e884589a4b9b27e4dba56bd_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjphNmJjZTUxMGFkNzk0YzI1YjMyYzk2YTk2ZDJjMTYwMl8xMDk5NTExNjI3ODI1_0c34c981-163d-4c6a-bfb2-03b1f6d50234">4.02</ix:nonFraction>%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d56da838e884589a4b9b27e4dba56bd_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzExLTEtMS0xLTA_741e26c3-d6e0-4590-82e3-d3d609dbce16">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d8b84cad2c648c3aac2a92756cb752e_I20191231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzExLTMtMS0xLTA_92881d37-0fed-424c-a4dc-e23712507903">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEyLTEtMS0xLTg5Njc_112a2d3e-08a9-4d7a-8fc0-5eacc145b449">255.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEyLTMtMS0xLTg5Njc_01c429b2-5804-4757-9f93-4e8ee3e1ff2e">258.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEzLTEtMS0xLTA_170e5e15-58b6-4cf0-b57c-fe9b4eebc52e">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEzLTMtMS0xLTA_852d3184-f899-4182-9dfa-cfc3e10df59c">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE0LTEtMS0xLTA_0e65c9f5-5836-4380-b23e-2eeb3a47bdb7">255.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE0LTMtMS0xLTg5Njk_9a3297a8-d227-4b9a-9e4c-cafd1b38746c">257.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE1LTEtMS0xLTA_d1bc60fe-a359-4a54-89ba-e1d62ebf06f3">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE1LTMtMS0xLTA_6a430f9c-3abd-4acc-b567-a0bc88bd3df0">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE2LTEtMS0xLTA_abc53287-d0ee-43ba-99bf-e445cef8cdbe">252.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE2LTMtMS0xLTA_509eec23-2a21-41b5-8c19-549c0f1f458d">255.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2d53ea4e3588419da22a61277212fba9" continuedAt="i032124909c3945afb5a71e2af8398c21"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement - Credit Facility </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains the Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5Mw_50d4aaff-f96e-432d-9ab1-fe6cb36271ab">300.0</ix:nonFraction>&#160;million, with sublimits of up to $<ix:nonFraction unitRef="usd" contextRef="i36499f4c892042c99421485b861d8b26_I20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:CreditFacilityIsAvailableForSwingLineLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUyMQ_cf2e446e-5f0a-4071-b388-c44775a98547">30.0</ix:nonFraction>&#160;million for swing line loans for domestic borrowers in USD and a $<ix:nonFraction unitRef="usd" contextRef="i053014645cf54e15bc7d157e3bd317fa_I20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:CreditFacilityIsAvailableForSwingLineLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzU4MQ_dd6c56f0-e5bf-4408-868f-75d279fc69f9">20.0</ix:nonFraction>&#160;million swing line loan for our German Holding Company and up to $<ix:nonFraction unitRef="usd" contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:CreditAvailableForIssuanceOfLettersOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzY0MQ_49d51a80-1e35-4da9-af77-e1a0f2aefc5b">30.0</ix:nonFraction>&#160;million for the issuance of standby letters of credit. The Credit Facility may be increased from time-to-time by the greater of $<ix:nonFraction unitRef="usd" contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:LineOfCreditFacilityAdditionalBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzc2Ng_ef6d1342-837c-40b9-97be-d3d5b7bb6021">350.0</ix:nonFraction>&#160;million and earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="i9a0baa710cca4e74ba3a4ba6d1ff9627_D20200101-20201231" decimals="1" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzExNjM_2a652ff3-3e18-4045-9d83-aecf487b7ed1">50</ix:nonFraction> basis points or the daily LIBOR, plus <ix:nonFraction unitRef="number" contextRef="ib790285c47534a188d7b8a25e56a0757_D20200101-20201231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEyMDQ_bffe0b0d-38cb-4f4f-a7ea-741596e3a553">1.00</ix:nonFraction>%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from <ix:nonFraction unitRef="number" contextRef="i79870e1d300248c4b2045f7b6b99751d_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzNDc_626943af-e3fc-4052-8688-505fbf12885e">0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i2dadaa6cfa6a402590d0baa08c3b3ff0_D20200101-20201231" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzNTM_7bba4fac-8285-4966-80d5-551cb7dd6db6">37.5</ix:nonFraction> basis points for base rate loans and <ix:nonFraction unitRef="number" contextRef="i9276b28f1b2f476a8f79b186a11cf9cc_D20200101-20201231" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzOTM_fe63e7b1-99d2-4e98-b86c-69602e2a0bf2">87.5</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i0d9aaaa15fea43d5b98afa0705388896_D20200101-20201231" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzOTk_613ef8ad-d1fb-4b50-8c59-2604fe511639">137.5</ix:nonFraction> basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than <ix:nonFraction unitRef="number" contextRef="ie84290cd198b4597b8a2abee7084ce4a_D20200101-20201231" decimals="1" name="wst:RatioOfDebtToEBITDA" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzE2MDM_8a08ec23-77cf-4cb2-b200-d608824cfd98">3.5</ix:nonFraction> to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to <ix:nonFraction unitRef="number" contextRef="i77bf362efbe64c2ea5409f4177fc61b9_D20200101-20201231" decimals="1" name="wst:RatioOfDebtToEBITDA" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzE4NTk_92a826b5-1866-4388-8feb-507c9da4e248">4.0</ix:nonFraction> to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December&#160;31, 2020 and 2019, total unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ib153aa539cbc4b36bc036f9670da7976_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMwNzI_d9c2c1f7-9711-425c-b5c6-9416f3a05025">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8cdb2635fb0940748713a05a2e05ede6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMwNjY_8bc252ef-c678-4c64-8451-ff08748370b0">1.1</ix:nonFraction>&#160;million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had <ix:nonFraction unitRef="usd" contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermLineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzI0MjA_d126b837-1023-45b9-a7bf-3ba577de7d29">no</ix:nonFraction> outstanding borrowings under the Credit Facility. At December&#160;31, 2020, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i0818ca18d1c04be49b0664009bcbaa77_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzI4MDA_315bb1ed-acbe-4a20-942b-e1303c77e507">2.5</ix:nonFraction> million, was $<ix:nonFraction unitRef="usd" contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNjY_f64a99c6-7a83-42db-94bd-99cfa55d3e6a">297.5</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement Amendment - Term Loan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#8220;First Amendment&#8221;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $<ix:nonFraction unitRef="usd" contextRef="ia8f18ec1636d4475a790dad18e1921a7_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzMyNDU_28bc4c53-22d0-4052-a318-78d42d45bb58">90.0</ix:nonFraction>&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month LIBOR plus <ix:nonFraction unitRef="number" contextRef="i0acb2d0db3f94443812b8dad4134f99f_D20190101-20191231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzMzNTk_86a3d98d-2b76-46dc-983e-806f2389bfd3">87.5</ix:nonFraction> basis points. As of December&#160;31, 2020, there were unamortized debt issuance costs remaining of $<ix:nonFraction unitRef="usd" contextRef="ief5c6bd09e604af9b7086fafcc87e380_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMwODI_9b40a5bf-aaaf-4d40-9675-d71b983f4c68">0.1</ix:nonFraction>&#160;million, which are being amortized as additional interest expense over the term of the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At December&#160;31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxMTA_504e6ccc-b16d-4938-abb2-81b223252403">87.7</ix:nonFraction>&#160;million in borrowings under the Term Loan, of which $<ix:nonFraction unitRef="usd" contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxMTQ_34015267-5871-4917-befc-ab1c7f876885">2.3</ix:nonFraction>&#160;million was classified as current and $<ix:nonFraction unitRef="usd" contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxMjU_bc85f1bc-f233-4c12-a21f-cd1866a22e8f">85.4</ix:nonFraction>&#160;million was classified as long-term. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_127">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Private Placement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, we concluded a private placement issuance of $<ix:nonFraction unitRef="usd" contextRef="i40b38bc3ea1249599a6fddd5077007ca_I20121231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzM5MDM_a300fec3-b8bf-43f5-b592-67752e5ce2b1">168.0</ix:nonFraction> million in senior unsecured notes. The total amount of the private placement issuance was divided into <ix:nonFraction unitRef="tranche" contextRef="if9b19f87e2fa4bd7b7446c6d36467a3b_I20121231" decimals="INF" format="ixt-sec:numwordsen" name="wst:DebtInstrumentNumberOfTranches" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzYwNDczMTM5NTg2MzI_df29e8fd-76d7-4bb0-869f-3475602e0dc5">three</ix:nonFraction> tranches - $<ix:nonFraction unitRef="usd" contextRef="ic05b210f28044eacb815b7c56280e7a8_I20121231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwMTg_d572cf95-d855-41d8-9e6d-a8b2500fbf59">42.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ic05b210f28044eacb815b7c56280e7a8_I20121231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwMjE_db87cb24-1b9e-4ded-ab9d-4b84805f9e5e">3.67</ix:nonFraction>% Series A Notes due <ix:nonNumeric contextRef="i1a8d1afadc494e8ca3807d39357fab2c_D20120101-20121231" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNDM_d876d693-f944-4a86-b356-3f067d13b193">July 5, 2022</ix:nonNumeric>, $<ix:nonFraction unitRef="usd" contextRef="ie1fdf8a78aa34446888179eb44e2ba9f_I20121231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNDc_bf7793ab-d0d1-4520-975b-c026c70499ac">53.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ie1fdf8a78aa34446888179eb44e2ba9f_I20121231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNTA_8d748dd0-4f87-4444-89d9-6b14c1687826">3.82</ix:nonFraction>% Series B Notes due <ix:nonNumeric contextRef="i7fe9b14827ba48db9e2a32e413c46681_D20120101-20121231" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNzI_32c283ba-5e7a-4bec-90d7-cfaf804a016f">July 5, 2024</ix:nonNumeric>, and $<ix:nonFraction unitRef="usd" contextRef="iac32389974424652ba8a1cd7cfffab8c_I20121231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwODA_ae48ce89-85e7-42af-8c51-1bf49fb29eef">73.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="iac32389974424652ba8a1cd7cfffab8c_I20121231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwODM_ddd737cd-dd26-4675-9bfb-30f863026f65">4.02</ix:nonFraction>% Series C Notes due <ix:nonNumeric contextRef="id54a356e860a44f0a5c4f4291d81c943_D20120101-20121231" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQxMDU_eb38a0fe-c88b-4a06-80f2-eca323051407">July 5, 2027</ix:nonNumeric> (the &#8220;Notes&#8221;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes is <ix:nonFraction unitRef="number" contextRef="i40b38bc3ea1249599a6fddd5077007ca_I20121231" decimals="INF" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQyNTM_5c48f548-c513-42d4-b324-90fb3b33e784">3.87</ix:nonFraction>%. As of December&#160;31, 2020 and 2019, there were unamortized debt issuance costs remaining of $<ix:nonFraction unitRef="usd" contextRef="i59aded202b8249ceaaa3c323b8b6ee44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxNDA_0b866632-55a1-4384-aa1c-13feb6955b13">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i85263fd85aef48eeb384af58612ce47d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxNDQ_eb405f71-ea95-4730-845b-7765b3f298aa">0.5</ix:nonFraction>&#160;million, respectively, which are being amortized as additional interest expense over the term of the Notes.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i032124909c3945afb5a71e2af8398c21"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2020, we were in compliance with all of our debt covenants. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest costs incurred during 2020, 2019 and 2018 were $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5NTQ_3d20f8c3-23b5-4882-b0ea-c6dddb8f57d2">9.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5NTg_56a8e624-a38c-421d-bb76-5572c7148a14">9.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5NjU_c6cf17db-548e-4c3b-b4ce-c7d2dac62dd6">9.3</ix:nonFraction> million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, were as follows: $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNzE_e6880efc-2210-41f4-8bc1-de2c2c593482">2.3</ix:nonFraction> million in 2021, 2022 $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNzU_8458ee52-28fd-4918-9add-f6b135e03ab9">44.2</ix:nonFraction> million, 2023 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNzk_1d42f531-71b3-49b0-8a07-3d39d527a6f6">2.2</ix:nonFraction> million, 2024 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyODM_cf84dc10-53c2-4213-bdd6-dc7685fc92c0">134.0</ix:nonFraction> million, 2025 - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyODc_aef76e5e-1de2-4333-909c-1b6f241b0ed4">0.0</ix:nonFraction> million, and thereafter - $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUxNjQ_6fdf1b59-c686-4645-adc5-edc41fe3c5b2">73.0</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMzg_6516d360-9b93-4afe-8a1c-d452d4b28e54" continuedAt="i5fd54d46f2fa4946afb743661e9caeaf" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5fd54d46f2fa4946afb743661e9caeaf" continuedAt="ie539acbc51744624925b15ac04c36264"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2020 and December&#160;31, 2019, the total amount of these forward exchange contracts was SGD <ix:nonFraction unitRef="sgd" contextRef="id2df6627be904a9aaf00483f12940dc4_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzk0OA_ff1b97b5-a8c4-4a64-a41c-c315b7c33600">601.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i252de83d670e4d1ba875a6c0d2fdd702_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzk1NQ_c71fa534-edca-44f4-a5d2-4e452f08e205">13.4</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to <ix:nonNumeric contextRef="i5ee03ed217f4413f827d72745983e40f_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:DerivativeTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzYwNDczMTM5NTg1Njg_fcec5f3e-72ab-487b-95d8-3fa4e54b0a18">eighteen months</ix:nonNumeric>, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMzk_427d647f-6d9f-4023-9467-066d7c264bef" continuedAt="i64b520fd05714937b80f95f641ef4858" escape="true">As of December&#160;31, 2020, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="i64b520fd05714937b80f95f641ef4858"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Euro</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897b04b0d4e34a368ecdaa5308ccf498_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzItMS0xLTEtMA_3c37205a-1f8c-4e42-a273-01bd54ba3796">57.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i531ab9f165fe49a0afa50abe554696f2_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzItMy0xLTEtMA_a2bbe920-76f8-4690-9079-620cac718518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i531ab9f165fe49a0afa50abe554696f2_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzItNC0xLTEtMA_b3a45fa7-c54f-4e88-9720-74864e4b4b98">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i5aed1c49d23b4bc8983a2bb4f02182d6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzMtMS0xLTEtMA_73baaeb7-c7c2-43ec-9bba-ccc87310e861">7,194.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabc497ed7d9444b85e9cce201865f83_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzMtMy0xLTEtMA_ecb57044-4e2e-4a51-8040-f5f39fd6cfd5">42.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ieabc497ed7d9444b85e9cce201865f83_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzMtNC0xLTEtMA_23a8be20-d80e-40b6-843f-ef0f14ad2f75">22.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sgd" contextRef="i01129bb47aaf431d90ed2cb429db9b45_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzQtMS0xLTEtMA_376e319b-296e-481c-bee4-8f56090f180f">42.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c2cfc044364719874b1386740f71fa_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzQtMy0xLTEtMA_f34de57a-0438-42e0-9921-6c82142c3477">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i04c2cfc044364719874b1386740f71fa_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzQtNC0xLTEtMA_a2dab304-a92d-4792-bbca-839cd1f4d0b9">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie539acbc51744624925b15ac04c36264" continuedAt="ie9a66e0390664353add5fc05dcbc01b6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a <ix:nonNumeric contextRef="idb1615ceaf2a499986cb01691d97764e_D20191201-20191231" format="ixt-sec:durwordsen" name="us-gaap:DerivativeTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzYwNDczMTM5NTkxNDU_32b7f9c2-05c3-4acf-ada3-9b6dc82662b5">five-year</ix:nonNumeric> floating-to-floating forward-starting cross-currency swap (the &#8220;cross-currency swap&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="i139517c5b19c4c238b0b6d76659ca642_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzI0NTY_7f2ced63-ea80-4786-ad61-8ef88592467a">90</ix:nonFraction>&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;<ix:nonFraction unitRef="jpy" contextRef="i6ff56989b09342d4bf86220442ddc67e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM1MzU_fa826cab-5991-4f97-8299-70454c794f9c">9.6</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="i6ff56989b09342d4bf86220442ddc67e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM1NDM_6e1d524c-0278-4ff4-b3e1-41291cb9d980">87.8</ix:nonFraction>&#160;million) as of December&#160;31, 2020. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through December 2020, we purchased several series of call options for a total of <ix:nonFraction unitRef="bbl" contextRef="iba0a8733971342b896a7d0f4d587b143_D20171101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DerivativeNonmonetaryNotionalAmountVolume" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzMzMzY_a189c404-496c-487a-b612-01f6ada3cb94">472,477</ix:nonFraction> barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had outstanding contracts to purchase <ix:nonFraction unitRef="bbl" contextRef="ibfdda46fe61740e6a80e78c142d7da03_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNonmonetaryNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzMzNDA_a34c620a-29a5-4a7a-ac88-85fff65dc71e">141,734</ix:nonFraction> barrels of crude oil from January 2021 to June 2022, at a weighted-average strike price of $<ix:nonFraction unitRef="usdPerBbl" contextRef="ibfdda46fe61740e6a80e78c142d7da03_I20201231" decimals="2" name="us-gaap:DerivativeAveragePriceRiskOptionStrikePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzMzNDQ_ca0e9ddf-106e-48d1-a6b4-1960b5df4cdb">59.14</ix:nonFraction> per barrel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_133">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMjg_173f4827-a030-404f-b858-bac5aa4456c9" continuedAt="i027aa2f84d924a1299a809742e159a4d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzMtMS0xLTEtNTYzMA_4af5c96e-b859-473e-83c3-00709e61d805">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzMtMy0xLTEtNTYzNA_ee4d191a-1ea8-4dde-9ed9-586ee5973f43">15.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMS0xLTEtNTYzMA_f862ed9e-154c-4a9d-81d1-035171ab7209">28.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMy0xLTEtNTY0NQ_5c4e555b-9c06-4d25-be14-4098d00a8d34">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzUtMS0xLTEtNTYzMA_1920bc3b-2428-43ad-965c-bd6d132b73ca">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzUtMy0xLTEtNTY0NQ_f928c390-432b-4f70-9071-ac225d3dc052">6.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMS0xLTEtMA_5139da23-1a67-4805-94fa-84f53511865d">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMy0xLTEtMA_3eb4f8ca-a4e8-4456-a6ca-f8aee083716b">6.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December&#160;31, 2020 and 2019 were $<ix:nonFraction unitRef="usd" contextRef="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM0Njk_27ff27a7-0731-43df-8498-ff1f99e0ee31">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM0NTg_fe886547-b245-4ec3-81f8-4d945be22d7b">8.7</ix:nonFraction> million, respectively. We expect to recognize $<ix:nonFraction unitRef="usd" contextRef="i5d779650ed364fd08c026185a18a616f_D20210101-20211231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM0Nzc_0382ed4a-8185-448a-b342-54708f96f157">1.8</ix:nonFraction> million in earnings, pre-tax, for forward point components in 2021.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie9a66e0390664353add5fc05dcbc01b6"><ix:continuation id="i027aa2f84d924a1299a809742e159a4d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia766950276184bbc849712d05a16b8c6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtMS0xLTEtMA_761a89d5-5acb-4eb6-856e-d1c03e45fb87">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia815265990ad4f3abe0d627f15f293cb_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtMy0xLTEtMA_79f67432-d787-4300-9f70-76595e729fb3">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia766950276184bbc849712d05a16b8c6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtNS0xLTEtMA_6a83388f-757c-4dc8-8b56-7b531d88306d">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia815265990ad4f3abe0d627f15f293cb_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtNy0xLTEtMA_318955ba-071e-40c0-a4f6-a0a9e3c51e10">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtMS0xLTEtMA_adb1a0f0-3580-439b-b1a4-1e2e4bba0b04">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtMy0xLTEtMTAwMjk_47071c37-72c9-4f95-87f9-ae37fd65f6de">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtNS0xLTEtMA_85cf2a8d-5ed7-4e16-ba40-0227280188e6">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtNy0xLTEtMTAwMzc_ff2671bc-73d3-4124-83e5-404719f5d53d">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f263abf32a8469dadba8af24398c81e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtMS0xLTEtMA_7638a058-41b7-4576-8f32-b66ffd341b9e">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9848d3f7103145a283f6dfcbf2d72655_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtMy0xLTEtMA_3520e18a-f1d9-4523-b273-255108ffa4bf">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f263abf32a8469dadba8af24398c81e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtNS0xLTEtMA_2dce38ed-c9c6-40d3-b4d9-079827d25f26">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9848d3f7103145a283f6dfcbf2d72655_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtNy0xLTEtMA_a0273e43-bc4e-4ba9-bf48-1435d664b5c9">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic495cc68ba6b4b1694f7a3fd4db93012_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctMS0xLTEtMA_dcfdc46f-4b28-4201-b8b3-a5ce2eaa486a">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16739f8659e14555937d0e778a704f20_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctMy0xLTEtMA_e6b323fa-ff9b-4ef8-94d0-9ffe028159f9">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic495cc68ba6b4b1694f7a3fd4db93012_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctNS0xLTEtMA_33dfc609-d03b-4d08-b35d-557b3225bcae">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16739f8659e14555937d0e778a704f20_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctNy0xLTEtMA_c8fa89aa-866b-44b5-ab12-b377bf6cd638">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13810f93490c470abbbb7b177ad2c70e_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktMS0xLTEtMA_ddd8891d-1160-4f5c-8b56-f3a1fbaeddc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5247f6308b4858a3772e7407bec118_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktMy0xLTEtMA_64dff4b4-8633-4338-a420-5baf60c568a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13810f93490c470abbbb7b177ad2c70e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktNS0xLTEtMA_d9758f15-7c87-4e1f-a2d5-e62b99c0be16">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5247f6308b4858a3772e7407bec118_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktNy0xLTEtMA_76fe6782-38e6-4ec1-82cb-294419016bda">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f77a45ab1ee47a3ada5f6fcca04c84e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTEtMS0xLTA_26cb7ec8-5550-4889-b4ff-85fc72012dc5">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic12ff4fafcd445b084b889fe3305c91c_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTMtMS0xLTA_3c58379b-0d1f-4e54-b383-9ab82831bdf2">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77a45ab1ee47a3ada5f6fcca04c84e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTUtMS0xLTA_7a4f40ab-af6c-4c75-9d2c-242c18af845b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic12ff4fafcd445b084b889fe3305c91c_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTctMS0xLTA_d4d6d5d8-3d38-44ca-b5f3-91b0fce5c82b">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9154515da1a548fea6cda75ecab6d22c_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTEtMS0xLTA_80e601a7-5628-4887-a5c2-21f661c6d7fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c3a44d90234809a59a5c72a954a186_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTMtMS0xLTA_ae63d5db-5112-40c4-9470-1c7fa808386b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9154515da1a548fea6cda75ecab6d22c_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTUtMS0xLTA_0fb2f3fa-8724-4544-bc51-bd52710eace6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c3a44d90234809a59a5c72a954a186_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTctMS0xLTA_34e1af10-6ec2-42ff-b1e0-9418a54c6419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if00c3d38891a437c9731668076f93583_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTEtMS0xLTA_58102ef6-ba99-4ddc-ad7a-382ce60940db">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa425d5cda7449f4a965d518a8498929_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTMtMS0xLTk4OA_b3a45eb1-55b2-4024-816e-992c35a37ede">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00c3d38891a437c9731668076f93583_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTUtMS0xLTk5MQ_2f25853b-8e71-4e41-b3ee-bc11a34f2c1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa425d5cda7449f4a965d518a8498929_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTctMS0xLTk5NA_52ce7e95-e170-4bc0-8092-0e52cf74e3a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98f2ce6380048b498942fe656d21ed9_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTEtMS0xLTA_8091c20f-e3d2-412a-9602-5dd16b8da641">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d44d9b0abe64e9c8fd7b8070ad808e7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTMtMS0xLTA_5f80bb30-c322-4b34-b3ad-39a2e0fdec5f">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98f2ce6380048b498942fe656d21ed9_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTUtMS0xLTA_653dd42f-2274-4270-a9f7-369ec9e65b28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d44d9b0abe64e9c8fd7b8070ad808e7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTctMS0xLTA_8614fa4e-7df1-4c7e-9e5e-09b488c084e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i910293864a4644e2bed118d404b0a767_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzEtMS0xLTEtMA_801b4bbd-7d34-41f2-9ed1-a2d5f5192179">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie74cfeda5713466fb73b2c27fca500a4_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzEtMy0xLTEtMA_7127f96d-9dd4-4963-9229-acfb17fc3239">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29005ee8df5b4ec39d6cdb0828b7dcb1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzItMS0xLTEtMA_4e33329c-2b5f-404a-b0e4-5e3454605b90">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94f10a3f9bbb4fff966da3ea80caf6b3_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzItMy0xLTEtMA_76568f15-4f44-45e2-9ebb-da7db3c22c7c">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzMtMS0xLTEtMA_f35508f7-7a0c-4d25-8000-a87288742a18">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzMtMy0xLTEtMA_646eec77-84a7-4e78-ad50-c33be3fb7201">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20703276ec2492ebfbc9c45c8e0ac7e_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzQtMS0xLTEtMA_a4d38878-2f7f-4009-af8a-3c003c8c53d7">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7734ad779fa1491187a73582966992ee_D20190101-20191231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzQtMy0xLTEtMA_6da734a3-333b-44fa-b047-62d3337bb995">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMzM_cb88923c-0d23-4089-9046-80bbfd7f3fae" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ec217f28a14172945a28df8210d239_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzItMS0xLTEtMA_0aa7cdad-cc93-430e-bdd2-6ffda27786b7">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9237b0939d04baab3100c204058459f_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzItMy0xLTEtMA_662b01fc-fe0e-4e78-a8f0-77b2fd40bec0">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c2886a63984bbfacf71552235bd450_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzMtMS0xLTEtMA_8953b4f5-ba0f-4a1f-8c6f-323ed967e3dc">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09837e92679f4dce8b31c888e3564350_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzMtMy0xLTEtMA_daaf90a1-3f3d-4ca4-9fa0-3e49cffb4b2c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2019, there was no material ineffectiveness related to our hedges.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_133"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5OTE_d28174d7-07d6-4533-824f-c233d575c5c3" continuedAt="i945b44d62e154c16977b324f9322650e" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i945b44d62e154c16977b324f9322650e" continuedAt="i278c1314530c44f78a10664ac836cf90"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5OTg_cb6bd8cb-0a43-4f75-b1f7-9b66df467264" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtMS0xLTEtMA_b75944a0-96ec-4723-87af-fb1a9ab3b670">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtMy0xLTEtMA_af8a03b6-7396-48b1-b264-72165b6ca354">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtNS0xLTEtMA_947db53e-6718-4267-a8fc-b1afaee0a71b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce83038c2641929269fa9febd355c8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtNy0xLTEtMA_7a128152-dcf5-4d94-b9f1-20a1755e4dc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtMS0xLTEtMA_25aa6835-97f6-4fe4-b8a4-7292e29d2350">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtMy0xLTEtMA_469bc0d7-ef38-418e-8c2b-9881dfcb3ee4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtNS0xLTEtMA_ddb58db2-2b45-4b4b-85b9-e6d803ab6455">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce83038c2641929269fa9febd355c8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtNy0xLTEtMA_092718ab-9cba-4887-82ea-5008f1e46c7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512334ec39334b2c92eadce7653de2b8_I20201231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtMS0xLTEtMA_607ec55d-89a8-4e6f-a51e-0695df6d497e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf21d4ddd1a4397b60f40f3bd3f765a_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtMy0xLTEtMA_ca689c94-4610-4898-b0e5-c9a84d925efa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaf35b6e1c0b46a8bb43590b974f7cf2_I20201231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtNS0xLTEtMA_2368956a-8be4-476e-91b9-4975aa3e5ba3">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8053738038f04d46be3849707bcbbdea_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtNy0xLTEtMA_c19c5bd2-2e59-423d-ae91-71280ccdea36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctMS0xLTEtMA_ca5ccaa7-7810-4613-81e8-14333da27305">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctMy0xLTEtMA_f77f90e5-c14b-49b6-97f4-15e115d660a0">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctNS0xLTEtMA_9be28d11-5cb3-42cc-905c-fb6da71a6751">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce83038c2641929269fa9febd355c8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctNy0xLTEtOTAzOA_61e21341-c114-4b48-b6ca-5f2823100100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktMS0xLTEtMA_34994bec-d063-41bf-8a00-7f154485849d">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktMy0xLTEtMA_131eb966-e85a-4b13-9870-6013642ec6d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktNS0xLTEtMA_9a16034e-98b0-4437-a57e-b73d4dd53d5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce83038c2641929269fa9febd355c8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktNy0xLTEtMA_236f267c-5190-4d64-acee-de8855518310">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTEtMS0xLTA_f6d17e17-a60f-49b1-bdc6-352d141ba3e8">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTMtMS0xLTA_7bc4616d-1b70-4248-890d-b0c191e29948">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTUtMS0xLTA_b00b2a05-7940-4f76-b76d-879b417655f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce83038c2641929269fa9febd355c8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTctMS0xLTA_e8bbf5eb-b372-4afd-bf78-d4a22e7d4f8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba0cd37398843499f9cfbbcc1d88190_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTEtMS0xLTA_9f239d00-81ca-476f-bb88-5dcb422d80af">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4124f16416b429fa6225456655a8660_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTMtMS0xLTA_5ffa24c9-f7ae-4b1e-b216-82dada77411b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea7dadd6e8e4893929788b5e7b6e3f9_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTUtMS0xLTA_fcc69327-7084-4c9c-8571-8baec953f4f9">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b77a899950e419aa8380f233b32847f_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTctMS0xLTA_53dca378-3934-4feb-be22-53607a4563a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideda06631bc243b6a3ad62cd4484d60c_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTEtMS0xLTA_a575e9d9-31c2-41c4-9fac-8811fc23bc00">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed7924e91c448cc906ea5c40bdcfde4_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTMtMS0xLTA_1ce36c8d-0fbe-46d4-aeab-8282b87b9330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e10d28fc0cc413fa59ffcb836fd2a62_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTUtMS0xLTA_a149b386-1ae3-498a-bbc5-e87198ca6a9c">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdc1f55bdfaa4f77bc2d00ee21f69a3d_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTctMS0xLTA_16a64b44-cb00-4522-8111-7ee320ea1f76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTEtMS0xLTA_d1c20330-3c3b-4b48-9357-eb7dd8d21e9b">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTMtMS0xLTA_ea882465-26ef-404d-a542-f1db0a97a08b">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTUtMS0xLTA_c5cef614-e9ff-4443-a9a8-290a93556a52">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce83038c2641929269fa9febd355c8_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTctMS0xLTA_628a2f4c-894f-438f-94f0-d4407f3a50ef">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtMS0xLTEtMA_d3c33832-e680-43d5-806d-832ae94ec89d">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtMy0xLTEtMA_aa686b13-3d44-424b-836e-e982618c02e1">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtNS0xLTEtMA_f3a1c5c4-62a5-4928-96db-14c061da1c37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtNy0xLTEtMA_e63f9b97-9777-4434-b85d-453977f46f74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtMS0xLTEtMA_6e328da8-7b31-4c87-aa1b-8079b417a8ce">7.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtMy0xLTEtMA_d82f2150-eb42-4a67-8004-369f17761b5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtNS0xLTEtMA_e17c49f6-b394-4278-90a1-25c94d0c0b5a">7.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtNy0xLTEtMA_ffb56b1f-8de4-43a7-a068-10ee7c4c293f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16fa19e29e634aeab2eb9224f0b45b18_I20191231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMS0xLTEtMTAwNg_2914136b-1db8-4bb5-a1d3-d41ecd58971d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i724fe533a83d433eae9b42977e2f7b50_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMy0xLTEtMzI1MA_dbf4627e-cb51-4c2e-8b0b-e155e790123f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c7a7f771134445a80565de94c28062f_I20191231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtNS0xLTEtMzI1NA_5be41a28-83b0-4e32-a8ea-b9778a04d907">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id048dc02c0b2469fbea105614ae2e480_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtNy0xLTEtMzI1Nw_ceaf547a-c899-4a58-91d3-57ba4073a2b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMS0xLTEtMA_5d611a97-af93-40a7-ba4c-d9b13ece3421">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMy0xLTEtMA_dc0b4973-1c33-4c99-8abd-720e138e332f">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtNS0xLTEtMA_01b4484f-de03-4ae2-aefd-af076d1fce89">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzctNy0xLTEtOTA2OQ_3af2820b-1b26-49ed-926f-b3f155607d3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtMS0xLTEtMA_d1fb8468-b54a-4061-94e5-6e93f582da5f">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtMy0xLTEtMA_842e48da-bd38-4b59-902c-971986a421ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtNS0xLTEtMA_3a2b0e02-4102-450d-bdf5-0fdcaff51dba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtNy0xLTEtMA_1f5b26d1-09ab-459c-9aec-cf55fbef3eb0">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktMS0xLTEtMA_004853e1-d07e-4921-b929-885b03f1e31c">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktMy0xLTEtMA_aa3bc2fa-adb4-4380-b8bf-4cc78e0a7dcc">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktNS0xLTEtMA_ab4a2160-f6b2-40fc-ac5c-a48e64a88c4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktNy0xLTEtMA_775021ee-c931-4f49-8588-c47f100f4f88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bde75d952ad42e98d7390be88bb1df2_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTEtMS0xLTkwNDU_53eddf52-efab-4af6-8e5e-fc6fdffd9057">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60ffcae4b075439ca55b2069a4fd47f1_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEwLTMtMS0xLTA_080e4fe8-b260-406a-969d-ee84cb471a0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c78a5b1b01444c69b59c15f8578421c_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEwLTUtMS0xLTA_b4984f9d-123f-4fe6-b5c9-3da61d6491db">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4cb3f26d5954c919726e7cb7785fd7d_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEwLTctMS0xLTA_937d5bad-a7b6-47ab-86d5-40ae7b951f8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0568fea18da421bbd3bca7960cc204a_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTEtMS0xLTA_5ca7c09b-ede2-4802-82ce-c10056d37149">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1207be39ba114326a769b349741e01cd_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTMtMS0xLTA_593eb568-9690-4355-8b3e-480b21949558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dbc3b28347940649422a5aabfb3dc04_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTUtMS0xLTA_3f3c49ec-75b5-42a6-a123-99e4959fabbb">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a4e354d29304999b66d6671f79f5028_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTctMS0xLTA_fd0b06eb-cb4c-476b-9034-5d070a6856ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTEtMS0xLTA_3761e8b2-20d2-4d40-8e0a-79df088fbcb9">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTMtMS0xLTA_3f29ca70-0ec5-472e-be37-9f77dd9871cc">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTUtMS0xLTA_1ddd4321-22f1-44bd-93c2-152448737972">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTctMS0xLTA_88222604-fc7e-4f9c-b8a2-9a8ea8dcd500">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i278c1314530c44f78a10664ac836cf90" continuedAt="i3cf3885897d8485e83718446c7b2478c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term liabilities, is valued using a market approach. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_127">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our derivatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration liability related to the SmartDose technology platform (the &#8220;SmartDose contingent consideration&#8221;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. Sales projections were derived using upside, base and downside forecasted cases for each partnership and applying probability-weighted scenarios of <ix:nonFraction unitRef="number" contextRef="iccc55ae3f38944cb8ac2a8bf2c81c4b4_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2NjM_f5d9e14a-040d-45dd-a797-e8812c578534">10</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i4447f5127f674e7f8698a17c77e3f3b5_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2Njc_c7ee7372-22de-41c0-82b3-cc03a86bc8f3">50</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie942ed6d0ed647738c0b530564afcfc5_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2NzE_d164cd39-d8e8-4d5c-8066-24f0a156ad93">40</ix:nonFraction>% to the three cases, respectively, to reflect the likelihood of West meeting the estimated sales projection targets. The probability of success factors included the probabilities of successful FDA approval for each partnership drug, which was estimated in a range of <ix:nonFraction unitRef="number" contextRef="id7f2ccbcf7004f9783ca3beb8c271c99_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2ODA_7f97d2e5-8642-4b52-b5cd-e1417796b779">19</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i196249d46fc346f1a73485f5ad2fbf3c_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2ODU_fdbed9e0-62a5-46a2-a39e-85c9b3b8057a">100</ix:nonFraction>% based on the development phase of each respective drug, and the probability of the successful execution of supply agreements with each partnership, which was estimated in the range of <ix:nonFraction unitRef="number" contextRef="i5e3b441cdb5d4c2da4292cead5f46a91_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2ODk_6cb5eef1-cd62-4bc7-b352-b952054529b0">25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i09071b9fb2a14ad282d0cfdd020d47c4_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2OTM_1a6b86b7-386c-467a-9513-7f264167d41e">100</ix:nonFraction>% based on historical, current, and future supply agreements with the respective partnerships. The fair value of this liability utilized a risk-adjusted discount rate of <ix:nonFraction unitRef="number" contextRef="ib058c9e2b3e74454af000898cd0285bf_I20201231" decimals="2" name="wst:BusinessCombinationContingentConsiderationMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2OTc_1fbea047-85d5-4a12-b45c-969afb332b5e">19</ix:nonFraction>% to present value the cash flows. The discount rate is calculated by determining the after-tax required returns on debt and equity and weighting each return by the respective percent of debt and equity to total capital. Key inputs for the discount rate include the risk-free rate on the 20-Year United States Treasury maturity, equity risk premium, company-specific risk premium, pre-tax cost of debt, and U.S. tax rate, among others. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzQwMDA_4211d60a-2b22-4780-bdad-cb950d160411" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzEtMS0xLTEtMA_f39ba641-c98f-4e07-b344-eb36d8ade648">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzItMS0xLTEtMA_64b217c2-c1c8-4345-a30a-3e8012724abf">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzMtMS0xLTEtMA_7a05c00e-6ed0-4cfc-8b9b-d4929e0593d2">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzQtMS0xLTEtMA_f5494f14-c25a-4d54-b746-61f7f083401e">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzUtMS0xLTEtMA_2f6f85ad-d2f9-415b-b1a1-c8d36c3b5c8a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzYtMS0xLTEtMA_5bf25015-7b00-485c-a682-4845cf598996">0.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzctMS0xLTEtMA_9d422886-f886-420d-880d-026ba25be4a5">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3cf3885897d8485e83718446c7b2478c">The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities, and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2020, the estimated fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM4NjE_cd6b21db-692a-414a-882f-e7296e054670">265.7</ix:nonFraction> million compared to a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM4OTc_468be1ff-10e8-4ba5-bb0d-734072aed9f8">252.9</ix:nonFraction> million. At December&#160;31, 2019, the estimated fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5NTU_f6f3efd3-edf9-46de-9424-d28f77d6e0dd">263.3</ix:nonFraction> million and the carrying amount was $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5ODY_e15f53a3-6a36-4de6-9802-3a95ee84f49f">255.0</ix:nonFraction> million.</ix:continuation></span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13:  <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90ZXh0cmVnaW9uOmM1Y2ZkMzg4MGYwNDRhNGRhMTQwYzVhN2I0YzU4M2U0XzQ1Ng_8ed2c76a-92ac-43a7-b4a7-0de11b16bef9" continuedAt="if5c895c4ec774abb971ae559d09a2588" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if5c895c4ec774abb971ae559d09a2588"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90ZXh0cmVnaW9uOmM1Y2ZkMzg4MGYwNDRhNGRhMTQwYzVhN2I0YzU4M2U0XzQ3OQ_cb27b145-e9de-442a-bb57-cdccefb0d334" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id84b7326bff74d6ebd4702280f7944cb_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtMS0xLTEtMA_963423c7-8b1f-4cf1-a055-407d11b4b55d">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f46e104061488a90e0e2d284629010_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtMy0xLTEtMA_923ef832-ee96-4f3d-914b-2209c33817b6">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i658cc38b8a3b41eda1a5d4e62559ac50_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtNS0xLTEtMA_6d1f675c-3f09-44d6-b8cb-81882e1b61f1">40.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51bfe342f5e747da8972ffeb014b1e1f_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtNy0xLTEtMA_ef7cb4e7-6f66-46a4-a504-11dc4144c1e0">113.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7db531a64e249498d81ca1360119f0c_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtOS0xLTEtMA_67ef522c-2296-4ae4-899c-b1812c9c8761">154.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItMS0xLTEtMA_ac2ff207-c422-406a-bef3-7b7d1192567f">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItMy0xLTEtMA_047bc4b9-cb2a-449a-84ab-2f3917b61789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItNS0xLTEtMA_4e35e32b-f36b-4840-90fd-5e9241bbdd03">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItNy0xLTEtMA_8c01f587-fc7c-4f74-a463-da2caccda0a6">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItOS0xLTEtMA_7deeebc2-9a24-4a33-86d7-e910983037a4">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtMS0xLTEtMA_d5ae3c29-980f-47d6-b217-177807696f7a">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtMy0xLTEtMA_08741186-307d-472f-89b0-421d270e457e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtNS0xLTEtMA_d26bed67-cf9d-4062-9288-f3be11afe75e">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtNy0xLTEtMA_91c3d575-905e-459c-837e-21b76ec50116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtOS0xLTEtMA_2773cb1c-0962-4a3a-9fbf-0fb8f287dbc9">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtMS0xLTEtMA_7b34ce7b-94ac-48e6-b40b-b7367a5833b2">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtMy0xLTEtMA_3c19a879-4033-4556-ab6a-e58db59f7310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtNS0xLTEtMA_c48f276d-cc98-4421-93bc-15dc15ed9bd3">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtNy0xLTEtMA_0268090b-59b3-4d2a-8d82-f87037588947">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtOS0xLTEtMA_25f8c6c1-ec61-4542-abfb-31c31017a53e">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id681882b891d45d7b8705f79a7375de1_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtMS0xLTEtMA_9543decd-5640-44b8-b37e-a6af372f3456">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7365acbeffa54ca3967c4b060d8a6454_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtMy0xLTEtMA_f1c8b765-6eb8-4363-9e6f-f9e6c8e369bc">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad1f1467c6694df4a0d7fc8661e6b67c_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtNS0xLTEtMA_07abc791-7691-47d9-be37-f90f8fa8fb9d">40.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394755247a4245c5b34c032dd17977d5_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtNy0xLTEtMA_cc4861c2-94b8-44de-864b-1aed371fa19e">108.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cd9ef6885cb4483a826dc5519bf65fb_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtOS0xLTEtMA_f0841ae1-b258-465f-94f3-b491396fba2d">149.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtMS0xLTEtMA_25d8731c-6ae1-4b27-8a5c-5c20537b1a90">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtMy0xLTEtMA_675cc8d3-eff9-471c-9b25-70fb2ee3763f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i896e20ef243241948a91a08bcb36aada_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtNS0xLTEtMA_b8fc6ca1-7a21-49cd-8a4d-b822946f9339">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8565969bde54458fb11c038691603413_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtNy0xLTEtMA_7c98c6d6-bdef-46bf-93bd-2d47556f6e50">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtOS0xLTEtMA_0b3fb879-2ba5-4c03-af65-aa466ca7de69">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctMS0xLTEtMA_20e4e6f9-c1c1-4e36-ac2b-15ab791f5041">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctMy0xLTEtMA_65a358b4-4304-445d-bd21-b21da6201d0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896e20ef243241948a91a08bcb36aada_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctNS0xLTEtMA_435c49c4-5d3f-4084-8d9c-af001a3b76b8">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8565969bde54458fb11c038691603413_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctNy0xLTEtMA_3bef270d-6c0a-427e-8405-5ddcbf70607d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctOS0xLTEtMA_49ddd478-6f4e-49b7-9745-7114435c9ed4">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtMS0xLTEtMA_44ab7c3a-c8d0-40ab-a53d-dfee59d1a22d">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtMy0xLTEtMA_9cd86151-a4bf-4fd2-b986-2e7c7b7a25cf">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i896e20ef243241948a91a08bcb36aada_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtNS0xLTEtMA_915b2954-a524-4fd5-9c41-d5bfdbc3eae8">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8565969bde54458fb11c038691603413_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtNy0xLTEtMA_ad839f18-3e51-4170-bff4-454a9bd628c3">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtOS0xLTEtMA_4ebfd969-9183-4a84-b7ad-b33a6b5f1167">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8143f0aa268c43be9cb5a90dc5b80fc0_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktMS0xLTEtMA_4ee62eef-6f9b-426c-ac44-ec0f126d5cd8">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie93df88f97024c308142319431bb90a2_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktMy0xLTEtMA_1f403490-faf2-411a-9293-d4812f64d2b2">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1754a699316c449f8f1f4261e2891243_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktNS0xLTEtMA_610f9641-d463-4efb-9583-4855d0ef71e6">40.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14e414bd78984a40bfeb308b44cb7247_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktNy0xLTEtMA_2280c9d6-f03b-4cc9-bace-4de45a471e2a">68.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief5c5adaa64e42959e00816c3bf6c2b3_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktOS0xLTEtMA_62d7686c-1f35-4381-94cf-dce9fb85029b">110.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90ZXh0cmVnaW9uOmM1Y2ZkMzg4MGYwNDRhNGRhMTQwYzVhN2I0YzU4M2U0XzQ2Mg_68e74111-0274-45d1-b364-f7996131d8d0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzItMi0xLTEtMA_6ec19699-f8b3-43de-833b-3f61a51a30ca">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzItNC0xLTEtMA_c7088fab-0eb6-41fe-ad37-e5c35c76356c">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzMtMi0xLTEtMA_a4cbce03-197f-44de-be72-903c43347f79">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzMtNC0xLTEtMA_f9443cc8-b77b-4851-ac23-ac012f608bcd">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzQtMi0xLTEtMA_a0b4c436-90fb-41ac-9914-a7857c10079e">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231" decimals="-5" name="us-gaap:OtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzQtNC0xLTEtMA_bb3fa15a-714d-4c28-b0e7-4b45e17580a1">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75da7f02f5094418a3c0f650caaf45e6_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzUtMi0xLTEtMA_3d9a24bd-cb9d-4126-bacf-14b466d96347">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib29ca945bd3c4f2e8e97e9cb0dd524b6_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzUtNC0xLTEtMA_26b1f82b-27e5-4d8e-b7f4-add8d8ed80e5">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzYtMi0xLTEtMA_30096f4f-8f2b-49a3-94b8-0b157e31962f">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzYtNC0xLTEtMA_4aff5065-1d33-4cfd-b151-2517c16d7fe1">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzctMi0xLTEtMA_613c91c9-3444-4c0a-8dc0-13341e2911a6">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzctNC0xLTEtMA_08f64201-ecca-427a-bcaa-497b8ca10329">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzgtMi0xLTEtMA_b860d957-9a36-4c88-883d-bd32e2943535">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzgtNC0xLTEtMA_88779c2a-f14b-4263-b2db-eae181e475b4">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzExLTItMS0xLTA_55a9a9d8-9de4-4a62-8ea6-a33a78df9033">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzExLTQtMS0xLTA_ed14b753-3580-4b5c-a930-5fa67c548a54">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzEyLTItMS0xLTA_f40d8442-6018-474b-aac3-ebeedee59581">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzEyLTQtMS0xLTA_930cf322-664b-4e48-b7e1-e18221bce4a9">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE0LTItMS0xLTA_5ab3acf0-e198-4160-a4df-6d17b2c9e7ef">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE0LTQtMS0xLTA_cca7a335-e753-4058-ab6f-ad33bf099bf2">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE1LTItMS0xLTA_5512e678-aa2b-403e-b818-43abb4275666">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE1LTQtMS0xLTA_8a8c6545-cf78-4f11-9b81-29d82eb2cf49">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE2LTItMS0xLTA_22a1f8fd-cfbe-4029-91a3-bb023636a22b">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE2LTQtMS0xLTA_46427aad-bb47-4ae1-82c0-2c1d3892d0e9">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE3LTItMS0xLTA_2a2902c3-9934-49cb-b839-94c1c1c70957">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE3LTQtMS0xLTA_d856680c-70b4-41c2-9d92-8448c478bb2c">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fadb2a71cac4c68a8087322aebf7865_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE4LTItMS0xLTA_b693056d-dc2c-440d-ba4b-64c365b9b744">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b53436536584f99949ba6e260846ce6_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE4LTQtMS0xLTA_ae49dfd7-8cfc-4d96-bdba-29e642207676">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_145">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwNTU_f9fdcc6e-e758-46f9-9300-9890a7aebe2d" continuedAt="i5fc32af41a1346c78a12939fb058bea0" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5fc32af41a1346c78a12939fb058bea0" continuedAt="i432a53f0df964a74ab2db88b6873d051"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2020, there were <ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzQ1MQ_1db0f949-861f-4b37-91d4-2403ac924263">2,761,911</ix:nonFraction> shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and stock appreciation rights reduce the number of shares available by <ix:nonFraction unitRef="shares" contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzU5Mw_3bd81959-c0b1-4aa0-89de-2062048109a3">one</ix:nonFraction> share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to <ix:nonFraction unitRef="shares" contextRef="i94d102ffa7174cdf958957e889097fa6_D20200101-20201231" decimals="INF" name="wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc0NA_7234c72c-7c41-4993-80dc-138938d1b36d">2.5</ix:nonFraction> times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i432a53f0df964a74ab2db88b6873d051" continuedAt="ib234776c6b1e4c94babf1f68e7da496d"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwMzA_d123cdae-d821-4d27-8ad0-faa1dc5999ae" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and appreciation rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd49877ac6e94e8ba65f322b6db5e98d_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzEtMS0xLTEtMA_862077bc-759e-4c89-84f6-0d5d9f4dfd95">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e981e6b5c1c4a0a96533e1a52c52939_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzEtMy0xLTEtMA_dc652c10-07b3-4128-bd09-798ea5fa6ad8">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcddbacbafaa4e1a88fe1be38aec0244_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzEtNS0xLTEtMA_e01aa732-2c3e-4ff3-bb7c-1e7b782e66a5">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, stock-settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b56de45b3d044729f17a76e52cedbc9_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzItMS0xLTEtMA_1bc7b375-3f26-42ed-9ef4-0325c9604544">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58338c0d70074d60967ae84164421b21_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzItMy0xLTEtMA_318eff22-0b66-4f52-b1bc-7d88f0634ffb">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08616f88160948b48f5aaa6efbddcba4_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzItNS0xLTEtMA_6722e11c-5ff1-42c4-ac86-208af2b82606">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, cash-settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzMtMS0xLTEtMA_6b2e9b09-1440-4aff-a76e-e3eb4dd96936">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzMtMy0xLTEtMA_dd57cdea-28a9-45cb-ae38-bd62a6da5801">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzMtNS0xLTEtMA_a5c6f5c8-a4f8-4799-b2de-8b877ab23855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d603594868f40508e7fe929d734564a_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzQtMS0xLTEtMA_434f54df-23a5-48a7-9832-6b07b287110e">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4526e48ffa5a4038b2bf9bfff300abac_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzQtMy0xLTEtMA_88ca3a4c-1453-4592-9074-f9fdac2c7384">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6835ccab784849ca91ebb01f7d09ae9c_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzQtNS0xLTEtMA_7382fd55-e43f-454f-9c68-30ad904326c4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzUtMS0xLTEtMA_7d90d49b-e527-4947-b58a-20ee4e01a14c">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbed69520f7a44dfaa08f657cc8f4421_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzUtMy0xLTEtMA_78237cbb-8540-401f-a369-f676eff478ab">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c545e42bb914c0c88935ba87d94b5fb_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzUtNS0xLTEtMA_4b799ba7-2ee0-45c6-a6db-a58a602709d1">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8d0c816eaf4dfca6437e6e6a59e325_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzYtMS0xLTEtMA_b07ab1d2-b79c-44a5-9ede-83d1ce764bf7">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d543f5f46e4f9a93d41fac73ca8d9b_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzYtMy0xLTEtMA_95d1eeb1-b3db-47bf-bac9-ebce481bc1e4">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d567413c754bd2bced1765c543f431_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzYtNS0xLTEtMA_3b3443d7-69af-4b91-9fe0-5ab83548dbdd">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzctMS0xLTEtMA_3bf9beee-0ffd-400d-b702-78f5aba6b5d0">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzctMy0xLTEtMA_9a5e829b-5bad-4814-94e2-ec0177de6e6c">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzctNS0xLTEtMA_33f02dd1-d7d3-4e6e-853a-c163cc17b9d7">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures. The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEyNzc_0b7962a5-e6a6-44e4-9f55-b6ebe836d6d0">31.7</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEzNTA_97acec64-4039-46f6-a307-45430e362a85">1.6</ix:nonNumeric> years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted to employees vest in equal increments. All awards expire <ix:nonNumeric contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE0NTY_a232dbd0-c940-4c38-9c5a-ea4c32e6e0b3">10</ix:nonNumeric> years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwMzQ_bcd7a8a1-3a5b-467f-9da2-f8004edf561c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding options:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzEtMS0xLTEtMA_77149cc4-52b9-497a-ad97-1e6558e3e199">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzEtMy0xLTEtMA_806c27a1-7295-4638-a3fb-68015e13f6e3">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzEtNS0xLTEtMA_21d1ab65-bf12-4bde-9b7e-3f7cac2b582c">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzItMS0xLTEtMA_c711a2cf-2a97-43ea-9eba-5be811290639">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzItMy0xLTEtMA_5b4fabc7-0d37-4f9d-b57f-d62c6f0c15dc">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzItNS0xLTEtMA_c8a49753-7867-4d61-89db-4f881447b885">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzMtMS0xLTEtMA_ba5f6723-6d77-4f3a-b0ae-1f8dbcc64d22">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzMtMy0xLTEtMA_4bcb3f92-f0d7-42d0-a0d1-608730b10a9b">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzMtNS0xLTEtMA_8bf9ed77-1aad-454d-8529-6b3caa8e4b8b">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzQtMS0xLTEtMA_f34df76b-d7f5-4a46-9243-07ec4e7455d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzQtMy0xLTEtMA_32569a1c-fbe6-4f4d-8c54-da193fb7b9bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzQtNS0xLTEtMA_910d5774-f484-4ebc-a1be-901b2487e261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzUtMS0xLTEtMA_cdeb5a79-4d25-4443-9250-6753b82c46e4">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzUtMy0xLTEtMA_df789cd5-bcb9-4b03-8f8e-cddeeb46d812">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzUtNS0xLTEtMA_23d6997b-ca28-4d67-81a2-0262a2771d3e">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzYtMS0xLTEtMA_c4d946a7-8d2f-4260-b98d-4f453412e58d">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzYtMy0xLTEtMA_11945808-91c4-48e7-98ba-b750d6d5ba50">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzYtNS0xLTEtMA_3b733b92-3dfb-48f4-92cd-ced04d2f30bb">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzEtMS0xLTEtMA_626fd2c1-d5da-48cf-9692-0fe33d7bc303">67.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzEtMy0xLTEtMA_230f8df6-6977-4fcd-8c58-fe7a3349bd78">58.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzEtNS0xLTEtMA_4506ebad-3f79-4f6a-8bbb-40310e2d537e">48.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzItMS0xLTEtMA_0952f99a-a87e-40bd-9783-95d3554ba037">178.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzItMy0xLTEtMA_f080f801-fb6a-47e3-88f0-76a3fa27ec8c">103.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzItNS0xLTEtMA_3e2ccde6-c275-4f25-88df-cb9a2a069342">90.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzMtMS0xLTEtMA_b9071673-3929-4650-a193-173fda287d0c">49.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzMtMy0xLTEtMA_999712b0-bc8f-497e-93c7-d03a0e1a739a">46.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzMtNS0xLTEtMA_7caebd7a-d856-41d7-96d8-cd7e9712e449">35.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzQtMS0xLTEtMA_3ba2aba3-8b39-41f2-9269-4a47d6dedb78">103.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzQtMy0xLTEtMA_5616e768-48b2-4900-9797-6416babdb239">92.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzQtNS0xLTEtMA_2f16dd7e-312f-432c-934f-e31671c72b09">75.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzUtMS0xLTEtMA_dbae6096-1fa5-4628-a35d-ff6b38251001">81.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzUtMy0xLTEtMA_d2440074-f481-49ce-b59e-d83a7e6a8952">67.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzUtNS0xLTEtMA_a61bc5d8-908f-4f08-8ce9-7c86e18bce7e">58.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzYtMS0xLTEtMA_c1a57b04-cceb-4dff-90e0-879b29de3c7e">62.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzYtMy0xLTEtMA_c0adbf70-c875-40fd-8c54-05207709441a">53.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzYtNS0xLTEtMA_3fe8a696-8c8a-467e-abad-9b01fb4d6093">45.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the weighted average remaining contractual life of options outstanding and of options exercisable was <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE3Nzg_929d96bb-bc98-4c7a-93bb-768d5bdd954b">5.9</ix:nonNumeric> years and <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE3OTE_2194473c-3887-44d7-85d8-d9c9cc13d75a">4.8</ix:nonNumeric> years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the aggregate intrinsic value of total options outstanding was $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE4ODk_dac0c4a7-41a7-4201-9cbe-a3e5a63c3218">481.2</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE5MDI_ea0ac5c1-2c2c-4d7d-9eec-a075071facea">351.7</ix:nonFraction> million represented vested options.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib234776c6b1e4c94babf1f68e7da496d" continuedAt="i4fe1e0b521eb4cfcaff0344b5e40a1ed"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2020, 2019 and 2018: a risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxNDQ_890ad0a7-b052-4257-8e98-c9f4b6924d01">1.3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxNDg_e413660d-142b-4e38-b2c6-767d92f652cf">2.3</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxNTY_bdf0dc49-9106-46bc-8755-9555a2c16299">2.7</ix:nonFraction>%, respectively; stock volatility of <ix:nonFraction unitRef="number" contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxOTQ_de7904f5-0a92-4d64-b766-34c52f78b5d0">22.4</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxOTg_6fa8ae96-9326-4e64-9bcf-5677ab626c81">22.5</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyMDY_60f13152-f985-4ca4-b844-72301760b813">19.8</ix:nonFraction>%, respectively; and dividend yields of <ix:nonFraction unitRef="number" contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyNDc_73a2e6fc-262b-4ff4-a0ae-e1c8b2482a07">0.4</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyNTE_ca393ec5-555b-461a-9d18-b669494e0575">0.7</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyNTk_a6edb50f-4240-41b6-80f3-a7e08b7fed35">0.7</ix:nonFraction>%, respectively. Stock volatility is estimated based on historical data and the impact from expected future trends. Expected lives, which are based on prior experience, averaged <ix:nonNumeric contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2MzY4NDA_464f9458-205c-4a96-be47-d48ad43480b2"><ix:nonNumeric contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2MzY4NDA_d02c4ede-5265-4996-aa6a-65ccc7f207b7"><ix:nonNumeric contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2MzY4NDA_fbeb8c4a-6322-499d-b547-626e588c488a">5.7</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> years for 2020, 2019 and 2018. The weighted average grant date fair value of options granted in 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI1NDM_5324c506-9746-4651-89d1-c22d615f57c6">40.28</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI1NDc_94f9cdcf-7502-4349-89f7-9a04b433c3f4">24.72</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI1NTQ_ed45fb52-0c1d-49b9-8010-979beeef3f9d">20.16</ix:nonFraction>, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, the intrinsic value of options exercised was $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI3NDY_4f7aafdc-84e4-4275-9dc6-aac1af28d580">88.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI3NTA_cf907333-c4e4-4930-ac39-33367a6313bb">46.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI3NTc_b44ce267-ac26-4d46-a88d-78a0f39102bb">61.3</ix:nonFraction> million, respectively. The grant date fair value of options vested during those same periods was $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI4NDk_f4317105-877d-47f2-b934-cc8dbda059c9">8.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI4NTM_c3c080cf-4464-4d43-bc38-fb28a9552170">7.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI4NjA_d6928466-50b4-45c9-b665-1f714374bf76">8.3</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock appreciation rights (&#8220;SARs&#8221;) granted to eligible international employees vest in equal annual increments over <ix:nonNumeric contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMwMjI_7463fa79-71a8-42de-8de2-3166290aa9f0">4</ix:nonNumeric> years of continuous service. All awards expire <ix:nonNumeric contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMwNjY_28f06862-36a2-4b3b-8eec-1087f3069d80">10</ix:nonNumeric> years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2020, SARs outstanding were <ix:nonFraction unitRef="shares" contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMyNjI_2803441e-23d6-4fc0-908d-3f0daee336be">27,679</ix:nonFraction>, of which <ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="INF" format="ixt:numdotdecimal" name="wst:CashSettledStockAppreciationRightsOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMyNzU_99563adf-7caf-4433-850c-5b594e246277">24,051</ix:nonFraction> were cash-settled and <ix:nonFraction unitRef="shares" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="INF" format="ixt:numdotdecimal" name="wst:StockSettledStockAppreciationRightsOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMzMDA_5a5416b4-d66f-4bb6-9b18-21282e8abe13">3,628</ix:nonFraction> were stock-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#8217;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwMTY_f1b52451-698b-4c15-a147-de9212db18a6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding SARs:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzEtMS0xLTEtMA_6f006a56-2675-439c-af86-ab75f87b04b0">35,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzEtMy0xLTEtMA_b15a2b85-36cf-4d2b-a74b-30f00f7da2ea">39,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie536733ecf0f49159c3492b03170fa5e_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzEtNS0xLTEtMA_216adb5b-e219-4196-8310-ed628ba01158">51,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzItMS0xLTEtMA_3cb6a9c1-a465-4798-a341-a1e5bbf8b041">3,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzItMy0xLTEtMA_3b12b519-ce52-4935-93b2-81155dca246b">3,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzItNS0xLTEtMA_0d031a16-f0af-492e-bb52-9b4716b2050a">3,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzMtMS0xLTEtMA_b52b1718-e96e-4e98-ac29-b5f17ec7b802">11,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzMtMy0xLTEtMA_07aba9cd-3d7b-421d-bdf1-2aafa863f11c">6,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzMtNS0xLTEtMA_3b16caa7-4376-4dda-9857-185baa7be4a2">14,629</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzQtMS0xLTEtMA_e4bb7040-2fd6-4323-a295-f976bf93ac9c">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzQtMy0xLTEtMA_f1ee77bf-1784-4315-9fae-ec450f4d76a0">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzQtNS0xLTEtMA_fa717bb9-020f-4855-b7a4-06e1e1d5fc0a">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzUtMS0xLTEtMA_4e808db3-0272-4609-a399-f853a804ae39">27,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzUtMy0xLTEtMA_53dd46a7-d788-4c65-a105-d888ffcabed1">35,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzUtNS0xLTEtMA_e813a4b4-586e-44de-ae5c-4ddfb1cbe7e7">39,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs exercisable, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzYtMS0xLTEtMA_2a2df7f0-b809-4589-bfc4-ea7fc2699a2f">27,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231" decimals="INF" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzYtMy0xLTEtMA_9a4313c2-bbd0-4162-8f0c-4961171561e3">27,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231" decimals="INF" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzYtNS0xLTEtMA_9673660c-1746-45d3-9861-3ffd9e9a653e">30,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzItMS0xLTEtMA_54c82b3b-9ee3-4786-90a5-6df0d1ff0c82">52.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzItMy0xLTEtMA_18de2e5c-22cf-4270-87fe-189acdb8990b">46.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie536733ecf0f49159c3492b03170fa5e_I20171231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzItNS0xLTEtMA_6681accf-eff7-4531-9845-7bd905dd6cdc">38.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzMtMS0xLTEtMA_8eda7ba4-83cc-4edf-8d34-970f4a4f4446">190.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzMtMy0xLTEtMA_aa5a64df-e89a-4ba2-9373-4e102f329f57">102.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzMtNS0xLTEtMA_fbf83e62-ccf2-4e6a-9e7d-32ce31c4d545">89.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzQtMS0xLTEtMA_25c283f0-9574-4568-a266-5cda5bfd6a89">35.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzQtMy0xLTEtMA_4dfc926d-4ae2-4329-a20c-2cf9d048b911">42.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzQtNS0xLTEtMA_a07dd23c-8869-4657-9dea-2415143b00bc">28.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzUtMS0xLTEtMA_e4161a88-f59d-498a-b426-a7ca5f2b6130">71.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzUtMy0xLTEtMA_c0dd8cbd-b578-487c-9200-305d83a89b81">63.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzUtNS0xLTEtMA_f0380122-da6b-4d57-9b8d-a2d2154ec5d3">63.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzYtMS0xLTEtMA_64e5a6e0-9852-48ed-ab3f-734e7b831c1d">75.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzYtMy0xLTEtMA_3f9e8a05-a14a-412d-8613-d719791ae062">52.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzYtNS0xLTEtMA_ad2d12b2-d849-4d0b-95e5-be4428a174b4">46.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs exercisable, December 31</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzctMS0xLTEtMA_cff83188-973d-4853-9bf5-b62640535e8b">40.23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzctMy0xLTEtMA_4f6b5d03-a830-40f9-9dc6-a58c3c3e2023">40.73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzctNS0xLTEtMA_3c9ce17b-21dd-492d-8ec1-ae11b4fd6a97">36.91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to stock options and SAR awards, we grant performance share unit (&#8220;PSU&#8221;) awards to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i4fe1e0b521eb4cfcaff0344b5e40a1ed" continuedAt="i72e0afc681e047babbe26d328e590841"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwNTM_f29eb2a8-4ed8-4952-b956-5c2e995767b0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEtMS0xLTEtMA_63cc258c-044e-4b33-9c26-e3ca1cf10f04">264,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEtMy0xLTEtMA_938dc038-3371-402f-90c7-fe666be0a4ae">296,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa7ad396fdcd47809883f36d39da738a_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEtNS0xLTEtMA_f0e3d633-bb6c-475a-b1c7-ffdd2327fe9c">341,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzItMS0xLTEtMA_5a2396b9-aba9-473e-9938-c002481d0b1e">53,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzItMy0xLTEtMA_60bf2a16-d7f0-45f3-bd20-dce9015d1539">84,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzItNS0xLTEtMA_a27cc240-4a9a-4320-961e-ad60b53f4f2e">102,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="INF" sign="-" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzMtMS0xLTEtMA_c85f85e2-b22a-40e9-b5d3-c099c5fe52c9">14,004</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="INF" sign="-" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzMtMy0xLTEtMA_f87b0b8c-1d03-4790-8769-fe114ff84807">50,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="INF" sign="-" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzMtNS0xLTEtMA_17f32a6a-adcf-4161-be04-e64db7cae619">2,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzQtMS0xLTEtMA_f743f2ad-b462-4a0a-8c53-4d4cb83dcfbb">70,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzQtMy0xLTEtMA_97449a77-0374-4d18-8cfc-3bc8d621e648">48,964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzQtNS0xLTEtMA_d4a96408-d406-4440-9731-c5c347d2c538">121,984</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzUtMS0xLTEtMA_21167092-e505-48be-b633-9dee3f48efa1">11,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzUtMy0xLTEtMA_d576aeb3-a442-418c-9708-1080f957cf65">16,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzUtNS0xLTEtMA_77d51ba4-7461-4470-bef8-4cb465673419">23,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if03468ad1c7345619b7c14865b28e6f4_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzYtMS0xLTEtMA_d967d65f-5478-4354-9469-4bf4ee19b90b">222,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzYtMy0xLTEtMA_b40d1f00-8979-4bc2-aee7-665e73388f2a">264,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzYtNS0xLTEtMA_f4c85fd6-a47a-4c7c-9cfd-49d50b5982d9">296,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzktMS0xLTEtMA_364b55ee-9815-4c06-aa2b-c020b7bc162f">92.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzktMy0xLTEtMA_080588a9-d32f-4467-937e-dedcfe6abb50">76.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa7ad396fdcd47809883f36d39da738a_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzktNS0xLTEtMA_bc876c77-90c0-4fbc-9bbc-53be8c950b3e">64.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEwLTEtMS0xLTA_8801f0cd-dc0a-4a45-a299-bd7aae4e03ac">177.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEwLTMtMS0xLTA_eea3af18-848c-40ef-8fde-f57d443b4430">103.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEwLTUtMS0xLTA_617a9916-5dd6-435d-96da-7e4b140b729e">90.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzExLTEtMS0xLTA_c1a52b3d-5c53-4e10-a3d0-51cb2ff92b77">77.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzExLTMtMS0xLTA_e895031f-c363-4f82-a77b-38c442aa3c91">83.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzExLTUtMS0xLTA_667387b3-c527-414e-89c8-68cb07041f17">33.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEyLTEtMS0xLTA_6c74465a-c797-44bd-b8ae-0d4f4c864a55">173.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEyLTMtMS0xLTA_959dc235-35c0-49fa-8684-b61bd3fc7bdc">102.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEyLTUtMS0xLTA_f2978721-d290-4222-8c29-43090f6828d1">93.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEzLTEtMS0xLTA_a8d99b56-73d4-41ca-b8c8-09b1941ca9cf">104.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEzLTMtMS0xLTA_6c4224a5-5331-429f-84b8-ee06148c5816">69.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEzLTUtMS0xLTA_fe541cf1-705e-4f4a-9602-7a884f6e3d3c">68.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if03468ad1c7345619b7c14865b28e6f4_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzE0LTEtMS0xLTA_245410ff-b867-4eb7-b11a-718f8d5dc9b7">116.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzE0LTMtMS0xLTA_13ee4727-5c06-47ff-a738-bce61affe089">92.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzE0LTUtMS0xLTA_2a312995-5b6d-4bbe-8b9c-4079ba341fd3">76.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares earned under PSU awards may vary from <ix:nonFraction unitRef="number" contextRef="ia4df90090669487784ddadbfee1e8f77_D20200101-20201231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzQ3MTg_022c712e-95e4-47a4-bc7d-10d9c1aa1fa1">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i5509bc461133464cbdfc6fefe5088ba4_D20200101-20201231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzQ3MjQ_e9f9cd55-0e4c-45c3-95e5-2bc8386ff644">200</ix:nonFraction>% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usdPerShare" contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUwOTg_b8a01d0d-e368-4db1-bbb3-ec0497c0eb46">177.31</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUxMDI_c9ca4f14-66f2-4699-8986-f7ee96bb293b">103.40</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUxMDk_76bb1d7d-dd94-46db-a75f-86a9957c3984">90.45</ix:nonFraction>, respectively. Including forfeiture and above-target achievement expectations, we expect that the stock-settled PSU awards will convert to <ix:nonFraction unitRef="shares" contextRef="if03468ad1c7345619b7c14865b28e6f4_I20201231" decimals="INF" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUyNTE_88307612-5c96-4d68-9c99-6eb47166f2cf">92,792</ix:nonFraction> shares to be issued over an average remaining term of <ix:nonNumeric contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUzMDg_0a2949c3-a8bd-4e8b-8014-1a7f78f4d1b2">one year</ix:nonNumeric>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwNDU_14415ce7-6549-4695-a153-3006ecbba010" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzEtMS0xLTEtMA_935baa3d-d3d4-48cf-b834-11b5f0deefa4">1,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzEtMy0xLTEtMA_184f7dc3-5d9d-4c72-bc28-b06ad966efd2">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2ffc58869ae424aa7cbc9aaf84a2dd4_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzEtNS0xLTEtMA_58c2b651-8052-4148-9fa3-7553888346ee">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzItMS0xLTEtMA_aff0b68f-e40b-4bfc-80b1-6109ec03049f">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzItMy0xLTEtMA_c2c0e9b9-f3f5-454c-82f0-f9d4c90d9a61">806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzItNS0xLTEtMA_6c39ad97-89fd-4b29-bcac-2db5d0e29976">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="INF" sign="-" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzMtMS0xLTEtMA_fa910d0e-4a1a-4d85-a4c8-1ce517a391a5">99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="INF" sign="-" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzMtMy0xLTEtMA_a5dcac8c-f969-4192-a937-01978499043c">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="INF" sign="-" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzMtNS0xLTEtMA_7c6cbd56-20e2-418e-8b2d-f9cf03f76cd8">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzQtMS0xLTEtMA_28bf8013-3ee9-440d-af35-cccfdf3fd10c">502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzQtMy0xLTEtMA_da88184b-32e9-4208-b223-e9830ef00caf">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzQtNS0xLTEtMA_b6a29117-cd10-4969-b7b6-f5e95c2ed06d">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzUtMS0xLTEtMA_3032fb71-e61f-464a-b4b8-22ecaf8e4ad1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzUtMy0xLTEtMA_036405f2-9b15-4c0a-968c-fda17937a084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzUtNS0xLTEtMA_04dd7870-dc58-42b5-93f3-8dee43da49ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c4540b26bb74a9a969cecf57c787621_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzYtMS0xLTEtMA_623619e3-ffe2-4d23-9838-4cee259279b5">2,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzYtMy0xLTEtMA_ceab7c11-ce99-43f9-b3c0-69ac90c81893">1,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzYtNS0xLTEtMA_2b6e6ae8-e12e-48e2-ba59-a0bf23753672">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzEtMS0xLTEtMA_cf4e2a0d-c718-4344-889a-256ac8cede65">93.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzEtMy0xLTEtMA_136b7bfc-3bb5-46b4-af32-c50d063172c5">79.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2ffc58869ae424aa7cbc9aaf84a2dd4_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzEtNS0xLTEtMA_5ea20ba0-ccdf-4a63-a4f8-fb81ac2a5268">92.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzItMS0xLTEtMA_742a3e1c-3140-40f1-98ef-e44bb4ce4567">190.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzItMy0xLTEtMA_212e689c-ce11-4494-802d-cf7bdd645148">102.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzItNS0xLTEtMA_3788b33a-a2df-489b-ab0c-287c8ac6e141">89.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzMtMS0xLTEtMA_91c61662-11d7-4270-bb4a-fdfd5301efa5">74.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzMtMy0xLTEtMA_f23d84c5-3326-4d7c-ab91-53e71df50356">56.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzMtNS0xLTEtMA_ec1315a0-8bf4-4170-a3c4-167965dc70bb">41.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzQtMS0xLTEtMA_4db2c1c8-8cf2-4d66-a163-9348923433e6">173.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzQtMy0xLTEtMA_d01c7761-7588-413b-bc85-b7fdfb2bd59a">102.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzQtNS0xLTEtMA_fb41ab6d-f3e5-4681-a93b-798bd8f6e2bf">93.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzUtMS0xLTEtMA_8494b7d7-5223-4c5a-b177-4430dbff4f9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzUtMy0xLTEtMA_07fb73b9-5152-4081-9612-2202e882c901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzUtNS0xLTEtMA_74e6a988-1b42-4e15-b1f5-5bcd29706b41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1c4540b26bb74a9a969cecf57c787621_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzYtMS0xLTEtMA_66295122-48b9-42fe-9ae0-8f9aa1c1d35d">130.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzYtMy0xLTEtMA_b51bab97-c73b-43d1-93a8-f37875927458">93.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzYtNS0xLTEtMA_8258feaa-e112-4c1f-af0e-365f436ddc31">79.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i72e0afc681e047babbe26d328e590841"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer an Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which provides for the sale of our common stock to eligible employees at <ix:nonFraction unitRef="number" contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzU4ODM_275467fa-194e-4914-abb5-f6964d06b584">85</ix:nonFraction>% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to <ix:nonFraction unitRef="number" contextRef="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYwMDc_27d4419b-8a8d-4b18-a954-b452ad8ce838">25</ix:nonFraction>% of the employee&#8217;s base salary, not to exceed $<ix:nonFraction unitRef="usd" contextRef="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231" decimals="0" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYwNTU_a4337317-235f-4da7-8bc0-b5c87647e8d7">25,000</ix:nonFraction> in any one calendar year. In addition, employees may not buy more than <ix:nonFraction unitRef="shares" contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYxMjk_acc2ec45-602b-4759-8c4d-c239e8591650">2,000</ix:nonFraction> shares during any offering period (<ix:nonFraction unitRef="shares" contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYxNjc_53adcf34-102b-4afa-bb9b-9eb66480845c">8,000</ix:nonFraction> shares per year). Purchases under the ESPP were <ix:nonFraction unitRef="shares" contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYyMTg_357e6a66-8526-4c79-b954-63e87010202d">36,494</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="idbed69520f7a44dfaa08f657cc8f4421_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYyMjk_a5456cbd-17e3-49ac-87bf-a6e7bcb9a127">51,391</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i7c545e42bb914c0c88935ba87d94b5fb_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYyNDM_791ce97f-9045-4242-b4f7-55261900f393">55,669</ix:nonFraction> shares for the years 2020, 2019 and 2018, respectively. At December&#160;31, 2020, there were approximately <ix:nonFraction unitRef="shares" contextRef="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYzMjg_9094019d-cd62-4972-8678-331636d7830e">3,793,218</ix:nonFraction> shares available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plans and Restricted Share Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of <ix:nonFraction unitRef="shares" contextRef="i417b7c21dd1b47b8b40d34cc70053be2_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="wst:DeferredCompensationArrangementWithIndividualConversionUnit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzY4MDc_cfc5742e-ece8-4cd2-b092-3cda16821eed">one</ix:nonFraction> share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2020, we granted <ix:nonFraction unitRef="shares" contextRef="ibae2919783b045ffaef7c87dc7aa860f_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzcyMzI_7a42f6e6-7000-4302-8cfb-d5faf854d619">10,302</ix:nonFraction> deferred stock awards, with a weighted grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibae2919783b045ffaef7c87dc7aa860f_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzcyOTA_e294e5f0-eb9a-44d4-9744-59692fd3e5e7">194.29</ix:nonFraction>. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. As of December&#160;31, 2020, the <ix:nonFraction unitRef="plan" contextRef="icd5b02eced6f45d7a117b354e107f82b_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="wst:DeferredCompensationArrangementWithIndividualNumberOfPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc0NTY_ba7edc43-5aa9-4b23-8ec5-eed04f30fb7d">two</ix:nonFraction> deferred compensation plans held a total of <ix:nonFraction unitRef="shares" contextRef="icd5b02eced6f45d7a117b354e107f82b_I20201231" decimals="INF" format="ixt:numdotdecimal" name="wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc1MDM_5b84848f-59b3-4c14-ae0a-3ce0152a1f17">358,890</ix:nonFraction> deferred stock units, including <ix:nonFraction unitRef="shares" contextRef="icd5b02eced6f45d7a117b354e107f82b_I20201231" decimals="INF" format="ixt:numdotdecimal" name="wst:DeferredStockUnitsPayableInCash" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc1Mzg_e80d6282-ba8e-4b44-ac40-2ab3e2cb28d9">6,274</ix:nonFraction> units to be paid in cash.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2020, we granted <ix:nonFraction unitRef="shares" contextRef="ib92f1d4eb98744d9bc103ffc68dd371b_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc2MDU_de637352-4789-4625-8863-3a18947322ea">8,721</ix:nonFraction> restricted share awards at a weighted grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib92f1d4eb98744d9bc103ffc68dd371b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc2NzE_ef390bbe-1bff-4b6d-b5c1-932cfefdfac7">200.35</ix:nonFraction> per share to employees under the 2016 Plan. During 2019, we granted <ix:nonFraction unitRef="shares" contextRef="i69fd39a6d2c54a91b93d39724d4934c1_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc3NDI_6f31d03a-7081-4d47-bdf7-fe532664115f">13,308</ix:nonFraction> restricted share awards at a weighted grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i69fd39a6d2c54a91b93d39724d4934c1_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc4MDg_ea73f461-2075-4b82-8a1c-788002b88d2b">116.39</ix:nonFraction> per share to employees under the 2016 Plan. During 2018, we granted <ix:nonFraction unitRef="shares" contextRef="ic09e3fbc0235485daae5c0994ee55f63_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2Mzc0MzI_8e481316-a336-4110-807a-063906c248a6">15,942</ix:nonFraction> restricted share awards at a weighted grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic09e3fbc0235485daae5c0994ee55f63_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2Mzc0NDA_7b08c555-c060-407a-a77b-b7b4f62d06eb">96.77</ix:nonFraction> per share to employees under the 2016 Plan. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual Incentive Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our annual incentive plan, participants are paid bonuses on the attainment of certain financial goals, which they can elect to receive in either cash or shares of our common stock. If the employee elects payment in shares, they are also given a restricted incentive stock award equal to one share for each four bonus shares issued. The incentive stock awards vest at the end of <ix:nonNumeric contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg0NjI_d0439e02-9ad3-4962-a882-abaa87d84833">four years</ix:nonNumeric>, provided that the participant has not made a disqualifying disposition of their bonus shares. Incentive stock award grants were <ix:nonFraction unitRef="shares" contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg1OTM_c197b4da-699d-4926-9f3a-fda5347568ec">350</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg2MDQ_815a044f-4cf9-440a-ada4-da9a92b6f64e">1,300</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg2MTg_5d0c126b-0e4a-4b2f-8927-1e23e6f9edc9">1,500</ix:nonFraction> shares in 2020, 2019 and 2018, respectively. Incentive stock forfeitures of <ix:nonFraction unitRef="shares" contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2Mzc1MDM_21e95c1e-293e-4428-8325-860b4379c09d">0</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg3NDI_bdf9fcc7-d0ab-4d2d-abcf-ae13e0b301c5">0</ix:nonFraction> shares, and <ix:nonFraction unitRef="shares" contextRef="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg3NTY_3b44067d-c1a7-4a41-9dc5-291f3419fe4a">200</ix:nonFraction> shares occurred in 2020, 2019 and 2018, respectively. Compensation expense is recognized over the vesting period based on the fair market value of common stock on the award date: $<ix:nonFraction unitRef="usdPerShare" contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg5Mjg_dfdbc43d-1255-4ccf-97cc-c8f1d19db5b6">156.49</ix:nonFraction> per share granted in 2020, $<ix:nonFraction unitRef="usdPerShare" contextRef="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg5NTY_350882df-6f8b-42fa-aca0-db038aeccc24">106.14</ix:nonFraction> per share granted in 2019 and $<ix:nonFraction unitRef="usdPerShare" contextRef="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg5ODc_81742884-33f7-4c62-862e-0f94cd9785e8">93.00</ix:nonFraction> per share granted in 2018.</span></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMTg_2aa6f8cd-c1a2-4c40-b267-371638e00bbc" continuedAt="i64d8ac49cdd048d6a642f48264a4944c" escape="true">Benefit Plans </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i64d8ac49cdd048d6a642f48264a4944c" continuedAt="i182a505fcf474cfbac88c02bd6725ea9">Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ4OA_14866a53-4186-49c1-958f-4b81b61355db">16.8</ix:nonFraction> million for 2020, $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ5OQ_c9b7bf57-f005-4e8e-8889-cba04d6dd9a6">15.6</ix:nonFraction> million for 2019 and $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzUxMw_047d214c-8af5-4b35-855f-7de5bf0787d9">6.5</ix:nonFraction> million for 2018. The increase in 401(k) plan contributions in 2019 was in response to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting).</ix:continuation></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i182a505fcf474cfbac88c02bd6725ea9" continuedAt="ia158cc77ddc447198b57f635c3438903"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension and Other Retirement Benefits</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMTM_d8b30166-b2dd-4a5f-a764-d6e250aa12c8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtMS0xLTEtMA_e3fe0f8d-4d62-4da2-a15a-a08011625654">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtMy0xLTEtMA_b21b6381-e130-4924-975f-62469a01768b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtNS0xLTEtMA_83948e63-0001-4c60-8157-59a150a2e042">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtNy0xLTEtMA_5253d550-09b5-49a3-84df-c7da82ce9084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtOS0xLTEtMA_2e5e0ad1-d226-43e0-b287-b5322ef30eea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtMTEtMS0xLTA_d3cedb1b-2aa9-40e1-bd27-cc09dc7731e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtMS0xLTEtMA_d144bfb5-5f7f-4a01-b3c1-c85dfe15d794">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtMy0xLTEtMA_14c7226c-dbbc-4f71-ae2d-adb1cc418d4f">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtNS0xLTEtMA_5f89fcc5-8c4e-4e01-a32f-28f25997fcb3">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtNy0xLTEtMA_445e454a-958e-4ef5-91ce-07fa3c63cecd">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtOS0xLTEtMA_2e52ba85-99cf-489f-99fe-2becb7f010b2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtMTEtMS0xLTA_8daff02b-812d-44f2-9eed-71531df76fde">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtMS0xLTEtMA_4ca9e900-f02a-4e57-a512-0f02debaf5c2">11.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtMy0xLTEtMA_b26cfe39-e1fa-4c17-8582-c87aeb4ddd0f">12.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtNS0xLTEtMA_95ee093b-0fe3-4b32-95b1-eb2ed3fbc3d6">15.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtNy0xLTEtMA_8de1e5d8-9d65-4536-8eb6-8bb6e2ef9a0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtOS0xLTEtMA_3f2f141b-9edd-4062-b461-75e45829610a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtMTEtMS0xLTA_6979be12-e20d-4af7-b3f3-1a4a9e57398f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtMS0xLTEtMA_d4189a8f-6814-4fcc-98e0-9e20f8034c88">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtMy0xLTEtMA_bdace5e7-ddae-4fa2-87a0-cf8c06f6972f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtNS0xLTEtMA_692586b1-6489-4724-8f15-dbe719411db4">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtNy0xLTEtMA_32551cf9-9bb7-41c4-8623-7f53e5bdcd00">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtOS0xLTEtMA_097e139f-e3e7-47bf-aa10-ef1a333b62b9">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtMTEtMS0xLTA_8a5867e6-5885-48d5-8e0b-11e698a60482">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtMS0xLTEtMA_46edd98c-131d-4246-b5fd-4131c5c63b2a">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtMy0xLTEtMA_69264a42-e1d7-4b31-bc28-33d478f2d67a">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtNS0xLTEtMA_d35923bd-c02d-4c44-80ae-af07cbde481d">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtNy0xLTEtMA_a2ebd3b6-ddd0-4f6d-b393-11169e74f765">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtOS0xLTEtMA_8dabbd4e-98cf-4471-81a9-11c85a1eea91">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtMTEtMS0xLTA_237fb41b-a2c6-4f4e-974f-0ef416ab98c0">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTEtMS0xLTA_ad7f31f9-30d5-4f5f-b3b9-4db45cd4c962">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTMtMS0xLTA_66e4fcab-48e1-470c-9653-ae6473c1d8cc">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTUtMS0xLTA_a75757a9-60f4-49ec-b6ce-4424480eb849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTctMS0xLTA_7236d30a-b416-4fcc-916e-1dcaae36dcae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTktMS0xLTA_780a9c56-e943-49f8-929a-776134119272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTExLTEtMS0w_e61f108f-86a9-46e5-815f-42acc1aee5bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTEtMS0xLTA_4f962c8d-b33a-4de2-a3c0-bf7656fc8b54">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTMtMS0xLTA_6ccbdf73-a34e-4926-afe7-66a195bd3e61">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTUtMS0xLTA_dd40ff62-a672-4eb4-add7-10226c36f20d">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTctMS0xLTA_7e5b57c1-bea0-4c95-ab28-8acf14bdc572">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTktMS0xLTA_19acd253-6ecb-4f22-ab2a-b37500388cb4">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTExLTEtMS0w_7ba8b256-5fe0-4b37-8d43-9e44330f44de">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain) arising during period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTEtMS0xLTA_4a28de8a-f817-45c5-8b90-38ae83b195e4">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTMtMS0xLTA_fc4c40e6-06bc-4c7b-b0e7-d0bdee24cadd">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTUtMS0xLTA_f17a3bc1-2e74-4f0d-b79b-26a4a05e966a">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTctMS0xLTA_7a470e8d-79ac-4f77-bb29-422bf5f11227">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTktMS0xLTA_e0834658-98a1-48bd-8e9a-e440de82dee9">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTExLTEtMS0w_b1e8f6c3-8d78-432e-ad2f-3f0a867d3e3a">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTEtMS0xLTA_116b346b-8036-4872-8672-da648fb64dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTMtMS0xLTA_e967ce43-e66e-4d10-84ce-bac236291f20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTUtMS0xLTA_01c28bc0-1f34-45a8-a08a-24be49b24f0c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTctMS0xLTA_d1ceaf53-4edb-4d54-814f-6f0d6320a48d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTktMS0xLTA_ad473bee-5ea9-4c5b-b0a1-466606385250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTExLTEtMS0w_cd33da2e-223d-4bfe-8e33-088ad550700b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTEtMS0xLTA_9abf4268-8d98-4179-b531-7a062c7954ee">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTMtMS0xLTA_1bcfa873-82a1-4ccb-b366-37d46ce1d411">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTUtMS0xLTA_a2b54160-fb3e-49bb-a34e-24450c512138">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTctMS0xLTA_eafdcabf-4577-4b67-846b-89323ebe1905">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTktMS0xLTA_f63a705d-448a-4330-a64b-ec0fead503ae">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTExLTEtMS0w_2a241c86-dfe2-4d28-8dd0-cf89087d5147">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTEtMS0xLTA_ece1f6b4-2709-45bd-a7ed-b1ad9566e257">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTMtMS0xLTA_79567d1e-c14b-4f0c-b345-d9c70c5260dc">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTUtMS0xLTA_86c70a50-f7f0-4f86-8a30-144ec8bfd1f9">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTctMS0xLTA_89dea8b4-060e-4b1d-a458-26e632107b95">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTktMS0xLTA_082855ff-e397-4253-8e51-9b04a28c396c">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTExLTEtMS0w_94092fad-46ed-4c1c-9a85-0f4ab1e252d2">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTEtMS0xLTA_4053e6bc-a09e-4b9d-b6d9-3e01f7e16bbf">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTMtMS0xLTA_c6f4fe61-a010-4046-bfe2-04e7ca848dae">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTUtMS0xLTA_3ae92a21-a411-493d-8e3e-8c631c190b1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTctMS0xLTA_6a13155a-4816-49be-a85b-a971901b7e2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTktMS0xLTA_89033cb5-4a8f-44fd-a40c-13773ae594a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTExLTEtMS0w_4caae007-d9f9-4ca7-a2d7-27b03034c9ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTEtMS0xLTA_be7a9988-d886-4664-afc1-b17ab4476f7a">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTMtMS0xLTA_341071ca-33f9-4288-9a46-a44d748d2c91">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTUtMS0xLTA_a989dd22-1d60-4bfd-a537-461dcb59b120">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTctMS0xLTA_3979ecec-fc96-44c0-9ef3-a6117eaa6126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTktMS0xLTA_664a1ea2-fa1b-4b89-a918-69b782afc64b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTExLTEtMS0w_2ac6e79a-8a9f-43c4-ad60-a9c91ef69bd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTEtMS0xLTA_5d12fc08-2c04-4b39-8bfa-080476491807">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTMtMS0xLTA_b890dd36-e807-4861-9f0f-1ee5c0df2fd0">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTUtMS0xLTA_3a0a9fc6-82a8-443e-8510-b94aaade5058">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTctMS0xLTA_d892acb7-f572-4b95-b48d-d04264c7bad1">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTktMS0xLTA_92aabb9a-a317-4d37-a447-baec8fa7ad70">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTExLTEtMS0w_ff6e23d0-1bc9-4d25-b724-63faaaaabedf">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTEtMS0xLTA_8f8e7387-b7f0-4967-b03e-2525ebe72893">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTMtMS0xLTA_a7f7c37f-22e8-44e6-bae5-26ab368a9662">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTUtMS0xLTA_60f601ab-9880-47da-852e-181539ad8426">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTctMS0xLTA_4e8815d5-2221-43b2-a918-c4b0e93f308a">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTktMS0xLTA_6e099f24-0151-4db9-a918-fb73e6313e92">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTExLTEtMS0w_ed56e159-c381-43bf-ab14-560f2c8959aa">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost by geographic location is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItMS0xLTEtMA_3b57e960-63cd-4989-a034-1fbf01b01fbd">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f8c2dff1fb47aa8d3c65c340678d15_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItMy0xLTEtMA_b79a77f7-9c55-4bad-bc8d-4125b020a3a8">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796caa67ee0e45cfb059041a1e2187bb_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItNS0xLTEtMA_751edfb8-b0a4-4604-bdf8-76e2e669c127">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if13e4b6d592a42489a6f499eb9fbfd39_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItNy0xLTEtMA_d282a596-ecee-463d-b691-d883ffaf742f">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i876e963861bb446cbb82e6c637fae2f2_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItOS0xLTEtMA_f6011af9-956c-409a-bb21-b4981374483e">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1478cc28dfaa4d7f889e3ee1528d58c4_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItMTEtMS0xLTA_6c4efe51-1f1a-41e1-9463-411d8eb9eaad">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386c37780a184cefb9928ebfdfedcfe7_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtMS0xLTEtMA_e25fe6f9-6656-4ab6-ab2e-c687fb8e3c63">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbb0433c970748fa8ef413c8bd5370f7_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtMy0xLTEtMA_d2e4a844-675c-4b06-9b4e-28ef9850ca56">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd3d667f6f24bf5bc61589ce38acb11_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtNS0xLTEtMA_27ef034b-5fa6-4551-8223-936276e81367">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2c88135cd14a78813b05c34e34ca53_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtNy0xLTEtMA_781cba45-dfe0-464e-ba6e-8fbe3897f652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc2f2f3b70d4f728400db29e64a3f7e_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtOS0xLTEtMA_9413e27f-9fb2-431a-a049-9ccd7a98ec74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba56c58d773f48009254ee34458305df_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtMTEtMS0xLTA_850c2e5c-fe8b-467a-be6d-04c5fd1be650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtMS0xLTEtMA_1bbce4c0-f777-4ca0-9acb-4bca5620f921">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtMy0xLTEtMA_ecdcd0d7-8baf-437e-9851-908ea3a761bd">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtNS0xLTEtMA_26d19ba6-3ee4-4fee-911f-b16231c9fb43">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtNy0xLTEtMA_96afba0c-5f71-4c1b-ab35-2a57859797fc">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtOS0xLTEtMA_ca15390d-3325-4723-9d14-e7f95f6ce2c0">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtMTEtMS0xLTA_4ef7d1c5-ea39-4343-a3c0-a7374c827039">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component included within net periodic benefit cost is considered employee compensation and is therefore presented within the selling, general, and administrative and costs of goods and services sold financial statement line items of our consolidated statements of income. The remaining components of net periodic benefit cost are reported separately and are therefore presented within the other nonoperating (income) expense financial statement line item of our consolidated statements of income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2019, we recorded $<ix:nonFraction unitRef="usd" contextRef="i5a02b0a604014333900498c1cfd05c7c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUwOTc_aafec250-1abb-4260-a3b8-d87bf2215e29">3.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i81cac794d7894db3846aa546dee94d08_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUxMzM_fd486c82-f0d7-4580-ab2a-5da86b95afd4">3.5</ix:nonFraction>&#160;million in pension settlement charges within other nonoperating (income) expense, respectively, as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we did <ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1Xzg3OTYwOTMwMzQxOTc_45163c3c-e842-4c7b-b0fe-1bf967990677">no</ix:nonFraction>t contribute to our U.S. qualified defined benefit pension plan. During 2019, we contributed $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUxNzU_891654f8-667c-45c7-b625-7cd84f6c98da">2.6</ix:nonFraction>&#160;million to our U.S. qualified defined benefit pension plan.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ia158cc77ddc447198b57f635c3438903" continuedAt="i4a4b92d7a9a34feab04f40803336b65b"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyNjQ_b8830767-9d51-4f3e-aa4b-5f74a4db9204" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtMS0xLTEtMA_3692d856-78ab-424d-9cc8-43bc2f22340d">287.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8190a671d354cd382c8d1942d0777c4_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtMy0xLTEtMA_4651ae05-6c9d-4c05-b6a0-ebd24d1a22e2">267.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtNS0xLTEtMA_de42e48e-1e69-43ab-a4dc-3bc7bfce9e49">6.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id23ad1f4c66d488cb8092ac2514b826f_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtNy0xLTEtMA_44463ef6-5efb-40cf-8799-bca178b4d94d">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtMS0xLTEtMA_801f5f22-b2a4-418f-b662-71b8bc897d43">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtMy0xLTEtMA_4fa9a0a6-9a34-4d60-962b-1484249f6513">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtNS0xLTEtMA_0cd1491f-f0a3-4b61-924c-f55ba77e25ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtNy0xLTEtMA_adf6daae-ab77-4e45-bceb-b769f5c73e66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtMS0xLTEtMA_f8a099a3-af3a-4fb6-90e3-4f30f4af6288">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtMy0xLTEtMA_8a4d4a0b-f845-473e-a1fd-a96e63e24f12">9.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtNS0xLTEtMA_037405b8-a34c-42d9-9d2d-ebe9b3ee5d9a">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtNy0xLTEtMA_d1786f09-dd00-4dab-a969-556cf1f2773d">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtMS0xLTEtMA_95f14473-ce65-404b-810e-16524f011940">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtMy0xLTEtMA_bc1dd983-6bed-4b6a-9434-f11e42e8ab2a">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtNS0xLTEtMA_f1f32db4-6dd9-41ee-bb8a-27a92f5958cf">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtNy0xLTEtMA_6f4783ff-4660-4554-9ac3-fcb7034cca5d">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctMS0xLTEtMA_203168f5-6198-4211-a191-32460de44976">22.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctMy0xLTEtMA_1bc226d6-140a-4822-9c5b-2498d09dbfcd">30.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctNS0xLTEtMA_d84de050-9ebe-48aa-ad63-9e7a075dbc06">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctNy0xLTEtMA_831f8557-af08-4037-b572-64a138ab804a">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktMS0xLTEtMA_ef25c2cf-368f-4dff-8196-cac85fe633d9">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktMy0xLTEtMA_26af262f-e9ae-479e-ad35-da3d5c7873af">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktNS0xLTEtMA_ef7125ea-0c3e-452b-96e7-e2e30eda1b8b">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktNy0xLTEtMA_cc741b8c-03a1-484e-a4f6-5de0bf455f7c">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTEtMS0xLTA_97af1327-4523-401b-9883-0593c5344890">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTMtMS0xLTA_fd2578d6-f50b-4ca4-8955-9aead555061e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTUtMS0xLTA_88cd961a-3d18-4e32-a822-fecc72bae55a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTctMS0xLTA_4f4c94b7-3124-4058-96eb-bc48c15fcf9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTEtMS0xLTA_83edf42d-f709-4288-bada-a49e52d08247">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTMtMS0xLTA_3c1144a9-6b3f-4dd4-8474-ab0af1a10338">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTUtMS0xLTA_0106c2fb-7092-4017-999f-da0259eef383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTctMS0xLTA_cc0eccbc-ad5b-4631-b3a9-183a91c7ef73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTEtMS0xLTA_924f31b9-007d-40dd-a519-164e3e2237ea">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTMtMS0xLTA_5027b5ec-3a83-4b52-ae5f-a37d3330f8b2">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTUtMS0xLTA_93413454-2afe-4b15-8891-996d11adfe68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTctMS0xLTA_cd9a1916-eb63-4899-8988-a962a0b8556a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, December 31</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTEtMS0xLTA_390f8ed0-7628-4f6b-9a4b-16e988cbb9e3">298.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTMtMS0xLTA_0dd602ea-b9bf-439a-8d28-415d2d570883">287.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTUtMS0xLTA_ae022593-ae1a-41ce-99b4-7dca5e7cee21">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTctMS0xLTA_ae78f403-9d3f-4650-b317-8d7b3fc67b20">6.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTEtMS0xLTA_e547d53d-aebd-46f3-8c18-c98865387355">244.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8190a671d354cd382c8d1942d0777c4_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTMtMS0xLTA_832aff11-c00c-4fb8-8907-76a848d84ec3">214.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTUtMS0xLTA_eec9fd59-95ba-490b-afd4-7ab9797aef1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id23ad1f4c66d488cb8092ac2514b826f_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTctMS0xLTA_3cac1791-a4f3-4a39-a8a6-4d8e6e91cb0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTEtMS0xLTA_efbc6116-531b-4c6d-8dfe-f4b8e5ab510f">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTMtMS0xLTA_dc6d0336-2e15-400b-9cd8-867fd9f6c014">41.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTUtMS0xLTA_0d2972e8-de34-405d-9a6c-7597eab90c53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTctMS0xLTA_d1cd123b-8219-4aa0-9009-4c0e7b415bc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTEtMS0xLTA_191b1823-fd20-4640-b182-e57df6e151fa">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTMtMS0xLTA_65d7926f-4e34-428a-a244-2e33eff190b0">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTUtMS0xLTA_c4f7a258-971a-4ccf-bee4-52afe0605325">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" sign="-" name="wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTctMS0xLTA_1b19231b-7186-4b46-a027-8ce310df3bf2">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTEtMS0xLTA_3d86e4d2-dcf4-4470-8332-72e4a3da3728">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTMtMS0xLTA_deffa771-5cea-4672-8c08-1f90cb584f7b">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTUtMS0xLTA_8cce50a2-1d83-48c4-996b-48cc5bb31c21">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTctMS0xLTA_fdeb3c80-9d4e-4fef-9880-b176faf151b1">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTEtMS0xLTA_9afca44a-33a1-41ea-ba61-ddb18caafa11">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTMtMS0xLTA_759445ba-efe6-46b2-acd8-1251777b51c2">6.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTUtMS0xLTA_140ddc9c-a7cb-4932-8f23-0009b35097a2">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTctMS0xLTA_47f5a031-609e-447f-9421-fda00af91047">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTEtMS0xLTA_d38791b1-6b2c-41f5-991a-0d2a9ef21a70">18.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTMtMS0xLTA_bba32879-dfb7-4094-9fc4-a3bc6dee3e4a">15.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTUtMS0xLTA_241b05fd-b9b2-472c-be05-ed01c8f22076">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTctMS0xLTA_85c0605b-79f8-4ce8-8543-4b26da938b0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTEtMS0xLTA_af1e4bfa-2a7d-4f1e-992a-9b5668be907e">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTMtMS0xLTA_01103d51-ce32-4770-b699-80f74ac19b44">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTUtMS0xLTA_d054d407-01ed-4306-a035-324fe1e8ff44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTctMS0xLTA_614a344a-a442-40fd-9fa7-2333659b2b23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, December 31</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTEtMS0xLTA_72912230-8866-4743-a9f7-256a669b1f45">258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTMtMS0xLTA_29160add-1dfe-4bfc-94cc-31d76477460d">244.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTUtMS0xLTA_3321e0db-4731-4291-a21f-16f3311c330b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTctMS0xLTA_0d9176b6-6f9e-4910-8559-a32c49dd7190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTEtMS0xLTA_b0b39b98-bca0-40a1-bc52-7e8c0ba6937b">40.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTMtMS0xLTA_288cc6a5-6a71-4660-8517-e68473d413c1">43.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTUtMS0xLTA_518b667e-ec51-4f86-b695-a7620ad9b871">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTctMS0xLTA_c9caa2be-5529-44df-9cea-1b0fc0729ccd">6.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International pension plan assets, at fair value, included in the preceding table were $<ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzE2OTk_0d5ebf6d-d2c1-4feb-80cf-121dfe870970">43.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzE3MDY_fc6748e0-e39e-4c0d-a8f3-a3023c5d2095">39.4</ix:nonFraction> million at December&#160;31, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyNzQ_e9f0252e-2591-4bf9-8e1d-d4c82ea8f7bc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="wst:AssetsDefinedBenefitPlansNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItMS0xLTEtMA_9fc6b220-6e5a-483b-8bff-5cdda0784eca">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="wst:AssetsDefinedBenefitPlansNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItMy0xLTEtMA_cc258875-7278-4482-806a-58c92021c457">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" format="ixt:zerodash" name="wst:AssetsDefinedBenefitPlansNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItNS0xLTEtMA_1178a255-7cb6-4c97-88f4-7bdb4172f8b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" format="ixt:zerodash" name="wst:AssetsDefinedBenefitPlansNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItNy0xLTEtMA_d9487f49-cc91-4807-acd8-ac7521176e2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtMS0xLTEtMA_1133068b-c1eb-484a-be4c-f865fc150e0f">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtMy0xLTEtMA_a575d5c2-9fb1-4671-8051-0a96bb162552">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtNS0xLTEtMA_e6ab1a58-6ec8-498d-9b58-8e938ad2cd25">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtNy0xLTEtMA_0daf253f-810c-4c25-88be-9021b00ef9ec">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtMS0xLTEtMA_6bb4db37-b341-45bb-8f44-723b38186ab5">52.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtMy0xLTEtMA_ce7949ad-6d30-4886-9d2a-fa172395f9d3">46.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtNS0xLTEtMA_3d316d15-bcb9-46c6-b0f0-cb2fdb3d6426">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtNy0xLTEtMA_aae4d5d7-79ea-4efc-9bd8-ff6969f1f017">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtMS0xLTEtMA_d25f9bd8-751d-4b30-9f3e-92ef9635fc86">40.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtMy0xLTEtMA_7ba6d2f5-a901-42c8-8df1-db7d96116687">43.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtNS0xLTEtMA_19bbd5c6-09c9-47a5-9cd5-fda70245e3ed">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtNy0xLTEtMA_c18c8828-6359-4399-be32-a1fa1e0a8e9b">6.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4a4b92d7a9a34feab04f40803336b65b" continuedAt="i303d1fefacd843da85eb81f332859978"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyNjU_0a4dd3e9-eeb1-4d36-a8a9-2b78a069c0ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItMS0xLTEtMA_debd4b78-6c96-4a8e-a6c7-00907b30ce88">67.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItMy0xLTEtMA_52af80b0-bd44-4ce3-9618-b56326d6eeb4">69.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItNS0xLTEtMA_75374d33-c2a4-4005-9245-caf6bb1023ab">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItNy0xLTEtMA_28006275-e531-46fa-a4fd-404b7ffa7fb8">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtMS0xLTEtMA_fdfb8d00-2dd7-48e5-811d-4d9e21f3151a">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtMy0xLTEtMA_66ded5e0-17eb-4580-a1e3-f49e286ea415">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtNS0xLTEtMA_ea025ab2-a88a-4b74-9dca-79d615b99e9e">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtNy0xLTEtMA_c8cd642d-1aa1-4e38-87bd-2aee665314a5">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtMS0xLTEtMA_3b4877c8-006a-48c1-8999-227107e4aea8">68.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtMy0xLTEtMA_e636003c-803b-4051-9407-705c9e7d1885">70.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtNS0xLTEtMA_dcadf95d-7e90-40b9-8ac9-5470a24ec16c">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtNy0xLTEtMA_33251d1d-e524-4177-bd15-6612261c9a64">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation for all defined benefit pension plans was $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0MTg_06b97e76-a69e-4af7-9f03-a99d995d5616">293.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0MjU_46d078d5-9ac8-44ad-9a5e-ff052c254ca1">283.9</ix:nonFraction> million at December&#160;31, 2020 and 2019, respectively, including $<ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0NjY_dbe5f00d-4f28-42e4-bf3a-696e99cbb45b">83.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0NzM_1a40e6bb-f45b-4921-818f-c4d48a139369">73.9</ix:nonFraction> million, respectively, for international pension plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, our U.S. qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2020 and December&#160;31, 2019, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMTA_d930e7f4-8867-4fe0-9abe-5a2460a57e93" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzEtMS0xLTEtMA_ab0eaa2e-81d7-46dd-a24b-4e2db4aaad56">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzEtMy0xLTEtMA_bf346d48-11e8-49b9-8901-8928cf9dfc55">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzEtNS0xLTEtMA_a7f1a8c1-08f1-4a6c-921e-fd19b8d46f91">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzItMS0xLTEtMA_fd5bc07a-a6e3-478c-862b-8acf193112a3">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzItMy0xLTEtMA_876917b0-0ada-42b5-a5b4-3f8c8c31cddf">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzItNS0xLTEtMA_1eab6e08-a9af-4f8a-bf2b-9f98462f4492">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzMtMS0xLTEtMA_dd08ed7b-62df-4568-a91b-e7ee6efa65a2">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzMtMy0xLTEtMA_c177349e-b3f3-4594-82d2-3ec10cadc8b4">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzMtNS0xLTEtMA_dd5791a5-70c4-4388-b1b6-ec4be4432d2b">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzQtMS0xLTEtMA_8c89f3be-78cc-4810-94a3-1cc8ae7c1b50">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzQtMy0xLTEtMA_74528a24-f805-429c-b3e0-d44374afa734">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzQtNS0xLTEtMA_a35d31d0-8323-4ccd-a0ca-a8437e0014ab">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzUtMS0xLTEtMA_70865f01-af0a-4d30-aa08-506e5f00a254">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzUtMy0xLTEtMA_806209db-ac04-4144-b3df-742d22fe1fcc">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzUtNS0xLTEtMA_1d13eed0-1392-4152-b25b-87a4aff4e533">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 to 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzYtMS0xLTEtMA_4a5c3e54-1829-4d5f-aa2f-3d3fc5b4a526">54.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzYtMy0xLTEtMA_b71dc390-7c0a-41f7-a364-5cc7693371bc">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzYtNS0xLTEtMA_e05482f0-f44e-495b-97fa-f321aa31ba5f">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzctMS0xLTEtMA_0631bcb4-a31d-4d25-a812-256fec9ade5a">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzctMy0xLTEtMA_7eccad22-9c32-4b4c-93b3-60b5965a019c">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzctNS0xLTEtMA_df87878e-5245-4c86-bbb7-8864f9e64c1a">168.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we expect to contribute $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUyMzI_8dd98811-0678-48eb-b192-ab93d33869de">3.6</ix:nonFraction>&#160;million to pension plans, of which $<ix:nonFraction unitRef="usd" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQzOTgwNDY1MjA2OTI_e596a674-8cb4-4963-8094-c5b419c27355">2.9</ix:nonFraction>&#160;million is for international plans. In addition, we expect to contribute $<ix:nonFraction unitRef="usd" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUyNDA_8b7fc485-a1ed-41df-bdaf-d5bf301206fc">0.7</ix:nonFraction>&#160;million for other retirement benefits in 2021. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyODA_eb627c1b-6618-446d-b8de-5dbf222bb597" continuedAt="i6d69b84375d94c568463c65a3c00e5f0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItMS0xLTEtMA_64b1127e-895a-4d3b-b258-c320a982c373">2.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItMy0xLTEtMA_2c806040-fad0-41af-8eb5-ea89251c3b5e">2.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItNS0xLTEtMA_1f25619a-a271-4b05-ad11-eb99435437ec">2.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItNy0xLTEtMA_0673405b-10ab-40a7-a8d1-3f6a83d5af50">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItOS0xLTEtMA_87a8a9f3-0d5a-4d43-af28-369d878d6d2c">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItMTEtMS0xLTA_a9cc7cc1-1e20-4d0b-ac9c-4dc3369c0234">3.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzMtMS0xLTEtMA_9ec570ef-65a4-4f42-8fe1-15e2ed3e11ca">2.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzMtMy0xLTEtMA_8f85e45e-224d-48f4-98c9-aa9199e4ba75">2.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzMtNS0xLTEtMA_40a38cdd-bd71-4269-9b13-878365d47a9f">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzQtMS0xLTEtMA_cf7fe551-ce96-4528-bac4-992a11c8185e">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzQtMy0xLTEtMA_403e0607-147e-46c6-a54a-7aee14a5e06f">5.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzQtNS0xLTEtMA_5739c9ad-f1b1-48a7-9b13-01ceb00db8f0">6.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i303d1fefacd843da85eb81f332859978" continuedAt="i92477465c9a8459c99cc4e00ff2c0926"><ix:continuation id="i6d69b84375d94c568463c65a3c00e5f0" continuedAt="i82c659362b4e4c918f99a3199dd6e780"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItMS0xLTEtMA_e1e9e884-82a7-412c-88b6-17b23778582d">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItMy0xLTEtMA_1adc26b1-af7e-43ea-b938-8f69798202f5">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItNS0xLTEtMA_c60d125c-b2c9-43f9-ae4b-7fc29bc8d035">2.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItNy0xLTEtMA_fb3e9ec8-5aa6-485f-b61a-9ff89e39d52d">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4075113bb61471da80f2c6ac352be97_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzMtMS0xLTEtMA_b6c75dc1-33a0-4515-8bd3-9f0a7cf6fff9">2.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzMtMy0xLTEtMA_06a9dbb3-a610-42f5-a377-d1070332b9f8">2.49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate used to determine the benefit obligations for U.S. pension plans was <ix:nonFraction unitRef="number" contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM3MTI_2341034c-c65e-4d25-8028-c14d47ffa4d8">2.60</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9cc77fb8f01142a38ee0cb161ae8c1cd_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM3MTk_f61bc0ad-8540-4e90-bcc7-0deb511a1f5c">3.35</ix:nonFraction>% as of December 31, 2020 and 2019, respectively. The weighted average discount rate used to determine the benefit obligations for all international plans was <ix:nonFraction unitRef="number" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM4NzY_e0b957a7-510d-4efb-afb5-25f4f7d9be4a">0.89</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM4ODM_56efe9bf-875d-4078-b00a-783f86922aca">1.28</ix:nonFraction>% as of December 31, 2020 and 2019, respectively. The rate of compensation increase for U.S. plans was <ix:nonFraction unitRef="number" contextRef="i9a86b5e8a2be41a4881009bd7646cbc1_I20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUyNzM_1a2f5df2-e0d0-471c-a745-1accaaccba5f">4.25</ix:nonFraction>% for 2018, while the weighted average rate for all international plans was <ix:nonFraction unitRef="number" contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQwNTg_cc79d54b-a70c-439a-b97e-fa80c3287621">2.58</ix:nonFraction>% for 2020 and <ix:nonFraction unitRef="number" contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQwNzI_b80df5d9-49e4-4370-bd31-ae75e8238f50">2.49</ix:nonFraction>% for 2019. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans, which accounts for <ix:nonFraction unitRef="number" contextRef="i2e8f7729b95c446d88cb96cfb7b67b5c_D20200101-20201231" decimals="3" name="wst:DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyMjE_45d9b29f-ba04-4848-8561-41270e5f13ff">83.0</ix:nonFraction>% of global plan assets, was <ix:nonFraction unitRef="number" contextRef="i2e8f7729b95c446d88cb96cfb7b67b5c_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyNTE_0bdd70ba-b872-4fab-9c34-a162ab7d5846">5.10</ix:nonFraction>% for 2020, <ix:nonFraction unitRef="number" contextRef="if5eafccc5cbf45f3b2b2941de558f722_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyNjI_9cf364e5-e5c6-44a5-8b1f-95cd8caf30e1">5.60</ix:nonFraction>% for 2019 and <ix:nonFraction unitRef="number" contextRef="i135ba46e2e694c4bbc75dbd5e31ab210_D20180101-20181231" decimals="2" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyNzY_023b1fcd-df5b-4af6-af0c-948e12d30809">7.00</ix:nonFraction>% for 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumed healthcare cost trend rate used to determine benefit obligations was <ix:nonFraction unitRef="number" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQzNzA_4665354b-62f0-4407-9d03-13b0faa76d25">6.50</ix:nonFraction>% for all participants in 2020, decreasing to <ix:nonFraction unitRef="number" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ0MTU_4a8b452d-5a01-4faa-baea-8f5ad7a641bc">5.00</ix:nonFraction>% by 2027. The assumed healthcare cost trend rate used to determine net periodic benefit cost was <ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="4" name="wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ2NTU_1daac30e-a650-4f70-8c84-de15b2d1fa92">6.25</ix:nonFraction>% for all participants in 2020, decreasing to <ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ3MDA_27dafd7f-e5eb-415c-a797-67c8729c4799">5.00</ix:nonFraction>% by 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The defined pension plan benefit obligation increased for the year ended December&#160;31, 2020 primarily due to a decrease in the discount rate used to calculate the obligation. The net actuarial losses will be impacted in future periods by actual asset returns, discount rate changes, currency exchange rate fluctuations, actual demographic experience, and certain other factors. The other retirement plan benefit obligation decreased slightly due to the activity mentioned above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has cash balance plans and other plans with promised interest crediting rates. For these plans, the interest crediting rates are set in line with plan rules or country legislation and do not change with market conditions. <ix:continuation id="i82c659362b4e4c918f99a3199dd6e780" continuedAt="i978366662b91454cbfbd08b1ac842d16">The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:</ix:continuation></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="i978366662b91454cbfbd08b1ac842d16"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzEtMS0xLTEtMTM0NTI_4a1c162d-059e-4bdb-aa7b-9989f76cfed0">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia2f8c2dff1fb47aa8d3c65c340678d15_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzEtMy0xLTEtMTM0NTM_4b0c0fb4-dc96-4e87-b3d0-c2adab541859">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i796caa67ee0e45cfb059041a1e2187bb_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzEtNS0xLTEtMTM0NTg_53c19d47-44dd-42fb-a276-0614390ad692">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i386c37780a184cefb9928ebfdfedcfe7_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzItMS0xLTEtMTM0NTM_8070183d-cb52-4d6e-9090-9881af707224">0.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icbb0433c970748fa8ef413c8bd5370f7_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzItMy0xLTEtMTM0NTM_9b1a076e-9c04-4588-b4b4-56b6641ecaee">0.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0dd3d667f6f24bf5bc61589ce38acb11_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzItNS0xLTEtMTM0NTg_8685656c-ca92-4784-9564-6ac5eb6aa8c8">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMzE_0eebded8-ffe1-4ded-8cb2-cbe13cde2259" continuedAt="iee7f4ba8ed4c4e66a0ea520856baa8f8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if288e4886a22444a9cb6096fee75382e_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzEtMS0xLTEtMA_e3e7280b-fddb-435a-8a2f-112ba42ce9de">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1f757014e0945a5bf6bc2c5b4dc7249_I20191231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzEtMy0xLTEtMA_12d6465f-05ee-4fb6-86ad-da1769a238c5">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5749a3d72efc471787a5d2c8be39e567_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzItMS0xLTEtMA_970a97af-5547-442d-aae6-11f5ada9bee7">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i702b7d354d8f47ca9dce932abfe26468_I20191231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzItMy0xLTEtMA_fc49ddbd-a944-4382-9a8c-6cce75c83ba6">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b55367d0664406584e5bef4f962b96b_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzMtMS0xLTEtMA_0cf20d1b-c1e9-4608-9279-48957a353502">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id543109bbee84ce08728e7c8c83af280_I20191231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzMtMy0xLTEtMA_f7955cf5-2cac-4407-89f3-b283807ca2f2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzQtMS0xLTEtMA_a5dfa28c-b42b-465a-9adb-d59a0257696b">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzQtMy0xLTEtMA_4d45ad79-73d0-478a-8c52-18f3429ddc1c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. pension plan is managed as a balanced portfolio comprised of two components: equity and fixed income debt securities. Equity investments are used to maximize the long-term real growth of fund assets, while fixed income investments are used to generate current income, provide for a more stable periodic return and provide some protection against a prolonged decline in the market value of equity investments. Temporary funds may be held as cash. We maintain a long-term strategic asset allocation policy which provides guidelines for ensuring that the fund&#8217;s investments are managed with the short-term and long-term financial goals of the fund, while allowing the flexibility to react to unexpected changes in capital markets.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i92477465c9a8459c99cc4e00ff2c0926"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.</span></div><div><span><br/></span></div><ix:continuation id="iee7f4ba8ed4c4e66a0ea520856baa8f8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the U.S. target asset allocations and acceptable allocation ranges:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target allocation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5187136b2ee4ca79301744704a7d717_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzEtMS0xLTEtMC90ZXh0cmVnaW9uOjEzMTZlMTk1OWEzZjQ3NDQ4OTIxZmIxMTNiZWRhODFjXzEwOTk1MTE2Mjc3ODY_c0ca80b5-a964-4f3c-8d3c-4233f309a7e1">30</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaa0d5d817d5451f853f49d5e75d6d4b_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzEtMy0xLTEtNTg5OC90ZXh0cmVnaW9uOjU0NjY4ZjE3MGQ0MjRmNTM4ZTk3ZTc5OTIzMjg1ZGZjXzEwOTk1MTE2Mjc3OTI_44de67b2-35c1-4b6d-a14d-66848fb541a7">27</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i4f4c146b4a9e4cc9ad5a9fb7c2736c33_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzEtMy0xLTEtNTg5OC90ZXh0cmVnaW9uOjU0NjY4ZjE3MGQ0MjRmNTM4ZTk3ZTc5OTIzMjg1ZGZjXzEwOTk1MTE2Mjc3OTc_ccef74bb-de82-4a95-8b1d-dde3cd3d339b">33</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11cf3bf12dcb4f7b89f6fa466bd6f61b_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzItMS0xLTEtMC90ZXh0cmVnaW9uOjI1MThmMmZiN2FjZDRjZTk5M2JhMzg2NmJiYTEwYjhkXzEwOTk1MTE2Mjc3ODY_aaa99022-49b3-4cbc-867e-60151912c300">70</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36f034759b184fafb0766fc3e84b1c36_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzItMy0xLTEtNTkwMS90ZXh0cmVnaW9uOjY1YWQ2YmRmMWZjMjQxZGJiMDJhYzNmNjdhYTdlYmVlXzEwOTk1MTE2Mjc4MDM_8f4703e3-9e7e-4463-81c4-9500b9e1bb95">67</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i87e6d40f72d74559bf0873f01c9b4e42_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzItMy0xLTEtNTkwMS90ZXh0cmVnaW9uOjY1YWQ2YmRmMWZjMjQxZGJiMDJhYzNmNjdhYTdlYmVlXzEwOTk1MTE2Mjc3OTg_139fde9d-8e32-4594-98b4-1b2ed9d18a9a">73</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i094b2113e7f547cd90c587fc0372659e_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzMtMS0xLTEtMC90ZXh0cmVnaW9uOmFkZGM2MjQwNTc4MDQzMzJhYjk3ZGVkNTQ1YzJhY2VkXzEwOTk1MTE2Mjc3ODQ_2500e4f2-902f-4cdb-bfde-416dc8ece2e9">&#8212;</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1999229824e84c8d9ca34567aec0c908_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzMtMy0xLTEtNTkwNC90ZXh0cmVnaW9uOjc1YTE5OTczNDhjMzQzNzc4MzEwMDRkYzJmNDg5ZTA4XzEwOTk1MTE2Mjc3OTI_ccdb5236-3450-4d14-af26-0f56cce52e4a">0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i96d0ab8218d949d2a659ec046d80a1bc_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzMtMy0xLTEtNTkwNC90ZXh0cmVnaW9uOjc1YTE5OTczNDhjMzQzNzc4MzEwMDRkYzJmNDg5ZTA4XzEwOTk1MTE2Mjc3OTg_a12e25fa-ee1c-4a53-bddf-572fcb7e26d3">3</ix:nonFraction>%</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_133">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie419e0a44aaf4d3eb5ee9c6b334f68ab_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtMS0xLTEtMA_3addb963-1c3e-499e-bde1-d015d65366bf">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa24c422d8c0405099e0de09723d85d1_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtMy0xLTEtMA_f303b452-397e-479e-b89c-87cf306854a1">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c91cc19e464254ad91d8affa894f9d_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtNS0xLTEtMA_6dbc614b-6693-4066-ba78-3154d58c2c68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4add538dc55426e88cd3a2c21336362_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtNy0xLTEtMA_ca2c2639-a380-445f-80f0-8e2829be3e7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60088b670a5d4762b599e56d5c4144e4_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtMS0xLTEtMA_de0c0c9a-0fef-4515-ac16-2c9d0e84ec0a">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19a7aa0c01fe487d95b11f1de2d144ad_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtMy0xLTEtMA_61aeb312-c020-47f5-89be-19eb30485f20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f5c08c9be044322af60b2edf7b438f0_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtNS0xLTEtMA_0ab17c29-855c-4a30-98e0-7f9c55fd3db8">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f71fa6b7014a0d9856ddccecd5f63e_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtNy0xLTEtMA_a8163626-8006-425c-b3b8-15096a537c71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8341c7060458474a822a8b5d2048ad64_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtMS0xLTEtMA_e8e0ecfa-0612-4ff8-8be4-16a109042902">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd0101c2ca4488b94dba592a0fb3f19_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtMy0xLTEtMA_c2c664b7-cd45-4bc3-878b-43fc873cf602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d50bf5e175c440783b2b9c219b372c4_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtNS0xLTEtMA_d90ec223-5e11-4f66-aeb8-48302ceea867">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266aa4fc9a0a43728336bfdd4f5d2243_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtNy0xLTEtMA_f8374115-7fe8-48ec-9afd-77084a28305d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f001b391204e3ca8e6364079ecc773_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTEtMS0xLTEyOTc1_4b98a297-cd4c-4c1e-9be1-df87c07e1349">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709ce196777d43518c28b2c94fdcce0f_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTMtMS0xLTEyOTgz_3720a355-42a6-4782-96e7-b0a2e414cfbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied72e1adf5634108a0178f0d097f1efb_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTUtMS0xLTEyOTg1_89efb3c3-2767-41da-a7d6-435c42443210">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98071b96fe31436b9c3b419eee7e32f3_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTctMS0xLTEyOTg4_497bc200-76f6-4bf7-b3c7-15b657b20a2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cda47cc19b4bf19d6b5dbe554f69ef_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTEtMS0xLTA_24e42191-15a6-4dc2-95a1-276713608e3d">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTMtMS0xLTA_3cdcf0a7-6e72-4c22-9729-c0583b720608">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTUtMS0xLTA_2b028080-c2e7-4240-945e-ba239abc5314">42.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce83038c2641929269fa9febd355c8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTctMS0xLTA_360d755a-a81a-426e-9253-74adc7266274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050e371f0fc64570a8371b4ee1d6bfd2_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzEyLTEtMS0xLTA_dcf8c591-a705-478d-b826-19eedd9d9415">214.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzEzLTEtMS0xLTA_505730f1-4e5f-4294-ae27-9d6909aef220">258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if951953d16294cdcbc6e8bb801ad899a_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtMS0xLTEtMA_45ce376e-0cb7-4c11-b7ca-040dc0863442">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib50dc684425d41089759a744a6bfe976_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtMy0xLTEtMA_19ac2e98-7967-476f-a581-a10dd7800aa0">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2f1128dce6466cac75150836fb94ec_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtNS0xLTEtMA_06ceaa41-2326-40eb-90d2-1010dd0d31d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494430ec845b43fea48e416c8601f31b_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtNy0xLTEtMA_b85aea3c-45f9-4f06-8f24-467facdc795d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60b7e3f1fcf4c8b9a2d92a956688b64_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtMS0xLTEtMA_6b9d665e-84ea-4efa-ac13-e2cfa036b201">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9cfb636098475aa47d5bd1a223dd8a_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtMy0xLTEtMA_6359ae20-5658-42d6-aa48-360da7bda90c">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0308ba03d22245b7b8e1dfe8f84611d6_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtNS0xLTEtMA_41b867a3-db97-4790-8221-6d311e3a6931">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf18620d1a2e439b9d01b280d170a058_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtNy0xLTEtMA_407c3f5b-4091-4916-ae87-59b34822ce37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3082f2f2d81a4f0883e8d344e51d25b3_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtMS0xLTEtMA_6e7007e3-48b3-475f-bbc0-1c46af347936">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb54b4a5ace54151917b1754f3a19fa8_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtMy0xLTEtMA_a71aa7c4-3338-4716-9487-6542ac2e7f35">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0a5df83d0b47c1b25e912b720d4e01_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtNS0xLTEtMA_4b083090-ca78-4cbc-9c04-f5457c1b5a44">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08860c9461ea45b79e3605f7916ca562_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtNy0xLTEtMA_c53308d9-01bc-4cf2-bb5b-dff99a5a61b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad97ef7bc454cc2becb3891d672bea5_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzExLTEtMS0xLTA_6ddf85f4-8d2f-4da2-9aa0-436b70a62277">39.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzExLTMtMS0xLTA_518018d3-86bb-4c23-9d9b-daa7f2a2165e">7.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzExLTUtMS0xLTA_82846d12-4c35-49c5-b6a0-6c12f48e5b8f">32.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9c0729d942243dcb1acd45b7a4b2302_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzEyLTEtMS0xLTA_fad26e13-d92a-496b-99b2-78bf4fd47627">204.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzEzLTEtMS0xLTA_4db256a7-8a9c-4f1b-81fb-9bb5929c03fa">244.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_151"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ1NDY_1fd6b8c7-d9b5-45fc-9e35-3a28f98a3864" continuedAt="ie2b9ae46d86c44dd90dda154e61dc5ee" escape="true">Other Expense (Income) </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie2b9ae46d86c44dd90dda154e61dc5ee" continuedAt="ibde3aa254ad7446eb31d8a523b8c6085"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ1MzU_5ae51dec-18c1-4f2f-8856-8b019ce3de67" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and post-employment benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzItMS0xLTEtMA_9f5bed80-1376-4f43-85d1-de54e376139b">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzItMy0xLTEtMA_b6f1181b-dbe5-44d7-89ec-b7416f85a75d">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzItNS0xLTEtMA_08c26d74-fd32-484c-a6d1-96b8fab82a5d">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzMtMS0xLTEtMA_7525b9dd-3e62-420f-acd7-0f7ba834c3b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzMtMy0xLTEtMA_c6fb317f-3df0-4249-a04d-988e6daa6dd6">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzMtNS0xLTEtMA_a8cb9897-c2f5-4caa-af46-76475c9a2148">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzQtMS0xLTEtMA_8ac44c0b-b160-42c5-a2c4-18a9152cf6d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzQtMy0xLTEtMA_3621bf94-1cf2-4a1a-af57-6c6580ad0d22">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzQtNS0xLTEtMA_6b862c66-73bc-487f-820f-a970a8871cd6">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and related charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzUtMS0xLTEtMA_ff987919-78f8-4054-be4c-306bbc3177c6">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzUtMy0xLTEtMA_d7fcfbab-0e91-4350-aba9-05bf970d99d9">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzUtNS0xLTEtMA_0dc0266b-287c-44d3-a5ee-dd76ec0742ea">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzYtMS0xLTEtMA_ef99927a-5067-42b4-aef1-d43d8db708ac">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzYtMy0xLTEtMA_d2649d4d-1eca-4112-b7a5-17ad8d936007">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzYtNS0xLTEtMA_571d42c9-ea64-4014-8302-5c0c99393529">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzctMS0xLTEtMA_845c6a34-a659-45b1-9ee7-c902a503b9dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzctMy0xLTEtMA_80939028-0c45-4f14-87c7-8768c5f491d7">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzctNS0xLTEtMA_f5d9faf3-9cbc-4acb-aef5-4fd40cb3288c">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil tax recovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzgtMS0xLTEtMA_27fa4c0e-e075-4191-b410-32c7386c4252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzgtMy0xLTEtMA_06cf4ca7-6574-4ccd-9612-d0f582e085f3">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzgtNS0xLTEtMA_ef7b0f25-0723-42a5-a13f-17c26d54969b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="wst:DevelopmentAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTEtMS0xLTA_9697b42f-d3b3-4763-b455-59977cf87cb3">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="wst:DevelopmentAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTMtMS0xLTA_47da5bce-b610-4986-b050-e86e30b8c135">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="wst:DevelopmentAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTUtMS0xLTA_4f34c588-7b26-40b3-992f-9cd6c96d7bb1">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEyLTEtMS0xLTA_8c7ef46f-7709-476f-9a1a-71ab844920ac">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEyLTMtMS0xLTA_32e6d749-6bcc-4d46-be43-7f01678e3879">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEyLTUtMS0xLTA_dce717ce-7b25-4f94-b632-5d95b311837e">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTEtMS0xLTQ1MDk_89b7aee4-ef46-417d-84ec-a6750b6c0af7">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTMtMS0xLTQ1MDk_e2005a1e-fa1c-476a-af18-2fb98cdb92b5">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTUtMS0xLTQ1MDk_4600973f-4776-4a8e-bc1d-c23c372e1552">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEzLTEtMS0xLTA_0270acc4-0084-4ce9-b30e-d8d4d7abc41e">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEzLTMtMS0xLTA_d084e38f-1a71-462f-9e4f-44ea1d15435a">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEzLTUtMS0xLTA_415b1710-2353-4e35-a822-c7b1f9830878">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzE0LTEtMS0xLTA_28366060-fc57-4211-af73-39fe4358ab07">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzE0LTMtMS0xLTA_89cfcdd2-04ea-4c07-8c0e-0ab84554ffb4">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzE0LTUtMS0xLTA_a6ab2b37-8642-4276-8fc0-82dc3bfa7760">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, our Board of Directors approved a restructuring plan designed to optimize certain organizational structures within the Company to better support our continued growth and business priorities. These changes are expected to be implemented over a period of up to <ix:nonNumeric contextRef="ifd693c0a25a2479690b679e348d38eb8_D20200701-20200731" format="ixt-sec:durwordsen" name="wst:RestructuringAndRelatedActivitiesPeriodOfImplementation" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzYwNDczMTM5NjE1NTU_a44fe7c6-4cb2-44b1-aab8-ad58a7441200">twenty-four months</ix:nonNumeric> from the date of the approval. The plan is expected to require restructuring and related charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i3279f29cb3d44ad398fdc8d0e4645742_I20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ5NDc4MDIzMzMwMzY_b0936623-4cf1-442b-99bd-37ab4fc97e53">15</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i2db454712df547c7ab009dafbba594fd_I20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ5NDc4MDIzMzMwNjU_4c20604d-6315-4275-b9e0-4164c511460f">17</ix:nonFraction>&#160;million. Since its approval, we recorded a net pre-tax amount equal to $<ix:nonFraction unitRef="usd" contextRef="i84165f2d4d454d8183ee94793f21eb44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ5NDc4MDIzMzMwOTU_db4db525-d01e-42ec-8e9e-8ae5297da5d9">4.6</ix:nonFraction>&#160;million in restructuring related charges associated with this plan. All charges recorded to date are severance related and recorded w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ithin other expense (income) in the consolidated statements of income. Once fully completed, we expect the plan will provide us with annualized savings in the range of $<ix:nonFraction unitRef="usd" contextRef="i3c10b1ae682d4560b9e68e567ee78779_D20200701-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EffectOnFutureEarningsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjUz_3572ab08-63d4-435b-9aea-e3146bc8eccf">3.5</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i9edfa646c3214875a75bd7a3a78ed53a_D20200701-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EffectOnFutureEarningsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjU3_c08f0ae1-be14-4b0e-8a45-3ad773574273">4.5</ix:nonFraction>&#160;million. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYz_570a30fc-2ee8-427f-a963-3cbe6bf1c6e1" continuedAt="i357f2e0528b74816a909e034f0d6a0d4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0c156b11b44bf9bb5fc1e2d121ddfb_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtMS0xLTEtNDgyMg_2d5d5b90-6fa1-4dbb-b401-0ed4e7fb9bda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9174797bed448da4f42a9ab90c7fe8_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtMy0xLTEtNjcxMw_1624db03-c39d-4006-a56f-2c9350a331e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd22d3c670e54cfa9c8332dd9e2049f9_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtNS0xLTEtNjcxMw_48d43d43-15de-4ee2-b1c7-2b606a447b4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011bfe673ee54bfcb6f9c6983b446443_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtNy0xLTEtOTk3NQ_c3998d0c-6316-4740-a4e6-4848c5620b32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810c968a3f8644c38105ee05c0745630_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItMS0xLTEtNDgyMg_327ed6d5-f7f9-4619-bb33-ba1252430f5a">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b33dcfc3132453a9eaf1f23d1e28a46_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItMy0xLTEtNjcxMw_9a0bfe11-cb2a-4d9a-b51a-5a8d2b0c21cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ea9955e84d40b0977aa384c11038ae_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItNS0xLTEtNjcxMw_a1dc4cf1-8fe9-4bde-99b5-bb47cbe1b207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e32d9c6ce54b18abbf607406fce66b_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItNy0xLTEtOTk3NQ_20627a56-79bd-48a2-9212-3e86b4567340">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810c968a3f8644c38105ee05c0745630_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtMS0xLTEtNDgyMg_9d1a2554-f468-4639-98f4-e57974eaf3ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b33dcfc3132453a9eaf1f23d1e28a46_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtMy0xLTEtNjcxMw_90604347-fb0e-40d8-811f-de50fc39e84d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ea9955e84d40b0977aa384c11038ae_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtNS0xLTEtNjcxMw_337f3c3a-0622-4364-9a47-bc6b5d524b8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e32d9c6ce54b18abbf607406fce66b_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtNy0xLTEtOTk3NQ_322074cd-f5ad-41a4-8653-41233966edc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ec7fb1237e40e185af54faa36233cd_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtMS0xLTEtOTk3MA_718346a2-977b-4057-a350-37a4ef81174f">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic176204c3afa46c5bf47f585a3fda12b_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtMy0xLTEtOTk3MQ_b4315903-0a6d-4654-94e2-b07cc0aade9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1051c2e627924a1084b2ece63cb73f04_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtNS0xLTEtOTk3Mw_0b4a2184-d831-478a-9983-683abf9d0802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84165f2d4d454d8183ee94793f21eb44_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtNy0xLTEtOTk3NQ_c576e4a7-03c2-4945-a93c-be08908009fe">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes were expected to be implemented over a period of up to <ix:nonNumeric contextRef="iceed54e3fc2843188a6afef50414dfb5_D20180201-20180228" format="ixt-sec:durwordsen" name="wst:RestructuringAndRelatedActivitiesPeriodOfImplementation" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzYwNDczMTM5NjE1ODQ_9aef078d-e876-4f31-86a1-67acfdfa9439">twenty-four months</ix:nonNumeric> from the date of the approval. The plan was expected to require restructuring and related charges of approximately $<ix:nonFraction unitRef="usd" contextRef="ia296001215624e7b9dab9ac52000b1bd_I20180228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ0OQ_6ebd80c4-0cc8-48a3-8ce7-ed9be0cadb01">16.0</ix:nonFraction> million. Since its approval, we recorded $<ix:nonFraction unitRef="usd" contextRef="ie24ddffb97cc4456a1f560750a4db57a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ4NQ_ae4987f3-bb31-4e9d-9753-e3aeaa60c4d1">13.7</ix:nonFraction>&#160;million in restructuring and related charges associated with this plan. The plan is now considered complete.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recorded $<ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzYxNQ_25c4b376-2a3d-4bad-9fdd-1e49edcf609a">4.9</ix:nonFraction> million in restructuring and related charges associated with this plan, consisting of $<ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzY5Ng_6f9bc92a-cc86-4f66-bdaf-6a25d4d96717">2.6</ix:nonFraction> million for severance charges, $<ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzcyMg_3c3359ed-15e1-4cb5-beed-5e135bf8932c">0.3</ix:nonFraction> million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $<ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzgxOQ_74200f72-784c-4715-a452-01f41e4acf6a">2.0</ix:nonFraction> million for other non-cash charges. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibde3aa254ad7446eb31d8a523b8c6085" continuedAt="i094aa63bf6294cf7b140bee887760273"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, we recorded $<ix:nonFraction unitRef="usd" contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjU4_e3a4d7be-b54b-4a38-aba1-8cbf5b7112d3">8.8</ix:nonFraction>&#160;million in restructuring and related charges associated with this plan, consisting of $<ix:nonFraction unitRef="usd" contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjU5_63b04b75-78c0-41e7-874d-d083ea3930ad">3.1</ix:nonFraction>&#160;million for severance charges, $<ix:nonFraction unitRef="usd" contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYw_258b8df5-2366-4c49-8d74-fe6d63103336">2.2</ix:nonFraction>&#160;million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $<ix:nonFraction unitRef="usd" contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYx_bc4c9a42-f9c5-4700-a8f2-61eac0d9297e">3.5</ix:nonFraction>&#160;million for other non-cash charges. </span></div><div><span><br/></span></div><ix:continuation id="i357f2e0528b74816a909e034f0d6a0d4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e15367dd044052a08c353d17ed4488_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtMS0xLTEtMA_00854919-8777-4d90-8af3-200bd622eca3">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f0a5d05a354c9ab3ed46523d85026b_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtMy0xLTEtMA_5690f55e-512c-49a8-9032-f602b521484f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eae9458001042abbe77ec865b769cdf_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtNS0xLTEtMA_4b3d9a15-cec6-4785-9404-82018276e6a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7f955de895424dbdb1f1a1c3db9fc2_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtNy0xLTEtMzU4Ng_a14368d7-702c-4577-96ca-10a884626d26">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItMS0xLTEtMA_e7d4cd16-2b3d-43fe-8b6b-3bc0bff5d47e">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb988feb4be406a9f663fd322648742_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItMy0xLTEtMA_5d956b55-90bd-4b52-b292-2b238eb774ae">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItNS0xLTEtMA_3e3bbe90-f2ea-46b2-a72f-83c4e7f8aab1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItNy0xLTEtMzU4NQ_c4a5ce05-132e-4613-b760-ed7ba0e00402">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtMS0xLTEtMA_db906b83-b822-425a-91e8-e9c2905146be">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb988feb4be406a9f663fd322648742_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtMy0xLTEtMA_c7fa171f-d716-4749-ae51-a6aeaa6ff938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtNS0xLTEtMA_75e69649-6054-4b36-bbcb-d4814dc2050e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtNy0xLTEtOTk0Ng_02395a2b-f74c-4a86-8829-061ce3382b0f">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash asset write-downs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtMS0xLTEtMA_a3881d65-683e-48d0-920c-b09918f2f098">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb988feb4be406a9f663fd322648742_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtMy0xLTEtMA_07a1c9c4-0cbd-4151-89e5-2c92ab57f120">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtNS0xLTEtMA_6a1ac0c6-3439-4af0-92cd-7d45ce9a29db">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtNy0xLTEtOTk0Ng_c7441552-f09a-4403-b602-c2b8a1f3d06a">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85908bb4116442599a19d848f1076448_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtMS0xLTEtMA_0327f81e-0f13-45f7-b195-fa5be77398b9">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f79a77bed344a6981d9eff588ca896_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtMy0xLTEtMA_71fbb8c1-a1c1-4698-844d-b6db6dd64487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f5f1f9c46284f9b908b58203e0fdd95_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtNS0xLTEtMA_69eb49d6-126b-448b-b4df-58ab4e57e35e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6629a2a3e6da4a748d04ed957a6ed07d_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtNy0xLTEtMA_a6697d08-a1f9-4ba9-831f-96a35fbbc2ab">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193830303b9d4d0193b328737f36c6c8_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctMS0xLTEtMA_5908a14a-7808-4f50-b32c-fccead2a59d0">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274376d36fa54890b82f08d6ed48bbee_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctMy0xLTEtMA_4504227f-8e29-4a21-95c8-53c34c8c48be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27d7dd7dc1104b2593a44cdf7974d37f_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctNS0xLTEtMA_8fe135ed-9bf7-4c91-b400-80a615bf78ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62905753722c4190871f9b11bf5dd843_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctNy0xLTEtMA_9fbf3e98-03ec-456a-955b-194302eebde3">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed2f680acea47a38a544ddfae0bede5_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktMS0xLTEtMA_5e5bd083-0762-460b-9642-eba6c74ec991">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb482e22f9f489f99c206b7e374b961_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktMy0xLTEtMA_b02fce19-7a68-4e90-9441-da007a9eb75a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ca23e5869c48d8b6e8710608fcbbdd_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktNS0xLTEtMA_728d6ab8-8d86-4e84-ba70-918e13f6c23b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24ddffb97cc4456a1f560750a4db57a_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktNy0xLTEtMA_059e4aa4-11cd-4373-94c2-85fec3ad6b94">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. During 2018, we recorded $<ix:nonFraction unitRef="usd" contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzE1NzI_e9f38889-21ec-4ed6-a0e8-3ed9efdebe70">0.3</ix:nonFraction> million in additional charges related to this restructuring plan. Our remaining restructuring obligations related to our 2016 restructuring plan are complete. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Items</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYy_6adb1ca5-2e65-444f-a0c5-185a3f4c9913">1.0</ix:nonFraction>&#160;million as a result of the continued devaluation of Argentina&#8217;s currency. During 2018, we recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzE5MDI_8a5e3a26-bacc-4446-98fc-f859adab45d7">1.1</ix:nonFraction> million related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recognized a tax recovery of $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzIwNjM_913d7d35-5968-4e20-9afb-2d554de340ed">4.7</ix:nonFraction>&#160;million related to previously-paid international excise taxes, following a favorable court ruling.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, we recorded development income of $<ix:nonFraction unitRef="usd" contextRef="i6b5aa17d4bf34a9381a6369cd9b7643e_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:DevelopmentAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMyNzM_7dca0a39-670b-4aec-9bda-0c97624378c6"><ix:nonFraction unitRef="usd" contextRef="i124cb2fa8c124903a808a37113465670_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:DevelopmentAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMyNzM_a96581e3-23b2-4637-9e66-3b8c4f9eb12e"><ix:nonFraction unitRef="usd" contextRef="i9daa8394ea5c4fff8c0bf665f388fdf8_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:DevelopmentAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMyNzM_d827e7ed-2a43-45b3-8a18-8f77b3bebb7f">0.9</ix:nonFraction></ix:nonFraction></ix:nonFraction> million in each year, related to a nonrefundable customer payment of $<ix:nonFraction unitRef="usd" contextRef="i7ab15527d47f4aa9a1633dab43f58d65_I20130630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMzNDk_3e13b98c-4dae-4589-8198-fdf4f1df28be">20.0</ix:nonFraction> million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_94">Revenue</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. </span></div></ix:continuation><div><span><br/></span></div><div><ix:continuation id="i094aa63bf6294cf7b140bee887760273" continuedAt="i0ce7a008e0754474a9575d4508fc177c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_133">Fair Value Measurements</a></span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0ce7a008e0754474a9575d4508fc177c">, for additional details.</ix:continuation> </span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_157"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNDU_e5a9c523-e9b6-4b3a-bfae-693c4d61a00a" continuedAt="iabf76015042c461f83297c66f0b0ef1f" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iabf76015042c461f83297c66f0b0ef1f" continuedAt="i581b11723d2e45d7921a38dd0516b737">As a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. During 2020, the statute of limitations for the 2016 U.S. federal tax year lapsed, leaving tax years 2017 through 2020 open to examination. For U.S. state and local jurisdictions, tax years 2013 through 2020 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2013 through 2020.</ix:continuation></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i581b11723d2e45d7921a38dd0516b737" continuedAt="i14ee877db3774fe496c0a85a144f73f8"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwMzg_a1a8a3ac-0cbf-4ee3-bc2f-be4ceb31eb07" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzEtMS0xLTEtMA_9d0fa993-05e1-418d-8b66-769eb86add9c">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzEtMy0xLTEtMA_69c0a41a-1224-453e-abe2-9b2995d5ec77">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzItMS0xLTEtMA_9c7fe3cb-1ad1-4b66-ac28-c1400abe1845">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzItMy0xLTEtMA_98a02ae7-9ce3-4174-9afb-888934f51348">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to prior year position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzMtMS0xLTEtMA_93e2bd7f-5924-4f3e-8004-31017511b7e4">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzMtMy0xLTEtMA_d7ab994a-6b6a-4635-a79c-aabe539cda47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzQtMS0xLTEtMA_5b71d0cc-9825-4ba8-9c25-9d29bfe4f0bf">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzQtMy0xLTEtMA_a0eb91f5-31aa-4af3-ab29-ea84776c6b28">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzUtMS0xLTEtMA_30c6d07e-e3e5-4d0a-a673-4f8270c61e5f">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzUtMy0xLTEtMA_519f21c6-5b63-4e64-948e-14c1622862c3">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we had balances in accrued liabilities for interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwOA_30cb951a-1017-4637-936f-d072bc4a392e">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2MzUzNTY_a70d98a3-055a-40a2-9b84-397b5078d9cc">0.2</ix:nonFraction> million at December&#160;31, 2020 and 2019, respectively. As of December&#160;31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzc0Nw_502f8ef5-d6fa-4788-84fb-394012f1db7c">10.4</ix:nonFraction> million of total gross unrecognized tax benefits, which, if recognized, would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwNDM_f0757f40-6e34-4e12-8334-3a0ceae97282">0.3</ix:nonFraction> million during the next twelve months, which would favorably impact our effective tax rate.</span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNTA_0815cc4c-10ca-4f11-a132-ac18acc847fc" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income before income taxes are:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzEtMS0xLTEtMA_c16238d9-17df-4e49-8bd7-cb4f6ca5568b">227.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzEtMy0xLTEtMA_50e9d2bc-36be-4047-9139-8ca1388a1195">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzEtNS0xLTEtMA_6e8c3e64-dd8d-4637-ab3c-88aea5bbaa7e">132.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzItMS0xLTEtMA_96a77a38-eec9-4d9f-81f9-3c92947683bc">174.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzItMy0xLTEtMA_6a37c328-dea7-4a4e-916c-0da4bdf57d5f">130.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzItNS0xLTEtMA_4f1469f9-060d-4c01-a49b-2d8a9e68ca80">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzMtMS0xLTEtMA_9aa2bae9-3046-472e-b50e-98b92a7deeca">401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzMtMy0xLTEtMA_1cea2be5-6ec6-499a-b0bb-988071f9378f">291.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzMtNS0xLTEtMA_ddda3bca-29c9-4022-a4f1-ad545d3c00f3">240.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNTE_b7b53038-79f9-44d1-a61f-e9394c3f4327" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related provision for income taxes consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzItMS0xLTEtMA_50957582-d422-41ff-bebe-3419f7f83b88">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzItMy0xLTEtMA_b0d9bb39-d1c3-4a60-bd82-c1a3ddf69974">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzItNS0xLTEtMA_658f3838-1969-4f10-b564-a28a2fa2272b">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzMtMS0xLTEtMA_f8721ea4-0f41-4aa4-973f-9c4b913519e0">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzMtMy0xLTEtMA_f67170e2-ed57-4b3b-8d04-4c5316ff99c9">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzMtNS0xLTEtMA_25730aac-e48d-42db-bf50-4b689c6ce082">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzQtMS0xLTEtMA_0950d00b-6e8a-4a87-9fb3-fe274f033446">46.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzQtMy0xLTEtMA_1a62f7a4-c9fb-4237-99ce-aff2d2be3b68">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzQtNS0xLTEtMA_008f7d1c-cb5e-4a15-beb6-d4dcadf4b15d">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzUtMS0xLTEtMA_48f34b54-0c20-4559-9632-aa2799f88433">78.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzUtMy0xLTEtMA_5c30113e-6b72-4512-b9fb-0edb926c00bc">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzUtNS0xLTEtMA_b99ffbd0-f168-4a52-8377-075bec47b462">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzctMS0xLTEtMA_c488bedd-4308-4ed8-a919-5e68d86427ae">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzctMy0xLTEtMA_da41f5c6-fb5b-4c74-9a5a-694e3d37b3e5">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzctNS0xLTEtMA_9670992d-edea-4c32-9eb4-fd16275c9fd7">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzgtMS0xLTEtMA_3e69bd42-2732-48dc-9748-0d2937b6cf7b">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzgtMy0xLTEtMA_1c7bd38c-bcdc-4af4-947e-f29c419c0273">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzgtNS0xLTEtMA_b1840870-f0e8-4870-ba43-827aee58afa2">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzktMS0xLTEtMA_d3f0e5bd-0398-40a7-a9ee-8e0310e750f9">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzktMy0xLTEtMA_173b2dbc-2c11-4d6f-bc5a-eb99cf258568">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzktNS0xLTEtMA_c301996c-635d-4a49-931f-73d5c2339e6e">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzEwLTEtMS0xLTA_c95b8369-66f7-4b38-a4e3-c490bc58c009">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzEwLTMtMS0xLTA_eb424a42-3b88-4286-89db-ca07bcf8fe60">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzEwLTUtMS0xLTA_0c54f11b-0714-4e32-b445-4af2033d6a51">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i14ee877db3774fe496c0a85a144f73f8" continuedAt="i5c79a09a38054936b35965add8e79407"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNDI_e586493a-33f5-4ad0-be28-377f1366b506" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzItMS0xLTEtMA_30d26325-3b8a-4e76-a2c0-49dab14732ed">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzItMy0xLTEtMA_8291e25a-404c-4c5c-bbc9-4092abbcbf78">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzMtMS0xLTEtMA_1d6ac040-01aa-4941-baa6-128dfd9f8561">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzMtMy0xLTEtMA_a3fefa55-39ae-4325-bd9f-7acaa634a4ea">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="wst:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzQtMS0xLTEtMA_cbdb27cd-4489-4089-9f2d-2c18ca90a61c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:zerodash" name="wst:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzQtMy0xLTEtMA_af0da417-3999-409e-9bd3-219aa437cec2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzUtMS0xLTEtMA_8c867cd5-96cd-4f12-bf05-f622b67d2949">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzUtMy0xLTEtMA_299ff75c-cd53-4a2e-b34c-494de0692ade">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzYtMS0xLTEtMA_3f0ff1d5-5f74-4e44-ab60-d86e15794ca2">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzYtMy0xLTEtMA_e026d635-1231-4189-bd38-c8e87f9de9a9">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzctMS0xLTEtMA_354047bd-86e6-432e-898b-c663e50463cf">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzctMy0xLTEtMA_9be4a115-e755-4655-ac66-40a6ade4799c">15.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzgtMS0xLTEtMA_7bc8f9ff-b2cd-4d3c-b8f2-7337e0462337">54.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzgtMy0xLTEtMA_a76a88df-cee3-49b8-a46f-e0906840bda6">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEwLTEtMS0xLTA_a5daa721-4554-4382-9a78-3604a15e3133">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEwLTMtMS0xLTA_453047f0-6421-4709-82e2-e89eefd4b03e">37.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzExLTEtMS0xLTA_20cd6ed2-6b80-4982-9eb9-655f4672f793">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzExLTMtMS0xLTA_c7bee1cf-f3c6-4f4e-b685-36bdacd298bf">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEyLTEtMS0xLTA_8392df83-75d5-4eab-b130-4c9a739e49db">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEyLTMtMS0xLTA_289976de-9ca3-4a8b-b0a7-7ed0e57ce08d">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEzLTEtMS0xLTA_dbd82194-b602-4dc8-9f56-20d911fd6647">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEzLTMtMS0xLTA_aeeedd5e-070b-4ba7-852d-3308fa9078d8">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax (liability) asset</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzE0LTEtMS0xLTA_e9ffa460-a826-4df4-bbd7-f36cf3376ff7">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzE0LTMtMS0xLTA_cf83a497-a058-427f-8d99-a6d76247fb23">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwMTE_c829709b-df2e-4494-a805-39a106448b46" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal corporate tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEtMS0xLTEtMA_65560acd-0f4e-4577-87f5-2c15b446077d">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEtMy0xLTEtMA_e7e612f6-3f7f-4f04-88e0-5816c7d4ff52">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEtNS0xLTEtMA_512b77f1-b2f4-49a0-bff1-108bf45b1718">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzItMS0xLTEtMA_34d0a2c5-502e-4868-a289-d542d254159a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzItMy0xLTEtMA_3cb717cd-7f30-41dc-a934-ea9d23c772e8">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzItNS0xLTEtMA_3cbe3822-7d8f-4fef-969d-2d36e4902191">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzUtMS0xLTEtMA_9bdebe70-38c0-4b34-8e0e-2c41d0d66536">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzUtMy0xLTEtMA_084e4dd4-e1e8-410b-ad13-642b3a054d07">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzUtNS0xLTEtMA_239c1f49-8697-42cd-b845-f2bc8cf86f37">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzYtMS0xLTEtMA_bc4adbf7-03cb-4927-93fa-39c7c873fef4">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzYtMy0xLTEtMA_8c20f47f-f5e6-4158-8d79-aeaf4a2f6550">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzYtNS0xLTEtMA_e95469d3-3131-4b19-a73f-e115d5ba2cf0">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income Deductions (FDII)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMS0xLTEtOTUxNQ_8bd1d590-024f-47a6-9083-9824909eadd6">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMy0xLTEtOTUxNQ_fb1d7731-374a-4474-ab0f-b3c701dedb91">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctNS0xLTEtOTUyNg_7170c03b-da81-4392-8407-eab6fe0cdba4">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMS0xLTEtMA_b38bba21-d0cf-4f10-aae6-9b0dbd02b915">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMy0xLTEtMA_55754203-fd21-45de-a6a7-9c1153fbec8f">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctNS0xLTEtMA_2f40e8f6-f405-450e-a63f-5818ab041edb">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzgtMS0xLTEtMA_724e599d-5519-4ee3-89df-f412df516901">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzgtMy0xLTEtMA_5a877d63-af90-4a70-9d66-4088c9c30a60">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzgtNS0xLTEtMA_d4458445-d7c9-4dc4-9142-a1f94297b97d">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzktMS0xLTEtMA_f2d42cd1-1163-47ec-97c3-968f2f8647d0">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzktMy0xLTEtMA_c684192c-f365-457b-b417-f6b339b6948a">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzktNS0xLTEtMA_b11c04ba-e1ee-40a6-9098-d42fe554598c">6.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of 2017 Tax Act</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEwLTEtMS0xLTA_56223bed-739c-435a-b583-c475342a1125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEwLTMtMS0xLTA_0d224411-d052-4c13-85c3-30817df40298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEwLTUtMS0xLTA_d52a5ee3-9850-4f17-a073-6fa88cf40b5e">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzExLTEtMS0xLTA_2f5e47bc-d31e-471d-a9dd-f9ed40b97031">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzExLTMtMS0xLTA_45fbff2d-e307-4031-848e-6dee1b641cdc">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzExLTUtMS0xLTA_dae3d533-5fa4-4c1d-983c-a841ebb087dc">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE2LTEtMS0xLTA_4aa41b53-97cb-4e3f-86a6-35f222ba736e">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE2LTMtMS0xLTA_e7eb14f6-77d5-43ed-845e-1672fec06c06">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE2LTUtMS0xLTA_8ba5658a-010f-474a-8aa0-6697c63637c1">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE3LTEtMS0xLTA_650868ae-cb42-4f85-9749-1a87a34ca0f3">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE3LTMtMS0xLTA_62cdb543-48e2-4317-8e67-a6ef836cfcbd">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE3LTUtMS0xLTA_c9fceb36-6362-4f57-8412-ffe8ec3de207">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3Nzc_2082007d-23f0-4901-8aa3-d9337adb9cad">0.5</ix:nonFraction>&#160;million due to the impact of tax law changes enacted during the year, as well as a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3OTY_6305d958-ba4c-460d-91c0-ffa81d964e66">20.8</ix:nonFraction>&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3MjI_5b6b06b3-1199-4312-ba09-894eee29acbc">0.3</ix:nonFraction>&#160;million due to the impact of tax law changes enacted during the year, as well as a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3MzM_36c5286e-6d8f-4a25-bce6-fd6e5e1c9a47">10.3</ix:nonFraction>&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, we recorded a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3NDA_a34d8154-9e7c-42af-847f-8a8cc45d2b3e">2.5</ix:nonFraction>&#160;million for the estimated impact of the 2017 Tax Act and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3NTQ_7c0f7682-5cfc-413e-a19f-052589a0dacf">14.3</ix:nonFraction>&#160;million associated with stock-based compensation.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5c79a09a38054936b35965add8e79407"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Tax Act, which was signed into law on December 22, 2017, has resulted in significant changes to the U.S. corporate income tax system. These changes include, but are not limited to, a federal statutory rate reduction from <ix:nonFraction unitRef="number" contextRef="if44a63268f854be99514777e8639749e_D20170101-20171231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzg3OTYwOTMwMzY0Njg_cc78d9a2-0fc0-4967-8168-8412c6ef4ecf">35.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzg3OTYwOTMwMzY0NzU_ce78a4d0-150a-4e6f-86a5-c900ae57cba4">21.0</ix:nonFraction>% effective for tax years beginning after December 31, 2017. Changes in tax rates and tax laws are accounted for in the period of enactment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Tax Act. We recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in our consolidated financial statements for the year ended December 31, 2017. As of December 31, 2018, we finalized our calculations and tax positions used in our analysis of the impact of the 2017 Tax Act in consideration of proposed regulations and other guidance issued during 2018. As a result, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQxMDQ_1a195661-9245-4d17-99e5-b121a7ebd4b2">7.5</ix:nonFraction> million tax benefit related to a reduction of the Transition Toll Tax and an incremental tax expense of $<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQyMDM_49972af2-9ce8-433c-91c9-da486f783d92">4.0</ix:nonFraction> million related to other adjustments. The final measurement reduced the Transition Toll Tax expense to $<ix:nonFraction unitRef="usd" contextRef="i1cd1fba210414204826670f7b9718de1_D20170101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQzMDE_77b79859-479a-44a6-9c73-ba8d31ab72cb">20.4</ix:nonFraction> million from $<ix:nonFraction unitRef="usd" contextRef="if44a63268f854be99514777e8639749e_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQzMDk_c14156c6-cb6f-4746-acec-bd8b285e2f8f">27.9</ix:nonFraction> million. The net impact of these adjustments resulted in a benefit of <ix:nonFraction unitRef="number" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="4" name="us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQzNzQ_8837d4f4-ac9d-4be4-b8b5-d87bce99e1a7">1.45</ix:nonFraction>% to the 2018 effective tax rate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Tax Act created a provision known as global intangible low-tax income (&#8220;GILTI&#8221;) that imposes a U.S. tax on certain earnings of controlled foreign subsidiaries. We made an accounting policy election to reflect GILTI taxes, if any, as a current income tax expense in the period incurred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have fully utilized all of our U.S. federal net operating loss carryforwards. State operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i595e0d99768d4fddb665c130376a4241_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ4Mzc_631becfd-bbb9-4d56-be51-34114b9f7303">204.1</ix:nonFraction> million created a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ4NzI_e194f207-52ba-4a5a-ac1f-261c7fcd8b63">14.0</ix:nonFraction> million, while foreign operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ia79ee42fd3854b1094384535405e880c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ5MjI_a0d36a10-909c-4b4e-8c5d-31367607c178">56.7</ix:nonFraction> million created a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ5NTc_bf60cc7b-0048-4589-9d72-115a045cbdf6">7.4</ix:nonFraction> million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been fully reserved. State loss carryforwards expire as follows: $<ix:nonFraction unitRef="usd" contextRef="id7054c41751544f6b384cd99197b808f_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUxNzk_af4eebe4-e7eb-4344-870a-2945ddb7248e">25.7</ix:nonFraction> million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="iff77fa642e814b6b8597126f28871557_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUxOTI_4b85339e-0424-4afd-ac73-ca45303727f5">178.4</ix:nonFraction> million thereafter. Foreign loss carryforwards will begin to expire in 2030, while $<ix:nonFraction unitRef="usd" contextRef="ia79ee42fd3854b1094384535405e880c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUyNzA_ba4ec6af-bce0-460b-9257-c81cd3b26fde">54.1</ix:nonFraction> million of the total $<ix:nonFraction unitRef="usd" contextRef="ia79ee42fd3854b1094384535405e880c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUyODY_a0d36a10-909c-4b4e-8c5d-31367607c178">56.7</ix:nonFraction> million will not expire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have utilized all available foreign tax credit carryforwards against the Transition Toll Tax. During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. As of December&#160;31, 2020, the $<ix:nonFraction unitRef="usd" contextRef="ie86aa1917b504d79b444ef1639528a31_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzU1MjI_037a2eb4-0d34-4457-a448-dbb8829c6a43">0.9</ix:nonFraction> million of state research and development credits expire after 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2MzY0MTA_dd45d9a6-2ba7-44a5-a1fa-47e7ff994da4">345.6</ix:nonFraction>&#160;million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</span></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_160"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEzNzM_7b4664af-0caa-47b3-bcec-1f51e97b1356" continuedAt="i0200b40717024655b1f3b1e12efcb4ca" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0200b40717024655b1f3b1e12efcb4ca" continuedAt="i7ab9e778ea0248378c370af41fb9a648"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we were obligated under various operating lease agreements. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_106">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_145">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i7ab9e778ea0248378c370af41fb9a648"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzUzMQ_28b329b1-a562-4f42-90ee-30ea4bb05276">118.4</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzU0NA_6388b7b8-41fe-44e4-bac4-2ed9fd22b19c">41.4</ix:nonFraction> million is due to be paid in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i0818ca18d1c04be49b0664009bcbaa77_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzYxMA_315bb1ed-acbe-4a20-942b-e1303c77e507">2.5</ix:nonFraction> million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $<ix:nonFraction unitRef="usd" contextRef="ib485a2f5d6d34d779c1f358e30597b6b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzc2OA_6e7b969c-5b1a-42c5-b123-b23503e587b8">3.0</ix:nonFraction> million at December&#160;31, 2020, of which $<ix:nonFraction unitRef="usd" contextRef="ib485a2f5d6d34d779c1f358e30597b6b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzc4Nw_e1da69bd-e264-4acc-a59f-c459674f7370">0.9</ix:nonFraction> million is in excess of our deductible and, therefore, is reimbursable by the insurance company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SmartDose contingent consideration is payable to the selling shareholders based upon a percentage of product sales over the life of the underlying product patent, with no cap on total payments. Given the length of the earnout period and the uncertainty in forecasted product sales, we do not believe it is meaningful to estimate the upper end of the range over the entire period. However, our estimated probable range which could become payable over the next <ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" format="ixt-sec:durwordsen" name="wst:ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEzNDM_f5fab70f-dba1-4d1a-abb1-b3e9fbfbb447">five years</ix:nonNumeric> is between <ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEzNjM_17f9b7b8-8d50-4084-82bf-f67f0593d8aa">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEwOTk1MTE2MjkxNjg_32451b6e-ee82-4d02-96f5-3835efe1ed11">4.3</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19:&#160;&#160;<ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzEyNjQ0MzgzNzIzODUy_f0c276bc-8fe8-48b8-9157-7ed197f78e67" continuedAt="i9399424f37574d36967fe548f430e065" escape="true"><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5Xzg3OTYwOTMwMjY2Mzc_05dcaef0-22e3-43a3-a617-2e5a7a5f0426" continuedAt="icf2ed5a94d494ac5830d170fb77cf49f" escape="true">Segment Information</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9399424f37574d36967fe548f430e065" continuedAt="i54a04783e9454416a317bb064eaea1a2"><ix:continuation id="icf2ed5a94d494ac5830d170fb77cf49f" continuedAt="i1bb8c3dea07b4369825012fa472cbcfb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into <ix:nonFraction unitRef="segment" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5Xzc5_e91fded6-c102-4f0e-adcd-069debe0f04a">two</ix:nonFraction> reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzIxMTQ_c20c0315-8a8d-429d-b04a-270a0de5ac81" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales information about our reportable segments, reconciled to consolidated totals:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzItMS0xLTEtMA_d58a3fe7-6b92-4ef0-bc96-80c1726dea64">1,648.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzItMy0xLTEtMA_e29a3d89-a72b-412a-bc2c-98dda445bba7">1,398.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzItNS0xLTEtMA_a99044e8-bc31-47ac-9e79-99df4cb7346b">1,308.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzMtMS0xLTEtMA_5d315ae7-5efe-4c01-9649-a1154712597f">498.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzMtMy0xLTEtMA_0d8f2e8a-aaa2-41e0-8fb8-2c72e7cfff7c">441.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzMtNS0xLTEtMA_218c103a-3aa0-45d6-9eac-b672d25125d8">409.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774d0f0cab54416082070e38f9410ff3_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzQtMS0xLTEtMA_810ce5e8-ae24-4be1-ad0e-a86c49f543c4">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bd2ce98d3354cb59bc39ace8c778f47_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzQtMy0xLTEtMA_a6397164-b93c-4f4b-a6af-423e855124bd">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f2732fdbddd435f8a75ce6550a1311f_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzQtNS0xLTEtMA_b90b4506-af9e-491c-8d97-e59caf1e7517">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzUtMS0xLTEtMA_a936de51-383c-4c62-8c43-028760f0fa32">2,146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzUtMy0xLTEtMA_5088c8d5-cb91-4708-a719-86ed09dc3727">1,839.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzUtNS0xLTEtMA_e7a2f116-e920-4aa3-8d34-57f7584db70d">1,717.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i54a04783e9454416a317bb064eaea1a2" continuedAt="i1c30994805694609bb993be476b9936d"><ix:continuation id="i1bb8c3dea07b4369825012fa472cbcfb" continuedAt="i68c390fc11114bc29a2abad61a83b6bb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any customers accounting for greater than 10% of consolidated net sales.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzIxMzQ_e1e1a8e9-f4b9-40ec-b9ad-66e4ef4112ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Lived Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccc9431b0b454feab552857b416ea0ec_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItMS0xLTEtMA_c3ad6ddc-6ef1-4e07-aada-60e69988c121">975.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d4d146be594713a85bdeb50230ab00_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItMy0xLTEtMA_fa2e9f64-1fd5-447a-8c80-2f9392f3b769">814.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf861532e0d24915b8be512c7b015ea5_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItNS0xLTEtMA_3ee22af5-8fe8-400b-8a1e-a68bce911c71">766.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6859fd0c19984b50987f791266a4b2e3_I20201231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItNy0xLTEtMA_32c4c9c0-a1ac-4d76-8465-6bdd26a23cb3">407.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icac6e86e417f4406a08009e46537f51c_I20191231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItOS0xLTEtMA_1b2a4b2b-2f69-4168-925d-68f55c633aac">364.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8b305543904c68b1b271d9387d71fb_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtMS0xLTEtMA_37fff1a4-6889-42b1-b4ec-b5b2389f05a6">282.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f8027821a434a1689f83110fca51907_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtMy0xLTEtMA_ca592149-9164-4426-86e7-0dc0de2dc253">236.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d0dacf1c0841d5a307f3bfc32d20da_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtNS0xLTEtMA_d0d2bc53-ff16-4461-b6de-d1d9040fa33d">235.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e114810392f4404aea674dae1f5b2f5_I20201231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtNy0xLTEtMA_d33f82de-9ba2-4a6d-bfa5-08af82697387">112.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6699e8acb7d14b0ca42ade817a9f705f_I20191231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtOS0xLTEtMA_bf0b6283-f4fb-4bd6-b91b-e2d30382df07">105.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d2ac6a7f541499ea8ccf5a4208ace40_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtMS0xLTEtMA_f242d018-10d0-4cca-9005-c5bcc55ea85f">226.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2805175e4f14fc5b6d7559c8e6d0bea_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtMy0xLTEtMA_63ca4293-3e60-4d76-9897-cefc0fadceb1">173.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieca17c3296344ba29f4960a8397d1ba5_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtNS0xLTEtMA_c159274c-86ab-445d-b815-37c001e6a678">138.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed92857acc241a2bf581f09e87478ee_I20201231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtNy0xLTEtMA_dd98655a-5e53-49ff-b727-9f4de272a4de">197.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib123a778d0474f6ab51dda0673a420c3_I20191231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtOS0xLTEtMA_7af26c9c-9466-452a-ae68-7ce1b986ace8">176.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id32983fbf1724e6ea83c4fa95b8a050f_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtMS0xLTEtMA_4eb47cb9-7e74-436f-88d3-eca62ba03fea">172.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0588f0020ff4e1380042e497db31675_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtMy0xLTEtMA_e1020e87-3e7d-43b1-91dc-ccafecdf5f4d">150.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4c8efe73a94954b43ffa84714f22f9_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtNS0xLTEtMA_9edf895f-a5a8-4fd5-b58a-5879d125809e">145.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id394f2aaf20a4f5a8065aac88dd87877_I20201231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtNy0xLTEtMA_8ba7cd0e-932a-4b7f-adfb-a3ad92b40e83">76.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9018f7f2975643e0a3f04da690ae1d48_I20191231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtOS0xLTEtMA_da8678fb-4caa-4a83-a3cd-3dbbe16623b9">53.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other European countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76813d2bec64911becdf36778a96555_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtMS0xLTEtMA_758292b5-897c-4271-8b42-060e9dc2f82e">236.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e63f25aee7c40ba95eaeefc7de3649d_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtMy0xLTEtMA_c74bf9ad-8930-4d40-8ead-0aec6175bcee">251.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i991655d17a3740aa8576ef108e472601_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtNS0xLTEtMA_bb693a34-3525-43f5-a166-1a6da9dc30d6">230.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieddac01d5e554b06879611717faa28f6_I20201231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtNy0xLTEtMA_d7dc63f4-42d2-42c2-bf05-10d03016566f">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81778baca03545dea6b871ec4c6c9f4d_I20191231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtOS0xLTEtMA_900a77fd-a096-4392-85f7-393ef1b79e2b">59.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb14a0610fac4aad8769dddc489dbe8e_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctMS0xLTEtMA_59141cf4-331b-4c5b-90ed-7be3d626606d">253.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i461ab78f5c0648c6b759cfad0b1be277_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctMy0xLTEtMA_f05b166d-0254-4145-b48b-57407858335b">213.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415eb61f5a0546a8871238557c61e7a0_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctNS0xLTEtMA_575e30d5-2a27-443b-a734-28d1a69afc34">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ced6416e1114dbb92b4432c973d7b0a_I20201231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctNy0xLTEtMA_035b989a-5b77-4e47-9fba-0dc0a14d28c9">151.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i416bd58eeeb14e2fb2be821ef3871bd3_I20191231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctOS0xLTEtMA_68985a14-f34b-4638-ae61-965c9bbbd0b3">149.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtMS0xLTEtMA_a6ef1ccf-5ca5-4be6-b709-56bbba3ea4e5">2,146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtMy0xLTEtMA_687604f5-5bc1-444a-a03e-4f42bd8d2caa">1,839.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtNS0xLTEtMA_f7d2e3ef-d250-4116-8094-3518eb956750">1,717.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtNy0xLTEtMA_35bbb6ba-2dc9-4198-9a6c-2b40262030ae">1,011.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtOS0xLTEtMA_dc048010-284d-41d2-8881-6199367a1049">909.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzIxMTk_e9f61c27-c0ba-412c-8ce3-05be6695815d" continuedAt="i50f2f0553d554be9ba1e3ec968d3fbe3" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzItMS0xLTEtMA_2319f133-8475-4acd-9c99-fc1a3c8b4304">434.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzItMy0xLTEtMA_d5c86fae-a25b-4ee9-8b86-ea95e26514f2">313.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzItNS0xLTEtMA_38fe00f3-c413-41e1-99a9-cbadbf3abbb1">266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzMtMS0xLTEtMA_7eaefc84-cf95-4ba2-af00-ef142402e701">68.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzMtMy0xLTEtMA_12116c1b-ae80-4a8f-a796-ebc27a25da46">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzMtNS0xLTEtMA_762e6e9c-78cd-498f-b4e6-078929660e30">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1438eab01bf433fbc35a309da3262d5_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMS0xLTEtMTI3MDA_caa3a068-64b7-4b9c-9ad9-f45562a4e208">503.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b7677acdc9401e83ce68aef09e830c_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMy0xLTEtMTI3MDA_0ebc7b7a-29d3-46b7-b3a5-c000626cacff">362.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie10fea7610d24805934edfad68c8e75b_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtNS0xLTEtOTU4MA_edc4c6a4-1c97-4422-8ed5-d5adc40a3026">310.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMS0xLTEtMTIyMjA_8525c57c-eab6-4734-8f7f-344ff0ebe4b1">34.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMy0xLTEtMTIyMjA_9bec6abe-eb81-41ff-94d2-0cd74232306a">24.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctNS0xLTEtMTIyMjA_c635c138-d450-43e8-89ee-09bb35002350">15.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMS0xLTEtMTIyMjA_034ada9b-10d1-4c60-b721-54ffe66c7781">52.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMy0xLTEtMTIyMjA_76e43037-4a0c-4fb5-aa3b-25e95a4c8a31">41.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtNS0xLTEtOTU4NA_d9ec1b54-f31d-41ec-9001-22994a5452c0">46.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTEtMS0xLTEyMjIw_1f91d4ad-a2f7-4af8-b09f-375f315b7e48">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTMtMS0xLTEyMjIw_36b41b09-d0fc-4300-a560-46e614385645">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTUtMS0xLTk1ODQ_d2f6c181-6ee1-45e1-8018-ea4252add366">9.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of Acquisition-related Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMS0xLTEtMA_1a2beafa-7f44-40f8-ae68-f1d2bf7fd3ff">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMy0xLTEtMA_9db3ead4-12c2-4dc9-bdf7-9d929512f6a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtNS0xLTEtMA_ef2b020e-612b-431c-9322-505561364172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" name="wst:CostInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtMS0xLTEtMA_476bf67b-ab5c-4357-8e35-4f1a552bfc36">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="wst:CostInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtMy0xLTEtMA_fcbf919b-be3d-4aac-acad-a17fd0534dde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:CostInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtNS0xLTEtMA_e49e245c-857b-459c-8263-f1ca99c98b27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on restructuring-related sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzYtMS0xLTEtMA_d17f866c-584f-4086-8c36-7e500c8d992b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzYtMy0xLTEtMA_3e36f7b7-f154-4e2a-9c6f-e838a1918245">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzYtNS0xLTEtMA_8383b634-8090-4129-9ece-78b5029f7faa">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="wst:GainLossOnArgentinaCurrencyDevaluation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMS0xLTEtMA_69f2e191-7fd2-4f48-8e92-86fb310243b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" sign="-" name="wst:GainLossOnArgentinaCurrencyDevaluation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMy0xLTEtMA_42484d82-44a2-4046-bb69-bf08a92d8b0f">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" sign="-" name="wst:GainLossOnArgentinaCurrencyDevaluation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctNS0xLTEtMA_50f9e275-5725-43b9-8ee0-881ff5eae4ed">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax recovery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMS0xLTEtMA_158c468e-7f68-4289-8960-b9e371a3beb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMy0xLTEtMA_af8c632d-2842-4ad6-8bb8-4d94b081cd94">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtNS0xLTEtMA_b1ee7e17-21f5-4763-89ba-2e0eb5f3cccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzktMS0xLTEtMA_93e0f864-d6ca-46e5-8c52-48309c26278c">96.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzktMy0xLTEtMA_0dcce247-7bea-4672-98fb-a2d83042e7b1">66.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzktNS0xLTEtMA_5bb4ab48-b458-423e-86d8-ac83240a6ec5">70.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTEtMS0xLTA_c74caed1-4ea8-45f3-921e-d309022e242e">406.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTMtMS0xLTA_334679d6-4dbe-423e-9719-5b592982731d">296.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTUtMS0xLTA_98c9539b-d8f8-4fb4-b0f1-a2260b2c75a5">240.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense/(income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEzLTEtMS0xLTA_d0dadbeb-a6ff-4d32-b757-c1f50a07ab40">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEzLTMtMS0xLTA_b63f5a2d-ff1b-41d0-92e1-cd81360a46d6">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEzLTUtMS0xLTA_6c7214da-78c2-4dbd-9192-ef14b0d329f4">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzE0LTEtMS0xLTA_b23c98d2-481f-4251-ae9c-0d85379bfd4c">401.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzE0LTMtMS0xLTA_0d8adb4d-f448-441a-822a-60b8aab41c8e">291.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzE0LTUtMS0xLTA_b4ceda2e-c118-43ff-8586-f99c36aa7205">240.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The Company recorded $<ix:nonFraction unitRef="usd" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzQzOTgwNDY1MTUyMDY_7dc4000b-d6fc-4814-a053-22ff1b7dde82">0.6</ix:nonFraction>&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During the twelve months ended December 31, 2019, the Company recorded a net tax recovery of $<ix:nonFraction unitRef="usd" contextRef="i60b7677acdc9401e83ce68aef09e830c_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:BrazilTaxRecovery" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzEwOTk1MTE2MzE1NjI_7362f7f9-91e5-4ac1-be33-20b46c84db90">4.4</ix:nonFraction> million related to previously-paid international excise taxes, following a favorable court ruling.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 16, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7db5523d9d74649b8592a121b55d512_151">Other Expense (Income)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of unallocated items. </span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1c30994805694609bb993be476b9936d"><ix:continuation id="i68c390fc11114bc29a2abad61a83b6bb"><ix:continuation id="i50f2f0553d554be9ba1e3ec968d3fbe3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ccb8142a6fd48a197381524a3af0e94_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzItMS0xLTEtMTI4NTU_d4b1665c-e836-46be-a9f6-f1712082a9c1">1,798.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0e7149a4524df1af74160af660cd5f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzItMy0xLTEtMTI4NTU_2b4131e4-f60f-4b18-9721-487ca6265b02">1,480.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a866adcce645a4a119d06e29948d8b_I20201231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzMtMS0xLTEtMTI4NTU_3914509a-6796-4c70-8320-6f8e5b7589f2">411.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35257ff2d24b4eb0b102a172b964a457_I20191231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzMtMy0xLTEtMTI4NTU_c05d471d-44c7-41ad-9bbc-6a901720e8b4">386.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cda55f4b25b43e7b343a66c73455087_I20201231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzQtMS0xLTEtMTI4NTU_c7b3eda0-2b3f-45a7-8faa-a10256955590">583.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543690089e2d4cd78c08099fc3cabbd8_I20191231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzQtMy0xLTEtMTI4NTU_f5af4e1a-5c58-4c43-a27f-bd522085506d">474.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzUtMS0xLTEtMTI4NzQ_1001eaa6-e242-4b2f-ae10-4f5c17ed3ce4">2,793.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzUtMy0xLTEtMTI4NzY_dea38305-6181-455c-acbe-c4534150b952">2,341.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Depreciation and Amortization</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzgtMS0xLTEtMTIzMzY_8cec8599-02de-43ec-b385-02265ae6eb91">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzgtMy0xLTEtMTIzMzY_b9e605ec-5d1e-430c-bea3-a7bf02f46436">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzgtNS0xLTEtMTIzMzY_b2d922cb-c8a9-4b32-89cd-c6f1b99d27c6">83.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzktMS0xLTEtMTIzMzY_76edf92f-4588-4dec-9124-e506dc90b0a9">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzktMy0xLTEtMTIzMzY_c0cd445e-5e7f-4c4a-94eb-b15c28d80fdf">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzktNS0xLTEtMTIzMzY_dc203c87-21ce-4e3b-a9a8-b3d332db5756">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzEwLTEtMS0xLTEyMzM2_9e745905-ecc1-450e-a389-aee438e5ddf4">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzEwLTMtMS0xLTEyMzM2_9a4d32cf-f57d-4327-917f-b66b36be585e">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzEwLTUtMS0xLTEyMzM2_d90eb0b0-ed79-4321-b884-b25de2961658">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzExLTEtMS0xLTEyMzM2_1d95f286-c236-4399-b2bd-287161291e6e">109.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzExLTMtMS0xLTEyMzM2_fb7ada9c-dfb2-4954-a12b-db14e619ae4f">103.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzExLTUtMS0xLTEyMzM2_118b6744-de79-42b5-9b89-ef039b2dd401">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Capital Expenditures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE0LTEtMS0xLTEyMzQ2_1aa19ed9-e0cb-401a-a46d-d3916b94c185">139.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE0LTMtMS0xLTEyMzQ2_b6b801f6-24a8-4083-bcc9-c659ee5fbab9">88.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE0LTUtMS0xLTEyMzQ2_f13f72c9-1eb8-4edd-b433-0dc595b24c81">79.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE1LTEtMS0xLTEyMzQ2_9d63c2a2-b3d5-4432-bd8f-9f813b7253d9">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE1LTMtMS0xLTEyMzQ2_56d346e0-cc37-4d42-9d73-d5f18782e841">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE1LTUtMS0xLTEyMzQ2_913b364f-249d-415d-8a84-6908c4f99491">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE2LTEtMS0xLTEyMzQ2_8978f6b5-0b6c-4262-bd98-fde0113e53a1">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE2LTMtMS0xLTEyMzQ2_2f0d8c3f-2511-486d-8077-3e6433513561">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE2LTUtMS0xLTEyMzQ2_cad97e41-2cc7-4bfa-86ed-1498577c1ba3">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE3LTEtMS0xLTEyNzY5_ca92518a-198a-497f-82f4-0b8d841f6b29">174.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE3LTMtMS0xLTEyNzYz_18354e86-e3ee-4577-97d5-e0dd6b332daa">126.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE3LTUtMS0xLTEyNzY1_c0fcbc61-c390-41d3-ba50-f47c4d53da0d">104.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_166"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Shareholders and Board of Directors of West Pharmaceutical Services, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have audited the accompanying consolidated balance sheets of West Pharmaceutical Services, Inc. and its subsidiaries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(the &#8220;Company&#8221;) as of December 31, 2020 and 2019, and the related consolidated statements of income, comprehensive income, equity and cash flows for each of the three years in the period ended December 31, 2020, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended December 31, 2020 appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In our opinion, the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Changes in Accounting Principles</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 6 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019 and as discussed in Note 3, the manner in which it accounts for revenues from contracts with customers in 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our audits of the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements included performing procedures to assess the risks of material misstatement of the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Provision for Income Taxes </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Notes 1 and 17 to the consolidated financial statements, the Company&#8217;s consolidated deferred tax assets were $54.6 million, net of a valuation allowance of $15.1 million, as of December 31, 2020, and income tax expense was $72.5 million for the year ended December 31, 2020.  As a global organization, the Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions.  As disclosed by management, management estimates income tax payable based upon current domestic and international tax legislation.  Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of assets and liabilities.  The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference.  Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized.  The realizability of deferred tax assets is subject to estimates of future taxable income, generally at the respective subsidiary company and the country level.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The principal considerations for our determination that performing procedures relating to the provision for income taxes is a critical audit matter are the significant judgment by management in determining the income tax provision due to the Company&#8217;s global footprint and complexity in the various tax laws applicable in determining the Company&#8217;s effective tax rate.  This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures and in evaluating audit evidence related to the income tax provision.  Also, the audit effort involved the use of professionals with specialized skill and knowledge.  </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to income taxes, including controls over the determination of the income tax provision.  These procedures also included, among others, (i) testing the income tax provision, including testing the Company&#8217;s rate reconciliation, return to provision adjustments, permanent and temporary differences, and financial data used in the income tax provision calculation, and (ii) testing the accuracy of the income tax rates utilized in the provision.  Professionals with specialized skill and knowledge were used to assist in evaluating the appropriateness of management&#8217;s application of relevant income tax law in certain jurisdictions.  </span></div><div style="margin-bottom:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ PricewaterhouseCoopers LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Philadelphia, Pennsylvania</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1963.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_169"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzYwNDczMTM5NjMyNzc_7d7ce24e-72c8-435b-b2c8-cc8c143ec115" continuedAt="i8cd347c447a74033aa13936aa1456275" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Operating and Per Share Data (Unaudited)</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzYwNDczMTM5NjMyNzg_2eef70e5-0b97-4ea2-bc46-7174b4649a46" continuedAt="idcf193327c194c1392a2d49e47233d02" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Full Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItMS0xLTEtMA_252e741d-7678-4612-afa8-f4e593183a13">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItMy0xLTEtMA_358341a5-3c5f-4955-b7d5-2f66e0d3eff4">527.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItNS0xLTEtMA_b8b152c8-888d-4626-b1b0-b0d2805feed9"><ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItNS0xLTEtMA_b9947f96-58ea-4b9e-babc-3d247957440b">548.0</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItNy0xLTEtMA_9126ba9b-c08f-45f1-be5d-309d37296804">580.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItOS0xLTEtMA_e9bbe102-a7c5-4e45-9fa2-b59d4312180f">2,146.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtMS0xLTEtMA_daaad73d-1ab2-4ee2-8fa9-1341d021cc16">167.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtMy0xLTEtMA_06fed8cc-84ab-40c4-9352-1545978006e2">195.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtNS0xLTEtMA_01d30c4c-914c-43b8-a39e-eb081a1cec2e"><ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtNS0xLTEtMA_f13fabc8-fa27-4c72-8ca0-a1d36b118e26">194.6</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtNy0xLTEtMA_e35b43e9-6a1f-4d35-b3cd-a4b5ed3ac379">211.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtOS0xLTEtMA_c2441dfa-f2f2-46ee-bf92-afdafc0a1e36">767.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtMS0xLTEtMA_38c925af-e79b-4601-ba30-5425d54532cc">74.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtMy0xLTEtMA_600803ac-a41b-4dc4-96a0-6cdcc5505bfb">91.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtNS0xLTEtMA_02d39931-15eb-4492-9ef3-759a24bc2d90"><ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtNS0xLTEtMA_fe452c93-fe0a-4af2-8350-47462d5b3b0a">82.3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtNy0xLTEtMA_3eb10623-8a0d-4a47-8732-160774717033">98.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtOS0xLTEtMA_92f151ab-6ec2-433e-93c6-4f655d666b0f">346.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtMS0xLTEtMA_4fdfe541-1d67-450f-a1bb-f7e023c8227e">1.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtMy0xLTEtMA_81fe3c0a-2e22-43d2-8bb8-36e6559fd666">1.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtNS0xLTEtMA_b81ecbf4-bab8-4ed9-82cb-5a7ad55a574b">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtNy0xLTEtMA_6646ab7a-e0f2-4c57-a8c9-666aff8b721e">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtOS0xLTEtMA_9f052c5b-b8d5-4ee8-9488-c68b8766bd0f">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctMS0xLTEtMA_183d9745-0244-462b-9164-5d98c2c04c59">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctMy0xLTEtMA_c44c277c-f9f7-443f-812c-e74222bdc88d">1.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctNS0xLTEtMA_60c51374-39eb-46ab-b7d8-b2b05ad93be5">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctNy0xLTEtMA_c09fc29e-50f5-4ab2-ae63-d84e6b97c20f">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctOS0xLTEtMA_65434d47-17c0-408d-a4ff-3b393913ae8a">4.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTEtMS0xLTA_1b466d36-1a7f-4d5b-91d2-f1941702ef1b">443.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTMtMS0xLTA_7f0b2e5f-d49b-445d-bb07-51dad3bbe1de">469.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTUtMS0xLTA_07217014-3b4f-4869-bdbd-89a7c48a6a11">456.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTctMS0xLTA_6aebfc03-ad1b-49d3-81d0-20f274ef6347">470.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTktMS0xLTA_e55ed845-79fb-456f-bf41-223a9f5cb9d2">1,839.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTEtMS0xLTA_b4b9601e-1f72-45fb-a150-30cf3e694ab6">146.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTMtMS0xLTA_4e33679c-368f-4948-a6af-4ae40590997d">157.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTUtMS0xLTA_574dc2c3-7b55-41ce-b99f-2cad8ec21a4b">147.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTctMS0xLTA_31201491-e77f-4f18-be16-1da40186d523">153.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTktMS0xLTA_9907b28a-6f95-47ce-9420-2d20dfff1f4c">605.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTEtMS0xLTA_fd982bdb-df5f-469e-9f5c-0cdf3b0594b7">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTMtMS0xLTA_bbed13bc-cb80-4840-8a8c-edf5556e787e">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTUtMS0xLTA_5b1c3ac6-d804-4fe4-8f04-56ae8db1cee6">56.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTctMS0xLTA_77ca677d-0587-4b75-a3be-3705097c7de7">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTktMS0xLTA_7ce66629-869e-4932-b8ae-4de86dff0b73">241.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTEtMS0xLTA_c866835e-bcbb-4260-b981-e6ae4b771b7f">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTMtMS0xLTA_4e4ea5af-338e-460d-8a95-1d39c609ffd6">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTUtMS0xLTA_230a2b50-bcee-4c81-9e8d-fabb3bc2240b">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTctMS0xLTA_2650670c-1c4f-4f7d-be48-be5d202b9760">0.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTktMS0xLTA_28d63c43-e577-4d6b-8072-7b744a355b2d">3.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTEtMS0xLTA_92c8219f-c248-4b9f-80e4-3ad9c947cd19">0.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTMtMS0xLTA_bb32f623-0c22-498a-8d68-34822b94922b">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTUtMS0xLTA_abfadcc0-d64a-4480-a5c2-0d973bef0cd2">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTctMS0xLTA_fe736497-e688-48f8-9615-4839080c735f">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTktMS0xLTA_f004d35f-99e1-4de4-ae83-e98b9dad5d9d">3.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sum of the quarterly amounts may not equal full year due to rounding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors affecting the comparability of the information reflected in the quarterly data:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income for the first quarter of 2020 included the impact of a pension settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="-5" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzI5ODc_35eb2775-4579-44c9-b865-0ef1d7bd2d78">1.1</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzI5OTU_8740848d-5782-4919-8881-677c40ac8f3e">0.01</ix:nonFraction> per diluted share), amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i719b99d7c88542fa96519a7e6ee06942_D20200101-20200331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTE2NjQ_6319915b-77b3-403b-a582-94c5889eee85">1.0</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i719b99d7c88542fa96519a7e6ee06942_D20200101-20200331" decimals="2" name="wst:AmortizationExpenseImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTE2ODA_9e60211c-2872-4d5d-8152-ad1bfe2d6847">0.01</ix:nonFraction> per diluted share) associated with an acquisition of increased ownership interest in Daikyo, and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="-5" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMDI_fef42fa5-6820-48ca-b379-4f3fc57c2ce4">5.1</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMDk_f9559571-a4b4-4bba-94a4-bd583654e13a">0.07</ix:nonFraction> per diluted share) associated with stock-based compensation. Net income for the first quarter of 2019 included the impact of restructuring and related charges of $<ix:nonFraction unitRef="usd" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="-5" format="ixt:numdotdecimal" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU1NzQ_8495ba31-472a-4247-a010-be83f8033382">0.4</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MDk_71fe9335-a682-4623-9578-cc2d873c4351">0.01</ix:nonFraction> per diluted share) and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="-5" format="ixt:numdotdecimal" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU1ODg_7850c1a2-95a6-47dc-a459-b3ec05c8d719">1.4</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MDI_d1f2909e-1e46-4e42-96ff-4c37e63cae44">0.02</ix:nonFraction> per diluted share) associated with stock-based compensation.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Second quarter 2020 net income included the impact of a pension settlement charge of $<ix:nonFraction unitRef="usd" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="-5" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMzA_ec2ca2ad-70d6-4381-8a73-7e8e41b69f0a">0.7</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMzg_f6e2c37e-d131-45b9-a5f7-1cb01e3f5b42">0.01</ix:nonFraction> per diluted share), amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i9d8b5816ea284568a1893e7fcb6f3fd7_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzkzNDU4NDg4NDY2MDg_044c9e46-e5c8-4e9f-bb45-e852492d19bc">1.1</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i9d8b5816ea284568a1893e7fcb6f3fd7_D20200401-20200630" decimals="2" name="wst:AmortizationExpenseImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0Xzg3OTYwOTMwMzI3MzQ_3f17ccb8-4d30-4cd2-92a1-a89c1e0cf2d9">0.01</ix:nonFraction> per diluted share) associated with the acquisition of intangible assets, a charge of $<ix:nonFraction unitRef="usd" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTA5OTE_9bf110da-803b-4b21-8ea9-5ee1bd63d8c4">1.6</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="2" name="wst:PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTEwMDQ_c0e24f95-642c-4eb5-b97e-559b5ef8be31">0.02</ix:nonFraction> per diluted share) related to severance costs, and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="-5" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNDU_b95c2c12-238f-432d-9b04-214c140a7e5c">6.9</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNTM_a6e529fa-0c29-4707-800e-4888e9be44e1">0.09</ix:nonFraction> per diluted share) associated with stock-based compensation. Second quarter 2019 net income included the impact of restructuring and related charges of $<ix:nonFraction unitRef="usd" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2Mzc_af31fc11-1173-494c-a6e6-0c6c336f868f">1.1</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2NTE_a6712e31-64ea-4bcc-9de3-db8299e6208d">0.01</ix:nonFraction> per diluted share) and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MTY_18a23365-e931-4a9d-b768-30960204b4a6">3.8</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MzA_f0a233d7-eb6e-4699-b9b8-007d8bc2c8ff">0.05</ix:nonFraction> per diluted share) associated with stock-based compensation. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income for the third quarter of 2020 included the impact of a pension settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="2" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNjA_91cd72e8-01a6-42a1-99f0-37fd3d975938">0.8</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNjg_28340164-0cd8-488e-b909-5100614ba8aa">0.01</ix:nonFraction> per diluted share), amortization expense of $<ix:nonFraction unitRef="usd" contextRef="ic26980b6c24b44caaac3a924b44a1e9e_D20200701-20200930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTIxNTY_8bd7209c-3bc5-41eb-913c-0ece1f7bff37">0.7</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ic26980b6c24b44caaac3a924b44a1e9e_D20200701-20200930" decimals="2" name="wst:AmortizationExpenseImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTIxNjQ_da86b48a-1bba-4f43-8d6a-56ad0de5be28">0.01</ix:nonFraction> per diluted share) associated with the acquisition of intangible assets, a restructuring and severance related charge of $<ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="wst:RestructuringAndSeveranceRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MTU_58d3ecbf-3772-4223-b5c6-a9b41270959a">3.4</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="2" name="wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTExODA_6b466b8a-4aac-4047-9431-34746c22dc5b">0.04</ix:nonFraction> per diluted share), and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="-5" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MDk_9631bfb4-c5fd-457e-8f8c-ec341eff0c85">2.0</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTEyNDU_a27dc874-3972-4fda-889a-c8ff0d50af4a">0.02</ix:nonFraction> per diluted share) associated with stock-based compensation. Net income for the third quarter of 2019 included the impact of restructuring and related charges of $<ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="wst:RestructuringAndSeveranceRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MjE_3e3497aa-c504-4ef4-a78e-b0cdbe6738bd">1.4</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="2" name="wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MzU_9f4bb7aa-5ff6-401d-9809-2f80de9e1508">0.01</ix:nonFraction> per diluted share), a pension settlement charge of $<ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MDc_3692ab3b-8531-432f-9b05-9c593340537c">2.1</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MDA_2509cf7e-e027-4327-b115-a3a455945749">0.03</ix:nonFraction> per diluted share), a charge of $<ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NDI_a46cd455-3361-4825-b677-051f1d06711c">0.7</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="2" name="wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NTY_0cf8cbf4-2087-4462-9a26-d958fa308c31">0.01</ix:nonFraction> per diluted share) related to the devaluation of Argentina&#8217;s currency, a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2NTg_8e9af450-f601-4c1f-b3f9-a06421f65fe4">1.0</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="2" name="wst:IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2NzI_7ad14b3c-00b2-41fe-9d55-eeb7e95f41fe">0.01</ix:nonFraction> per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2ODY_392d8d78-1618-4d93-a895-980a455d8eb7">4.0</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2Nzk_6cfd23c4-90dd-4c35-a9f3-474c71a3204e">0.05</ix:nonFraction> per diluted share) associated with stock-based compensation.</span></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8cd347c447a74033aa13936aa1456275" continuedAt="i951de3ab0a9f4134a3970b9301dc4432"><ix:continuation id="idcf193327c194c1392a2d49e47233d02" continuedAt="ie2022cdc8e8a4d6180e7f5437092da84">(4)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i951de3ab0a9f4134a3970b9301dc4432"><ix:continuation id="ie2022cdc8e8a4d6180e7f5437092da84">Fourth quarter 2020 net income included the impact of a pension settlement charge of $<ix:nonFraction unitRef="usd" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MTk5NzQ_89988be1-4d95-466e-aa92-2b5ea7597194">0.3</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MTk5ODk_e67a42fb-6d95-4adf-a8b9-3cefdb354639">0.01</ix:nonFraction> per diluted share), amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i7fe7bd6c2ccf4155b6958ffbe633b8b2_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA2MTA_9210c08b-8871-40bc-9d17-2e3e9801addb">0.7</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="i7fe7bd6c2ccf4155b6958ffbe633b8b2_D20201001-20201231" decimals="2" name="wst:AmortizationExpenseImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA2Mjg_41f6075c-c0c4-4650-937b-2118e2ebf641">0.01</ix:nonFraction> per diluted share) associated with the acquisition of intangible assets, an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA3NDU_6755ccc0-29e2-4e91-b028-f5149deef534">2.5</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="2" name="wst:PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA3NTQ_b6265321-1ba0-48c0-8281-d0514d2f84b1">0.03</ix:nonFraction> per diluted share) related to a cost investment, and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="-5" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MTk_2ac47eec-454e-496d-92b8-cdbe4a2b73c3">6.8</ix:nonFraction> million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MjY_b7575335-505f-460b-9288-680ea393c296">0.09</ix:nonFraction> per diluted share) associated with stock-based compensation. Fourth quarter 2019 net income included the impact of restructuring and related charges of $<ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:RestructuringAndSeveranceRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4NzU_76adc082-c6e3-4125-baa2-63e41d228a22">0.8</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4Njg_3689afeb-efef-4dae-b8e9-58150fb1f2f5">0.02</ix:nonFraction> per diluted share), a gain on the sale of fixed assets as a result of our restructuring plan of $<ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:FixedAssetImpairmentFromRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4NTQ_00342996-ff25-46f4-a51a-195689597693">1.3</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="wst:FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4NDc_4898f2b2-4aaf-49f1-9cf8-fb83172f71b8">0.02</ix:nonFraction> per diluted share), a pension settlement charge of $<ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:PensionSettlementAndRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MzM_df8fbcfb-4f0b-42fb-adf6-8e22e8aaeab7">0.6</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MjY_b50560d0-cb32-48d1-820f-cb95b51fadb7">0.01</ix:nonFraction> per diluted share), a tax recovery related to previously-paid international excise taxes of $<ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:PaymentOfExciseTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MTI_0d2595e0-c7d8-49b3-a409-4f82eb245755">2.9</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="wst:PaymentOfExciseTaxesImpactOnDilutedEarningsShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MDU_e83add79-b2c6-4f4c-b0fb-89a156b53510">0.04</ix:nonFraction> per diluted share), a tax charge of $<ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3OTE_d7a80b4f-aaec-4f18-b6fb-9bae369988f5">0.7</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3ODQ_337bcf78-deae-4ba1-8caa-538b028a28fa">0.01</ix:nonFraction> per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:IncomeTaxBenefitFromStockBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NzA_ea98a209-503d-4a40-9451-187c83e3ffb8">1.1</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usdPerShare" contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231" decimals="2" name="wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NjM_659f30df-67d3-4766-b8aa-9cdc2b678aec">0.02</ix:nonFraction> per diluted share) associated with stock-based compensation.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this annual report, is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our CEO and Chief Financial Officer (&#8220;CFO&#8221;), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls include some, but not all, components of our internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934), as of the end of the period covered by this Form 10-K. Based on this evaluation, our CEO and CFO have concluded that, as of December&#160;31, 2020, our disclosure controls and procedures are effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is a process designed under the supervision of our CEO and CFO to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2020 based on the framework established in &#8220;Internal Control-Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, management has determined that our internal control over financial reporting was effective as of December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Internal control over financial reporting has inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to reduce, though not eliminate, this risk.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of December&#160;31, 2020 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which is included herein. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December&#160;31, 2020, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_178"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.  OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_181"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_184"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal 1 - Election of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Documents and Policies - Ethics and Our Code of Business Conduct</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting and Other Information - 2022 Shareholder Proposals or Nominations; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Board and Director Information and Policies - Committees - Audit Committee </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our 2021 Proxy Statement. The balance of the information required by this item is contained in the discussion entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Information About Our Executive Officers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Part&#160;I of this Form 10-K.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_187"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.  EXECUTIVE COMPENSATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about director and executive compensation is incorporated by reference from the discussion under the headings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Director Compensation, Compensation Committee Report, Compensation Discussion and Analysis,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Tables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2021 Proxy Statement. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_190"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="padding-left:9pt;text-indent:-6.75pt"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this Item is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Ownership </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our 2021 Proxy Statement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information Table</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information about the grants of stock options, all share units and other rights under all of the Company&#8217;s equity compensation plans as of the close of business on December&#160;31, 2020. The table does not include information about tax-qualified plans such as the West 401(k) Plan or the West Contract Manufacturing Savings and Retirement Plan.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">to be Issued Upon</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrants and Rights (a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrants and Rights (b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining Available for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Future Issuance Under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plans (Excluding Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reflected in Columns (a)) (c)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by security holders</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,555,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by security holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889,524&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,555,129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Includes 1,259,456 outstanding stock options, 222,799 performance share units, 27,062 restricted retention share units, 144,866 deferred stock-equivalents units, and 308 restricted stock-equivalents units granted to directors under the 2016 Plan. Includes 1,104,631 outstanding stock options, 3,628 outstanding stock-settled stock appreciation rights, and 108,074 deferred stock-equivalents units under the 2011 Plan (which was terminated in 2016). Includes 18,700 outstanding stock options under the Non-Qualified Deferred Compensation Plan for Non-Employee Directors under the 2007 Omnibus Incentive Compensation Plan (which was terminated in 2011). The average term of remaining options and stock-settled stock appreciation rights granted is 5.9 years. No future grants or awards may be made under the terminated plans.&#160;The total includes restricted performance share units at 100% of grant. The restricted performance share unit payouts were at 82.61%, 49.39%, and 96.6% in 2020, 2019 and 2018, respectively. The total does not include stock-equivalent units granted or credited to directors under the Non-Qualified Deferred Compensation Plan for Non-Employee Directors to be settled only in cash.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All share units and deferred stock-equivalent units are excluded when determining the weighted-average exercise price of outstanding options. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents 3,793,218 shares reserved under the Company&#8217;s Employee Stock Purchase Plan and 2,761,911 shares remaining available for issuance under the 2016 Plan.&#160;The estimated number of shares that could be issued for 2020 from the Employee Stock Purchase Plan is 173,019.&#160;This number of shares is calculated by multiplying the 107 shares per offering period per participant limit by 1,617, the number of current participants in the plan. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_193"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information called for by this Item is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Documents and Policies - Related Person Transactions and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2021 Proxy Statement. Information about director independence is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Documents and Policies - Director Independence </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our 2021 Proxy Statement.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_196"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information is incorporated by reference from the discussion under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Auditors and Fees - Fees Paid to PricewaterhouseCoopers LLP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Auditors and Fees - Audit Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our 2021 Proxy Statement.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_199"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_202"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15.&#160;&#160;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) 1.  Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are included in Part II, Item 8:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Income for the years ended December&#160;31, 2020, 2019 and 2018 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Comprehensive Income for the years ended December&#160;31, 2020, 2019 and 2018 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets at December&#160;31, 2020 and 2019 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statement of Equity for the years ended December&#160;31, 2020, 2019 and 2018 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2020, 2019 and 2018 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) 2.  Financial Statement Schedules</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90ZXh0cmVnaW9uOjJjMTdhYTAwMTg1MjQyZDliNzU5NTI4MjVjMTJkOGZhXzEzMzI_c3a5ced7-becd-4a96-9c1d-54deaa71a225" continuedAt="i9b9297e404a940c3886a97bd16650828" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule II - Valuation and Qualifying Accounts</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">beginning of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses (1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions (2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">end of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ea59d55ee44d4ab3fe01dfb28f7c7e_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtMS0xLTEtMA_89946350-73d9-4215-8cc2-2b464ed1b271">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd2fec9ee1f4945b5522f7f39694676_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtMi0xLTEtMA_6b78c604-5c1d-4205-9727-4c3ccb7618d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fd2fec9ee1f4945b5522f7f39694676_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtMy0xLTEtMA_c4da6c59-1313-45fd-98b9-884bfea1bd11">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc2b6d65de7432a8a9361729083f9c7_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtNC0xLTEtMA_05a272ef-ccbf-4d58-84f4-d959e57a5485">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd68a9b944eb48d7acb4f4672ce330e2_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtMS0xLTEtMA_cdb3e0b1-13b0-4bb5-93f8-6c09440b668a">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5d2c8af23c24659a9310a2a892a4f62_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtMi0xLTEtMA_6e21f4f2-272a-4669-8e9c-ccd06632dec4">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5d2c8af23c24659a9310a2a892a4f62_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtMy0xLTEtMA_83cea88d-5399-4c40-888d-d166c813ec85">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec6d3b519f94b4fa556d9176df56073_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtNC0xLTEtMA_046c0142-8135-45ab-b397-0ae9e3a34b8b">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtMS0xLTEtMA_25a40db0-936a-4bd1-8617-4f16a060ab2c">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtMi0xLTEtMA_351bcc95-493a-4f48-81d9-2de71c5ce1ed">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtMy0xLTEtMA_c75a79a2-ac8f-4e4d-9927-ca978e935469">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtNC0xLTEtMA_0b74293a-722e-49c1-95c6-8e06a467eca7">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82896f6ac3984e04b4105c6005e58772_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktMS0xLTEtMA_8d4ea161-ee65-4ad8-ab5c-e90126312f3a">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67679e92fa7e4c908452f2ce5a3f225e_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktMi0xLTEtMA_be2a7c7a-26dd-442f-8133-fce5676b0dd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67679e92fa7e4c908452f2ce5a3f225e_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktMy0xLTEtMA_e216651a-77e8-4b8c-a1a3-6eb81ef29195">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ea59d55ee44d4ab3fe01dfb28f7c7e_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktNC0xLTEtMA_fd51f03b-9dd1-451a-a8cf-ec59f4cf7a63">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882a8d63ebbb4201a759ff4643894e63_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTEtMS0xLTA_0d7e9cbc-ddc8-435f-a2da-a39cf328598c">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71aaf080ab884248b5379505dab9cfc7_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTItMS0xLTA_9e501859-efe9-4525-980f-82f0ad3810a1">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71aaf080ab884248b5379505dab9cfc7_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTMtMS0xLTA_728461f5-76f3-433c-8707-b211a96fcd8f">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd68a9b944eb48d7acb4f4672ce330e2_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTQtMS0xLTA_891e7642-cacf-4748-8c5b-f6067f0485b0">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTEtMS0xLTA_8a2d4822-6724-409e-8bba-2c85bfaf4d2e">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTItMS0xLTA_127ac7ea-dda6-493c-a01f-1041c1586b2d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTMtMS0xLTA_d9917a74-e3a1-4e5e-b775-3af367e43de9">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0230c88584154e91a07b322788cd39a8_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTQtMS0xLTA_28793f09-a86b-4998-8c0d-4aa13931fd96">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if820fa9d156f4d8abd00df5a22472ff0_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTEtMS0xLTA_92248a98-491d-45c0-bb02-6c79d7c80618">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i742f81f943014659ab25279911503298_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTItMS0xLTA_5e8b19fe-bfed-41b4-b4e1-3de3ebc2d81b">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i742f81f943014659ab25279911503298_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTMtMS0xLTA_7b016c6e-1456-45ff-93bd-996721637e37">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82896f6ac3984e04b4105c6005e58772_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTQtMS0xLTA_b7b0dca9-34a1-4358-a4fa-1140edd320e6">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906d2c0507c14130885513cc846a85fc_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTEtMS0xLTA_c5b7d4aa-4d96-4376-9973-834afdf4faa3">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0f9eef8a8d405ba0c12024d16f0191_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTItMS0xLTA_816c034a-3e40-4c3e-87b8-edf95204aaed">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0f9eef8a8d405ba0c12024d16f0191_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTMtMS0xLTA_5b6b6a6f-a6cc-419c-9e11-7c6a4f2c1ea3">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882a8d63ebbb4201a759ff4643894e63_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTQtMS0xLTA_9ea3c3cd-109e-46a8-87a1-6704a9c5b1c7">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTEtMS0xLTA_e222f6dd-68a7-4c71-8115-685ffb8518e9">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTItMS0xLTA_57a167eb-766f-4bec-817c-f456a9705b01">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTMtMS0xLTA_1d894737-614d-44c1-9af8-f4269b9de45a">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTQtMS0xLTA_4b45a63c-4fa0-4633-909a-3be7a0f6eb0c">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included within the allowance for doubtful accounts activity is the effect of the modified retrospective application of a new accounting standard mentioned in Note 2.</span></div></ix:nonNumeric><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9b9297e404a940c3886a97bd16650828" continuedAt="i1932fe8cc5204af58b037d4df9c1cdee">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i1932fe8cc5204af58b037d4df9c1cdee">Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules are omitted because they are either not applicable, not required or because the information required is contained in the consolidated financial statements or notes thereto.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) 3.&#160;&#160;&#160;&#160;Exhibits - An index of the exhibits included in this Form 10-K is contained on pages F-1 through F-3 and is incorporated herein by reference.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;See subsection (a) 3. above.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Financial Statements of affiliates are omitted because they do not meet the tests of a significant subsidiary at the 20% level.</span></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_205"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ic7db5523d9d74649b8592a121b55d512_208"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WEST PHARMACEUTICAL SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant)</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By: /s/ Bernard J. Birkett</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President and Chief Financial Officer</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2021 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of West Pharmaceutical Services, Inc. and in the capacities and on the dates indicated.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.596%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Eric M. Green</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, President and Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric M. Green</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bernard J. Birkett</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Birkett</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Chad R. Winters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer and Corporate Controller</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chad R. Winters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark A. Buthman</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark A. Buthman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William F. Feehery, Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William F. Feehery, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert F. Friel</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert F. Friel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas W. Hofmann</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas W. Hofmann</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Paula A. Johnson, M.D., MPH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paula A. Johnson, M.D., MPH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Deborah L.V. Keller</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deborah L.V. Keller</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Myla P. Lai-Goldman, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Myla P. Lai-Goldman, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Douglas A. Michels</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Douglas A. Michels</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Paolo Pucci</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paolo Pucci</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Patrick J. Zenner</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director and Chairman of the Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick J. Zenner</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="ic7db5523d9d74649b8592a121b55d512_211"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000045/ex31articlesofincorpor.htm">Our Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form 10-Q report for the quarter ended June 30, 2020, filed July 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000015/ex32bylaws.htm">Our Bylaws, as amended through May 5, 2015 (incorporated by reference to Exhibit 3.2 to the Company's Form 10-Q report for the quarter ended March 31, 2015, filed May 6, 2015).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/0000105770-99-000016-index.html">Form of stock certificate for common stock (incorporated by reference to Exhibit 4 to the Company's 1998 Form 10-K, filed May 6, 1999)</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000045/ex31articlesofincorpor.htm">Article 5, 6, 8(c) and 9 of our Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form 10-Q report for the quarter ended June 30, 2020, filed July 24, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000015/ex32bylaws.htm">Article I and V of our Bylaws, as amended through May 5, 2015 (incorporated by reference to Exhibit 3.2 to the Company's Form 10-Q report for the quarter ended March 31, 2015, filed May 6, 2015).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex44descriptionofregistere.htm">Description of Registered Securities.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments defining the rights of holders of long-term debt securities of West and its subsidiaries constituting less than 10% of West's total assets have been omitted.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000016/exh101march282019creditagr.htm">Credit Agreement, dated as of March 28, 2019, between West, certain of its subsidiaries, the lenders party thereto from time to time, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender; Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Wells Fargo Securities, LLC, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Wells Fargo Bank, National Association, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Co-Syndication Agents (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated April 1, 2019).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000015/ex102firstamendmentand.htm">First Amendment and Incremental Facility Amendment, dated as of December 30, 2019, between West, each of the lenders party thereto from time to time, and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Company's 2019 10-K file February 24, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000015/ex102firstamendmentand.htm">)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577012000048/exh10_1.htm">Note Purchase Agreement, dated July 5, 2012, among the Company and the Purchasers named therein (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed July 10, 2012).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000011/exhibit101executiveemploym.htm">Employment Agreement, dated as of April 13, 2015, between us and Eric M. Green (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated April 15, 2015). </a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000013/exh101indemnificationagree.htm">Indemnification Agreement, dated as of April 24, 2015, between us and Eric M. Green (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated April 30, 2015).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000013/exh102retentionawardagreem.htm">Sign-On Retention Award Notice, dated as of April 24, 2015, from us to Eric M. Green (incorporated by reference to Exhibit 10.2 to the Company's Form 8-K dated April 30, 2015).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577018000022/exh101employmentagreement.htm">Employment Agreement, dated May 29, 2018, between us and Bernard J. Birkett (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed June 21, 2018).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577016000101/ex101employmentagreement.htm">Employment Agreement, dated August 28, 2016, between David Montecalvo and us (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended September 30, 2016, filed October 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000016/exhibit1017.htm">Supplemental Employees&#8217; Retirement Plan, as amended and restated effective January 1, 2008 (incorporated by reference to Exhibit 10.17 to the Company's 2008 Form 10-K report, filed February 27, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577020000057/ex10102020amendedresta.htm">Non-Qualified Deferred Compensation Plan for Designated Employees, as amended and restated effective January 1, 2020 (incorporated by reference to Exhibit 10.10 to the Company's Form 10-Q report for the quarter ended September 30, 2020, filed October 23, 2020).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000005/ex1026nqdeferredcompensati.htm">Deferred Compensation Plan for Outside Directors, as amended and restated effective June 30, 2013 (incorporated by reference to Exhibit 10.26 to the Company's 2013 Form 10-K report, filed February 27, 2014).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465916117151/a16-10405_1s8.htm">2016 Omnibus Incentive Compensation Plan (incorporated by reference to the Company's Form S-8 filed May 3, 2016).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577011000025/inctiveplan.htm">2011 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed May 6, 2011).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465907023945/a07-6354_2def14a.htm#a2007OmnibusIncentiveCompensation_015515">2007 Omnibus Incentive Compensation Plan effective as of May 1, 2007 (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Form 8-K filed May 4, 2007).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906032995/a06-10941_1ex10d2.htm">Form of Executive 2006 Non-Qualified Stock Option Award is incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended March 31, 2006, filed May 10, 2006).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906051878/a06-15767_1ex10d1.htm">Form of Director 2006 Non-Qualified Stock Option Award Notice (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended June 30, 2006, filed August 7, 2006).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906051878/a06-15767_1ex10d2.htm">Form of Director 2006 Stock Unit Award Notice (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended June 30, 2006, filed August 7, 2006).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465907058768/a07-19128_1ex10d2.htm">Form of Director 2007 Deferred Stock Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended June 30, 2007, filed August 3, 2007).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000110465908031034/a08-11514_1ex10d2.htm">Form of 2008 Non-Qualified Stock Option and Performance-Vesting Share Unit Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended March 31, 2008, filed May 8, 2008).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000016/exhibit1041.htm">Form of Director 2008 Deferred Stock Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.41 to the Company's 2008 Form 10-K report, filed February 27, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000049/exhibit101.htm">Form of 2009 Supplemental Long-Term Incentive Award (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended September 30, 2009, filed November 14, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000016/ex1012014ltipaward.htm">Form of 2014 Long-Term Incentive Plan Award (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended March 31, 2014, filed May 8, 2014).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000046/ex1012014rsuawardletter.htm">Form of 2014 Stock-Settled Restricted Stock Unit Award (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended June 30, 2014, filed August 1, 2014).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1022019psuawardagreement.htm">Form of 2019 Performance Stock Unit (PSU) Award issued under the 2016 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended March 31, 2019, filed May 8, 2019).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1032019stockoptionawarda.htm">Form of 2019 Stock Option Award issued under the 2016 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.3 to the Company's Form 10-Q report for the quarter ended March 31, 2019, filed May 8, 2019).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000002/exh10.htm">Indemnification agreements between us and each of our directors (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K report filed January 6, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000050/ex101change-inxcontrolagre.htm">Form of Change-in-Control Agreement between us and certain of our executive officers (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended September 30, 2017, filed October 31, 2017).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577005000400/exh10d.htm">Agreement, effective as of January 1, 2005, between us and The Goodyear Tire &amp; Rubber Company (incorporated by reference to Exhibit 10d to the Company's Form 10-Q report for the quarter ended June 30, 2005, filed August 9, 2005).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000027/exhibit101.htm">First Agreement, effective as of July 1, 2008, to amend Agreement between us and The Goodyear Tire &amp; Rubber Company (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q report for the quarter ended March 31, 2009, filed May 6, 2009).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577016000101/ex102goodyearamendment.htm">Second Agreement, dated August 16, 2016, to amend Agreement between us and The Goodyear Tire &amp; Rubber Company and us (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended September 30, 2016, filed October 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1039distributoragreement.htm">Distributorship Agreement, dated and effective January 18, 2017, between Daikyo Seiko, Ltd. and us (incorporated by reference to Exhibit 10.39 to the Company's 2016 Form 10-K report filed February 28, 2017).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1040licenseagreement_2016.htm">Amended and Restated Technology Exchange and CrossLicense Agreement, dated and effective January 18, 2017, between Daikyo Seiko, Ltd. and us (incorporated by reference to Exhibit 10.40 to the Company's 2016 Form 10-K report, filed February 28, 2017).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577018000032/ex102amendedagreement.htm">Amended Agreement, dated and effective July 2, 2018, between Daikyo Seiko, Ltd. and us (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q report for the quarter ended June 30, 2018, filed July 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000040/exh101amendmentagreeme.htm">Amendment Agreement, dated as of October 15, 2019, between us and Daikyo Seiko, Ltd., (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed October 16, 2019).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/105770/000010577020000002/exh101exxonsupplyagree.htm">Global Master Supply Agreement by and between ExxonMobil Chemical Company and us, entered into on January 10, 2020, and effective January 1, 2019 through December 31, 2023 (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K report filed January 16, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex21listofsubsidiaries_2020.htm">Subsidiaries of the Company.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex23consent_2020.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex311ceo302certification_2.htm">Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex312cfo302certification_2.htm">Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex321ceo906certification_2.htm">Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex322cfo906certification_2.htm">Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL for the cover page of this Annual Report on Form 10-K, included in the Exhibit 101 Inline XBRL Document Set.</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We agree to furnish to the SEC, upon request, a copy of each instrument with respect to issuances of long-term debt of the Company and its subsidiaries.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management compensatory plan.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment order of the SEC. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Portions of this exhibit (indicated therein by asterisks) have been omitted for confidential treatment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Furnished, not filed. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>2
<FILENAME>ex44descriptionofregistere.htm
<DESCRIPTION>EX-4.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id8a371cc1a23456bb2b9b3083f072b92_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 4.4</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">WEST PHARMACEUTICAL SERVICES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">DESCRIPTION OF SECURITIES</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2020, the common stock of West Pharmaceutical Services, Inc. (&#8220;West&#8221; or the &#8220;Company&#8221;) is registered under Section 12(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The summary of the general terms and provisions of the Company&#8217;s common stock set forth below does not purport to be complete and is subject to, and qualified by, reference to the Company&#8217;s Articles of Incorporation (as amended, the &#8220;Articles&#8221;) and Bylaws (as amended, the &#8220;Bylaws,&#8221; and together with the Articles, the &#8220;Charter Documents&#8221;), each of which is incorporated by reference as an exhibit to the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission of which this Exhibit is a part. For additional information, please read the Company&#8217;s Charter Documents and the applicable provisions of the Pennsylvania Business Corporation Law of 1988 (as amended from time to time, the &#8220;PBCL&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Description of Capital Stock</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Authorized Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company is authorized under the Articles to issue 203,000,000 shares, divided into 200,000,000 shares of common stock, par value $.25 per share, and 3,000,000 shares of preferred stock, par value $.25 per share. As of December&#160;31, 2020, the Company had 74,021,306 shares of common stock outstanding and zero shares of preferred stock outstanding. The outstanding shares of the Company&#8217;s common stock are fully paid and nonassessable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except as otherwise provided by law or any certificate creating any series of preferred stock, the holders of common stock have the exclusive voting power, and every holder of common stock is entitled to one vote for every share of common stock standing in the name of the shareholder on the Company&#8217;s books. Except as otherwise provided in the PBCL or the Charter Documents, whenever any corporate action is to be taken by vote of the shareholders of the Company (other than the election of directors), it shall be authorized by the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter. Subject to the Charter Documents, the persons receiving a majority of the votes cast shall be elected as directors&#59; provided, that in contested elections, directors shall be elected by a plurality of the votes of the shares represented in person or represented by proxy at such meeting and entitled to vote on the election of directors. The Board of Directors of the Company (the &#8220;Board&#8221;) shall have the full authority permitted by law to determine the voting rights, if any, and designations, preferences, limitations, and special rights of any class or any series of any class of preferred stock that may be desired to the extent not determined by the Charter Documents.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Holders of common stock do not have cumulative voting rights in the election of directors, except upon&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the public announcement by West or a shareholder that such shareholder has become a 40% Shareholder (as described below), and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">such 40% Shareholder engages, directly or indirectly, in a proxy solicitation or participates in an election contest, seeks to advise or influence any person with respect to voting shares of the Company, or executes a written consent in lieu of a shareholder meeting of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A &#8220;40% Shareholder&#8221; means any person who, together with affiliates and associates, beneficially owns 40% or more of the voting stock of the Company, other than the Company or its wholly-owned subsidiaries or employee benefit plans.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Holders of common stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by the Board, in its discretion, out of funds legally available therefor, subject to any preferential dividend rights of outstanding preferred stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Liquidation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the event of a liquidation, dissolution or winding up of the Company, the holders of the Company&#8217;s common stock are entitled to share ratably in all assets remaining after the payment of all of the Company&#8217;s liabilities and after all amounts to which holders of any outstanding preferred stock are entitled have been paid or set aside for payment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Rights and Preferences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company&#8217;s common stock does not carry preemptive rights, is not redeemable, does not have any conversion rights, is not subject to further calls and is not subject to any sinking fund provisions. The rights and preferences of holders of the Company&#8217;s common stock are subject to the rights of any series of preferred stock that the Company may issue.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company&#8217;s common stock is listed on The New York Stock Exchange under the trading symbol &#8220;WST&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Certain Anti-Takeover Provisions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Vote Required for Certain Significant Transactions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  The Articles require that, in addition to any vote required by law or the Articles, the affirmative vote of the holders of at least 80% of the voting power of then outstanding shares of voting stock, voting as a single class, is required for any of the following transactions (each, a &#8220;Significant Transaction&#8221;)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">any merger or consolidation of the Company or any of its subsidiaries with any Related Person (as defined below) or any other corporation which is or would be an affiliate of a Related Person&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">any sale, lease or other disposition to or with any Related Person or any of its affiliates of any assets of the Company or any of its subsidiaries having a fair market value of $1.0 million or more&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the issuance or transfer by the Company or any of its subsidiaries of any of their securities to any Related Person or any of its affiliates in exchange for cash, securities or other property having a fair market value of $1.0 million or more&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the purchase by the Company or any of its subsidiaries of any shares of voting stock of the Company in exchange for cash, securities or other property having a fair market value of $1.0 million or more&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the adoption of a plan or proposal for the liquidation or dissolution of the Company proposed by or on behalf of a Related Person or any of its affiliates&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">any reclassification of securities or recapitalization of the Company, or any merger or consolidation of the Company with any of its subsidiaries or any other transaction which has the effect, directly or indirectly, or increasing the proportionate share of the outstanding shares of any class of equity or convertible securities of the Company or any of its subsidiaries which is directly or indirectly owned by any Related Person or any of its affiliates.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The higher vote requirement described above does not apply to a Significant Transaction if it is approved by a majority of Continuing Directors (as defined below) and certain fair price provisions and other requirements set forth in Article 6 of the Articles are satisfied.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;Related Person&#8221; means any person (other than the Company or any its subsidiaries) who (i) beneficially owns more than 10% of the voting power of outstanding voting stock or (ii) is an affiliate of the Company and at any time during the preceding two years beneficially owned 10% or more of such voting power, or (iii) is an assignee or has otherwise succeeded to any shares of voting stock which were at any time during the preceding two years beneficially owned by any Related Person, if such assignment or succession occurred in the course of a transaction not involving a public offering.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;Continuing Director&#8221; means any member of the Board who (i) was a member as of May 5, 1983, or (ii) is not affiliated with a Related Person and was a member of the Board prior to the time the Related Person became a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Related Person, or (iii) is a successor of a Continuing Director who is unaffiliated with the Related Person and is recommended to succeed a Continuing Director by a majority of the Continuing Directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Evaluation of Certain Proposals by the Board.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  The Articles provide that the Board, when evaluating a proposal from another party to acquire the Company or engage in a similar transaction, shall give due consideration to the following when exercising its judgment in determining what is in the best interests of the Company and its shareholders&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the character, integrity, business philosophy and financial status of the other party or parties to the transaction&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the consideration to be received by the Company or its shareholders in connection with such transaction, as compared to&#58; (i) the current market price or value of the Company&#8217;s properties or securities&#59; (ii) the estimated future value of the Company, its properties or securities&#59; and (iii) such other measures of the value of the Company, its properties or securities as the directors may deem appropriate.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the projected social, legal and economic effects of the proposed action or transaction upon the Company, its employees, suppliers and customers and the communities in which the Company does business&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the general desirability of the Company&#8217;s continuing as an independent entity&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">such other factors as the Board may deem relevant. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Potential Issuances of the Company&#8217;s Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Although the Company does not currently have any shares of preferred stock outstanding, it is authorized under the Articles to issue 3,000,000 shares of preferred stock, and the rights, preferences and privileges of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any series of preferred stock that the Company may designate and issue in the future. The Articles also authorize the Board to establish, from the authorized but unissued shares, one or more series of the shares of preferred stock and to determine, with respect to any such series of the Company&#8217;s preferred shares, the terms and rights of such series, including, for example, the designation, the number of shares, the dividend rate of the shares, the right, if any, of the Company to redeem shares, the voting power, if any, the obligation, if any, of the Company to retire shares, the terms and conditions, if any, upon which shares shall be convertible into or exchangeable for shares of stock of any other class or classes, and any other rights, preferences or limitations of the shares of such series.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board has authorized the issuance of 50,000 shares of preferred stock as Series A junior participating preferred stock in connection with its adoption of a shareholder rights plan that has expired. No shares of the Series A preferred stock are outstanding, and the Company does not intend to issue any of these shares. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The authorized shares of the Company, including shares of preferred stock and common stock, will be available for issuance without further action by the Company&#8217;s shareholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which the Company&#8217;s securities may be listed or traded.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Provisions for Shareholder Nominations and Shareholder Proposals at Annual Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company&#8217;s Bylaws establish an advance notice procedure for shareholders to nominate candidates for election as directors or to bring other business before annual meetings of the Company&#8217;s shareholders (the &#8220;Shareholder Notice Procedure&#8221;). The Shareholder Notice Procedure requires that written notice of nominations or proposals for substantive business must be delivered to the Company not less than 90 days prior to the first anniversary of the date of the prior year&#8217;s annual meeting of shareholders&#59; provided, that if less than 21 days&#8217; notice or prior public disclosure of the meeting date is given, the notice must be delivered not later than the earlier of (1) the 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> day after notice of the meeting date was mailed or disclosed,  or (2) the 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> day prior to the meeting. The nomination must contain information about the nominees as specified in the Bylaws. The notice must include information specified in the Bylaws, including, among other things, information concerning the nominee or proposal, as the case may be, and information about the shareholder's ownership of and agreements related to shares of the Company&#8217;s common stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A shareholder who wishes to recommend a candidate to be considered by the Nominating and Corporate Governance Committee of the Board for nomination as a Director must deliver the recommendation in writing to the Secretary of the Company following the Shareholder Notice Procedure described above and include the information set forth in the Bylaws. The Nominating and Corporate Governance Committee will consider all recommended candidates when making its recommendation to the full Board to nominate a slate of Directors for election. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Provisions Relating to the Election of the Company&#8217;s Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Under the Articles, shareholders are entitled to only one vote for each share held in all elections for directors. Directors are elected by a majority of votes cast, except in the case of contested elections, as described above. Holders of common stock do not have cumulative voting rights in the election of directors, except upon certain circumstances described above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Director Vacancies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Under the Articles, vacancies in the Board of Directors, including vacancies resulting from an increase in the number of Directors, shall be filled only by a majority vote of the remaining members of the Board though less than a quorum, and each person so selected shall be a Director to serve until the next annual meeting of shareholders, and until a successor has been duly elected and qualified.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amendment to Articles.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Any amendment to the articles requires the affirmative vote of a majority of the votes cast by all shareholders entitled to vote thereon and, if any class or series of shares is entitled to vote thereon as a class, the affirmative vote of a majority of the votes cast in each such class vote, except for amendments on matters specified in Section 1914(c) of the PBCL that do not require shareholder approval&#59; provided that alteration, amendment supplementing or repeal of the following provisions of the Articles requires the affirmative vote of the holders of at least 80% of the outstanding shares of capital stock entitled to vote generally in the election of directors, considered as one class&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Article 6, which relates to the vote required for certain significant transactions, as described in &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Vote Required for Certain Significant Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; above</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Article 7, which relates to the evaluation of certain proposals by the Board, as described in &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Evaluation of Certain Proposals by the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; above</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Article 8, which relates the Board, including vacancies and cumulative voting in certain circumstances</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Article 10, which relates to the vote required to amend the Articles</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amendment to Bylaws. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Except as restricted by applicable law, authority to adopt, amend and repeal the Bylaws is expressly vested in the Board, subject to the power of the shareholders to change such action.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Special Meeting of Company Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Charter Documents do not contain a provision permitting shareholders to call a special meeting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Shareholder Action by Written Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Charter Documents do not contain a provision permitting action by written consent of the shareholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pennsylvania Anti-Takeover Statutes.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Section 1715 of the PBCL, directors stand in a fiduciary relation to their corporation. In discharging their duties, directors may, in considering the best interests of their corporation, consider various constituencies, including, shareholders, employees, suppliers, customers and creditors of the corporation, and upon communities in which offices or other establishments of the corporation are located. Absent a breach of fiduciary duty, a lack of good faith or self-dealing, any act of the Board of Directors, a committee thereof or an individual director is presumed to be in the best interests of the corporation. The PBCL expressly provides that the fiduciary duty of directors does not require them to (i) redeem or otherwise render inapplicable outstanding rights issued under any shareholder rights plan&#59; (ii) render inapplicable certain of the anti-takeover statutes set forth in Chapter 25 of the PBCL described below&#59; or (iii) take any action solely because of the effect it may have on a proposed acquisition or the consideration to be received by shareholders in such a transaction.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chapter 25 of the PBCL contains several anti-takeover statutes applicable to publicly-traded corporations. Corporations may opt-out of such anti-takeover statutes under certain circumstances. The Company has not opted-out of any of the following statutes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Section 2538 of Subchapter 25D of the PBCL requires certain transactions with an &#8220;interested shareholder&#8221; to be approved by a majority of disinterested shareholders. &#8220;Interested shareholder&#8221; is defined broadly to include any shareholder who is a party to the transaction or who is treated differently than other shareholders and affiliates of the corporation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subchapter 25E of the PBCL requires a person or group of persons acting in concert which acquires 20% or more of the voting shares of the corporation to offer to purchase the shares of any other shareholder at &#8220;fair value.&#8221; &#8220;Fair value&#8221; means the value not less than the highest price paid by the controlling person or group during the 90-day period prior to the control transaction, plus a control premium. Among other exceptions, Subchapter 25E does not apply to shares acquired directly from the corporation in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subchapter 25F of the PBCL applies to a transaction with an interested shareholder (defined generally to be any beneficial owner of 20% or more of the corporation&#8217;s voting stock). Subchapter F prohibits such a corporation from engaging in a &#8220;business combination&#8221; (as defined in the PBCL) with an interested shareholder unless (i) the board of directors of such corporation gives approval to the proposed transaction or gives approval to the interested shareholder&#8217;s acquisition of 20% of the shares entitled to vote in an election of directors of such corporation, in either case prior to the date on which the shareholder first becomes an interested shareholder (the &#8220;Share Acquisition Date&#8221;)&#59; (ii) the interested shareholder owns at least 80% of the stock of such corporation entitled to vote in an election of directors of such corporation, and no earlier than three months after such interested shareholder reaches such 80% level, the majority of the remaining shareholders approve the proposed transaction, shareholders receive a minimum &#8220;fair price&#8221; for their shares (as set forth in the PBCL) in the transaction and the other conditions of Subchapter F are met&#59; (iii) holders of all outstanding shares of common stock of the corporation approve the transaction&#59; (iv) no earlier than five years after the Share Acquisition Date, a majority of the holders of the remaining shares entitled to vote in an election of directors approve the transaction&#59; or (v) no earlier than five years after the Share Acquisition Date, a majority of all holders of the shares of the corporation approve the transaction, all shareholders receive a minimum &#8220;fair price&#8221; for their shares (as set forth in the PBCL) and the other conditions of Subchapter F are met.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subchapter 25G of the PBCL provides that &#8220;control shares&#8221; lose voting rights unless such rights are restored by the affirmative vote of a majority of (i) the disinterested shares (generally, shares held by persons other than the acquirer, executive officers of the corporation and certain employee stock plans) and (ii) the outstanding voting shares of the corporation. &#8220;Control shares&#8221; are defined as shares which, upon acquisition, will result in a person or group acquiring for the first time voting control of (a) at least 20%, (b) at least 33-1&#47;3% or (c) 50% or more of the outstanding shares, together with shares acquired within 180 days of attaining the applicable threshold and shares purchased with the intention of attaining such threshold. A corporation may redeem control shares if the acquiring person does not request restoration of voting rights as permitted by Subchapter 25G. Among other exceptions, Subchapter 25G does not apply to a merger, consolidation or a share exchange if the corporation is a party to the transaction agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subchapter 25I of the PBCL mandates severance compensation for eligible employees who are terminated within 24 months after the approval of a control share acquisition. Eligible employees generally are all employees employed in Pennsylvania for at least two years prior to the control share approval. Severance equals the weekly compensation of the employee multiplied by the employee's years of service (up to 26 years), less payments made due to the termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subchapter 25J of the PBCL requires the continuation of certain labor contracts relating to business operations owned at the time of a control share approval.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has opted out of Subchapter 25H of the PBCL, which relates to disgorgement by certain controlling shareholders following attempts to acquire control.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>3
<FILENAME>ex21listofsubsidiaries_2020.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0461a03a0ba741d89b4d2197dfc222ea_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUBSIDIARIES OF THE COMPANY</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.026%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">State&#47; Country of Incorporation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Ownership</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent Co.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tech Group Europe Limited (dba West)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tech Group Grand Rapids, Inc. (dba West)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TGPR Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">W.P.S.F. Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WD SG Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Analytical Services, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Contract Manufacturing, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharma. Services IL, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Packaging (China) Company Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Packaging India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Products Ireland, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Argentina S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Asia, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Australia Pty. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services AZ, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Beograd d.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Brasil Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Colombia S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Cornwall Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Danmark A&#47;S</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Delaware Acquisition, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Deutschland GmbH Co KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services France S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Group Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Hispania S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding II GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Danmark ApS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Ireland North, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Ireland South, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holding Japan, GK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Italia S.r.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Korea Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Lakewood, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Normandie SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services of Delaware, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services of Florida, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Shanghai Medical Rubber Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Singapore (Holding) Pte. Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Switzerland GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Venezuela C.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venezuela</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Pharmaceutical Services Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>ex23consent_2020.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4be7ff5059f041ff86dd210e52e0a293_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-133863 and 333-145186) and Form S-8 (No. 333-106977, 333-143129, 333-156492, 333-171453, 333-174153 and 333-211088) of West Pharmaceutical Services, Inc. of our report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dated February&#160;23, 2021 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Philadelphia, Pennsylvania</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2021&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex311ceo302certification_2.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8f249a50156c4c98b40ec11e18df5086_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eric M. Green, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of West Pharmaceutical Services, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Eric M. Green           </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;23, 2021 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex312cfo302certification_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i159b27c1e17b4d26a1cf0a020ed9061e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bernard J. Birkett, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of West Pharmaceutical Services, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President and Chief Financial Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;23, 2021 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ex321ceo906certification_2.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie2a4a16dec6744dd87484c964e80754d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended December&#160;31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Eric M. Green, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;23, 2021</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>ex322cfo906certification_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3fd67cd43cf24522bb162a66678f9f75_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended December&#160;31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Bernard J. Birkett, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President and Chief Financial Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;23, 2021</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>wst-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a80a1d85-d222-4f41-ba9f-844636cf1f8b,g:17422749-133e-4fe3-9091-dc8e0f45c575-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wst="http://www.westpharma.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.westpharma.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.westpharma.com/role/Cover">
        <link:definition>000010001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>100010002 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical">
        <link:definition>100030004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100040005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100050006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>100060007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100070008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails">
        <link:definition>240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingStandards" roleURI="http://www.westpharma.com/role/NewAccountingStandards">
        <link:definition>210051002 - Disclosure - New Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingStandardsDetails" roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails">
        <link:definition>240064002 - Disclosure - New Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.westpharma.com/role/Revenue">
        <link:definition>210071003 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.westpharma.com/role/RevenueTables">
        <link:definition>230083002 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueAdoptionofASC606Details" roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details">
        <link:definition>240094003 - Disclosure - Revenue - Adoption of ASC 606 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenueRecognitionDetails" roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails">
        <link:definition>240104004 - Disclosure - Revenue - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractsAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails">
        <link:definition>240114005 - Disclosure - Revenue - Contracts Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractsandLiabilitiesNarrativeDetails" roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails">
        <link:definition>240124006 - Disclosure - Revenue - Contracts and Liabilities, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSupplyChainFinancingDetails" roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails">
        <link:definition>240134007 - Disclosure - Revenue - Supply Chain Financing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueVoluntaryRecallDetails" roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails">
        <link:definition>240144008 - Disclosure - Revenue - Voluntary Recall (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.westpharma.com/role/NetIncomePerShare">
        <link:definition>210151004 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.westpharma.com/role/NetIncomePerShareTables">
        <link:definition>230163003 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails" roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails">
        <link:definition>240174009 - Disclosure - Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment">
        <link:definition>210181005 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables">
        <link:definition>230193004 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails">
        <link:definition>240204010 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNarrativeDetails" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails">
        <link:definition>240214011 - Disclosure - Property, Plant and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.westpharma.com/role/Leases">
        <link:definition>210221006 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.westpharma.com/role/LeasesTables">
        <link:definition>230233005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdoptionofASC842Details" roleURI="http://www.westpharma.com/role/LeasesAdoptionofASC842Details">
        <link:definition>240244012 - Disclosure - Leases - Adoption of ASC 842 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails">
        <link:definition>240254013 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCashFlowandSupplementalInformationDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails">
        <link:definition>240264014 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseWeightedAverageDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails">
        <link:definition>240274015 - Disclosure - Leases - Lease Weighted Average (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>240284016 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>240284016 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompanies" roleURI="http://www.westpharma.com/role/AffiliatedCompanies">
        <link:definition>210291007 - Disclosure - Affiliated Companies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesTables" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables">
        <link:definition>230303006 - Disclosure - Affiliated Companies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesScheduleofInvestmentsDetails" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails">
        <link:definition>240314017 - Disclosure - Affiliated Companies - Schedule of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesNarrativeDetails" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails">
        <link:definition>240324018 - Disclosure - Affiliated Companies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets">
        <link:definition>210331008 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>230343007 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails">
        <link:definition>240354019 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>240364020 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails">
        <link:definition>240374021 - Disclosure - Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilities" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities">
        <link:definition>210381009 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesTables" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables">
        <link:definition>230393008 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesDetails" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails">
        <link:definition>240404022 - Disclosure - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.westpharma.com/role/Debt">
        <link:definition>210411010 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.westpharma.com/role/DebtTables">
        <link:definition>230423009 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails" roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails">
        <link:definition>240434023 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails_1" roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1">
        <link:definition>240434023 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.westpharma.com/role/DebtNarrativeDetails">
        <link:definition>240444024 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments">
        <link:definition>210451011 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>230463010 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsNarrativeDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails">
        <link:definition>240474025 - Disclosure - Derivative Financial Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails">
        <link:definition>240484026 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails">
        <link:definition>240494027 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.westpharma.com/role/FairValueMeasurements">
        <link:definition>210501012 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables">
        <link:definition>230513011 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails">
        <link:definition>240524028 - Disclosure - Fair Value Measurements - Fair Value of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails">
        <link:definition>240534029 - Disclosure - Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsOtherFinancialInstrumentsDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails">
        <link:definition>240544030 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>210551013 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>230563012 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>240574031 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails">
        <link:definition>240584032 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.westpharma.com/role/StockBasedCompensation">
        <link:definition>210591014 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.westpharma.com/role/StockBasedCompensationTables">
        <link:definition>230603013 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>240614033 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails">
        <link:definition>240624034 - Disclosure - Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionsActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails">
        <link:definition>240634035 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockAppreciationRightsAwardActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails">
        <link:definition>240644036 - Disclosure - Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails">
        <link:definition>240654037 - Disclosure - Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.westpharma.com/role/BenefitPlans">
        <link:definition>210661015 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.westpharma.com/role/BenefitPlansTables">
        <link:definition>230673014 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansNarrativeDetails" roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails">
        <link:definition>240684038 - Disclosure - Benefit Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>240694039 - Disclosure - Benefit Plans - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails">
        <link:definition>240704040 - Disclosure - Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAmountsRecognizedinBalanceSheetDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails">
        <link:definition>240714041 - Disclosure - Benefit Plans - Amounts Recognized in Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
        <link:definition>240724042 - Disclosure - Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansExpectedBenefitPaymentsDetails" roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails">
        <link:definition>240734043 - Disclosure - Benefit Plans - Expected Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAssumptionsUsedDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails">
        <link:definition>240744044 - Disclosure - Benefit Plans - Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" roleURI="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails">
        <link:definition>240754045 - Disclosure - Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAllocationofPlanAssetsDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails">
        <link:definition>240764046 - Disclosure - Benefit Plans - Allocation of Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncome" roleURI="http://www.westpharma.com/role/OtherExpenseIncome">
        <link:definition>210771016 - Disclosure - Other Expense (Income)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeTables" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables">
        <link:definition>230783015 - Disclosure - Other Expense (Income) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails">
        <link:definition>240794047 - Disclosure - Other Expense (Income) - Schedule of Other (Income) Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeNarrativeDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails">
        <link:definition>240804048 - Disclosure - Other Expense (Income) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails">
        <link:definition>240814049 - Disclosure - Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.westpharma.com/role/IncomeTaxes">
        <link:definition>210821017 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.westpharma.com/role/IncomeTaxesTables">
        <link:definition>230833016 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>240844050 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240854051 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeIncomeTaxesDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails">
        <link:definition>240864052 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails">
        <link:definition>240874053 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240884054 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveIncomeTaxReconciliationDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails">
        <link:definition>240894055 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.westpharma.com/role/CommitmentsandContingencies">
        <link:definition>210901018 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesDetails">
        <link:definition>240914056 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.westpharma.com/role/SegmentInformation">
        <link:definition>210921019 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.westpharma.com/role/SegmentInformationTables">
        <link:definition>230933017 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails">
        <link:definition>240944057 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSalesbyProductGroupDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails">
        <link:definition>240954058 - Disclosure - Segment Information - Sales by Product Group (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails">
        <link:definition>240964059 - Disclosure - Segment Information - Sales and Long-lived Assets by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentFinancialInformationDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails">
        <link:definition>240974060 - Disclosure - Segment Information - Segment Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyOperatingandPerShareDataUnaudited" roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited">
        <link:definition>210981020 - Disclosure - Quarterly Operating and Per Share Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyOperatingandPerShareDataUnauditedTables" roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables">
        <link:definition>230993018 - Disclosure - Quarterly Operating and Per Share Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyOperatingandPerShareDataUnauditedDetails" roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails">
        <link:definition>241004061 - Disclosure - Quarterly Operating and Per Share Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccounts" roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts">
        <link:definition>211011021 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsDetails" roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails">
        <link:definition>241024062 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="wst_PharmaTapSADeCVMember" abstract="true" name="PharmaTapSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_ExpirationPeriodDomain" abstract="true" name="ExpirationPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_YearAfter2021Member" abstract="true" name="YearAfter2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PharmaCustomersMember" abstract="true" name="PharmaCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ContractManufacturedCustomersMember" abstract="true" name="ContractManufacturedCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_CreditFacilityIsAvailableForSwingLineLoans" abstract="false" name="CreditFacilityIsAvailableForSwingLineLoans" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_BusinessCombinationContingentConsiderationMeasurementInput" abstract="false" name="BusinessCombinationContingentConsiderationMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" abstract="false" name="LegalMattersContingenciesAndLegalCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_PensionSettlementAndRelatedCharges" abstract="false" name="PensionSettlementAndRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" abstract="false" name="ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityRollForward" abstract="true" name="ContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_OtherMutualFundsMember" abstract="true" name="OtherMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_NotesPayableAndOtherDebtCurrent" abstract="false" name="NotesPayableAndOtherDebtCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_StockSettledStockAppreciationRightsOutstanding" abstract="false" name="StockSettledStockAppreciationRightsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_GenericsCustomersMember" abstract="true" name="GenericsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_AssetsDefinedBenefitPlansNoncurrent" abstract="false" name="AssetsDefinedBenefitPlansNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_The2020RestructuringPlanMember" abstract="true" name="The2020RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" abstract="false" name="ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_CostInvestmentImpairment" abstract="false" name="CostInvestmentImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_CashSettledPSUAwardsMember" abstract="true" name="CashSettledPSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" abstract="false" name="DeferredCompensationArrangementWithIndividualNumberOfPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" abstract="false" name="IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" abstract="false" name="FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_DaikyoSeikoLtdDaikyoMember" abstract="true" name="DaikyoSeikoLtdDaikyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" abstract="false" name="IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_CreditAvailableForIssuanceOfLettersOfCredit" abstract="false" name="CreditAvailableForIssuanceOfLettersOfCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_LineOfCreditFacilityAdditionalBorrowingCapacity" abstract="false" name="LineOfCreditFacilityAdditionalBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DevelopmentAndLicensingIncome" abstract="false" name="DevelopmentAndLicensingIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_WestCompanyMexicoSADeCVMember" abstract="true" name="WestCompanyMexicoSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_LesseeOperatingLeaseOptionToTerminateTerm" abstract="false" name="LesseeOperatingLeaseOptionToTerminateTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_ProbabilitiesOfSuccessfulFDAApprovalMember" abstract="true" name="ProbabilitiesOfSuccessfulFDAApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_IncentiveStockAwardsMember" abstract="true" name="IncentiveStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_StandardPackagingMember" abstract="true" name="StandardPackagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_BiologicsCustomersMember" abstract="true" name="BiologicsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ContractWithCustomerAssetRollForward" abstract="true" name="ContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_ContractManufacturedProductsMember" abstract="true" name="ContractManufacturedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" abstract="false" name="DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_FixedAssetImpairmentFromRestructuring" abstract="false" name="FixedAssetImpairmentFromRestructuring" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" abstract="true" name="PerformanceVestingSharesOrUnitsDividendEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ComputerHardwareAndSoftwareMember" abstract="true" name="ComputerHardwareAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_WeightedAverageSharesOutstandingAbstract" abstract="true" name="WeightedAverageSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" abstract="false" name="RestructuringAndRelatedActivitiesPeriodOfImplementation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AmortizationExpenseImpactOnDilutedEarningsPerShare" abstract="false" name="AmortizationExpenseImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_StockSettledPSUAwardsMember" abstract="true" name="StockSettledPSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PensionAndOtherPostretirementBenefitExpenseNet" abstract="false" name="PensionAndOtherPostretirementBenefitExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare" abstract="false" name="PaymentOfExciseTaxesImpactOnDilutedEarningsShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_RestructuringAndSeveranceRelatedCharges" abstract="false" name="RestructuringAndSeveranceRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ProprietaryProductsMember" abstract="true" name="ProprietaryProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_NetSalesMember" abstract="true" name="NetSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" abstract="true" name="AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_IncomeTaxBenefitFromStockBasedCompensation" abstract="false" name="IncomeTaxBenefitFromStockBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" abstract="false" name="DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_BrazilTaxRecovery" abstract="false" name="BrazilTaxRecovery" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_SeniorBNotesDue2024Member" abstract="true" name="SeniorBNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" abstract="false" name="DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_PharmaRubberSADeCVMember" abstract="true" name="PharmaRubberSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_RatioOfDebtToEBITDA" abstract="false" name="RatioOfDebtToEBITDA" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="wst_SalesToEquityMethodInvestees" abstract="false" name="SalesToEquityMethodInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember" abstract="true" name="ProbabilitiesOfSuccessfulExecutionOfAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_CashSettledStockAppreciationRightsOutstanding" abstract="false" name="CashSettledStockAppreciationRightsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_TermLoanDue2024Member" abstract="true" name="TermLoanDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" abstract="false" name="PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_RevolvingCreditFacilityDue2024Member" abstract="true" name="RevolvingCreditFacilityDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" abstract="false" name="RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_Year2021Member" abstract="true" name="Year2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ProvisionForProductReturns" abstract="false" name="ProvisionForProductReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AccruedSalariesWagesAndBenefitsCurrent" abstract="false" name="AccruedSalariesWagesAndBenefitsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_OtherIncomeExpense" abstract="false" name="OtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_SeniorNotesDue2022Member" abstract="true" name="SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_SeniorCNotesDue2027Member" abstract="true" name="SeniorCNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" abstract="false" name="PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" abstract="false" name="EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_OtherFinancialInstrumentsAbstract" abstract="true" name="OtherFinancialInstrumentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" abstract="false" name="LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_OtherEuropeCountriesMember" abstract="true" name="OtherEuropeCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualConversionUnit" abstract="false" name="DeferredCompensationArrangementWithIndividualConversionUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" abstract="false" name="ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" abstract="false" name="DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="wst_ContractWithCustomerAssetIncreaseDecrease" abstract="false" name="ContractWithCustomerAssetIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_GainLossOnArgentinaCurrencyDevaluation" abstract="false" name="GainLossOnArgentinaCurrencyDevaluation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ExpirationPeriodAxis" abstract="true" name="ExpirationPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" abstract="false" name="PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_IWPharmaGroupLLCMember" abstract="true" name="IWPharmaGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" abstract="false" name="ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" abstract="false" name="ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" abstract="false" name="ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_SalesProjectionsMember" abstract="true" name="SalesProjectionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_DebtInstrumentNumberOfTranches" abstract="false" name="DebtInstrumentNumberOfTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" abstract="false" name="DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_DeferredStockUnitsPayableInCash" abstract="false" name="DeferredStockUnitsPayableInCash" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_HighValueProductDeliveryDevicesMember" abstract="true" name="HighValueProductDeliveryDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherCurrentLiabilitiesAbstract" abstract="true" name="OtherCurrentLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityRecognitionPeriod" abstract="false" name="ContractWithCustomerLiabilityRecognitionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_OtherExpenseIncomeAbstract" abstract="true" name="OtherExpenseIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_DefinedBenefitPlanExpectedFutureBenefitPayments" abstract="false" name="DefinedBenefitPlanExpectedFutureBenefitPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_SmartDoseMember" abstract="true" name="SmartDoseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" abstract="false" name="ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PaymentOfExciseTaxes" abstract="false" name="PaymentOfExciseTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" abstract="false" name="ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_The2018RestructuringPlanMember" abstract="true" name="The2018RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_AssetRelatedChargesMember" abstract="true" name="AssetRelatedChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" abstract="false" name="DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_AluplastSADeCVMember" abstract="true" name="AluplastSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_EmployeeStockPurchasePlanEsppMember" abstract="true" name="EmployeeStockPurchasePlanEsppMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" abstract="false" name="OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_HighValueProductComponentsMember" abstract="true" name="HighValueProductComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_StockOptionAndAppreciationRightsMember" abstract="true" name="StockOptionAndAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" abstract="false" name="ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_SouthKoreaDistributorMember" abstract="true" name="SouthKoreaDistributorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_PatentsAndLicensingMember" abstract="true" name="PatentsAndLicensingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>wst-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a80a1d85-d222-4f41-ba9f-844636cf1f8b,g:17422749-133e-4fe3-9091-dc8e0f45c575-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/Cover" xlink:type="simple" xlink:href="wst-20201231.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5b879611-9285-4c48-8b32-491478c34712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bc78f9a2-4854-48e2-9bfb-715a1c90eb6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5b879611-9285-4c48-8b32-491478c34712" xlink:to="loc_us-gaap_OperatingIncomeLoss_bc78f9a2-4854-48e2-9bfb-715a1c90eb6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_de939a2a-c5b2-4905-8129-2d481768b0e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5b879611-9285-4c48-8b32-491478c34712" xlink:to="loc_us-gaap_InterestExpense_de939a2a-c5b2-4905-8129-2d481768b0e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_da5a4699-bec7-441b-8179-29c98956dfd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5b879611-9285-4c48-8b32-491478c34712" xlink:to="loc_us-gaap_InvestmentIncomeNet_da5a4699-bec7-441b-8179-29c98956dfd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_cedab0b9-8c7a-428f-b36f-82cc28ffc341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5b879611-9285-4c48-8b32-491478c34712" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_cedab0b9-8c7a-428f-b36f-82cc28ffc341" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b5a3f50f-68d8-4f1b-bcc8-3af7366de29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cb108751-7cca-43c6-8d6c-e2f76815052a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b5a3f50f-68d8-4f1b-bcc8-3af7366de29f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cb108751-7cca-43c6-8d6c-e2f76815052a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bd4cc801-a37d-4cc3-81d4-7e77914187f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b5a3f50f-68d8-4f1b-bcc8-3af7366de29f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bd4cc801-a37d-4cc3-81d4-7e77914187f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2763e240-3994-41c1-89fc-1fd7d5d6bcee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b5a3f50f-68d8-4f1b-bcc8-3af7366de29f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2763e240-3994-41c1-89fc-1fd7d5d6bcee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_302097e4-c749-4bef-9984-93c7b81ce477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2208a014-3180-41f5-a2fd-89c726c566d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_302097e4-c749-4bef-9984-93c7b81ce477" xlink:to="loc_us-gaap_GrossProfit_2208a014-3180-41f5-a2fd-89c726c566d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0a5ff12b-2a6b-426d-a894-d89f8e918b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_302097e4-c749-4bef-9984-93c7b81ce477" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0a5ff12b-2a6b-426d-a894-d89f8e918b7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0def9d20-fc0d-4f5f-967d-54937d0093d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_302097e4-c749-4bef-9984-93c7b81ce477" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0def9d20-fc0d-4f5f-967d-54937d0093d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_2cd187f8-50a7-464a-8e10-9a4a697e9295" xlink:href="wst-20201231.xsd#wst_OtherIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_302097e4-c749-4bef-9984-93c7b81ce477" xlink:to="loc_wst_OtherIncomeExpense_2cd187f8-50a7-464a-8e10-9a4a697e9295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e1313928-275b-4c98-ae18-6967a74b5287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_390b38af-1600-4746-b104-fa1777d3c1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_e1313928-275b-4c98-ae18-6967a74b5287" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_390b38af-1600-4746-b104-fa1777d3c1d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a2450026-cd27-4a1f-9757-9369df946382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_e1313928-275b-4c98-ae18-6967a74b5287" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a2450026-cd27-4a1f-9757-9369df946382" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_643d2753-ac89-4160-84a3-ba8df4d91d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_643d2753-ac89-4160-84a3-ba8df4d91d22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_3b757a02-9c8a-43d6-b5ac-25695fa29134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_3b757a02-9c8a-43d6-b5ac-25695fa29134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_53592a44-aca5-4ed9-807b-255040679660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_53592a44-aca5-4ed9-807b-255040679660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_d90a26c7-9232-429a-b105-7d9fbeb3c49f" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_d90a26c7-9232-429a-b105-7d9fbeb3c49f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_655fcbd7-3a00-4083-abf2-6c7012ac97e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_655fcbd7-3a00-4083-abf2-6c7012ac97e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_a6f15c52-2bb0-4a20-9438-2c30bf3d0ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_a6f15c52-2bb0-4a20-9438-2c30bf3d0ee3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6b5ebeff-57b0-4101-87eb-e93a0a06b5c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6b5ebeff-57b0-4101-87eb-e93a0a06b5c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_60dd30b6-f362-4e25-b9ac-de2bcb54ab7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad79f32b-5a71-42a7-a9e9-06cf1a4db34d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_60dd30b6-f362-4e25-b9ac-de2bcb54ab7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a093f782-4915-4c43-9b92-70bc69dfcd63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3e86ad11-cddf-4c86-bb3b-ad3d56fc2eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a093f782-4915-4c43-9b92-70bc69dfcd63" xlink:to="loc_us-gaap_NetIncomeLoss_3e86ad11-cddf-4c86-bb3b-ad3d56fc2eda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_00bebec4-846f-4f94-aede-f5be2f396f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a093f782-4915-4c43-9b92-70bc69dfcd63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_00bebec4-846f-4f94-aede-f5be2f396f63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ff4ec022-689b-4d0e-935c-0062d70ae419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:to="loc_us-gaap_LiabilitiesCurrent_ff4ec022-689b-4d0e-935c-0062d70ae419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_daf4d595-c298-4069-b1b1-5acbc872f2df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_daf4d595-c298-4069-b1b1-5acbc872f2df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_273c3d3e-c42a-400f-92ff-4b25263704e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_273c3d3e-c42a-400f-92ff-4b25263704e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6f416c0f-a82d-44d3-b02b-dd672184d1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6f416c0f-a82d-44d3-b02b-dd672184d1e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0fb697a4-b5b5-4279-8ed5-4653dd6b42bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0fb697a4-b5b5-4279-8ed5-4653dd6b42bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_396ae0a7-1a24-4a8f-a4c2-c0abfaecbd76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_396ae0a7-1a24-4a8f-a4c2-c0abfaecbd76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53b649d6-ea8f-4095-8d37-a6bf024096c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4325bf20-f498-4307-ad77-9d47f86f7543" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53b649d6-ea8f-4095-8d37-a6bf024096c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_374cfd0f-e5b0-4e53-99c0-90c29d5c6ee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dcddef46-f70f-4cf4-b695-d8e442582536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_374cfd0f-e5b0-4e53-99c0-90c29d5c6ee0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dcddef46-f70f-4cf4-b695-d8e442582536" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2702ab05-720a-4d80-8a1d-0f1ad12cafb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_374cfd0f-e5b0-4e53-99c0-90c29d5c6ee0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2702ab05-720a-4d80-8a1d-0f1ad12cafb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1b791cd0-39d5-43f5-9840-5d952133bd90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_02d571aa-1258-4725-a48b-8a604be51db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1b791cd0-39d5-43f5-9840-5d952133bd90" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_02d571aa-1258-4725-a48b-8a604be51db6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_884abc62-5bf8-4565-bfa1-e7b8d6d2163a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1b791cd0-39d5-43f5-9840-5d952133bd90" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_884abc62-5bf8-4565-bfa1-e7b8d6d2163a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cf9265de-3275-4efe-ac7c-b0bd4af093df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1b791cd0-39d5-43f5-9840-5d952133bd90" xlink:to="loc_us-gaap_InventoryNet_cf9265de-3275-4efe-ac7c-b0bd4af093df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_91aa2dd3-4b5a-4899-af4f-6b29bd655d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1b791cd0-39d5-43f5-9840-5d952133bd90" xlink:to="loc_us-gaap_OtherAssetsCurrent_91aa2dd3-4b5a-4899-af4f-6b29bd655d57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d1bb16a0-e546-46e7-b107-be099e1ce3c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b6d68daa-0c8e-42d3-b82d-d3559ec06610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d1bb16a0-e546-46e7-b107-be099e1ce3c5" xlink:to="loc_us-gaap_Liabilities_b6d68daa-0c8e-42d3-b82d-d3559ec06610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2e7985ef-bfc0-41d3-85d1-a48f78deb17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d1bb16a0-e546-46e7-b107-be099e1ce3c5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2e7985ef-bfc0-41d3-85d1-a48f78deb17b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_588a86a9-ceb9-4403-8f74-5eda4e8015b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d1bb16a0-e546-46e7-b107-be099e1ce3c5" xlink:to="loc_us-gaap_StockholdersEquity_588a86a9-ceb9-4403-8f74-5eda4e8015b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d71707f7-cd7d-4d7d-adcb-dc4e808f741d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_AssetsCurrent_d71707f7-cd7d-4d7d-adcb-dc4e808f741d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0fa02021-2ef1-42e9-9b86-76dc7f94a2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0fa02021-2ef1-42e9-9b86-76dc7f94a2ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d35b4b35-3b02-4401-bda4-57fc9c9adc5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d35b4b35-3b02-4401-bda4-57fc9c9adc5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_10a018b5-ed5c-4e2b-a416-1346fce03c7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_Goodwill_10a018b5-ed5c-4e2b-a416-1346fce03c7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_d647625e-bbbc-4db4-a00d-47e1c5635cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_d647625e-bbbc-4db4-a00d-47e1c5635cef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a84ce1c7-c89d-4ca6-8c84-2e1156ce047e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a84ce1c7-c89d-4ca6-8c84-2e1156ce047e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_955138bd-d4df-4722-8a99-ca1adff0695e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_955138bd-d4df-4722-8a99-ca1adff0695e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8cab9843-e72e-4a9e-9e9d-00ae3e248f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8cab9843-e72e-4a9e-9e9d-00ae3e248f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_31fb6d69-f687-4755-b5b2-3031750fa4b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6fcdb26e-3a97-4e02-bf1d-391cebe7860b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_31fb6d69-f687-4755-b5b2-3031750fa4b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b1f309e2-a003-455c-9e52-f2907e7a7235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a516aefe-a60d-45d4-8481-6b85c9e135d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1f309e2-a003-455c-9e52-f2907e7a7235" xlink:to="loc_us-gaap_PreferredStockValue_a516aefe-a60d-45d4-8481-6b85c9e135d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_07e104e1-6699-4159-95b6-284e697c6c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1f309e2-a003-455c-9e52-f2907e7a7235" xlink:to="loc_us-gaap_CommonStockValue_07e104e1-6699-4159-95b6-284e697c6c4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0f3beff4-9754-4ba5-923b-c35f73736a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1f309e2-a003-455c-9e52-f2907e7a7235" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0f3beff4-9754-4ba5-923b-c35f73736a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b5a0a1fd-dc3e-471a-b06c-9b59c5d6e23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1f309e2-a003-455c-9e52-f2907e7a7235" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b5a0a1fd-dc3e-471a-b06c-9b59c5d6e23b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a94f2073-cb62-44be-a6b2-36c87665fef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1f309e2-a003-455c-9e52-f2907e7a7235" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a94f2073-cb62-44be-a6b2-36c87665fef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_53bd5379-0cc0-47d1-a0d2-92dfc00c0217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1f309e2-a003-455c-9e52-f2907e7a7235" xlink:to="loc_us-gaap_TreasuryStockValue_53bd5379-0cc0-47d1-a0d2-92dfc00c0217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_fa487025-95b7-4d3a-88f3-66d5ad1fa893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_fa487025-95b7-4d3a-88f3-66d5ad1fa893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_56eaa0e5-9607-4016-b212-8827825155e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:to="loc_us-gaap_AccountsPayableCurrent_56eaa0e5-9607-4016-b212-8827825155e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_d057b491-25da-49a9-99df-72772c807476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_d057b491-25da-49a9-99df-72772c807476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_f807ba8d-9ddb-48ea-a65d-32eab704f561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_f807ba8d-9ddb-48ea-a65d-32eab704f561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ed384680-fa81-4045-bed6-48ab746984ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ed384680-fa81-4045-bed6-48ab746984ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_ee429b62-ca5e-4913-9861-8d55889956ef" xlink:href="wst-20201231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_ee429b62-ca5e-4913-9861-8d55889956ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_dcd5307b-e82e-4240-9df0-e495e5f692d8" xlink:href="wst-20201231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_537d383a-1590-4956-88c6-e849b05e3a9e" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_dcd5307b-e82e-4240-9df0-e495e5f692d8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d781934d-16a6-408c-a815-66d3b38c1570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82a85a4c-666c-4dd1-9a78-c7ff3a7242d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d781934d-16a6-408c-a815-66d3b38c1570" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82a85a4c-666c-4dd1-9a78-c7ff3a7242d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88447aa3-32ba-43f1-9eab-5dbe7722032c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d781934d-16a6-408c-a815-66d3b38c1570" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88447aa3-32ba-43f1-9eab-5dbe7722032c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7226ed68-b60d-4cda-9f03-f39993bd52a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d781934d-16a6-408c-a815-66d3b38c1570" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7226ed68-b60d-4cda-9f03-f39993bd52a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_3ce013b9-b077-44da-8d12-59b47cf66cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d781934d-16a6-408c-a815-66d3b38c1570" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_3ce013b9-b077-44da-8d12-59b47cf66cb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_b7564246-8b4f-4194-a120-4dbbe9b938e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_b7564246-8b4f-4194-a120-4dbbe9b938e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_ef4c983e-1e40-46e8-be7a-d2f58340b000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_ef4c983e-1e40-46e8-be7a-d2f58340b000" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ca17f65b-c79c-4ea2-92dd-371b47724606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ca17f65b-c79c-4ea2-92dd-371b47724606" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_c2de6edc-1083-4e59-903a-563d2c3de2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_c2de6edc-1083-4e59-903a-563d2c3de2f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_6c9f48c1-a94b-4614-a0dd-3179da45b516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_6c9f48c1-a94b-4614-a0dd-3179da45b516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5db685c0-fd22-4dbe-8023-195dba2ae9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5db685c0-fd22-4dbe-8023-195dba2ae9ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5156a6ac-31f9-4a49-8b16-4037a107a37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5156a6ac-31f9-4a49-8b16-4037a107a37a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d009b45c-5e86-4457-bf5f-6fd660997cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d009b45c-5e86-4457-bf5f-6fd660997cba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_94fd8f67-3d6d-40f8-ad00-1253fd9cb6fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_605bc8c6-aa98-4cd1-9903-74bd821aec16" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_94fd8f67-3d6d-40f8-ad00-1253fd9cb6fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4c0e31fb-1eed-4414-ab49-72c5e78c21bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ffe30687-44fe-43c1-a5f1-983767ab3eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4c0e31fb-1eed-4414-ab49-72c5e78c21bd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ffe30687-44fe-43c1-a5f1-983767ab3eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_f545bd4f-2716-4e64-beed-ff59e653dc91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4c0e31fb-1eed-4414-ab49-72c5e78c21bd" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_f545bd4f-2716-4e64-beed-ff59e653dc91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8a20dd71-2ac5-4416-a693-15a2a513264e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4c0e31fb-1eed-4414-ab49-72c5e78c21bd" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8a20dd71-2ac5-4416-a693-15a2a513264e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a57ba079-e9d8-4e4c-9676-d1982499e0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4c0e31fb-1eed-4414-ab49-72c5e78c21bd" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a57ba079-e9d8-4e4c-9676-d1982499e0d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc172cb5-4879-4d30-8db8-73dc22be94c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_NetIncomeLoss_fc172cb5-4879-4d30-8db8-73dc22be94c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_605e4310-615c-45d4-a044-90fd66aa3ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_Depreciation_605e4310-615c-45d4-a044-90fd66aa3ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_bc34fa6e-d70e-499a-b231-45009804b247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_AdjustmentForAmortization_bc34fa6e-d70e-499a-b231-45009804b247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4bd9d75d-379c-45bb-a67e-ca6e4ecbcc0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_ShareBasedCompensation_4bd9d75d-379c-45bb-a67e-ca6e4ecbcc0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_d31a76d4-a69d-4322-97b3-9b622361dfef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_d31a76d4-a69d-4322-97b3-9b622361dfef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4595af7b-f44d-40d4-9fbf-0bd93f7486b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4595af7b-f44d-40d4-9fbf-0bd93f7486b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_41cf7928-1908-4bdd-82cd-3a81c79769cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_41cf7928-1908-4bdd-82cd-3a81c79769cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5b79dd76-902e-4734-b516-9e65be863323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5b79dd76-902e-4734-b516-9e65be863323" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0cc8ab2a-eac0-4f48-9a26-74092211063a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0cc8ab2a-eac0-4f48-9a26-74092211063a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_acf0a25f-e380-48f4-9679-bd7b87c5135e" xlink:href="wst-20201231.xsd#wst_PensionAndOtherPostretirementBenefitExpenseNet"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_acf0a25f-e380-48f4-9679-bd7b87c5135e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_1e9adcde-94c2-42b7-85dc-6986ecdc30ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_1e9adcde-94c2-42b7-85dc-6986ecdc30ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_75ee4262-5782-4f90-a620-b0687cfdb272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_75ee4262-5782-4f90-a620-b0687cfdb272" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6ffb530f-57a1-4cc0-9b4d-1251e9173119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6ffb530f-57a1-4cc0-9b4d-1251e9173119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_d077f572-ab86-4d71-9fd1-0b8d9f17bf22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_d077f572-ab86-4d71-9fd1-0b8d9f17bf22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8a683d3c-1e39-440b-a374-fc8692cf9a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8a683d3c-1e39-440b-a374-fc8692cf9a59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f38dfe05-e918-408a-8229-37f4dcbd7b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f68d72c-9927-4665-9dbe-68a0c741259e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f38dfe05-e918-408a-8229-37f4dcbd7b25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a73e9d49-ebe7-4527-8460-0d421998422d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1656f8f2-21f5-4711-a224-6b5109d83428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a73e9d49-ebe7-4527-8460-0d421998422d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1656f8f2-21f5-4711-a224-6b5109d83428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_384c5401-60c0-4b56-9e0d-5bccd1c1ac3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a73e9d49-ebe7-4527-8460-0d421998422d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_384c5401-60c0-4b56-9e0d-5bccd1c1ac3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_70a40018-ee3d-4cd7-a1b0-0487cde7a92e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a73e9d49-ebe7-4527-8460-0d421998422d" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_70a40018-ee3d-4cd7-a1b0-0487cde7a92e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20201231.xsd#NewAccountingStandards"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#NewAccountingStandardsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Revenue" xlink:type="simple" xlink:href="wst-20201231.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueTables" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueAdoptionofASC606Details"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueContractsandLiabilitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueSupplyChainFinancingDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueVoluntaryRecallDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShare"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShareTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_612a0347-bfe1-4538-a641-5751d0e9868f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b391e454-d5c3-489e-b916-067ed6d7c325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_612a0347-bfe1-4538-a641-5751d0e9868f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b391e454-d5c3-489e-b916-067ed6d7c325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_96def39b-1d7f-4a08-9d49-8fedfbb481fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_612a0347-bfe1-4538-a641-5751d0e9868f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_96def39b-1d7f-4a08-9d49-8fedfbb481fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipment"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesAdoptionofASC842Details" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesAdoptionofASC842Details"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesAdoptionofASC842Details" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_93a8b72a-cb97-4b1a-aeab-fe72397eadb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_80f3ea95-4e2e-4eb5-8612-ffcce896c24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_93a8b72a-cb97-4b1a-aeab-fe72397eadb8" xlink:to="loc_us-gaap_OperatingLeaseCost_80f3ea95-4e2e-4eb5-8612-ffcce896c24a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_24c9c138-976c-46b7-be71-90908e8ac9a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_93a8b72a-cb97-4b1a-aeab-fe72397eadb8" xlink:to="loc_us-gaap_ShortTermLeaseCost_24c9c138-976c-46b7-be71-90908e8ac9a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_1d1e98a2-0b6b-4829-92cd-75f86bc9af11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_93a8b72a-cb97-4b1a-aeab-fe72397eadb8" xlink:to="loc_us-gaap_VariableLeaseCost_1d1e98a2-0b6b-4829-92cd-75f86bc9af11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseCashFlowandSupplementalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseWeightedAverageDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_904c7384-a63f-4b53-9d72-f6ede7ee8280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_97cc1554-3e75-450f-9241-185154a143e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_904c7384-a63f-4b53-9d72-f6ede7ee8280" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_97cc1554-3e75-450f-9241-185154a143e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_53affca4-d830-430f-8c94-4bdb31e25ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_904c7384-a63f-4b53-9d72-f6ede7ee8280" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_53affca4-d830-430f-8c94-4bdb31e25ec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_558f1e7f-845a-462f-a38b-8e308fc73b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_904c7384-a63f-4b53-9d72-f6ede7ee8280" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_558f1e7f-845a-462f-a38b-8e308fc73b5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cf8137e2-e07a-44ac-bfd8-7cdd5eee9a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_904c7384-a63f-4b53-9d72-f6ede7ee8280" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cf8137e2-e07a-44ac-bfd8-7cdd5eee9a44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_09314bbf-07e9-4833-96de-3aba0df2c72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_904c7384-a63f-4b53-9d72-f6ede7ee8280" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_09314bbf-07e9-4833-96de-3aba0df2c72e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6869ed4b-e0d5-4525-9d66-5832e4045cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_904c7384-a63f-4b53-9d72-f6ede7ee8280" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6869ed4b-e0d5-4525-9d66-5832e4045cb2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0827ef76-d91d-4478-a8fd-44b781e6d8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cc75a0dc-a052-44d4-b343-cdea2bba0f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0827ef76-d91d-4478-a8fd-44b781e6d8e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cc75a0dc-a052-44d4-b343-cdea2bba0f2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6876f8c8-cb99-48c9-a411-14db60580a8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0827ef76-d91d-4478-a8fd-44b781e6d8e3" xlink:to="loc_us-gaap_OperatingLeaseLiability_6876f8c8-cb99-48c9-a411-14db60580a8b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompanies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesScheduleofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e17d85b1-16d7-4e65-a345-c83de497ffff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9087b083-58e7-452a-bd21-962c7f20287f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e17d85b1-16d7-4e65-a345-c83de497ffff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9087b083-58e7-452a-bd21-962c7f20287f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_162c61cc-d55f-45fe-9fa3-bd6410428eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e17d85b1-16d7-4e65-a345-c83de497ffff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_162c61cc-d55f-45fe-9fa3-bd6410428eef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilities"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_33baa362-960b-4f2d-b3f5-74e9dddc9756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_RestructuringReserve_33baa362-960b-4f2d-b3f5-74e9dddc9756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_a1863105-06db-4049-ba2a-4bc58424c424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_a1863105-06db-4049-ba2a-4bc58424c424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_79205824-76b3-4a86-b39e-44a3c38d3925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_79205824-76b3-4a86-b39e-44a3c38d3925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_9d90bf9b-a89f-4136-8ac7-ca71605c7dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_DividendsPayableCurrent_9d90bf9b-a89f-4136-8ac7-ca71605c7dbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_71c3c9fe-19f8-4b41-b780-d95f0a1b4112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_71c3c9fe-19f8-4b41-b780-d95f0a1b4112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_0fa76aea-fceb-4b76-a2bf-5b0e39a81525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_DeferredRevenueCurrent_0fa76aea-fceb-4b76-a2bf-5b0e39a81525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_4ee4211e-8946-4a6f-89ba-602794b8f8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_InterestPayableCurrent_4ee4211e-8946-4a6f-89ba-602794b8f8a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_07346ffc-b63b-4a9f-a88b-10032e4b71c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_07346ffc-b63b-4a9f-a88b-10032e4b71c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_70acb838-0d8d-4572-b24f-74780d32133a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_70acb838-0d8d-4572-b24f-74780d32133a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_995241f4-93bb-46db-bdec-1fb8495a166b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_01c11703-4b7c-465f-9643-f1bfc751f48b" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_995241f4-93bb-46db-bdec-1fb8495a166b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20201231.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d7d8299c-f07f-4af5-ac11-19ef85bbab00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9c2cafb2-ba7f-4b19-a2fc-d40835a16cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_d7d8299c-f07f-4af5-ac11-19ef85bbab00" xlink:to="loc_us-gaap_LongTermDebtCurrent_9c2cafb2-ba7f-4b19-a2fc-d40835a16cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_73a3e7cf-b547-46f4-9aa6-cc83dde2f416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_d7d8299c-f07f-4af5-ac11-19ef85bbab00" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_73a3e7cf-b547-46f4-9aa6-cc83dde2f416" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtScheduleofDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_541d9c47-b1be-48cc-8a61-a7b9b7ad404b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_570c0336-20b1-430e-bf16-5d0f1d5e43cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_541d9c47-b1be-48cc-8a61-a7b9b7ad404b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_570c0336-20b1-430e-bf16-5d0f1d5e43cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_fcae7e66-c4a5-4154-a386-6f60b75bb8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_541d9c47-b1be-48cc-8a61-a7b9b7ad404b" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_fcae7e66-c4a5-4154-a386-6f60b75bb8c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_4390b617-5eee-4b7b-bda8-fee44391e805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_4c863f91-0e64-451f-adc3-c7618828811f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_4390b617-5eee-4b7b-bda8-fee44391e805" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_4c863f91-0e64-451f-adc3-c7618828811f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_f7a7f2b9-a304-4cbd-9698-9991b23270c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_4390b617-5eee-4b7b-bda8-fee44391e805" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_f7a7f2b9-a304-4cbd-9698-9991b23270c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ea77948f-7ce5-477f-914f-30a5b44a8506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_4390b617-5eee-4b7b-bda8-fee44391e805" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ea77948f-7ce5-477f-914f-30a5b44a8506" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6b1730e4-c57e-4aa1-ae4a-11ca52aba2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fe5caf97-b349-4d90-91aa-8a3e7098ca17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6b1730e4-c57e-4aa1-ae4a-11ca52aba2a6" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fe5caf97-b349-4d90-91aa-8a3e7098ca17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_62d57a94-be7e-44e4-b544-ac0f03ceda6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6b1730e4-c57e-4aa1-ae4a-11ca52aba2a6" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_62d57a94-be7e-44e4-b544-ac0f03ceda6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_7d57f154-18c1-4699-a9c4-a848f80d7dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6b1730e4-c57e-4aa1-ae4a-11ca52aba2a6" xlink:to="loc_us-gaap_DerivativeAssets_7d57f154-18c1-4699-a9c4-a848f80d7dfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_c45ddf00-05e4-422f-9314-aaaefb676a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c79e88f1-118f-4376-8c99-6a18da48b097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c45ddf00-05e4-422f-9314-aaaefb676a7f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c79e88f1-118f-4376-8c99-6a18da48b097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_f16a6161-e06e-4f68-8952-8cdba4f9880e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c45ddf00-05e4-422f-9314-aaaefb676a7f" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_f16a6161-e06e-4f68-8952-8cdba4f9880e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_5c3467c1-0461-4f01-8876-8c9e03803669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c45ddf00-05e4-422f-9314-aaaefb676a7f" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_5c3467c1-0461-4f01-8876-8c9e03803669" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_14786044-a105-4290-833d-23558789b91f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_1856a0ef-1a97-42b1-b684-46390170b487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_14786044-a105-4290-833d-23558789b91f" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_1856a0ef-1a97-42b1-b684-46390170b487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e25ea3ea-eb44-4cfa-8cae-21ffeb121873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_14786044-a105-4290-833d-23558789b91f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e25ea3ea-eb44-4cfa-8cae-21ffeb121873" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlans"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15ab5b05-ddf6-4eec-b074-aad846c6e302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_0250fa6c-91ee-4a7c-9a77-be21c804b0af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15ab5b05-ddf6-4eec-b074-aad846c6e302" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_0250fa6c-91ee-4a7c-9a77-be21c804b0af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_80666074-fd57-48af-9772-3c3e64483440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15ab5b05-ddf6-4eec-b074-aad846c6e302" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_80666074-fd57-48af-9772-3c3e64483440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_a108e7be-06bd-46af-9835-dc2b1cf76bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15ab5b05-ddf6-4eec-b074-aad846c6e302" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_a108e7be-06bd-46af-9835-dc2b1cf76bab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_105d76f1-28f8-4221-badd-b48f1f00a574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15ab5b05-ddf6-4eec-b074-aad846c6e302" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_105d76f1-28f8-4221-badd-b48f1f00a574" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_2c7fedac-d67d-4df5-9feb-72ce099ed2d3" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15ab5b05-ddf6-4eec-b074-aad846c6e302" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_2c7fedac-d67d-4df5-9feb-72ce099ed2d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_af51eea2-9ee9-4079-bf26-5b8621f2ea24" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15ab5b05-ddf6-4eec-b074-aad846c6e302" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_af51eea2-9ee9-4079-bf26-5b8621f2ea24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35fc5b3b-f30c-450b-bce3-98b7c0f3f421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_2bc0826f-47ef-4587-8056-854f717f026a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35fc5b3b-f30c-450b-bce3-98b7c0f3f421" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_2bc0826f-47ef-4587-8056-854f717f026a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_47d8c085-043e-4350-8118-261edaebb2c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35fc5b3b-f30c-450b-bce3-98b7c0f3f421" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_47d8c085-043e-4350-8118-261edaebb2c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b01fb853-0740-4779-b132-b03648f2e3da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35fc5b3b-f30c-450b-bce3-98b7c0f3f421" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b01fb853-0740-4779-b132-b03648f2e3da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_3212eb64-f016-4c73-960b-9e1ccb806e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35fc5b3b-f30c-450b-bce3-98b7c0f3f421" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_3212eb64-f016-4c73-960b-9e1ccb806e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6324268f-5730-4157-920f-97d66f9676b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35fc5b3b-f30c-450b-bce3-98b7c0f3f421" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6324268f-5730-4157-920f-97d66f9676b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_41494994-be81-4f7e-bcdc-58ae992223ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35fc5b3b-f30c-450b-bce3-98b7c0f3f421" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_41494994-be81-4f7e-bcdc-58ae992223ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f95b6c00-d0a3-4442-a346-ddb92644911d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b07e3969-a859-480f-859d-f815b38118fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f95b6c00-d0a3-4442-a346-ddb92644911d" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b07e3969-a859-480f-859d-f815b38118fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b6d65373-9c8c-4253-b033-1ab56b59de56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_f95b6c00-d0a3-4442-a346-ddb92644911d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b6d65373-9c8c-4253-b033-1ab56b59de56" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e7e54ee5-7caa-45aa-80bb-797a8b6580b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6572b673-3ac4-4b90-b3ac-3db07025174f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e7e54ee5-7caa-45aa-80bb-797a8b6580b7" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6572b673-3ac4-4b90-b3ac-3db07025174f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ef32fd1d-4690-42b1-8156-843ccc51af7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e7e54ee5-7caa-45aa-80bb-797a8b6580b7" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ef32fd1d-4690-42b1-8156-843ccc51af7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_bb9ba21a-2243-42ed-b52a-649c2e7d5d30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_e0c85b4d-16d8-4f72-8808-03ffc7400485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_bb9ba21a-2243-42ed-b52a-649c2e7d5d30" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_e0c85b4d-16d8-4f72-8808-03ffc7400485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6a189ee5-8edf-4ce9-bd89-b5584a77ecd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_bb9ba21a-2243-42ed-b52a-649c2e7d5d30" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6a189ee5-8edf-4ce9-bd89-b5584a77ecd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_653ac814-345a-4d87-9a74-fbbe8797b469" xlink:href="wst-20201231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_bb9ba21a-2243-42ed-b52a-649c2e7d5d30" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_653ac814-345a-4d87-9a74-fbbe8797b469" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_05d34a12-89c8-4122-a472-973713311682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_a35fc800-e4ee-4843-8025-2173ac48ebd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_05d34a12-89c8-4122-a472-973713311682" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_a35fc800-e4ee-4843-8025-2173ac48ebd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_d3838655-e392-4b70-80f5-8fe23f36ab45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_05d34a12-89c8-4122-a472-973713311682" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_d3838655-e392-4b70-80f5-8fe23f36ab45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_4454acd4-d94e-4c85-82a0-ca002c3de6f1" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_9fb8fcc8-0768-4ba5-9298-92dd9ccf4c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_4454acd4-d94e-4c85-82a0-ca002c3de6f1" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_9fb8fcc8-0768-4ba5-9298-92dd9ccf4c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_a4c8ed12-8d9d-4ce3-bb31-d3882d28294e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_4454acd4-d94e-4c85-82a0-ca002c3de6f1" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_a4c8ed12-8d9d-4ce3-bb31-d3882d28294e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_95d4d5d5-fb98-4bcd-8294-88a8e5987d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_4454acd4-d94e-4c85-82a0-ca002c3de6f1" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_95d4d5d5-fb98-4bcd-8294-88a8e5987d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_96472b0e-badb-4f4a-8348-cd778b60cffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_4454acd4-d94e-4c85-82a0-ca002c3de6f1" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_96472b0e-badb-4f4a-8348-cd778b60cffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_6834e989-f1dc-4163-9327-ab496adfd556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_4454acd4-d94e-4c85-82a0-ca002c3de6f1" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_6834e989-f1dc-4163-9327-ab496adfd556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_9d2a0fcd-d281-4ab1-ba4f-91beb43f32cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_4454acd4-d94e-4c85-82a0-ca002c3de6f1" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_9d2a0fcd-d281-4ab1-ba4f-91beb43f32cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncome"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_9e114041-4327-4299-8bd3-26d9bfd3f3b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_8df90239-be86-421a-bf2f-a108519c0c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_9e114041-4327-4299-8bd3-26d9bfd3f3b6" xlink:to="loc_us-gaap_SeveranceCosts1_8df90239-be86-421a-bf2f-a108519c0c37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_75fcbd1b-8fdb-4005-8f29-2d4b51913968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_9e114041-4327-4299-8bd3-26d9bfd3f3b6" xlink:to="loc_us-gaap_AssetImpairmentCharges_75fcbd1b-8fdb-4005-8f29-2d4b51913968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_3861c7ba-bcd4-4a68-9349-02cedd969b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_9e114041-4327-4299-8bd3-26d9bfd3f3b6" xlink:to="loc_us-gaap_OtherRestructuringCosts_3861c7ba-bcd4-4a68-9349-02cedd969b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:href="wst-20201231.xsd#wst_OtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_581b741c-05b8-40b6-b7a1-810914e1c6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_581b741c-05b8-40b6-b7a1-810914e1c6b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_cec47bcd-9e38-496d-a5e2-95948abb0df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_cec47bcd-9e38-496d-a5e2-95948abb0df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ec10c8d3-f422-48a6-bdfc-09941038658f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ec10c8d3-f422-48a6-bdfc-09941038658f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentAndLicensingIncome_414d1942-e662-4cb0-bbc5-3bd4ca02db17" xlink:href="wst-20201231.xsd#wst_DevelopmentAndLicensingIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_wst_DevelopmentAndLicensingIncome_414d1942-e662-4cb0-bbc5-3bd4ca02db17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_488fc7fc-71b5-4f11-9d5c-400a9656b476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_488fc7fc-71b5-4f11-9d5c-400a9656b476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_459a9031-3357-47ec-abb4-3ed15c8f45af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_459a9031-3357-47ec-abb4-3ed15c8f45af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_fc5fddb5-0cc4-4e8f-a69b-93baa9e9854c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_fc5fddb5-0cc4-4e8f-a69b-93baa9e9854c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BrazilTaxRecovery_9a35cdd9-62e6-404e-8cbf-fd98daee208b" xlink:href="wst-20201231.xsd#wst_BrazilTaxRecovery"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_51b9362b-7251-47d6-871b-4be7cf57a5af" xlink:to="loc_wst_BrazilTaxRecovery_9a35cdd9-62e6-404e-8cbf-fd98daee208b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ae83c963-5d42-4018-ae5c-4567181ca812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_486990b7-42ce-4bed-971e-9eb995b516e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ae83c963-5d42-4018-ae5c-4567181ca812" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_486990b7-42ce-4bed-971e-9eb995b516e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ce4f08be-2592-47f1-9f4c-413ebd070abb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ae83c963-5d42-4018-ae5c-4567181ca812" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ce4f08be-2592-47f1-9f4c-413ebd070abb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_62607dc2-74a6-42b4-974e-013f26a3d7ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_92e29671-a390-4764-8722-c53d9facd30f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_62607dc2-74a6-42b4-974e-013f26a3d7ce" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_92e29671-a390-4764-8722-c53d9facd30f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b57693ee-1437-4843-9296-1efb5cc23b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_62607dc2-74a6-42b4-974e-013f26a3d7ce" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b57693ee-1437-4843-9296-1efb5cc23b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_611b2595-d537-4e94-abd2-dfffe7f90481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_62607dc2-74a6-42b4-974e-013f26a3d7ce" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_611b2595-d537-4e94-abd2-dfffe7f90481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_36e737e8-696c-4c36-bbdf-927491494c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9dfc9898-a389-425f-bf19-3395887f2afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_36e737e8-696c-4c36-bbdf-927491494c8a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9dfc9898-a389-425f-bf19-3395887f2afb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_172b9432-3e36-4950-b74a-10d5b5e7496d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_36e737e8-696c-4c36-bbdf-927491494c8a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_172b9432-3e36-4950-b74a-10d5b5e7496d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f47530ad-fc2b-48b6-af43-cfd64e774462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_f667d144-f267-4a61-8bfa-1e637a7e5ef2" xlink:href="wst-20201231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f47530ad-fc2b-48b6-af43-cfd64e774462" xlink:to="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_f667d144-f267-4a61-8bfa-1e637a7e5ef2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ed9dd55a-36eb-4abe-a9d2-02aa342dc010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f47530ad-fc2b-48b6-af43-cfd64e774462" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ed9dd55a-36eb-4abe-a9d2-02aa342dc010" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_7f92d69a-2cae-4510-8989-a1299a7a6516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a799fd21-1f3c-466c-bb28-d3fa92355013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7f92d69a-2cae-4510-8989-a1299a7a6516" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a799fd21-1f3c-466c-bb28-d3fa92355013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_32e80a75-9eab-4658-8a5f-ad87e191cdb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7f92d69a-2cae-4510-8989-a1299a7a6516" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_32e80a75-9eab-4658-8a5f-ad87e191cdb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_ba660dc2-e4c0-4fab-bb26-a4fc2e34d9bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7f92d69a-2cae-4510-8989-a1299a7a6516" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_ba660dc2-e4c0-4fab-bb26-a4fc2e34d9bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_c4dba3c2-6ff7-41fe-b2e6-61ed66ced643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_32c6ff52-dddb-430e-9f95-8d85a63e153b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_c4dba3c2-6ff7-41fe-b2e6-61ed66ced643" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_32c6ff52-dddb-430e-9f95-8d85a63e153b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_483c7acb-c9ce-444c-b612-3f8db3d8c748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_c4dba3c2-6ff7-41fe-b2e6-61ed66ced643" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_483c7acb-c9ce-444c-b612-3f8db3d8c748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_cfa04e62-263f-47d1-894e-65ad806daa57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e1351e2f-5dab-4336-9612-540a8ef3276e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cfa04e62-263f-47d1-894e-65ad806daa57" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e1351e2f-5dab-4336-9612-540a8ef3276e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_b24f4a6c-2775-4fd2-bd24-f56a40fa9d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cfa04e62-263f-47d1-894e-65ad806daa57" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_b24f4a6c-2775-4fd2-bd24-f56a40fa9d8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_76fa4d68-5a21-4942-8e33-fa4e9c9bd62c" xlink:href="wst-20201231.xsd#wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cfa04e62-263f-47d1-894e-65ad806daa57" xlink:to="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_76fa4d68-5a21-4942-8e33-fa4e9c9bd62c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_0d166c96-acd9-42f7-b956-cae7e8731262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cfa04e62-263f-47d1-894e-65ad806daa57" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_0d166c96-acd9-42f7-b956-cae7e8731262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_289d19d2-5b0e-4e9d-8bde-58b076e85fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cfa04e62-263f-47d1-894e-65ad806daa57" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_289d19d2-5b0e-4e9d-8bde-58b076e85fad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_98ced995-bd6b-475c-8131-164321e42740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cfa04e62-263f-47d1-894e-65ad806daa57" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_98ced995-bd6b-475c-8131-164321e42740" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_04405256-1da8-4f58-85c5-615b8c836507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_7fb7f77b-ca0d-4f57-a9ab-78f49defb799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_04405256-1da8-4f58-85c5-615b8c836507" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_7fb7f77b-ca0d-4f57-a9ab-78f49defb799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d55dff49-8220-4250-b238-3c3712e77a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_04405256-1da8-4f58-85c5-615b8c836507" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_d55dff49-8220-4250-b238-3c3712e77a33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e5de05e1-5b62-4d99-a649-009a898f77ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e5de05e1-5b62-4d99-a649-009a898f77ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b9bca053-ead1-4d82-8823-571399b574d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b9bca053-ead1-4d82-8823-571399b574d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_9bee58a6-aa94-4335-9290-8edf193a10dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_9bee58a6-aa94-4335-9290-8edf193a10dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_5861ea83-f016-41a5-862c-7bee879d4f0d" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_5861ea83-f016-41a5-862c-7bee879d4f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_012973da-7963-4592-b665-8e5c7b9d48cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_012973da-7963-4592-b665-8e5c7b9d48cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_163e91fe-ca4e-4d9a-adfa-b1f4c5a800c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_163e91fe-ca4e-4d9a-adfa-b1f4c5a800c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4ccdf5de-3cac-41ef-a779-bc781ad1280f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4ccdf5de-3cac-41ef-a779-bc781ad1280f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_109eb07b-cc92-4f7b-b687-65f618cab5fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_109eb07b-cc92-4f7b-b687-65f618cab5fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_766aba6f-dab2-4b67-831d-d47456f6e031" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_766aba6f-dab2-4b67-831d-d47456f6e031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9045a631-b8fa-4810-bc6f-15fb28810bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9045a631-b8fa-4810-bc6f-15fb28810bd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent_37fc18f6-b446-44a8-8b38-dd24bb24676b" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a34827e-d38a-450c-947d-1cc9e2895586" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent_37fc18f6-b446-44a8-8b38-dd24bb24676b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformation"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_86ffcf23-fe75-4e1e-84ad-0173f7d57f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c18d3293-e6cf-4eaa-a44e-41a0e9af172f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_86ffcf23-fe75-4e1e-84ad-0173f7d57f3b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c18d3293-e6cf-4eaa-a44e-41a0e9af172f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6da8e2bf-1ce2-4d69-a078-397ee36b77e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_86ffcf23-fe75-4e1e-84ad-0173f7d57f3b" xlink:to="loc_us-gaap_OperatingIncomeLoss_6da8e2bf-1ce2-4d69-a078-397ee36b77e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnaudited"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnauditedTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnauditedDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="wst-20201231.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>wst-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a80a1d85-d222-4f41-ba9f-844636cf1f8b,g:17422749-133e-4fe3-9091-dc8e0f45c575-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Cover" xlink:type="simple" xlink:href="wst-20201231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/Cover" xlink:type="extended" id="i0a6a7dd9422342b2be85a30b08ceb079_Cover"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended" id="i36ec833448d8444892411f99c4359569_CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended" id="i83890c187c6a41909c99ec3a924992e1_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended" id="i0dddbf34cd45431a94a37f243542fb70_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i1f6ec50d3cad45ca8488f217299b96c2_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="ic579177f57bb4fe99c953d992f4cdb0d_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended" id="i4f3d87ce69754476883f4f1a2c0fe560_CONSOLIDATEDSTATEMENTOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_768c0340-207f-4a2d-92e9-be62a33f2ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_768c0340-207f-4a2d-92e9-be62a33f2ca0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d4eeccf9-b4a8-490e-941b-0579e92420d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_SharesIssued_d4eeccf9-b4a8-490e-941b-0579e92420d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_693812cf-c63d-4cde-ad74-93405c45a14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockholdersEquity_693812cf-c63d-4cde-ad74-93405c45a14a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b0e8eb0d-c04a-4ccc-9d93-7501d5a9aea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b0e8eb0d-c04a-4ccc-9d93-7501d5a9aea3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dcbe6229-ad8e-4f53-a73d-27b316a14491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_NetIncomeLoss_dcbe6229-ad8e-4f53-a73d-27b316a14491" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_74fbf891-482d-4a51-a5d0-8091d37619de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_74fbf891-482d-4a51-a5d0-8091d37619de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ad84fb5d-3d04-4522-9d87-32ea6fe09eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ad84fb5d-3d04-4522-9d87-32ea6fe09eaf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f832e086-8ef6-4e24-affc-c642c3fe21b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f832e086-8ef6-4e24-affc-c642c3fe21b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6a82c104-ac8a-440e-8ce4-58c114f64f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6a82c104-ac8a-440e-8ce4-58c114f64f60" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1b1f411f-6594-4e17-b1a9-9f0a8c467652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1b1f411f-6594-4e17-b1a9-9f0a8c467652" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_f1e26010-e747-431f-9555-13db05e5c94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_f1e26010-e747-431f-9555-13db05e5c94d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_4cf61ac3-f94a-44ac-9cea-e3067b46e57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_DividendsCommonStockCash_4cf61ac3-f94a-44ac-9cea-e3067b46e57a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2ebc9d7d-70c9-4416-8264-9691eb2028ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2ebc9d7d-70c9-4416-8264-9691eb2028ef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_fad5d214-13aa-42e7-b83a-eb0627912ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_28844755-1e49-499f-8c78-9317ae7bf344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_768c0340-207f-4a2d-92e9-be62a33f2ca0" xlink:to="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa" xlink:to="loc_us-gaap_EquityComponentDomain_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa" xlink:to="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0a204800-9529-4d3e-bf08-abbcfaa041c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_CommonStockMember_0a204800-9529-4d3e-bf08-abbcfaa041c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bf4b8ae2-6f5d-4c39-9794-79c272e592b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bf4b8ae2-6f5d-4c39-9794-79c272e592b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_88f3bc94-6b92-43d1-84e6-4bb1792b7ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_TreasuryStockMember_88f3bc94-6b92-43d1-84e6-4bb1792b7ebc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8901c496-bb55-4a0b-adca-c9a690c3d774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_RetainedEarningsMember_8901c496-bb55-4a0b-adca-c9a690c3d774" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d2156d-ecf2-4926-8472-a3605d22bdca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d2156d-ecf2-4926-8472-a3605d22bdca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30c1cc01-1199-4681-8a2a-ac4ff0755025" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30c1cc01-1199-4681-8a2a-ac4ff0755025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_30c1cc01-1199-4681-8a2a-ac4ff0755025_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30c1cc01-1199-4681-8a2a-ac4ff0755025" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_30c1cc01-1199-4681-8a2a-ac4ff0755025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_53ee5976-610b-4621-b174-b2c248b9a44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30c1cc01-1199-4681-8a2a-ac4ff0755025" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_53ee5976-610b-4621-b174-b2c248b9a44c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_661ea7e9-4094-4088-9dc0-3c8b00890adc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_53ee5976-610b-4621-b174-b2c248b9a44c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_661ea7e9-4094-4088-9dc0-3c8b00890adc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i43c5df1ae20e4dbebd87aa841af09aa5_CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended" id="i96d5b78ff73147469c5c3e5bd77a38d5_BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i43d996a6669843718a33544e6d83170c_BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="icd895d2040eb4987bd98c587e586dedf_BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="ie35f61ff799d472bb2842e946a8ccc68_BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_950dd9c4-0997-4122-a11b-cf6c3b518254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3d174653-ace8-40b2-b4ce-8eeb9ed239c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_950dd9c4-0997-4122-a11b-cf6c3b518254" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3d174653-ace8-40b2-b4ce-8eeb9ed239c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_643156ac-423c-4b5c-97d9-78d4ee94930a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_950dd9c4-0997-4122-a11b-cf6c3b518254" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_643156ac-423c-4b5c-97d9-78d4ee94930a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_643156ac-423c-4b5c-97d9-78d4ee94930a" xlink:to="loc_srt_RangeAxis_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb" xlink:to="loc_srt_RangeMember_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb" xlink:to="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_300697e9-da2e-4f0a-9f99-41470a0d98d5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:to="loc_srt_MinimumMember_300697e9-da2e-4f0a-9f99-41470a0d98d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f806114e-cce4-4eac-8fcc-061ab3af8b1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:to="loc_srt_MaximumMember_f806114e-cce4-4eac-8fcc-061ab3af8b1f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20201231.xsd#NewAccountingStandards"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended" id="i7ff049c3db4a4efea925c1f255ac52a3_NewAccountingStandards"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#NewAccountingStandardsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="extended" id="i11d230ca3cc04bfaabedb2f06d5c6f13_NewAccountingStandardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_49d6d618-2099-43e0-9f9e-91ace9ea8c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a4160488-e94e-4056-8650-a65710f31398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_49d6d618-2099-43e0-9f9e-91ace9ea8c7f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a4160488-e94e-4056-8650-a65710f31398" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d3064d5a-a325-4717-8567-1a6e74f2dc4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_49d6d618-2099-43e0-9f9e-91ace9ea8c7f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d3064d5a-a325-4717-8567-1a6e74f2dc4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3df2635a-2c9f-44bb-b83a-25440737afd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d3064d5a-a325-4717-8567-1a6e74f2dc4b" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3df2635a-2c9f-44bb-b83a-25440737afd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3df2635a-2c9f-44bb-b83a-25440737afd3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3df2635a-2c9f-44bb-b83a-25440737afd3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3df2635a-2c9f-44bb-b83a-25440737afd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_464e9b79-3af2-4a88-8554-31ccb66fdd75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3df2635a-2c9f-44bb-b83a-25440737afd3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_464e9b79-3af2-4a88-8554-31ccb66fdd75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_38e5f2ae-b86c-4bd3-8209-9b843e0f8fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_464e9b79-3af2-4a88-8554-31ccb66fdd75" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_38e5f2ae-b86c-4bd3-8209-9b843e0f8fa4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Revenue" xlink:type="simple" xlink:href="wst-20201231.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/Revenue" xlink:type="extended" id="if92411d1b09641a8b8bedbf87aadadb2_Revenue"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueTables" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueTables" xlink:type="extended" id="i370a9c02700841ea962ef4459d927f08_RevenueTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueAdoptionofASC606Details"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="extended" id="i1643190f95da42438fc167b22e6f136d_RevenueAdoptionofASC606Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e618208f-b562-49cc-8a39-dfda8ac58be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c9cadcf-0176-4717-8107-0940e7063432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e618208f-b562-49cc-8a39-dfda8ac58be0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c9cadcf-0176-4717-8107-0940e7063432" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e618208f-b562-49cc-8a39-dfda8ac58be0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d3cf63c6-6eea-4988-af02-f97783c9dc98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d3cf63c6-6eea-4988-af02-f97783c9dc98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_d3cf63c6-6eea-4988-af02-f97783c9dc98_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d3cf63c6-6eea-4988-af02-f97783c9dc98" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_d3cf63c6-6eea-4988-af02-f97783c9dc98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_e0455334-edf4-4e2b-8bca-10f0f14d9b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d3cf63c6-6eea-4988-af02-f97783c9dc98" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_e0455334-edf4-4e2b-8bca-10f0f14d9b6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e90eff9f-32c5-4baf-abab-12768600cd11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_e0455334-edf4-4e2b-8bca-10f0f14d9b6c" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e90eff9f-32c5-4baf-abab-12768600cd11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_361f2516-c548-46ab-acf4-4792bae3f1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_361f2516-c548-46ab-acf4-4792bae3f1b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_361f2516-c548-46ab-acf4-4792bae3f1b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_361f2516-c548-46ab-acf4-4792bae3f1b3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_361f2516-c548-46ab-acf4-4792bae3f1b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_d58dc50c-c9be-418a-ac62-7d5d7bd656b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_361f2516-c548-46ab-acf4-4792bae3f1b3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_d58dc50c-c9be-418a-ac62-7d5d7bd656b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_76ed2275-b0c9-4e6e-a72e-687e416156af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_d58dc50c-c9be-418a-ac62-7d5d7bd656b3" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_76ed2275-b0c9-4e6e-a72e-687e416156af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended" id="ifb3e67d78ef545d39d1afa6f880fb95b_RevenueRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7817b4bf-df26-4cd9-bce0-10727929ac93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7817b4bf-df26-4cd9-bce0-10727929ac93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e8cc3189-4de6-4ec3-89a4-ab4fbe71c2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e8cc3189-4de6-4ec3-89a4-ab4fbe71c2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_61c595fa-9d97-4c82-85c4-cfc9cc1d8cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_61c595fa-9d97-4c82-85c4-cfc9cc1d8cc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0b1ea2ad-a1bd-4ead-895f-a091eca6f984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0b1ea2ad-a1bd-4ead-895f-a091eca6f984" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_588398ad-c380-42ed-afbc-3e02f05cf8fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_us-gaap_NatureOfExpenseAxis_588398ad-c380-42ed-afbc-3e02f05cf8fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_588398ad-c380-42ed-afbc-3e02f05cf8fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_588398ad-c380-42ed-afbc-3e02f05cf8fb" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_588398ad-c380-42ed-afbc-3e02f05cf8fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4b48787e-9f72-4eae-87d2-b6970fecd3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_588398ad-c380-42ed-afbc-3e02f05cf8fb" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4b48787e-9f72-4eae-87d2-b6970fecd3e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_cdb701b0-44b7-4033-a2fa-e0756b729d03" xlink:href="wst-20201231.xsd#wst_SmartDoseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4b48787e-9f72-4eae-87d2-b6970fecd3e8" xlink:to="loc_wst_SmartDoseMember_cdb701b0-44b7-4033-a2fa-e0756b729d03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_995b42e1-af26-4859-a628-2cc58c2b5db8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_srt_MajorCustomersAxis_995b42e1-af26-4859-a628-2cc58c2b5db8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_995b42e1-af26-4859-a628-2cc58c2b5db8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_995b42e1-af26-4859-a628-2cc58c2b5db8" xlink:to="loc_srt_NameOfMajorCustomerDomain_995b42e1-af26-4859-a628-2cc58c2b5db8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_995b42e1-af26-4859-a628-2cc58c2b5db8" xlink:to="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_b359cda7-4e00-494f-baad-5a58c637aa67" xlink:href="wst-20201231.xsd#wst_BiologicsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_BiologicsCustomersMember_b359cda7-4e00-494f-baad-5a58c637aa67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_300b3e3b-6ff5-4914-b885-e61797ff7db7" xlink:href="wst-20201231.xsd#wst_GenericsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_GenericsCustomersMember_300b3e3b-6ff5-4914-b885-e61797ff7db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_78e95746-6104-4486-8925-a94f727343ba" xlink:href="wst-20201231.xsd#wst_PharmaCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_PharmaCustomersMember_78e95746-6104-4486-8925-a94f727343ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_79566505-cd8b-431e-b354-6d4f85226c8e" xlink:href="wst-20201231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_ContractManufacturedCustomersMember_79566505-cd8b-431e-b354-6d4f85226c8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_srt_ProductOrServiceAxis_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec" xlink:to="loc_srt_ProductsAndServicesDomain_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec" xlink:to="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_67254fff-0dab-445a-bd62-4996622313d4" xlink:href="wst-20201231.xsd#wst_SmartDoseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_SmartDoseMember_67254fff-0dab-445a-bd62-4996622313d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductComponentsMember_8ebaf18b-27a6-47ed-b752-d9c3d33f9323" xlink:href="wst-20201231.xsd#wst_HighValueProductComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_HighValueProductComponentsMember_8ebaf18b-27a6-47ed-b752-d9c3d33f9323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductDeliveryDevicesMember_fb21e873-35a8-49c0-80af-e8865d96747d" xlink:href="wst-20201231.xsd#wst_HighValueProductDeliveryDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_HighValueProductDeliveryDevicesMember_fb21e873-35a8-49c0-80af-e8865d96747d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_323786b0-6b48-4247-894d-aa5393d9ea94" xlink:href="wst-20201231.xsd#wst_StandardPackagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_StandardPackagingMember_323786b0-6b48-4247-894d-aa5393d9ea94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_f5d2f9cd-7e6a-4b71-a00d-7607eb272e24" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_ContractManufacturedProductsMember_f5d2f9cd-7e6a-4b71-a00d-7607eb272e24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4706b5ae-8b5b-4f66-9691-20e9a1b88edc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_srt_StatementGeographicalAxis_4706b5ae-8b5b-4f66-9691-20e9a1b88edc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4706b5ae-8b5b-4f66-9691-20e9a1b88edc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4706b5ae-8b5b-4f66-9691-20e9a1b88edc" xlink:to="loc_srt_SegmentGeographicalDomain_4706b5ae-8b5b-4f66-9691-20e9a1b88edc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4706b5ae-8b5b-4f66-9691-20e9a1b88edc" xlink:to="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_90066435-9110-49f7-b21c-5ccdc6f0e1da" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:to="loc_srt_AmericasMember_90066435-9110-49f7-b21c-5ccdc6f0e1da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_512189da-dc74-4cb2-9075-a3a84537335c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:to="loc_us-gaap_EMEAMember_512189da-dc74-4cb2-9075-a3a84537335c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c97dd1fc-b783-4efe-8d65-bec3214fa53f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:to="loc_srt_AsiaPacificMember_c97dd1fc-b783-4efe-8d65-bec3214fa53f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6e2732f3-2b9e-470b-a3e9-44965d41dc7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6e2732f3-2b9e-470b-a3e9-44965d41dc7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e2732f3-2b9e-470b-a3e9-44965d41dc7f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6e2732f3-2b9e-470b-a3e9-44965d41dc7f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e2732f3-2b9e-470b-a3e9-44965d41dc7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5d795b8-b754-45aa-937e-fd0340e5b8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6e2732f3-2b9e-470b-a3e9-44965d41dc7f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5d795b8-b754-45aa-937e-fd0340e5b8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_3090649a-1dc0-4829-8764-584064ee4886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5d795b8-b754-45aa-937e-fd0340e5b8f1" xlink:to="loc_us-gaap_SalesRevenueNetMember_3090649a-1dc0-4829-8764-584064ee4886" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_404cdf93-391d-4668-ae60-521932945be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_404cdf93-391d-4668-ae60-521932945be6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_404cdf93-391d-4668-ae60-521932945be6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_404cdf93-391d-4668-ae60-521932945be6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_404cdf93-391d-4668-ae60-521932945be6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_404cdf93-391d-4668-ae60-521932945be6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_76cf6940-3d37-47a9-a7a8-51ff7cab104f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_76cf6940-3d37-47a9-a7a8-51ff7cab104f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_f7941d42-b543-407b-a7ba-05fcdcdd2cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_f7941d42-b543-407b-a7ba-05fcdcdd2cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_82162e91-25c0-47e6-8000-89ae70ceb050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_82162e91-25c0-47e6-8000-89ae70ceb050" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="extended" id="i4f0d0c907f7147629cad20b107803623_RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueContractsandLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="extended" id="ia40c44b3b7fc43a0afc7e13d4617d22f_RevenueContractsandLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRecognitionPeriod_f1d41f8b-1e9b-45cc-aecc-1f39cf0eb9a4" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRecognitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:to="loc_wst_ContractWithCustomerLiabilityRecognitionPeriod_f1d41f8b-1e9b-45cc-aecc-1f39cf0eb9a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_188c0460-aef1-4164-bfe1-ae4c1ef1fb7a" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:to="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_188c0460-aef1-4164-bfe1-ae4c1ef1fb7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod_a44b184f-6985-425b-87f9-20ccfdb60d97" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:to="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod_a44b184f-6985-425b-87f9-20ccfdb60d97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_74d8d7d3-de47-443e-b701-c38dea6e944c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_74d8d7d3-de47-443e-b701-c38dea6e944c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c761ba2d-ad3a-42af-b888-652d36ad2b49" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74d8d7d3-de47-443e-b701-c38dea6e944c" xlink:to="loc_srt_RangeAxis_c761ba2d-ad3a-42af-b888-652d36ad2b49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c761ba2d-ad3a-42af-b888-652d36ad2b49_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c761ba2d-ad3a-42af-b888-652d36ad2b49" xlink:to="loc_srt_RangeMember_c761ba2d-ad3a-42af-b888-652d36ad2b49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c761ba2d-ad3a-42af-b888-652d36ad2b49" xlink:to="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_126d6830-ec8a-4a89-bfec-c56ed1399a0d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:to="loc_srt_MinimumMember_126d6830-ec8a-4a89-bfec-c56ed1399a0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cb0f893-2b15-4ef5-88b6-278f553d9938" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:to="loc_srt_MaximumMember_5cb0f893-2b15-4ef5-88b6-278f553d9938" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueSupplyChainFinancingDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="extended" id="i48f4045d1c6d457d8ca69ac2cfe049c1_RevenueSupplyChainFinancingDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueVoluntaryRecallDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="extended" id="i69e57fbed78147d59b3e203197470ccf_RevenueVoluntaryRecallDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShare"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended" id="ice15ad6e553a426fa2ff9a756a874f2d_NetIncomePerShare"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShareTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended" id="i39584469581a4e80a79548f149cadb52_NetIncomePerShareTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="extended" id="i86e4893c20bf42feb57b45c59fbc3cc6_NetIncomePerShareDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipment"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="extended" id="i6d0ac8abd1754218b71f34c5970fc4b5_PropertyPlantandEquipment"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended" id="i8b548ef31e3743a997311e7919a81721_PropertyPlantandEquipmentTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended" id="i1767a58fc57b4f2aa6e289b20402e293_PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d2f1d7ce-b54f-4785-9124-a0cb63681a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d2f1d7ce-b54f-4785-9124-a0cb63681a6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c0794fcb-ef31-469f-ba28-70b6b809f74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c0794fcb-ef31-469f-ba28-70b6b809f74a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935c1f71-35f8-47f4-9f67-6e4f57338e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935c1f71-35f8-47f4-9f67-6e4f57338e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_935c1f71-35f8-47f4-9f67-6e4f57338e08_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935c1f71-35f8-47f4-9f67-6e4f57338e08" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_935c1f71-35f8-47f4-9f67-6e4f57338e08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935c1f71-35f8-47f4-9f67-6e4f57338e08" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_dab1b982-f470-4e55-a269-e754b00acb4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_LandMember_dab1b982-f470-4e55-a269-e754b00acb4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_c6f0a4bc-163a-4ed2-b558-acd6a27ef0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_c6f0a4bc-163a-4ed2-b558-acd6a27ef0e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1e7949d0-4d37-4268-b957-6f613e985b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1e7949d0-4d37-4268-b957-6f613e985b4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_44eed4ce-4976-4e05-907c-2be702053d72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_44eed4ce-4976-4e05-907c-2be702053d72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember_15c8d6ef-b9fa-4b77-8fe6-7e32d1eb4658" xlink:href="wst-20201231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_wst_ComputerHardwareAndSoftwareMember_15c8d6ef-b9fa-4b77-8fe6-7e32d1eb4658" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_d9a20365-fdaf-4719-a1dd-c406105c4ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_ConstructionInProgressMember_d9a20365-fdaf-4719-a1dd-c406105c4ed9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7140a34f-7da7-4c75-94fa-0b246c8fdc10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:to="loc_srt_RangeAxis_7140a34f-7da7-4c75-94fa-0b246c8fdc10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7140a34f-7da7-4c75-94fa-0b246c8fdc10_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7140a34f-7da7-4c75-94fa-0b246c8fdc10" xlink:to="loc_srt_RangeMember_7140a34f-7da7-4c75-94fa-0b246c8fdc10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7140a34f-7da7-4c75-94fa-0b246c8fdc10" xlink:to="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5274249c-ecbe-4a6d-b3b5-2df39e9f3d79" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:to="loc_srt_MinimumMember_5274249c-ecbe-4a6d-b3b5-2df39e9f3d79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8fb65b2f-8bab-41a0-aeed-5cf4a5b5b5b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:to="loc_srt_MaximumMember_8fb65b2f-8bab-41a0-aeed-5cf4a5b5b5b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended" id="i2fd8baa60079417cbb1ac43cd358e206_PropertyPlantandEquipmentNarrativeDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended" id="ib13ad959c23a40b980a1d7fcca66020a_Leases"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended" id="i45d97e3eeb6042128456686a230a6180_LeasesTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesAdoptionofASC842Details" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesAdoptionofASC842Details"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesAdoptionofASC842Details" xlink:type="extended" id="i9ca73eef086c42c8b6aabc11e660271a_LeasesAdoptionofASC842Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_7caa72e0-5920-49fd-baf5-7031a3d0a7e9" xlink:href="wst-20201231.xsd#wst_LesseeOperatingLeaseOptionToTerminateTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:to="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_7caa72e0-5920-49fd-baf5-7031a3d0a7e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_26265de5-0b38-4807-9b85-f24f2264dac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:to="loc_us-gaap_FinanceLeaseLiability_26265de5-0b38-4807-9b85-f24f2264dac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fe50e33-a058-433f-aa05-40cbce85957c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fe50e33-a058-433f-aa05-40cbce85957c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_66bd4f91-1d0c-4b41-af35-19741d2df49d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_66bd4f91-1d0c-4b41-af35-19741d2df49d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_38224f20-c00b-43ff-8019-b307b081356b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_66bd4f91-1d0c-4b41-af35-19741d2df49d" xlink:to="loc_srt_RangeAxis_38224f20-c00b-43ff-8019-b307b081356b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38224f20-c00b-43ff-8019-b307b081356b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_38224f20-c00b-43ff-8019-b307b081356b" xlink:to="loc_srt_RangeMember_38224f20-c00b-43ff-8019-b307b081356b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ab86450-b34b-4221-8800-8e968b0bee0f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_38224f20-c00b-43ff-8019-b307b081356b" xlink:to="loc_srt_RangeMember_1ab86450-b34b-4221-8800-8e968b0bee0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_76c12001-1f66-4e5b-b711-920e16bcbcdd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1ab86450-b34b-4221-8800-8e968b0bee0f" xlink:to="loc_srt_MaximumMember_76c12001-1f66-4e5b-b711-920e16bcbcdd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseCostDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended" id="i6ae0fe01680f4618af813e33a4249c66_LeasesLeaseCostDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseCashFlowandSupplementalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="extended" id="ib8282469b364471cbbb0dd51b01dbca3_LeasesLeaseCashFlowandSupplementalInformationDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseWeightedAverageDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="extended" id="icd48c074be8d498d90181a1ad28ef1b0_LeasesLeaseWeightedAverageDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended" id="i8c3ead70b63e4fb3a5513b0f58b25d52_LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompanies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended" id="i55daf6f75bdd487d93c1f8089a5d6770_AffiliatedCompanies"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="extended" id="ic2c84e7df6da43a8a568d2d5ffa29ff2_AffiliatedCompaniesTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesScheduleofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="extended" id="i860007cf916e48e38e74b2c5be62eb5e_AffiliatedCompaniesScheduleofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1665bf9d-bc7c-4166-859d-767426e1e0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_522c58d5-3689-49da-8b5d-d614070d51b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1665bf9d-bc7c-4166-859d-767426e1e0b3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_522c58d5-3689-49da-8b5d-d614070d51b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_33ecf7df-00d9-44b7-9184-3346b669847e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1665bf9d-bc7c-4166-859d-767426e1e0b3" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_33ecf7df-00d9-44b7-9184-3346b669847e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b270b4a5-e794-41a6-9953-844a0ebd84ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_33ecf7df-00d9-44b7-9184-3346b669847e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b270b4a5-e794-41a6-9953-844a0ebd84ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b270b4a5-e794-41a6-9953-844a0ebd84ac_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b270b4a5-e794-41a6-9953-844a0ebd84ac" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b270b4a5-e794-41a6-9953-844a0ebd84ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b270b4a5-e794-41a6-9953-844a0ebd84ac" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember_abb3f72e-8326-4572-846a-7d9faa327d4c" xlink:href="wst-20201231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_WestCompanyMexicoSADeCVMember_abb3f72e-8326-4572-846a-7d9faa327d4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember_49cf7339-3d7e-4fde-8994-e49a6ba347cd" xlink:href="wst-20201231.xsd#wst_AluplastSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_AluplastSADeCVMember_49cf7339-3d7e-4fde-8994-e49a6ba347cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember_2c9d9b28-7f49-4f90-af81-925316e0e206" xlink:href="wst-20201231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_PharmaTapSADeCVMember_2c9d9b28-7f49-4f90-af81-925316e0e206" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember_f5bb9ca3-6363-48d7-b69b-cabf188f3546" xlink:href="wst-20201231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_PharmaRubberSADeCVMember_f5bb9ca3-6363-48d7-b69b-cabf188f3546" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IWPharmaGroupLLCMember_9f5df507-032d-4de8-8c0f-83aab92a533f" xlink:href="wst-20201231.xsd#wst_IWPharmaGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_IWPharmaGroupLLCMember_9f5df507-032d-4de8-8c0f-83aab92a533f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_0f1cf6c3-d6a9-4710-9cb6-018ceff55fbe" xlink:href="wst-20201231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_0f1cf6c3-d6a9-4710-9cb6-018ceff55fbe" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="extended" id="i4e10fafb0b8e4245b0f8906ad426c299_AffiliatedCompaniesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_775d9d2e-bc79-4833-a2e0-1d99adfeb487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_775d9d2e-bc79-4833-a2e0-1d99adfeb487" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_05e1bb97-119b-41ac-85da-90e213596437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_05e1bb97-119b-41ac-85da-90e213596437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_6b1b3246-7ec1-4b79-99f9-f657925d1d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_6b1b3246-7ec1-4b79-99f9-f657925d1d14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_e6c3075d-8ff9-4a05-99ec-0a786c692c84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_e6c3075d-8ff9-4a05-99ec-0a786c692c84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d3bd74b8-5ec4-4215-bb5e-7fab7c614b74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d3bd74b8-5ec4-4215-bb5e-7fab7c614b74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_cf5e4b59-3793-4a9a-a8a8-84cc4e5baf5e" xlink:href="wst-20201231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_cf5e4b59-3793-4a9a-a8a8-84cc4e5baf5e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_12e6a7c3-70e5-4adc-a32e-9cfde74c8f36" xlink:href="wst-20201231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_12e6a7c3-70e5-4adc-a32e-9cfde74c8f36" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_06409c0e-6cdf-42a4-9b12-ee2afadfe8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_06409c0e-6cdf-42a4-9b12-ee2afadfe8e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees_a420fcbf-cbb9-433f-aeb6-ff6ebf16adb9" xlink:href="wst-20201231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_wst_SalesToEquityMethodInvestees_a420fcbf-cbb9-433f-aeb6-ff6ebf16adb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_bc2229f4-a727-45ef-b056-be0779a573c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_DueFromAffiliates_bc2229f4-a727-45ef-b056-be0779a573c1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0d07d3b4-2803-4e12-9553-3f1b6cec6d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquityMethodInvestments_0d07d3b4-2803-4e12-9553-3f1b6cec6d6e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7f4c8e6e-4609-4e99-92ae-251c7438b1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7f4c8e6e-4609-4e99-92ae-251c7438b1ee" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_425aa0a5-e248-40dd-ba87-bf34efa1f2e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_425aa0a5-e248-40dd-ba87-bf34efa1f2e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_69249797-c0eb-4e62-812d-de3b04eb20fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_425aa0a5-e248-40dd-ba87-bf34efa1f2e2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_69249797-c0eb-4e62-812d-de3b04eb20fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_69249797-c0eb-4e62-812d-de3b04eb20fd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_69249797-c0eb-4e62-812d-de3b04eb20fd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_69249797-c0eb-4e62-812d-de3b04eb20fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4c445241-fa7d-46fd-b3bc-13839b33978f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_69249797-c0eb-4e62-812d-de3b04eb20fd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4c445241-fa7d-46fd-b3bc-13839b33978f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_94c52c51-a921-4aaf-aea8-4d53cb656f03" xlink:href="wst-20201231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c445241-fa7d-46fd-b3bc-13839b33978f" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_94c52c51-a921-4aaf-aea8-4d53cb656f03" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended" id="ifdcb9b73a5c94dc78beeb756ca505654_GoodwillandIntangibleAssets"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended" id="i72c049445cb74d7a87c7bdbd962dc4ec_GoodwillandIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i0692b8d51a49427a9fb38f4c25af61a0_GoodwillandIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5724543a-98a1-4362-8b69-ebfd2a887ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5724543a-98a1-4362-8b69-ebfd2a887ae0" xlink:to="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_42d4f7ab-fe72-4b46-b51b-13e85157a2ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:to="loc_us-gaap_Goodwill_42d4f7ab-fe72-4b46-b51b-13e85157a2ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f8c8d876-1503-4b60-9798-2b889cf317ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f8c8d876-1503-4b60-9798-2b889cf317ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_97b8f2ba-5f0c-4181-97ca-7ed2c43a1e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_97b8f2ba-5f0c-4181-97ca-7ed2c43a1e5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4a5771f9-3f77-41aa-9d0b-7610c15d8026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ee3935ca-4105-40f8-81cc-007f0c896786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_5724543a-98a1-4362-8b69-ebfd2a887ae0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ee3935ca-4105-40f8-81cc-007f0c896786" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0669c54d-5c7b-4921-84a3-9f279e6dd453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ee3935ca-4105-40f8-81cc-007f0c896786" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0669c54d-5c7b-4921-84a3-9f279e6dd453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0669c54d-5c7b-4921-84a3-9f279e6dd453_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0669c54d-5c7b-4921-84a3-9f279e6dd453" xlink:to="loc_us-gaap_SegmentDomain_0669c54d-5c7b-4921-84a3-9f279e6dd453_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0669c54d-5c7b-4921-84a3-9f279e6dd453" xlink:to="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_07a9325f-c96d-43ee-9cbd-5d63316affea" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:to="loc_wst_ProprietaryProductsMember_07a9325f-c96d-43ee-9cbd-5d63316affea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_4a6fdd54-1ee8-49ee-bb0a-aeb1d4de4338" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:to="loc_wst_ContractManufacturedProductsMember_4a6fdd54-1ee8-49ee-bb0a-aeb1d4de4338" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i98a1fcc760194b219fa9b60cfb66805d_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d595a9ed-3340-4b23-978a-546934cb9875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d595a9ed-3340-4b23-978a-546934cb9875" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_07b2d96f-3184-4540-b1dd-49396fe7f2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_07b2d96f-3184-4540-b1dd-49396fe7f2d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_461ff77c-5c2b-4e9c-832d-04f3287faabd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_461ff77c-5c2b-4e9c-832d-04f3287faabd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_76529295-cf2d-40bf-8219-cdaa8423c294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_76529295-cf2d-40bf-8219-cdaa8423c294" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_d39afb30-7150-4634-a54e-ad365ea1a4d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_d39afb30-7150-4634-a54e-ad365ea1a4d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d77dbd0c-b20d-44f8-8b57-26e1dddf7559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d77dbd0c-b20d-44f8-8b57-26e1dddf7559" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d6ee0a34-c09f-4aa9-b7c3-d9bcdb56e4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d6ee0a34-c09f-4aa9-b7c3-d9bcdb56e4a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6e112f75-d3b1-4495-b5aa-a71848d64044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6e112f75-d3b1-4495-b5aa-a71848d64044" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4c278c07-ba37-4b92-a7b1-9a295323b836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4c278c07-ba37-4b92-a7b1-9a295323b836" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f44fd5cc-6e2a-4e6b-8dce-abcb0c2af59d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f44fd5cc-6e2a-4e6b-8dce-abcb0c2af59d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_540f4db5-c980-4924-a7ea-15274c306ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_540f4db5-c980-4924-a7ea-15274c306ee8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03713ad6-5536-4ec3-b6de-79c6f276b7ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03713ad6-5536-4ec3-b6de-79c6f276b7ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SouthKoreaDistributorMember_8584b8b5-50ff-4a79-9beb-5255b01fd560" xlink:href="wst-20201231.xsd#wst_SouthKoreaDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03713ad6-5536-4ec3-b6de-79c6f276b7ee" xlink:to="loc_wst_SouthKoreaDistributorMember_8584b8b5-50ff-4a79-9beb-5255b01fd560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd1f7d59-2a4a-4d37-8653-bb830c6f5358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd1f7d59-2a4a-4d37-8653-bb830c6f5358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7d4c7b93-3b52-4331-89ef-396845fba81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd1f7d59-2a4a-4d37-8653-bb830c6f5358" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7d4c7b93-3b52-4331-89ef-396845fba81f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3bd002c7-4e1f-4790-9f28-ba5cd47557c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3bd002c7-4e1f-4790-9f28-ba5cd47557c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3bd002c7-4e1f-4790-9f28-ba5cd47557c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3bd002c7-4e1f-4790-9f28-ba5cd47557c2" xlink:to="loc_us-gaap_SegmentDomain_3bd002c7-4e1f-4790-9f28-ba5cd47557c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc0f73ec-b9ac-42c6-b2e7-e1c6d35b23e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3bd002c7-4e1f-4790-9f28-ba5cd47557c2" xlink:to="loc_us-gaap_SegmentDomain_fc0f73ec-b9ac-42c6-b2e7-e1c6d35b23e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_430dd0c2-eb65-466e-86f2-f69ae11e65bd" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fc0f73ec-b9ac-42c6-b2e7-e1c6d35b23e8" xlink:to="loc_wst_ProprietaryProductsMember_430dd0c2-eb65-466e-86f2-f69ae11e65bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended" id="ie182ddbf0f8145b6b5f277cfa43d569b_GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails">
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9062d040-95fb-45f2-a0c4-00c5a61c89b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9062d040-95fb-45f2-a0c4-00c5a61c89b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_51911251-b694-432b-ac8a-14c9bf9cdc00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_51911251-b694-432b-ac8a-14c9bf9cdc00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a6dad66-5b7e-489f-bea2-becdaac2edee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a6dad66-5b7e-489f-bea2-becdaac2edee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_54deb49a-96ba-4c6c-b942-07b4c38fe8ad" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_54deb49a-96ba-4c6c-b942-07b4c38fe8ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_116ff164-a7fc-44b2-bf1b-ded99bb074e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_54deb49a-96ba-4c6c-b942-07b4c38fe8ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_116ff164-a7fc-44b2-bf1b-ded99bb074e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_116ff164-a7fc-44b2-bf1b-ded99bb074e9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_116ff164-a7fc-44b2-bf1b-ded99bb074e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_116ff164-a7fc-44b2-bf1b-ded99bb074e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_116ff164-a7fc-44b2-bf1b-ded99bb074e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember_5ddd33dd-3583-4de5-8d3d-2f5c57a63c78" xlink:href="wst-20201231.xsd#wst_PatentsAndLicensingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_wst_PatentsAndLicensingMember_5ddd33dd-3583-4de5-8d3d-2f5c57a63c78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_3082d4d0-36b1-4f9d-adc2-3efaa1d70ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_3082d4d0-36b1-4f9d-adc2-3efaa1d70ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4118c575-0cbb-45d1-9643-a7ef419cd35e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_TrademarksMember_4118c575-0cbb-45d1-9643-a7ef419cd35e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a5bee8bd-a0d2-4be9-96b8-35094643c1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a5bee8bd-a0d2-4be9-96b8-35094643c1f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_b9397f78-5052-47a7-959b-0b74804d0733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_CustomerContractsMember_b9397f78-5052-47a7-959b-0b74804d0733" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilities"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="extended" id="i24902e93645c48a59c7fa352c5efaa1a_OtherCurrentLiabilities"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended" id="i31c0f9c95f0b4eb9ada0e29e62b22537_OtherCurrentLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended" id="i705c30c71f7949e7a952696f46331210_OtherCurrentLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20201231.xsd#Debt"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended" id="i41f0ebd8e1184dda9751c947d0a037ba_Debt"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended" id="if3a877ee8f604bc78c4dbb0d0426a527_DebtTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="extended" id="ieeb35f35a5244a08b623761d86fea1de_DebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a50daca4-e1d3-480e-b0ca-c93ed2c0d0e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a50daca4-e1d3-480e-b0ca-c93ed2c0d0e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_494d691a-0312-4b92-b1d7-3facd0a5ad70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_494d691a-0312-4b92-b1d7-3facd0a5ad70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_4c7d71c5-b0a4-4ecc-b268-0a854bf3db65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_4c7d71c5-b0a4-4ecc-b268-0a854bf3db65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c404dd7c-7250-4702-a641-4807bb605699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_LongTermDebt_c404dd7c-7250-4702-a641-4807bb605699" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_eb3f32eb-8f13-41ad-8056-55a2705e7461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_LongTermDebtCurrent_eb3f32eb-8f13-41ad-8056-55a2705e7461" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_dac3694d-4f21-4028-9b4f-8776653022ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_dac3694d-4f21-4028-9b4f-8776653022ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b3392ec4-acde-4dab-a85d-d256f7c4e70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_DebtInstrumentTable_b3392ec4-acde-4dab-a85d-d256f7c4e70c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b3392ec4-acde-4dab-a85d-d256f7c4e70c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_fe46fa7a-fb35-4685-90b5-0b9a0cea1164" xlink:href="wst-20201231.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_TermLoanDue2024Member_fe46fa7a-fb35-4685-90b5-0b9a0cea1164" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_b2cb8b33-6620-41b4-9dc9-ea2f82a41d5e" xlink:href="wst-20201231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_SeniorNotesDue2022Member_b2cb8b33-6620-41b4-9dc9-ea2f82a41d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_612dca3e-d568-491b-8ad3-5a6db5bd5145" xlink:href="wst-20201231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_SeniorBNotesDue2024Member_612dca3e-d568-491b-8ad3-5a6db5bd5145" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_0bdc0170-01bc-4a83-aeb4-1ee5193b3ecd" xlink:href="wst-20201231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_SeniorCNotesDue2027Member_0bdc0170-01bc-4a83-aeb4-1ee5193b3ecd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="extended" id="iabaed713d548431d94d12f78ed96d6d4_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_2bc4fce1-6cf0-46c5-bb9b-4944bcc5ca76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_2bc4fce1-6cf0-46c5-bb9b-4944bcc5ca76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_3e643080-8e69-447c-a5fc-231e27dfb8ed" xlink:href="wst-20201231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_3e643080-8e69-447c-a5fc-231e27dfb8ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_03f85d00-d370-4b4d-a6b6-16952fc8306b" xlink:href="wst-20201231.xsd#wst_CreditAvailableForIssuanceOfLettersOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_03f85d00-d370-4b4d-a6b6-16952fc8306b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c1dcb905-4082-4b3f-9255-f0ebf1469621" xlink:href="wst-20201231.xsd#wst_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c1dcb905-4082-4b3f-9255-f0ebf1469621" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a5b4d71-f281-4bce-9768-8f2f650fdffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a5b4d71-f281-4bce-9768-8f2f650fdffa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RatioOfDebtToEBITDA_6020ccd7-f39f-4473-8eb7-1635f5a7a12a" xlink:href="wst-20201231.xsd#wst_RatioOfDebtToEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_RatioOfDebtToEBITDA_6020ccd7-f39f-4473-8eb7-1635f5a7a12a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_fe5af9b4-eaf7-45c6-8767-9e3771491517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_fe5af9b4-eaf7-45c6-8767-9e3771491517" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_6618cec6-fb9a-48ae-9a28-7d6c7a36e115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermLineOfCredit_6618cec6-fb9a-48ae-9a28-7d6c7a36e115" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_575a2660-a75e-417f-9f30-fe679cb72663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LineOfCredit_575a2660-a75e-417f-9f30-fe679cb72663" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d79da60a-8bf5-48d1-a6b9-766bd1de740a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d79da60a-8bf5-48d1-a6b9-766bd1de740a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7c16738d-8948-497d-852d-3a77fe369703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7c16738d-8948-497d-852d-3a77fe369703" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_516f7f3f-c599-49a5-809f-2da0207d84ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_516f7f3f-c599-49a5-809f-2da0207d84ec" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8a0e1b77-6b99-43d7-9583-482a93ae447d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermDebtCurrent_8a0e1b77-6b99-43d7-9583-482a93ae447d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2337ca37-abf7-455e-82ed-e9a48c0802c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2337ca37-abf7-455e-82ed-e9a48c0802c4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfTranches_cf8873b6-7382-424a-949f-dff3ebc4baff" xlink:href="wst-20201231.xsd#wst_DebtInstrumentNumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_DebtInstrumentNumberOfTranches_cf8873b6-7382-424a-949f-dff3ebc4baff" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f4f94b8-57f8-482e-bcfc-d8cb8dfc4401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f4f94b8-57f8-482e-bcfc-d8cb8dfc4401" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1175087f-840b-4124-9ddd-ffbb156e4b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1175087f-840b-4124-9ddd-ffbb156e4b7e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_aaf365b4-2354-4d1a-b8e3-7b7260390fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_aaf365b4-2354-4d1a-b8e3-7b7260390fb0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_4133bdf5-41a6-4937-a302-c0c70d3d83fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_4133bdf5-41a6-4937-a302-c0c70d3d83fd" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_673d7c75-80fc-455a-8acb-1430c164c84e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_InterestExpenseDebt_673d7c75-80fc-455a-8acb-1430c164c84e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8d883e62-cbcc-48f4-b97e-494f107d48a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8d883e62-cbcc-48f4-b97e-494f107d48a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e275b08-7867-46aa-aef1-769970e1fa57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e275b08-7867-46aa-aef1-769970e1fa57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ab8e400d-3454-4b26-83d5-e533735d285f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ab8e400d-3454-4b26-83d5-e533735d285f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_00b75d94-27bc-4e11-9221-adf2b4d25c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_00b75d94-27bc-4e11-9221-adf2b4d25c7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3e646ebf-e2ba-4e14-b6d0-9d2adc9d3326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3e646ebf-e2ba-4e14-b6d0-9d2adc9d3326" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_be4cc1b9-1aed-43f7-b649-fa639c885471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_be4cc1b9-1aed-43f7-b649-fa639c885471" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9058f002-3614-42fa-9b63-4a6d521416ce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_srt_RangeAxis_9058f002-3614-42fa-9b63-4a6d521416ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9058f002-3614-42fa-9b63-4a6d521416ce_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9058f002-3614-42fa-9b63-4a6d521416ce" xlink:to="loc_srt_RangeMember_9058f002-3614-42fa-9b63-4a6d521416ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9058f002-3614-42fa-9b63-4a6d521416ce" xlink:to="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff422752-571f-42db-a5d1-4631a62cf165" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:to="loc_srt_MinimumMember_ff422752-571f-42db-a5d1-4631a62cf165" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d044076e-7644-4125-89e9-275d08388769" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:to="loc_srt_MaximumMember_d044076e-7644-4125-89e9-275d08388769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f3f7e292-9a20-41d1-891f-3bde27ceeeb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_us-gaap_CreditFacilityAxis_f3f7e292-9a20-41d1-891f-3bde27ceeeb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f3f7e292-9a20-41d1-891f-3bde27ceeeb8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f3f7e292-9a20-41d1-891f-3bde27ceeeb8" xlink:to="loc_us-gaap_CreditFacilityDomain_f3f7e292-9a20-41d1-891f-3bde27ceeeb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f3f7e292-9a20-41d1-891f-3bde27ceeeb8" xlink:to="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_9c99258c-82bb-4832-914b-4c4805a3187f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_9c99258c-82bb-4832-914b-4c4805a3187f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_073c739b-da9d-4e43-a4f1-e865a95e8058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_073c739b-da9d-4e43-a4f1-e865a95e8058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_23c6c5cf-f3fb-4fcb-ad92-54af91763599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_23c6c5cf-f3fb-4fcb-ad92-54af91763599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_cd6cf2b8-e8a5-46a9-89b4-1ef0b81515d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_BaseRateMember_cd6cf2b8-e8a5-46a9-89b4-1ef0b81515d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c786b1ca-5995-4e8e-8e85-da72a86b6def" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c786b1ca-5995-4e8e-8e85-da72a86b6def" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b7860960-0710-48fe-a1cf-09e0d29a331f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_LetterOfCreditMember_b7860960-0710-48fe-a1cf-09e0d29a331f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_723eb4f1-caa2-4260-9e34-65e16953db5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_723eb4f1-caa2-4260-9e34-65e16953db5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_723eb4f1-caa2-4260-9e34-65e16953db5f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_723eb4f1-caa2-4260-9e34-65e16953db5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_723eb4f1-caa2-4260-9e34-65e16953db5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_723eb4f1-caa2-4260-9e34-65e16953db5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_6d64c65b-c39b-4c19-aec6-00ced244946c" xlink:href="wst-20201231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_6d64c65b-c39b-4c19-aec6-00ced244946c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_e1d7af1c-5e07-49e7-8587-746d1e3fde54" xlink:href="wst-20201231.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:to="loc_wst_TermLoanDue2024Member_e1d7af1c-5e07-49e7-8587-746d1e3fde54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0c20b589-2453-462c-92ea-a2860e74314f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:to="loc_us-gaap_SeniorNotesMember_0c20b589-2453-462c-92ea-a2860e74314f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_us-gaap_DebtInstrumentAxis_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_83641fff-54d8-4f4d-8ab5-641182ffbe54" xlink:href="wst-20201231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:to="loc_wst_SeniorNotesDue2022Member_83641fff-54d8-4f4d-8ab5-641182ffbe54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_7d5f2cd7-852f-424c-8d8a-770cb1f9d570" xlink:href="wst-20201231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:to="loc_wst_SeniorBNotesDue2024Member_7d5f2cd7-852f-424c-8d8a-770cb1f9d570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_434f05d3-82e6-4ddc-bdf7-049fd9088502" xlink:href="wst-20201231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:to="loc_wst_SeniorCNotesDue2027Member_434f05d3-82e6-4ddc-bdf7-049fd9088502" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended" id="ie3732cd9deab45a8827d98ec9e9d48e5_DerivativeFinancialInstruments"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended" id="ie16331aee3e44b87aa8a47dba3d21f8c_DerivativeFinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended" id="icf9d7517d13c444e8603a65b07d639b3_DerivativeFinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f6e84b7b-d6a6-4ecd-b92a-6b52ac31a4ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f6e84b7b-d6a6-4ecd-b92a-6b52ac31a4ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_afdd56f5-87da-4d6b-97cf-95eaf4199a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeTermOfContract_afdd56f5-87da-4d6b-97cf-95eaf4199a80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_eec86920-57e6-4393-9078-667c1f43db01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_eec86920-57e6-4393-9078-667c1f43db01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_efb3fdcf-5850-46e8-9cac-9b885b38822b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_efb3fdcf-5850-46e8-9cac-9b885b38822b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_5c107e8d-9c74-4775-afdb-1a3060cdc620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_5c107e8d-9c74-4775-afdb-1a3060cdc620" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_005adbb8-ed62-4734-bd17-ebdf1bf1a9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_005adbb8-ed62-4734-bd17-ebdf1bf1a9ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_af2f69d7-dd6c-4298-a86f-f069e6c325ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_af2f69d7-dd6c-4298-a86f-f069e6c325ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_af2f69d7-dd6c-4298-a86f-f069e6c325ff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_af2f69d7-dd6c-4298-a86f-f069e6c325ff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_af2f69d7-dd6c-4298-a86f-f069e6c325ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_af2f69d7-dd6c-4298-a86f-f069e6c325ff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_9c632f0f-7873-4c17-b5cc-3f5fb70a7e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_OptionMember_9c632f0f-7873-4c17-b5cc-3f5fb70a7e9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_b0095cd3-24c1-4580-a6c6-14bd5e97b1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_ForwardContractsMember_b0095cd3-24c1-4580-a6c6-14bd5e97b1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_dc2e67f4-da6f-49c5-932a-3e25f89c0d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_dc2e67f4-da6f-49c5-932a-3e25f89c0d13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_48e03cf9-17cf-4da5-93ba-01cb6c8182c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_48e03cf9-17cf-4da5-93ba-01cb6c8182c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bc24c93-6982-4bc6-815a-4fe57b37d826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bc24c93-6982-4bc6-815a-4fe57b37d826" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7bc24c93-6982-4bc6-815a-4fe57b37d826_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bc24c93-6982-4bc6-815a-4fe57b37d826" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7bc24c93-6982-4bc6-815a-4fe57b37d826_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bc24c93-6982-4bc6-815a-4fe57b37d826" xlink:to="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_e3e1b73a-c0e7-4b46-b785-becfcc429863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:to="loc_us-gaap_FairValueHedgingMember_e3e1b73a-c0e7-4b46-b785-becfcc429863" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_239d7338-7df5-42e5-b53e-6c0537103324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_239d7338-7df5-42e5-b53e-6c0537103324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_36a3b9b9-aad8-433c-98e9-e58aee8781a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EnergyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_EnergyAxis_36a3b9b9-aad8-433c-98e9-e58aee8781a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_36a3b9b9-aad8-433c-98e9-e58aee8781a3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_EnergyAxis_36a3b9b9-aad8-433c-98e9-e58aee8781a3" xlink:to="loc_srt_EnergyDomain_36a3b9b9-aad8-433c-98e9-e58aee8781a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_f5110d10-707a-4e9d-9361-42149e0621ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_EnergyAxis_36a3b9b9-aad8-433c-98e9-e58aee8781a3" xlink:to="loc_srt_EnergyDomain_f5110d10-707a-4e9d-9361-42149e0621ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e2d5b529-a07f-41a1-a87e-3c4237cdf7db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_VariableRateAxis_e2d5b529-a07f-41a1-a87e-3c4237cdf7db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e2d5b529-a07f-41a1-a87e-3c4237cdf7db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e2d5b529-a07f-41a1-a87e-3c4237cdf7db" xlink:to="loc_us-gaap_VariableRateDomain_e2d5b529-a07f-41a1-a87e-3c4237cdf7db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_05e6f45d-be8d-4beb-b81b-9a9f9cd7248a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e2d5b529-a07f-41a1-a87e-3c4237cdf7db" xlink:to="loc_us-gaap_VariableRateDomain_05e6f45d-be8d-4beb-b81b-9a9f9cd7248a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_8f381b71-08e5-4989-8242-bb6f6117b67f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_PositionAxis_8f381b71-08e5-4989-8242-bb6f6117b67f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_8f381b71-08e5-4989-8242-bb6f6117b67f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_8f381b71-08e5-4989-8242-bb6f6117b67f" xlink:to="loc_us-gaap_PositionDomain_8f381b71-08e5-4989-8242-bb6f6117b67f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_17088fab-6bc8-4d7a-9b4f-d2685e929ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_8f381b71-08e5-4989-8242-bb6f6117b67f" xlink:to="loc_us-gaap_PositionDomain_17088fab-6bc8-4d7a-9b4f-d2685e929ee2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_RangeAxis_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62" xlink:to="loc_srt_RangeMember_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61c552bf-fd35-4b22-8ba2-ba3fff4e03a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62" xlink:to="loc_srt_RangeMember_61c552bf-fd35-4b22-8ba2-ba3fff4e03a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a56d0f54-5339-46ab-a3e6-41cd81066edc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_StatementScenarioAxis_a56d0f54-5339-46ab-a3e6-41cd81066edc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a56d0f54-5339-46ab-a3e6-41cd81066edc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a56d0f54-5339-46ab-a3e6-41cd81066edc" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a56d0f54-5339-46ab-a3e6-41cd81066edc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a70c7537-7413-4168-b985-eb436dea349d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a56d0f54-5339-46ab-a3e6-41cd81066edc" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a70c7537-7413-4168-b985-eb436dea349d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e135c607-837c-4a9f-8a0a-4664747c42b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a70c7537-7413-4168-b985-eb436dea349d" xlink:to="loc_srt_ScenarioForecastMember_e135c607-837c-4a9f-8a0a-4664747c42b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_4e5d9f09-e676-412a-b194-aed1d68107b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_CurrencyAxis_4e5d9f09-e676-412a-b194-aed1d68107b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_4e5d9f09-e676-412a-b194-aed1d68107b8_default" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_4e5d9f09-e676-412a-b194-aed1d68107b8" xlink:to="loc_currency_AllCurrenciesDomain_4e5d9f09-e676-412a-b194-aed1d68107b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_4e5d9f09-e676-412a-b194-aed1d68107b8" xlink:to="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_165d5d8c-0436-429d-8252-1e4d3f899e22" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:to="loc_currency_SGD_165d5d8c-0436-429d-8252-1e4d3f899e22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_6ab77f52-ab30-413d-b0b5-7e6bb994f166" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:to="loc_currency_USD_6ab77f52-ab30-413d-b0b5-7e6bb994f166" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="extended" id="i7cb9a71880474d3596e0e4d3c9c8e159_DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5ff82074-2419-42f3-8971-2bad65546369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_85c548b9-0719-4d6c-ba7e-d4185ac7e0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5ff82074-2419-42f3-8971-2bad65546369" xlink:to="loc_us-gaap_DerivativeNotionalAmount_85c548b9-0719-4d6c-ba7e-d4185ac7e0d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5ff82074-2419-42f3-8971-2bad65546369" xlink:to="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_02a61f6c-f6cd-4d52-8621-e2001f817285" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_srt_CurrencyAxis_02a61f6c-f6cd-4d52-8621-e2001f817285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_02a61f6c-f6cd-4d52-8621-e2001f817285_default" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_02a61f6c-f6cd-4d52-8621-e2001f817285" xlink:to="loc_currency_AllCurrenciesDomain_02a61f6c-f6cd-4d52-8621-e2001f817285_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_02a61f6c-f6cd-4d52-8621-e2001f817285" xlink:to="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_9a155b54-2ff1-4936-acdd-8a8f1db3d3cf" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:to="loc_currency_USD_9a155b54-2ff1-4936-acdd-8a8f1db3d3cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_f2c2709b-8eac-454f-a4d0-989140343636" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:to="loc_currency_JPY_f2c2709b-8eac-454f-a4d0-989140343636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_d219fcf6-fd53-4bf0-ab12-a4674027d69c" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:to="loc_currency_SGD_d219fcf6-fd53-4bf0-ab12-a4674027d69c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e725d2ae-4c85-480e-a800-c39e104a8b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e725d2ae-4c85-480e-a800-c39e104a8b2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e725d2ae-4c85-480e-a800-c39e104a8b2c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e725d2ae-4c85-480e-a800-c39e104a8b2c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e725d2ae-4c85-480e-a800-c39e104a8b2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1fb3a21e-21c1-4d82-b3ca-1dc610fec9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e725d2ae-4c85-480e-a800-c39e104a8b2c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1fb3a21e-21c1-4d82-b3ca-1dc610fec9b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_13ae2beb-90f3-498e-8c1e-21debaf6d0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fb3a21e-21c1-4d82-b3ca-1dc610fec9b4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_13ae2beb-90f3-498e-8c1e-21debaf6d0e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_cddba3e8-4a55-4c71-b832-79a1e28781ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_us-gaap_PositionAxis_cddba3e8-4a55-4c71-b832-79a1e28781ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_cddba3e8-4a55-4c71-b832-79a1e28781ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_cddba3e8-4a55-4c71-b832-79a1e28781ee" xlink:to="loc_us-gaap_PositionDomain_cddba3e8-4a55-4c71-b832-79a1e28781ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_cddba3e8-4a55-4c71-b832-79a1e28781ee" xlink:to="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_9f071f91-6cb2-43bf-ba93-ca2d3a8c79a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:to="loc_us-gaap_LongMember_9f071f91-6cb2-43bf-ba93-ca2d3a8c79a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_6f49e5e9-5702-4dbb-832a-3b98dc027a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:to="loc_us-gaap_ShortMember_6f49e5e9-5702-4dbb-832a-3b98dc027a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_us-gaap_HedgingDesignationAxis_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f" xlink:to="loc_us-gaap_HedgingDesignationDomain_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a9aa1992-fea0-4b4e-86b4-76e237d04fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f" xlink:to="loc_us-gaap_HedgingDesignationDomain_a9aa1992-fea0-4b4e-86b4-76e237d04fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a11024b-b077-4efe-97ac-55501d0818cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a9aa1992-fea0-4b4e-86b4-76e237d04fbd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a11024b-b077-4efe-97ac-55501d0818cc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended" id="ib4b27f2a81d7419a8da79525b16a39f2_DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c1919499-3cb8-4b4f-aa37-3e0c4c799056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c1919499-3cb8-4b4f-aa37-3e0c4c799056" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_544bcd27-25f6-4b86-972f-8284a2557e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_544bcd27-25f6-4b86-972f-8284a2557e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_7b2ef129-8853-4737-abde-5153c295e916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_7b2ef129-8853-4737-abde-5153c295e916" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_008512cc-48c6-4ef2-b884-e7421cd30bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_008512cc-48c6-4ef2-b884-e7421cd30bec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3070d6b7-6b36-49a2-83ed-5eebc41a8608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3070d6b7-6b36-49a2-83ed-5eebc41a8608" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c6c73d5e-3e79-4ace-afc9-50b116216fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c6c73d5e-3e79-4ace-afc9-50b116216fde" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c4e1e71-fb94-42a4-8f6a-e2f40900189b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c4e1e71-fb94-42a4-8f6a-e2f40900189b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_df0f5d8a-c3e9-4c6a-92d3-62127552585b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_df0f5d8a-c3e9-4c6a-92d3-62127552585b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_559efa48-0ff0-4936-95a0-1c03a8d4714c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_559efa48-0ff0-4936-95a0-1c03a8d4714c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_75c06665-c8f1-460b-bf08-0c81b7d016d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_75c06665-c8f1-460b-bf08-0c81b7d016d3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f29d83f1-1290-4f34-8d57-e75069b3b6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f29d83f1-1290-4f34-8d57-e75069b3b6e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f29d83f1-1290-4f34-8d57-e75069b3b6e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f29d83f1-1290-4f34-8d57-e75069b3b6e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f29d83f1-1290-4f34-8d57-e75069b3b6e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f29d83f1-1290-4f34-8d57-e75069b3b6e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_6a227131-c1ec-464b-a391-9a49f75513e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_6a227131-c1ec-464b-a391-9a49f75513e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_bb0a7f2a-ed63-4f16-9cb2-447e9ed93aa5" xlink:href="wst-20201231.xsd#wst_NetSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_wst_NetSalesMember_bb0a7f2a-ed63-4f16-9cb2-447e9ed93aa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b7886d08-2c72-4c61-ab32-ab1761d6516d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_us-gaap_CostOfSalesMember_b7886d08-2c72-4c61-ab32-ab1761d6516d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4e69a048-d0a6-49c6-b9ad-c482acbfead8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_us-gaap_InterestExpenseMember_4e69a048-d0a6-49c6-b9ad-c482acbfead8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58140562-2e31-4e22-a51e-0a0f07e79b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58140562-2e31-4e22-a51e-0a0f07e79b8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_58140562-2e31-4e22-a51e-0a0f07e79b8e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58140562-2e31-4e22-a51e-0a0f07e79b8e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_58140562-2e31-4e22-a51e-0a0f07e79b8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58140562-2e31-4e22-a51e-0a0f07e79b8e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_2893f580-1e76-4f5d-a9bd-0a38709794d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:to="loc_us-gaap_FairValueHedgingMember_2893f580-1e76-4f5d-a9bd-0a38709794d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0537e02b-28f3-439e-b9ac-42a89d4f95c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:to="loc_us-gaap_CashFlowHedgingMember_0537e02b-28f3-439e-b9ac-42a89d4f95c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f137b18b-e5a4-4576-823e-54547c74a3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f137b18b-e5a4-4576-823e-54547c74a3ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f2b71011-d41c-4fa3-9bb4-25cb844a4637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f2b71011-d41c-4fa3-9bb4-25cb844a4637" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f2b71011-d41c-4fa3-9bb4-25cb844a4637_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f2b71011-d41c-4fa3-9bb4-25cb844a4637" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f2b71011-d41c-4fa3-9bb4-25cb844a4637_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f2b71011-d41c-4fa3-9bb4-25cb844a4637" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b0ee67bd-fd41-4a42-b1e2-8ed0da4ba3b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b0ee67bd-fd41-4a42-b1e2-8ed0da4ba3b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_11a854b2-c034-47c2-9ae6-c782db76ce11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_TreasuryLockMember_11a854b2-c034-47c2-9ae6-c782db76ce11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyDenominatedDebtMember_648ce990-71bf-4511-a85f-e752ec6cb9da" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_wst_ForeignCurrencyDenominatedDebtMember_648ce990-71bf-4511-a85f-e752ec6cb9da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b9734a91-e982-4aa8-8e0e-d114047e8b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_CurrencySwapMember_b9734a91-e982-4aa8-8e0e-d114047e8b04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_75e9d838-bfc8-47e8-b00b-b3262535771b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_CommodityOptionMember_75e9d838-bfc8-47e8-b00b-b3262535771b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f3a576e6-c6e8-4049-86a2-a89fa681d33d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_HedgingDesignationAxis_f3a576e6-c6e8-4049-86a2-a89fa681d33d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f3a576e6-c6e8-4049-86a2-a89fa681d33d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f3a576e6-c6e8-4049-86a2-a89fa681d33d" xlink:to="loc_us-gaap_HedgingDesignationDomain_f3a576e6-c6e8-4049-86a2-a89fa681d33d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3fe41163-18bf-46c1-adc2-b0c3845b7edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f3a576e6-c6e8-4049-86a2-a89fa681d33d" xlink:to="loc_us-gaap_HedgingDesignationDomain_3fe41163-18bf-46c1-adc2-b0c3845b7edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f6c0d943-3eb0-41d1-9954-c1ec7b70ed40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3fe41163-18bf-46c1-adc2-b0c3845b7edd" xlink:to="loc_us-gaap_NondesignatedMember_f6c0d943-3eb0-41d1-9954-c1ec7b70ed40" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended" id="i5eef7af23832488db3ad05e055e0a37b_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i2c00b260661c46a295b46ddf94478277_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended" id="i6f1804ee417640e585a7fc4ffd185644_FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_cd857056-fa84-4f31-b9e3-851b35d3f19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_cd857056-fa84-4f31-b9e3-851b35d3f19a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b33ff14e-618e-42f5-880c-22dad32018be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b33ff14e-618e-42f5-880c-22dad32018be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_64685388-6e5a-4675-a456-30cea0376806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:to="loc_us-gaap_DerivativeAssets_64685388-6e5a-4675-a456-30cea0376806" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_14c83364-cbe8-48fb-a5cc-7c63d24ec8d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_14c83364-cbe8-48fb-a5cc-7c63d24ec8d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dc7debda-ffc4-49d0-afeb-1080187401af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dc7debda-ffc4-49d0-afeb-1080187401af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_61714907-0b60-462a-ae14-72d88568d5f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_61714907-0b60-462a-ae14-72d88568d5f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a26aab71-6714-472d-9102-9137fb142084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a26aab71-6714-472d-9102-9137fb142084" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2d9e7831-2746-4dc1-b3c5-002119896241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_2d9e7831-2746-4dc1-b3c5-002119896241" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4521ca37-5f49-40c9-a376-cb3cb9a7faf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4521ca37-5f49-40c9-a376-cb3cb9a7faf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7d37f2a5-a02f-4b06-9f74-17ba9f057872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7d37f2a5-a02f-4b06-9f74-17ba9f057872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85fd1980-8668-4ff5-9258-25f8f0e8f1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85fd1980-8668-4ff5-9258-25f8f0e8f1a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_31012cc8-e06b-4fe7-9e4b-94403412fa8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_31012cc8-e06b-4fe7-9e4b-94403412fa8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_31012cc8-e06b-4fe7-9e4b-94403412fa8b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_31012cc8-e06b-4fe7-9e4b-94403412fa8b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_31012cc8-e06b-4fe7-9e4b-94403412fa8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_31012cc8-e06b-4fe7-9e4b-94403412fa8b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember_01bcacc7-14c3-48b7-8fca-3de3bfc3e50c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:to="loc_us-gaap_CommodityMember_01bcacc7-14c3-48b7-8fca-3de3bfc3e50c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_db65a96a-f130-4d7f-bf7a-b263c6232816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:to="loc_us-gaap_CurrencySwapMember_db65a96a-f130-4d7f-bf7a-b263c6232816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_275d4206-292d-4e58-8abe-9d0e1ee47df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_275d4206-292d-4e58-8abe-9d0e1ee47df7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="extended" id="i9453162c48e745f4ab1d3ce03604980c_FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BusinessCombinationContingentConsiderationMeasurementInput_6b1f742a-3285-439b-ade2-b52a998869de" xlink:href="wst-20201231.xsd#wst_BusinessCombinationContingentConsiderationMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:to="loc_wst_BusinessCombinationContingentConsiderationMeasurementInput_6b1f742a-3285-439b-ade2-b52a998869de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5fc5b007-26e9-4565-8a05-11031fc980fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5fc5b007-26e9-4565-8a05-11031fc980fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ab8fa4e4-1af8-4e06-8ab7-cc89fb591f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ab8fa4e4-1af8-4e06-8ab7-cc89fb591f15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_8b06881b-ab01-431d-8289-74e161809bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_8b06881b-ab01-431d-8289-74e161809bf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_451a8fa9-97de-4bb2-afd1-79f39393741e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesProjectionsMember_bed5b8be-164d-4fd1-9c99-c60a0b0d196f" xlink:href="wst-20201231.xsd#wst_SalesProjectionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_wst_SalesProjectionsMember_bed5b8be-164d-4fd1-9c99-c60a0b0d196f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProbabilitiesOfSuccessfulFDAApprovalMember_89917e38-4fb6-49fd-824b-d3a04550aaa6" xlink:href="wst-20201231.xsd#wst_ProbabilitiesOfSuccessfulFDAApprovalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_wst_ProbabilitiesOfSuccessfulFDAApprovalMember_89917e38-4fb6-49fd-824b-d3a04550aaa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember_e91dc551-6ba4-4b15-8f15-dce78114b504" xlink:href="wst-20201231.xsd#wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember_e91dc551-6ba4-4b15-8f15-dce78114b504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_61635d2d-968b-4ce1-8744-bb2e28aa5eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_61635d2d-968b-4ce1-8744-bb2e28aa5eb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d54bd7e3-6f7a-484c-8449-eb3bc016bc66" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:to="loc_srt_RangeAxis_d54bd7e3-6f7a-484c-8449-eb3bc016bc66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d54bd7e3-6f7a-484c-8449-eb3bc016bc66_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d54bd7e3-6f7a-484c-8449-eb3bc016bc66" xlink:to="loc_srt_RangeMember_d54bd7e3-6f7a-484c-8449-eb3bc016bc66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d54bd7e3-6f7a-484c-8449-eb3bc016bc66" xlink:to="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_57348501-f215-4f1d-b5de-03fd79398476" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:to="loc_srt_MinimumMember_57348501-f215-4f1d-b5de-03fd79398476" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7ed62d66-0818-4acd-98df-a71188e4e980" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:to="loc_srt_MaximumMember_7ed62d66-0818-4acd-98df-a71188e4e980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_bd5e1876-100e-435d-ab9e-b7163176ed62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:to="loc_srt_WeightedAverageMember_bd5e1876-100e-435d-ab9e-b7163176ed62" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended" id="i41360df5dc6a4da8b41416913d2c4bad_FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" id="i0a7d1360a1ab4c0f86c6445acf723fa1_AccumulatedOtherComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" id="i6b00d2d15a02479e9689ee828d883e5a_AccumulatedOtherComprehensiveLossTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i0f25449e32a64df494d683a8a625ac24_AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a685085e-3f63-445c-9d0e-d5fba942b2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a685085e-3f63-445c-9d0e-d5fba942b2ad" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d92498b5-2e71-482d-bcfa-6b2d29d88862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_StockholdersEquity_d92498b5-2e71-482d-bcfa-6b2d29d88862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4e8a657-f887-4f26-83b6-968a27cae068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4e8a657-f887-4f26-83b6-968a27cae068" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_7cc3d167-4c9a-4060-aff5-66ccffa6f340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_7cc3d167-4c9a-4060-aff5-66ccffa6f340" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1fc332f9-2504-41a7-b677-f3ca868a0e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1fc332f9-2504-41a7-b677-f3ca868a0e9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_56a163ee-974c-451a-9ea6-e541befa8fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9326b8b8-5283-4d84-af82-6de0c4dfb9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a685085e-3f63-445c-9d0e-d5fba942b2ad" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9326b8b8-5283-4d84-af82-6de0c4dfb9c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_099bf3c0-84f4-4098-87a3-6961b9a29106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9326b8b8-5283-4d84-af82-6de0c4dfb9c0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_099bf3c0-84f4-4098-87a3-6961b9a29106" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_099bf3c0-84f4-4098-87a3-6961b9a29106_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_099bf3c0-84f4-4098-87a3-6961b9a29106" xlink:to="loc_us-gaap_EquityComponentDomain_099bf3c0-84f4-4098-87a3-6961b9a29106_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_099bf3c0-84f4-4098-87a3-6961b9a29106" xlink:to="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_8c5f7c62-f301-4c8d-a46f-554dba24990a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_8c5f7c62-f301-4c8d-a46f-554dba24990a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_2ab8a603-7c68-4297-ac8f-abb8d95b6db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_2ab8a603-7c68-4297-ac8f-abb8d95b6db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f6087562-882c-43b5-b258-1d0e4a79f5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f6087562-882c-43b5-b258-1d0e4a79f5d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7951e921-20d6-43e5-afdb-34c9139d8b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7951e921-20d6-43e5-afdb-34c9139d8b29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3ad9b30f-d26f-4a72-93f8-e5e0bf6bf567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3ad9b30f-d26f-4a72-93f8-e5e0bf6bf567" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended" id="i2b353ca078824fc08b6aa6556a20e8de_AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f056c478-6f23-4fd4-8937-19f02896a614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f056c478-6f23-4fd4-8937-19f02896a614" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ee0e8f6c-2e44-4964-8cdd-1cec93b16e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ee0e8f6c-2e44-4964-8cdd-1cec93b16e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_466ddac4-7391-4d4b-9fd5-0668fcc1b24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_OtherIncome_466ddac4-7391-4d4b-9fd5-0668fcc1b24b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7024300c-9940-4ff7-af1a-a6b0d4f6546d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_InterestExpense_7024300c-9940-4ff7-af1a-a6b0d4f6546d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_9aba8b51-10bf-4b23-8b4b-ac16d385ecea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_9aba8b51-10bf-4b23-8b4b-ac16d385ecea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d0e73b23-6bb5-4d81-9337-ed813813fe5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d0e73b23-6bb5-4d81-9337-ed813813fe5b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b18d01ff-9eb2-4f76-a190-0b4f9850c092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b18d01ff-9eb2-4f76-a190-0b4f9850c092" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1c6fcbdc-4f2c-4752-adb8-901f5679de92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1c6fcbdc-4f2c-4752-adb8-901f5679de92" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5bdc9c00-fb66-41c5-b51e-8fbcd51c2dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5bdc9c00-fb66-41c5-b51e-8fbcd51c2dc3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1bbbe9fd-1860-44ac-81f8-270adfe2cd8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_NetIncomeLoss_1bbbe9fd-1860-44ac-81f8-270adfe2cd8e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b605a713-6a6b-4759-a1d0-45814d43dde1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b605a713-6a6b-4759-a1d0-45814d43dde1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b605a713-6a6b-4759-a1d0-45814d43dde1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b605a713-6a6b-4759-a1d0-45814d43dde1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b605a713-6a6b-4759-a1d0-45814d43dde1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b605a713-6a6b-4759-a1d0-45814d43dde1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0563044e-6cd6-451f-ab04-159417d9ffc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0563044e-6cd6-451f-ab04-159417d9ffc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_f12b1615-fa7b-4683-b6c5-f3bb58df8d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:to="loc_us-gaap_TreasuryLockMember_f12b1615-fa7b-4683-b6c5-f3bb58df8d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8adf2ae2-a7a1-4197-a8ac-40d3536e8532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8adf2ae2-a7a1-4197-a8ac-40d3536e8532" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8adf2ae2-a7a1-4197-a8ac-40d3536e8532_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8adf2ae2-a7a1-4197-a8ac-40d3536e8532" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8adf2ae2-a7a1-4197-a8ac-40d3536e8532_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_85bc920e-b63b-4b37-bc1a-bc4345d53973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8adf2ae2-a7a1-4197-a8ac-40d3536e8532" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_85bc920e-b63b-4b37-bc1a-bc4345d53973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_1e98a0ad-4270-4d1a-85dc-b0c17ef3352a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_85bc920e-b63b-4b37-bc1a-bc4345d53973" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_1e98a0ad-4270-4d1a-85dc-b0c17ef3352a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3d191259-5ed5-450d-b28a-b86fc53347c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3d191259-5ed5-450d-b28a-b86fc53347c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d191259-5ed5-450d-b28a-b86fc53347c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3d191259-5ed5-450d-b28a-b86fc53347c1" xlink:to="loc_us-gaap_EquityComponentDomain_3d191259-5ed5-450d-b28a-b86fc53347c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3d191259-5ed5-450d-b28a-b86fc53347c1" xlink:to="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_910f4553-b096-47f8-acf9-70c976546e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_910f4553-b096-47f8-acf9-70c976546e5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3ee3c5ce-24a0-4f94-9806-aa37631a0614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3ee3c5ce-24a0-4f94-9806-aa37631a0614" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended" id="i44db10bf2c494056888d71e8920c41ff_StockBasedCompensation"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="extended" id="idf88a2bfacdb43b3a2fe4b3fd47375b5_StockBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="i43704468be5548f598898ff129249ec3_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_35fd2da1-a51a-4128-b1f9-98aa3d2d9d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_35fd2da1-a51a-4128-b1f9-98aa3d2d9d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_eaf44227-a2dd-4f24-88e6-83dfd0620245" xlink:href="wst-20201231.xsd#wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_eaf44227-a2dd-4f24-88e6-83dfd0620245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_33fe0961-5069-4f58-855d-6a1f00109f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_33fe0961-5069-4f58-855d-6a1f00109f72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d6def9a-98a1-4a53-87ed-3c8019b7634c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d6def9a-98a1-4a53-87ed-3c8019b7634c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_786fc1d5-4ecd-48ab-8640-b9489507f63f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_786fc1d5-4ecd-48ab-8640-b9489507f63f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_401771c2-4aef-49e8-9326-0b508b12fb3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_401771c2-4aef-49e8-9326-0b508b12fb3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledStockAppreciationRightsOutstanding_98c3e4bb-7fa1-4a8a-9e22-7d2f196ed7e7" xlink:href="wst-20201231.xsd#wst_CashSettledStockAppreciationRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_CashSettledStockAppreciationRightsOutstanding_98c3e4bb-7fa1-4a8a-9e22-7d2f196ed7e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledStockAppreciationRightsOutstanding_a8c3337e-120d-469c-82c0-e8d25d5d7611" xlink:href="wst-20201231.xsd#wst_StockSettledStockAppreciationRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_StockSettledStockAppreciationRightsOutstanding_a8c3337e-120d-469c-82c0-e8d25d5d7611" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_be0b8ef1-aa02-4550-af84-b9f04c9077cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_be0b8ef1-aa02-4550-af84-b9f04c9077cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d4a27d2e-2d38-4164-aa13-3ece99b2f9b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d4a27d2e-2d38-4164-aa13-3ece99b2f9b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_d724ea71-a96e-4b42-bc88-7ca100e0f019" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_d724ea71-a96e-4b42-bc88-7ca100e0f019" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1fa68e1c-2801-4527-ba5f-2fba9f8546a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1fa68e1c-2801-4527-ba5f-2fba9f8546a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_28fdf4a7-1875-4f56-bb1c-ccb7371660b2" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_28fdf4a7-1875-4f56-bb1c-ccb7371660b2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_408ed486-2192-47c7-be71-c35a58c1b5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_408ed486-2192-47c7-be71-c35a58c1b5db" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_6c63db94-88c1-477b-bc85-11ccbb9d456f" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualConversionUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_6c63db94-88c1-477b-bc85-11ccbb9d456f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34fdbf55-9ae7-4824-84ae-a92ed8b660e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34fdbf55-9ae7-4824-84ae-a92ed8b660e7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5c26e444-1294-4b3a-af0c-ce78dfc81397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5c26e444-1294-4b3a-af0c-ce78dfc81397" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6fe01e83-7a30-4913-9029-73666f59db50" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6fe01e83-7a30-4913-9029-73666f59db50" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_80080726-4cc0-4db9-9376-b9fbff6735dc" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_80080726-4cc0-4db9-9376-b9fbff6735dc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableInCash_fa537fa5-390c-423a-bfb9-84727ee64cfe" xlink:href="wst-20201231.xsd#wst_DeferredStockUnitsPayableInCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredStockUnitsPayableInCash_fa537fa5-390c-423a-bfb9-84727ee64cfe" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate_9ee8dbf2-54ab-45d0-ba97-cb1de55659b5" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate_9ee8dbf2-54ab-45d0-ba97-cb1de55659b5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_18de936b-e593-4008-8966-3c52ccffbc06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_18de936b-e593-4008-8966-3c52ccffbc06" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_baf75820-a04e-4832-bc9c-7b0723beef59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_baf75820-a04e-4832-bc9c-7b0723beef59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_baf75820-a04e-4832-bc9c-7b0723beef59_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_baf75820-a04e-4832-bc9c-7b0723beef59" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_baf75820-a04e-4832-bc9c-7b0723beef59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d4b17221-8a77-4cc5-8dae-2c6ca9ae7cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_baf75820-a04e-4832-bc9c-7b0723beef59" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d4b17221-8a77-4cc5-8dae-2c6ca9ae7cfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_46dd903c-38b7-40a7-92d0-7dd75e43d00c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d4b17221-8a77-4cc5-8dae-2c6ca9ae7cfb" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_46dd903c-38b7-40a7-92d0-7dd75e43d00c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_srt_RangeAxis_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb" xlink:to="loc_srt_RangeMember_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb" xlink:to="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_50847494-b5ca-4cec-b1f8-83eee1aae661" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:to="loc_srt_MinimumMember_50847494-b5ca-4cec-b1f8-83eee1aae661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b535fa68-191c-40ac-8182-71c42b606adf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:to="loc_srt_MaximumMember_b535fa68-191c-40ac-8182-71c42b606adf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0f34d998-cc7c-4dac-8433-d56d4bd503d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_srt_TitleOfIndividualAxis_0f34d998-cc7c-4dac-8433-d56d4bd503d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f34d998-cc7c-4dac-8433-d56d4bd503d6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_0f34d998-cc7c-4dac-8433-d56d4bd503d6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f34d998-cc7c-4dac-8433-d56d4bd503d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3ffab5fc-19b2-4af9-93f0-92bdb5206d69" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_0f34d998-cc7c-4dac-8433-d56d4bd503d6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3ffab5fc-19b2-4af9-93f0-92bdb5206d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c2aecea4-53f8-47c7-a3f2-729f0693cefe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3ffab5fc-19b2-4af9-93f0-92bdb5206d69" xlink:to="loc_srt_DirectorMember_c2aecea4-53f8-47c7-a3f2-729f0693cefe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_171e8ce5-12da-4267-b44c-02e13841661e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_us-gaap_AwardTypeAxis_171e8ce5-12da-4267-b44c-02e13841661e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_171e8ce5-12da-4267-b44c-02e13841661e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_171e8ce5-12da-4267-b44c-02e13841661e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_171e8ce5-12da-4267-b44c-02e13841661e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_171e8ce5-12da-4267-b44c-02e13841661e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3a79f1b7-cb95-4b0d-bea0-a07d4c4b8114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3a79f1b7-cb95-4b0d-bea0-a07d4c4b8114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_be7c1020-6709-41b2-953b-d84161c087e9" xlink:href="wst-20201231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_be7c1020-6709-41b2-953b-d84161c087e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_12a78d7e-74a6-465c-9b34-2c1d1499e0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_12a78d7e-74a6-465c-9b34-2c1d1499e0a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_4c0e3f49-ff7b-401e-a10c-ff209c94e2e4" xlink:href="wst-20201231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_4c0e3f49-ff7b-401e-a10c-ff209c94e2e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fb11ae65-8fa5-4b48-a956-b9478ad7d735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_us-gaap_RestrictedStockMember_fb11ae65-8fa5-4b48-a956-b9478ad7d735" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_6f4be14b-1c8f-428f-a6b8-282fbc11eb97" xlink:href="wst-20201231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_IncentiveStockAwardsMember_6f4be14b-1c8f-428f-a6b8-282fbc11eb97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_2b59b060-54a9-4519-a272-609bd3169e99" xlink:href="wst-20201231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_StockSettledPSUAwardsMember_2b59b060-54a9-4519-a272-609bd3169e99" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended" id="i370e5a91ba8f4a548d1bb3100b266775_StockBasedCompensationAllocationofSharebasedCompensationCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2aadf5e8-403a-41dc-a6be-21666093c1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_23eb6d63-8bdb-4982-9f9f-662085eab75f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2aadf5e8-403a-41dc-a6be-21666093c1c0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_23eb6d63-8bdb-4982-9f9f-662085eab75f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61c5ae66-7abb-4e60-9a3c-1d2056412662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2aadf5e8-403a-41dc-a6be-21666093c1c0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61c5ae66-7abb-4e60-9a3c-1d2056412662" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c4026a5a-ca56-467b-ba3b-59a100ba2c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61c5ae66-7abb-4e60-9a3c-1d2056412662" xlink:to="loc_us-gaap_AwardTypeAxis_c4026a5a-ca56-467b-ba3b-59a100ba2c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4026a5a-ca56-467b-ba3b-59a100ba2c71_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c4026a5a-ca56-467b-ba3b-59a100ba2c71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4026a5a-ca56-467b-ba3b-59a100ba2c71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c4026a5a-ca56-467b-ba3b-59a100ba2c71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember_6113804f-31a7-4933-bb97-511405deff47" xlink:href="wst-20201231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_StockOptionAndAppreciationRightsMember_6113804f-31a7-4933-bb97-511405deff47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_89b4754c-ea7a-4db4-8a2f-f900b97c5ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_us-gaap_PerformanceSharesMember_89b4754c-ea7a-4db4-8a2f-f900b97c5ca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_421c00c9-e1b4-4c58-9db3-ac339ae0dbaa" xlink:href="wst-20201231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_CashSettledPSUAwardsMember_421c00c9-e1b4-4c58-9db3-ac339ae0dbaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_d0acd2e2-8031-401a-b5ed-e40b8dc0f9f9" xlink:href="wst-20201231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_d0acd2e2-8031-401a-b5ed-e40b8dc0f9f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_67806d26-c934-4994-82b3-f463cc15621c" xlink:href="wst-20201231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_67806d26-c934-4994-82b3-f463cc15621c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_b58f8441-2a44-4d0c-b7f1-6e4d88a47f88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_b58f8441-2a44-4d0c-b7f1-6e4d88a47f88" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended" id="i1bf25c631e7e4cb6815f3f6b41c20aca_StockBasedCompensationStockOptionsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2fde3404-a403-4d9e-8d51-24b901902aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2fde3404-a403-4d9e-8d51-24b901902aa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_803ff4fb-3c69-4af0-bf0c-5a68c3bd6230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_803ff4fb-3c69-4af0-bf0c-5a68c3bd6230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_89fcc915-56b0-4be0-bf0a-1da9d6734445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_89fcc915-56b0-4be0-bf0a-1da9d6734445" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56521b7e-662d-4060-9222-e515d96b034d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56521b7e-662d-4060-9222-e515d96b034d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_68a2da77-5673-4d0f-b777-f3bc9380a5b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_68a2da77-5673-4d0f-b777-f3bc9380a5b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_434a002a-7012-43c9-bbf5-9eb200eacfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_434a002a-7012-43c9-bbf5-9eb200eacfeb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_434a002a-7012-43c9-bbf5-9eb200eacfeb" xlink:to="loc_us-gaap_AwardTypeAxis_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dffaf7e3-22aa-45d4-9aac-633b49390f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dffaf7e3-22aa-45d4-9aac-633b49390f08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6f49212d-229d-462c-9966-3055e722e428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dffaf7e3-22aa-45d4-9aac-633b49390f08" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6f49212d-229d-462c-9966-3055e722e428" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended" id="i9ad67ad5efcc43feb314e9da04b71426_StockBasedCompensationStockAppreciationRightsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b20035fa-95eb-4fca-aea6-21fc3f85c71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b20035fa-95eb-4fca-aea6-21fc3f85c71b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_61a2a44f-fc4d-47c1-9490-79b9a75399dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_61a2a44f-fc4d-47c1-9490-79b9a75399dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_e976e0cc-f9a5-4760-bcf1-e34463f24ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_e976e0cc-f9a5-4760-bcf1-e34463f24ffc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3bc956d0-d3f0-43e1-bf2d-4ea87f20729a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3bc956d0-d3f0-43e1-bf2d-4ea87f20729a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_71494251-01d8-4497-8bbc-ee5fb1c2b5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_71494251-01d8-4497-8bbc-ee5fb1c2b5dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_139d8b3b-397f-4219-a18a-7649dce3f469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281d463c-bf4f-495a-9899-6e3fc5b750ed" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281d463c-bf4f-495a-9899-6e3fc5b750ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_cec22084-f941-482c-a84f-f455e7281a7d" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_cec22084-f941-482c-a84f-f455e7281a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_f8515b91-ca47-41b4-b199-fa5399ad5b3c" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_f8515b91-ca47-41b4-b199-fa5399ad5b3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_1cacd918-0899-4561-a191-d0828d3c1c57" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_1cacd918-0899-4561-a191-d0828d3c1c57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_83ff8f00-6556-4a19-8d14-c253dba22a23" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_83ff8f00-6556-4a19-8d14-c253dba22a23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_52b4a8fa-044b-4296-b956-5fa3f82ef9db" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_8dadf795-c745-4b1b-b96f-62287bb4b27c" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_8dadf795-c745-4b1b-b96f-62287bb4b27c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_79ab608f-2cc3-4176-91c8-c0c8d96d2e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_79ab608f-2cc3-4176-91c8-c0c8d96d2e2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e9dd06df-8a84-442e-9fba-4b8a82f82c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_79ab608f-2cc3-4176-91c8-c0c8d96d2e2c" xlink:to="loc_us-gaap_AwardTypeAxis_e9dd06df-8a84-442e-9fba-4b8a82f82c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9dd06df-8a84-442e-9fba-4b8a82f82c8b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e9dd06df-8a84-442e-9fba-4b8a82f82c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9dd06df-8a84-442e-9fba-4b8a82f82c8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48fc215a-ba18-4207-8a07-8010342729da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e9dd06df-8a84-442e-9fba-4b8a82f82c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48fc215a-ba18-4207-8a07-8010342729da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_f48e64ee-9cf8-42e1-8b57-71560b953793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48fc215a-ba18-4207-8a07-8010342729da" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_f48e64ee-9cf8-42e1-8b57-71560b953793" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended" id="ic1c840f95a1646e98477d0057eb14324_StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_b29a2f5d-dbf1-4209-ace0-9b6d524b1a4b" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_b29a2f5d-dbf1-4209-ace0-9b6d524b1a4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_9b634758-5371-430c-9e97-5ad7637b64f1" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_9b634758-5371-430c-9e97-5ad7637b64f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_9401dcf2-df76-4e59-92c4-8492d5c67c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_9401dcf2-df76-4e59-92c4-8492d5c67c8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7b4f0547-6a04-4f48-83e7-690caa2dcd5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7b4f0547-6a04-4f48-83e7-690caa2dcd5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c76f3922-bb00-46ce-a022-ea3c9760b27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c76f3922-bb00-46ce-a022-ea3c9760b27f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_18609b82-7449-4398-a3a8-36fc025e41c5" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_18609b82-7449-4398-a3a8-36fc025e41c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_462314c7-a974-4f58-bead-da75bc246e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_462314c7-a974-4f58-bead-da75bc246e10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6416744-e059-4fc4-be51-157f9dfd1121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6416744-e059-4fc4-be51-157f9dfd1121" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_66d24cdb-4022-428d-8488-74edddf9858a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_067ae50f-3396-4f55-8d48-1337798260f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_067ae50f-3396-4f55-8d48-1337798260f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7482b150-1c06-4ed2-825b-491653ddf67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7482b150-1c06-4ed2-825b-491653ddf67a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_9206f644-2e78-4fb1-bc53-e38bc1f02fff" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_9206f644-2e78-4fb1-bc53-e38bc1f02fff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_322ac756-d65f-47df-bab3-c41e8e0c9f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_322ac756-d65f-47df-bab3-c41e8e0c9f10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4931b9c5-e7b6-46a5-90f3-6d6edfee8451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4931b9c5-e7b6-46a5-90f3-6d6edfee8451" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c9d59da7-9984-40d8-a9f0-e13fb9d86de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_24df9af9-af78-46ab-b40c-c31e06a97f1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_srt_RangeAxis_24df9af9-af78-46ab-b40c-c31e06a97f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_24df9af9-af78-46ab-b40c-c31e06a97f1a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_24df9af9-af78-46ab-b40c-c31e06a97f1a" xlink:to="loc_srt_RangeMember_24df9af9-af78-46ab-b40c-c31e06a97f1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_24df9af9-af78-46ab-b40c-c31e06a97f1a" xlink:to="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_efc16dad-0ed0-40d5-8327-5a67b013329d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:to="loc_srt_MinimumMember_efc16dad-0ed0-40d5-8327-5a67b013329d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cb24d42-70c9-4f3a-bf08-4a71284473b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:to="loc_srt_MaximumMember_5cb24d42-70c9-4f3a-bf08-4a71284473b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9a3d8efd-e70d-485b-9766-f585745af344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_us-gaap_AwardTypeAxis_9a3d8efd-e70d-485b-9766-f585745af344" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3d8efd-e70d-485b-9766-f585745af344_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9a3d8efd-e70d-485b-9766-f585745af344" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3d8efd-e70d-485b-9766-f585745af344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9a3d8efd-e70d-485b-9766-f585745af344" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_6025c45e-6f57-46ce-806c-7ea3168b7921" xlink:href="wst-20201231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_wst_IncentiveStockAwardsMember_6025c45e-6f57-46ce-806c-7ea3168b7921" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_4547d9bf-b7d1-4cb3-8951-a2b26ce26d95" xlink:href="wst-20201231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_wst_StockSettledPSUAwardsMember_4547d9bf-b7d1-4cb3-8951-a2b26ce26d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_25cbf8ae-e6aa-4349-b2cf-b7bbcb4988ce" xlink:href="wst-20201231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_wst_CashSettledPSUAwardsMember_25cbf8ae-e6aa-4349-b2cf-b7bbcb4988ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_81e15810-ac6c-4ca5-8430-6e79f119ae84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_us-gaap_RestrictedStockMember_81e15810-ac6c-4ca5-8430-6e79f119ae84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_f70e6697-5cae-4850-ac1e-7a3d01f67f09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_srt_TitleOfIndividualAxis_f70e6697-5cae-4850-ac1e-7a3d01f67f09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f70e6697-5cae-4850-ac1e-7a3d01f67f09_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_f70e6697-5cae-4850-ac1e-7a3d01f67f09" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f70e6697-5cae-4850-ac1e-7a3d01f67f09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_53f8f14c-c9c9-4fd7-9926-92e95fd9c02e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_f70e6697-5cae-4850-ac1e-7a3d01f67f09" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_53f8f14c-c9c9-4fd7-9926-92e95fd9c02e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_d5011e17-1227-4232-8e35-cbebb831b350" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_53f8f14c-c9c9-4fd7-9926-92e95fd9c02e" xlink:to="loc_srt_DirectorMember_d5011e17-1227-4232-8e35-cbebb831b350" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_e81afe95-fc9f-4c0f-ad2b-966f24a02dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_e81afe95-fc9f-4c0f-ad2b-966f24a02dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_93019f04-4068-4516-b7b1-6b853aa7a726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_e81afe95-fc9f-4c0f-ad2b-966f24a02dc2" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_93019f04-4068-4516-b7b1-6b853aa7a726" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlans"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended" id="ic6a41b69ad8d47018e5ecaa648dfc6fa_BenefitPlans"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended" id="i5c22d7fdcc064e36919bac7cf3395ee8_BenefitPlansTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="extended" id="i31769bd62cce46c1a643fa4ef3712d48_BenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_b57601a3-18e8-486f-b1c3-a75da51aea5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_b57601a3-18e8-486f-b1c3-a75da51aea5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1b04fb95-b735-4036-9fac-d7fd5aea0a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1b04fb95-b735-4036-9fac-d7fd5aea0a2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e754a62a-51cb-47d1-ad81-72d78016da2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e754a62a-51cb-47d1-ad81-72d78016da2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f0a6cb84-4239-465e-ad36-f24eab207464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f0a6cb84-4239-465e-ad36-f24eab207464" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d5f05e5c-9c0f-4723-a148-c8608d3e75ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d5f05e5c-9c0f-4723-a148-c8608d3e75ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_f1726cea-8d81-4f5e-b985-a887cd1511c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_f1726cea-8d81-4f5e-b985-a887cd1511c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_97309566-5b82-41ce-8413-20ae9c2ac9a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_97309566-5b82-41ce-8413-20ae9c2ac9a1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ba62f46d-fec9-4872-a4c1-3b0309d77d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ba62f46d-fec9-4872-a4c1-3b0309d77d7a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_47d82744-c06d-4e3d-9c0f-7ba53498a9fe" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_47d82744-c06d-4e3d-9c0f-7ba53498a9fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_04c14545-9cdd-4fba-9bd3-044ed5f8478c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_04c14545-9cdd-4fba-9bd3-044ed5f8478c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_069b613f-6659-47a1-84c0-cdaf6ae7b4c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_069b613f-6659-47a1-84c0-cdaf6ae7b4c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_dd2fb3e8-192e-4667-bd0c-b524bc6f4e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_dd2fb3e8-192e-4667-bd0c-b524bc6f4e62" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_2aa44aec-5e14-40cb-b73e-450b3f255de9" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_2aa44aec-5e14-40cb-b73e-450b3f255de9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_c72a4c0f-3634-4fe9-b768-12c6c455a9d1" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_c72a4c0f-3634-4fe9-b768-12c6c455a9d1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bc030e1c-c204-4374-98dd-53b546f0dcba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bc030e1c-c204-4374-98dd-53b546f0dcba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_209d0d84-4258-468f-afa9-006941fdedb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_209d0d84-4258-468f-afa9-006941fdedb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f6c47a41-846a-4b07-98db-7527eb398d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f6c47a41-846a-4b07-98db-7527eb398d59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f6c47a41-846a-4b07-98db-7527eb398d59_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f6c47a41-846a-4b07-98db-7527eb398d59" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f6c47a41-846a-4b07-98db-7527eb398d59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f6c47a41-846a-4b07-98db-7527eb398d59" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d260eaca-88dc-47f0-835d-7682a7260597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d260eaca-88dc-47f0-835d-7682a7260597" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5ef4d5ed-71ee-46da-8aaa-a47c866219b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5ef4d5ed-71ee-46da-8aaa-a47c866219b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_2c44aac3-db5e-4971-8dac-72e293cf7a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_2c44aac3-db5e-4971-8dac-72e293cf7a8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_2c44aac3-db5e-4971-8dac-72e293cf7a8a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_2c44aac3-db5e-4971-8dac-72e293cf7a8a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_2c44aac3-db5e-4971-8dac-72e293cf7a8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_2c44aac3-db5e-4971-8dac-72e293cf7a8a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_1a93b5dc-164f-4073-850f-97ac52f52a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:to="loc_us-gaap_DomesticPlanMember_1a93b5dc-164f-4073-850f-97ac52f52a33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9e9f740e-3249-4a38-99a4-c84c9dbf5a57" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_1a93b5dc-164f-4073-850f-97ac52f52a33" xlink:to="loc_country_US_9e9f740e-3249-4a38-99a4-c84c9dbf5a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1fcfd93e-653a-43ca-9b33-f24aa36be8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:to="loc_us-gaap_ForeignPlanMember_1fcfd93e-653a-43ca-9b33-f24aa36be8bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c412c0e4-8fe9-4b2c-8f2b-59da5a3426ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c412c0e4-8fe9-4b2c-8f2b-59da5a3426ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_98ec3256-f861-4442-b5b5-336b4ef7ef40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c412c0e4-8fe9-4b2c-8f2b-59da5a3426ef" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_98ec3256-f861-4442-b5b5-336b4ef7ef40" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="ib70c9464e0684b9aa738a63ed7fe02a9_BenefitPlansComponentsofNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_43825fde-0374-4234-b2d3-496485432d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_43825fde-0374-4234-b2d3-496485432d42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_65c20771-106f-421e-8422-29f2c25782d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_65c20771-106f-421e-8422-29f2c25782d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6db65227-f302-47a0-ba96-2c7e9de7b5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6db65227-f302-47a0-ba96-2c7e9de7b5bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4390d35b-eec6-4880-b3ca-17f4b2049ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4390d35b-eec6-4880-b3ca-17f4b2049ba6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_dcb9339a-836b-4316-b741-30285f4752ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_dcb9339a-836b-4316-b741-30285f4752ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_54b8b3b2-5a70-4579-a664-67f65ea1e897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_54b8b3b2-5a70-4579-a664-67f65ea1e897" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_143c7065-af2e-42eb-a717-40318d34c73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_143c7065-af2e-42eb-a717-40318d34c73d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_dcbefcec-b090-47f5-ab38-d74dd53121ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_dcbefcec-b090-47f5-ab38-d74dd53121ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_9d0c7870-46cd-4ea4-9283-f2ee1c1507a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_9d0c7870-46cd-4ea4-9283-f2ee1c1507a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_0850bb23-92a6-4ae6-8a8d-0f002e0f3533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_0850bb23-92a6-4ae6-8a8d-0f002e0f3533" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fba00c8b-2949-4cbd-9fa7-015dd2a224f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fba00c8b-2949-4cbd-9fa7-015dd2a224f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_8ab71979-0819-49de-863b-d44b2fcb9f2e" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_8ab71979-0819-49de-863b-d44b2fcb9f2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_4296bd3b-042d-4203-a5d0-540678070dec" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_4296bd3b-042d-4203-a5d0-540678070dec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f571c57b-0eff-4f92-9cd7-6898bddd174a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f571c57b-0eff-4f92-9cd7-6898bddd174a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_dc0799f3-ef61-406c-9e56-457983c47932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:to="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_dc0799f3-ef61-406c-9e56-457983c47932" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2ecfaa6a-c26e-47b6-bb2a-9f7d93e24d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2ecfaa6a-c26e-47b6-bb2a-9f7d93e24d32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_cc7634bb-a201-42ba-a1cc-3a8417fdb4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_cc7634bb-a201-42ba-a1cc-3a8417fdb4b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_01aa6973-be64-4c19-95b2-8bfe4b01c8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:to="loc_us-gaap_DomesticPlanMember_01aa6973-be64-4c19-95b2-8bfe4b01c8a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eeba660d-0c02-4b43-bc72-74ba958c82f7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_01aa6973-be64-4c19-95b2-8bfe4b01c8a2" xlink:to="loc_country_US_eeba660d-0c02-4b43-bc72-74ba958c82f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0f5fefb6-2210-4a63-b907-1d1305942b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:to="loc_us-gaap_ForeignPlanMember_0f5fefb6-2210-4a63-b907-1d1305942b2b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended" id="ib201addd53594160a58b596545614f3a_BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_72b6f788-ced1-4705-bbcc-880a0fc5973a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_72b6f788-ced1-4705-bbcc-880a0fc5973a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_9e20eb8b-0962-4e78-89e4-8b073d33f927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_9e20eb8b-0962-4e78-89e4-8b073d33f927" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ffe5ba58-4edd-450b-a0a2-244abf3dd111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ffe5ba58-4edd-450b-a0a2-244abf3dd111" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_c47ca5dd-ad86-4ef3-b2fe-cb83bcac569b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_c47ca5dd-ad86-4ef3-b2fe-cb83bcac569b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_047491b2-3013-4fca-890f-d1350f0891b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_047491b2-3013-4fca-890f-d1350f0891b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_37f970ce-fac5-4fe9-bb02-d8473fb3d9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_37f970ce-fac5-4fe9-bb02-d8473fb3d9c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_860c41f8-121a-4de0-a234-a62af0c30394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_860c41f8-121a-4de0-a234-a62af0c30394" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6db36bfc-1938-4211-95c2-f8d89893b80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6db36bfc-1938-4211-95c2-f8d89893b80e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_54c7fcaf-0ad6-48be-bbae-977793c8970c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_54c7fcaf-0ad6-48be-bbae-977793c8970c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7c5b6d6c-e54e-48ad-bbf6-5a0495067d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_970183d9-81a8-428d-8ff7-6d143a2be64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_970183d9-81a8-428d-8ff7-6d143a2be64c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1db0a930-126a-413e-831d-19da949b4f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1db0a930-126a-413e-831d-19da949b4f93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_cee02dc1-07d1-489a-815e-5b832e668be0" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_cee02dc1-07d1-489a-815e-5b832e668be0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_4d4d5cfe-3d97-4ee5-8ea5-182f18cb1faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_4d4d5cfe-3d97-4ee5-8ea5-182f18cb1faf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_901497a8-c11b-4000-bc79-f80353e07e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_901497a8-c11b-4000-bc79-f80353e07e18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_fc9ce0dc-2508-4a42-9147-10e9c417e199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_fc9ce0dc-2508-4a42-9147-10e9c417e199" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1fa56965-f0e2-45b2-a0d5-7ad8588bff80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1fa56965-f0e2-45b2-a0d5-7ad8588bff80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9aa3ac32-6937-4549-8a89-a293f3449b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_94a8a48a-53d6-4b37-927e-4f4e37f7154e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_94a8a48a-53d6-4b37-927e-4f4e37f7154e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b58bf0f1-8c05-49c8-bda8-7e2ba3859152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b58bf0f1-8c05-49c8-bda8-7e2ba3859152" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e3dc6132-99d0-4354-82c6-968a29d7f3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b58bf0f1-8c05-49c8-bda8-7e2ba3859152" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e3dc6132-99d0-4354-82c6-968a29d7f3b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e3dc6132-99d0-4354-82c6-968a29d7f3b0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e3dc6132-99d0-4354-82c6-968a29d7f3b0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e3dc6132-99d0-4354-82c6-968a29d7f3b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e3dc6132-99d0-4354-82c6-968a29d7f3b0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_62e1db75-5bf2-4115-b127-18c2b21f2732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_62e1db75-5bf2-4115-b127-18c2b21f2732" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d6095328-6e0c-4fbc-b197-acc7eb3247fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d6095328-6e0c-4fbc-b197-acc7eb3247fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended" id="i68c7b3dd70cf480bbfc14263e7faae86_BenefitPlansAmountsRecognizedinBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_ccc7cb71-836e-49dc-99fb-292c8addaeee" xlink:href="wst-20201231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_ccc7cb71-836e-49dc-99fb-292c8addaeee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_f82193c4-c10d-43a4-87ff-32460ead9d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_f82193c4-c10d-43a4-87ff-32460ead9d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f9497c6e-c877-4513-9f95-63035f420945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f9497c6e-c877-4513-9f95-63035f420945" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_96450672-16e4-423d-9e08-70804e6a612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_96450672-16e4-423d-9e08-70804e6a612b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fa844d6c-fbb2-4a93-b3bf-367fb04affd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fa844d6c-fbb2-4a93-b3bf-367fb04affd3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4d4aa414-8cb3-4f82-8cba-69d56069ce57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fa844d6c-fbb2-4a93-b3bf-367fb04affd3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4d4aa414-8cb3-4f82-8cba-69d56069ce57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4d4aa414-8cb3-4f82-8cba-69d56069ce57_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4d4aa414-8cb3-4f82-8cba-69d56069ce57" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4d4aa414-8cb3-4f82-8cba-69d56069ce57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4d4aa414-8cb3-4f82-8cba-69d56069ce57" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_93059a96-cc15-4f93-89fc-e2c70a9c813a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_93059a96-cc15-4f93-89fc-e2c70a9c813a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_6df42eba-6e99-41dc-93dd-4e74d797bdf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_6df42eba-6e99-41dc-93dd-4e74d797bdf3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i6716fe2914c84e55b86842e52c33368d_BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_7c22a934-5d5f-4124-80c1-27c873acc972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_7c22a934-5d5f-4124-80c1-27c873acc972" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0223ee09-d535-4428-ac31-88e24cede648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0223ee09-d535-4428-ac31-88e24cede648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_1cf2d5c5-1d8c-4923-9406-a6277b1044a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_1cf2d5c5-1d8c-4923-9406-a6277b1044a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_536b1967-0029-41d2-895f-c61e89a4f54d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_536b1967-0029-41d2-895f-c61e89a4f54d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_536b1967-0029-41d2-895f-c61e89a4f54d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e1506c33-fa01-4dc3-8031-9e6e448a4dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e1506c33-fa01-4dc3-8031-9e6e448a4dce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6466870-a0c6-4901-9119-6e42fb5b5cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6466870-a0c6-4901-9119-6e42fb5b5cdd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended" id="id2d5d68b2ba34fa78dfa215184516ce4_BenefitPlansExpectedBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_77866932-7b6b-4d22-a9b4-f4fa4f4ed687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_77866932-7b6b-4d22-a9b4-f4fa4f4ed687" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_46078a86-25db-4a1c-aca9-691ac4cced64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_46078a86-25db-4a1c-aca9-691ac4cced64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e7018837-8b15-43e9-b1d3-633e263c0fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e7018837-8b15-43e9-b1d3-633e263c0fae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_26189244-d59f-4f94-9b01-5bc25a29e2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_26189244-d59f-4f94-9b01-5bc25a29e2de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bd4a5045-3628-4078-a988-450d0dead8b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bd4a5045-3628-4078-a988-450d0dead8b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2984e0a8-727a-4238-b7b9-565c983b5bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2984e0a8-727a-4238-b7b9-565c983b5bc4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_aab75356-dabf-4d20-be5e-2564f6b1612a" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_aab75356-dabf-4d20-be5e-2564f6b1612a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9c3da163-216e-43e5-a252-9b312e0dca9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9c3da163-216e-43e5-a252-9b312e0dca9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9c3da163-216e-43e5-a252-9b312e0dca9b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_2a0c7de5-369f-4c09-9c82-685c03d91b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:to="loc_us-gaap_DomesticPlanMember_2a0c7de5-369f-4c09-9c82-685c03d91b6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_90754793-346b-4443-852d-4901e1b0ea34" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_2a0c7de5-369f-4c09-9c82-685c03d91b6e" xlink:to="loc_country_US_90754793-346b-4443-852d-4901e1b0ea34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_a1c00563-074e-4c14-b349-d746a020b684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:to="loc_us-gaap_ForeignPlanMember_a1c00563-074e-4c14-b349-d746a020b684" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended" id="i3f92ce1d6379484e8aa3db758631eaa1_BenefitPlansAssumptionsUsedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_ed76b91a-69e6-419f-96d4-c77bd0750b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_ed76b91a-69e6-419f-96d4-c77bd0750b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_1201d226-de6c-467e-9ca1-ab77599f2a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_1201d226-de6c-467e-9ca1-ab77599f2a22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bf75fe20-6c80-490b-b530-68df25f9d127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bf75fe20-6c80-490b-b530-68df25f9d127" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b2e30514-8127-4ac8-b30e-0af1621be25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b2e30514-8127-4ac8-b30e-0af1621be25c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_a2ff824f-9085-4111-8ba6-c0c73929f983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_a2ff824f-9085-4111-8ba6-c0c73929f983" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a3decc89-f891-4dd0-8273-b583a8c18c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a3decc89-f891-4dd0-8273-b583a8c18c24" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9d7800ff-5e19-449c-be8f-a69648f04b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a3decc89-f891-4dd0-8273-b583a8c18c24" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9d7800ff-5e19-449c-be8f-a69648f04b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9d7800ff-5e19-449c-be8f-a69648f04b44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9d7800ff-5e19-449c-be8f-a69648f04b44" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9d7800ff-5e19-449c-be8f-a69648f04b44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9d7800ff-5e19-449c-be8f-a69648f04b44" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_aad2d823-e5dc-4a0a-b95f-02dddd38e5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_aad2d823-e5dc-4a0a-b95f-02dddd38e5a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_28e7275e-c3a8-49ed-8338-1e797f636c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_28e7275e-c3a8-49ed-8338-1e797f636c53" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="extended" id="i1599301bd91d4c56bce11fd2574b2edf_BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_e62e2555-aa42-450a-a604-d0f4af2c70d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_2518748d-0aa9-42d4-9037-ba4b38cb6410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_e62e2555-aa42-450a-a604-d0f4af2c70d2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_2518748d-0aa9-42d4-9037-ba4b38cb6410" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_e62e2555-aa42-450a-a604-d0f4af2c70d2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0fa9f948-b005-4763-8093-265d91f01e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0fa9f948-b005-4763-8093-265d91f01e77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0fa9f948-b005-4763-8093-265d91f01e77_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0fa9f948-b005-4763-8093-265d91f01e77" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0fa9f948-b005-4763-8093-265d91f01e77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3704028b-3a48-4217-aaa8-da501a10d04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0fa9f948-b005-4763-8093-265d91f01e77" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3704028b-3a48-4217-aaa8-da501a10d04f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_130e7ae5-24a6-499d-8587-e83755c36d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3704028b-3a48-4217-aaa8-da501a10d04f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_130e7ae5-24a6-499d-8587-e83755c36d90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_81bb3bb3-fe27-4421-b852-d68fa128084a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_81bb3bb3-fe27-4421-b852-d68fa128084a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_81bb3bb3-fe27-4421-b852-d68fa128084a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_81bb3bb3-fe27-4421-b852-d68fa128084a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_81bb3bb3-fe27-4421-b852-d68fa128084a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_81bb3bb3-fe27-4421-b852-d68fa128084a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_6b25b8bb-1741-4d29-825d-bf26c1462769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:to="loc_us-gaap_DomesticPlanMember_6b25b8bb-1741-4d29-825d-bf26c1462769" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c5940858-d7fe-4527-813d-6b4cc9f7e5fd" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_6b25b8bb-1741-4d29-825d-bf26c1462769" xlink:to="loc_country_US_c5940858-d7fe-4527-813d-6b4cc9f7e5fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0475b323-4ec6-43af-a68e-cdf8936efca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:to="loc_us-gaap_ForeignPlanMember_0475b323-4ec6-43af-a68e-cdf8936efca5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended" id="ieb9282c540b84b3dade0c44ddc4e00ff_BenefitPlansAllocationofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6b526dc6-d485-40cc-b31e-98a5ff50558c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6b526dc6-d485-40cc-b31e-98a5ff50558c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_d116e980-3b8b-49fc-b0da-8cb4d15f6b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_d116e980-3b8b-49fc-b0da-8cb4d15f6b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_625972fe-5e87-4020-8384-cfd14e27d9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_625972fe-5e87-4020-8384-cfd14e27d9d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5dcf704a-80fa-4062-aae7-0edeaa4bd395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_srt_RangeAxis_5dcf704a-80fa-4062-aae7-0edeaa4bd395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5dcf704a-80fa-4062-aae7-0edeaa4bd395_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5dcf704a-80fa-4062-aae7-0edeaa4bd395" xlink:to="loc_srt_RangeMember_5dcf704a-80fa-4062-aae7-0edeaa4bd395_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5dcf704a-80fa-4062-aae7-0edeaa4bd395" xlink:to="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ce5a24be-c1c8-4a33-9752-bb70a09e0c21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:to="loc_srt_MinimumMember_ce5a24be-c1c8-4a33-9752-bb70a09e0c21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c9c65ea-96e1-4a2b-b467-c07beb5fe325" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:to="loc_srt_MaximumMember_0c9c65ea-96e1-4a2b-b467-c07beb5fe325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9d9900ee-c8ad-41db-8006-0a4ac686fed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9d9900ee-c8ad-41db-8006-0a4ac686fed9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_9d9900ee-c8ad-41db-8006-0a4ac686fed9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9d9900ee-c8ad-41db-8006-0a4ac686fed9" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_9d9900ee-c8ad-41db-8006-0a4ac686fed9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9d9900ee-c8ad-41db-8006-0a4ac686fed9" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_7a513eb7-3595-4d39-960c-7fdca01cf1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_7a513eb7-3595-4d39-960c-7fdca01cf1ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_9f89956f-3c75-4c55-bf13-46d28d16b8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_9f89956f-3c75-4c55-bf13-46d28d16b8d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ceb1fc02-c7a8-491a-bf54-623f733f581a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ceb1fc02-c7a8-491a-bf54-623f733f581a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_6fbc6cf7-d3f5-49b3-ae84-ec4b1f55f6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_OtherInvestmentsMember_6fbc6cf7-d3f5-49b3-ae84-ec4b1f55f6ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_0e05e85a-dc62-4950-a37d-a72f25f7890d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_MutualFundMember_0e05e85a-dc62-4950-a37d-a72f25f7890d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMutualFundsMember_a3e82a65-8862-4553-8114-912529ba347a" xlink:href="wst-20201231.xsd#wst_OtherMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_wst_OtherMutualFundsMember_a3e82a65-8862-4553-8114-912529ba347a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77e74d4b-edee-4163-a82f-aea6d6daa8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77e74d4b-edee-4163-a82f-aea6d6daa8f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77e74d4b-edee-4163-a82f-aea6d6daa8f4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77e74d4b-edee-4163-a82f-aea6d6daa8f4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77e74d4b-edee-4163-a82f-aea6d6daa8f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77e74d4b-edee-4163-a82f-aea6d6daa8f4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5e4138da-2b52-44af-bddd-a40a165ac275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5e4138da-2b52-44af-bddd-a40a165ac275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_994139ac-14b6-4427-a4f4-b031f24687da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_994139ac-14b6-4427-a4f4-b031f24687da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_49244c7c-4327-4ded-8f6a-45034bb0ca5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_49244c7c-4327-4ded-8f6a-45034bb0ca5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9ca73d61-eb23-4b67-a886-7dfb7851d00b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9ca73d61-eb23-4b67-a886-7dfb7851d00b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_04c7ca36-0890-4160-a02a-f2fb9d9911c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_04c7ca36-0890-4160-a02a-f2fb9d9911c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_f1993e56-7d3f-429b-ae52-7e2adb1565e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_04c7ca36-0890-4160-a02a-f2fb9d9911c3" xlink:to="loc_us-gaap_DomesticPlanMember_f1993e56-7d3f-429b-ae52-7e2adb1565e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2a2add4f-7a41-47c5-962d-4b5ebe1496ac" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_f1993e56-7d3f-429b-ae52-7e2adb1565e6" xlink:to="loc_country_US_2a2add4f-7a41-47c5-962d-4b5ebe1496ac" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncome"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="extended" id="iab8170bbb9444691b89bae3265110d0f_OtherExpenseIncome"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="extended" id="ib52291e3c28945358611e82102d4ff92_OtherExpenseIncomeTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="extended" id="ib03906b53c054900b8264e8340517887_OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="extended" id="i337544016a34400087693adf171c1b02_OtherExpenseIncomeNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_dee03289-7a42-4d1f-aa45-7d1e8be0cf1a" xlink:href="wst-20201231.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_dee03289-7a42-4d1f-aa45-7d1e8be0cf1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_13ec26ab-616f-4284-81fc-e11754a389e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_13ec26ab-616f-4284-81fc-e11754a389e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48922282-d5eb-4736-99d3-aec61b4b2f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48922282-d5eb-4736-99d3-aec61b4b2f13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount_169d5109-545e-4d45-ada0-4dd9f63dd3a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_EffectOnFutureEarningsAmount_169d5109-545e-4d45-ada0-4dd9f63dd3a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_1847b97a-6c91-4c47-aa05-c7133e20e357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_1847b97a-6c91-4c47-aa05-c7133e20e357" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2b97d0d7-088a-43c1-bee6-ecb864fba9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_SeveranceCosts1_2b97d0d7-088a-43c1-bee6-ecb864fba9e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8cc6b7b9-f8ab-4baa-a2ee-febc57a0ac32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_AssetImpairmentCharges_8cc6b7b9-f8ab-4baa-a2ee-febc57a0ac32" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_12358667-6a0d-4e68-aafe-94d2bed808c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_OtherRestructuringCosts_12358667-6a0d-4e68-aafe-94d2bed808c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_f020aed5-39ac-42fd-b715-45b95f72121e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_f020aed5-39ac-42fd-b715-45b95f72121e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BrazilTaxRecovery_023709ac-38c3-4dca-83e5-bcdbb15548c6" xlink:href="wst-20201231.xsd#wst_BrazilTaxRecovery"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_wst_BrazilTaxRecovery_023709ac-38c3-4dca-83e5-bcdbb15548c6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentAndLicensingIncome_e8010d8b-3bbc-4435-a40b-6e9c498a5559" xlink:href="wst-20201231.xsd#wst_DevelopmentAndLicensingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_wst_DevelopmentAndLicensingIncome_e8010d8b-3bbc-4435-a40b-6e9c498a5559" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c1079ad1-cddc-417d-aeff-c9a90421251b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c1079ad1-cddc-417d-aeff-c9a90421251b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_549655dc-0ec3-48db-945f-510090ff7922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringCharges_549655dc-0ec3-48db-945f-510090ff7922" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:to="loc_srt_RangeAxis_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d" xlink:to="loc_srt_RangeMember_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d" xlink:to="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ef90031-7764-4f2a-89a4-215a1e6d2db8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:to="loc_srt_MinimumMember_6ef90031-7764-4f2a-89a4-215a1e6d2db8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e8eb8be1-c164-44c0-ac61-ec7a1701940b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:to="loc_srt_MaximumMember_e8eb8be1-c164-44c0-ac61-ec7a1701940b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_53938b61-be57-4251-b146-6b2bde1f9357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:to="loc_us-gaap_RestructuringPlanAxis_53938b61-be57-4251-b146-6b2bde1f9357" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_53938b61-be57-4251-b146-6b2bde1f9357_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_53938b61-be57-4251-b146-6b2bde1f9357" xlink:to="loc_us-gaap_RestructuringPlanDomain_53938b61-be57-4251-b146-6b2bde1f9357_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_53938b61-be57-4251-b146-6b2bde1f9357" xlink:to="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_afd93d21-0028-40ef-80be-4029499152cb" xlink:href="wst-20201231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:to="loc_wst_The2020RestructuringPlanMember_afd93d21-0028-40ef-80be-4029499152cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2018RestructuringPlanMember_b88f5080-a40e-4480-a597-084836fdb414" xlink:href="wst-20201231.xsd#wst_The2018RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:to="loc_wst_The2018RestructuringPlanMember_b88f5080-a40e-4480-a597-084836fdb414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_5ea750a0-a495-4257-8864-63c87798dd60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:to="loc_us-gaap_NatureOfExpenseAxis_5ea750a0-a495-4257-8864-63c87798dd60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_5ea750a0-a495-4257-8864-63c87798dd60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_5ea750a0-a495-4257-8864-63c87798dd60" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_5ea750a0-a495-4257-8864-63c87798dd60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_df2b9076-1c46-40f8-8bc8-4d9f2ba4e0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_5ea750a0-a495-4257-8864-63c87798dd60" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_df2b9076-1c46-40f8-8bc8-4d9f2ba4e0e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_a7edba00-8a84-4c9f-a1e3-7fa3837ceed2" xlink:href="wst-20201231.xsd#wst_SmartDoseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_df2b9076-1c46-40f8-8bc8-4d9f2ba4e0e8" xlink:to="loc_wst_SmartDoseMember_a7edba00-8a84-4c9f-a1e3-7fa3837ceed2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="extended" id="i5fdd5bae37f948b5bdae10e39af6af03_OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_44d632e6-c152-4d2e-bdb8-15bcc756cddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_44d632e6-c152-4d2e-bdb8-15bcc756cddc" xlink:to="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7bc78ccd-20df-458b-95b4-8ac0f62c5a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_RestructuringReserve_7bc78ccd-20df-458b-95b4-8ac0f62c5a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_49796ae3-2c12-49c3-b9f7-f6b32151936b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_RestructuringCharges_49796ae3-2c12-49c3-b9f7-f6b32151936b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_ba63716d-bf95-49d8-9a67-19154fa25cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_PaymentsForRestructuring_ba63716d-bf95-49d8-9a67-19154fa25cd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_20b773ce-b242-4ab0-9db6-6828fb2d6854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_20b773ce-b242-4ab0-9db6-6828fb2d6854" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_395243fb-9213-49ea-a575-5f1663073af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_44d632e6-c152-4d2e-bdb8-15bcc756cddc" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ed81e70d-bb7e-4abe-ad59-66fda9866e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:to="loc_us-gaap_RestructuringPlanAxis_ed81e70d-bb7e-4abe-ad59-66fda9866e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ed81e70d-bb7e-4abe-ad59-66fda9866e37_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_ed81e70d-bb7e-4abe-ad59-66fda9866e37" xlink:to="loc_us-gaap_RestructuringPlanDomain_ed81e70d-bb7e-4abe-ad59-66fda9866e37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_ed81e70d-bb7e-4abe-ad59-66fda9866e37" xlink:to="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_c879b09a-6dbd-48b9-83fe-0d47e83c9576" xlink:href="wst-20201231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:to="loc_wst_The2020RestructuringPlanMember_c879b09a-6dbd-48b9-83fe-0d47e83c9576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2018RestructuringPlanMember_5afd84f5-3753-412c-8f36-d94d25087b7c" xlink:href="wst-20201231.xsd#wst_The2018RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:to="loc_wst_The2018RestructuringPlanMember_5afd84f5-3753-412c-8f36-d94d25087b7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_3254b696-cb9f-475f-8c27-46c333cb8353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:to="loc_us-gaap_EmployeeSeveranceMember_3254b696-cb9f-475f-8c27-46c333cb8353" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_bb737d29-0771-4465-8a22-0cc2adc6bbb2" xlink:href="wst-20201231.xsd#wst_AssetRelatedChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:to="loc_wst_AssetRelatedChargesMember_bb737d29-0771-4465-8a22-0cc2adc6bbb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_1b63c760-b6b2-4bb9-93b9-daf794c7eef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:to="loc_us-gaap_OtherRestructuringMember_1b63c760-b6b2-4bb9-93b9-daf794c7eef3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended" id="i82da46f1492240719840bbdeae4a6f91_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="extended" id="i17172057b5dc4b05a658886e658bb820_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i991c6dda4c774c2a9f1d590a5d7725ff_IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="iaadd34101c0b4f95bcf0c09f4743e132_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ab24a400-b36c-4c83-a84b-4b701e4b6f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ab24a400-b36c-4c83-a84b-4b701e4b6f86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_fe23b2df-ef90-468b-ac0a-881db6dbf6ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_fe23b2df-ef90-468b-ac0a-881db6dbf6ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_977503a6-5b68-4c30-b429-ea999e82f4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_977503a6-5b68-4c30-b429-ea999e82f4b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_049f3d8c-c880-4323-8dd3-cafadbc2c023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_049f3d8c-c880-4323-8dd3-cafadbc2c023" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_eb3e46d0-3c34-443e-b872-d1b6d613c05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_eb3e46d0-3c34-443e-b872-d1b6d613c05c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cd966e04-c2ee-4196-9957-0f144702b506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cd966e04-c2ee-4196-9957-0f144702b506" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_10d87063-0fca-46b0-b8f7-39a68947a69f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_10d87063-0fca-46b0-b8f7-39a68947a69f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_9546525c-0d3c-47a9-98b5-8720dbaa2ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_9546525c-0d3c-47a9-98b5-8720dbaa2ca0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_860662b9-bfc7-4848-ab00-adb88466d41e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_860662b9-bfc7-4848-ab00-adb88466d41e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_406fc788-ef48-4442-b793-55147ceadcc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_OperatingLossCarryforwards_406fc788-ef48-4442-b793-55147ceadcc9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_59cade28-8506-4e14-b020-3e0aad7e52ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_59cade28-8506-4e14-b020-3e0aad7e52ed" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_a05899f7-ea9b-47f7-94a8-c32316bfc0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_a05899f7-ea9b-47f7-94a8-c32316bfc0e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b46fcd79-3186-4b26-9e3c-12d58e03d63b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b46fcd79-3186-4b26-9e3c-12d58e03d63b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_b4210a5e-1306-45f9-9619-04ecda3e8ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_b4210a5e-1306-45f9-9619-04ecda3e8ca0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a62cc67e-2f10-42b8-b654-02d8aefe0a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a62cc67e-2f10-42b8-b654-02d8aefe0a63" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_7261f52a-3e9d-485c-8648-724932457540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_7261f52a-3e9d-485c-8648-724932457540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_7261f52a-3e9d-485c-8648-724932457540_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_7261f52a-3e9d-485c-8648-724932457540" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_7261f52a-3e9d-485c-8648-724932457540_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_f742558d-d933-42ce-a227-eb679ba1e164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_7261f52a-3e9d-485c-8648-724932457540" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_f742558d-d933-42ce-a227-eb679ba1e164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_b3e2e677-8523-4fd5-bcd8-bda22665c01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f742558d-d933-42ce-a227-eb679ba1e164" xlink:to="loc_us-gaap_ResearchMember_b3e2e677-8523-4fd5-bcd8-bda22665c01c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis_517eac73-0453-4519-a90a-55647aa47833" xlink:href="wst-20201231.xsd#wst_ExpirationPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:to="loc_wst_ExpirationPeriodAxis_517eac73-0453-4519-a90a-55647aa47833" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_517eac73-0453-4519-a90a-55647aa47833_default" xlink:href="wst-20201231.xsd#wst_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_wst_ExpirationPeriodAxis_517eac73-0453-4519-a90a-55647aa47833" xlink:to="loc_wst_ExpirationPeriodDomain_517eac73-0453-4519-a90a-55647aa47833_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:href="wst-20201231.xsd#wst_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_wst_ExpirationPeriodAxis_517eac73-0453-4519-a90a-55647aa47833" xlink:to="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2021Member_c0903828-1319-4257-96fd-193b9b25e1e1" xlink:href="wst-20201231.xsd#wst_Year2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:to="loc_wst_Year2021Member_c0903828-1319-4257-96fd-193b9b25e1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2021Member_a75b7dbe-4073-4b14-aace-919622bcd46b" xlink:href="wst-20201231.xsd#wst_YearAfter2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:to="loc_wst_YearAfter2021Member_a75b7dbe-4073-4b14-aace-919622bcd46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_20aa21bd-a4c4-4087-b636-b9acf855c64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_20aa21bd-a4c4-4087-b636-b9acf855c64b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_20aa21bd-a4c4-4087-b636-b9acf855c64b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_20aa21bd-a4c4-4087-b636-b9acf855c64b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_20aa21bd-a4c4-4087-b636-b9acf855c64b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_20aa21bd-a4c4-4087-b636-b9acf855c64b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f72d1cc0-f25d-4787-9984-949dbf5e0ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f72d1cc0-f25d-4787-9984-949dbf5e0ed4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2c2bc39a-08ca-4e58-a8a7-103841af5ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:to="loc_us-gaap_ForeignCountryMember_2c2bc39a-08ca-4e58-a8a7-103841af5ddb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended" id="i80a2b5bcd5bb483b830b3df0c78f06e7_IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended" id="ic1034d7ce23642658baee6b07a6fcaed_IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i0d28be1edf934286ba32889f05741b96_IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended" id="i6a817de0f02c4e2da6619d22e8682ec9_IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20201231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended" id="ia7f7628c432d4f8aaf6af413aaeb5706_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="id2201029ed334b42a58ab58a8dd4f715_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_2b01c85e-387c-44bb-9328-5630124cca86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_2b01c85e-387c-44bb-9328-5630124cca86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_dec51237-bbc8-4a7b-9cc0-9891b3936256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_dec51237-bbc8-4a7b-9cc0-9891b3936256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5b516b75-0568-4d32-8a8e-4fb40761e8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_LineOfCredit_5b516b75-0568-4d32-8a8e-4fb40761e8cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_583cfcbb-25e7-47d7-b0bf-c79cc152a82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_583cfcbb-25e7-47d7-b0bf-c79cc152a82b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable_6ef22abf-a30e-400a-8096-d36ee549720b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_LossContingencyReceivable_6ef22abf-a30e-400a-8096-d36ee549720b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod_49f75a72-802e-4f59-b1c1-5488eaf27a43" xlink:href="wst-20201231.xsd#wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod_49f75a72-802e-4f59-b1c1-5488eaf27a43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_d060206a-24fd-45c2-a73d-329ea628fca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_d060206a-24fd-45c2-a73d-329ea628fca6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb0234b-ba19-455e-bac7-0d84f7d379fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb0234b-ba19-455e-bac7-0d84f7d379fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea9b17d8-9560-4e36-9312-b3ebefcb52f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:to="loc_us-gaap_CreditFacilityAxis_ea9b17d8-9560-4e36-9312-b3ebefcb52f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ea9b17d8-9560-4e36-9312-b3ebefcb52f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ea9b17d8-9560-4e36-9312-b3ebefcb52f8" xlink:to="loc_us-gaap_CreditFacilityDomain_ea9b17d8-9560-4e36-9312-b3ebefcb52f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b750cf9f-5e54-459a-9e9a-2b55047356d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ea9b17d8-9560-4e36-9312-b3ebefcb52f8" xlink:to="loc_us-gaap_CreditFacilityDomain_b750cf9f-5e54-459a-9e9a-2b55047356d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_43b40dec-86a6-4bff-b269-43fefda081f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b750cf9f-5e54-459a-9e9a-2b55047356d1" xlink:to="loc_us-gaap_LetterOfCreditMember_43b40dec-86a6-4bff-b269-43fefda081f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7fbaffd5-cb50-4980-9041-23196ae21e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7fbaffd5-cb50-4980-9041-23196ae21e00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7fbaffd5-cb50-4980-9041-23196ae21e00_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7fbaffd5-cb50-4980-9041-23196ae21e00" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7fbaffd5-cb50-4980-9041-23196ae21e00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec906dc2-7384-40ee-bcec-ba0bf1fd6d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7fbaffd5-cb50-4980-9041-23196ae21e00" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec906dc2-7384-40ee-bcec-ba0bf1fd6d32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_ed7401aa-11b9-4985-8b2b-3378332d3950" xlink:href="wst-20201231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec906dc2-7384-40ee-bcec-ba0bf1fd6d32" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_ed7401aa-11b9-4985-8b2b-3378332d3950" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_99e5d4a6-f57c-444d-bfdd-4664b838b8c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_99e5d4a6-f57c-444d-bfdd-4664b838b8c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_99e5d4a6-f57c-444d-bfdd-4664b838b8c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_99e5d4a6-f57c-444d-bfdd-4664b838b8c0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_99e5d4a6-f57c-444d-bfdd-4664b838b8c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_bedd1ea6-c586-4df6-9781-d0a3c7624c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_99e5d4a6-f57c-444d-bfdd-4664b838b8c0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_bedd1ea6-c586-4df6-9781-d0a3c7624c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember_f7a7ecaa-d49a-4851-816b-7ddb40f3900d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_bedd1ea6-c586-4df6-9781-d0a3c7624c79" xlink:to="loc_us-gaap_InsuranceClaimsMember_f7a7ecaa-d49a-4851-816b-7ddb40f3900d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformation"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended" id="i137c903251104aa683bb0746cf6385c1_SegmentInformation"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended" id="i832d6789791d4e889cc85189b9bd4f25_SegmentInformationTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="ice768f9d547944f890f461773ff97dd1_SegmentInformationNarrativeDetails"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended" id="i4132f4ed3acc482cb54cee4ba25afcce_SegmentInformationSalesbyProductGroupDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_7610bfd1-2326-4946-b8bd-64836f61c33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d83889f8-a23c-40ea-8887-f7b64dce8b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_7610bfd1-2326-4946-b8bd-64836f61c33b" xlink:to="loc_us-gaap_Revenues_d83889f8-a23c-40ea-8887-f7b64dce8b8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_7610bfd1-2326-4946-b8bd-64836f61c33b" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4333a4b2-5c91-46d9-a844-ddb10431ff51" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:to="loc_srt_ConsolidationItemsAxis_4333a4b2-5c91-46d9-a844-ddb10431ff51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4333a4b2-5c91-46d9-a844-ddb10431ff51_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4333a4b2-5c91-46d9-a844-ddb10431ff51" xlink:to="loc_srt_ConsolidationItemsDomain_4333a4b2-5c91-46d9-a844-ddb10431ff51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4333a4b2-5c91-46d9-a844-ddb10431ff51" xlink:to="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9ae4d796-75b0-4ae7-88d8-145533ce30ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:to="loc_us-gaap_OperatingSegmentsMember_9ae4d796-75b0-4ae7-88d8-145533ce30ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_78bf9348-dd7b-4291-849e-3ea5043a64b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:to="loc_us-gaap_IntersegmentEliminationMember_78bf9348-dd7b-4291-849e-3ea5043a64b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_513f7a59-f0d6-49ec-ac58-00102f0a0cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_513f7a59-f0d6-49ec-ac58-00102f0a0cc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_513f7a59-f0d6-49ec-ac58-00102f0a0cc2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_513f7a59-f0d6-49ec-ac58-00102f0a0cc2" xlink:to="loc_us-gaap_SegmentDomain_513f7a59-f0d6-49ec-ac58-00102f0a0cc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_513f7a59-f0d6-49ec-ac58-00102f0a0cc2" xlink:to="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_36edcaa4-82fd-4463-b505-3ebf2819c3f1" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:to="loc_wst_ProprietaryProductsMember_36edcaa4-82fd-4463-b505-3ebf2819c3f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_23d27eca-a8d9-48e4-84e8-c06f78d98af8" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:to="loc_wst_ContractManufacturedProductsMember_23d27eca-a8d9-48e4-84e8-c06f78d98af8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="extended" id="i6f7a4833cf7d41bca8fbf61917e51dec_SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8705551d-cc45-44d6-94d3-39ce51c4f6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:to="loc_us-gaap_Revenues_8705551d-cc45-44d6-94d3-39ce51c4f6bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_9dc56d6c-f3b5-4613-9a89-1f1b8459858e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:to="loc_us-gaap_NoncurrentAssets_9dc56d6c-f3b5-4613-9a89-1f1b8459858e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff6d5244-2e01-4f19-91e7-2896d8724b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff6d5244-2e01-4f19-91e7-2896d8724b93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff6d5244-2e01-4f19-91e7-2896d8724b93" xlink:to="loc_srt_StatementGeographicalAxis_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c" xlink:to="loc_srt_SegmentGeographicalDomain_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c" xlink:to="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_be194db0-0b8d-42a0-a7b5-ffdd21914244" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_US_be194db0-0b8d-42a0-a7b5-ffdd21914244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_bc92ee4b-4e31-4423-9cf8-61bf585905c9" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_DE_bc92ee4b-4e31-4423-9cf8-61bf585905c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_eb4b5ca0-9fb4-4699-9ea7-5185bf7287ce" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_IE_eb4b5ca0-9fb4-4699-9ea7-5185bf7287ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_4787eddd-1b17-4cb2-a513-3bf03eba82a8" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_FR_4787eddd-1b17-4cb2-a513-3bf03eba82a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember_89dc428c-67ee-4042-8e91-085c0f8be559" xlink:href="wst-20201231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_wst_OtherEuropeCountriesMember_89dc428c-67ee-4042-8e91-085c0f8be559" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember_cfb4b3ce-90a8-41ec-8e4b-e9998f7f4d3b" xlink:href="wst-20201231.xsd#wst_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_wst_OtherCountriesMember_cfb4b3ce-90a8-41ec-8e4b-e9998f7f4d3b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended" id="i0cd026da38984710a57edcc5973cd769_SegmentInformationSegmentFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4a57a220-fd06-4dde-8ba3-b9fa10bc36a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_OperatingIncomeLoss_4a57a220-fd06-4dde-8ba3-b9fa10bc36a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ae4da2a7-4d8e-4305-9693-b2d797eff96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_ShareBasedCompensation_ae4da2a7-4d8e-4305-9693-b2d797eff96f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7d08389e-0d11-4cf1-b36f-883bbec2bf00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7d08389e-0d11-4cf1-b36f-883bbec2bf00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b019c042-78d0-4480-97a6-409dfba11886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_RestructuringCharges_b019c042-78d0-4480-97a6-409dfba11886" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9855a4f1-8e41-4444-9238-4c357e8d28e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9855a4f1-8e41-4444-9238-4c357e8d28e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CostInvestmentImpairment_fddbe164-e484-4aca-89eb-eafdbab685e4" xlink:href="wst-20201231.xsd#wst_CostInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_wst_CostInvestmentImpairment_fddbe164-e484-4aca-89eb-eafdbab685e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9a45ec83-c8bf-4068-8fbb-915d0c60dc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9a45ec83-c8bf-4068-8fbb-915d0c60dc69" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GainLossOnArgentinaCurrencyDevaluation_e373a065-d3b1-413f-84ed-b918856ac0be" xlink:href="wst-20201231.xsd#wst_GainLossOnArgentinaCurrencyDevaluation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_wst_GainLossOnArgentinaCurrencyDevaluation_e373a065-d3b1-413f-84ed-b918856ac0be" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BrazilTaxRecovery_3ac0197e-9db0-48a8-884c-eab8a20785b6" xlink:href="wst-20201231.xsd#wst_BrazilTaxRecovery"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_wst_BrazilTaxRecovery_3ac0197e-9db0-48a8-884c-eab8a20785b6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6faaa30b-693c-4c3b-92b8-830efb14dbf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6faaa30b-693c-4c3b-92b8-830efb14dbf5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a93f22e0-c412-4a0f-aeca-1cc20871418f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a93f22e0-c412-4a0f-aeca-1cc20871418f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d6024dc0-90d3-417f-b164-6de63c019177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_Assets_d6024dc0-90d3-417f-b164-6de63c019177" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b5871410-fe29-49e5-bd7d-290900a5bfe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b5871410-fe29-49e5-bd7d-290900a5bfe9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_703dbba7-5ced-4c4a-bded-47dd3516b300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_703dbba7-5ced-4c4a-bded-47dd3516b300" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e7ec3338-924a-4026-8ec0-ed75db15e29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e7ec3338-924a-4026-8ec0-ed75db15e29c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e7ec3338-924a-4026-8ec0-ed75db15e29c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e7ec3338-924a-4026-8ec0-ed75db15e29c" xlink:to="loc_us-gaap_SegmentDomain_e7ec3338-924a-4026-8ec0-ed75db15e29c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e7ec3338-924a-4026-8ec0-ed75db15e29c" xlink:to="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_6b08aa44-cf7b-4c0e-aa31-c68c82615cc4" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:to="loc_wst_ProprietaryProductsMember_6b08aa44-cf7b-4c0e-aa31-c68c82615cc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_13ccf65f-e2d4-4bfb-b5b5-47c585710594" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:to="loc_wst_ContractManufacturedProductsMember_13ccf65f-e2d4-4bfb-b5b5-47c585710594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_355571c0-86b4-4ab6-bf8f-acdb30707aa9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:to="loc_srt_ConsolidationItemsAxis_355571c0-86b4-4ab6-bf8f-acdb30707aa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_355571c0-86b4-4ab6-bf8f-acdb30707aa9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_355571c0-86b4-4ab6-bf8f-acdb30707aa9" xlink:to="loc_srt_ConsolidationItemsDomain_355571c0-86b4-4ab6-bf8f-acdb30707aa9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_355571c0-86b4-4ab6-bf8f-acdb30707aa9" xlink:to="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c070a33a-8389-4ca7-89ad-9d95b0f93b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:to="loc_us-gaap_OperatingSegmentsMember_c070a33a-8389-4ca7-89ad-9d95b0f93b76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_19b1f6b8-c05c-49ce-a992-a5b5511449c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:to="loc_us-gaap_CorporateNonSegmentMember_19b1f6b8-c05c-49ce-a992-a5b5511449c9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnaudited"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited" xlink:type="extended" id="ic7adf38adeb7430aade50a6641815bdb_QuarterlyOperatingandPerShareDataUnaudited"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnauditedTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables" xlink:type="extended" id="i66e308bf061b4d23b3a90886c5ca7c20_QuarterlyOperatingandPerShareDataUnauditedTables"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnauditedDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails" xlink:type="extended" id="iffd9d0d84dfd4cf39205911646d94afe_QuarterlyOperatingandPerShareDataUnauditedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3bd09536-fc10-41c7-9a60-2c37a97d453e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3bd09536-fc10-41c7-9a60-2c37a97d453e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bb006cbc-76a6-4277-b738-213b73b79510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_GrossProfit_bb006cbc-76a6-4277-b738-213b73b79510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cc52c9d4-372a-4a53-841c-072f88ad9a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_NetIncomeLoss_cc52c9d4-372a-4a53-841c-072f88ad9a8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ed3925f0-5a8c-4b0d-b555-2918fe96ce32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_EarningsPerShareBasic_ed3925f0-5a8c-4b0d-b555-2918fe96ce32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c21ed34c-5bb8-4061-85fd-fac3b4fbc959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c21ed34c-5bb8-4061-85fd-fac3b4fbc959" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionSettlementAndRelatedCharges_2d4f435f-e08a-4362-995d-3eb8b93d4b11" xlink:href="wst-20201231.xsd#wst_PensionSettlementAndRelatedCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PensionSettlementAndRelatedCharges_2d4f435f-e08a-4362-995d-3eb8b93d4b11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare_506d25fd-0044-4c69-82ff-684a01c84ee3" xlink:href="wst-20201231.xsd#wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare_506d25fd-0044-4c69-82ff-684a01c84ee3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2ad6916f-7f1a-4601-9ae2-c47de6982215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2ad6916f-7f1a-4601-9ae2-c47de6982215" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare_ad08fc35-1338-4e6d-a838-8a578e13f7f6" xlink:href="wst-20201231.xsd#wst_AmortizationExpenseImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare_ad08fc35-1338-4e6d-a838-8a578e13f7f6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromStockBasedCompensation_970ce17c-eb32-4cd4-a66c-6741d49cbccb" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromStockBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_IncomeTaxBenefitFromStockBasedCompensation_970ce17c-eb32-4cd4-a66c-6741d49cbccb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare_4ca143ab-5829-4145-bce0-aa2d596c0366" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare_4ca143ab-5829-4145-bce0-aa2d596c0366" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6935e275-c633-4abe-ae90-eb276cfb9194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6935e275-c633-4abe-ae90-eb276cfb9194" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare_9685f418-13d9-4964-9f80-ac6dbbffa93f" xlink:href="wst-20201231.xsd#wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare_9685f418-13d9-4964-9f80-ac6dbbffa93f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndSeveranceRelatedCharges_b379fd70-636d-4ebc-a178-1b33cd4bb81c" xlink:href="wst-20201231.xsd#wst_RestructuringAndSeveranceRelatedCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_RestructuringAndSeveranceRelatedCharges_b379fd70-636d-4ebc-a178-1b33cd4bb81c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare_9848f798-b513-4b58-a66e-7dbf5e3c59e9" xlink:href="wst-20201231.xsd#wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare_9848f798-b513-4b58-a66e-7dbf5e3c59e9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency_b0faa2c8-e90a-4c3e-af2e-1351868e03c1" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency_b0faa2c8-e90a-4c3e-af2e-1351868e03c1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare_98eddee2-323f-4aca-a0f7-119f4a41fd36" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare_98eddee2-323f-4aca-a0f7-119f4a41fd36" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f1351217-8d0f-44af-a645-8e81edc939a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f1351217-8d0f-44af-a645-8e81edc939a0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare_6f3d0010-424a-4905-97c4-8ce61f397a38" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare_6f3d0010-424a-4905-97c4-8ce61f397a38" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FixedAssetImpairmentFromRestructuring_e014b963-5515-4a82-a5d1-dc83b4f5bd1b" xlink:href="wst-20201231.xsd#wst_FixedAssetImpairmentFromRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_FixedAssetImpairmentFromRestructuring_e014b963-5515-4a82-a5d1-dc83b4f5bd1b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare_15a34366-b744-4f19-a59f-a6ce7bbfb6c6" xlink:href="wst-20201231.xsd#wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare_15a34366-b744-4f19-a59f-a6ce7bbfb6c6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentOfExciseTaxes_4d72a1aa-7347-4754-9f9f-f4bd966d9522" xlink:href="wst-20201231.xsd#wst_PaymentOfExciseTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PaymentOfExciseTaxes_4d72a1aa-7347-4754-9f9f-f4bd966d9522" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare_34f4e9ea-48cd-40f7-ba8c-da48c934904c" xlink:href="wst-20201231.xsd#wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare_34f4e9ea-48cd-40f7-ba8c-da48c934904c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d19fe083-91c4-4c19-8e53-a91de4663dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d19fe083-91c4-4c19-8e53-a91de4663dc8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_15c1a8c0-b37b-4e58-8663-bde8341726cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d19fe083-91c4-4c19-8e53-a91de4663dc8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_15c1a8c0-b37b-4e58-8663-bde8341726cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_15c1a8c0-b37b-4e58-8663-bde8341726cb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_15c1a8c0-b37b-4e58-8663-bde8341726cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_15c1a8c0-b37b-4e58-8663-bde8341726cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_15c1a8c0-b37b-4e58-8663-bde8341726cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_692c94c6-37ae-43fc-b557-5573bb5ca9d5" xlink:href="wst-20201231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_692c94c6-37ae-43fc-b557-5573bb5ca9d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_981d5b07-0b78-4ef3-9d0c-beb1a2c7b798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_981d5b07-0b78-4ef3-9d0c-beb1a2c7b798" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="wst-20201231.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended" id="i6fbd445ae41d49d4a0c9a5ea21489bc6_ScheduleIIValuationandQualifyingAccounts"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended" id="idbb2d12fc07c45d58461a6efd470838c_ScheduleIIValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e37df14e-a295-44d9-9aba-14de28458429" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e37df14e-a295-44d9-9aba-14de28458429" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a5d96002-b268-4b32-a837-526203aef263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_a5d96002-b268-4b32-a837-526203aef263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_302a51dc-d5a5-4718-8135-115fb912234e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_302a51dc-d5a5-4718-8135-115fb912234e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_79841771-209d-4220-8ce2-7c0ff79088e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_79841771-209d-4220-8ce2-7c0ff79088e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_cb184c12-39b2-44f2-aaa1-5c0c22edfef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_340b184f-ab90-4a51-b7d9-221f30a08cb7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e37df14e-a295-44d9-9aba-14de28458429" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_340b184f-ab90-4a51-b7d9-221f30a08cb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f3566eb-a479-47ca-917b-5b170fe7fd28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_340b184f-ab90-4a51-b7d9-221f30a08cb7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f3566eb-a479-47ca-917b-5b170fe7fd28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_6f3566eb-a479-47ca-917b-5b170fe7fd28_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f3566eb-a479-47ca-917b-5b170fe7fd28" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_6f3566eb-a479-47ca-917b-5b170fe7fd28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f3566eb-a479-47ca-917b-5b170fe7fd28" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bbece5d0-24a0-48fb-8c06-aeb02f4cfc94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bbece5d0-24a0-48fb-8c06-aeb02f4cfc94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_8df96ffa-1e09-46e4-a822-885832dfec87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_8df96ffa-1e09-46e4-a822-885832dfec87" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>wst-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a80a1d85-d222-4f41-ba9f-844636cf1f8b,g:17422749-133e-4fe3-9091-dc8e0f45c575-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d55c6f67-1a32-4cc0-a112-ef6bdc29e62a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ca59ea52-17b2-4a9b-81fc-298e94cd958b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_75c16df4-62bf-4106-b0e4-285eab7988f0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target allocation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4534f5f7-0d73-49f9-ae09-a803c3f1c34d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of total options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0a102df1-929f-484d-bc1f-c188db437c0c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_1f618831-b810-4858-b29d-022870a638f6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected contribution to the plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_3612f5ca-c48c-496d-ba78-0d43e00ec31a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_99fcc049-e703-4c65-9d85-b0405ec8d75c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_f5a758c5-0d03-4d31-a12a-a50aefbe01b7_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_1c5769c0-522c-4f47-91ef-fee920153dfc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Deferred Compensation, All Types [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8e92d7f-bc45-4d67-bf27-a55b3d007c85_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_0b6f71b7-1a80-46bc-a02d-6bde307c8b4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from impact of tax law changes enacted</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7ccac129-b3a8-4bad-9456-f3be69291aea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit for impact of tax law changes enacted</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_47218d6a-9a97-4e1c-a7e5-825837d3c539_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_6d60c701-8d97-4931-9360-e2e69267ee12_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred income - (increase) decrease</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_34555d14-1de9-4b45-8997-5966a2235d08_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_964332dd-eed1-4e17-9ad5-901ef5b431eb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de79c775-5361-47b9-90f4-e3cb1218ccd0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_d07971e1-22c8-4966-a2a4-563aa02a9684_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in affiliated companies</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_c5fd2ec4-ff63-4930-8e2d-83c3d4b7b459_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase in investment in affiliated companies in cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9295eaac-2f78-4813-b1d9-8d86fda212a0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_01f42f36-4677-417c-8108-e3aa8da5e705_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate healthcare cost trend rate, net periodic benefit cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:to="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EnergyAxis_f63ea7d3-116b-4d5e-85ef-c01dd370a84b_terseLabel_en-US" xlink:label="lab_srt_EnergyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Axis]</link:label>
    <link:label id="lab_srt_EnergyAxis_label_en-US" xlink:label="lab_srt_EnergyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EnergyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EnergyAxis" xlink:to="lab_srt_EnergyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SalesProjectionsMember_21b51d88-0c5d-42cc-9575-42fee3683866_terseLabel_en-US" xlink:label="lab_wst_SalesProjectionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Projections</link:label>
    <link:label id="lab_wst_SalesProjectionsMember_label_en-US" xlink:label="lab_wst_SalesProjectionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Projections [Member]</link:label>
    <link:label id="lab_wst_SalesProjectionsMember_documentation_en-US" xlink:label="lab_wst_SalesProjectionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Projections [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesProjectionsMember" xlink:href="wst-20201231.xsd#wst_SalesProjectionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SalesProjectionsMember" xlink:to="lab_wst_SalesProjectionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b4ba6d5c-ca4a-46d0-bb3e-84b10e02260d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_59c97a1e-e0e0-4e46-8ba7-98362f1ccffb_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5be49569-02f2-450e-95e1-5aa2d9de6eaf_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_03f745c3-be46-45c2-a441-2a7ea04d7af0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_35cd5266-89e3-45ae-acc5-721293f63ac2_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_bdd78505-05dc-47f3-8357-935b32ea70f3_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_51411880-5331-42b5-93fa-3779e9c62854_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments above/(below) target (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_9506f6b9-b756-45d3-816e-92d605c16eb6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_88e80a40-8c7d-42ee-89a5-e9cfe3bcac4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_c0674b40-7bdf-47ff-a939-f1779f381df3_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5108aae0-4ff8-491c-9cf8-22ffd0a7cf21_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5f3cf558-d893-4c15-80c6-af5f5182fbda_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_6c43edef-bba8-41ee-8335-f4ddc3791d56_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_7680aea5-da03-4d35-a407-01fdc43fcd67_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_14f72fd5-42d0-4d97-9611-50224a257c02_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f815fe13-d0da-4cae-b470-dafd2f17bb24_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_42156889-c980-425c-a577-2af1187c98fc_terseLabel_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:href="wst-20201231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:to="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09e8fd11-2d81-49be-8fd3-b6ca2b8d2ab6_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1fda1ba7-108c-4778-bfa4-562ee242bdd4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f8337122-5c96-4a41-b59c-d9e1bbba1eab_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_dce2dad2-23c4-4f9d-856c-3014f4b38967_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity related to stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3b05175e-c1ab-4852-a181-55b4aa608964_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_5a37ae68-1cdb-4570-8adc-363c075f4257_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_e8fe75f5-8f73-439f-be12-064b839f56a5_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed healthcare cost trend rate, net periodic benefit cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:to="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_4367974b-3a0f-4095-86b2-4a7b20be5454_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_909c31fe-904c-463b-94a7-b0e17f1a34ae_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_b953f3dc-2612-488a-9a32-81742f803e84_terseLabel_en-US" xlink:label="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reduced for each award granted (in shares)</link:label>
    <link:label id="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_label_en-US" xlink:label="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction In Number Of Shares Available For Grant For Each Award Granted</link:label>
    <link:label id="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_documentation_en-US" xlink:label="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction In Number Of Shares Available For Grant For Each Award Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:href="wst-20201231.xsd#wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:to="lab_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_9ff1a5f7-3a21-46d2-a5d4-437d70b6954c_terseLabel_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C notes, due July 5, 2027 (4.02%)</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_label_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_documentation_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member" xlink:href="wst-20201231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorCNotesDue2027Member" xlink:to="lab_wst_SeniorCNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d97fc30a-7a88-4ee8-8b61-9a5225160f06_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired finite-lived intangible assets, weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8a98c2bf-f646-4924-9c25-2595415d942d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_81f449cd-2cc0-4559-8aca-f4d2440fb9f0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_431e0284-25e6-405e-9f33-518fc8f63653_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0882fe0f-6e0b-4cfd-9001-a0058028be41_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a64fef60-20d4-413b-b98d-7d1bc47cf81c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8d825040-50ea-4907-a5ea-f8ce01b4268d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_30ee9f71-5897-4054-972a-84dd2989a9c5_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense for all nonvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionMember_df99a06e-f2ca-4aae-8a16-f07e17312198_terseLabel_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Call Options</link:label>
    <link:label id="lab_us-gaap_OptionMember_label_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Held [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionMember" xlink:to="lab_us-gaap_OptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_eee1fce7-f07c-4837-baf5-446481af6c57_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_ab7a1731-3c0e-47a6-b907-8e6201352056_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_533f036e-1aa9-4727-9e29-05d46751130f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_074ca6ba-0cbf-49a7-830a-ade0f9b89dad_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_bb7ca5fa-ed81-4c2b-8873-f6e86f60f72b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding in 2020 and 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_648bca2e-3a1c-4aae-a00b-7b9d50c9fc50_terseLabel_en-US" xlink:label="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, additional borrowing capacity</link:label>
    <link:label id="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_label_en-US" xlink:label="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Additional Borrowing Capacity</link:label>
    <link:label id="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_documentation_en-US" xlink:label="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Additional Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:href="wst-20201231.xsd#wst_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:to="lab_wst_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6bd6ac80-c804-4cbe-b28d-3a17d77fbc04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_0b1b2c3a-3346-4900-8df7-121723e89b92_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_e19aa188-0f58-41d3-97e5-8528446b4ac4_negatedLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash asset write-downs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_239cecb9-772b-44e2-9da8-898448d1d628_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_739e13df-8a5c-4df8-8744-4bf6887a0af0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_23773f4b-c11c-4052-99e4-75f514ad27b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_a04f77bd-7629-4a7b-b6c0-9c6bc9bf9b63_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_a59d22c9-9998-4283-a0f4-302956739a55_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_339fb123-baa5-482e-a5d2-61025e11c8ce_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm_9dd32b8e-fdee-4d0c-b8b5-2525a8be9714_terseLabel_en-US" xlink:label="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, operating lease, terminate term</link:label>
    <link:label id="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm_label_en-US" xlink:label="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option To Terminate, Term</link:label>
    <link:label id="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm_documentation_en-US" xlink:label="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option To Terminate, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:href="wst-20201231.xsd#wst_LesseeOperatingLeaseOptionToTerminateTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:to="lab_wst_LesseeOperatingLeaseOptionToTerminateTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_79ec1a09-4f39-4791-b500-42db27ebc29d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRecognitionPeriod_887c4798-02f5-49e8-bf81-22e27b3bd7ee_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer liability recognized</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRecognitionPeriod_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Recognition Period</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRecognitionPeriod_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Recognition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRecognitionPeriod" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRecognitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityRecognitionPeriod" xlink:to="lab_wst_ContractWithCustomerLiabilityRecognitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_faa731c9-2c72-4bfd-b85b-cf02279f6370_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_34aec815-f990-4ccd-83e6-08a433dbc00a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_444abe27-6caf-4dcd-afd1-d9261732ca25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityMember_07ff46fc-30d9-4b85-9dab-7d7aeec3180b_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_CommodityMember_label_en-US" xlink:label="lab_us-gaap_CommodityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityMember" xlink:to="lab_us-gaap_CommodityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_a830ee16-e09a-4d6a-bcb9-de2828c5e093_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of certain accounts receivable</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_65355606-4fbc-49c2-bba6-bec8fde85279_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net sales</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c781de3e-0cd9-468d-844d-9fe3702d09af_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c5fe0d21-5946-4d83-9390-e421729227e0_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_e07203f5-110c-4a46-9dc2-b24abef753ba_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SGD</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d712a397-4b44-47e7-ae7a-be0e0c2b948d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_a082966e-8357-4ed8-bd31-5e14a9442052_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average of the coupon interest rate</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_83328481-5823-4a00-ae71-8d7fdf9a463a_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProbabilitiesOfSuccessfulFDAApprovalMember_ac121814-cab7-420e-91aa-79fab920288d_terseLabel_en-US" xlink:label="lab_wst_ProbabilitiesOfSuccessfulFDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probabilities of Successful FDA Approval</link:label>
    <link:label id="lab_wst_ProbabilitiesOfSuccessfulFDAApprovalMember_label_en-US" xlink:label="lab_wst_ProbabilitiesOfSuccessfulFDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probabilities of Successful FDA Approval [Member]</link:label>
    <link:label id="lab_wst_ProbabilitiesOfSuccessfulFDAApprovalMember_documentation_en-US" xlink:label="lab_wst_ProbabilitiesOfSuccessfulFDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probabilities of Successful FDA Approval [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProbabilitiesOfSuccessfulFDAApprovalMember" xlink:href="wst-20201231.xsd#wst_ProbabilitiesOfSuccessfulFDAApprovalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProbabilitiesOfSuccessfulFDAApprovalMember" xlink:to="lab_wst_ProbabilitiesOfSuccessfulFDAApprovalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_cbf49777-7386-455b-8394-52c758b2e8b1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_c0f8c645-738e-4660-9013-5696af1838c1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_712a5025-e562-46cd-b529-44d47a898d29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_daec2c46-3ec4-4661-909a-2f14de7c422b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_706b1ed9-471a-4395-b62d-94c1b506143b_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_87a7b73a-7e00-4210-9948-ddffc1a42a85_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_f84d3783-99ec-43ab-a087-3db9aadb7010_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_24f90dd8-e751-46d4-bb62-33a0b06e3374_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_BrazilTaxRecovery_0603553b-1038-49d6-af4d-0827799d0306_negatedLabel_en-US" xlink:label="lab_wst_BrazilTaxRecovery" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil tax recovery</link:label>
    <link:label id="lab_wst_BrazilTaxRecovery_6a5c83d9-9ace-4aee-bde1-574680b993e9_terseLabel_en-US" xlink:label="lab_wst_BrazilTaxRecovery" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax recovery</link:label>
    <link:label id="lab_wst_BrazilTaxRecovery_cd06c88c-e416-4829-903e-0ce9ded78ef8_netLabel_en-US" xlink:label="lab_wst_BrazilTaxRecovery" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax recovery</link:label>
    <link:label id="lab_wst_BrazilTaxRecovery_label_en-US" xlink:label="lab_wst_BrazilTaxRecovery" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Tax Recovery</link:label>
    <link:label id="lab_wst_BrazilTaxRecovery_documentation_en-US" xlink:label="lab_wst_BrazilTaxRecovery" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Tax Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BrazilTaxRecovery" xlink:href="wst-20201231.xsd#wst_BrazilTaxRecovery"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_BrazilTaxRecovery" xlink:to="lab_wst_BrazilTaxRecovery" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_be37c4b1-8b8a-48ae-8cbf-f541b5af3109_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:to="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_15222ac0-6a00-47cc-9d18-3ebea276786e_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_52b912a8-53df-4071-8bec-4e3add8b7887_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of 2017 Tax Act</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_485b827a-559a-414b-8a32-ab4917c19325_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on undistributed earnings of subsidiaries</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_0626f244-1d29-431d-acb9-210dfc08cdff_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1bc6045c-8159-4fad-bbc7-7d13b065e91d_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_e569455f-488d-46f8-b60d-19ed0d6c653a_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_ab84239e-7611-490e-9c88-76145468c77c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21b09ed2-05fa-42dc-b54c-e6cdf9ca1521_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_fb0431bb-af95-4b37-b123-36ab75df63fa_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_399435b4-8524-413a-bdf4-8710a102c9cc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits on share-based payments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_513b34f6-da43-4dfb-b7eb-881ff3434df9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bcb68bea-565f-498a-87d1-b47031b04e3a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IncomeTaxBenefitFromStockBasedCompensation_982018dd-3fbf-4f18-a955-7f1ab5181ebb_terseLabel_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from stock-based compensation</link:label>
    <link:label id="lab_wst_IncomeTaxBenefitFromStockBasedCompensation_label_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit From Stock-Based Compensation</link:label>
    <link:label id="lab_wst_IncomeTaxBenefitFromStockBasedCompensation_documentation_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit From Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromStockBasedCompensation" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromStockBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IncomeTaxBenefitFromStockBasedCompensation" xlink:to="lab_wst_IncomeTaxBenefitFromStockBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_4c829055-6a81-41dd-96d3-4560b5f1e70e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities for interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6690f62e-d483-440d-9962-0caf43e0629a_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5e3fd857-0a65-41f6-a33c-53e8f20377e2_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_91719754-8df6-4067-9829-65bb4e1ff03d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Unallocated</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aabf38f6-f039-4e90-bec8-94d2c64f2cde_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the 2016 Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_82ccfd7e-cb7e-47a3-8bf0-bfce36d3e95c_terseLabel_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled PSU awards</link:label>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_label_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled PSU Awards [Member]</link:label>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_documentation_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled PSU Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember" xlink:href="wst-20201231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockSettledPSUAwardsMember" xlink:to="lab_wst_StockSettledPSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5fdb4978-45bc-400e-8da1-7bd08313e516_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified out</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ae503b1d-efed-4e86-8693-1b32a9c3f52c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_4c61bbd7-99ae-4bbc-93a2-7e2a67e8a446_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_YearAfter2021Member_de49fe27-a144-465d-a6dd-cc4ae4f02e08_terseLabel_en-US" xlink:label="lab_wst_YearAfter2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2021</link:label>
    <link:label id="lab_wst_YearAfter2021Member_label_en-US" xlink:label="lab_wst_YearAfter2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2021 [Member]</link:label>
    <link:label id="lab_wst_YearAfter2021Member_documentation_en-US" xlink:label="lab_wst_YearAfter2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2021Member" xlink:href="wst-20201231.xsd#wst_YearAfter2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_YearAfter2021Member" xlink:to="lab_wst_YearAfter2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_ed5548cc-52fd-48fa-9f1c-a32923b6a52f_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_a3f640a0-d6e5-43be-adf9-9b32b6605dd7_terseLabel_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters, Contingencies and Legal Costs [Policy Text Block]</link:label>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters, Contingencies and Legal Costs [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:href="wst-20201231.xsd#wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:to="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc912c-dfe3-4019-a0c9-43642a9449b6_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_7d3612d7-d76b-4245-afbc-26635f360915_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued commissions, rebates and royalties</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0432b868-cae0-43e9-9ead-228746ae1525_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_9f45665e-bace-4595-bb98-2ed49cf77bc3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare_3b351362-8b09-48d9-8838-47b2454e7509_terseLabel_en-US" xlink:label="lab_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets (in dollars per share)</link:label>
    <link:label id="lab_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_16efff81-0dd3-4a45-98bb-5f8500819dd2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_19e57582-b12e-4a9a-8ec9-95d502b2f3a0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare_ef274452-a3d6-4e6a-bf98-8465f8a29c08_terseLabel_en-US" xlink:label="lab_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlement and related charges (in dollars per share)</link:label>
    <link:label id="lab_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Settlement And Related Charges, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Settlement And Related Charges, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_53056dbf-edff-46c7-918d-f7555c7cb100_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_99b027fc-2dca-4ecd-8fca-81a652e1a658_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_3aec224c-713d-4878-b675-731ecd87939c_terseLabel_en-US" xlink:label="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and impairment charges</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_label_en-US" xlink:label="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_documentation_en-US" xlink:label="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:href="wst-20201231.xsd#wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:to="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_37136eea-3f15-4c4c-9b70-350c33310838_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_f603ebe6-1388-4763-bc10-1795e747a3ba_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_4b5b8f53-d995-4344-be17-469b4d82e0cb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_d165f137-bb14-4164-8b13-2b039ae7ea4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sales by Significant Product Group</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_84661888-9c73-4bc5-aa84-fe7639d52b25_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cf2287e1-611f-4312-abd1-5cee230c66eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in affiliated companies</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f8e44a4a-d3e4-4bc5-b68d-fe7b64bd36d4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_876b09c0-2c25-4d98-884d-a38cff23d00d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_b5559d8f-60bd-441d-a263-e235f81e925c_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22b09587-43ab-47de-a601-259c0d4ad7a0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_a547e800-5d4e-427c-959a-3f8d1a6fa0f1_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_119ceff2-c44f-48f8-ad8b-2513927cdb3b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency hedge contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_04138f05-73c2-441b-a2b7-35e5cd6e476c_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_9e3a9fc9-98f6-4301-a2bb-c519fc535ec5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_c2f51a14-7b46-4207-9011-a2202617a610_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward treasury locks</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_33e810de-048f-4abd-abda-ea1995ed3554_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d8952fdb-535d-4b05-912e-0012869dff4b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_06e118d0-6694-4ac2-9991-53a8d1c80833_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_29e30971-e3d1-4134-863e-cd2dfacd6502_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_6cc50d91-c3c4-47ae-b0a5-1e272577f5b6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6b6ccd01-3d59-412e-9904-dab5ea6803a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_08e55f59-3a7c-4b29-959d-6a0db3e26413_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_47233308-2adb-43a6-8735-138bc02f59de_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_f9362e37-c3d8-4e81-9339-545676c32a4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_351dd7f5-1aeb-4add-817a-da76cfac7bf0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_d1f1fb3d-97ae-454a-b571-af2797b0b5b9_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_4ab7d434-0080-4fc5-9f1f-cb9c8aa1db1e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_8d48eaa9-4575-44b3-84cc-9a05cb28daaf_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_c2c70c2b-98dd-4c3d-9ad3-fb8dbe98e65a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_63365415-f4c6-4ce1-8eac-8e6b6cfb6935_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from stock-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredStockUnitsPayableInCash_825e41da-690b-4555-8556-c65735a9eaaa_terseLabel_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred stock units payable in cash (in shares)</link:label>
    <link:label id="lab_wst_DeferredStockUnitsPayableInCash_label_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units Payable In Cash</link:label>
    <link:label id="lab_wst_DeferredStockUnitsPayableInCash_documentation_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units Payable In Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableInCash" xlink:href="wst-20201231.xsd#wst_DeferredStockUnitsPayableInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredStockUnitsPayableInCash" xlink:to="lab_wst_DeferredStockUnitsPayableInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_12432eed-8f1d-41f9-bdcd-4975117abfa6_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_a407f177-0082-4c9a-aacb-873dd1465c2b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_fc6fa27a-b4e7-457b-81bf-b88231f61f92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_cfefa7cb-6c81-4331-967c-f57c8f41ffde_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8c144ae2-0204-4cb6-885d-093b44178189_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d50ede08-5c60-4a5c-9f73-c85756035d42_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1b716b53-821d-47b3-a996-2c239b03c4a8_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed lease interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_d7e0965e-d973-45e4-bd06-f75ba7b898b7_terseLabel_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_label_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Defined Benefit Plans, Noncurrent</link:label>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_documentation_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:href="wst-20201231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:to="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_8ccb2458-4986-43f8-8c2b-fc7edb544c43_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PatentsAndLicensingMember_73c3fc12-6df5-4598-9b6e-137f6a6461a0_terseLabel_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and licensing</link:label>
    <link:label id="lab_wst_PatentsAndLicensingMember_label_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licensing [Member]</link:label>
    <link:label id="lab_wst_PatentsAndLicensingMember_documentation_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licensing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember" xlink:href="wst-20201231.xsd#wst_PatentsAndLicensingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PatentsAndLicensingMember" xlink:to="lab_wst_PatentsAndLicensingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6ba24447-8fdd-46eb-aecb-f10f56515a79_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c764c042-a49e-4db0-ad6f-bab56001731b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_a37d9faa-bb75-4933-b883-350d7d23f81f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition toll tax</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_a9bf1f34-e109-4ddd-a2bc-ccf73cb3fc52_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerAssetIncreaseDecrease_914e9494-acdf-4bfd-a26c-3763b7507db1_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contract assets - increase (decrease)</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetIncreaseDecrease_label_en-US" xlink:label="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Increase (Decrease)</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetIncreaseDecrease_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerAssetIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:to="lab_wst_ContractWithCustomerAssetIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_fad85c39-4ee1-421a-98c4-82915ac0f1bb_terseLabel_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and state</link:label>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:href="wst-20201231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d1b2584b-1ea9-4928-819c-53cc41a6bd11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested PSU Awards [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_30f48ac4-1240-4534-a16a-18f37f47da9e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_a9b2b3bb-4ded-4aec-932a-4474b1401f37_terseLabel_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related activities, period of implementation</link:label>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_label_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Activities, Period Of Implementation</link:label>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_documentation_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Activities, Period Of Implementation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:href="wst-20201231.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:to="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3ea1df13-5a0c-4d8d-82ec-df1f78ea3c7b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess of Par Value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_3b6fcf0b-1eac-46b5-b8d9-8c3f8024ac72_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_7ddba155-bfd7-491f-8b84-0f909405b920_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_ca93b5ce-2848-48fa-a42a-21ce09d1de01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_bd26028b-7e45-4463-b1e2-dd70376570a2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_3678355b-d218-4cc2-ad52-295c7703eebd_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_fb4d4865-2659-4d8b-afe0-bba292a9061e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f5afb82b-f0df-4c3d-9db0-b439bbc00222_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0b8935d4-bea3-43b6-8c41-450af956d099_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_241a250e-4ddb-4633-b592-ea9f6e4999a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_6d7402c3-cba5-4e98-8390-f31ba30448f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative contract term</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_63e5c6a6-fccf-4348-8c6f-5d50de2953d2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d6ab7d76-f140-4e0e-923a-116aed01cf76_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0636b72d-2839-469e-82d2-0637f1a0bbd4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7b6a2508-aabf-4b0d-9f33-b43305d75d28_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0911a8c0-3669-4283-bbc6-962c2ed73559_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of equity awards, based on the treasury stock method (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_b75d35bc-8ab2-4bc0-a6ac-a040d0321867_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_label_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember" xlink:href="wst-20201231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedCustomersMember" xlink:to="lab_wst_ContractManufacturedCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f404dac5-8c0c-4968-a19a-bb80fd5c0813_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_8340e027-700a-4e27-b5d3-e77f9b112c13_terseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement effects arising during period, tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_GainLossOnArgentinaCurrencyDevaluation_a6539153-d36a-4a6d-82ac-d6c6f19e1c8a_terseLabel_en-US" xlink:label="lab_wst_GainLossOnArgentinaCurrencyDevaluation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Argentina currency devaluation</link:label>
    <link:label id="lab_wst_GainLossOnArgentinaCurrencyDevaluation_label_en-US" xlink:label="lab_wst_GainLossOnArgentinaCurrencyDevaluation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Argentina Currency Devaluation</link:label>
    <link:label id="lab_wst_GainLossOnArgentinaCurrencyDevaluation_documentation_en-US" xlink:label="lab_wst_GainLossOnArgentinaCurrencyDevaluation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Argentina Currency Devaluation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GainLossOnArgentinaCurrencyDevaluation" xlink:href="wst-20201231.xsd#wst_GainLossOnArgentinaCurrencyDevaluation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_GainLossOnArgentinaCurrencyDevaluation" xlink:to="lab_wst_GainLossOnArgentinaCurrencyDevaluation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_f3ab5160-3cea-4183-8222-474a54d5a46e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b6716ed2-191e-49e5-b66f-5103151571db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_66526b99-54e2-4d15-ad9b-af11f46cfd7d_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_0ee73a8e-3e30-4d2c-a6a8-2b14e9bc8795_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_98732fa2-3600-45f4-88d0-38da5de452ca_terseLabel_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable and other current debt</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_label_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_documentation_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:href="wst-20201231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:to="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_83f3f5ba-8546-433c-9206-fc1bbe75adff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_978f7bd0-a578-49ff-bbff-09edca859651_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cd7ce341-a910-47fd-91e0-df7f32ad8a8b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CashSettledStockAppreciationRightsOutstanding_f22f901e-1a2e-41bf-bc77-91d6cdd7c6e3_terseLabel_en-US" xlink:label="lab_wst_CashSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-settled SARs, outstanding (in shares)</link:label>
    <link:label id="lab_wst_CashSettledStockAppreciationRightsOutstanding_label_en-US" xlink:label="lab_wst_CashSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-Settled Stock Appreciation Rights, Outstanding</link:label>
    <link:label id="lab_wst_CashSettledStockAppreciationRightsOutstanding_documentation_en-US" xlink:label="lab_wst_CashSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cash-settled stock appreciation rights outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledStockAppreciationRightsOutstanding" xlink:href="wst-20201231.xsd#wst_CashSettledStockAppreciationRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CashSettledStockAppreciationRightsOutstanding" xlink:to="lab_wst_CashSettledStockAppreciationRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_b0a7d796-5e14-4571-84b6-b5c6e72aa942_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit</link:label>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticLineOfCreditMember" xlink:to="lab_us-gaap_DomesticLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6c9338fa-b65d-4126-bbab-b5cfb49100bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of prior service credit, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ba5f0951-aad3-4c01-af71-2347b586aa2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_caa8027c-1edc-40b6-b28b-d0bde04d26c4_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_8dcd24d1-9fa6-46f8-bd42-8ce2f626e871_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, state and local</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_9daaa8f4-9f0d-41d6-8385-c3aef57d2838_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_bc713f1d-3c69-45c4-9526-9eea6296ee7e_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated increase (decrease) in the liability for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_ed7fc5c8-8541-45e5-8744-5a76be00ac3a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_21c69a8b-e169-404d-b739-bb8476374b2d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, nonmonetary notional amount, volume</link:label>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_label_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Nonmonetary Notional Amount, Volume</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:to="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_1f0255ee-9b7f-443a-9170-5c73c380d5d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_d2e1ce7e-3a22-4309-a052-31e6a333e41e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityOptionMember_e582ec06-3ad4-421c-9c01-a855da7928a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_CommodityOptionMember_label_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityOptionMember" xlink:to="lab_us-gaap_CommodityOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceClaimsMember_f58fd346-ce4e-4818-a63f-f47751c3b8cb_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Claims</link:label>
    <link:label id="lab_us-gaap_InsuranceClaimsMember_label_en-US" xlink:label="lab_us-gaap_InsuranceClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceClaimsMember" xlink:to="lab_us-gaap_InsuranceClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_b9c5fe81-168f-4dd5-b4f2-e714ef156218_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7f5c21c3-f9ce-44fc-a13b-0ea8337827db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_a6d1db64-2e37-4030-9044-229267983045_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a01f1b07-3989-47a0-a866-380199d7d0d6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f79d014e-2607-4939-af0f-287d8e43f18a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_4faaaaa4-07f0-4b3b-8204-5e61cdad7c44_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_a8662624-2de9-49ae-9c30-58b36bc364c5_terseLabel_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Instruments [Abstract]</link:label>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_label_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Instruments [Abstract]</link:label>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_documentation_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherFinancialInstrumentsAbstract" xlink:href="wst-20201231.xsd#wst_OtherFinancialInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract" xlink:to="lab_wst_OtherFinancialInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_05839fbd-0f2e-4de1-a751-39a6763c9e2a_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_c1b4038b-93be-43ff-bc02-5ad779e886f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ff942359-541a-43e3-af16-c9b2fc59fc46_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_8a25f448-d5b8-4c8d-ac49-0cb4ee3d1682_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_d9189228-02e4-4ccd-81fc-3a6126d04b40_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for insurance obligations</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a250909e-5005-475e-9284-2a7ab98d6cfa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_dbeb7a13-68db-467c-af6c-d2a154595c57_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_ce810275-6b3a-41f2-8f36-52039fb5c4d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_22ba10f9-b264-4ee5-a1d0-898aff2f85f4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_a02f1bad-18de-42c7-8845-95550dc871e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ddf7abcc-e731-44d4-8654-a05a61cf4afa_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_130acdf5-b03e-4aeb-8f20-4b79b7b4d7a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_dcfd3477-78da-4fc5-86e5-58eff528ab32_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1187139d-6005-4ea4-9693-9af5093d01cc_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2d6e58c8-cb11-4f82-8460-d152b0f3a797_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated goodwill impairment losses</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ea5a418a-ca75-492b-be87-22f1b7abb7e9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f20eeb0f-8aae-4322-8ed8-0bc1bd42f6ec_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 to 2030</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1e11f04c-2ab0-4fc1-a041-b2bb2baaf072_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_bb290e28-2488-4331-88d0-ff3772f30f70_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_7c3cbe5d-5547-4e39-87a4-a982ace82733_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill recorded due to acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_cbae6b99-318a-4c64-94f0-57b16db90a66_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Expense (Income)</link:label>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income And Expense, By Component [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income and Expense, by Component [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:href="wst-20201231.xsd#wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:to="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_c8e359fa-faf7-48d1-969e-03416a2c36ee_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Operating and Per Share Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_bd795f87-4d9e-4617-bd91-17c5e867f558_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee, per year (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_f8475a6a-31fb-45ca-853a-d7ae4b3ad5ea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-based Payments</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-based Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_07f4a196-aafd-4b55-bf5c-4fd2e504bd45_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:to="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_c4961256-6af0-4b77-90a5-c3e6d0d9eb24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_85b828a2-949b-4186-a22b-d38d5459b33f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_17f11b2a-229f-44c8-8351-029b3c3ba42e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_b1e95d19-bb57-4adc-a85a-114eb56c039f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_983c485a-8fc2-4ebb-aa80-f625c43321f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_7d11f8e1-d93c-44dd-9a9b-23253294576d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax (liability) asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_342e92ad-f0ed-4088-8dfd-3faf414f61b0_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_8bbd0f21-7b4e-41dc-bf19-bb7febd910fa_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_78c12cad-3d98-4071-b6ab-80d940771818_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0e9235b3-ed01-4aa6-93b5-cc17d1939996_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_44005fc4-64ff-4d85-a439-99c29d8a95a1_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_17ce3653-5320-4c99-b05c-b070ec9d5489_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_8d3cca3c-47e1-45a7-9154-44e0b5df648c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate healthcare cost trend rate, benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:to="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_15aa54ce-4d84-418f-9853-e23b7a69760f_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_19078942-47bd-43c1-a554-c865543836f0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_39561991-160e-44be-8039-cc23b79c707d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8addab1d-46c4-4c87-9e07-e4d5350fae4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3fde54cd-e70c-4b79-a063-056fc72f0099_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_a34dfb64-e28f-4416-b10c-c191adb14e95_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_1c27ebd5-7a48-4a72-a0e0-3860c1d2fd57_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_7eabb63c-b2c4-492f-a37b-04dd8c05558a_terseLabel_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to affiliates</link:label>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_label_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to Equity Method Investees</link:label>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_documentation_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees" xlink:href="wst-20201231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SalesToEquityMethodInvestees" xlink:to="lab_wst_SalesToEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_de6265ec-7aca-49f1-9d0f-f0ca9c073b1e_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9f80ac26-191c-49c0-8b8e-90965ed1f667_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_53c2f3cb-f20e-4111-8b77-fcbf7e225c92_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_e6b5f746-3985-4299-b457-0fc4044951a9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TermLoanDue2024Member_49f4be19-8dd0-4043-8922-e98cf3728a51_terseLabel_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, due December 31, 2024 (1.13%)</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_label_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024 [Member]</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_documentation_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member" xlink:href="wst-20201231.xsd#wst_TermLoanDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TermLoanDue2024Member" xlink:to="lab_wst_TermLoanDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11946d35-38d6-4b86-a000-7db4ec804dad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_877064dd-eceb-4c4d-8618-1829c4808fc1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-related charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_cc970716-f96e-4a4c-9213-d3418cdf54ea_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment sales elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_353f162a-cb50-46bd-ba9c-0c4b608c2c4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_4e8dce88-ddd3-4c3c-9f40-890c3266b47c_terseLabel_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V.</link:label>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_label_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_documentation_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember" xlink:href="wst-20201231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaRubberSADeCVMember" xlink:to="lab_wst_PharmaRubberSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_d96377ef-f30d-487e-8b6e-f0ffd3f8aad3_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_44afeef0-2314-47af-857c-212802f9702c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_788638de-89bd-445a-9997-a23d568c006a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_b236426a-0b70-4cc0-9316-80c771c7a999_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and severance related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_62053284-3762-4c66-be06-6d13eba4128b_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_d4d2cc46-758e-4cf3-bc99-23e9c9623d0b_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring , ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b31a8189-c972-432d-a0af-5de35a932d6e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaCustomersMember_dafb648b-c94a-4ef1-9530-ccd26bd3850f_terseLabel_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_label_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_documentation_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember" xlink:href="wst-20201231.xsd#wst_PharmaCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaCustomersMember" xlink:to="lab_wst_PharmaCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_62013446-f7bb-4259-81d4-a680671725bb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_16f38313-e4a4-4239-94d7-0d4f1d716cc7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_3d65d1a7-54df-4173-aca8-2661fa6a258b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of current market price for sales to eligible employees</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_8216f3da-ef10-446e-aa13-6fb6f4c7c70d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_89f59023-51bb-4c9a-95fb-04508ae3af2c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c40150e8-5b3f-4597-9ea5-1bffd6224a58_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_4e36b9f1-ae3f-491b-b2a0-1cd2fd7af393_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_01e4d67a-e7b6-4fcb-be92-52ac8186b27c_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1af49b01-77a2-4fa3-ad02-3171c1a07cfd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_344deb58-6e7e-43f6-a8a2-adabdb76515c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f5828bc7-8bc0-4afc-84ca-dc9dd2811c5c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_e97fbf73-298d-486f-b5bf-7714dc44d5e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_65c318ca-9ca7-4b0a-9d05-38ff2944f5c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_e3465dfc-f0b1-42f8-b29e-71b5040556e8_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_106fd019-a922-4c3f-ada2-41ffd1f61b22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherEuropeCountriesMember_0d06102f-f782-4e5d-a05e-3457035e4603_terseLabel_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other European countries</link:label>
    <link:label id="lab_wst_OtherEuropeCountriesMember_label_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Europe Countries [Member]</link:label>
    <link:label id="lab_wst_OtherEuropeCountriesMember_documentation_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Europe Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember" xlink:href="wst-20201231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherEuropeCountriesMember" xlink:to="lab_wst_OtherEuropeCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_3e2985a2-1b74-41ff-b836-b2f1f3442e9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7e15d852-1771-4bcd-83b3-d0c96a7a3621_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_f738d6b6-97aa-401e-a9f7-b0207b882391_verboseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares to be issued upon conversion (in shares)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_07c3f522-3b10-471e-902b-24cb75782448_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_4b381941-825f-46d6-8975-de3343afb0ca_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_e05c6435-cffd-4340-aa66-95dfc65f469b_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East, Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_b044beff-5c13-4929-a87b-837e8e023350_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RestructuringAndSeveranceRelatedCharges_8e9ee646-fcdd-4e09-a96f-e0e8c72d5c4b_terseLabel_en-US" xlink:label="lab_wst_RestructuringAndSeveranceRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and severance related charges</link:label>
    <link:label id="lab_wst_RestructuringAndSeveranceRelatedCharges_label_en-US" xlink:label="lab_wst_RestructuringAndSeveranceRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Severance Related Charges</link:label>
    <link:label id="lab_wst_RestructuringAndSeveranceRelatedCharges_documentation_en-US" xlink:label="lab_wst_RestructuringAndSeveranceRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Severance Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndSeveranceRelatedCharges" xlink:href="wst-20201231.xsd#wst_RestructuringAndSeveranceRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RestructuringAndSeveranceRelatedCharges" xlink:to="lab_wst_RestructuringAndSeveranceRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_aad516b6-9f3d-4af3-b515-4be4421d35b5_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetRollForward" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerAssetRollForward" xlink:to="lab_wst_ContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_69cc7df9-8f5d-467c-99b9-410fa7a0d292_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_8bc0ca77-446e-41bf-8b89-a81c44349531_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_32d9868b-0c55-4f56-8dfc-d5bc3b008e62_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reserves for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1735e090-74ce-44e5-8594-1bc6a1f9eb76_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_4e307afc-038a-4115-8813-a8a23cd90006_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_aff4b5ca-954a-4c68-8d75-32c32144c25b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of actuarial loss, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_61f2a89a-12cb-4a73-9e24-97606e4fd0b4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7e47c486-9cab-46bc-8d3b-c91a9bc778c9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2660936e-4e97-442c-9343-e16954c8af98_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares assuming dilution (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare_14d6e13f-d414-46ac-ab4b-be913760bb6e_terseLabel_en-US" xlink:label="lab_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets restructuring plan (in dollars per share)</link:label>
    <link:label id="lab_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Impairment From Restructuring, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Impairment From Restructuring, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_f980be50-bc31-46b3-ba58-3154beeaf78d_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_379165a2-32f7-4960-b0ea-f50018a52e4a_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation and Compliance Costs</link:label>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_label_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalCostsPolicy" xlink:to="lab_us-gaap_EnvironmentalCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_f785ff32-9d10-4777-9a41-97d68a758c42_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_edfbca18-7014-4a55-9cb8-56cc0a9dd772_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3e24c6b7-0d64-4cb6-a4d6-e866aef3e7af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_11260be7-f3e7-4263-9fca-ccc43633b834_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f4957044-2ecc-450c-bac9-d10f290f9f91_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorNotesDue2022Member_9430d31e-b4c7-4364-b32b-b491530c6a4a_terseLabel_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A notes, due July 5, 2022 (3.67%)</link:label>
    <link:label id="lab_wst_SeniorNotesDue2022Member_label_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes Due 2022 [Member]</link:label>
    <link:label id="lab_wst_SeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member" xlink:href="wst-20201231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorNotesDue2022Member" xlink:to="lab_wst_SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_FixedAssetImpairmentFromRestructuring_bbbfdb6f-bdb3-48e7-ab20-9d520b92084c_terseLabel_en-US" xlink:label="lab_wst_FixedAssetImpairmentFromRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets restructuring plan</link:label>
    <link:label id="lab_wst_FixedAssetImpairmentFromRestructuring_label_en-US" xlink:label="lab_wst_FixedAssetImpairmentFromRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Impairment From Restructuring</link:label>
    <link:label id="lab_wst_FixedAssetImpairmentFromRestructuring_documentation_en-US" xlink:label="lab_wst_FixedAssetImpairmentFromRestructuring" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Impairment From Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FixedAssetImpairmentFromRestructuring" xlink:href="wst-20201231.xsd#wst_FixedAssetImpairmentFromRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_FixedAssetImpairmentFromRestructuring" xlink:to="lab_wst_FixedAssetImpairmentFromRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_ced9888c-61af-4bf1-b7b5-8322ee2c078b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_112ed128-209e-4c5b-994c-e1d76d00d6be_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_5e9eb651-324a-4561-8f97-487112a968e1_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance cost</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NetSalesMember_35e4a829-49a3-4147-b9c1-fd036f25c578_terseLabel_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_wst_NetSalesMember_label_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales [Member]</link:label>
    <link:label id="lab_wst_NetSalesMember_documentation_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember" xlink:href="wst-20201231.xsd#wst_NetSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NetSalesMember" xlink:to="lab_wst_NetSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c3bdd395-1534-471b-89d1-fb7562e2741c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_cb5d7e54-3583-4e18-9c1e-99a6b31020f8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_aba5c1e8-6b15-4b1a-932e-a10730cddd97_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9f7d60ef-b411-493a-a0b5-e1d8d8a77de6_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at January 1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3178fbef-b73a-4210-8dcf-0ac9369a0145_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_2e9a0d28-f2c5-42ae-ba09-6e7cec67183d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1bf98380-b3da-44a6-9bc0-ac1c9dd4c160_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.25 per share; 200 million shares authorized; shares issued: 75.3 million in 2020 and 2019; shares outstanding: 74.0 million and 74.1 million in 2020 and 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_8e9e0a32-b3e1-44e3-85a9-61784608136a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_79ecbd7c-7a4f-4651-bab9-118d1524abac_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_221aa0b8-7fa8-4329-98bb-ffe62e5aa6b9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ceee834f-f518-4621-bbd3-faae3b4602c8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_754093fc-ea82-4ce9-9508-f1ed490174e2_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_fc9fae74-16e7-4f05-b379-d20e992ed629_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_aab0a58b-8a9d-4403-8757-ffe5e94b04c8_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_69ad3ce1-cf7c-43db-96f1-91dd9046d4ac_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_172caa28-4fdb-4b1c-9e5b-23880fffc2c5_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a8c5eac5-11d8-4ba1-b7fa-6527997a2364_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in fair value recorded in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_42219de1-a522-4a9a-aa42-7197a79e9a61_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related cost, expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_b2b9af08-2a6d-4234-b94b-1e75cf5a3610_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_f7c5c260-3f2f-42bd-b33a-1b704421c293_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_The2020RestructuringPlanMember_33e76907-0064-4e92-bb84-0700b5b37489_terseLabel_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:label id="lab_wst_The2020RestructuringPlanMember_0a8bdb6e-a800-4915-a4c2-55d7510c5df9_verboseLabel_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:label id="lab_wst_The2020RestructuringPlanMember_label_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_The2020RestructuringPlanMember_documentation_en-US" xlink:label="lab_wst_The2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember" xlink:href="wst-20201231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_The2020RestructuringPlanMember" xlink:to="lab_wst_The2020RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_2779fb42-4bbb-491d-86e2-df88183e40db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_386c997d-b0d7-4cd5-86df-0d6dffbbd277_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2695c068-1962-41b6-8c05-ed88b89512fe_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_dfc25a29-012a-4d06-bbac-6812cfe224fa_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, including cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_97c010c1-4180-4bfd-a101-42acaa35b9e5_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, including cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_10631cb0-15f3-4f70-8123-9e6b8aa702f1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_12fcde9b-9e40-44a6-b1f2-853d9cea29de_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax (liability) asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9a90a289-760c-49ec-a8ed-1c8fbde934bf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_c1d3a12e-c57c-43cc-8bba-6fe7dfcb0838_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_86b6da4d-0ae5-4e3e-bb46-44ce44fb8e5f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_ec10271d-9693-48d8-a717-6ec1d12ea41b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d9300ee5-bd93-4596-a45f-e6b09f540556_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_68a46044-2bdc-4346-a1e8-841e367101f4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_40c2839a-5e91-4ad6-9d16-13c6d16e7fb9_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f776239c-de07-4820-9760-ebb228a92984_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit_3f59105b-2bc2-451a-b46b-f67e5fdb9e78_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation conversion unit (in shares)</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Conversion Unit</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Conversion Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualConversionUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualConversionUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_303107d6-c116-4cf5-b6f8-1c93b16af5d9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_f2029591-7343-44cc-baab-795633d7d5bf_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d1428fb7-1219-499d-b463-25d3552157f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod_78708a1f-14a6-477c-9a0a-dcf7ce79e4e4_terseLabel_en-US" xlink:label="lab_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, payable period</link:label>
    <link:label id="lab_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod_label_en-US" xlink:label="lab_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangements, Range Of Outcomes, Payable Period</link:label>
    <link:label id="lab_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod_documentation_en-US" xlink:label="lab_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangements, Range Of Outcomes, Payable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" xlink:href="wst-20201231.xsd#wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" xlink:to="lab_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_561482d3-3b72-489c-92d6-47f585b5c81e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed healthcare cost trend rate, benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_3a35dfcb-b738-4e87-a3d2-8f18ae952516_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation on payroll deductions of employee's base salary, percent</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_453f73ac-e04e-4870-915e-2ff83af220bc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_4f379081-7913-4dac-8459-19862c82fe31_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_d2527ff0-1dc4-465b-9348-9c0d13619ac8_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_2e2d4c07-7e3f-4e56-a12b-0026f4d81cba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_4726cf0f-0d46-450d-8e45-114d682b579f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_9b64a39a-4850-451c-b9c8-beb3fd989198_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (loss) arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5a3f1c97-0b35-4307-ad23-c3559cb1331b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset impairments and sale of equipment, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_33092567-60fa-4a56-9604-4f1a6c7165ab_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on undistributed earnings of subsidiaries</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_795be3b3-3d41-4cd9-9996-6f261b113b56_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_3f3f7228-a165-43b8-a066-b7d732933a1d_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_260e920f-e5e6-4dcb-ba72-c5b9776d2150_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_4b760171-7674-422f-8fde-1b46fa3149f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a36d0cc8-b86e-4465-acd8-4f9936d68110_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_eb75a3b8-7424-4401-ac49-972b1bca1186_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_73a130aa-5955-44bf-964e-7b5bca8df9c9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_763f574b-b315-44af-9d4a-c9eece392863_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare_54f89650-fab4-4dd0-82bd-7c2aaac76f40_terseLabel_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit for impact of tax law changes enacted (in dollars per share)</link:label>
    <link:label id="lab_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit From Change In Enacted Tax Rate, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit From Change In Enacted Tax Rate, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_09dc58fe-fa00-4ad0-b494-82d4e7f3e115_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_225746b8-95d0-46d2-98e4-9e8902f8fcac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8c40dd66-86ae-4081-8741-ef2ba46649e1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_87f2caa1-6006-432c-a04c-bd1a28457304_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_3651e63b-ccfb-4326-a250-82e11fbb5191_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_bc8aa14b-e200-418d-a19f-520b7b3c054f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c1e4055a-e891-4480-83cf-f30b147e7f22_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_21b57eba-e55c-4f05-bbe9-190a1778ead6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and severance related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_4afc2091-ef73-439d-a1fa-61b93feabc69_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_b98fcc4c-ac63-45e9-9253-35a041f38174_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and severance related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f829e8c9-ca44-4c6d-9a7e-35ae1cd8fd6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CostInvestmentImpairment_d00576a1-1509-431e-bff4-5e09afbf3097_negatedTerseLabel_en-US" xlink:label="lab_wst_CostInvestmentImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost investment impairment</link:label>
    <link:label id="lab_wst_CostInvestmentImpairment_label_en-US" xlink:label="lab_wst_CostInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost investment impairment</link:label>
    <link:label id="lab_wst_CostInvestmentImpairment_documentation_en-US" xlink:label="lab_wst_CostInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost investment impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CostInvestmentImpairment" xlink:href="wst-20201231.xsd#wst_CostInvestmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CostInvestmentImpairment" xlink:to="lab_wst_CostInvestmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_0658d161-9c79-42ee-98e1-5192c769a42d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_709fe6de-33cc-46ca-8697-a2b271e0db37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets measured at NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_487448ff-4488-475b-b932-8630f7dab2bc_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_78ff0d0b-5cbe-4d0a-81dd-a630174b757e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax effect</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d455d0e3-66f1-45ce-ac2c-2b05502a852b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension and other postretirement plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ebcf347f-cbf3-42d9-a82a-0f31612b9037_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Defined Benefit Pension and Other Postretirement Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_2ed74b17-fc18-4243-b9e5-df0d645e78ef_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_dd980049-86dc-4c05-9b52-8774e5a90fb7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_17bfef6c-3b69-4968-a509-eef4eeab9687_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_70f12439-4438-4fed-8979-6946470d68bb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_bdceabb0-52a2-4e74-9446-4a4ef4983af8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of actuarial (gain) loss, net of tax of $0, $0, and $0.3</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RatioOfDebtToEBITDA_093b38e7-d0b7-4c6c-8ca1-4a744c00ecd7_terseLabel_en-US" xlink:label="lab_wst_RatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA</link:label>
    <link:label id="lab_wst_RatioOfDebtToEBITDA_label_en-US" xlink:label="lab_wst_RatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA</link:label>
    <link:label id="lab_wst_RatioOfDebtToEBITDA_documentation_en-US" xlink:label="lab_wst_RatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RatioOfDebtToEBITDA" xlink:href="wst-20201231.xsd#wst_RatioOfDebtToEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RatioOfDebtToEBITDA" xlink:to="lab_wst_RatioOfDebtToEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6062b80a-84c3-447b-9cd9-536efc96a80a_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_70597cc3-2fd6-4619-b2ec-584a6679885f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_0adcca8b-0ab6-414f-8898-858787640174_terseLabel_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents</link:label>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_label_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents [Member]</link:label>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_documentation_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:href="wst-20201231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:to="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_747ab9d9-c7d7-47eb-a0d3-eadc3745c8ab_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_52464d87-2250-483a-b207-55703fbc1e2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets in the fair value hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e2e03ac5-0bdd-47bc-93c3-9964d7f5da6a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9f5e9cd6-cabb-45bf-8f17-7de94739b353_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_74cbd39e-2259-4a56-a0e9-028bd8fbe6d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_41d0607d-768b-411f-8136-66b31df0b5b4_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_4bfb3510-c9dd-433d-aef4-1e3bf71d6a2b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) gain on derivatives, net of tax of $(0.6), $(0.2), and $1.5</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2229f611-5557-433e-a3fd-09d2a7b24b91_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on international operations other than U.S. tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_e262bb05-7ca6-4374-a3d4-93244c33b4a5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_6f28fda1-c695-4d17-8cbb-15c10a72d42f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reclassification out of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_83540e1a-b5ae-4886-9f77-abba959c79b2_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401 (k) plan contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_39bc26af-98ba-47ed-a789-fefabc77dfc2_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_08d6231e-7807-4274-8071-07446e83eb68_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding unconditional contractual commitments due to be paid in 2021</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_1a5c221e-7dcf-46e3-a771-cf426ddeef95_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_fc483608-2fba-4912-b664-c50f2ea65e34_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_2e2aba66-b1e9-4cdd-84a7-5f725826483e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_7f2b2741-3649-4a47-bb53-f6f4bc42ddce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, estimated outcome, low</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent_da6d46b9-e0b8-475e-b091-8cf8a8dec166_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign-Derived Intangible Income Deductions (FDII)</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign-Derived Intangible Income Deductions (FDII), Percent</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign-Derived Intangible Income Deductions (FDII), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ef1fca04-7646-401c-af88-4ecf2ed5c043_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ed1df092-379b-4dc5-87d2-18af1b196360_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_a40acea5-b588-4174-86fe-91194a1d9f4f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared, not paid</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_e486271c-9c74-44ff-a2aa-331ef52dc726_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1fb7ab19-0b23-4b74-864b-8b3c8b75bbe9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_121b3118-c61d-408a-8e69-17a28dac0e81_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_0609e002-ce4f-44f7-bc57-3b50e4314ac0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense/(income), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_e253857b-07ca-4055-a042-18acafb91431_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_4a95b2ae-cf9a-48ee-8830-836acaef1d50_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_fa7ce714-87ee-467f-8b9e-6fa8cd8f9b5a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative (gain) loss on hedged item, fair value hedges</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_04734502-7f52-49eb-a835-0515ec74e630_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_91f7fe26-b16b-4417-8406-dd06606652fc_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRollForward" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward" xlink:to="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_1d0444e2-639a-443b-badf-a7673c0b6223_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherMutualFundsMember_1fe7a557-8b33-45f5-96db-05e4db5f1497_terseLabel_en-US" xlink:label="lab_wst_OtherMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other mutual funds</link:label>
    <link:label id="lab_wst_OtherMutualFundsMember_label_en-US" xlink:label="lab_wst_OtherMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_OtherMutualFundsMember_documentation_en-US" xlink:label="lab_wst_OtherMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Mutual Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMutualFundsMember" xlink:href="wst-20201231.xsd#wst_OtherMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherMutualFundsMember" xlink:to="lab_wst_OtherMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_fcff65ac-5b2e-41c0-8ad4-86db7067136a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a2167753-44e1-48ff-a3d9-58324713379e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9daa83a0-adfb-4423-890b-4cc156660497_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_66a06b09-a20e-4df3-97ec-2f43bd4a9f4f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_3895895e-81ac-489e-bfc2-461344448871_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, net of amounts capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_9246bf44-b3c1-43d1-94b4-a6a154e8e802_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_BusinessCombinationContingentConsiderationMeasurementInput_5e40f6a4-3b71-4a8d-9e96-cabdd1d6852c_terseLabel_en-US" xlink:label="lab_wst_BusinessCombinationContingentConsiderationMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, measurement input</link:label>
    <link:label id="lab_wst_BusinessCombinationContingentConsiderationMeasurementInput_label_en-US" xlink:label="lab_wst_BusinessCombinationContingentConsiderationMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Measurement Input</link:label>
    <link:label id="lab_wst_BusinessCombinationContingentConsiderationMeasurementInput_documentation_en-US" xlink:label="lab_wst_BusinessCombinationContingentConsiderationMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BusinessCombinationContingentConsiderationMeasurementInput" xlink:href="wst-20201231.xsd#wst_BusinessCombinationContingentConsiderationMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_BusinessCombinationContingentConsiderationMeasurementInput" xlink:to="lab_wst_BusinessCombinationContingentConsiderationMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_d372cb0f-8ca1-4d52-9112-b28f2d8f0944_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_6f82b779-fc71-40f1-9f6d-8a672d23c928_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_642110b4-4869-4b77-8999-cd211c4ca5c5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_c129f9f8-a06a-421f-ae1f-e915ae6d141b_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1ab356d2-e7b9-4bff-b182-b54c8d26757a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_772495d5-f3ef-4c9b-aaa6-6ab9e674b992_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_9045adcb-9965-4b91-bc11-e1536415d4be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, average price risk option strike price</link:label>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_label_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Average Price Risk Option Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:to="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_d8096532-2a8a-476a-90fd-b9e19fc1ecf5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_d8afc050-3fa2-43bb-993f-114d0b375d28_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on restructuring-related sale of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_a1b262c6-f1af-4f4a-8883-20eabb76838c_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maturity date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_df7148ef-6bfd-4076-9e9b-1fc316872289_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_290e7aad-3598-4bf9-85f5-592d9a9dabf1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_32a1b00d-5776-4e7b-8efd-be75309ba277_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_3147e9b0-5dbf-4846-84e9-f788a05d1007_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sales and Long-Lived Assets, by Geographical Areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1a8f3578-b8ba-4639-a474-c5b725a7faae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_44773a2a-794b-488e-8042-1ecfcaec1e3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Obligations, Net of Current Maturities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_d802c3cd-2a9f-47c1-b326-2deb8a35c6ba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_e7fd40f9-2b8e-4af4-acae-a546610faa63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_2c6b4a3f-aaa8-4fe8-ba8d-dc3432c88a6b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_399a46eb-3df6-4669-827d-b69660113d0d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_47389cbd-9ef6-402c-a588-34629bd02765_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b232a0a7-50c6-4c05-bf13-5ed9822a709e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_37e3331a-be69-40fb-be64-6af38c5d8958_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromAffiliates_b0446fd8-90d1-43ac-9d71-290e453f26e7_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount receivable from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromAffiliates_label_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromAffiliates" xlink:to="lab_us-gaap_DueFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_604da493-d972-4ccd-b0d4-d4146b699823_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fba70dca-034a-4d80-bc29-c0fb48144207_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_c6ed5200-c99f-456f-aefa-38bfbc2705b0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_0abd25bb-5d5b-434b-98b6-74babb68a614_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7a6a0b1c-c4bd-4b19-89ec-bd45dcdb083b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_5dfe86df-6a9f-4baf-a9fd-9d78bcc514fd_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_91d51b05-cf0c-4e7b-bd82-b87ee14ace4b_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cee77b56-8ef7-4e06-9e02-eac5f51f9298_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d17f7f5-9e99-4931-9003-76a24c6f4d53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ae857879-acd0-46ca-9045-0514038d4627_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other retirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cc969f3f-c774-4ed5-ad88-749bdc40b765_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9cba19a7-4dbb-47b0-92c2-8cd56d514da4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_574ff347-21bb-44f3-85ee-03a77695af00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_966a02cb-847c-431b-b3e7-f3fa0d03ae07_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining term of shares issued at conversion</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e157ccd0-ee48-4d07-8e56-bc7505b0eda7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock-based compensation awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_e5bbdc45-94cd-40ad-afe3-18b07ac78426_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, December 31, 2019</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_bd28696c-b2ca-4ebe-845f-4319b1fc1687_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, December 31, 2020</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_d67b9e48-059c-4df4-876f-5ae4720195a1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8f72e1da-0ceb-43b8-b641-67d58909eacd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_cc0d9ba8-8fbf-414a-a801-184e8fec9e79_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_0b255895-3142-4a04-9c69-67b5ad3b0ab5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_81ca8823-882d-4718-b04b-8a94bc437ecf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued retirement plans (excluding pension)</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Other Retirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_254f588a-555d-4d8b-b126-93ff5dfc5641_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8f99f7de-5ddd-443b-8ee0-466ead02300f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_ebccd110-8fc5-4d07-952b-8209a72fdad1_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_df3242d3-3359-445b-a50c-86a70c0d1571_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other nonoperating (income) expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_2be33a63-d251-4fbc-bf57-d122c63219d7_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation on payroll deductions of employee's base salary, amount</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bb9c4ae4-dbcd-4c54-915d-c5c260c8cdbb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a91fd2a1-cb86-41f9-93df-2d2fbb8d3a43_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_536c240e-5534-4cac-8ec1-19c0ce750ed0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_72dbb68a-b279-4400-b723-3ff508757585_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ce429345-4869-41b9-ab80-b7e6f34a1597_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_686f2487-abf2-4fe0-8e18-ee15887edc22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and converted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5b06bd94-ca10-4edb-983f-7c0ea263c5fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_a5bad77c-2bcc-4730-b239-462e2bd64d41_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5ef6c5b2-375a-4a87-9cf6-0ccfb23ae4b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_0a88efb3-8bd9-4837-8298-70922d0a6068_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency_7b4dbb7b-11cd-4b06-9341-fc105be84750_terseLabel_en-US" xlink:label="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devaluation of Argentina</link:label>
    <link:label id="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency_label_en-US" xlink:label="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Charges From Devaluation Of Argentina Currency</link:label>
    <link:label id="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency_documentation_en-US" xlink:label="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Charges From Devaluation Of Argentina Currency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" xlink:to="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_d8ae9674-86f5-4fd5-8dcb-58203caed090_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_af2b2ead-9596-431a-adbc-60265a08537e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss arising during period, net of tax of $(0.7), $(0.3), and $(0.2)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_bd520a69-9e77-4438-a3c7-6880f7bc4799_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b0ae9253-aa39-482d-8d05-1611702f68dd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_b5437196-55ca-4279-aaf1-4246168869d2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_4d96a0d1-799c-492d-8df7-fb2394c291df_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_a064f231-9154-4c36-9446-306836e246bf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b12a9789-c0ff-43d0-b3a8-c595b441df95_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1b495c94-6103-4a24-a465-033e896be849_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_8cd18b2d-eea2-4e4f-8d71-dd6201e12bc7_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual payout range</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_8cb5fd3d-5e45-4f25-a87f-d97b4ca36aff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_88d9a7ec-82c0-4ec9-8a21-6fe36671790d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d907e850-6aab-4708-b32f-b9fc0d3afe8b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_46c8195f-c3b8-4f60-a7d7-12fce1e1d513_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_3285ca77-e8df-4f5f-b432-03e02970e07b_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and post-employment benefits</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_4e5f1732-b710-4f85-b802-09872b41e199_netLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8c3d4066-25c5-4885-951d-3c9de808e987_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Contract with Customer, Asset and Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_c917d515-c74b-414e-a9c9-65d8a95060b0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_55696020-2e47-476c-9cf2-0d2078b16b15_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_5e4ebae9-6c4a-4435-afcd-f5fcae62921c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase programs</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e0d3a66d-699f-4c74-a4e7-ca5fc79f06b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_148c1308-2590-4973-9c0b-80aa9db737d1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f2986580-d8ec-40c5-bd75-ed696d219b68_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8661af1c-f763-412f-a4af-6aa3a85dae25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and converted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8a37c7d1-be28-492b-9d4e-a92c46bcd727_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b9bbe858-8676-4dbc-8ed1-b47c5a6876d1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8d7322a6-08fd-4a3a-9fd0-6639002d4f77_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_a8d1629d-b064-4e76-8b41-773518101065_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under revolving credit agreements</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_013ed22f-056b-4d99-8c5c-2dd850cfab8f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherExpenseIncomeAbstract_8917ca84-5370-4c3a-be68-fd1247cda426_terseLabel_en-US" xlink:label="lab_wst_OtherExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income) [Abstract]</link:label>
    <link:label id="lab_wst_OtherExpenseIncomeAbstract_label_en-US" xlink:label="lab_wst_OtherExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income) [Abstract]</link:label>
    <link:label id="lab_wst_OtherExpenseIncomeAbstract_documentation_en-US" xlink:label="lab_wst_OtherExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeAbstract" xlink:href="wst-20201231.xsd#wst_OtherExpenseIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherExpenseIncomeAbstract" xlink:to="lab_wst_OtherExpenseIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fa3e1f9a-3308-463f-9d95-530f49f24d52_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_a291d980-16a7-4cc2-ad55-40145e940f8b_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_21dbce24-5733-435e-b331-b52ff4f16026_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyReceivable_10406fad-b37f-4c57-b358-53f4804b4290_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reimbursable by the insurance company</link:label>
    <link:label id="lab_us-gaap_LossContingencyReceivable_label_en-US" xlink:label="lab_us-gaap_LossContingencyReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyReceivable" xlink:to="lab_us-gaap_LossContingencyReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmount_54bf1616-7dd8-4ba3-a017-6c9fd8bd4c4f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, nonmonetary notional amount outstanding</link:label>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Nonmonetary Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:to="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_5fde3341-fc04-4a78-a434-8c2f790ad46d_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_724b5eff-dea4-469e-a366-4693a8fda07d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation gains (losses)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7460e28e-26a6-4dae-bc47-2efbefffb260_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments not designated as hedging instruments, gain (loss), net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_95e62482-3565-47cc-9165-414aa71e4464_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_dc5180c8-3b24-49ed-8e02-a6b64b0fcbaf_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_d291b9b2-aed4-4393-97ff-58cafaf136ce_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_56db9eb8-e6c0-4155-b219-7c1b10ddc082_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOnFutureEarningsAmount_8d3793e6-be98-42ea-95b1-3590b6313bbc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on future earnings, amount</link:label>
    <link:label id="lab_us-gaap_EffectOnFutureEarningsAmount_label_en-US" xlink:label="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOnFutureEarningsAmount" xlink:to="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d25add19-d7eb-495e-96e9-02418f9ae7bd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_48d17516-3266-4a14-8d7a-46d7c70f60a6_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_3d5c2896-ba10-41da-aed5-367672287a0f_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_80367cfe-9667-44f4-8198-6585ea877d9b_terseLabel_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference Between Revenue Guidance in Effect Before and After Topic 606</link:label>
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_label_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between Revenue Guidance in Effect before and after Topic 606 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:to="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_cc6cedf7-334b-4675-8bf3-3fb8eff2ef63_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1ff83f65-8800-4215-8d53-2c5bc99f7aea_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_66d8efa0-d739-42d1-9360-96b81f011801_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_015681fd-254c-4803-b866-3f321e86550c_terseLabel_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2024</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_label_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Due 2024 [Member]</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_documentation_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:href="wst-20201231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:to="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_3b703642-4dad-4307-8fdf-5739d5633b88_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_91749083-cf01-492d-9c01-784cd998f6c1_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember_2c11fbb5-5dd3-4943-844b-6df82cb1937e_terseLabel_en-US" xlink:label="lab_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probabilities of Successful Execution of Agreement</link:label>
    <link:label id="lab_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember_label_en-US" xlink:label="lab_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probabilities of Successful Execution of Agreement [Member]</link:label>
    <link:label id="lab_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember_documentation_en-US" xlink:label="lab_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probabilities of Successful Execution of Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember" xlink:href="wst-20201231.xsd#wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember" xlink:to="lab_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_15e9c25a-cca0-4624-bc54-25edf36df20c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4af43c70-d3c0-47d6-a3cf-f42d1153ffbc_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_874affd8-a3c6-4e5d-a26f-7f3e2b3030f8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7b3d33eb-637e-476c-a94f-88a748e11088_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_245359ef-411a-41d3-b8c7-b7d23aea7d40_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c6384ed2-df8c-4bf9-bb61-883a118f3bae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_7e7031a4-4e4e-4763-91d0-24a4803ad249_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_2a17dbd1-0b0f-4e07-b4eb-dae55a75dded_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status</link:label>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Changes In Fair Value Of Plan Assets, Projected Benefit Obligations And Net Funded Status [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:href="wst-20201231.xsd#wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:to="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_GenericsCustomersMember_3e3e0492-9b23-4100-805b-e3710ef5c180_terseLabel_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_label_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_documentation_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember" xlink:href="wst-20201231.xsd#wst_GenericsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_GenericsCustomersMember" xlink:to="lab_wst_GenericsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_c7d17222-c2b7-4f68-b6be-f111963afefa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under revolving credit agreements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_57129992-c8dc-4b3e-a700-9809d107ab46_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_c69040cc-185c-4001-92e3-e0c07f46759d_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_c22ceef4-5349-46de-b0e6-0b16bd14c08f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_80f130f6-6d5c-4322-9d1d-ed83741e98ef_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_c7a7ad15-ae1f-4bcf-9589-06ae9efef5e9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_34c189ee-aa10-4564-a681-3230b38cc5a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_d8f07f20-c6fe-4335-887a-07819af31c43_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in benefit obligations:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_cc5a7b7f-d8ef-4eec-a563-4afea9a8c2cc_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_02872514-9e62-4400-b544-4375df7a7fba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d74d7de7-ef5b-466c-9ab4-e3a043e89813_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d956d43-d5e2-4d42-9269-2d7324fe7ac3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a95c32aa-4706-479f-9328-a991df0843aa_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockSettledStockAppreciationRightsOutstanding_2a4d8a7e-a860-4523-9b29-675d8977f69a_terseLabel_en-US" xlink:label="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled SARs, outstanding (in shares)</link:label>
    <link:label id="lab_wst_StockSettledStockAppreciationRightsOutstanding_label_en-US" xlink:label="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled Stock Appreciation Rights, Outstanding</link:label>
    <link:label id="lab_wst_StockSettledStockAppreciationRightsOutstanding_documentation_en-US" xlink:label="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stock-settled stock appreciation rights outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledStockAppreciationRightsOutstanding" xlink:href="wst-20201231.xsd#wst_StockSettledStockAppreciationRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockSettledStockAppreciationRightsOutstanding" xlink:to="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare_84ee031c-1095-48e6-990b-dac8d05bd1bd_terseLabel_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from stock-based compensation (in dollars per share)</link:label>
    <link:label id="lab_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit From Stock-Based Compensation, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit From Stock-Based Compensation, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_c9c32929-a0fd-4b18-a5c5-f535a41b3ac2_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative (gain) loss on amount excluded from effectiveness testing, fair value hedges</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_176e4c75-a091-416b-827e-4ee95417a890_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_963d61ee-7dfd-48bf-b552-682835bca1f5_verboseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs remaining</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a699b952-d5b8-4c54-850b-a415de8118f8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SouthKoreaDistributorMember_9d24d2dd-1e79-4c8a-a25d-471796c6ce33_terseLabel_en-US" xlink:label="lab_wst_SouthKoreaDistributorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea Distributor</link:label>
    <link:label id="lab_wst_SouthKoreaDistributorMember_label_en-US" xlink:label="lab_wst_SouthKoreaDistributorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea Distributor [Member]</link:label>
    <link:label id="lab_wst_SouthKoreaDistributorMember_documentation_en-US" xlink:label="lab_wst_SouthKoreaDistributorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea Distributor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SouthKoreaDistributorMember" xlink:href="wst-20201231.xsd#wst_SouthKoreaDistributorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SouthKoreaDistributorMember" xlink:to="lab_wst_SouthKoreaDistributorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_d8083727-c7cb-4fc5-83a4-580eef7fb281_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8af82e27-b3ca-4c28-bade-7459b398a8f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Basic to Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_467d02ca-c228-4393-bfd3-900bff56c2b4_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_a745d51a-fae9-46b3-981b-59d4432ccf4d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_72df7a76-b393-42c6-bb6e-320669a874f1_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_883652d1-8d1e-4979-ad81-6443b573de1c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_d3faecf6-f912-4182-a233-1537124bc917_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding amount</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_4f5cc0e0-c4bf-4a43-9be4-58449e7b944f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit supporting the reimbursement of workers' compensation and other claims</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7b1b24a7-5016-40b1-acf4-b14c1233fded_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_c91762dc-fcd5-4100-9ee9-7d2b13cf8dd9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_645c9149-d2b3-4d57-a441-aaef5280ac14_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_73f83114-913a-4774-a544-c18fccf0e783_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_f33a700f-bfb4-45e0-a09d-d70259279fa9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaTapSADeCVMember_a8361ba4-054b-461f-94d9-5dbba6bc4485_terseLabel_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A. de C.V.</link:label>
    <link:label id="lab_wst_PharmaTapSADeCVMember_label_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaTapSADeCVMember_documentation_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember" xlink:href="wst-20201231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaTapSADeCVMember" xlink:to="lab_wst_PharmaTapSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AluplastSADeCVMember_6bd0a24e-33c7-473f-99c6-134f73a14bb3_terseLabel_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V.</link:label>
    <link:label id="lab_wst_AluplastSADeCVMember_label_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_AluplastSADeCVMember_documentation_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember" xlink:href="wst-20201231.xsd#wst_AluplastSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AluplastSADeCVMember" xlink:to="lab_wst_AluplastSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4216496e-401c-424e-bb58-fa3106f80275_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_618d87f9-2a43-4149-88ed-94e32a2f3990_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_95564d9b-5d57-48c6-b129-ffac155715a1_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount due and payable to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_7b4822fe-cd84-4fae-be37-14b8fc2a7ecb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08e42f37-5e2b-4f15-8e20-dffc80abb677_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_87808206-e11a-4c7e-bb11-1bc20e7412f8_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_50e9988b-c3ab-49c8-9dc6-648ef8e73272_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_87bedc7b-1dab-4caf-a632-f6c00793693c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_33b8276d-d899-4497-b4cf-18b03626f57a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings, Undistributed Earnings from Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:to="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_32a0dcb1-c906-4362-884d-00fb6d5bdcd5_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_e6149d6c-6392-406c-8190-ae8cfc018962_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_15d3f497-ffeb-4d15-a550-2d2fdfec6599_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_8f71658d-12e9-4ad5-b568-38fc4262a07b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_92ff3129-0ee1-421a-bf14-369eb2b358d6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_c8eab6b8-c29c-4280-8cc7-82e44930b33e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_87d9a39e-58ba-4368-a4e7-692dc7c57f2c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2517d9fc-450a-4701-9e2e-b9b4c19bd21a_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3f56ea1d-626e-4e97-89c3-8c0cb3c3989c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program, average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_15cc6b85-e2a1-4df1-bcc8-4d8a41c79b38_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_31020b6d-fda3-4a8c-8728-d6afeb063ebd_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_0a5d80f0-7059-4acb-ae38-15fdb98df78e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_1c922790-958d-42ad-bed4-a44a69da6b1a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a5c92288-2876-4107-8eb5-9a5a7e5df680_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquisition-related Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c3894e47-d98f-437e-bdbc-222b5343da9d_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquisition-related Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_ca66b96e-6626-4dd4-902f-dd30861de7b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_041aabfe-0f9c-4ec4-a420-d24e8ad12663_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Companies</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_cdd7fc00-4b64-4291-ac6a-d3ca72cef714_terseLabel_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-Settled PSU Awards</link:label>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_label_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-Settled PSU Awards [Member]</link:label>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_documentation_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-Settled PSU Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember" xlink:href="wst-20201231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CashSettledPSUAwardsMember" xlink:to="lab_wst_CashSettledPSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_70f1e11a-0625-4f2c-96a1-eaccdc1d8145_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_b4faad21-1d9b-42d8-b124-59bb738d356d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain recognized in earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:to="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_5b56c09c-e813-4f31-82de-053d3eca0b54_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_c1bc9b5f-dac9-447e-95ad-19db08e8046d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_f4ab5d32-3816-434f-90db-0513ecf789ed_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_3bbc416f-9499-4969-b26a-c9bb8d280248_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3dfc67dc-7b68-4b31-81b7-e4e7fecb1fb5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_62226531-75d5-4a99-91e3-d9a7e7bde4d9_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_0d57b5a6-6ad6-44da-82a0-d2e23714730a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d4ea6f8a-5331-4f6d-93ae-6e56661ccf17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_20a38c55-e1b1-4903-8968-41e6eaf12f62_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_2e110412-8d4b-423a-8055-c32cbced9c99_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_b2c8c102-1893-4484-9bbf-66bd3a4537b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments in excess of acquisition-date liability</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_5951b046-c6e7-4785-b7f7-0cf6d63324a0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_d5a011fa-15e5-427d-b6f6-746f288b1c34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a10333f3-e399-450d-aa05-bd6996fbc38e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_5b920fe6-6145-4f4f-972d-1df2ec35028b_terseLabel_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer hardware and software</link:label>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_label_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software [Member]</link:label>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_documentation_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember" xlink:href="wst-20201231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ComputerHardwareAndSoftwareMember" xlink:to="lab_wst_ComputerHardwareAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_3e58087b-f2e2-4bfd-8803-f3ecff0e8e73_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_96457627-25b1-4b49-9309-e21629f97e35_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aa99a2fd-d860-444b-8f13-05fcb9d9edde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_41d39b95-de93-4c07-92f4-6aa5eec5d370_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_68b1fa5d-5e14-44cb-bd6e-1d90b32cee72_negatedLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_634252b7-5642-4263-bee2-7b2dbee818e8_terseLabel_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments</link:label>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_label_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</link:label>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_documentation_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:href="wst-20201231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:to="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_a352c7ba-fe76-415b-8e6c-a3b2c72ec4e3_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a70a01a8-f6cb-4636-a4a6-60166be46355_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_3cad167d-d7f2-48a6-9c61-ae7c2a97b0bd_terseLabel_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility is available for swing-line loans</link:label>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_label_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility is available for swing-line loans</link:label>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_documentation_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This refers to credit facility is available for swing-line loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:href="wst-20201231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:to="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_0c1cac1b-59a6-4028-8583-60226db69545_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other charges</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StandardPackagingMember_f0715921-6db1-4306-ac99-f3253d4e1b3f_terseLabel_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging</link:label>
    <link:label id="lab_wst_StandardPackagingMember_label_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:label id="lab_wst_StandardPackagingMember_documentation_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember" xlink:href="wst-20201231.xsd#wst_StandardPackagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StandardPackagingMember" xlink:to="lab_wst_StandardPackagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_caa00209-4295-457e-aa48-84b8006ab41a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_26a84600-4682-40e5-aeb7-4fee8afb2665_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f708cc8a-ec36-4526-80e5-d54e5164e03b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, amount of gain (loss) recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_The2018RestructuringPlanMember_b2694b14-1a2f-457f-9934-244f022e6a94_terseLabel_en-US" xlink:label="lab_wst_The2018RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Restructuring Plan</link:label>
    <link:label id="lab_wst_The2018RestructuringPlanMember_label_en-US" xlink:label="lab_wst_The2018RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_The2018RestructuringPlanMember_documentation_en-US" xlink:label="lab_wst_The2018RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2018RestructuringPlanMember" xlink:href="wst-20201231.xsd#wst_The2018RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_The2018RestructuringPlanMember" xlink:to="lab_wst_The2018RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4e9d3f5f-e761-4a49-b2f3-9a6768838ddd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6551cedf-085d-42ec-890b-7701f0028f6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_e0717f9b-a2f7-4251-8345-39f159b0e737_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_988126a5-2ecc-4364-b555-75724bf56652_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Argentina currency devaluation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0793a0d8-0737-4d6f-b767-2ce79f771d6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_c19773ef-2872-4591-b3c9-c65bd5b5ca21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_2cee1c95-4089-4277-a0c0-9f37d7930984_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_a18939ff-8a81-437d-800b-a9b71e425b81_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d1391436-b3ba-46e0-be55-027a84a880a9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_ce48897d-cef4-46d4-acab-6543f48cae70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5e084479-1018-40b3-bf54-7cde6722b6e4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_db29baf8-a366-4c9a-835f-237b9602343c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate_fd4a29d0-4a6e-433c-8cb7-2bcbdf056546_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion rate</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Conversion Rate</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Conversion Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_612b6887-56d1-4d89-9e79-4ab5cba0aa4d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_8d8e6f11-78a0-4819-80b3-269026220190_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Appreciation Rights Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_4a4d4578-78f9-4d50-b0b1-6da62b853e99_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_a81b5e6e-62c4-475f-8ee2-6f00824843ca_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_c83a3fa7-3d88-4798-b8d0-1c5cec43b70f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_dd9cea75-926f-40f5-99c2-4f90698b3ad6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset impairments and sale of equipment, net</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedProductsMember_8a28a10b-6276-4bfd-8043-1de4f4b62eb7_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_576742e1-b9a6-4698-8daf-ce0d675cddab_verboseLabel_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_label_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedProductsMember" xlink:to="lab_wst_ContractManufacturedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_6bcd048b-3625-4dec-bc54-05e5e587d41d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_5d02aada-6459-44f0-8115-5485d5b47aee_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_b492dd17-6537-4b6b-9727-082bf1b49336_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_7cfa6267-2f72-4d91-a38d-d9343a06d0cf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2021Member_00e956ff-e361-4da4-8a6a-a8a8c5ddda37_terseLabel_en-US" xlink:label="lab_wst_Year2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2021</link:label>
    <link:label id="lab_wst_Year2021Member_label_en-US" xlink:label="lab_wst_Year2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2021 [Member]</link:label>
    <link:label id="lab_wst_Year2021Member_documentation_en-US" xlink:label="lab_wst_Year2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2021Member" xlink:href="wst-20201231.xsd#wst_Year2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2021Member" xlink:to="lab_wst_Year2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_98079260-0a2d-4807-9ab9-88160e6b83a9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts and swaps</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_b455cdee-6b07-4f6f-857e-edf16b3a3258_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments received in advance</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:to="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_db7bc6a6-e228-42c6-b54a-0f1d64836fa4_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on disposition of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f887f617-7eab-4d7d-9dcd-baaee1c57b6d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5d5d3c8e-7b3d-42da-8304-dd04783fc187_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForeignCurrencyDenominatedDebtMember_84887858-52b6-4db4-a6b1-e5548201da3f_terseLabel_en-US" xlink:label="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency-denominated debt</link:label>
    <link:label id="lab_wst_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency, Denominated Debt [Member]</link:label>
    <link:label id="lab_wst_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency-denominated debt designated as a hedge of our net investments in foreign operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyDenominatedDebtMember" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_3e1474ae-39e6-47eb-8809-fa5c65983012_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_c02af546-35ef-4cd3-aa92-321b17ad09fc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_f5563e7d-5a78-48d3-8a82-e2970403264f_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_d32f1f1a-57dd-45b3-a172-f44b56e5dcfc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet_7c5d3d35-013e-46fd-904e-453f2eaa9e1f_terseLabel_en-US" xlink:label="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other retirement plans, net</link:label>
    <link:label id="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet_label_en-US" xlink:label="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Benefit Expense, Net</link:label>
    <link:label id="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet_documentation_en-US" xlink:label="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:href="wst-20201231.xsd#wst_PensionAndOtherPostretirementBenefitExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:to="lab_wst_PensionAndOtherPostretirementBenefitExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6a097921-0825-48b0-97e4-be3a76c99bed_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3b9e8c43-461e-4912-a31b-98db35d1d633_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_0e52fe83-ccfe-447a-b61d-e43973aab015_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d6f93ca2-a965-4c23-9385-8ac325c3f6a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d7e66299-78ef-4816-a7ab-2dbb81c27a85_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_fdf7de6c-b1a1-466e-8f52-3ec8107509cc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare_24d76f4f-1ac4-432b-9524-0101fd80f866_terseLabel_en-US" xlink:label="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devaluation of Argentina diluted share (in dollars per share)</link:label>
    <link:label id="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Charges From Devaluation Of Argentina Currency, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Charges From Devaluation Of Argentina Currency, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ExpirationPeriodAxis_5e8b5b7c-6b26-4192-ab46-e514d182d5d4_terseLabel_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_wst_ExpirationPeriodAxis_label_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_wst_ExpirationPeriodAxis_documentation_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis" xlink:href="wst-20201231.xsd#wst_ExpirationPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ExpirationPeriodAxis" xlink:to="lab_wst_ExpirationPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_88c8cd62-2077-4191-94c3-0e862fee3903_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_af431c4d-b825-4aac-8d0d-5021e72ed2c6_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_de591a18-4206-4e4d-9feb-4a578baac1cd_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_71a99b1f-0318-4933-aef7-fb54620a2dc0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtInstrumentNumberOfTranches_4129d79a-281f-4b21-b4ae-9f150243e901_terseLabel_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Tranches</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfTranches_label_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Tranches</link:label>
    <link:label id="lab_wst_DebtInstrumentNumberOfTranches_documentation_en-US" xlink:label="lab_wst_DebtInstrumentNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfTranches" xlink:href="wst-20201231.xsd#wst_DebtInstrumentNumberOfTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtInstrumentNumberOfTranches" xlink:to="lab_wst_DebtInstrumentNumberOfTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_4148dbac-b2d8-4342-8852-c8e9dc20b675_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4b067eaa-8e5a-441d-a049-72cad5877e92_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_120b4f2a-4583-4371-aa9c-79b660b3ff1f_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_1a4b6f4b-bedb-4124-ae1c-dd20d744afeb_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2fbb3f7a-2ee2-46f7-863d-fc25f1833e4f_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative instruments, net, pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_6002fee8-acb5-4eae-b4e5-efad2d0664b0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_22ee45ee-4a22-4f3d-b7c6-21df7e7c362f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_3be15d2e-9c6e-4965-99d0-1a0e2cbe01cb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_18c52cb4-01eb-4af1-8e4c-f8c8cc49f06f_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_eba49c56-fb10-4700-b1f0-bf713484d7ab_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_450ea67d-8c4f-49b7-9a1e-9466ef023810_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of Share-based Compensation Costs by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_2d580b2b-aa2a-4142-ada1-b972eb2f7921_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_12d161f5-2497-4767-875b-5aec974cdce0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_5bdefca0-fb13-465e-9058-a34c9b3ddb4f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_4fd34d30-8dee-4b8c-84c1-87635eed689e_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_da782548-2d6e-4808-bf7e-e750bf4c6aa2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_0082f9f6-6b45-4559-91f1-f636164243cc_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_64b3018f-abca-4ad2-9963-0ed48f9f1777_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_896e4d60-7fde-4c37-96cd-f0f0c16b1bfe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_8c02cc88-5285-44ca-853f-ea08194c9574_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received from affiliated companies</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_47a2120e-134c-4d47-9532-e744ed8d742f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost arising during period, net of tax of $0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_143591f5-b174-44ac-8ff6-866e161bf612_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_994550d3-1260-4a5d-80de-080894eb077a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_968d6ffe-d256-4b59-9b2a-44ba2e8d7d7d_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_8be10694-bcd6-46b9-a3b4-c61e4f31f2cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit_31218f20-0221-448d-883d-dde0c0e6807a_terseLabel_en-US" xlink:label="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit available for the issuance of letters of credit</link:label>
    <link:label id="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit_label_en-US" xlink:label="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit available for the issuance of letters of credit</link:label>
    <link:label id="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit_documentation_en-US" xlink:label="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">this refers to Credit available for the issuance of letters of credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:href="wst-20201231.xsd#wst_CreditAvailableForIssuanceOfLettersOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:to="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetRelatedChargesMember_0cbf2270-c9a7-4b71-8cc0-0b1878d7bb6c_terseLabel_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-related charges</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_label_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_documentation_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember" xlink:href="wst-20201231.xsd#wst_AssetRelatedChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetRelatedChargesMember" xlink:to="lab_wst_AssetRelatedChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_9881170b-d9aa-40ae-ae97-691148ab6ef9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_c6c945ad-78de-49c0-962a-d39cbc1d748c_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred compensation plans</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Number Of Plans</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Number Of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IWPharmaGroupLLCMember_210333ee-6dea-44ae-8263-981b2972b586_terseLabel_en-US" xlink:label="lab_wst_IWPharmaGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I&amp;W Pharma Group LLC</link:label>
    <link:label id="lab_wst_IWPharmaGroupLLCMember_label_en-US" xlink:label="lab_wst_IWPharmaGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I&amp;W Pharma Group LLC [Member]</link:label>
    <link:label id="lab_wst_IWPharmaGroupLLCMember_documentation_en-US" xlink:label="lab_wst_IWPharmaGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I&amp;W Pharma Group LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IWPharmaGroupLLCMember" xlink:href="wst-20201231.xsd#wst_IWPharmaGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IWPharmaGroupLLCMember" xlink:to="lab_wst_IWPharmaGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_18f8b7b4-44f0-4c10-b840-a46596439973_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. tax on international earnings, net of foreign tax credits</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_b9c5f0cd-69e7-4cce-833a-d8eba98ee088_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_64babbb4-ab92-470f-a030-5ca3bf4ecff9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_e00b6aee-970d-41de-be3a-c96a4ae5afc7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income)</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_35812944-87fc-46dc-8ec0-688c2fc504d3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_f5ecf08a-bff0-4786-b72b-48d9e430d92f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f4c679bf-6503-48a3-a5b6-0effa1f6341a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9f1693aa-49b6-434f-b028-971f3287d0b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5428918f-52a2-47f2-a556-f50466965a82_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_52229906-6ff2-4914-9535-3497da39858a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_0a99b618-6a6f-48d7-a00c-f008f5d1b024_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_23b21824-88c6-490b-8641-346b1b094188_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period adjustment, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_c6678be2-ff6e-4e14-8de0-18f425b19f76_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_9abe401c-8887-4db0-9028-16a94f451b87_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_HighValueProductComponentsMember_5b28025b-c1c5-4934-a64a-77660358e229_terseLabel_en-US" xlink:label="lab_wst_HighValueProductComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Product Components</link:label>
    <link:label id="lab_wst_HighValueProductComponentsMember_label_en-US" xlink:label="lab_wst_HighValueProductComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Product Components [Member]</link:label>
    <link:label id="lab_wst_HighValueProductComponentsMember_documentation_en-US" xlink:label="lab_wst_HighValueProductComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductComponentsMember" xlink:href="wst-20201231.xsd#wst_HighValueProductComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_HighValueProductComponentsMember" xlink:to="lab_wst_HighValueProductComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6848ee17-adbb-4a38-8ff1-5acc52ff7d4e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare_4e6fac79-5029-4ca3-8b43-5d6b6dc62171_terseLabel_en-US" xlink:label="lab_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of excise taxes (in dollars per share)</link:label>
    <link:label id="lab_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare_label_en-US" xlink:label="lab_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Excise Taxes, Impact On Diluted Earnings Share</link:label>
    <link:label id="lab_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare_documentation_en-US" xlink:label="lab_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Excise Taxes, Impact On Diluted Earnings Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare" xlink:href="wst-20201231.xsd#wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare" xlink:to="lab_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_65ecc710-a3c3-4682-8450-1965eec62eba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_4b5d44f4-d346-429e-80ca-add1d6d73555_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_cca3ee3b-2a6d-4baf-8c4b-2267d80b18ed_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4f829da4-aa15-4f3c-9821-805349403590_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_9f6a084f-ff57-4e16-84c4-becbeff49e28_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_28b24517-8cbd-4a7a-8189-96df2d1664f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7bb5f842-d940-4224-b1fa-3eb40c499113_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b13c2854-7e84-4095-83d9-541e69a88933_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a2cbeb0a-1b57-488f-a6a4-74e5fa5142f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_4081e726-2b96-42ff-9e46-5948d84edc30_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a27e9d09-7acd-4b34-9591-0576bec1001b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_537c98f6-940f-4dc8-8dd9-e3ea2fa5556a_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_d4fdc4da-bc41-4d13-8627-4d81c11d46ed_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement effects arising during period, net of tax of $0.9, $0.8, and $0</link:label>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Loss, Defined Benefit Plans Settlement Effects, Net Of Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:to="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5e61d3b4-f85f-4c1c-a5b0-9142640c041c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_64911f2b-627f-4d86-87c6-d59c1b2c9aa7_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_1f13a9f9-1ae7-4ebd-bc42-391560c5c3b6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_040dfa67-0766-4255-ab00-817b9d3d07a8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_1e41e84a-790a-45b4-a6c0-9f290d9647ea_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_952d2a62-9dfc-4ab7-91a7-86f32c451bfc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_9038934f-b910-402c-81c5-fb1c2342bc92_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs Activity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_ca567b13-e7f7-4b46-89c6-9c368f02fd62_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_47a65b31-9fc3-4189-bb3e-6af53de1d409_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_ffb22147-1491-4f76-9822-18d9ebbcdfea_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6a2d9b3c-648e-42b8-b09c-4e5a2e3813e5_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_14fb56b3-a050-4633-8787-2ceaaccc8dbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_a7aa596e-4e01-4c97-b081-d13f0724f1ad_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_3d56481f-e9a4-468b-b6e5-0b4cca6a0507_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_3883866c-2df6-4f21-89f4-cbcaa6498c6d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_f17cae06-5088-4104-9a1a-33320d186567_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_caa329fc-b9ab-4afd-b1f5-675a2cff1a00_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3dbe6a1f-377a-4ffc-afc7-945398bc6174_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability payments due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_8236866c-ddac-453d-ae59-268c30b5ceab_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_2537831a-9754-49b7-b18a-cbab8a2366d1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_db7a8c8e-e7ab-4967-9e32-4fdf84ba4d2c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_4246fa57-1cdc-4077-bbce-ab3be2dd4d00_terseLabel_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo</link:label>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_label_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo Seiko, Ltd. (Daikyo) [Member]</link:label>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_documentation_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo Seiko, Ltd. (Daikyo) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember" xlink:href="wst-20201231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DaikyoSeikoLtdDaikyoMember" xlink:to="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_70567765-5b41-4dd5-9a23-79b0bd17088c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average interest crediting rating used to determine net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_0127b970-32ec-48ce-9694-6dca297584fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in undistributed earnings of affiliates, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f8eea3a2-47dc-4baf-988e-4e6f122b88c2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_2f2e2fd8-6e0c-408f-af88-3322a6ca283b_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_6ef59047-3caf-4b06-a004-37ca313cb0e3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b28d1782-0e76-4a6f-a25b-c22fb0e0eb45_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_4490c6f6-292e-4e92-b6f3-2e414440c013_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bfb25d0d-7957-41ce-80ed-9faf0f7e6206_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_f46ea39e-86d7-4907-89fd-edbd2d0046de_terseLabel_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP)</link:label>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_label_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_documentation_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember" xlink:href="wst-20201231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EmployeeStockPurchasePlanEsppMember" xlink:to="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_52bf7ee4-a77a-49a8-a621-54ce261650a3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of prior service credit, net of tax of $(0.1), $(0.1) and $(0.5).</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_101dc454-8e4c-4455-a7cb-03c8e4db2fad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_578dd3d6-c5c2-482e-b24d-3501f4f8fa76_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod_c8ec2554-d830-4975-8370-2c5d11600eb4_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized during the period</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Revenue Recognized During The Period</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Revenue Recognized During The Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" xlink:to="lab_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_f5a191c8-7a4a-479b-8c03-a41afe226841_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_24a3b9b2-da0a-4494-922f-4327c31658f2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22db4902-7aaf-41f4-ad8f-606a9da4cfa1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_1afa7b23-c0b7-4310-8518-d34a42f18ccb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_0d7db465-6abb-43c3-92b1-3b9bb47f4244_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PensionSettlementAndRelatedCharges_8558cc7c-5cfe-47b9-baad-71b22cf14e34_terseLabel_en-US" xlink:label="lab_wst_PensionSettlementAndRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlement and related charges</link:label>
    <link:label id="lab_wst_PensionSettlementAndRelatedCharges_label_en-US" xlink:label="lab_wst_PensionSettlementAndRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Settlement And Related Charges</link:label>
    <link:label id="lab_wst_PensionSettlementAndRelatedCharges_documentation_en-US" xlink:label="lab_wst_PensionSettlementAndRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Settlement And Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionSettlementAndRelatedCharges" xlink:href="wst-20201231.xsd#wst_PensionSettlementAndRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PensionSettlementAndRelatedCharges" xlink:to="lab_wst_PensionSettlementAndRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_609ce38c-8be1-4e19-ad41-977ab7d27935_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_a93acb9c-c4dc-40e2-ba8c-36037ada600b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_bdae2664-9926-4132-a38d-a2ece72266a2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_c6728d56-a4aa-465d-b066-050d58444703_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual funds</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cab534e9-1b24-4c3f-a481-a28eb115d2ac_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b84d430c-070a-403c-ac7e-9cd91d08123f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_ba93af15-3e36-4d81-b898-14968fbd2836_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on investment securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_537465c1-f2e9-4384-a988-e478e4c4a58c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_0bb33b71-b65c-4b95-b728-e439e77e8c19_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes other than income</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_3bc107d1-56db-48c7-9856-dbe3e2554919_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlement charge</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6e7b109f-60c7-4c78-b68b-369dfbe496fa_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d5c4c8c7-d7ba-4eac-9ce0-8ff11d5c2bc3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_cba2e2f3-d179-424b-8e66-0d063aaf8dd8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_55903230-cd02-4559-9f8c-f12e2c030733_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_93ee8d28-ded0-4852-8af4-5df2c7698572_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments above/(below) target (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_0bc45fff-6a0a-4d9e-803b-6d5b24eb5edd_terseLabel_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V.</link:label>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_label_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_documentation_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember" xlink:href="wst-20201231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_WestCompanyMexicoSADeCVMember" xlink:to="lab_wst_WestCompanyMexicoSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_a2d2eb1a-8732-404c-86f0-ea64d60241d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_5a6630a7-c2a1-412e-9f66-c1e5d16d5a4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of total options vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_78f18704-6129-4442-a22a-7eb290f39b90_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_437119ab-c405-4b9d-ad5c-40379225b914_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in equity affiliate investment AOCI</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5d78e859-33b6-4593-a6d4-66f519cb25fd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_bdbccc46-4727-400a-a87a-7c9399b46215_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ToolsDiesAndMoldsMember_e3a541ed-7844-4fca-abdf-dc98eca2bd35_terseLabel_en-US" xlink:label="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds and dies</link:label>
    <link:label id="lab_us-gaap_ToolsDiesAndMoldsMember_label_en-US" xlink:label="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tools, Dies and Molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ToolsDiesAndMoldsMember" xlink:to="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_eb84bba7-e768-4e47-be17-487d0faf285d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_3d09ea0a-eb9b-4d1f-a69b-1dd35bd10352_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_5c0be253-fce2-4624-aac0-ee626166d99b_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_25d7d7b4-ee20-400c-a716-244640f19ce4_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ad505752-4e04-441e-8f8b-eead7e75e06e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity related to stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e9ebda95-5aea-4f32-b0f0-2235b8b92a2e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_116ae1a1-4037-4c57-b33c-7b582dbd9691_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f3b2fd0b-e05a-4026-8398-e4f4cde4f717_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e0cc5cb-739c-47ae-bf12-e196c5082bba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_dbba35de-7c82-464a-931a-22793bddf6a9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_5bee4a79-f888-4aab-889b-53fcd762f049_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProvisionForProductReturns_c9a97072-8605-44f3-85bc-335fdc36db93_terseLabel_en-US" xlink:label="lab_wst_ProvisionForProductReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for product returns</link:label>
    <link:label id="lab_wst_ProvisionForProductReturns_label_en-US" xlink:label="lab_wst_ProvisionForProductReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Product Returns</link:label>
    <link:label id="lab_wst_ProvisionForProductReturns_documentation_en-US" xlink:label="lab_wst_ProvisionForProductReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Product Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProvisionForProductReturns" xlink:href="wst-20201231.xsd#wst_ProvisionForProductReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProvisionForProductReturns" xlink:to="lab_wst_ProvisionForProductReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherCountriesMember_922f8937-d294-4b64-9dba-0d0d3568af61_terseLabel_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_wst_OtherCountriesMember_label_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_wst_OtherCountriesMember_documentation_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-European Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember" xlink:href="wst-20201231.xsd#wst_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherCountriesMember" xlink:to="lab_wst_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_44034e4b-69f8-4740-b758-673b7dc5edde_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d5678385-0f23-4f52-ad72-5c9b36d376de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_24a7cfcd-4a34-44af-8c0e-686b47638d8e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Debt Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:to="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_9ad33d62-23aa-4e5d-b1bb-8223a80e9533_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SmartDoseMember_fcf0e724-2892-41fe-bea6-7003063185d7_terseLabel_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose</link:label>
    <link:label id="lab_wst_SmartDoseMember_label_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose [Member]</link:label>
    <link:label id="lab_wst_SmartDoseMember_documentation_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember" xlink:href="wst-20201231.xsd#wst_SmartDoseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SmartDoseMember" xlink:to="lab_wst_SmartDoseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_64aaaba6-6b4c-4149-b64c-05f16e68f75d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3de12c8a-4d59-4927-bce2-a767e9809fe4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_453cad7a-744c-4957-823d-75116f9ccb4f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_a172d704-38e3-4d60-8eee-ddc71519d16e_terseLabel_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries, wages and benefits</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_label_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_documentation_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:href="wst-20201231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:to="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_3548d53b-9c53-4c23-902f-b40500dee78d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative (gain) loss recognized in income, fair value hedges</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_e19d2dfb-d6ef-4858-bb58-4e60c1f762f3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_828e0df4-0996-4eb1-89e4-eaa762e06fac_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_1f8a13a6-e8d6-494f-ad86-39eecec76574_terseLabel_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option and appreciation rights</link:label>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_label_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_documentation_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember" xlink:href="wst-20201231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockOptionAndAppreciationRightsMember" xlink:to="lab_wst_StockOptionAndAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_66ecef21-bc0f-4939-bd2b-144f4816289a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_0c937d9f-0cc6-46d8-ba78-a24b354ec0ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16ec0b84-b488-44ca-8b1a-66fdc5047f22_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f23a1dc7-d573-41fb-a876-acd9e073e2cf_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_HighValueProductDeliveryDevicesMember_d89ca5d5-0e68-4682-930d-4a516de7e97b_terseLabel_en-US" xlink:label="lab_wst_HighValueProductDeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Product Delivery Devices</link:label>
    <link:label id="lab_wst_HighValueProductDeliveryDevicesMember_label_en-US" xlink:label="lab_wst_HighValueProductDeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High Value Product Delivery Devices [Member]</link:label>
    <link:label id="lab_wst_HighValueProductDeliveryDevicesMember_documentation_en-US" xlink:label="lab_wst_HighValueProductDeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High Value Product Delivery Devices Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductDeliveryDevicesMember" xlink:href="wst-20201231.xsd#wst_HighValueProductDeliveryDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_HighValueProductDeliveryDevicesMember" xlink:to="lab_wst_HighValueProductDeliveryDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_784c24b0-065c-443e-a88b-b5ac615d398a_verboseLabel_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_label_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding: [Abstract]</link:label>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WeightedAverageSharesOutstandingAbstract" xlink:href="wst-20201231.xsd#wst_WeightedAverageSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract" xlink:to="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_0009fd19-770f-4875-b963-4a485ecc15ef_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction for expiration of statute of limitations/audits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_93c77c4d-2ac3-4086-b650-5463e77237aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_02459e7a-5c02-4cf2-9d11-9f4c9ea429af_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_39a6d135-f08b-4e0c-8073-c1763e747a0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate general costs</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aa6a9457-a8ad-44c9-a8c4-bbc865e029bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_c6045fcb-ad3c-4af2-b1da-f7e715aead6b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_eda5e2a7-1a5e-45a1-94ba-a01916195423_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_6e7b037c-5cdf-44ad-8951-0848e71a702f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other charges</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b7913724-886a-40c0-8126-fdd69f885767_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive options excluded from computation of diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0a3e573c-7bd9-4276-be61-122fc0b1a2d9_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9c7b07c9-703b-46ca-9d8d-9e1a9845ac78_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to prior year position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_477cd2c3-86ee-4dda-aa00-54945dddbca6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to current year position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_73133480-6afb-4968-b86f-01fe676f0b0f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c9ffd8bb-e457-4c0f-987f-86532c83eb2e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_717303a8-cca4-4862-83c7-f8a20eb60753_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $0, $0, and $(0.1)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ExpirationPeriodDomain_774f9dbb-ef1a-4b53-860c-ef95d4cc15c3_terseLabel_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_wst_ExpirationPeriodDomain_label_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_wst_ExpirationPeriodDomain_documentation_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Expiration Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain" xlink:href="wst-20201231.xsd#wst_ExpirationPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ExpirationPeriodDomain" xlink:to="lab_wst_ExpirationPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_fe6bab1f-0903-45ef-aed9-0dc6e2a28761_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherIncomeExpense_38904e87-a3c4-4a18-9cf4-150da81038a6_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_dec6ea31-926f-4d82-af2d-e5d943a7470e_negatedTotalLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_label_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_documentation_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense" xlink:href="wst-20201231.xsd#wst_OtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherIncomeExpense" xlink:to="lab_wst_OtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_f26d1033-e0a9-4e22-bc61-e36349fc4c4d_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_f6a04626-6090-421d-a091-4cf2bd791a46_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d3268e09-1b73-40d4-add4-268dd9634bea_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_60bf024d-302b-4c25-9fa7-c4e7dff96de7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_8a382690-b70f-4780-855f-8fc05c376fa4_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation benefits</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_22855522-2384-4200-96a2-792ea84ccf29_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2d948348-0194-4a52-94df-69b069d5a4e4_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_0847c8a3-76b2-4360-a34f-78560e59989b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c0a477db-ba5e-41c6-b652-d8079a98781c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_275f39db-1fe7-40ca-96d6-f574cd43edaf_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a20bc07c-1e92-454d-8908-eddb9a1e5edd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_6f5352f7-5d7e-4243-bb1a-014d7dc36dc4_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_594ed4f9-31fe-486a-a041-e55e9b79bdf7_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_dc87002e-b4cb-4c4f-b2ae-2f4d9a8ff764_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3520fb9a-26b4-4bc6-9ad9-d76024b37dbe_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f528aec8-cd13-4a63-b358-fe020c9ebf27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a60379ae-eadf-4a8c-89a2-db0b652f079f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_730d9216-7a61-4f7b-b3ee-ec708faeb341_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85bdd230-fa6a-45eb-8c22-c4261d29f9ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_763e37df-8e2d-44e9-b8eb-c518dce66d96_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred stock units (in shares)</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Share Equivalents Balance</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Share Equivalents Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PaymentOfExciseTaxes_62673f0d-9e89-4f16-b01a-60334a47ea8a_terseLabel_en-US" xlink:label="lab_wst_PaymentOfExciseTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of excise taxes</link:label>
    <link:label id="lab_wst_PaymentOfExciseTaxes_label_en-US" xlink:label="lab_wst_PaymentOfExciseTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Excise Taxes</link:label>
    <link:label id="lab_wst_PaymentOfExciseTaxes_documentation_en-US" xlink:label="lab_wst_PaymentOfExciseTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Excise Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentOfExciseTaxes" xlink:href="wst-20201231.xsd#wst_PaymentOfExciseTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PaymentOfExciseTaxes" xlink:to="lab_wst_PaymentOfExciseTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_bc093cf4-c700-4747-b74e-98eaeae83206_periodStartLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_0d1905b7-c870-4b86-9645-b9df2296dbc2_periodEndLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_944007ec-677f-4569-b3f7-39cfb7fd8966_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_2ce8da01-c7b2-4796-852a-b0c4b1195d62_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit</link:label>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignLineOfCreditMember" xlink:to="lab_us-gaap_ForeignLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_94917f3a-349e-4b51-bebc-29f4bae6bca0_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_cb6919d3-f3e0-447c-a50f-902bbfb1161f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_29b13262-fb1b-4e45-95e4-5ec6445a1e7d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related cost, cumulative cost incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e911f9ee-bb08-452c-bc94-f4208ede6a4f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_91ac37fb-6409-4527-a278-74470fbea6b8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3b0f9dc8-2b3b-4df9-9842-278c2fe5858b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_4e744aed-2d67-48d8-af0d-dfc996d61edd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on derivatives, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_0c6d2ad4-788e-4e70-a101-b4f5d5dd3318_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e66a21ec-9900-4659-ba97-e50d3e28c468_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_62e28ca5-08c4-4a67-b4a5-6a0463910896_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_7a5888d0-49f5-47d8-b7ae-a507774d87a5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_78dd2db0-5e35-4c14-96ef-9c01ad1c23a4_totalLabel_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and OCI</link:label>
    <link:label id="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_15841a15-db9b-4702-bb19-49e36cb147f9_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_09a4622c-a3e9-4a04-85ba-6e56c7379308_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, unused commitment level</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_2a0c5ba9-a330-443c-98a4-573ffff79974_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare_0628697c-2b98-4b42-9d47-9e76b2dfc2aa_terseLabel_en-US" xlink:label="lab_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense (in dollars per share)</link:label>
    <link:label id="lab_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Expense, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Expense, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_AmortizationExpenseImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_472ac2c5-9504-4f75-ae35-71844f4bb89d_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_f0bb373b-73e9-4c8f-8b10-16cfc5f0b159_terseLabel_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B notes, due July 5, 2024 (3.82%)</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_label_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_documentation_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member" xlink:href="wst-20201231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorBNotesDue2024Member" xlink:to="lab_wst_SeniorBNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2db63f44-c586-4f51-b781-479c692dba3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2409760b-aaa6-4b41-8fb6-0aeecb851a3e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_24a1aaeb-e5c7-4600-badf-b6235b8ac09b_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_d6d1c50a-5da7-433e-a863-63c8dc888b20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_2d21812e-4a73-48b8-9171-327d9650ebe7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_399f222c-c52b-4706-abbe-c114321b9940_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_14b90bca-2847-4ef3-9944-315cff1c3821_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net impact to the 2018 effective tax rate, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Increase (Decrease) in Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f450e383-4da9-40da-91a3-b760fc8b4f8e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9713e13c-23cf-44e4-8b3b-ad73c56dbb22_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_35e7666f-a261-42a7-a971-9e555d5c7898_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_46186af8-bc7b-4e40-bdb1-c6bc4660f501_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f8b26a76-c702-474b-a0d3-95d0cb631468_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_6a681e58-7113-4b7e-bfb4-805f2260271b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in affiliated companies, treasury stock</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7d6ded7a-40f7-4fa2-9d07-039ca12b22b7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in affiliated companies</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_083be8ef-ea5a-4c64-a373-d03abfe6efd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_52c51ac5-3fc3-47c5-acdd-b659b6a2f7f2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_126f46ee-7fe3-42b3-a47e-0d56d74ba025_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IncentiveStockAwardsMember_b7ac4196-e414-41d1-aa43-834141c4b760_verboseLabel_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incentive Plan</link:label>
    <link:label id="lab_wst_IncentiveStockAwardsMember_6ed76f37-8496-4197-8a07-9cc17d2780a6_terseLabel_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Awards</link:label>
    <link:label id="lab_wst_IncentiveStockAwardsMember_label_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Awards [Member]</link:label>
    <link:label id="lab_wst_IncentiveStockAwardsMember_documentation_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember" xlink:href="wst-20201231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IncentiveStockAwardsMember" xlink:to="lab_wst_IncentiveStockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_39b9f3fc-6f2c-444b-a8af-8ec51848a8eb_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_a4bebd67-b2fd-4464-83b5-5e8c953b5b17_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_e7ae502d-e031-42dc-b61a-e6882faef1cc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProprietaryProductsMember_21e291b4-09b5-4295-b542-f97aaef5510b_terseLabel_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_label_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_documentation_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProprietaryProductsMember" xlink:to="lab_wst_ProprietaryProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_0106212b-cf8c-4f74-8e99-11fb6c871c42_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of global plan assets</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:to="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_adb6563b-99b1-4bda-a06c-c91292583eba_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, foreign</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_8eee42d0-0bfa-4f28-bc96-6bfcbbce6f5d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_23eeb861-42f6-4a10-b583-e27824db78fd_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_29b2da01-6218-4cd6-ba40-c80aaf02d308_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains (losses)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_64c9f08a-ae3a-44ae-9254-9298dd98503a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (loss) gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_e3de36c4-3068-49f0-9219-46f81ef165e2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_48fac429-700d-421d-9d5f-f9b9d00f64e9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1ab45358-8b9d-4222-a974-c815fb1b404b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange transaction gains</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_09968a3e-4d33-49b7-a4d4-6d88b6bf0b73_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d8d82b33-3686-4b9f-b743-df0d6396ffb6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2bd42024-1a61-485b-81c5-abcd3d0d1931_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5cfb3e6d-1d3c-4afd-a0f6-2ac0655baa32_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_24e6be7d-ad39-4ee3-a4bc-db1a27a30116_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_68a6675a-4fc2-4760-819f-d9da3a29b33b_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual with Relationship to Entity [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1a5b3dda-f31c-42cd-8241-271dc9708b2c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_ab1ae43d-d36e-4e46-8654-e82c78805399_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6e518460-befb-4980-828a-c0443c4880ff_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_9a0b8bdc-04cd-483d-9732-2219b72699ce_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_9e32c5e9-2a7e-40c8-870b-7a34813f9729_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_4c3693db-664d-49fa-97a9-dad092ebeed6_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:to="lab_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_03b8735d-2f40-4028-a002-2efa39ba0f91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_5a45a74d-0274-47ab-a957-79196912befa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Level 3 Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_ccc9de9b-a330-43ea-a955-18d939350ae8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_4d9e8549-1b61-4dae-a0da-bbdddb836bec_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_cb9046eb-7c1b-4993-9a02-66b840920f14_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Losses) gains on derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2152a830-8883-4fee-ad05-99b14e63ee9c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c473819b-24b2-4a60-a5be-ae1fffe28cd6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 Fair Value Measurements [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_7dbdfe68-5d73-4352-9a79-ca6a374d16db_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_399860b2-7034-4fd7-9469-8aedd5160978_totalLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total benefit payments expected</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:to="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b35ed12c-0b6f-4977-92cb-119f111a242b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_0869ac28-3fa3-4dcb-b395-665b2de27d12_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, December 31, 2019</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_75cbcccb-ff6a-4e6a-a7c3-22d00c838d3d_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, December 31, 2020</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_65eb6e35-5b1d-4ffa-bb92-936b660ad4d5_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare_457f7a99-165c-474d-b442-34faeefad984_terseLabel_en-US" xlink:label="lab_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and severance related charges (in dollars per share)</link:label>
    <link:label id="lab_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare_label_en-US" xlink:label="lab_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Severance Related Charges, Impact On Diluted Earnings Per Share</link:label>
    <link:label id="lab_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare_documentation_en-US" xlink:label="lab_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Severance Related Charges, Impact On Diluted Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" xlink:href="wst-20201231.xsd#wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" xlink:to="lab_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EnergyDomain_bddd2f06-5b12-43c4-9057-40560052de0b_terseLabel_en-US" xlink:label="lab_srt_EnergyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Domain]</link:label>
    <link:label id="lab_srt_EnergyDomain_label_en-US" xlink:label="lab_srt_EnergyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EnergyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EnergyDomain" xlink:to="lab_srt_EnergyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_5b129be2-d1d3-48e4-b03d-1837bbd27964_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e0d0a502-8d7a-4892-b93f-67f5ce337434_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, estimated outcome, high</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a9efe646-f004-49a5-a9a9-51d548e2ea28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_86f24832-3c81-4ac2-8835-673685dc349a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in net periodic benefit cost:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_de8b264a-ac2d-4b75-9f86-7dd310e46ff4_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a64d8a9a-9c54-4932-8e26-2ee57c7b03db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_c65ca5e5-5523-4580-91e3-919ffb57727b_terseLabel_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_documentation_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract" xlink:href="wst-20201231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract" xlink:to="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_0110b021-78e6-4ef5-8449-5aa4d2fe439b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_7559f807-b891-43de-9b7d-1da0d5edfea7_terseLabel_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and royalty payments made to affiliates</link:label>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_label_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Royalty Payments from Equity Method Investees</link:label>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_documentation_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Royalty Payments from Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:href="wst-20201231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:to="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_68348c6b-307f-4b87-af1a-af0e266a758c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan contributions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity" xlink:to="lab_us-gaap_ProceedsFromOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_aef66440-0e71-49d0-9630-c6b88fd3f4cf_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_32caac26-b4a2-408d-b72d-bfa6768faa36_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_0cf3cd3f-b701-4e87-b89d-389ba4d72aa0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_4b388dbd-5d61-45d7-b1f6-c52170026854_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_456a37e0-8220-4bad-b4ab-d47d957b912f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8ade96a9-d526-4040-8162-6d3b45fec54f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78baad82-c6f3-4965-8770-1852aa9cd026_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_67025faf-c485-44bf-a215-14f9526de8c8_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_1442f240-aab4-4f85-9bb0-7d04b5ad6be3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_32a9961c-dc1f-4f52-bc15-084f68bdddd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_444e5362-2d0a-436d-ae40-d1c61594d87f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_62031dee-4750-46db-9aa4-9a0700fcd132_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DevelopmentAndLicensingIncome_dd5f2643-41c7-440c-9f0a-9a1bae28247b_negatedTerseLabel_en-US" xlink:label="lab_wst_DevelopmentAndLicensingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income</link:label>
    <link:label id="lab_wst_DevelopmentAndLicensingIncome_2bb9b2e2-7758-4889-b2fe-656bef64170b_terseLabel_en-US" xlink:label="lab_wst_DevelopmentAndLicensingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income</link:label>
    <link:label id="lab_wst_DevelopmentAndLicensingIncome_label_en-US" xlink:label="lab_wst_DevelopmentAndLicensingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development And Licensing Income</link:label>
    <link:label id="lab_wst_DevelopmentAndLicensingIncome_documentation_en-US" xlink:label="lab_wst_DevelopmentAndLicensingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentAndLicensingIncome" xlink:href="wst-20201231.xsd#wst_DevelopmentAndLicensingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DevelopmentAndLicensingIncome" xlink:to="lab_wst_DevelopmentAndLicensingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_BiologicsCustomersMember_d3f444db-586a-44dc-bd34-351ac62880ef_terseLabel_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_label_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_documentation_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember" xlink:href="wst-20201231.xsd#wst_BiologicsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_BiologicsCustomersMember" xlink:to="lab_wst_BiologicsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_5c30eb21-223c-4747-b02f-38c6718789a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (1.3 million and 1.2 million shares in 2020 and 2019)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_03d95557-1d0b-4f59-9a1a-6e9ac20dc933_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension benefits</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_185bc717-b6ce-4093-8758-b75e62b6f6a6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_4360934a-39a1-4bf1-a33a-929a4d6a8405_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_6b519f4e-6fe8-43c9-a71d-66a848115cba_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d9a6c3ac-1853-450b-830a-aa29428a8d50_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal corporate tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_529deeb1-d2d3-48bd-850d-120dd3ffc312_terseLabel_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow and Supplemental information</link:label>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_label_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessee, lease Cash Flow and Supplemental information [Table Text Block]</link:label>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_documentation_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessee, lease Cash Flow and Supplemental information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:href="wst-20201231.xsd#wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:to="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_0c5fc081-0a3d-4512-9c23-1687c252b4a4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d54e23da-df77-4e89-ba38-1e1cf2d437a3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_cc6006ab-b900-444b-aa60-f0e9a5ac839e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3ad7b92e-306f-47dd-ae90-720c5fa031dd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>wst-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a80a1d85-d222-4f41-ba9f-844636cf1f8b,g:17422749-133e-4fe3-9091-dc8e0f45c575-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/Cover" xlink:type="simple" xlink:href="wst-20201231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cbd23dc9-8d23-40f4-a9f8-e51f70b5ef82" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_DocumentType_cbd23dc9-8d23-40f4-a9f8-e51f70b5ef82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_afd02c50-1b17-48c5-9814-c8cd1be52438" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_DocumentAnnualReport_afd02c50-1b17-48c5-9814-c8cd1be52438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_33387f58-1914-4efa-b344-61ded1dde897" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_DocumentPeriodEndDate_33387f58-1914-4efa-b344-61ded1dde897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_df2758ac-916f-4a02-832c-99ed67a2bc0d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_CurrentFiscalYearEndDate_df2758ac-916f-4a02-832c-99ed67a2bc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_fbae547b-03e9-49e1-8a0f-db5c573d0c96" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_DocumentTransitionReport_fbae547b-03e9-49e1-8a0f-db5c573d0c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_dce39d94-123e-4b13-8bae-47e2d8c83093" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityFileNumber_dce39d94-123e-4b13-8bae-47e2d8c83093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a6adad0e-ad8f-4a81-b079-9361c8183c1d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityRegistrantName_a6adad0e-ad8f-4a81-b079-9361c8183c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ce5f3f5a-c63f-4d0e-8468-1559d594ca56" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ce5f3f5a-c63f-4d0e-8468-1559d594ca56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_64244cd3-8206-41d1-9b28-ac70642851a1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityTaxIdentificationNumber_64244cd3-8206-41d1-9b28-ac70642851a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7e032192-6411-4bc7-bda7-4d8cd4b70f44" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityAddressAddressLine1_7e032192-6411-4bc7-bda7-4d8cd4b70f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7171d58b-86bb-4413-a605-fcfed17de3b8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityAddressCityOrTown_7171d58b-86bb-4413-a605-fcfed17de3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5eea5cb4-c34c-4de5-b882-f6c0eef9edc9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityAddressStateOrProvince_5eea5cb4-c34c-4de5-b882-f6c0eef9edc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7e3ceabc-c011-4d49-8c10-6c7021f8ac8b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityAddressPostalZipCode_7e3ceabc-c011-4d49-8c10-6c7021f8ac8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e6fdff03-a96e-407c-ace0-773a1fcf0237" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_CityAreaCode_e6fdff03-a96e-407c-ace0-773a1fcf0237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_19b84dcf-36d5-4c5f-b066-16f550f8cafb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_LocalPhoneNumber_19b84dcf-36d5-4c5f-b066-16f550f8cafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_69e7fbfb-b028-42a3-927d-70725c4a7b49" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_Security12bTitle_69e7fbfb-b028-42a3-927d-70725c4a7b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b0086fcc-2069-422f-90e9-e50a2fb2b705" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_TradingSymbol_b0086fcc-2069-422f-90e9-e50a2fb2b705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f2506b01-2b83-4dd1-8dcd-969afc3ee034" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_SecurityExchangeName_f2506b01-2b83-4dd1-8dcd-969afc3ee034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_79633fc8-144e-49df-a4b2-8cc700f3f0f5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_79633fc8-144e-49df-a4b2-8cc700f3f0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_7a60604a-9a2b-4796-b9eb-317bdef1dc5d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityVoluntaryFilers_7a60604a-9a2b-4796-b9eb-317bdef1dc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_af0d513f-417a-4226-940c-31a431bc8666" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityCurrentReportingStatus_af0d513f-417a-4226-940c-31a431bc8666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3f2867d9-9111-40d9-b574-a999707f6ef0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityInteractiveDataCurrent_3f2867d9-9111-40d9-b574-a999707f6ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_114b7b08-46d9-4c1c-a4f1-1a3cee4a015c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityFilerCategory_114b7b08-46d9-4c1c-a4f1-1a3cee4a015c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_97c0b509-00a8-46fa-ad7b-44969a1e454a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntitySmallBusiness_97c0b509-00a8-46fa-ad7b-44969a1e454a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e6f54454-48a9-4735-826a-74db450b0ea3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityEmergingGrowthCompany_e6f54454-48a9-4735-826a-74db450b0ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_d58cb613-8781-42a2-8b58-399801e63c8a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_IcfrAuditorAttestationFlag_d58cb613-8781-42a2-8b58-399801e63c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_fd3e08a8-b133-4a1c-97e4-a919804cfb8f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityShellCompany_fd3e08a8-b133-4a1c-97e4-a919804cfb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_2060d93f-0efe-4c9c-a686-3cec3ee2917e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityPublicFloat_2060d93f-0efe-4c9c-a686-3cec3ee2917e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d26249ce-0528-40cb-b004-ab5772a6124a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d26249ce-0528-40cb-b004-ab5772a6124a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d65830fc-c0ce-480c-942f-d56df1392219" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d65830fc-c0ce-480c-942f-d56df1392219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_152eb77d-b8df-4c85-aea7-8c72c5622b06" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_EntityCentralIndexKey_152eb77d-b8df-4c85-aea7-8c72c5622b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_67ed607f-e96a-4285-ab26-31806e9d0eaf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_DocumentFiscalYearFocus_67ed607f-e96a-4285-ab26-31806e9d0eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_16863b73-3cb1-4d1a-8fc0-ba4cf1f4c31a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_DocumentFiscalPeriodFocus_16863b73-3cb1-4d1a-8fc0-ba4cf1f4c31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1e126348-518e-4c3a-81bc-083f12ecb7be" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fcd6a51a-90bc-426b-a21d-26e2965e4f67" xlink:to="loc_dei_AmendmentFlag_1e126348-518e-4c3a-81bc-083f12ecb7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3b363549-7432-4537-8054-08e1692cb6d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3b363549-7432-4537-8054-08e1692cb6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3946c242-2c93-4fb6-820a-6db2e4fbdb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3946c242-2c93-4fb6-820a-6db2e4fbdb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d404114d-a95c-4c05-9a58-418490850a3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_GrossProfit_d404114d-a95c-4c05-9a58-418490850a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_224da8a2-a1c5-442a-b2b7-9959277f220b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_224da8a2-a1c5-442a-b2b7-9959277f220b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d931079b-87c6-4f81-b51b-4b3f130c1aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d931079b-87c6-4f81-b51b-4b3f130c1aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_4b9d97b2-f33c-4786-b6ca-ee566f4258cc" xlink:href="wst-20201231.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_wst_OtherIncomeExpense_4b9d97b2-f33c-4786-b6ca-ee566f4258cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_43c628ee-bbbf-4ddc-96f4-23e050665f8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_OperatingIncomeLoss_43c628ee-bbbf-4ddc-96f4-23e050665f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_620f49c5-fda4-4db6-a7f2-b59d5a3f0737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_InterestExpense_620f49c5-fda4-4db6-a7f2-b59d5a3f0737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_e33fddc0-a268-4aca-ba94-ae22c286433a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_InvestmentIncomeNet_e33fddc0-a268-4aca-ba94-ae22c286433a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_609a403c-f7f0-4c78-933c-897e16f3fd44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_609a403c-f7f0-4c78-933c-897e16f3fd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ea871b47-ac49-40d5-bda3-48324e00ac6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ea871b47-ac49-40d5-bda3-48324e00ac6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6e09a2e8-7bff-4d12-86bf-2fd6e23c6fbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6e09a2e8-7bff-4d12-86bf-2fd6e23c6fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_293af575-7326-43cc-b65a-05cd65a8b1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_293af575-7326-43cc-b65a-05cd65a8b1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c584241f-4651-4741-93b2-6779753ff7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_NetIncomeLoss_c584241f-4651-4741-93b2-6779753ff7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c5a49283-cbd1-4f92-bb6e-01cc574070f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_us-gaap_EarningsPerShareAbstract_c5a49283-cbd1-4f92-bb6e-01cc574070f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6b1aee09-bf8b-4c25-a478-1816c91d2fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c5a49283-cbd1-4f92-bb6e-01cc574070f3" xlink:to="loc_us-gaap_EarningsPerShareBasic_6b1aee09-bf8b-4c25-a478-1816c91d2fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_30bbd731-3486-4810-9caa-9271c1911955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c5a49283-cbd1-4f92-bb6e-01cc574070f3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_30bbd731-3486-4810-9caa-9271c1911955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WeightedAverageSharesOutstandingAbstract_d5225ea4-02bf-4aae-8b0d-85dfe722fa23" xlink:href="wst-20201231.xsd#wst_WeightedAverageSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_901560f4-e8f0-4a6c-8b1f-3ac4dc166243" xlink:to="loc_wst_WeightedAverageSharesOutstandingAbstract_d5225ea4-02bf-4aae-8b0d-85dfe722fa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a5dbf6b9-ae5c-4505-a1ac-2fa41741a2e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_d5225ea4-02bf-4aae-8b0d-85dfe722fa23" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a5dbf6b9-ae5c-4505-a1ac-2fa41741a2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9af0f42-9cbb-451a-9f03-9e88cb773566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_d5225ea4-02bf-4aae-8b0d-85dfe722fa23" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9af0f42-9cbb-451a-9f03-9e88cb773566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f567f6ea-ea61-4bc8-804e-f37dc451ddbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c6f26817-26b6-4dce-b6a2-64db3486b47d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f567f6ea-ea61-4bc8-804e-f37dc451ddbc" xlink:to="loc_us-gaap_NetIncomeLoss_c6f26817-26b6-4dce-b6a2-64db3486b47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f567f6ea-ea61-4bc8-804e-f37dc451ddbc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_34f409a1-941c-447e-b891-02a05c1939ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_34f409a1-941c-447e-b891-02a05c1939ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_b3833c76-46f8-44a3-9c82-19f749e66d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_b3833c76-46f8-44a3-9c82-19f749e66d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_ca2cbc7c-e630-4d27-a955-3a252d8af88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_ca2cbc7c-e630-4d27-a955-3a252d8af88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_d2ced0ae-ef9b-4d6c-b5bc-0da0596d2ee6" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax_d2ced0ae-ef9b-4d6c-b5bc-0da0596d2ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_38da7165-2a85-407a-8bf2-f317b4a8fe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_38da7165-2a85-407a-8bf2-f317b4a8fe5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_3bac39a6-6a5c-4fd4-87d4-5549e695ecbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_3bac39a6-6a5c-4fd4-87d4-5549e695ecbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a5823ab0-b3f1-4fc1-9573-2e05dde57e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a5823ab0-b3f1-4fc1-9573-2e05dde57e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_8b6d1129-e5b1-41f3-86db-ee444bc8f75c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_8b6d1129-e5b1-41f3-86db-ee444bc8f75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_104508b3-26f0-4304-b64a-776f09de5240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_806a3698-f4dd-445b-9095-e8d009e5decc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_104508b3-26f0-4304-b64a-776f09de5240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_aec059c6-3eae-44a7-9539-9094af34b1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f567f6ea-ea61-4bc8-804e-f37dc451ddbc" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_aec059c6-3eae-44a7-9539-9094af34b1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_56ba0373-d605-4dd6-ad6c-8cc532198926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_56ba0373-d605-4dd6-ad6c-8cc532198926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_de5e0a4f-5e70-4e08-9a82-c1ecaebfb0dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_de5e0a4f-5e70-4e08-9a82-c1ecaebfb0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_fadb5b62-3f4b-4774-9020-ad9260b03ca9" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_fadb5b62-3f4b-4774-9020-ad9260b03ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_3bb640c1-4052-44f6-836e-ef303302fbf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_3bb640c1-4052-44f6-836e-ef303302fbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6fec860f-8358-4f0c-883d-01df63c81ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6fec860f-8358-4f0c-883d-01df63c81ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_f20c8412-fb5b-4ace-b736-2d9056ca6de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_f20c8412-fb5b-4ace-b736-2d9056ca6de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_8cdb6d5e-7e65-489c-a3d1-fa91232af34d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_908b96ef-1670-4d1e-b026-54c9d8a23ed7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_8cdb6d5e-7e65-489c-a3d1-fa91232af34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_daf7b4c4-d958-47af-b560-d1f0b19892b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_daf7b4c4-d958-47af-b560-d1f0b19892b0" xlink:to="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_67df9bab-d5b5-4dab-a51c-d41422133787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_67df9bab-d5b5-4dab-a51c-d41422133787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf9e0b5e-59e0-436f-ba23-5b65e89072df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67df9bab-d5b5-4dab-a51c-d41422133787" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf9e0b5e-59e0-436f-ba23-5b65e89072df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b16c4821-2077-4cb5-96d6-e0a9a78251cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67df9bab-d5b5-4dab-a51c-d41422133787" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b16c4821-2077-4cb5-96d6-e0a9a78251cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e7a2232c-ae2b-462c-9088-9ee99bd5bdd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67df9bab-d5b5-4dab-a51c-d41422133787" xlink:to="loc_us-gaap_InventoryNet_e7a2232c-ae2b-462c-9088-9ee99bd5bdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b2feb23f-eded-42d9-aada-fcba506ad78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67df9bab-d5b5-4dab-a51c-d41422133787" xlink:to="loc_us-gaap_OtherAssetsCurrent_b2feb23f-eded-42d9-aada-fcba506ad78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3d914937-50fa-49d6-9e06-aa9ec7c86171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67df9bab-d5b5-4dab-a51c-d41422133787" xlink:to="loc_us-gaap_AssetsCurrent_3d914937-50fa-49d6-9e06-aa9ec7c86171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_effb617e-1e9b-4586-9b94-36474b65bfc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_effb617e-1e9b-4586-9b94-36474b65bfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5c7f3931-6e36-489e-9ee7-e6af10d83f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5c7f3931-6e36-489e-9ee7-e6af10d83f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9124087f-b288-48f6-81f1-f6ecf4fc0557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9124087f-b288-48f6-81f1-f6ecf4fc0557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_76df2c10-3108-408b-87cc-3e1135ea12d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_76df2c10-3108-408b-87cc-3e1135ea12d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_33357dd9-f801-48e0-97e9-1ddb61c94161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_33357dd9-f801-48e0-97e9-1ddb61c94161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3ae90631-7faa-4e7d-bdc7-2d5f856d2702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_Goodwill_3ae90631-7faa-4e7d-bdc7-2d5f856d2702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ed31c2bc-f370-4412-ad3b-1d467f51578d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ed31c2bc-f370-4412-ad3b-1d467f51578d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_20b1f832-183c-4b38-8184-b96239d9ce7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_20b1f832-183c-4b38-8184-b96239d9ce7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_6fb13272-7f3c-49ff-a747-b92cc2afbfd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_6fb13272-7f3c-49ff-a747-b92cc2afbfd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_53bcdf44-65f3-4b6e-9482-986d7f5dbe59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_53bcdf44-65f3-4b6e-9482-986d7f5dbe59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_82c1dd2b-7179-4d67-92e2-b1280096fed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e6138978-1078-4ce9-854a-117411bdf5e3" xlink:to="loc_us-gaap_Assets_82c1dd2b-7179-4d67-92e2-b1280096fed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_daf7b4c4-d958-47af-b560-d1f0b19892b0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_7198355d-5e62-4bf9-bfcb-2436d4485f8c" xlink:href="wst-20201231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_7198355d-5e62-4bf9-bfcb-2436d4485f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_20e440f9-3ddd-48e1-8a17-343f74538afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_us-gaap_AccountsPayableCurrent_20e440f9-3ddd-48e1-8a17-343f74538afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ff56e81f-5c69-4da2-b8cb-dd50f033b72d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ff56e81f-5c69-4da2-b8cb-dd50f033b72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_2c5b2bf9-a0b4-4753-aaef-50f0244892cb" xlink:href="wst-20201231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_2c5b2bf9-a0b4-4753-aaef-50f0244892cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_f2f2d10f-f7b0-43e5-8485-8bfbf336219d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_f2f2d10f-f7b0-43e5-8485-8bfbf336219d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_869a77e3-87a8-4a60-bd92-111f03ea696b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_869a77e3-87a8-4a60-bd92-111f03ea696b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_9ae7ee4d-0848-4a05-a6bc-8e84a45bf253" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_9ae7ee4d-0848-4a05-a6bc-8e84a45bf253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5d84b053-a167-483c-aabe-1efd10f9e362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_44ee46ae-2ef5-49fc-b341-5541a8c45b49" xlink:to="loc_us-gaap_LiabilitiesCurrent_5d84b053-a167-483c-aabe-1efd10f9e362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2cd87590-5c8c-4189-918f-747c2a88f114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2cd87590-5c8c-4189-918f-747c2a88f114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_418970a8-3470-4e99-b4b1-c7a94858c583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_418970a8-3470-4e99-b4b1-c7a94858c583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_dd6fdccd-9bbc-4b7a-bdc2-fa7c1184b987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_dd6fdccd-9bbc-4b7a-bdc2-fa7c1184b987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6b44589e-3ccc-4587-926c-bf31850c7a91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6b44589e-3ccc-4587-926c-bf31850c7a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_68f57579-0da0-4094-9c75-22c47b023bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_68f57579-0da0-4094-9c75-22c47b023bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f7451e91-60ff-437d-83b5-4121a730d3df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f7451e91-60ff-437d-83b5-4121a730d3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_120e1be0-a0a5-453f-b7fd-cdd461b695fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_Liabilities_120e1be0-a0a5-453f-b7fd-cdd461b695fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b2a726f3-4c39-4311-8e16-846ada7f9281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b2a726f3-4c39-4311-8e16-846ada7f9281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_902de7e3-6817-4251-a347-2ac3392fbdce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:to="loc_us-gaap_PreferredStockValue_902de7e3-6817-4251-a347-2ac3392fbdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fe9225fd-e8c4-4fa6-8234-154fef512c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:to="loc_us-gaap_CommonStockValue_fe9225fd-e8c4-4fa6-8234-154fef512c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f6e41753-02dd-4ea3-bb55-517865c7604c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f6e41753-02dd-4ea3-bb55-517865c7604c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_58a649b0-e958-4756-af42-57869c0a6bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_58a649b0-e958-4756-af42-57869c0a6bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43168ccc-0a18-41e8-bcc8-9099e4cee31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43168ccc-0a18-41e8-bcc8-9099e4cee31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2a292de3-ac23-4bf1-8432-9239791573f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:to="loc_us-gaap_TreasuryStockValue_2a292de3-ac23-4bf1-8432-9239791573f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_50e71062-7723-4c45-bc54-3623c048a7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_623a016b-e20e-49db-83ec-00a682546843" xlink:to="loc_us-gaap_StockholdersEquity_50e71062-7723-4c45-bc54-3623c048a7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0d1559cc-58bc-42ba-9807-d4d7a4c814fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19273ce0-3084-491f-a19c-a64493b3a1c9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0d1559cc-58bc-42ba-9807-d4d7a4c814fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7d1e9433-60fb-47b2-a132-422f238423b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7d1e9433-60fb-47b2-a132-422f238423b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a2b68a2d-f181-4932-b160-fb2708118911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a2b68a2d-f181-4932-b160-fb2708118911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_cc9fd312-d8bd-4dfe-b793-27d1873ac3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_cc9fd312-d8bd-4dfe-b793-27d1873ac3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_61627e2b-8b87-40d9-98b9-3f9d10339c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_61627e2b-8b87-40d9-98b9-3f9d10339c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9b237a3a-882c-4e3a-8235-72c9c93c4813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9b237a3a-882c-4e3a-8235-72c9c93c4813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2c4b09ce-a806-463f-ab6a-f092e22f5498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_CommonStockSharesIssued_2c4b09ce-a806-463f-ab6a-f092e22f5498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_51551c8d-3c48-42c2-955c-40e946315fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_51551c8d-3c48-42c2-955c-40e946315fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_0d553d16-3e31-4068-aa8d-d9f42b8638f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba7cfb7f-e976-4771-9df7-4e61a47e9655" xlink:to="loc_us-gaap_TreasuryStockShares_0d553d16-3e31-4068-aa8d-d9f42b8638f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e37fb29a-92ca-4517-81fd-37b2fbc95165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e37fb29a-92ca-4517-81fd-37b2fbc95165" xlink:to="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f76cfd9-2bce-44e7-9d59-b62b2d2bd5fa" xlink:to="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0a204800-9529-4d3e-bf08-abbcfaa041c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_CommonStockMember_0a204800-9529-4d3e-bf08-abbcfaa041c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bf4b8ae2-6f5d-4c39-9794-79c272e592b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bf4b8ae2-6f5d-4c39-9794-79c272e592b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_88f3bc94-6b92-43d1-84e6-4bb1792b7ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_TreasuryStockMember_88f3bc94-6b92-43d1-84e6-4bb1792b7ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8901c496-bb55-4a0b-adca-c9a690c3d774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_RetainedEarningsMember_8901c496-bb55-4a0b-adca-c9a690c3d774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d2156d-ecf2-4926-8472-a3605d22bdca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54b055ed-7432-460e-8a0d-6d9117870b90" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d2156d-ecf2-4926-8472-a3605d22bdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30c1cc01-1199-4681-8a2a-ac4ff0755025" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30c1cc01-1199-4681-8a2a-ac4ff0755025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_53ee5976-610b-4621-b174-b2c248b9a44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_30c1cc01-1199-4681-8a2a-ac4ff0755025" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_53ee5976-610b-4621-b174-b2c248b9a44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_661ea7e9-4094-4088-9dc0-3c8b00890adc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_53ee5976-610b-4621-b174-b2c248b9a44c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_661ea7e9-4094-4088-9dc0-3c8b00890adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_768c0340-207f-4a2d-92e9-be62a33f2ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_241f8d8b-5547-46cd-81c4-d65e2e717ec2" xlink:to="loc_us-gaap_StatementLineItems_768c0340-207f-4a2d-92e9-be62a33f2ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_768c0340-207f-4a2d-92e9-be62a33f2ca0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d4eeccf9-b4a8-490e-941b-0579e92420d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_SharesIssued_d4eeccf9-b4a8-490e-941b-0579e92420d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_693812cf-c63d-4cde-ad74-93405c45a14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockholdersEquity_693812cf-c63d-4cde-ad74-93405c45a14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b0e8eb0d-c04a-4ccc-9d93-7501d5a9aea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b0e8eb0d-c04a-4ccc-9d93-7501d5a9aea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dcbe6229-ad8e-4f53-a73d-27b316a14491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_NetIncomeLoss_dcbe6229-ad8e-4f53-a73d-27b316a14491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_74fbf891-482d-4a51-a5d0-8091d37619de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_74fbf891-482d-4a51-a5d0-8091d37619de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ad84fb5d-3d04-4522-9d87-32ea6fe09eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ad84fb5d-3d04-4522-9d87-32ea6fe09eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f832e086-8ef6-4e24-affc-c642c3fe21b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f832e086-8ef6-4e24-affc-c642c3fe21b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6a82c104-ac8a-440e-8ce4-58c114f64f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6a82c104-ac8a-440e-8ce4-58c114f64f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1b1f411f-6594-4e17-b1a9-9f0a8c467652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1b1f411f-6594-4e17-b1a9-9f0a8c467652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_f1e26010-e747-431f-9555-13db05e5c94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_f1e26010-e747-431f-9555-13db05e5c94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_4cf61ac3-f94a-44ac-9cea-e3067b46e57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_DividendsCommonStockCash_4cf61ac3-f94a-44ac-9cea-e3067b46e57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2ebc9d7d-70c9-4416-8264-9691eb2028ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2ebc9d7d-70c9-4416-8264-9691eb2028ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_fad5d214-13aa-42e7-b83a-eb0627912ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_SharesIssued_fad5d214-13aa-42e7-b83a-eb0627912ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_28844755-1e49-499f-8c78-9317ae7bf344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d69454cd-97c1-46fd-a3e9-26f315bfa40d" xlink:to="loc_us-gaap_StockholdersEquity_28844755-1e49-499f-8c78-9317ae7bf344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0e7ce9e9-36c7-4111-a262-5247c674b596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0e7ce9e9-36c7-4111-a262-5247c674b596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a025c510-5761-4a46-a4e1-e328376dc681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0e7ce9e9-36c7-4111-a262-5247c674b596" xlink:to="loc_us-gaap_NetIncomeLoss_a025c510-5761-4a46-a4e1-e328376dc681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0e7ce9e9-36c7-4111-a262-5247c674b596" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4bb14144-171b-44bc-9062-ddef1cb75da4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_Depreciation_4bb14144-171b-44bc-9062-ddef1cb75da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_655c1ae9-1190-4ac1-b479-1abefb531ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_AdjustmentForAmortization_655c1ae9-1190-4ac1-b479-1abefb531ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_60a7433d-69c3-4a81-8e39-5c1789611b3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_ShareBasedCompensation_60a7433d-69c3-4a81-8e39-5c1789611b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7b011bda-0931-4454-9a7b-92c7bef24ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_7b011bda-0931-4454-9a7b-92c7bef24ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_2026c3d8-be7d-4731-b554-02a418ecba4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_2026c3d8-be7d-4731-b554-02a418ecba4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_7d8f0a3a-c8c7-4a10-82ea-15a43701c3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_7d8f0a3a-c8c7-4a10-82ea-15a43701c3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_71d8b1ac-af8d-4db7-819a-af1b84a782c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_71d8b1ac-af8d-4db7-819a-af1b84a782c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3ffb9b27-fe6d-438a-af54-543ca75933b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3ffb9b27-fe6d-438a-af54-543ca75933b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_aa1d6a1d-7bde-4ac9-8fc3-55977fa87d64" xlink:href="wst-20201231.xsd#wst_PensionAndOtherPostretirementBenefitExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_wst_PensionAndOtherPostretirementBenefitExpenseNet_aa1d6a1d-7bde-4ac9-8fc3-55977fa87d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_fa0098cb-e4a7-4213-9e69-d5966a1e0f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c97f81ea-dd1c-41de-9a8e-79e0cdb875ee" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_fa0098cb-e4a7-4213-9e69-d5966a1e0f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7888586-bd54-41cb-b7ef-d28696c6b8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0e7ce9e9-36c7-4111-a262-5247c674b596" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7888586-bd54-41cb-b7ef-d28696c6b8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_71120857-fe27-4603-99b5-3ca122acf81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7888586-bd54-41cb-b7ef-d28696c6b8fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_71120857-fe27-4603-99b5-3ca122acf81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7b466fc8-e3d8-4f8e-ac0f-eb1206735a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7888586-bd54-41cb-b7ef-d28696c6b8fe" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7b466fc8-e3d8-4f8e-ac0f-eb1206735a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_42a1493e-703e-4389-90b8-36861aa89a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7888586-bd54-41cb-b7ef-d28696c6b8fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_42a1493e-703e-4389-90b8-36861aa89a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d40a6b08-f476-49f6-ae1b-e443f93707c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7888586-bd54-41cb-b7ef-d28696c6b8fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d40a6b08-f476-49f6-ae1b-e443f93707c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3cdf2d19-ccf9-4a51-83ca-f8585cf94a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a7888586-bd54-41cb-b7ef-d28696c6b8fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3cdf2d19-ccf9-4a51-83ca-f8585cf94a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_459a2704-4799-4de1-bfde-507726b20dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0e7ce9e9-36c7-4111-a262-5247c674b596" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_459a2704-4799-4de1-bfde-507726b20dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b98baee-0da3-405a-8b86-9bbe48616de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b98baee-0da3-405a-8b86-9bbe48616de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_da37c104-510d-46dc-86bc-4503f734bbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b98baee-0da3-405a-8b86-9bbe48616de4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_da37c104-510d-46dc-86bc-4503f734bbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_860857e1-4ea4-4e01-bed1-c52852dce92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b98baee-0da3-405a-8b86-9bbe48616de4" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_860857e1-4ea4-4e01-bed1-c52852dce92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_00a42346-b24c-46d2-b239-0901ec9630ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b98baee-0da3-405a-8b86-9bbe48616de4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_00a42346-b24c-46d2-b239-0901ec9630ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3eafaabd-7bfc-4938-92a2-6fec31dc988f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b98baee-0da3-405a-8b86-9bbe48616de4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3eafaabd-7bfc-4938-92a2-6fec31dc988f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b481045-5945-44be-8432-1a0f42386f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b98baee-0da3-405a-8b86-9bbe48616de4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b481045-5945-44be-8432-1a0f42386f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_a4421168-42e0-4c6f-b19b-6d3487fde7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_a4421168-42e0-4c6f-b19b-6d3487fde7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_30c43742-a2f3-4852-a691-810f271bc64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_30c43742-a2f3-4852-a691-810f271bc64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_39f3faf0-1586-4cee-9a50-bd064e7f4bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_39f3faf0-1586-4cee-9a50-bd064e7f4bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ac79c642-bba8-4816-b2cc-1318537b6f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ac79c642-bba8-4816-b2cc-1318537b6f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_00bbc6bf-f02b-4ad1-835f-d9585e7d9b08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_00bbc6bf-f02b-4ad1-835f-d9585e7d9b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6009062c-8881-4015-85b7-fa9c289538b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_6009062c-8881-4015-85b7-fa9c289538b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9e9ab666-34c5-4725-8f77-a3d6d8e96e71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9e9ab666-34c5-4725-8f77-a3d6d8e96e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_34af4124-cf76-4f0a-862a-5efe5cacda1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_34af4124-cf76-4f0a-862a-5efe5cacda1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_949d4099-7181-4be7-92b1-911283a060b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_949d4099-7181-4be7-92b1-911283a060b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1cfb92ef-f362-4dfc-b367-2645a1a92663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b939e966-a543-44f5-b6fe-b209fed4c624" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1cfb92ef-f362-4dfc-b367-2645a1a92663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d2c7c197-8a06-41ab-965f-a64b823e2cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d2c7c197-8a06-41ab-965f-a64b823e2cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_203fcc4e-f848-4a1a-bc46-ca7411485b4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_203fcc4e-f848-4a1a-bc46-ca7411485b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9fbead9a-5f10-400d-ba00-6f4710085670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9fbead9a-5f10-400d-ba00-6f4710085670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2f4841cb-c5a6-428b-a377-a480167fd7da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2f4841cb-c5a6-428b-a377-a480167fd7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_601882b1-f5d1-4ec5-a177-a9112457bf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa4fb428-7c29-4d41-806b-0a97dd455567" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_601882b1-f5d1-4ec5-a177-a9112457bf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_48c2f777-9290-4eb1-b6f9-832fc24f54d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_601882b1-f5d1-4ec5-a177-a9112457bf8c" xlink:to="loc_us-gaap_InterestPaidNet_48c2f777-9290-4eb1-b6f9-832fc24f54d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_fe040bad-f26e-484b-8eb4-259392d2e444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_601882b1-f5d1-4ec5-a177-a9112457bf8c" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_fe040bad-f26e-484b-8eb4-259392d2e444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_eab78482-8241-42bb-ad44-2c66d8ed332e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_601882b1-f5d1-4ec5-a177-a9112457bf8c" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_eab78482-8241-42bb-ad44-2c66d8ed332e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_7b9ff328-a10c-484a-9789-198a1c7443e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_601882b1-f5d1-4ec5-a177-a9112457bf8c" xlink:to="loc_us-gaap_DividendsPayableCurrent_7b9ff328-a10c-484a-9789-198a1c7443e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_b436f997-ed32-42df-aaf0-8bc59c68688a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_601882b1-f5d1-4ec5-a177-a9112457bf8c" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_b436f997-ed32-42df-aaf0-8bc59c68688a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ddbe2420-ae3a-46e8-b38d-125009a8408f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c10d1b57-e9d0-4175-ad11-10bd2003d86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ddbe2420-ae3a-46e8-b38d-125009a8408f" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c10d1b57-e9d0-4175-ad11-10bd2003d86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_89f40c7b-d1fa-4051-a365-a935bcae291f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_89f40c7b-d1fa-4051-a365-a935bcae291f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1b77ef27-bedc-4c9d-9970-3133d7a31033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_UseOfEstimates_1b77ef27-bedc-4c9d-9970-3133d7a31033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b259e4a2-c7f1-4c2d-9f34-091f65771a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b259e4a2-c7f1-4c2d-9f34-091f65771a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_c599b67c-4b7b-4e2b-a298-7026570078e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_c599b67c-4b7b-4e2b-a298-7026570078e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_0efe7495-04f0-49cf-89db-17090bf400fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_0efe7495-04f0-49cf-89db-17090bf400fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_19da17f8-0244-4202-acd5-9dc784605d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_19da17f8-0244-4202-acd5-9dc784605d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_4ec4dd6d-7729-4b35-8548-fc6e1812a222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_4ec4dd6d-7729-4b35-8548-fc6e1812a222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_a62d47e6-3fe6-40c5-9516-016a6503d4fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_a62d47e6-3fe6-40c5-9516-016a6503d4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9dd777bc-b897-4cd6-961f-79a632c91d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9dd777bc-b897-4cd6-961f-79a632c91d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_23a5141b-13ee-407c-b6e4-894b3652b18f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_23a5141b-13ee-407c-b6e4-894b3652b18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_02511aad-52a8-4acc-9d6c-42d10fb10a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_02511aad-52a8-4acc-9d6c-42d10fb10a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_af9e4436-aa96-4f01-b43b-411e91217f9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_af9e4436-aa96-4f01-b43b-411e91217f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_12d36229-f939-42a6-a874-7aa70424fd48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_12d36229-f939-42a6-a874-7aa70424fd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_71c146bc-84f8-4a78-bd32-8c0129b4dc7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_71c146bc-84f8-4a78-bd32-8c0129b4dc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9d2959f1-0f8e-4045-b833-9e670198a09e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9d2959f1-0f8e-4045-b833-9e670198a09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy_65f32c92-2029-4c2b-892c-f46b85722bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_EnvironmentalCostsPolicy_65f32c92-2029-4c2b-892c-f46b85722bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_d91035e0-c348-4e3c-bded-177c85f4afb8" xlink:href="wst-20201231.xsd#wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_d91035e0-c348-4e3c-bded-177c85f4afb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_34cbbc15-9545-43c4-853d-afba679f4f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_34cbbc15-9545-43c4-853d-afba679f4f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b863c709-94bb-42c0-aa29-71f6201d5dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b863c709-94bb-42c0-aa29-71f6201d5dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_44e49ddd-172e-4563-8f55-84ffcd18fd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_44e49ddd-172e-4563-8f55-84ffcd18fd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0548bbac-d088-4020-9cd7-7b222da9f4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90edc5e0-dcab-4ab9-b8c7-99649b84c990" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0548bbac-d088-4020-9cd7-7b222da9f4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a2056947-78ab-44b3-8348-b98a02d528d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c466810f-ea44-411e-b904-f0d60688f52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a2056947-78ab-44b3-8348-b98a02d528d5" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c466810f-ea44-411e-b904-f0d60688f52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_4969e049-c2cc-40ab-af7c-e8fab4be7344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_4969e049-c2cc-40ab-af7c-e8fab4be7344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f512c49d-3b31-4087-b891-0673cc3b5e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f512c49d-3b31-4087-b891-0673cc3b5e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4e8dd443-9a21-466f-8e3e-dfc2593e5644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4e8dd443-9a21-466f-8e3e-dfc2593e5644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e932851e-67ef-4d8b-b8f8-306bd5cf2bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e932851e-67ef-4d8b-b8f8-306bd5cf2bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e1988b3a-c932-4512-87f9-71337c10fbfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e1988b3a-c932-4512-87f9-71337c10fbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ace2e13d-2f05-47ae-8be4-4796a7ea5ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ace2e13d-2f05-47ae-8be4-4796a7ea5ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d6bee1cf-c3ac-4c05-8068-a0e1dc3b41aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d6bee1cf-c3ac-4c05-8068-a0e1dc3b41aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2c88563e-f49e-4d16-a72d-b2f34d5ab4c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2c88563e-f49e-4d16-a72d-b2f34d5ab4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_744862fa-fcbd-4f9a-8385-2591a2ea1112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_744862fa-fcbd-4f9a-8385-2591a2ea1112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1cdf389f-75b2-4f4d-9cee-f1fc10aa0f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_InventoryNet_1cdf389f-75b2-4f4d-9cee-f1fc10aa0f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_643156ac-423c-4b5c-97d9-78d4ee94930a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe2482a3-1fe6-4779-9692-bc6728f58625" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_643156ac-423c-4b5c-97d9-78d4ee94930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_643156ac-423c-4b5c-97d9-78d4ee94930a" xlink:to="loc_srt_RangeAxis_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a1d1a5dc-1f85-4a45-a4d8-cf43f82219cb" xlink:to="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_300697e9-da2e-4f0a-9f99-41470a0d98d5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:to="loc_srt_MinimumMember_300697e9-da2e-4f0a-9f99-41470a0d98d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f806114e-cce4-4eac-8fcc-061ab3af8b1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_14553c3e-2c77-4ef6-bcb0-c2f57258128c" xlink:to="loc_srt_MaximumMember_f806114e-cce4-4eac-8fcc-061ab3af8b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_950dd9c4-0997-4122-a11b-cf6c3b518254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_643156ac-423c-4b5c-97d9-78d4ee94930a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_950dd9c4-0997-4122-a11b-cf6c3b518254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3d174653-ace8-40b2-b4ce-8eeb9ed239c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_950dd9c4-0997-4122-a11b-cf6c3b518254" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3d174653-ace8-40b2-b4ce-8eeb9ed239c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20201231.xsd#NewAccountingStandards"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_77bc7afc-15d3-4c38-81ab-ea5bf740ba16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a6a66e26-96f0-4bc4-bfae-43f368c37f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_77bc7afc-15d3-4c38-81ab-ea5bf740ba16" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a6a66e26-96f0-4bc4-bfae-43f368c37f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#NewAccountingStandardsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1bb31976-a7b0-43fa-9723-45e831a7a18e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d3064d5a-a325-4717-8567-1a6e74f2dc4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1bb31976-a7b0-43fa-9723-45e831a7a18e" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d3064d5a-a325-4717-8567-1a6e74f2dc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3df2635a-2c9f-44bb-b83a-25440737afd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d3064d5a-a325-4717-8567-1a6e74f2dc4b" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3df2635a-2c9f-44bb-b83a-25440737afd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_464e9b79-3af2-4a88-8554-31ccb66fdd75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3df2635a-2c9f-44bb-b83a-25440737afd3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_464e9b79-3af2-4a88-8554-31ccb66fdd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_38e5f2ae-b86c-4bd3-8209-9b843e0f8fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_464e9b79-3af2-4a88-8554-31ccb66fdd75" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_38e5f2ae-b86c-4bd3-8209-9b843e0f8fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_49d6d618-2099-43e0-9f9e-91ace9ea8c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d3064d5a-a325-4717-8567-1a6e74f2dc4b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_49d6d618-2099-43e0-9f9e-91ace9ea8c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a4160488-e94e-4056-8650-a65710f31398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_49d6d618-2099-43e0-9f9e-91ace9ea8c7f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a4160488-e94e-4056-8650-a65710f31398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Revenue" xlink:type="simple" xlink:href="wst-20201231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3a66e8e8-6760-415e-a4e9-53fa0c1d21d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8a79f219-98ca-49fe-bde5-2c62f27a397c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3a66e8e8-6760-415e-a4e9-53fa0c1d21d3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8a79f219-98ca-49fe-bde5-2c62f27a397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueTables" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b0972cd1-75b1-4dd3-8d88-f147cd2fc2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_df59e2f6-4c3c-48ec-852e-99437b3bc1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b0972cd1-75b1-4dd3-8d88-f147cd2fc2c9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_df59e2f6-4c3c-48ec-852e-99437b3bc1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1a78a7f9-47b1-410e-97d9-6beb56bee953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b0972cd1-75b1-4dd3-8d88-f147cd2fc2c9" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1a78a7f9-47b1-410e-97d9-6beb56bee953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueAdoptionofASC606Details"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7d8a6848-ad64-442a-bc07-008209b8e09a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7d8a6848-ad64-442a-bc07-008209b8e09a" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d3cf63c6-6eea-4988-af02-f97783c9dc98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d3cf63c6-6eea-4988-af02-f97783c9dc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_e0455334-edf4-4e2b-8bca-10f0f14d9b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d3cf63c6-6eea-4988-af02-f97783c9dc98" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_e0455334-edf4-4e2b-8bca-10f0f14d9b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e90eff9f-32c5-4baf-abab-12768600cd11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_e0455334-edf4-4e2b-8bca-10f0f14d9b6c" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e90eff9f-32c5-4baf-abab-12768600cd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_361f2516-c548-46ab-acf4-4792bae3f1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_361f2516-c548-46ab-acf4-4792bae3f1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_d58dc50c-c9be-418a-ac62-7d5d7bd656b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_361f2516-c548-46ab-acf4-4792bae3f1b3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_d58dc50c-c9be-418a-ac62-7d5d7bd656b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_76ed2275-b0c9-4e6e-a72e-687e416156af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_d58dc50c-c9be-418a-ac62-7d5d7bd656b3" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_76ed2275-b0c9-4e6e-a72e-687e416156af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e618208f-b562-49cc-8a39-dfda8ac58be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bc3cf210-c850-4503-95ec-92b4715dd567" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e618208f-b562-49cc-8a39-dfda8ac58be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c9cadcf-0176-4717-8107-0940e7063432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e618208f-b562-49cc-8a39-dfda8ac58be0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c9cadcf-0176-4717-8107-0940e7063432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_2fc03d8d-6125-43c2-ae79-1da4f84da31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_2fc03d8d-6125-43c2-ae79-1da4f84da31b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_588398ad-c380-42ed-afbc-3e02f05cf8fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_us-gaap_NatureOfExpenseAxis_588398ad-c380-42ed-afbc-3e02f05cf8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4b48787e-9f72-4eae-87d2-b6970fecd3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_588398ad-c380-42ed-afbc-3e02f05cf8fb" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4b48787e-9f72-4eae-87d2-b6970fecd3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_cdb701b0-44b7-4033-a2fa-e0756b729d03" xlink:href="wst-20201231.xsd#wst_SmartDoseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4b48787e-9f72-4eae-87d2-b6970fecd3e8" xlink:to="loc_wst_SmartDoseMember_cdb701b0-44b7-4033-a2fa-e0756b729d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_995b42e1-af26-4859-a628-2cc58c2b5db8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_srt_MajorCustomersAxis_995b42e1-af26-4859-a628-2cc58c2b5db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_995b42e1-af26-4859-a628-2cc58c2b5db8" xlink:to="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_b359cda7-4e00-494f-baad-5a58c637aa67" xlink:href="wst-20201231.xsd#wst_BiologicsCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_BiologicsCustomersMember_b359cda7-4e00-494f-baad-5a58c637aa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_300b3e3b-6ff5-4914-b885-e61797ff7db7" xlink:href="wst-20201231.xsd#wst_GenericsCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_GenericsCustomersMember_300b3e3b-6ff5-4914-b885-e61797ff7db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_78e95746-6104-4486-8925-a94f727343ba" xlink:href="wst-20201231.xsd#wst_PharmaCustomersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_PharmaCustomersMember_78e95746-6104-4486-8925-a94f727343ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_79566505-cd8b-431e-b354-6d4f85226c8e" xlink:href="wst-20201231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_59192415-9169-49c2-8c64-6473640d298b" xlink:to="loc_wst_ContractManufacturedCustomersMember_79566505-cd8b-431e-b354-6d4f85226c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_srt_ProductOrServiceAxis_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d823bfbf-4f0c-4b41-900b-3b0a7365c0ec" xlink:to="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_67254fff-0dab-445a-bd62-4996622313d4" xlink:href="wst-20201231.xsd#wst_SmartDoseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_SmartDoseMember_67254fff-0dab-445a-bd62-4996622313d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductComponentsMember_8ebaf18b-27a6-47ed-b752-d9c3d33f9323" xlink:href="wst-20201231.xsd#wst_HighValueProductComponentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_HighValueProductComponentsMember_8ebaf18b-27a6-47ed-b752-d9c3d33f9323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueProductDeliveryDevicesMember_fb21e873-35a8-49c0-80af-e8865d96747d" xlink:href="wst-20201231.xsd#wst_HighValueProductDeliveryDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_HighValueProductDeliveryDevicesMember_fb21e873-35a8-49c0-80af-e8865d96747d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_323786b0-6b48-4247-894d-aa5393d9ea94" xlink:href="wst-20201231.xsd#wst_StandardPackagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_StandardPackagingMember_323786b0-6b48-4247-894d-aa5393d9ea94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_f5d2f9cd-7e6a-4b71-a00d-7607eb272e24" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d785fb60-a883-4303-b115-1bd32d56e8ea" xlink:to="loc_wst_ContractManufacturedProductsMember_f5d2f9cd-7e6a-4b71-a00d-7607eb272e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4706b5ae-8b5b-4f66-9691-20e9a1b88edc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_srt_StatementGeographicalAxis_4706b5ae-8b5b-4f66-9691-20e9a1b88edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4706b5ae-8b5b-4f66-9691-20e9a1b88edc" xlink:to="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_90066435-9110-49f7-b21c-5ccdc6f0e1da" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:to="loc_srt_AmericasMember_90066435-9110-49f7-b21c-5ccdc6f0e1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_512189da-dc74-4cb2-9075-a3a84537335c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:to="loc_us-gaap_EMEAMember_512189da-dc74-4cb2-9075-a3a84537335c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c97dd1fc-b783-4efe-8d65-bec3214fa53f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c8a346a8-12e9-4ce3-91f4-c85d09470911" xlink:to="loc_srt_AsiaPacificMember_c97dd1fc-b783-4efe-8d65-bec3214fa53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6e2732f3-2b9e-470b-a3e9-44965d41dc7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6e2732f3-2b9e-470b-a3e9-44965d41dc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5d795b8-b754-45aa-937e-fd0340e5b8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6e2732f3-2b9e-470b-a3e9-44965d41dc7f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5d795b8-b754-45aa-937e-fd0340e5b8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_3090649a-1dc0-4829-8764-584064ee4886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a5d795b8-b754-45aa-937e-fd0340e5b8f1" xlink:to="loc_us-gaap_SalesRevenueNetMember_3090649a-1dc0-4829-8764-584064ee4886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_404cdf93-391d-4668-ae60-521932945be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_404cdf93-391d-4668-ae60-521932945be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_404cdf93-391d-4668-ae60-521932945be6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_76cf6940-3d37-47a9-a7a8-51ff7cab104f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_76cf6940-3d37-47a9-a7a8-51ff7cab104f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_f7941d42-b543-407b-a7ba-05fcdcdd2cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_f7941d42-b543-407b-a7ba-05fcdcdd2cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_82162e91-25c0-47e6-8000-89ae70ceb050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_53ab318d-1be7-4a1e-88bf-d3c75480ad05" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_82162e91-25c0-47e6-8000-89ae70ceb050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c80596d3-6fa1-43b1-9e86-87d05b45ce4f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7817b4bf-df26-4cd9-bce0-10727929ac93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7817b4bf-df26-4cd9-bce0-10727929ac93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e8cc3189-4de6-4ec3-89a4-ab4fbe71c2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e8cc3189-4de6-4ec3-89a4-ab4fbe71c2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_61c595fa-9d97-4c82-85c4-cfc9cc1d8cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_61c595fa-9d97-4c82-85c4-cfc9cc1d8cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0b1ea2ad-a1bd-4ead-895f-a091eca6f984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8a6f8f02-9e91-472a-9034-61c2c2f73223" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0b1ea2ad-a1bd-4ead-895f-a091eca6f984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e5cacce7-1f1b-4530-aa37-699ba3c6a5b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetRollForward_6a9ccd17-56a2-4932-a1c3-7a21bedd6653" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e5cacce7-1f1b-4530-aa37-699ba3c6a5b8" xlink:to="loc_wst_ContractWithCustomerAssetRollForward_6a9ccd17-56a2-4932-a1c3-7a21bedd6653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_f275cc47-e366-4df2-be96-9df1dcb34fee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_6a9ccd17-56a2-4932-a1c3-7a21bedd6653" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_f275cc47-e366-4df2-be96-9df1dcb34fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_3246be1f-8cd5-4fdc-9d5a-6aaa0caddce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_6a9ccd17-56a2-4932-a1c3-7a21bedd6653" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_3246be1f-8cd5-4fdc-9d5a-6aaa0caddce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetIncreaseDecrease_243f2eb2-3153-4f77-a62a-f857cc13c76d" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerAssetIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_6a9ccd17-56a2-4932-a1c3-7a21bedd6653" xlink:to="loc_wst_ContractWithCustomerAssetIncreaseDecrease_243f2eb2-3153-4f77-a62a-f857cc13c76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRollForward_ccd207a7-87d7-44e4-9970-e238eb5ab06e" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_6a9ccd17-56a2-4932-a1c3-7a21bedd6653" xlink:to="loc_wst_ContractWithCustomerLiabilityRollForward_ccd207a7-87d7-44e4-9970-e238eb5ab06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e1a4af76-cc2b-4efb-8505-015a7fb1145b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_ccd207a7-87d7-44e4-9970-e238eb5ab06e" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e1a4af76-cc2b-4efb-8505-015a7fb1145b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9aca84ac-460b-4840-ba45-6e1734615e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_ccd207a7-87d7-44e4-9970-e238eb5ab06e" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9aca84ac-460b-4840-ba45-6e1734615e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_b6fafe92-3fdd-4cb2-b450-bd87912340b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_ccd207a7-87d7-44e4-9970-e238eb5ab06e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_b6fafe92-3fdd-4cb2-b450-bd87912340b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueContractsandLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fe3e458d-e4cb-48be-9ae3-02e23b2d2644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_74d8d7d3-de47-443e-b701-c38dea6e944c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fe3e458d-e4cb-48be-9ae3-02e23b2d2644" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_74d8d7d3-de47-443e-b701-c38dea6e944c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c761ba2d-ad3a-42af-b888-652d36ad2b49" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74d8d7d3-de47-443e-b701-c38dea6e944c" xlink:to="loc_srt_RangeAxis_c761ba2d-ad3a-42af-b888-652d36ad2b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c761ba2d-ad3a-42af-b888-652d36ad2b49" xlink:to="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_126d6830-ec8a-4a89-bfec-c56ed1399a0d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:to="loc_srt_MinimumMember_126d6830-ec8a-4a89-bfec-c56ed1399a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cb0f893-2b15-4ef5-88b6-278f553d9938" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_28a10659-932d-4b6f-856c-34e412cb846c" xlink:to="loc_srt_MaximumMember_5cb0f893-2b15-4ef5-88b6-278f553d9938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74d8d7d3-de47-443e-b701-c38dea6e944c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRecognitionPeriod_f1d41f8b-1e9b-45cc-aecc-1f39cf0eb9a4" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRecognitionPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:to="loc_wst_ContractWithCustomerLiabilityRecognitionPeriod_f1d41f8b-1e9b-45cc-aecc-1f39cf0eb9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_188c0460-aef1-4164-bfe1-ae4c1ef1fb7a" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:to="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_188c0460-aef1-4164-bfe1-ae4c1ef1fb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod_a44b184f-6985-425b-87f9-20ccfdb60d97" xlink:href="wst-20201231.xsd#wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1a1d7222-f9c8-4fca-b9e8-66b8eb006d84" xlink:to="loc_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod_a44b184f-6985-425b-87f9-20ccfdb60d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueSupplyChainFinancingDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b5f32986-bcfe-4da4-a9d3-17f5329e9fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_70a7d562-3e1d-405b-97b1-dbeef19972b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b5f32986-bcfe-4da4-a9d3-17f5329e9fdd" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_70a7d562-3e1d-405b-97b1-dbeef19972b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#RevenueVoluntaryRecallDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07c9c938-a862-4d5d-8e6d-f21711fe49df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProvisionForProductReturns_68a242ec-9d4d-445b-b1fe-530e1f3af0f3" xlink:href="wst-20201231.xsd#wst_ProvisionForProductReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07c9c938-a862-4d5d-8e6d-f21711fe49df" xlink:to="loc_wst_ProvisionForProductReturns_68a242ec-9d4d-445b-b1fe-530e1f3af0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_031dd921-44ba-4be7-a4bb-51e6c6a7f16c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_55b1606e-e5cd-4ec8-95e8-b000d2781703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_031dd921-44ba-4be7-a4bb-51e6c6a7f16c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_55b1606e-e5cd-4ec8-95e8-b000d2781703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f068b58e-de6a-48fe-8eac-4aca85750c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d63c947b-8ce8-4aa4-b200-ed3fb101b671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f068b58e-de6a-48fe-8eac-4aca85750c9f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d63c947b-8ce8-4aa4-b200-ed3fb101b671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#NetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17841b36-4525-4a51-8275-ca7f0a971513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_NetIncomeLoss_17841b36-4525-4a51-8275-ca7f0a971513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6cce03d-287e-4e26-a66b-79448dd1ef37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6cce03d-287e-4e26-a66b-79448dd1ef37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8ca13566-0706-4e30-89a8-b1a562ef1b19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8ca13566-0706-4e30-89a8-b1a562ef1b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba2594a5-1aef-4b99-8514-0570129ffffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba2594a5-1aef-4b99-8514-0570129ffffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e2533714-037d-4eae-8983-5c58d43db4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e2533714-037d-4eae-8983-5c58d43db4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_244a8d2e-b410-42fc-ab43-446b6b18c31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_244a8d2e-b410-42fc-ab43-446b6b18c31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3e5cca18-8041-4bfe-a7e3-e63b4c73e93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3e5cca18-8041-4bfe-a7e3-e63b4c73e93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_088d0dbc-f8d7-47d5-80d9-28ad7de53aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_088d0dbc-f8d7-47d5-80d9-28ad7de53aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0e365402-229d-4e65-a5be-38802a66e8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ec3ccac1-d1fc-430a-a957-e2a8a23b4151" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0e365402-229d-4e65-a5be-38802a66e8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fd59e7b-977b-4ea3-bce8-749e585e26cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_842960f8-31b2-4785-ba3b-c3e527095997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fd59e7b-977b-4ea3-bce8-749e585e26cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_842960f8-31b2-4785-ba3b-c3e527095997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_71874110-5eb4-43dc-9727-f92330ed4025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cc7b87d2-983a-4ed5-a60c-9aba10591166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_71874110-5eb4-43dc-9727-f92330ed4025" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cc7b87d2-983a-4ed5-a60c-9aba10591166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_21038da7-d8cc-4a17-b7a4-bce60c3d31a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_21038da7-d8cc-4a17-b7a4-bce60c3d31a1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935c1f71-35f8-47f4-9f67-6e4f57338e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935c1f71-35f8-47f4-9f67-6e4f57338e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_935c1f71-35f8-47f4-9f67-6e4f57338e08" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_dab1b982-f470-4e55-a269-e754b00acb4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_LandMember_dab1b982-f470-4e55-a269-e754b00acb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_c6f0a4bc-163a-4ed2-b558-acd6a27ef0e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_c6f0a4bc-163a-4ed2-b558-acd6a27ef0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1e7949d0-4d37-4268-b957-6f613e985b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1e7949d0-4d37-4268-b957-6f613e985b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_44eed4ce-4976-4e05-907c-2be702053d72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_44eed4ce-4976-4e05-907c-2be702053d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember_15c8d6ef-b9fa-4b77-8fe6-7e32d1eb4658" xlink:href="wst-20201231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_wst_ComputerHardwareAndSoftwareMember_15c8d6ef-b9fa-4b77-8fe6-7e32d1eb4658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_d9a20365-fdaf-4719-a1dd-c406105c4ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bfcde8ad-2fda-4411-bb1b-09414cfdee19" xlink:to="loc_us-gaap_ConstructionInProgressMember_d9a20365-fdaf-4719-a1dd-c406105c4ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7140a34f-7da7-4c75-94fa-0b246c8fdc10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:to="loc_srt_RangeAxis_7140a34f-7da7-4c75-94fa-0b246c8fdc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7140a34f-7da7-4c75-94fa-0b246c8fdc10" xlink:to="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5274249c-ecbe-4a6d-b3b5-2df39e9f3d79" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:to="loc_srt_MinimumMember_5274249c-ecbe-4a6d-b3b5-2df39e9f3d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8fb65b2f-8bab-41a0-aeed-5cf4a5b5b5b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dd1ba837-8a98-491a-a7f3-a644b35cc6cb" xlink:to="loc_srt_MaximumMember_8fb65b2f-8bab-41a0-aeed-5cf4a5b5b5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e336eb5b-0bb3-4e28-a2f6-9f0555458d7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d2f1d7ce-b54f-4785-9124-a0cb63681a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d2f1d7ce-b54f-4785-9124-a0cb63681a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c0794fcb-ef31-469f-ba28-70b6b809f74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_97846a53-9a3d-4fd1-9e46-9a944879019f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c0794fcb-ef31-469f-ba28-70b6b809f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f42a9fbc-c197-40dd-944a-d50b58e3b37d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d9bdc75c-db01-4000-b12c-b3ef0c3a20cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f42a9fbc-c197-40dd-944a-d50b58e3b37d" xlink:to="loc_us-gaap_Depreciation_d9bdc75c-db01-4000-b12c-b3ef0c3a20cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_ba7f030a-6673-416a-b398-27a8890da4a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f42a9fbc-c197-40dd-944a-d50b58e3b37d" xlink:to="loc_us-gaap_InterestCostsCapitalized_ba7f030a-6673-416a-b398-27a8890da4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_05fb22d5-ad91-477c-9d41-24f41782e16b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f42a9fbc-c197-40dd-944a-d50b58e3b37d" xlink:to="loc_us-gaap_AssetImpairmentCharges_05fb22d5-ad91-477c-9d41-24f41782e16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_3bf56d06-31d6-4628-9001-e285ed5ffd8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f42a9fbc-c197-40dd-944a-d50b58e3b37d" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_3bf56d06-31d6-4628-9001-e285ed5ffd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1d7938b7-82e0-49fd-96d2-7457113863c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_cd80ad54-fa51-4502-8e48-0183d6e953bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1d7938b7-82e0-49fd-96d2-7457113863c1" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_cd80ad54-fa51-4502-8e48-0183d6e953bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_36d8c681-b3be-4188-b47d-03041530ad82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_e81ac5f9-d187-496a-b177-b34e6a1188e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36d8c681-b3be-4188-b47d-03041530ad82" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_e81ac5f9-d187-496a-b177-b34e6a1188e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_fdaba00d-e907-4e46-be80-c7f4c0661563" xlink:href="wst-20201231.xsd#wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36d8c681-b3be-4188-b47d-03041530ad82" xlink:to="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_fdaba00d-e907-4e46-be80-c7f4c0661563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0f82ac22-ae67-4597-a4ec-128e24d1cb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36d8c681-b3be-4188-b47d-03041530ad82" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0f82ac22-ae67-4597-a4ec-128e24d1cb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesAdoptionofASC842Details" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesAdoptionofASC842Details"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesAdoptionofASC842Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bada2ebe-3c70-4360-9f94-557f167951cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_66bd4f91-1d0c-4b41-af35-19741d2df49d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bada2ebe-3c70-4360-9f94-557f167951cd" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_66bd4f91-1d0c-4b41-af35-19741d2df49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_38224f20-c00b-43ff-8019-b307b081356b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_66bd4f91-1d0c-4b41-af35-19741d2df49d" xlink:to="loc_srt_RangeAxis_38224f20-c00b-43ff-8019-b307b081356b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ab86450-b34b-4221-8800-8e968b0bee0f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_38224f20-c00b-43ff-8019-b307b081356b" xlink:to="loc_srt_RangeMember_1ab86450-b34b-4221-8800-8e968b0bee0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_76c12001-1f66-4e5b-b711-920e16bcbcdd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1ab86450-b34b-4221-8800-8e968b0bee0f" xlink:to="loc_srt_MaximumMember_76c12001-1f66-4e5b-b711-920e16bcbcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_66bd4f91-1d0c-4b41-af35-19741d2df49d" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_7caa72e0-5920-49fd-baf5-7031a3d0a7e9" xlink:href="wst-20201231.xsd#wst_LesseeOperatingLeaseOptionToTerminateTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:to="loc_wst_LesseeOperatingLeaseOptionToTerminateTerm_7caa72e0-5920-49fd-baf5-7031a3d0a7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_26265de5-0b38-4807-9b85-f24f2264dac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:to="loc_us-gaap_FinanceLeaseLiability_26265de5-0b38-4807-9b85-f24f2264dac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fe50e33-a058-433f-aa05-40cbce85957c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b3926b33-bf10-4f22-8f8c-7361fdc61bc7" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fe50e33-a058-433f-aa05-40cbce85957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9ceedb7f-9a60-4904-bd98-6659c3219332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_63fc289b-ec72-4cc6-91de-e72fcab15017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9ceedb7f-9a60-4904-bd98-6659c3219332" xlink:to="loc_us-gaap_OperatingLeaseCost_63fc289b-ec72-4cc6-91de-e72fcab15017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_d1fb4703-5af6-4eca-b75a-0782acac0bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9ceedb7f-9a60-4904-bd98-6659c3219332" xlink:to="loc_us-gaap_ShortTermLeaseCost_d1fb4703-5af6-4eca-b75a-0782acac0bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_314e23e3-cf72-4b02-a81c-ada9dac5f794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9ceedb7f-9a60-4904-bd98-6659c3219332" xlink:to="loc_us-gaap_VariableLeaseCost_314e23e3-cf72-4b02-a81c-ada9dac5f794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_fc8f87ea-de54-4c75-86d9-cae69a051117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9ceedb7f-9a60-4904-bd98-6659c3219332" xlink:to="loc_us-gaap_LeaseCost_fc8f87ea-de54-4c75-86d9-cae69a051117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_3f01b6b7-cbb4-454d-bab2-d19624eaca53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9ceedb7f-9a60-4904-bd98-6659c3219332" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_3f01b6b7-cbb4-454d-bab2-d19624eaca53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseCashFlowandSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_26711b5a-b35a-4223-89cd-3061d7b2b54b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_9349f846-0505-4e5b-88f3-38474c4eeafb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_26711b5a-b35a-4223-89cd-3061d7b2b54b" xlink:to="loc_us-gaap_OperatingLeasePayments_9349f846-0505-4e5b-88f3-38474c4eeafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6d731fac-cdeb-44b7-b5b9-df5e92393549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_26711b5a-b35a-4223-89cd-3061d7b2b54b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6d731fac-cdeb-44b7-b5b9-df5e92393549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesLeaseWeightedAverageDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5fd069f7-78d0-4f01-986f-1886ecde1833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4bca4c41-32a0-4173-9615-a453c9da2869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5fd069f7-78d0-4f01-986f-1886ecde1833" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4bca4c41-32a0-4173-9615-a453c9da2869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0c48fa2d-69bf-47cc-89d9-d0a599db637a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5fd069f7-78d0-4f01-986f-1886ecde1833" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0c48fa2d-69bf-47cc-89d9-d0a599db637a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_838cf250-b72a-432c-9fcb-447b57d858fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_838cf250-b72a-432c-9fcb-447b57d858fa" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_75fe2410-e7c4-4c14-8695-1043d436b9a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_75fe2410-e7c4-4c14-8695-1043d436b9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a2125133-bd1d-421c-9025-98f7de9ad2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a2125133-bd1d-421c-9025-98f7de9ad2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a5ab865-2cb3-4c3c-b848-60eda679e665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a5ab865-2cb3-4c3c-b848-60eda679e665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f663adab-94c6-4d9f-bf3d-d88b5fbc1f45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f663adab-94c6-4d9f-bf3d-d88b5fbc1f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ecadace0-6519-4e5a-89d6-2085f0dfe0dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ecadace0-6519-4e5a-89d6-2085f0dfe0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_084cfdd5-2c31-4968-a397-7002c81ac1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_084cfdd5-2c31-4968-a397-7002c81ac1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6f6a30d-d1f2-4e47-9fb9-faf3f33bf485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6f6a30d-d1f2-4e47-9fb9-faf3f33bf485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_815f3c21-7121-403a-a61c-551da9249cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_815f3c21-7121-403a-a61c-551da9249cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_368a4fe8-dd0f-4fe0-bcc2-506a79e46bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36d73851-2585-4657-b4ce-74e9a4f5f2b0" xlink:to="loc_us-gaap_OperatingLeaseLiability_368a4fe8-dd0f-4fe0-bcc2-506a79e46bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompanies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7cac3e03-d13a-4f7c-96a8-4ae00df202a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_1b11afeb-8231-417b-9c48-2c7d94df06c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7cac3e03-d13a-4f7c-96a8-4ae00df202a5" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_1b11afeb-8231-417b-9c48-2c7d94df06c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_25493e08-d732-4390-8276-c6e038c63ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_42755435-7b68-4235-bf6f-e80dcf44fb74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_25493e08-d732-4390-8276-c6e038c63ac4" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_42755435-7b68-4235-bf6f-e80dcf44fb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesScheduleofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_5b3a28f7-1f10-411d-8dc4-5e42bfa67100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_33ecf7df-00d9-44b7-9184-3346b669847e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_5b3a28f7-1f10-411d-8dc4-5e42bfa67100" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_33ecf7df-00d9-44b7-9184-3346b669847e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b270b4a5-e794-41a6-9953-844a0ebd84ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_33ecf7df-00d9-44b7-9184-3346b669847e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b270b4a5-e794-41a6-9953-844a0ebd84ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b270b4a5-e794-41a6-9953-844a0ebd84ac" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember_abb3f72e-8326-4572-846a-7d9faa327d4c" xlink:href="wst-20201231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_WestCompanyMexicoSADeCVMember_abb3f72e-8326-4572-846a-7d9faa327d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember_49cf7339-3d7e-4fde-8994-e49a6ba347cd" xlink:href="wst-20201231.xsd#wst_AluplastSADeCVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_AluplastSADeCVMember_49cf7339-3d7e-4fde-8994-e49a6ba347cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember_2c9d9b28-7f49-4f90-af81-925316e0e206" xlink:href="wst-20201231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_PharmaTapSADeCVMember_2c9d9b28-7f49-4f90-af81-925316e0e206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember_f5bb9ca3-6363-48d7-b69b-cabf188f3546" xlink:href="wst-20201231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_PharmaRubberSADeCVMember_f5bb9ca3-6363-48d7-b69b-cabf188f3546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IWPharmaGroupLLCMember_9f5df507-032d-4de8-8c0f-83aab92a533f" xlink:href="wst-20201231.xsd#wst_IWPharmaGroupLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_IWPharmaGroupLLCMember_9f5df507-032d-4de8-8c0f-83aab92a533f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_0f1cf6c3-d6a9-4710-9cb6-018ceff55fbe" xlink:href="wst-20201231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8c9325a7-162a-4aeb-98e8-db24ac3db100" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_0f1cf6c3-d6a9-4710-9cb6-018ceff55fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1665bf9d-bc7c-4166-859d-767426e1e0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_33ecf7df-00d9-44b7-9184-3346b669847e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1665bf9d-bc7c-4166-859d-767426e1e0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_522c58d5-3689-49da-8b5d-d614070d51b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1665bf9d-bc7c-4166-859d-767426e1e0b3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_522c58d5-3689-49da-8b5d-d614070d51b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AffiliatedCompaniesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_9af898fd-7411-45d0-9c51-86a635dd9652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_425aa0a5-e248-40dd-ba87-bf34efa1f2e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_9af898fd-7411-45d0-9c51-86a635dd9652" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_425aa0a5-e248-40dd-ba87-bf34efa1f2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_69249797-c0eb-4e62-812d-de3b04eb20fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_425aa0a5-e248-40dd-ba87-bf34efa1f2e2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_69249797-c0eb-4e62-812d-de3b04eb20fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4c445241-fa7d-46fd-b3bc-13839b33978f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_69249797-c0eb-4e62-812d-de3b04eb20fd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4c445241-fa7d-46fd-b3bc-13839b33978f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_94c52c51-a921-4aaf-aea8-4d53cb656f03" xlink:href="wst-20201231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c445241-fa7d-46fd-b3bc-13839b33978f" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_94c52c51-a921-4aaf-aea8-4d53cb656f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_425aa0a5-e248-40dd-ba87-bf34efa1f2e2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_775d9d2e-bc79-4833-a2e0-1d99adfeb487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_775d9d2e-bc79-4833-a2e0-1d99adfeb487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_05e1bb97-119b-41ac-85da-90e213596437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_05e1bb97-119b-41ac-85da-90e213596437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_6b1b3246-7ec1-4b79-99f9-f657925d1d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_6b1b3246-7ec1-4b79-99f9-f657925d1d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_e6c3075d-8ff9-4a05-99ec-0a786c692c84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_e6c3075d-8ff9-4a05-99ec-0a786c692c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d3bd74b8-5ec4-4215-bb5e-7fab7c614b74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d3bd74b8-5ec4-4215-bb5e-7fab7c614b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_cf5e4b59-3793-4a9a-a8a8-84cc4e5baf5e" xlink:href="wst-20201231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_cf5e4b59-3793-4a9a-a8a8-84cc4e5baf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_12e6a7c3-70e5-4adc-a32e-9cfde74c8f36" xlink:href="wst-20201231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_12e6a7c3-70e5-4adc-a32e-9cfde74c8f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_06409c0e-6cdf-42a4-9b12-ee2afadfe8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_06409c0e-6cdf-42a4-9b12-ee2afadfe8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees_a420fcbf-cbb9-433f-aeb6-ff6ebf16adb9" xlink:href="wst-20201231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_wst_SalesToEquityMethodInvestees_a420fcbf-cbb9-433f-aeb6-ff6ebf16adb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_bc2229f4-a727-45ef-b056-be0779a573c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromAffiliates"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_DueFromAffiliates_bc2229f4-a727-45ef-b056-be0779a573c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0d07d3b4-2803-4e12-9553-3f1b6cec6d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquityMethodInvestments_0d07d3b4-2803-4e12-9553-3f1b6cec6d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7f4c8e6e-4609-4e99-92ae-251c7438b1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a06dfcc2-3016-463f-92e3-c1dfb05ded8b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7f4c8e6e-4609-4e99-92ae-251c7438b1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf0f4725-ee99-44a5-ad8f-dcd6032b8eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_071cbdc2-6142-4735-90a5-061615ed2eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf0f4725-ee99-44a5-ad8f-dcd6032b8eaf" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_071cbdc2-6142-4735-90a5-061615ed2eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0e65da81-3b68-479e-8bd3-0ac9ba8ccd46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_4449e553-281a-436e-93d5-a3e8086ce4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0e65da81-3b68-479e-8bd3-0ac9ba8ccd46" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_4449e553-281a-436e-93d5-a3e8086ce4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_0b76bc69-e1b0-46e2-b08b-a38bbf023493" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0e65da81-3b68-479e-8bd3-0ac9ba8ccd46" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_0b76bc69-e1b0-46e2-b08b-a38bbf023493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_eb48e64d-6c3f-4b99-8ff2-9c24f81e9030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ee3935ca-4105-40f8-81cc-007f0c896786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_eb48e64d-6c3f-4b99-8ff2-9c24f81e9030" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ee3935ca-4105-40f8-81cc-007f0c896786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0669c54d-5c7b-4921-84a3-9f279e6dd453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ee3935ca-4105-40f8-81cc-007f0c896786" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0669c54d-5c7b-4921-84a3-9f279e6dd453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0669c54d-5c7b-4921-84a3-9f279e6dd453" xlink:to="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_07a9325f-c96d-43ee-9cbd-5d63316affea" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:to="loc_wst_ProprietaryProductsMember_07a9325f-c96d-43ee-9cbd-5d63316affea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_4a6fdd54-1ee8-49ee-bb0a-aeb1d4de4338" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_67b755d4-a7b1-46d5-a5f7-e14e5a2fb9d9" xlink:to="loc_wst_ContractManufacturedProductsMember_4a6fdd54-1ee8-49ee-bb0a-aeb1d4de4338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5724543a-98a1-4362-8b69-ebfd2a887ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ee3935ca-4105-40f8-81cc-007f0c896786" xlink:to="loc_us-gaap_GoodwillLineItems_5724543a-98a1-4362-8b69-ebfd2a887ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5724543a-98a1-4362-8b69-ebfd2a887ae0" xlink:to="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_42d4f7ab-fe72-4b46-b51b-13e85157a2ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:to="loc_us-gaap_Goodwill_42d4f7ab-fe72-4b46-b51b-13e85157a2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f8c8d876-1503-4b60-9798-2b889cf317ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f8c8d876-1503-4b60-9798-2b889cf317ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_97b8f2ba-5f0c-4181-97ca-7ed2c43a1e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_97b8f2ba-5f0c-4181-97ca-7ed2c43a1e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4a5771f9-3f77-41aa-9d0b-7610c15d8026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6e80acdb-2677-4251-b72c-9d4121f5e6e7" xlink:to="loc_us-gaap_Goodwill_4a5771f9-3f77-41aa-9d0b-7610c15d8026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_401239cb-3b6b-4798-86bc-73acc8f30320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_401239cb-3b6b-4798-86bc-73acc8f30320" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03713ad6-5536-4ec3-b6de-79c6f276b7ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_72d49c09-42b9-43d3-a9a4-7b0dd93c2aae" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03713ad6-5536-4ec3-b6de-79c6f276b7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SouthKoreaDistributorMember_8584b8b5-50ff-4a79-9beb-5255b01fd560" xlink:href="wst-20201231.xsd#wst_SouthKoreaDistributorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03713ad6-5536-4ec3-b6de-79c6f276b7ee" xlink:to="loc_wst_SouthKoreaDistributorMember_8584b8b5-50ff-4a79-9beb-5255b01fd560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd1f7d59-2a4a-4d37-8653-bb830c6f5358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a82dfe7-c8c6-4b14-803f-010a3bb5bb21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd1f7d59-2a4a-4d37-8653-bb830c6f5358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7d4c7b93-3b52-4331-89ef-396845fba81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd1f7d59-2a4a-4d37-8653-bb830c6f5358" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7d4c7b93-3b52-4331-89ef-396845fba81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3bd002c7-4e1f-4790-9f28-ba5cd47557c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3bd002c7-4e1f-4790-9f28-ba5cd47557c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc0f73ec-b9ac-42c6-b2e7-e1c6d35b23e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3bd002c7-4e1f-4790-9f28-ba5cd47557c2" xlink:to="loc_us-gaap_SegmentDomain_fc0f73ec-b9ac-42c6-b2e7-e1c6d35b23e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_430dd0c2-eb65-466e-86f2-f69ae11e65bd" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fc0f73ec-b9ac-42c6-b2e7-e1c6d35b23e8" xlink:to="loc_wst_ProprietaryProductsMember_430dd0c2-eb65-466e-86f2-f69ae11e65bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_28e0c099-3395-4a19-9d40-99663138a594" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d595a9ed-3340-4b23-978a-546934cb9875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d595a9ed-3340-4b23-978a-546934cb9875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_07b2d96f-3184-4540-b1dd-49396fe7f2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_07b2d96f-3184-4540-b1dd-49396fe7f2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_461ff77c-5c2b-4e9c-832d-04f3287faabd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_461ff77c-5c2b-4e9c-832d-04f3287faabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_76529295-cf2d-40bf-8219-cdaa8423c294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_76529295-cf2d-40bf-8219-cdaa8423c294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_d39afb30-7150-4634-a54e-ad365ea1a4d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_d39afb30-7150-4634-a54e-ad365ea1a4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d77dbd0c-b20d-44f8-8b57-26e1dddf7559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d77dbd0c-b20d-44f8-8b57-26e1dddf7559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b25c06b1-ecfa-4eff-8937-4d97e44246ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d6ee0a34-c09f-4aa9-b7c3-d9bcdb56e4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d6ee0a34-c09f-4aa9-b7c3-d9bcdb56e4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6e112f75-d3b1-4495-b5aa-a71848d64044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6e112f75-d3b1-4495-b5aa-a71848d64044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4c278c07-ba37-4b92-a7b1-9a295323b836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4c278c07-ba37-4b92-a7b1-9a295323b836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f44fd5cc-6e2a-4e6b-8dce-abcb0c2af59d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f44fd5cc-6e2a-4e6b-8dce-abcb0c2af59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_540f4db5-c980-4924-a7ea-15274c306ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0b76a0c-b830-4511-a97d-f5aa3c8532c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_540f4db5-c980-4924-a7ea-15274c306ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_62115f84-0da5-4aab-88aa-1ac08ec0b4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_54deb49a-96ba-4c6c-b942-07b4c38fe8ad" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_62115f84-0da5-4aab-88aa-1ac08ec0b4ee" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_54deb49a-96ba-4c6c-b942-07b4c38fe8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_116ff164-a7fc-44b2-bf1b-ded99bb074e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_54deb49a-96ba-4c6c-b942-07b4c38fe8ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_116ff164-a7fc-44b2-bf1b-ded99bb074e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_116ff164-a7fc-44b2-bf1b-ded99bb074e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember_5ddd33dd-3583-4de5-8d3d-2f5c57a63c78" xlink:href="wst-20201231.xsd#wst_PatentsAndLicensingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_wst_PatentsAndLicensingMember_5ddd33dd-3583-4de5-8d3d-2f5c57a63c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_3082d4d0-36b1-4f9d-adc2-3efaa1d70ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_3082d4d0-36b1-4f9d-adc2-3efaa1d70ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4118c575-0cbb-45d1-9643-a7ef419cd35e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_TrademarksMember_4118c575-0cbb-45d1-9643-a7ef419cd35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a5bee8bd-a0d2-4be9-96b8-35094643c1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a5bee8bd-a0d2-4be9-96b8-35094643c1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_b9397f78-5052-47a7-959b-0b74804d0733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_36f50eca-a264-42d6-8da3-b0134fda0630" xlink:to="loc_us-gaap_CustomerContractsMember_b9397f78-5052-47a7-959b-0b74804d0733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:href="wst-20201231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_54deb49a-96ba-4c6c-b942-07b4c38fe8ad" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9062d040-95fb-45f2-a0c4-00c5a61c89b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9062d040-95fb-45f2-a0c4-00c5a61c89b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_51911251-b694-432b-ac8a-14c9bf9cdc00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_51911251-b694-432b-ac8a-14c9bf9cdc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a6dad66-5b7e-489f-bea2-becdaac2edee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_abb48be9-7ca8-4c8c-90ee-cde5532579a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a6dad66-5b7e-489f-bea2-becdaac2edee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_526547da-2226-4b06-9414-d50b21ac98c1" xlink:href="wst-20201231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_b22bd83f-8206-4b8a-92bb-3c373d42d2b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_526547da-2226-4b06-9414-d50b21ac98c1" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_b22bd83f-8206-4b8a-92bb-3c373d42d2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_254a2cd3-4330-460b-a698-86af65732004" xlink:href="wst-20201231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_9bd4731b-761f-4564-9aa0-a8da51faace8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_254a2cd3-4330-460b-a698-86af65732004" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_9bd4731b-761f-4564-9aa0-a8da51faace8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:href="wst-20201231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_7009ff55-480d-4689-8557-ddabcff4ac96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_DeferredRevenueCurrent_7009ff55-480d-4689-8557-ddabcff4ac96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_969091d1-a43f-4c51-b778-1dbeffcaaec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_DividendsPayableCurrent_969091d1-a43f-4c51-b778-1dbeffcaaec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_d80c9980-9cf1-4a0d-a1b6-dd2329c7764d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_d80c9980-9cf1-4a0d-a1b6-dd2329c7764d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_28a063fb-8121-4363-acbc-c19fa6fe8997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_28a063fb-8121-4363-acbc-c19fa6fe8997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_3f1387e8-1d97-4021-882f-667d83a003c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_3f1387e8-1d97-4021-882f-667d83a003c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_2b0ebb34-5553-46ed-8f68-307b4414c4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_2b0ebb34-5553-46ed-8f68-307b4414c4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_b8cb9c58-7d1b-4dd4-b55b-b2527cf17107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_InterestPayableCurrent_b8cb9c58-7d1b-4dd4-b55b-b2527cf17107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b012ac34-3b1f-47ba-8d2c-bc2e5e70e27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_RestructuringReserve_b012ac34-3b1f-47ba-8d2c-bc2e5e70e27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_d28981c9-8ab5-4014-830a-6858084a82de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_d28981c9-8ab5-4014-830a-6858084a82de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_44fb49c1-f0b7-4fda-81b5-e3bfdaf9c875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_44fb49c1-f0b7-4fda-81b5-e3bfdaf9c875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_808e42f9-6960-4f36-997f-03b93d0a0cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_b5d7993c-bcff-436f-87eb-5557bf1ce1c0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_808e42f9-6960-4f36-997f-03b93d0a0cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20201231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6c651c47-8925-46c3-b88f-74612dd3d1b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_5b37d47e-bc03-4498-b8a0-baa035be5e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6c651c47-8925-46c3-b88f-74612dd3d1b5" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_5b37d47e-bc03-4498-b8a0-baa035be5e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_14c91a87-5d3c-4a88-bf16-9ecc4405e5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_c939cf5a-578b-43c7-86aa-85eefaddec4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_14c91a87-5d3c-4a88-bf16-9ecc4405e5ee" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_c939cf5a-578b-43c7-86aa-85eefaddec4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3e72c02c-59df-4dfc-af67-b6eb6bde39c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b3392ec4-acde-4dab-a85d-d256f7c4e70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3e72c02c-59df-4dfc-af67-b6eb6bde39c2" xlink:to="loc_us-gaap_DebtInstrumentTable_b3392ec4-acde-4dab-a85d-d256f7c4e70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b3392ec4-acde-4dab-a85d-d256f7c4e70c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1e5faf7b-9c83-40c0-bbc5-1df7b84695ca" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_fe46fa7a-fb35-4685-90b5-0b9a0cea1164" xlink:href="wst-20201231.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_TermLoanDue2024Member_fe46fa7a-fb35-4685-90b5-0b9a0cea1164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_b2cb8b33-6620-41b4-9dc9-ea2f82a41d5e" xlink:href="wst-20201231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_SeniorNotesDue2022Member_b2cb8b33-6620-41b4-9dc9-ea2f82a41d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_612dca3e-d568-491b-8ad3-5a6db5bd5145" xlink:href="wst-20201231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_SeniorBNotesDue2024Member_612dca3e-d568-491b-8ad3-5a6db5bd5145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_0bdc0170-01bc-4a83-aeb4-1ee5193b3ecd" xlink:href="wst-20201231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39340e7f-c48e-4cfd-b5f9-46c1f59ba164" xlink:to="loc_wst_SeniorCNotesDue2027Member_0bdc0170-01bc-4a83-aeb4-1ee5193b3ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b3392ec4-acde-4dab-a85d-d256f7c4e70c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a50daca4-e1d3-480e-b0ca-c93ed2c0d0e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a50daca4-e1d3-480e-b0ca-c93ed2c0d0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_494d691a-0312-4b92-b1d7-3facd0a5ad70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_494d691a-0312-4b92-b1d7-3facd0a5ad70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_4c7d71c5-b0a4-4ecc-b268-0a854bf3db65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_4c7d71c5-b0a4-4ecc-b268-0a854bf3db65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c404dd7c-7250-4702-a641-4807bb605699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_LongTermDebt_c404dd7c-7250-4702-a641-4807bb605699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_eb3f32eb-8f13-41ad-8056-55a2705e7461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_LongTermDebtCurrent_eb3f32eb-8f13-41ad-8056-55a2705e7461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_dac3694d-4f21-4028-9b4f-8776653022ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0b56719-1e36-4834-a87d-dbd7c38d7695" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_dac3694d-4f21-4028-9b4f-8776653022ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtScheduleofDebtDetails_1"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3eec44f6-5561-44a2-9c36-199e320e3d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3eec44f6-5561-44a2-9c36-199e320e3d4b" xlink:to="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9058f002-3614-42fa-9b63-4a6d521416ce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_srt_RangeAxis_9058f002-3614-42fa-9b63-4a6d521416ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9058f002-3614-42fa-9b63-4a6d521416ce" xlink:to="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff422752-571f-42db-a5d1-4631a62cf165" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:to="loc_srt_MinimumMember_ff422752-571f-42db-a5d1-4631a62cf165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d044076e-7644-4125-89e9-275d08388769" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bfcdddc2-3606-4ae1-9f96-ff58a21fc8bc" xlink:to="loc_srt_MaximumMember_d044076e-7644-4125-89e9-275d08388769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f3f7e292-9a20-41d1-891f-3bde27ceeeb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_us-gaap_CreditFacilityAxis_f3f7e292-9a20-41d1-891f-3bde27ceeeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f3f7e292-9a20-41d1-891f-3bde27ceeeb8" xlink:to="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_9c99258c-82bb-4832-914b-4c4805a3187f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_9c99258c-82bb-4832-914b-4c4805a3187f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_073c739b-da9d-4e43-a4f1-e865a95e8058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_073c739b-da9d-4e43-a4f1-e865a95e8058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_23c6c5cf-f3fb-4fcb-ad92-54af91763599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_23c6c5cf-f3fb-4fcb-ad92-54af91763599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_cd6cf2b8-e8a5-46a9-89b4-1ef0b81515d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_BaseRateMember_cd6cf2b8-e8a5-46a9-89b4-1ef0b81515d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c786b1ca-5995-4e8e-8e85-da72a86b6def" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c786b1ca-5995-4e8e-8e85-da72a86b6def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b7860960-0710-48fe-a1cf-09e0d29a331f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a0ec4b29-d096-4d06-93ca-b1365a63621e" xlink:to="loc_us-gaap_LetterOfCreditMember_b7860960-0710-48fe-a1cf-09e0d29a331f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_723eb4f1-caa2-4260-9e34-65e16953db5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_723eb4f1-caa2-4260-9e34-65e16953db5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_723eb4f1-caa2-4260-9e34-65e16953db5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_6d64c65b-c39b-4c19-aec6-00ced244946c" xlink:href="wst-20201231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_6d64c65b-c39b-4c19-aec6-00ced244946c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_e1d7af1c-5e07-49e7-8587-746d1e3fde54" xlink:href="wst-20201231.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:to="loc_wst_TermLoanDue2024Member_e1d7af1c-5e07-49e7-8587-746d1e3fde54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0c20b589-2453-462c-92ea-a2860e74314f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8c66529e-7dfe-4fe9-857b-e24a967d242c" xlink:to="loc_us-gaap_SeniorNotesMember_0c20b589-2453-462c-92ea-a2860e74314f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_us-gaap_DebtInstrumentAxis_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9b77b374-753b-4b8d-86a9-5dea0ab2c6cf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_83641fff-54d8-4f4d-8ab5-641182ffbe54" xlink:href="wst-20201231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:to="loc_wst_SeniorNotesDue2022Member_83641fff-54d8-4f4d-8ab5-641182ffbe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_7d5f2cd7-852f-424c-8d8a-770cb1f9d570" xlink:href="wst-20201231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:to="loc_wst_SeniorBNotesDue2024Member_7d5f2cd7-852f-424c-8d8a-770cb1f9d570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_434f05d3-82e6-4ddc-bdf7-049fd9088502" xlink:href="wst-20201231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d49dfa91-f863-4c3f-8941-2e8752a17edc" xlink:to="loc_wst_SeniorCNotesDue2027Member_434f05d3-82e6-4ddc-bdf7-049fd9088502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_24f2b960-26df-487a-a96f-9dab17d84bdf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_2bc4fce1-6cf0-46c5-bb9b-4944bcc5ca76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_2bc4fce1-6cf0-46c5-bb9b-4944bcc5ca76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_3e643080-8e69-447c-a5fc-231e27dfb8ed" xlink:href="wst-20201231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_3e643080-8e69-447c-a5fc-231e27dfb8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_03f85d00-d370-4b4d-a6b6-16952fc8306b" xlink:href="wst-20201231.xsd#wst_CreditAvailableForIssuanceOfLettersOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_03f85d00-d370-4b4d-a6b6-16952fc8306b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c1dcb905-4082-4b3f-9255-f0ebf1469621" xlink:href="wst-20201231.xsd#wst_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_LineOfCreditFacilityAdditionalBorrowingCapacity_c1dcb905-4082-4b3f-9255-f0ebf1469621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a5b4d71-f281-4bce-9768-8f2f650fdffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1a5b4d71-f281-4bce-9768-8f2f650fdffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RatioOfDebtToEBITDA_6020ccd7-f39f-4473-8eb7-1635f5a7a12a" xlink:href="wst-20201231.xsd#wst_RatioOfDebtToEBITDA"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_RatioOfDebtToEBITDA_6020ccd7-f39f-4473-8eb7-1635f5a7a12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_fe5af9b4-eaf7-45c6-8767-9e3771491517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_fe5af9b4-eaf7-45c6-8767-9e3771491517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_6618cec6-fb9a-48ae-9a28-7d6c7a36e115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermLineOfCredit_6618cec6-fb9a-48ae-9a28-7d6c7a36e115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_575a2660-a75e-417f-9f30-fe679cb72663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LineOfCredit_575a2660-a75e-417f-9f30-fe679cb72663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d79da60a-8bf5-48d1-a6b9-766bd1de740a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d79da60a-8bf5-48d1-a6b9-766bd1de740a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7c16738d-8948-497d-852d-3a77fe369703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7c16738d-8948-497d-852d-3a77fe369703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_516f7f3f-c599-49a5-809f-2da0207d84ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_516f7f3f-c599-49a5-809f-2da0207d84ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8a0e1b77-6b99-43d7-9583-482a93ae447d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermDebtCurrent_8a0e1b77-6b99-43d7-9583-482a93ae447d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2337ca37-abf7-455e-82ed-e9a48c0802c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2337ca37-abf7-455e-82ed-e9a48c0802c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtInstrumentNumberOfTranches_cf8873b6-7382-424a-949f-dff3ebc4baff" xlink:href="wst-20201231.xsd#wst_DebtInstrumentNumberOfTranches"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_wst_DebtInstrumentNumberOfTranches_cf8873b6-7382-424a-949f-dff3ebc4baff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f4f94b8-57f8-482e-bcfc-d8cb8dfc4401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f4f94b8-57f8-482e-bcfc-d8cb8dfc4401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1175087f-840b-4124-9ddd-ffbb156e4b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1175087f-840b-4124-9ddd-ffbb156e4b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_aaf365b4-2354-4d1a-b8e3-7b7260390fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_aaf365b4-2354-4d1a-b8e3-7b7260390fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_4133bdf5-41a6-4937-a302-c0c70d3d83fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_4133bdf5-41a6-4937-a302-c0c70d3d83fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_673d7c75-80fc-455a-8acb-1430c164c84e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_InterestExpenseDebt_673d7c75-80fc-455a-8acb-1430c164c84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9e15b308-ad42-43a4-b9b9-ea5fce76b63d" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8d883e62-cbcc-48f4-b97e-494f107d48a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8d883e62-cbcc-48f4-b97e-494f107d48a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e275b08-7867-46aa-aef1-769970e1fa57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e275b08-7867-46aa-aef1-769970e1fa57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ab8e400d-3454-4b26-83d5-e533735d285f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ab8e400d-3454-4b26-83d5-e533735d285f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_00b75d94-27bc-4e11-9221-adf2b4d25c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_00b75d94-27bc-4e11-9221-adf2b4d25c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3e646ebf-e2ba-4e14-b6d0-9d2adc9d3326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3e646ebf-e2ba-4e14-b6d0-9d2adc9d3326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_be4cc1b9-1aed-43f7-b649-fa639c885471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_903141de-6518-4c99-ac47-f14e5a943c7b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_be4cc1b9-1aed-43f7-b649-fa639c885471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0c120c36-3689-4ebc-8bc3-561cb47ff311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_60e3c6b8-2476-4b1d-92a5-534edb922c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0c120c36-3689-4ebc-8bc3-561cb47ff311" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_60e3c6b8-2476-4b1d-92a5-534edb922c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e66462ad-2547-47cb-84f5-466559ecd1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_2dfb254c-6c2b-47e9-b1b3-3a96063f0b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e66462ad-2547-47cb-84f5-466559ecd1ef" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_2dfb254c-6c2b-47e9-b1b3-3a96063f0b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4c23593e-ff8f-4ecd-8164-253f61a81aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e66462ad-2547-47cb-84f5-466559ecd1ef" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4c23593e-ff8f-4ecd-8164-253f61a81aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dd345c3f-afa8-4b70-9933-0180c7c79326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e66462ad-2547-47cb-84f5-466559ecd1ef" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dd345c3f-afa8-4b70-9933-0180c7c79326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40d78364-442a-421a-905d-48f87bde1d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40d78364-442a-421a-905d-48f87bde1d5d" xlink:to="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_af2f69d7-dd6c-4298-a86f-f069e6c325ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_af2f69d7-dd6c-4298-a86f-f069e6c325ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_af2f69d7-dd6c-4298-a86f-f069e6c325ff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_9c632f0f-7873-4c17-b5cc-3f5fb70a7e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_OptionMember_9c632f0f-7873-4c17-b5cc-3f5fb70a7e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_b0095cd3-24c1-4580-a6c6-14bd5e97b1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_ForwardContractsMember_b0095cd3-24c1-4580-a6c6-14bd5e97b1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_dc2e67f4-da6f-49c5-932a-3e25f89c0d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_dc2e67f4-da6f-49c5-932a-3e25f89c0d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_48e03cf9-17cf-4da5-93ba-01cb6c8182c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ae1a4d-3eca-4ec3-a76d-fd69fb8f13bc" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_48e03cf9-17cf-4da5-93ba-01cb6c8182c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bc24c93-6982-4bc6-815a-4fe57b37d826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bc24c93-6982-4bc6-815a-4fe57b37d826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7bc24c93-6982-4bc6-815a-4fe57b37d826" xlink:to="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_e3e1b73a-c0e7-4b46-b785-becfcc429863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:to="loc_us-gaap_FairValueHedgingMember_e3e1b73a-c0e7-4b46-b785-becfcc429863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_239d7338-7df5-42e5-b53e-6c0537103324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44d3de7c-9f1e-41c4-b210-ec478575e420" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_239d7338-7df5-42e5-b53e-6c0537103324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_36a3b9b9-aad8-433c-98e9-e58aee8781a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EnergyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_EnergyAxis_36a3b9b9-aad8-433c-98e9-e58aee8781a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_f5110d10-707a-4e9d-9361-42149e0621ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EnergyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EnergyAxis_36a3b9b9-aad8-433c-98e9-e58aee8781a3" xlink:to="loc_srt_EnergyDomain_f5110d10-707a-4e9d-9361-42149e0621ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e2d5b529-a07f-41a1-a87e-3c4237cdf7db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_VariableRateAxis_e2d5b529-a07f-41a1-a87e-3c4237cdf7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_05e6f45d-be8d-4beb-b81b-9a9f9cd7248a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e2d5b529-a07f-41a1-a87e-3c4237cdf7db" xlink:to="loc_us-gaap_VariableRateDomain_05e6f45d-be8d-4beb-b81b-9a9f9cd7248a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_8f381b71-08e5-4989-8242-bb6f6117b67f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_PositionAxis_8f381b71-08e5-4989-8242-bb6f6117b67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_17088fab-6bc8-4d7a-9b4f-d2685e929ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_8f381b71-08e5-4989-8242-bb6f6117b67f" xlink:to="loc_us-gaap_PositionDomain_17088fab-6bc8-4d7a-9b4f-d2685e929ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_RangeAxis_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61c552bf-fd35-4b22-8ba2-ba3fff4e03a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b5f34f3d-b5ae-41ed-8bc7-313bebbe0f62" xlink:to="loc_srt_RangeMember_61c552bf-fd35-4b22-8ba2-ba3fff4e03a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a56d0f54-5339-46ab-a3e6-41cd81066edc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_StatementScenarioAxis_a56d0f54-5339-46ab-a3e6-41cd81066edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a70c7537-7413-4168-b985-eb436dea349d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a56d0f54-5339-46ab-a3e6-41cd81066edc" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a70c7537-7413-4168-b985-eb436dea349d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e135c607-837c-4a9f-8a0a-4664747c42b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a70c7537-7413-4168-b985-eb436dea349d" xlink:to="loc_srt_ScenarioForecastMember_e135c607-837c-4a9f-8a0a-4664747c42b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_4e5d9f09-e676-412a-b194-aed1d68107b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_srt_CurrencyAxis_4e5d9f09-e676-412a-b194-aed1d68107b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_4e5d9f09-e676-412a-b194-aed1d68107b8" xlink:to="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_165d5d8c-0436-429d-8252-1e4d3f899e22" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SGD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:to="loc_currency_SGD_165d5d8c-0436-429d-8252-1e4d3f899e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_6ab77f52-ab30-413d-b0b5-7e6bb994f166" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_45302488-9ef4-4660-b436-3e371e6b73c5" xlink:to="loc_currency_USD_6ab77f52-ab30-413d-b0b5-7e6bb994f166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ccea8623-7cd6-460e-aace-51e47807440e" xlink:to="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f6e84b7b-d6a6-4ecd-b92a-6b52ac31a4ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f6e84b7b-d6a6-4ecd-b92a-6b52ac31a4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_afdd56f5-87da-4d6b-97cf-95eaf4199a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeTermOfContract_afdd56f5-87da-4d6b-97cf-95eaf4199a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_eec86920-57e6-4393-9078-667c1f43db01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_eec86920-57e6-4393-9078-667c1f43db01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_efb3fdcf-5850-46e8-9cac-9b885b38822b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_efb3fdcf-5850-46e8-9cac-9b885b38822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_5c107e8d-9c74-4775-afdb-1a3060cdc620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_5c107e8d-9c74-4775-afdb-1a3060cdc620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_005adbb8-ed62-4734-bd17-ebdf1bf1a9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fac912a0-baae-4cd1-84bb-bf83f0b04862" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_005adbb8-ed62-4734-bd17-ebdf1bf1a9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f93ee57-3f40-4b6d-89ef-e31fe8987a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f93ee57-3f40-4b6d-89ef-e31fe8987a68" xlink:to="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_02a61f6c-f6cd-4d52-8621-e2001f817285" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_srt_CurrencyAxis_02a61f6c-f6cd-4d52-8621-e2001f817285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_02a61f6c-f6cd-4d52-8621-e2001f817285" xlink:to="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_9a155b54-2ff1-4936-acdd-8a8f1db3d3cf" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:to="loc_currency_USD_9a155b54-2ff1-4936-acdd-8a8f1db3d3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_f2c2709b-8eac-454f-a4d0-989140343636" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:to="loc_currency_JPY_f2c2709b-8eac-454f-a4d0-989140343636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_d219fcf6-fd53-4bf0-ab12-a4674027d69c" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SGD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_94e22b51-93df-4bd6-9eae-0ea490d19ab2" xlink:to="loc_currency_SGD_d219fcf6-fd53-4bf0-ab12-a4674027d69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e725d2ae-4c85-480e-a800-c39e104a8b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e725d2ae-4c85-480e-a800-c39e104a8b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1fb3a21e-21c1-4d82-b3ca-1dc610fec9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e725d2ae-4c85-480e-a800-c39e104a8b2c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1fb3a21e-21c1-4d82-b3ca-1dc610fec9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_13ae2beb-90f3-498e-8c1e-21debaf6d0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fb3a21e-21c1-4d82-b3ca-1dc610fec9b4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_13ae2beb-90f3-498e-8c1e-21debaf6d0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_cddba3e8-4a55-4c71-b832-79a1e28781ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_us-gaap_PositionAxis_cddba3e8-4a55-4c71-b832-79a1e28781ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_cddba3e8-4a55-4c71-b832-79a1e28781ee" xlink:to="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_9f071f91-6cb2-43bf-ba93-ca2d3a8c79a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:to="loc_us-gaap_LongMember_9f071f91-6cb2-43bf-ba93-ca2d3a8c79a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_6f49e5e9-5702-4dbb-832a-3b98dc027a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_e65df04a-3e1b-4b5e-8e05-456be9187cd1" xlink:to="loc_us-gaap_ShortMember_6f49e5e9-5702-4dbb-832a-3b98dc027a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_us-gaap_HedgingDesignationAxis_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a9aa1992-fea0-4b4e-86b4-76e237d04fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_da1a05b9-1087-4bbf-9ea6-4ae7fc41078f" xlink:to="loc_us-gaap_HedgingDesignationDomain_a9aa1992-fea0-4b4e-86b4-76e237d04fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a11024b-b077-4efe-97ac-55501d0818cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a9aa1992-fea0-4b4e-86b4-76e237d04fbd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a11024b-b077-4efe-97ac-55501d0818cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5ff82074-2419-42f3-8971-2bad65546369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c36b9b82-b501-4a42-af47-d9d1548ca015" xlink:to="loc_us-gaap_DerivativeLineItems_5ff82074-2419-42f3-8971-2bad65546369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_85c548b9-0719-4d6c-ba7e-d4185ac7e0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5ff82074-2419-42f3-8971-2bad65546369" xlink:to="loc_us-gaap_DerivativeNotionalAmount_85c548b9-0719-4d6c-ba7e-d4185ac7e0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b0a1819d-b9d4-4bd9-9f34-a86f2a04dcd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b0a1819d-b9d4-4bd9-9f34-a86f2a04dcd4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f29d83f1-1290-4f34-8d57-e75069b3b6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f29d83f1-1290-4f34-8d57-e75069b3b6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f29d83f1-1290-4f34-8d57-e75069b3b6e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_6a227131-c1ec-464b-a391-9a49f75513e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_6a227131-c1ec-464b-a391-9a49f75513e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_bb0a7f2a-ed63-4f16-9cb2-447e9ed93aa5" xlink:href="wst-20201231.xsd#wst_NetSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_wst_NetSalesMember_bb0a7f2a-ed63-4f16-9cb2-447e9ed93aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b7886d08-2c72-4c61-ab32-ab1761d6516d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_us-gaap_CostOfSalesMember_b7886d08-2c72-4c61-ab32-ab1761d6516d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4e69a048-d0a6-49c6-b9ad-c482acbfead8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e76a6c53-c83d-4ee5-aa90-6faf6bf640f7" xlink:to="loc_us-gaap_InterestExpenseMember_4e69a048-d0a6-49c6-b9ad-c482acbfead8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58140562-2e31-4e22-a51e-0a0f07e79b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58140562-2e31-4e22-a51e-0a0f07e79b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58140562-2e31-4e22-a51e-0a0f07e79b8e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_2893f580-1e76-4f5d-a9bd-0a38709794d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:to="loc_us-gaap_FairValueHedgingMember_2893f580-1e76-4f5d-a9bd-0a38709794d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0537e02b-28f3-439e-b9ac-42a89d4f95c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:to="loc_us-gaap_CashFlowHedgingMember_0537e02b-28f3-439e-b9ac-42a89d4f95c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f137b18b-e5a4-4576-823e-54547c74a3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b3434f7-64bb-4bc0-ac86-e18175432129" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f137b18b-e5a4-4576-823e-54547c74a3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f2b71011-d41c-4fa3-9bb4-25cb844a4637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f2b71011-d41c-4fa3-9bb4-25cb844a4637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f2b71011-d41c-4fa3-9bb4-25cb844a4637" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b0ee67bd-fd41-4a42-b1e2-8ed0da4ba3b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b0ee67bd-fd41-4a42-b1e2-8ed0da4ba3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_11a854b2-c034-47c2-9ae6-c782db76ce11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_TreasuryLockMember_11a854b2-c034-47c2-9ae6-c782db76ce11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyDenominatedDebtMember_648ce990-71bf-4511-a85f-e752ec6cb9da" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_wst_ForeignCurrencyDenominatedDebtMember_648ce990-71bf-4511-a85f-e752ec6cb9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b9734a91-e982-4aa8-8e0e-d114047e8b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_CurrencySwapMember_b9734a91-e982-4aa8-8e0e-d114047e8b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_75e9d838-bfc8-47e8-b00b-b3262535771b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b507cc7e-158b-48ff-8478-02467286d7df" xlink:to="loc_us-gaap_CommodityOptionMember_75e9d838-bfc8-47e8-b00b-b3262535771b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f3a576e6-c6e8-4049-86a2-a89fa681d33d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_HedgingDesignationAxis_f3a576e6-c6e8-4049-86a2-a89fa681d33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3fe41163-18bf-46c1-adc2-b0c3845b7edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f3a576e6-c6e8-4049-86a2-a89fa681d33d" xlink:to="loc_us-gaap_HedgingDesignationDomain_3fe41163-18bf-46c1-adc2-b0c3845b7edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f6c0d943-3eb0-41d1-9954-c1ec7b70ed40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3fe41163-18bf-46c1-adc2-b0c3845b7edd" xlink:to="loc_us-gaap_NondesignatedMember_f6c0d943-3eb0-41d1-9954-c1ec7b70ed40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbc573be-6505-49e9-b5b6-562fb94d39d3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c1919499-3cb8-4b4f-aa37-3e0c4c799056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c1919499-3cb8-4b4f-aa37-3e0c4c799056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_544bcd27-25f6-4b86-972f-8284a2557e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_544bcd27-25f6-4b86-972f-8284a2557e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_7b2ef129-8853-4737-abde-5153c295e916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_7b2ef129-8853-4737-abde-5153c295e916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_008512cc-48c6-4ef2-b884-e7421cd30bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_008512cc-48c6-4ef2-b884-e7421cd30bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3070d6b7-6b36-49a2-83ed-5eebc41a8608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3070d6b7-6b36-49a2-83ed-5eebc41a8608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c6c73d5e-3e79-4ace-afc9-50b116216fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_c6c73d5e-3e79-4ace-afc9-50b116216fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c4e1e71-fb94-42a4-8f6a-e2f40900189b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c4e1e71-fb94-42a4-8f6a-e2f40900189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_df0f5d8a-c3e9-4c6a-92d3-62127552585b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_df0f5d8a-c3e9-4c6a-92d3-62127552585b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_559efa48-0ff0-4936-95a0-1c03a8d4714c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_559efa48-0ff0-4936-95a0-1c03a8d4714c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_75c06665-c8f1-460b-bf08-0c81b7d016d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d1a965ad-f86c-4290-839c-97a5ac0dcd2b" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_75c06665-c8f1-460b-bf08-0c81b7d016d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d4d08b9a-a0e4-43f1-8c41-cfd1883accf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_27154f4f-20ae-488d-ab50-d789453d1308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d4d08b9a-a0e4-43f1-8c41-cfd1883accf3" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_27154f4f-20ae-488d-ab50-d789453d1308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_93114717-1ba3-43a4-86f2-ba959f203f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_afe5fe21-738d-4a99-82b1-5be62598b413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_93114717-1ba3-43a4-86f2-ba959f203f25" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_afe5fe21-738d-4a99-82b1-5be62598b413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0e585750-0e2c-457e-bfff-96a45f749dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_93114717-1ba3-43a4-86f2-ba959f203f25" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0e585750-0e2c-457e-bfff-96a45f749dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c4a9ffc1-9454-4e85-a717-ca65701819eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c4a9ffc1-9454-4e85-a717-ca65701819eb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3b3e269-61c5-4a72-ade8-9f5f1ed1aea3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4521ca37-5f49-40c9-a376-cb3cb9a7faf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4521ca37-5f49-40c9-a376-cb3cb9a7faf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7d37f2a5-a02f-4b06-9f74-17ba9f057872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7d37f2a5-a02f-4b06-9f74-17ba9f057872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85fd1980-8668-4ff5-9258-25f8f0e8f1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9a8e9588-e866-4b84-8460-0e0c67193741" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85fd1980-8668-4ff5-9258-25f8f0e8f1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_31012cc8-e06b-4fe7-9e4b-94403412fa8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_31012cc8-e06b-4fe7-9e4b-94403412fa8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_31012cc8-e06b-4fe7-9e4b-94403412fa8b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember_01bcacc7-14c3-48b7-8fca-3de3bfc3e50c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:to="loc_us-gaap_CommodityMember_01bcacc7-14c3-48b7-8fca-3de3bfc3e50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_db65a96a-f130-4d7f-bf7a-b263c6232816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:to="loc_us-gaap_CurrencySwapMember_db65a96a-f130-4d7f-bf7a-b263c6232816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_275d4206-292d-4e58-8abe-9d0e1ee47df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1782041-a608-42ad-95fe-7f6f4bdd2b5c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_275d4206-292d-4e58-8abe-9d0e1ee47df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d422839-fcba-4bfc-98ea-2e54e96b6d4f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_cd857056-fa84-4f31-b9e3-851b35d3f19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_cd857056-fa84-4f31-b9e3-851b35d3f19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b33ff14e-618e-42f5-880c-22dad32018be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b33ff14e-618e-42f5-880c-22dad32018be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_64685388-6e5a-4675-a456-30cea0376806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8b1efd54-1b64-4af1-82df-d4f2b8b1f1df" xlink:to="loc_us-gaap_DerivativeAssets_64685388-6e5a-4675-a456-30cea0376806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_14c83364-cbe8-48fb-a5cc-7c63d24ec8d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_14c83364-cbe8-48fb-a5cc-7c63d24ec8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f1082092-ae02-4d03-987e-427e1f29647e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dc7debda-ffc4-49d0-afeb-1080187401af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dc7debda-ffc4-49d0-afeb-1080187401af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_61714907-0b60-462a-ae14-72d88568d5f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_61714907-0b60-462a-ae14-72d88568d5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a26aab71-6714-472d-9102-9137fb142084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a26aab71-6714-472d-9102-9137fb142084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2d9e7831-2746-4dc1-b3c5-002119896241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_69c502d0-4482-4efb-b497-8ee8ab6c60d8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_2d9e7831-2746-4dc1-b3c5-002119896241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_74b71f29-e1ad-4746-96b6-11788cf2c5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_74b71f29-e1ad-4746-96b6-11788cf2c5c6" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_bf9ccf63-5cc2-4051-a3b3-ffac2ff2dca1" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesProjectionsMember_bed5b8be-164d-4fd1-9c99-c60a0b0d196f" xlink:href="wst-20201231.xsd#wst_SalesProjectionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_wst_SalesProjectionsMember_bed5b8be-164d-4fd1-9c99-c60a0b0d196f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProbabilitiesOfSuccessfulFDAApprovalMember_89917e38-4fb6-49fd-824b-d3a04550aaa6" xlink:href="wst-20201231.xsd#wst_ProbabilitiesOfSuccessfulFDAApprovalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_wst_ProbabilitiesOfSuccessfulFDAApprovalMember_89917e38-4fb6-49fd-824b-d3a04550aaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember_e91dc551-6ba4-4b15-8f15-dce78114b504" xlink:href="wst-20201231.xsd#wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember_e91dc551-6ba4-4b15-8f15-dce78114b504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_61635d2d-968b-4ce1-8744-bb2e28aa5eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c18ed32a-4119-4614-9b5f-4c2e5eb7f918" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_61635d2d-968b-4ce1-8744-bb2e28aa5eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d54bd7e3-6f7a-484c-8449-eb3bc016bc66" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:to="loc_srt_RangeAxis_d54bd7e3-6f7a-484c-8449-eb3bc016bc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d54bd7e3-6f7a-484c-8449-eb3bc016bc66" xlink:to="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_57348501-f215-4f1d-b5de-03fd79398476" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:to="loc_srt_MinimumMember_57348501-f215-4f1d-b5de-03fd79398476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7ed62d66-0818-4acd-98df-a71188e4e980" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:to="loc_srt_MaximumMember_7ed62d66-0818-4acd-98df-a71188e4e980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_bd5e1876-100e-435d-ab9e-b7163176ed62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13a606df-b45c-421e-95cd-d0f8aff3cb7b" xlink:to="loc_srt_WeightedAverageMember_bd5e1876-100e-435d-ab9e-b7163176ed62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_74ed6070-5670-4404-96a5-79395ab775a8" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BusinessCombinationContingentConsiderationMeasurementInput_6b1f742a-3285-439b-ade2-b52a998869de" xlink:href="wst-20201231.xsd#wst_BusinessCombinationContingentConsiderationMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:to="loc_wst_BusinessCombinationContingentConsiderationMeasurementInput_6b1f742a-3285-439b-ade2-b52a998869de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_addcc234-854e-4f59-9140-a8788d506e3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5fc5b007-26e9-4565-8a05-11031fc980fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5fc5b007-26e9-4565-8a05-11031fc980fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ab8fa4e4-1af8-4e06-8ab7-cc89fb591f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ab8fa4e4-1af8-4e06-8ab7-cc89fb591f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_8b06881b-ab01-431d-8289-74e161809bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_8b06881b-ab01-431d-8289-74e161809bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_451a8fa9-97de-4bb2-afd1-79f39393741e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_98d449e8-396c-4d4f-93ae-4e4c6f02f795" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_451a8fa9-97de-4bb2-afd1-79f39393741e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherFinancialInstrumentsAbstract_0e86775a-b5a5-4ba4-be62-6695ee050791" xlink:href="wst-20201231.xsd#wst_OtherFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_03a13fd5-3433-4f2e-97f2-9eaafa4ada79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract_0e86775a-b5a5-4ba4-be62-6695ee050791" xlink:to="loc_us-gaap_LongTermDebtFairValue_03a13fd5-3433-4f2e-97f2-9eaafa4ada79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_31a6fc09-760d-405c-b2d6-b14065bdad18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract_0e86775a-b5a5-4ba4-be62-6695ee050791" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_31a6fc09-760d-405c-b2d6-b14065bdad18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_479dcea0-33bb-4879-b5d1-d092eb65912e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b2e0c1b8-520e-4f3f-86f8-41a0d39fc90c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_479dcea0-33bb-4879-b5d1-d092eb65912e" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b2e0c1b8-520e-4f3f-86f8-41a0d39fc90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e31e32cc-6c5d-4f0c-9208-3bf0d24ed4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9b58d531-112f-452b-951c-455f987d371d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e31e32cc-6c5d-4f0c-9208-3bf0d24ed4b9" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9b58d531-112f-452b-951c-455f987d371d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_73075552-b7ad-4f4e-b04b-bfb51472342c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e31e32cc-6c5d-4f0c-9208-3bf0d24ed4b9" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_73075552-b7ad-4f4e-b04b-bfb51472342c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_26604b7e-7e86-4d11-8b5a-71c768b1c133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9326b8b8-5283-4d84-af82-6de0c4dfb9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_26604b7e-7e86-4d11-8b5a-71c768b1c133" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9326b8b8-5283-4d84-af82-6de0c4dfb9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_099bf3c0-84f4-4098-87a3-6961b9a29106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9326b8b8-5283-4d84-af82-6de0c4dfb9c0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_099bf3c0-84f4-4098-87a3-6961b9a29106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_099bf3c0-84f4-4098-87a3-6961b9a29106" xlink:to="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_8c5f7c62-f301-4c8d-a46f-554dba24990a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_8c5f7c62-f301-4c8d-a46f-554dba24990a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_2ab8a603-7c68-4297-ac8f-abb8d95b6db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_2ab8a603-7c68-4297-ac8f-abb8d95b6db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f6087562-882c-43b5-b258-1d0e4a79f5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f6087562-882c-43b5-b258-1d0e4a79f5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7951e921-20d6-43e5-afdb-34c9139d8b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_7951e921-20d6-43e5-afdb-34c9139d8b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3ad9b30f-d26f-4a72-93f8-e5e0bf6bf567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_87cc42e3-be75-4031-b133-a9a3967e0e3a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3ad9b30f-d26f-4a72-93f8-e5e0bf6bf567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a685085e-3f63-445c-9d0e-d5fba942b2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9326b8b8-5283-4d84-af82-6de0c4dfb9c0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a685085e-3f63-445c-9d0e-d5fba942b2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a685085e-3f63-445c-9d0e-d5fba942b2ad" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d92498b5-2e71-482d-bcfa-6b2d29d88862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_StockholdersEquity_d92498b5-2e71-482d-bcfa-6b2d29d88862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4e8a657-f887-4f26-83b6-968a27cae068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a4e8a657-f887-4f26-83b6-968a27cae068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_7cc3d167-4c9a-4060-aff5-66ccffa6f340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_7cc3d167-4c9a-4060-aff5-66ccffa6f340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1fc332f9-2504-41a7-b677-f3ca868a0e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1fc332f9-2504-41a7-b677-f3ca868a0e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_56a163ee-974c-451a-9ea6-e541befa8fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f30697dd-42ef-4e43-8a18-c14d919527a2" xlink:to="loc_us-gaap_StockholdersEquity_56a163ee-974c-451a-9ea6-e541befa8fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e734c931-6e5b-4657-8bca-eaae43fc93f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e734c931-6e5b-4657-8bca-eaae43fc93f3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b605a713-6a6b-4759-a1d0-45814d43dde1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b605a713-6a6b-4759-a1d0-45814d43dde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b605a713-6a6b-4759-a1d0-45814d43dde1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0563044e-6cd6-451f-ab04-159417d9ffc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0563044e-6cd6-451f-ab04-159417d9ffc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_f12b1615-fa7b-4683-b6c5-f3bb58df8d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8e6486d-ed2b-4432-bf51-a888c50ac70d" xlink:to="loc_us-gaap_TreasuryLockMember_f12b1615-fa7b-4683-b6c5-f3bb58df8d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8adf2ae2-a7a1-4197-a8ac-40d3536e8532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8adf2ae2-a7a1-4197-a8ac-40d3536e8532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_85bc920e-b63b-4b37-bc1a-bc4345d53973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8adf2ae2-a7a1-4197-a8ac-40d3536e8532" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_85bc920e-b63b-4b37-bc1a-bc4345d53973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_1e98a0ad-4270-4d1a-85dc-b0c17ef3352a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_85bc920e-b63b-4b37-bc1a-bc4345d53973" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_1e98a0ad-4270-4d1a-85dc-b0c17ef3352a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3d191259-5ed5-450d-b28a-b86fc53347c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3d191259-5ed5-450d-b28a-b86fc53347c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3d191259-5ed5-450d-b28a-b86fc53347c1" xlink:to="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_910f4553-b096-47f8-acf9-70c976546e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_910f4553-b096-47f8-acf9-70c976546e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3ee3c5ce-24a0-4f94-9806-aa37631a0614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f2ac4ca-1c2f-4888-aada-5715fd811b7e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3ee3c5ce-24a0-4f94-9806-aa37631a0614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_27f2102a-3b7b-4b1d-9096-d0e4659c4273" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f056c478-6f23-4fd4-8937-19f02896a614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f056c478-6f23-4fd4-8937-19f02896a614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ee0e8f6c-2e44-4964-8cdd-1cec93b16e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ee0e8f6c-2e44-4964-8cdd-1cec93b16e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_466ddac4-7391-4d4b-9fd5-0668fcc1b24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_OtherIncome_466ddac4-7391-4d4b-9fd5-0668fcc1b24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7024300c-9940-4ff7-af1a-a6b0d4f6546d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_InterestExpense_7024300c-9940-4ff7-af1a-a6b0d4f6546d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_9aba8b51-10bf-4b23-8b4b-ac16d385ecea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_9aba8b51-10bf-4b23-8b4b-ac16d385ecea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d0e73b23-6bb5-4d81-9337-ed813813fe5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d0e73b23-6bb5-4d81-9337-ed813813fe5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b18d01ff-9eb2-4f76-a190-0b4f9850c092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b18d01ff-9eb2-4f76-a190-0b4f9850c092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1c6fcbdc-4f2c-4752-adb8-901f5679de92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1c6fcbdc-4f2c-4752-adb8-901f5679de92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5bdc9c00-fb66-41c5-b51e-8fbcd51c2dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5bdc9c00-fb66-41c5-b51e-8fbcd51c2dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1bbbe9fd-1860-44ac-81f8-270adfe2cd8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_78ae6908-cfdc-4a6f-9f54-6526b1f852ae" xlink:to="loc_us-gaap_NetIncomeLoss_1bbbe9fd-1860-44ac-81f8-270adfe2cd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26fb3a65-eb24-4d49-86fc-0639f54a9446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0a79c380-7dab-4f48-a93d-98152b741c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26fb3a65-eb24-4d49-86fc-0639f54a9446" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0a79c380-7dab-4f48-a93d-98152b741c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4991c3c-cf1d-4772-b984-f48b073b07e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_74535b65-ee27-4375-b610-23451822ebe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4991c3c-cf1d-4772-b984-f48b073b07e9" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_74535b65-ee27-4375-b610-23451822ebe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a19b2b70-1930-49e5-afcd-cb849c0f22eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4991c3c-cf1d-4772-b984-f48b073b07e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a19b2b70-1930-49e5-afcd-cb849c0f22eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_687a9dd4-f8a1-4bb5-84e4-f80fc205e932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4991c3c-cf1d-4772-b984-f48b073b07e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_687a9dd4-f8a1-4bb5-84e4-f80fc205e932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_863c1702-83fb-4aec-bc7a-e6991afcef1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4991c3c-cf1d-4772-b984-f48b073b07e9" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_863c1702-83fb-4aec-bc7a-e6991afcef1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_716a58c7-0bae-433c-949d-6e55f586d744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4991c3c-cf1d-4772-b984-f48b073b07e9" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_716a58c7-0bae-433c-949d-6e55f586d744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_93ac1e97-04e0-4a06-9079-0fcf93135e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_93ac1e97-04e0-4a06-9079-0fcf93135e8e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_baf75820-a04e-4832-bc9c-7b0723beef59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_baf75820-a04e-4832-bc9c-7b0723beef59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d4b17221-8a77-4cc5-8dae-2c6ca9ae7cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_baf75820-a04e-4832-bc9c-7b0723beef59" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d4b17221-8a77-4cc5-8dae-2c6ca9ae7cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_46dd903c-38b7-40a7-92d0-7dd75e43d00c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d4b17221-8a77-4cc5-8dae-2c6ca9ae7cfb" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_46dd903c-38b7-40a7-92d0-7dd75e43d00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_srt_RangeAxis_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d9f6263f-d9e9-495e-8900-7b7fa9d57dcb" xlink:to="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_50847494-b5ca-4cec-b1f8-83eee1aae661" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:to="loc_srt_MinimumMember_50847494-b5ca-4cec-b1f8-83eee1aae661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b535fa68-191c-40ac-8182-71c42b606adf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5cacd8fe-af6d-4d4b-a451-00bf603db8b7" xlink:to="loc_srt_MaximumMember_b535fa68-191c-40ac-8182-71c42b606adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0f34d998-cc7c-4dac-8433-d56d4bd503d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_srt_TitleOfIndividualAxis_0f34d998-cc7c-4dac-8433-d56d4bd503d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3ffab5fc-19b2-4af9-93f0-92bdb5206d69" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_0f34d998-cc7c-4dac-8433-d56d4bd503d6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3ffab5fc-19b2-4af9-93f0-92bdb5206d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c2aecea4-53f8-47c7-a3f2-729f0693cefe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3ffab5fc-19b2-4af9-93f0-92bdb5206d69" xlink:to="loc_srt_DirectorMember_c2aecea4-53f8-47c7-a3f2-729f0693cefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_171e8ce5-12da-4267-b44c-02e13841661e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_us-gaap_AwardTypeAxis_171e8ce5-12da-4267-b44c-02e13841661e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_171e8ce5-12da-4267-b44c-02e13841661e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3a79f1b7-cb95-4b0d-bea0-a07d4c4b8114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3a79f1b7-cb95-4b0d-bea0-a07d4c4b8114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_be7c1020-6709-41b2-953b-d84161c087e9" xlink:href="wst-20201231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_be7c1020-6709-41b2-953b-d84161c087e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_12a78d7e-74a6-465c-9b34-2c1d1499e0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_12a78d7e-74a6-465c-9b34-2c1d1499e0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_4c0e3f49-ff7b-401e-a10c-ff209c94e2e4" xlink:href="wst-20201231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_4c0e3f49-ff7b-401e-a10c-ff209c94e2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fb11ae65-8fa5-4b48-a956-b9478ad7d735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_us-gaap_RestrictedStockMember_fb11ae65-8fa5-4b48-a956-b9478ad7d735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_6f4be14b-1c8f-428f-a6b8-282fbc11eb97" xlink:href="wst-20201231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_IncentiveStockAwardsMember_6f4be14b-1c8f-428f-a6b8-282fbc11eb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_2b59b060-54a9-4519-a272-609bd3169e99" xlink:href="wst-20201231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cda3cfb-2b8e-4a75-ab51-249b121bdaa0" xlink:to="loc_wst_StockSettledPSUAwardsMember_2b59b060-54a9-4519-a272-609bd3169e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03a3d496-d3f9-488d-8639-18cbfe4b9804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_35fd2da1-a51a-4128-b1f9-98aa3d2d9d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_35fd2da1-a51a-4128-b1f9-98aa3d2d9d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_eaf44227-a2dd-4f24-88e6-83dfd0620245" xlink:href="wst-20201231.xsd#wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted_eaf44227-a2dd-4f24-88e6-83dfd0620245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_33fe0961-5069-4f58-855d-6a1f00109f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_33fe0961-5069-4f58-855d-6a1f00109f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d6def9a-98a1-4a53-87ed-3c8019b7634c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d6def9a-98a1-4a53-87ed-3c8019b7634c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_786fc1d5-4ecd-48ab-8640-b9489507f63f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_786fc1d5-4ecd-48ab-8640-b9489507f63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_401771c2-4aef-49e8-9326-0b508b12fb3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_401771c2-4aef-49e8-9326-0b508b12fb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledStockAppreciationRightsOutstanding_98c3e4bb-7fa1-4a8a-9e22-7d2f196ed7e7" xlink:href="wst-20201231.xsd#wst_CashSettledStockAppreciationRightsOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_CashSettledStockAppreciationRightsOutstanding_98c3e4bb-7fa1-4a8a-9e22-7d2f196ed7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledStockAppreciationRightsOutstanding_a8c3337e-120d-469c-82c0-e8d25d5d7611" xlink:href="wst-20201231.xsd#wst_StockSettledStockAppreciationRightsOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_StockSettledStockAppreciationRightsOutstanding_a8c3337e-120d-469c-82c0-e8d25d5d7611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_be0b8ef1-aa02-4550-af84-b9f04c9077cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_be0b8ef1-aa02-4550-af84-b9f04c9077cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d4a27d2e-2d38-4164-aa13-3ece99b2f9b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d4a27d2e-2d38-4164-aa13-3ece99b2f9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_d724ea71-a96e-4b42-bc88-7ca100e0f019" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_d724ea71-a96e-4b42-bc88-7ca100e0f019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1fa68e1c-2801-4527-ba5f-2fba9f8546a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1fa68e1c-2801-4527-ba5f-2fba9f8546a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_28fdf4a7-1875-4f56-bb1c-ccb7371660b2" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_28fdf4a7-1875-4f56-bb1c-ccb7371660b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_408ed486-2192-47c7-be71-c35a58c1b5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_408ed486-2192-47c7-be71-c35a58c1b5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_6c63db94-88c1-477b-bc85-11ccbb9d456f" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualConversionUnit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualConversionUnit_6c63db94-88c1-477b-bc85-11ccbb9d456f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34fdbf55-9ae7-4824-84ae-a92ed8b660e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_34fdbf55-9ae7-4824-84ae-a92ed8b660e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5c26e444-1294-4b3a-af0c-ce78dfc81397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5c26e444-1294-4b3a-af0c-ce78dfc81397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6fe01e83-7a30-4913-9029-73666f59db50" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6fe01e83-7a30-4913-9029-73666f59db50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_80080726-4cc0-4db9-9376-b9fbff6735dc" xlink:href="wst-20201231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_80080726-4cc0-4db9-9376-b9fbff6735dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableInCash_fa537fa5-390c-423a-bfb9-84727ee64cfe" xlink:href="wst-20201231.xsd#wst_DeferredStockUnitsPayableInCash"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_DeferredStockUnitsPayableInCash_fa537fa5-390c-423a-bfb9-84727ee64cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate_9ee8dbf2-54ab-45d0-ba97-cb1de55659b5" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate_9ee8dbf2-54ab-45d0-ba97-cb1de55659b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_18de936b-e593-4008-8966-3c52ccffbc06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_875b5367-711d-4b01-9ac0-1ab6317db35f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_18de936b-e593-4008-8966-3c52ccffbc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3742a389-504b-4280-999e-fc1d37596bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61c5ae66-7abb-4e60-9a3c-1d2056412662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3742a389-504b-4280-999e-fc1d37596bea" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61c5ae66-7abb-4e60-9a3c-1d2056412662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c4026a5a-ca56-467b-ba3b-59a100ba2c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61c5ae66-7abb-4e60-9a3c-1d2056412662" xlink:to="loc_us-gaap_AwardTypeAxis_c4026a5a-ca56-467b-ba3b-59a100ba2c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c4026a5a-ca56-467b-ba3b-59a100ba2c71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember_6113804f-31a7-4933-bb97-511405deff47" xlink:href="wst-20201231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_StockOptionAndAppreciationRightsMember_6113804f-31a7-4933-bb97-511405deff47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_89b4754c-ea7a-4db4-8a2f-f900b97c5ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_us-gaap_PerformanceSharesMember_89b4754c-ea7a-4db4-8a2f-f900b97c5ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_421c00c9-e1b4-4c58-9db3-ac339ae0dbaa" xlink:href="wst-20201231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_CashSettledPSUAwardsMember_421c00c9-e1b4-4c58-9db3-ac339ae0dbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_d0acd2e2-8031-401a-b5ed-e40b8dc0f9f9" xlink:href="wst-20201231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_d0acd2e2-8031-401a-b5ed-e40b8dc0f9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_67806d26-c934-4994-82b3-f463cc15621c" xlink:href="wst-20201231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_67806d26-c934-4994-82b3-f463cc15621c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_b58f8441-2a44-4d0c-b7f1-6e4d88a47f88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5865c94-bf3a-477c-8c12-6d2e90a40917" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_b58f8441-2a44-4d0c-b7f1-6e4d88a47f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2aadf5e8-403a-41dc-a6be-21666093c1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61c5ae66-7abb-4e60-9a3c-1d2056412662" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2aadf5e8-403a-41dc-a6be-21666093c1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_23eb6d63-8bdb-4982-9f9f-662085eab75f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2aadf5e8-403a-41dc-a6be-21666093c1c0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_23eb6d63-8bdb-4982-9f9f-662085eab75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_434a002a-7012-43c9-bbf5-9eb200eacfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_434a002a-7012-43c9-bbf5-9eb200eacfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_434a002a-7012-43c9-bbf5-9eb200eacfeb" xlink:to="loc_us-gaap_AwardTypeAxis_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dffaf7e3-22aa-45d4-9aac-633b49390f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5d5d1dbc-1ad6-46f9-9430-257c2f3608ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dffaf7e3-22aa-45d4-9aac-633b49390f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6f49212d-229d-462c-9966-3055e722e428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dffaf7e3-22aa-45d4-9aac-633b49390f08" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6f49212d-229d-462c-9966-3055e722e428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_434a002a-7012-43c9-bbf5-9eb200eacfeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2fde3404-a403-4d9e-8d51-24b901902aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2fde3404-a403-4d9e-8d51-24b901902aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_803ff4fb-3c69-4af0-bf0c-5a68c3bd6230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_803ff4fb-3c69-4af0-bf0c-5a68c3bd6230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_89fcc915-56b0-4be0-bf0a-1da9d6734445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_89fcc915-56b0-4be0-bf0a-1da9d6734445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56521b7e-662d-4060-9222-e515d96b034d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56521b7e-662d-4060-9222-e515d96b034d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_68a2da77-5673-4d0f-b777-f3bc9380a5b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36e7bdb3-d274-477e-b9fa-e9000510f382" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_68a2da77-5673-4d0f-b777-f3bc9380a5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9f78be7-0ae3-4135-88e3-9f5d49b33c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9f78be7-0ae3-4135-88e3-9f5d49b33c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_57dcbf73-13a7-4af3-b4d5-83807d4eb898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_57dcbf73-13a7-4af3-b4d5-83807d4eb898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3c73b321-efc3-47c9-99c0-21d4ffa3c0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3c73b321-efc3-47c9-99c0-21d4ffa3c0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_98d424f5-b40b-4448-8dc5-5926adfcd5df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_98d424f5-b40b-4448-8dc5-5926adfcd5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6baefd9b-80bc-470c-a3b5-d11896371b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6baefd9b-80bc-470c-a3b5-d11896371b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b9baee1a-bf95-4141-b193-cbd80474c573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b9baee1a-bf95-4141-b193-cbd80474c573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_5eea692c-dee7-414b-be21-38d8fbab8110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_5eea692c-dee7-414b-be21-38d8fbab8110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5628b11f-ff5f-41c7-a974-1875f2977b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5628b11f-ff5f-41c7-a974-1875f2977b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_aa272ee1-1872-44c9-ba17-31c7082d0925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5628b11f-ff5f-41c7-a974-1875f2977b0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_aa272ee1-1872-44c9-ba17-31c7082d0925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_51c362b4-cc29-42ba-ae31-48ff59ae3a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5628b11f-ff5f-41c7-a974-1875f2977b0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_51c362b4-cc29-42ba-ae31-48ff59ae3a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ef3126a9-2850-47dc-958d-8101dc74abdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5628b11f-ff5f-41c7-a974-1875f2977b0f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ef3126a9-2850-47dc-958d-8101dc74abdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a6f5e3f0-c607-44b7-a6a0-5614c276a1db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5628b11f-ff5f-41c7-a974-1875f2977b0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a6f5e3f0-c607-44b7-a6a0-5614c276a1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_73d29de3-4b53-4c90-9e09-00d732f00d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5628b11f-ff5f-41c7-a974-1875f2977b0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_73d29de3-4b53-4c90-9e09-00d732f00d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c416745a-45c9-48fb-915f-56b68e3cfdd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c416745a-45c9-48fb-915f-56b68e3cfdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f36c638d-9ce9-4cbf-b95f-90eb848ab4b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f36c638d-9ce9-4cbf-b95f-90eb848ab4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4773c5ff-7e92-404e-81a7-98e0355d80ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f36c638d-9ce9-4cbf-b95f-90eb848ab4b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4773c5ff-7e92-404e-81a7-98e0355d80ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_82388238-3345-4d97-ac2b-5813f9156a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f36c638d-9ce9-4cbf-b95f-90eb848ab4b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_82388238-3345-4d97-ac2b-5813f9156a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_012f6d75-1294-485b-a66a-ded1c1c070ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f36c638d-9ce9-4cbf-b95f-90eb848ab4b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_012f6d75-1294-485b-a66a-ded1c1c070ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_31b8e1f1-b389-4dde-b2dc-cd54fd0820af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f36c638d-9ce9-4cbf-b95f-90eb848ab4b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_31b8e1f1-b389-4dde-b2dc-cd54fd0820af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3cf6d1e3-30f4-4001-bbfd-6d79adddb1a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f36c638d-9ce9-4cbf-b95f-90eb848ab4b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3cf6d1e3-30f4-4001-bbfd-6d79adddb1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a83280ee-9ab8-4ff8-98f4-8bacdefcbee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55200f9e-c674-4b66-a67e-8d52a23f6102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a83280ee-9ab8-4ff8-98f4-8bacdefcbee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69b697b3-6120-4a8d-883c-05ae10d43ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_79ab608f-2cc3-4176-91c8-c0c8d96d2e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69b697b3-6120-4a8d-883c-05ae10d43ba5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_79ab608f-2cc3-4176-91c8-c0c8d96d2e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e9dd06df-8a84-442e-9fba-4b8a82f82c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_79ab608f-2cc3-4176-91c8-c0c8d96d2e2c" xlink:to="loc_us-gaap_AwardTypeAxis_e9dd06df-8a84-442e-9fba-4b8a82f82c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48fc215a-ba18-4207-8a07-8010342729da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e9dd06df-8a84-442e-9fba-4b8a82f82c8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48fc215a-ba18-4207-8a07-8010342729da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_f48e64ee-9cf8-42e1-8b57-71560b953793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48fc215a-ba18-4207-8a07-8010342729da" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_f48e64ee-9cf8-42e1-8b57-71560b953793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_79ab608f-2cc3-4176-91c8-c0c8d96d2e2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b20035fa-95eb-4fca-aea6-21fc3f85c71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b20035fa-95eb-4fca-aea6-21fc3f85c71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_61a2a44f-fc4d-47c1-9490-79b9a75399dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_61a2a44f-fc4d-47c1-9490-79b9a75399dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_e976e0cc-f9a5-4760-bcf1-e34463f24ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_e976e0cc-f9a5-4760-bcf1-e34463f24ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3bc956d0-d3f0-43e1-bf2d-4ea87f20729a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3bc956d0-d3f0-43e1-bf2d-4ea87f20729a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_71494251-01d8-4497-8bbc-ee5fb1c2b5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_71494251-01d8-4497-8bbc-ee5fb1c2b5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_139d8b3b-397f-4219-a18a-7649dce3f469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fa072236-3b33-4f0d-bed0-6e22fbe31863" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_139d8b3b-397f-4219-a18a-7649dce3f469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281d463c-bf4f-495a-9899-6e3fc5b750ed" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_281d463c-bf4f-495a-9899-6e3fc5b750ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_cec22084-f941-482c-a84f-f455e7281a7d" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_cec22084-f941-482c-a84f-f455e7281a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_f8515b91-ca47-41b4-b199-fa5399ad5b3c" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_f8515b91-ca47-41b4-b199-fa5399ad5b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_1cacd918-0899-4561-a191-d0828d3c1c57" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_1cacd918-0899-4561-a191-d0828d3c1c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_83ff8f00-6556-4a19-8d14-c253dba22a23" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_83ff8f00-6556-4a19-8d14-c253dba22a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_52b4a8fa-044b-4296-b956-5fa3f82ef9db" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_bd840b75-139b-4a84-8931-2587391792a7" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_52b4a8fa-044b-4296-b956-5fa3f82ef9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_8dadf795-c745-4b1b-b96f-62287bb4b27c" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e01fae6-31c8-404e-91fa-87baf3910ba9" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_8dadf795-c745-4b1b-b96f-62287bb4b27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c84f66d1-bf5b-48f3-9c80-e3fcfb732671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c84f66d1-bf5b-48f3-9c80-e3fcfb732671" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_24df9af9-af78-46ab-b40c-c31e06a97f1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_srt_RangeAxis_24df9af9-af78-46ab-b40c-c31e06a97f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_24df9af9-af78-46ab-b40c-c31e06a97f1a" xlink:to="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_efc16dad-0ed0-40d5-8327-5a67b013329d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:to="loc_srt_MinimumMember_efc16dad-0ed0-40d5-8327-5a67b013329d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cb24d42-70c9-4f3a-bf08-4a71284473b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_67616851-7d6b-4cea-8aa9-cb60bb5ebb2d" xlink:to="loc_srt_MaximumMember_5cb24d42-70c9-4f3a-bf08-4a71284473b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9a3d8efd-e70d-485b-9766-f585745af344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_us-gaap_AwardTypeAxis_9a3d8efd-e70d-485b-9766-f585745af344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9a3d8efd-e70d-485b-9766-f585745af344" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_6025c45e-6f57-46ce-806c-7ea3168b7921" xlink:href="wst-20201231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_wst_IncentiveStockAwardsMember_6025c45e-6f57-46ce-806c-7ea3168b7921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_4547d9bf-b7d1-4cb3-8951-a2b26ce26d95" xlink:href="wst-20201231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_wst_StockSettledPSUAwardsMember_4547d9bf-b7d1-4cb3-8951-a2b26ce26d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_25cbf8ae-e6aa-4349-b2cf-b7bbcb4988ce" xlink:href="wst-20201231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_wst_CashSettledPSUAwardsMember_25cbf8ae-e6aa-4349-b2cf-b7bbcb4988ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_81e15810-ac6c-4ca5-8430-6e79f119ae84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_448e442b-5051-4044-bbb0-6956787eb38d" xlink:to="loc_us-gaap_RestrictedStockMember_81e15810-ac6c-4ca5-8430-6e79f119ae84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_f70e6697-5cae-4850-ac1e-7a3d01f67f09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_srt_TitleOfIndividualAxis_f70e6697-5cae-4850-ac1e-7a3d01f67f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_53f8f14c-c9c9-4fd7-9926-92e95fd9c02e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_f70e6697-5cae-4850-ac1e-7a3d01f67f09" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_53f8f14c-c9c9-4fd7-9926-92e95fd9c02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_d5011e17-1227-4232-8e35-cbebb831b350" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_53f8f14c-c9c9-4fd7-9926-92e95fd9c02e" xlink:to="loc_srt_DirectorMember_d5011e17-1227-4232-8e35-cbebb831b350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_e81afe95-fc9f-4c0f-ad2b-966f24a02dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_75f5e9c4-7e8d-4f7a-8aff-ddc753c0b469" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_e81afe95-fc9f-4c0f-ad2b-966f24a02dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_93019f04-4068-4516-b7b1-6b853aa7a726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_e81afe95-fc9f-4c0f-ad2b-966f24a02dc2" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_93019f04-4068-4516-b7b1-6b853aa7a726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a38a345-213e-4377-952d-b4c7678df57a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_b29a2f5d-dbf1-4209-ace0-9b6d524b1a4b" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_b29a2f5d-dbf1-4209-ace0-9b6d524b1a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_9b634758-5371-430c-9e97-5ad7637b64f1" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_9b634758-5371-430c-9e97-5ad7637b64f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_9401dcf2-df76-4e59-92c4-8492d5c67c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_9401dcf2-df76-4e59-92c4-8492d5c67c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7b4f0547-6a04-4f48-83e7-690caa2dcd5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7b4f0547-6a04-4f48-83e7-690caa2dcd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c76f3922-bb00-46ce-a022-ea3c9760b27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c76f3922-bb00-46ce-a022-ea3c9760b27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_18609b82-7449-4398-a3a8-36fc025e41c5" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_18609b82-7449-4398-a3a8-36fc025e41c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_462314c7-a974-4f58-bead-da75bc246e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_462314c7-a974-4f58-bead-da75bc246e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6416744-e059-4fc4-be51-157f9dfd1121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6416744-e059-4fc4-be51-157f9dfd1121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_66d24cdb-4022-428d-8488-74edddf9858a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1c841666-0838-4144-b1c5-5c17290f6973" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_66d24cdb-4022-428d-8488-74edddf9858a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_390e1e33-8199-4d52-8a70-29c6327c2198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_067ae50f-3396-4f55-8d48-1337798260f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_067ae50f-3396-4f55-8d48-1337798260f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7482b150-1c06-4ed2-825b-491653ddf67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7482b150-1c06-4ed2-825b-491653ddf67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_9206f644-2e78-4fb1-bc53-e38bc1f02fff" xlink:href="wst-20201231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_9206f644-2e78-4fb1-bc53-e38bc1f02fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_322ac756-d65f-47df-bab3-c41e8e0c9f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_322ac756-d65f-47df-bab3-c41e8e0c9f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4931b9c5-e7b6-46a5-90f3-6d6edfee8451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4931b9c5-e7b6-46a5-90f3-6d6edfee8451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c9d59da7-9984-40d8-a9f0-e13fb9d86de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9302a6bd-5a1a-4dc8-9827-59e679ab3677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c9d59da7-9984-40d8-a9f0-e13fb9d86de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_827af09d-dab5-4ec7-944b-33c0c1f98a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_a03008b3-755a-4f44-85d9-26bb04b0adaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_827af09d-dab5-4ec7-944b-33c0c1f98a6a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_a03008b3-755a-4f44-85d9-26bb04b0adaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e03c29b9-a155-44bb-9f46-0765d8b0de4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e03c29b9-a155-44bb-9f46-0765d8b0de4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_bd9c0de3-4ec2-4425-8e65-720c97631279" xlink:href="wst-20201231.xsd#wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:to="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_bd9c0de3-4ec2-4425-8e65-720c97631279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_319ebb8f-0edc-4961-b6ca-09d7a82c5b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_319ebb8f-0edc-4961-b6ca-09d7a82c5b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_0994d2cb-8130-4f22-a006-d5a669c83761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_0994d2cb-8130-4f22-a006-d5a669c83761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_82b7d488-704a-4383-822e-52f5c12b7fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_82b7d488-704a-4383-822e-52f5c12b7fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_bf18714d-b1dd-49d8-a799-f12cd206736d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_bf18714d-b1dd-49d8-a799-f12cd206736d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_4cb5266c-1bda-4093-beda-b939db0821dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bd895494-fee1-4801-9ac2-5b06479c39c0" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_4cb5266c-1bda-4093-beda-b939db0821dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b834c5e6-70c3-495f-89e8-e73c4618ac5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b834c5e6-70c3-495f-89e8-e73c4618ac5a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c5dbe7b-bbf0-4cdf-96cf-cc287a2dba0c" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bc030e1c-c204-4374-98dd-53b546f0dcba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_bc030e1c-c204-4374-98dd-53b546f0dcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_209d0d84-4258-468f-afa9-006941fdedb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_91959c51-43ec-4221-843a-acb5ed39d78c" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_209d0d84-4258-468f-afa9-006941fdedb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f6c47a41-846a-4b07-98db-7527eb398d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f6c47a41-846a-4b07-98db-7527eb398d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f6c47a41-846a-4b07-98db-7527eb398d59" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d260eaca-88dc-47f0-835d-7682a7260597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d260eaca-88dc-47f0-835d-7682a7260597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5ef4d5ed-71ee-46da-8aaa-a47c866219b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4fa189eb-723b-4136-9aa9-7350904afb53" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5ef4d5ed-71ee-46da-8aaa-a47c866219b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_2c44aac3-db5e-4971-8dac-72e293cf7a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_2c44aac3-db5e-4971-8dac-72e293cf7a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_2c44aac3-db5e-4971-8dac-72e293cf7a8a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_1a93b5dc-164f-4073-850f-97ac52f52a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:to="loc_us-gaap_DomesticPlanMember_1a93b5dc-164f-4073-850f-97ac52f52a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9e9f740e-3249-4a38-99a4-c84c9dbf5a57" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_1a93b5dc-164f-4073-850f-97ac52f52a33" xlink:to="loc_country_US_9e9f740e-3249-4a38-99a4-c84c9dbf5a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1fcfd93e-653a-43ca-9b33-f24aa36be8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c4793a4b-6d59-492a-b4fc-5f982161a1f7" xlink:to="loc_us-gaap_ForeignPlanMember_1fcfd93e-653a-43ca-9b33-f24aa36be8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c412c0e4-8fe9-4b2c-8f2b-59da5a3426ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f114e38-a4a5-4c90-bba4-3ded6f0f93d4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c412c0e4-8fe9-4b2c-8f2b-59da5a3426ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_98ec3256-f861-4442-b5b5-336b4ef7ef40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c412c0e4-8fe9-4b2c-8f2b-59da5a3426ef" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_98ec3256-f861-4442-b5b5-336b4ef7ef40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1b6af60c-5382-4911-b11e-80bd63eef59e" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_b57601a3-18e8-486f-b1c3-a75da51aea5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_b57601a3-18e8-486f-b1c3-a75da51aea5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1b04fb95-b735-4036-9fac-d7fd5aea0a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_1b04fb95-b735-4036-9fac-d7fd5aea0a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e754a62a-51cb-47d1-ad81-72d78016da2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e754a62a-51cb-47d1-ad81-72d78016da2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f0a6cb84-4239-465e-ad36-f24eab207464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f0a6cb84-4239-465e-ad36-f24eab207464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d5f05e5c-9c0f-4723-a148-c8608d3e75ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d5f05e5c-9c0f-4723-a148-c8608d3e75ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_f1726cea-8d81-4f5e-b985-a887cd1511c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_f1726cea-8d81-4f5e-b985-a887cd1511c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_97309566-5b82-41ce-8413-20ae9c2ac9a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_97309566-5b82-41ce-8413-20ae9c2ac9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ba62f46d-fec9-4872-a4c1-3b0309d77d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ba62f46d-fec9-4872-a4c1-3b0309d77d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_47d82744-c06d-4e3d-9c0f-7ba53498a9fe" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_47d82744-c06d-4e3d-9c0f-7ba53498a9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_04c14545-9cdd-4fba-9bd3-044ed5f8478c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_04c14545-9cdd-4fba-9bd3-044ed5f8478c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_069b613f-6659-47a1-84c0-cdaf6ae7b4c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_069b613f-6659-47a1-84c0-cdaf6ae7b4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_dd2fb3e8-192e-4667-bd0c-b524bc6f4e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_dd2fb3e8-192e-4667-bd0c-b524bc6f4e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_2aa44aec-5e14-40cb-b73e-450b3f255de9" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_2aa44aec-5e14-40cb-b73e-450b3f255de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_c72a4c0f-3634-4fe9-b768-12c6c455a9d1" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5681b375-8538-4cd8-8f7c-b05f61b139e9" xlink:to="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_c72a4c0f-3634-4fe9-b768-12c6c455a9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5bdc7d90-3d56-403e-b190-2424e0f1bd6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5bdc7d90-3d56-403e-b190-2424e0f1bd6c" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_82e0cc13-2cd5-4ceb-a95b-fe5d2d599bf5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2ecfaa6a-c26e-47b6-bb2a-9f7d93e24d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2ecfaa6a-c26e-47b6-bb2a-9f7d93e24d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_cc7634bb-a201-42ba-a1cc-3a8417fdb4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aa3befc1-9df9-428e-a3e5-3ac96c3168db" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_cc7634bb-a201-42ba-a1cc-3a8417fdb4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ef560d8-3a87-45f6-bbc5-5fc05c647ef4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_01aa6973-be64-4c19-95b2-8bfe4b01c8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:to="loc_us-gaap_DomesticPlanMember_01aa6973-be64-4c19-95b2-8bfe4b01c8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_eeba660d-0c02-4b43-bc72-74ba958c82f7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_01aa6973-be64-4c19-95b2-8bfe4b01c8a2" xlink:to="loc_country_US_eeba660d-0c02-4b43-bc72-74ba958c82f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0f5fefb6-2210-4a63-b907-1d1305942b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7e626560-4b35-49e2-bfe6-84d306c7765c" xlink:to="loc_us-gaap_ForeignPlanMember_0f5fefb6-2210-4a63-b907-1d1305942b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_14574db6-8eb2-45cc-bc9c-87a931a2c148" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_43825fde-0374-4234-b2d3-496485432d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_43825fde-0374-4234-b2d3-496485432d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_65c20771-106f-421e-8422-29f2c25782d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_65c20771-106f-421e-8422-29f2c25782d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6db65227-f302-47a0-ba96-2c7e9de7b5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6db65227-f302-47a0-ba96-2c7e9de7b5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4390d35b-eec6-4880-b3ca-17f4b2049ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4390d35b-eec6-4880-b3ca-17f4b2049ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_dcb9339a-836b-4316-b741-30285f4752ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_dcb9339a-836b-4316-b741-30285f4752ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_54b8b3b2-5a70-4579-a664-67f65ea1e897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_54b8b3b2-5a70-4579-a664-67f65ea1e897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_143c7065-af2e-42eb-a717-40318d34c73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b6d1af14-aa6b-4903-86e7-f17ef1d6ee17" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_143c7065-af2e-42eb-a717-40318d34c73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_dcbefcec-b090-47f5-ab38-d74dd53121ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_dcbefcec-b090-47f5-ab38-d74dd53121ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_9d0c7870-46cd-4ea4-9283-f2ee1c1507a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_9d0c7870-46cd-4ea4-9283-f2ee1c1507a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_0850bb23-92a6-4ae6-8a8d-0f002e0f3533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_0850bb23-92a6-4ae6-8a8d-0f002e0f3533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fba00c8b-2949-4cbd-9fa7-015dd2a224f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_fba00c8b-2949-4cbd-9fa7-015dd2a224f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_8ab71979-0819-49de-863b-d44b2fcb9f2e" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax_8ab71979-0819-49de-863b-d44b2fcb9f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_4296bd3b-042d-4203-a5d0-540678070dec" xlink:href="wst-20201231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_4296bd3b-042d-4203-a5d0-540678070dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f571c57b-0eff-4f92-9cd7-6898bddd174a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_b6dc43b5-2a69-4051-bf37-4b40154243a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f571c57b-0eff-4f92-9cd7-6898bddd174a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_dc0799f3-ef61-406c-9e56-457983c47932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_1b482508-5ee1-413c-b8d0-95c01c4020a3" xlink:to="loc_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax_dc0799f3-ef61-406c-9e56-457983c47932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d66767c4-8985-4447-a3e1-cebb01cc9107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b58bf0f1-8c05-49c8-bda8-7e2ba3859152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d66767c4-8985-4447-a3e1-cebb01cc9107" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b58bf0f1-8c05-49c8-bda8-7e2ba3859152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e3dc6132-99d0-4354-82c6-968a29d7f3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b58bf0f1-8c05-49c8-bda8-7e2ba3859152" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e3dc6132-99d0-4354-82c6-968a29d7f3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e3dc6132-99d0-4354-82c6-968a29d7f3b0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_62e1db75-5bf2-4115-b127-18c2b21f2732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_62e1db75-5bf2-4115-b127-18c2b21f2732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d6095328-6e0c-4fbc-b197-acc7eb3247fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_67570357-a183-4c69-a24e-c3aace9bd3fe" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d6095328-6e0c-4fbc-b197-acc7eb3247fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b58bf0f1-8c05-49c8-bda8-7e2ba3859152" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_72b6f788-ced1-4705-bbcc-880a0fc5973a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_72b6f788-ced1-4705-bbcc-880a0fc5973a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_9e20eb8b-0962-4e78-89e4-8b073d33f927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_9e20eb8b-0962-4e78-89e4-8b073d33f927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ffe5ba58-4edd-450b-a0a2-244abf3dd111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ffe5ba58-4edd-450b-a0a2-244abf3dd111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_c47ca5dd-ad86-4ef3-b2fe-cb83bcac569b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_c47ca5dd-ad86-4ef3-b2fe-cb83bcac569b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_047491b2-3013-4fca-890f-d1350f0891b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_047491b2-3013-4fca-890f-d1350f0891b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_37f970ce-fac5-4fe9-bb02-d8473fb3d9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_37f970ce-fac5-4fe9-bb02-d8473fb3d9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_860c41f8-121a-4de0-a234-a62af0c30394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_860c41f8-121a-4de0-a234-a62af0c30394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6db36bfc-1938-4211-95c2-f8d89893b80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6db36bfc-1938-4211-95c2-f8d89893b80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_54c7fcaf-0ad6-48be-bbae-977793c8970c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_54c7fcaf-0ad6-48be-bbae-977793c8970c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7c5b6d6c-e54e-48ad-bbf6-5a0495067d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_41e9f1aa-a4e9-4f14-b439-5fa7217e7506" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7c5b6d6c-e54e-48ad-bbf6-5a0495067d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_970183d9-81a8-428d-8ff7-6d143a2be64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_970183d9-81a8-428d-8ff7-6d143a2be64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1db0a930-126a-413e-831d-19da949b4f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1db0a930-126a-413e-831d-19da949b4f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_cee02dc1-07d1-489a-815e-5b832e668be0" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums_cee02dc1-07d1-489a-815e-5b832e668be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_4d4d5cfe-3d97-4ee5-8ea5-182f18cb1faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_4d4d5cfe-3d97-4ee5-8ea5-182f18cb1faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_901497a8-c11b-4000-bc79-f80353e07e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_901497a8-c11b-4000-bc79-f80353e07e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_fc9ce0dc-2508-4a42-9147-10e9c417e199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_fc9ce0dc-2508-4a42-9147-10e9c417e199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1fa56965-f0e2-45b2-a0d5-7ad8588bff80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1fa56965-f0e2-45b2-a0d5-7ad8588bff80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9aa3ac32-6937-4549-8a89-a293f3449b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4f381f45-6c8d-4cdc-a98a-a9c4e52a34af" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9aa3ac32-6937-4549-8a89-a293f3449b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_94a8a48a-53d6-4b37-927e-4f4e37f7154e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_12a9e0bc-6a1c-43c9-bc19-8c714ac78b3a" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_94a8a48a-53d6-4b37-927e-4f4e37f7154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_49edb6a9-fcca-43d6-9be5-87a49a75c4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fa844d6c-fbb2-4a93-b3bf-367fb04affd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_49edb6a9-fcca-43d6-9be5-87a49a75c4ee" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fa844d6c-fbb2-4a93-b3bf-367fb04affd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4d4aa414-8cb3-4f82-8cba-69d56069ce57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fa844d6c-fbb2-4a93-b3bf-367fb04affd3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4d4aa414-8cb3-4f82-8cba-69d56069ce57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4d4aa414-8cb3-4f82-8cba-69d56069ce57" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_93059a96-cc15-4f93-89fc-e2c70a9c813a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_93059a96-cc15-4f93-89fc-e2c70a9c813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_6df42eba-6e99-41dc-93dd-4e74d797bdf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cf1d7d54-724f-4975-929c-6abb0d9aad1b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_6df42eba-6e99-41dc-93dd-4e74d797bdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fa844d6c-fbb2-4a93-b3bf-367fb04affd3" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_ccc7cb71-836e-49dc-99fb-292c8addaeee" xlink:href="wst-20201231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_ccc7cb71-836e-49dc-99fb-292c8addaeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_f82193c4-c10d-43a4-87ff-32460ead9d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_f82193c4-c10d-43a4-87ff-32460ead9d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f9497c6e-c877-4513-9f95-63035f420945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f9497c6e-c877-4513-9f95-63035f420945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_96450672-16e4-423d-9e08-70804e6a612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f8e448ae-e95c-4795-89ed-5fa8ce8ea2ad" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_96450672-16e4-423d-9e08-70804e6a612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c70474b8-3f14-449e-8304-a3e10826fc6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_536b1967-0029-41d2-895f-c61e89a4f54d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c70474b8-3f14-449e-8304-a3e10826fc6b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_536b1967-0029-41d2-895f-c61e89a4f54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_536b1967-0029-41d2-895f-c61e89a4f54d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1157bbdb-11f7-4a4a-8de0-8a917d1d5afe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e1506c33-fa01-4dc3-8031-9e6e448a4dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e1506c33-fa01-4dc3-8031-9e6e448a4dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6466870-a0c6-4901-9119-6e42fb5b5cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_478a5a52-04d4-4875-9df9-9e167d6dc49c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6466870-a0c6-4901-9119-6e42fb5b5cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_536b1967-0029-41d2-895f-c61e89a4f54d" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_7c22a934-5d5f-4124-80c1-27c873acc972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_7c22a934-5d5f-4124-80c1-27c873acc972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0223ee09-d535-4428-ac31-88e24cede648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_0223ee09-d535-4428-ac31-88e24cede648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_1cf2d5c5-1d8c-4923-9406-a6277b1044a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5f318f18-d05f-470f-9fc4-ceee235378a9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_1cf2d5c5-1d8c-4923-9406-a6277b1044a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d63cf84c-97ea-4a06-912c-918700504ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9c3da163-216e-43e5-a252-9b312e0dca9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d63cf84c-97ea-4a06-912c-918700504ca0" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9c3da163-216e-43e5-a252-9b312e0dca9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9c3da163-216e-43e5-a252-9b312e0dca9b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_cfcfd988-1b90-4c42-b9ca-c42e5d4b58bb" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_2a0c7de5-369f-4c09-9c82-685c03d91b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:to="loc_us-gaap_DomesticPlanMember_2a0c7de5-369f-4c09-9c82-685c03d91b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_90754793-346b-4443-852d-4901e1b0ea34" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_2a0c7de5-369f-4c09-9c82-685c03d91b6e" xlink:to="loc_country_US_90754793-346b-4443-852d-4901e1b0ea34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_a1c00563-074e-4c14-b349-d746a020b684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9f1a0c63-0b54-476c-8529-427d95e395cf" xlink:to="loc_us-gaap_ForeignPlanMember_a1c00563-074e-4c14-b349-d746a020b684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9c3da163-216e-43e5-a252-9b312e0dca9b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_77866932-7b6b-4d22-a9b4-f4fa4f4ed687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_77866932-7b6b-4d22-a9b4-f4fa4f4ed687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_46078a86-25db-4a1c-aca9-691ac4cced64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_46078a86-25db-4a1c-aca9-691ac4cced64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e7018837-8b15-43e9-b1d3-633e263c0fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e7018837-8b15-43e9-b1d3-633e263c0fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_26189244-d59f-4f94-9b01-5bc25a29e2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_26189244-d59f-4f94-9b01-5bc25a29e2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bd4a5045-3628-4078-a988-450d0dead8b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bd4a5045-3628-4078-a988-450d0dead8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2984e0a8-727a-4238-b7b9-565c983b5bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2984e0a8-727a-4238-b7b9-565c983b5bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_aab75356-dabf-4d20-be5e-2564f6b1612a" xlink:href="wst-20201231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a367722e-0a06-4497-bc49-a798a3d3e459" xlink:to="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_aab75356-dabf-4d20-be5e-2564f6b1612a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0b4e8dc8-19bf-4f43-8db9-b4d283981d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a3decc89-f891-4dd0-8273-b583a8c18c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0b4e8dc8-19bf-4f43-8db9-b4d283981d0f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a3decc89-f891-4dd0-8273-b583a8c18c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9d7800ff-5e19-449c-be8f-a69648f04b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a3decc89-f891-4dd0-8273-b583a8c18c24" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9d7800ff-5e19-449c-be8f-a69648f04b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9d7800ff-5e19-449c-be8f-a69648f04b44" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_aad2d823-e5dc-4a0a-b95f-02dddd38e5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_aad2d823-e5dc-4a0a-b95f-02dddd38e5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_28e7275e-c3a8-49ed-8338-1e797f636c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4a51d3d2-689a-47a9-9894-e818789eedd9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_28e7275e-c3a8-49ed-8338-1e797f636c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a3decc89-f891-4dd0-8273-b583a8c18c24" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_ed76b91a-69e6-419f-96d4-c77bd0750b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_ed76b91a-69e6-419f-96d4-c77bd0750b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_1201d226-de6c-467e-9ca1-ab77599f2a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_1201d226-de6c-467e-9ca1-ab77599f2a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bf75fe20-6c80-490b-b530-68df25f9d127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b550bdc8-c84f-4267-ae5f-0226014f31d1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bf75fe20-6c80-490b-b530-68df25f9d127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7b6b095e-7ab8-4f45-b507-f625924b4539" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b2e30514-8127-4ac8-b30e-0af1621be25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b2e30514-8127-4ac8-b30e-0af1621be25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_a2ff824f-9085-4111-8ba6-c0c73929f983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_1964b13d-c256-4751-b71c-72c12a1bb8a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_a2ff824f-9085-4111-8ba6-c0c73929f983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9eeb51c0-a76c-42a0-9649-252af651d002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9eeb51c0-a76c-42a0-9649-252af651d002" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0fa9f948-b005-4763-8093-265d91f01e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0fa9f948-b005-4763-8093-265d91f01e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3704028b-3a48-4217-aaa8-da501a10d04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0fa9f948-b005-4763-8093-265d91f01e77" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3704028b-3a48-4217-aaa8-da501a10d04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_130e7ae5-24a6-499d-8587-e83755c36d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3704028b-3a48-4217-aaa8-da501a10d04f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_130e7ae5-24a6-499d-8587-e83755c36d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_81bb3bb3-fe27-4421-b852-d68fa128084a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_81bb3bb3-fe27-4421-b852-d68fa128084a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_81bb3bb3-fe27-4421-b852-d68fa128084a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_6b25b8bb-1741-4d29-825d-bf26c1462769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:to="loc_us-gaap_DomesticPlanMember_6b25b8bb-1741-4d29-825d-bf26c1462769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c5940858-d7fe-4527-813d-6b4cc9f7e5fd" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_6b25b8bb-1741-4d29-825d-bf26c1462769" xlink:to="loc_country_US_c5940858-d7fe-4527-813d-6b4cc9f7e5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0475b323-4ec6-43af-a68e-cdf8936efca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_34e174fb-cb5c-4688-91a9-66e8bcc16d44" xlink:to="loc_us-gaap_ForeignPlanMember_0475b323-4ec6-43af-a68e-cdf8936efca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_e62e2555-aa42-450a-a604-d0f4af2c70d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce75e670-1951-4539-a5c9-2358c5de8a73" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_e62e2555-aa42-450a-a604-d0f4af2c70d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_2518748d-0aa9-42d4-9037-ba4b38cb6410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_e62e2555-aa42-450a-a604-d0f4af2c70d2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_2518748d-0aa9-42d4-9037-ba4b38cb6410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f30292cb-7b62-422e-880b-8919e8952579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f30292cb-7b62-422e-880b-8919e8952579" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5dcf704a-80fa-4062-aae7-0edeaa4bd395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_srt_RangeAxis_5dcf704a-80fa-4062-aae7-0edeaa4bd395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5dcf704a-80fa-4062-aae7-0edeaa4bd395" xlink:to="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ce5a24be-c1c8-4a33-9752-bb70a09e0c21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:to="loc_srt_MinimumMember_ce5a24be-c1c8-4a33-9752-bb70a09e0c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c9c65ea-96e1-4a2b-b467-c07beb5fe325" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_67923683-dde5-4408-a4db-0116a186a200" xlink:to="loc_srt_MaximumMember_0c9c65ea-96e1-4a2b-b467-c07beb5fe325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9d9900ee-c8ad-41db-8006-0a4ac686fed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9d9900ee-c8ad-41db-8006-0a4ac686fed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9d9900ee-c8ad-41db-8006-0a4ac686fed9" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_7a513eb7-3595-4d39-960c-7fdca01cf1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_7a513eb7-3595-4d39-960c-7fdca01cf1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_9f89956f-3c75-4c55-bf13-46d28d16b8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_9f89956f-3c75-4c55-bf13-46d28d16b8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ceb1fc02-c7a8-491a-bf54-623f733f581a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ceb1fc02-c7a8-491a-bf54-623f733f581a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_6fbc6cf7-d3f5-49b3-ae84-ec4b1f55f6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_OtherInvestmentsMember_6fbc6cf7-d3f5-49b3-ae84-ec4b1f55f6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_0e05e85a-dc62-4950-a37d-a72f25f7890d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_us-gaap_MutualFundMember_0e05e85a-dc62-4950-a37d-a72f25f7890d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMutualFundsMember_a3e82a65-8862-4553-8114-912529ba347a" xlink:href="wst-20201231.xsd#wst_OtherMutualFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3e2e46cd-974e-4dc6-9e5f-db3f48b065f4" xlink:to="loc_wst_OtherMutualFundsMember_a3e82a65-8862-4553-8114-912529ba347a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77e74d4b-edee-4163-a82f-aea6d6daa8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77e74d4b-edee-4163-a82f-aea6d6daa8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_77e74d4b-edee-4163-a82f-aea6d6daa8f4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5e4138da-2b52-44af-bddd-a40a165ac275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5e4138da-2b52-44af-bddd-a40a165ac275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_994139ac-14b6-4427-a4f4-b031f24687da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_994139ac-14b6-4427-a4f4-b031f24687da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_49244c7c-4327-4ded-8f6a-45034bb0ca5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_1a897ee9-d9aa-4067-9a56-d87ab36606cc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_49244c7c-4327-4ded-8f6a-45034bb0ca5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9ca73d61-eb23-4b67-a886-7dfb7851d00b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34aeab74-6c98-4814-b9ed-f80098690f8e" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9ca73d61-eb23-4b67-a886-7dfb7851d00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_04c7ca36-0890-4160-a02a-f2fb9d9911c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_18b3fb4b-c9b5-41bf-9ad0-11df91ba0d4d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_04c7ca36-0890-4160-a02a-f2fb9d9911c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_f1993e56-7d3f-429b-ae52-7e2adb1565e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_04c7ca36-0890-4160-a02a-f2fb9d9911c3" xlink:to="loc_us-gaap_DomesticPlanMember_f1993e56-7d3f-429b-ae52-7e2adb1565e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2a2add4f-7a41-47c5-962d-4b5ebe1496ac" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_f1993e56-7d3f-429b-ae52-7e2adb1565e6" xlink:to="loc_country_US_2a2add4f-7a41-47c5-962d-4b5ebe1496ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d323fff0-c3ce-4617-9ae3-ef8c345df53d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6b526dc6-d485-40cc-b31e-98a5ff50558c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_6b526dc6-d485-40cc-b31e-98a5ff50558c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_d116e980-3b8b-49fc-b0da-8cb4d15f6b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_d116e980-3b8b-49fc-b0da-8cb4d15f6b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_625972fe-5e87-4020-8384-cfd14e27d9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7fd8bd48-252d-4232-bd9c-e9b260726a9d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_625972fe-5e87-4020-8384-cfd14e27d9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncome"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_79f7c70d-9f61-45bc-ba96-d75b84d51b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_1a7173ad-ce53-4d98-a279-6fbac8a426f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_79f7c70d-9f61-45bc-ba96-d75b84d51b24" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_1a7173ad-ce53-4d98-a279-6fbac8a426f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_1ce2ff8b-0096-4957-b573-ae54d83fe92c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_e3086306-7748-45c8-af66-c690cef90d8b" xlink:href="wst-20201231.xsd#wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1ce2ff8b-0096-4957-b573-ae54d83fe92c" xlink:to="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_e3086306-7748-45c8-af66-c690cef90d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_ab61ed0d-d927-4932-8b9b-3456a86d721d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1ce2ff8b-0096-4957-b573-ae54d83fe92c" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_ab61ed0d-d927-4932-8b9b-3456a86d721d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_45e2de89-f28f-41a3-b9d3-c01977b77ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_SeveranceCosts1_45e2de89-f28f-41a3-b9d3-c01977b77ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_a752069e-3204-4cef-b7bc-c29f0423c482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_AssetImpairmentCharges_a752069e-3204-4cef-b7bc-c29f0423c482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_e0bcc9a8-b21a-4f14-bf78-ab5554f2e0de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_OtherRestructuringCosts_e0bcc9a8-b21a-4f14-bf78-ab5554f2e0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_09cc4216-2a94-4c72-9b1a-8b660b006bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_09cc4216-2a94-4c72-9b1a-8b660b006bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_bcd240c5-4625-4062-a3be-470c508b5d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_bcd240c5-4625-4062-a3be-470c508b5d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_086402ce-29ba-40d1-9f22-c1bd528adfd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_086402ce-29ba-40d1-9f22-c1bd528adfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BrazilTaxRecovery_20dc19d3-5ead-493f-9cb4-33f58e9811ba" xlink:href="wst-20201231.xsd#wst_BrazilTaxRecovery"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_wst_BrazilTaxRecovery_20dc19d3-5ead-493f-9cb4-33f58e9811ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentAndLicensingIncome_a0dbd70f-4094-497a-8e14-9b11cf97092d" xlink:href="wst-20201231.xsd#wst_DevelopmentAndLicensingIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_wst_DevelopmentAndLicensingIncome_a0dbd70f-4094-497a-8e14-9b11cf97092d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d386db00-90d9-47dc-a73e-070d08af12b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d386db00-90d9-47dc-a73e-070d08af12b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_23e8bfe1-0fa1-43fb-ba4c-fdfe2298fb41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_23e8bfe1-0fa1-43fb-ba4c-fdfe2298fb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_9fd902e0-d5df-43fd-b062-7d4ce65cad07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_9fd902e0-d5df-43fd-b062-7d4ce65cad07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_90810187-8ef8-4929-afbe-44404c3fc847" xlink:href="wst-20201231.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_131ca16c-7a52-43c5-b7ab-feb7f2c9d3df" xlink:to="loc_wst_OtherIncomeExpense_90810187-8ef8-4929-afbe-44404c3fc847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeAbstract_03ddec67-29fa-4252-9c3b-023fb246f8ca" xlink:href="wst-20201231.xsd#wst_OtherExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_03ddec67-29fa-4252-9c3b-023fb246f8ca" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:to="loc_srt_RangeAxis_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_02d31e4a-cd47-47a4-a0ef-23a0837c3a5d" xlink:to="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ef90031-7764-4f2a-89a4-215a1e6d2db8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:to="loc_srt_MinimumMember_6ef90031-7764-4f2a-89a4-215a1e6d2db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e8eb8be1-c164-44c0-ac61-ec7a1701940b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c036f636-c1c2-4464-b549-249220ab2d86" xlink:to="loc_srt_MaximumMember_e8eb8be1-c164-44c0-ac61-ec7a1701940b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_53938b61-be57-4251-b146-6b2bde1f9357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:to="loc_us-gaap_RestructuringPlanAxis_53938b61-be57-4251-b146-6b2bde1f9357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_53938b61-be57-4251-b146-6b2bde1f9357" xlink:to="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_afd93d21-0028-40ef-80be-4029499152cb" xlink:href="wst-20201231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:to="loc_wst_The2020RestructuringPlanMember_afd93d21-0028-40ef-80be-4029499152cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2018RestructuringPlanMember_b88f5080-a40e-4480-a597-084836fdb414" xlink:href="wst-20201231.xsd#wst_The2018RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1ef0c881-aeef-4222-803d-eb81277998fd" xlink:to="loc_wst_The2018RestructuringPlanMember_b88f5080-a40e-4480-a597-084836fdb414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_5ea750a0-a495-4257-8864-63c87798dd60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:to="loc_us-gaap_NatureOfExpenseAxis_5ea750a0-a495-4257-8864-63c87798dd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_df2b9076-1c46-40f8-8bc8-4d9f2ba4e0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_5ea750a0-a495-4257-8864-63c87798dd60" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_df2b9076-1c46-40f8-8bc8-4d9f2ba4e0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_a7edba00-8a84-4c9f-a1e3-7fa3837ceed2" xlink:href="wst-20201231.xsd#wst_SmartDoseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_df2b9076-1c46-40f8-8bc8-4d9f2ba4e0e8" xlink:to="loc_wst_SmartDoseMember_a7edba00-8a84-4c9f-a1e3-7fa3837ceed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_693a5883-a59f-40ff-ac9c-aa642f1e5e7b" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_dee03289-7a42-4d1f-aa45-7d1e8be0cf1a" xlink:href="wst-20201231.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_dee03289-7a42-4d1f-aa45-7d1e8be0cf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_13ec26ab-616f-4284-81fc-e11754a389e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_13ec26ab-616f-4284-81fc-e11754a389e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48922282-d5eb-4736-99d3-aec61b4b2f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_48922282-d5eb-4736-99d3-aec61b4b2f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount_169d5109-545e-4d45-ada0-4dd9f63dd3a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_EffectOnFutureEarningsAmount_169d5109-545e-4d45-ada0-4dd9f63dd3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_1847b97a-6c91-4c47-aa05-c7133e20e357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_1847b97a-6c91-4c47-aa05-c7133e20e357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2b97d0d7-088a-43c1-bee6-ecb864fba9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_SeveranceCosts1_2b97d0d7-088a-43c1-bee6-ecb864fba9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8cc6b7b9-f8ab-4baa-a2ee-febc57a0ac32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_AssetImpairmentCharges_8cc6b7b9-f8ab-4baa-a2ee-febc57a0ac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_12358667-6a0d-4e68-aafe-94d2bed808c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_OtherRestructuringCosts_12358667-6a0d-4e68-aafe-94d2bed808c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_f020aed5-39ac-42fd-b715-45b95f72121e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_f020aed5-39ac-42fd-b715-45b95f72121e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BrazilTaxRecovery_023709ac-38c3-4dca-83e5-bcdbb15548c6" xlink:href="wst-20201231.xsd#wst_BrazilTaxRecovery"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_wst_BrazilTaxRecovery_023709ac-38c3-4dca-83e5-bcdbb15548c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentAndLicensingIncome_e8010d8b-3bbc-4435-a40b-6e9c498a5559" xlink:href="wst-20201231.xsd#wst_DevelopmentAndLicensingIncome"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_wst_DevelopmentAndLicensingIncome_e8010d8b-3bbc-4435-a40b-6e9c498a5559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c1079ad1-cddc-417d-aeff-c9a90421251b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c1079ad1-cddc-417d-aeff-c9a90421251b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_549655dc-0ec3-48db-945f-510090ff7922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_43239958-0ef6-4a2a-958c-f3676d09d941" xlink:to="loc_us-gaap_RestructuringCharges_549655dc-0ec3-48db-945f-510090ff7922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeAbstract_a12314de-1ae1-4ea9-9efe-ecdd990225cc" xlink:href="wst-20201231.xsd#wst_OtherExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_a12314de-1ae1-4ea9-9efe-ecdd990225cc" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ed81e70d-bb7e-4abe-ad59-66fda9866e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:to="loc_us-gaap_RestructuringPlanAxis_ed81e70d-bb7e-4abe-ad59-66fda9866e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_ed81e70d-bb7e-4abe-ad59-66fda9866e37" xlink:to="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2020RestructuringPlanMember_c879b09a-6dbd-48b9-83fe-0d47e83c9576" xlink:href="wst-20201231.xsd#wst_The2020RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:to="loc_wst_The2020RestructuringPlanMember_c879b09a-6dbd-48b9-83fe-0d47e83c9576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2018RestructuringPlanMember_5afd84f5-3753-412c-8f36-d94d25087b7c" xlink:href="wst-20201231.xsd#wst_The2018RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1fa92f44-57e3-4357-a858-7a5cbcf4d264" xlink:to="loc_wst_The2018RestructuringPlanMember_5afd84f5-3753-412c-8f36-d94d25087b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_69e2fefc-aa12-4eb7-9167-ee3b1e297b1a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_3254b696-cb9f-475f-8c27-46c333cb8353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:to="loc_us-gaap_EmployeeSeveranceMember_3254b696-cb9f-475f-8c27-46c333cb8353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_bb737d29-0771-4465-8a22-0cc2adc6bbb2" xlink:href="wst-20201231.xsd#wst_AssetRelatedChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:to="loc_wst_AssetRelatedChargesMember_bb737d29-0771-4465-8a22-0cc2adc6bbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_1b63c760-b6b2-4bb9-93b9-daf794c7eef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_70652b16-152a-4d32-9931-4894b6221f50" xlink:to="loc_us-gaap_OtherRestructuringMember_1b63c760-b6b2-4bb9-93b9-daf794c7eef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_44d632e6-c152-4d2e-bdb8-15bcc756cddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28b1d229-1e0c-4cd1-995e-5a74df2ac38a" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_44d632e6-c152-4d2e-bdb8-15bcc756cddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_44d632e6-c152-4d2e-bdb8-15bcc756cddc" xlink:to="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7bc78ccd-20df-458b-95b4-8ac0f62c5a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_RestructuringReserve_7bc78ccd-20df-458b-95b4-8ac0f62c5a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_49796ae3-2c12-49c3-b9f7-f6b32151936b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_RestructuringCharges_49796ae3-2c12-49c3-b9f7-f6b32151936b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_ba63716d-bf95-49d8-9a67-19154fa25cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_PaymentsForRestructuring_ba63716d-bf95-49d8-9a67-19154fa25cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_20b773ce-b242-4ab0-9db6-6828fb2d6854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_20b773ce-b242-4ab0-9db6-6828fb2d6854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_395243fb-9213-49ea-a575-5f1663073af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_851bda3b-552e-4b1a-b4d9-c10c9c1be276" xlink:to="loc_us-gaap_RestructuringReserve_395243fb-9213-49ea-a575-5f1663073af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_29b6dca6-5b39-4975-9149-fd23c4c65ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1424a0dd-c2e3-4f56-8db8-eaf86d04b69a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29b6dca6-5b39-4975-9149-fd23c4c65ba8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1424a0dd-c2e3-4f56-8db8-eaf86d04b69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_568ccc6a-7ab4-42fb-a452-252edaa412ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_93b1287b-da21-4571-9210-3f0a05075fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_568ccc6a-7ab4-42fb-a452-252edaa412ed" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_93b1287b-da21-4571-9210-3f0a05075fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_d8cdb73a-a8d4-40f7-8c0a-65e325a29a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_568ccc6a-7ab4-42fb-a452-252edaa412ed" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_d8cdb73a-a8d4-40f7-8c0a-65e325a29a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_bcaba2ef-8828-4098-86ac-bcda6fb6ce24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_568ccc6a-7ab4-42fb-a452-252edaa412ed" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_bcaba2ef-8828-4098-86ac-bcda6fb6ce24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9a2a8d92-6f12-45ff-9524-c9e95c3cfe44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_568ccc6a-7ab4-42fb-a452-252edaa412ed" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9a2a8d92-6f12-45ff-9524-c9e95c3cfe44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_876de12d-2e3c-42ed-83df-7b50b749d1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_568ccc6a-7ab4-42fb-a452-252edaa412ed" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_876de12d-2e3c-42ed-83df-7b50b749d1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_20d17460-50f6-4d49-9fbc-8bd306cbfa0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c6d3548f-c623-4fe5-9295-c880ffab2340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_20d17460-50f6-4d49-9fbc-8bd306cbfa0c" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c6d3548f-c623-4fe5-9295-c880ffab2340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4579d2e3-c291-4165-9ba6-cae8559055ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c6d3548f-c623-4fe5-9295-c880ffab2340" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4579d2e3-c291-4165-9ba6-cae8559055ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b38ba85c-595e-440e-9b20-fbd09f9495d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c6d3548f-c623-4fe5-9295-c880ffab2340" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b38ba85c-595e-440e-9b20-fbd09f9495d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_2c68920a-e785-4653-acdc-5cd4ad950b4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c6d3548f-c623-4fe5-9295-c880ffab2340" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_2c68920a-e785-4653-acdc-5cd4ad950b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_9450cfee-482b-4647-a725-44f0144caebe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c6d3548f-c623-4fe5-9295-c880ffab2340" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_9450cfee-482b-4647-a725-44f0144caebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8ccd79e8-9302-4dbd-98d0-8e5ee0783606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c6d3548f-c623-4fe5-9295-c880ffab2340" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8ccd79e8-9302-4dbd-98d0-8e5ee0783606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2f1a8a4f-bded-42e4-b29e-ff10b6cdd885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2f1a8a4f-bded-42e4-b29e-ff10b6cdd885" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_7261f52a-3e9d-485c-8648-724932457540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_7261f52a-3e9d-485c-8648-724932457540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_f742558d-d933-42ce-a227-eb679ba1e164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_7261f52a-3e9d-485c-8648-724932457540" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_f742558d-d933-42ce-a227-eb679ba1e164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_b3e2e677-8523-4fd5-bcd8-bda22665c01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_f742558d-d933-42ce-a227-eb679ba1e164" xlink:to="loc_us-gaap_ResearchMember_b3e2e677-8523-4fd5-bcd8-bda22665c01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis_517eac73-0453-4519-a90a-55647aa47833" xlink:href="wst-20201231.xsd#wst_ExpirationPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:to="loc_wst_ExpirationPeriodAxis_517eac73-0453-4519-a90a-55647aa47833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:href="wst-20201231.xsd#wst_ExpirationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodAxis_517eac73-0453-4519-a90a-55647aa47833" xlink:to="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2021Member_c0903828-1319-4257-96fd-193b9b25e1e1" xlink:href="wst-20201231.xsd#wst_Year2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:to="loc_wst_Year2021Member_c0903828-1319-4257-96fd-193b9b25e1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2021Member_a75b7dbe-4073-4b14-aace-919622bcd46b" xlink:href="wst-20201231.xsd#wst_YearAfter2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_253db97e-16c5-42ca-a99a-3e028cc6b7b9" xlink:to="loc_wst_YearAfter2021Member_a75b7dbe-4073-4b14-aace-919622bcd46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_20aa21bd-a4c4-4087-b636-b9acf855c64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_20aa21bd-a4c4-4087-b636-b9acf855c64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_20aa21bd-a4c4-4087-b636-b9acf855c64b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f72d1cc0-f25d-4787-9984-949dbf5e0ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f72d1cc0-f25d-4787-9984-949dbf5e0ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2c2bc39a-08ca-4e58-a8a7-103841af5ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_52a53383-61ad-4d64-b2ec-b0792bf8aaa2" xlink:to="loc_us-gaap_ForeignCountryMember_2c2bc39a-08ca-4e58-a8a7-103841af5ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_130d06e0-ca87-4fa4-a9af-3a1b1f0a096e" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ab24a400-b36c-4c83-a84b-4b701e4b6f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ab24a400-b36c-4c83-a84b-4b701e4b6f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_fe23b2df-ef90-468b-ac0a-881db6dbf6ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_fe23b2df-ef90-468b-ac0a-881db6dbf6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_977503a6-5b68-4c30-b429-ea999e82f4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_977503a6-5b68-4c30-b429-ea999e82f4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_049f3d8c-c880-4323-8dd3-cafadbc2c023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_049f3d8c-c880-4323-8dd3-cafadbc2c023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_eb3e46d0-3c34-443e-b872-d1b6d613c05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_eb3e46d0-3c34-443e-b872-d1b6d613c05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cd966e04-c2ee-4196-9957-0f144702b506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cd966e04-c2ee-4196-9957-0f144702b506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_10d87063-0fca-46b0-b8f7-39a68947a69f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_10d87063-0fca-46b0-b8f7-39a68947a69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_9546525c-0d3c-47a9-98b5-8720dbaa2ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_9546525c-0d3c-47a9-98b5-8720dbaa2ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_860662b9-bfc7-4848-ab00-adb88466d41e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_860662b9-bfc7-4848-ab00-adb88466d41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_406fc788-ef48-4442-b793-55147ceadcc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_OperatingLossCarryforwards_406fc788-ef48-4442-b793-55147ceadcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_59cade28-8506-4e14-b020-3e0aad7e52ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_59cade28-8506-4e14-b020-3e0aad7e52ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_a05899f7-ea9b-47f7-94a8-c32316bfc0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_a05899f7-ea9b-47f7-94a8-c32316bfc0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b46fcd79-3186-4b26-9e3c-12d58e03d63b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b46fcd79-3186-4b26-9e3c-12d58e03d63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_b4210a5e-1306-45f9-9619-04ecda3e8ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_b4210a5e-1306-45f9-9619-04ecda3e8ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a62cc67e-2f10-42b8-b654-02d8aefe0a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_72adab90-14f3-44ce-bb08-daa019c6c9c6" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a62cc67e-2f10-42b8-b654-02d8aefe0a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a6e00912-6cf1-4e68-b5be-2c42ce8f2606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d9eb53f8-0dde-4404-8c06-9fa3be35f0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a6e00912-6cf1-4e68-b5be-2c42ce8f2606" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d9eb53f8-0dde-4404-8c06-9fa3be35f0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_19c45318-3d1f-4b38-a415-5eef385b56c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a6e00912-6cf1-4e68-b5be-2c42ce8f2606" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_19c45318-3d1f-4b38-a415-5eef385b56c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_21300046-30df-4b17-96e9-e033c637df5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a6e00912-6cf1-4e68-b5be-2c42ce8f2606" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_21300046-30df-4b17-96e9-e033c637df5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ebc4c8f3-429c-4e23-bb5c-a41aa59185b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ec61b83-751a-4dbe-aec4-8117d01b733d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ebc4c8f3-429c-4e23-bb5c-a41aa59185b8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ec61b83-751a-4dbe-aec4-8117d01b733d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aa810de4-62cb-4226-847c-9d67a5260544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ec61b83-751a-4dbe-aec4-8117d01b733d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aa810de4-62cb-4226-847c-9d67a5260544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7d9c7183-2eab-4790-9329-ebab198f8d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ec61b83-751a-4dbe-aec4-8117d01b733d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7d9c7183-2eab-4790-9329-ebab198f8d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_cc967704-f9b5-44b3-ba1e-b1b174564f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ec61b83-751a-4dbe-aec4-8117d01b733d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_cc967704-f9b5-44b3-ba1e-b1b174564f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d430afa6-b6d1-40d0-89fc-98cb67003142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ec61b83-751a-4dbe-aec4-8117d01b733d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d430afa6-b6d1-40d0-89fc-98cb67003142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3907d0a8-80a0-4557-bfff-211037e651f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ebc4c8f3-429c-4e23-bb5c-a41aa59185b8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3907d0a8-80a0-4557-bfff-211037e651f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_cbb62201-8a0b-43cb-8a00-d32c10902828" xlink:href="wst-20201231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3907d0a8-80a0-4557-bfff-211037e651f4" xlink:to="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_cbb62201-8a0b-43cb-8a00-d32c10902828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_358c2881-f27f-4adb-97a9-802b96770eee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3907d0a8-80a0-4557-bfff-211037e651f4" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_358c2881-f27f-4adb-97a9-802b96770eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_be604b8d-2f0a-4a3a-ba87-5020e51fa469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3907d0a8-80a0-4557-bfff-211037e651f4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_be604b8d-2f0a-4a3a-ba87-5020e51fa469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f3c90f60-c8a6-465c-b9f1-3fbfa53a0e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ebc4c8f3-429c-4e23-bb5c-a41aa59185b8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f3c90f60-c8a6-465c-b9f1-3fbfa53a0e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0f2ab261-5629-4493-a2fb-14db5cb06b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0f2ab261-5629-4493-a2fb-14db5cb06b7a" xlink:to="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4f7744b2-90dc-4f1f-b5ec-ba4ebb299bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4f7744b2-90dc-4f1f-b5ec-ba4ebb299bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_bb410a60-b4c3-4807-b661-5405c144b99a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_bb410a60-b4c3-4807-b661-5405c144b99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_a4e1ea2e-a1b8-4fdd-ab30-8b1aa7fa9483" xlink:href="wst-20201231.xsd#wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:to="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_a4e1ea2e-a1b8-4fdd-ab30-8b1aa7fa9483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_1e7ee831-bc68-46a6-8e4e-ee9af0e60dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_1e7ee831-bc68-46a6-8e4e-ee9af0e60dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7fb87f1f-b696-49f6-8ecd-1f6062ca8417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7fb87f1f-b696-49f6-8ecd-1f6062ca8417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_15f52369-6063-4620-8052-7e15d7d37f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_15f52369-6063-4620-8052-7e15d7d37f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_c349fe76-6adc-4bb5-8140-20c206e32b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_20ceda09-b640-415d-aac9-49d0d4f1b765" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_c349fe76-6adc-4bb5-8140-20c206e32b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_44ac307e-c27c-46a4-8ca5-3f5a9273ee09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0f2ab261-5629-4493-a2fb-14db5cb06b7a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_44ac307e-c27c-46a4-8ca5-3f5a9273ee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f0d4a233-87f5-46d6-84fd-aeec320433f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_44ac307e-c27c-46a4-8ca5-3f5a9273ee09" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f0d4a233-87f5-46d6-84fd-aeec320433f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_08354447-1df5-452e-abfd-cde898005f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_44ac307e-c27c-46a4-8ca5-3f5a9273ee09" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_08354447-1df5-452e-abfd-cde898005f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_e47744e6-5c23-4123-b6b6-111a70d4b2b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_44ac307e-c27c-46a4-8ca5-3f5a9273ee09" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_e47744e6-5c23-4123-b6b6-111a70d4b2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d05af70d-29df-43cb-bc51-508810cf9aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_44ac307e-c27c-46a4-8ca5-3f5a9273ee09" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_d05af70d-29df-43cb-bc51-508810cf9aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bcddba99-081d-4638-8eff-850ffd266758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0f2ab261-5629-4493-a2fb-14db5cb06b7a" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bcddba99-081d-4638-8eff-850ffd266758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f4367928-a024-442b-a69c-930016c2e8d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0f2ab261-5629-4493-a2fb-14db5cb06b7a" xlink:to="loc_us-gaap_DeferredTaxLiabilities_f4367928-a024-442b-a69c-930016c2e8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_30af0450-c6e5-4ef2-b393-941df79b95e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_30af0450-c6e5-4ef2-b393-941df79b95e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2d822218-5d15-43c6-9a21-5fa63222aad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2d822218-5d15-43c6-9a21-5fa63222aad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_f173c64a-b900-4dd6-b0cd-8ed7a898af62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_f173c64a-b900-4dd6-b0cd-8ed7a898af62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_48c247b5-4b27-4ae0-bf58-590aa96dbe2f" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent_48c247b5-4b27-4ae0-bf58-590aa96dbe2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent_50a59033-1da0-43c7-a6ae-1774ebeab75d" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent_50a59033-1da0-43c7-a6ae-1774ebeab75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d62fc954-2736-46ab-af44-e97583b88439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d62fc954-2736-46ab-af44-e97583b88439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4bdac7f9-83d8-4e60-9861-a9e1a13d8450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4bdac7f9-83d8-4e60-9861-a9e1a13d8450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_27022383-22e9-4ea5-88a3-41dfe40105df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_27022383-22e9-4ea5-88a3-41dfe40105df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_35995b47-65fe-4b4a-865f-df0b0beb9fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_35995b47-65fe-4b4a-865f-df0b0beb9fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_957f5ae5-7331-4755-ba14-01f3d0b4d902" xlink:href="wst-20201231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage_957f5ae5-7331-4755-ba14-01f3d0b4d902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_83c29a5b-5f4e-4f12-8ee8-fd3234b4fad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_83c29a5b-5f4e-4f12-8ee8-fd3234b4fad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_62b964bf-02f1-43ec-9302-1b8570bb0c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10fc3e1f-913b-4cda-8a5f-e97002f606d9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_62b964bf-02f1-43ec-9302-1b8570bb0c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20201231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36ac108c-d4ed-490f-9c27-2c1fd98e7289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2c08d504-8350-4382-b67f-f024c8f4c445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36ac108c-d4ed-490f-9c27-2c1fd98e7289" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2c08d504-8350-4382-b67f-f024c8f4c445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_95af7cd9-7605-4475-a8f5-24697e33094a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_95af7cd9-7605-4475-a8f5-24697e33094a" xlink:to="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea9b17d8-9560-4e36-9312-b3ebefcb52f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:to="loc_us-gaap_CreditFacilityAxis_ea9b17d8-9560-4e36-9312-b3ebefcb52f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b750cf9f-5e54-459a-9e9a-2b55047356d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ea9b17d8-9560-4e36-9312-b3ebefcb52f8" xlink:to="loc_us-gaap_CreditFacilityDomain_b750cf9f-5e54-459a-9e9a-2b55047356d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_43b40dec-86a6-4bff-b269-43fefda081f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b750cf9f-5e54-459a-9e9a-2b55047356d1" xlink:to="loc_us-gaap_LetterOfCreditMember_43b40dec-86a6-4bff-b269-43fefda081f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7fbaffd5-cb50-4980-9041-23196ae21e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7fbaffd5-cb50-4980-9041-23196ae21e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec906dc2-7384-40ee-bcec-ba0bf1fd6d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7fbaffd5-cb50-4980-9041-23196ae21e00" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec906dc2-7384-40ee-bcec-ba0bf1fd6d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_ed7401aa-11b9-4985-8b2b-3378332d3950" xlink:href="wst-20201231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec906dc2-7384-40ee-bcec-ba0bf1fd6d32" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_ed7401aa-11b9-4985-8b2b-3378332d3950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_99e5d4a6-f57c-444d-bfdd-4664b838b8c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_99e5d4a6-f57c-444d-bfdd-4664b838b8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_bedd1ea6-c586-4df6-9781-d0a3c7624c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_99e5d4a6-f57c-444d-bfdd-4664b838b8c0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_bedd1ea6-c586-4df6-9781-d0a3c7624c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember_f7a7ecaa-d49a-4851-816b-7ddb40f3900d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_bedd1ea6-c586-4df6-9781-d0a3c7624c79" xlink:to="loc_us-gaap_InsuranceClaimsMember_f7a7ecaa-d49a-4851-816b-7ddb40f3900d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ec62c661-113c-4e18-adea-05cdb7f098d5" xlink:to="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_2b01c85e-387c-44bb-9328-5630124cca86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_2b01c85e-387c-44bb-9328-5630124cca86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_dec51237-bbc8-4a7b-9cc0-9891b3936256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_dec51237-bbc8-4a7b-9cc0-9891b3936256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5b516b75-0568-4d32-8a8e-4fb40761e8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_LineOfCredit_5b516b75-0568-4d32-8a8e-4fb40761e8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_583cfcbb-25e7-47d7-b0bf-c79cc152a82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_583cfcbb-25e7-47d7-b0bf-c79cc152a82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable_6ef22abf-a30e-400a-8096-d36ee549720b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_LossContingencyReceivable_6ef22abf-a30e-400a-8096-d36ee549720b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod_49f75a72-802e-4f59-b1c1-5488eaf27a43" xlink:href="wst-20201231.xsd#wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod_49f75a72-802e-4f59-b1c1-5488eaf27a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_d060206a-24fd-45c2-a73d-329ea628fca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_d060206a-24fd-45c2-a73d-329ea628fca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb0234b-ba19-455e-bac7-0d84f7d379fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_12d0e485-cf89-4fb3-a241-23b697e94078" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7eb0234b-ba19-455e-bac7-0d84f7d379fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d1f1238d-eda4-4de0-8154-acbea7f29743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_96ced74e-940f-468d-8786-371a3e2e6280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d1f1238d-eda4-4de0-8154-acbea7f29743" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_96ced74e-940f-468d-8786-371a3e2e6280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c2836f07-7448-4156-9331-67ebe1f72170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_99d60c80-8a99-427f-b91f-9ee0b6c4fb98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c2836f07-7448-4156-9331-67ebe1f72170" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_99d60c80-8a99-427f-b91f-9ee0b6c4fb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_8f0b65ea-d8dd-4e91-86f2-10b3a318c4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c2836f07-7448-4156-9331-67ebe1f72170" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_8f0b65ea-d8dd-4e91-86f2-10b3a318c4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a5e7d2f8-0000-4e3a-b232-8d51ebf43380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c2836f07-7448-4156-9331-67ebe1f72170" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a5e7d2f8-0000-4e3a-b232-8d51ebf43380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_51c70f6e-3c59-4256-ab10-d9df11e909ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_032488be-656f-4dd0-a620-cdb9f99c533a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_51c70f6e-3c59-4256-ab10-d9df11e909ad" xlink:to="loc_us-gaap_NumberOfReportableSegments_032488be-656f-4dd0-a620-cdb9f99c533a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d265df04-1b61-474d-bb4e-7e47308ea46f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d265df04-1b61-474d-bb4e-7e47308ea46f" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4333a4b2-5c91-46d9-a844-ddb10431ff51" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:to="loc_srt_ConsolidationItemsAxis_4333a4b2-5c91-46d9-a844-ddb10431ff51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4333a4b2-5c91-46d9-a844-ddb10431ff51" xlink:to="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9ae4d796-75b0-4ae7-88d8-145533ce30ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:to="loc_us-gaap_OperatingSegmentsMember_9ae4d796-75b0-4ae7-88d8-145533ce30ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_78bf9348-dd7b-4291-849e-3ea5043a64b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ab18ab8c-1284-4213-91b8-1c4c00589f97" xlink:to="loc_us-gaap_IntersegmentEliminationMember_78bf9348-dd7b-4291-849e-3ea5043a64b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_513f7a59-f0d6-49ec-ac58-00102f0a0cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_513f7a59-f0d6-49ec-ac58-00102f0a0cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_513f7a59-f0d6-49ec-ac58-00102f0a0cc2" xlink:to="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_36edcaa4-82fd-4463-b505-3ebf2819c3f1" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:to="loc_wst_ProprietaryProductsMember_36edcaa4-82fd-4463-b505-3ebf2819c3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_23d27eca-a8d9-48e4-84e8-c06f78d98af8" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7918a0de-883b-457d-8cfe-f66f682f8d20" xlink:to="loc_wst_ContractManufacturedProductsMember_23d27eca-a8d9-48e4-84e8-c06f78d98af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_7610bfd1-2326-4946-b8bd-64836f61c33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_35a63839-dda3-44dc-9ce3-a4cc5afcae8b" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_7610bfd1-2326-4946-b8bd-64836f61c33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d83889f8-a23c-40ea-8887-f7b64dce8b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_7610bfd1-2326-4946-b8bd-64836f61c33b" xlink:to="loc_us-gaap_Revenues_d83889f8-a23c-40ea-8887-f7b64dce8b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3faaf455-b063-4e2c-9673-3b8f628a5f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff6d5244-2e01-4f19-91e7-2896d8724b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3faaf455-b063-4e2c-9673-3b8f628a5f06" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff6d5244-2e01-4f19-91e7-2896d8724b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff6d5244-2e01-4f19-91e7-2896d8724b93" xlink:to="loc_srt_StatementGeographicalAxis_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_03bd053f-4ec6-4c02-90e0-7fdaa2bb3c4c" xlink:to="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_be194db0-0b8d-42a0-a7b5-ffdd21914244" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_US_be194db0-0b8d-42a0-a7b5-ffdd21914244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_bc92ee4b-4e31-4423-9cf8-61bf585905c9" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_DE_bc92ee4b-4e31-4423-9cf8-61bf585905c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_eb4b5ca0-9fb4-4699-9ea7-5185bf7287ce" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_IE_eb4b5ca0-9fb4-4699-9ea7-5185bf7287ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_4787eddd-1b17-4cb2-a513-3bf03eba82a8" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_FR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_country_FR_4787eddd-1b17-4cb2-a513-3bf03eba82a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember_89dc428c-67ee-4042-8e91-085c0f8be559" xlink:href="wst-20201231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_wst_OtherEuropeCountriesMember_89dc428c-67ee-4042-8e91-085c0f8be559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember_cfb4b3ce-90a8-41ec-8e4b-e9998f7f4d3b" xlink:href="wst-20201231.xsd#wst_OtherCountriesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_07c5b5ec-47c5-4e72-9498-49078e845b03" xlink:to="loc_wst_OtherCountriesMember_cfb4b3ce-90a8-41ec-8e4b-e9998f7f4d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff6d5244-2e01-4f19-91e7-2896d8724b93" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8705551d-cc45-44d6-94d3-39ce51c4f6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:to="loc_us-gaap_Revenues_8705551d-cc45-44d6-94d3-39ce51c4f6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_9dc56d6c-f3b5-4613-9a89-1f1b8459858e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_a059a06f-0228-41f7-9ade-5781f34feae2" xlink:to="loc_us-gaap_NoncurrentAssets_9dc56d6c-f3b5-4613-9a89-1f1b8459858e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2c60e109-832e-4d57-a5e0-6ca2b6be1c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2c60e109-832e-4d57-a5e0-6ca2b6be1c85" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e7ec3338-924a-4026-8ec0-ed75db15e29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e7ec3338-924a-4026-8ec0-ed75db15e29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e7ec3338-924a-4026-8ec0-ed75db15e29c" xlink:to="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_6b08aa44-cf7b-4c0e-aa31-c68c82615cc4" xlink:href="wst-20201231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:to="loc_wst_ProprietaryProductsMember_6b08aa44-cf7b-4c0e-aa31-c68c82615cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_13ccf65f-e2d4-4bfb-b5b5-47c585710594" xlink:href="wst-20201231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed3c5af8-42b6-477a-b41e-65d9a32e0732" xlink:to="loc_wst_ContractManufacturedProductsMember_13ccf65f-e2d4-4bfb-b5b5-47c585710594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_355571c0-86b4-4ab6-bf8f-acdb30707aa9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:to="loc_srt_ConsolidationItemsAxis_355571c0-86b4-4ab6-bf8f-acdb30707aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_355571c0-86b4-4ab6-bf8f-acdb30707aa9" xlink:to="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c070a33a-8389-4ca7-89ad-9d95b0f93b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:to="loc_us-gaap_OperatingSegmentsMember_c070a33a-8389-4ca7-89ad-9d95b0f93b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_19b1f6b8-c05c-49ce-a992-a5b5511449c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0d61a128-91ca-49ae-bf83-c12724e62584" xlink:to="loc_us-gaap_CorporateNonSegmentMember_19b1f6b8-c05c-49ce-a992-a5b5511449c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2e086e30-fa0f-4dfa-b914-1fc8fd39c9fb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4a57a220-fd06-4dde-8ba3-b9fa10bc36a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_OperatingIncomeLoss_4a57a220-fd06-4dde-8ba3-b9fa10bc36a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ae4da2a7-4d8e-4305-9693-b2d797eff96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_ShareBasedCompensation_ae4da2a7-4d8e-4305-9693-b2d797eff96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7d08389e-0d11-4cf1-b36f-883bbec2bf00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7d08389e-0d11-4cf1-b36f-883bbec2bf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b019c042-78d0-4480-97a6-409dfba11886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_RestructuringCharges_b019c042-78d0-4480-97a6-409dfba11886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9855a4f1-8e41-4444-9238-4c357e8d28e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9855a4f1-8e41-4444-9238-4c357e8d28e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CostInvestmentImpairment_fddbe164-e484-4aca-89eb-eafdbab685e4" xlink:href="wst-20201231.xsd#wst_CostInvestmentImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_wst_CostInvestmentImpairment_fddbe164-e484-4aca-89eb-eafdbab685e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9a45ec83-c8bf-4068-8fbb-915d0c60dc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9a45ec83-c8bf-4068-8fbb-915d0c60dc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GainLossOnArgentinaCurrencyDevaluation_e373a065-d3b1-413f-84ed-b918856ac0be" xlink:href="wst-20201231.xsd#wst_GainLossOnArgentinaCurrencyDevaluation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_wst_GainLossOnArgentinaCurrencyDevaluation_e373a065-d3b1-413f-84ed-b918856ac0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BrazilTaxRecovery_3ac0197e-9db0-48a8-884c-eab8a20785b6" xlink:href="wst-20201231.xsd#wst_BrazilTaxRecovery"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_wst_BrazilTaxRecovery_3ac0197e-9db0-48a8-884c-eab8a20785b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6faaa30b-693c-4c3b-92b8-830efb14dbf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6faaa30b-693c-4c3b-92b8-830efb14dbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a93f22e0-c412-4a0f-aeca-1cc20871418f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a93f22e0-c412-4a0f-aeca-1cc20871418f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d6024dc0-90d3-417f-b164-6de63c019177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_Assets_d6024dc0-90d3-417f-b164-6de63c019177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b5871410-fe29-49e5-bd7d-290900a5bfe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b5871410-fe29-49e5-bd7d-290900a5bfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_703dbba7-5ced-4c4a-bded-47dd3516b300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6da59978-1e25-405b-8922-57052bdb565b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_703dbba7-5ced-4c4a-bded-47dd3516b300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_a286a560-fde3-4327-91e0-c7bac26c8ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_6f1b8243-911c-428d-8067-e2d56f72e90c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_a286a560-fde3-4327-91e0-c7bac26c8ede" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_6f1b8243-911c-428d-8067-e2d56f72e90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_4310593d-1e98-45ee-859c-aeaa974d28ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_bc0a03d1-0527-4550-b36e-8d9af35e82c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_4310593d-1e98-45ee-859c-aeaa974d28ff" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_bc0a03d1-0527-4550-b36e-8d9af35e82c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#QuarterlyOperatingandPerShareDataUnauditedDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a9ca716-7f9a-4497-aa39-008c4e78c1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d19fe083-91c4-4c19-8e53-a91de4663dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a9ca716-7f9a-4497-aa39-008c4e78c1fc" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d19fe083-91c4-4c19-8e53-a91de4663dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_15c1a8c0-b37b-4e58-8663-bde8341726cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d19fe083-91c4-4c19-8e53-a91de4663dc8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_15c1a8c0-b37b-4e58-8663-bde8341726cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_15c1a8c0-b37b-4e58-8663-bde8341726cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_692c94c6-37ae-43fc-b557-5573bb5ca9d5" xlink:href="wst-20201231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_692c94c6-37ae-43fc-b557-5573bb5ca9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_981d5b07-0b78-4ef3-9d0c-beb1a2c7b798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84469d47-7598-4d6d-96bb-8765dec2821e" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_981d5b07-0b78-4ef3-9d0c-beb1a2c7b798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d19fe083-91c4-4c19-8e53-a91de4663dc8" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3bd09536-fc10-41c7-9a60-2c37a97d453e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3bd09536-fc10-41c7-9a60-2c37a97d453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bb006cbc-76a6-4277-b738-213b73b79510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_GrossProfit_bb006cbc-76a6-4277-b738-213b73b79510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cc52c9d4-372a-4a53-841c-072f88ad9a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_NetIncomeLoss_cc52c9d4-372a-4a53-841c-072f88ad9a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ed3925f0-5a8c-4b0d-b555-2918fe96ce32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_EarningsPerShareBasic_ed3925f0-5a8c-4b0d-b555-2918fe96ce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c21ed34c-5bb8-4061-85fd-fac3b4fbc959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c21ed34c-5bb8-4061-85fd-fac3b4fbc959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionSettlementAndRelatedCharges_2d4f435f-e08a-4362-995d-3eb8b93d4b11" xlink:href="wst-20201231.xsd#wst_PensionSettlementAndRelatedCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PensionSettlementAndRelatedCharges_2d4f435f-e08a-4362-995d-3eb8b93d4b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare_506d25fd-0044-4c69-82ff-684a01c84ee3" xlink:href="wst-20201231.xsd#wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare_506d25fd-0044-4c69-82ff-684a01c84ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2ad6916f-7f1a-4601-9ae2-c47de6982215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2ad6916f-7f1a-4601-9ae2-c47de6982215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare_ad08fc35-1338-4e6d-a838-8a578e13f7f6" xlink:href="wst-20201231.xsd#wst_AmortizationExpenseImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare_ad08fc35-1338-4e6d-a838-8a578e13f7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromStockBasedCompensation_970ce17c-eb32-4cd4-a66c-6741d49cbccb" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromStockBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_IncomeTaxBenefitFromStockBasedCompensation_970ce17c-eb32-4cd4-a66c-6741d49cbccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare_4ca143ab-5829-4145-bce0-aa2d596c0366" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare_4ca143ab-5829-4145-bce0-aa2d596c0366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6935e275-c633-4abe-ae90-eb276cfb9194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6935e275-c633-4abe-ae90-eb276cfb9194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare_9685f418-13d9-4964-9f80-ac6dbbffa93f" xlink:href="wst-20201231.xsd#wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare_9685f418-13d9-4964-9f80-ac6dbbffa93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndSeveranceRelatedCharges_b379fd70-636d-4ebc-a178-1b33cd4bb81c" xlink:href="wst-20201231.xsd#wst_RestructuringAndSeveranceRelatedCharges"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_RestructuringAndSeveranceRelatedCharges_b379fd70-636d-4ebc-a178-1b33cd4bb81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare_9848f798-b513-4b58-a66e-7dbf5e3c59e9" xlink:href="wst-20201231.xsd#wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare_9848f798-b513-4b58-a66e-7dbf5e3c59e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency_b0faa2c8-e90a-4c3e-af2e-1351868e03c1" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency_b0faa2c8-e90a-4c3e-af2e-1351868e03c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare_98eddee2-323f-4aca-a0f7-119f4a41fd36" xlink:href="wst-20201231.xsd#wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare_98eddee2-323f-4aca-a0f7-119f4a41fd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f1351217-8d0f-44af-a645-8e81edc939a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f1351217-8d0f-44af-a645-8e81edc939a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare_6f3d0010-424a-4905-97c4-8ce61f397a38" xlink:href="wst-20201231.xsd#wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare_6f3d0010-424a-4905-97c4-8ce61f397a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FixedAssetImpairmentFromRestructuring_e014b963-5515-4a82-a5d1-dc83b4f5bd1b" xlink:href="wst-20201231.xsd#wst_FixedAssetImpairmentFromRestructuring"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_FixedAssetImpairmentFromRestructuring_e014b963-5515-4a82-a5d1-dc83b4f5bd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare_15a34366-b744-4f19-a59f-a6ce7bbfb6c6" xlink:href="wst-20201231.xsd#wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare_15a34366-b744-4f19-a59f-a6ce7bbfb6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentOfExciseTaxes_4d72a1aa-7347-4754-9f9f-f4bd966d9522" xlink:href="wst-20201231.xsd#wst_PaymentOfExciseTaxes"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PaymentOfExciseTaxes_4d72a1aa-7347-4754-9f9f-f4bd966d9522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare_34f4e9ea-48cd-40f7-ba8c-da48c934904c" xlink:href="wst-20201231.xsd#wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_910f2d8d-a57b-4d56-9190-019d5f96884f" xlink:to="loc_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare_34f4e9ea-48cd-40f7-ba8c-da48c934904c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="wst-20201231.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_21942b79-7c29-48c4-b2d5-c355535d69bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_dd7571fc-b041-4cc7-8d0b-596b3dd1ca06" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_21942b79-7c29-48c4-b2d5-c355535d69bc" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_dd7571fc-b041-4cc7-8d0b-596b3dd1ca06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20201231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_5d15f045-43a9-4322-8021-986374c8945f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_340b184f-ab90-4a51-b7d9-221f30a08cb7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_5d15f045-43a9-4322-8021-986374c8945f" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_340b184f-ab90-4a51-b7d9-221f30a08cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f3566eb-a479-47ca-917b-5b170fe7fd28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_340b184f-ab90-4a51-b7d9-221f30a08cb7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f3566eb-a479-47ca-917b-5b170fe7fd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6f3566eb-a479-47ca-917b-5b170fe7fd28" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bbece5d0-24a0-48fb-8c06-aeb02f4cfc94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_bbece5d0-24a0-48fb-8c06-aeb02f4cfc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_8df96ffa-1e09-46e4-a822-885832dfec87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_d827dd1c-ece5-46c9-8757-b53ddb8b4a47" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_8df96ffa-1e09-46e4-a822-885832dfec87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e37df14e-a295-44d9-9aba-14de28458429" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_340b184f-ab90-4a51-b7d9-221f30a08cb7" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e37df14e-a295-44d9-9aba-14de28458429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e37df14e-a295-44d9-9aba-14de28458429" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a5d96002-b268-4b32-a837-526203aef263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_a5d96002-b268-4b32-a837-526203aef263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_302a51dc-d5a5-4718-8135-115fb912234e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_302a51dc-d5a5-4718-8135-115fb912234e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_79841771-209d-4220-8ce2-7c0ff79088e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_79841771-209d-4220-8ce2-7c0ff79088e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_cb184c12-39b2-44f2-aaa1-5c0c22edfef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_55ce9906-669a-429d-a0d0-2f06b44f4484" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_cb184c12-39b2-44f2-aaa1-5c0c22edfef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>wst-20201231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 wst-20201231_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*\)^$])D5+K6;]U9Q&K-D11JB,[RD$*   S,B-Y[I/\ P5P\2?"+]NKX?_L
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M[3!J/A^_N1/)IUY;SO!-#YJJHF3<FY) J[D=251LJ #WVBBB@ HHHH ****
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MU'PA?V%A?OJL0AN+J*STCS8$DW;6D3[//N4'(\E\_=-?N_10!^$__!K+\1?
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M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
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M^S[K>]&VVWBGPO>2L+'Q!8;LM;3J.AZE)0-T;?,,C<K?U_?\$Y/^"C?[./\
MP4[_ &<=._:)_9V\0[XWVV_B+P[>2*+_ $"_V@O:7* \$=5<?+(N&4D'@ ]U
M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
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M-EI$SV8F\U8A')F_G\L'/SE.,@'B/_!%GX7?\$;O%O[6-Q>_#W]EOXH_"O\
M:A^'MC/>ZWX/^-WB'5GU=EGB,$^IQ17%R]O=*XG.9%C1E,P8(BLC'U3]A/3/
MAY_P52_:N_:S^,7[4O@'2_&GAOP%\4[KX3?#GP_XBM%N;/0[#38@+ZXM8W!$
M-Q=SRK*]PN)<)$@95C4#OO%VA? K]NG_ (*8?L^_M5?LI^,-$\5P_!NR\2R>
M-?B-X0O8KO3IK&^TU[.UT4WL):*YF-Q.;GR59S D$C.(C/$9.$_X)XWG@#_@
MF1^T_P#M?_ W]I?QOI/@W1O$OQ7O/B]X)UOQ!>I:VVKZ+JL*FY^S.Y'G-9SP
M>1*BY=2\1(Q*A8 [_P#X(+?M,_$7X^_L?^*/AO\ %WQA=^(_$?P1^+OB#X:W
MOB/4IC)=ZM!ILL;6MS.YYDD^SSPQM(>7:(LQ+%C7VU7P]_P0&_9P^(?P._8W
M\4?%#XK^$[S0-?\ CA\7_$/Q*N- U.V,-WIMMJ,L:VL,R, 8W-O;Q2F,\H9B
MK ,& ^X: "BBB@#Y^_8&\0:+IGP:U:VU#48XI/\ A.=9;:YYQ]I;FO;_ /A,
M?#'_ $&H/^^J\9_X)^6EK/\ !75GFMHW/_"=:R,L@)_X^37N7]G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
MSXP_]^A0!3_X3'PQ_P!!J#_OJLOPEXET&QTR2&[U2*-C=2L%8]BW!KH/[.T_
M_GQA_P"_0K(\%V5G+I4C2VD3'[9*,M&#QNH M_\ "8^&/^@U!_WU1_PF/AC_
M *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_ *#4'_?5'_"8
M^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"
M8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\
M?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H
M-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\ Y\8?^_0H I_\)CX8
M_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8
M^&/^@U!_WU67:>)=!3Q;=WKZI$(GM8U23/!()R*Z#^SM/_Y\8?\ OT*R+.RL
MSXSO8C:1;19QD+Y8P#DT 6_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\
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M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
MY\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/
M_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L
M[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^
M_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3_P#G
MQA_[]"O@_P#X.,OV_+#_ ()[?\$S_%>N^$K^&S\=?$$-X3\$&+"S03W,;_:;
MQ,<J8+83.K]!*80?O"@#\O-2U?3O^#@[_@Y6CDOKU=1^!7P1EPK,Q>TO-*TN
M?/\ NN+_ %%_9C;/W\JOZ)_^$Q\,?]!J#_OJOS-_X-2_^"==O^R#_P $Y;7X
M\>//#J1>-/C;-#X@NS<0_O+?1E5ETR#D=&C>2Z_[? #]T5^GW]G:?_SXP_\
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M*J@ #V%1:IH&A:X]M)K6BVEXUG<">T:ZMED,$HZ2)N!VL,GYAS5NB@ HHHH
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M"61LYWI!;N"<T ?L%I6E:9H6EVVAZ+I\-I9V=ND%I:VT82.&)%"JBJ.%4
M#@ 58HHH Q[+_D=[W_KRB_F:V*Q[+_D=[W_KRB_F:V* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO_@GO_P D3U;_ +'O6?\
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M10!C^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% !1110 4444
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MZO\ ]"A>_P#?2UF>%=<U&UTZ2.'PW<S@W,C%T9< ENGX4 =716/_ ,)+J_\
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M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
MH4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^
MA0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O
M?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V*S?&/\ R+%[_P!<
M#4/_  DNK_\ 0H7O_?2U1\2Z]J=SH-U!-X8NH5:(@RNRX7W- '0:=_R#X/\
MKBO\A4U85EXCU5+.)%\)7C 1* P9<'CK4O\ PDNK_P#0H7O_ 'TM &Q16/\
M\)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK
M_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\
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M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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M K'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYF@#8HHHH **** "BBB@ HHHH
M**** "BBB@ K'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\ Z_3_ .@F@#8HHHH
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M4.G?\@^#_KBO\A4U !1110 4444 %%%% !1110 4444 %%%% &/X'_Y!$O\
MU^S?^A5L5C^!_P#D$2_]?LW_ *%6Q0 4444 %%%% !7X\?\ !X%^W]>_!?\
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M4 %%%% !1110!CV7_([WO_7E%_,UL5CV7_([WO\ UY1?S-;% !1110 4444
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M_"2ZO_T*%[_WTM;%% &/_P )+J__ $*%[_WTM9EKKFHKXINKI?#=RSO;1JT
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M275_^A0O?^^EK0TG2=,T'2K;0]$T^&TLK*W2"TM;>,)'#$BA415'"J   !T
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M* "L?P/_ ,@B7_K]F_\ 0JV*Q_ __((E_P"OV;_T*@#8HHHH **** "BBB@
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M]$BTSP]X6T6UTG0].A^[;6EO$L448_W411GVH W:*** "BBB@ HHHH ****
M,>R_Y'>]_P"O*+^9K8K'LO\ D=[W_KRB_F:V* "BBB@ HHHH **** "BBB@
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M/+H ZG_@T$_8S\7^.;CXH_\ !7O]H'SM2\4?$36KW2?"^J7ZYDN0]S]HU;4
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MO&__ $&[+_P&/^-'V+QO_P!!NR_\!C_C0!L5C^!_^01+_P!?LW_H5'V+QO\
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M6J6SNUR1 RP$!6V]3ZT =716/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
M&Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
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M9O\ T*MBL?P/_P @B7_K]F_]"H V**** "BBB@ HHHH **** "BBB@ HHHH
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MUL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\D3U;_L>]9_\
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M* "L?P/_ ,@B7_K]F_\ 0JV*Q_ __((E_P"OV;_T*@#8HHHH **** "BBB@
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MXU_$31OA+\)?!NH>(?$OB'4(['1=%TJW,MQ>7#G"HBCJ??H "20 37]?O_!
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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MQQ\+P27K>+M?NS';>,+AE!ELYX=QCLXR5Q 4SY721I-SR5^J?[$7["W[-/\
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M@_ZXK_(5-4.G?\@^#_KBO\A4U !1110 4444 %%%% !7RE_P5<_X*_?LM_\
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M*** "BBB@#PO_@GO_P D3U;_ +'O6?\ TI->Z5X7_P $]_\ DB>K?]CWK/\
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MG:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\
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M*/VSOVQ_V7_V O@3JG[1/[4/C:P\/^'M.79 AB5[K4KD@E+2TA'S3SO@X0<
M LQ5%9@ =7\4_P!H7X(_!#X>:O\ %GXN?$[2/#OAO0;)KO5]9U2Z$4%M$O\
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M]ES]C_P"?BA^T_\ &#PKX&T+S/*AO_$5_%;_ &B7&?*A0_//)C)V1AFP"<4
M=#:>)=!3Q;=WKZI$(GM8U23/!()R*U/^$Q\,?]!J#_OJOD?]G?\ X+<_\$D?
MVG/C,?AS\'OVTO!UYJU^L=OIFGZO!<Z4;R?) B@-_#"LKD\!4)+'H#7V)_9V
MG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\
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MJ'E'E:>YE"GD1O$3@D@ 'ZMT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >%_\$]_^2)ZM_P!CWK/_ *4FO=*\+_X)[_\ )$]6_P"Q
M[UG_ -*37NE !1110 4444 %8_@?_D$2_P#7[-_Z%6Q6/X'_ .01+_U^S?\
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M_P .-:?_ !BC_A@7_@\D_P"CU1_X<:T_^,4 ?O\ 45^ /_# O_!Y)_T>J/\
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M=-^SCX+E_:\MO#\/Q-;P_;GQK'X6=FL%O]O[SRBWX;L94-N"DKM) /0****
M"BBB@ HHHH **** "BBB@ HK+\<>-O"?PU\%ZO\ $7Q[X@MM)T/0=,GU'6=4
MO9-D-G:P1M)+,[=E5%9B?0&OYN/^"AG_  >+?M?_ ! ^*.I>&?\ @GEHVC^
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MA_X6O+;/FZ/>>)(9-1XZXLXF>X;'^S&:^:W_ .#@WX7?&)OL'_!/C]AKX_\
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M[X@^&M[XCU*8R7>K0:;+&UK<SN>9)/L\\,;2'EVB+,2Q8U]M4 %%%% 'A?\
MP3W_ .2)ZM_V/>L_^E)KW2OG[]@;Q!HNF?!K5K;4-1CBD_X3G66VN><?:6YK
MV_\ X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?
M^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2K'\#_\ ((E_Z_9O_0JF_P"$Q\,?
M]!J#_OJLOPEXET&QTR2&[U2*-C=2L%8]BW!H Z:BLW_A,?#'_0:@_P"^J/\
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MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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MU7+_ !:_:>_9T^ GA27QW\</C?X7\(:+#G?JGB76H;*#(&=H>9E!;T4<GL*
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MA4 :7]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\
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M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M$/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A7.?$OXY?!/X+V/\ :GQB^,/A;PG;;=WVCQ+X@MK"/'KNG=1BOF7X
ML_\ !?[_ ((W?!AY(O%?_!0#P-?R(VWR_",T^O%FZ87^S8IP>?PH ^O?[.T_
M_GQA_P"_0K\Z_P#@NC_P6E\"_P#!*/QY\#_!MKHUGJFI>*_&45_XTT]80\MG
MX4B?RKJ9%'(F=WQ#GAC;RCM7C'_!2+_@Z[^"7P;_ &<-1U#]CCX+_$G4/%_B
M!&M/!/B_QK\/I],\/)+\OF7 >Z9)+EXT;>L2QX+%=Y"YS_-U^T'^T?\ '?\
M:N^*-_\ &K]H_P"*^M^,O%.ID"ZUG7;UII-@)*Q(#\L42Y.V) J(#A5 XH _
MNR\,:KX/\:>&]/\ &/A.ZL=1TK5K&*\TS4+3:\5S;RH'CE1APRLK!@1U!%7O
M[.T__GQA_P"_0K^43_@AM_P<6_M'?\$[O&ND_ ;XZ3^*OB?\&KJ-;&Q\)616
M\U;0I3Q#_97G.N4+80VA=8R&RFQ@=W[C:;_P<I?\$Q]'OHM&_:"U/XF_!S4)
MG")8?%/X3:M8.'/\+-##,B_4L![T ?>O]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%>"?"+_@J]_P $SOCOY47PJ_;R^%&J7,^/*TYO&]G;WC?]N\TB2_\ CM>]
M:9JFF:U81:KHVHP7=K.NZ&YMIEDCD'JK*2"/I0 O]G:?_P ^,/\ WZ%']G:?
M_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^
M,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U
M% $/]G:?_P ^,/\ WZ%9WBZQLH_#5X\=G$K"$X*Q@$5KUF^,?^18O?\ K@:
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MX,TL:'/?6K$%XI+K3S#<$.!M?]YEU+*Q*LP/X\_\0,?_ %E%_P#,)_\ WZH
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M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\
MGQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH
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MO]#U:VO8"<":TG61"?JI(K^8?XJ?L>?\&K%O=SQ_L^_\%8?B/I6H39*65_\
M"FZ\3VZ$$CY%?18FVC'(,I)ZYKPS5OV5?V=?AW?2:M^R]\14^,M[G_1I]9^
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MHH **** ,?P/_P @B7_K]F_]"K8K'\#_ /((E_Z_9O\ T*MB@ HHHH ****
M"BBB@ HHHH **** "BBB@#'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYFMB@
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M ^,6LP-M?2/A1\+]5U.4MV57DABB?/8JY'O7K?P9_P"",7_!*7X ^3+\,_V
M?AA#<6^/(OM8\,1:I=1D=UGOA-*#[ALU]'Z#X>T#PKI<6A^&-#L]-LH!B"SL
M+9(8HQZ*B  ?@* /Q*_X+T?\%,?VFOVJO^"3_P 5?!.G?\$EOC9\/OA_J/\
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M_P CO>_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%%
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M:)\,DM])^(W@;Q?HWC[X<Q:Y,JPPZ[ILOFQVUP\1=5$D;SVY="RH90X+!<$
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M_P#H4+W_ +Z6CP/_ ,@B7_K]F_\ 0JV* ,?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EK8HH Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EK8HH Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M:V** ,?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EK8HH Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI:V** .4M=<U%?%-U=+X;N6=[:-6@#+N4 GDUI_\ "2ZO
M_P!"A>_]]+19?\CO>_\ 7E%_,UL4 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\
M0H7O_?2U:TK5;W4)'2ZT2>U"KD-*1AO;BKU% !1110 4444 %%%% !1110 4
M444 %%%% !1110!X7_P3W_Y(GJW_ &/>L_\ I2:]TKPO_@GO_P D3U;_ +'O
M6?\ TI->Z4 %%%% !1110 5C^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A
M4 ;%%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_P!>47\S6Q6/9?\
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MH **** "BBB@ HHHH **** /"_\ @GO_ ,D3U;_L>]9_]*37NE>%_P#!/?\
MY(GJW_8]ZS_Z4FO=* "BBB@ HHHH *Q_ _\ R")?^OV;_P!"K8K'\#_\@B7_
M *_9O_0J -BBBB@ HHHH **** "BBB@ HHHH **** "L>R_Y'>]_Z\HOYFMB
ML>R_Y'>]_P"O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH *Q_$O_(7T
M?_K]/_H)K8K'\2_\A?1_^OT_^@F@#8HHHH **** "BBB@ HHHH **** "BBB
M@ K-\8_\BQ>_]<#6E6;XQ_Y%B]_ZX&@"YIW_ "#X/^N*_P A4U0Z=_R#X/\
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M7@O_  K[_@H?_P!'!>!/_"7>C_A7W_!0_P#Z."\"?^$N] 'O5%>"_P#"OO\
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M7@O_  K[_@H?_P!'!>!/_"7>C_A7W_!0_P#Z."\"?^$N] 'O5%>"_P#"OO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ9JFB7ZV.O"YU=1;:3='&(+NY'[BTEY7*3.C#<,@9% %W5OV ?V-M:_9&?\
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M\/ZEX.5$<^)['4XY;$HVPJPF4E"I$B$,#@AQZUC? K]M+]D;]J"[N;']F_\
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MA^RS_P!'*_#_ /\ "RL?_CM?/_\ PX(_X(V_](]OA_\ ^ <W_P <H_X<$?\
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MX1^*YUJZM?MT484M<3HTZF./*J&P[$A=C[O_  1%^.WP+\ _L6_MH_"W5/$
M\,S^'?CI\0]4O]-UZRGL!HVG2P6T%L+IKA56V=F1XUBE99&,,H"GRWQYWX&U
M'3OB=_P99ZGX7^'6HV^N:EHOP_G_ +8T_2IUGGL3#XF:XE$R(2T96%&E(8#Y
M!NZ<T >K_P#!:CQW\6/%?_!%?P%XI^._PKB\,WUG\5/ ;VL=KXA_MF2]MP\+
M?:BT<*,LCEI!Y8#-QU.[%?54G_!5#QWX*_;=^''[*O[0/[$OBCP!X;^,KZA;
M_"_Q]JGB:QN7O[RT@$[6][I\!:33F>,J4#R,^9$5D1A((_C;_@LE^V;^R_\
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M0!G:-X0\)^'+V\U+P]X7TZPN-1E\W4)[*RCB>Y?D[I&4 N>3R<GDUHU\S_\
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M*/CI%!IMF\V;_P"$=]9PNX&$C::8+'%O<J@9B "PS7Z+5^ /_!YM_P %(O\
MD5/^"8OPSU[_ )X^*/B;]GE^O]G6#X_X'=.A_P"G5A0!^0EK_P %*OVCK;_@
MI(O_  5 .N;OB /B ?$[KYK"%E+X.GYZBV-L3:[?^>/RU_3+X$_X.</^"?WC
M_P ':;XST3X5?'6>VU&T297L?A#?W42L1\R+-"&CDVL&4LI()4X-?R+U_0-_
MP9E?\%(OM-AXK_X)B_$O7OGMO.\4?#+[1+UC)']HV"9]&*72(.3ONF/2@#[X
M_P"(D#]A3_HCW[0'_ADM4_\ B:/^(D#]A3_HCW[0'_ADM4_^)K[^HH ^ ?\
MB) _84_Z(]^T!_X9+5/_ (FO;_V(?^"HG[/?[??BK7/"'P8\$?$C2KKP_I\=
MY>R>./ -WH\4D;OL B>< 2-GJHY YKZ/HH H^)_#NE^+_#6H^$];B9[+5+&:
MTO$1RI:*1"C@$<@[6/-?B_\ #KXU_P#!37_@VAT<? []H7X'WWQZ_9%T:_F/
MA7XD>#HE&L^$K&6=I#'=Q<* K2$[)MD6Z3$=R% B7]EOB':ZE?> -<LM&CD>
M\FT>Y2T6$X<R&)@H4^N<8KY+_9V_:H_;1^'W[*_AGX;?MG_\$X?B1K?Q!L_"
MEMIVJGP1=:+K&E^(YEMQ&SF:2_C^RM+@F5+I8T1F8*\JX8@'I7[+W[7_ .PC
MK?[#[_MD?!'XKZ18_!^5]9\2ZGK]_*UO'IT]S?W%[J N$D :&474\^8B,[F
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MB?6OAM\(_#GB#2_$WB"#Q/X>A>:34+._M(Y+>WGU-)GC0SQ2-N1&VDX4L-M
M&=I7[(?[4G[:W_!=_P !_P#!3'QO\!-7^%7PQ^"OP_N=!\.#Q;>6?]M>+;V>
M+4(V?[-:S3&UMD_M&0CS6#'RAA?WK"+]+:;#(TL*2O"T;,H)C<C*GT."1D>Q
M(JCXIUG4?#_A^ZUG2?"FH:Y<V\>Z+2=+DMTN+DY VH;F6*('G/SR*, \YP*
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MQ1\:?CEJ&B^$_!T-_:+;:?=^(]4NI8H9;B.W";+>*..25E3:6$00,I?>+_\
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M_'7@_P#:G^.$O[$4OC/3;/P-X:6VO_CE=7&I1Q?VBLBK-9^&%W,"?M"[;B\
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MO_LCZ#X;O]?^-OBRU^%=^E];W3O\/KOR5M+9!;SR>3 RJX\F4+*O\2C(J?\
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MA^[NK<23Z+JTML]S9L>L<C6LTT)8>L<CKZ$UHT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!S?Q?\ "?B_QY\--9\%^!?%]GH.I:K82VD6KWVCF_2V
M612C.(1-#O8*3MR^T'!(894^1?\ !,S]A[5/^"<O[)OA_P#8_A^+Z>,O#_A+
M[2OAW49_#OV"\2.XNY[N59RMQ(DW[R<A2J1X50#O/-?0-% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
7 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>wst-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:wst="http://www.westpharma.com/20201231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wst-20201231.xsd" xlink:type="simple"/>
    <context id="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2b3afcd93c148b5a5a8c3bf86ada02c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i821435e98b7349719699f23a9fabd11f_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iac1e5371f0134eb9995482f7560ead18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0230c88584154e91a07b322788cd39a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89754d8eff0a4a21b0723157da2cda70_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7eb7e11a1b0044108c665a9e8425b3d8_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ieff9a042b0cb4730aae3ec835e713476_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6198c5c042db47db99a2b2ffabc3425f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i73ec1277012249aaaba2bbc8e69b9dc1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="if44a63268f854be99514777e8639749e_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ia863152d72be424e95b4eccddadd94e2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7a5e4a6111d54b648e0349ce16e32a15_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i89a2d506efbe4e4abf499bcddf045827_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifb45a33c02564935aa8568f277f49d7b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic2eb6236c6ef4de2b1b88eb4b6d0f67f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ide2eaf9f89f64fc3b8edf54395816f7a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icc36a7c52d664ddd9d308b197d911005_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5a2b0616539540d2afdbb1aef826ba8e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8d2860bdad8e4c5f80b333c36791f4e5_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i840b6e15466f480a85b720e9d8dd1aa9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id7db531a64e249498d81ca1360119f0c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8c9f256a412b4a58b1583e63cb3d853b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib93b62e40fb3459c8fa7a41ab3cd4a0a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i505c1698fd5746dda4e419a17470e15e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i82e08973cd064954b4b8f835bc97cd66_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd079bb091934d528c33b541a4ccce8e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i57c744ccf1da46369f9ffda6a48eaeb7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i953aa2443d1a4326b4f15164b962ef7f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7cd9ef6885cb4483a826dc5519bf65fb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3839e393aceb4fd0834689e157654cf3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e0b9a4c775c4c6d99c01d89bdb05da3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8ce2e61c66d64a13aa94d7b58161681e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6986700a9d62490d965d3d1f40d2a0ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55957b9eba4c467ba3e5b0bba2e29a4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46a9cd662cd140e6a0bf37cf6471e2d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f5468dc7ce54d57819464e399e6c5bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie45120a724f04b6dbac9726ee336f7ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if961352725c24b75a3c9007e9847415b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief5c5adaa64e42959e00816c3bf6c2b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i1d47931a6e3740b480deaae11058a69d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37e2e771b55940c7ab603ef0b73ffe0d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia62094f562004390b81aa8036d7b155e_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="idf9d37b38c2447e990845dc75ad10954_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="i7ab15527d47f4aa9a1633dab43f58d65_I20130630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-06-30</instant>
        </period>
    </context>
    <context id="ie910eb49306b47f19aade26345fa3e40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20906f3f318b4a2cba7c15716696f1dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i923c8a6896e54de69ca69cbbcaea99ec_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id367f23378974623b9859df2596c8183_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iff18b4560ebb4519988e5000afc9573e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifd0748450e4b47baad0f75ab4d3d1e44_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0d22ca205d074fadb933b7fd00da1f1c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia3e7a414c18f47b2b7c9f8868c4db4a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9aa616b221f246a086f3ff77b50744fd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i018928bacb95446581fa8dd22ce885b4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2940c5a94a5545e9b92428881a4b24ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b52db3c7d824219b44bf0415c21dd9b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife59a6f7e63848cfbf9db3761a806465_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i314b3eadc19f481a9a5cefedb7076b5d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id5c8bb5e908445ac94163109d6f187fe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic80d6874e9d04c2c969ac30de82af315_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i695ca37571594a2f90e91281811f3f60_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ca2c0bc504f46c09b0f5349f5d4babc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b1d30e86ad0440eae32d35a5c10f6cf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueProductDeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icebffe8ea45e44b7ac1fb37ca2ab6e4e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i045d57ee128a4dfbab51df17a738c76d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i05f318a8522b4df3a88ab126fbe483fd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iacdb2fa885c04d209366d073597b6e65_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i286700d9c43745be93c8819dcc7cbe24_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id754473ec64a4fc7bf5cd626c8c7f917_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id933de360a3a4f38a4f172632d39f380_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib979385c7bde4ce2b05dee2c7e29ab4e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3f265678664c4854ba64c2adc9a8a208_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib0b1fc94713546ad8ea568bae5635986_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9ade024d2944ee28eb78ee61e0a8c28_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6b8a3f92e87547398e250cd6e50d2471_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if5a8e9607c46467ea4f32c403fb194c4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3c3a0fd2c284cc5b42da67050e9f64e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7e55590c051146b6bb265c367a817a3b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5338787af4fd49bb99c35be9bb0ef3b9_D20200101-20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="i73877135951c49808f223e59689acc98_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i797e7706a95c4087904100b08ffda29a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43893472b07f462daa1936e31dd6e050_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7dc331021b39487eae7d8020f2a6bbb9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifac82b7c5e944f5e9ef69d0cc9b23961_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b9f3baa155749da88ba56d5f039aae7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib84fd26354a144cea716d068af99f852_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieac0052e9268404c8537a172e384ec54_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i623144efe05d406b97fe87c5de9251ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i22f0862b68a74914864a578b3eccdf30_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i238e2384b1ff420ebcc2252db6a22803_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5c646a3c66bd4b32b179638b0f4f3410_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a501f1bfd934f5986193d345963b2c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b6725930a324da584fa5818f87a7c19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0813f85e68a04705a535a614e3d8d1aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i74e88843a60b49ff82c73cb0b8167faf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b9182def7704d2e8b4c70f42352b523_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8fb2ab515f964445a7edbb1dcb815cb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c5e7423241f495ea2428efc693f1c2c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8af390c674040738b060151f2548d1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72fa20c7d6fe45dd9143b6334b282969_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1e509ff0f5b945d2a61627e10cf74c19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3be748d3389b4043bbf41058de1b56a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:WestCompanyMexicoSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3f00119f82f45ffaaf450f7f33b594d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:AluplastSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic55755bcb9b447d0bcdb031080c38641_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaTapSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idca87fb6336b4470ae7aa7facb3cb9dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaRubberSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief5faa8076a2458484658e4551e6e62a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:IWPharmaGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa409a36165643678fa489cb0bfba317_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7eb5c5ab7e624c9cb50fc001dee5e2ef_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ic8e22ea7f9ce44e9bab1f731e0385e4c_I20191101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-01</instant>
        </period>
    </context>
    <context id="i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-01</endDate>
        </period>
    </context>
    <context id="if35f246fd3544635b81e8a42dbd0deae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ife9245eb0c4a4874b266ec836a4fdc4f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i10b64636eec7496ab4fe500fe0014523_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4d80b77bc4ac4259a6a16b2462cb3040_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8da13621281d4304b07876e3311d46e7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibfe51fd72fce4c61b52e43766f31dd16_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie604f66c47674b3483e91758ca61fca3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3bd440b2a0d4e18b3b9208a2c52f423_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4310b97395d143c894afeb7bfaa7db95_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5dbef396511e4f7d99df2d1f6bf9ea78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b8653a82cd240399911d2be8d12b1c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d40747cb76f4017801fff732122769f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0d1e9f54b0d4246bce9c1710ee63360_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SouthKoreaDistributorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45f82da0975740ea962df3a9317d294c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff44052635f445ae955fe9e5585b43a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6e9699cda854495a74995b636566af6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id22d02338f104289981b9d9ff7b017ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i11d276e7e42d4f86a942aeb848b531f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i675a7006751b46918799584d6d648565_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2aca41366c9f474c9c65cbd82020f94d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id040728146984679be5dc82bedb6dd6b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie61c5d576f4c47feb0147ea226ccf081_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SouthKoreaDistributorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="id71719218e6a4641a583e3045ba927ad_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:SouthKoreaDistributorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8f18ec1636d4475a790dad18e1921a7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4fd969a8862944cda67258a0d270f5df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf89ae5341df4d38abf9f74b7c69e08b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic8f4f2eff7da48748127b29635896464_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6bb6da4755b453bac747d67b20ec2c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3d56da838e884589a4b9b27e4dba56bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d8b84cad2c648c3aac2a92756cb752e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36499f4c892042c99421485b861d8b26_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i053014645cf54e15bc7d157e3bd317fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9a0baa710cca4e74ba3a4ba6d1ff9627_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib790285c47534a188d7b8a25e56a0757_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79870e1d300248c4b2045f7b6b99751d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2dadaa6cfa6a402590d0baa08c3b3ff0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9276b28f1b2f476a8f79b186a11cf9cc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d9aaaa15fea43d5b98afa0705388896_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie84290cd198b4597b8a2abee7084ce4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i77bf362efbe64c2ea5409f4177fc61b9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib153aa539cbc4b36bc036f9670da7976_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8cdb2635fb0940748713a05a2e05ede6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0818ca18d1c04be49b0664009bcbaa77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0acb2d0db3f94443812b8dad4134f99f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief5c6bd09e604af9b7086fafcc87e380_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i40b38bc3ea1249599a6fddd5077007ca_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="if9b19f87e2fa4bd7b7446c6d36467a3b_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="ic05b210f28044eacb815b7c56280e7a8_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="i1a8d1afadc494e8ca3807d39357fab2c_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="ie1fdf8a78aa34446888179eb44e2ba9f_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="i7fe9b14827ba48db9e2a32e413c46681_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="iac32389974424652ba8a1cd7cfffab8c_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="id54a356e860a44f0a5c4f4291d81c943_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="i59aded202b8249ceaaa3c323b8b6ee44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85263fd85aef48eeb384af58612ce47d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id2df6627be904a9aaf00483f12940dc4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i252de83d670e4d1ba875a6c0d2fdd702_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ee03ed217f4413f827d72745983e40f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i897b04b0d4e34a368ecdaa5308ccf498_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i531ab9f165fe49a0afa50abe554696f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5aed1c49d23b4bc8983a2bb4f02182d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieabc497ed7d9444b85e9cce201865f83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01129bb47aaf431d90ed2cb429db9b45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04c2cfc044364719874b1386740f71fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb1615ceaf2a499986cb01691d97764e_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i139517c5b19c4c238b0b6d76659ca642_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ff56989b09342d4bf86220442ddc67e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba0a8733971342b896a7d0f4d587b143_D20171101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibfdda46fe61740e6a80e78c142d7da03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75443478f88f440a974d749223372bba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d779650ed364fd08c026185a18a616f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia766950276184bbc849712d05a16b8c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia815265990ad4f3abe0d627f15f293cb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2f263abf32a8469dadba8af24398c81e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9848d3f7103145a283f6dfcbf2d72655_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic495cc68ba6b4b1694f7a3fd4db93012_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i16739f8659e14555937d0e778a704f20_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i13810f93490c470abbbb7b177ad2c70e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e5247f6308b4858a3772e7407bec118_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f77a45ab1ee47a3ada5f6fcca04c84e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic12ff4fafcd445b084b889fe3305c91c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9154515da1a548fea6cda75ecab6d22c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id1c3a44d90234809a59a5c72a954a186_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if00c3d38891a437c9731668076f93583_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaa425d5cda7449f4a965d518a8498929_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie98f2ce6380048b498942fe656d21ed9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d44d9b0abe64e9c8fd7b8070ad808e7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i910293864a4644e2bed118d404b0a767_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie74cfeda5713466fb73b2c27fca500a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i29005ee8df5b4ec39d6cdb0828b7dcb1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94f10a3f9bbb4fff966da3ea80caf6b3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id20703276ec2492ebfbc9c45c8e0ac7e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7734ad779fa1491187a73582966992ee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i45ec217f28a14172945a28df8210d239_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9237b0939d04baab3100c204058459f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic0c2886a63984bbfacf71552235bd450_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i09837e92679f4dce8b31c888e3564350_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9ce83038c2641929269fa9febd355c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i512334ec39334b2c92eadce7653de2b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9cf21d4ddd1a4397b60f40f3bd3f765a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaf35b6e1c0b46a8bb43590b974f7cf2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8053738038f04d46be3849707bcbbdea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icba0cd37398843499f9cfbbcc1d88190_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4124f16416b429fa6225456655a8660_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ea7dadd6e8e4893929788b5e7b6e3f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b77a899950e419aa8380f233b32847f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ideda06631bc243b6a3ad62cd4484d60c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifed7924e91c448cc906ea5c40bdcfde4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e10d28fc0cc413fa59ffcb836fd2a62_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icdc1f55bdfaa4f77bc2d00ee21f69a3d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i253a14ec94054a06b279f6ab052a1335_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i047657ac51d94d94bcf8cfad62457a39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5dd2da93f35e4130a407403f3b757235_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i16fa19e29e634aeab2eb9224f0b45b18_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i724fe533a83d433eae9b42977e2f7b50_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c7a7f771134445a80565de94c28062f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id048dc02c0b2469fbea105614ae2e480_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2bde75d952ad42e98d7390be88bb1df2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i60ffcae4b075439ca55b2069a4fd47f1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9c78a5b1b01444c69b59c15f8578421c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if4cb3f26d5954c919726e7cb7785fd7d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0568fea18da421bbd3bca7960cc204a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1207be39ba114326a769b349741e01cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9dbc3b28347940649422a5aabfb3dc04_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9a4e354d29304999b66d6671f79f5028_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iccc55ae3f38944cb8ac2a8bf2c81c4b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:SalesProjectionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4447f5127f674e7f8698a17c77e3f3b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:SalesProjectionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie942ed6d0ed647738c0b530564afcfc5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:SalesProjectionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7f2ccbcf7004f9783ca3beb8c271c99_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulFDAApprovalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i196249d46fc346f1a73485f5ad2fbf3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulFDAApprovalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e3b441cdb5d4c2da4292cead5f46a91_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulExecutionOfAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09071b9fb2a14ad282d0cfdd020d47c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">wst:ProbabilitiesOfSuccessfulExecutionOfAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib058c9e2b3e74454af000898cd0285bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id84b7326bff74d6ebd4702280f7944cb_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i73f46e104061488a90e0e2d284629010_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i658cc38b8a3b41eda1a5d4e62559ac50_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i51bfe342f5e747da8972ffeb014b1e1f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id681882b891d45d7b8705f79a7375de1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7365acbeffa54ca3967c4b060d8a6454_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iad1f1467c6694df4a0d7fc8661e6b67c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i394755247a4245c5b34c032dd17977d5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i896e20ef243241948a91a08bcb36aada_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8565969bde54458fb11c038691603413_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8143f0aa268c43be9cb5a90dc5b80fc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie93df88f97024c308142319431bb90a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1754a699316c449f8f1f4261e2891243_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14e414bd78984a40bfeb308b44cb7247_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i75da7f02f5094418a3c0f650caaf45e6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib29ca945bd3c4f2e8e97e9cb0dd524b6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2fadb2a71cac4c68a8087322aebf7865_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b53436536584f99949ba6e260846ce6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94d102ffa7174cdf958957e889097fa6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd49877ac6e94e8ba65f322b6db5e98d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e981e6b5c1c4a0a96533e1a52c52939_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idcddbacbafaa4e1a88fe1be38aec0244_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2b56de45b3d044729f17a76e52cedbc9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58338c0d70074d60967ae84164421b21_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i08616f88160948b48f5aaa6efbddcba4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idddb809162cb4f63a286d585b789e694_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4d603594868f40508e7fe929d734564a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4526e48ffa5a4038b2bf9bfff300abac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6835ccab784849ca91ebb01f7d09ae9c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbed69520f7a44dfaa08f657cc8f4421_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c545e42bb914c0c88935ba87d94b5fb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9d8d0c816eaf4dfca6437e6e6a59e325_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34d543f5f46e4f9a93d41fac73ca8d9b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id6d567413c754bd2bced1765c543f431_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i96c87fad149e472cb246ab4b33e1c09e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f2ed4fc5d284253859a0c77c2b51762_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie536733ecf0f49159c3492b03170fa5e_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia94b75e19c564babaabe3bbd0f85500a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf9f594c3975439797d9bcdaebc0d887_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifa7ad396fdcd47809883f36d39da738a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if03468ad1c7345619b7c14865b28e6f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4df90090669487784ddadbfee1e8f77_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5509bc461133464cbdfc6fefe5088ba4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a997b8a25584ec488869d0d3049d1c0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie2ffc58869ae424aa7cbc9aaf84a2dd4_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i1c4540b26bb74a9a969cecf57c787621_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i417b7c21dd1b47b8b40d34cc70053be2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibae2919783b045ffaef7c87dc7aa860f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd5b02eced6f45d7a117b354e107f82b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib92f1d4eb98744d9bc103ffc68dd371b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69fd39a6d2c54a91b93d39724d4934c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic09e3fbc0235485daae5c0994ee55f63_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia2f8c2dff1fb47aa8d3c65c340678d15_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i796caa67ee0e45cfb059041a1e2187bb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if13e4b6d592a42489a6f499eb9fbfd39_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i876e963861bb446cbb82e6c637fae2f2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1478cc28dfaa4d7f889e3ee1528d58c4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i386c37780a184cefb9928ebfdfedcfe7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icbb0433c970748fa8ef413c8bd5370f7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0dd3d667f6f24bf5bc61589ce38acb11_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8c2c88135cd14a78813b05c34e34ca53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5fc2f2f3b70d4f728400db29e64a3f7e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iba56c58d773f48009254ee34458305df_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5a02b0a604014333900498c1cfd05c7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81cac794d7894db3846aa546dee94d08_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib040619d3008485c9326df9c3dbf6e37_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib8190a671d354cd382c8d1942d0777c4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia2f09f2b9514472e85759120e9c8f6cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id23ad1f4c66d488cb8092ac2514b826f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if4075113bb61471da80f2c6ac352be97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2afddaa78ba4eb9a300b205038274cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e90da744d994db1aa27a052c7ea5372_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9cc77fb8f01142a38ee0cb161ae8c1cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9a86b5e8a2be41a4881009bd7646cbc1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2e8f7729b95c446d88cb96cfb7b67b5c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if5eafccc5cbf45f3b2b2941de558f722_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i135ba46e2e694c4bbc75dbd5e31ab210_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if288e4886a22444a9cb6096fee75382e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1f757014e0945a5bf6bc2c5b4dc7249_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5749a3d72efc471787a5d2c8be39e567_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i702b7d354d8f47ca9dce932abfe26468_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4b55367d0664406584e5bef4f962b96b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id543109bbee84ce08728e7c8c83af280_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie5187136b2ee4ca79301744704a7d717_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibaa0d5d817d5451f853f49d5e75d6d4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f4c146b4a9e4cc9ad5a9fb7c2736c33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11cf3bf12dcb4f7b89f6fa466bd6f61b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36f034759b184fafb0766fc3e84b1c36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87e6d40f72d74559bf0873f01c9b4e42_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i094b2113e7f547cd90c587fc0372659e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1999229824e84c8d9ca34567aec0c908_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96d0ab8218d949d2a659ec046d80a1bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie419e0a44aaf4d3eb5ee9c6b334f68ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa24c422d8c0405099e0de09723d85d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72c91cc19e464254ad91d8affa894f9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4add538dc55426e88cd3a2c21336362_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60088b670a5d4762b599e56d5c4144e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19a7aa0c01fe487d95b11f1de2d144ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f5c08c9be044322af60b2edf7b438f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34f71fa6b7014a0d9856ddccecd5f63e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8341c7060458474a822a8b5d2048ad64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcd0101c2ca4488b94dba592a0fb3f19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d50bf5e175c440783b2b9c219b372c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i266aa4fc9a0a43728336bfdd4f5d2243_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44f001b391204e3ca8e6364079ecc773_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i709ce196777d43518c28b2c94fdcce0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied72e1adf5634108a0178f0d097f1efb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98071b96fe31436b9c3b419eee7e32f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7cda47cc19b4bf19d6b5dbe554f69ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i050e371f0fc64570a8371b4ee1d6bfd2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if951953d16294cdcbc6e8bb801ad899a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib50dc684425d41089759a744a6bfe976_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc2f1128dce6466cac75150836fb94ec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i494430ec845b43fea48e416c8601f31b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if60b7e3f1fcf4c8b9a2d92a956688b64_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idd9cfb636098475aa47d5bd1a223dd8a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0308ba03d22245b7b8e1dfe8f84611d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaf18620d1a2e439b9d01b280d170a058_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3082f2f2d81a4f0883e8d344e51d25b3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibb54b4a5ace54151917b1754f3a19fa8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9b0a5df83d0b47c1b25e912b720d4e01_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i08860c9461ea45b79e3605f7916ca562_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idad97ef7bc454cc2becb3891d672bea5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if9c0729d942243dcb1acd45b7a4b2302_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd693c0a25a2479690b679e348d38eb8_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i3279f29cb3d44ad398fdc8d0e4645742_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i2db454712df547c7ab009dafbba594fd_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i84165f2d4d454d8183ee94793f21eb44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c10b1ae682d4560b9e68e567ee78779_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i9edfa646c3214875a75bd7a3a78ed53a_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i0f0c156b11b44bf9bb5fc1e2d121ddfb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8c9174797bed448da4f42a9ab90c7fe8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd22d3c670e54cfa9c8332dd9e2049f9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i011bfe673ee54bfcb6f9c6983b446443_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i810c968a3f8644c38105ee05c0745630_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b33dcfc3132453a9eaf1f23d1e28a46_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99ea9955e84d40b0977aa384c11038ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i23e32d9c6ce54b18abbf607406fce66b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia5ec7fb1237e40e185af54faa36233cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic176204c3afa46c5bf47f585a3fda12b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1051c2e627924a1084b2ece63cb73f04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iceed54e3fc2843188a6afef50414dfb5_D20180201-20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="ia296001215624e7b9dab9ac52000b1bd_I20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="ie24ddffb97cc4456a1f560750a4db57a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i50f424d813e44fc58d59312550371a32_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i28e15367dd044052a08c353d17ed4488_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i70f0a5d05a354c9ab3ed46523d85026b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0eae9458001042abbe77ec865b769cdf_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idd7f955de895424dbdb1f1a1c3db9fc2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iecb988feb4be406a9f663fd322648742_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i85908bb4116442599a19d848f1076448_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i32f79a77bed344a6981d9eff588ca896_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f5f1f9c46284f9b908b58203e0fdd95_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6629a2a3e6da4a748d04ed957a6ed07d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i193830303b9d4d0193b328737f36c6c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i274376d36fa54890b82f08d6ed48bbee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27d7dd7dc1104b2593a44cdf7974d37f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62905753722c4190871f9b11bf5dd843_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ed2f680acea47a38a544ddfae0bede5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibdb482e22f9f489f99c206b7e374b961_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4ca23e5869c48d8b6e8710608fcbbdd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b5aa17d4bf34a9381a6369cd9b7643e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i124cb2fa8c124903a808a37113465670_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9daa8394ea5c4fff8c0bf665f388fdf8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1cd1fba210414204826670f7b9718de1_D20170101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i595e0d99768d4fddb665c130376a4241_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia79ee42fd3854b1094384535405e880c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7054c41751544f6b384cd99197b808f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff77fa642e814b6b8597126f28871557_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie86aa1917b504d79b444ef1639528a31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib485a2f5d6d34d779c1f358e30597b6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i774d0f0cab54416082070e38f9410ff3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2bd2ce98d3354cb59bc39ace8c778f47_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f2732fdbddd435f8a75ce6550a1311f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iccc9431b0b454feab552857b416ea0ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic2d4d146be594713a85bdeb50230ab00_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibf861532e0d24915b8be512c7b015ea5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6859fd0c19984b50987f791266a4b2e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icac6e86e417f4406a08009e46537f51c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibd8b305543904c68b1b271d9387d71fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f8027821a434a1689f83110fca51907_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i12d0dacf1c0841d5a307f3bfc32d20da_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2e114810392f4404aea674dae1f5b2f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6699e8acb7d14b0ca42ade817a9f705f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d2ac6a7f541499ea8ccf5a4208ace40_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia2805175e4f14fc5b6d7559c8e6d0bea_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieca17c3296344ba29f4960a8397d1ba5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2ed92857acc241a2bf581f09e87478ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib123a778d0474f6ab51dda0673a420c3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id32983fbf1724e6ea83c4fa95b8a050f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0588f0020ff4e1380042e497db31675_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6f4c8efe73a94954b43ffa84714f22f9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id394f2aaf20a4f5a8065aac88dd87877_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9018f7f2975643e0a3f04da690ae1d48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia76813d2bec64911becdf36778a96555_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e63f25aee7c40ba95eaeefc7de3649d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i991655d17a3740aa8576ef108e472601_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ieddac01d5e554b06879611717faa28f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81778baca03545dea6b871ec4c6c9f4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb14a0610fac4aad8769dddc489dbe8e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i461ab78f5c0648c6b759cfad0b1be277_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i415eb61f5a0546a8871238557c61e7a0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2ced6416e1114dbb92b4432c973d7b0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i416bd58eeeb14e2fb2be821ef3871bd3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1438eab01bf433fbc35a309da3262d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60b7677acdc9401e83ce68aef09e830c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie10fea7610d24805934edfad68c8e75b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2ccb8142a6fd48a197381524a3af0e94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a0e7149a4524df1af74160af660cd5f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie5a866adcce645a4a119d06e29948d8b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35257ff2d24b4eb0b102a172b964a457_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8cda55f4b25b43e7b343a66c73455087_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i543690089e2d4cd78c08099fc3cabbd8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i719b99d7c88542fa96519a7e6ee06942_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9d8b5816ea284568a1893e7fcb6f3fd7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic26980b6c24b44caaac3a924b44a1e9e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7fe7bd6c2ccf4155b6958ffbe633b8b2_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1ea59d55ee44d4ab3fe01dfb28f7c7e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4fd2fec9ee1f4945b5522f7f39694676_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbc2b6d65de7432a8a9361729083f9c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd68a9b944eb48d7acb4f4672ce330e2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5d2c8af23c24659a9310a2a892a4f62_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idec6d3b519f94b4fa556d9176df56073_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82896f6ac3984e04b4105c6005e58772_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i67679e92fa7e4c908452f2ce5a3f225e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i882a8d63ebbb4201a759ff4643894e63_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i71aaf080ab884248b5379505dab9cfc7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if820fa9d156f4d8abd00df5a22472ff0_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i742f81f943014659ab25279911503298_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i906d2c0507c14130885513cc846a85fc_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i8c0f9eef8a8d405ba0c12024d16f0191_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="tranche">
        <measure>wst:tranche</measure>
    </unit>
    <unit id="sgd">
        <measure>iso4217:SGD</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="bbl">
        <measure>utr:bbl</measure>
    </unit>
    <unit id="usdPerBbl">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>wst:bbl</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="plan">
        <measure>wst:plan</measure>
    </unit>
    <unit id="segment">
        <measure>wst:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV80LTEtMS0xLTA_7258f3e3-53b5-4b67-92da-4d2b6d6143d2">0000105770</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV85LTEtMS0xLTA_49cb21ae-a3fc-48d6-baa4-20d2f5a4e357">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV8xMC0xLTEtMS0w_cb06743d-c29d-4051-92c0-ec4f9f0a9260">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl80L2ZyYWc6M2NjM2EyYjk1MWJmNGU0MzhiMjExNDRmZjYxOGE5NGQvdGFibGU6ZDA1ODg1MTA1OTUxNDg0MTlmMzUwMmEyNjUxY2U0ZGUvdGFibGVyYW5nZTpkMDU4ODUxMDU5NTE0ODQxOWYzNTAyYTI2NTFjZTRkZV8xMS0xLTEtMS0w_592e0796-d00b-453d-8e1f-043064b678a9">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="if44a63268f854be99514777e8639749e_D20170101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMi0wLTEtMS0w_9af21823-f8b7-4576-99a8-b548961451d6">us-gaap:AccountingStandardsUpdate201409Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMC0xLTEtMTIxNTk_023aae83-1a7a-4eef-830d-157299dbe663">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate
      contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDIvZnJhZzo2N2FmMzZkZGNjMjg0ZGViODZhMjgzNzZhODljYzhmZC90ZXh0cmVnaW9uOjY3YWYzNmRkY2MyODRkZWI4NmEyODM3NmE4OWNjOGZkXzYwNDczMTM5NTMxNDQ_45133a60-5b19-454b-98c6-745f7c68c0ae"
      unitRef="number">0.25</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate>
    <dei:DocumentType
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGJmMjQ2N2RkZTJhNDY2Nzk2MDNhNmFkZjgxYTNjZTEvdGFibGVyYW5nZTo0YmYyNDY3ZGRlMmE0NjY3OTYwM2E2YWRmODFhM2NlMV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjo0NGM0NWFiYjVkYWM0ODFjYThlNGQ0YjE0ZmU3MzljOV85_68c1870c-f749-4ee1-8758-46072b0e87c1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MDZlZTA5ODk0YjhlNDg1ZWFiOTYzYWVhNzM4YWQwYTkvdGFibGVyYW5nZTowNmVlMDk4OTRiOGU0ODVlYWI5NjNhZWE3MzhhZDBhOV8wLTAtMS0xLTA_85ec3c2f-94bb-470c-8d24-a80bd6650cea">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4Njc2_dbd4f4de-edf0-4a6d-a859-8a065dde70b5">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4Njc2_a448b017-0cfd-4b72-8f5b-364c51b4cd00">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6ZTdhZDViZDM5MDkwNDEyYTg1Y2UxMzBhMDYwYjYzMWQvdGFibGVyYW5nZTplN2FkNWJkMzkwOTA0MTJhODVjZTEzMGEwNjBiNjMxZF8wLTAtMS0xLTA_569e11bf-dd55-44c4-a2e6-16bf108293b8">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8xMjk_a958e568-7437-4558-82ff-cb8e4839fe9f">1-8036</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6OGM4Y2U4NmM1ZWE3NDUwZDk3NGExNjg3MjlkZjJhMjMvdGFibGVyYW5nZTo4YzhjZTg2YzVlYTc0NTBkOTc0YTE2ODcyOWRmMmEyM18wLTAtMS0xLTAvdGV4dHJlZ2lvbjpiZDk0MWRhMWFhMzM0ZTVjYmRmNjIyZjBjZTI5YTA2M181_388abd33-aea7-4757-9bc9-304ae9efd202">WEST PHARMACEUTICAL SERVICES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8wLTAtMS0xLTA_efe85c34-639d-4a5e-b2bb-0ab725cdad6f">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8wLTEtMS0xLTA_a2e427c2-0716-462d-b847-e102c448806a">23-1210010</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjozYjExNGQxNjI2YTg0NTlhYThiMjg2ODQ2ZDU3ZDc5Zl80_7bc1c93b-5683-44e2-bfc3-67aac9aa12ef">530 Herman O. West Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjozYjExNGQxNjI2YTg0NTlhYThiMjg2ODQ2ZDU3ZDc5Zl84_5ebde6f4-3416-4c09-830c-baa239c1dc5c">Exton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjozYjExNGQxNjI2YTg0NTlhYThiMjg2ODQ2ZDU3ZDc5Zl8xMg_fa9199c7-64fc-4db5-9776-7243d91d046b">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6NGFlNWM3NWEyZjA1NDdiNDg2NTRjNDMzNjY0YjRlMmEvdGFibGVyYW5nZTo0YWU1Yzc1YTJmMDU0N2I0ODY1NGM0MzM2NjRiNGUyYV8zLTEtMS0xLTA_32cd47a8-ffe8-4941-909b-f6cc8302762f">19341-0645</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8xODk_fb946234-0e2d-4da6-8162-a025c7bfef3b">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8xOTI_1f5f15a4-3704-4020-8de8-9d0cc484a3d6">594-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6YTk2MWZiOTI4NjcwNDYzOWIzOTI5MWYwYjcyOWE0NGQvdGFibGVyYW5nZTphOTYxZmI5Mjg2NzA0NjM5YjM5MjkxZjBiNzI5YTQ0ZF8xLTAtMS0xLTA_1b13323e-d537-40be-8b55-3287b6a266f0">Common Stock, par value $.25 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6YTk2MWZiOTI4NjcwNDYzOWIzOTI5MWYwYjcyOWE0NGQvdGFibGVyYW5nZTphOTYxZmI5Mjg2NzA0NjM5YjM5MjkxZjBiNzI5YTQ0ZF8xLTEtMS0xLTA_a455e474-7ef2-48a0-a663-cc4f02180ff6">WST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6YTk2MWZiOTI4NjcwNDYzOWIzOTI5MWYwYjcyOWE0NGQvdGFibGVyYW5nZTphOTYxZmI5Mjg2NzA0NjM5YjM5MjkxZjBiNzI5YTQ0ZF8xLTItMS0xLTA_ccc49c6d-5271-47db-8e4f-3bda9334c370">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzQ4_c99cad24-2ad4-4cdb-87d2-4616777307f5">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4Njc5_f7d14242-ebce-47fe-8e5e-31b5431660a7">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzUw_3b0092c1-2bc6-4708-b3d2-e1c8caa1f84c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzUx_532fb7c9-f9ff-42d7-8266-9f795ce76cab">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MTZjMTRiZjY4YzRjNGI2NTlkMmI4OTgxM2E4NzFjNGEvdGFibGVyYW5nZToxNmMxNGJmNjhjNGM0YjY1OWQyYjg5ODEzYTg3MWM0YV8wLTAtMS0xLTA_52d61c24-4ca5-4efc-98c7-8c824bc7d261">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MTZjMTRiZjY4YzRjNGI2NTlkMmI4OTgxM2E4NzFjNGEvdGFibGVyYW5nZToxNmMxNGJmNjhjNGM0YjY1OWQyYjg5ODEzYTg3MWM0YV8xLTQtMS0xLTA_e7c94544-3c78-4311-a2f9-e06513fbf000">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGFibGU6MTZjMTRiZjY4YzRjNGI2NTlkMmI4OTgxM2E4NzFjNGEvdGFibGVyYW5nZToxNmMxNGJmNjhjNGM0YjY1OWQyYjg5ODEzYTg3MWM0YV8yLTQtMS0xLTA_ca2f2b64-4e33-4a08-9710-26fbd89bf24a">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU3NDk4_fd51e32f-45c9-4f58-a581-ef69276fc294">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl8yMzUy_943d26bc-134b-4a1e-b439-af6048be8089">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="id2b3afcd93c148b5a5a8c3bf86ada02c_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4NjYx_6c4bdd1f-1248-48e5-bada-c52b0ab170d1"
      unitRef="usd">16742194934</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i821435e98b7349719699f23a9fabd11f_I20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU4NjY5_5fc214b3-c1aa-4715-88d7-988b58d0bfa8"
      unitRef="shares">74103026</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xL2ZyYWc6OWQ2ZWVhMGRlYWNmNDQ2OGFiMWFlODlmN2E2OTYzYjYvdGV4dHJlZ2lvbjo5ZDZlZWEwZGVhY2Y0NDY4YWIxYWU4OWY3YTY5NjNiNl82MDQ3MzEzOTU3NTM3_3b42ea75-9c41-4489-8338-79828f366562">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.261%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Document&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Parts Into Which Incorporated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Proxy Statement for the Annual Meeting of Shareholders to be held May 4, 2021.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Part III&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMS0yLTEtMS0w_cb2a202d-10e8-4a39-bdd2-3397c7b6b1c6"
      unitRef="usd">2146900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMS00LTEtMS0w_e55ed845-79fb-456f-bf41-223a9f5cb9d2"
      unitRef="usd">1839900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMS02LTEtMS0w_79f90d20-e5d2-493b-81c7-864e1295fde7"
      unitRef="usd">1717400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMi0yLTEtMS0w_d7045f78-49e1-4934-8347-a2422f952a7b"
      unitRef="usd">1379100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMi00LTEtMS0w_7d3fc790-2cc0-47dd-a52d-9a64ac739c27"
      unitRef="usd">1234200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMi02LTEtMS0w_c4e55e17-6ae8-4178-b2a7-22648873f5db"
      unitRef="usd">1172000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMy0yLTEtMS0w_c2441dfa-f2f2-46ee-bf92-afdafc0a1e36"
      unitRef="usd">767800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMy00LTEtMS0w_9907b28a-6f95-47ce-9420-2d20dfff1f4c"
      unitRef="usd">605700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMy02LTEtMS0w_8904883a-7efb-42cc-aa40-1a887a1cf9ce"
      unitRef="usd">545400000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNC0yLTEtMS0w_ffc3f40d-5e28-4d36-8bde-b925b7fa5ffe"
      unitRef="usd">46900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNC00LTEtMS0w_1fd95241-4d01-4e70-a9eb-7d891d91e23a"
      unitRef="usd">38900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNC02LTEtMS0w_c493aa88-ade8-401f-86b8-e10aeaa36189"
      unitRef="usd">40300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNS0yLTEtMS0w_cd675cc7-6011-4640-9ca2-7a12d666dade"
      unitRef="usd">302000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNS00LTEtMS0w_69005be3-3573-41e8-9e77-3d5601ac7373"
      unitRef="usd">272700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNS02LTEtMS0w_7107eb5d-5a0b-4391-a409-349d4eb1d6e1"
      unitRef="usd">262900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <wst:OtherIncomeExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNi0yLTEtMS0w_2ad26949-db25-485d-81a3-c912841ec367"
      unitRef="usd">-12000000.0</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNi00LTEtMS0w_813efe4c-1d37-4299-8d25-68e8be626974"
      unitRef="usd">2500000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNi02LTEtMS0w_8e2c77de-d11f-4dea-a633-f836194f8b50"
      unitRef="usd">-1900000</wst:OtherIncomeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNy0yLTEtMS0w_32792673-c256-4dfb-9315-19bd694dba35"
      unitRef="usd">406900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNy00LTEtMS0w_6f78d9ea-519e-46da-9494-b99068851c20"
      unitRef="usd">296600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfNy02LTEtMS0w_269702ce-c5fe-4a56-927f-a8deaf2bb00b"
      unitRef="usd">240300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOC0yLTEtMS0w_f76843d0-cc8f-43a0-9262-10c744ce82f0"
      unitRef="usd">8200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOC00LTEtMS0w_59f898b2-7da8-4c38-bad7-8bf61eaabda1"
      unitRef="usd">8500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOC02LTEtMS0w_e5b359fb-470b-496c-a2f8-de371930ef34"
      unitRef="usd">8400000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOS0yLTEtMS0w_c0d0fba9-4dd5-41fe-998a-3ab4e06d0f51"
      unitRef="usd">1400000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOS00LTEtMS0w_925a1cb9-d5e0-4ae5-b6a9-9fc8c424aca2"
      unitRef="usd">3800000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfOS02LTEtMS0w_537b69cf-a55e-4422-ae10-066df619b594"
      unitRef="usd">2100000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTAtMi0xLTEtMA_fc01c7e9-a4eb-43b2-bb3c-f167ac55f7d7"
      unitRef="usd">1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTAtNC0xLTEtMA_71975b1f-47ff-418a-aa50-0e1e44128dc7"
      unitRef="usd">-100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTAtNi0xLTEtMA_9e6bdff4-8652-4ae3-a618-f3db5cca38dd"
      unitRef="usd">6700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTEtMi0xLTEtMA_ff4b699e-bf2d-488f-a935-1ec19ed93d4e"
      unitRef="usd">401300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTEtNC0xLTEtMA_bb4b8d37-1313-4744-9f10-32d414df3150"
      unitRef="usd">291800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTEtNi0xLTEtMA_177235c9-4470-4b13-bc6d-651e3ece5d2c"
      unitRef="usd">240700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTItMi0xLTEtMA_1570d4b0-6820-4cb5-8806-4a91c0cb6952"
      unitRef="usd">72500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTItNC0xLTEtMA_0d432a29-2d14-442f-acf1-e1fe5a4c3236"
      unitRef="usd">59000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTItNi0xLTEtMA_1bc9a894-b4e2-4a4f-bc27-0b5680dfffd7"
      unitRef="usd">41400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTMtMi0xLTEtMA_70f347f2-a1fc-469a-8a20-72d97a470491"
      unitRef="usd">17400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTMtNC0xLTEtMA_5fb081c2-3408-40e0-9478-1c1e5e1450ba"
      unitRef="usd">8900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTMtNi0xLTEtMA_81e77cb5-e568-45a2-b6eb-d0b013a665f6"
      unitRef="usd">7600000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTQtMi0xLTEtMA_92f151ab-6ec2-433e-93c6-4f655d666b0f"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTQtNC0xLTEtMA_7ce66629-869e-4932-b8ae-4de86dff0b73"
      unitRef="usd">241700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTQtNi0xLTEtMA_dec68d9e-fea2-4974-8dc8-320bfb3bb050"
      unitRef="usd">206900000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTctMi0xLTEtMA_dd0fb535-4b8d-49dd-956d-68d04f97143f"
      unitRef="usdPerShare">4.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTctNC0xLTEtMA_28d63c43-e577-4d6b-8072-7b744a355b2d"
      unitRef="usdPerShare">3.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTctNi0xLTEtMA_30c701d3-6cfd-4941-950d-a940b2320186"
      unitRef="usdPerShare">2.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTgtMi0xLTEtMA_3db70476-0775-4ce2-a07c-e3ec2a51320e"
      unitRef="usdPerShare">4.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTgtNC0xLTEtMA_f004d35f-99e1-4de4-ae83-e98b9dad5d9d"
      unitRef="usdPerShare">3.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMTgtNi0xLTEtMA_877867f7-a965-4712-86fe-da1efa29ca4f"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjEtMi0xLTEtMA_bcf7daa5-bde4-4c10-b01c-79d3a5250f8b"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjEtNC0xLTEtMA_f5d5a3f5-b2a8-4453-9bf5-e2c548f55bfc"
      unitRef="shares">74000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjEtNi0xLTEtMA_beb7167a-0175-4e1c-856d-fb3ea1f8941a"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjItMi0xLTEtMA_f1290544-5b9b-4bca-a460-920c4439866a"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjItNC0xLTEtMA_8ee49628-c110-4776-8586-6231dc174f62"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl81OC9mcmFnOmQyYWQ3YzgyZWZiNDQwYWQ5ZjFlZWZmNjdiMTljOGExL3RhYmxlOmIwYTA4NjkxMDE1MjQwZDFiZWQxNDEwOGYzZWZlNDA4L3RhYmxlcmFuZ2U6YjBhMDg2OTEwMTUyNDBkMWJlZDE0MTA4ZjNlZmU0MDhfMjItNi0xLTEtMA_c8a49c8d-ac28-491d-8095-cbfd45077545"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMS0xLTEtMS0w_dcf82920-1f86-458c-8231-b00061a07601"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMS0zLTEtMS0w_e91ddc06-cefd-4e1f-ad6a-e52ba98f0a70"
      unitRef="usd">241700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMS01LTEtMS0w_958ea339-4c26-4f00-82eb-2cdd73458aed"
      unitRef="usd">206900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMy0xLTEtMS0w_594c6090-1920-4bd5-877c-977f5ad58cb0"
      unitRef="usd">40100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMy0zLTEtMS0w_46b4a2cf-c7d3-449d-9a1e-d75ce02e5404"
      unitRef="usd">4900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMy01LTEtMS0w_3b7bd28c-7cd3-4db1-b3a5-ca3160a9c36d"
      unitRef="usd">-39200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0wLTEtMS0wL3RleHRyZWdpb246YjBiNzY4YTk1ZDYxNDFhMTg1OTE2OGNiODBkMGFjMjhfMTA5OTUxMTYyNzg0MA_a7897bed-2cdb-4551-9c59-bd5adb3f599f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0wLTEtMS0wL3RleHRyZWdpb246YjBiNzY4YTk1ZDYxNDFhMTg1OTE2OGNiODBkMGFjMjhfMTA5OTUxMTYyNzg0MA_a7c1a8b0-a5f8-4a1c-821a-1745b622fa56"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0wLTEtMS0wL3RleHRyZWdpb246YjBiNzY4YTk1ZDYxNDFhMTg1OTE2OGNiODBkMGFjMjhfMTA5OTUxMTYyNzg0MA_f2b42922-d0df-428b-9226-841e568b84e9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0xLTEtMS0w_13806dd4-e67c-4a68-a140-1742ddf4a4ca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS0zLTEtMS0w_e76484b4-10b2-4888-a813-6c4efe55d34d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNS01LTEtMS0w_ea835769-da8a-4f9e-b602-03af3fe7305d"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZTE1ZGUyZDNkNDFmNDI4ZGE2NGFiZmIwNDhhNDU4MzJfMTA5OTUxMTYyNzg2OA_fb65e4ef-839a-4683-8ee2-646ee1b0762b"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZTE1ZGUyZDNkNDFmNDI4ZGE2NGFiZmIwNDhhNDU4MzJfMTA5OTUxMTYyNzg3OA_6f420e0d-ad93-4a59-ad0e-d8c1fb2fc5c9"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZTE1ZGUyZDNkNDFmNDI4ZGE2NGFiZmIwNDhhNDU4MzJfMTA5OTUxMTYyNzg4Nw_2536eb33-6f6e-4502-a72a-8fb6127fde3b"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0xLTEtMS0w_b7aaff2e-db8c-486a-b030-8c4892484295"
      unitRef="usd">-2500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi0zLTEtMS0w_db8f9183-8245-4c41-a08a-dabf0169dc32"
      unitRef="usd">-1900000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNi01LTEtMS0w_10f992c5-9444-4cfe-9b86-cc0aa723334b"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0wLTEtMS0wL3RleHRyZWdpb246MDVmYzg2OTNkODIxNGM0MGFkMzEwYjY0NWVhYTQ0MjJfMTA5OTUxMTYyNzg1Ng_56969252-92a1-47eb-9fb9-41e3ad8b2a76"
      unitRef="usd">900000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0wLTEtMS0wL3RleHRyZWdpb246MDVmYzg2OTNkODIxNGM0MGFkMzEwYjY0NWVhYTQ0MjJfMTA5OTUxMTYyNzg2Mw_4d15f420-b9bc-460d-96b4-63873f544c0d"
      unitRef="usd">800000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0wLTEtMS0wL3RleHRyZWdpb246MDVmYzg2OTNkODIxNGM0MGFkMzEwYjY0NWVhYTQ0MjJfMTA5OTUxMTYyNzg2Nw_35c213a0-13b8-4354-aa83-0a9e61ae393f"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0xLTEtMS0w_4b0acec1-de8d-4dab-a734-fc1190531568"
      unitRef="usd">-2900000</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy0zLTEtMS0w_54db89ec-3e9c-4bcc-a6ac-c1cc2c44697a"
      unitRef="usd">-2700000</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfNy01LTEtMS0w_3fbf2b50-7316-421d-b28a-8f0c9bd3e24a"
      unitRef="usd">0</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0wLTEtMS0wL3RleHRyZWdpb246NTg0MzQwZjU4ZTY5NGE5NWFiNDc4NzJmMzI3NWVjMWFfMTA5OTUxMTYyNzg1OA_22955790-67c7-412a-89b4-d3b740d1564c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0wLTEtMS0wL3RleHRyZWdpb246NTg0MzQwZjU4ZTY5NGE5NWFiNDc4NzJmMzI3NWVjMWFfMTA5OTUxMTYyNzg2Mw_849bd26b-e007-4be3-bbe6-ebc5b8de9c16"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0wLTEtMS0wL3RleHRyZWdpb246NTg0MzQwZjU4ZTY5NGE5NWFiNDc4NzJmMzI3NWVjMWFfMTA5OTUxMTYyNzg3MQ_ca89749c-4829-419a-b066-3629475c7e31"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0xLTEtMS0w_ed4234ea-ba90-4c8d-a760-0e2f26a4a484"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC0zLTEtMS0w_89698db5-0288-457d-a1a8-4918f2341eb1"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOC01LTEtMS0w_92bb6a6d-a285-45a9-bbcc-c9bf22802c03"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0wLTEtMS0wL3RleHRyZWdpb246OTJkNWRjMjAzNDlhNDRlOTk5NWFlMTRjYzBlYzlmNWNfMTA5OTUxMTYyNzg2Mg_b7d5e68a-f078-447c-8c92-373b7939d598"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0wLTEtMS0wL3RleHRyZWdpb246OTJkNWRjMjAzNDlhNDRlOTk5NWFlMTRjYzBlYzlmNWNfMTA5OTUxMTYyNzg3MQ_b68199f7-a934-433d-817b-d00cbebfe51c"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0wLTEtMS0wL3RleHRyZWdpb246OTJkNWRjMjAzNDlhNDRlOTk5NWFlMTRjYzBlYzlmNWNfMTA5OTUxMTYyNzg4MA_9ecc0ab4-be19-48c7-b2bd-ab4ef692b82a"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0xLTEtMS0w_fee2fdba-3559-460d-a725-576f165c7621"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS0zLTEtMS0w_e2ed4e8b-b0b2-4131-9ed8-e9d1f703f69b"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfOS01LTEtMS0w_d0851ac3-372b-4c3d-94b1-36fc3733ea34"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmRkNzg2MjgyODU0NDQ5OWFiODc0MGI3Njk5ZTRiMmZiXzEwOTk1MTE2Mjc4NTM_81077cfb-6624-4044-8c55-ea4307d42a45"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmRkNzg2MjgyODU0NDQ5OWFiODc0MGI3Njk5ZTRiMmZiXzEwOTk1MTE2Mjc4NjI_41aadf84-c9a8-40e9-b68f-b667b88685ca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmRkNzg2MjgyODU0NDQ5OWFiODc0MGI3Njk5ZTRiMmZiXzEwOTk1MTE2Mjc4NzM_a96c4347-0b30-41e9-9d17-214454bc8901"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMS0xLTEtMA_172e8ea2-b276-4dde-b954-4b5d7578358c"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtMy0xLTEtMA_6f5898a4-0a52-43bb-8a6e-6d612ab01655"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTEtNS0xLTEtMA_e6b50469-35c1-4057-82bd-30dc9cbc80e8"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjkxYzBiMWY2MTFiNDQzMTNiMDM5NjkxZWRhNmFmMjU5XzEwOTk1MTE2Mjc4NDg_191d4fd0-4e71-4240-b866-bf778b17678f"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjkxYzBiMWY2MTFiNDQzMTNiMDM5NjkxZWRhNmFmMjU5XzEwOTk1MTE2Mjc4NTM_9dba184a-5f7b-4631-9466-16e79839e02c"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjkxYzBiMWY2MTFiNDQzMTNiMDM5NjkxZWRhNmFmMjU5XzEwOTk1MTE2Mjc4NjI_f308a816-705e-4bd9-974d-d8f3c2714d16"
      unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMS0xLTEtMA_b43ef9fc-d6f3-400c-83ad-23565c775269"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItMy0xLTEtMA_3e32dc98-a897-432a-9da2-93adf2b085eb"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTItNS0xLTEtMA_14e70443-0caf-4b53-83b4-4d807ba80ac6"
      unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTMtMS0xLTEtMA_1709b09f-6742-4067-afb6-c8d3d8896c40"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTMtMy0xLTEtMA_e892fe11-7625-468c-920f-68bc054c1e72"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTMtNS0xLTEtMA_2d34c263-71de-47ca-a0da-6b00ac646d0b"
      unitRef="usd">-36900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTQtMS0xLTEtMA_34bbe18a-ccaa-4f4a-9577-9f955852a853"
      unitRef="usd">385200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTQtMy0xLTEtMA_1b3bdff7-1a3c-487f-9651-7e4a5adad544"
      unitRef="usd">246300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82MS9mcmFnOjU2MjcwZjZlNTQ3NjRlN2I5ZTQyMWZiNmE3ZjM1ZTdkL3RhYmxlOmE0YjM2N2JjZmRkOTRhNDliMWY1YzU5ZGUxOGY0MTU5L3RhYmxlcmFuZ2U6YTRiMzY3YmNmZGQ5NGE0OWIxZjVjNTlkZTE4ZjQxNTlfMTQtNS0xLTEtMA_1f5346a4-59d5-4b09-a460-d54ea2cf3f7a"
      unitRef="usd">170000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMy0xLTEtMS0w_7cb793f6-e006-4daf-922f-b7aa96f269dc"
      unitRef="usd">615500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMy0zLTEtMS0w_708f04df-9bef-46b1-89da-37079c44caa0"
      unitRef="usd">439100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNC0xLTEtMS0w_4936abe1-8167-45ad-a213-abe975277376"
      unitRef="usd">385300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNC0zLTEtMS0w_a49134d3-f952-4eda-96f3-df785704b0b9"
      unitRef="usd">319300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNS0xLTEtMS0w_199c8c3b-26e9-42c4-82a2-2aca05cf635a"
      unitRef="usd">321300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNS0zLTEtMS0w_45dd7f14-4cfa-4be2-bb21-86572e32e6f5"
      unitRef="usd">235700000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNi0xLTEtMS0w_710820d9-d20c-47a0-a0c7-b5e42fba977e"
      unitRef="usd">51600000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNi0zLTEtMS0w_4fab8049-b7c9-46f6-8ca0-c81004585846"
      unitRef="usd">64600000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNy0xLTEtMS0w_c518c1c9-14c1-4083-8fc8-9ce6a55e9840"
      unitRef="usd">1373700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNy0zLTEtMS0w_c64511bd-6bd5-4a8b-b41e-b5c2b4689778"
      unitRef="usd">1058700000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOC0xLTEtMS0w_ecaf1131-4a8e-4a79-a7f2-b0d527648123"
      unitRef="usd">2035500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOC0zLTEtMS0w_b702c863-78a5-46df-9d83-9d267ee33bdb"
      unitRef="usd">1820100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOS0xLTEtMS0w_2d96cd96-dce5-4233-9a0a-bbab97042677"
      unitRef="usd">1092300000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfOS0zLTEtMS0w_9657b21f-c62f-4fa4-8805-5f7c17e22c61"
      unitRef="usd">980800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTAtMS0xLTEtMA_6e4c9110-6359-4c06-8b73-3ff0e971aaf1"
      unitRef="usd">943200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTAtMy0xLTEtMA_8e503746-708b-4be0-8237-8bf3fabe9827"
      unitRef="usd">839300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTEtMS0xLTEtMA_b4dfa837-6b9c-4735-81a8-a20b602e6821"
      unitRef="usd">68300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTEtMy0xLTEtMA_e5ad112d-3d79-4a2c-81ec-7a76ddea3c62"
      unitRef="usd">70100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTItMS0xLTEtMA_2a58a0ad-4c8a-4f46-b215-1c457d496478"
      unitRef="usd">214700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTItMy0xLTEtMA_b6b0371c-bde1-4c8f-80d3-25c0bec5ddb8"
      unitRef="usd">192700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTMtMS0xLTEtMA_a03a45ec-2c6b-4f9d-b30f-c7589a80a594"
      unitRef="usd">111100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTMtMy0xLTEtMA_13b1887e-0e89-4175-bd74-8c58818a2171"
      unitRef="usd">107800000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMS0xLTEtMjUxNw_728aaa57-418a-435c-ac30-f487fc950542"
      unitRef="usd">30500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMy0xLTEtMjUxNw_60ca09bc-596a-41d1-abc4-c610b91625b0"
      unitRef="usd">29800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMS0xLTEtMA_7aa65e28-48fd-43f5-a7ce-70d471fb87be"
      unitRef="usd">16000000.0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTQtMy0xLTEtMA_ec106c5d-214d-4452-8bbb-ba3ab0da7ff2"
      unitRef="usd">14000000.0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTYtMS0xLTEtMA_533f776b-aec8-42da-b331-2ebe6ec82739"
      unitRef="usd">12900000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTYtMy0xLTEtMA_acd63721-0d6a-43ca-87a5-76294c1c94d7"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTctMS0xLTEtMA_e980d1b8-0703-48d5-89ae-a5fae2dacabc"
      unitRef="usd">23400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTctMy0xLTEtMA_71b1c9ad-528a-4f09-98d4-0e931ab2f05a"
      unitRef="usd">24700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTgtMS0xLTEtMA_e2bd7181-57f6-40a9-8fdc-24ac18659efc"
      unitRef="usd">2793800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMTgtMy0xLTEtMA_39a0b0ff-65a3-46e7-90b2-e959261ead43"
      unitRef="usd">2341400000</us-gaap:Assets>
    <wst:NotesPayableAndOtherDebtCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjItMS0xLTEtMA_0d60f02f-23c6-477c-ab96-fbd8fe70fd71"
      unitRef="usd">2300000</wst:NotesPayableAndOtherDebtCurrent>
    <wst:NotesPayableAndOtherDebtCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjItMy0xLTEtMA_01af71df-d37c-4c66-8738-a1e2960a1812"
      unitRef="usd">2300000</wst:NotesPayableAndOtherDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjMtMS0xLTEtMA_c86675a8-5ff3-47f8-b3e1-b1458b709460"
      unitRef="usd">213100000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjMtMy0xLTEtMA_d5d8a2a7-7ade-4de3-8de6-be27d4eb0c0e"
      unitRef="usd">156800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjQtMS0xLTEtMA_c6c5000a-31af-4812-b546-b633c266a853"
      unitRef="usd">2300000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjQtMy0xLTEtMA_2f28d451-9c14-40d5-b1d2-6e7bdf194ed9"
      unitRef="usd">2200000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <wst:AccruedSalariesWagesAndBenefitsCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjUtMS0xLTEtMA_b06ca1a6-a498-45b6-90c6-eb94a60825c6"
      unitRef="usd">106000000.0</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <wst:AccruedSalariesWagesAndBenefitsCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjUtMy0xLTEtMA_538b98e6-d52a-4b04-ad9a-c42a2bff2d78"
      unitRef="usd">73000000.0</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjYtMS0xLTEtMA_9bfe9a15-ef12-48a5-afd2-3ace43ddb255"
      unitRef="usd">26000000.0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjYtMy0xLTEtMA_c8ee0f00-b319-4f00-b1c8-93534aaaaf66"
      unitRef="usd">6400000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjctMS0xLTEtMA_22307bc0-0af9-415d-85da-7e39426002b4"
      unitRef="usd">10100000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjctMy0xLTEtMA_50c0613e-d0c8-4309-a5e9-94931c0da60c"
      unitRef="usd">9600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjgtMS0xLTEtMA_f6b085cd-8652-47cf-a7ec-f226705910b0"
      unitRef="usd">143600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjgtMy0xLTEtMA_b9709493-0514-40ef-b251-1e13cab3106c"
      unitRef="usd">91300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjktMS0xLTEtMA_949d7f73-8154-48e0-997b-3d091b62ea1c"
      unitRef="usd">503400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMjktMy0xLTEtMA_c06718e3-c043-47ca-ac83-9d4381e9211a"
      unitRef="usd">341600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzAtMS0xLTEtMA_c93bd5ab-1225-4457-b5f8-377d9b69fb96"
      unitRef="usd">252900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzAtMy0xLTEtMA_06c3f907-ed74-4423-bdd0-980fd5e2f9c1"
      unitRef="usd">255000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzEtMS0xLTEtMA_ce768d06-f82c-43f5-8c8e-bb25c892283c"
      unitRef="usd">10400000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzEtMy0xLTEtMA_87a306c1-d34f-4c2b-a776-7c75da4ed2a6"
      unitRef="usd">15500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzItMS0xLTEtMA_4822794a-eece-4cbb-9032-66e2e6d998a4"
      unitRef="usd">57500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzItMy0xLTEtMA_4d3cd1a8-db5d-4b13-9449-fc1c9b86d5ee"
      unitRef="usd">52500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzMtMS0xLTEtMA_e55fd01f-f37c-4fd6-8d03-666e57201a62"
      unitRef="usd">60400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzMtMy0xLTEtMA_850e6185-030d-4244-a472-ee0224b7008c"
      unitRef="usd">62400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMS0xLTEtMTExNTc_f37b1694-a322-43ee-85fb-d87f3c5e1469"
      unitRef="usd">22900000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMy0xLTEtMTExNTc_96ff953e-7a52-4a97-8c31-52e7a959344a"
      unitRef="usd">17800000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMS0xLTEtMA_e4179ccc-eab4-49e5-9fd8-5d8a12a15257"
      unitRef="usd">31800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzQtMy0xLTEtMA_acf58ec6-5d0d-4c86-b18c-6d5d5a1b894e"
      unitRef="usd">23400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzUtMS0xLTEtMA_75a6ff67-25ed-4c00-9fad-71f8be4d78d8"
      unitRef="usd">939300000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzUtMy0xLTEtMA_2383bacf-f0e9-4550-a9ca-5ac0a358f1e8"
      unitRef="usd">768200000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzctMS0xLTEtMA_0f1b9b06-acc8-4093-ae9a-22986eecb247"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfMzctMy0xLTEtMA_957aee56-e037-4ca0-9559-092a874a819b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDU_170b4497-351a-4dba-9be1-727323918385"
      unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDU_a760c3b6-2511-4e5b-998d-8630ae064dd6"
      unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_17c0a4fe-b740-4a17-af76-806abdbcaf78"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_7a2153b3-5ed7-4445-92df-a1c71c210b8d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_c65a4a1e-752b-43f3-b5b3-312a5d379d20"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjJlNGIxMzU2NjdkMzRmZjE4MDQ0YzFhMDQ0OGI3NmE0XzEwOTk1MTE2Mjc5MDk_ef461f6e-6d3b-445f-aa3b-9d5bf2f53db0"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMS0xLTEtMA_f82220d1-74e0-4801-8ea7-ffd218d3fb19"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDAtMy0xLTEtMA_4a95e934-1d1b-486e-8bb4-6d698c793bbd"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTI_387dfce9-9efd-4b3e-a83f-5dd928b846ac"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTI_40c1acca-fa27-4412-b4ca-81bd9bdf1249"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTk_34bfb519-ab24-42bd-981b-74389b9a0d78"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwOTk_fdb61460-a6d1-4633-b3fd-c67c77145404"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwNzg_0e36929e-888b-41ea-a70a-2793e42a310e"
      unitRef="shares">75300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwNjg_4832aadc-3e32-4f97-a39d-03e099c92da4"
      unitRef="shares">74000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NDc0YTcyMGRjNTQxNWI4NTczZDEzZjQ1MTc1NTY0XzEwOTk1MTE2MjgwODU_72ca55cb-1c3f-4b82-8085-76df7ca64b17"
      unitRef="shares">74100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMS0xLTEtMA_106f3287-34c0-4f60-860c-eab3b93216bf"
      unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDEtMy0xLTEtMA_c8ae3c57-4ce9-4d2d-8126-2f2d5a45eb0b"
      unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDItMS0xLTEtMA_5f5c1fdf-c0b3-4c97-a056-79396f2e71e9"
      unitRef="usd">267300000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDItMy0xLTEtMA_f241a6a3-8b0c-426a-8920-ed56d991d02a"
      unitRef="usd">272700000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDMtMS0xLTEtMA_e549bcec-a886-46c4-a2ce-b65a464216a8"
      unitRef="usd">1846700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDMtMy0xLTEtMA_9f8cd481-d5cb-4aac-9e95-3e2d03a6a606"
      unitRef="usd">1549400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDQtMS0xLTEtMA_4fa56968-0099-4475-8b58-4a0de76dd07c"
      unitRef="usd">-110600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDQtMy0xLTEtMA_1bc453fa-af39-4730-8ea7-402c0ca1c97f"
      unitRef="usd">-149600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3N2ZhOTFkNDU2NjQyYzlhOTRlOWYxYjQxNDI2M2Y0XzEwOTk1MTE2Mjc4OTQ_05a29a35-398b-49fa-a6d3-83778b3b387b"
      unitRef="shares">1300000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3N2ZhOTFkNDU2NjQyYzlhOTRlOWYxYjQxNDI2M2Y0XzEwOTk1MTE2Mjc4ODk_570284d1-f0d9-40ee-9151-cb2bb6ba93e1"
      unitRef="shares">1200000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMS0xLTEtMA_d66eed42-8732-426d-ba59-ad752e2a39c8"
      unitRef="usd">167700000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDUtMy0xLTEtMA_39780fde-9280-4fcd-98dc-42170b6cbd64"
      unitRef="usd">118100000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDYtMS0xLTEtMA_01627902-d3ee-4449-8c62-ccd69371007a"
      unitRef="usd">1854500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDYtMy0xLTEtMA_bd433c33-b30c-48ae-ac5d-1619ffc6be30"
      unitRef="usd">1573200000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDctMS0xLTEtMA_e01f6bd3-9bbe-4bb0-8597-ef468f48bfe3"
      unitRef="usd">2793800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl82Ny9mcmFnOjFhMzcxNTYzYzhiMTQzZTdhNjBhMzdhMzZhZGNiOWI3L3RhYmxlOmUyM2MyODhkM2M1ZjRlNmNhNDEyODAxM2Y5ZGI2YWZmL3RhYmxlcmFuZ2U6ZTIzYzI4OGQzYzVmNGU2Y2E0MTI4MDEzZjlkYjZhZmZfNDctMy0xLTEtMA_e322a6a0-43bc-487d-b9ab-72ad98fb1e5b"
      unitRef="usd">2341400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i89754d8eff0a4a21b0723157da2cda70_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xLTEtMS0w_09b56a54-f784-41f4-bf2d-8063456e3ccb"
      unitRef="shares">75200000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i89754d8eff0a4a21b0723157da2cda70_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0zLTEtMS0w_6fc5e1ec-1d43-4abe-8d99-4f11141eb373"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7eb7e11a1b0044108c665a9e8425b3d8_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS01LTEtMS0w_d8ee150e-0141-476d-9b6b-7a335b8b79b5"
      unitRef="usd">309300000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ieff9a042b0cb4730aae3ec835e713476_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS03LTEtMS0w_a87d2e03-6ba1-4227-889a-9e3e60565d8f"
      unitRef="shares">1300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ieff9a042b0cb4730aae3ec835e713476_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS05LTEtMS0w_50d2cce6-023a-4b6a-aa65-7224829c1ad2"
      unitRef="usd">-109100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6198c5c042db47db99a2b2ffabc3425f_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xMS0xLTEtMA_25e379f1-e626-4aac-b070-61994226010c"
      unitRef="usd">1178200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73ec1277012249aaaba2bbc8e69b9dc1_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xMy0xLTEtMA_81f13940-eb09-4fe2-87cc-2c8eb11f6b94"
      unitRef="usd">-117300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMS0xNS0xLTEtMA_ecb515c5-f5af-4a98-8ad3-189a3dc96a0e"
      unitRef="usd">1279900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia863152d72be424e95b4eccddadd94e2_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMi0xMS0xLTEtMA_f0e9421a-7719-4182-b214-f6ecce985611"
      unitRef="usd">11400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a5e4a6111d54b648e0349ce16e32a15_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMi0xNS0xLTEtMA_4f9521fb-8655-4413-ab39-f4946f721a59"
      unitRef="usd">11400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i89a2d506efbe4e4abf499bcddf045827_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMy0xMS0xLTEtMA_8b17a134-1da8-4326-8a0f-526e5f21ba18"
      unitRef="usd">206900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMy0xNS0xLTEtMA_83b09a85-0a0b-4894-ab5c-2ece7475599a"
      unitRef="usd">206900000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ifb45a33c02564935aa8568f277f49d7b_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC0xLTEtMS0w_82f33ebe-a823-42a7-897e-b8a8b9965bf8"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic2eb6236c6ef4de2b1b88eb4b6d0f67f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC01LTEtMS0w_d7341ec7-964e-4d40-8cc8-5c4b53fa42a4"
      unitRef="usd">-27300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC03LTEtMS0w_4ca6ad20-ac6d-4e06-a629-9d042a8963f5"
      unitRef="shares">-900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC05LTEtMS0w_a3954d5c-3b39-47f9-ada1-ba55f3bf3f40"
      unitRef="usd">76200000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNC0xNS0xLTEtMA_af1822d9-c225-4e4a-a9fa-808f05f9c996"
      unitRef="usd">48900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNS03LTEtMS0w_12ee4af0-a547-4cca-9b74-4eca437d9f98"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i90002108aa0447e5a2a82b67c7842597_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNS05LTEtMS0w_be13ecd4-ed94-48f5-bae0-6f82d5d19b09"
      unitRef="usd">70800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNS0xNS0xLTEtMA_c624c22d-5069-4b55-8d62-8f39527785ef"
      unitRef="usd">70800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNy0wLTEtMS0wL3RleHRyZWdpb246MTMxYjVkMzliNTNmNGZkZmI2NDZhYWU5MDRkNmI2YjhfMTA5OTUxMTYyNzgyMQ_a111758c-0932-4fb2-b30b-79fa20d83408"
      unitRef="usdPerShare">0.58</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i89a2d506efbe4e4abf499bcddf045827_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNy0xMS0xLTEtMA_af53e0c0-69df-485b-a6b3-be8ef7575b90"
      unitRef="usd">43100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfNy0xNS0xLTEtMA_c729f4c1-fd6d-472d-9ef4-6123677b373e"
      unitRef="usd">43100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ide2eaf9f89f64fc3b8edf54395816f7a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfOS0xMy0xLTEtMA_1b391cf2-dd48-4467-b56f-bf1684eb50b1"
      unitRef="usd">-36900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfOS0xNS0xLTEtMA_5f3d8a32-3590-433d-8be8-b3ec9a8e2d75"
      unitRef="usd">-36900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="icc36a7c52d664ddd9d308b197d911005_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMS0xLTEtMA_7f7f932a-aced-4e8a-a823-b990bd490beb"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icc36a7c52d664ddd9d308b197d911005_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMy0xLTEtMA_5c13b7b8-7d33-4286-a004-e55162d33873"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a2b0616539540d2afdbb1aef826ba8e_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtNS0xLTEtMA_a505f389-fa86-4e4e-82f7-826bbd27d862"
      unitRef="usd">282000000.0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i8d2860bdad8e4c5f80b333c36791f4e5_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtNy0xLTEtMA_7a4e9a38-ffc0-4c57-8fce-6eecd7b5f83a"
      unitRef="shares">1200000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i8d2860bdad8e4c5f80b333c36791f4e5_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtOS0xLTEtMA_5d9936a6-4b7e-4b2b-aebd-e364be377fc7"
      unitRef="usd">-103700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i840b6e15466f480a85b720e9d8dd1aa9_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMTEtMS0xLTA_9c76b38c-74f5-470f-9e62-c5251136b50d"
      unitRef="usd">1353400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7db531a64e249498d81ca1360119f0c_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMTMtMS0xLTA_d66e2f1d-2eef-411e-a676-bf3b53583dce"
      unitRef="usd">-154200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTAtMTUtMS0xLTA_b3ed766e-dc1d-4706-a594-b1d41a5af67a"
      unitRef="usd">1396300000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i8c9f256a412b4a58b1583e63cb3d853b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTItMTEtMS0xLTA_016fb6a6-7955-4ed9-ab19-957b5aa0f401"
      unitRef="usd">241700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTItMTUtMS0xLTA_0d49303c-bf6e-4b2a-8980-4fc7a8ee28b0"
      unitRef="usd">241700000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib93b62e40fb3459c8fa7a41ab3cd4a0a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtNS0xLTEtMA_0f8edc25-ec20-405d-8cb3-c83218f6056d"
      unitRef="usd">-11100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtNy0xLTEtMA_7650ccde-06d5-4584-908f-c61c1da11f4a"
      unitRef="shares">-800000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtOS0xLTEtMA_07bd21f7-889f-40ca-92aa-b6d87f5dd7dc"
      unitRef="usd">65600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTMtMTUtMS0xLTA_d5e5e098-5e71-42e5-a39b-208d749cea43"
      unitRef="usd">54500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTUtNy0xLTEtMA_799dd224-790c-4acf-a2a9-28bacd426541"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTUtOS0xLTEtMA_e2a05715-936d-4613-9a68-ab8ceeefb22c"
      unitRef="usd">83100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTUtMTUtMS0xLTA_6d25b042-22db-4d81-94d0-a8937d3ddd52"
      unitRef="usd">83100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ib93b62e40fb3459c8fa7a41ab3cd4a0a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTYtNS0xLTEtMA_8e7fdfb2-86cb-476f-b051-289d5170a7d4"
      unitRef="usd">1800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ifc5740ca02914277a0fc5a20f2cc2f32_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTYtOS0xLTEtMA_3696b5a9-ab77-4ef6-a303-64c4ab5c9ee1"
      unitRef="usd">3100000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTYtMTUtMS0xLTA_86768429-f2f1-4e97-9430-b462c0fbddd1"
      unitRef="usd">4900000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmZhNWMzZjQ1YjMwNjRhYzU5ZjZjMzNkZmJkODI0YjcwXzEwOTk1MTE2Mjc4MjE_42c3a4f5-98d7-4e09-9e24-035a21279ad1"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8c9f256a412b4a58b1583e63cb3d853b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTctMTEtMS0xLTA_48415c97-4ae1-4341-922c-b619543c4e5d"
      unitRef="usd">45700000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTctMTUtMS0xLTA_78bc16f5-2822-4c98-8e70-93991c72bbaf"
      unitRef="usd">45700000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i505c1698fd5746dda4e419a17470e15e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTktMTMtMS0xLTA_20ca8807-1ec0-46d5-b5ef-9a823d46d4f3"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMTktMTUtMS0xLTA_b2ab10d2-cd7b-45ab-a106-538282604626"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i82e08973cd064954b4b8f835bc97cd66_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMS0xLTEtMA_1b457e50-b6cd-465e-8b70-e08b3cb16c19"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i82e08973cd064954b4b8f835bc97cd66_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMy0xLTEtMA_829d4045-fc9a-42cd-87f9-e7b5cbb9eb72"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd079bb091934d528c33b541a4ccce8e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtNS0xLTEtMA_85f62449-285b-4943-8e43-160cc60e6341"
      unitRef="usd">272700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i57c744ccf1da46369f9ffda6a48eaeb7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtNy0xLTEtMA_89b95f9c-ba5f-4695-a590-42b8960a1ed4"
      unitRef="shares">1200000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i57c744ccf1da46369f9ffda6a48eaeb7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtOS0xLTEtMA_db9dd3bd-f291-4777-abcb-fc958b39f5ba"
      unitRef="usd">-118100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i953aa2443d1a4326b4f15164b962ef7f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTEtMS0xLTA_aac890c0-4083-41ef-8764-10b9a689618a"
      unitRef="usd">1549400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cd9ef6885cb4483a826dc5519bf65fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTMtMS0xLTA_7168ab0d-19e5-4a10-a448-0637fce028c1"
      unitRef="usd">-149600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTUtMS0xLTA_a193acda-f169-4f19-aaec-3700501975f3"
      unitRef="usd">1573200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3839e393aceb4fd0834689e157654cf3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjEtMTEtMS0xLTExNzMw_9ab07d7e-c180-40fc-9eac-2ece2df98e76"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e0b9a4c775c4c6d99c01d89bdb05da3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjAtMTUtMS0xLTExODcz_3a6558af-1829-4359-a7a7-a0929839c03d"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i8ce2e61c66d64a13aa94d7b58161681e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjItMTEtMS0xLTA_2197e7a6-c00d-43cf-97f5-5498c6fa42d4"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjItMTUtMS0xLTA_03a00320-7a37-4758-b6c1-afcb638cc4ba"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6986700a9d62490d965d3d1f40d2a0ec_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtNS0xLTEtMA_b3f50848-2317-4cd3-90ff-093c54a45848"
      unitRef="usd">-5400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtNy0xLTEtMA_cec9050f-5a70-4a25-8a99-5de23d3eedf0"
      unitRef="shares">-700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtOS0xLTEtMA_71f98af5-5ed7-4462-89ef-22c024492d76"
      unitRef="usd">65900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjMtMTUtMS0xLTA_4d9e9015-29d3-4b78-be4f-840d163e6da7"
      unitRef="usd">60500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjUtNy0xLTEtMA_c7209d26-8bed-4088-9201-c7106fb0c9cb"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i73a506622293415f9d15256cd4b72d8f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjUtOS0xLTEtMA_935cdc5b-44ff-437c-9482-fc4ef9f81859"
      unitRef="usd">115500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjUtMTUtMS0xLTA_80ee017d-cce8-433a-b302-932a8041cb3a"
      unitRef="usd">115500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjctMC0xLTEtMjU1MC90ZXh0cmVnaW9uOjk0YmMxODhkZGY1MTQ3Y2NiMWZiYmVhZWYzZTU3ZTI2XzEwOTk1MTE2Mjc4MjE_d5ad5f22-f581-48c3-a956-dc85eeadeaf0"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8ce2e61c66d64a13aa94d7b58161681e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjctMTEtMS0xLTA_f4fd3d3a-d419-4e2c-826e-a9925f71a5cb"
      unitRef="usd">48800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjctMTUtMS0xLTA_f4dee45c-ea21-4df7-9a30-370993c82bc0"
      unitRef="usd">48800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i55957b9eba4c467ba3e5b0bba2e29a4b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjktMTMtMS0xLTA_501c3745-1da5-43bb-9414-87806e5320e2"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMjktMTUtMS0xLTA_7150513e-f906-4471-8c6f-45dfd407fbda"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i46a9cd662cd140e6a0bf37cf6471e2d5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMS0xLTEtMA_1a795daa-de2b-4470-b6f3-4cd156062cf3"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i46a9cd662cd140e6a0bf37cf6471e2d5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMy0xLTEtMA_5dde83a9-3f31-4e85-ab26-4f8b3b22b666"
      unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f5468dc7ce54d57819464e399e6c5bb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtNS0xLTEtMA_309b7284-ac81-4915-80e1-2b56942be6a4"
      unitRef="usd">267300000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ie45120a724f04b6dbac9726ee336f7ee_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtNy0xLTEtMA_8e6f46bc-b0b5-4415-b157-fb91233a96cb"
      unitRef="shares">1300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie45120a724f04b6dbac9726ee336f7ee_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtOS0xLTEtMA_2108f967-f05c-45ae-842e-f015b74de0a8"
      unitRef="usd">-167700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if961352725c24b75a3c9007e9847415b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMTEtMS0xLTA_96b21071-0991-485d-b817-1968db8d077a"
      unitRef="usd">1846700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief5c5adaa64e42959e00816c3bf6c2b3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMTMtMS0xLTA_ed73d935-aead-4a1c-986e-f1776edbf55c"
      unitRef="usd">-110600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83My9mcmFnOjMzM2Q1OGMwNjIxNzQzNDA5OWZiNmM5YTM4YjFiOWUxL3RhYmxlOjMwOGY5OWE5ZjJhNDQ3NGQ5Zjc5ZWVkNmNiMTdlZWIxL3RhYmxlcmFuZ2U6MzA4Zjk5YTlmMmE0NDc0ZDlmNzllZWQ2Y2IxN2VlYjFfMzAtMTUtMS0xLTA_d031d8dc-2d87-4ded-b2af-7cc22d0dce8c"
      unitRef="usd">1854500000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMi0xLTEtMS0w_88ba288e-e04f-4b5a-8349-c45f5a1e7607"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMi0zLTEtMS0w_d64497dc-58b9-487c-9cba-7739efefe7e6"
      unitRef="usd">241700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMi01LTEtMS0w_c470f792-e85f-46e5-9b19-c80eb885d29e"
      unitRef="usd">206900000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNC0xLTEtMS0w_972d54ed-6591-47b5-8a64-38b545c0e2d0"
      unitRef="usd">104700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNC0zLTEtMS0w_d36a4c7e-247c-4dde-83ee-748dd08ed6c2"
      unitRef="usd">100000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNC01LTEtMS0w_a7691ae1-da6f-4ade-acec-18efd49a159b"
      unitRef="usd">101700000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNS0xLTEtMS0w_bd99d634-59f4-4f31-b13d-9a3a10ba1bce"
      unitRef="usd">4400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNS0zLTEtMS0w_c66a069e-1016-4ac3-a9d9-fe23d118efb5"
      unitRef="usd">3400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNS01LTEtMS0w_dc6bf331-6cbc-4f71-9f0d-555723b247f9"
      unitRef="usd">2700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNi0xLTEtMS0w_b1e9813d-ed21-4ca2-a9ba-e032cac18e7a"
      unitRef="usd">34000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNi0zLTEtMS0w_d0fec537-f595-4a6e-a960-5b174e59e337"
      unitRef="usd">24400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNi01LTEtMS0w_91142263-d89e-4709-91d6-a67ff6503e51"
      unitRef="usd">15100000</us-gaap:ShareBasedCompensation>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNy0xLTEtMS0w_13277aff-1a62-4603-a3b6-52841e9327ef"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNy0zLTEtMS0w_3164d6a1-2535-4187-a0f9-ae6824ff0395"
      unitRef="usd">2300000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNy01LTEtMS0w_d8a87fb6-b019-45f4-aa41-f6d9b5f72fde"
      unitRef="usd">2200000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfOC0xLTEtMS0w_bf3c804c-9da4-427c-97c3-d3a76b100518"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfOC0zLTEtMS0w_81ca8c4d-9c0d-47a7-9a0e-60e9a859aa78"
      unitRef="usd">-3500000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfOC01LTEtMS0w_261df1df-fd9e-423b-b2c8-2f13b063aca0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTAtMS0xLTEtMA_0f42b43c-2620-4e73-bbc0-07688320b00f"
      unitRef="usd">900000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTAtMy0xLTEtMA_6c2a9c7e-b32b-4d7b-90b7-f373187f4187"
      unitRef="usd">500000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTAtNS0xLTEtMA_1c258c09-bccf-487c-a798-5a006c9a3a27"
      unitRef="usd">600000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTEtMS0xLTEtMA_242b1305-9218-4504-bae9-ef329469c1d7"
      unitRef="usd">-7700000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTEtMy0xLTEtMA_f2c2de87-1a25-4170-a456-a66a3a602c98"
      unitRef="usd">-800000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTEtNS0xLTEtMA_5967e8d4-44ef-46c1-a82c-8c42e1aa1f19"
      unitRef="usd">-1800000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTItMS0xLTEtMA_1884dca6-ebb1-4297-a1a6-074ba2ea5bb2"
      unitRef="usd">-5800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTItMy0xLTEtMA_fc5eae97-9a4e-4303-b2fe-2f0f47ae3b1f"
      unitRef="usd">15300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTItNS0xLTEtMA_cbdec2f4-a4f6-40c5-8ab5-8d47dbeb1c0d"
      unitRef="usd">900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <wst:PensionAndOtherPostretirementBenefitExpenseNet
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTMtMS0xLTEtMA_534e52d5-458d-48ef-98ca-4bcd9413e3c4"
      unitRef="usd">4600000</wst:PensionAndOtherPostretirementBenefitExpenseNet>
    <wst:PensionAndOtherPostretirementBenefitExpenseNet
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTMtMy0xLTEtMA_fe0cc653-f09c-45a5-91a7-291dcdc2d270"
      unitRef="usd">-2600000</wst:PensionAndOtherPostretirementBenefitExpenseNet>
    <wst:PensionAndOtherPostretirementBenefitExpenseNet
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTMtNS0xLTEtMA_242a7dd3-77d7-4581-9a87-cdfa6f6ef8fa"
      unitRef="usd">-7900000</wst:PensionAndOtherPostretirementBenefitExpenseNet>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTQtMS0xLTEtMA_f2c71a08-dcac-4a46-850e-ba4325871516"
      unitRef="usd">15800000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTQtMy0xLTEtMA_6405396b-eb12-4207-b3d6-d3ac8d755f61"
      unitRef="usd">6700000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTQtNS0xLTEtMA_2e570eaa-b905-423f-a22b-72ab3a231e3a"
      unitRef="usd">5900000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTYtMS0xLTEtMA_7b1d7a5a-0571-48cd-86a9-ef68df75119c"
      unitRef="usd">46600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTYtMy0xLTEtMA_bff7abf4-c966-4dd9-9aff-4e9304b46cb3"
      unitRef="usd">33300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTYtNS0xLTEtMA_92d36c79-8742-400a-808e-68b602dbb003"
      unitRef="usd">43800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTctMS0xLTEtMA_98b29e50-f48b-43f4-840f-ea44a0475d51"
      unitRef="usd">73700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTctMy0xLTEtMA_2597bce4-b34e-4fe9-975f-e3beeaf57118"
      unitRef="usd">18600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTctNS0xLTEtMA_29e3d9f7-0067-46e6-a833-88bf671c82cd"
      unitRef="usd">7000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTgtMS0xLTEtMA_20b29a18-2cd7-438a-8672-8f1c745da5b2"
      unitRef="usd">-5500000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTgtMy0xLTEtMA_fbf7343c-1c73-4032-b35c-8c36ef0be53e"
      unitRef="usd">-2600000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTgtNS0xLTEtMA_6b34dfd7-ae94-4d5c-8b22-7e8ff63d8e57"
      unitRef="usd">6200000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTktMS0xLTEtMA_9df252e6-5c9d-4a99-824d-dd938555ec68"
      unitRef="usd">36600000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTktMy0xLTEtMA_e8895c54-89d7-4252-8a9f-978b5c608eeb"
      unitRef="usd">25300000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMTktNS0xLTEtMA_a2e8e01c-6f43-45a5-9b31-d1d0dba05fdf"
      unitRef="usd">400000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjAtMS0xLTEtMA_0532c63f-6f7b-48aa-9cb9-d4fce3eff371"
      unitRef="usd">-67900000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjAtMy0xLTEtMA_af2b0766-568a-445c-8e17-ea88a3e308b1"
      unitRef="usd">-9600000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjAtNS0xLTEtMA_97103eb9-f598-4b4c-a782-047715a193ac"
      unitRef="usd">-28300000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjEtMS0xLTEtMA_7606f1ec-7045-4aa6-aafe-34203ed1fec6"
      unitRef="usd">472500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjEtMy0xLTEtMA_54e6624c-7095-4b39-bf4f-02d3adfb04ff"
      unitRef="usd">367200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjEtNS0xLTEtMA_0ba3339c-5bae-4c92-8bca-dbdf875904fe"
      unitRef="usd">288600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjMtMS0xLTEtMA_25008827-f729-45a7-a840-9a9795634524"
      unitRef="usd">174400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjMtMy0xLTEtMA_fde2e8c6-0546-4f8f-8b79-1ef057addc3c"
      unitRef="usd">126400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjMtNS0xLTEtMA_fed68eae-1fe9-41ec-acff-14b329cd8bbe"
      unitRef="usd">104700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjQtMS0xLTEtMA_374df669-0744-443e-84c2-b0e3b5c9924f"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjQtMy0xLTEtMA_e5930859-3536-458d-91ae-51e697f36c12"
      unitRef="usd">85100000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjQtNS0xLTEtMA_2f7266c1-b820-4675-b819-09d2ed02d3fa"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjUtMS0xLTEtMA_63e88734-2f98-4e73-a6bb-103fde92d6ee"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjUtMy0xLTEtMA_a6c5a1e7-c57f-4713-99e5-aa8300450505"
      unitRef="usd">18900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjUtNS0xLTEtMA_4e3a6766-b51d-49b1-af9b-ed0eebba8ada"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjktMS0xLTEtMA_e5356d8e-a5d3-4295-a254-22286962e2c2"
      unitRef="usd">5100000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjktMy0xLTEtMA_0ddb96b2-659b-43e6-b347-8b1e109ab1f6"
      unitRef="usd">-2400000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMjktNS0xLTEtMA_08badb66-d6dd-47fd-bb18-ab3fd24c5c79"
      unitRef="usd">-3900000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzAtMS0xLTEtMA_31a6c1c4-0659-4bd4-8b7c-9fa1ec6b616e"
      unitRef="usd">-179500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzAtMy0xLTEtMA_65ee64e2-fc7f-4e85-b946-a6df2f4283c0"
      unitRef="usd">-228000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzAtNS0xLTEtMA_10694e3d-abbd-47ce-b2e0-d90f10d476f2"
      unitRef="usd">-100800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzItMS0xLTEtMA_e458e7ff-f5a5-490d-856c-4ff140f42d35"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzItMy0xLTEtMA_b9e0b8c5-589d-4719-b218-a0e3f8de45a5"
      unitRef="usd">108500000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzItNS0xLTEtMA_57aeb3a5-fcda-45e3-8fdd-a1b2b701efe3"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzMtMS0xLTEtMA_1bde671c-9f99-46e3-aca2-4e3a1c0a65ee"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzMtMy0xLTEtMA_d5337025-7403-4f3a-9298-1b09cf7265c4"
      unitRef="usd">136300000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzMtNS0xLTEtMA_1a54c928-9aa2-453d-a7ab-65c991ed19ef"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzQtMS0xLTEtMA_6634db1c-db91-4d80-8736-19f91bf21b79"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzQtMy0xLTEtMA_8d3af33c-18b0-4e1e-8202-0a3909ae401c"
      unitRef="usd">90000000.0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzQtNS0xLTEtMA_61dcbfb4-6750-467c-a383-e4e157ac3b1e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzUtMS0xLTEtMA_784e3634-ef24-471c-a670-a223be6e6953"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzUtMy0xLTEtMA_37e21e2e-07a0-4592-aef5-51d7d79a851d"
      unitRef="usd">1200000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzUtNS0xLTEtMA_ede3a6c8-6aa4-40ca-8f71-255fb204d1f8"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzYtMS0xLTEtMA_cc4aad47-358f-481d-bfdb-dd6627b7a70e"
      unitRef="usd">2300000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzYtMy0xLTEtMA_da6ec662-2475-4d0d-a7dd-434d29cb2ace"
      unitRef="usd">100000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzYtNS0xLTEtMA_ecd7a0b7-b09d-49a6-a8c2-d7cf8d3f6b39"
      unitRef="usd">100000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzctMS0xLTEtMA_fe583dd1-0c36-4e80-8f57-65f0e579ed86"
      unitRef="usd">48100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzctMy0xLTEtMA_3a918a5e-e556-4d5d-bfcc-a41415beee83"
      unitRef="usd">45100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzctNS0xLTEtMA_13810a58-abab-493d-ba28-f23f5c4d95d5"
      unitRef="usd">42100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzktMS0xLTEtMA_c3eac46a-088d-447a-b5b0-48711adfba95"
      unitRef="usd">22400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzktMy0xLTEtMA_60201ab8-adf7-454f-aa70-91e6f3f45b0e"
      unitRef="usd">25100000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfMzktNS0xLTEtMA_7739d487-cb0d-4d16-ad29-cfc88e21e70b"
      unitRef="usd">27400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDAtMS0xLTEtMA_06a20497-97a7-4b4e-aa02-4b98c9481a2d"
      unitRef="usd">6400000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDAtMy0xLTEtMA_2a6ec1c0-77e1-415f-8192-e926b1beb45f"
      unitRef="usd">5400000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDAtNS0xLTEtMA_a06e6832-d6d7-4f92-b0d2-bd3f6fa31250"
      unitRef="usd">4900000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDEtMS0xLTEtMA_a3dd445a-e29a-4cd7-be21-bf995db06e4f"
      unitRef="usd">115500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDEtMy0xLTEtMA_8c18d2d1-d85b-4861-95b8-968d332cc812"
      unitRef="usd">83100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDEtNS0xLTEtMA_9c2689ee-fe34-464b-acbe-968ddfa232da"
      unitRef="usd">70800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDItMS0xLTEtMA_b805ff03-7076-4ad7-8f32-90ca78dad729"
      unitRef="usd">-137100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDItMy0xLTEtMA_a9dc677a-ca59-4892-8d1a-ab7f1c915d35"
      unitRef="usd">-36800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDItNS0xLTEtMA_e253fb07-4c92-49da-b9bf-ee86ff63d8d0"
      unitRef="usd">-80700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDMtMS0xLTEtMA_6a2018d9-0b0d-446d-9549-d9009754f89b"
      unitRef="usd">20500000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDMtMy0xLTEtMA_247b3f93-0e4f-4918-9b9d-7406bee7810a"
      unitRef="usd">-700000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDMtNS0xLTEtMA_63c98a20-2e6f-44d8-a0b1-1d4e1273f9ac"
      unitRef="usd">-5600000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDQtMS0xLTEtMA_50fa294f-6151-4263-945e-690653fc1197"
      unitRef="usd">176400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDQtMy0xLTEtMA_870a1624-3f01-4223-bd65-9d455db83ee9"
      unitRef="usd">101700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDQtNS0xLTEtMA_a6b9d058-b55c-4dba-93a0-9aa07ffb3dee"
      unitRef="usd">101500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDUtMS0xLTEtMA_6bd1e9df-ba4e-43b3-a9a4-7795abe2723a"
      unitRef="usd">439100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDUtMy0xLTEtMA_d65b6a97-984d-40c6-ae3f-c3c6aa0598e5"
      unitRef="usd">337400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDUtNS0xLTEtMA_be7d126b-9fff-481c-aeab-dc9952754405"
      unitRef="usd">235900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDYtMS0xLTEtMA_ad536554-2a13-4c55-b0a8-4978b598aa43"
      unitRef="usd">615500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDYtMy0xLTEtMA_603a0626-56a7-46fb-9731-6222abc8feb5"
      unitRef="usd">439100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDYtNS0xLTEtMA_5dc6ca6e-ec00-44a9-a39f-0cbbdc1fd3f6"
      unitRef="usd">337400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDktMS0xLTEtMA_d15cc9cb-0d24-43cf-ad6e-ca486166d98d"
      unitRef="usd">8100000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDktMy0xLTEtMA_6a452fd2-e05d-4a75-ac45-6fa4cd554c04"
      unitRef="usd">8600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNDktNS0xLTEtMA_430999e7-f8fb-40d9-b044-01f1d7be4be2"
      unitRef="usd">8400000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTAtMS0xLTEtMA_a67bd389-d070-41ee-8dc8-b20e39e23213"
      unitRef="usd">48400000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTAtMy0xLTEtMA_5eceb28b-fad0-413f-b707-08716ccef935"
      unitRef="usd">47500000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTAtNS0xLTEtMA_1dc710ac-d12c-44c6-a9bb-cd72333cb131"
      unitRef="usd">42000000.0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTEtMS0xLTEtMA_52f38a39-e898-4deb-930f-bd3eec8b520e"
      unitRef="usd">31300000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTEtMy0xLTEtMA_69e49a7b-430a-4604-9c8a-254caddb6a9a"
      unitRef="usd">17000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTEtNS0xLTEtMA_6a451780-c860-4e99-ba8b-5ca8c6a0e1e1"
      unitRef="usd">15000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTItMS0xLTEtMA_de003504-2d70-458f-9dc7-6c1bf14d8a70"
      unitRef="usd">12600000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTItMy0xLTEtMA_47924429-c88a-4065-9cbc-14926283e6aa"
      unitRef="usd">11800000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTItNS0xLTEtMA_0f109280-5f57-4388-9c03-a82305714154"
      unitRef="usd">11300000</us-gaap:DividendsPayableCurrent>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTMtMS0xLTEtMA_f9ba654a-1205-468b-a5cb-afecedf54785"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTMtMy0xLTEtMA_908481bb-86e4-410b-97d7-c1b3073f8021"
      unitRef="usd">4900000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl83OS9mcmFnOmQ4YWM3YjU4YzVmYzRhZjhiMGFiMDUwYmUzYzI1MjA3L3RhYmxlOmFkMzI0OWVlYTI5ZTQ5OGI4MmFkOTU2NmM0NDZjNzk0L3RhYmxlcmFuZ2U6YWQzMjQ5ZWVhMjllNDk4YjgyYWQ5NTY2YzQ0NmM3OTRfNTMtNS0xLTEtMA_8e3130b1-b66a-41ee-b721-8a927fbf0cce"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMTQ_8b090077-154e-4c6d-b34f-d260b0c18e7e">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;West has been actively monitoring the novel coronavirus (&#x201c;COVID-19&#x201d;) situation and its impact globally. Our production facilities continued to operate during the year as they had prior to the COVID-19 pandemic, other than for enhanced safety measures intended to prevent the spread of the virus and higher levels of production at certain plant locations to meet additional customer demand. The remote working arrangements and travel restrictions imposed by various governments had limited impact on our ability to maintain operations during the year, as our manufacturing operations have generally been exempted from stay-at-home orders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our accounts receivable balance was net of an allowance for doubtful accounts of $1.1 million and $0.5 million at December&#160;31, 2020 and 2019, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. The following is a summary of inventories at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2020. Please refer to Note 6, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Leases&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#x2019;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#x2019;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Benefits:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for a more detailed discussion of our pension and other retirement plans. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#x2019;s gain or loss is initially reported as a component of other comprehensive income (&#x201c;OCI&#x201d;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#x2019;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification ("ASC") 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims. Please refer to Note 3, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revenue&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;,&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental Remediation and Compliance Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_157" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for a more detailed discussion of our stock-based compensation plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfODc5NjA5MzA0MjE5OQ_19075acc-c1ef-491a-888a-7737cb3a6803">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMzU4_1ea70ada-c53b-47e9-9006-47137d29e5c9"
      unitRef="usd">18900000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTA4_eb5bf97d-7c4d-4aa3-8bff-fd958afcc35d"
      unitRef="usd">4500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTEy_aa9a6790-6e9b-4e60-8e1f-ae26d29de5ed"
      unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTE2_e9e2257c-f7e7-4b17-b899-e4d61c743094"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i2c002af1ee644b9c8cd78b9164f93d0f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTIz_77382e97-cb9e-4052-9c9b-1d93fcb96233"
      unitRef="usd">11200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:UseOfEstimates
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNjM_23c87f52-e42b-4bfe-ab78-2d87545311c6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNjQ_58afbfa6-bf59-42fb-9f7e-27f70a215c85">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMTU_91ccca20-8a5e-44bc-9d40-c62432594580">Accounts Receivable: Our accounts receivable balance was net of an allowance for doubtful accounts of $1.1 million and $0.5 million at December&#160;31, 2020 and 2019, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTU4MQ_0576c7d9-d3ab-4cf1-9521-d231d3ba08cc"
      unitRef="usd">1100000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTU4OA_aad4a34e-15d7-4223-8213-1b95ec591c4a"
      unitRef="usd">500000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMzM_a356043c-1171-4671-8a47-2ddfddae0b69">Inventories: Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5NTI_66251ea8-24ce-4df9-b19f-b451036b937c">The following is a summary of inventories at December 31:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMS0xLTEtMS0w_0e119cfb-113c-4f0c-a6a8-178d9221a77b"
      unitRef="usd">133500000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMS0zLTEtMS0w_20ea8ede-575b-4a42-9146-ce50704ec75a"
      unitRef="usd">100900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMi0xLTEtMS0w_0d6f09fb-d0fd-4830-87f9-b625bb9791fe"
      unitRef="usd">54900000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMi0zLTEtMS0w_242a7931-2bf4-4abe-beec-611064c65e95"
      unitRef="usd">37400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMy0xLTEtMS0w_ca5e2236-0148-4b29-a6bf-d28bd9f5c625"
      unitRef="usd">132900000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfMy0zLTEtMS0w_cfd2a31e-0fe3-4688-b99e-13f1944b8c5d"
      unitRef="usd">97400000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfNC0xLTEtMS0w_cd162456-9303-4acb-a590-ba04d117ec00"
      unitRef="usd">321300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RhYmxlOjc3ZTNkZjJmODUxNzRhYTY5ZWU1MmNjZGMyYzgwZGQ5L3RhYmxlcmFuZ2U6NzdlM2RmMmY4NTE3NGFhNjllZTUyY2NkYzJjODBkZDlfNC0zLTEtMS0w_9fcdf5e5-2cec-4d58-9ab3-3072313132aa"
      unitRef="usd">235700000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMjU_fd78cdab-ed79-44c9-bd99-e15d8018b3ba">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5NTk_4530790f-5cbc-4e87-88e2-d5130eaeead8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2020. Please refer to Note 6, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Leases&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5NTY_b1535aeb-6d25-4a30-b049-6a4254bb47bd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#x2019;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.&lt;/span&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDA_5e64ef2c-1839-42e0-a696-7f94caeee30b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#x2019;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1d47931a6e3740b480deaae11058a69d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTg3MA_737b9113-f9d3-4973-bf7e-3151d3b76a9b">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i37e2e771b55940c7ab603ef0b73ffe0d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfNTg3Ng_68f6a60b-5fc6-45d7-bd4e-6214d39148b3">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5MTA_558b905b-0e3f-4bc2-a966-94789e89b3b7">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Benefits:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;, for a more detailed discussion of our pension and other retirement plans.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMDU_71d4e05f-135f-4d98-9d37-a2f45edbe5b0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#x2019;s gain or loss is initially reported as a component of other comprehensive income (&#x201c;OCI&#x201d;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#x2019;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.&lt;/span&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5MTQ_e095172a-8f22-4980-9623-cbbaff14ec54">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5ODM_336c65c6-f5d8-4965-9e46-360e34b78d48">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification ("ASC") 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims. Please refer to Note 3, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revenue&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;,&lt;/a&gt;&lt;/span&gt; for additional information.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5Mjc_a56feb1f-fc49-46ab-868b-93ed7c175960">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.&lt;/span&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMTc_0786a9ec-e206-4f73-a728-0729d4a75f0e">Research and Development: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EnvironmentalCostsPolicy
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDQ_6b0c307c-e260-4db1-b538-0741d99fdaab">Environmental Remediation and Compliance Costs: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.</us-gaap:EnvironmentalCostsPolicy>
    <wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDY_5833c396-9947-4cff-ad42-81ee37ea118b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.&lt;/span&gt;</wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTM5ODA_68351bbb-b52f-4aab-9228-f30a3d713aa2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_157" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwNDc_0b7fb27f-a6ee-4172-8fd9-12fae547cbd0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for a more detailed discussion of our stock-based compensation plans.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84NS9mcmFnOjc5MGI3MjY2ZTA4YTQ1ZWFhYzBjZmM2Mjg3NDAzODMzL3RleHRyZWdpb246NzkwYjcyNjZlMDhhNDVlYWFjMGNmYzYyODc0MDM4MzNfMTQwMjI_da662ccb-dd02-473d-a0da-9eae460b85be">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84OC9mcmFnOjU5ZmZjZTE1YTkwNTRlYTZhYzhjZWM2MjE3M2QxMzhjL3RleHRyZWdpb246NTlmZmNlMTVhOTA1NGVhNmFjOGNlYzYyMTczZDEzOGNfNjk5NQ_76927d1d-3976-4f48-97f1-4224a6178881">New Accounting Standards&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 and by clarifying and amending existing ASC Topic 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We early adopted this guidance, which did not have a material impact to our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the FASB issued guidance which clarifies and improves areas related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance and the respective disclosure updates are reflected in our financial statements, which did not have a material impact.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020. The adoption did not have a material impact on our financial statements. Please refer to Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under the previous guidance, an entity reflected credit losses on financial assets measured on an amortized cost basis only when it was probable that losses had incurred, generally considering only past events and current conditions when determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a modified retrospective basis, to the accounts receivable and contract asset balances as of January 1, 2020. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. The effect of the adoption on the financial statement line items of accounts receivable and contract assets was not material as of January 1, 2020. As a result of our adoption, we recorded a cumulative-effect adjustment of $0.1&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2020, to reflect the incremental estimated lifetime expected credit losses on the accounts receivable balance as of January 1, 2020. We have not presented the amortized cost basis within each credit quality indicator by year of origination as all of our accounts receivable are due within one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Standards Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;i&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;ng&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; the impact to our financial statements, the transition, and disclosure requirements of this guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84OC9mcmFnOjU5ZmZjZTE1YTkwNTRlYTZhYzhjZWM2MjE3M2QxMzhjL3RleHRyZWdpb246NTlmZmNlMTVhOTA1NGVhNmFjOGNlYzYyMTczZDEzOGNfOTg5NTYwNDY3MTQwMQ_5a50e562-69e8-4ccb-bd48-70fb495e2a78">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 and by clarifying and amending existing ASC Topic 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We early adopted this guidance, which did not have a material impact to our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the FASB issued guidance which clarifies and improves areas related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance and the respective disclosure updates are reflected in our financial statements, which did not have a material impact.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020. The adoption did not have a material impact on our financial statements. Please refer to Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under the previous guidance, an entity reflected credit losses on financial assets measured on an amortized cost basis only when it was probable that losses had incurred, generally considering only past events and current conditions when determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a modified retrospective basis, to the accounts receivable and contract asset balances as of January 1, 2020. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. The effect of the adoption on the financial statement line items of accounts receivable and contract assets was not material as of January 1, 2020. As a result of our adoption, we recorded a cumulative-effect adjustment of $0.1&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2020, to reflect the incremental estimated lifetime expected credit losses on the accounts receivable balance as of January 1, 2020. We have not presented the amortized cost basis within each credit quality indicator by year of origination as all of our accounts receivable are due within one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Standards Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;i&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;ng&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; the impact to our financial statements, the transition, and disclosure requirements of this guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia62094f562004390b81aa8036d7b155e_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl84OC9mcmFnOjU5ZmZjZTE1YTkwNTRlYTZhYzhjZWM2MjE3M2QxMzhjL3RleHRyZWdpb246NTlmZmNlMTVhOTA1NGVhNmFjOGNlYzYyMTczZDEzOGNfNDk0NzgwMjMzODcyOQ_20fa8cb4-55e5-4446-8d4d-a790f2891f46"
      unitRef="usd">100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODU5OQ_d9596ac8-9507-4ab4-a3f1-00cbb76abaff">Revenue&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Adoption of ASC 606&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2018, we adopted ASC 606, on a modified retrospective basis, applied to those contracts which were not completed as of January 1, 2018. As a result of our adoption, we recorded a cumulative-effect adjustment of $11.4&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2018, to reflect a change in the timing of revenue recognition under ASC 606, from point in time to over time, on our Contract-Manufactured Products product sales, certain Proprietary Products product sales, development and tooling agreements, as well as an acceleration on a portion of the remaining unearned income from a nonrefundable customer payment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. As of December&#160;31, 2020, there was $4.7 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $3.8 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard Packaging &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets and liabilities result from transactions with revenue primarily recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet within other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contract assets - increase (decrease)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred income - (increase) decrease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has entered into new capacity reservation agreements, which include the receipt of up-front cash and therefore caused an increase in the deferred income account balance. The Company expects revenue related to the capacity reservation agreements to be recognized over the next 1 to 2 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in deferred income during 2020 was primarily due to additional cash payments of $100.3&#160;million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $83.9&#160;million, including $26.9&#160;million of revenue that was included in deferred income at the beginning of the year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supply Chain Financing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of December&#160;31, 2020 and 2019, we derecognized accounts receivable of $14.1&#160;million and $10.1&#160;million, respectively, under these agreements. Discount fees related to the sale of such accounts receivable on our consolidated income statements for 2020 and 2019 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Voluntary Recall&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 24, 2019, we issued a voluntary recall of our Vial2Bag&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During 2019, we recorded a net provision of $5.4&#160;million for inventory returns from our customers and related in-house inventory, partially offset by a reduction in our pro&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;vision for product returns. On October 21, 2020 we received market clearance from the FDA for our Vial2BagAdvanced&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0mm Admixture Device and continue to work to get the products back on the market.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idf9d37b38c2447e990845dc75ad10954_I20180101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMjY5_d8b3aae1-89dc-486d-ae04-d3ff1866ece5"
      unitRef="usd">11400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i7ab15527d47f4aa9a1633dab43f58d65_I20130630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzU1NA_547bf445-603c-4d3c-b861-d584ba766970"
      unitRef="usd">20000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie910eb49306b47f19aade26345fa3e40_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzcwNA_832cebe9-991e-49a8-b286-017b97788d16"
      unitRef="usd">4700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie910eb49306b47f19aade26345fa3e40_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzc2MA_020a35a8-43fa-4334-9138-5298ddfcb918"
      unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ie910eb49306b47f19aade26345fa3e40_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMzgwOQ_24969347-50c6-4b5c-8b22-5f88a3c68c1c"
      unitRef="usd">3800000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODYwMg_8f4fde8c-8385-43ec-8e68-35a836ac82c8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard Packaging &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i20906f3f318b4a2cba7c15716696f1dc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMS0xLTEtMS0w_b046b843-fc7f-494f-b715-5e5c7304bf41"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i923c8a6896e54de69ca69cbbcaea99ec_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMS0zLTEtMS0w_1f5d2724-0c32-4b6a-821d-2dd4cb59ec68"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id367f23378974623b9859df2596c8183_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMS01LTEtMS0yNjMz_62d87707-d7f1-4d41-8788-79404bd0ba4e"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iff18b4560ebb4519988e5000afc9573e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMi0xLTEtMS0w_de3ff0f5-b11b-44f8-bf05-d0618c0ba814"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifd0748450e4b47baad0f75ab4d3d1e44_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMi0zLTEtMS0w_817ec41f-5320-46ed-84b7-dbab6dde47e9"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0d22ca205d074fadb933b7fd00da1f1c_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMi01LTEtMS0yNjM2_34ea1666-0b29-4850-a28f-e0ccbbe28fd8"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia3e7a414c18f47b2b7c9f8868c4db4a5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMy0xLTEtMS0w_0d3095cd-a728-4062-9dc3-2ed2aab8ceb0"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9aa616b221f246a086f3ff77b50744fd_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMy0zLTEtMS0w_5ec54909-273c-4dbb-a427-4ee12a97a272"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i018928bacb95446581fa8dd22ce885b4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfMy01LTEtMS0yNjM5_bc247c25-c024-472d-a2e6-02202501451d"
      unitRef="number">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2940c5a94a5545e9b92428881a4b24ae_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNC0xLTEtMS0w_7b9a267f-f3a3-4ce0-b0ac-988cb97983c8"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4b52db3c7d824219b44bf0415c21dd9b_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNC0zLTEtMS0w_4f472fce-f62a-4ea5-ab3c-e3ba178a3286"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ife59a6f7e63848cfbf9db3761a806465_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNC01LTEtMS0yNjM5_4a45c336-5394-4d4e-9dad-d7bdf113dab5"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNS0xLTEtMS0w_2d3660f6-b990-494c-87de-402bbc4316d5"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNS0zLTEtMS0w_8dcd3cd6-45f8-414d-acac-566c37e9a7b1"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU5YTkyMDY2OGM4OTRiYzM4NDdlNmRkZTk2ZWM0YTE5L3RhYmxlcmFuZ2U6ZTlhOTIwNjY4Yzg5NGJjMzg0N2U2ZGRlOTZlYzRhMTlfNS01LTEtMS0yNjQz_658bc5d6-7c12-41c5-b4a5-0adc410fc6fb"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i314b3eadc19f481a9a5cefedb7076b5d_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMS0xLTEtMS0w_98a8d9d9-6821-4a45-8840-b258dc6b14ef"
      unitRef="number">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id5c8bb5e908445ac94163109d6f187fe_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMS0zLTEtMS0w_c14ced34-ceec-454e-9d24-6a5f2480a09b"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic80d6874e9d04c2c969ac30de82af315_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMS01LTEtMS0yNjcz_932f227d-8b1d-4a05-9e6a-e4aa19b08514"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i695ca37571594a2f90e91281811f3f60_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMi0xLTEtMS0w_42dec7b8-1c69-4fdc-b63b-5d2b2aa7f8ea"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8ca2c0bc504f46c09b0f5349f5d4babc_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMi0zLTEtMS0w_632bcbc9-f020-4e91-84d5-fe9faff0d92f"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9b1d30e86ad0440eae32d35a5c10f6cf_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMi01LTEtMS0yNjcz_73d62b81-e457-4a11-abe2-27699412d3c8"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icebffe8ea45e44b7ac1fb37ca2ab6e4e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMy0xLTEtMS0w_2ff7deee-a1d4-4a81-80b0-eb68e341229c"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i045d57ee128a4dfbab51df17a738c76d_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMy0zLTEtMS0w_29757465-5407-45e5-856d-6ebb1886e738"
      unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i05f318a8522b4df3a88ab126fbe483fd_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfMy01LTEtMS0yNjcz_b30854a9-91d4-4865-8931-1f0ce1ffcb7f"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iacdb2fa885c04d209366d073597b6e65_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNC0xLTEtMS0w_7b0afdfe-fce0-4e4f-90c0-cdc4bc6ae55f"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i286700d9c43745be93c8819dcc7cbe24_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNC0zLTEtMS0w_7f3dd64f-409e-4ab9-a090-f70a9f6078af"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id754473ec64a4fc7bf5cd626c8c7f917_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNC01LTEtMS0yNjcz_5fe55953-8740-4c60-ae9c-9e14a3163ff7"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNS0xLTEtMS0w_0e73bc86-df52-4303-8dc4-7dcc72951b83"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNS0zLTEtMS0w_46e73c6e-e774-42f5-893f-68e776cc8e34"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjQ1ODIzNWRjODZkNDQxMzlhNjZlNmYwNmQxZTU5NzdlL3RhYmxlcmFuZ2U6NDU4MjM1ZGM4NmQ0NDEzOWE2NmU2ZjA2ZDFlNTk3N2VfNS01LTEtMS0yNjcz_b891521d-85d0-438e-bfa8-cc793f297761"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id933de360a3a4f38a4f172632d39f380_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMS0xLTEtMS0w_ba338729-ce76-423b-8b7a-f6608d16866a"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib979385c7bde4ce2b05dee2c7e29ab4e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMS0zLTEtMS0w_ffc0b82d-b64a-43b4-8694-327470d7229b"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3f265678664c4854ba64c2adc9a8a208_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMS00LTEtMS0yNjYy_9cdf3ea1-ec76-45a7-9372-2cd516dd8f00"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib0b1fc94713546ad8ea568bae5635986_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMi0xLTEtMS0w_74c56172-1782-4a94-99d0-e1f1ba7a27df"
      unitRef="number">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie9ade024d2944ee28eb78ee61e0a8c28_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMi0zLTEtMS0w_ac2c50c1-1489-403f-adb5-64032dc089c1"
      unitRef="number">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6b8a3f92e87547398e250cd6e50d2471_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMi00LTEtMS0yNjYy_4048f509-cd00-47f2-8ac1-d0b9043820fb"
      unitRef="number">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if5a8e9607c46467ea4f32c403fb194c4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMy0xLTEtMS0w_12f907d3-c0d9-4923-aca7-3eb3333b63c1"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic3c3a0fd2c284cc5b42da67050e9f64e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMy0zLTEtMS0w_53276bfa-c571-4047-97e7-7382b69cd8ef"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7e55590c051146b6bb265c367a817a3b_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfMy00LTEtMS0yNjYy_e6aacdb7-b2e7-4d7e-bf51-32ba4fcbcc14"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfNC0xLTEtMS0w_301f4b82-fcd2-4b4b-9288-e37edaf76db4"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfNC0zLTEtMS0w_ff6c6f23-c6df-42a7-93e1-6afce4d8dd35"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOmU2YWZkMGU0ZDJiMDQ2Mzg5MTc5M2QxY2I2OWIwZDdkL3RhYmxlcmFuZ2U6ZTZhZmQwZTRkMmIwNDYzODkxNzkzZDFjYjY5YjBkN2RfNC00LTEtMS0yNjYy_ba5396f6-363a-408b-96df-3175babf7ecd"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODYwMw_a1137de1-334a-45ab-8c8e-0941009a6327">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contract assets - increase (decrease)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred income - (increase) decrease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfMS0xLTEtMS0w_95a92a28-5303-4ce3-9289-11e51bc4dc39"
      unitRef="usd">9800000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfMi0xLTEtMS0w_abae4c3d-6cff-44dc-bf1c-eac7848ff0ed"
      unitRef="usd">10900000</us-gaap:ContractWithCustomerAssetNet>
    <wst:ContractWithCustomerAssetIncreaseDecrease
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfMy0xLTEtMS0w_33af6758-93d9-46c4-95fd-21c1dea25c41"
      unitRef="usd">1100000</wst:ContractWithCustomerAssetIncreaseDecrease>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfNS0xLTEtMS0w_02863d5b-1ce5-4a95-8751-8160efaf7bb8"
      unitRef="usd">34900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfNi0xLTEtMS0w_97d5cdef-62e7-4b19-9b4d-d97f05468f96"
      unitRef="usd">57100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RhYmxlOjU2MjNlZTYwM2RlNTQ0Nzg5MzJlNjZmNTRjZTBiNmRjL3RhYmxlcmFuZ2U6NTYyM2VlNjAzZGU1NDQ3ODkzMmU2NmY1NGNlMGI2ZGNfNy0xLTEtMS0w_b742f054-9613-4ac1-b8da-90beb35726b2"
      unitRef="usd">-22200000</us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized>
    <wst:ContractWithCustomerLiabilityRecognitionPeriod
      contextRef="i1d47931a6e3740b480deaae11058a69d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODc5NjA5MzAzMzE4MQ_2f876d70-0555-41ac-9eb0-518d89539f37">P1Y</wst:ContractWithCustomerLiabilityRecognitionPeriod>
    <wst:ContractWithCustomerLiabilityRecognitionPeriod
      contextRef="i37e2e771b55940c7ab603ef0b73ffe0d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODc5NjA5MzAzMzE3OQ_2d2c953d-43b9-448e-b90c-611806e5e0a4">P2Y</wst:ContractWithCustomerLiabilityRecognitionPeriod>
    <wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzAzMg_58298525-0388-449c-bf9c-72b55609caaa"
      unitRef="usd">100300000</wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments>
    <wst:ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzAzNg_938a6717-8475-4d0c-97fb-2062d3f95ec7"
      unitRef="usd">83900000</wst:ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod>
    <wst:ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod
      contextRef="i5338787af4fd49bb99c35be9bb0ef3b9_D20200101-20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzA0MA_42f7140f-8861-4c85-a515-8d4e2f5ac294"
      unitRef="usd">26900000</wst:ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzA4OQ_5f6adc25-d384-448b-a103-6963d31b75cc"
      unitRef="usd">14100000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfMTA5OTUxMTYzNzA3OQ_52043b67-d48b-45bb-93f7-a4161431aa75"
      unitRef="usd">10100000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount>
    <wst:ProvisionForProductReturns
      contextRef="i73877135951c49808f223e59689acc98_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODE1NQ_465540ba-aa3a-4c10-a0eb-370f0b40caa7"
      unitRef="usd">11300000</wst:ProvisionForProductReturns>
    <wst:ProvisionForProductReturns
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85NC9mcmFnOjdiOTFhYzQ0M2JmOTRhYTVhMjdlMjRmNzA1N2E3YWQzL3RleHRyZWdpb246N2I5MWFjNDQzYmY5NGFhNWEyN2UyNGY3MDU3YTdhZDNfODM5NA_100bee03-3b0c-4dba-a9c7-e849dde3cd97"
      unitRef="usd">5400000</wst:ProvisionForProductReturns>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMTQ0Mg_c680a0a4-e838-4ec1-b02c-484f6ccd8f63">Net Income Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, 2019 and 2018, there were 0.0 million, 0.1 million, and 0.4 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. There were no shares purchased during the three months ended December 31, 2020. During the year ended December 31, 2020, we purchased 761,500 shares of our common stock under the now completed program at a cost of $115.5&#160;million, or an average price of $151.65 per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2020, we announced a share repurchase program for calendar-year 2021 authorizing the repurchase of up to 631,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMTQzOA_0d2576a5-cf8b-4469-915d-293d19f986b1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMS0xLTEtMS0w_015da4c3-5ba6-4d63-ac8d-f76a2bff1315"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMS0zLTEtMS0w_376bbe9a-a28b-4828-a24d-678ce14e8bf1"
      unitRef="usd">241700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMS01LTEtMS0w_1b7a02c4-4502-4784-8271-09c81b3c94a2"
      unitRef="usd">206900000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMi0xLTEtMS0w_3cb2c2d6-8728-42e6-a735-f046d9b10a42"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMi0zLTEtMS0w_d64ba62d-c65b-404c-9401-ac1317f50811"
      unitRef="shares">74000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMi01LTEtMS0w_6fc130c4-cf73-4764-9ab7-43be9a701068"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMy0xLTEtMS0w_e4292bdf-a31b-4c0a-aea3-1fef95df87a5"
      unitRef="shares">1900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMy0zLTEtMS0w_967a826a-17ae-4f33-ae65-f55ebab1a081"
      unitRef="shares">1400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfMy01LTEtMS0w_c6d565e1-8d08-40d1-9c1b-aff88d782bab"
      unitRef="shares">1500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfNS0xLTEtMS0w_0f90d11d-26d2-4e5f-81f0-525a4303c726"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfNS0zLTEtMS0w_41426d26-9c43-4ff3-8301-a995165fecbb"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RhYmxlOjBiNWRjNzZjMTg0YjQ4OGVhNTkwYzRjZDBmMDc3ZmI1L3RhYmxlcmFuZ2U6MGI1ZGM3NmMxODRiNDg4ZWE1OTBjNGNkMGYwNzdmYjVfNS01LTEtMS0w_3833acab-8344-4d7e-8019-33dec8df31bc"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMjE2_2ad41dbe-c808-4cc9-8f72-ee1d4953bf3c"
      unitRef="shares">0.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMjIw_04011746-790d-4cea-b69c-b5c7d80babb2"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMjI4_03b8cf95-8175-410b-be3f-d1d39f8b5dd4"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfMTA1Ng_ae86f099-397d-44ca-a1ac-a419d2446ac3"
      unitRef="shares">848000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjEwMw_868eccde-370c-4bef-8c89-84e71e2a0034"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA2Ng_42b5dd8c-b117-4946-81f5-ac3108c1f637"
      unitRef="shares">761500</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA3NQ_14fb3c2e-dce1-4d2c-9a2a-2a2988368395"
      unitRef="usd">115500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA5MQ_a1688507-ba1b-42a5-86a8-2bd445df08f5"
      unitRef="usdPerShare">151.65</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl85Ny9mcmFnOjUyMTM2YTc2NmUwNDQzNjg4ZjNhOGZmYWQwY2YyNmQxL3RleHRyZWdpb246NTIxMzZhNzY2ZTA0NDM2ODhmM2E4ZmZhZDBjZjI2ZDFfNjA0NzMxMzk1NjA1Nw_3aa96091-7c30-4048-a265-de6713bd7c53"
      unitRef="shares">631000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2Xzg3OTYwOTMwMjM0MTA_884e81e7-152e-4232-a493-957ea08a4852">Property, Plant and Equipment&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of gross property, plant and equipment at December 31 is presented in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected useful lives (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15-35&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds and dies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,035.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for the years ended December&#160;31, 2020, 2019 and 2018 was $104.7 million, $100.0 million and $101.7 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2020, 2019 and 2018 was $1.4 million, $1.0 million and $0.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019 and 2018, as part of our 2018 restructuring plan, we recorded within other expense (income) $0.3&#160;million and $2.2&#160;million, respectively, for non-cash asset write-downs associated with the discontinued use of certain equipment. During 2019 and 2018, as part of our restructuring plans, we recorded within other expense (income) $1.9&#160;million and $1.1&#160;million, respectively, for gains on the sale of fixed assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzEwNjM_88086b87-b786-42ef-877b-19ac3c054aa8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of gross property, plant and equipment at December 31 is presented in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected useful lives (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15-35&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds and dies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,035.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i797e7706a95c4087904100b08ffda29a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzEtMy0xLTEtMA_c3baa2d4-4c2c-4682-9e41-436a0b58e8b8"
      unitRef="usd">24800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i43893472b07f462daa1936e31dd6e050_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzEtNS0xLTEtMA_7e25c2bc-1702-4498-ac6b-503652df2616"
      unitRef="usd">22100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7dc331021b39487eae7d8020f2a6bbb9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItMS0xLTEtNTkxMS90ZXh0cmVnaW9uOjY1NDk4MTRkZGQ4NDQxZmU4ODVmZWZiOGE2YmM4ZjlkXzEwOTk1MTE2Mjc3ODc_758ba0ad-65fc-4a1b-a286-222f599ec627">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ifac82b7c5e944f5e9ef69d0cc9b23961_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItMS0xLTEtNTkxMS90ZXh0cmVnaW9uOjY1NDk4MTRkZGQ4NDQxZmU4ODVmZWZiOGE2YmM4ZjlkXzEwOTk1MTE2Mjc3OTI_a9d09d07-c63b-4b47-b503-a29d68db3b69">P35Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5b9f3baa155749da88ba56d5f039aae7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItMy0xLTEtMA_5b7dedab-ce50-4275-aa59-ac2488682977"
      unitRef="usd">618100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib84fd26354a144cea716d068af99f852_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzItNS0xLTEtMA_f72dda4a-7baa-459e-95cf-91c4b1ecad9d"
      unitRef="usd">572900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ieac0052e9268404c8537a172e384ec54_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtMS0xLTEtNTkxNC90ZXh0cmVnaW9uOmM5ZjYyZDA0MjY5YjRkMmZiNmVmOWMwYzk3MjVjN2I5XzEwOTk1MTE2Mjc3ODU_0d56e508-f34a-46bb-bdfd-2bdfd6c33bd7">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i623144efe05d406b97fe87c5de9251ae_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtMS0xLTEtNTkxNC90ZXh0cmVnaW9uOmM5ZjYyZDA0MjY5YjRkMmZiNmVmOWMwYzk3MjVjN2I5XzEwOTk1MTE2Mjc3OTA_351e97b0-7bb2-4379-9f03-e8f011518c11">P12Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i22f0862b68a74914864a578b3eccdf30_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtMy0xLTEtMA_52567968-6e3b-4775-bc13-3ac46058e111"
      unitRef="usd">911800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i238e2384b1ff420ebcc2252db6a22803_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzMtNS0xLTEtMA_b48fe0a2-af3c-424a-ab6f-a5eb7f9d096d"
      unitRef="usd">817000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5c646a3c66bd4b32b179638b0f4f3410_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtMS0xLTEtNTkxNy90ZXh0cmVnaW9uOjQ1NzU5Y2YyNmU0ODRkYjZhODFhMTgxZGYxYjI1ZjhiXzEwOTk1MTE2Mjc3ODQ_24bb7b45-8fa5-45b0-b4c2-6b36e4b6a5de">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9a501f1bfd934f5986193d345963b2c0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtMS0xLTEtNTkxNy90ZXh0cmVnaW9uOjQ1NzU5Y2YyNmU0ODRkYjZhODFhMTgxZGYxYjI1ZjhiXzEwOTk1MTE2Mjc3ODg_cb0136f6-ea6a-449c-977d-37c63b43e42a">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5b6725930a324da584fa5818f87a7c19_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtMy0xLTEtMA_2c11f0dd-3ac3-4ff0-beb8-b4979aa2dfad"
      unitRef="usd">131200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0813f85e68a04705a535a614e3d8d1aa_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzQtNS0xLTEtMA_380e2fd5-6578-4905-9b3f-a5b013bbed52"
      unitRef="usd">123800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i74e88843a60b49ff82c73cb0b8167faf_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtMS0xLTEtNTkyMC90ZXh0cmVnaW9uOmZhMDkyZGYzYWIyNTRjYzViYjAwMjJhNjdkZjgzMjA3XzEwOTk1MTE2Mjc3ODU_487f3736-c586-4019-be86-2a97639db463">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6b9182def7704d2e8b4c70f42352b523_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtMS0xLTEtNTkyMC90ZXh0cmVnaW9uOmZhMDkyZGYzYWIyNTRjYzViYjAwMjJhNjdkZjgzMjA3XzEwOTk1MTE2Mjc3ODk_04515077-cff2-411f-bf9c-2236f4851687">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8fb2ab515f964445a7edbb1dcb815cb7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtMy0xLTEtMA_c9015722-22aa-402d-8434-65eab5043f0f"
      unitRef="usd">157500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3c5e7423241f495ea2428efc693f1c2c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzUtNS0xLTEtMA_50ea26d8-5de2-45c8-9c30-9174acf95ecb"
      unitRef="usd">155600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if8af390c674040738b060151f2548d1e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzYtMy0xLTEtMA_77ccb991-bc31-409a-bae2-87b7eecd9015"
      unitRef="usd">192100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i72fa20c7d6fe45dd9143b6334b282969_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzYtNS0xLTEtMA_8fa40194-a108-4891-8ffe-4b97f3e78401"
      unitRef="usd">128700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzctMy0xLTEtMA_b974160c-b387-4eb2-96f6-828d5ff2f591"
      unitRef="usd">2035500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90YWJsZToyOTg3N2M0OGI4Nzg0Zjc0ODAwMjUwNGI1YTdmNGM3NS90YWJsZXJhbmdlOjI5ODc3YzQ4Yjg3ODRmNzQ4MDAyNTA0YjVhN2Y0Yzc1XzctNS0xLTEtMA_391e0f28-5ad4-49d9-bc52-858d3dfc485b"
      unitRef="usd">1820100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:Depreciation
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzIwOA_737de742-e481-4a62-b6b6-ed44d8f38fc7"
      unitRef="usd">104700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzIxMg_a8aae951-8046-491d-82ca-eb24efb67de7"
      unitRef="usd">100000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzIxOQ_71eb93c7-ce8e-404f-8761-890a837811c2"
      unitRef="usd">101700000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzYzNg_c8afaa3b-a2fa-4b04-ae78-f78bcf8b2a84"
      unitRef="usd">1400000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzY0MA_c8918be6-9d1b-40cb-9881-c28aa1433e6a"
      unitRef="usd">1000000.0</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzY0Nw_1145cfe6-c339-4ba7-90e6-f5b9cc207d1f"
      unitRef="usd">900000</us-gaap:InterestCostsCapitalized>
    <us-gaap:AssetImpairmentCharges
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzEwOTk1MTE2Mjg4NDI_c6fb317f-3df0-4249-a04d-988e6daa6dd6"
      unitRef="usd">300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2XzEwOTk1MTE2Mjg4NDY_a8cb9897-c2f5-4caa-af46-76475c9a2148"
      unitRef="usd">2200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2Xzk4NQ_42a80a05-e8e2-4dbc-9a7e-18cbf2ccaf08"
      unitRef="usd">1900000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDAvZnJhZzplMThkMjZhMmQyMmY0MDM1ODYwOTIwZTRhZjBjNzRmNi90ZXh0cmVnaW9uOmUxOGQyNmEyZDIyZjQwMzU4NjA5MjBlNGFmMGM3NGY2Xzk5Mg_d2bd995e-638f-48fc-9936-984e8dc6caaf"
      unitRef="usd">1100000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTU_061400db-b451-45d7-ade3-07d41e629fa9">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Adoption of ASC 842&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of December&#160;31, 2020, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases provide us with an option, exercisable at our sole discretion, to terminate the lease or extend the lease term for one year or more. We had no finance leases as of December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease expense for 2018 was $14.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 and December&#160;31, 2019, the weighted average remaining lease term for operating leases was 11.1 years and 11.7 years and the weighted average discount rate was 3.68% and 3.76%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected to adopt practical expedients around the combination of lease and non-lease components and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <wst:LesseeOperatingLeaseOptionToTerminateTerm
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzc0MA_ca0da83c-e1b3-48c6-b920-98b56ad676c2">P1Y</wst:LesseeOperatingLeaseOptionToTerminateTerm>
    <us-gaap:FinanceLeaseLiability
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzc1Ng_4e548ac4-1fac-40f2-92a4-c00f1d004279"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzc1Ng_efc6e348-60e1-4634-a499-c8e35771a256"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTg_827f4584-8b2b-4f7e-8612-9f83fb62cd14">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzEtMS0xLTEtMA_15dd81a2-6451-4ad4-8e89-bae80d4c301c"
      unitRef="usd">12800000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzEtMy0xLTEtMjkxMA_0304e832-f01e-415c-bd55-b2e204fcbe34"
      unitRef="usd">12900000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzItMS0xLTEtMA_ac58b885-8ad1-4680-9a78-bd4b67aee18f"
      unitRef="usd">800000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzItMy0xLTEtMjkxMA_de59820e-5c4e-4002-b47c-927ab24c14ae"
      unitRef="usd">800000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzMtMS0xLTEtMA_b0705851-494f-4a59-a128-813437551d9a"
      unitRef="usd">3800000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzMtMy0xLTEtMjkxMA_4b851532-d071-4af2-9380-72feccd8682c"
      unitRef="usd">3300000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzQtMS0xLTEtMA_2e388ab0-f269-40ae-acf0-8750f75245fb"
      unitRef="usd">17400000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo1ZGEyNmJiZWU4ZjY0MThhYWM0OTMxYjIwZTM0MGMzZS90YWJsZXJhbmdlOjVkYTI2YmJlZThmNjQxOGFhYzQ5MzFiMjBlMzQwYzNlXzQtMy0xLTEtMjkxMA_64ddf3e6-26c7-4447-bc2b-47fdaf8e7d2c"
      unitRef="usd">17000000.0</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzM5Mzc_b9eea502-9933-4d1a-8081-8df9008d44a1"
      unitRef="usd">14500000</us-gaap:OperatingLeasesRentExpenseNet>
    <wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTk_c3e12da1-bd66-434a-ab01-bd2536ac35d0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzItMS0xLTEtMA_8d6bcc8b-4d35-4342-b931-ed6b5b875542"
      unitRef="usd">12600000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzItMy0xLTEtMjkwNA_e3babba0-6333-4281-b462-18cc8274105c"
      unitRef="usd">12500000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzQtMS0xLTEtMA_2ff45578-1497-423e-8e23-e067214c9876"
      unitRef="usd">6100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo2YWU4ZjE4NzBhN2Q0NzBlODg3NDE2NjgzOTQ0NzE3ZC90YWJsZXJhbmdlOjZhZThmMTg3MGE3ZDQ3MGU4ODc0MTY2ODM5NDQ3MTdkXzQtMy0xLTEtMjkwNw_1653a02a-d821-4f0e-af01-ccbc9ff640e7"
      unitRef="usd">9100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxNTE_5dc9110d-b018-4e04-9847-8c4e915e3777">P11Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxODE_57bbd37b-deae-47d3-af97-58a21778af65">P11Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxNTU_241af146-7213-4fd2-b728-45c51f009920"
      unitRef="number">0.0368</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzEwOTk1MTE2MzMxODU_82689cc2-6953-47db-9227-b7a93ec5721b"
      unitRef="number">0.0376</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUyNTM_cf6c0710-1515-41ac-b7a8-a626b2047032">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzItMS0xLTEtMA_46544d54-aaba-45f1-bc01-dd8186ae69e7"
      unitRef="usd">12400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzMtMS0xLTEtMA_3acfe051-69df-4c79-95eb-344022245ed3"
      unitRef="usd">10400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzQtMS0xLTEtMA_9cc6a8c3-d43d-40e1-a493-80218f8b74ed"
      unitRef="usd">9300000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzUtMS0xLTEtMA_6d678577-d72a-4278-9f8a-3776bfb1a039"
      unitRef="usd">8700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzYtMS0xLTEtMA_0d316e6e-a0ea-478a-924c-c4eb53c8f9a4"
      unitRef="usd">6900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzctMS0xLTEtMA_78d5bad7-1569-4aed-9a5b-14d0d2bbe7c1"
      unitRef="usd">37500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzgtMS0xLTEtMA_5e1bda98-0774-4681-9a71-63b1fd0c67c1"
      unitRef="usd">85200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzktMS0xLTEtMA_58391b69-219a-4bee-8c1e-0eba67ea1b62"
      unitRef="usd">14700000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90YWJsZTo0ZDkwNTg2Zjk2MmY0MzExYjUzYzA3NDcyODlhNmU3Yy90YWJsZXJhbmdlOjRkOTA1ODZmOTYyZjQzMTFiNTNjMDc0NzI4OWE2ZTdjXzEwLTEtMS0xLTA_c74b2e61-bc46-42a2-9a80-cda5f34a67c2"
      unitRef="usd">70500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i1e509ff0f5b945d2a61627e10cf74c19_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDYvZnJhZzoyMzYzNzBhZjlkNzc0ZjU2YWExYTExMTNhZWU3ZWQxMC90ZXh0cmVnaW9uOjIzNjM3MGFmOWQ3NzRmNTZhYTFhMTExM2FlZTdlZDEwXzUxMzY_d16cad19-16fc-4bb8-8ff8-a0eccc07aa1c">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzIwNTY_f9cdf328-7f1b-42e5-9168-b667248c8046">Affiliated Companies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the following affiliated companies were accounted for under the equity method:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The West Company Mexico, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aluplast S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Tap S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Rubber S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&amp;amp;W Pharma Group LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Daikyo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2019, in connection with the amendment of certain commercial agreements with Daikyo, we increased our ownership interest from 25% to 49% in Daikyo in exchange for $85.1&#160;million in cash and $4.9&#160;million in shares of our treasury stock to certain stockholders of Daikyo.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unremitted income of affiliated companies included in consolidated retained earnings amounted to $98.2 million, $82.4 million and $75.8 million at December&#160;31, 2020, 2019 and 2018, respectively. Dividends received from affiliated companies were $1.6 million in 2020, $2.2 million in 2019 and $1.7 million in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our equity in net unrealized gains of Daikyo&#x2019;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $0.6 million, $0.4 million and $0.4 million at December&#160;31, 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our purchases from, and royalty payments made to, affiliates totaled $143.3 million, $115.1 million and $86.3 million, respectively, in 2020, 2019 and 2018, of which $33.6 million and $20.8 million was due and payable as of December&#160;31, 2020 and 2019, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $9.7 million, $9.2 million and $9.6 million, respectively, in 2020, 2019 and 2018, of which $1.4 million and $1.9 million was receivable as of December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020 and 2019, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $201.9 million and $179.3 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $12.8 million and $13.4 million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzIwNjM_f4d1a895-3183-446e-b0d3-128affb32deb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the following affiliated companies were accounted for under the equity method:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The West Company Mexico, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aluplast S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Tap S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma Rubber S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&amp;amp;W Pharma Group LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Daikyo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3be748d3389b4043bbf41058de1b56a6_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzEtMi0xLTEtMA_f4f5461b-c07b-4958-b1a2-cf7bdf479ccc"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="if3f00119f82f45ffaaf450f7f33b594d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzItMi0xLTEtMA_590f19c5-e4b5-4d5a-a1d0-85c09c922259"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ic55755bcb9b447d0bcdb031080c38641_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzMtMi0xLTEtMA_f3a2680e-a66c-4196-b687-4b62e9640152"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idca87fb6336b4470ae7aa7facb3cb9dc_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzQtMi0xLTEtMA_f63b22d1-cb6f-4426-8ae0-7c767d50cd61"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ief5faa8076a2458484658e4551e6e62a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzUtMi0xLTEtMA_489c8dfa-c923-4d42-8535-336f33a3bf14"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ifa409a36165643678fa489cb0bfba317_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90YWJsZTpiZmZlODg1ZTU1ZmI0MDNlOTkzYTdlZDgyZTVkNzM4NC90YWJsZXJhbmdlOmJmZmU4ODVlNTVmYjQwM2U5OTNhN2VkODJlNWQ3Mzg0XzYtMi0xLTEtMA_38a1404a-1150-4d53-bc43-582f312d6242"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i7eb5c5ab7e624c9cb50fc001dee5e2ef_I20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzI2Ng_106f8d88-c239-4f75-963d-17d8c234e50e"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ic8e22ea7f9ce44e9bab1f731e0385e4c_I20191101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzI3Mg_f1cefa6b-430c-4d67-9013-cdb28080de8c"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzMwMQ_12a85cf4-5323-4bca-8276-53fcccfba150"
      unitRef="usd">85100000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzMxNg_f662b19b-692c-4be5-92f8-4e5861b10989"
      unitRef="usd">4900000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzU5Ng_c2d35588-d7ed-436b-88d7-0c147e755f5b"
      unitRef="usd">98200000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzYwMA_f26f7925-4eed-4d2c-b1bd-0d34c2445aa7"
      unitRef="usd">82400000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzYwNw_38c77537-f939-44fb-9899-b591bbea62cf"
      unitRef="usd">75800000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzY5Mg_832f4353-5c6d-4d8e-941c-fdef797e34d3"
      unitRef="usd">1600000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzcwMg_cedfcd20-efa8-4c0d-9e94-02903f8af7a0"
      unitRef="usd">2200000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzcxNQ_fbaa87bd-c248-4492-8498-3c56a2751137"
      unitRef="usd">1700000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="ifa409a36165643678fa489cb0bfba317_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzkwOA_24b1b141-6035-4458-8b05-62132a97a09c"
      unitRef="usd">600000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="if35f246fd3544635b81e8a42dbd0deae_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzkxMg_34aa5ec6-912e-4622-8fb9-e8e1bb170e66"
      unitRef="usd">400000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="ife9245eb0c4a4874b266ec836a4fdc4f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzkxOQ_06fefc81-63c9-4e0e-86d4-0d206248d259"
      unitRef="usd">400000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwMjU_e72d2c40-557e-46b5-a654-f963d6a38501"
      unitRef="usd">143300000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwMjk_57a074b9-5ad2-4cc9-8475-d6335553ede8"
      unitRef="usd">115100000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwMzY_5666abd8-9230-4f2e-8c80-c1d75d762f05"
      unitRef="usd">86300000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <us-gaap:DueToAffiliateCurrentAndNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwODE_96fe10c1-3731-4af4-9853-a7bfa65c8928"
      unitRef="usd">33600000</us-gaap:DueToAffiliateCurrentAndNoncurrent>
    <us-gaap:DueToAffiliateCurrentAndNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwODg_2b4da9d9-1dd1-4bfb-a22d-85e5f457cb42"
      unitRef="usd">20800000</us-gaap:DueToAffiliateCurrentAndNoncurrent>
    <wst:SalesToEquityMethodInvestees
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzMDk_1e0cf3e6-20be-4458-9b42-a3783b6cf1b1"
      unitRef="usd">9700000</wst:SalesToEquityMethodInvestees>
    <wst:SalesToEquityMethodInvestees
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzMTM_b9a95393-699b-445e-9480-7615375d2f11"
      unitRef="usd">9200000</wst:SalesToEquityMethodInvestees>
    <wst:SalesToEquityMethodInvestees
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzMjA_cd71ec3b-5e72-4c66-bd78-489f7ef52096"
      unitRef="usd">9600000</wst:SalesToEquityMethodInvestees>
    <us-gaap:DueFromAffiliates
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzNjU_2a445dbe-2bf5-4451-9f45-66a266e5e96a"
      unitRef="usd">1400000</us-gaap:DueFromAffiliates>
    <us-gaap:DueFromAffiliates
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEzNzI_77a6262d-96a2-4e37-a69d-cfb58954de6d"
      unitRef="usd">1900000</us-gaap:DueFromAffiliates>
    <us-gaap:EquityMethodInvestments
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzE1NTk_ed617f56-ea69-408e-b48b-d3a76cc18a01"
      unitRef="usd">201900000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzE1NjY_3da011f7-4add-4a04-8791-79adbbf2f6ae"
      unitRef="usd">179300000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzE3MTU_612bd491-50d0-42ca-82ae-47ec0a226ea8"
      unitRef="usd">12800000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMDkvZnJhZzoxNDRkZWQ1OGZiYjQ0MjgxYTdiNjhhYjMyYzA4NDBmNS90ZXh0cmVnaW9uOjE0NGRlZDU4ZmJiNDQyODFhN2I2OGFiMzJjMDg0MGY1XzEwOTk1MTE2Mjk4OTI_55ee5eee-29a2-44f0-ad19-425a1993e209"
      unitRef="usd">13400000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzExMTU_0256b49f-83f6-4d8b-9495-eb4eab11b19e">Goodwill and Intangible Assets&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill recorded due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded goodwill of $2.6&#160;million. The goodwill was recorded within our Proprietary Products reportable segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we had no accumulated goodwill impairment losses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and accumulated amortization as of December 31 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the acquisition of our South Korean distributor in April 2019, we recorded a customer relationships intangible asset of $11.2&#160;million, which is being amortized over ten years. &lt;/span&gt;&lt;/div&gt;The cost basis of intangible assets includes a foreign currency translation gain of $1.3 million and a foreign currency translation loss of $0.3 million for the years ended December&#160;31, 2020 and 2019, respectively. Amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 was $4.4 million, $3.4 million and $2.7 million, respectively. Estimated annual amortization expense for the next five years is as follows: 2021 - $3.8&#160;million, 2022 - $3.8&#160;million, 2023 - $3.7&#160;million, 2024 - $3.6&#160;million and 2025 - $3.4&#160;million.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTc_8210dee4-83b0-45cf-924f-dbc59d15f11b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill recorded due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i10b64636eec7496ab4fe500fe0014523_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzEtMS0xLTEtMA_da774c8a-b579-4855-b1a5-aad8aceb2c4e"
      unitRef="usd">76000000.0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4d80b77bc4ac4259a6a16b2462cb3040_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzEtMy0xLTEtMA_492a08d1-99c5-4bc3-a4bc-3f6e43ff4d04"
      unitRef="usd">29800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzEtNS0xLTEtMA_43b5e315-f2ce-4371-ba3b-5e0aa901791e"
      unitRef="usd">105800000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8da13621281d4304b07876e3311d46e7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzItMS0xLTEtMA_fab9de13-1b6f-4999-a516-c26c95940f88"
      unitRef="usd">2600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibfe51fd72fce4c61b52e43766f31dd16_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzItMy0xLTEtMA_fa7b4bf1-146b-4f86-8903-1eda9a60477d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzItNS0xLTEtNTcyMg_dd6344de-eeb0-49be-802d-34be2020170d"
      unitRef="usd">2600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8da13621281d4304b07876e3311d46e7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzMtMS0xLTEtMA_00ab10ae-6f02-494f-ad46-4200f68a09f8"
      unitRef="usd">-500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibfe51fd72fce4c61b52e43766f31dd16_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzMtMy0xLTEtMA_6a75e079-257a-424f-b11b-72c14d35b98b"
      unitRef="usd">-100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzMtNS0xLTEtMA_3bb7494e-0d05-4067-94c7-e369330c32c5"
      unitRef="usd">-600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ie604f66c47674b3483e91758ca61fca3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzQtMS0xLTEtMA_c06d5a32-19e0-4929-b025-32d02c21f7bd"
      unitRef="usd">78100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3bd440b2a0d4e18b3b9208a2c52f423_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzQtMy0xLTEtMA_bf6db2e7-4da5-45f4-be54-48a23fb7f6bc"
      unitRef="usd">29700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzQtNS0xLTEtMA_9603085a-5c91-4fe6-8971-23941597f366"
      unitRef="usd">107800000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4310b97395d143c894afeb7bfaa7db95_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzYtMS0xLTEtMA_93d9a60c-3453-433f-9a09-e53faac3eb3a"
      unitRef="usd">2800000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5dbef396511e4f7d99df2d1f6bf9ea78_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzYtMy0xLTEtMA_b6ec7f94-70ec-4cbb-ba60-28cf1aae223f"
      unitRef="usd">500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzYtNS0xLTEtMA_ab9a0f1a-f26c-4def-a70a-6568649238cb"
      unitRef="usd">3300000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i9b8653a82cd240399911d2be8d12b1c9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzctMS0xLTEtMA_e1877e0f-2891-47cc-8bc5-acbaa57d55cd"
      unitRef="usd">80900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4d40747cb76f4017801fff732122769f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzctMy0xLTEtMA_9971b8a4-49c5-498f-8b45-ff2849471cc3"
      unitRef="usd">30200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkYzAzYTRhNDkwOWU0NDFkOWZlZDRjYjI0MjcyYTgzNi90YWJsZXJhbmdlOmRjMDNhNGE0OTA5ZTQ0MWQ5ZmVkNGNiMjQyNzJhODM2XzctNS0xLTEtMA_b606d837-ba50-4be0-b66e-21f4a6a12a49"
      unitRef="usd">111100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib0d1e9f54b0d4246bce9c1710ee63360_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzI2Ng_0c1a1d7a-127a-4330-890e-59f9c11ad82e"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzYwNDczMTM5NTM5MTE_4e743792-8990-4e24-890d-235ae6597897"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzExMDA_067ca9db-aee8-4463-9768-41c6d7bb5fe8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and accumulated amortization as of December 31 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItMS0xLTEtMA_dbc9f868-632a-4ef6-afd8-d12c9dc8a145"
      unitRef="usd">25900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItMy0xLTEtMA_3f29435d-4a09-477e-8089-5f549c975d9d"
      unitRef="usd">17900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i899fd7721acf442f9c8a7b1aa1895b2a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItNS0xLTEtMA_5f654622-9a22-4031-9244-4881bb4eff5b"
      unitRef="usd">8000000.0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i45f82da0975740ea962df3a9317d294c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItNy0xLTEtMA_bf365a5a-e364-4f6f-9893-23a86a095f2b"
      unitRef="usd">21500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i45f82da0975740ea962df3a9317d294c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItOS0xLTEtMA_03542255-9da7-4a5e-acb6-2191120c84d8"
      unitRef="usd">16000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i45f82da0975740ea962df3a9317d294c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzItMTEtMS0xLTA_ef2ef103-7098-4e25-ac54-44c82b807c0c"
      unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iff44052635f445ae955fe9e5585b43a6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtMS0xLTEtMA_4b5fd4f0-1a12-4e08-8722-1412e6068165"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iff44052635f445ae955fe9e5585b43a6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtMy0xLTEtMA_2e56aa9c-ae41-4c7b-bceb-2b487709f740"
      unitRef="usd">1700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iff44052635f445ae955fe9e5585b43a6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtNS0xLTEtMA_19ece3cb-acdf-4d9e-bb70-448da8261ac7"
      unitRef="usd">1600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia6e9699cda854495a74995b636566af6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtNy0xLTEtMA_f0993605-a7ef-46d1-a7bf-60eff38d97f5"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia6e9699cda854495a74995b636566af6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtOS0xLTEtMA_b9dc4d85-2653-4778-8663-186a47e7846b"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia6e9699cda854495a74995b636566af6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzMtMTEtMS0xLTA_feea1739-43a1-4c9e-a5ad-89160ae9289e"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtMS0xLTEtMA_846d2fb0-3aac-4ae8-bc0c-a398689c28fd"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtMy0xLTEtMA_f3801fc9-04fc-47b7-a2e6-92449565702e"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3658a7589a8f4ece84d57bee6ee4bf0f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtNS0xLTEtMA_ff70466d-8b4f-49e4-bda0-103248c3b7e7"
      unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id22d02338f104289981b9d9ff7b017ce_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtNy0xLTEtMA_fc189c86-6ea2-4545-9363-c91a8e369274"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id22d02338f104289981b9d9ff7b017ce_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtOS0xLTEtMA_d5c74001-78dc-48f6-a0f0-c606da09d872"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id22d02338f104289981b9d9ff7b017ce_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzQtMTEtMS0xLTA_a2fccac9-76a5-4e31-b14b-ebede1cf5edc"
      unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i11d276e7e42d4f86a942aeb848b531f3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtMS0xLTEtMA_1ef6804e-49ae-4cc9-8b60-35eeb53e4985"
      unitRef="usd">40900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i11d276e7e42d4f86a942aeb848b531f3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtMy0xLTEtMA_99a8dd5e-5dfb-43ed-bf3e-b44803b49f0a"
      unitRef="usd">23400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i11d276e7e42d4f86a942aeb848b531f3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtNS0xLTEtMA_7ebfc947-573b-4a2a-a208-50ba362ff2e1"
      unitRef="usd">17500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i675a7006751b46918799584d6d648565_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtNy0xLTEtMA_703b51fb-cc78-4d69-89ca-5dac8454de94"
      unitRef="usd">40300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i675a7006751b46918799584d6d648565_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtOS0xLTEtMA_5e3db3f7-ab68-4eeb-bd7d-79ef4b36f851"
      unitRef="usd">21600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i675a7006751b46918799584d6d648565_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzUtMTEtMS0xLTA_c37df9eb-a4fb-4399-bfdc-4a149e0ce926"
      unitRef="usd">18700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2aca41366c9f474c9c65cbd82020f94d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtMS0xLTEtMA_3a37650c-4021-4b60-92fc-5da28ec4b43a"
      unitRef="usd">11100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2aca41366c9f474c9c65cbd82020f94d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtMy0xLTEtMA_5bdc42f9-3a0d-4dd8-9e68-a0cb992c0f75"
      unitRef="usd">7900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2aca41366c9f474c9c65cbd82020f94d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtNS0xLTEtMA_1c4eceb1-fcae-4d35-93f1-75c19f1b4904"
      unitRef="usd">3200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id040728146984679be5dc82bedb6dd6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtNy0xLTEtMA_b1aa5068-749c-4e23-80b5-089b5c72810c"
      unitRef="usd">11000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id040728146984679be5dc82bedb6dd6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtOS0xLTEtMA_edd0cdad-230b-418b-ae36-7457bae24551"
      unitRef="usd">7400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id040728146984679be5dc82bedb6dd6b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzYtMTEtMS0xLTA_1f082c06-bcee-4066-bbb3-27b46c091c2b"
      unitRef="usd">3600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctMS0xLTEtMA_f75ecb86-6c9a-4459-8a6a-33caf2b953ec"
      unitRef="usd">83200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctMy0xLTEtMA_602eb19c-cf13-471d-ac33-daa213510ff5"
      unitRef="usd">52700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctNS0xLTEtMA_9289e050-464d-4c9b-b7a8-e21c60acc6be"
      unitRef="usd">30500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctNy0xLTEtMA_c3bd9ddd-aba7-4409-9283-96f6c2a157ab"
      unitRef="usd">78100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctOS0xLTEtMA_78bcfdd6-69d9-438a-abb9-b9cabc7d3393"
      unitRef="usd">48300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90YWJsZTpkNjg3OGNkYmVjMTY0OWI4OGVhYTA3ZGFkYWE4YTFkOC90YWJsZXJhbmdlOmQ2ODc4Y2RiZWMxNjQ5Yjg4ZWFhMDdkYWRhYThhMWQ4XzctMTEtMS0xLTA_07b337ce-2b61-4baa-b60e-b46700a735d0"
      unitRef="usd">29800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ie61c5d576f4c47feb0147ea226ccf081_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzY2MQ_b4ba6f24-70b4-4592-b097-d0d436256d21"
      unitRef="usd">11200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id71719218e6a4641a583e3045ba927ad_D20190401-20190430"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzYwNDczMTM5NTQwODg_f1351d0b-b8c3-45a5-88dd-313748cb2d13">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzc5MA_2f704d32-5800-4616-b0a7-265b640d863d"
      unitRef="usd">1300000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzgzNA_0710735f-09f7-415a-a297-0aa76e63e773"
      unitRef="usd">-300000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzk0MQ_e5ef343e-720f-4b98-9bdb-15d591ca93e4"
      unitRef="usd">4400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzk0NQ_01b50bfa-572a-4be3-8900-0546e9efa412"
      unitRef="usd">3400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2Xzk1Mg_1f8112eb-240b-4247-811e-bde3519a506e"
      unitRef="usd">2700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg4OTc_a0982705-955b-498d-aa4e-37de692628b5"
      unitRef="usd">3800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MDE_9766c7fe-5693-488b-a326-1ba13aff2bb7"
      unitRef="usd">3800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MDU_4226c81b-ae8a-4498-94c1-fada1fac703d"
      unitRef="usd">3700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MDk_53219b69-80c4-4e24-8e75-e17ff3c5ff73"
      unitRef="usd">3600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTUvZnJhZzowOTVkOTUzNDNmYmU0NjQ0OTNkYjgzM2RlNzQ4ZTQ5Ni90ZXh0cmVnaW9uOjA5NWQ5NTM0M2ZiZTQ2NDQ5M2RiODMzZGU3NDhlNDk2XzEwOTk1MTE2Mjg5MTM_3030229e-db37-4b9e-8883-1bd9ddf109ce"
      unitRef="usd">3400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90ZXh0cmVnaW9uOjI4ZTQyZjEyZTUxYTQ2ZDE5ZWY5ZmFkMDViMDBiOGI1XzExOA_503a588e-a4b2-44e9-b41f-ef0baa24c97a">Other Current Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities as of December 31 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued commissions, rebates and royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued retirement plans (excluding pension)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes other than income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90ZXh0cmVnaW9uOjI4ZTQyZjEyZTUxYTQ2ZDE5ZWY5ZmFkMDViMDBiOGI1XzExNA_a95d953a-aa63-47fb-820c-7ac89fd9fd3e">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued commissions, rebates and royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued retirement plans (excluding pension)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes other than income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEtMS0xLTEtMA_b8869f46-261b-43b9-9837-e3cc349846ae"
      unitRef="usd">51000000.0</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEtMy0xLTEtMA_66a5ed4a-812d-46e3-be69-07ac4a2cc2ca"
      unitRef="usd">27500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzItMS0xLTEtMA_c8a83d97-540f-43bf-96d9-11c5a639659d"
      unitRef="usd">12600000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzItMy0xLTEtMA_ef2ab29c-51f5-473d-b34e-05ab0597c095"
      unitRef="usd">11800000</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzMtMS0xLTEtMA_4dfe3966-8628-4200-bb20-2ee49b686c0a"
      unitRef="usd">10000000.0</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzMtMy0xLTEtMA_e9dae2e1-bd3f-4a28-a17f-3fe2cfadaa0a"
      unitRef="usd">9700000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzQtMS0xLTEtMA_8dfa934b-b74f-454f-9f47-9f39e8f10f55"
      unitRef="usd">8400000</us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent>
    <us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzQtMy0xLTEtMA_fc01ee3d-e7ee-49e0-b4b6-737477a0fec0"
      unitRef="usd">7900000</us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzUtMS0xLTEtMA_0f1e23f2-7985-4f83-abae-53f269cd7fa7"
      unitRef="usd">15400000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzUtMy0xLTEtMA_92d1c0d7-7701-4110-9bbc-0b527f021bfb"
      unitRef="usd">6500000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzYtMS0xLTEtMA_16d88deb-93c8-4b33-88b0-104d077e2554"
      unitRef="usd">3700000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzYtMy0xLTEtMA_c9bf4a23-bb90-49de-935a-2a525790b0c2"
      unitRef="usd">5900000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzctMS0xLTEtMA_7248ed60-29b4-4a3c-ab98-0f6fdaad1aa4"
      unitRef="usd">3300000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzctMy0xLTEtMA_e39173c3-5a33-4c62-ad8c-e78694a1c797"
      unitRef="usd">3300000</us-gaap:InterestPayableCurrent>
    <us-gaap:RestructuringReserve
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzgtMS0xLTEtMA_39e71a2d-0441-4d7e-83d8-4cc689f645d4"
      unitRef="usd">7800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzgtMy0xLTEtMA_3f106b8f-bf5c-4f2a-83df-60d4a4e101d0"
      unitRef="usd">2600000</us-gaap:RestructuringReserve>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMS0xLTEtMTA1MzM_9c682fe1-9fa9-4472-a22d-699f7570c4b9"
      unitRef="usd">9500000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMy0xLTEtMTA1MzY_01a9cb53-0238-44bf-83d2-f50c3d074046"
      unitRef="usd">200000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMS0xLTEtMA_571b040d-29b4-4b19-8231-4cc3f0e87258"
      unitRef="usd">21900000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzktMy0xLTEtMA_9f4d7d8e-c3f8-43eb-b75c-f21ea4c3a9cd"
      unitRef="usd">15900000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEwLTEtMS0xLTA_45fbe08a-09c4-4c1c-9173-345bdbc1840d"
      unitRef="usd">143600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMTgvZnJhZzoyOGU0MmYxMmU1MWE0NmQxOWVmOWZhZDA1YjAwYjhiNS90YWJsZTo0MmJlZmYwYjU2NGQ0MDM1YjI2Y2U0ZjA4MmI3NmQzOC90YWJsZXJhbmdlOjQyYmVmZjBiNTY0ZDQwMzViMjZjZTRmMDgyYjc2ZDM4XzEwLTMtMS0xLTA_7ab128db-73c4-4a26-8187-16363363a8e8"
      unitRef="usd">91300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUxNzI_203b043c-279f-4593-95e5-24c2c3f2708d">Debt&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, due December 31, 2024 (1.13%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A notes, due July 5, 2022 (3.67%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C notes, due July 5, 2027 (4.02%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Agreement - Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains the Credit Facility of $300.0&#160;million, with sublimits of up to $30.0&#160;million for swing line loans for domestic borrowers in USD and a $20.0&#160;million swing line loan for our German Holding Company and up to $30.0&#160;million for the issuance of standby letters of credit. The Credit Facility may be increased from time-to-time by the greater of $350.0&#160;million and earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily LIBOR, plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December&#160;31, 2020 and 2019, total unamortized debt issuance costs of $0.4&#160;million and $1.1&#160;million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we had no outstanding borrowings under the Credit Facility. At December&#160;31, 2020, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.5 million, was $297.5 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Agreement Amendment - Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#x201c;First Amendment&#x201d;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $90.0&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month LIBOR plus 87.5 basis points. As of December&#160;31, 2020, there were unamortized debt issuance costs remaining of $0.1&#160;million, which are being amortized as additional interest expense over the term of the Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At December&#160;31, 2020, we had $87.7&#160;million in borrowings under the Term Loan, of which $2.3&#160;million was classified as current and $85.4&#160;million was classified as long-term. Please refer to Note 11, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"&gt;Derivative Financial Instruments&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, for a discussion of the foreign currency hedge associated with the Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, we concluded a private placement issuance of $168.0 million in senior unsecured notes. The total amount of the private placement issuance was divided into three tranches - $42.0 million 3.67% Series A Notes due July 5, 2022, $53.0 million 3.82% Series B Notes due July 5, 2024, and $73.0 million 4.02% Series C Notes due July 5, 2027 (the &#x201c;Notes&#x201d;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes is 3.87%. As of December&#160;31, 2020 and 2019, there were unamortized debt issuance costs remaining of $0.4&#160;million and $0.5&#160;million, respectively, which are being amortized as additional interest expense over the term of the Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Covenants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2020, we were in compliance with all of our debt covenants. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest costs incurred during 2020, 2019 and 2018 were $9.6 million, $9.4 million and $9.3 million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, were as follows: $2.3 million in 2021, 2022 $44.2 million, 2023 - $2.2 million, 2024 - $134.0 million, 2025 - $0.0 million, and thereafter - $73.0 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUxNzM_68666dca-a98d-434f-8ba3-2679fb35de1b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, due December 31, 2024 (1.13%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A notes, due July 5, 2022 (3.67%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C notes, due July 5, 2027 (4.02%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzgtMC0xLTEtMC90ZXh0cmVnaW9uOjVmYWRjNzAwMTkyNzRlNWM4YWYwYzIyZGNmMzM5NWY3XzEwOTk1MTE2Mjc4MjU_be5b5424-346b-461c-a3f5-46a4f9f36ee6"
      unitRef="number">0.0113</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzgtMS0xLTEtMA_86a72f48-44a2-4a61-b3a6-cccdab1fb0f7"
      unitRef="usd">87700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia8f18ec1636d4475a790dad18e1921a7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzgtMy0xLTEtMA_b5558c97-d434-4def-bfcc-ad47a015adf2"
      unitRef="usd">90000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4fd969a8862944cda67258a0d270f5df_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzktMC0xLTEtMC90ZXh0cmVnaW9uOjkyNzIwOWEzODE3MDQ0Yjk5MzJiMjExYjc5NmU3MmY1XzEwOTk1MTE2Mjc4MjU_dcd23989-1a4d-4634-8c93-313c6d5e5fbe"
      unitRef="number">0.0367</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4fd969a8862944cda67258a0d270f5df_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzktMS0xLTEtMA_5d186424-f01e-4f93-9f5a-220ad0240c45"
      unitRef="usd">42000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idf89ae5341df4d38abf9f74b7c69e08b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzktMy0xLTEtMA_a181afbb-46e5-4b4f-a96a-a3f4113fe06d"
      unitRef="usd">42000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8f4f2eff7da48748127b29635896464_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo1NmI2ZTJlNjc5Mzk0ODRkODg2YmE4OGMxODY4M2FjOF8xMDk5NTExNjI3ODI1_074555c0-50d0-46ec-a57f-708053aeacb0"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic8f4f2eff7da48748127b29635896464_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEwLTEtMS0xLTA_a3fb99fd-753d-46a9-9583-394310629b0c"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia6bb6da4755b453bac747d67b20ec2c5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEwLTMtMS0xLTA_e569b3b9-14b3-4b05-a1a3-913b5073bfde"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3d56da838e884589a4b9b27e4dba56bd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjphNmJjZTUxMGFkNzk0YzI1YjMyYzk2YTk2ZDJjMTYwMl8xMDk5NTExNjI3ODI1_0c34c981-163d-4c6a-bfb2-03b1f6d50234"
      unitRef="number">0.0402</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3d56da838e884589a4b9b27e4dba56bd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzExLTEtMS0xLTA_741e26c3-d6e0-4590-82e3-d3d609dbce16"
      unitRef="usd">73000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4d8b84cad2c648c3aac2a92756cb752e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzExLTMtMS0xLTA_92881d37-0fed-424c-a4dc-e23712507903"
      unitRef="usd">73000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEyLTEtMS0xLTg5Njc_112a2d3e-08a9-4d7a-8fc0-5eacc145b449"
      unitRef="usd">255700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEyLTMtMS0xLTg5Njc_01c429b2-5804-4757-9f93-4e8ee3e1ff2e"
      unitRef="usd">258000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEzLTEtMS0xLTA_170e5e15-58b6-4cf0-b57c-fe9b4eebc52e"
      unitRef="usd">500000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzEzLTMtMS0xLTA_852d3184-f899-4182-9dfa-cfc3e10df59c"
      unitRef="usd">700000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebt
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE0LTEtMS0xLTA_0e65c9f5-5836-4380-b23e-2eeb3a47bdb7"
      unitRef="usd">255200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE0LTMtMS0xLTg5Njk_9a3297a8-d227-4b9a-9e4c-cafd1b38746c"
      unitRef="usd">257300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE1LTEtMS0xLTA_d1bc60fe-a359-4a54-89ba-e1d62ebf06f3"
      unitRef="usd">2300000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE1LTMtMS0xLTA_6a430f9c-3abd-4acc-b567-a0bc88bd3df0"
      unitRef="usd">2300000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE2LTEtMS0xLTA_abc53287-d0ee-43ba-99bf-e445cef8cdbe"
      unitRef="usd">252900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90YWJsZToyMmJlMDY4OTA4OWI0MzA5ODhlNTdlNzY5MTFjNjJiNS90YWJsZXJhbmdlOjIyYmUwNjg5MDg5YjQzMDk4OGU1N2U3NjkxMWM2MmI1XzE2LTMtMS0xLTA_509eec23-2a21-41b5-8c19-549c0f1f458d"
      unitRef="usd">255000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5Mw_50d4aaff-f96e-432d-9ab1-fe6cb36271ab"
      unitRef="usd">300000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <wst:CreditFacilityIsAvailableForSwingLineLoans
      contextRef="i36499f4c892042c99421485b861d8b26_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUyMQ_cf2e446e-5f0a-4071-b388-c44775a98547"
      unitRef="usd">30000000.0</wst:CreditFacilityIsAvailableForSwingLineLoans>
    <wst:CreditFacilityIsAvailableForSwingLineLoans
      contextRef="i053014645cf54e15bc7d157e3bd317fa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzU4MQ_dd6c56f0-e5bf-4408-868f-75d279fc69f9"
      unitRef="usd">20000000.0</wst:CreditFacilityIsAvailableForSwingLineLoans>
    <wst:CreditAvailableForIssuanceOfLettersOfCredit
      contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzY0MQ_49d51a80-1e35-4da9-af77-e1a0f2aefc5b"
      unitRef="usd">30000000.0</wst:CreditAvailableForIssuanceOfLettersOfCredit>
    <wst:LineOfCreditFacilityAdditionalBorrowingCapacity
      contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzc2Ng_ef6d1342-837c-40b9-97be-d3d5b7bb6021"
      unitRef="usd">350000000.0</wst:LineOfCreditFacilityAdditionalBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9a0baa710cca4e74ba3a4ba6d1ff9627_D20200101-20201231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzExNjM_2a652ff3-3e18-4045-9d83-aecf487b7ed1"
      unitRef="number">0.50</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib790285c47534a188d7b8a25e56a0757_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEyMDQ_bffe0b0d-38cb-4f4f-a7ea-741596e3a553"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i79870e1d300248c4b2045f7b6b99751d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzNDc_626943af-e3fc-4052-8688-505fbf12885e"
      unitRef="number">0</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2dadaa6cfa6a402590d0baa08c3b3ff0_D20200101-20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzNTM_7bba4fac-8285-4966-80d5-551cb7dd6db6"
      unitRef="number">0.00375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9276b28f1b2f476a8f79b186a11cf9cc_D20200101-20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzOTM_fe63e7b1-99d2-4e98-b86c-69602e2a0bf2"
      unitRef="number">0.00875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0d9aaaa15fea43d5b98afa0705388896_D20200101-20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEzOTk_613ef8ad-d1fb-4b50-8c59-2604fe511639"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <wst:RatioOfDebtToEBITDA
      contextRef="ie84290cd198b4597b8a2abee7084ce4a_D20200101-20201231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzE2MDM_8a08ec23-77cf-4cb2-b200-d608824cfd98"
      unitRef="number">3.5</wst:RatioOfDebtToEBITDA>
    <wst:RatioOfDebtToEBITDA
      contextRef="i77bf362efbe64c2ea5409f4177fc61b9_D20200101-20201231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzE4NTk_92a826b5-1866-4388-8feb-507c9da4e248"
      unitRef="number">4.0</wst:RatioOfDebtToEBITDA>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="ib153aa539cbc4b36bc036f9670da7976_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMwNzI_d9c2c1f7-9711-425c-b5c6-9416f3a05025"
      unitRef="usd">400000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="i8cdb2635fb0940748713a05a2e05ede6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMwNjY_8bc252ef-c678-4c64-8451-ff08748370b0"
      unitRef="usd">1100000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:LongTermLineOfCredit
      contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzI0MjA_d126b837-1023-45b9-a7bf-3ba577de7d29"
      unitRef="usd">0</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i0818ca18d1c04be49b0664009bcbaa77_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzI4MDA_315bb1ed-acbe-4a20-942b-e1303c77e507"
      unitRef="usd">2500000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ie7a4ef16802b4b559193ac9ec27c88a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNjY_f64a99c6-7a83-42db-94bd-99cfa55d3e6a"
      unitRef="usd">297500000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia8f18ec1636d4475a790dad18e1921a7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzMyNDU_28bc4c53-22d0-4052-a318-78d42d45bb58"
      unitRef="usd">90000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0acb2d0db3f94443812b8dad4134f99f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzMzNTk_86a3d98d-2b76-46dc-983e-806f2389bfd3"
      unitRef="number">0.875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="ief5c6bd09e604af9b7086fafcc87e380_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMwODI_9b40a5bf-aaaf-4d40-9675-d71b983f4c68"
      unitRef="usd">100000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxMTA_504e6ccc-b16d-4938-abb2-81b223252403"
      unitRef="usd">87700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxMTQ_34015267-5871-4917-befc-ab1c7f876885"
      unitRef="usd">2300000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic3d583fd75694db6ac1a6d54b75f9a43_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxMjU_bc85f1bc-f233-4c12-a21f-cd1866a22e8f"
      unitRef="usd">85400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i40b38bc3ea1249599a6fddd5077007ca_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzM5MDM_a300fec3-b8bf-43f5-b592-67752e5ce2b1"
      unitRef="usd">168000000.0</us-gaap:DebtInstrumentFaceAmount>
    <wst:DebtInstrumentNumberOfTranches
      contextRef="if9b19f87e2fa4bd7b7446c6d36467a3b_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzYwNDczMTM5NTg2MzI_df29e8fd-76d7-4bb0-869f-3475602e0dc5"
      unitRef="tranche">3</wst:DebtInstrumentNumberOfTranches>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic05b210f28044eacb815b7c56280e7a8_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwMTg_d572cf95-d855-41d8-9e6d-a8b2500fbf59"
      unitRef="usd">42000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic05b210f28044eacb815b7c56280e7a8_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwMjE_db87cb24-1b9e-4ded-ab9d-4b84805f9e5e"
      unitRef="number">0.0367</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i1a8d1afadc494e8ca3807d39357fab2c_D20120101-20121231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNDM_d876d693-f944-4a86-b356-3f067d13b193">2022-07-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie1fdf8a78aa34446888179eb44e2ba9f_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNDc_bf7793ab-d0d1-4520-975b-c026c70499ac"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie1fdf8a78aa34446888179eb44e2ba9f_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNTA_8d748dd0-4f87-4444-89d9-6b14c1687826"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i7fe9b14827ba48db9e2a32e413c46681_D20120101-20121231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwNzI_32c283ba-5e7a-4bec-90d7-cfaf804a016f">2024-07-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iac32389974424652ba8a1cd7cfffab8c_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwODA_ae48ce89-85e7-42af-8c51-1bf49fb29eef"
      unitRef="usd">73000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iac32389974424652ba8a1cd7cfffab8c_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQwODM_ddd737cd-dd26-4675-9bfb-30f863026f65"
      unitRef="number">0.0402</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="id54a356e860a44f0a5c4f4291d81c943_D20120101-20121231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQxMDU_eb38a0fe-c88b-4a06-80f2-eca323051407">2027-07-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i40b38bc3ea1249599a6fddd5077007ca_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQyNTM_5c48f548-c513-42d4-b324-90fb3b33e784"
      unitRef="number">0.0387</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i59aded202b8249ceaaa3c323b8b6ee44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxNDA_0b866632-55a1-4384-aa1c-13feb6955b13"
      unitRef="usd">400000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i85263fd85aef48eeb384af58612ce47d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMxNDQ_eb405f71-ea95-4730-845b-7765b3f298aa"
      unitRef="usd">500000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5NTQ_3d20f8c3-23b5-4882-b0ea-c6dddb8f57d2"
      unitRef="usd">9600000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5NTg_56a8e624-a38c-421d-bb76-5572c7148a14"
      unitRef="usd">9400000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzQ5NjU_c6cf17db-548e-4c3b-b4ce-c7d2dac62dd6"
      unitRef="usd">9300000</us-gaap:InterestExpenseDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNzE_e6880efc-2210-41f4-8bc1-de2c2c593482"
      unitRef="usd">2300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNzU_8458ee52-28fd-4918-9add-f6b135e03ab9"
      unitRef="usd">44200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyNzk_1d42f531-71b3-49b0-8a07-3d39d527a6f6"
      unitRef="usd">2200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyODM_cf84dc10-53c2-4213-bdd6-dc7685fc92c0"
      unitRef="usd">134000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzEwOTk1MTE2MzMyODc_aef76e5e-1de2-4333-909c-1b6f241b0ed4"
      unitRef="usd">0.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjEvZnJhZzo4ZDUwODUyMDQ3NDU0NzgyYTcwMmY5NGVjMDNmM2FlZS90ZXh0cmVnaW9uOjhkNTA4NTIwNDc0NTQ3ODJhNzAyZjk0ZWMwM2YzYWVlXzUxNjQ_6fdf1b59-c686-4645-adc5-edc41fe3c5b2"
      unitRef="usd">73000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMzg_6516d360-9b93-4afe-8a1c-d452d4b28e54">Derivative Financial Instruments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2020 and December&#160;31, 2019, the total amount of these forward exchange contracts was SGD 601.5 million and $13.4 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2020, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,194.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, we entered into a five-year floating-to-floating forward-starting cross-currency swap (the &#x201c;cross-currency swap&#x201d;) for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#xa5;9.6&#160;billion ($87.8&#160;million) as of December&#160;31, 2020. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Commodity Price Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From November 2017 through December 2020, we purchased several series of call options for a total of 472,477 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we had outstanding contracts to purchase 141,734 barrels of crude oil from January 2021 to June 2022, at a weighted-average strike price of $59.14 per barrel.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Effects of Derivative Instruments on Financial Position and Results of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged item (intercompany loan)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative designated as hedging instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December&#160;31, 2020 and 2019 were $6.3 million and $8.7 million, respectively. We expect to recognize $1.8 million in earnings, pre-tax, for forward point components in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss (Gain) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020 and 2019, there was no material ineffectiveness related to our hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id2df6627be904a9aaf00483f12940dc4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzk0OA_ff1b97b5-a8c4-4a64-a41c-c315b7c33600"
      unitRef="sgd">601500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i252de83d670e4d1ba875a6c0d2fdd702_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzk1NQ_c71fa534-edca-44f4-a5d2-4e452f08e205"
      unitRef="usd">13400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract
      contextRef="i5ee03ed217f4413f827d72745983e40f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzYwNDczMTM5NTg1Njg_fcec5f3e-72ab-487b-95d8-3fa4e54b0a18">P18M</us-gaap:DerivativeTermOfContract>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMzk_427d647f-6d9f-4023-9467-066d7c264bef">As of December&#160;31, 2020, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,194.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i897b04b0d4e34a368ecdaa5308ccf498_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzItMS0xLTEtMA_3c37205a-1f8c-4e42-a273-01bd54ba3796"
      unitRef="usd">57000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i531ab9f165fe49a0afa50abe554696f2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzItMy0xLTEtMA_a2bbe920-76f8-4690-9079-620cac718518"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i531ab9f165fe49a0afa50abe554696f2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzItNC0xLTEtMA_b3a45fa7-c54f-4e88-9720-74864e4b4b98"
      unitRef="eur">49200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5aed1c49d23b4bc8983a2bb4f02182d6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzMtMS0xLTEtMA_73baaeb7-c7c2-43ec-9bba-ccc87310e861"
      unitRef="jpy">7194100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieabc497ed7d9444b85e9cce201865f83_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzMtMy0xLTEtMA_ecb57044-4e2e-4a51-8040-f5f39fd6cfd5"
      unitRef="usd">42700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieabc497ed7d9444b85e9cce201865f83_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzMtNC0xLTEtMA_23a8be20-d80e-40b6-843f-ef0f14ad2f75"
      unitRef="eur">22000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i01129bb47aaf431d90ed2cb429db9b45_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzQtMS0xLTEtMA_376e319b-296e-481c-bee4-8f56090f180f"
      unitRef="sgd">42900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i04c2cfc044364719874b1386740f71fa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzQtMy0xLTEtMA_f34de57a-0438-42e0-9921-6c82142c3477"
      unitRef="usd">25000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i04c2cfc044364719874b1386740f71fa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo0YzQzNTRjNGMyM2U0YjZkYmE2MDA1MjZlYTJiNzM4NC90YWJsZXJhbmdlOjRjNDM1NGM0YzIzZTRiNmRiYTYwMDUyNmVhMmI3Mzg0XzQtNC0xLTEtMA_a2dab304-a92d-4792-bbca-839cd1f4d0b9"
      unitRef="eur">5000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract
      contextRef="idb1615ceaf2a499986cb01691d97764e_D20191201-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzYwNDczMTM5NTkxNDU_32b7f9c2-05c3-4acf-ada3-9b6dc82662b5">P5Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i139517c5b19c4c238b0b6d76659ca642_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzI0NTY_7f2ced63-ea80-4786-ad61-8ef88592467a"
      unitRef="usd">90000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6ff56989b09342d4bf86220442ddc67e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM1MzU_fa826cab-5991-4f97-8299-70454c794f9c"
      unitRef="jpy">9600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6ff56989b09342d4bf86220442ddc67e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM1NDM_6e1d524c-0278-4ff4-b3e1-41291cb9d980"
      unitRef="usd">87800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNonmonetaryNotionalAmountVolume
      contextRef="iba0a8733971342b896a7d0f4d587b143_D20171101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzMzMzY_a189c404-496c-487a-b612-01f6ada3cb94"
      unitRef="bbl">472477</us-gaap:DerivativeNonmonetaryNotionalAmountVolume>
    <us-gaap:DerivativeNonmonetaryNotionalAmount
      contextRef="ibfdda46fe61740e6a80e78c142d7da03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzMzNDA_a34c620a-29a5-4a7a-ac88-85fff65dc71e"
      unitRef="bbl">141734</us-gaap:DerivativeNonmonetaryNotionalAmount>
    <us-gaap:DerivativeAveragePriceRiskOptionStrikePrice
      contextRef="ibfdda46fe61740e6a80e78c142d7da03_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzMzNDQ_ca0e9ddf-106e-48d1-a6b4-1960b5df4cdb"
      unitRef="usdPerBbl">59.14</us-gaap:DerivativeAveragePriceRiskOptionStrikePrice>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMjg_173f4827-a030-404f-b858-bac5aa4456c9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged item (intercompany loan)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative designated as hedging instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzMtMS0xLTEtNTYzMA_4af5c96e-b859-473e-83c3-00709e61d805"
      unitRef="usd">-28500000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzMtMy0xLTEtNTYzNA_ee4d191a-1ea8-4dde-9ed9-586ee5973f43"
      unitRef="usd">15300000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMS0xLTEtNTYzMA_f862ed9e-154c-4a9d-81d1-035171ab7209"
      unitRef="usd">28500000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMy0xLTEtNTY0NQ_5c4e555b-9c06-4d25-be14-4098d00a8d34"
      unitRef="usd">-15300000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzUtMS0xLTEtNTYzMA_1920bc3b-2428-43ad-965c-bd6d132b73ca"
      unitRef="usd">6100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzUtMy0xLTEtNTY0NQ_f928c390-432b-4f70-9071-ac225d3dc052"
      unitRef="usd">6900000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMS0xLTEtMA_5139da23-1a67-4805-94fa-84f53511865d"
      unitRef="usd">6100000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo5NWQwNTA0ZTk0Zjc0ODkyYTQ0ZWUyMjMyMTY1ZGI4NS90YWJsZXJhbmdlOjk1ZDA1MDRlOTRmNzQ4OTJhNDRlZTIyMzIxNjVkYjg1XzQtMy0xLTEtMA_3eb4f8ca-a4e8-4456-a6ca-f8aee083716b"
      unitRef="usd">6900000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM0Njk_27ff27a7-0731-43df-8498-ff1f99e0ee31"
      unitRef="usd">6300000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM0NTg_fe886547-b245-4ec3-81f8-4d945be22d7b"
      unitRef="usd">8700000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i5d779650ed364fd08c026185a18a616f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzEwOTk1MTE2MzM0Nzc_0382ed4a-8185-448a-b342-54708f96f157"
      unitRef="usd">1800000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia766950276184bbc849712d05a16b8c6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtMS0xLTEtMA_761a89d5-5acb-4eb6-856e-d1c03e45fb87"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia815265990ad4f3abe0d627f15f293cb_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtMy0xLTEtMA_79f67432-d787-4300-9f70-76595e729fb3"
      unitRef="usd">4800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ia766950276184bbc849712d05a16b8c6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtNS0xLTEtMA_6a83388f-757c-4dc8-8b56-7b531d88306d"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ia815265990ad4f3abe0d627f15f293cb_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzMtNy0xLTEtMA_318955ba-071e-40c0-a4f6-a0a9e3c51e10"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtMS0xLTEtMA_adb1a0f0-3580-439b-b1a4-1e2e4bba0b04"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtMy0xLTEtMTAwMjk_47071c37-72c9-4f95-87f9-ae37fd65f6de"
      unitRef="usd">4800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtNS0xLTEtMA_85cf2a8d-5ed7-4e16-ba40-0227280188e6"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i1a07ee0ade4044028ea94e0fb1055fc2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzQtNy0xLTEtMTAwMzc_ff2671bc-73d3-4124-83e5-404719f5d53d"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2f263abf32a8469dadba8af24398c81e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtMS0xLTEtMA_7638a058-41b7-4576-8f32-b66ffd341b9e"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9848d3f7103145a283f6dfcbf2d72655_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtMy0xLTEtMA_3520e18a-f1d9-4523-b273-255108ffa4bf"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i2f263abf32a8469dadba8af24398c81e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtNS0xLTEtMA_2dce38ed-c9c6-40d3-b4d9-079827d25f26"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i9848d3f7103145a283f6dfcbf2d72655_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzYtNy0xLTEtMA_a0273e43-bc4e-4ba9-bf48-1435d664b5c9"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic495cc68ba6b4b1694f7a3fd4db93012_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctMS0xLTEtMA_dcfdc46f-4b28-4201-b8b3-a5ce2eaa486a"
      unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i16739f8659e14555937d0e778a704f20_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctMy0xLTEtMA_e6b323fa-ff9b-4ef8-94d0-9ffe028159f9"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ic495cc68ba6b4b1694f7a3fd4db93012_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctNS0xLTEtMA_33dfc609-d03b-4d08-b35d-557b3225bcae"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i16739f8659e14555937d0e778a704f20_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzctNy0xLTEtMA_c8fa89aa-866b-44b5-ab12-b377bf6cd638"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i13810f93490c470abbbb7b177ad2c70e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktMS0xLTEtMA_ddd8891d-1160-4f5c-8b56-f3a1fbaeddc0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1e5247f6308b4858a3772e7407bec118_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktMy0xLTEtMA_64dff4b4-8633-4338-a420-5baf60c568a3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i13810f93490c470abbbb7b177ad2c70e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktNS0xLTEtMA_d9758f15-7c87-4e1f-a2d5-e62b99c0be16"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i1e5247f6308b4858a3772e7407bec118_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzktNy0xLTEtMA_76fe6782-38e6-4ec1-82cb-294419016bda"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1f77a45ab1ee47a3ada5f6fcca04c84e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTEtMS0xLTA_26cb7ec8-5550-4889-b4ff-85fc72012dc5"
      unitRef="usd">-1200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic12ff4fafcd445b084b889fe3305c91c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTMtMS0xLTA_3c58379b-0d1f-4e54-b383-9ab82831bdf2"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i1f77a45ab1ee47a3ada5f6fcca04c84e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTUtMS0xLTA_7a4f40ab-af6c-4c75-9d2c-242c18af845b"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ic12ff4fafcd445b084b889fe3305c91c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEwLTctMS0xLTA_d4d6d5d8-3d38-44ca-b5f3-91b0fce5c82b"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9154515da1a548fea6cda75ecab6d22c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTEtMS0xLTA_80e601a7-5628-4887-a5c2-21f661c6d7fe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id1c3a44d90234809a59a5c72a954a186_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTMtMS0xLTA_ae63d5db-5112-40c4-9470-1c7fa808386b"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i9154515da1a548fea6cda75ecab6d22c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTUtMS0xLTA_0fb2f3fa-8724-4544-bc51-bd52710eace6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="id1c3a44d90234809a59a5c72a954a186_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEyLTctMS0xLTA_34e1af10-6ec2-42ff-b1e0-9418a54c6419"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if00c3d38891a437c9731668076f93583_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTEtMS0xLTA_58102ef6-ba99-4ddc-ad7a-382ce60940db"
      unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaa425d5cda7449f4a965d518a8498929_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTMtMS0xLTk4OA_b3a45eb1-55b2-4024-816e-992c35a37ede"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="if00c3d38891a437c9731668076f93583_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTUtMS0xLTk5MQ_2f25853b-8e71-4e41-b3ee-bc11a34f2c1a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="iaa425d5cda7449f4a965d518a8498929_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzEzLTctMS0xLTk5NA_52ce7e95-e170-4bc0-8092-0e52cf74e3a3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie98f2ce6380048b498942fe656d21ed9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTEtMS0xLTA_8091c20f-e3d2-412a-9602-5dd16b8da641"
      unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6d44d9b0abe64e9c8fd7b8070ad808e7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTMtMS0xLTA_5f80bb30-c322-4b34-b3ad-39a2e0fdec5f"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ie98f2ce6380048b498942fe656d21ed9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTUtMS0xLTA_653dd42f-2274-4270-a9f7-369ec9e65b28"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i6d44d9b0abe64e9c8fd7b8070ad808e7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWFlODlhMTY2ZDU0MzJkYWQ3ZmY2YjA2NDVlZDQzMS90YWJsZXJhbmdlOjY1YWU4OWExNjZkNTQzMmRhZDdmZjZiMDY0NWVkNDMxXzE0LTctMS0xLTA_8614fa4e-7df1-4c7e-9e5e-09b488c084e0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i910293864a4644e2bed118d404b0a767_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzEtMS0xLTEtMA_801b4bbd-7d34-41f2-9ed1-a2d5f5192179"
      unitRef="usd">200000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie74cfeda5713466fb73b2c27fca500a4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzEtMy0xLTEtMA_7127f96d-9dd4-4963-9229-acfb17fc3239"
      unitRef="usd">-900000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i29005ee8df5b4ec39d6cdb0828b7dcb1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzItMS0xLTEtMA_4e33329c-2b5f-404a-b0e4-5e3454605b90"
      unitRef="usd">-100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i94f10a3f9bbb4fff966da3ea80caf6b3_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzItMy0xLTEtMA_76568f15-4f44-45e2-9ebb-da7db3c22c7c"
      unitRef="usd">-600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i75443478f88f440a974d749223372bba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzMtMS0xLTEtMA_f35508f7-7a0c-4d25-8000-a87288742a18"
      unitRef="usd">-4300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic56c3f1afcb544389c539fb7e8fde70a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzMtMy0xLTEtMA_646eec77-84a7-4e78-ad50-c33be3fb7201"
      unitRef="usd">-4600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="id20703276ec2492ebfbc9c45c8e0ac7e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzQtMS0xLTEtMA_a4d38878-2f7f-4009-af8a-3c003c8c53d7"
      unitRef="usd">300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i7734ad779fa1491187a73582966992ee_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZToyNDMwODFiNmRhZjA0ZTBjYjRkMjVkNzEzMzc1NjM4Ny90YWJsZXJhbmdlOjI0MzA4MWI2ZGFmMDRlMGNiNGQyNWQ3MTMzNzU2Mzg3XzQtMy0xLTEtMA_6da734a3-333b-44fa-b047-62d3337bb995"
      unitRef="usd">300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90ZXh0cmVnaW9uOmFkY2RjM2QzNDkzMDQ3OGZhZTI5NDViZDA2MTdhZjZkXzUyMzM_cb88923c-0d23-4089-9046-80bbfd7f3fae">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss (Gain) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i45ec217f28a14172945a28df8210d239_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzItMS0xLTEtMA_0aa7cdad-cc93-430e-bdd2-6ffda27786b7"
      unitRef="usd">200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ie9237b0939d04baab3100c204058459f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzItMy0xLTEtMA_662b01fc-fe0e-4e78-a8f0-77b2fd40bec0"
      unitRef="usd">400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic0c2886a63984bbfacf71552235bd450_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzMtMS0xLTEtMA_8953b4f5-ba0f-4a1f-8c6f-323ed967e3dc"
      unitRef="usd">200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i09837e92679f4dce8b31c888e3564350_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMjcvZnJhZzphZGNkYzNkMzQ5MzA0NzhmYWUyOTQ1YmQwNjE3YWY2ZC90YWJsZTo2NWI2MDI0NjZiOTA0MjVlYTViMGI4MzRhODg5NDVjNi90YWJsZXJhbmdlOjY1YjYwMjQ2NmI5MDQyNWVhNWIwYjgzNGE4ODk0NWM2XzMtMy0xLTEtMA_daaf90a1-3f3d-4ca4-9fa0-3e49cffb4b2c"
      unitRef="usd">400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5OTE_d28174d7-07d6-4533-824f-c233d575c5c3">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unobservable inputs that reflect the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#x2019; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term liabilities, is valued using a market approach. Please refer to Note 11, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Financial Instruments&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of our derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3 Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the contingent consideration liability related to the SmartDose technology platform (the &#x201c;SmartDose contingent consideration&#x201d;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. Sales projections were derived using upside, base and downside forecasted cases for each partnership and applying probability-weighted scenarios of 10%, 50% and 40% to the three cases, respectively, to reflect the likelihood of West meeting the estimated sales projection targets. The probability of success factors included the probabilities of successful FDA approval for each partnership drug, which was estimated in a range of 19% to 100% based on the development phase of each respective drug, and the probability of the successful execution of supply agreements with each partnership, which was estimated in the range of 25% to 100% based on historical, current, and future supply agreements with the respective partnerships. The fair value of this liability utilized a risk-adjusted discount rate of 19% to present value the cash flows. The discount rate is calculated by determining the after-tax required returns on debt and equity and weighting each return by the respective percent of debt and equity to total capital. Key inputs for the discount rate include the risk-free rate on the 20-Year United States Treasury maturity, equity risk premium, company-specific risk premium, pre-tax cost of debt, and U.S. tax rate, among others. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of changes in our Level 3 fair value measurements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in fair value recorded in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in fair value recorded in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.&lt;/span&gt;&lt;/div&gt;The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities, and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2020, the estimated fair value of long-term debt was $265.7 million compared to a carrying amount of $252.9 million. At December&#160;31, 2019, the estimated fair value of long-term debt was $263.3 million and the carrying amount was $255.0 million.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5OTg_cb6bd8cb-0a43-4f75-b1f7-9b66df467264">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtMS0xLTEtMA_b75944a0-96ec-4723-87af-fb1a9ab3b670"
      unitRef="usd">12800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtMy0xLTEtMA_af8a03b6-7396-48b1-b264-72165b6ca354"
      unitRef="usd">12800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtNS0xLTEtMA_947db53e-6718-4267-a8fc-b1afaee0a71b"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="if9ce83038c2641929269fa9febd355c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzQtNy0xLTEtMA_7a128152-dcf5-4d94-b9f1-20a1755e4dc4"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtMS0xLTEtMA_25aa6835-97f6-4fe4-b8a4-7292e29d2350"
      unitRef="usd">3000000.0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtMy0xLTEtMA_469bc0d7-ef38-418e-8c2b-9881dfcb3ee4"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtNS0xLTEtMA_ddb58db2-2b45-4b4b-85b9-e6d803ab6455"
      unitRef="usd">3000000.0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if9ce83038c2641929269fa9febd355c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzUtNy0xLTEtMA_092718ab-9cba-4887-82ea-5008f1e46c7f"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i512334ec39334b2c92eadce7653de2b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtMS0xLTEtMA_607ec55d-89a8-4e6f-a51e-0695df6d497e"
      unitRef="usd">300000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i9cf21d4ddd1a4397b60f40f3bd3f765a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtMy0xLTEtMA_ca689c94-4610-4898-b0e5-c9a84d925efa"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="idaf35b6e1c0b46a8bb43590b974f7cf2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtNS0xLTEtMA_2368956a-8be4-476e-91b9-4975aa3e5ba3"
      unitRef="usd">300000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i8053738038f04d46be3849707bcbbdea_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzYtNy0xLTEtMA_c19c5bd2-2e59-423d-ae91-71280ccdea36"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctMS0xLTEtMA_ca5ccaa7-7810-4613-81e8-14333da27305"
      unitRef="usd">16100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctMy0xLTEtMA_f77f90e5-c14b-49b6-97f4-15e115d660a0"
      unitRef="usd">12800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctNS0xLTEtMA_9be28d11-5cb3-42cc-905c-fb6da71a6751"
      unitRef="usd">3300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if9ce83038c2641929269fa9febd355c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzctNy0xLTEtOTAzOA_61e21341-c114-4b48-b6ca-5f2823100100"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktMS0xLTEtMA_34994bec-d063-41bf-8a00-7f154485849d"
      unitRef="usd">3600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktMy0xLTEtMA_131eb966-e85a-4b13-9870-6013642ec6d6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktNS0xLTEtMA_9a16034e-98b0-4437-a57e-b73d4dd53d5b"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if9ce83038c2641929269fa9febd355c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzktNy0xLTEtMA_236f267c-5190-4d64-acee-de8855518310"
      unitRef="usd">3600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTEtMS0xLTA_f6d17e17-a60f-49b1-bdc6-352d141ba3e8"
      unitRef="usd">14500000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTMtMS0xLTA_7bc4616d-1b70-4248-890d-b0c191e29948"
      unitRef="usd">14500000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTUtMS0xLTA_b00b2a05-7940-4f76-b76d-879b417655f7"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="if9ce83038c2641929269fa9febd355c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEwLTctMS0xLTA_e8bbf5eb-b372-4afd-bf78-d4a22e7d4f8f"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="icba0cd37398843499f9cfbbcc1d88190_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTEtMS0xLTA_9f239d00-81ca-476f-bb88-5dcb422d80af"
      unitRef="usd">5600000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ie4124f16416b429fa6225456655a8660_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTMtMS0xLTA_5ffa24c9-f7ae-4b1e-b216-82dada77411b"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i6ea7dadd6e8e4893929788b5e7b6e3f9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTUtMS0xLTA_fcc69327-7084-4c9c-8571-8baec953f4f9"
      unitRef="usd">5600000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i5b77a899950e419aa8380f233b32847f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzExLTctMS0xLTA_53dca378-3934-4feb-be22-53607a4563a5"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ideda06631bc243b6a3ad62cd4484d60c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTEtMS0xLTA_a575e9d9-31c2-41c4-9fac-8811fc23bc00"
      unitRef="usd">9700000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ifed7924e91c448cc906ea5c40bdcfde4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTMtMS0xLTA_1ce36c8d-0fbe-46d4-aeab-8282b87b9330"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i8e10d28fc0cc413fa59ffcb836fd2a62_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTUtMS0xLTA_a149b386-1ae3-498a-bbc5-e87198ca6a9c"
      unitRef="usd">9700000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="icdc1f55bdfaa4f77bc2d00ee21f69a3d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEyLTctMS0xLTA_16a64b44-cb00-4522-8111-7ee320ea1f76"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTEtMS0xLTA_d1c20330-3c3b-4b48-9357-eb7dd8d21e9b"
      unitRef="usd">33400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTMtMS0xLTA_ea882465-26ef-404d-a542-f1db0a97a08b"
      unitRef="usd">14500000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTUtMS0xLTA_c5cef614-e9ff-4443-a9a8-290a93556a52"
      unitRef="usd">15300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if9ce83038c2641929269fa9febd355c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTpmNzAxY2YxMmVhODk0NDkwYTY4Njk1NDdhYThkOTNlZS90YWJsZXJhbmdlOmY3MDFjZjEyZWE4OTQ0OTBhNjg2OTU0N2FhOGQ5M2VlXzEzLTctMS0xLTA_628a2f4c-894f-438f-94f0-d4407f3a50ef"
      unitRef="usd">3600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtMS0xLTEtMA_d3c33832-e680-43d5-806d-832ae94ec89d"
      unitRef="usd">11300000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtMy0xLTEtMA_aa686b13-3d44-424b-836e-e982618c02e1"
      unitRef="usd">11300000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtNS0xLTEtMA_f3a1c5c4-62a5-4928-96db-14c061da1c37"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzQtNy0xLTEtMA_e63f9b97-9777-4434-b85d-453977f46f74"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtMS0xLTEtMA_6e328da8-7b31-4c87-aa1b-8079b417a8ce"
      unitRef="usd">7700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtMy0xLTEtMA_d82f2150-eb42-4a67-8004-369f17761b5a"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtNS0xLTEtMA_e17c49f6-b394-4278-90a1-25c94d0c0b5a"
      unitRef="usd">7700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzUtNy0xLTEtMA_ffb56b1f-8de4-43a7-a068-10ee7c4c293f"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i16fa19e29e634aeab2eb9224f0b45b18_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMS0xLTEtMTAwNg_2914136b-1db8-4bb5-a1d3-d41ecd58971d"
      unitRef="usd">100000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i724fe533a83d433eae9b42977e2f7b50_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMy0xLTEtMzI1MA_dbf4627e-cb51-4c2e-8b0b-e155e790123f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0c7a7f771134445a80565de94c28062f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtNS0xLTEtMzI1NA_5be41a28-83b0-4e32-a8ea-b9778a04d907"
      unitRef="usd">100000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id048dc02c0b2469fbea105614ae2e480_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtNy0xLTEtMzI1Nw_ceaf547a-c899-4a58-91d3-57ba4073a2b1"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMS0xLTEtMA_5d611a97-af93-40a7-ba4c-d9b13ece3421"
      unitRef="usd">19100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtMy0xLTEtMA_dc0b4973-1c33-4c99-8abd-720e138e332f"
      unitRef="usd">11300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzYtNS0xLTEtMA_01b4484f-de03-4ae2-aefd-af076d1fce89"
      unitRef="usd">7800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzctNy0xLTEtOTA2OQ_3af2820b-1b26-49ed-926f-b3f155607d3c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtMS0xLTEtMA_d1fb8468-b54a-4061-94e5-6e93f582da5f"
      unitRef="usd">3300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtMy0xLTEtMA_842e48da-bd38-4b59-902c-971986a421ff"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtNS0xLTEtMA_3a2b0e02-4102-450d-bdf5-0fdcaff51dba"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzgtNy0xLTEtMA_1f5b26d1-09ab-459c-9aec-cf55fbef3eb0"
      unitRef="usd">3300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktMS0xLTEtMA_004853e1-d07e-4921-b929-885b03f1e31c"
      unitRef="usd">12800000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktMy0xLTEtMA_aa3bc2fa-adb4-4380-b8bf-4cc78e0a7dcc"
      unitRef="usd">12800000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktNS0xLTEtMA_ab4a2160-f6b2-40fc-ac5c-a48e64a88c4c"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
      contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzktNy0xLTEtMA_775021ee-c931-4f49-8588-c47f100f4f88"
      unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i2bde75d952ad42e98d7390be88bb1df2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTEtMS0xLTkwNDU_53eddf52-efab-4af6-8e5e-fc6fdffd9057"
      unitRef="usd">1400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i60ffcae4b075439ca55b2069a4fd47f1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEwLTMtMS0xLTA_080e4fe8-b260-406a-969d-ee84cb471a0f"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i9c78a5b1b01444c69b59c15f8578421c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEwLTUtMS0xLTA_b4984f9d-123f-4fe6-b5c9-3da61d6491db"
      unitRef="usd">1400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="if4cb3f26d5954c919726e7cb7785fd7d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEwLTctMS0xLTA_937d5bad-a7b6-47ab-86d5-40ae7b951f8e"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ib0568fea18da421bbd3bca7960cc204a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTEtMS0xLTA_5ca7c09b-ede2-4802-82ce-c10056d37149"
      unitRef="usd">300000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1207be39ba114326a769b349741e01cd_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTMtMS0xLTA_593eb568-9690-4355-8b3e-480b21949558"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i9dbc3b28347940649422a5aabfb3dc04_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTUtMS0xLTA_3f3c49ec-75b5-42a6-a123-99e4959fabbb"
      unitRef="usd">300000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i9a4e354d29304999b66d6671f79f5028_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzExLTctMS0xLTA_fd0b06eb-cb4c-476b-9034-5d070a6856ed"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTEtMS0xLTA_3761e8b2-20d2-4d40-8e0a-79df088fbcb9"
      unitRef="usd">17800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTMtMS0xLTA_3f29ca70-0ec5-472e-be37-9f77dd9871cc"
      unitRef="usd">12800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTUtMS0xLTA_1ddd4321-22f1-44bd-93c2-152448737972"
      unitRef="usd">1700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5dd2da93f35e4130a407403f3b757235_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplM2QzMTZiZDhhNjU0YWY4ODljZmE1ZmM1ODliM2YyMy90YWJsZXJhbmdlOmUzZDMxNmJkOGE2NTRhZjg4OWNmYTVmYzU4OWIzZjIzXzEyLTctMS0xLTA_88222604-fc7e-4f9c-b8a2-9a8ea8dcd500"
      unitRef="usd">3300000</us-gaap:LiabilitiesFairValueDisclosure>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="iccc55ae3f38944cb8ac2a8bf2c81c4b4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2NjM_f5d9e14a-040d-45dd-a797-e8812c578534"
      unitRef="number">0.10</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i4447f5127f674e7f8698a17c77e3f3b5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2Njc_c7ee7372-22de-41c0-82b3-cc03a86bc8f3"
      unitRef="number">0.50</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="ie942ed6d0ed647738c0b530564afcfc5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2NzE_d164cd39-d8e8-4d5c-8066-24f0a156ad93"
      unitRef="number">0.40</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="id7f2ccbcf7004f9783ca3beb8c271c99_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2ODA_7f97d2e5-8642-4b52-b5cd-e1417796b779"
      unitRef="number">0.19</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i196249d46fc346f1a73485f5ad2fbf3c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2ODU_fdbed9e0-62a5-46a2-a39e-85c9b3b8057a"
      unitRef="number">1</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i5e3b441cdb5d4c2da4292cead5f46a91_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2ODk_6cb5eef1-cd62-4bc7-b352-b952054529b0"
      unitRef="number">0.25</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="i09071b9fb2a14ad282d0cfdd020d47c4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2OTM_1a6b86b7-386c-467a-9513-7f264167d41e"
      unitRef="number">1</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <wst:BusinessCombinationContingentConsiderationMeasurementInput
      contextRef="ib058c9e2b3e74454af000898cd0285bf_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzEwOTk1MTE2Mzc2OTc_1fbea047-85d5-4a12-b45c-969afb332b5e"
      unitRef="number">0.19</wst:BusinessCombinationContingentConsiderationMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzQwMDA_4211d60a-2b22-4780-bdad-cb950d160411">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of changes in our Level 3 fair value measurements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in fair value recorded in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in fair value recorded in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzEtMS0xLTEtMA_f39ba641-c98f-4e07-b344-eb36d8ade648"
      unitRef="usd">1700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzItMS0xLTEtMA_64b217c2-c1c8-4345-a30a-3e8012724abf"
      unitRef="usd">-2100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzMtMS0xLTEtMA_7a05c00e-6ed0-4cfc-8b9b-d4929e0593d2"
      unitRef="usd">500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzQtMS0xLTEtMA_f5494f14-c25a-4d54-b746-61f7f083401e"
      unitRef="usd">3300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzUtMS0xLTEtMA_2f6f85ad-d2f9-415b-b1a1-c8d36c3b5c8a"
      unitRef="usd">-1200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzYtMS0xLTEtMA_5bf25015-7b00-485c-a682-4845cf598996"
      unitRef="usd">900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90YWJsZTplMjlkMmQwNTJkOTU0Y2VlYjVjOGE5NDJmNGVkYzczOS90YWJsZXJhbmdlOmUyOWQyZDA1MmQ5NTRjZWViNWM4YTk0MmY0ZWRjNzM5XzctMS0xLTEtMA_9d422886-f886-420d-880d-026ba25be4a5"
      unitRef="usd">3600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM4NjE_cd6b21db-692a-414a-882f-e7296e054670"
      unitRef="usd">265700000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM4OTc_468be1ff-10e8-4ba5-bb0d-734072aed9f8"
      unitRef="usd">252900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtFairValue
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5NTU_f6f3efd3-edf9-46de-9424-d28f77d6e0dd"
      unitRef="usd">263300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzMvZnJhZzo2MWI4M2NlNWMxOTI0YTgzOTQ0MTBmYWZjY2ViYTQ0Yy90ZXh0cmVnaW9uOjYxYjgzY2U1YzE5MjRhODM5NDQxMGZhZmNjZWJhNDRjXzM5ODY_e15f53a3-6a36-4de6-9802-3a95ee84f49f"
      unitRef="usd">255000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90ZXh0cmVnaW9uOmM1Y2ZkMzg4MGYwNDRhNGRhMTQwYzVhN2I0YzU4M2U0XzQ1Ng_8ed2c76a-92ac-43a7-b4a7-0de11b16bef9">Accumulated Other Comprehensive Loss&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Losses) gains on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit pension and other postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90ZXh0cmVnaW9uOmM1Y2ZkMzg4MGYwNDRhNGRhMTQwYzVhN2I0YzU4M2U0XzQ3OQ_cb27b145-e9de-442a-bb57-cdccefb0d334">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Losses) gains on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit pension and other postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="id84b7326bff74d6ebd4702280f7944cb_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtMS0xLTEtMA_963423c7-8b1f-4cf1-a055-407d11b4b55d"
      unitRef="usd">-400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73f46e104061488a90e0e2d284629010_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtMy0xLTEtMA_923ef832-ee96-4f3d-914b-2209c33817b6"
      unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i658cc38b8a3b41eda1a5d4e62559ac50_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtNS0xLTEtMA_6d1f675c-3f09-44d6-b8cb-81882e1b61f1"
      unitRef="usd">-40400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51bfe342f5e747da8972ffeb014b1e1f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtNy0xLTEtMA_ef7cb4e7-6f66-46a4-a504-11dc4144c1e0"
      unitRef="usd">-113800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7db531a64e249498d81ca1360119f0c_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzEtOS0xLTEtMA_67ef522c-2296-4ae4-899c-b1812c9c8761"
      unitRef="usd">-154200000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItMS0xLTEtMA_ac2ff207-c422-406a-bef3-7b7d1192567f"
      unitRef="usd">5400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItMy0xLTEtMA_047bc4b9-cb2a-449a-84ab-2f3917b61789"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItNS0xLTEtMA_4e35e32b-f36b-4840-90fd-5e9241bbdd03"
      unitRef="usd">-1900000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItNy0xLTEtMA_8c01f587-fc7c-4f74-a463-da2caccda0a6"
      unitRef="usd">4900000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzItOS0xLTEtMA_7deeebc2-9a24-4a33-86d7-e910983037a4"
      unitRef="usd">8400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtMS0xLTEtMA_d5ae3c29-980f-47d6-b217-177807696f7a"
      unitRef="usd">5800000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtMy0xLTEtMA_08741186-307d-472f-89b0-421d270e457e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtNS0xLTEtMA_d26bed67-cf9d-4062-9288-f3be11afe75e"
      unitRef="usd">-2000000.0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtNy0xLTEtMA_91c3d575-905e-459c-837e-21b76ec50116"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzMtOS0xLTEtMA_2773cb1c-0962-4a3a-9fbf-0fb8f287dbc9"
      unitRef="usd">3800000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i720d5801200d49aaa8de0612f616d6ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtMS0xLTEtMA_7b34ce7b-94ac-48e6-b40b-b7367a5833b2"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1108366bebda4acd9fea9e0a96f5be99_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtMy0xLTEtMA_3c19a879-4033-4556-ab6a-e58db59f7310"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id6320f7bd1de4059952e6984cd05d959_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtNS0xLTEtMA_c48f276d-cc98-4421-93bc-15dc15ed9bd3"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4709cd4f880a411b971d65a82dff5048_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtNy0xLTEtMA_0268090b-59b3-4d2a-8d82-f87037588947"
      unitRef="usd">4900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzQtOS0xLTEtMA_25f8c6c1-ec61-4542-abfb-31c31017a53e"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="id681882b891d45d7b8705f79a7375de1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtMS0xLTEtMA_9543decd-5640-44b8-b37e-a6af372f3456"
      unitRef="usd">-800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7365acbeffa54ca3967c4b060d8a6454_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtMy0xLTEtMA_f1c8b765-6eb8-4363-9e6f-f9e6c8e369bc"
      unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iad1f1467c6694df4a0d7fc8661e6b67c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtNS0xLTEtMA_07abc791-7691-47d9-be37-f90f8fa8fb9d"
      unitRef="usd">-40300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i394755247a4245c5b34c032dd17977d5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtNy0xLTEtMA_cc4861c2-94b8-44de-864b-1aed371fa19e"
      unitRef="usd">-108900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cd9ef6885cb4483a826dc5519bf65fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzUtOS0xLTEtMA_f0841ae1-b258-465f-94f3-b491396fba2d"
      unitRef="usd">-149600000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtMS0xLTEtMA_25d8731c-6ae1-4b27-8a5c-5c20537b1a90"
      unitRef="usd">2800000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtMy0xLTEtMA_675cc8d3-eff9-471c-9b25-70fb2ee3763f"
      unitRef="usd">200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i896e20ef243241948a91a08bcb36aada_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtNS0xLTEtMA_b8fc6ca1-7a21-49cd-8a4d-b822946f9339"
      unitRef="usd">-2500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i8565969bde54458fb11c038691603413_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtNy0xLTEtMA_7c98c6d6-bdef-46bf-93bd-2d47556f6e50"
      unitRef="usd">40100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzYtOS0xLTEtMA_0b3fb879-2ba5-4c03-af65-aa466ca7de69"
      unitRef="usd">40600000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctMS0xLTEtMA_20e4e6f9-c1c1-4e36-ac2b-15ab791f5041"
      unitRef="usd">3900000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctMy0xLTEtMA_65a358b4-4304-445d-bd21-b21da6201d0a"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i896e20ef243241948a91a08bcb36aada_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctNS0xLTEtMA_435c49c4-5d3f-4084-8d9c-af001a3b76b8"
      unitRef="usd">-2300000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i8565969bde54458fb11c038691603413_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctNy0xLTEtMA_3bef270d-6c0a-427e-8405-5ddcbf70607d"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzctOS0xLTEtMA_49ddd478-6f4e-49b7-9745-7114435c9ed4"
      unitRef="usd">1600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8a03d8134f6a46f0aa0bbad4f60d2b7c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtMS0xLTEtMA_44ab7c3a-c8d0-40ab-a53d-dfee59d1a22d"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icdff9444c7d74a70ab604300f85b9e4a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtMy0xLTEtMA_9cd86151-a4bf-4fd2-b986-2e7c7b7a25cf"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i896e20ef243241948a91a08bcb36aada_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtNS0xLTEtMA_915b2954-a524-4fd5-9c41-d5bfdbc3eae8"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8565969bde54458fb11c038691603413_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtNy0xLTEtMA_ad839f18-3e51-4170-bff4-454a9bd628c3"
      unitRef="usd">40100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzgtOS0xLTEtMA_4ebfd969-9183-4a84-b7ad-b33a6b5f1167"
      unitRef="usd">39000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i8143f0aa268c43be9cb5a90dc5b80fc0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktMS0xLTEtMA_4ee62eef-6f9b-426c-ac44-ec0f126d5cd8"
      unitRef="usd">-1900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie93df88f97024c308142319431bb90a2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktMy0xLTEtMA_1f403490-faf2-411a-9293-d4812f64d2b2"
      unitRef="usd">600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1754a699316c449f8f1f4261e2891243_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktNS0xLTEtMA_610f9641-d463-4efb-9583-4855d0ef71e6"
      unitRef="usd">-40500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14e414bd78984a40bfeb308b44cb7247_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktNy0xLTEtMA_2280c9d6-f03b-4cc9-bace-4de45a471e2a"
      unitRef="usd">-68800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief5c5adaa64e42959e00816c3bf6c2b3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpjNzUxOWRjMTk4YTc0NGQ0YjRiNjlmOTgwZGEzNzJkNS90YWJsZXJhbmdlOmM3NTE5ZGMxOThhNzQ0ZDRiNGI2OWY5ODBkYTM3MmQ1XzktOS0xLTEtMA_62d7686c-1f35-4381-94cf-dce9fb85029b"
      unitRef="usd">-110600000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90ZXh0cmVnaW9uOmM1Y2ZkMzg4MGYwNDRhNGRhMTQwYzVhN2I0YzU4M2U0XzQ2Mg_68e74111-0274-45d1-b364-f7996131d8d0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzItMi0xLTEtMA_6ec19699-f8b3-43de-833b-3f61a51a30ca"
      unitRef="usd">-200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzItNC0xLTEtMA_c7088fab-0eb6-41fe-ad37-e5c35c76356c"
      unitRef="usd">1000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzMtMi0xLTEtMA_a4cbce03-197f-44de-be72-903c43347f79"
      unitRef="usd">-100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzMtNC0xLTEtMA_f9443cc8-b77b-4851-ac23-ac012f608bcd"
      unitRef="usd">-1000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherIncome
      contextRef="if178d1ff24d14b1a8feae4d3d3472d11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzQtMi0xLTEtMA_a0b4c436-90fb-41ac-9914-a7857c10079e"
      unitRef="usd">5900000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i1b1907b110964ee087e6d5ab37818350_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzQtNC0xLTEtMA_bb3fa15a-714d-4c28-b0e7-4b45e17580a1"
      unitRef="usd">6900000</us-gaap:OtherIncome>
    <us-gaap:InterestExpense
      contextRef="i75da7f02f5094418a3c0f650caaf45e6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzUtMi0xLTEtMA_3d9a24bd-cb9d-4126-bacf-14b466d96347"
      unitRef="usd">400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib29ca945bd3c4f2e8e97e9cb0dd524b6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzUtNC0xLTEtMA_26b1f82b-27e5-4d8e-b7f4-add8d8ed80e5"
      unitRef="usd">500000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzYtMi0xLTEtMA_30096f4f-8f2b-49a3-94b8-0b157e31962f"
      unitRef="usd">5400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzYtNC0xLTEtMA_4aff5065-1d33-4cfd-b151-2517c16d7fe1"
      unitRef="usd">8400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzctMi0xLTEtMA_613c91c9-3444-4c0a-8dc0-13341e2911a6"
      unitRef="usd">1500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzctNC0xLTEtMA_08f64201-ecca-427a-bcaa-497b8ca10329"
      unitRef="usd">2600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i9583d2fc5a904390b291b8dbed9461f8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzgtMi0xLTEtMA_b860d957-9a36-4c88-883d-bd32e2943535"
      unitRef="usd">3900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7b01441260fe4f9b9586088ff0940693_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzgtNC0xLTEtMA_88779c2a-f14b-4263-b2db-eae181e475b4"
      unitRef="usd">5800000</us-gaap:NetIncomeLoss>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzExLTItMS0xLTA_55a9a9d8-9de4-4a62-8ea6-a33a78df9033"
      unitRef="usd">-600000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzExLTQtMS0xLTA_ed14b753-3580-4b5c-a930-5fa67c548a54"
      unitRef="usd">-600000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzEyLTItMS0xLTA_f40d8442-6018-474b-aac3-ebeedee59581"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzEyLTQtMS0xLTA_930cf322-664b-4e48-b7e1-e18221bce4a9"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE0LTItMS0xLTA_5ab3acf0-e198-4160-a4df-6d17b2c9e7ef"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE0LTQtMS0xLTA_cca7a335-e753-4058-ab6f-ad33bf099bf2"
      unitRef="usd">-3500000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE1LTItMS0xLTA_5512e678-aa2b-403e-b818-43abb4275666"
      unitRef="usd">-3200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE1LTQtMS0xLTA_8a8c6545-cf78-4f11-9b81-29d82eb2cf49"
      unitRef="usd">-2700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE2LTItMS0xLTA_22a1f8fd-cfbe-4029-91a3-bb023636a22b"
      unitRef="usd">-900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE2LTQtMS0xLTA_46427aad-bb47-4ae1-82c0-2c1d3892d0e9"
      unitRef="usd">-700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ied6aee795cfd4e36b1177977a3d79d48_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE3LTItMS0xLTA_2a2902c3-9934-49cb-b839-94c1c1c70957"
      unitRef="usd">-2300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id653a72d62594340bd19ad8e717b1c94_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE3LTQtMS0xLTA_d856680c-70b4-41c2-9d92-8448c478bb2c"
      unitRef="usd">-2000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2fadb2a71cac4c68a8087322aebf7865_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE4LTItMS0xLTA_b693056d-dc2c-440d-ba4b-64c365b9b744"
      unitRef="usd">1600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6b53436536584f99949ba6e260846ce6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzYvZnJhZzpjNWNmZDM4ODBmMDQ0YTRkYTE0MGM1YTdiNGM1ODNlNC90YWJsZTpmNjAwNTBiZGMxZmI0MWE3OGNkZWMxYzk3ZWEzNDg1Zi90YWJsZXJhbmdlOmY2MDA1MGJkYzFmYjQxYTc4Y2RlYzFjOTdlYTM0ODVmXzE4LTQtMS0xLTA_ae49dfd7-8cfc-4d96-bdba-29e642207676"
      unitRef="usd">3800000</us-gaap:NetIncomeLoss>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwNTU_f9fdcc6e-e758-46f9-9300-9890a7aebe2d">Stock-Based Compensation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#x201c;2016 Plan&#x201d;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2020, there were 2,761,911 shares remaining in the 2016 Plan for future grants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options and stock appreciation rights reduce the number of shares available by one share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to 2.5 times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option and appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, stock-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, cash-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, dividend equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plans and restricted share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates expected forfeitures. The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2020 was approximately $31.7 million, which is expected to be recognized over a weighted average period of 1.6 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options granted to employees vest in equal increments. All awards expire 10 years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the weighted average remaining contractual life of options outstanding and of options exercisable was 5.9 years and 4.8 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the aggregate intrinsic value of total options outstanding was $481.2 million, of which $351.7 million represented vested options.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2020, 2019 and 2018: a risk-free interest rate of 1.3%, 2.3%, and 2.7%, respectively; stock volatility of 22.4%, 22.5%, and 19.8%, respectively; and dividend yields of 0.4%, 0.7%, and 0.7%, respectively. Stock volatility is estimated based on historical data and the impact from expected future trends. Expected lives, which are based on prior experience, averaged 5.7 years for 2020, 2019 and 2018. The weighted average grant date fair value of options granted in 2020, 2019 and 2018 was $40.28, $24.72 and $20.16, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2020, 2019 and 2018, the intrinsic value of options exercised was $88.8 million, $46.9 million and $61.3 million, respectively. The grant date fair value of options vested during those same periods was $8.4 million, $7.5 million and $8.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Appreciation Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock appreciation rights (&#x201c;SARs&#x201d;) granted to eligible international employees vest in equal annual increments over 4 years of continuous service. All awards expire 10 years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2020, SARs outstanding were 27,679, of which 24,051 were cash-settled and 3,628 were stock-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#x2019;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding SARs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to stock options and SAR awards, we grant performance share unit (&#x201c;PSU&#x201d;) awards to eligible employees. These awards are earned based on the Company&#x2019;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding stock-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares earned under PSU awards may vary from 0% to 200% of an employee&#x2019;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2020, 2019 and 2018 was $177.31, $103.40 and $90.45, respectively. Including forfeiture and above-target achievement expectations, we expect that the stock-settled PSU awards will convert to 92,792 shares to be issued over an average remaining term of one year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding cash-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer an Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which provides for the sale of our common stock to eligible employees at 85% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to 25% of the employee&#x2019;s base salary, not to exceed $25,000 in any one calendar year. In addition, employees may not buy more than 2,000 shares during any offering period (8,000 shares per year). Purchases under the ESPP were 36,494 shares, 51,391 shares and 55,669 shares for the years 2020, 2019 and 2018, respectively. At December&#160;31, 2020, there were approximately 3,793,218 shares available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Compensation Plans and Restricted Share Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of one share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2020, we granted 10,302 deferred stock awards, with a weighted grant date fair value of $194.29. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. As of December&#160;31, 2020, the two deferred compensation plans held a total of 358,890 deferred stock units, including 6,274 units to be paid in cash.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition, during 2020, we granted 8,721 restricted share awards at a weighted grant-date fair value of $200.35 per share to employees under the 2016 Plan. During 2019, we granted 13,308 restricted share awards at a weighted grant-date fair value of $116.39 per share to employees under the 2016 Plan. During 2018, we granted 15,942 restricted share awards at a weighted grant-date fair value of $96.77 per share to employees under the 2016 Plan. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Annual Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our annual incentive plan, participants are paid bonuses on the attainment of certain financial goals, which they can elect to receive in either cash or shares of our common stock. If the employee elects payment in shares, they are also given a restricted incentive stock award equal to one share for each four bonus shares issued. The incentive stock awards vest at the end of four years, provided that the participant has not made a disqualifying disposition of their bonus shares. Incentive stock award grants were 350 shares, 1,300 shares and 1,500 shares in 2020, 2019 and 2018, respectively. Incentive stock forfeitures of 0 shares, 0 shares, and 200 shares occurred in 2020, 2019 and 2018, respectively. Compensation expense is recognized over the vesting period based on the fair market value of common stock on the award date: $156.49 per share granted in 2020, $106.14 per share granted in 2019 and $93.00 per share granted in 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzQ1MQ_1db0f949-861f-4b37-91d4-2403ac924263"
      unitRef="shares">2761911</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted
      contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzU5Mw_3bd81959-c0b1-4aa0-89de-2062048109a3"
      unitRef="shares">1</wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted>
    <wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted
      contextRef="i94d102ffa7174cdf958957e889097fa6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc0NA_7234c72c-7c41-4993-80dc-138938d1b36d"
      unitRef="shares">2.5</wst:ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwMzA_d123cdae-d821-4d27-8ad0-faa1dc5999ae">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option and appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, stock-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, cash-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units, dividend equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plans and restricted share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibd49877ac6e94e8ba65f322b6db5e98d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzEtMS0xLTEtMA_862077bc-759e-4c89-84f6-0d5d9f4dfd95"
      unitRef="usd">10200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0e981e6b5c1c4a0a96533e1a52c52939_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzEtMy0xLTEtMA_dc652c10-07b3-4128-bd09-798ea5fa6ad8"
      unitRef="usd">9100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idcddbacbafaa4e1a88fe1be38aec0244_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzEtNS0xLTEtMA_e01aa732-2c3e-4ff3-bb7c-1e7b782e66a5"
      unitRef="usd">8600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b56de45b3d044729f17a76e52cedbc9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzItMS0xLTEtMA_1bc7b375-3f26-42ed-9ef4-0325c9604544"
      unitRef="usd">16600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i58338c0d70074d60967ae84164421b21_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzItMy0xLTEtMA_318eff22-0b66-4f52-b1bc-7d88f0634ffb"
      unitRef="usd">9500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i08616f88160948b48f5aaa6efbddcba4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzItNS0xLTEtMA_6722e11c-5ff1-42c4-ac86-208af2b82606"
      unitRef="usd">2500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzMtMS0xLTEtMA_6b2e9b09-1440-4aff-a76e-e3eb4dd96936"
      unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzMtMy0xLTEtMA_dd57cdea-28a9-45cb-ae38-bd62a6da5801"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzMtNS0xLTEtMA_a5c6f5c8-a4f8-4799-b2de-8b877ab23855"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4d603594868f40508e7fe929d734564a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzQtMS0xLTEtMA_434f54df-23a5-48a7-9832-6b07b287110e"
      unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4526e48ffa5a4038b2bf9bfff300abac_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzQtMy0xLTEtMA_88ca3a4c-1453-4592-9074-f9fdac2c7384"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6835ccab784849ca91ebb01f7d09ae9c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzQtNS0xLTEtMA_7382fd55-e43f-454f-9c68-30ad904326c4"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzUtMS0xLTEtMA_7d90d49b-e527-4947-b58a-20ee4e01a14c"
      unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idbed69520f7a44dfaa08f657cc8f4421_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzUtMy0xLTEtMA_78237cbb-8540-401f-a369-f676eff478ab"
      unitRef="usd">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7c545e42bb914c0c88935ba87d94b5fb_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzUtNS0xLTEtMA_4b799ba7-2ee0-45c6-a6db-a58a602709d1"
      unitRef="usd">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9d8d0c816eaf4dfca6437e6e6a59e325_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzYtMS0xLTEtMA_b07ab1d2-b79c-44a5-9ede-83d1ce764bf7"
      unitRef="usd">5100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i34d543f5f46e4f9a93d41fac73ca8d9b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzYtMy0xLTEtMA_95d1eeb1-b3db-47bf-bac9-ebce481bc1e4"
      unitRef="usd">4600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id6d567413c754bd2bced1765c543f431_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzYtNS0xLTEtMA_3b3443d7-69af-4b91-9fe0-5ab83548dbdd"
      unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzctMS0xLTEtMA_3bf9beee-0ffd-400d-b702-78f5aba6b5d0"
      unitRef="usd">34000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzctMy0xLTEtMA_9a5e829b-5bad-4814-94e2-ec0177de6e6c"
      unitRef="usd">24400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo0YWEwOGJiMDBiMmE0MDYzODg0NTYyZjc2OWNmZWY3OS90YWJsZXJhbmdlOjRhYTA4YmIwMGIyYTQwNjM4ODQ1NjJmNzY5Y2ZlZjc5XzctNS0xLTEtMA_33f02dd1-d7d3-4e6e-853a-c163cc17b9d7"
      unitRef="usd">15100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEyNzc_0b7962a5-e6a6-44e4-9f55-b6ebe836d6d0"
      unitRef="usd">31700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEzNTA_97acec64-4039-46f6-a307-45430e362a85">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE0NTY_a232dbd0-c940-4c38-9c5a-ea4c32e6e0b3">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwMzQ_bcd7a8a1-3a5b-467f-9da2-f8004edf561c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzEtMS0xLTEtMA_77149cc4-52b9-497a-ad97-1e6558e3e199"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzEtMy0xLTEtMA_806c27a1-7295-4638-a3fb-68015e13f6e3"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzEtNS0xLTEtMA_21d1ab65-bf12-4bde-9b7e-3f7cac2b582c"
      unitRef="shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzItMS0xLTEtMA_c711a2cf-2a97-43ea-9eba-5be811290639"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzItMy0xLTEtMA_5b4fabc7-0d37-4f9d-b57f-d62c6f0c15dc"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzItNS0xLTEtMA_c8a49753-7867-4d61-89db-4f881447b885"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzMtMS0xLTEtMA_ba5f6723-6d77-4f3a-b0ae-1f8dbcc64d22"
      unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzMtMy0xLTEtMA_4bcb3f92-f0d7-42d0-a0d1-608730b10a9b"
      unitRef="shares">600000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzMtNS0xLTEtMA_8bf9ed77-1aad-454d-8529-6b3caa8e4b8b"
      unitRef="shares">1000000.0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzQtMS0xLTEtMA_f34df76b-d7f5-4a46-9243-07ec4e7455d5"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzQtMy0xLTEtMA_32569a1c-fbe6-4f4d-8c54-da193fb7b9bf"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzQtNS0xLTEtMA_910d5774-f484-4ebc-a1be-901b2487e261"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzUtMS0xLTEtMA_cdeb5a79-4d25-4443-9250-6753b82c46e4"
      unitRef="shares">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzUtMy0xLTEtMA_df789cd5-bcb9-4b03-8f8e-cddeeb46d812"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzUtNS0xLTEtMA_23d6997b-ca28-4d67-81a2-0262a2771d3e"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzYtMS0xLTEtMA_c4d946a7-8d2f-4260-b98d-4f453412e58d"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzYtMy0xLTEtMA_11945808-91c4-48e7-98ba-b750d6d5ba50"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo4NWRmYTI1YjZmYzg0ZjBiYThhY2JhNDA0ZjJjOGIyOS90YWJsZXJhbmdlOjg1ZGZhMjViNmZjODRmMGJhOGFjYmE0MDRmMmM4YjI5XzYtNS0xLTEtMA_3b733b92-3dfb-48f4-92cd-ced04d2f30bb"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzEtMS0xLTEtMA_626fd2c1-d5da-48cf-9692-0fe33d7bc303"
      unitRef="usdPerShare">67.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzEtMy0xLTEtMA_230f8df6-6977-4fcd-8c58-fe7a3349bd78"
      unitRef="usdPerShare">58.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzEtNS0xLTEtMA_4506ebad-3f79-4f6a-8bbb-40310e2d537e"
      unitRef="usdPerShare">48.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzItMS0xLTEtMA_0952f99a-a87e-40bd-9783-95d3554ba037"
      unitRef="usdPerShare">178.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzItMy0xLTEtMA_f080f801-fb6a-47e3-88f0-76a3fa27ec8c"
      unitRef="usdPerShare">103.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzItNS0xLTEtMA_3e2ccde6-c275-4f25-88df-cb9a2a069342"
      unitRef="usdPerShare">90.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzMtMS0xLTEtMA_b9071673-3929-4650-a193-173fda287d0c"
      unitRef="usdPerShare">49.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzMtMy0xLTEtMA_999712b0-bc8f-497e-93c7-d03a0e1a739a"
      unitRef="usdPerShare">46.42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzMtNS0xLTEtMA_7caebd7a-d856-41d7-96d8-cd7e9712e449"
      unitRef="usdPerShare">35.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzQtMS0xLTEtMA_3ba2aba3-8b39-41f2-9269-4a47d6dedb78"
      unitRef="usdPerShare">103.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzQtMy0xLTEtMA_5616e768-48b2-4900-9797-6416babdb239"
      unitRef="usdPerShare">92.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzQtNS0xLTEtMA_2f16dd7e-312f-432c-934f-e31671c72b09"
      unitRef="usdPerShare">75.32</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzUtMS0xLTEtMA_dbae6096-1fa5-4628-a35d-ff6b38251001"
      unitRef="usdPerShare">81.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzUtMy0xLTEtMA_d2440074-f481-49ce-b59e-d83a7e6a8952"
      unitRef="usdPerShare">67.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzUtNS0xLTEtMA_a61bc5d8-908f-4f08-8ce9-7c86e18bce7e"
      unitRef="usdPerShare">58.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzYtMS0xLTEtMA_c1a57b04-cceb-4dff-90e0-879b29de3c7e"
      unitRef="usdPerShare">62.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzYtMy0xLTEtMA_c0adbf70-c875-40fd-8c54-05207709441a"
      unitRef="usdPerShare">53.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTozMmVhZTk3Y2ZjYzU0ZmZkYjMyMGY4MWZlZTlhMTgzNy90YWJsZXJhbmdlOjMyZWFlOTdjZmNjNTRmZmRiMzIwZjgxZmVlOWExODM3XzYtNS0xLTEtMA_3fe8a696-8c8a-467e-abad-9b01fb4d6093"
      unitRef="usdPerShare">45.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE3Nzg_929d96bb-bc98-4c7a-93bb-768d5bdd954b">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE3OTE_2194473c-3887-44d7-85d8-d9c9cc13d75a">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE4ODk_dac0c4a7-41a7-4201-9cbe-a3e5a63c3218"
      unitRef="usd">481200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzE5MDI_ea0ac5c1-2c2c-4d7d-9eec-a075071facea"
      unitRef="usd">351700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxNDQ_890ad0a7-b052-4257-8e98-c9f4b6924d01"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxNDg_e413660d-142b-4e38-b2c6-767d92f652cf"
      unitRef="number">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxNTY_bdf0dc49-9106-46bc-8755-9555a2c16299"
      unitRef="number">0.027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxOTQ_de7904f5-0a92-4d64-b766-34c52f78b5d0"
      unitRef="number">0.224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIxOTg_6fa8ae96-9326-4e64-9bcf-5677ab626c81"
      unitRef="number">0.225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyMDY_60f13152-f985-4ca4-b844-72301760b813"
      unitRef="number">0.198</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyNDc_73a2e6fc-262b-4ff4-a0ae-e1c8b2482a07"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyNTE_ca393ec5-555b-461a-9d18-b669494e0575"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzIyNTk_a6edb50f-4240-41b6-80f3-a7e08b7fed35"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6dfa601e712e43c3804db0add26e5ade_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2MzY4NDA_464f9458-205c-4a96-be47-d48ad43480b2">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i88eb3a0f0d6e46e4950e0c23209fb2be_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2MzY4NDA_d02c4ede-5265-4996-aa6a-65ccc7f207b7">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i211048b536314cddb8c58c561b0ab85f_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2MzY4NDA_fbeb8c4a-6322-499d-b547-626e588c488a">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI1NDM_5324c506-9746-4651-89d1-c22d615f57c6"
      unitRef="usdPerShare">40.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI1NDc_94f9cdcf-7502-4349-89f7-9a04b433c3f4"
      unitRef="usdPerShare">24.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI1NTQ_ed45fb52-0c1d-49b9-8010-979beeef3f9d"
      unitRef="usdPerShare">20.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI3NDY_4f7aafdc-84e4-4275-9dc6-aac1af28d580"
      unitRef="usd">88800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI3NTA_cf907333-c4e4-4930-ac39-33367a6313bb"
      unitRef="usd">46900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI3NTc_b44ce267-ac26-4d46-a88d-78a0f39102bb"
      unitRef="usd">61300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI4NDk_f4317105-877d-47f2-b934-cc8dbda059c9"
      unitRef="usd">8400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI4NTM_c3c080cf-4464-4d43-bc38-fb28a9552170"
      unitRef="usd">7500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzI4NjA_d6928466-50b4-45c9-b665-1f714374bf76"
      unitRef="usd">8300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMwMjI_7463fa79-71a8-42de-8de2-3166290aa9f0">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMwNjY_28f06862-36a2-4b3b-8eec-1087f3069d80">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMyNjI_2803441e-23d6-4fc0-908d-3f0daee336be"
      unitRef="shares">27679</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <wst:CashSettledStockAppreciationRightsOutstanding
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMyNzU_99563adf-7caf-4433-850c-5b594e246277"
      unitRef="shares">24051</wst:CashSettledStockAppreciationRightsOutstanding>
    <wst:StockSettledStockAppreciationRightsOutstanding
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzMzMDA_5a5416b4-d66f-4bb6-9b18-21282e8abe13"
      unitRef="shares">3628</wst:StockSettledStockAppreciationRightsOutstanding>
    <us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwMTY_f1b52451-698b-4c15-a147-de9212db18a6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in outstanding SARs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzEtMS0xLTEtMA_6f006a56-2675-439c-af86-ab75f87b04b0"
      unitRef="shares">35993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzEtMy0xLTEtMA_b15a2b85-36cf-4d2b-a74b-30f00f7da2ea"
      unitRef="shares">39819</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ie536733ecf0f49159c3492b03170fa5e_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzEtNS0xLTEtMA_216adb5b-e219-4196-8310-ed628ba01158"
      unitRef="shares">51368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzItMS0xLTEtMA_3cb6a9c1-a465-4798-a341-a1e5bbf8b041"
      unitRef="shares">3272</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzItMy0xLTEtMA_3b12b519-ce52-4935-93b2-81155dca246b"
      unitRef="shares">3364</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzItNS0xLTEtMA_0d031a16-f0af-492e-bb52-9b4716b2050a"
      unitRef="shares">3480</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzMtMS0xLTEtMA_b52b1718-e96e-4e98-ac29-b5f17ec7b802"
      unitRef="shares">11261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzMtMy0xLTEtMA_07aba9cd-3d7b-421d-bdf1-2aafa863f11c"
      unitRef="shares">6790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzMtNS0xLTEtMA_3b16caa7-4376-4dda-9857-185baa7be4a2"
      unitRef="shares">14629</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzQtMS0xLTEtMA_e4bb7040-2fd6-4323-a295-f976bf93ac9c"
      unitRef="shares">325</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzQtMy0xLTEtMA_f1ee77bf-1784-4315-9fae-ec450f4d76a0"
      unitRef="shares">400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzQtNS0xLTEtMA_fa717bb9-020f-4855-b7a4-06e1e1d5fc0a"
      unitRef="shares">400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzUtMS0xLTEtMA_4e808db3-0272-4609-a399-f853a804ae39"
      unitRef="shares">27679</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzUtMy0xLTEtMA_53dd46a7-d788-4c65-a105-d888ffcabed1"
      unitRef="shares">35993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzUtNS0xLTEtMA_e813a4b4-586e-44de-ae5c-4ddfb1cbe7e7"
      unitRef="shares">39819</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzYtMS0xLTEtMA_2a2df7f0-b809-4589-bfc4-ea7fc2699a2f"
      unitRef="shares">27182</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzYtMy0xLTEtMA_9a4313c2-bbd0-4162-8f0c-4961171561e3"
      unitRef="shares">27781</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplMWI4ZDhmOWIxZmE0NGMwYWZkZjUxOTk3MGE2ZjQ5MC90YWJsZXJhbmdlOmUxYjhkOGY5YjFmYTQ0YzBhZmRmNTE5OTcwYTZmNDkwXzYtNS0xLTEtMA_9673660c-1746-45d3-9861-3ffd9e9a653e"
      unitRef="shares">30285</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzItMS0xLTEtMA_54c82b3b-9ee3-4786-90a5-6df0d1ff0c82"
      unitRef="usdPerShare">52.36</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzItMy0xLTEtMA_18de2e5c-22cf-4270-87fe-189acdb8990b"
      unitRef="usdPerShare">46.48</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="ie536733ecf0f49159c3492b03170fa5e_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzItNS0xLTEtMA_6681accf-eff7-4531-9845-7bd905dd6cdc"
      unitRef="usdPerShare">38.55</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzMtMS0xLTEtMA_8eda7ba4-83cc-4edf-8d34-970f4a4f4446"
      unitRef="usdPerShare">190.97</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzMtMy0xLTEtMA_aa5a64df-e89a-4ba2-9373-4e102f329f57"
      unitRef="usdPerShare">102.51</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzMtNS0xLTEtMA_fbf83e62-ccf2-4e6a-9e7d-32ce31c4d545"
      unitRef="usdPerShare">89.64</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzQtMS0xLTEtMA_25c283f0-9574-4568-a266-5cda5bfd6a89"
      unitRef="usdPerShare">35.37</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzQtMy0xLTEtMA_4dfc926d-4ae2-4329-a20c-2cf9d048b911"
      unitRef="usdPerShare">42.08</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzQtNS0xLTEtMA_a07dd23c-8869-4657-9dea-2415143b00bc"
      unitRef="usdPerShare">28.45</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzUtMS0xLTEtMA_e4161a88-f59d-498a-b426-a7ca5f2b6130"
      unitRef="usdPerShare">71.43</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i39d9cc4007e14b09a2fbe661b08ad08e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzUtMy0xLTEtMA_c0dd8cbd-b578-487c-9200-305d83a89b81"
      unitRef="usdPerShare">63.43</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ibd8e2be9380e4727b5bace928c1b38f9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzUtNS0xLTEtMA_f0380122-da6b-4d57-9b8d-a2d2154ec5d3"
      unitRef="usdPerShare">63.43</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzYtMS0xLTEtMA_64e5a6e0-9852-48ed-ab3f-734e7b831c1d"
      unitRef="usdPerShare">75.43</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzYtMy0xLTEtMA_3f9e8a05-a14a-412d-8613-d719791ae062"
      unitRef="usdPerShare">52.36</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzYtNS0xLTEtMA_ad2d12b2-d849-4d0b-95e5-be4428a174b4"
      unitRef="usdPerShare">46.48</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="i96c87fad149e472cb246ab4b33e1c09e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzctMS0xLTEtMA_cff83188-973d-4853-9bf5-b62640535e8b"
      unitRef="usdPerShare">40.23</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="i5f2ed4fc5d284253859a0c77c2b51762_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzctMy0xLTEtMA_4f6b5d03-a830-40f9-9dc6-a58c3c3e2023"
      unitRef="usdPerShare">40.73</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="i60272ca2ab3b4271b9d2e0caa79f263e_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZToyMjBjNzM4ZmI5NzI0NWU0YTc1MDE5N2FmODk5MTkyMC90YWJsZXJhbmdlOjIyMGM3MzhmYjk3MjQ1ZTRhNzUwMTk3YWY4OTkxOTIwXzctNS0xLTEtMA_3c9ce17b-21dd-492d-8ec1-ae11b4fd6a97"
      unitRef="usdPerShare">36.91</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwNTM_f29eb2a8-4ed8-4952-b956-5c2e995767b0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding stock-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEtMS0xLTEtMA_63cc258c-044e-4b33-9c26-e3ca1cf10f04"
      unitRef="shares">264622</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEtMy0xLTEtMA_938dc038-3371-402f-90c7-fe666be0a4ae"
      unitRef="shares">296037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ifa7ad396fdcd47809883f36d39da738a_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEtNS0xLTEtMA_f0e3d633-bb6c-475a-b1c7-ffdd2327fe9c"
      unitRef="shares">341944</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzItMS0xLTEtMA_5a2396b9-aba9-473e-9938-c002481d0b1e"
      unitRef="shares">53659</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzItMy0xLTEtMA_60bf2a16-d7f0-45f3-bd20-dce9015d1539"
      unitRef="shares">84309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzItNS0xLTEtMA_a27cc240-4a9a-4320-961e-ad60b53f4f2e"
      unitRef="shares">102307</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzMtMS0xLTEtMA_c85f85e2-b22a-40e9-b5d3-c099c5fe52c9"
      unitRef="shares">-14004</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzMtMy0xLTEtMA_f87b0b8c-1d03-4790-8769-fe114ff84807"
      unitRef="shares">-50556</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzMtNS0xLTEtMA_17f32a6a-adcf-4161-be04-e64db7cae619"
      unitRef="shares">-2284</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzQtMS0xLTEtMA_f743f2ad-b462-4a0a-8c53-4d4cb83dcfbb"
      unitRef="shares">70074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzQtMy0xLTEtMA_97449a77-0374-4d18-8cfc-3bc8d621e648"
      unitRef="shares">48964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzQtNS0xLTEtMA_d4a96408-d406-4440-9731-c5c347d2c538"
      unitRef="shares">121984</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzUtMS0xLTEtMA_21167092-e505-48be-b633-9dee3f48efa1"
      unitRef="shares">11404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzUtMy0xLTEtMA_d576aeb3-a442-418c-9708-1080f957cf65"
      unitRef="shares">16204</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzUtNS0xLTEtMA_77d51ba4-7461-4470-bef8-4cb465673419"
      unitRef="shares">23946</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if03468ad1c7345619b7c14865b28e6f4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzYtMS0xLTEtMA_d967d65f-5478-4354-9469-4bf4ee19b90b"
      unitRef="shares">222799</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzYtMy0xLTEtMA_b40d1f00-8979-4bc2-aee7-665e73388f2a"
      unitRef="shares">264622</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzYtNS0xLTEtMA_f4c85fd6-a47a-4c7c-9cfd-49d50b5982d9"
      unitRef="shares">296037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzktMS0xLTEtMA_364b55ee-9815-4c06-aa2b-c020b7bc162f"
      unitRef="usdPerShare">92.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzktMy0xLTEtMA_080588a9-d32f-4467-937e-dedcfe6abb50"
      unitRef="usdPerShare">76.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifa7ad396fdcd47809883f36d39da738a_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzktNS0xLTEtMA_bc876c77-90c0-4fbc-9bbc-53be8c950b3e"
      unitRef="usdPerShare">64.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEwLTEtMS0xLTA_8801f0cd-dc0a-4a45-a299-bd7aae4e03ac"
      unitRef="usdPerShare">177.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEwLTMtMS0xLTA_eea3af18-848c-40ef-8fde-f57d443b4430"
      unitRef="usdPerShare">103.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEwLTUtMS0xLTA_617a9916-5dd6-435d-96da-7e4b140b729e"
      unitRef="usdPerShare">90.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzExLTEtMS0xLTA_c1a52b3d-5c53-4e10-a3d0-51cb2ff92b77"
      unitRef="usdPerShare">77.02</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzExLTMtMS0xLTA_e895031f-c363-4f82-a77b-38c442aa3c91"
      unitRef="usdPerShare">83.89</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzExLTUtMS0xLTA_667387b3-c527-414e-89c8-68cb07041f17"
      unitRef="usdPerShare">33.86</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEyLTEtMS0xLTA_6c74465a-c797-44bd-b8ae-0d4f4c864a55"
      unitRef="usdPerShare">173.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEyLTMtMS0xLTA_959dc235-35c0-49fa-8684-b61bd3fc7bdc"
      unitRef="usdPerShare">102.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEyLTUtMS0xLTA_f2978721-d290-4222-8c29-43090f6828d1"
      unitRef="usdPerShare">93.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEzLTEtMS0xLTA_a8d99b56-73d4-41ca-b8c8-09b1941ca9cf"
      unitRef="usdPerShare">104.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEzLTMtMS0xLTA_6c4224a5-5331-429f-84b8-ee06148c5816"
      unitRef="usdPerShare">69.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzEzLTUtMS0xLTA_fe541cf1-705e-4f4a-9602-7a884f6e3d3c"
      unitRef="usdPerShare">68.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if03468ad1c7345619b7c14865b28e6f4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzE0LTEtMS0xLTA_245410ff-b867-4eb7-b11a-718f8d5dc9b7"
      unitRef="usdPerShare">116.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia94b75e19c564babaabe3bbd0f85500a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzE0LTMtMS0xLTA_13ee4727-5c06-47ff-a738-bce61affe089"
      unitRef="usdPerShare">92.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idf9f594c3975439797d9bcdaebc0d887_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTplYWVkMTY1YTRiZmU0ZjZkYWYzZmJhNWY3ZDY4OGQwOS90YWJsZXJhbmdlOmVhZWQxNjVhNGJmZTRmNmRhZjNmYmE1ZjdkNjg4ZDA5XzE0LTUtMS0xLTA_2a312995-5b6d-4bbe-8b9c-4079ba341fd3"
      unitRef="usdPerShare">76.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="ia4df90090669487784ddadbfee1e8f77_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzQ3MTg_022c712e-95e4-47a4-bc7d-10d9c1aa1fa1"
      unitRef="number">0</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="i5509bc461133464cbdfc6fefe5088ba4_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzQ3MjQ_e9f9cd55-0e4c-45c3-95e5-2bc8386ff644"
      unitRef="number">2</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUwOTg_b8a01d0d-e368-4db1-bbb3-ec0497c0eb46"
      unitRef="usdPerShare">177.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9252070c9df8421c9700af118fdb5aff_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUxMDI_c9ca4f14-66f2-4699-8986-f7ee96bb293b"
      unitRef="usdPerShare">103.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5bbe274ee3946a1a723a16589cda5d4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUxMDk_76bb1d7d-dd94-46db-a75f-86a9957c3984"
      unitRef="usdPerShare">90.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting
      contextRef="if03468ad1c7345619b7c14865b28e6f4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUyNTE_88307612-5c96-4d68-9c99-6eb47166f2cf"
      unitRef="shares">92792</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="iaa552df152364af5806ef8ee39cb5c28_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzUzMDg_0a2949c3-a8bd-4e8b-8014-1a7f78f4d1b2">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzkwNDU_14415ce7-6549-4695-a153-3006ecbba010">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in our outstanding cash-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzEtMS0xLTEtMA_935baa3d-d3d4-48cf-b834-11b5f0deefa4"
      unitRef="shares">1981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzEtMy0xLTEtMA_184f7dc3-5d9d-4c72-bc28-b06ad966efd2"
      unitRef="shares">1592</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie2ffc58869ae424aa7cbc9aaf84a2dd4_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzEtNS0xLTEtMA_58c2b651-8052-4148-9fa3-7553888346ee"
      unitRef="shares">1972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzItMS0xLTEtMA_aff0b68f-e40b-4bfc-80b1-6109ec03049f"
      unitRef="shares">732</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzItMy0xLTEtMA_c2c0e9b9-f3f5-454c-82f0-f9d4c90d9a61"
      unitRef="shares">806</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzItNS0xLTEtMA_6c39ad97-89fd-4b29-bcac-2db5d0e29976"
      unitRef="shares">560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzMtMS0xLTEtMA_fa910d0e-4a1a-4d85-a4c8-1ce517a391a5"
      unitRef="shares">-99</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzMtMy0xLTEtMA_a5dcac8c-f969-4192-a937-01978499043c"
      unitRef="shares">-206</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzMtNS0xLTEtMA_7c6cbd56-20e2-418e-8b2d-f9cf03f76cd8"
      unitRef="shares">-30</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzQtMS0xLTEtMA_28bf8013-3ee9-440d-af35-cccfdf3fd10c"
      unitRef="shares">502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzQtMy0xLTEtMA_da88184b-32e9-4208-b223-e9830ef00caf"
      unitRef="shares">211</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzQtNS0xLTEtMA_b6a29117-cd10-4969-b7b6-f5e95c2ed06d"
      unitRef="shares">910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzUtMS0xLTEtMA_3032fb71-e61f-464a-b4b8-22ecaf8e4ad1"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzUtMy0xLTEtMA_036405f2-9b15-4c0a-968c-fda17937a084"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzUtNS0xLTEtMA_04dd7870-dc58-42b5-93f3-8dee43da49ca"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1c4540b26bb74a9a969cecf57c787621_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzYtMS0xLTEtMA_623619e3-ffe2-4d23-9838-4cee259279b5"
      unitRef="shares">2112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzYtMy0xLTEtMA_ceab7c11-ce99-43f9-b3c0-69ac90c81893"
      unitRef="shares">1981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo5NWNkZjJkMTA5ODQ0Y2VmYjY4NTYwOTllMDA1MjNhNy90YWJsZXJhbmdlOjk1Y2RmMmQxMDk4NDRjZWZiNjg1NjA5OWUwMDUyM2E3XzYtNS0xLTEtMA_2b6e6ae8-e12e-48e2-ba59-a0bf23753672"
      unitRef="shares">1592</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzEtMS0xLTEtMA_cf4e2a0d-c718-4344-889a-256ac8cede65"
      unitRef="usdPerShare">93.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzEtMy0xLTEtMA_136b7bfc-3bb5-46b4-af32-c50d063172c5"
      unitRef="usdPerShare">79.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie2ffc58869ae424aa7cbc9aaf84a2dd4_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzEtNS0xLTEtMA_5ea20ba0-ccdf-4a63-a4f8-fb81ac2a5268"
      unitRef="usdPerShare">92.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzItMS0xLTEtMA_742a3e1c-3140-40f1-98ef-e44bb4ce4567"
      unitRef="usdPerShare">190.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzItMy0xLTEtMA_212e689c-ce11-4494-802d-cf7bdd645148"
      unitRef="usdPerShare">102.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzItNS0xLTEtMA_3788b33a-a2df-489b-ab0c-287c8ac6e141"
      unitRef="usdPerShare">89.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzMtMS0xLTEtMA_91c61662-11d7-4270-bb4a-fdfd5301efa5"
      unitRef="usdPerShare">74.43</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzMtMy0xLTEtMA_f23d84c5-3326-4d7c-ab91-53e71df50356"
      unitRef="usdPerShare">56.95</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzMtNS0xLTEtMA_ec1315a0-8bf4-4170-a3c4-167965dc70bb"
      unitRef="usdPerShare">41.53</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzQtMS0xLTEtMA_4db2c1c8-8cf2-4d66-a163-9348923433e6"
      unitRef="usdPerShare">173.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzQtMy0xLTEtMA_d01c7761-7588-413b-bc85-b7fdfb2bd59a"
      unitRef="usdPerShare">102.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzQtNS0xLTEtMA_fb41ab6d-f3e5-4681-a93b-798bd8f6e2bf"
      unitRef="usdPerShare">93.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i828d7c93435a4f0eb11b0ccb60608685_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzUtMS0xLTEtMA_8494b7d7-5223-4c5a-b177-4430dbff4f9c"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i57e02bd3caeb45bc93c7c08bf99500c6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzUtMy0xLTEtMA_07fb73b9-5152-4081-9612-2202e882c901"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="idddb809162cb4f63a286d585b789e694_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzUtNS0xLTEtMA_74e6a988-1b42-4e15-b1f5-5bcd29706b41"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1c4540b26bb74a9a969cecf57c787621_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzYtMS0xLTEtMA_66295122-48b9-42fe-9ae0-8f9aa1c1d35d"
      unitRef="usdPerShare">130.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id9dd1ab30b39465b8dd22c96d9b2ea45_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzYtMy0xLTEtMA_b51bab97-c73b-43d1-93a8-f37875927458"
      unitRef="usdPerShare">93.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0a997b8a25584ec488869d0d3049d1c0_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90YWJsZTo2YjBlMzAwYzJiMTk0NDZmYTQ5NjYwNDI2NmMwZTU3ZC90YWJsZXJhbmdlOjZiMGUzMDBjMmIxOTQ0NmZhNDk2NjA0MjY2YzBlNTdkXzYtNS0xLTEtMA_8258feaa-e112-4c1f-af0e-365f436ddc31"
      unitRef="usdPerShare">79.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzU4ODM_275467fa-194e-4914-abb5-f6964d06b584"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYwMDc_27d4419b-8a8d-4b18-a954-b452ad8ce838"
      unitRef="number">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount
      contextRef="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYwNTU_a4337317-235f-4da7-8bc0-b5c87647e8d7"
      unitRef="usd">25000</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYxMjk_acc2ec45-602b-4759-8c4d-c239e8591650"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear
      contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYxNjc_53adcf34-102b-4afa-bb9b-9eb66480845c"
      unitRef="shares">8000</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ib53b604146d24e2a8dc01ba49b5059ec_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYyMTg_357e6a66-8526-4c79-b954-63e87010202d"
      unitRef="shares">36494</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idbed69520f7a44dfaa08f657cc8f4421_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYyMjk_a5456cbd-17e3-49ac-87bf-a6e7bcb9a127"
      unitRef="shares">51391</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7c545e42bb914c0c88935ba87d94b5fb_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYyNDM_791ce97f-9045-4242-b4f7-55261900f393"
      unitRef="shares">55669</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="if4d46a66c3ac4f9eaf047e8a0be49cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzYzMjg_9094019d-cd62-4972-8678-331636d7830e"
      unitRef="shares">3793218</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <wst:DeferredCompensationArrangementWithIndividualConversionUnit
      contextRef="i417b7c21dd1b47b8b40d34cc70053be2_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzY4MDc_cfc5742e-ece8-4cd2-b092-3cda16821eed"
      unitRef="shares">1</wst:DeferredCompensationArrangementWithIndividualConversionUnit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibae2919783b045ffaef7c87dc7aa860f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzcyMzI_7a42f6e6-7000-4302-8cfb-d5faf854d619"
      unitRef="shares">10302</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibae2919783b045ffaef7c87dc7aa860f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzcyOTA_e294e5f0-eb9a-44d4-9744-59692fd3e5e7"
      unitRef="usdPerShare">194.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:DeferredCompensationArrangementWithIndividualNumberOfPlans
      contextRef="icd5b02eced6f45d7a117b354e107f82b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc0NTY_ba7edc43-5aa9-4b23-8ec5-eed04f30fb7d"
      unitRef="plan">2</wst:DeferredCompensationArrangementWithIndividualNumberOfPlans>
    <wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance
      contextRef="icd5b02eced6f45d7a117b354e107f82b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc1MDM_5b84848f-59b3-4c14-ae0a-3ce0152a1f17"
      unitRef="shares">358890</wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance>
    <wst:DeferredStockUnitsPayableInCash
      contextRef="icd5b02eced6f45d7a117b354e107f82b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc1Mzg_e80d6282-ba8e-4b44-ac40-2ab3e2cb28d9"
      unitRef="shares">6274</wst:DeferredStockUnitsPayableInCash>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib92f1d4eb98744d9bc103ffc68dd371b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc2MDU_de637352-4789-4625-8863-3a18947322ea"
      unitRef="shares">8721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib92f1d4eb98744d9bc103ffc68dd371b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc2NzE_ef390bbe-1bff-4b6d-b5c1-932cfefdfac7"
      unitRef="usdPerShare">200.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i69fd39a6d2c54a91b93d39724d4934c1_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc3NDI_6f31d03a-7081-4d47-bdf7-fe532664115f"
      unitRef="shares">13308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i69fd39a6d2c54a91b93d39724d4934c1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzc4MDg_ea73f461-2075-4b82-8a1c-788002b88d2b"
      unitRef="usdPerShare">116.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic09e3fbc0235485daae5c0994ee55f63_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2Mzc0MzI_8e481316-a336-4110-807a-063906c248a6"
      unitRef="shares">15942</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic09e3fbc0235485daae5c0994ee55f63_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2Mzc0NDA_7b08c555-c060-407a-a77b-b7b4f62d06eb"
      unitRef="usdPerShare">96.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg0NjI_d0439e02-9ad3-4962-a882-abaa87d84833">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg1OTM_c197b4da-699d-4926-9f3a-fda5347568ec"
      unitRef="shares">350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg2MDQ_815a044f-4cf9-440a-ada4-da9a92b6f64e"
      unitRef="shares">1300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg2MTg_5d0c126b-0e4a-4b2f-8927-1e23e6f9edc9"
      unitRef="shares">1500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3XzEwOTk1MTE2Mzc1MDM_21e95c1e-293e-4428-8325-860b4379c09d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg3NDI_bdf9fcc7-d0ab-4d2d-abcf-ae13e0b301c5"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg3NTY_3b44067d-c1a7-4a41-9dc5-291f3419fe4a"
      unitRef="shares">200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3cb0512bd3da4536a19ed659ac491a71_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg5Mjg_dfdbc43d-1255-4ccf-97cc-c8f1d19db5b6"
      unitRef="usdPerShare">156.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i15912203da1f44189c75c3d7e9058bf6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg5NTY_350882df-6f8b-42fa-aca0-db038aeccc24"
      unitRef="usdPerShare">106.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i25ecdea574c94c449782ab61354b27e9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xMzkvZnJhZzplNTZlMzIwZmYxOTQ0NGM1YmU2ZWUzMDRjNTc5YzgzNy90ZXh0cmVnaW9uOmU1NmUzMjBmZjE5NDQ0YzViZTZlZTMwNGM1NzljODM3Xzg5ODc_81742884-33f7-4c62-862e-0f94cd9785e8"
      unitRef="usdPerShare">93.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMTg_2aa6f8cd-c1a2-4c40-b267-371638e00bbc">Benefit Plans Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $16.8 million for 2020, $15.6 million for 2019 and $6.5 million for 2018. The increase in 401(k) plan contributions in 2019 was in response to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting).&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension and Other Retirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost and other amounts recognized in OCI were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (gain) arising during period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit arising during period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit cost by geographic location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The service cost component included within net periodic benefit cost is considered employee compensation and is therefore presented within the selling, general, and administrative and costs of goods and services sold financial statement line items of our consolidated statements of income. The remaining components of net periodic benefit cost are reported separately and are therefore presented within the other nonoperating (income) expense financial statement line item of our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020 and 2019, we recorded $3.7&#160;million and $3.5&#160;million in pension settlement charges within other nonoperating (income) expense, respectively, as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, we did not contribute to our U.S. qualified defined benefit pension plan. During 2019, we contributed $2.6&#160;million to our U.S. qualified defined benefit pension plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International pension plan assets, at fair value, included in the preceding table were $43.9 million and $39.4 million at December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in the balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts in accumulated other comprehensive loss, pre-tax, consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated benefit obligation for all defined benefit pension plans was $293.9 million and $283.9 million at December&#160;31, 2020 and 2019, respectively, including $83.1 million and $73.9 million, respectively, for international pension plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 and December&#160;31, 2019, our U.S. qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2020 and December&#160;31, 2019, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 to 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, we expect to contribute $3.6&#160;million to pension plans, of which $2.9&#160;million is for international plans. In addition, we expect to contribute $0.7&#160;million for other retirement benefits in 2021. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine the benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount rate used to determine the benefit obligations for U.S. pension plans was 2.60% and 3.35% as of December 31, 2020 and 2019, respectively. The weighted average discount rate used to determine the benefit obligations for all international plans was 0.89% and 1.28% as of December 31, 2020 and 2019, respectively. The rate of compensation increase for U.S. plans was 4.25% for 2018, while the weighted average rate for all international plans was 2.58% for 2020 and 2.49% for 2019. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans, which accounts for 83.0% of global plan assets, was 5.10% for 2020, 5.60% for 2019 and 7.00% for 2018. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumed healthcare cost trend rate used to determine benefit obligations was 6.50% for all participants in 2020, decreasing to 5.00% by 2027. The assumed healthcare cost trend rate used to determine net periodic benefit cost was 6.25% for all participants in 2020, decreasing to 5.00% by 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The defined pension plan benefit obligation increased for the year ended December&#160;31, 2020 primarily due to a decrease in the discount rate used to calculate the obligation. The net actuarial losses will be impacted in future periods by actual asset returns, discount rate changes, currency exchange rate fluctuations, actual demographic experience, and certain other factors. The other retirement plan benefit obligation decreased slightly due to the activity mentioned above.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company has cash balance plans and other plans with promised interest crediting rates. For these plans, the interest crediting rates are set in line with plan rules or country legislation and do not change with market conditions. The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. pension plan is managed as a balanced portfolio comprised of two components: equity and fixed income debt securities. Equity investments are used to maximize the long-term real growth of fund assets, while fixed income investments are used to generate current income, provide for a more stable periodic return and provide some protection against a prolonged decline in the market value of equity investments. Temporary funds may be held as cash. We maintain a long-term strategic asset allocation policy which provides guidelines for ensuring that the fund&#x2019;s investments are managed with the short-term and long-term financial goals of the fund, while allowing the flexibility to react to unexpected changes in capital markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the U.S. target asset allocations and acceptable allocation ranges:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27% - 33%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67% - 73%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% - 3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#x201c;NAV&#x201d;) have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ4OA_14866a53-4186-49c1-958f-4b81b61355db"
      unitRef="usd">16800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ5OQ_c9b7bf57-f005-4e8e-8889-cba04d6dd9a6"
      unitRef="usd">15600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzUxMw_047d214c-8af5-4b35-855f-7de5bf0787d9"
      unitRef="usd">6500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMTM_d8b30166-b2dd-4a5f-a764-d6e250aa12c8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost and other amounts recognized in OCI were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (gain) arising during period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit arising during period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit cost by geographic location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtMS0xLTEtMA_e3fe0f8d-4d62-4da2-a15a-a08011625654"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtMy0xLTEtMA_b21b6381-e130-4924-975f-62469a01768b"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtNS0xLTEtMA_83948e63-0001-4c60-8157-59a150a2e042"
      unitRef="usd">10800000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtNy0xLTEtMA_5253d550-09b5-49a3-84df-c7da82ce9084"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtOS0xLTEtMA_2e5e0ad1-d226-43e0-b287-b5322ef30eea"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzMtMTEtMS0xLTA_d3cedb1b-2aa9-40e1-bd27-cc09dc7731e9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtMS0xLTEtMA_d144bfb5-5f7f-4a01-b3c1-c85dfe15d794"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtMy0xLTEtMA_14c7226c-dbbc-4f71-ae2d-adb1cc418d4f"
      unitRef="usd">9200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtNS0xLTEtMA_5f89fcc5-8c4e-4e01-a32f-28f25997fcb3"
      unitRef="usd">9400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtNy0xLTEtMA_445e454a-958e-4ef5-91ce-07fa3c63cecd"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtOS0xLTEtMA_2e52ba85-99cf-489f-99fe-2becb7f010b2"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzQtMTEtMS0xLTA_8daff02b-812d-44f2-9eed-71531df76fde"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtMS0xLTEtMA_4ca9e900-f02a-4e57-a512-0f02debaf5c2"
      unitRef="usd">11700000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtMy0xLTEtMA_b26cfe39-e1fa-4c17-8582-c87aeb4ddd0f"
      unitRef="usd">12000000.0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtNS0xLTEtMA_95ee093b-0fe3-4b32-95b1-eb2ed3fbc3d6"
      unitRef="usd">15700000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtNy0xLTEtMA_8de1e5d8-9d65-4536-8eb6-8bb6e2ef9a0a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtOS0xLTEtMA_3f2f141b-9edd-4062-b461-75e45829610a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzUtMTEtMS0xLTA_6979be12-e20d-4af7-b3f3-1a4a9e57398f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtMS0xLTEtMA_d4189a8f-6814-4fcc-98e0-9e20f8034c88"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtMy0xLTEtMA_bdace5e7-ddae-4fa2-87a0-cf8c06f6972f"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtNS0xLTEtMA_692586b1-6489-4724-8f15-dbe719411db4"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtNy0xLTEtMA_32551cf9-9bb7-41c4-8623-7f53e5bdcd00"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtOS0xLTEtMA_097e139f-e3e7-47bf-aa10-ef1a333b62b9"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzYtMTEtMS0xLTA_8a5867e6-5885-48d5-8e0b-11e698a60482"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtMS0xLTEtMA_46edd98c-131d-4246-b5fd-4131c5c63b2a"
      unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtMy0xLTEtMA_69264a42-e1d7-4b31-bc28-33d478f2d67a"
      unitRef="usd">-2100000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtNS0xLTEtMA_d35923bd-c02d-4c44-80ae-af07cbde481d"
      unitRef="usd">-3800000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtNy0xLTEtMA_a2ebd3b6-ddd0-4f6d-b393-11169e74f765"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtOS0xLTEtMA_8dabbd4e-98cf-4471-81a9-11c85a1eea91"
      unitRef="usd">2300000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzgtMTEtMS0xLTA_237fb41b-a2c6-4f4e-974f-0ef416ab98c0"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTEtMS0xLTA_ad7f31f9-30d5-4f5f-b3b9-4db45cd4c962"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTMtMS0xLTA_66e4fcab-48e1-470c-9653-ae6473c1d8cc"
      unitRef="usd">-3500000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTUtMS0xLTA_a75757a9-60f4-49ec-b6ce-4424480eb849"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTctMS0xLTA_7236d30a-b416-4fcc-916e-1dcaae36dcae"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTktMS0xLTA_780a9c56-e943-49f8-929a-776134119272"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEwLTExLTEtMS0w_e61f108f-86a9-46e5-815f-42acc1aee5bb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTEtMS0xLTA_4f962c8d-b33a-4de2-a3c0-bf7656fc8b54"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTMtMS0xLTA_6ccbdf73-a34e-4926-afe7-66a195bd3e61"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTUtMS0xLTA_dd40ff62-a672-4eb4-add7-10226c36f20d"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTctMS0xLTA_7e5b57c1-bea0-4c95-ab28-8acf14bdc572"
      unitRef="usd">-2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTktMS0xLTA_19acd253-6ecb-4f22-ab2a-b37500388cb4"
      unitRef="usd">-2800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzExLTExLTEtMS0w_7ba8b256-5fe0-4b37-8d43-9e44330f44de"
      unitRef="usd">-2900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTEtMS0xLTA_4a28de8a-f817-45c5-8b90-38ae83b195e4"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTMtMS0xLTA_fc4c40e6-06bc-4c7b-b0e7-d0bdee24cadd"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTUtMS0xLTA_f17a3bc1-2e74-4f0d-b79b-26a4a05e966a"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTctMS0xLTA_7a470e8d-79ac-4f77-bb29-422bf5f11227"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTktMS0xLTA_e0834658-98a1-48bd-8e9a-e440de82dee9"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzEzLTExLTEtMS0w_b1e8f6c3-8d78-432e-ad2f-3f0a867d3e3a"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTEtMS0xLTA_116b346b-8036-4872-8672-da648fb64dc7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTMtMS0xLTA_e967ce43-e66e-4d10-84ce-bac236291f20"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTUtMS0xLTA_01c28bc0-1f34-45a8-a08a-24be49b24f0c"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTctMS0xLTA_d1ceaf53-4edb-4d54-814f-6f0d6320a48d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTktMS0xLTA_ad473bee-5ea9-4c5b-b0a1-466606385250"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE0LTExLTEtMS0w_cd33da2e-223d-4bfe-8e33-088ad550700b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTEtMS0xLTA_9abf4268-8d98-4179-b531-7a062c7954ee"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTMtMS0xLTA_1bcfa873-82a1-4ccb-b366-37d46ce1d411"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTUtMS0xLTA_a2b54160-fb3e-49bb-a34e-24450c512138"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTctMS0xLTA_eafdcabf-4577-4b67-846b-89323ebe1905"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTktMS0xLTA_f63a705d-448a-4330-a64b-ec0fead503ae"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE1LTExLTEtMS0w_2a241c86-dfe2-4d28-8dd0-cf89087d5147"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTEtMS0xLTA_ece1f6b4-2709-45bd-a7ed-b1ad9566e257"
      unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTMtMS0xLTA_79567d1e-c14b-4f0c-b345-d9c70c5260dc"
      unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTUtMS0xLTA_86c70a50-f7f0-4f86-8a30-144ec8bfd1f9"
      unitRef="usd">-3800000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTctMS0xLTA_89dea8b4-060e-4b1d-a458-26e632107b95"
      unitRef="usd">1900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTktMS0xLTA_082855ff-e397-4253-8e51-9b04a28c396c"
      unitRef="usd">2300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE3LTExLTEtMS0w_94092fad-46ed-4c1c-9a85-0f4ab1e252d2"
      unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTEtMS0xLTA_4053e6bc-a09e-4b9d-b6d9-3e01f7e16bbf"
      unitRef="usd">3700000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTMtMS0xLTA_c6f4fe61-a010-4046-bfe2-04e7ca848dae"
      unitRef="usd">3500000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTUtMS0xLTA_3ae92a21-a411-493d-8e3e-8c631c190b1d"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTctMS0xLTA_6a13155a-4816-49be-a85b-a971901b7e2c"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTktMS0xLTA_89033cb5-4a8f-44fd-a40c-13773ae594a6"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzE5LTExLTEtMS0w_4caae007-d9f9-4ca7-a2d7-27b03034c9ba"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTEtMS0xLTA_be7a9988-d886-4664-afc1-b17ab4476f7a"
      unitRef="usd">-1800000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTMtMS0xLTA_341071ca-33f9-4288-9a46-a44d748d2c91"
      unitRef="usd">-600000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTUtMS0xLTA_a989dd22-1d60-4bfd-a537-461dcb59b120"
      unitRef="usd">1200000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTctMS0xLTA_3979ecec-fc96-44c0-9ef3-a6117eaa6126"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTktMS0xLTA_664a1ea2-fa1b-4b89-a918-69b782afc64b"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIwLTExLTEtMS0w_2ac6e79a-8a9f-43c4-ad60-a9c91ef69bd8"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTEtMS0xLTA_5d12fc08-2c04-4b39-8bfa-080476491807"
      unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTMtMS0xLTA_b890dd36-e807-4861-9f0f-1ee5c0df2fd0"
      unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTUtMS0xLTA_3a0a9fc6-82a8-443e-8510-b94aaade5058"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTctMS0xLTA_d892acb7-f572-4b95-b48d-d04264c7bad1"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTktMS0xLTA_92aabb9a-a317-4d37-a447-baec8fa7ad70"
      unitRef="usd">3100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIxLTExLTEtMS0w_ff6e23d0-1bc9-4d25-b724-63faaaaabedf"
      unitRef="usd">1700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTEtMS0xLTA_8f8e7387-b7f0-4967-b03e-2525ebe72893"
      unitRef="usd">500000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTMtMS0xLTA_a7f7c37f-22e8-44e6-bae5-26ab368a9662"
      unitRef="usd">700000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTUtMS0xLTA_60f601ab-9880-47da-852e-181539ad8426"
      unitRef="usd">7100000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTctMS0xLTA_4e8815d5-2221-43b2-a918-c4b0e93f308a"
      unitRef="usd">-200000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTktMS0xLTA_6e099f24-0151-4db9-a918-fb73e6313e92"
      unitRef="usd">300000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo5YTM0OTQ3YzE1YWU0M2M5YWFjMzQ0ZTE0ZGFlMDYzZi90YWJsZXJhbmdlOjlhMzQ5NDdjMTVhZTQzYzlhYWMzNDRlMTRkYWUwNjNmXzIyLTExLTEtMS0w_ed56e159-c381-43bf-ab14-560f2c8959aa"
      unitRef="usd">-1200000</us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItMS0xLTEtMA_3b57e960-63cd-4989-a034-1fbf01b01fbd"
      unitRef="usd">1200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia2f8c2dff1fb47aa8d3c65c340678d15_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItMy0xLTEtMA_b79a77f7-9c55-4bad-bc8d-4125b020a3a8"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i796caa67ee0e45cfb059041a1e2187bb_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItNS0xLTEtMA_751edfb8-b0a4-4604-bdf8-76e2e669c127"
      unitRef="usd">4800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if13e4b6d592a42489a6f499eb9fbfd39_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItNy0xLTEtMA_d282a596-ecee-463d-b691-d883ffaf742f"
      unitRef="usd">-2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i876e963861bb446cbb82e6c637fae2f2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItOS0xLTEtMA_f6011af9-956c-409a-bb21-b4981374483e"
      unitRef="usd">-2800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1478cc28dfaa4d7f889e3ee1528d58c4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzItMTEtMS0xLTA_6c4efe51-1f1a-41e1-9463-411d8eb9eaad"
      unitRef="usd">-2900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i386c37780a184cefb9928ebfdfedcfe7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtMS0xLTEtMA_e25fe6f9-6656-4ab6-ab2e-c687fb8e3c63"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="icbb0433c970748fa8ef413c8bd5370f7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtMy0xLTEtMA_d2e4a844-675c-4b06-9b4e-28ef9850ca56"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0dd3d667f6f24bf5bc61589ce38acb11_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtNS0xLTEtMA_27ef034b-5fa6-4551-8223-936276e81367"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8c2c88135cd14a78813b05c34e34ca53_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtNy0xLTEtMA_781cba45-dfe0-464e-ba6e-8fbe3897f652"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5fc2f2f3b70d4f728400db29e64a3f7e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtOS0xLTEtMA_9413e27f-9fb2-431a-a049-9ccd7a98ec74"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iba56c58d773f48009254ee34458305df_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzMtMTEtMS0xLTA_850c2e5c-fe8b-467a-be6d-04c5fd1be650"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtMS0xLTEtMA_1bbce4c0-f777-4ca0-9acb-4bca5620f921"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtMy0xLTEtMA_ecdcd0d7-8baf-437e-9851-908ea3a761bd"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtNS0xLTEtMA_26d19ba6-3ee4-4fee-911f-b16231c9fb43"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtNy0xLTEtMA_96afba0c-5f71-4c1b-ab35-2a57859797fc"
      unitRef="usd">-2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtOS0xLTEtMA_ca15390d-3325-4723-9d14-e7f95f6ce2c0"
      unitRef="usd">-2800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NGY2ODJmZjM0MGQ0ZGI3OGE3M2I1OTcxNWU2M2NhMS90YWJsZXJhbmdlOjc0ZjY4MmZmMzQwZDRkYjc4YTczYjU5NzE1ZTYzY2ExXzQtMTEtMS0xLTA_4ef7d1c5-ea39-4343-a3c0-a7374c827039"
      unitRef="usd">-2900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i5a02b0a604014333900498c1cfd05c7c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUwOTc_aafec250-1abb-4260-a3b8-d87bf2215e29"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i81cac794d7894db3846aa546dee94d08_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUxMzM_fd486c82-f0d7-4580-ab2a-5da86b95afd4"
      unitRef="usd">3500000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1Xzg3OTYwOTMwMzQxOTc_45163c3c-e842-4c7b-b0fe-1bf967990677"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUxNzU_891654f8-667c-45c7-b625-7cd84f6c98da"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyNjQ_b8830767-9d51-4f3e-aa4b-5f74a4db9204">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtMS0xLTEtMA_3692d856-78ab-424d-9cc8-43bc2f22340d"
      unitRef="usd">287900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib8190a671d354cd382c8d1942d0777c4_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtMy0xLTEtMA_4651ae05-6c9d-4c05-b6a0-ebd24d1a22e2"
      unitRef="usd">267000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtNS0xLTEtMA_de42e48e-1e69-43ab-a4dc-3bc7bfce9e49"
      unitRef="usd">6600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id23ad1f4c66d488cb8092ac2514b826f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzMtNy0xLTEtMA_44463ef6-5efb-40cf-8799-bca178b4d94d"
      unitRef="usd">6000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtMS0xLTEtMA_801f5f22-b2a4-418f-b662-71b8bc897d43"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtMy0xLTEtMA_4fa9a0a6-9a34-4d60-962b-1484249f6513"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtNS0xLTEtMA_0cd1491f-f0a3-4b61-924c-f55ba77e25ae"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzQtNy0xLTEtMA_adf6daae-ab77-4e45-bceb-b769f5c73e66"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtMS0xLTEtMA_f8a099a3-af3a-4fb6-90e3-4f30f4af6288"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtMy0xLTEtMA_8a4d4a0b-f845-473e-a1fd-a96e63e24f12"
      unitRef="usd">9200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtNS0xLTEtMA_037405b8-a34c-42d9-9d2d-ebe9b3ee5d9a"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzUtNy0xLTEtMA_d1786f09-dd00-4dab-a969-556cf1f2773d"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtMS0xLTEtMA_95f14473-ce65-404b-810e-16524f011940"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtMy0xLTEtMA_bc1dd983-6bed-4b6a-9434-f11e42e8ab2a"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtNS0xLTEtMA_f1f32db4-6dd9-41ee-bb8a-27a92f5958cf"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzYtNy0xLTEtMA_6f4783ff-4660-4554-9ac3-fcb7034cca5d"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctMS0xLTEtMA_203168f5-6198-4211-a191-32460de44976"
      unitRef="usd">-22100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctMy0xLTEtMA_1bc226d6-140a-4822-9c5b-2498d09dbfcd"
      unitRef="usd">-30800000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctNS0xLTEtMA_d84de050-9ebe-48aa-ad63-9e7a075dbc06"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzctNy0xLTEtMA_831f8557-af08-4037-b572-64a138ab804a"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktMS0xLTEtMA_ef25c2cf-368f-4dff-8196-cac85fe633d9"
      unitRef="usd">6200000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktMy0xLTEtMA_26af262f-e9ae-479e-ad35-da3d5c7873af"
      unitRef="usd">6800000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktNS0xLTEtMA_ef7125ea-0c3e-452b-96e7-e2e30eda1b8b"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzktNy0xLTEtMA_cc741b8c-03a1-484e-a4f6-5de0bf455f7c"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTEtMS0xLTA_97af1327-4523-401b-9883-0593c5344890"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTMtMS0xLTA_fd2578d6-f50b-4ca4-8955-9aead555061e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTUtMS0xLTA_88cd961a-3d18-4e32-a822-fecc72bae55a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEwLTctMS0xLTA_4f4c94b7-3124-4058-96eb-bc48c15fcf9b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTEtMS0xLTA_83edf42d-f709-4288-bada-a49e52d08247"
      unitRef="usd">18600000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTMtMS0xLTA_3c1144a9-6b3f-4dd4-8474-ab0af1a10338"
      unitRef="usd">15000000.0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTUtMS0xLTA_0106c2fb-7092-4017-999f-da0259eef383"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzExLTctMS0xLTA_cc0eccbc-ad5b-4631-b3a9-183a91c7ef73"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTEtMS0xLTA_924f31b9-007d-40dd-a519-164e3e2237ea"
      unitRef="usd">-4900000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTMtMS0xLTA_5027b5ec-3a83-4b52-ae5f-a37d3330f8b2"
      unitRef="usd">-1000000.0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTUtMS0xLTA_93413454-2afe-4b15-8891-996d11adfe68"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEyLTctMS0xLTA_cd9a1916-eb63-4899-8988-a962a0b8556a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTEtMS0xLTA_390f8ed0-7628-4f6b-9a4b-16e988cbb9e3"
      unitRef="usd">298900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTMtMS0xLTA_0dd602ea-b9bf-439a-8d28-415d2d570883"
      unitRef="usd">287900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTUtMS0xLTA_ae022593-ae1a-41ce-99b4-7dca5e7cee21"
      unitRef="usd">6100000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzEzLTctMS0xLTA_ae78f403-9d3f-4650-b317-8d7b3fc67b20"
      unitRef="usd">6600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTEtMS0xLTA_e547d53d-aebd-46f3-8c18-c98865387355"
      unitRef="usd">244100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib8190a671d354cd382c8d1942d0777c4_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTMtMS0xLTA_832aff11-c00c-4fb8-8907-76a848d84ec3"
      unitRef="usd">214500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTUtMS0xLTA_eec9fd59-95ba-490b-afd4-7ab9797aef1b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id23ad1f4c66d488cb8092ac2514b826f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE2LTctMS0xLTA_3cac1791-a4f3-4a39-a8a6-4d8e6e91cb0a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTEtMS0xLTA_efbc6116-531b-4c6d-8dfe-f4b8e5ab510f"
      unitRef="usd">31800000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTMtMS0xLTA_dc6d0336-2e15-400b-9cd8-867fd9f6c014"
      unitRef="usd">41300000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTUtMS0xLTA_0d2972e8-de34-405d-9a6c-7597eab90c53"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE3LTctMS0xLTA_d1cd123b-8219-4aa0-9009-4c0e7b415bc1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTEtMS0xLTA_191b1823-fd20-4640-b182-e57df6e151fa"
      unitRef="usd">4800000</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTMtMS0xLTA_65d7926f-4e34-428a-a244-2e33eff190b0"
      unitRef="usd">8000000.0</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTUtMS0xLTA_c4f7a258-971a-4ccf-bee4-52afe0605325"
      unitRef="usd">200000</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE4LTctMS0xLTA_1b19231b-7186-4b46-a027-8ce310df3bf2"
      unitRef="usd">-200000</wst:DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTEtMS0xLTA_3d86e4d2-dcf4-4470-8332-72e4a3da3728"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTMtMS0xLTA_deffa771-5cea-4672-8c08-1f90cb584f7b"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTUtMS0xLTA_8cce50a2-1d83-48c4-996b-48cc5bb31c21"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzE5LTctMS0xLTA_fdeb3c80-9d4e-4fef-9880-b176faf151b1"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTEtMS0xLTA_9afca44a-33a1-41ea-ba61-ddb18caafa11"
      unitRef="usd">6000000.0</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTMtMS0xLTA_759445ba-efe6-46b2-acd8-1251777b51c2"
      unitRef="usd">6300000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTUtMS0xLTA_140ddc9c-a7cb-4932-8f23-0009b35097a2"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIwLTctMS0xLTA_47f5a031-609e-447f-9421-fda00af91047"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTEtMS0xLTA_d38791b1-6b2c-41f5-991a-0d2a9ef21a70"
      unitRef="usd">18600000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTMtMS0xLTA_bba32879-dfb7-4094-9fc4-a3bc6dee3e4a"
      unitRef="usd">15000000.0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTUtMS0xLTA_241b05fd-b9b2-472c-be05-ed01c8f22076"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIxLTctMS0xLTA_85c0605b-79f8-4ce8-8543-4b26da938b0b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTEtMS0xLTA_af1e4bfa-2a7d-4f1e-992a-9b5668be907e"
      unitRef="usd">-1700000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTMtMS0xLTA_01103d51-ce32-4770-b699-80f74ac19b44"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTUtMS0xLTA_d054d407-01ed-4306-a035-324fe1e8ff44"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIyLTctMS0xLTA_614a344a-a442-40fd-9fa7-2333659b2b23"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTEtMS0xLTA_72912230-8866-4743-a9f7-256a669b1f45"
      unitRef="usd">258100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTMtMS0xLTA_29160add-1dfe-4bfc-94cc-31d76477460d"
      unitRef="usd">244100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTUtMS0xLTA_3321e0db-4731-4291-a21f-16f3311c330b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzIzLTctMS0xLTA_0d9176b6-6f9e-4910-8559-a32c49dd7190"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTEtMS0xLTA_b0b39b98-bca0-40a1-bc52-7e8c0ba6937b"
      unitRef="usd">-40800000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTMtMS0xLTA_288cc6a5-6a71-4660-8517-e68473d413c1"
      unitRef="usd">-43800000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTUtMS0xLTA_518b667e-ec51-4f86-b695-a7620ad9b871"
      unitRef="usd">-6100000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTplMDJjYTYzMmE4NTI0NzhiYjA1NjI5OWZlNzIwNjE3OC90YWJsZXJhbmdlOmUwMmNhNjMyYTg1MjQ3OGJiMDU2Mjk5ZmU3MjA2MTc4XzI1LTctMS0xLTA_c9caa2be-5529-44df-9cea-1b0fc0729ccd"
      unitRef="usd">-6600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzE2OTk_0d5ebf6d-d2c1-4feb-80cf-121dfe870970"
      unitRef="usd">43900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzE3MDY_fc6748e0-e39e-4c0d-a8f3-a3023c5d2095"
      unitRef="usd">39400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyNzQ_e9f0252e-2591-4bf9-8e1d-d4c82ea8f7bc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in the balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItMS0xLTEtMA_9fc6b220-6e5a-483b-8bff-5cdda0784eca"
      unitRef="usd">12900000</wst:AssetsDefinedBenefitPlansNoncurrent>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItMy0xLTEtMA_cc258875-7278-4482-806a-58c92021c457"
      unitRef="usd">4300000</wst:AssetsDefinedBenefitPlansNoncurrent>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItNS0xLTEtMA_1178a255-7cb6-4c97-88f4-7bdb4172f8b4"
      unitRef="usd">0</wst:AssetsDefinedBenefitPlansNoncurrent>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzItNy0xLTEtMA_d9487f49-cc91-4807-acd8-ac7521176e2f"
      unitRef="usd">0</wst:AssetsDefinedBenefitPlansNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtMS0xLTEtMA_1133068b-c1eb-484a-be4c-f865fc150e0f"
      unitRef="usd">1600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtMy0xLTEtMA_a575d5c2-9fb1-4671-8051-0a96bb162552"
      unitRef="usd">1500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtNS0xLTEtMA_e6ab1a58-6ec8-498d-9b58-8e938ad2cd25"
      unitRef="usd">700000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzMtNy0xLTEtMA_0daf253f-810c-4c25-88be-9021b00ef9ec"
      unitRef="usd">700000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtMS0xLTEtMA_6bb4db37-b341-45bb-8f44-723b38186ab5"
      unitRef="usd">52100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtMy0xLTEtMA_ce7949ad-6d30-4886-9d2a-fa172395f9d3"
      unitRef="usd">46600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtNS0xLTEtMA_3d316d15-bcb9-46c6-b0f0-cb2fdb3d6426"
      unitRef="usd">5400000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzQtNy0xLTEtMA_aae4d5d7-79ea-4efc-9bd8-ff6969f1f017"
      unitRef="usd">5900000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtMS0xLTEtMA_d25f9bd8-751d-4b30-9f3e-92ef9635fc86"
      unitRef="usd">40800000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtMy0xLTEtMA_7ba6d2f5-a901-42c8-8df1-db7d96116687"
      unitRef="usd">43800000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtNS0xLTEtMA_19bbd5c6-09c9-47a5-9cd5-fda70245e3ed"
      unitRef="usd">6100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpiYTEwYTI3ZDc5NzM0MWRhYWMzZmI5ZjcwYWYzM2I0Ny90YWJsZXJhbmdlOmJhMTBhMjdkNzk3MzQxZGFhYzNmYjlmNzBhZjMzYjQ3XzUtNy0xLTEtMA_c18c8828-6359-4399-be32-a1fa1e0a8e9b"
      unitRef="usd">6600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyNjU_0a4dd3e9-eeb1-4d36-a8a9-2b78a069c0ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts in accumulated other comprehensive loss, pre-tax, consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItMS0xLTEtMA_debd4b78-6c96-4a8e-a6c7-00907b30ce88"
      unitRef="usd">-67300000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItMy0xLTEtMA_52af80b0-bd44-4ce3-9618-b56326d6eeb4"
      unitRef="usd">-69400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItNS0xLTEtMA_75374d33-c2a4-4005-9245-caf6bb1023ab"
      unitRef="usd">5400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzItNy0xLTEtMA_28006275-e531-46fa-a4fd-404b7ffa7fb8"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtMS0xLTEtMA_fdfb8d00-2dd7-48e5-811d-4d9e21f3151a"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtMy0xLTEtMA_66ded5e0-17eb-4580-a1e3-f49e286ea415"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtNS0xLTEtMA_ea025ab2-a88a-4b74-9dca-79d615b99e9e"
      unitRef="usd">-400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzQtNy0xLTEtMA_c8cd642d-1aa1-4e38-87bd-2aee665314a5"
      unitRef="usd">-1000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtMS0xLTEtMA_3b4877c8-006a-48c1-8999-227107e4aea8"
      unitRef="usd">68100000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtMy0xLTEtMA_e636003c-803b-4051-9407-705c9e7d1885"
      unitRef="usd">70200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtNS0xLTEtMA_dcadf95d-7e90-40b9-8ac9-5470a24ec16c"
      unitRef="usd">-5800000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo1NDY4NGJjMDNlMzk0MDFkOTU4YzU5Y2FlY2EzM2U3NC90YWJsZXJhbmdlOjU0Njg0YmMwM2UzOTQwMWQ5NThjNTljYWVjYTMzZTc0XzUtNy0xLTEtMA_33251d1d-e524-4177-bd15-6612261c9a64"
      unitRef="usd">-8000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0MTg_06b97e76-a69e-4af7-9f03-a99d995d5616"
      unitRef="usd">293900000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0MjU_46d078d5-9ac8-44ad-9a5e-ff052c254ca1"
      unitRef="usd">283900000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0NjY_dbe5f00d-4f28-42e4-bf3a-696e99cbb45b"
      unitRef="usd">83100000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzI0NzM_1a40e6bb-f45b-4921-818f-c4d48a139369"
      unitRef="usd">73900000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMTA_d930e7f4-8867-4fe0-9abe-5a2460a57e93">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 to 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzEtMS0xLTEtMA_ab0eaa2e-81d7-46dd-a24b-4e2db4aaad56"
      unitRef="usd">21900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzEtMy0xLTEtMA_bf346d48-11e8-49b9-8901-8928cf9dfc55"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzEtNS0xLTEtMA_a7f1a8c1-08f1-4a6c-921e-fd19b8d46f91"
      unitRef="usd">24300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzItMS0xLTEtMA_fd5bc07a-a6e3-478c-862b-8acf193112a3"
      unitRef="usd">14800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzItMy0xLTEtMA_876917b0-0ada-42b5-a5b4-3f8c8c31cddf"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzItNS0xLTEtMA_1eab6e08-a9af-4f8a-bf2b-9f98462f4492"
      unitRef="usd">17800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzMtMS0xLTEtMA_dd08ed7b-62df-4568-a91b-e7ee6efa65a2"
      unitRef="usd">14400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzMtMy0xLTEtMA_c177349e-b3f3-4594-82d2-3ec10cadc8b4"
      unitRef="usd">2500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzMtNS0xLTEtMA_dd5791a5-70c4-4388-b1b6-ec4be4432d2b"
      unitRef="usd">16900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzQtMS0xLTEtMA_8c89f3be-78cc-4810-94a3-1cc8ae7c1b50"
      unitRef="usd">14000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzQtMy0xLTEtMA_74528a24-f805-429c-b3e0-d44374afa734"
      unitRef="usd">3200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzQtNS0xLTEtMA_a35d31d0-8323-4ccd-a0ca-a8437e0014ab"
      unitRef="usd">17200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzUtMS0xLTEtMA_70865f01-af0a-4d30-aa08-506e5f00a254"
      unitRef="usd">13200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzUtMy0xLTEtMA_806209db-ac04-4144-b3df-742d22fe1fcc"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzUtNS0xLTEtMA_1d13eed0-1392-4152-b25b-87a4aff4e533"
      unitRef="usd">17100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzYtMS0xLTEtMA_4a5c3e54-1829-4d5f-aa2f-3d3fc5b4a526"
      unitRef="usd">54500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzYtMy0xLTEtMA_b71dc390-7c0a-41f7-a364-5cc7693371bc"
      unitRef="usd">20200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzYtNS0xLTEtMA_e05482f0-f44e-495b-97fa-f321aa31ba5f"
      unitRef="usd">74700000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzctMS0xLTEtMA_0631bcb4-a31d-4d25-a812-256fec9ade5a"
      unitRef="usd">132800000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzctMy0xLTEtMA_7eccad22-9c32-4b4c-93b3-60b5965a019c"
      unitRef="usd">35200000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NWQ4NDJjODFmYjU0YWMyOWEzZmVjNWMyZWQ5ZTk3Zi90YWJsZXJhbmdlOjc1ZDg0MmM4MWZiNTRhYzI5YTNmZWM1YzJlZDllOTdmXzctNS0xLTEtMA_df87878e-5245-4c86-bbb7-8864f9e64c1a"
      unitRef="usd">168000000.0</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUyMzI_8dd98811-0678-48eb-b192-ab93d33869de"
      unitRef="usd">3600000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQzOTgwNDY1MjA2OTI_e596a674-8cb4-4963-8094-c5b419c27355"
      unitRef="usd">2900000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUyNDA_8b7fc485-a1ed-41df-bdaf-d5bf301206fc"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyODA_eb627c1b-6618-446d-b8de-5dbf222bb597">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine the benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItMS0xLTEtMA_64b1127e-895a-4d3b-b258-c320a982c373"
      unitRef="number">0.0261</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItMy0xLTEtMA_2c806040-fad0-41af-8eb5-ea89251c3b5e"
      unitRef="number">0.0270</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItNS0xLTEtMA_1f25619a-a271-4b05-ad11-eb99435437ec"
      unitRef="number">0.0291</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="iee347bce232c4a8791af1a0ac2fde71f_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItNy0xLTEtMA_0673405b-10ab-40a7-a8d1-3f6a83d5af50"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="id8ddf44d055449a288ecbb0736d90488_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItOS0xLTEtMA_87a8a9f3-0d5a-4d43-af28-369d878d6d2c"
      unitRef="number">0.0420</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ic74d4b3f77024784b890ee64d185a0e9_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzItMTEtMS0xLTA_a9cc7cc1-1e20-4d0b-ac9c-4dc3369c0234"
      unitRef="number">0.0345</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzMtMS0xLTEtMA_9ec570ef-65a4-4f42-8fe1-15e2ed3e11ca"
      unitRef="number">0.0233</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzMtMy0xLTEtMA_8f85e45e-224d-48f4-98c9-aa9199e4ba75"
      unitRef="number">0.0241</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzMtNS0xLTEtMA_40a38cdd-bd71-4269-9b13-878365d47a9f"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzQtMS0xLTEtMA_cf7fe551-ce96-4528-bac4-992a11c8185e"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i7f9d293e768d42d3863fc70063af3d19_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzQtMy0xLTEtMA_403e0607-147e-46c6-a54a-7aee14a5e06f"
      unitRef="number">0.0554</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ia672f2eed60c45678c7f9da207f4c19a_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo2NWYyMWM4M2ExMjA0Y2JhOTgyNzExZDcyMzU0Nzc4NS90YWJsZXJhbmdlOjY1ZjIxYzgzYTEyMDRjYmE5ODI3MTFkNzIzNTQ3Nzg1XzQtNS0xLTEtMA_5739c9ad-f1b1-48a7-9b13-01ceb00db8f0"
      unitRef="number">0.0671</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItMS0xLTEtMA_e1e9e884-82a7-412c-88b6-17b23778582d"
      unitRef="number">0.0210</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItMy0xLTEtMA_1adc26b1-af7e-43ea-b938-8f69798202f5"
      unitRef="number">0.0279</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ie2afddaa78ba4eb9a300b205038274cc_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItNS0xLTEtMA_c60d125c-b2c9-43f9-ae4b-7fc29bc8d035"
      unitRef="number">0.0230</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ia2f09f2b9514472e85759120e9c8f6cf_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzItNy0xLTEtMA_fb3e9ec8-5aa6-485f-b61a-9ff89e39d52d"
      unitRef="number">0.0420</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="if4075113bb61471da80f2c6ac352be97_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzMtMS0xLTEtMA_b6c75dc1-33a0-4515-8bd3-9f0a7cf6fff9"
      unitRef="number">0.0258</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ib040619d3008485c9326df9c3dbf6e37_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowNWU4NWUyMWM0ZjA0MTk0YWUxNWEyZGE3ZjlhYmI1Zi90YWJsZXJhbmdlOjA1ZTg1ZTIxYzRmMDQxOTRhZTE1YTJkYTdmOWFiYjVmXzMtMy0xLTEtMA_06a9dbb3-a610-42f5-a377-d1070332b9f8"
      unitRef="number">0.0249</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i5e90da744d994db1aa27a052c7ea5372_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM3MTI_2341034c-c65e-4d25-8028-c14d47ffa4d8"
      unitRef="number">0.0260</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i9cc77fb8f01142a38ee0cb161ae8c1cd_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM3MTk_f61bc0ad-8540-4e90-bcc7-0deb511a1f5c"
      unitRef="number">0.0335</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM4NzY_e0b957a7-510d-4efb-afb5-25f4f7d9be4a"
      unitRef="number">0.0089</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzM4ODM_56efe9bf-875d-4078-b00a-783f86922aca"
      unitRef="number">0.0128</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i9a86b5e8a2be41a4881009bd7646cbc1_I20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzEwOTk1MTE2MzUyNzM_1a2f5df2-e0d0-471c-a745-1accaaccba5f"
      unitRef="number">0.0425</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ie1a899edcb6045b4b2db6153ae0f2e4b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQwNTg_cc79d54b-a70c-439a-b97e-fa80c3287621"
      unitRef="number">0.0258</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i1921707b6a3b4e9f800e0668a4f61e5f_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQwNzI_b80df5d9-49e4-4370-bd31-ae75e8238f50"
      unitRef="number">0.0249</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <wst:DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets
      contextRef="i2e8f7729b95c446d88cb96cfb7b67b5c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyMjE_45d9b29f-ba04-4848-8561-41270e5f13ff"
      unitRef="number">0.830</wst:DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i2e8f7729b95c446d88cb96cfb7b67b5c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyNTE_0bdd70ba-b872-4fab-9c34-a162ab7d5846"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="if5eafccc5cbf45f3b2b2941de558f722_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyNjI_9cf364e5-e5c6-44a5-8b1f-95cd8caf30e1"
      unitRef="number">0.0560</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i135ba46e2e694c4bbc75dbd5e31ab210_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQyNzY_023b1fcd-df5b-4af6-af0c-948e12d30809"
      unitRef="number">0.0700</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQzNzA_4665354b-62f0-4407-9d03-13b0faa76d25"
      unitRef="number">0.0650</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ0MTU_4a8b452d-5a01-4faa-baea-8f5ad7a641bc"
      unitRef="number">0.0500</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ2NTU_1daac30e-a650-4f70-8c84-de15b2d1fa92"
      unitRef="number">0.0625</wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost>
    <wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzQ3MDA_27dafd7f-e5eb-415c-a797-67c8729c4799"
      unitRef="number">0.0500</wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzEtMS0xLTEtMTM0NTI_4a1c162d-059e-4bdb-aa7b-9989f76cfed0"
      unitRef="number">0.0330</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="ia2f8c2dff1fb47aa8d3c65c340678d15_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzEtMy0xLTEtMTM0NTM_4b0c0fb4-dc96-4e87-b3d0-c2adab541859"
      unitRef="number">0.0330</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i796caa67ee0e45cfb059041a1e2187bb_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzEtNS0xLTEtMTM0NTg_53c19d47-44dd-42fb-a276-0614390ad692"
      unitRef="number">0.0330</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i386c37780a184cefb9928ebfdfedcfe7_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzItMS0xLTEtMTM0NTM_8070183d-cb52-4d6e-9090-9881af707224"
      unitRef="number">0.0052</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="icbb0433c970748fa8ef413c8bd5370f7_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzItMy0xLTEtMTM0NTM_9b1a076e-9c04-4588-b4b4-56b6641ecaee"
      unitRef="number">0.0085</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i0dd3d667f6f24bf5bc61589ce38acb11_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3NDcxZmYzMzcyMDE0OTZjOWIyM2Y2ZmJkYTZkMGZlZC90YWJsZXJhbmdlOjc0NzFmZjMzNzIwMTQ5NmM5YjIzZjZmYmRhNmQwZmVkXzItNS0xLTEtMTM0NTg_8685656c-ca92-4784-9564-6ac5eb6aa8c8"
      unitRef="number">0.0041</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90ZXh0cmVnaW9uOmE3NmJjNzVjNzgyMjQ3Y2M4NTBhODhlOWFiODQwY2Q1XzcyMzE_0eebded8-ffe1-4ded-8cb2-cbe13cde2259">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the U.S. target asset allocations and acceptable allocation ranges:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27% - 33%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67% - 73%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% - 3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#x201c;NAV&#x201d;) have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="if288e4886a22444a9cb6096fee75382e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzEtMS0xLTEtMA_e3e7280b-fddb-435a-8a2f-112ba42ce9de"
      unitRef="number">0.34</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ic1f757014e0945a5bf6bc2c5b4dc7249_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzEtMy0xLTEtMA_12d6465f-05ee-4fb6-86ad-da1769a238c5"
      unitRef="number">0.33</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i5749a3d72efc471787a5d2c8be39e567_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzItMS0xLTEtMA_970a97af-5547-442d-aae6-11f5ada9bee7"
      unitRef="number">0.64</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i702b7d354d8f47ca9dce932abfe26468_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzItMy0xLTEtMA_fc49ddbd-a944-4382-9a8c-6cce75c83ba6"
      unitRef="number">0.65</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4b55367d0664406584e5bef4f962b96b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzMtMS0xLTEtMA_0cf20d1b-c1e9-4608-9279-48957a353502"
      unitRef="number">0.02</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="id543109bbee84ce08728e7c8c83af280_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzMtMy0xLTEtMA_f7955cf5-2cac-4407-89f3-b283807ca2f2"
      unitRef="number">0.02</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzQtMS0xLTEtMA_a5dfa28c-b42b-465a-9adb-d59a0257696b"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTpkZDljOGI3MDQwMmM0OWNhODE5ZjQ1ODMyOThlMWZiZC90YWJsZXJhbmdlOmRkOWM4YjcwNDAyYzQ5Y2E4MTlmNDU4MzI5OGUxZmJkXzQtMy0xLTEtMA_4d45ad79-73d0-478a-8c52-18f3429ddc1c"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ie5187136b2ee4ca79301744704a7d717_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzEtMS0xLTEtMC90ZXh0cmVnaW9uOjEzMTZlMTk1OWEzZjQ3NDQ4OTIxZmIxMTNiZWRhODFjXzEwOTk1MTE2Mjc3ODY_c0ca80b5-a964-4f3c-8d3c-4233f309a7e1"
      unitRef="number">0.30</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ibaa0d5d817d5451f853f49d5e75d6d4b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzEtMy0xLTEtNTg5OC90ZXh0cmVnaW9uOjU0NjY4ZjE3MGQ0MjRmNTM4ZTk3ZTc5OTIzMjg1ZGZjXzEwOTk1MTE2Mjc3OTI_44de67b2-35c1-4b6d-a14d-66848fb541a7"
      unitRef="number">0.27</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4f4c146b4a9e4cc9ad5a9fb7c2736c33_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzEtMy0xLTEtNTg5OC90ZXh0cmVnaW9uOjU0NjY4ZjE3MGQ0MjRmNTM4ZTk3ZTc5OTIzMjg1ZGZjXzEwOTk1MTE2Mjc3OTc_ccef74bb-de82-4a95-8b1d-dde3cd3d339b"
      unitRef="number">0.33</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i11cf3bf12dcb4f7b89f6fa466bd6f61b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzItMS0xLTEtMC90ZXh0cmVnaW9uOjI1MThmMmZiN2FjZDRjZTk5M2JhMzg2NmJiYTEwYjhkXzEwOTk1MTE2Mjc3ODY_aaa99022-49b3-4cbc-867e-60151912c300"
      unitRef="number">0.70</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i36f034759b184fafb0766fc3e84b1c36_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzItMy0xLTEtNTkwMS90ZXh0cmVnaW9uOjY1YWQ2YmRmMWZjMjQxZGJiMDJhYzNmNjdhYTdlYmVlXzEwOTk1MTE2Mjc4MDM_8f4703e3-9e7e-4463-81c4-9500b9e1bb95"
      unitRef="number">0.67</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i87e6d40f72d74559bf0873f01c9b4e42_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzItMy0xLTEtNTkwMS90ZXh0cmVnaW9uOjY1YWQ2YmRmMWZjMjQxZGJiMDJhYzNmNjdhYTdlYmVlXzEwOTk1MTE2Mjc3OTg_139fde9d-8e32-4594-98b4-1b2ed9d18a9a"
      unitRef="number">0.73</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i094b2113e7f547cd90c587fc0372659e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzMtMS0xLTEtMC90ZXh0cmVnaW9uOmFkZGM2MjQwNTc4MDQzMzJhYjk3ZGVkNTQ1YzJhY2VkXzEwOTk1MTE2Mjc3ODQ_2500e4f2-902f-4cdb-bfde-416dc8ece2e9"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1999229824e84c8d9ca34567aec0c908_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzMtMy0xLTEtNTkwNC90ZXh0cmVnaW9uOjc1YTE5OTczNDhjMzQzNzc4MzEwMDRkYzJmNDg5ZTA4XzEwOTk1MTE2Mjc3OTI_ccdb5236-3450-4d14-af26-0f56cce52e4a"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i96d0ab8218d949d2a659ec046d80a1bc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo4Mjc3YTAxMDRkOGY0ZDIwOTI5OWFhMTlkNzFjYzBkOS90YWJsZXJhbmdlOjgyNzdhMDEwNGQ4ZjRkMjA5Mjk5YWExOWQ3MWNjMGQ5XzMtMy0xLTEtNTkwNC90ZXh0cmVnaW9uOjc1YTE5OTczNDhjMzQzNzc4MzEwMDRkYzJmNDg5ZTA4XzEwOTk1MTE2Mjc3OTg_a12e25fa-ee1c-4a53-bddf-572fcb7e26d3"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie419e0a44aaf4d3eb5ee9c6b334f68ab_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtMS0xLTEtMA_3addb963-1c3e-499e-bde1-d015d65366bf"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifa24c422d8c0405099e0de09723d85d1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtMy0xLTEtMA_f303b452-397e-479e-b89c-87cf306854a1"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i72c91cc19e464254ad91d8affa894f9d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtNS0xLTEtMA_6dbc614b-6693-4066-ba78-3154d58c2c68"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib4add538dc55426e88cd3a2c21336362_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzMtNy0xLTEtMA_ca2c2639-a380-445f-80f0-8e2829be3e7d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i60088b670a5d4762b599e56d5c4144e4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtMS0xLTEtMA_de0c0c9a-0fef-4515-ac16-2c9d0e84ec0a"
      unitRef="usd">20600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i19a7aa0c01fe487d95b11f1de2d144ad_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtMy0xLTEtMA_61aeb312-c020-47f5-89be-19eb30485f20"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f5c08c9be044322af60b2edf7b438f0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtNS0xLTEtMA_0ab17c29-855c-4a30-98e0-7f9c55fd3db8"
      unitRef="usd">20600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i34f71fa6b7014a0d9856ddccecd5f63e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzYtNy0xLTEtMA_a8163626-8006-425c-b3b8-15096a537c71"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8341c7060458474a822a8b5d2048ad64_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtMS0xLTEtMA_e8e0ecfa-0612-4ff8-8be4-16a109042902"
      unitRef="usd">18700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idcd0101c2ca4488b94dba592a0fb3f19_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtMy0xLTEtMA_c2c664b7-cd45-4bc3-878b-43fc873cf602"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4d50bf5e175c440783b2b9c219b372c4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtNS0xLTEtMA_d90ec223-5e11-4f66-aeb8-48302ceea867"
      unitRef="usd">18700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i266aa4fc9a0a43728336bfdd4f5d2243_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzgtNy0xLTEtMA_f8374115-7fe8-48ec-9afd-77084a28305d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i44f001b391204e3ca8e6364079ecc773_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTEtMS0xLTEyOTc1_4b98a297-cd4c-4c1e-9be1-df87c07e1349"
      unitRef="usd">2900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i709ce196777d43518c28b2c94fdcce0f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTMtMS0xLTEyOTgz_3720a355-42a6-4782-96e7-b0a2e414cfbb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ied72e1adf5634108a0178f0d097f1efb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTUtMS0xLTEyOTg1_89efb3c3-2767-41da-a7d6-435c42443210"
      unitRef="usd">2900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i98071b96fe31436b9c3b419eee7e32f3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTctMS0xLTEyOTg4_497bc200-76f6-4bf7-b3c7-15b657b20a2b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib7cda47cc19b4bf19d6b5dbe554f69ef_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTEtMS0xLTA_24e42191-15a6-4dc2-95a1-276713608e3d"
      unitRef="usd">43700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2b3910a60b1a4f8f93875c45a7306eb0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTMtMS0xLTA_3cdcf0a7-6e72-4c22-9729-c0583b720608"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i90e214dc2b574d6a927f3dd38b69a1a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTUtMS0xLTA_2b028080-c2e7-4240-945e-ba239abc5314"
      unitRef="usd">42200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9ce83038c2641929269fa9febd355c8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzExLTctMS0xLTA_360d755a-a81a-426e-9253-74adc7266274"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i050e371f0fc64570a8371b4ee1d6bfd2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzEyLTEtMS0xLTA_dcf8c591-a705-478d-b826-19eedd9d9415"
      unitRef="usd">214400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTo3YjAwMWIxYTE3MWM0NjQxYTMyMTkzMTAzNmE3YjYwNS90YWJsZXJhbmdlOjdiMDAxYjFhMTcxYzQ2NDFhMzIxOTMxMDM2YTdiNjA1XzEzLTEtMS0xLTA_505730f1-4e5f-4294-ae27-9d6909aef220"
      unitRef="usd">258100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if951953d16294cdcbc6e8bb801ad899a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtMS0xLTEtMA_45ce376e-0cb7-4c11-b7ca-040dc0863442"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib50dc684425d41089759a744a6bfe976_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtMy0xLTEtMA_19ac2e98-7967-476f-a581-a10dd7800aa0"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idc2f1128dce6466cac75150836fb94ec_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtNS0xLTEtMA_06ceaa41-2326-40eb-90d2-1010dd0d31d5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i494430ec845b43fea48e416c8601f31b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzMtNy0xLTEtMA_b85aea3c-45f9-4f06-8f24-467facdc795d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if60b7e3f1fcf4c8b9a2d92a956688b64_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtMS0xLTEtMA_6b9d665e-84ea-4efa-ac13-e2cfa036b201"
      unitRef="usd">15500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idd9cfb636098475aa47d5bd1a223dd8a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtMy0xLTEtMA_6359ae20-5658-42d6-aa48-360da7bda90c"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0308ba03d22245b7b8e1dfe8f84611d6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtNS0xLTEtMA_41b867a3-db97-4790-8221-6d311e3a6931"
      unitRef="usd">14200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaf18620d1a2e439b9d01b280d170a058_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzYtNy0xLTEtMA_407c3f5b-4091-4916-ae87-59b34822ce37"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3082f2f2d81a4f0883e8d344e51d25b3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtMS0xLTEtMA_6e7007e3-48b3-475f-bbc0-1c46af347936"
      unitRef="usd">21700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibb54b4a5ace54151917b1754f3a19fa8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtMy0xLTEtMA_a71aa7c4-3338-4716-9487-6542ac2e7f35"
      unitRef="usd">3800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9b0a5df83d0b47c1b25e912b720d4e01_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtNS0xLTEtMA_4b083090-ca78-4cbc-9c04-f5457c1b5a44"
      unitRef="usd">17900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i08860c9461ea45b79e3605f7916ca562_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzgtNy0xLTEtMA_c53308d9-01bc-4cf2-bb5b-dff99a5a61b8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idad97ef7bc454cc2becb3891d672bea5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzExLTEtMS0xLTA_6ddf85f4-8d2f-4da2-9aa0-436b70a62277"
      unitRef="usd">39400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i253a14ec94054a06b279f6ab052a1335_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzExLTMtMS0xLTA_518018d3-86bb-4c23-9d9b-daa7f2a2165e"
      unitRef="usd">7300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i047657ac51d94d94bcf8cfad62457a39_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzExLTUtMS0xLTA_82846d12-4c35-49c5-b6a0-6c12f48e5b8f"
      unitRef="usd">32100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9c0729d942243dcb1acd45b7a4b2302_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzEyLTEtMS0xLTA_fad26e13-d92a-496b-99b2-78bf4fd47627"
      unitRef="usd">204700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNDUvZnJhZzphNzZiYzc1Yzc4MjI0N2NjODUwYTg4ZTlhYjg0MGNkNS90YWJsZTowYmQ5YjBlMDZlZDQ0OWU2ODk1MDcwZDRlYzY3NDQyYS90YWJsZXJhbmdlOjBiZDliMGUwNmVkNDQ5ZTY4OTUwNzBkNGVjNjc0NDJhXzEzLTEtMS0xLTA_4db256a7-8a9c-4f1b-81fb-9bb5929c03fa"
      unitRef="usd">244100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ1NDY_1fd6b8c7-d9b5-45fc-9e35-3a28f98a3864">Other Expense (Income) &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense (income) consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset impairments and sale of equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Argentina currency devaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazil tax recovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange transaction gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restructuring and Related Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, our Board of Directors approved a restructuring plan designed to optimize certain organizational structures within the Company to better support our continued growth and business priorities. These changes are expected to be implemented over a period of up to twenty-four months from the date of the approval. The plan is expected to require restructuring and related charges of approximately $15&#160;million to $17&#160;million. Since its approval, we recorded a net pre-tax amount equal to $4.6&#160;million in restructuring related charges associated with this plan. All charges recorded to date are severance related and recorded w&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ithin other expense (income) in the consolidated statements of income. Once fully completed, we expect the plan will provide us with annualized savings in the range of $3.5&#160;million to $4.5&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes were expected to be implemented over a period of up to twenty-four months from the date of the approval. The plan was expected to require restructuring and related charges of approximately $16.0 million. Since its approval, we recorded $13.7&#160;million in restructuring and related charges associated with this plan. The plan is now considered complete.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we recorded $4.9 million in restructuring and related charges associated with this plan, consisting of $2.6 million for severance charges, $0.3 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $2.0 million for other non-cash charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2018, we recorded $8.8&#160;million in restructuring and related charges associated with this plan, consisting of $3.1&#160;million for severance charges, $2.2&#160;million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $3.5&#160;million for other non-cash charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. During 2018, we recorded $0.3 million in additional charges related to this restructuring plan. Our remaining restructuring obligations related to our 2016 restructuring plan are complete. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Items&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we recorded a charge of $1.0&#160;million as a result of the continued devaluation of Argentina&#x2019;s currency. During 2018, we recorded a charge of $1.1 million related to the classification of Argentina&#x2019;s economy as highly inflationary under U.S. GAAP as of July 1, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we recognized a tax recovery of $4.7&#160;million related to previously-paid international excise taxes, following a favorable court ruling.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, 2019 and 2018, we recorded development income of $0.9 million in each year, related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revenue&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 12, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;, for additional details.</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ1MzU_5ae51dec-18c1-4f2f-8856-8b019ce3de67">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense (income) consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed asset impairments and sale of equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Argentina currency devaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazil tax recovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange transaction gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzItMS0xLTEtMA_9f5bed80-1376-4f43-85d1-de54e376139b"
      unitRef="usd">4600000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzItMy0xLTEtMA_b6f1181b-dbe5-44d7-89ec-b7416f85a75d"
      unitRef="usd">2600000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzItNS0xLTEtMA_08c26d74-fd32-484c-a6d1-96b8fab82a5d"
      unitRef="usd">3100000</us-gaap:SeveranceCosts1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzMtMS0xLTEtMA_7525b9dd-3e62-420f-acd7-0f7ba834c3b5"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzMtMy0xLTEtMA_c6fb317f-3df0-4249-a04d-988e6daa6dd6"
      unitRef="usd">300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzMtNS0xLTEtMA_a8cb9897-c2f5-4caa-af46-76475c9a2148"
      unitRef="usd">2200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherRestructuringCosts
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzQtMS0xLTEtMA_8ac44c0b-b160-42c5-a2c4-18a9152cf6d7"
      unitRef="usd">0</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzQtMy0xLTEtMA_3621bf94-1cf2-4a1a-af57-6c6580ad0d22"
      unitRef="usd">2000000.0</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzQtNS0xLTEtMA_6b862c66-73bc-487f-820f-a970a8871cd6"
      unitRef="usd">3800000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzUtMS0xLTEtMA_ff987919-78f8-4054-be4c-306bbc3177c6"
      unitRef="usd">4600000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzUtMy0xLTEtMA_d7fcfbab-0e91-4350-aba9-05bf970d99d9"
      unitRef="usd">4900000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzUtNS0xLTEtMA_0dc0266b-287c-44d3-a5ee-dd76ec0742ea"
      unitRef="usd">9100000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzYtMS0xLTEtMA_ef99927a-5067-42b4-aef1-d43d8db708ac"
      unitRef="usd">7700000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzYtMy0xLTEtMA_d2649d4d-1eca-4112-b7a5-17ad8d936007"
      unitRef="usd">800000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzYtNS0xLTEtMA_571d42c9-ea64-4014-8302-5c0c99393529"
      unitRef="usd">1800000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzctMS0xLTEtMA_845c6a34-a659-45b1-9ee7-c902a503b9dd"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzctMy0xLTEtMA_80939028-0c45-4f14-87c7-8768c5f491d7"
      unitRef="usd">1000000.0</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzctNS0xLTEtMA_f5d9faf3-9cbc-4acb-aef5-4fd40cb3288c"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <wst:BrazilTaxRecovery
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzgtMS0xLTEtMA_27fa4c0e-e075-4191-b410-32c7386c4252"
      unitRef="usd">0</wst:BrazilTaxRecovery>
    <wst:BrazilTaxRecovery
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzgtMy0xLTEtMA_06cf4ca7-6574-4ccd-9612-d0f582e085f3"
      unitRef="usd">4700000</wst:BrazilTaxRecovery>
    <wst:BrazilTaxRecovery
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzgtNS0xLTEtMA_ef7b0f25-0723-42a5-a13f-17c26d54969b"
      unitRef="usd">0</wst:BrazilTaxRecovery>
    <wst:DevelopmentAndLicensingIncome
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTEtMS0xLTA_9697b42f-d3b3-4763-b455-59977cf87cb3"
      unitRef="usd">900000</wst:DevelopmentAndLicensingIncome>
    <wst:DevelopmentAndLicensingIncome
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTMtMS0xLTA_47da5bce-b610-4986-b050-e86e30b8c135"
      unitRef="usd">900000</wst:DevelopmentAndLicensingIncome>
    <wst:DevelopmentAndLicensingIncome
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTUtMS0xLTA_4f34c588-7b26-40b3-992f-9cd6c96d7bb1"
      unitRef="usd">900000</wst:DevelopmentAndLicensingIncome>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEyLTEtMS0xLTA_8c7ef46f-7709-476f-9a1a-71ab844920ac"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEyLTMtMS0xLTA_32e6d749-6bcc-4d46-be43-7f01678e3879"
      unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEyLTUtMS0xLTA_dce717ce-7b25-4f94-b632-5d95b311837e"
      unitRef="usd">-2600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTEtMS0xLTQ1MDk_89b7aee4-ef46-417d-84ec-a6750b6c0af7"
      unitRef="usd">1500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTMtMS0xLTQ1MDk_e2005a1e-fa1c-476a-af18-2fb98cdb92b5"
      unitRef="usd">4600000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzExLTUtMS0xLTQ1MDk_4600973f-4776-4a8e-bc1d-c23c372e1552"
      unitRef="usd">5500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEzLTEtMS0xLTA_0270acc4-0084-4ce9-b30e-d8d4d7abc41e"
      unitRef="usd">-900000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEzLTMtMS0xLTA_d084e38f-1a71-462f-9e4f-44ea1d15435a"
      unitRef="usd">1100000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzEzLTUtMS0xLTA_415b1710-2353-4e35-a822-c7b1f9830878"
      unitRef="usd">1100000</us-gaap:OtherOperatingIncomeExpenseNet>
    <wst:OtherIncomeExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzE0LTEtMS0xLTA_28366060-fc57-4211-af73-39fe4358ab07"
      unitRef="usd">-12000000.0</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzE0LTMtMS0xLTA_89cfcdd2-04ea-4c07-8c0e-0ab84554ffb4"
      unitRef="usd">2500000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo4NDRjOTk4NjE2OTE0ZGI4YWJjMTlkNzIwZTBiNzJlMy90YWJsZXJhbmdlOjg0NGM5OTg2MTY5MTRkYjhhYmMxOWQ3MjBlMGI3MmUzXzE0LTUtMS0xLTA_a6ab2b37-8642-4276-8fc0-82dc3bfa7760"
      unitRef="usd">-1900000</wst:OtherIncomeExpense>
    <wst:RestructuringAndRelatedActivitiesPeriodOfImplementation
      contextRef="ifd693c0a25a2479690b679e348d38eb8_D20200701-20200731"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzYwNDczMTM5NjE1NTU_a44fe7c6-4cb2-44b1-aab8-ad58a7441200">P24M</wst:RestructuringAndRelatedActivitiesPeriodOfImplementation>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i3279f29cb3d44ad398fdc8d0e4645742_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ5NDc4MDIzMzMwMzY_b0936623-4cf1-442b-99bd-37ab4fc97e53"
      unitRef="usd">15000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i2db454712df547c7ab009dafbba594fd_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ5NDc4MDIzMzMwNjU_4c20604d-6315-4275-b9e0-4164c511460f"
      unitRef="usd">17000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i84165f2d4d454d8183ee94793f21eb44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ5NDc4MDIzMzMwOTU_db4db525-d01e-42ec-8e9e-8ae5297da5d9"
      unitRef="usd">4600000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:EffectOnFutureEarningsAmount
      contextRef="i3c10b1ae682d4560b9e68e567ee78779_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjUz_3572ab08-63d4-435b-9aea-e3146bc8eccf"
      unitRef="usd">3500000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:EffectOnFutureEarningsAmount
      contextRef="i9edfa646c3214875a75bd7a3a78ed53a_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjU3_c08f0ae1-be14-4b0e-8a45-3ad773574273"
      unitRef="usd">4500000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYz_570a30fc-2ee8-427f-a963-3cbe6bf1c6e1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i0f0c156b11b44bf9bb5fc1e2d121ddfb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtMS0xLTEtNDgyMg_2d5d5b90-6fa1-4dbb-b401-0ed4e7fb9bda"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8c9174797bed448da4f42a9ab90c7fe8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtMy0xLTEtNjcxMw_1624db03-c39d-4006-a56f-2c9350a331e2"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifd22d3c670e54cfa9c8332dd9e2049f9_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtNS0xLTEtNjcxMw_48d43d43-15de-4ee2-b1c7-2b606a447b4f"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i011bfe673ee54bfcb6f9c6983b446443_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzEtNy0xLTEtOTk3NQ_c3998d0c-6316-4740-a4e6-4848c5620b32"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i810c968a3f8644c38105ee05c0745630_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItMS0xLTEtNDgyMg_327ed6d5-f7f9-4619-bb33-ba1252430f5a"
      unitRef="usd">4600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9b33dcfc3132453a9eaf1f23d1e28a46_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItMy0xLTEtNjcxMw_9a0bfe11-cb2a-4d9a-b51a-5a8d2b0c21cb"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i99ea9955e84d40b0977aa384c11038ae_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItNS0xLTEtNjcxMw_a1dc4cf1-8fe9-4bde-99b5-bb47cbe1b207"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i23e32d9c6ce54b18abbf607406fce66b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzItNy0xLTEtOTk3NQ_20627a56-79bd-48a2-9212-3e86b4567340"
      unitRef="usd">4600000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i810c968a3f8644c38105ee05c0745630_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtMS0xLTEtNDgyMg_9d1a2554-f468-4639-98f4-e57974eaf3ec"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9b33dcfc3132453a9eaf1f23d1e28a46_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtMy0xLTEtNjcxMw_90604347-fb0e-40d8-811f-de50fc39e84d"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i99ea9955e84d40b0977aa384c11038ae_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtNS0xLTEtNjcxMw_337f3c3a-0622-4364-9a47-bc6b5d524b8a"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i23e32d9c6ce54b18abbf607406fce66b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzMtNy0xLTEtOTk3NQ_322074cd-f5ad-41a4-8653-41233966edc3"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="ia5ec7fb1237e40e185af54faa36233cd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtMS0xLTEtOTk3MA_718346a2-977b-4057-a350-37a4ef81174f"
      unitRef="usd">4600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic176204c3afa46c5bf47f585a3fda12b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtMy0xLTEtOTk3MQ_b4315903-0a6d-4654-94e2-b07cc0aade9c"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1051c2e627924a1084b2ece63cb73f04_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtNS0xLTEtOTk3Mw_0b4a2184-d831-478a-9983-683abf9d0802"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i84165f2d4d454d8183ee94793f21eb44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZToxNTFlYzkzM2RiYmM0OTNiOTYxNTYxZGFmYmEyMTM2MS90YWJsZXJhbmdlOjE1MWVjOTMzZGJiYzQ5M2I5NjE1NjFkYWZiYTIxMzYxXzQtNy0xLTEtOTk3NQ_c576e4a7-03c2-4945-a93c-be08908009fe"
      unitRef="usd">4600000</us-gaap:RestructuringReserve>
    <wst:RestructuringAndRelatedActivitiesPeriodOfImplementation
      contextRef="iceed54e3fc2843188a6afef50414dfb5_D20180201-20180228"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzYwNDczMTM5NjE1ODQ_9aef078d-e876-4f31-86a1-67acfdfa9439">P24M</wst:RestructuringAndRelatedActivitiesPeriodOfImplementation>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ia296001215624e7b9dab9ac52000b1bd_I20180228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ0OQ_6ebd80c4-0cc8-48a3-8ce7-ed9be0cadb01"
      unitRef="usd">16000000.0</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="ie24ddffb97cc4456a1f560750a4db57a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzQ4NQ_ae4987f3-bb31-4e9d-9753-e3aeaa60c4d1"
      unitRef="usd">13700000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzYxNQ_25c4b376-2a3d-4bad-9fdd-1e49edcf609a"
      unitRef="usd">4900000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:SeveranceCosts1
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzY5Ng_6f9bc92a-cc86-4f66-bdaf-6a25d4d96717"
      unitRef="usd">2600000</us-gaap:SeveranceCosts1>
    <us-gaap:AssetImpairmentCharges
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzcyMg_3c3359ed-15e1-4cb5-beed-5e135bf8932c"
      unitRef="usd">300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherRestructuringCosts
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzgxOQ_74200f72-784c-4715-a452-01f41e4acf6a"
      unitRef="usd">2000000.0</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjU4_e3a4d7be-b54b-4a38-aba1-8cbf5b7112d3"
      unitRef="usd">8800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:SeveranceCosts1
      contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjU5_63b04b75-78c0-41e7-874d-d083ea3930ad"
      unitRef="usd">3100000</us-gaap:SeveranceCosts1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYw_258b8df5-2366-4c49-8d74-fe6d63103336"
      unitRef="usd">2200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherRestructuringCosts
      contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYx_bc4c9a42-f9c5-4700-a8f2-61eac0d9297e"
      unitRef="usd">3500000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringReserve
      contextRef="i28e15367dd044052a08c353d17ed4488_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtMS0xLTEtMA_00854919-8777-4d90-8af3-200bd622eca3"
      unitRef="usd">2300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i70f0a5d05a354c9ab3ed46523d85026b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtMy0xLTEtMA_5690f55e-512c-49a8-9032-f602b521484f"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0eae9458001042abbe77ec865b769cdf_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtNS0xLTEtMA_4b3d9a15-cec6-4785-9404-82018276e6a6"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idd7f955de895424dbdb1f1a1c3db9fc2_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzEtNy0xLTEtMzU4Ng_a14368d7-702c-4577-96ca-10a884626d26"
      unitRef="usd">2300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItMS0xLTEtMA_e7d4cd16-2b3d-43fe-8b6b-3bc0bff5d47e"
      unitRef="usd">2600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iecb988feb4be406a9f663fd322648742_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItMy0xLTEtMA_5d956b55-90bd-4b52-b292-2b238eb774ae"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItNS0xLTEtMA_3e3bbe90-f2ea-46b2-a72f-83c4e7f8aab1"
      unitRef="usd">2000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzItNy0xLTEtMzU4NQ_c4a5ce05-132e-4613-b760-ed7ba0e00402"
      unitRef="usd">4900000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtMS0xLTEtMA_db906b83-b822-425a-91e8-e9c2905146be"
      unitRef="usd">3500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="iecb988feb4be406a9f663fd322648742_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtMy0xLTEtMA_c7fa171f-d716-4749-ae51-a6aeaa6ff938"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtNS0xLTEtMA_75e69649-6054-4b36-bbcb-d4814dc2050e"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzMtNy0xLTEtOTk0Ng_02395a2b-f74c-4a86-8829-061ce3382b0f"
      unitRef="usd">3500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i3628edc21cdc4fd5837333a9dd7a48e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtMS0xLTEtMA_a3881d65-683e-48d0-920c-b09918f2f098"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="iecb988feb4be406a9f663fd322648742_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtMy0xLTEtMA_07a1c9c4-0cbd-4151-89e5-2c92ab57f120"
      unitRef="usd">300000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i07c9180c03c047f0aee28282cb87d674_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtNS0xLTEtMA_6a1ac0c6-3439-4af0-92cd-7d45ce9a29db"
      unitRef="usd">2000000.0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzQtNy0xLTEtOTk0Ng_c7441552-f09a-4403-b602-c2b8a1f3d06a"
      unitRef="usd">2300000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="i85908bb4116442599a19d848f1076448_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtMS0xLTEtMA_0327f81e-0f13-45f7-b195-fa5be77398b9"
      unitRef="usd">1400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i32f79a77bed344a6981d9eff588ca896_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtMy0xLTEtMA_71fbb8c1-a1c1-4698-844d-b6db6dd64487"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1f5f1f9c46284f9b908b58203e0fdd95_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtNS0xLTEtMA_69eb49d6-126b-448b-b4df-58ab4e57e35e"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6629a2a3e6da4a748d04ed957a6ed07d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzUtNy0xLTEtMA_a6697d08-a1f9-4ba9-831f-96a35fbbc2ab"
      unitRef="usd">1400000</us-gaap:RestructuringReserve>
    <us-gaap:PaymentsForRestructuring
      contextRef="i193830303b9d4d0193b328737f36c6c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctMS0xLTEtMA_5908a14a-7808-4f50-b32c-fccead2a59d0"
      unitRef="usd">1300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i274376d36fa54890b82f08d6ed48bbee_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctMy0xLTEtMA_4504227f-8e29-4a21-95c8-53c34c8c48be"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i27d7dd7dc1104b2593a44cdf7974d37f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctNS0xLTEtMA_8fe135ed-9bf7-4c91-b400-80a615bf78ab"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i62905753722c4190871f9b11bf5dd843_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzctNy0xLTEtMA_9fbf3e98-03ec-456a-955b-194302eebde3"
      unitRef="usd">1300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i1ed2f680acea47a38a544ddfae0bede5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktMS0xLTEtMA_5e5bd083-0762-460b-9642-eba6c74ec991"
      unitRef="usd">100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibdb482e22f9f489f99c206b7e374b961_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktMy0xLTEtMA_b02fce19-7a68-4e90-9441-da007a9eb75a"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic4ca23e5869c48d8b6e8710608fcbbdd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktNS0xLTEtMA_728d6ab8-8d86-4e84-ba70-918e13f6c23b"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie24ddffb97cc4456a1f560750a4db57a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90YWJsZTo1OTIzZDdiODk3N2M0NmQ2YTg2ZWQ3ZTA5NjU2ZmRiMi90YWJsZXJhbmdlOjU5MjNkN2I4OTc3YzQ2ZDZhODZlZDdlMDk2NTZmZGIyXzktNy0xLTEtMA_059e4aa4-11cd-4373-94c2-85fec3ad6b94"
      unitRef="usd">100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzE1NzI_e9f38889-21ec-4ed6-a0e8-3ed9efdebe70"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="if081d3807fe340578952575c4c7a4fcd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzEyMDk0NjI3OTE0MjYy_6adb1ca5-2e65-444f-a0c5-185a3f4c9913"
      unitRef="usd">1000000.0</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i50f424d813e44fc58d59312550371a32_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzE5MDI_8a5e3a26-bacc-4446-98fc-f859adab45d7"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <wst:BrazilTaxRecovery
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzIwNjM_913d7d35-5968-4e20-9afb-2d554de340ed"
      unitRef="usd">4700000</wst:BrazilTaxRecovery>
    <wst:DevelopmentAndLicensingIncome
      contextRef="i6b5aa17d4bf34a9381a6369cd9b7643e_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMyNzM_7dca0a39-670b-4aec-9bda-0c97624378c6"
      unitRef="usd">900000</wst:DevelopmentAndLicensingIncome>
    <wst:DevelopmentAndLicensingIncome
      contextRef="i124cb2fa8c124903a808a37113465670_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMyNzM_a96581e3-23b2-4637-9e66-3b8c4f9eb12e"
      unitRef="usd">900000</wst:DevelopmentAndLicensingIncome>
    <wst:DevelopmentAndLicensingIncome
      contextRef="i9daa8394ea5c4fff8c0bf665f388fdf8_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMyNzM_d827e7ed-2a43-45b3-8a18-8f77b3bebb7f"
      unitRef="usd">900000</wst:DevelopmentAndLicensingIncome>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i7ab15527d47f4aa9a1633dab43f58d65_I20130630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTEvZnJhZzo2NGYwMjZkZDI3YzA0MmE3OTc1ZDIyM2IyMjQzZWFmZi90ZXh0cmVnaW9uOjY0ZjAyNmRkMjdjMDQyYTc5NzVkMjIzYjIyNDNlYWZmXzMzNDk_3e13b98c-4dae-4589-8198-fdf4f1df28be"
      unitRef="usd">20000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNDU_e5a9c523-e9b6-4b3a-bfae-693c4d61a00a">Income TaxesAs a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. During 2020, the statute of limitations for the 2016 U.S. federal tax year lapsed, leaving tax years 2017 through 2020 open to examination. For U.S. state and local jurisdictions, tax years 2013 through 2020 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2013 through 2020.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to prior year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction for expiration of statute of limitations/audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we had balances in accrued liabilities for interest and penalties of $0.3 million and $0.2 million at December&#160;31, 2020 and 2019, respectively. As of December&#160;31, 2020, we had $10.4 million of total gross unrecognized tax benefits, which, if recognized, would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $0.3 million during the next twelve months, which would favorably impact our effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of income before income taxes are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related provision for income taxes consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal and state&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of our deferred tax assets and liabilities at December 31 are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax (liability) asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal corporate tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on international operations other than U.S. tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reserves for unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. tax on international earnings, net of foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-Derived Intangible Income Deductions (FDII)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of 2017 Tax Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, we recorded a tax benefit of $0.5&#160;million due to the impact of tax law changes enacted during the year, as well as a tax benefit of $20.8&#160;million associated with stock-based compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we recorded a tax benefit of $0.3&#160;million due to the impact of tax law changes enacted during the year, as well as a tax benefit of $10.3&#160;million associated with stock-based compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2018, we recorded a net tax benefit of $2.5&#160;million for the estimated impact of the 2017 Tax Act and a tax benefit of $14.3&#160;million associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2017 Tax Act, which was signed into law on December 22, 2017, has resulted in significant changes to the U.S. corporate income tax system. These changes include, but are not limited to, a federal statutory rate reduction from 35.0% to 21.0% effective for tax years beginning after December 31, 2017. Changes in tax rates and tax laws are accounted for in the period of enactment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Tax Act. We recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in our consolidated financial statements for the year ended December 31, 2017. As of December 31, 2018, we finalized our calculations and tax positions used in our analysis of the impact of the 2017 Tax Act in consideration of proposed regulations and other guidance issued during 2018. As a result, we recorded a $7.5 million tax benefit related to a reduction of the Transition Toll Tax and an incremental tax expense of $4.0 million related to other adjustments. The final measurement reduced the Transition Toll Tax expense to $20.4 million from $27.9 million. The net impact of these adjustments resulted in a benefit of 1.45% to the 2018 effective tax rate. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2017 Tax Act created a provision known as global intangible low-tax income (&#x201c;GILTI&#x201d;) that imposes a U.S. tax on certain earnings of controlled foreign subsidiaries. We made an accounting policy election to reflect GILTI taxes, if any, as a current income tax expense in the period incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we have fully utilized all of our U.S. federal net operating loss carryforwards. State operating loss carryforwards of $204.1 million created a deferred tax asset of $14.0 million, while foreign operating loss carryforwards of $56.7 million created a deferred tax asset of $7.4 million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been fully reserved. State loss carryforwards expire as follows: $25.7 million in 2021 and $178.4 million thereafter. Foreign loss carryforwards will begin to expire in 2030, while $54.1 million of the total $56.7 million will not expire.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we have utilized all available foreign tax credit carryforwards against the Transition Toll Tax. During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. As of December&#160;31, 2020, the $0.9 million of state research and development credits expire after 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $345.6&#160;million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwMzg_a1a8a3ac-0cbf-4ee3-bc2f-be4ceb31eb07">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to prior year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction for expiration of statute of limitations/audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzEtMS0xLTEtMA_9d0fa993-05e1-418d-8b66-769eb86add9c"
      unitRef="usd">5000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzEtMy0xLTEtMA_69c0a41a-1224-453e-abe2-9b2995d5ec77"
      unitRef="usd">3900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzItMS0xLTEtMA_9c7fe3cb-1ad1-4b66-ac28-c1400abe1845"
      unitRef="usd">4900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzItMy0xLTEtMA_98a02ae7-9ce3-4174-9afb-888934f51348"
      unitRef="usd">1600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzMtMS0xLTEtMA_93e2bd7f-5924-4f3e-8004-31017511b7e4"
      unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzMtMy0xLTEtMA_d7ab994a-6b6a-4635-a79c-aabe539cda47"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzQtMS0xLTEtMA_5b71d0cc-9825-4ba8-9c25-9d29bfe4f0bf"
      unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzQtMy0xLTEtMA_a0eb91f5-31aa-4af3-ab29-ea84776c6b28"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzUtMS0xLTEtMA_30c6d07e-e3e5-4d0a-a673-4f8270c61e5f"
      unitRef="usd">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTo1NGQ3OTc2M2VhMDk0N2FlYTI3ZjNlZWEwNTc4MGRmMi90YWJsZXJhbmdlOjU0ZDc5NzYzZWEwOTQ3YWVhMjdmM2VlYTA1NzgwZGYyXzUtMy0xLTEtMA_519f21c6-5b63-4e64-948e-14c1622862c3"
      unitRef="usd">5000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwOA_30cb951a-1017-4637-936f-d072bc4a392e"
      unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2MzUzNTY_a70d98a3-055a-40a2-9b84-397b5078d9cc"
      unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzc0Nw_502f8ef5-d6fa-4788-84fb-394012f1db7c"
      unitRef="usd">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwNDM_f0757f40-6e34-4e12-8334-3a0ceae97282"
      unitRef="usd">-300000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNTA_0815cc4c-10ca-4f11-a132-ac18acc847fc">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of income before income taxes are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzEtMS0xLTEtMA_c16238d9-17df-4e49-8bd7-cb4f6ca5568b"
      unitRef="usd">227000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzEtMy0xLTEtMA_50e9d2bc-36be-4047-9139-8ca1388a1195"
      unitRef="usd">161200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzEtNS0xLTEtMA_6e8c3e64-dd8d-4637-ab3c-88aea5bbaa7e"
      unitRef="usd">132900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzItMS0xLTEtMA_96a77a38-eec9-4d9f-81f9-3c92947683bc"
      unitRef="usd">174300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzItMy0xLTEtMA_6a37c328-dea7-4a4e-916c-0da4bdf57d5f"
      unitRef="usd">130600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzItNS0xLTEtMA_4f1469f9-060d-4c01-a49b-2d8a9e68ca80"
      unitRef="usd">107800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzMtMS0xLTEtMA_9aa2bae9-3046-472e-b50e-98b92a7deeca"
      unitRef="usd">401300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzMtMy0xLTEtMA_1cea2be5-6ec6-499a-b0bb-988071f9378f"
      unitRef="usd">291800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTplYzczYjU0MDQyNjg0NzQzOWVjOTJkZGM3YmY3YWIzOC90YWJsZXJhbmdlOmVjNzNiNTQwNDI2ODQ3NDM5ZWM5MmRkYzdiZjdhYjM4XzMtNS0xLTEtMA_ddda3bca-29c9-4022-a4f1-ad545d3c00f3"
      unitRef="usd">240700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNTE_b7b53038-79f9-44d1-a61f-e9394c3f4327">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related provision for income taxes consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal and state&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzItMS0xLTEtMA_50957582-d422-41ff-bebe-3419f7f83b88"
      unitRef="usd">28900000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzItMy0xLTEtMA_b0d9bb39-d1c3-4a60-bd82-c1a3ddf69974"
      unitRef="usd">10800000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzItNS0xLTEtMA_658f3838-1969-4f10-b564-a28a2fa2272b"
      unitRef="usd">2100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzMtMS0xLTEtMA_f8721ea4-0f41-4aa4-973f-9c4b913519e0"
      unitRef="usd">3400000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzMtMy0xLTEtMA_f67170e2-ed57-4b3b-8d04-4c5316ff99c9"
      unitRef="usd">2400000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzMtNS0xLTEtMA_25730aac-e48d-42db-bf50-4b689c6ce082"
      unitRef="usd">3300000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzQtMS0xLTEtMA_0950d00b-6e8a-4a87-9fb3-fe274f033446"
      unitRef="usd">46000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzQtMy0xLTEtMA_1a62f7a4-c9fb-4237-99ce-aff2d2be3b68"
      unitRef="usd">30500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzQtNS0xLTEtMA_008f7d1c-cb5e-4a15-beb6-d4dcadf4b15d"
      unitRef="usd">35100000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzUtMS0xLTEtMA_48f34b54-0c20-4559-9632-aa2799f88433"
      unitRef="usd">78300000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzUtMy0xLTEtMA_5c30113e-6b72-4512-b9fb-0edb926c00bc"
      unitRef="usd">43700000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzUtNS0xLTEtMA_b99ffbd0-f168-4a52-8377-075bec47b462"
      unitRef="usd">40500000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzctMS0xLTEtMA_c488bedd-4308-4ed8-a919-5e68d86427ae"
      unitRef="usd">200000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzctMy0xLTEtMA_da41f5c6-fb5b-4c74-9a5a-694e3d37b3e5"
      unitRef="usd">10300000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzctNS0xLTEtMA_9670992d-edea-4c32-9eb4-fd16275c9fd7"
      unitRef="usd">1400000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzgtMS0xLTEtMA_3e69bd42-2732-48dc-9748-0d2937b6cf7b"
      unitRef="usd">-6000000.0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzgtMy0xLTEtMA_1c7bd38c-bcdc-4af4-947e-f29c419c0273"
      unitRef="usd">5000000.0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzgtNS0xLTEtMA_b1840870-f0e8-4870-ba43-827aee58afa2"
      unitRef="usd">-500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzktMS0xLTEtMA_d3f0e5bd-0398-40a7-a9ee-8e0310e750f9"
      unitRef="usd">-5800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzktMy0xLTEtMA_173b2dbc-2c11-4d6f-bc5a-eb99cf258568"
      unitRef="usd">15300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzktNS0xLTEtMA_c301996c-635d-4a49-931f-73d5c2339e6e"
      unitRef="usd">900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzEwLTEtMS0xLTA_c95b8369-66f7-4b38-a4e3-c490bc58c009"
      unitRef="usd">72500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzEwLTMtMS0xLTA_eb424a42-3b88-4286-89db-ca07bcf8fe60"
      unitRef="usd">59000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowNDE5MzFhNzA2NjI0MmVlYmMzMzZiNzhkOGU2YmViZi90YWJsZXJhbmdlOjA0MTkzMWE3MDY2MjQyZWViYzMzNmI3OGQ4ZTZiZWJmXzEwLTUtMS0xLTA_0c54f11b-0714-4e32-b445-4af2033d6a51"
      unitRef="usd">41400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwNDI_e586493a-33f5-4ad0-be28-377f1366b506">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of our deferred tax assets and liabilities at December 31 are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax (liability) asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzItMS0xLTEtMA_30d26325-3b8a-4e76-a2c0-49dab14732ed"
      unitRef="usd">21400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzItMy0xLTEtMA_8291e25a-404c-4c5c-bbc9-4092abbcbf78"
      unitRef="usd">21900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzMtMS0xLTEtMA_1d6ac040-01aa-4941-baa6-128dfd9f8561"
      unitRef="usd">2000000.0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzMtMy0xLTEtMA_a3fefa55-39ae-4325-bd9f-7acaa634a4ea"
      unitRef="usd">2800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <wst:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzQtMS0xLTEtMA_cbdb27cd-4489-4089-9f2d-2c18ca90a61c"
      unitRef="usd">400000</wst:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges>
    <wst:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzQtMy0xLTEtMA_af0da417-3999-409e-9bd3-219aa437cec2"
      unitRef="usd">0</wst:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzUtMS0xLTEtMA_8c867cd5-96cd-4f12-bf05-f622b67d2949"
      unitRef="usd">35300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzUtMy0xLTEtMA_299ff75c-cd53-4a2e-b34c-494de0692ade"
      unitRef="usd">25600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzYtMS0xLTEtMA_3f0ff1d5-5f74-4e44-ab60-d86e15794ca2"
      unitRef="usd">10600000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzYtMy0xLTEtMA_e026d635-1231-4189-bd38-c8e87f9de9a9"
      unitRef="usd">9200000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzctMS0xLTEtMA_354047bd-86e6-432e-898b-c663e50463cf"
      unitRef="usd">15100000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzctMy0xLTEtMA_9be4a115-e755-4655-ac66-40a6ade4799c"
      unitRef="usd">15900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzgtMS0xLTEtMA_7bc8f9ff-b2cd-4d3c-b8f2-7337e0462337"
      unitRef="usd">54600000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzgtMy0xLTEtMA_a76a88df-cee3-49b8-a46f-e0906840bda6"
      unitRef="usd">43600000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEwLTEtMS0xLTA_a5daa721-4554-4382-9a78-3604a15e3133"
      unitRef="usd">42100000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEwLTMtMS0xLTA_453047f0-6421-4709-82e2-e89eefd4b03e"
      unitRef="usd">37900000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzExLTEtMS0xLTA_20cd6ed2-6b80-4982-9eb9-655f4672f793"
      unitRef="usd">6500000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzExLTMtMS0xLTA_c7bee1cf-f3c6-4f4e-b685-36bdacd298bf"
      unitRef="usd">6300000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEyLTEtMS0xLTA_8392df83-75d5-4eab-b130-4c9a739e49db"
      unitRef="usd">400000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEyLTMtMS0xLTA_289976de-9ca3-4a8b-b0a7-7ed0e57ce08d"
      unitRef="usd">900000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEzLTEtMS0xLTA_dbd82194-b602-4dc8-9f56-20d911fd6647"
      unitRef="usd">49000000.0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzEzLTMtMS0xLTA_aeeedd5e-070b-4ba7-852d-3308fa9078d8"
      unitRef="usd">45100000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzE0LTEtMS0xLTA_e9ffa460-a826-4df4-bbd7-f36cf3376ff7"
      unitRef="usd">5600000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTpkMDgxYzZmNGNlOTQ0MzQ4OTczMjVkOTc1MjBlN2M5Yi90YWJsZXJhbmdlOmQwODFjNmY0Y2U5NDQzNDg5NzMyNWQ5NzUyMGU3YzliXzE0LTMtMS0xLTA_cf83a497-a058-427f-8d99-a6d76247fb23"
      unitRef="usd">1500000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzcwMTE_c829709b-df2e-4494-a805-39a106448b46">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal corporate tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on international operations other than U.S. tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reserves for unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. tax on international earnings, net of foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign-Derived Intangible Income Deductions (FDII)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of 2017 Tax Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEtMS0xLTEtMA_65560acd-0f4e-4577-87f5-2c15b446077d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEtMy0xLTEtMA_e7e612f6-3f7f-4f04-88e0-5816c7d4ff52"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEtNS0xLTEtMA_512b77f1-b2f4-49a0-bff1-108bf45b1718"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzItMS0xLTEtMA_34d0a2c5-502e-4868-a289-d542d254159a"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzItMy0xLTEtMA_3cb717cd-7f30-41dc-a934-ea9d23c772e8"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzItNS0xLTEtMA_3cbe3822-7d8f-4fef-969d-2d36e4902191"
      unitRef="number">0.048</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzUtMS0xLTEtMA_9bdebe70-38c0-4b34-8e0e-2c41d0d66536"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzUtMy0xLTEtMA_084e4dd4-e1e8-410b-ad13-642b3a054d07"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzUtNS0xLTEtMA_239c1f49-8697-42cd-b845-f2bc8cf86f37"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzYtMS0xLTEtMA_bc4adbf7-03cb-4927-93fa-39c7c873fef4"
      unitRef="number">0.004</wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent>
    <wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzYtMy0xLTEtMA_8c20f47f-f5e6-4158-8d79-aeaf4a2f6550"
      unitRef="number">0.004</wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent>
    <wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzYtNS0xLTEtMA_e95469d3-3131-4b19-a73f-e115d5ba2cf0"
      unitRef="number">-0.002</wst:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent>
    <wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMS0xLTEtOTUxNQ_8bd1d590-024f-47a6-9083-9824909eadd6"
      unitRef="number">-0.011</wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent>
    <wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMy0xLTEtOTUxNQ_fb1d7731-374a-4474-ab0f-b3c701dedb91"
      unitRef="number">-0.006</wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent>
    <wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctNS0xLTEtOTUyNg_7170c03b-da81-4392-8407-eab6fe0cdba4"
      unitRef="number">-0.004</wst:EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMS0xLTEtMA_b38bba21-d0cf-4f10-aae6-9b0dbd02b915"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctMy0xLTEtMA_55754203-fd21-45de-a6a7-9c1153fbec8f"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzctNS0xLTEtMA_2f40e8f6-f405-450e-a63f-5818ab041edb"
      unitRef="number">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzgtMS0xLTEtMA_724e599d-5519-4ee3-89df-f412df516901"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzgtMy0xLTEtMA_5a877d63-af90-4a70-9d66-4088c9c30a60"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzgtNS0xLTEtMA_d4458445-d7c9-4dc4-9142-a1f94297b97d"
      unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzktMS0xLTEtMA_f2d42cd1-1163-47ec-97c3-968f2f8647d0"
      unitRef="number">-0.052</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzktMy0xLTEtMA_c684192c-f365-457b-b417-f6b339b6948a"
      unitRef="number">-0.035</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzktNS0xLTEtMA_b11c04ba-e1ee-40a6-9098-d42fe554598c"
      unitRef="number">-0.060</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEwLTEtMS0xLTA_56223bed-739c-435a-b583-c475342a1125"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEwLTMtMS0xLTA_0d224411-d052-4c13-85c3-30817df40298"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzEwLTUtMS0xLTA_d52a5ee3-9850-4f17-a073-6fa88cf40b5e"
      unitRef="number">-0.029</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzExLTEtMS0xLTA_2f5e47bc-d31e-471d-a9dd-f9ed40b97031"
      unitRef="number">0.001</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzExLTMtMS0xLTA_45fbff2d-e307-4031-848e-6dee1b641cdc"
      unitRef="number">-0.002</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzExLTUtMS0xLTA_dae3d533-5fa4-4c1d-983c-a841ebb087dc"
      unitRef="number">-0.013</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE2LTEtMS0xLTA_4aa41b53-97cb-4e3f-86a6-35f222ba736e"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE2LTMtMS0xLTA_e7eb14f6-77d5-43ed-845e-1672fec06c06"
      unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE2LTUtMS0xLTA_8ba5658a-010f-474a-8aa0-6697c63637c1"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE3LTEtMS0xLTA_650868ae-cb42-4f85-9749-1a87a34ca0f3"
      unitRef="number">0.181</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE3LTMtMS0xLTA_62cdb543-48e2-4317-8e67-a6ef836cfcbd"
      unitRef="number">0.202</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90YWJsZTowMjYxODY5NGJiZTM0YzQ2ODM3ZjY4ZjM4YTYwYzhiMS90YWJsZXJhbmdlOjAyNjE4Njk0YmJlMzRjNDY4MzdmNjhmMzhhNjBjOGIxXzE3LTUtMS0xLTA_c9fceb36-6362-4f57-8412-ffe8ec3de207"
      unitRef="number">0.172</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3Nzc_2082007d-23f0-4901-8aa3-d9337adb9cad"
      unitRef="usd">-500000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3OTY_6305d958-ba4c-460d-91c0-ffa81d964e66"
      unitRef="usd">-20800000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3MjI_5b6b06b3-1199-4312-ba09-894eee29acbc"
      unitRef="usd">-300000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3MzM_36c5286e-6d8f-4a25-bce6-fd6e5e1c9a47"
      unitRef="usd">-10300000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3NDA_a34d8154-9e7c-42af-847f-8a8cc45d2b3e"
      unitRef="usd">-2500000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2Mzg3NTQ_7c0f7682-5cfc-413e-a19f-052589a0dacf"
      unitRef="usd">-14300000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if44a63268f854be99514777e8639749e_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzg3OTYwOTMwMzY0Njg_cc78d9a2-0fc0-4967-8168-8412c6ef4ecf"
      unitRef="number">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzg3OTYwOTMwMzY0NzU_ce78a4d0-150a-4e6f-86a5-c900ae57cba4"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQxMDQ_1a195661-9245-4d17-99e5-b121a7ebd4b2"
      unitRef="usd">-7500000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQyMDM_49972af2-9ce8-433c-91c9-da486f783d92"
      unitRef="usd">4000000.0</us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="i1cd1fba210414204826670f7b9718de1_D20170101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQzMDE_77b79859-479a-44a6-9c73-ba8d31ab72cb"
      unitRef="usd">20400000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="if44a63268f854be99514777e8639749e_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQzMDk_c14156c6-cb6f-4746-acec-bd8b285e2f8f"
      unitRef="usd">27900000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQzNzQ_8837d4f4-ac9d-4be4-b8b5-d87bce99e1a7"
      unitRef="number">0.0145</us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i595e0d99768d4fddb665c130376a4241_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ4Mzc_631becfd-bbb9-4d56-be51-34114b9f7303"
      unitRef="usd">204100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ4NzI_e194f207-52ba-4a5a-ac1f-261c7fcd8b63"
      unitRef="usd">14000000.0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia79ee42fd3854b1094384535405e880c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ5MjI_a0d36a10-909c-4b4e-8c5d-31367607c178"
      unitRef="usd">56700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzQ5NTc_bf60cc7b-0048-4589-9d72-115a045cbdf6"
      unitRef="usd">7400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:OperatingLossCarryforwards
      contextRef="id7054c41751544f6b384cd99197b808f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUxNzk_af4eebe4-e7eb-4344-870a-2945ddb7248e"
      unitRef="usd">25700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="iff77fa642e814b6b8597126f28871557_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUxOTI_4b85339e-0424-4afd-ac73-ca45303727f5"
      unitRef="usd">178400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="ia79ee42fd3854b1094384535405e880c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUyNzA_ba4ec6af-bce0-460b-9257-c81cd3b26fde"
      unitRef="usd">54100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia79ee42fd3854b1094384535405e880c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzUyODY_a0d36a10-909c-4b4e-8c5d-31367607c178"
      unitRef="usd">56700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ie86aa1917b504d79b444ef1639528a31_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzU1MjI_037a2eb4-0d34-4457-a448-dbb8829c6a43"
      unitRef="usd">900000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNTcvZnJhZzphY2ZkYWU5MGE5NTA0ZjNiOGQ3OTdkYjI4NTQ0MDk2Mi90ZXh0cmVnaW9uOmFjZmRhZTkwYTk1MDRmM2I4ZDc5N2RiMjg1NDQwOTYyXzEwOTk1MTE2MzY0MTA_dd45d9a6-2ba7-44a5-a1fa-47e7ff994da4"
      unitRef="usd">345600000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEzNzM_7b4664af-0caa-47b3-bcec-1f51e97b1356">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we were obligated under various operating lease agreements. Please refer to Note 6, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Leases&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements. Please refer to Note 15, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Benefit Plans&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $118.4 million, of which $41.4 million is due to be paid in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have letters of credit totaling $2.5 million supporting the reimbursement of workers&#x2019; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.0 million at December&#160;31, 2020, of which $0.9 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our SmartDose contingent consideration is payable to the selling shareholders based upon a percentage of product sales over the life of the underlying product patent, with no cap on total payments. Given the length of the earnout period and the uncertainty in forecasted product sales, we do not believe it is meaningful to estimate the upper end of the range over the entire period. However, our estimated probable range which could become payable over the next five years is between zero and $4.3&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzUzMQ_28b329b1-a562-4f42-90ee-30ea4bb05276"
      unitRef="usd">118400000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzU0NA_6388b7b8-41fe-44e4-bac4-2ed9fd22b19c"
      unitRef="usd">41400000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <us-gaap:LineOfCredit
      contextRef="i0818ca18d1c04be49b0664009bcbaa77_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzYxMA_315bb1ed-acbe-4a20-942b-e1303c77e507"
      unitRef="usd">2500000</us-gaap:LineOfCredit>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ib485a2f5d6d34d779c1f358e30597b6b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzc2OA_6e7b969c-5b1a-42c5-b123-b23503e587b8"
      unitRef="usd">3000000.0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyReceivable
      contextRef="ib485a2f5d6d34d779c1f358e30597b6b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzc4Nw_e1da69bd-e264-4acc-a59f-c459674f7370"
      unitRef="usd">900000</us-gaap:LossContingencyReceivable>
    <wst:ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEzNDM_f5fab70f-dba1-4d1a-abb1-b3e9fbfbb447">P5Y</wst:ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEzNjM_17f9b7b8-8d50-4084-82bf-f67f0593d8aa"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjAvZnJhZzoyNDU0ODM0NWU5ZWY0YjhjYTZkNjkyZTkzMmJlNTlmZi90ZXh0cmVnaW9uOjI0NTQ4MzQ1ZTllZjRiOGNhNmQ2OTJlOTMyYmU1OWZmXzEwOTk1MTE2MjkxNjg_32451b6e-ee82-4d02-96f5-3835efe1ed11"
      unitRef="usd">4300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzEyNjQ0MzgzNzIzODUy_f0c276bc-8fe8-48b8-9157-7ed197f78e67">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment sales elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not have any customers accounting for greater than 10% of consolidated net sales.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other European countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The following tables provide summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total business segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate general costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated Items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of Acquisition-related Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost investment impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on restructuring-related sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Argentina currency devaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax recovery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense/(income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) The Company recorded $0.6&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) During the twelve months ended December 31, 2019, the Company recorded a net tax recovery of $4.4 million related to previously-paid international excise taxes, following a favorable court ruling.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 16, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_151" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Expense (Income)&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of unallocated items. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,793.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5Xzg3OTYwOTMwMjY2Mzc_05dcaef0-22e3-43a3-a617-2e5a7a5f0426">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment sales elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not have any customers accounting for greater than 10% of consolidated net sales.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other European countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The following tables provide summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total business segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate general costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated Items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of Acquisition-related Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost investment impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on restructuring-related sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Argentina currency devaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax recovery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense/(income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) The Company recorded $0.6&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) During the twelve months ended December 31, 2019, the Company recorded a net tax recovery of $4.4 million related to previously-paid international excise taxes, following a favorable court ruling.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 16, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#ic7db5523d9d74649b8592a121b55d512_151" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Expense (Income)&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of unallocated items. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,793.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5Xzc5_e91fded6-c102-4f0e-adcd-069debe0f04a"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzIxMTQ_c20c0315-8a8d-429d-b04a-270a0de5ac81">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment sales elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzItMS0xLTEtMA_d58a3fe7-6b92-4ef0-bc96-80c1726dea64"
      unitRef="usd">1648600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzItMy0xLTEtMA_e29a3d89-a72b-412a-bc2c-98dda445bba7"
      unitRef="usd">1398600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzItNS0xLTEtMA_a99044e8-bc31-47ac-9e79-99df4cb7346b"
      unitRef="usd">1308600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzMtMS0xLTEtMA_5d315ae7-5efe-4c01-9649-a1154712597f"
      unitRef="usd">498600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzMtMy0xLTEtMA_0d8f2e8a-aaa2-41e0-8fb8-2c72e7cfff7c"
      unitRef="usd">441500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzMtNS0xLTEtMA_218c103a-3aa0-45d6-9eac-b672d25125d8"
      unitRef="usd">409100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i774d0f0cab54416082070e38f9410ff3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzQtMS0xLTEtMA_810ce5e8-ae24-4be1-ad0e-a86c49f543c4"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2bd2ce98d3354cb59bc39ace8c778f47_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzQtMy0xLTEtMA_a6397164-b93c-4f4b-a6af-423e855124bd"
      unitRef="usd">-200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f2732fdbddd435f8a75ce6550a1311f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzQtNS0xLTEtMA_b90b4506-af9e-491c-8d97-e59caf1e7517"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzUtMS0xLTEtMA_a936de51-383c-4c62-8c43-028760f0fa32"
      unitRef="usd">2146900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzUtMy0xLTEtMA_5088c8d5-cb91-4708-a719-86ed09dc3727"
      unitRef="usd">1839900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo3NmE5ZDg4NWYxNjI0YzNmYWVjYzUyZGE2MWEwODAxNy90YWJsZXJhbmdlOjc2YTlkODg1ZjE2MjRjM2ZhZWNjNTJkYTYxYTA4MDE3XzUtNS0xLTEtMA_e7a2f116-e920-4aa3-8d34-57f7584db70d"
      unitRef="usd">1717400000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzIxMzQ_e1e1a8e9-f4b9-40ec-b9ad-66e4ef4112ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other European countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="iccc9431b0b454feab552857b416ea0ec_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItMS0xLTEtMA_c3ad6ddc-6ef1-4e07-aada-60e69988c121"
      unitRef="usd">975600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2d4d146be594713a85bdeb50230ab00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItMy0xLTEtMA_fa2e9f64-1fd5-447a-8c80-2f9392f3b769"
      unitRef="usd">814700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibf861532e0d24915b8be512c7b015ea5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItNS0xLTEtMA_3ee22af5-8fe8-400b-8a1e-a68bce911c71"
      unitRef="usd">766100000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i6859fd0c19984b50987f791266a4b2e3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItNy0xLTEtMA_32c4c9c0-a1ac-4d76-8465-6bdd26a23cb3"
      unitRef="usd">407800000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="icac6e86e417f4406a08009e46537f51c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzItOS0xLTEtMA_1b2a4b2b-2f69-4168-925d-68f55c633aac"
      unitRef="usd">364700000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="ibd8b305543904c68b1b271d9387d71fb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtMS0xLTEtMA_37fff1a4-6889-42b1-b4ec-b5b2389f05a6"
      unitRef="usd">282100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f8027821a434a1689f83110fca51907_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtMy0xLTEtMA_ca592149-9164-4426-86e7-0dc0de2dc253"
      unitRef="usd">236300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12d0dacf1c0841d5a307f3bfc32d20da_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtNS0xLTEtMA_d0d2bc53-ff16-4461-b6de-d1d9040fa33d"
      unitRef="usd">235900000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i2e114810392f4404aea674dae1f5b2f5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtNy0xLTEtMA_d33f82de-9ba2-4a6d-bfa5-08af82697387"
      unitRef="usd">112000000.0</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6699e8acb7d14b0ca42ade817a9f705f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzMtOS0xLTEtMA_bf0b6283-f4fb-4bd6-b91b-e2d30382df07"
      unitRef="usd">105500000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="i5d2ac6a7f541499ea8ccf5a4208ace40_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtMS0xLTEtMA_f242d018-10d0-4cca-9005-c5bcc55ea85f"
      unitRef="usd">226000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2805175e4f14fc5b6d7559c8e6d0bea_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtMy0xLTEtMA_63ca4293-3e60-4d76-9897-cefc0fadceb1"
      unitRef="usd">173800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieca17c3296344ba29f4960a8397d1ba5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtNS0xLTEtMA_c159274c-86ab-445d-b815-37c001e6a678"
      unitRef="usd">138100000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i2ed92857acc241a2bf581f09e87478ee_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtNy0xLTEtMA_dd98655a-5e53-49ff-b727-9f4de272a4de"
      unitRef="usd">197600000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ib123a778d0474f6ab51dda0673a420c3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzQtOS0xLTEtMA_7af26c9c-9466-452a-ae68-7ce1b986ace8"
      unitRef="usd">176600000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="id32983fbf1724e6ea83c4fa95b8a050f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtMS0xLTEtMA_4eb47cb9-7e74-436f-88d3-eca62ba03fea"
      unitRef="usd">172700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0588f0020ff4e1380042e497db31675_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtMy0xLTEtMA_e1020e87-3e7d-43b1-91dc-ccafecdf5f4d"
      unitRef="usd">150600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f4c8efe73a94954b43ffa84714f22f9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtNS0xLTEtMA_9edf895f-a5a8-4fd5-b58a-5879d125809e"
      unitRef="usd">145000000.0</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="id394f2aaf20a4f5a8065aac88dd87877_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtNy0xLTEtMA_8ba7cd0e-932a-4b7f-adfb-a3ad92b40e83"
      unitRef="usd">76000000.0</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i9018f7f2975643e0a3f04da690ae1d48_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzUtOS0xLTEtMA_da8678fb-4caa-4a83-a3cd-3dbbe16623b9"
      unitRef="usd">53800000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="ia76813d2bec64911becdf36778a96555_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtMS0xLTEtMA_758292b5-897c-4271-8b42-060e9dc2f82e"
      unitRef="usd">236800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e63f25aee7c40ba95eaeefc7de3649d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtMy0xLTEtMA_c74bf9ad-8930-4d40-8ead-0aec6175bcee"
      unitRef="usd">251100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i991655d17a3740aa8576ef108e472601_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtNS0xLTEtMA_bb693a34-3525-43f5-a166-1a6da9dc30d6"
      unitRef="usd">230500000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="ieddac01d5e554b06879611717faa28f6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtNy0xLTEtMA_d7dc63f4-42d2-42c2-bf05-10d03016566f"
      unitRef="usd">66800000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i81778baca03545dea6b871ec4c6c9f4d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzYtOS0xLTEtMA_900a77fd-a096-4392-85f7-393ef1b79e2b"
      unitRef="usd">59700000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="ifb14a0610fac4aad8769dddc489dbe8e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctMS0xLTEtMA_59141cf4-331b-4c5b-90ed-7be3d626606d"
      unitRef="usd">253700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i461ab78f5c0648c6b759cfad0b1be277_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctMy0xLTEtMA_f05b166d-0254-4145-b48b-57407858335b"
      unitRef="usd">213400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i415eb61f5a0546a8871238557c61e7a0_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctNS0xLTEtMA_575e30d5-2a27-443b-a734-28d1a69afc34"
      unitRef="usd">201800000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="i2ced6416e1114dbb92b4432c973d7b0a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctNy0xLTEtMA_035b989a-5b77-4e47-9fba-0dc0a14d28c9"
      unitRef="usd">151300000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i416bd58eeeb14e2fb2be821ef3871bd3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzctOS0xLTEtMA_68985a14-f34b-4638-ae61-965c9bbbd0b3"
      unitRef="usd">149100000</us-gaap:NoncurrentAssets>
    <us-gaap:Revenues
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtMS0xLTEtMA_a6ef1ccf-5ca5-4be6-b709-56bbba3ea4e5"
      unitRef="usd">2146900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtMy0xLTEtMA_687604f5-5bc1-444a-a03e-4f42bd8d2caa"
      unitRef="usd">1839900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtNS0xLTEtMA_f7d2e3ef-d250-4116-8094-3518eb956750"
      unitRef="usd">1717400000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtNy0xLTEtMA_35bbb6ba-2dc9-4198-9a6c-2b40262030ae"
      unitRef="usd">1011500000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTplZGQzNTg3ZDZiYzM0YTQyYjNmYWI0N2ViYjQ2NzJjZi90YWJsZXJhbmdlOmVkZDM1ODdkNmJjMzRhNDJiM2ZhYjQ3ZWJiNDY3MmNmXzgtOS0xLTEtMA_dc048010-284d-41d2-8881-6199367a1049"
      unitRef="usd">909400000</us-gaap:NoncurrentAssets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzIxMTk_e9f61c27-c0ba-412c-8ce3-05be6695815d">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The following tables provide summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total business segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate general costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated Items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and severance related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of Acquisition-related Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost investment impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on restructuring-related sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Argentina currency devaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax recovery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense/(income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) The Company recorded $0.6&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) During the twelve months ended December 31, 2019, the Company recorded a net tax recovery of $4.4 million related to previously-paid international excise taxes, following a favorable court ruling.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,793.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total consolidated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzItMS0xLTEtMA_2319f133-8475-4acd-9c99-fc1a3c8b4304"
      unitRef="usd">434500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzItMy0xLTEtMA_d5c86fae-a25b-4ee9-8b86-ea95e26514f2"
      unitRef="usd">313600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzItNS0xLTEtMA_38fe00f3-c413-41e1-99a9-cbadbf3abbb1"
      unitRef="usd">266400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzMtMS0xLTEtMA_7eaefc84-cf95-4ba2-af00-ef142402e701"
      unitRef="usd">68600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzMtMy0xLTEtMA_12116c1b-ae80-4a8f-a796-ebc27a25da46"
      unitRef="usd">49100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzMtNS0xLTEtMA_762e6e9c-78cd-498f-b4e6-078929660e30"
      unitRef="usd">44300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic1438eab01bf433fbc35a309da3262d5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMS0xLTEtMTI3MDA_caa3a068-64b7-4b9c-9ad9-f45562a4e208"
      unitRef="usd">503100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i60b7677acdc9401e83ce68aef09e830c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMy0xLTEtMTI3MDA_0ebc7b7a-29d3-46b7-b3a5-c000626cacff"
      unitRef="usd">362700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie10fea7610d24805934edfad68c8e75b_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtNS0xLTEtOTU4MA_edc4c6a4-1c97-4422-8ed5-d5adc40a3026"
      unitRef="usd">310700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMS0xLTEtMTIyMjA_8525c57c-eab6-4734-8f7f-344ff0ebe4b1"
      unitRef="usd">34000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMy0xLTEtMTIyMjA_9bec6abe-eb81-41ff-94d2-0cd74232306a"
      unitRef="usd">24400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctNS0xLTEtMTIyMjA_c635c138-d450-43e8-89ee-09bb35002350"
      unitRef="usd">15100000</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMS0xLTEtMTIyMjA_034ada9b-10d1-4c60-b721-54ffe66c7781"
      unitRef="usd">52100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMy0xLTEtMTIyMjA_76e43037-4a0c-4fb5-aa3b-25e95a4c8a31"
      unitRef="usd">41900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtNS0xLTEtOTU4NA_d9ec1b54-f31d-41ec-9001-22994a5452c0"
      unitRef="usd">46200000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTEtMS0xLTEyMjIw_1f91d4ad-a2f7-4af8-b09f-375f315b7e48"
      unitRef="usd">7000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTMtMS0xLTEyMjIw_36b41b09-d0fc-4300-a560-46e614385645"
      unitRef="usd">4900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTUtMS0xLTk1ODQ_d2f6c181-6ee1-45e1-8018-ea4252add366"
      unitRef="usd">9100000</us-gaap:RestructuringCharges>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMS0xLTEtMA_1a2beafa-7f44-40f8-ae68-f1d2bf7fd3ff"
      unitRef="usd">600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtMy0xLTEtMA_9db3ead4-12c2-4dc9-bdf7-9d929512f6a6"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzQtNS0xLTEtMA_ef2b020e-612b-431c-9322-505561364172"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <wst:CostInvestmentImpairment
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtMS0xLTEtMA_476bf67b-ab5c-4357-8e35-4f1a552bfc36"
      unitRef="usd">2500000</wst:CostInvestmentImpairment>
    <wst:CostInvestmentImpairment
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtMy0xLTEtMA_fcbf919b-be3d-4aac-acad-a17fd0534dde"
      unitRef="usd">0</wst:CostInvestmentImpairment>
    <wst:CostInvestmentImpairment
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzUtNS0xLTEtMA_e49e245c-857b-459c-8263-f1ca99c98b27"
      unitRef="usd">0</wst:CostInvestmentImpairment>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzYtMS0xLTEtMA_d17f866c-584f-4086-8c36-7e500c8d992b"
      unitRef="usd">0</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzYtMy0xLTEtMA_3e36f7b7-f154-4e2a-9c6f-e838a1918245"
      unitRef="usd">1700000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzYtNS0xLTEtMA_8383b634-8090-4129-9ece-78b5029f7faa"
      unitRef="usd">1100000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <wst:GainLossOnArgentinaCurrencyDevaluation
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMS0xLTEtMA_69f2e191-7fd2-4f48-8e92-86fb310243b4"
      unitRef="usd">0</wst:GainLossOnArgentinaCurrencyDevaluation>
    <wst:GainLossOnArgentinaCurrencyDevaluation
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctMy0xLTEtMA_42484d82-44a2-4046-bb69-bf08a92d8b0f"
      unitRef="usd">-1000000.0</wst:GainLossOnArgentinaCurrencyDevaluation>
    <wst:GainLossOnArgentinaCurrencyDevaluation
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzctNS0xLTEtMA_50f9e275-5725-43b9-8ee0-881ff5eae4ed"
      unitRef="usd">-1100000</wst:GainLossOnArgentinaCurrencyDevaluation>
    <wst:BrazilTaxRecovery
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMS0xLTEtMA_158c468e-7f68-4289-8960-b9e371a3beb2"
      unitRef="usd">0</wst:BrazilTaxRecovery>
    <wst:BrazilTaxRecovery
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtMy0xLTEtMA_af8c632d-2842-4ad6-8bb8-4d94b081cd94"
      unitRef="usd">4400000</wst:BrazilTaxRecovery>
    <wst:BrazilTaxRecovery
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzgtNS0xLTEtMA_b1ee7e17-21f5-4763-89ba-2e0eb5f3cccb"
      unitRef="usd">0</wst:BrazilTaxRecovery>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzktMS0xLTEtMA_93e0f864-d6ca-46e5-8c52-48309c26278c"
      unitRef="usd">-96200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzktMy0xLTEtMA_0dcce247-7bea-4672-98fb-a2d83042e7b1"
      unitRef="usd">-66100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzktNS0xLTEtMA_5bb4ab48-b458-423e-86d8-ac83240a6ec5"
      unitRef="usd">-70400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTEtMS0xLTA_c74caed1-4ea8-45f3-921e-d309022e242e"
      unitRef="usd">406900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTMtMS0xLTA_334679d6-4dbe-423e-9719-5b592982731d"
      unitRef="usd">296600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEwLTUtMS0xLTA_98c9539b-d8f8-4fb4-b0f1-a2260b2c75a5"
      unitRef="usd">240300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEzLTEtMS0xLTA_d0dadbeb-a6ff-4d32-b757-c1f50a07ab40"
      unitRef="usd">-5600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEzLTMtMS0xLTA_b63f5a2d-ff1b-41d0-92e1-cd81360a46d6"
      unitRef="usd">-4800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzEzLTUtMS0xLTA_6c7214da-78c2-4dbd-9192-ef14b0d329f4"
      unitRef="usd">400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzE0LTEtMS0xLTA_b23c98d2-481f-4251-ae9c-0d85379bfd4c"
      unitRef="usd">401300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzE0LTMtMS0xLTA_0d8adb4d-f448-441a-822a-60b8aab41c8e"
      unitRef="usd">291800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5YzI2ZDg5MjU0MzE0OTA3YWIzM2MzY2M2NDI2MDhhNC90YWJsZXJhbmdlOjljMjZkODkyNTQzMTQ5MDdhYjMzYzNjYzY0MjYwOGE0XzE0LTUtMS0xLTA_b4ceda2e-c118-43ff-8586-f99c36aa7205"
      unitRef="usd">240700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzQzOTgwNDY1MTUyMDY_7dc4000b-d6fc-4814-a053-22ff1b7dde82"
      unitRef="usd">600000</us-gaap:AmortizationOfIntangibleAssets>
    <wst:BrazilTaxRecovery
      contextRef="i60b7677acdc9401e83ce68aef09e830c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90ZXh0cmVnaW9uOjJmMDdiMmNlNmVlNzQzMjJhNjlmZDdjNjE0MWNhZTM5XzEwOTk1MTE2MzE1NjI_7362f7f9-91e5-4ac1-be33-20b46c84db90"
      unitRef="usd">4400000</wst:BrazilTaxRecovery>
    <us-gaap:Assets
      contextRef="i2ccb8142a6fd48a197381524a3af0e94_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzItMS0xLTEtMTI4NTU_d4b1665c-e836-46be-a9f6-f1712082a9c1"
      unitRef="usd">1798300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4a0e7149a4524df1af74160af660cd5f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzItMy0xLTEtMTI4NTU_2b4131e4-f60f-4b18-9721-487ca6265b02"
      unitRef="usd">1480600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie5a866adcce645a4a119d06e29948d8b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzMtMS0xLTEtMTI4NTU_3914509a-6796-4c70-8320-6f8e5b7589f2"
      unitRef="usd">411600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i35257ff2d24b4eb0b102a172b964a457_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzMtMy0xLTEtMTI4NTU_c05d471d-44c7-41ad-9bbc-6a901720e8b4"
      unitRef="usd">386000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8cda55f4b25b43e7b343a66c73455087_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzQtMS0xLTEtMTI4NTU_c7b3eda0-2b3f-45a7-8faa-a10256955590"
      unitRef="usd">583900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i543690089e2d4cd78c08099fc3cabbd8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzQtMy0xLTEtMTI4NTU_f5af4e1a-5c58-4c43-a27f-bd522085506d"
      unitRef="usd">474800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzUtMS0xLTEtMTI4NzQ_1001eaa6-e242-4b2f-ae10-4f5c17ed3ce4"
      unitRef="usd">2793800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZToyNzRjMDU2NDcxYzM0NzUwOTIyNmE2NDgzMWZjZGNhMC90YWJsZXJhbmdlOjI3NGMwNTY0NzFjMzQ3NTA5MjI2YTY0ODMxZmNkY2EwXzUtMy0xLTEtMTI4NzY_dea38305-6181-455c-acbe-c4534150b952"
      unitRef="usd">2341400000</us-gaap:Assets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzgtMS0xLTEtMTIzMzY_8cec8599-02de-43ec-b385-02265ae6eb91"
      unitRef="usd">84600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzgtMy0xLTEtMTIzMzY_b9e605ec-5d1e-430c-bea3-a7bf02f46436"
      unitRef="usd">82200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzgtNS0xLTEtMTIzMzY_b2d922cb-c8a9-4b32-89cd-c6f1b99d27c6"
      unitRef="usd">83900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzktMS0xLTEtMTIzMzY_76edf92f-4588-4dec-9124-e506dc90b0a9"
      unitRef="usd">20400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzktMy0xLTEtMTIzMzY_c0cd445e-5e7f-4c4a-94eb-b15c28d80fdf"
      unitRef="usd">17900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzktNS0xLTEtMTIzMzY_dc203c87-21ce-4e3b-a9a8-b3d332db5756"
      unitRef="usd">17200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzEwLTEtMS0xLTEyMzM2_9e745905-ecc1-450e-a389-aee438e5ddf4"
      unitRef="usd">4100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzEwLTMtMS0xLTEyMzM2_9a4d32cf-f57d-4327-917f-b66b36be585e"
      unitRef="usd">3300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzEwLTUtMS0xLTEyMzM2_d90eb0b0-ed79-4321-b884-b25de2961658"
      unitRef="usd">3300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzExLTEtMS0xLTEyMzM2_1d95f286-c236-4399-b2bd-287161291e6e"
      unitRef="usd">109100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzExLTMtMS0xLTEyMzM2_fb7ada9c-dfb2-4954-a12b-db14e619ae4f"
      unitRef="usd">103400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzExLTUtMS0xLTEyMzM2_118b6744-de79-42b5-9b89-ef039b2dd401"
      unitRef="usd">104400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE0LTEtMS0xLTEyMzQ2_1aa19ed9-e0cb-401a-a46d-d3916b94c185"
      unitRef="usd">139500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i08dc3f4ebae94a448c4c179fe964cf13_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE0LTMtMS0xLTEyMzQ2_b6b801f6-24a8-4083-bcc9-c659ee5fbab9"
      unitRef="usd">88700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i06b12001f2fc43b8a30f076a5b9bd748_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE0LTUtMS0xLTEyMzQ2_f13f72c9-1eb8-4edd-b433-0dc595b24c81"
      unitRef="usd">79100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibfd803ec609c4cfb8ed3982697eb2007_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE1LTEtMS0xLTEyMzQ2_9d63c2a2-b3d5-4432-bd8f-9f813b7253d9"
      unitRef="usd">25000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia6bad404ac0543d1a33ef7b7dec066f5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE1LTMtMS0xLTEyMzQ2_56d346e0-cc37-4d42-9d73-d5f18782e841"
      unitRef="usd">36100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2720d9d3ee1d4de0909b54c6dc34d1bb_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE1LTUtMS0xLTEyMzQ2_913b364f-249d-415d-8a84-6908c4f99491"
      unitRef="usd">24300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3da9815b39bd49fb9cd01d34df787e00_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE2LTEtMS0xLTEyMzQ2_8978f6b5-0b6c-4262-bd98-fde0113e53a1"
      unitRef="usd">9900000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6fca70c80a1f4f378967a269997b1285_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE2LTMtMS0xLTEyMzQ2_2f0d8c3f-2511-486d-8077-3e6433513561"
      unitRef="usd">1600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia9b5fd2834ff408aaf888253d5b1d606_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE2LTUtMS0xLTEyMzQ2_cad97e41-2cc7-4bfa-86ed-1498577c1ba3"
      unitRef="usd">1300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE3LTEtMS0xLTEyNzY5_ca92518a-198a-497f-82f4-0b8d841f6b29"
      unitRef="usd">174400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE3LTMtMS0xLTEyNzYz_18354e86-e3ee-4577-97d5-e0dd6b332daa"
      unitRef="usd">126400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjMvZnJhZzoyZjA3YjJjZTZlZTc0MzIyYTY5ZmQ3YzYxNDFjYWUzOS90YWJsZTo5OWYyOTY1MzFhNzg0MjczYTJlYjUyYzg1NGU0NzFkNS90YWJsZXJhbmdlOjk5ZjI5NjUzMWE3ODQyNzNhMmViNTJjODU0ZTQ3MWQ1XzE3LTUtMS0xLTEyNzY1_c0fcbc61-c390-41d3-ba50-f47c4d53da0d"
      unitRef="usd">104700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzYwNDczMTM5NjMyNzc_7d7ce24e-72c8-435b-b2c8-cc8c143ec115">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quarterly Operating and Per Share Data (Unaudited)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Full Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sum of the quarterly amounts may not equal full year due to rounding. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Factors affecting the comparability of the information reflected in the quarterly data:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Net income for the first quarter of 2020 included the impact of a pension settlement charge of $1.1 million ($0.01 per diluted share), amortization expense of $1.0 million ($0.01 per diluted share) associated with an acquisition of increased ownership interest in Daikyo, and a tax benefit of $5.1 million ($0.07 per diluted share) associated with stock-based compensation. Net income for the first quarter of 2019 included the impact of restructuring and related charges of $0.4&#160;million ($0.01 per diluted share) and a tax benefit of $1.4&#160;million ($0.02 per diluted share) associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Second quarter 2020 net income included the impact of a pension settlement charge of $0.7 million ($0.01 per diluted share), amortization expense of $1.1&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, a charge of $1.6 million ($0.02 per diluted share) related to severance costs, and a tax benefit of $6.9 million ($0.09 per diluted share) associated with stock-based compensation. Second quarter 2019 net income included the impact of restructuring and related charges of $1.1&#160;million ($0.01 per diluted share) and a tax benefit of $3.8&#160;million ($0.05 per diluted share) associated with stock-based compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Net income for the third quarter of 2020 included the impact of a pension settlement charge of $0.8 million ($0.01 per diluted share), amortization expense of $0.7 million ($0.01 per diluted share) associated with the acquisition of intangible assets, a restructuring and severance related charge of $3.4 million ($0.04 per diluted share), and a tax benefit of $2.0 million ($0.02 per diluted share) associated with stock-based compensation. Net income for the third quarter of 2019 included the impact of restructuring and related charges of $1.4&#160;million ($0.01 per diluted share), a pension settlement charge of $2.1&#160;million ($0.03 per diluted share), a charge of $0.7&#160;million ($0.01 per diluted share) related to the devaluation of Argentina&#x2019;s currency, a tax benefit of $1.0&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $4.0&#160;million ($0.05 per diluted share) associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;(4)Fourth quarter 2020 net income included the impact of a pension settlement charge of $0.3&#160;million ($0.01 per diluted share), amortization expense of $0.7&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, an impairment charge of $2.5&#160;million ($0.03 per diluted share) related to a cost investment, and a tax benefit of $6.8 million ($0.09 per diluted share) associated with stock-based compensation. Fourth quarter 2019 net income included the impact of restructuring and related charges of $0.8&#160;million ($0.02 per diluted share), a gain on the sale of fixed assets as a result of our restructuring plan of $1.3&#160;million ($0.02 per diluted share), a pension settlement charge of $0.6&#160;million ($0.01 per diluted share), a tax recovery related to previously-paid international excise taxes of $2.9&#160;million ($0.04 per diluted share), a tax charge of $0.7&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $1.1&#160;million ($0.02 per diluted share) associated with stock-based compensation.</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzYwNDczMTM5NjMyNzg_2eef70e5-0b97-4ea2-bc46-7174b4649a46">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Full Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sum of the quarterly amounts may not equal full year due to rounding. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Factors affecting the comparability of the information reflected in the quarterly data:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Net income for the first quarter of 2020 included the impact of a pension settlement charge of $1.1 million ($0.01 per diluted share), amortization expense of $1.0 million ($0.01 per diluted share) associated with an acquisition of increased ownership interest in Daikyo, and a tax benefit of $5.1 million ($0.07 per diluted share) associated with stock-based compensation. Net income for the first quarter of 2019 included the impact of restructuring and related charges of $0.4&#160;million ($0.01 per diluted share) and a tax benefit of $1.4&#160;million ($0.02 per diluted share) associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Second quarter 2020 net income included the impact of a pension settlement charge of $0.7 million ($0.01 per diluted share), amortization expense of $1.1&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, a charge of $1.6 million ($0.02 per diluted share) related to severance costs, and a tax benefit of $6.9 million ($0.09 per diluted share) associated with stock-based compensation. Second quarter 2019 net income included the impact of restructuring and related charges of $1.1&#160;million ($0.01 per diluted share) and a tax benefit of $3.8&#160;million ($0.05 per diluted share) associated with stock-based compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Net income for the third quarter of 2020 included the impact of a pension settlement charge of $0.8 million ($0.01 per diluted share), amortization expense of $0.7 million ($0.01 per diluted share) associated with the acquisition of intangible assets, a restructuring and severance related charge of $3.4 million ($0.04 per diluted share), and a tax benefit of $2.0 million ($0.02 per diluted share) associated with stock-based compensation. Net income for the third quarter of 2019 included the impact of restructuring and related charges of $1.4&#160;million ($0.01 per diluted share), a pension settlement charge of $2.1&#160;million ($0.03 per diluted share), a charge of $0.7&#160;million ($0.01 per diluted share) related to the devaluation of Argentina&#x2019;s currency, a tax benefit of $1.0&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $4.0&#160;million ($0.05 per diluted share) associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;(4)Fourth quarter 2020 net income included the impact of a pension settlement charge of $0.3&#160;million ($0.01 per diluted share), amortization expense of $0.7&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, an impairment charge of $2.5&#160;million ($0.03 per diluted share) related to a cost investment, and a tax benefit of $6.8 million ($0.09 per diluted share) associated with stock-based compensation. Fourth quarter 2019 net income included the impact of restructuring and related charges of $0.8&#160;million ($0.02 per diluted share), a gain on the sale of fixed assets as a result of our restructuring plan of $1.3&#160;million ($0.02 per diluted share), a pension settlement charge of $0.6&#160;million ($0.01 per diluted share), a tax recovery related to previously-paid international excise taxes of $2.9&#160;million ($0.04 per diluted share), a tax charge of $0.7&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $1.1&#160;million ($0.02 per diluted share) associated with stock-based compensation.</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItMS0xLTEtMA_252e741d-7678-4612-afa8-f4e593183a13"
      unitRef="usd">491500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItMy0xLTEtMA_358341a5-3c5f-4955-b7d5-2f66e0d3eff4"
      unitRef="usd">527200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItNS0xLTEtMA_b8b152c8-888d-4626-b1b0-b0d2805feed9"
      unitRef="usd">548000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItNS0xLTEtMA_b9947f96-58ea-4b9e-babc-3d247957440b"
      unitRef="usd">548000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItNy0xLTEtMA_9126ba9b-c08f-45f1-be5d-309d37296804"
      unitRef="usd">580200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzItOS0xLTEtMA_e9bbe102-a7c5-4e45-9fa2-b59d4312180f"
      unitRef="usd">2146900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtMS0xLTEtMA_daaad73d-1ab2-4ee2-8fa9-1341d021cc16"
      unitRef="usd">167000000.0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtMy0xLTEtMA_06fed8cc-84ab-40c4-9352-1545978006e2"
      unitRef="usd">195100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtNS0xLTEtMA_01d30c4c-914c-43b8-a39e-eb081a1cec2e"
      unitRef="usd">194600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtNS0xLTEtMA_f13fabc8-fa27-4c72-8ca0-a1d36b118e26"
      unitRef="usd">194600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtNy0xLTEtMA_e35b43e9-6a1f-4d35-b3cd-a4b5ed3ac379"
      unitRef="usd">211100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzMtOS0xLTEtMA_c2441dfa-f2f2-46ee-bf92-afdafc0a1e36"
      unitRef="usd">767800000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtMS0xLTEtMA_38c925af-e79b-4601-ba30-5425d54532cc"
      unitRef="usd">74300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtMy0xLTEtMA_600803ac-a41b-4dc4-96a0-6cdcc5505bfb"
      unitRef="usd">91200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtNS0xLTEtMA_02d39931-15eb-4492-9ef3-759a24bc2d90"
      unitRef="usd">82300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtNS0xLTEtMA_fe452c93-fe0a-4af2-8350-47462d5b3b0a"
      unitRef="usd">82300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtNy0xLTEtMA_3eb10623-8a0d-4a47-8732-160774717033"
      unitRef="usd">98400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzQtOS0xLTEtMA_92f151ab-6ec2-433e-93c6-4f655d666b0f"
      unitRef="usd">346200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtMS0xLTEtMA_4fdfe541-1d67-450f-a1bb-f7e023c8227e"
      unitRef="usdPerShare">1.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtMy0xLTEtMA_81fe3c0a-2e22-43d2-8bb8-36e6559fd666"
      unitRef="usdPerShare">1.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtNS0xLTEtMA_b81ecbf4-bab8-4ed9-82cb-5a7ad55a574b"
      unitRef="usdPerShare">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtNy0xLTEtMA_6646ab7a-e0f2-4c57-a8c9-666aff8b721e"
      unitRef="usdPerShare">1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzYtOS0xLTEtMA_9f052c5b-b8d5-4ee8-9488-c68b8766bd0f"
      unitRef="usdPerShare">4.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctMS0xLTEtMA_183d9745-0244-462b-9164-5d98c2c04c59"
      unitRef="usdPerShare">0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctMy0xLTEtMA_c44c277c-f9f7-443f-812c-e74222bdc88d"
      unitRef="usdPerShare">1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctNS0xLTEtMA_60c51374-39eb-46ab-b7d8-b2b05ad93be5"
      unitRef="usdPerShare">1.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctNy0xLTEtMA_c09fc29e-50f5-4ab2-ae63-d84e6b97c20f"
      unitRef="usdPerShare">1.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzctOS0xLTEtMA_65434d47-17c0-408d-a4ff-3b393913ae8a"
      unitRef="usdPerShare">4.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTEtMS0xLTA_1b466d36-1a7f-4d5b-91d2-f1941702ef1b"
      unitRef="usd">443500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTMtMS0xLTA_7f0b2e5f-d49b-445d-bb07-51dad3bbe1de"
      unitRef="usd">469700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTUtMS0xLTA_07217014-3b4f-4869-bdbd-89a7c48a6a11"
      unitRef="usd">456100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTctMS0xLTA_6aebfc03-ad1b-49d3-81d0-20f274ef6347"
      unitRef="usd">470600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEwLTktMS0xLTA_e55ed845-79fb-456f-bf41-223a9f5cb9d2"
      unitRef="usd">1839900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTEtMS0xLTA_b4b9601e-1f72-45fb-a150-30cf3e694ab6"
      unitRef="usd">146800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTMtMS0xLTA_4e33679c-368f-4948-a6af-4ae40590997d"
      unitRef="usd">157900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTUtMS0xLTA_574dc2c3-7b55-41ce-b99f-2cad8ec21a4b"
      unitRef="usd">147800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTctMS0xLTA_31201491-e77f-4f18-be16-1da40186d523"
      unitRef="usd">153200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzExLTktMS0xLTA_9907b28a-6f95-47ce-9420-2d20dfff1f4c"
      unitRef="usd">605700000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTEtMS0xLTA_fd982bdb-df5f-469e-9f5c-0cdf3b0594b7"
      unitRef="usd">55400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTMtMS0xLTA_bbed13bc-cb80-4840-8a8c-edf5556e787e"
      unitRef="usd">66100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTUtMS0xLTA_5b1c3ac6-d804-4fe4-8f04-56ae8db1cee6"
      unitRef="usd">56300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTctMS0xLTA_77ca677d-0587-4b75-a3be-3705097c7de7"
      unitRef="usd">63900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzEyLTktMS0xLTA_7ce66629-869e-4932-b8ae-4de86dff0b73"
      unitRef="usd">241700000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTEtMS0xLTA_c866835e-bcbb-4260-b981-e6ae4b771b7f"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTMtMS0xLTA_4e4ea5af-338e-460d-8a95-1d39c609ffd6"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTUtMS0xLTA_230a2b50-bcee-4c81-9e8d-fabb3bc2240b"
      unitRef="usdPerShare">0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTctMS0xLTA_2650670c-1c4f-4f7d-be48-be5d202b9760"
      unitRef="usdPerShare">0.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE0LTktMS0xLTA_28d63c43-e577-4d6b-8072-7b744a355b2d"
      unitRef="usdPerShare">3.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTEtMS0xLTA_92c8219f-c248-4b9f-80e4-3ad9c947cd19"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTMtMS0xLTA_bb32f623-0c22-498a-8d68-34822b94922b"
      unitRef="usdPerShare">0.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTUtMS0xLTA_abfadcc0-d64a-4480-a5c2-0d973bef0cd2"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTctMS0xLTA_fe736497-e688-48f8-9615-4839080c735f"
      unitRef="usdPerShare">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90YWJsZTozYTEzOTEwNWZlZDE0NjgyYjlkMWIwMjM4YjQ0MjgxYy90YWJsZXJhbmdlOjNhMTM5MTA1ZmVkMTQ2ODJiOWQxYjAyMzhiNDQyODFjXzE1LTktMS0xLTA_f004d35f-99e1-4de4-ae83-e98b9dad5d9d"
      unitRef="usdPerShare">3.21</us-gaap:EarningsPerShareDiluted>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzI5ODc_35eb2775-4579-44c9-b865-0ef1d7bd2d78"
      unitRef="usd">1100000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzI5OTU_8740848d-5782-4919-8881-677c40ac8f3e"
      unitRef="usdPerShare">0.01</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i719b99d7c88542fa96519a7e6ee06942_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTE2NjQ_6319915b-77b3-403b-a582-94c5889eee85"
      unitRef="usd">1000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <wst:AmortizationExpenseImpactOnDilutedEarningsPerShare
      contextRef="i719b99d7c88542fa96519a7e6ee06942_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTE2ODA_9e60211c-2872-4d5d-8152-ad1bfe2d6847"
      unitRef="usdPerShare">0.01</wst:AmortizationExpenseImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMDI_fef42fa5-6820-48ca-b379-4f3fc57c2ce4"
      unitRef="usd">5100000</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="i0a8266a831534cb98d031cdaf5da6301_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMDk_f9559571-a4b4-4bba-94a4-bd583654e13a"
      unitRef="usdPerShare">0.07</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU1NzQ_8495ba31-472a-4247-a010-be83f8033382"
      unitRef="usd">400000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MDk_71fe9335-a682-4623-9578-cc2d873c4351"
      unitRef="usdPerShare">0.01</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU1ODg_7850c1a2-95a6-47dc-a459-b3ec05c8d719"
      unitRef="usd">1400000</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="i79acba4e44c2484894ed9a1a737765f8_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MDI_d1f2909e-1e46-4e42-96ff-4c37e63cae44"
      unitRef="usdPerShare">0.02</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMzA_ec2ca2ad-70d6-4381-8a73-7e8e41b69f0a"
      unitRef="usd">700000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwMzg_f6e2c37e-d131-45b9-a5f7-1cb01e3f5b42"
      unitRef="usdPerShare">0.01</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9d8b5816ea284568a1893e7fcb6f3fd7_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzkzNDU4NDg4NDY2MDg_044c9e46-e5c8-4e9f-bb45-e852492d19bc"
      unitRef="usd">1100000</us-gaap:AmortizationOfIntangibleAssets>
    <wst:AmortizationExpenseImpactOnDilutedEarningsPerShare
      contextRef="i9d8b5816ea284568a1893e7fcb6f3fd7_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0Xzg3OTYwOTMwMzI3MzQ_3f17ccb8-4d30-4cd2-92a1-a89c1e0cf2d9"
      unitRef="usdPerShare">0.01</wst:AmortizationExpenseImpactOnDilutedEarningsPerShare>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTA5OTE_9bf110da-803b-4b21-8ea9-5ee1bd63d8c4"
      unitRef="usd">1600000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <wst:PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTEwMDQ_c0e24f95-642c-4eb5-b97e-559b5ef8be31"
      unitRef="usdPerShare">0.02</wst:PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNDU_b95c2c12-238f-432d-9b04-214c140a7e5c"
      unitRef="usd">6900000</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="icb759617c07b438881d6de4ad4b15bca_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNTM_a6e529fa-0c29-4707-800e-4888e9be44e1"
      unitRef="usdPerShare">0.09</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2Mzc_af31fc11-1173-494c-a6e6-0c6c336f868f"
      unitRef="usd">1100000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2NTE_a6712e31-64ea-4bcc-9de3-db8299e6208d"
      unitRef="usdPerShare">0.01</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MTY_18a23365-e931-4a9d-b768-30960204b4a6"
      unitRef="usd">3800000</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="i448f7000cbc947e19eaf6fc42872d132_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2MzA_f0a233d7-eb6e-4699-b9b8-007d8bc2c8ff"
      unitRef="usdPerShare">0.05</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNjA_91cd72e8-01a6-42a1-99f0-37fd3d975938"
      unitRef="usd">800000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzMwNjg_28340164-0cd8-488e-b909-5100614ba8aa"
      unitRef="usdPerShare">0.01</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic26980b6c24b44caaac3a924b44a1e9e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTIxNTY_8bd7209c-3bc5-41eb-913c-0ece1f7bff37"
      unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <wst:AmortizationExpenseImpactOnDilutedEarningsPerShare
      contextRef="ic26980b6c24b44caaac3a924b44a1e9e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTIxNjQ_da86b48a-1bba-4f43-8d6a-56ad0de5be28"
      unitRef="usdPerShare">0.01</wst:AmortizationExpenseImpactOnDilutedEarningsPerShare>
    <wst:RestructuringAndSeveranceRelatedCharges
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MTU_58d3ecbf-3772-4223-b5c6-a9b41270959a"
      unitRef="usd">3400000</wst:RestructuringAndSeveranceRelatedCharges>
    <wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTExODA_6b466b8a-4aac-4047-9431-34746c22dc5b"
      unitRef="usdPerShare">0.04</wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MDk_9631bfb4-c5fd-457e-8f8c-ec341eff0c85"
      unitRef="usd">2000000.0</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="i52e71af89f95439d8c5b6112c9a2a755_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzE2NDkyNjc0NTEyNDU_a27dc874-3972-4fda-889a-c8ff0d50af4a"
      unitRef="usdPerShare">0.02</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <wst:RestructuringAndSeveranceRelatedCharges
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MjE_3e3497aa-c504-4ef4-a78e-b0cdbe6738bd"
      unitRef="usd">1400000</wst:RestructuringAndSeveranceRelatedCharges>
    <wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MzU_9f4bb7aa-5ff6-401d-9809-2f80de9e1508"
      unitRef="usdPerShare">0.01</wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MDc_3692ab3b-8531-432f-9b05-9c593340537c"
      unitRef="usd">2100000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3MDA_2509cf7e-e027-4327-b115-a3a455945749"
      unitRef="usdPerShare">0.03</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NDI_a46cd455-3361-4825-b677-051f1d06711c"
      unitRef="usd">700000</wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency>
    <wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NTY_0cf8cbf4-2087-4462-9a26-d958fa308c31"
      unitRef="usdPerShare">0.01</wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2NTg_8e9af450-f601-4c1f-b3f9-a06421f65fe4"
      unitRef="usd">1000000.0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <wst:IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2NzI_7ad14b3c-00b2-41fe-9d55-eeb7e95f41fe"
      unitRef="usdPerShare">0.01</wst:IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2ODY_392d8d78-1618-4d93-a895-980a455d8eb7"
      unitRef="usd">4000000.0</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="ie86813f6c078423bb0288f665c4f1ee5_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU2Nzk_6cfd23c4-90dd-4c35-a9f3-474c71a3204e"
      unitRef="usdPerShare">0.05</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MTk5NzQ_89988be1-4d95-466e-aa92-2b5ea7597194"
      unitRef="usd">300000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MTk5ODk_e67a42fb-6d95-4adf-a8b9-3cefdb354639"
      unitRef="usdPerShare">0.01</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7fe7bd6c2ccf4155b6958ffbe633b8b2_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA2MTA_9210c08b-8871-40bc-9d17-2e3e9801addb"
      unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <wst:AmortizationExpenseImpactOnDilutedEarningsPerShare
      contextRef="i7fe7bd6c2ccf4155b6958ffbe633b8b2_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA2Mjg_41f6075c-c0c4-4650-937b-2118e2ebf641"
      unitRef="usdPerShare">0.01</wst:AmortizationExpenseImpactOnDilutedEarningsPerShare>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA3NDU_6755ccc0-29e2-4e91-b028-f5149deef534"
      unitRef="usd">2500000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <wst:PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzQzOTgwNDY1MjA3NTQ_b6265321-1ba0-48c0-8281-d0514d2f84b1"
      unitRef="usdPerShare">0.03</wst:PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MTk_2ac47eec-454e-496d-92b8-cdbe4a2b73c3"
      unitRef="usd">6800000</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzY2MjY_b7575335-505f-460b-9288-680ea393c296"
      unitRef="usdPerShare">0.09</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <wst:RestructuringAndSeveranceRelatedCharges
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4NzU_76adc082-c6e3-4125-baa2-63e41d228a22"
      unitRef="usd">800000</wst:RestructuringAndSeveranceRelatedCharges>
    <wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4Njg_3689afeb-efef-4dae-b8e9-58150fb1f2f5"
      unitRef="usdPerShare">0.02</wst:RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare>
    <wst:FixedAssetImpairmentFromRestructuring
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4NTQ_00342996-ff25-46f4-a51a-195689597693"
      unitRef="usd">1300000</wst:FixedAssetImpairmentFromRestructuring>
    <wst:FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4NDc_4898f2b2-4aaf-49f1-9cf8-fb83172f71b8"
      unitRef="usdPerShare">0.02</wst:FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare>
    <wst:PensionSettlementAndRelatedCharges
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MzM_df8fbcfb-4f0b-42fb-adf6-8e22e8aaeab7"
      unitRef="usd">600000</wst:PensionSettlementAndRelatedCharges>
    <wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MjY_b50560d0-cb32-48d1-820f-cb95b51fadb7"
      unitRef="usdPerShare">0.01</wst:PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare>
    <wst:PaymentOfExciseTaxes
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MTI_0d2595e0-c7d8-49b3-a409-4f82eb245755"
      unitRef="usd">2900000</wst:PaymentOfExciseTaxes>
    <wst:PaymentOfExciseTaxesImpactOnDilutedEarningsShare
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU4MDU_e83add79-b2c6-4f4c-b0fb-89a156b53510"
      unitRef="usdPerShare">0.04</wst:PaymentOfExciseTaxesImpactOnDilutedEarningsShare>
    <wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3OTE_d7a80b4f-aaec-4f18-b6fb-9bae369988f5"
      unitRef="usd">700000</wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency>
    <wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3ODQ_337bcf78-deae-4ba1-8caa-538b028a28fa"
      unitRef="usdPerShare">0.01</wst:ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare>
    <wst:IncomeTaxBenefitFromStockBasedCompensation
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NzA_ea98a209-503d-4a40-9451-187c83e3ffb8"
      unitRef="usd">1100000</wst:IncomeTaxBenefitFromStockBasedCompensation>
    <wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare
      contextRef="ifb4bbd9acc414a18bb8e6e158baef582_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8xNjkvZnJhZzphZWQ3ZmYwNWRiOWU0MWFmYTU0MGZkOWE2NmJkZWUyNC90ZXh0cmVnaW9uOmFlZDdmZjA1ZGI5ZTQxYWZhNTQwZmQ5YTY2YmRlZTI0XzEwOTk1MTE2MzU3NjM_659f30df-67d3-4766-b8aa-9cdc2b678aec"
      unitRef="usdPerShare">0.02</wst:IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90ZXh0cmVnaW9uOjJjMTdhYTAwMTg1MjQyZDliNzU5NTI4MjVjMTJkOGZhXzEzMzI_c3a5ced7-becd-4a96-9c1d-54deaa71a225">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Schedule II - Valuation and Qualifying Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;beginning of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;end of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included within the allowance for doubtful accounts activity is the effect of the modified retrospective application of a new accounting standard mentioned in Note 2.&lt;/span&gt;&lt;/div&gt;(2)Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie1ea59d55ee44d4ab3fe01dfb28f7c7e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtMS0xLTEtMA_89946350-73d9-4215-8cc2-2b464ed1b271"
      unitRef="usd">15900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4fd2fec9ee1f4945b5522f7f39694676_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtMi0xLTEtMA_6b78c604-5c1d-4205-9727-4c3ccb7618d8"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4fd2fec9ee1f4945b5522f7f39694676_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtMy0xLTEtMA_c4da6c59-1313-45fd-98b9-884bfea1bd11"
      unitRef="usd">800000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idbc2b6d65de7432a8a9361729083f9c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzMtNC0xLTEtMA_05a272ef-ccbf-4d58-84f4-d959e57a5485"
      unitRef="usd">15100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icd68a9b944eb48d7acb4f4672ce330e2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtMS0xLTEtMA_cdb3e0b1-13b0-4bb5-93f8-6c09440b668a"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia5d2c8af23c24659a9310a2a892a4f62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtMi0xLTEtMA_6e21f4f2-272a-4669-8e9c-ccd06632dec4"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia5d2c8af23c24659a9310a2a892a4f62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtMy0xLTEtMA_83cea88d-5399-4c40-888d-d166c813ec85"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idec6d3b519f94b4fa556d9176df56073_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzQtNC0xLTEtMA_046c0142-8135-45ab-b397-0ae9e3a34b8b"
      unitRef="usd">1100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtMS0xLTEtMA_25a40db0-936a-4bd1-8617-4f16a060ab2c"
      unitRef="usd">16400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtMi0xLTEtMA_351bcc95-493a-4f48-81d9-2de71c5ce1ed"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtMy0xLTEtMA_c75a79a2-ac8f-4e4d-9927-ca978e935469"
      unitRef="usd">900000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iac1e5371f0134eb9995482f7560ead18_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzUtNC0xLTEtMA_0b74293a-722e-49c1-95c6-8e06a467eca7"
      unitRef="usd">16200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i82896f6ac3984e04b4105c6005e58772_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktMS0xLTEtMA_8d4ea161-ee65-4ad8-ab5c-e90126312f3a"
      unitRef="usd">16000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i67679e92fa7e4c908452f2ce5a3f225e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktMi0xLTEtMA_be2a7c7a-26dd-442f-8133-fce5676b0dd5"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i67679e92fa7e4c908452f2ce5a3f225e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktMy0xLTEtMA_e216651a-77e8-4b8c-a1a3-6eb81ef29195"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie1ea59d55ee44d4ab3fe01dfb28f7c7e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzktNC0xLTEtMA_fd51f03b-9dd1-451a-a8cf-ec59f4cf7a63"
      unitRef="usd">15900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i882a8d63ebbb4201a759ff4643894e63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTEtMS0xLTA_0d7e9cbc-ddc8-435f-a2da-a39cf328598c"
      unitRef="usd">2000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i71aaf080ab884248b5379505dab9cfc7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTItMS0xLTA_9e501859-efe9-4525-980f-82f0ad3810a1"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i71aaf080ab884248b5379505dab9cfc7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTMtMS0xLTA_728461f5-76f3-433c-8707-b211a96fcd8f"
      unitRef="usd">1600000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icd68a9b944eb48d7acb4f4672ce330e2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzEwLTQtMS0xLTA_891e7642-cacf-4748-8c5b-f6067f0485b0"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTEtMS0xLTA_8a2d4822-6724-409e-8bba-2c85bfaf4d2e"
      unitRef="usd">18000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTItMS0xLTA_127ac7ea-dda6-493c-a01f-1041c1586b2d"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i343d81ec063d4333a981fe827588f9d6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTMtMS0xLTA_d9917a74-e3a1-4e5e-b775-3af367e43de9"
      unitRef="usd">1700000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0230c88584154e91a07b322788cd39a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzExLTQtMS0xLTA_28793f09-a86b-4998-8c0d-4aa13931fd96"
      unitRef="usd">16400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if820fa9d156f4d8abd00df5a22472ff0_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTEtMS0xLTA_92248a98-491d-45c0-bb02-6c79d7c80618"
      unitRef="usd">20900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i742f81f943014659ab25279911503298_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTItMS0xLTA_5e8b19fe-bfed-41b4-b4e1-3de3ebc2d81b"
      unitRef="usd">-3000000.0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i742f81f943014659ab25279911503298_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTMtMS0xLTA_7b016c6e-1456-45ff-93bd-996721637e37"
      unitRef="usd">1900000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i82896f6ac3984e04b4105c6005e58772_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE1LTQtMS0xLTA_b7b0dca9-34a1-4358-a4fa-1140edd320e6"
      unitRef="usd">16000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i906d2c0507c14130885513cc846a85fc_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTEtMS0xLTA_c5b7d4aa-4d96-4376-9973-834afdf4faa3"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i8c0f9eef8a8d405ba0c12024d16f0191_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTItMS0xLTA_816c034a-3e40-4c3e-87b8-edf95204aaed"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i8c0f9eef8a8d405ba0c12024d16f0191_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTMtMS0xLTA_5b6b6a6f-a6cc-419c-9e11-7c6a4f2c1ea3"
      unitRef="usd">-800000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i882a8d63ebbb4201a759ff4643894e63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE2LTQtMS0xLTA_9ea3c3cd-109e-46a8-87a1-6704a9c5b1c7"
      unitRef="usd">2000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTEtMS0xLTA_e222f6dd-68a7-4c71-8115-685ffb8518e9"
      unitRef="usd">21400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTItMS0xLTA_57a167eb-766f-4bec-817c-f456a9705b01"
      unitRef="usd">-2300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i1193f9d09fd6409a89d97169dd23ab81_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTMtMS0xLTA_1d894737-614d-44c1-9af8-f4269b9de45a"
      unitRef="usd">1100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3ZGI1NTIzZDlkNzQ2NDliODU5MmExMjFiNTVkNTEyL3NlYzpjN2RiNTUyM2Q5ZDc0NjQ5Yjg1OTJhMTIxYjU1ZDUxMl8yMDIvZnJhZzoyYzE3YWEwMDE4NTI0MmQ5Yjc1OTUyODI1YzEyZDhmYS90YWJsZTphM2JlNGMwNzk3NWQ0ZGEyYjMxNWU3NjExZTBmM2I3Zi90YWJsZXJhbmdlOmEzYmU0YzA3OTc1ZDRkYTJiMzE1ZTc2MTFlMGYzYjdmXzE3LTQtMS0xLTA_4b45a63c-4fa0-4633-909a-3be7a0f6eb0c"
      unitRef="usd">18000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285631880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 27, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WEST PHARMACEUTICAL SERVICES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-1210010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">530 Herman O. West Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Exton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19341-0645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">594-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.25 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,742,194,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,103,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.261%"><tr><td style="width:1.0%"/><td style="width:68.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Parts Into Which Incorporated</span></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proxy Statement for the Annual Meeting of Shareholders to be held May 4, 2021.</span></td><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Part III</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000105770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732426169544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,146.9<span></span>
</td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">1,379.1<span></span>
</td>
<td class="nump">1,234.2<span></span>
</td>
<td class="nump">1,172.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">767.8<span></span>
</td>
<td class="nump">605.7<span></span>
</td>
<td class="nump">545.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">46.9<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">302.0<span></span>
</td>
<td class="nump">272.7<span></span>
</td>
<td class="nump">262.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Other expense (income)</a></td>
<td class="nump">12.0<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">406.9<span></span>
</td>
<td class="nump">296.6<span></span>
</td>
<td class="nump">240.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating (income) expense</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">401.3<span></span>
</td>
<td class="nump">291.8<span></span>
</td>
<td class="nump">240.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">72.5<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
<td class="nump">41.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net income of affiliated companies</a></td>
<td class="num">(17.4)<span></span>
</td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 346.2<span></span>
</td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 4.57<span></span>
</td>
<td class="nump">$ 3.21<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_WeightedAverageSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">73.9<span></span>
</td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">73.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">75.8<span></span>
</td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">75.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_WeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_WeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285852168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 346.2<span></span>
</td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="num">(39.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Prior service cost arising during period, net of tax of $0</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Net actuarial loss arising during period, net of tax of $(0.7), $(0.3), and $(0.2)</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax', window );">Settlement effects arising during period, net of tax of $0.9, $0.8, and $0</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Less: amortization of actuarial (gain) loss, net of tax of $0, $0, and $0.3</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax', window );">Less: amortization of prior service credit, net of tax of $(0.1), $(0.1) and $(0.5).</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $0, $0, and $(0.1)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Net (loss) gain on derivatives, net of tax of $(0.6), $(0.2), and $1.5</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">39.0<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(36.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 385.2<span></span>
</td>
<td class="nump">$ 246.3<span></span>
</td>
<td class="nump">$ 170.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732407665416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect', window );">Prior service credit arising during period, tax</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Net actuarial gain (loss) arising during period, tax</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax', window );">Settlement effects arising during period, tax</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Less: amortization of actuarial loss, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax', window );">Less: amortization of prior service credit, tax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Net gain (loss) on investment securities, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Net gain (loss) on derivatives, tax</a></td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285830424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 615.5<span></span>
</td>
<td class="nump">$ 439.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">385.3<span></span>
</td>
<td class="nump">319.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">321.3<span></span>
</td>
<td class="nump">235.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">51.6<span></span>
</td>
<td class="nump">64.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,373.7<span></span>
</td>
<td class="nump">1,058.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">2,035.5<span></span>
</td>
<td class="nump">1,820.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="nump">1,092.3<span></span>
</td>
<td class="nump">980.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">943.2<span></span>
</td>
<td class="nump">839.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">68.3<span></span>
</td>
<td class="nump">70.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in affiliated companies</a></td>
<td class="nump">214.7<span></span>
</td>
<td class="nump">192.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">111.1<span></span>
</td>
<td class="nump">107.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Pension and other postretirement benefits</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">23.4<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">2,793.8<span></span>
</td>
<td class="nump">2,341.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_NotesPayableAndOtherDebtCurrent', window );">Notes payable and other current debt</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">213.1<span></span>
</td>
<td class="nump">156.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Pension and other postretirement benefits</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AccruedSalariesWagesAndBenefitsCurrent', window );">Accrued salaries, wages and benefits</a></td>
<td class="nump">106.0<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">26.0<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">143.6<span></span>
</td>
<td class="nump">91.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">503.4<span></span>
</td>
<td class="nump">341.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">252.9<span></span>
</td>
<td class="nump">255.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and other postretirement benefits</a></td>
<td class="nump">57.5<span></span>
</td>
<td class="nump">52.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">60.4<span></span>
</td>
<td class="nump">62.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation benefits</a></td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">31.8<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">939.3<span></span>
</td>
<td class="nump">768.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding in 2020 and 2019</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.25 per share; 200 million shares authorized; shares issued: 75.3 million in 2020 and 2019; shares outstanding: 74.0 million and 74.1 million in 2020 and 2019</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value</a></td>
<td class="nump">267.3<span></span>
</td>
<td class="nump">272.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,846.7<span></span>
</td>
<td class="nump">1,549.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(110.6)<span></span>
</td>
<td class="num">(149.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (1.3 million and 1.2 million shares in 2020 and 2019)</a></td>
<td class="num">(167.7)<span></span>
</td>
<td class="num">(118.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Equity</a></td>
<td class="nump">1,854.5<span></span>
</td>
<td class="nump">1,573.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 2,793.8<span></span>
</td>
<td class="nump">$ 2,341.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AccruedSalariesWagesAndBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Salaries, Wages, and Benefits, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AccruedSalariesWagesAndBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_NotesPayableAndOtherDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Payable and Other Debt, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_NotesPayableAndOtherDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732289223528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200.0<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283214200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Capital in Excess of Par Value</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2017</a></td>
<td class="nump">$ 1,279.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 309.3<span></span>
</td>
<td class="num">$ (109.1)<span></span>
</td>
<td class="nump">$ 1,178.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (117.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">206.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Activity related to stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">48.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.3)<span></span>
</td>
<td class="nump">$ 76.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">$ (70.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (70.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">$ (43.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(36.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36.9)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="nump">$ 1,396.3<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">282.0<span></span>
</td>
<td class="num">$ (103.7)<span></span>
</td>
<td class="nump">1,353.4<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="num">(154.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Activity related to stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">54.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.1)<span></span>
</td>
<td class="nump">$ 65.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">(83.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (83.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Purchase of investment in affiliated companies</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">$ (45.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">1,573.2<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">272.7<span></span>
</td>
<td class="num">$ (118.1)<span></span>
</td>
<td class="nump">1,549.4<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">(149.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">346.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Activity related to stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">$ 60.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="nump">$ 65.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="nump">761,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">$ (115.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (115.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">$ (48.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">39.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,854.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 267.3<span></span>
</td>
<td class="num">$ (167.7)<span></span>
</td>
<td class="nump">$ 1,846.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (110.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287649272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 346.2<span></span>
</td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">104.7<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
<td class="nump">101.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">34.0<span></span>
</td>
<td class="nump">24.4<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Pension settlement charge</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Contingent consideration payments in excess of acquisition-date liability</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Fixed asset impairments and sale of equipment, net</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PensionAndOtherPostretirementBenefitExpenseNet', window );">Pension and other retirement plans, net</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in undistributed earnings of affiliates, net of dividends</a></td>
<td class="num">(15.8)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
<td class="num">(46.6)<span></span>
</td>
<td class="num">(33.3)<span></span>
</td>
<td class="num">(43.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(73.7)<span></span>
</td>
<td class="num">(18.6)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase in accounts payable</a></td>
<td class="nump">36.6<span></span>
</td>
<td class="nump">25.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Changes in other assets and liabilities</a></td>
<td class="nump">67.9<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">472.5<span></span>
</td>
<td class="nump">367.2<span></span>
</td>
<td class="nump">288.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(174.4)<span></span>
</td>
<td class="num">(126.4)<span></span>
</td>
<td class="num">(104.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase of investment in affiliated companies</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(85.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisition of business</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(18.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(179.5)<span></span>
</td>
<td class="num">(228.0)<span></span>
</td>
<td class="num">(100.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Borrowings under revolving credit agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">108.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under revolving credit agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(136.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Issuance of long-term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">90.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Debt issuance cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Repayments of long-term debt</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividend payments</a></td>
<td class="num">(48.1)<span></span>
</td>
<td class="num">(45.1)<span></span>
</td>
<td class="num">(42.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock-based compensation awards</a></td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">25.1<span></span>
</td>
<td class="nump">27.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Employee stock purchase plan contributions</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Shares purchased under share repurchase programs</a></td>
<td class="num">(115.5)<span></span>
</td>
<td class="num">(83.1)<span></span>
</td>
<td class="num">(70.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(137.1)<span></span>
</td>
<td class="num">(36.8)<span></span>
</td>
<td class="num">(80.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rates on cash</a></td>
<td class="nump">20.5<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">176.4<span></span>
</td>
<td class="nump">101.7<span></span>
</td>
<td class="nump">101.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, including cash equivalents at beginning of period</a></td>
<td class="nump">439.1<span></span>
</td>
<td class="nump">337.4<span></span>
</td>
<td class="nump">235.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, including cash equivalents at end of period</a></td>
<td class="nump">615.5<span></span>
</td>
<td class="nump">439.1<span></span>
</td>
<td class="nump">337.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid, net of amounts capitalized</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net</a></td>
<td class="nump">48.4<span></span>
</td>
<td class="nump">47.5<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued capital expenditures</a></td>
<td class="nump">31.3<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends declared, not paid</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">11.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Purchase of investment in affiliated companies, treasury stock</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PensionAndOtherPostretirementBenefitExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PensionAndOtherPostretirementBenefitExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280265272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West has been actively monitoring the novel coronavirus (&#8220;COVID-19&#8221;) situation and its impact globally. Our production facilities continued to operate during the year as they had prior to the COVID-19 pandemic, other than for enhanced safety measures intended to prevent the spread of the virus and higher levels of production at certain plant locations to meet additional customer demand. The remote working arrangements and travel restrictions imposed by various governments had limited impact on our ability to maintain operations during the year, as our manufacturing operations have generally been exempted from stay-at-home orders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our accounts receivable balance was net of an allowance for doubtful accounts of $1.1 million and $0.5 million at December&#160;31, 2020 and 2019, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. The following is a summary of inventories at December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.519%"><tr><td style="width:1.0%"/><td style="width:68.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2020. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a more detailed discussion of our pension and other retirement plans. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification ("ASC") 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Revenue</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Remediation and Compliance Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_157" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a more detailed discussion of our stock-based compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288657320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New Accounting Standards<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 and by clarifying and amending existing ASC Topic 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We early adopted this guidance, which did not have a material impact to our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the FASB issued guidance which clarifies and improves areas related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance and the respective disclosure updates are reflected in our financial statements, which did not have a material impact.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020. The adoption did not have a material impact on our financial statements. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under the previous guidance, an entity reflected credit losses on financial assets measured on an amortized cost basis only when it was probable that losses had incurred, generally considering only past events and current conditions when determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a modified retrospective basis, to the accounts receivable and contract asset balances as of January 1, 2020. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. The effect of the adoption on the financial statement line items of accounts receivable and contract assets was not material as of January 1, 2020. As a result of our adoption, we recorded a cumulative-effect adjustment of $0.1&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2020, to reflect the incremental estimated lifetime expected credit losses on the accounts receivable balance as of January 1, 2020. We have not presented the amortized cost basis within each credit quality indicator by year of origination as all of our accounts receivable are due within one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluat</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ng</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the impact to our financial statements, the transition, and disclosure requirements of this guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281447512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of ASC 606</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, we adopted ASC 606, on a modified retrospective basis, applied to those contracts which were not completed as of January 1, 2018. As a result of our adoption, we recorded a cumulative-effect adjustment of $11.4&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2018, to reflect a change in the timing of revenue recognition under ASC 606, from point in time to over time, on our Contract-Manufactured Products product sales, certain Proprietary Products product sales, development and tooling agreements, as well as an acceleration on a portion of the remaining unearned income from a nonrefundable customer payment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. As of December&#160;31, 2020, there was $4.7 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $3.8 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets and liabilities result from transactions with revenue primarily recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet within other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"/><td style="width:83.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.852%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2019</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2019</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - (increase) decrease</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has entered into new capacity reservation agreements, which include the receipt of up-front cash and therefore caused an increase in the deferred income account balance. The Company expects revenue related to the capacity reservation agreements to be recognized over the next 1 to 2 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in deferred income during 2020 was primarily due to additional cash payments of $100.3&#160;million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $83.9&#160;million, including $26.9&#160;million of revenue that was included in deferred income at the beginning of the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain Financing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of December&#160;31, 2020 and 2019, we derecognized accounts receivable of $14.1&#160;million and $10.1&#160;million, respectively, under these agreements. Discount fees related to the sale of such accounts receivable on our consolidated income statements for 2020 and 2019 were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voluntary Recall</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 24, 2019, we issued a voluntary recall of our Vial2Bag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During 2019, we recorded a net provision of $5.4&#160;million for inventory returns from our customers and related in-house inventory, partially offset by a reduction in our pro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vision for product returns. On October 21, 2020 we received market clearance from the FDA for our Vial2BagAdvanced</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0mm Admixture Device and continue to work to get the products back on the market.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732279918888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, there were 0.0 million, 0.1 million, and 0.4 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. There were no shares purchased during the three months ended December 31, 2020. During the year ended December 31, 2020, we purchased 761,500 shares of our common stock under the now completed program at a cost of $115.5&#160;million, or an average price of $151.65 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2020, we announced a share repurchase program for calendar-year 2021 authorizing the repurchase of up to 631,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281924232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected useful lives (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15-35</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-12</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds and dies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,035.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2020, 2019 and 2018 was $104.7 million, $100.0 million and $101.7 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2020, 2019 and 2018 was $1.4 million, $1.0 million and $0.9 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019 and 2018, as part of our 2018 restructuring plan, we recorded within other expense (income) $0.3&#160;million and $2.2&#160;million, respectively, for non-cash asset write-downs associated with the discontinued use of certain equipment. During 2019 and 2018, as part of our restructuring plans, we recorded within other expense (income) $1.9&#160;million and $1.1&#160;million, respectively, for gains on the sale of fixed assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288397480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of ASC 842</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of December&#160;31, 2020, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases provide us with an option, exercisable at our sole discretion, to terminate the lease or extend the lease term for one year or more. We had no finance leases as of December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense for 2018 was $14.5&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, the weighted average remaining lease term for operating leases was 11.1 years and 11.7 years and the weighted average discount rate was 3.68% and 3.76%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to adopt practical expedients around the combination of lease and non-lease components and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281420312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Affiliated Companies</a></td>
<td class="text">Affiliated Companies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the following affiliated companies were accounted for under the equity method:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aluplast S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I&amp;W Pharma Group LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daikyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2019, in connection with the amendment of certain commercial agreements with Daikyo, we increased our ownership interest from 25% to 49% in Daikyo in exchange for $85.1&#160;million in cash and $4.9&#160;million in shares of our treasury stock to certain stockholders of Daikyo.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unremitted income of affiliated companies included in consolidated retained earnings amounted to $98.2 million, $82.4 million and $75.8 million at December&#160;31, 2020, 2019 and 2018, respectively. Dividends received from affiliated companies were $1.6 million in 2020, $2.2 million in 2019 and $1.7 million in 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity in net unrealized gains of Daikyo&#8217;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $0.6 million, $0.4 million and $0.4 million at December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases from, and royalty payments made to, affiliates totaled $143.3 million, $115.1 million and $86.3 million, respectively, in 2020, 2019 and 2018, of which $33.6 million and $20.8 million was due and payable as of December&#160;31, 2020 and 2019, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $9.7 million, $9.2 million and $9.6 million, respectively, in 2020, 2019 and 2018, of which $1.4 million and $1.9 million was receivable as of December&#160;31, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $201.9 million and $179.3 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $12.8 million and $13.4 million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281336904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill recorded due to acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded goodwill of $2.6&#160;million. The goodwill was recorded within our Proprietary Products reportable segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had no accumulated goodwill impairment losses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licensing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the acquisition of our South Korean distributor in April 2019, we recorded a customer relationships intangible asset of $11.2&#160;million, which is being amortized over ten years. </span></div>The cost basis of intangible assets includes a foreign currency translation gain of $1.3 million and a foreign currency translation loss of $0.3 million for the years ended December&#160;31, 2020 and 2019, respectively. Amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 was $4.4 million, $3.4 million and $2.7 million, respectively. Estimated annual amortization expense for the next five years is as follows: 2021 - $3.8&#160;million, 2022 - $3.8&#160;million, 2023 - $3.7&#160;million, 2024 - $3.6&#160;million and 2025 - $3.4&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281420312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">Other Current Liabilities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities as of December 31 included the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281390408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.485%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (1.13%)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A notes, due July 5, 2022 (3.67%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (4.02%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement - Credit Facility </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains the Credit Facility of $300.0&#160;million, with sublimits of up to $30.0&#160;million for swing line loans for domestic borrowers in USD and a $20.0&#160;million swing line loan for our German Holding Company and up to $30.0&#160;million for the issuance of standby letters of credit. The Credit Facility may be increased from time-to-time by the greater of $350.0&#160;million and earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily LIBOR, plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December&#160;31, 2020 and 2019, total unamortized debt issuance costs of $0.4&#160;million and $1.1&#160;million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we had no outstanding borrowings under the Credit Facility. At December&#160;31, 2020, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.5 million, was $297.5 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement Amendment - Term Loan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#8220;First Amendment&#8221;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $90.0&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month LIBOR plus 87.5 basis points. As of December&#160;31, 2020, there were unamortized debt issuance costs remaining of $0.1&#160;million, which are being amortized as additional interest expense over the term of the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At December&#160;31, 2020, we had $87.7&#160;million in borrowings under the Term Loan, of which $2.3&#160;million was classified as current and $85.4&#160;million was classified as long-term. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Private Placement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, we concluded a private placement issuance of $168.0 million in senior unsecured notes. The total amount of the private placement issuance was divided into three tranches - $42.0 million 3.67% Series A Notes due July 5, 2022, $53.0 million 3.82% Series B Notes due July 5, 2024, and $73.0 million 4.02% Series C Notes due July 5, 2027 (the &#8220;Notes&#8221;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes is 3.87%. As of December&#160;31, 2020 and 2019, there were unamortized debt issuance costs remaining of $0.4&#160;million and $0.5&#160;million, respectively, which are being amortized as additional interest expense over the term of the Notes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2020, we were in compliance with all of our debt covenants. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest costs incurred during 2020, 2019 and 2018 were $9.6 million, $9.4 million and $9.3 million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, were as follows: $2.3 million in 2021, 2022 $44.2 million, 2023 - $2.2 million, 2024 - $134.0 million, 2025 - $0.0 million, and thereafter - $73.0 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280245688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2020 and December&#160;31, 2019, the total amount of these forward exchange contracts was SGD 601.5 million and $13.4 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2020, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Euro</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,194.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, we entered into a five-year floating-to-floating forward-starting cross-currency swap (the &#8220;cross-currency swap&#8221;) for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;9.6&#160;billion ($87.8&#160;million) as of December&#160;31, 2020. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through December 2020, we purchased several series of call options for a total of 472,477 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had outstanding contracts to purchase 141,734 barrels of crude oil from January 2021 to June 2022, at a weighted-average strike price of $59.14 per barrel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.228%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December&#160;31, 2020 and 2019 were $6.3 million and $8.7 million, respectively. We expect to recognize $1.8 million in earnings, pre-tax, for forward point components in 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.773%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2019, there was no material ineffectiveness related to our hedges.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732279992120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term liabilities, is valued using a market approach. Please refer to Note 11, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our derivatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration liability related to the SmartDose technology platform (the &#8220;SmartDose contingent consideration&#8221;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. Sales projections were derived using upside, base and downside forecasted cases for each partnership and applying probability-weighted scenarios of 10%, 50% and 40% to the three cases, respectively, to reflect the likelihood of West meeting the estimated sales projection targets. The probability of success factors included the probabilities of successful FDA approval for each partnership drug, which was estimated in a range of 19% to 100% based on the development phase of each respective drug, and the probability of the successful execution of supply agreements with each partnership, which was estimated in the range of 25% to 100% based on historical, current, and future supply agreements with the respective partnerships. The fair value of this liability utilized a risk-adjusted discount rate of 19% to present value the cash flows. The discount rate is calculated by determining the after-tax required returns on debt and equity and weighting each return by the respective percent of debt and equity to total capital. Key inputs for the discount rate include the risk-free rate on the 20-Year United States Treasury maturity, equity risk premium, company-specific risk premium, pre-tax cost of debt, and U.S. tax rate, among others. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.</span></div>The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities, and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2020, the estimated fair value of long-term debt was $265.7 million compared to a carrying amount of $252.9 million. At December&#160;31, 2019, the estimated fair value of long-term debt was $263.3 million and the carrying amount was $255.0 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281400136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281273848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2020, there were 2,761,911 shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and stock appreciation rights reduce the number of shares available by one share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to 2.5 times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and appreciation rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, stock-settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, cash-settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates expected forfeitures. The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2020 was approximately $31.7 million, which is expected to be recognized over a weighted average period of 1.6 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted to employees vest in equal increments. All awards expire 10 years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding options:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the weighted average remaining contractual life of options outstanding and of options exercisable was 5.9 years and 4.8 years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the aggregate intrinsic value of total options outstanding was $481.2 million, of which $351.7 million represented vested options.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2020, 2019 and 2018: a risk-free interest rate of 1.3%, 2.3%, and 2.7%, respectively; stock volatility of 22.4%, 22.5%, and 19.8%, respectively; and dividend yields of 0.4%, 0.7%, and 0.7%, respectively. Stock volatility is estimated based on historical data and the impact from expected future trends. Expected lives, which are based on prior experience, averaged 5.7 years for 2020, 2019 and 2018. The weighted average grant date fair value of options granted in 2020, 2019 and 2018 was $40.28, $24.72 and $20.16, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, the intrinsic value of options exercised was $88.8 million, $46.9 million and $61.3 million, respectively. The grant date fair value of options vested during those same periods was $8.4 million, $7.5 million and $8.3 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock appreciation rights (&#8220;SARs&#8221;) granted to eligible international employees vest in equal annual increments over 4 years of continuous service. All awards expire 10 years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2020, SARs outstanding were 27,679, of which 24,051 were cash-settled and 3,628 were stock-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#8217;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding SARs:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,629)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs exercisable, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,781&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,285&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs exercisable, December 31</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to stock options and SAR awards, we grant performance share unit (&#8220;PSU&#8221;) awards to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,004)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,074)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,799&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares earned under PSU awards may vary from 0% to 200% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2020, 2019 and 2018 was $177.31, $103.40 and $90.45, respectively. Including forfeiture and above-target achievement expectations, we expect that the stock-settled PSU awards will convert to 92,792 shares to be issued over an average remaining term of one year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer an Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which provides for the sale of our common stock to eligible employees at 85% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to 25% of the employee&#8217;s base salary, not to exceed $25,000 in any one calendar year. In addition, employees may not buy more than 2,000 shares during any offering period (8,000 shares per year). Purchases under the ESPP were 36,494 shares, 51,391 shares and 55,669 shares for the years 2020, 2019 and 2018, respectively. At December&#160;31, 2020, there were approximately 3,793,218 shares available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plans and Restricted Share Awards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of one share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2020, we granted 10,302 deferred stock awards, with a weighted grant date fair value of $194.29. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. As of December&#160;31, 2020, the two deferred compensation plans held a total of 358,890 deferred stock units, including 6,274 units to be paid in cash.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2020, we granted 8,721 restricted share awards at a weighted grant-date fair value of $200.35 per share to employees under the 2016 Plan. During 2019, we granted 13,308 restricted share awards at a weighted grant-date fair value of $116.39 per share to employees under the 2016 Plan. During 2018, we granted 15,942 restricted share awards at a weighted grant-date fair value of $96.77 per share to employees under the 2016 Plan. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual Incentive Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our annual incentive plan, participants are paid bonuses on the attainment of certain financial goals, which they can elect to receive in either cash or shares of our common stock. If the employee elects payment in shares, they are also given a restricted incentive stock award equal to one share for each four bonus shares issued. The incentive stock awards vest at the end of four years, provided that the participant has not made a disqualifying disposition of their bonus shares. Incentive stock award grants were 350 shares, 1,300 shares and 1,500 shares in 2020, 2019 and 2018, respectively. Incentive stock forfeitures of 0 shares, 0 shares, and 200 shares occurred in 2020, 2019 and 2018, respectively. Compensation expense is recognized over the vesting period based on the fair market value of common stock on the award date: $156.49 per share granted in 2020, $106.14 per share granted in 2019 and $93.00 per share granted in 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280206456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $16.8 million for 2020, $15.6 million for 2019 and $6.5 million for 2018. The increase in 401(k) plan contributions in 2019 was in response to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting).<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension and Other Retirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain) arising during period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost by geographic location is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"/><td style="width:43.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component included within net periodic benefit cost is considered employee compensation and is therefore presented within the selling, general, and administrative and costs of goods and services sold financial statement line items of our consolidated statements of income. The remaining components of net periodic benefit cost are reported separately and are therefore presented within the other nonoperating (income) expense financial statement line item of our consolidated statements of income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2019, we recorded $3.7&#160;million and $3.5&#160;million in pension settlement charges within other nonoperating (income) expense, respectively, as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we did not contribute to our U.S. qualified defined benefit pension plan. During 2019, we contributed $2.6&#160;million to our U.S. qualified defined benefit pension plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, December 31</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, December 31</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International pension plan assets, at fair value, included in the preceding table were $43.9 million and $39.4 million at December&#160;31, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation for all defined benefit pension plans was $293.9 million and $283.9 million at December&#160;31, 2020 and 2019, respectively, including $83.1 million and $73.9 million, respectively, for international pension plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, our U.S. qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2020 and December&#160;31, 2019, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 to 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we expect to contribute $3.6&#160;million to pension plans, of which $2.9&#160;million is for international plans. In addition, we expect to contribute $0.7&#160;million for other retirement benefits in 2021. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate used to determine the benefit obligations for U.S. pension plans was 2.60% and 3.35% as of December 31, 2020 and 2019, respectively. The weighted average discount rate used to determine the benefit obligations for all international plans was 0.89% and 1.28% as of December 31, 2020 and 2019, respectively. The rate of compensation increase for U.S. plans was 4.25% for 2018, while the weighted average rate for all international plans was 2.58% for 2020 and 2.49% for 2019. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans, which accounts for 83.0% of global plan assets, was 5.10% for 2020, 5.60% for 2019 and 7.00% for 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumed healthcare cost trend rate used to determine benefit obligations was 6.50% for all participants in 2020, decreasing to 5.00% by 2027. The assumed healthcare cost trend rate used to determine net periodic benefit cost was 6.25% for all participants in 2020, decreasing to 5.00% by 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The defined pension plan benefit obligation increased for the year ended December&#160;31, 2020 primarily due to a decrease in the discount rate used to calculate the obligation. The net actuarial losses will be impacted in future periods by actual asset returns, discount rate changes, currency exchange rate fluctuations, actual demographic experience, and certain other factors. The other retirement plan benefit obligation decreased slightly due to the activity mentioned above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has cash balance plans and other plans with promised interest crediting rates. For these plans, the interest crediting rates are set in line with plan rules or country legislation and do not change with market conditions. The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. pension plan is managed as a balanced portfolio comprised of two components: equity and fixed income debt securities. Equity investments are used to maximize the long-term real growth of fund assets, while fixed income investments are used to generate current income, provide for a more stable periodic return and provide some protection against a prolonged decline in the market value of equity investments. Temporary funds may be held as cash. We maintain a long-term strategic asset allocation policy which provides guidelines for ensuring that the fund&#8217;s investments are managed with the short-term and long-term financial goals of the fund, while allowing the flexibility to react to unexpected changes in capital markets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the U.S. target asset allocations and acceptable allocation ranges:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target allocation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27% - 33%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67% - 73%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% - 3%</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287901896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Expense (Income)</a></td>
<td class="text">Other Expense (Income) <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and post-employment benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and related charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil tax recovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, our Board of Directors approved a restructuring plan designed to optimize certain organizational structures within the Company to better support our continued growth and business priorities. These changes are expected to be implemented over a period of up to twenty-four months from the date of the approval. The plan is expected to require restructuring and related charges of approximately $15&#160;million to $17&#160;million. Since its approval, we recorded a net pre-tax amount equal to $4.6&#160;million in restructuring related charges associated with this plan. All charges recorded to date are severance related and recorded w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ithin other expense (income) in the consolidated statements of income. Once fully completed, we expect the plan will provide us with annualized savings in the range of $3.5&#160;million to $4.5&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes were expected to be implemented over a period of up to twenty-four months from the date of the approval. The plan was expected to require restructuring and related charges of approximately $16.0 million. Since its approval, we recorded $13.7&#160;million in restructuring and related charges associated with this plan. The plan is now considered complete.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recorded $4.9 million in restructuring and related charges associated with this plan, consisting of $2.6 million for severance charges, $0.3 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $2.0 million for other non-cash charges. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, we recorded $8.8&#160;million in restructuring and related charges associated with this plan, consisting of $3.1&#160;million for severance charges, $2.2&#160;million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $3.5&#160;million for other non-cash charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash asset write-downs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. During 2018, we recorded $0.3 million in additional charges related to this restructuring plan. Our remaining restructuring obligations related to our 2016 restructuring plan are complete. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Items</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recorded a charge of $1.0&#160;million as a result of the continued devaluation of Argentina&#8217;s currency. During 2018, we recorded a charge of $1.1 million related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recognized a tax recovery of $4.7&#160;million related to previously-paid international excise taxes, following a favorable court ruling.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, we recorded development income of $0.9 million in each year, related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Revenue</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span>, for additional details.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287255256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesAs a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. During 2020, the statute of limitations for the 2016 U.S. federal tax year lapsed, leaving tax years 2017 through 2020 open to examination. For U.S. state and local jurisdictions, tax years 2013 through 2020 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2013 through 2020.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to prior year position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we had balances in accrued liabilities for interest and penalties of $0.3 million and $0.2 million at December&#160;31, 2020 and 2019, respectively. As of December&#160;31, 2020, we had $10.4 million of total gross unrecognized tax benefits, which, if recognized, would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $0.3 million during the next twelve months, which would favorably impact our effective tax rate.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income before income taxes are:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related provision for income taxes consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax (liability) asset</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal corporate tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income Deductions (FDII)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of 2017 Tax Act</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we recorded a tax benefit of $0.5&#160;million due to the impact of tax law changes enacted during the year, as well as a tax benefit of $20.8&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we recorded a tax benefit of $0.3&#160;million due to the impact of tax law changes enacted during the year, as well as a tax benefit of $10.3&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, we recorded a net tax benefit of $2.5&#160;million for the estimated impact of the 2017 Tax Act and a tax benefit of $14.3&#160;million associated with stock-based compensation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Tax Act, which was signed into law on December 22, 2017, has resulted in significant changes to the U.S. corporate income tax system. These changes include, but are not limited to, a federal statutory rate reduction from 35.0% to 21.0% effective for tax years beginning after December 31, 2017. Changes in tax rates and tax laws are accounted for in the period of enactment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Tax Act. We recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in our consolidated financial statements for the year ended December 31, 2017. As of December 31, 2018, we finalized our calculations and tax positions used in our analysis of the impact of the 2017 Tax Act in consideration of proposed regulations and other guidance issued during 2018. As a result, we recorded a $7.5 million tax benefit related to a reduction of the Transition Toll Tax and an incremental tax expense of $4.0 million related to other adjustments. The final measurement reduced the Transition Toll Tax expense to $20.4 million from $27.9 million. The net impact of these adjustments resulted in a benefit of 1.45% to the 2018 effective tax rate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Tax Act created a provision known as global intangible low-tax income (&#8220;GILTI&#8221;) that imposes a U.S. tax on certain earnings of controlled foreign subsidiaries. We made an accounting policy election to reflect GILTI taxes, if any, as a current income tax expense in the period incurred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have fully utilized all of our U.S. federal net operating loss carryforwards. State operating loss carryforwards of $204.1 million created a deferred tax asset of $14.0 million, while foreign operating loss carryforwards of $56.7 million created a deferred tax asset of $7.4 million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been fully reserved. State loss carryforwards expire as follows: $25.7 million in 2021 and $178.4 million thereafter. Foreign loss carryforwards will begin to expire in 2030, while $54.1 million of the total $56.7 million will not expire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have utilized all available foreign tax credit carryforwards against the Transition Toll Tax. During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. As of December&#160;31, 2020, the $0.9 million of state research and development credits expire after 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $345.6&#160;million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281424744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we were obligated under various operating lease agreements. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $118.4 million, of which $41.4 million is due to be paid in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have letters of credit totaling $2.5 million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.0 million at December&#160;31, 2020, of which $0.9 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SmartDose contingent consideration is payable to the selling shareholders based upon a percentage of product sales over the life of the underlying product patent, with no cap on total payments. Given the length of the earnout period and the uncertainty in forecasted product sales, we do not believe it is meaningful to estimate the upper end of the range over the entire period. However, our estimated probable range which could become payable over the next five years is between zero and $4.3&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281270328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales information about our reportable segments, reconciled to consolidated totals:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any customers accounting for greater than 10% of consolidated net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Lived Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other European countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of Acquisition-related Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on restructuring-related sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax recovery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense/(income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The Company recorded $0.6&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During the twelve months ended December 31, 2019, the Company recorded a net tax recovery of $4.4 million related to previously-paid international excise taxes, following a favorable court ruling.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 16, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_151" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Expense (Income)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of unallocated items. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Depreciation and Amortization</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Capital Expenditures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281468504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Operating and Per Share Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Operating and Per Share Data (Unaudited)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Operating and Per Share Data (Unaudited)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Full Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sum of the quarterly amounts may not equal full year due to rounding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors affecting the comparability of the information reflected in the quarterly data:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income for the first quarter of 2020 included the impact of a pension settlement charge of $1.1 million ($0.01 per diluted share), amortization expense of $1.0 million ($0.01 per diluted share) associated with an acquisition of increased ownership interest in Daikyo, and a tax benefit of $5.1 million ($0.07 per diluted share) associated with stock-based compensation. Net income for the first quarter of 2019 included the impact of restructuring and related charges of $0.4&#160;million ($0.01 per diluted share) and a tax benefit of $1.4&#160;million ($0.02 per diluted share) associated with stock-based compensation.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Second quarter 2020 net income included the impact of a pension settlement charge of $0.7 million ($0.01 per diluted share), amortization expense of $1.1&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, a charge of $1.6 million ($0.02 per diluted share) related to severance costs, and a tax benefit of $6.9 million ($0.09 per diluted share) associated with stock-based compensation. Second quarter 2019 net income included the impact of restructuring and related charges of $1.1&#160;million ($0.01 per diluted share) and a tax benefit of $3.8&#160;million ($0.05 per diluted share) associated with stock-based compensation. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income for the third quarter of 2020 included the impact of a pension settlement charge of $0.8 million ($0.01 per diluted share), amortization expense of $0.7 million ($0.01 per diluted share) associated with the acquisition of intangible assets, a restructuring and severance related charge of $3.4 million ($0.04 per diluted share), and a tax benefit of $2.0 million ($0.02 per diluted share) associated with stock-based compensation. Net income for the third quarter of 2019 included the impact of restructuring and related charges of $1.4&#160;million ($0.01 per diluted share), a pension settlement charge of $2.1&#160;million ($0.03 per diluted share), a charge of $0.7&#160;million ($0.01 per diluted share) related to the devaluation of Argentina&#8217;s currency, a tax benefit of $1.0&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $4.0&#160;million ($0.05 per diluted share) associated with stock-based compensation.</span></div>(4)Fourth quarter 2020 net income included the impact of a pension settlement charge of $0.3&#160;million ($0.01 per diluted share), amortization expense of $0.7&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, an impairment charge of $2.5&#160;million ($0.03 per diluted share) related to a cost investment, and a tax benefit of $6.8 million ($0.09 per diluted share) associated with stock-based compensation. Fourth quarter 2019 net income included the impact of restructuring and related charges of $0.8&#160;million ($0.02 per diluted share), a gain on the sale of fixed assets as a result of our restructuring plan of $1.3&#160;million ($0.02 per diluted share), a pension settlement charge of $0.6&#160;million ($0.01 per diluted share), a tax recovery related to previously-paid international excise taxes of $2.9&#160;million ($0.04 per diluted share), a tax charge of $0.7&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $1.1&#160;million ($0.02 per diluted share) associated with stock-based compensation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732279992120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule of Valuation and Qualifying Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule II - Valuation and Qualifying Accounts</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.323%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">beginning of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses (1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions (2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">end of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">period</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="padding-left:27pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included within the allowance for doubtful accounts activity is the effect of the modified retrospective application of a new accounting standard mentioned in Note 2.</span></div>(2)Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732286698104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents include time deposits, certificates of deposit and all highly liquid short-term instruments with maturities of three months or less at the time of purchase.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text">Accounts Receivable: Our accounts receivable balance was net of an allowance for doubtful accounts of $1.1 million and $0.5 million at December&#160;31, 2020 and 2019, respectively. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories: Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other expense (income). Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2020. Please refer to Note 6, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Leases</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other expense (income) for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Impairment of Goodwill and Other Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our annual impairment test. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 3 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Employee Benefits</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Benefits:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span>, for a more detailed discussion of our pension and other retirement plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Financial Instruments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification ("ASC") 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience and specific identification of customer claims. Please refer to Note 3, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Revenue</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</a></span> for additional information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">Research and Development: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are primarily expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EnvironmentalCostsPolicy', window );">Environmental Remediation and Compliance Costs</a></td>
<td class="text">Environmental Remediation and Compliance Costs: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock', window );">Litigation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_157" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other expense (income). The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a more detailed discussion of our stock-based compensation plans.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 and by clarifying and amending existing ASC Topic 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We early adopted this guidance, which did not have a material impact to our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the FASB issued guidance which clarifies and improves areas related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of this guidance. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance and the respective disclosure updates are reflected in our financial statements, which did not have a material impact.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020. The adoption did not have a material impact on our financial statements. Please refer to Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under the previous guidance, an entity reflected credit losses on financial assets measured on an amortized cost basis only when it was probable that losses had incurred, generally considering only past events and current conditions when determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. We adopted this guidance as of January 1, 2020, on a modified retrospective basis, to the accounts receivable and contract asset balances as of January 1, 2020. Under the current expected credit loss model, we have adopted a provision matrix approach, utilizing historical loss rates based on the number of days past due, adjusted to reflect current economic conditions and forecasts of future economic conditions. The effect of the adoption on the financial statement line items of accounts receivable and contract assets was not material as of January 1, 2020. As a result of our adoption, we recorded a cumulative-effect adjustment of $0.1&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2020, to reflect the incremental estimated lifetime expected credit losses on the accounts receivable balance as of January 1, 2020. We have not presented the amortized cost basis within each credit quality indicator by year of origination as all of our accounts receivable are due within one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2020, the FASB issued guidance which provides optional expedients and exceptions to address the impact of reference rate reform where contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate need to be discontinued. This guidance was effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluat</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ng</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the impact to our financial statements, the transition, and disclosure requirements of this guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2175709<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13669-110860<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13185-110859<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13231-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Matters, Contingencies and Legal Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281474744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text">The following is a summary of inventories at December 31:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.519%"><tr><td style="width:1.0%"/><td style="width:68.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281574296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Change in Contract with Customer, Asset and Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"/><td style="width:83.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.852%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2019</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2019</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - (increase) decrease</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732279936584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of Basic to Diluted Net Income Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287682984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property, Plant and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected useful lives (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15-35</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-12</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds and dies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,035.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288076456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock', window );">Cash Flow and Supplemental information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>lessee, lease Cash Flow and Supplemental information [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732282072664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the following affiliated companies were accounted for under the equity method:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aluplast S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I&amp;W Pharma Group LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daikyo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280452376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill recorded due to acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock', window );">Schedule of Intangible Assets by Major Class</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licensing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Intangible Assets by Major Class [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732282859592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes other than income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281492264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-term Debt Obligations, Net of Current Maturities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.485%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (1.13%)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A notes, due July 5, 2022 (3.67%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (4.02%)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288301096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Foreign Currency Contracts</a></td>
<td class="text">As of December&#160;31, 2020, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Euro</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,194.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.228%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.773%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281272728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Level 3 Fair Value Measurements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value recorded in earnings</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281288008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Components of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Schedule of Reclassification out of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on derivatives:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_145" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plans</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732493915448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Allocation of Share-based Compensation Costs by Plan</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and appreciation rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, stock-settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, cash-settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units, dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding options:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, December 31</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of Stock Appreciation Rights Award Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in outstanding SARs:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,629)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs exercisable, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,781&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,285&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs outstanding, December 31</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs exercisable, December 31</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Performance-based Share Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,004)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,074)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,799&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Nonvested Performance-based Units Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at target level</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments above/(below) target</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested cash-settled PSU awards, December 31</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280095016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain) arising during period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost by geographic location is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"/><td style="width:43.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock', window );">Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, December 31</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets, December 31</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Amounts Recognized in Balance Sheet</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 to 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Assumptions Used</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other retirement benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The weighted average interest crediting rating used to determine net periodic benefit cost by geographic location for our pension plans, at December 31, were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.906%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the U.S. target asset allocations and acceptable allocation ranges:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target allocation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27% - 33%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67% - 73%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% - 3%</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ic7db5523d9d74649b8592a121b55d512_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets in the fair value hierarchy</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets measured at NAV</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732279976200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock', window );">Schedule of Other Expense (Income)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and post-employment benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and related charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset impairments and sale of equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil tax recovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2020 restructuring plan:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-related charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash asset write-downs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Other Income and Expense, by Component [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732286503144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year position</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to prior year position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Components of Income Before Income Taxes</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income before income taxes are:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related provision for income taxes consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax (liability) asset</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal corporate tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income Deductions (FDII)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of 2017 Tax Act</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281636808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Sales by Significant Product Group</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales information about our reportable segments, reconciled to consolidated totals:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment sales elimination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Sales and Long-Lived Assets, by Geographical Areas</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales and long-lived assets, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Lived Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other European countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of Acquisition-related Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost investment impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on restructuring-related sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina currency devaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax recovery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense/(income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The Company recorded $0.6&#160;million of amortization expense within operating profit associated with an acquisition of an intangible asset during the second quarter of 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During the twelve months ended December 31, 2019, the Company recorded a net tax recovery of $4.4 million related to previously-paid international excise taxes, following a favorable court ruling.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Depreciation and Amortization</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Capital Expenditures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total consolidated</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281960408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Operating and Per Share Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Financial Information</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarter</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Full Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sum of the quarterly amounts may not equal full year due to rounding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors affecting the comparability of the information reflected in the quarterly data:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income for the first quarter of 2020 included the impact of a pension settlement charge of $1.1 million ($0.01 per diluted share), amortization expense of $1.0 million ($0.01 per diluted share) associated with an acquisition of increased ownership interest in Daikyo, and a tax benefit of $5.1 million ($0.07 per diluted share) associated with stock-based compensation. Net income for the first quarter of 2019 included the impact of restructuring and related charges of $0.4&#160;million ($0.01 per diluted share) and a tax benefit of $1.4&#160;million ($0.02 per diluted share) associated with stock-based compensation.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Second quarter 2020 net income included the impact of a pension settlement charge of $0.7 million ($0.01 per diluted share), amortization expense of $1.1&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, a charge of $1.6 million ($0.02 per diluted share) related to severance costs, and a tax benefit of $6.9 million ($0.09 per diluted share) associated with stock-based compensation. Second quarter 2019 net income included the impact of restructuring and related charges of $1.1&#160;million ($0.01 per diluted share) and a tax benefit of $3.8&#160;million ($0.05 per diluted share) associated with stock-based compensation. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net income for the third quarter of 2020 included the impact of a pension settlement charge of $0.8 million ($0.01 per diluted share), amortization expense of $0.7 million ($0.01 per diluted share) associated with the acquisition of intangible assets, a restructuring and severance related charge of $3.4 million ($0.04 per diluted share), and a tax benefit of $2.0 million ($0.02 per diluted share) associated with stock-based compensation. Net income for the third quarter of 2019 included the impact of restructuring and related charges of $1.4&#160;million ($0.01 per diluted share), a pension settlement charge of $2.1&#160;million ($0.03 per diluted share), a charge of $0.7&#160;million ($0.01 per diluted share) related to the devaluation of Argentina&#8217;s currency, a tax benefit of $1.0&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $4.0&#160;million ($0.05 per diluted share) associated with stock-based compensation.</span></div>(4)Fourth quarter 2020 net income included the impact of a pension settlement charge of $0.3&#160;million ($0.01 per diluted share), amortization expense of $0.7&#160;million ($0.01 per diluted share) associated with the acquisition of intangible assets, an impairment charge of $2.5&#160;million ($0.03 per diluted share) related to a cost investment, and a tax benefit of $6.8 million ($0.09 per diluted share) associated with stock-based compensation. Fourth quarter 2019 net income included the impact of restructuring and related charges of $0.8&#160;million ($0.02 per diluted share), a gain on the sale of fixed assets as a result of our restructuring plan of $1.3&#160;million ($0.02 per diluted share), a pension settlement charge of $0.6&#160;million ($0.01 per diluted share), a tax recovery related to previously-paid international excise taxes of $2.9&#160;million ($0.04 per diluted share), a tax charge of $0.7&#160;million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $1.1&#160;million ($0.02 per diluted share) associated with stock-based compensation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732426650936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business acquisition, transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business acquisition, recognized inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business acquisition, recognized property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business acquisition, recognized goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business acquisition, recognized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">133.5<span></span>
</td>
<td class="nump">100.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">54.9<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">132.9<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 321.3<span></span>
</td>
<td class="nump">$ 235.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of finite-lived intangible assets</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of finite-lived intangible assets</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288694296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>New Accounting Standards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 1,846.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,549.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732289557400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Adoption of ASC 606 (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 1,846.7<span></span>
</td>
<td class="nump">$ 1,549.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member', window );">Difference Between Revenue Guidance in Effect Before and After Topic 606 | Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283477816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue Recognition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 57.1<span></span>
</td>
<td class="nump">$ 34.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East, Africa | Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_SmartDoseMember', window );">SmartDose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred income, current</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred income, noncurrent</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_HighValueProductComponentsMember', window );">High-Value Product Components | Revenue Benchmark | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_HighValueProductDeliveryDevicesMember', window );">High-Value Product Delivery Devices | Revenue Benchmark | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_StandardPackagingMember', window );">Standard Packaging | Revenue Benchmark | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products | Revenue Benchmark | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_BiologicsCustomersMember', window );">Biologics | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_GenericsCustomersMember', window );">Generics | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_PharmaCustomersMember', window );">Pharma | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember', window );">Contract-Manufactured Products | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember', window );">SmartDose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_SmartDoseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_SmartDoseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_HighValueProductComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_HighValueProductComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_HighValueProductDeliveryDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_HighValueProductDeliveryDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_StandardPackagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_StandardPackagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_BiologicsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_BiologicsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_GenericsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_GenericsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_PharmaCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_PharmaCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283435048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Contracts Assets and Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerAssetRollForward', window );"><strong>Contract With Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, December 31, 2019</a></td>
<td class="nump">$ 9.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, December 31, 2020</a></td>
<td class="nump">10.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerAssetIncreaseDecrease', window );">Change in contract assets - increase (decrease)</a></td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityRollForward', window );"><strong>Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December 31, 2019</a></td>
<td class="num">(34.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December 31, 2020</a></td>
<td class="num">(57.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized', window );">Change in deferred income - (increase) decrease</a></td>
<td class="num">$ (22.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerAssetIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerAssetIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732279874024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Contracts and Liabilities, Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments', window );">Cash payments received in advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod', window );">Revenue recognized during the period</a></td>
<td class="nump">$ 26.9<span></span>
</td>
<td class="nump">$ 83.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityRecognitionPeriod', window );">Contract with customer liability recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityRecognitionPeriod', window );">Contract with customer liability recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityRecognitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Recognition Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityRecognitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Revenue Recognized During The Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281334056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Supply Chain Financing (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount', window );">Sales of certain accounts receivable</a></td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280254136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Voluntary Recall (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ProvisionForProductReturns', window );">Provision for product returns</a></td>
<td class="nump">$ 11.3<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ProvisionForProductReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for Product Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ProvisionForProductReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732284107976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 98.4<span></span>
</td>
<td class="nump">$ 82.3<span></span>
</td>
<td class="nump">$ 91.2<span></span>
</td>
<td class="nump">$ 74.3<span></span>
</td>
<td class="nump">$ 63.9<span></span>
</td>
<td class="nump">$ 56.3<span></span>
</td>
<td class="nump">$ 66.1<span></span>
</td>
<td class="nump">$ 55.4<span></span>
</td>
<td class="nump">$ 346.2<span></span>
</td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,900,000<span></span>
</td>
<td class="nump">74,000,000.0<span></span>
</td>
<td class="nump">73,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of equity awards, based on the treasury stock method (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares assuming dilution (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,800,000<span></span>
</td>
<td class="nump">75,400,000<span></span>
</td>
<td class="nump">75,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive options excluded from computation of diluted net income per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock repurchase program, shares authorized (in shares)</a></td>
<td class="nump">631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631,000<span></span>
</td>
<td class="nump">848,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">761,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115.5<span></span>
</td>
<td class="nump">$ 83.1<span></span>
</td>
<td class="nump">$ 70.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Shares purchased under share repurchase program, average cost per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732284060744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 2,035.5<span></span>
</td>
<td class="nump">$ 1,820.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">24.8<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 618.1<span></span>
</td>
<td class="nump">572.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">35 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 911.8<span></span>
</td>
<td class="nump">817.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and dies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 131.2<span></span>
</td>
<td class="nump">123.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and dies | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and dies | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 157.5<span></span>
</td>
<td class="nump">155.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer hardware and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 192.1<span></span>
</td>
<td class="nump">$ 128.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280015960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 104.7<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="nump">$ 101.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (loss) on disposition of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288931880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Adoption of ASC 842 (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LesseeOperatingLeaseOptionToTerminateTerm', window );">Lease, operating lease, terminate term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LesseeOperatingLeaseOptionToTerminateTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Option To Terminate, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LesseeOperatingLeaseOptionToTerminateTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288255976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 12.8<span></span>
</td>
<td class="nump">$ 12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 17.4<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283594296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cash Flow and Supplemental Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287682136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Weighted Average (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">11 years 1 month 6 days<span></span>
</td>
<td class="text">11 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">3.68%<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285273048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating Lease Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 12.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">9.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">8.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">6.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">37.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Operating lease liability payments due</a></td>
<td class="nump">85.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed lease interest</a></td>
<td class="num">(14.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 70.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288206968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Affiliated Companies - Schedule of Investments (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 01, 2019</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember', window );">The West Company Mexico, S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember', window );">Aluplast S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember', window );">Pharma Tap S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember', window );">Pharma Rubber S.A. de C.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_IWPharmaGroupLLCMember', window );">I&amp;W Pharma Group LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember', window );">Daikyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_IWPharmaGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_IWPharmaGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732294740568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase in investment in affiliated companies in cash</a></td>
<td class="nump">$ 85.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 85.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Purchase of investment in affiliated companies</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees', window );">Unremitted income of affiliated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.2<span></span>
</td>
<td class="nump">82.4<span></span>
</td>
<td class="nump">75.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends received from affiliated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees', window );">Purchases and royalty payments made to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143.3<span></span>
</td>
<td class="nump">115.1<span></span>
</td>
<td class="nump">86.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrentAndNoncurrent', window );">Amount due and payable to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
<td class="nump">20.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_SalesToEquityMethodInvestees', window );">Sales to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromAffiliates', window );">Amount receivable from affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201.9<span></span>
</td>
<td class="nump">179.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.8<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember', window );">Daikyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect', window );">Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.12(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120604989&amp;loc=d3e56071-112765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consolidated retained earnings that represent undistributed (not yet received) earnings from 50% or less owned persons accounted for by the equity method (equity method investees).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6462270&amp;loc=d3e57205-112772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases and Royalty Payments from Equity Method Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_SalesToEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales to Equity Method Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_SalesToEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732286957944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 107.8<span></span>
</td>
<td class="nump">$ 105.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">111.1<span></span>
</td>
<td class="nump">107.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">78.1<span></span>
</td>
<td class="nump">76.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">80.9<span></span>
</td>
<td class="nump">78.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">29.7<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="nump">$ 29.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287550712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business acquisition, recognized goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business acquisition, recognized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization expense, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wst_SouthKoreaDistributorMember', window );">South Korea Distributor | Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business acquisition, recognized goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wst_SouthKoreaDistributorMember', window );">South Korea Distributor | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business acquisition, recognized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wst_SouthKoreaDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wst_SouthKoreaDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285234936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible Assets by Major Class (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 83.2<span></span>
</td>
<td class="nump">$ 78.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(52.7)<span></span>
</td>
<td class="num">(48.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember', window );">Patents and licensing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(17.9)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">40.9<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(23.4)<span></span>
</td>
<td class="num">(21.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">17.5<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Intangible Assets by Major Class [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732383763800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred income</a></td>
<td class="nump">$ 51.0<span></span>
</td>
<td class="nump">$ 27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">$ 11.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Accrued commissions, rebates and royalties</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent', window );">Accrued retirement plans (excluding pension)</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Accrued taxes other than income</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring and severance related charges</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Short term derivative instruments</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">21.9<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 143.6<span></span>
</td>
<td class="nump">$ 91.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for retirement benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287548632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 255.7<span></span>
</td>
<td class="nump">$ 258.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Less: unamortized debt issuance costs</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">255.2<span></span>
</td>
<td class="nump">257.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">$ 252.9<span></span>
</td>
<td class="nump">255.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan, due December 31, 2024 (1.13%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 87.7<span></span>
</td>
<td class="nump">90.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">$ 85.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member', window );">Series A notes, due July 5, 2022 (3.67%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 42.0<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member', window );">Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 53.0<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member', window );">Series C notes, due July 5, 2027 (4.02%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732286061848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>USD ($) </div>
<div>tranche</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 255,700,000<span></span>
</td>
<td class="nump">$ 258,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">252,900,000<span></span>
</td>
<td class="nump">255,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DebtInstrumentNumberOfTranches', window );">Number Tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs remaining</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">9,600,000<span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
<td class="nump">$ 9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Aggregate annual maturities of long-term debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">44,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">134,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">73,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member', window );">Series A notes, due July 5, 2022 (3.67%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  05,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member', window );">Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  05,  2024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member', window );">Series C notes, due July 5, 2027 (4.02%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  05,  2027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, current borrowing capacity</a></td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CreditAvailableForIssuanceOfLettersOfCredit', window );">Credit available for the issuance of letters of credit</a></td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LineOfCreditFacilityAdditionalBorrowingCapacity', window );">Line of credit facility, additional borrowing capacity</a></td>
<td class="nump">350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment', window );">Debt issuance costs</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Line of credit, noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, unused commitment level</a></td>
<td class="nump">297,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan, due December 31, 2024 (1.13%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment', window );">Debt issuance costs</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">87,700,000<span></span>
</td>
<td class="nump">90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">$ 85,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average of the coupon interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.87%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs remaining</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series A notes, due July 5, 2022 (3.67%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.67%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.82%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series C notes, due July 5, 2027 (4.02%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.02%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember', window );">Domestic Line of Credit | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CreditFacilityIsAvailableForSwingLineLoans', window );">Credit facility is available for swing-line loans</a></td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember', window );">Foreign Line of Credit | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CreditFacilityIsAvailableForSwingLineLoans', window );">Credit facility is available for swing-line loans</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_FederalFundsEffectiveSwapRateMember', window );">Fed Funds Effective Rate Overnight Index Swap Rate | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Term Loan, due December 31, 2024 (1.13%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding amount</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RatioOfDebtToEBITDA', window );">Ratio of debt to EBITDA</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | London Interbank Offered Rate (LIBOR) | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">0.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RatioOfDebtToEBITDA', window );">Ratio of debt to EBITDA</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | London Interbank Offered Rate (LIBOR) | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=7656903&amp;loc=SL6757497-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CreditAvailableForIssuanceOfLettersOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>this refers to Credit available for the issuance of letters of credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CreditAvailableForIssuanceOfLettersOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CreditFacilityIsAvailableForSwingLineLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This refers to credit facility is available for swing-line loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CreditFacilityIsAvailableForSwingLineLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DebtInstrumentNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DebtInstrumentNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LineOfCreditFacilityAdditionalBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility Additional Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LineOfCreditFacilityAdditionalBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RatioOfDebtToEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio of debt to EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RatioOfDebtToEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285883768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">38 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>SGD ($) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>JPY (&#165;) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Gain recognized in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Gain recognized in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember', window );">Commodity Call Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNonmonetaryNotionalAmountVolume', window );">Derivative, nonmonetary notional amount, volume | bbl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNonmonetaryNotionalAmount', window );">Derivative, nonmonetary notional amount outstanding | bbl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,734<span></span>
</td>
<td class="nump">141,734<span></span>
</td>
<td class="nump">141,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice', window );">Derivative, average price risk option strike price | $ / bbl</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.14<span></span>
</td>
<td class="nump">59.14<span></span>
</td>
<td class="nump">59.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Forward Contracts | SGD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Forward Contracts | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative contract term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract | Net Investment Hedges | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,800,000<span></span>
</td>
<td class="nump">&#165; 9,600,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative contract term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average strike price on the group of price risk option contracts such as put options or call options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAveragePriceRiskOptionStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNonmonetaryNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal number of units used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNonmonetaryNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNonmonetaryNotionalAmountVolume">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal volume used to calculate payments on a derivative instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNonmonetaryNotionalAmountVolume</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:volumeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287940456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Foreign Exchange Rate Risk (Details) - Dec. 31, 2020 - Foreign Exchange Forward - Designated as Hedging Instrument<br> &#8364; in Millions, &#165; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th"><div>SGD ($)</div></th>
<th class="th"><div>USD ($)</div></th>
<th class="th"><div>EUR (&#8364;)</div></th>
<th class="th"><div>JPY (&#165;)</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">&#8364; 49.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Yen | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 7,194.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Yen | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.7<span></span>
</td>
<td class="nump">22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">SGD | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 42.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">SGD | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="nump">&#8364; 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283786456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Derivative (gain) loss recognized in income, fair value hedges</a></td>
<td class="num">$ (6.1)<span></span>
</td>
<td class="num">$ (6.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Other expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Derivative (gain) loss on hedged item, fair value hedges</a></td>
<td class="nump">28.5<span></span>
</td>
<td class="num">(15.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</a></td>
<td class="num">(28.5)<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Derivative (gain) loss on amount excluded from effectiveness testing, fair value hedges</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(6.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Other expense (income) | Fair Value Hedges | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Other expense (income) | Net Investment Hedges | Foreign currency-denominated debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Other expense (income) | Net Investment Hedges | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember', window );">Net sales | Cash Flow Hedges | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold | Commodity call options | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold | Cash Flow Hedges | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense | Cash Flow Hedges | Forward treasury locks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=wst_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283834136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">$ 12.8<span></span>
</td>
<td class="nump">$ 11.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">19.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">33.4<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember', window );">Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">11.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">11.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Commodity call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts and swaps</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the liabilities, classified as other, for deferred compensation arrangements payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287953272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Level 3 Fair Value Measurements [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning of period</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Increase in fair value recorded in earnings</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, end of period</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=wst_SalesProjectionsMember', window );">Sales Projections | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=wst_SalesProjectionsMember', window );">Sales Projections | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=wst_SalesProjectionsMember', window );">Sales Projections | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulFDAApprovalMember', window );">Probabilities of Successful FDA Approval | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulFDAApprovalMember', window );">Probabilities of Successful FDA Approval | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember', window );">Probabilities of Successful Execution of Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember', window );">Probabilities of Successful Execution of Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BusinessCombinationContingentConsiderationMeasurementInput', window );">Business combination, contingent consideration, measurement input</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_BusinessCombinationContingentConsiderationMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_BusinessCombinationContingentConsiderationMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=wst_SalesProjectionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=wst_SalesProjectionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulFDAApprovalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulFDAApprovalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281319032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Other Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherFinancialInstrumentsAbstract', window );"><strong>Other Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 265.7<span></span>
</td>
<td class="nump">$ 263.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 252.9<span></span>
</td>
<td class="nump">$ 255.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283210280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 1,573.2<span></span>
</td>
<td class="nump">$ 1,396.3<span></span>
</td>
<td class="nump">$ 1,279.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">39.0<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(36.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">1,854.5<span></span>
</td>
<td class="nump">1,573.2<span></span>
</td>
<td class="nump">1,396.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">(Losses) gains on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Change in equity affiliate investment AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined benefit pension and other postretirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(40.3)<span></span>
</td>
<td class="num">(40.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(40.5)<span></span>
</td>
<td class="num">(40.3)<span></span>
</td>
<td class="num">(40.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(108.9)<span></span>
</td>
<td class="num">(113.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(68.8)<span></span>
</td>
<td class="num">(108.9)<span></span>
</td>
<td class="num">(113.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(149.6)<span></span>
</td>
<td class="num">(154.2)<span></span>
</td>
<td class="num">(117.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (110.6)<span></span>
</td>
<td class="num">$ (149.6)<span></span>
</td>
<td class="num">$ (154.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283710072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Proprietary Products</a></td>
<td class="nump">$ 580.2<span></span>
</td>
<td class="nump">$ 548.0<span></span>
</td>
<td class="nump">$ 527.2<span></span>
</td>
<td class="nump">$ 491.5<span></span>
</td>
<td class="nump">$ 470.6<span></span>
</td>
<td class="nump">$ 456.1<span></span>
</td>
<td class="nump">$ 469.7<span></span>
</td>
<td class="nump">$ 443.5<span></span>
</td>
<td class="nump">$ 2,146.9<span></span>
</td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,379.1)<span></span>
</td>
<td class="num">(1,234.2)<span></span>
</td>
<td class="num">(1,172.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="num">(8.5)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401.3<span></span>
</td>
<td class="nump">291.8<span></span>
</td>
<td class="nump">240.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72.5)<span></span>
</td>
<td class="num">(59.0)<span></span>
</td>
<td class="num">(41.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 98.4<span></span>
</td>
<td class="nump">$ 82.3<span></span>
</td>
<td class="nump">$ 91.2<span></span>
</td>
<td class="nump">$ 74.3<span></span>
</td>
<td class="nump">$ 63.9<span></span>
</td>
<td class="nump">$ 56.3<span></span>
</td>
<td class="nump">$ 66.1<span></span>
</td>
<td class="nump">$ 55.4<span></span>
</td>
<td class="nump">346.2<span></span>
</td>
<td class="nump">241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | Gains (losses) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | Amortization of Defined Benefit Pension and Other Postretirement Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Reclassification out of Accumulated Other Comprehensive Loss | Gains (losses) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Forward treasury locks | Reclassification out of Accumulated Other Comprehensive Loss | Gains (losses) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283852728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>plan </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the 2016 Plan (in shares)</a></td>
<td class="nump">2,761,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense for all nonvested awards | $</a></td>
<td class="nump">$ 31,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CashSettledStockAppreciationRightsOutstanding', window );">Cash-settled SARs, outstanding (in shares)</a></td>
<td class="nump">24,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_StockSettledStockAppreciationRightsOutstanding', window );">Stock-settled SARs, outstanding (in shares)</a></td>
<td class="nump">3,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted', window );">Number of shares reduced for each award granted (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember', window );">Award Types Other than Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted', window );">Number of shares reduced for each award granted (in shares)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember', window );">Employee Stock Purchase Plan (ESPP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the 2016 Plan (in shares)</a></td>
<td class="nump">3,793,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of current market price for sales to eligible employees</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Limitation on payroll deductions of employee's base salary, percent</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount', window );">Limitation on payroll deductions of employee's base salary, amount | $</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear', window );">Maximum number of shares per employee, per year (in shares)</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchases of shares (in shares)</a></td>
<td class="nump">36,494<span></span>
</td>
<td class="nump">51,391<span></span>
</td>
<td class="nump">55,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">8,721<span></span>
</td>
<td class="nump">13,308<span></span>
</td>
<td class="nump">15,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 200.35<span></span>
</td>
<td class="nump">$ 116.39<span></span>
</td>
<td class="nump">$ 96.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember', window );">Annual Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 156.49<span></span>
</td>
<td class="nump">$ 106.14<span></span>
</td>
<td class="nump">$ 93.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate', window );">Conversion rate</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">53,659<span></span>
</td>
<td class="nump">84,309<span></span>
</td>
<td class="nump">102,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 177.31<span></span>
</td>
<td class="nump">$ 103.40<span></span>
</td>
<td class="nump">$ 90.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period (in shares)</a></td>
<td class="nump">11,404<span></span>
</td>
<td class="nump">16,204<span></span>
</td>
<td class="nump">23,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation, Share-based Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualConversionUnit', window );">Deferred compensation conversion unit (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans', window );">Number of deferred compensation plans | plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance', window );">Number of deferred stock units (in shares)</a></td>
<td class="nump">358,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredStockUnitsPayableInCash', window );">Number of deferred stock units payable in cash (in shares)</a></td>
<td class="nump">6,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation, Share-based Payments | Non-Employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">10,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 194.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CashSettledStockAppreciationRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of cash-settled stock appreciation rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CashSettledStockAppreciationRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualConversionUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement With Individual, Conversion Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualConversionUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement With Individual, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement With Individual, Share Equivalents Balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredStockUnitsPayableInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Stock Units Payable In Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredStockUnitsPayableInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction In Number Of Shares Available For Grant For Each Award Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Conversion Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_StockSettledStockAppreciationRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock-settled stock appreciation rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_StockSettledStockAppreciationRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288066488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 34.0<span></span>
</td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="nump">$ 15.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember', window );">Stock option and appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember', window );">Cash-Settled PSU Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember', window );">Performance-vesting Shares or Units Dividend Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember', window );">Employee Stock Purchase Plan (ESPP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation, Share-based Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285951304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Options Activity (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of options outstanding</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life of options exercisable</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of total options outstanding</a></td>
<td class="nump">$ 481.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value of total options vested</a></td>
<td class="nump">$ 351.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 40.28<span></span>
</td>
<td class="nump">$ 24.72<span></span>
</td>
<td class="nump">$ 20.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 88.8<span></span>
</td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="nump">$ 61.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Grant date fair value of options vested</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning (in shares)</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending (in shares)</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Stock Options, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 67.02<span></span>
</td>
<td class="nump">$ 58.93<span></span>
</td>
<td class="nump">$ 48.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">178.11<span></span>
</td>
<td class="nump">103.40<span></span>
</td>
<td class="nump">90.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">49.99<span></span>
</td>
<td class="nump">46.42<span></span>
</td>
<td class="nump">35.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">103.51<span></span>
</td>
<td class="nump">92.71<span></span>
</td>
<td class="nump">75.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, ending (in dollars per share)</a></td>
<td class="nump">81.37<span></span>
</td>
<td class="nump">67.02<span></span>
</td>
<td class="nump">58.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable (in dollars per share)</a></td>
<td class="nump">$ 62.42<span></span>
</td>
<td class="nump">$ 53.12<span></span>
</td>
<td class="nump">$ 45.32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Stock volatility</a></td>
<td class="nump">22.40%<span></span>
</td>
<td class="nump">22.50%<span></span>
</td>
<td class="nump">19.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285936088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details) - Stock Appreciation Rights (SARs) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>SARs Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning (in shares)</a></td>
<td class="nump">35,993<span></span>
</td>
<td class="nump">39,819<span></span>
</td>
<td class="nump">51,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted (in shares)</a></td>
<td class="nump">3,272<span></span>
</td>
<td class="nump">3,364<span></span>
</td>
<td class="nump">3,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(11,261)<span></span>
</td>
<td class="num">(6,790)<span></span>
</td>
<td class="num">(14,629)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited (in shares)</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, ending (in shares)</a></td>
<td class="nump">27,679<span></span>
</td>
<td class="nump">35,993<span></span>
</td>
<td class="nump">39,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">27,182<span></span>
</td>
<td class="nump">27,781<span></span>
</td>
<td class="nump">30,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward', window );"><strong>SARs, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 52.36<span></span>
</td>
<td class="nump">$ 46.48<span></span>
</td>
<td class="nump">$ 38.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">190.97<span></span>
</td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">89.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">35.37<span></span>
</td>
<td class="nump">42.08<span></span>
</td>
<td class="nump">28.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">71.43<span></span>
</td>
<td class="nump">63.43<span></span>
</td>
<td class="nump">63.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending (in dollars per share)</a></td>
<td class="nump">75.43<span></span>
</td>
<td class="nump">52.36<span></span>
</td>
<td class="nump">46.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 40.23<span></span>
</td>
<td class="nump">$ 40.73<span></span>
</td>
<td class="nump">$ 36.91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732377018808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Nonvested Performance-based Award Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Non-Employee Directors | Deferred Compensation, Share-based Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">10,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">$ 194.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember', window );">Incentive Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">$ 156.49<span></span>
</td>
<td class="nump">$ 106.14<span></span>
</td>
<td class="nump">$ 93.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting', window );">Number of shares to be issued upon conversion (in shares)</a></td>
<td class="nump">92,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Average remaining term of shares issued at conversion</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning (in shares)</a></td>
<td class="nump">264,622<span></span>
</td>
<td class="nump">296,037<span></span>
</td>
<td class="nump">341,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">53,659<span></span>
</td>
<td class="nump">84,309<span></span>
</td>
<td class="nump">102,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget', window );">Adjustments above/(below) target (in shares)</a></td>
<td class="num">(14,004)<span></span>
</td>
<td class="num">(50,556)<span></span>
</td>
<td class="num">(2,284)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and converted (in shares)</a></td>
<td class="num">(70,074)<span></span>
</td>
<td class="num">(48,964)<span></span>
</td>
<td class="num">(121,984)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(11,404)<span></span>
</td>
<td class="num">(16,204)<span></span>
</td>
<td class="num">(23,946)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending (in shares)</a></td>
<td class="nump">222,799<span></span>
</td>
<td class="nump">264,622<span></span>
</td>
<td class="nump">296,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 92.80<span></span>
</td>
<td class="nump">$ 76.84<span></span>
</td>
<td class="nump">$ 64.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">177.31<span></span>
</td>
<td class="nump">103.40<span></span>
</td>
<td class="nump">90.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue', window );">Adjustments above/(below) target (in dollars per share)</a></td>
<td class="nump">77.02<span></span>
</td>
<td class="nump">83.89<span></span>
</td>
<td class="nump">33.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and converted (in dollars per share)</a></td>
<td class="nump">173.22<span></span>
</td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">93.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">104.43<span></span>
</td>
<td class="nump">69.09<span></span>
</td>
<td class="nump">68.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending (in dollars per share)</a></td>
<td class="nump">$ 116.37<span></span>
</td>
<td class="nump">$ 92.80<span></span>
</td>
<td class="nump">$ 76.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember', window );">Cash-Settled PSU Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning (in shares)</a></td>
<td class="nump">1,981<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">732<span></span>
</td>
<td class="nump">806<span></span>
</td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget', window );">Adjustments above/(below) target (in shares)</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and converted (in shares)</a></td>
<td class="num">(502)<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="num">(910)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending (in shares)</a></td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">1,981<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 93.28<span></span>
</td>
<td class="nump">$ 79.48<span></span>
</td>
<td class="nump">$ 92.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">190.71<span></span>
</td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">89.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue', window );">Adjustments above/(below) target (in dollars per share)</a></td>
<td class="nump">74.43<span></span>
</td>
<td class="nump">56.95<span></span>
</td>
<td class="nump">41.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and converted (in dollars per share)</a></td>
<td class="nump">173.22<span></span>
</td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">93.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending (in dollars per share)</a></td>
<td class="nump">$ 130.13<span></span>
</td>
<td class="nump">$ 93.28<span></span>
</td>
<td class="nump">$ 79.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level (in shares)</a></td>
<td class="nump">8,721<span></span>
</td>
<td class="nump">13,308<span></span>
</td>
<td class="nump">15,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level (in dollars per share)</a></td>
<td class="nump">$ 200.35<span></span>
</td>
<td class="nump">$ 116.39<span></span>
</td>
<td class="nump">$ 96.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Stock-settled PSU awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Stock-settled PSU awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283213928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">401 (k) plan contributions</a></td>
<td class="nump">$ 16,800,000<span></span>
</td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">258,100,000<span></span>
</td>
<td class="nump">244,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">293,900,000<span></span>
</td>
<td class="nump">283,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contribution to the plan</a></td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Assumed healthcare cost trend rate, benefit obligation</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Ultimate healthcare cost trend rate, benefit obligation</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost', window );">Assumed healthcare cost trend rate, net periodic benefit cost</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost', window );">Ultimate healthcare cost trend rate, net periodic benefit cost</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets', window );">Percentage of global plan assets</a></td>
<td class="nump">83.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 43,900,000<span></span>
</td>
<td class="nump">$ 39,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">83,100,000<span></span>
</td>
<td class="nump">$ 73,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contribution to the plan</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">0.89%<span></span>
</td>
<td class="nump">1.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.58%<span></span>
</td>
<td class="nump">2.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="num">$ (3,700,000)<span></span>
</td>
<td class="num">$ (3,500,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 258,100,000<span></span>
</td>
<td class="nump">$ 244,100,000<span></span>
</td>
<td class="nump">$ 214,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.58%<span></span>
</td>
<td class="nump">2.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.54%<span></span>
</td>
<td class="nump">6.71%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlements</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contribution to the plan</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ultimate trend rate for health care cost for defined benefit postretirement plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283861096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Components of Net Periodic Benefit Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="num">(15.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial loss (gain)</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement loss</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss (gain) arising during period</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service credit arising during period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service credit</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial (loss) gain</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax', window );">Settlement loss</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges', window );">Foreign currency translation</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in OCI</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits | International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial loss (gain)</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss (gain) arising during period</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service credit arising during period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service credit</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial (loss) gain</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in OCI</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits | International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285970904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">$ 244.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">258.1<span></span>
</td>
<td class="nump">$ 244.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(287.9)<span></span>
</td>
<td class="num">(267.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">$ (10.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (loss) gain</a></td>
<td class="num">(22.1)<span></span>
</td>
<td class="num">(30.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Curtailment gain</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement loss</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(298.9)<span></span>
</td>
<td class="num">(287.9)<span></span>
</td>
<td class="num">(267.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">244.1<span></span>
</td>
<td class="nump">214.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">31.8<span></span>
</td>
<td class="nump">41.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums', window );">Employer contribution</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement loss</a></td>
<td class="num">(18.6)<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">258.1<span></span>
</td>
<td class="nump">244.1<span></span>
</td>
<td class="nump">214.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(40.8)<span></span>
</td>
<td class="num">(43.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (loss) gain</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Curtailment gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums', window );">Employer contribution</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">$ (6.1)<span></span>
</td>
<td class="num">$ (6.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288901320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Amounts Recognized in Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">$ (2.3)<span></span>
</td>
<td class="num">$ (2.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(57.5)<span></span>
</td>
<td class="num">(52.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AssetsDefinedBenefitPlansNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(52.1)<span></span>
</td>
<td class="num">(46.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Total liabilities</a></td>
<td class="num">(40.8)<span></span>
</td>
<td class="num">(43.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AssetsDefinedBenefitPlansNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Total liabilities</a></td>
<td class="num">$ (6.1)<span></span>
</td>
<td class="num">$ (6.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AssetsDefinedBenefitPlansNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AssetsDefinedBenefitPlansNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732286764104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">$ 67.3<span></span>
</td>
<td class="nump">$ 69.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">68.1<span></span>
</td>
<td class="nump">70.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="num">$ (5.8)<span></span>
</td>
<td class="num">$ (8.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287887352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Expected Benefit Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 24.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2022</a></td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2023</a></td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2024</a></td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2025</a></td>
<td class="nump">17.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2026 to 2030</a></td>
<td class="nump">74.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">168.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2021</a></td>
<td class="nump">21.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2022</a></td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2023</a></td>
<td class="nump">14.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2024</a></td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2025</a></td>
<td class="nump">13.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2026 to 2030</a></td>
<td class="nump">54.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">132.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">International plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2021</a></td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2022</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2023</a></td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2024</a></td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2025</a></td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2026 to 2030</a></td>
<td class="nump">20.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">$ 35.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Expected Future Benefit Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanExpectedFutureBenefitPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732286604344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Assumptions Used (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted average assumptions used in net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.61%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.91%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.33%<span></span>
</td>
<td class="nump">2.41%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.54%<span></span>
</td>
<td class="nump">6.71%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted average assumptions used in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.58%<span></span>
</td>
<td class="nump">2.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted average assumptions used in net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted average assumptions used in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287679864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details) - Pension benefits<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Weighted-average interest crediting rating used to determine net periodic benefit cost</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Weighted-average interest crediting rating used to determine net periodic benefit cost</a></td>
<td class="nump">0.52%<span></span>
</td>
<td class="nump">0.85%<span></span>
</td>
<td class="nump">0.41%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732278638024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Allocation of Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 258.1<span></span>
</td>
<td class="nump">$ 244.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member', window );">Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">39.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">42.2<span></span>
</td>
<td class="nump">32.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Pension plan assets measured at NAV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">214.4<span></span>
</td>
<td class="nump">204.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Cash | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 20.6<span></span>
</td>
<td class="nump">$ 15.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">64.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember', window );">Debt securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 18.7<span></span>
</td>
<td class="nump">$ 21.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember', window );">Mutual funds | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Pension plan assets in the fair value hierarchy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember', window );">Other mutual funds | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equity securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Debt securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equity securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Debt securities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">73.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288697608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Schedule of Other (Income) Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and post-employment benefits</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related charges</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Fixed asset impairments and sale of equipment, net</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax', window );">Argentina currency devaluation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BrazilTaxRecovery', window );">Brazil tax recovery</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DevelopmentAndLicensingIncome', window );">Development and licensing income</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction gains</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other items</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Total other expense</a></td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="num">$ (2.5)<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_BrazilTaxRecovery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Brazil Tax Recovery</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_BrazilTaxRecovery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DevelopmentAndLicensingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DevelopmentAndLicensingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732286091240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax', window );">Argentina currency devaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BrazilTaxRecovery', window );">Tax recovery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DevelopmentAndLicensingIncome', window );">Development and licensing income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.1<span></span>
</td>
<td class="nump">34.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember', window );">SmartDose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DevelopmentAndLicensingIncome', window );">Development and licensing income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation', window );">Restructuring and related activities, period of implementation</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related cost, cumulative cost incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and severance related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember', window );">2018 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation', window );">Restructuring and related activities, period of implementation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related cost, expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and related cost, cumulative cost incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax', window );">Argentina currency devaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and severance related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | 2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related cost, expected cost</a></td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related cost, expected cost</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOnFutureEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The quantified amount of the future effect on earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOnFutureEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfInvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfInvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_BrazilTaxRecovery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Brazil Tax Recovery</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_BrazilTaxRecovery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DevelopmentAndLicensingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DevelopmentAndLicensingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Activities, Period Of Implementation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RestructuringAndRelatedActivitiesPeriodOfImplementation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283222696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Schedule of Restructuring and Related Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">$ (2.3)<span></span>
</td>
<td class="num">$ (2.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan | Severance and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan | Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember', window );">2020 Restructuring Plan | Other charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember', window );">2018 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember', window );">2018 Restructuring Plan | Severance and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember', window );">2018 Restructuring Plan | Asset-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember', window );">2018 Restructuring Plan | Other charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring , ending balance</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2020RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2018RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280154008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at January 1</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase due to current year position</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase due to prior year position</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reduction for expiration of statute of limitations/audits</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at December 31</a></td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285916680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued liabilities for interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Total gross unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Estimated increase (decrease) in the liability for unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Tax benefit from impact of tax law changes enacted</a></td>
<td class="num">$ (1.0)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Tax benefit from stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.8<span></span>
</td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal corporate tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense', window );">Transition toll tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7.5)<span></span>
</td>
<td class="nump">$ 27.9<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit', window );">Measurement period adjustment, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate', window );">Net impact to the 2018 effective tax rate, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Operating loss carryforwards, state and local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Operating loss carryforwards, foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ExpirationPeriodAxis=wst_Year2021Member', window );">Year 2021 | State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ExpirationPeriodAxis=wst_YearAfter2021Member', window );">Year After 2021 | State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward | State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase (decrease) in effective tax rate for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_Year2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_Year2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_YearAfter2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_YearAfter2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732289334808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="nump">$ 227.0<span></span>
</td>
<td class="nump">$ 161.2<span></span>
</td>
<td class="nump">$ 132.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International operations</a></td>
<td class="nump">174.3<span></span>
</td>
<td class="nump">130.6<span></span>
</td>
<td class="nump">107.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 401.3<span></span>
</td>
<td class="nump">$ 291.8<span></span>
</td>
<td class="nump">$ 240.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732290082824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 28.9<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">46.0<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax provision</a></td>
<td class="nump">78.3<span></span>
</td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">40.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit', window );">Federal and state</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 72.5<span></span>
</td>
<td class="nump">$ 59.0<span></span>
</td>
<td class="nump">$ 41.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Federal, State and Local Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288914696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 21.4<span></span>
</td>
<td class="nump">$ 21.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges', window );">Restructuring and impairment charges</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Pension and deferred compensation</a></td>
<td class="nump">35.3<span></span>
</td>
<td class="nump">25.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(15.1)<span></span>
</td>
<td class="num">(15.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">54.6<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">42.1<span></span>
</td>
<td class="nump">37.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Tax on undistributed earnings of subsidiaries</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="nump">49.0<span></span>
</td>
<td class="nump">45.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax (liability) asset</a></td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax (liability) asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732288689160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Income Tax Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal corporate tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Tax on international operations other than U.S. tax rate</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Adjustments to reserves for unrecognized tax benefits</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent', window );">U.S. tax on international earnings, net of foreign tax credits</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent', window );">Foreign-Derived Intangible Income Deductions (FDII)</a></td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax effect</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">U.S. research and development credits</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Excess tax benefits on share-based payments</a></td>
<td class="num">(5.20%)<span></span>
</td>
<td class="num">(3.50%)<span></span>
</td>
<td class="num">(6.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Impact of 2017 Tax Act</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage', window );">Tax on undistributed earnings of subsidiaries</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(1.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">18.10%<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
<td class="nump">17.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign-Derived Intangible Income Deductions (FDII), Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732287514136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment</a></td>
<td class="nump">$ 118.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">Outstanding unconditional contractual commitments due to be paid in 2021</a></td>
<td class="nump">$ 41.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod', window );">Contingent consideration, payable period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Contingent consideration, estimated outcome, low</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, estimated outcome, high</a></td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember', window );">Insurance Claims</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for insurance obligations</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyReceivable', window );">Amount reimbursable by the insurance company</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Revolving credit facility, due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letters of credit supporting the reimbursement of workers' compensation and other claims</a></td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration Arrangements, Range Of Outcomes, Payable Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732280261480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732289079416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Sales by Product Group (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">$ 2,146.9<span></span>
</td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">1,648.6<span></span>
</td>
<td class="nump">1,398.6<span></span>
</td>
<td class="nump">1,308.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">498.6<span></span>
</td>
<td class="nump">441.5<span></span>
</td>
<td class="nump">409.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment sales elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732376989016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Sales and Long-lived Assets by Geographic Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">$ 2,146.9<span></span>
</td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">1,011.5<span></span>
</td>
<td class="nump">909.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">975.6<span></span>
</td>
<td class="nump">814.7<span></span>
</td>
<td class="nump">766.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">407.8<span></span>
</td>
<td class="nump">364.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">282.1<span></span>
</td>
<td class="nump">236.3<span></span>
</td>
<td class="nump">235.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">112.0<span></span>
</td>
<td class="nump">105.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">226.0<span></span>
</td>
<td class="nump">173.8<span></span>
</td>
<td class="nump">138.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">197.6<span></span>
</td>
<td class="nump">176.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">172.7<span></span>
</td>
<td class="nump">150.6<span></span>
</td>
<td class="nump">145.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">76.0<span></span>
</td>
<td class="nump">53.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember', window );">Other European countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">236.8<span></span>
</td>
<td class="nump">251.1<span></span>
</td>
<td class="nump">230.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">66.8<span></span>
</td>
<td class="nump">59.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=wst_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Proprietary Products</a></td>
<td class="nump">253.7<span></span>
</td>
<td class="nump">213.4<span></span>
</td>
<td class="nump">$ 201.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">$ 151.3<span></span>
</td>
<td class="nump">$ 149.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=wst_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=wst_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732283532616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Segment Financial Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 406.9<span></span>
</td>
<td class="nump">$ 296.6<span></span>
</td>
<td class="nump">$ 240.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34.0)<span></span>
</td>
<td class="num">(24.4)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Acquisition-related Intangible Assets</a></td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BrazilTaxRecovery', window );">Tax recovery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense/(income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401.3<span></span>
</td>
<td class="nump">291.8<span></span>
</td>
<td class="nump">240.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,793.8<span></span>
</td>
<td class="nump">2,341.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109.1<span></span>
</td>
<td class="nump">103.4<span></span>
</td>
<td class="nump">104.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174.4<span></span>
</td>
<td class="nump">126.4<span></span>
</td>
<td class="nump">104.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503.1<span></span>
</td>
<td class="nump">362.7<span></span>
</td>
<td class="nump">310.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BrazilTaxRecovery', window );">Tax recovery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(96.2)<span></span>
</td>
<td class="num">(66.1)<span></span>
</td>
<td class="num">(70.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34.0)<span></span>
</td>
<td class="num">(24.4)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Corporate general costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52.1)<span></span>
</td>
<td class="num">(41.9)<span></span>
</td>
<td class="num">(46.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and severance related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(9.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Acquisition-related Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CostInvestmentImpairment', window );">Cost investment impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Gain on restructuring-related sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_GainLossOnArgentinaCurrencyDevaluation', window );">Argentina currency devaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_BrazilTaxRecovery', window );">Tax recovery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583.9<span></span>
</td>
<td class="nump">474.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434.5<span></span>
</td>
<td class="nump">313.6<span></span>
</td>
<td class="nump">266.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,798.3<span></span>
</td>
<td class="nump">1,480.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">83.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139.5<span></span>
</td>
<td class="nump">88.7<span></span>
</td>
<td class="nump">79.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.6<span></span>
</td>
<td class="nump">49.1<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411.6<span></span>
</td>
<td class="nump">386.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.4<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital Expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="nump">$ 36.1<span></span>
</td>
<td class="nump">$ 24.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_BrazilTaxRecovery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Brazil Tax Recovery</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_BrazilTaxRecovery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CostInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost investment impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CostInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_GainLossOnArgentinaCurrencyDevaluation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Argentina Currency Devaluation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_GainLossOnArgentinaCurrencyDevaluation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732284216888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Operating and Per Share Data (Unaudited) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Proprietary Products</a></td>
<td class="nump">$ 580,200,000<span></span>
</td>
<td class="nump">$ 548,000,000.0<span></span>
</td>
<td class="nump">$ 527,200,000<span></span>
</td>
<td class="nump">$ 491,500,000<span></span>
</td>
<td class="nump">$ 470,600,000<span></span>
</td>
<td class="nump">$ 456,100,000<span></span>
</td>
<td class="nump">$ 469,700,000<span></span>
</td>
<td class="nump">$ 443,500,000<span></span>
</td>
<td class="nump">$ 2,146,900,000<span></span>
</td>
<td class="nump">$ 1,839,900,000<span></span>
</td>
<td class="nump">$ 1,717,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">211,100,000<span></span>
</td>
<td class="nump">194,600,000<span></span>
</td>
<td class="nump">195,100,000<span></span>
</td>
<td class="nump">167,000,000.0<span></span>
</td>
<td class="nump">153,200,000<span></span>
</td>
<td class="nump">147,800,000<span></span>
</td>
<td class="nump">157,900,000<span></span>
</td>
<td class="nump">146,800,000<span></span>
</td>
<td class="nump">767,800,000<span></span>
</td>
<td class="nump">605,700,000<span></span>
</td>
<td class="nump">545,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 98,400,000<span></span>
</td>
<td class="nump">$ 82,300,000<span></span>
</td>
<td class="nump">$ 91,200,000<span></span>
</td>
<td class="nump">$ 74,300,000<span></span>
</td>
<td class="nump">$ 63,900,000<span></span>
</td>
<td class="nump">$ 56,300,000<span></span>
</td>
<td class="nump">$ 66,100,000<span></span>
</td>
<td class="nump">$ 55,400,000<span></span>
</td>
<td class="nump">$ 346,200,000<span></span>
</td>
<td class="nump">$ 241,700,000<span></span>
</td>
<td class="nump">$ 206,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.32<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="nump">$ 1.24<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.76<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.29<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
<td class="nump">$ 4.57<span></span>
</td>
<td class="nump">$ 3.21<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PensionSettlementAndRelatedCharges', window );">Pension settlement and related charges</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare', window );">Pension settlement and related charges (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Acquisition-related Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_IncomeTaxBenefitFromStockBasedCompensation', window );">Tax benefit from stock-based compensation</a></td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="nump">$ 6,900,000<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare', window );">Tax benefit from stock-based compensation (in dollars per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare', window );">Intangible assets (in dollars per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RestructuringAndSeveranceRelatedCharges', window );">Restructuring and severance related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare', window );">Restructuring and severance related charges (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency', window );">Devaluation of Argentina</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare', window );">Devaluation of Argentina diluted share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Tax benefit for impact of tax law changes enacted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (500,000)<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
<td class="num">$ (2,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare', window );">Tax benefit for impact of tax law changes enacted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_FixedAssetImpairmentFromRestructuring', window );">Fixed assets restructuring plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare', window );">Fixed assets restructuring plan (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PaymentOfExciseTaxes', window );">Payment of excise taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare', window );">Payment of excise taxes (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wst_DaikyoSeikoLtdDaikyoMember', window );">Daikyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Acquisition-related Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare', window );">Amortization expense (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Other acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Acquisition-related Intangible Assets</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare', window );">Amortization expense (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AmortizationExpenseImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Expense, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AmortizationExpenseImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_FixedAssetImpairmentFromRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed Asset Impairment From Restructuring</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_FixedAssetImpairmentFromRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed Asset Impairment From Restructuring, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Charges From Devaluation Of Argentina Currency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Charges From Devaluation Of Argentina Currency, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Benefit From Change In Enacted Tax Rate, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_IncomeTaxBenefitFromStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Benefit From Stock-Based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_IncomeTaxBenefitFromStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Benefit From Stock-Based Compensation, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PaymentOfExciseTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment Of Excise Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PaymentOfExciseTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment Of Excise Taxes, Impact On Diluted Earnings Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Intangible Assets, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PensionSettlementAndRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pension Settlement And Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PensionSettlementAndRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pension Settlement And Related Charges, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RestructuringAndSeveranceRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Severance Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RestructuringAndSeveranceRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Severance Related Charges, Impact On Diluted Earnings Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wst_DaikyoSeikoLtdDaikyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wst_DaikyoSeikoLtdDaikyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732285284136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">$ 16.4<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred tax asset valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139732281530936">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2014-09 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>127
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M3JT-+Z[(M_E\HGAJ=LH95[#OFF$$1R,BM '<GW.NUA.]^9:'K<$_4$L#!!0
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M3S(AP#]?,I:]WHC?%^Q^=7/^/U!+ P04    "  JAE=28+*X?D )  #B*0
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M(SI'^848$@+6C@G>'5,@:7I\@/_!=\*>5-/^IA*0_?CA8)'6W+B&'I'%U'3
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MA(TGK/C@31-.-1OC<48*MR4.I639 .M;8_SA@3?HC[GK/P%02P,$%     @
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M^&%._*-A =I?:.VV$S;0OBC/_@)02P,$%     @ *H974B(2P"Q;!   (0H
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M!WHXQ^TSC:5"@;AJV7ACN3</^!N7]"NB$S&X0 +U<OAML3J;'U0K8/?5[*D
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MP[+$'4Y:5L#WE3%^+["#_E9X^2]02P,$%     @ *H974@:^-M(' P  C08
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M2T\5TAT)PQHA8?UV6\/M9&6.51G#N/F19@)R_*$+N759R922!0,G5T5BGO\
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M+*1!6&/M-3TAW^O+#L^^8U!T49" SP52J"KGL"FET<8U&P=J8+EB(<^Q&!G
M0:K,EJCY/@9&4N$[,9V-7F[_&)39Z\X5BB1*H!$DOC(9H@[E@/*J%\>C2;NL
M>_W6EJ7-*2? WC!XQ%5,1L?MDNXUF+\83;<R'./=EO\/6X#/0=F0!<D.$,/#
MJ5Q4AW:]."A_?',8A*[QIB>CT_C3[&S5<=;[HU9_OY:5. 7-YGWW^A&T7HW.
MVF7=:PAX/#HA]8DY_DY9?Y+Z_\9'IBQ2^OM#/G+6T;1[W>LCTXZ/3+L^\BKZ
M2)3A;,=;G^XCA^6/;Y[@(^2@_/,4'YG"JLW[[O4C:#T2(F?=,)T"R<>$;A*4
M:Q-[C@8TK. AL:P8:R+[T$UFM)YS5HYJ2;E*-C5;5I6S,EMQJYQ32DLIOJGI
MVQJX5Q!2.NVDPX6PM:.BT(/"L$?F5F!(VJ/%D%JF-;=#OG=78<WR*"A7=FT[
MI+YK5W=#<MA2]2L/'=;2Y:TNZCY#N5ZBUJ"%B9#Z"I4KW>[7H4ZC\P">[&!\
M_"EH'BBX;]Q^60Y'U-.EZ8<\1\M>>X)U43M>F_I1G^8[IPH98N?69*V.A)V^
MT1\2/_]F3$.&?;,F9^9F4(G:<$?+C4-9%7:CE$^] V2]4SYPU]I.I-'NVO>
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M M/VS@W1DJU407AN4&0N_6_%U>0?6 J)8I3^30?)#J4VZG]9AJ?#?P)=JW^
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MMQQ/O7$ <Q=!O&&G@K .+:UW&^.?!I6U"MPQ=,=(71.6W;Y:VK\9NF<:5SN
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MPC7H%1W(#D;)^>'&\]:0)"1/=&X.?P0I4MAO#.X',/HA S0!>#0B E;!<H9
MUHY'R%L E!T[2)/C0Q((RP^.Z3V:7WI1..A^3BO2P_H9C6_>#K,^2\E)?6)^
M'#ZQ^W4X/=2.NJT=]4&S?U=J'>)PP$QEV8WAEF*5W4F8SAL+'Y6EA0WAOBW7
MEXIK^,%!3<QZPTSI92&_")8)ZZ$B0TWB6GX)]H'PS69P7DF_Q )H X,B(/2:
M",R$]X(J4UD:ZX- 63!W!08+)+Q?!CUF%7PDG&.EE<9*+X5+V$]+ 9-$:T-J
M*X*9,A]EFPD*/"7(U92-" HH5 H0"/I6):WR*TROC^;$N8BP.;>F"'+F,!VM
MI/=H$ZX"UV@(Z3;X60IGR/#U; ')0.Y9HI8)>*.?'C<8093ZZ6GSF;!'2;E/
M*=Z(,& K$<+<YL%'E#MH XXH^GEA*L0I1('UB13E94-:ZBWAM@5#NII,AB%R
M%Q2'CJ1KPJZ5:I>UO,$@V(A,[UJ<:JA&U>NE*Q;]OR.<Z\B@_#)*YF&_\_B+
MJ &+Q94)^T0LYI6"V3  _V)IL$CT12 3W+."UHPLAH1E50Q R*1A&40LH= 3
M;. :UC;D+!CU)\FF-Z8OW]'[<Z/009$!/9\!RF!\%\&-&AOIUZT)*$406)M6
M-S,E%R%#W/;"4!Y>Y]SK.K)9%=HJ\#;F;V)\A)4;KFC[ ("8B6*&^5C@4P+P
M!BSWOS680B'6C#7_-';+W9*5?!U=N+UB^W^70.-16UW>$H9F &KOQ<Q6:&5#
M6?T&P(:N6A&8!UC@NIKS9FG&2YZ1CT,\Y6C,=;X-12OQ5V/1BG]#,#I!8?G#
M^--/)\GI;HAYB^4>F.F"JT:[UQ1<VEUG>\+N(FD*UBU9J/_X-J(,FD8N9"Q0
M8=P!4IS .GA7TQJP/C55W37:Z*.,LB#V02L4+G&4FY5^BS%\+-U+\:M<\'=3
M6#N]$NG1'[_X*+"*N-HRK&7JVNILRU9G:+/^)%M1^_DU6U'S^1?9J@OH^VSU
M9V,[&OZ_%]O/P@%AL@-*::;!=(KV>$08A:9^$\L/)M1S;B-X'/UQMQ_;A:!\
M2(WK*#SQOK<:I<ETA\0TLR592N1>29;N8Q(JS @A^S83FOG4J3#I<9#LY)M4
MF;*R.-(UW9,B0D05!/(JGAQ0>:0*#2]%2=LHST-W3%27<K$\HJ,1!:M!?RP\
MB5F3B">N;D4KZ^,+N-$48+40%NFEFA G5MA0T$44I9H6(G>-9%JL4!#M9X3B
MW&1(O T*W?9_'_9T@1):\3R7M4@O/6:;/ %G7EL2K6!(/[KOBLWL'T_$D[<\
M0UWL2Y&I+RG"R6QGP>&UO 'UT@XDHQP'[U?*-U7[!:ZZ)UE,MF?=$'.GW[OV
MS+O'A%N<7_!VPW#@JI"'<BZS/>Q 4YMB34)3,*$'D'JN8I @DBJ- LQ^3AX3
M]L_KZWM:!C+A&%G#RMLE>:%#G\TWC^4D[[33,73D!=8^25,YM3XJN<PA!<Z&
MN@E6G*LE,@7$J'Z\X#1'BCP9&] Z@W\]LY7"1$<H.NL&,*& ?VW+O',G4-\"
MD)2CS69"\&S)UH+;05=F3G7$BCF,%"4(%X6P5PU)L7<8=4(#;(4D>)!T%M>"
M!)K$"HQHC!6*/ =]%4Z]3Z(I;S3XB-SS=X087F1+;919K"EZ/5T*-V=LSAPZ
M07(Z[;&\%)7'.^*;)^Q>">Y(^3F$A (_&C26DP%[@!$0G6P0!.AD)&(A7+J&
ME-YY%P(H:RIETP77!ZLYEY9%?'JE1+:#W XQT_& O2=ROP1R'[&DLO&(^-9]
MX;!S&0N7+,*5LZ,@T3[>R[:C[:WV=;S,?5D>K\0_(M?H!D>).;:.DM/C'K/Q
MFCE^>%.&J]V9\?!_>%T*#GUH >;G!@K4'\2@O>N_^B]02P,$%     @ *H97
M4FWL,BRH#0  AB4  !D   !X;"]W;W)K<VAE971S+W-H965T,C4N>&ULO5K;
M<ANY$?T5E"*GI"J:X@Q)7;RVJV3+WB@5[[IL[>8AE0=P!B2Q'@YH8$84\_4Y
MW0#F0I&2LP]YD'@#&GT]?1KDZXVQW]Q2J4H\K(K2O3E:5M7ZU=F9RY9J)=W0
MK%6)3^;&KF2%EW9QYM96R9PWK8JS=#0Z/UM)71Z]?<WO?;9O7YNZ*G2I/EOA
MZM5*VNT[59C-FZ/D*+[Q12^6%;UQ]O;U6B[45U7]MOYL\>JLD9+KE2J=-J6P
M:O[FZ#IY]6Y"ZWG![UIM7.>Y($MFQGRC%[?YFZ,1*:0*E54D0>+A7KU714&"
MH,;W(/.H.9(V=I]'Z1_9=M@RDTZ]-\4_=5XMWQQ='HE<S65=5%_,YF\JV#,E
M>9DI'/\7&[]V/#X26>TJLPJ;H<%*E_Y1/@0_=#9<C@YL2,.&E/7V![&6-[*2
M;U];LQ&65D,:/6%3>3>4TR4%Y6ME\:G&ONKM;9F9E1)W\D&YUV<5)-+[9UG8
M_<[O3@_L3E+QR935THD/9:[ROH SJ-+HDT9]WJ5/2KQ1V5",DX%(1^GH"7GC
MQKXQRQL_:Y^XT2XKC*NM$O^ZGKG*(B/^_<01D^:("1\Q^9,N_/'=UTY(L2C,
M3!8"=29+_1])N3L0&R5DF0M34SW-G,ZUM%HY,=>%$MJ+J&"C555M2X>W1+54
MXK?AUZ&8JUQ92/RCMMKE.E0#I-U#AJF=<)6LO'P4.=*X["UU0W&#E^6"0S)@
MN;2CQAXS%X5>Z8JU=+2=/TY'R7G_;-)MJZ05A5P[E0]$H>0]R8P?.-IT@=W6
MU(LE'R4(>41EA'J0R'P^8RA0BUYTJW5ALAWSW* O>-P7+)$">X7_4_%GLG"&
M_/P'H&-G#7DV^FVOM[P3#A\^%->(4F;*3!?:BX07R6LSM=!E24XAHU29\].5
MJ<LJ+L&.&;956SZE+DG0 EFB<CYRIDHUUQ7"CT0B30I@KGLE3HY)[94N"M+P
MU#L!FEV)=[*090:+*_%W6=: 99&(8S$=CO!_/+P22$]@O5,BKQ6Y(JNM55"(
M@[DV3K,%$ZQ,AN>/5J_A*+NS=H1U?_W+99JD/XDO*J]]/I(]ZF&M;>.2_3EV
M)NN<+#P9#9-3^C\][1H!^%"KF;* $!B0C(:38,TM4C[/=5--2YD#S7D?5XO,
M,EO#C='#7%S029>5LLI5'!.DC"SX(RAU/!J.HT_Y4[R1MF_T=!F$O,,J<OL
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MGA+BF')S638LE/1!XUK!$ROM!@&FX/DF*VC0HFKUTU'.QZGO-?DJ9)@IU4O
M)\2V-48GU'"QW9.#/@F$ETO%-C/W! ,942QH6Z 7EJ8'CZJ+C,P#\C#E4&HM
M39&'+WGI.S,;+[[X)5OCOW0)-]WUFI,]."DDX\[7.N,)71EV:O+ ;0NSI+V1
MZ R?W-I]*C<;B5/HTM\FS-3!7/Y86[(EI@Z"YA,G B#X,D-RZ%]$)- Y*OKQ
M <.B<8'"TP>]Z[R#5ZN[4SSEVJ%J\>7$?7NF,EF[.$)AS"MZDK<MS_'!F-$
MMJ:!@I"E##/80TOZ*15[PT(D^!3J^-UXG'\YJSA#_7 \$)FV6;T"E/)7&  8
MQVT[U@ U,,_QVSP8""?A5GBKT-]I.O!O-@DUAUW&NN&^'W.<=7X;LU)VP;\
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MZEI'1#D&4K:D&V>CMGNVA>:PF468$,%9,<!=]W#+K\ MEO06"%6@GVS)Y><
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M Q.=-' 5P@-RX[>(E,J-]0;-4')82;I*/-[2^?.\9%4:70.W%IV])$B)QOB
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MD/41%F0COLASZ/LB&)HKMU@'^VU10=:.N,(($Y$3#BEAB$]*!Z6B+\]$0)X
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M_+&A#P^U4R!YI90]7!S!\(7F_P!02P,$%     @ *H974I9J(,_? P  O0D
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M&L5H1F+*UD)+G8G8XBFPCRR<D*#1KZ# T#JJ?VP$K6]RCAW"PDL<>Y-QA.)
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M.6IG0/>%4G:_<0&Z/X?Y'U!+ P04    "  JAE=2=<A^ >P"   ;!@  &0
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MU-/=].P$JQH_L7;*4IA^6]$?#M3N =WOE;)GP1GH_\(L_P902P,$%     @
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MZ(*R#$BOI#3=CS70K\[+?P%02P,$%     @ *H974J3+RD@2!0  N@P  !D
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MC\-Y<S>=A$G0EFR7'EEA+=B0: J '$(I(%>IXM;*7*8>A653^/[YIWD2)[_
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M"_QS(0QMP/M<(Z%V00'Z?U<N_P-02P,$%     @ *H974@$*#[?&!@  JQ0
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M:J73DJ5USM(<T"PH9\2QO6P+XYH9./&@4MTR17!@**:J%DJCH&_9V91!9U5
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M^61%3A8?(CP6-$4QHO$<$0>OI<E8?@ J0;B?6J3'M!G';O"X:W#0(HD >$&
MCQ,7J7I,$G@!1/O"]6(F8M<?<B3BKB]9*!_'\>1,B4B^//)H/#]8A8U-=G-$
MLPS=9+1_1#TYHA>3X]]-?8>.1T>WQ]Z[:VKV=#5*CU$[?YX>^H BAZ>-F]O/
MN]9\1!O$]&87U"F9@YX2$OX!Q21T/%1=^MQ)?+]'2FK@IE[AE:Y4=ZK$9N6$
M0<)BWY%>0@#"'+%Y_G^\7U3V8)(NFCLU.UO02]KY7IAHYGD^"!5X3A!06Q(
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M#?&,@_$AZ?*GF5M]YZ2,XW8Y/VO$K5KB_B<O (">&?E3.$S1ZO!ND"($P=W
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MGJD/%#I.";95T=0(4-ED\BO1V)RTE*!L/5T^LQFX7&F,R]%N%'A5$&Z<EGP
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M@D/I@ /@_5P!X%4=7*#YV\+E?P%02P,$%     @ *H974HJXBF$[!   ; L
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MR"KGU/#C3TJN(.0>!7I*O*\,EMU5ZF_*O7<75-%:.7NH"+WVN7^/[59F=#I
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MAT.O?]R01$%9 +^OM7;M"QOH_K<X^P=02P,$%     @ *H974ALS8QMH!P
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MJ.'X]Z']AP]_8]7:?6R8*VM5[98KP4NA:0/>+Y2RVQLZH/_Z=/4G4$L#!!0
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MV-@BNTNNFVC1NF/_)+2Y1-RP-O\%E#; ["^%T&\3>Y,,?YKB-U!+ P04
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M6M0YIUSTIFMN)E;5OH\\*$M=R0\7]*%![0"T7RIEMQ/7FMI/U^@O4$L#!!0
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MCE1&Y%1.6 XXWP\(#0-Z$-QS)M<9N&,1B4X)'&5]-05XF,(<6AD#$O8!\JX
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MNN%,66%:0^@7+R@F4!=VZ'6;CU 73V@OGA<4DQHF?VBJ)G5 :"HG=4"OIIY
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M-!:&H Y85]%]+6R^71P:Z7JS-/"US/BPXS30BN+;.YM+TL#.9!;V.J!1V!L
M3]UP=(QC5XSW;!CY6C3\0<?QTP+AVSN2)AM&=R7GX&BG)#\S/-DH<8Y.4Q5C
M7!QC9R#D6R;WIY+5T^JH_+8X(/[E^=S['.P/O#7-_OS]'@O50F4@(2M%Z?9'
MRB"Q/]+>WTB^*<YLG[A4TRHNUP1'1.0OJ-]7G,O#33Y ]1\+9O\#4$L#!!0
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M^![Y1)'93IL76R$Z>*VELM.H<JZY9<P6%=;<CG2#BD[6VM3<D6DVS#8&>1E
MM63)>'S%:BY4E&=A;V'R3+=."H4+ [:M:VY^WJ/4NVD41_N-I=A4SF^P/&OX
M!A_1/34+0Q8;6$I1H[)"*S"XGD9W\>ULXOV#P[/ G3U8@U>RTOK%&U_*:33V
M":'$PGD&3K\MSE!*3T1I_.@YHR&D!QZN]^R?@G;2LN(69UI^%:6KIM%-!"6N
M>2O=4N\^8Z_GTO,56MKPA5WG>T41B]8Z7?=@LFNANC]_[>_A $ \QP%)#TC^
M!%R] 4A[0!J$=ID%67/N>)X9O0/CO8G-+\+=!#2I$<I7\=$9.A6$<_D2MZA:
MA/?PK&6K'%42EEAP*>%\CHX+:2_H\.EQ#N=G%W &0L&#D))*8#/F* //PXH^
MVGT7+7DC6@H/6KG*PD=58GD$/SN-CY,3!(RD#_J3O?[[Y"3C'(L1I/$[2,;Q
MS;&$_A_^X40ZZ5".-/"E_RC'VN@:9B35T#NG)^$JF(7'@ :^W:ULV/]^(N!D
M"#@) 2=O!%P8O16A)6DB0&-TV5) @ZXUQPO<T5T'.C\BMGD<C]*,;0\O[6^G
MR]%D\.D290>/EF1M0B];*#2]PN[]#KO#N+@+7<)^NW>SYH&;C5 6)*X).AY=
M4[.9KG\[P^DFM,!*.[K#L*QHY*'Q#G2^UMKM#1]@&*+Y+U!+ P04    "  J
MAE=2:%A:E*0$  !L$@  &0   'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6RM
M6%U/XS@4_2M6-0\@L?E.FJ)2"2C,4&"%!K'SL-H'T[AM1!)G;(?"_OJ]=M*0
M)F[(:J8/D#CG7/O<>VU?>[JE[(5O"!'H+4TR?C;:")&?FB9?;DB*N4%SDL&7
M%64I%O#*UB;/&<&1(J6)Z5A68*8XSD:SJ6I[8+,I+4029^2!(5ZD*6;O%R2A
MV[.1/=HU?(_7&R$;S-DTQVOR2,13_L#@S:RM1'%*,A[3##&R.AN=VZ=WMB,)
M"O%73+:\\8RDE&=*7^3+370VLN2(2$*60IK \.^57)(DD99@'#\KHZ.Z3TEL
M/N^L7ROQ(.89<W))DQ]Q)#9GHW"$(K+"12*^T^TW4@GRI;TE3;CZB[85UAJA
M9<$%32LRC""-L_(_?JL<T2" '3W!J0A.F^ =(+@5P1U*\"J"-Y3@5P1_*"&H
M",%0PK@BC(<2PHH0#B5,*L*D30@.!<[:1<X:VH==![L3[8.47;C+Q#?+Q%)9
M.<<"SZ:,;A&3>+ G'U1J*SXD8YS)6?@H&'R-@2=F?\)$O\F6-"7H@3#TN,&,
MH*,Y$3A.^#'Z ST]SM'1EV/T!9F(RZ\<Q1EZRF+!3Z 1GN_C)($)Q:>F@ %)
ML^:RZORB[-PYT+F+[FDF-AQ=91&)-/Q%/]]V>@R8X(G:'<[.'1=.K\4Y61K(
MM4^08SF69D"7_?1'D@/=.DB?]],71=9+O^JGWV/6._CKP=KMB8;^=;!V+?W;
M8.U:^LU@[5KZXM?B?OMKKKL;3@][LMBM)[6K[+D'[%UAEL79FC>F]-_GSUPP
MV//^Z;'OU?8]9=_K631BM6CHYGS)'2NN+ )>9Y/0\*S&SYZ:K\U)U66$CN'N
M@^8:L[;A[(.NNJ"QU[9TW04%KC'9!WWM@OR@;>F;QE)@6)/F;Y]QHS'K&]X^
M:-$%N5[0UGK;13F>;8SW47<:E!4TU.XE@%\G@-^; #]4<4,BA%\)@V(-02ZD
M4%-5&P14>US@+((<1$?QKOE8-RW+?H)FP-R)2I*66@VPRJF6X $6]S0'M>:@
M5_,\3@I9,2*R6D$)B>@*D9]%+-X1WF(6P6XHJ\$(@1O$AB !-3$OV#N"37SY
M@E(B-C3ZS!M!9^RVUAD:G*?SA0;G][AB7+MB_/_"7\4=<RCF9= CY2OPQ"=Z
MQ]U8^:%.L ZH53P N"<YK"6'O9+/,Q%'NPR@N13'$7E;)@44'FC%:"KG0%X(
MK'1#<B@T?,OJQ1+EL!SSLL+J]TO84=%V2!=AZ]S1A?4Y8U([8]+KC$>5THSD
M!5MN(.E1SNB:X?2D3H0"LIW%_Y+/,OYBTAE@X-H='===6.B%'=ABF+7;3ZWM
M><6V/FIIJ]\OI?J=6R)40%FZ"WG779_YINJM)PT6&L@XD'/\@)3&L<#^G5*T
MM;O=V7ILVS?\5C TL-#MW43O-)2Q980'-#L?FIW?J?FDL?MQT9K<$4T2S/A'
MJW:>5P.:["W0MA'X+2EFXX"7$K96UQ8<^BTR49:%=6M]-7*N#HBM]@O[],;6
MM"_D58HZ4'Z8+^]AH+!>Q[#6)60%75G&&/975EYME"^"YNIX^4P%'%?5XX9@
M<)P$P/<5I6+W(CNH+YAF_P%02P,$%     @ *H974OZ+65N3!   4QD  !D
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MMN$:#"_EMET(G^&V 2"T$W!*YBO]2+S8_@MWM0VR8'0%@PW$X.#"6!D<8&4
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ML5,L3\SB3(OO/'/Y.!I&D.&:;85[T+O/6,73\WRI%C9\85?:#@81I%OKM*S
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MZEV1+MVTGF9B5>U?[U)9Z@5^6%*W1NT":+]0RFXG[H"N_T_^ E!+ P04
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ME<8 OF^%T"\=,T%U0UO^!5!+ P04    "  JAE=27N 0+'($  "W$0  &0
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MG@Q!6UG>$I0O6JSM(74N-$Q*^[BB)*72=(#O"R'T]L4XJ.]J)O\"4$L#!!0
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MJ$$: _R^%T*_+LP(ULWHZS]02P,$%     @ *H974DY,76GD P  91   !D
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MN\9'2]&\9BF3XZ6XS5*FQTO1*RDR\6,  .$O8Q=-HY!N-$C_ -=,+-DXX8M
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MD5?3[-DJ"Q7M3$6[B5>;:!Z5K-H0%Y(AR9ZKU2KA*U]RYL=QYH>P2LDL"60
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M);!PE0'\/F=,/CVH <JKHE?_ 5!+ P04    "  JAE=25#?#G#L&  !=)P
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M-1*=,#*#S"?QX))$810>H4\_31_<'-(#TY*^+U'?E\CIQ2?T/JK^Y]W*!.8
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ME7TZ%CIMZ/R^'[IKB%NV$5"="MWOT>&X-=]7'U\_<1FA?_T&)M%')=+BWQ9
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MT@+,\ZT0^G-B7U#\1S'['U!+ P04    "  JAE=2D4]^KR@&  #O&P  &0
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MS#N2C'<30FF9*UEF.=!PU99YM67>V];!5L07%VX1MFYPQ!HS+P86 "'P7B3
MD,9Q[M$]8666_* RO+3 ;T^I:2"O-KS,3S(*V8:+KE&! F4:<*:>!+^>!%\[
M"5]DIW06O-HCON01SS.ZO&20/3/\#BT9-(.&I68%S:8DFEI>?PSYLG^Q59JO
MN!EVAYH"Y!I.AYI2DV6V_V /T5;MA_IRH:[P/Y_$^@2BK<HK@JX*0-2,A+13
M^DW.(C=@1;916N3./"C*=D$9"95RK[U\6Q%<S6H)FK4#O3NGLAZK-?'7W)J:
M"ZWAY5)%MHZ$)0UN&JA+0@62:*A ?32:2@WU9?/3)60'B=C2\+=F=_T^J%&S
M+A5;<MIMW[)N:C34%TRQ<C<D&N,21QK=[-(8A 1:R#6%IBY#?6%6Q@LI?@=)
MS13!(J4@%<CM$IMI(NJ:6%/1H;ZD?Y,[HD%"KF0K["ZDAS&@0 GJZ01@TPI
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M.TH/@H7KW&@?CXCG34;[,$H&MXO\LWMQN^!'&4<)NQ<H/>[WH?AVQV+^?#/
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M\5=O9'XH'WH_Y%+F:?ERS^B&\4*@OM_FN7QY4S30_-!B^1]02P,$%     @
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M\:1S7N).$O54%$Q^N\9<G#<!#5YO?.&/)VUO1-MUQ1[Q#O5]M9-F%'51#KS
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M2ON">7X40K\.[)FG.[)N_P-02P,$%     @ *H974@ZA#=%1 P  =PT  !D
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MMP4  %,B   9    >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;+6:7V^C.!#
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MBGE8><Q;S%-Z &DNS:WE!\5D%MH\_##)U_V%I?S7D.NQQ>]L2U+P]9WG44;
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M OSW-:7LXR0?H/J.9/$?4$L#!!0    ( "J&5U((6KH&[P(  /@'   9
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M,D 16]%=K#^+_<^L",@W^D(1J^POVN>R03! X4YID11@\"#A:?Z?WA6)J %
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M @#?;])4OIP4-VA^8W'Q/U!+ P04    "  JAE=2_=K!>) '  !O*   &@
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#DN>&ULO9I;<^HV$(#_BH;I0\Y,#UCR
ME4R2F00#@7#:]*2G?>CT00$E>.(+1Q:Y]-=7-@[&TB+,G+0\)-A\N[KL:G<E
M^^PEXT_YDC&!7I,XS<\[2R%6I[U>/E^RA.;=;,52^<M#QA,JY"5_[.4KSNBB
M%$KB'K$LKY?0*.U<G)7W;OG%6;86<92R6X[R=9)0_G;%XNSEO(,[[S>^1H]+
M4=SH79RMZ".[8^+;ZI;+J]Y6RR)*6)I'68HX>SCO7.+3F6T7 B7Q1\1>\IWO
MJ!C*?98]%1>3Q7G'*GK$8C87A0HJ_SVS 8OC0I/LQ_=*:6?;9B&X^_U=^Z@<
MO!S,/<W9((O_C!9B>=X).FC!'N@Z%E^SEVM6#<@M],VS."__HI<-Z]L=-%_G
M(DLJ8=F#)$HW_^EK-1$[ E(/+$ J :(*>'L$[$K 5@6</0).)>"T%7 K ;>M
M@%<)>&T%_$K ;RL05 )!6X%^)=!O.ZW8>K><U=9T>&OLUM;&[^;&I;U[&\<J
MO3*D@EZ<\>P%\8*7^HHOI6N7\M(9H[18A7>"RU\C*2<N?EM3+AB/W]"O*\:I
MB-)'1-,%NF4<W2TI9ZA0BTZ^I72]B 1;?$(G(1,TBO-/Z#/Z=A>BDY\^G?6$
M[$NAL3>OVKW:M$OVM&NC+UDJECD:I@NV .2G9GE,# IZ<A*V,T'>9^**&#6&
M;-Y%-OX9$8M80(<&9O$[MI+BUE[QT"P^7:=&\:%9_ OEQLZ/6H\=]P'Q<>NQ
M@^+7K<<.BD]:CQT4G_Z8W6]^;.IF[<4#@Q?;V_5LE_KL/?J^LESP]5RL>;&2
M!UDNRN4L;S/^S-!?,\FCB6!)_K>A-6?;FE.VYNQI[99G*Q[)<,#?D/R^D WG
M4"S8:'%++45=\'SA!G*VB\]9[WEWD0&D$U@ &0(D\2&=0YUT^M@%R!% ^I8'
MD&. =#T,D-< Z?5]@)P I&-#_9SJ),%2*X#>Z"@.[#Z$S@#4Q[[31!M^XF[]
MQ#7ZR9AG>8Y6/'N(!.0?&VFO,1X,S>9 )W'?@2P40J0+Z1P"I.=#/C<"2->&
M?&X,D(X?0/X!Z?0A^TP@G1ZD<ZJ3O@>V?J.3GN5"WCG32==Q3<[A;9W#,SK'
M+W*O$:7S+&&0:WB:4_8#!^C?0 <#8D.. 6C$8-S00=^!-(YTT+,A"XYUT/4@
MC=> 1C"Z3 "-JE$V+J&#MN-!P[[12>)@T"4 TE*C4,,E_*U+^$:7N*)Y-$<G
M48H661Q3+F.'K$?SHAX%:\V-MO[NRNC:1'$0",)8<0X((H[B&!!D*9I&.F1U
M T]Q" CR%>@:@OJ*'X"*7,4'=,CI>H%B?AVRN\17+*]#I!O -@^V-@^,-@^C
M>"WW%T=8/8!LI4S, ((L!0I!38I!ASHDS:!H&D%0H/C/&()48UV#FA1C34!-
MMF)V'7*ZKF+1&QVRM2F8Z1#I^@YL]_[6[GUS#5D=Z>1,B)@E+-U4K)S%M'"'
MN33_(P.KRKX>TJ#$H&-0)@QU#(IY0QT#"Y61SH%UI(X1L(ILV>Q$YTPI&EOU
M,8'U 58Z8O%6[35=5PVB@U94V(H:MJ)&K:@Q3"D+[[J5KLDAJFFQG8,=;+38
M99)Q$?U#R\/.[ %=SK^OHSPJ+C^_FVV2"IH^1O<Q0Y>Y-"VTS,*JG4.N/ 4X
M!RI%;@#0AL 9 !+?Y,ZDGAQBG)S?Z2NZ9RF3^Q'TP+,$Y2*;/WTNSG.E,V?)
M2KI[.7.@ZQ)]0J"0,@!  NTK0D@C5$ . 1#<TXP $ P88P!TH#Y> Z -C7H"
M-6T,0O79!K8_QFK'Q"$;6GUJ%0%31#5C&UU#F*HVG.\?+2RUZ< 8IM3*HA4U
M.=1BTX;UB1$V'QGMA!RZ+^1<8>"  SH("0$0>R9?JT\LL/G(0NOG,3[EML@.
M(4SMF^!Z-XW-V^GF"6"1I'/VS#A-YZQ%437 T$81C## AAL,,#IG#@?U)A&;
M=XE'C+2]\088VDI9CCIZD-+6(TCM2^WU3@D?V"JQ9QJOZ\PN1YB***70P7^E
MZE!=.S[,-3M;E_?87-_OZRQ:5!N^TA3M#32JVCM4H1V@FL^(ZCJ8F.O@1@K*
M.(J2%9V+8F!"_A+3E\+CTL+C6"I_ !]MC:LV&DL"RKE3 /P,Q<$;"(0V0S,(
M5$-K<VKJ@I.8"\ZCIZ:]S<=5TRVM69>!Q%P&CJ)7V8TJOO-&.%G%%"K^1@2H
M;FS3_-75#3%7-P<Z<\0*(<>D;E*G;G+@:0]]*S=^TJ+L=1[EK# LF$5&!$C@
MIH-!4N=E8L[+>SIQS.R >7?/*0:I\RXQY]V01D]OF>E!=)W8R"8O_+</\4B=
M3X@YGWS45G%(]"2B!K9F%^LL0LQ9I-%%]EI4^D?DC"$Y)AO8=3:PS=G@5[&4
MS=)ZNG+3(]PZDMKX?["_78=!VQP&/\K^5[8>'*%B8]"2"P%.W<4VA[SSF-P<
M;'_,GZYL,,*JIU>MJ/ 0M1EA;^<=GX3)(JIX<RV7N]YU*C:O!VSO;M^.NRS?
M$5+N7^'3"0;N3_'I;//N6ZU^\RK>%UE"1VF.8O8@FRJ.JCN(;]YNVUR(;%6^
M872?"9$EY=<EHPO&"T#^_I!EXOVB:&#[CN'%OU!+ P04    "  JAE=2#BP/
M[PT$  "6$   &@   'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&ULS5A-;]LX
M$/TKA-!#"R26*'\7MH'8ZF)S")!-T.YAL0=:&MM"*=%+4G;Z[TM2LCYI);N;
M0R^Q*+UYG,<9SI!9G!G_+@X $KTD-!5+YR#E\;/KBO  "1$#=H14?=DQGA"I
MAGSOBB,'$AFCA+J^YTW<A,2ILUJ8=X]\M6"9I'$*CQR)+$D(_[$&RLY+!SN7
M%T_Q_B#U"W>U.)(]/(/\>GSD:N26+%&<0"IBEB(.NZ5SAS\'>*X-#.);#&=1
M>T9:RI:Q[WIP'RT=3WL$%$*I*8CZ.<$&*-5,RH]_"E*GG%,;UI\O[+\9\4K,
ME@C8,/IG',G#TIDY*((=R:A\8N??H1 TUGPAH\+\1><"ZSDHS(1D26&L/$CB
M-/\E+\5"U SPY(J!7QCX;8/1%8-A83!\J\&H,!B9E<FEF'4(B"2K!6=GQ#5:
ML>D'LYC&6LF/4QWW9\G5UUC9R=6S2J0HHX#N[]$M^D9H1O)XI!'Z(R,TWOV(
MTSVZ"T.6I5*@CP%($E/Q2:&_/@?HXX=/Z .*4_004ZH,Q<*5RBU-[H:%"^O<
M!?^*"]A'#RR5!X&^I!%$30)7Z2E%^1=1:[^7,8!P@(;X!OF>[UD<VKS9',\M
MYL';S6<]:H9EB(:&;W@M1%\VZ!*F&X3]6V]^HU;L!&K[2;WT5=3NJ-K') U!
MF  ^@0!^4H._GABE2&V4,^'1WST^C4J?1L:GT16?UH3J:1"1: O[.$UUDK =
M.@*/663+@9QO:OAT,3JM\&0P6KBG>EQRT+@.FC4A09?'QS6>AIIQJ6;<JV9S
M('P/$9(,A4S(?/'@1=56 =:$SNEF-2>\P;2EQ8;!+3%=S*T_&-K%3$HQDUXQ
M@4H44U.MGD^Z,WJ#><MU"PBW]056$+;[/BU]G[XUK4"%H#>AIIWY54+Y+256
M4"OK@APTL6==0\>LU#%[)08[X%QG%'E!1 C5OT]5:;ULTIY]."\GFO\RM0%[
M54_QWKDZ%(2-0(T[>5F@&I&:M()I8?+K&=Z45&N3^'U+1,%7]]5KRWD5$E@@
MMU?J _8K+?[_J!"%<:M$S-J^6U'M^F9#X:O!J!HB'KY;F2BH6IF%VW*LJ'E;
MSK O_YIBJDZ*^UMIN2^1.L6CB&5;N<NH.A#G)ZZ^#5GU-SS^=<I$U:AP?Z?Z
M#V6BVW2\P;@=RTDG2GX[D/T\33U5\\+]W>O?UXAN>^J>(ZR@SD;K9VH*JKH8
M?JV-]1:*V1M*P,:&PH-.U>ZBZC6GZ7_5'/'\_>K$O'M [8KI@CKY%Q2@L37_
M<B5N[<*6@$H:??$5R.SX_)I3OBTOUW?F2MEZO]:7;G,1K&CR&_N#RL4X%8C"
M3E&J9%#^\/P2G \D.YIKX99)=<DTCP<@$7 -4-]WC,G+0$]0_BMB]1-02P,$
M%     @ *H974G%;:^[C 0  4P0  !H   !X;"]W;W)K<VAE971S+W-H965T
M,3$Q+GAM;)V4WT_;,!#'_Q4K[^ T%,90$@DZIDT"J:("'A":G.226/A'9E^6
M[K^?[:2AFUH>]A+[[/M\[\X^)QVT>;,M )*M%,IF48O875%JRQ8DLZ>Z ^5V
M:FTD0V>:AMK. *L") 5-XOB"2L95E*=A;6WR5/<HN(*U(;:7DIG?-R#TD$6+
M:+?PP)L6_0+-TXXUL %\[-;&6716J;@$9;E6Q$"=1=>+JU7B_8/#$X?![LV)
MKZ30^LT;WZLLBGU"(*!$K\#<\ M6((07<FG\G#2C.:0']^<[]:^A=E=+P2RL
MM'CF%;99=!F1"FK6"WS0PS>8ZCGW>J46-GS),/HN+R)2]A:UG&"7@>1J'-EV
M.H=]X/((D$Q \B]P?@0XFX"S4.B862CK"T.6IT8/Q'AOI^8GX6P"[:KARM_B
M!HW;Y8[#_(X5(%**3LHOT'+";C[&;@6XJ\0#X&H$DR/@$Q,]_(U1E_*<=S+G
MG02=Y1&=Z[+4O4*N&K)!IBIF*DL>NXHAD)?;+?H^*P20.V[Q]5!]'\OW]J1A
MK/OQ'F:.,@9Y#^$C'#J'_\\_B1?+D_@S>;D'68!Y/71<=._*_7.[9Z;ARA(!
MM8L7GWYR[6/&%AX-U%VXSD*CZZDP;=VK!^,=W'ZM->X,WUCS?R3_ U!+ P04
M    "  JAE=2(.,NU)L"   Z$   #0   'AL+W-T>6QE<RYX;6S5F-UNVC 4
MQU_%,M/42A/Y8(6Q$J2M4J5)VU2I7.RN,HD#EOR1.0Z#7NY=>K>GV*/L26;'
M)@F44-:+%6ZPSSGV__QR["0.HURM*+Z=8ZS DE&>1W"N5/;>\_)XCAG*NR+#
M7$=2(1E2VI0S+\\D1DEN)C'JA;[?]Q@B'(Y'O&#73.4@%@57$1Q6+F";3TD$
M@_Y;"*S<E4AP!._.7G\OA+I\!6S;>=/I^'?GE]O^LS)P#KV=HA<'B';;9;NM
MPOU-X5KHJ8F#@XCV(;5*O]LM_?NAI8158'\-A[ME__S\U5K%.O9$.0;^(<S=
M/=3MTL%!W'NHVX3#G6OO^\WE]]TR>6[SCT>IX/4]T(/6H?41PV"!: 2O$"53
M2<RL%#%"5]8=&D<LJ)! Z9M/)PR,)[^WX<!:YKYT.HQP(<O<-H/]G;KA6X&U
M90 )I15@"*UC/,J04ECR:VV4@TOGHQ!P_<DJTX0SB59!> 'K"66CDTR%3+"L
MT@1P[1J/*$X-CB2SN6F5R#P35$HPW4D(F@F.2H;U#-?1LC&F]-8\M+ZE&]K+
MM+%RY5[C55<#N:Z5L8;1;ZI9[:9L_UFZ(",+H3X6^G)X:9N-AF\D3LFRM)=I
M!="F'K2KHRRCJP^4S#C#]N(/3C@>H?4\,!>2W.ML9JO$VH$E! LL%8F;GA\2
M91.\5.OMM$S;F<,39/Z_=9YACB6B36B]]X^YRL\F=F_YEV N'RO;Q#LA>X/C
M9W0GFV.'[)\"Y DL=V]X_(SN_'GLD*=0R<&+/=G_!3(X!<CP*"$]=Z9L'%PW
MCJV5%YC/@PA^-9\;M$X*I@6ABG!GS4F28/[H]*KE%9KJ#_D-?3T^P2DJJ)I4
MP0C6_2\X(04;5J-N3"'<J+K_V5R>/@J;A/6_!>._4$L#!!0    ( "J&5U*7
MBKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E
M\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!
M2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/
M06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3
MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MZ&/=!?A.O>?S=\?/Y[\O/V[VK^&=Z^%KC.GF+U!+ P04    "  JAE=24'Y
MNGP"  "Q/@  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VT]OFS 8Q_&W$G&M
M K8!&Z:FEW;7K8>] 09.@\(_8;=+W_T<TE;:U$6K,FG?"PAL/[\'6_K<N/[V
M/%FW.O3=X#;1SOOI4Y*X>F?[RL7C9(<PLAWGOO+A<7Y(IJK>5P\V44+HI!X'
M;P>_]L<:T<WUG=U6CYU??3Z$UZX=ATTTV\Y%J]O3Q&/6)JJFJ6OKRH?QY&EH
M?DM9OR3$8>4RQ^W:R5V%"5'R;L)QY,\!+^N^/MEY;AN[NJ]F_Z7JPZSDT"7.
M/W?6Q>=+O-/CN-VVM6W&^K$/2V(WS;9JW,Y:WW?QJ>C5^60?=MB>KO+B_*7,
MN< P\WX>)Q=.;+8?CWL]DN/J]10*V=FWYS_Q+3&4OOC[[/&T&]O\97;8WA_C
MO%_.PR7+[?(]_O6,W^I_L \%Z2.%])%!^L@A?6A('P;21P'IHX3T(06E$8JH
MDD*JI)@J*:A*BJJ2PJJDN"HIL$J*K(HBJZ+(JBBR*HJLBB*KHLBJ*+(JBJR*
M(JNBR)I29$TILJ8465.*K"E%UI0B:TJ1-:7(FE)D32FR9A19,XJL&476C")K
M1I$UH\B:463-*+)F%%DSBJPY1=:<(FM.D36GR)I39,TILN8467.*K#E%UIPB
MJZ;(JBFR:HJLFB*KILBJ*;)JBJR:(JNFR*HILAJ*K(8BJZ'(:BBR&HJLAB*K
MH<AJ*+(:BJR&(FM!D;6@R%I09"THLA8460N*K 5%UH(B:T&1M:#(6E)D+2FR
MEA192XJL)476DB)K29&UI,A:4F0M*;)*0:%5"HJM4E!PE8*BJQ047J6@^"H%
M!5@I*,)*02%6"HRQH-^Q_J>QW\=Q_X_CEWO<5^WPFI\L?ZK?_ 102P$"% ,4
M    "  JAE=2!T%-8H$   "Q    $               @ $     9&]C4')O
M<',O87!P+GAM;%!+ 0(4 Q0    ( "J&5U*$2B<<[P   "L"   1
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M965T,BYX;6Q02P$"% ,4    "  JAE=2ZPSOEH\$  "Y#P  &
M    @('A$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M*H974M^["!5H P  " L  !@              ("!IA@  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( "J&5U(]MJ'O70<  (T@   8
M          " @40<  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    "  JAE=2H$@/&O,"  !X"0  &               @('7(P  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ *H974K>V37Q%!P  @2,
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( "J&5U)!B3!F@ 0  /(*   9
M      " @?)E  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ *H974C#F<UD2!   K0D  !D              ("!J6H  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  JAE=2/@Q+TPH)   J&
M&0              @('R;@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( "J&5U*U2$"JLP4  %T.   9              " @3-X  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ *H974B(2P"Q;
M!   (0H  !D              ("!'7X  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    "  JAE=2!KXVT@<#  "-!@  &0
M@(&O@@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( "J&
M5U+L KXKN D  ,09   9              " @>V%  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ *H974HS5+6[D"@  WQ\  !D
M         ("!W(\  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    "  JAE=2@]:5B;D)  "4'   &0              @('WF@  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( "J&5U+((_(KZ 0    ,
M   9              " @>>D  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ *H974L5I\SX#$0  *S4  !D              ("!!JH
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  JAE=2=R_G
M9>\0  #%-0  &0              @(% NP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( "J&5U+U2T01-0@  /<7   9
M  " @6;,  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M*H974FWL,BRH#0  AB4  !D              ("!TM0  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    "  JAE=24#$9/)4$   ^"@  &0
M            @(&QX@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( "J&5U)FS)AXA0D  &P8   9              " @7WG  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ *H974H!"QM$]!0
MM1   !D              ("!.?$  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    "  JAE=2:#@G9FX#  #S"   &0              @(&M
M]@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( "J&5U)J
M 8^Y 1L  *!:   9              " @5+Z  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ *H974LL ?A&% @  3@4  !D
M     ("!BA4! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "J&5U(]<D5DJ@(  -(%   9              "
M@4TF 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ *H97
M4M CZ0?; P  S@@  !D              ("!+BD! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    "  JAE=2XF ]:OX"  !$!@  &0
M        @(% +0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( "J&5U(7QTH1*P,  .$&   9              " @74P 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ *H974J%<@SEO!0  3A
M !D              ("!US,! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    "  JAE=2I']^F=,#  !&"P  &0              @(%].0$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( "J&5U*DR\I(
M$@4  +H,   9              " @8<] 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ *H974@$*#[?&!@  JQ0  !D
M ("!T$(! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  J
MAE=2IA+.Y@8*  #"(   &0              @('-20$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( "J&5U**N(IA.P0  &P+   9
M          " @0I4 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#
M%     @ *H974D@*S^1M!@  PQ   !D              ("!?%@! 'AL+W=O
M<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    "  JAE=2&S-C&V@'  ")
M$@  &0              @($@7P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM
M;%!+ 0(4 Q0    ( "J&5U)=S\HW1P4  '@0   9              " @;]F
M 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ *H974H&Z
MBW<%!    @X  !D              ("!/6P! 'AL+W=O<FMS:&5E=',O<VAE
M970T.2YX;6Q02P$"% ,4    "  JAE=2*M('KEL"  !U!@  &0
M    @(%Y< $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M "J&5U)!O>9GFP(  ,8&   9              " @0MS 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ *H974C7BE6UI!0  9"   !D
M             ("!W74! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    "  JAE=2R-RB7,<"  #>!P  &0              @(%]>P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( "J&5U+RR*7?K (
M .4'   9              " @7M^ 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ *H974GG#)10? @  D00  !D              ("!
M7H$! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    "  JAE=2
MEFX%+$8"  !0!0  &0              @(&T@P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( "J&5U)H6%J4I 0  &P2   9
M      " @3&& 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ *H974OZ+65N3!   4QD  !D              ("!#(L! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  JAE=2-N68[=0"  #I!P
M&0              @('6CP$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( "J&5U+?;?Y@FP(  #0'   9              " @>&2 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ *H974L,?.KJA
M @  N@<  !D              ("!LY4! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    "  JAE=2QRZ#)8H"   +!@  &0
M@(&+F $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( "J&
M5U(KB\QN'0(  '4%   9              " @4R; 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ *H974EX9Y?"> @  H0<  !D
M         ("!H)T! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
M    "  JAE=2-4J@Z_("  "'#   &0              @(%UH $ >&PO=V]R
M:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( "J&5U)DR'26=00  'P0
M   9              " @9ZC 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL
M4$L! A0#%     @ *H974BE6L&26 P  K0T  !D              ("!2J@!
M 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    "  JAE=27N 0
M+'($  "W$0  &0              @($7K $ >&PO=V]R:W-H965T<R]S:&5E
M=#8X+GAM;%!+ 0(4 Q0    ( "J&5U+(/S;7!00  /X2   9
M  " @<"P 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
M*H974MX]P_.- P  KPL  !D              ("!_+0! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    "  JAE=23DQ=:>0#  !E$   &0
M            @(' N $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( "J&5U+2^0*(RP@  .@T   9              " @=N\ 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ *H974IH!8,RI!
MF!,  !D              ("!W<4! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    "  JAE=2,0<@53\#  !F#   &0              @(&]
MR@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( "J&5U)]
M_Y'S_P8  #8J   9              " @3/. 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ *H974E0WPYP[!@  72<  !D
M     ("!:=4! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "J&5U(I9'"PM0<  .TE   9              "
M@5CO 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ *H97
M4E<\(6[C P  KQ   !D              ("!1/<! 'AL+W=O<FMS:&5E=',O
M<VAE970X,BYX;6Q02P$"% ,4    "  JAE=2D4]^KR@&  #O&P  &0
M        @(%>^P$ >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0
M   ( "J&5U(A'4,U8 0  /$0   9              " @;T! @!X;"]W;W)K
M<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ *H974I+N%W#@!P  \RH
M !D              ("!5 8" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q0
M2P$"% ,4    "  JAE=2E$ ZP;@%  !^'0  &0              @(%K#@(
M>&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( "J&5U)H<C=[
MU08  /@E   9              " @5H4 @!X;"]W;W)K<VAE971S+W-H965T
M.#<N>&UL4$L! A0#%     @ *H974GUE-=93!@  ="$  !D
M ("!9AL" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    "  J
MAE=2IG&-R"T#   N#   &0              @('P(0( >&PO=V]R:W-H965T
M<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( "J&5U*J_M7]\@(  #@)   9
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M970Y-"YX;6Q02P$"% ,4    "  JAE=2RA:VIC $  "?#@  &0
M    @($3.@( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0    (
M "J&5U+8*]89JP4  "(<   9              " @7H^ @!X;"]W;W)K<VAE
M971S+W-H965T.38N>&UL4$L! A0#%     @ *H974CC;.WZW!0  4R(  !D
M             ("!7$0" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX;6Q02P$"
M% ,4    "  JAE=2"%JZ!N\"  #X!P  &0              @(%*2@( >&PO
M=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    ( "J&5U+5!X=JK04
M (07   9              " @7!- @!X;"]W;W)K<VAE971S+W-H965T.3DN
M>&UL4$L! A0#%     @ *H974B0[;JND @  3@<  !H              ("!
M5%," 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L! A0#%     @ *H97
M4JA&?K1. P  / L  !H              ("!,%8" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,#$N>&UL4$L! A0#%     @ *H974E/ PG>N P  BPP  !H
M         ("!MED" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL4$L! A0#
M%     @ *H974KEI'Z=H!   @!(  !H              ("!G%T" 'AL+W=O
M<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @ *H974G&M&(R; P
MM@H  !H              ("!/&(" 'AL+W=O<FMS:&5E=',O<VAE970Q,#0N
M>&UL4$L! A0#%     @ *H974H^I4IL* @  6P0  !H              ("!
M#V8" 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%     @ *H97
M4KL]@&XF P  ^0H  !H              ("!46@" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,#8N>&UL4$L! A0#%     @ *H974IJ>(DIP!   /Q0  !H
M         ("!KVL" 'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&UL4$L! A0#
M%     @ *H974N6HJA3I!@  ;R$  !H              ("!5W " 'AL+W=O
M<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @ *H974OW:P7B0!P
M;R@  !H              ("!>'<" 'AL+W=O<FMS:&5E=',O<VAE970Q,#DN
M>&UL4$L! A0#%     @ *H974@XL#^\-!   EA   !H              ("!
M0'\" 'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L! A0#%     @ *H97
M4G%;:^[C 0  4P0  !H              ("!A8," 'AL+W=O<FMS:&5E=',O
M<VAE970Q,3$N>&UL4$L! A0#%     @ *H974B#C+M2; @  .A    T
M         ( !H(4" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  JAE=2EXJ[
M',     3 @  "P              @ %FB ( 7W)E;',O+G)E;'-02P$"% ,4
M    "  JAE=2\0,*HPT(  #82   #P              @ %/B0( >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ *H974G[6,B8> P  +D$  !H
M     ( !B9$" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ *H974E!^0+I\ @  L3X  !,              ( !WY0" %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     '< =P#$(   C)<"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>551</ContextCount>
  <ElementCount>678</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>154</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210051002 - Disclosure - New Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NewAccountingStandards</Role>
      <ShortName>New Accounting Standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210071003 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210151004 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210181005 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210221006 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210291007 - Disclosure - Affiliated Companies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompanies</Role>
      <ShortName>Affiliated Companies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210331008 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210381009 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210411010 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210451011 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210501012 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210551013 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210591014 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210661015 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210771016 - Disclosure - Other Expense (Income)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncome</Role>
      <ShortName>Other Expense (Income)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210821017 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210901018 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210921019 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>210981020 - Disclosure - Quarterly Operating and Per Share Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited</Role>
      <ShortName>Quarterly Operating and Per Share Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>211011021 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230083002 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Revenue</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230163003 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NetIncomePerShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230193004 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230233005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230303006 - Disclosure - Affiliated Companies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesTables</Role>
      <ShortName>Affiliated Companies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AffiliatedCompanies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230343007 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230393008 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230423009 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Debt</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230463010 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230513011 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/FairValueMeasurements</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230563012 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230603013 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensation</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230673014 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlans</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230783015 - Disclosure - Other Expense (Income) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeTables</Role>
      <ShortName>Other Expense (Income) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncome</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230833016 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxes</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230933017 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformation</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230993018 - Disclosure - Quarterly Operating and Per Share Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables</Role>
      <ShortName>Quarterly Operating and Per Share Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - New Accounting Standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NewAccountingStandardsDetails</Role>
      <ShortName>New Accounting Standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NewAccountingStandards</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240094003 - Disclosure - Revenue - Adoption of ASC 606 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueAdoptionofASC606Details</Role>
      <ShortName>Revenue - Adoption of ASC 606 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240104004 - Disclosure - Revenue - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueRevenueRecognitionDetails</Role>
      <ShortName>Revenue - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240114005 - Disclosure - Revenue - Contracts Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails</Role>
      <ShortName>Revenue - Contracts Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240124006 - Disclosure - Revenue - Contracts and Liabilities, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails</Role>
      <ShortName>Revenue - Contracts and Liabilities, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240134007 - Disclosure - Revenue - Supply Chain Financing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails</Role>
      <ShortName>Revenue - Supply Chain Financing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240144008 - Disclosure - Revenue - Voluntary Recall (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueVoluntaryRecallDetails</Role>
      <ShortName>Revenue - Voluntary Recall (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240174009 - Disclosure - Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NetIncomePerShareTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240204010 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails</Role>
      <ShortName>Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240214011 - Disclosure - Property, Plant and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240244012 - Disclosure - Leases - Adoption of ASC 842 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesAdoptionofASC842Details</Role>
      <ShortName>Leases - Adoption of ASC 842 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240254013 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240264014 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails</Role>
      <ShortName>Leases - Lease Cash Flow and Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240274015 - Disclosure - Leases - Lease Weighted Average (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails</Role>
      <ShortName>Leases - Lease Weighted Average (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240284016 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240314017 - Disclosure - Affiliated Companies - Schedule of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails</Role>
      <ShortName>Affiliated Companies - Schedule of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240324018 - Disclosure - Affiliated Companies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails</Role>
      <ShortName>Affiliated Companies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240354019 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240364020 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240374021 - Disclosure - Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240404022 - Disclosure - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240434023 - Disclosure - Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtScheduleofDebtDetails</Role>
      <ShortName>Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240444024 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240474025 - Disclosure - Derivative Financial Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Financial Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240484026 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails</Role>
      <ShortName>Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240494027 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails</Role>
      <ShortName>Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240524028 - Disclosure - Fair Value Measurements - Fair Value of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240534029 - Disclosure - Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240544030 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Other Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240574031 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240584032 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240614033 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240624034 - Disclosure - Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails</Role>
      <ShortName>Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240634035 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240644036 - Disclosure - Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240654037 - Disclosure - Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240684038 - Disclosure - Benefit Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansNarrativeDetails</Role>
      <ShortName>Benefit Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240694039 - Disclosure - Benefit Plans - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Benefit Plans - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240704040 - Disclosure - Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails</Role>
      <ShortName>Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240714041 - Disclosure - Benefit Plans - Amounts Recognized in Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails</Role>
      <ShortName>Benefit Plans - Amounts Recognized in Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240724042 - Disclosure - Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240734043 - Disclosure - Benefit Plans - Expected Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails</Role>
      <ShortName>Benefit Plans - Expected Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240744044 - Disclosure - Benefit Plans - Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails</Role>
      <ShortName>Benefit Plans - Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240754045 - Disclosure - Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails</Role>
      <ShortName>Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240764046 - Disclosure - Benefit Plans - Allocation of Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails</Role>
      <ShortName>Benefit Plans - Allocation of Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240794047 - Disclosure - Other Expense (Income) - Schedule of Other (Income) Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails</Role>
      <ShortName>Other Expense (Income) - Schedule of Other (Income) Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240804048 - Disclosure - Other Expense (Income) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails</Role>
      <ShortName>Other Expense (Income) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240814049 - Disclosure - Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails</Role>
      <ShortName>Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240844050 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240854051 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240864052 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240874053 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240884054 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240894055 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Income Tax Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240914056 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/CommitmentsandContingencies</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240944057 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240954058 - Disclosure - Segment Information - Sales by Product Group (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails</Role>
      <ShortName>Segment Information - Sales by Product Group (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240964059 - Disclosure - Segment Information - Sales and Long-lived Assets by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails</Role>
      <ShortName>Segment Information - Sales and Long-lived Assets by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240974060 - Disclosure - Segment Information - Segment Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails</Role>
      <ShortName>Segment Information - Segment Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>241004061 - Disclosure - Quarterly Operating and Per Share Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails</Role>
      <ShortName>Quarterly Operating and Per Share Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>241024062 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="wst-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - wst-20201231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - wst-20201231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="wst-20201231.htm">wst-20201231.htm</File>
    <File>ex21listofsubsidiaries_2020.htm</File>
    <File>ex23consent_2020.htm</File>
    <File>ex311ceo302certification_2.htm</File>
    <File>ex312cfo302certification_2.htm</File>
    <File>ex321ceo906certification_2.htm</File>
    <File>ex322cfo906certification_2.htm</File>
    <File>ex44descriptionofregistere.htm</File>
    <File>wst-20201231.xsd</File>
    <File>wst-20201231_cal.xml</File>
    <File>wst-20201231_def.xml</File>
    <File>wst-20201231_lab.xml</File>
    <File>wst-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>wst-20201231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>133
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "wst-20201231.htm": {
   "axisCustom": 1,
   "axisStandard": 43,
   "contextCount": 551,
   "dts": {
    "calculationLink": {
     "local": [
      "wst-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wst-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "wst-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "wst-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wst-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "wst-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 979,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 2,
    "http://www.westpharma.com/20201231": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 7
   },
   "keyCustom": 80,
   "keyStandard": 598,
   "memberCustom": 44,
   "memberStandard": 100,
   "nsprefix": "wst",
   "nsuri": "http://www.westpharma.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover",
     "role": "http://www.westpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210051002 - Disclosure - New Accounting Standards",
     "role": "http://www.westpharma.com/role/NewAccountingStandards",
     "shortName": "New Accounting Standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864052 - Disclosure - Income Taxes - Income Before Income Taxes (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Income Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874053 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes - Components of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884054 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894055 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
     "shortName": "Income Taxes - Effective Income Tax Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914056 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944057 - Disclosure - Segment Information - Narrative (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954058 - Disclosure - Segment Information - Sales by Product Group (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
     "shortName": "Segment Information - Sales by Product Group (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i49868d4c1f404b4b8d7b8514ef6ed8c8_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964059 - Disclosure - Segment Information - Sales and Long-lived Assets by Geographic Location (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails",
     "shortName": "Segment Information - Sales and Long-lived Assets by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974060 - Disclosure - Segment Information - Segment Financial Information (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails",
     "shortName": "Segment Information - Segment Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004061 - Disclosure - Quarterly Operating and Per Share Data (Unaudited) (Details)",
     "role": "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails",
     "shortName": "Quarterly Operating and Per Share Data (Unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210071003 - Disclosure - Revenue",
     "role": "http://www.westpharma.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024062 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)",
     "role": "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iffaa8ffc9a384cc1a21542a1c910c4d9_I20171231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210151004 - Disclosure - Net Income Per Share",
     "role": "http://www.westpharma.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210181005 - Disclosure - Property, Plant and Equipment",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210221006 - Disclosure - Leases",
     "role": "http://www.westpharma.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210291007 - Disclosure - Affiliated Companies",
     "role": "http://www.westpharma.com/role/AffiliatedCompanies",
     "shortName": "Affiliated Companies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210331008 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210381009 - Disclosure - Other Current Liabilities",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilities",
     "shortName": "Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210411010 - Disclosure - Debt",
     "role": "http://www.westpharma.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210451011 - Disclosure - Derivative Financial Instruments",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210501012 - Disclosure - Fair Value Measurements",
     "role": "http://www.westpharma.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210551013 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210591014 - Disclosure - Stock-Based Compensation",
     "role": "http://www.westpharma.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210661015 - Disclosure - Benefit Plans",
     "role": "http://www.westpharma.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771016 - Disclosure - Other Expense (Income)",
     "role": "http://www.westpharma.com/role/OtherExpenseIncome",
     "shortName": "Other Expense (Income)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210821017 - Disclosure - Income Taxes",
     "role": "http://www.westpharma.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210901018 - Disclosure - Commitments and Contingencies",
     "role": "http://www.westpharma.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210921019 - Disclosure - Segment Information",
     "role": "http://www.westpharma.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981020 - Disclosure - Quarterly Operating and Per Share Data (Unaudited)",
     "role": "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited",
     "shortName": "Quarterly Operating and Per Share Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211011021 - Disclosure - Schedule II - Valuation and Qualifying Accounts",
     "role": "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts",
     "shortName": "Schedule II - Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230083002 - Disclosure - Revenue (Tables)",
     "role": "http://www.westpharma.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230163003 - Disclosure - Net Income Per Share (Tables)",
     "role": "http://www.westpharma.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230193004 - Disclosure - Property, Plant and Equipment (Tables)",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230233005 - Disclosure - Leases (Tables)",
     "role": "http://www.westpharma.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230303006 - Disclosure - Affiliated Companies (Tables)",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesTables",
     "shortName": "Affiliated Companies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230343007 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230393008 - Disclosure - Other Current Liabilities (Tables)",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230423009 - Disclosure - Debt (Tables)",
     "role": "http://www.westpharma.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230463010 - Disclosure - Derivative Financial Instruments (Tables)",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230513011 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230563012 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230603013 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230673014 - Disclosure - Benefit Plans (Tables)",
     "role": "http://www.westpharma.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783015 - Disclosure - Other Expense (Income) (Tables)",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeTables",
     "shortName": "Other Expense (Income) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230833016 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.westpharma.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230933017 - Disclosure - Segment Information (Tables)",
     "role": "http://www.westpharma.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993018 - Disclosure - Quarterly Operating and Per Share Data (Unaudited) (Tables)",
     "role": "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables",
     "shortName": "Quarterly Operating and Per Share Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i2c002af1ee644b9c8cd78b9164f93d0f_I20190401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i2c002af1ee644b9c8cd78b9164f93d0f_I20190401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - New Accounting Standards (Details)",
     "role": "http://www.westpharma.com/role/NewAccountingStandardsDetails",
     "shortName": "New Accounting Standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "ia62094f562004390b81aa8036d7b155e_I20200101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094003 - Disclosure - Revenue - Adoption of ASC 606 (Details)",
     "role": "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
     "shortName": "Revenue - Adoption of ASC 606 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "idf9d37b38c2447e990845dc75ad10954_I20180101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104004 - Disclosure - Revenue - Revenue Recognition (Details)",
     "role": "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
     "shortName": "Revenue - Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114005 - Disclosure - Revenue - Contracts Assets and Liabilities (Details)",
     "role": "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
     "shortName": "Revenue - Contracts Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124006 - Disclosure - Revenue - Contracts and Liabilities, Narrative (Details)",
     "role": "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails",
     "shortName": "Revenue - Contracts and Liabilities, Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134007 - Disclosure - Revenue - Supply Chain Financing (Details)",
     "role": "http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails",
     "shortName": "Revenue - Supply Chain Financing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i73877135951c49808f223e59689acc98_D20181001-20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "wst:ProvisionForProductReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144008 - Disclosure - Revenue - Voluntary Recall (Details)",
     "role": "http://www.westpharma.com/role/RevenueVoluntaryRecallDetails",
     "shortName": "Revenue - Voluntary Recall (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i73877135951c49808f223e59689acc98_D20181001-20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "wst:ProvisionForProductReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174009 - Disclosure - Net Income Per Share (Details)",
     "role": "http://www.westpharma.com/role/NetIncomePerShareDetails",
     "shortName": "Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204010 - Disclosure - Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
     "shortName": "Property, Plant and Equipment - Property, Plant and Equipment, Gross (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i797e7706a95c4087904100b08ffda29a_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214011 - Disclosure - Property, Plant and Equipment - Narrative (Details)",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails",
     "shortName": "Property, Plant and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestCostsCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:LesseeOperatingLeaseOptionToTerminateTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244012 - Disclosure - Leases - Adoption of ASC 842 (Details)",
     "role": "http://www.westpharma.com/role/LeasesAdoptionofASC842Details",
     "shortName": "Leases - Adoption of ASC 842 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:LesseeOperatingLeaseOptionToTerminateTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254013 - Disclosure - Leases - Lease Cost (Details)",
     "role": "http://www.westpharma.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264014 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)",
     "role": "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails",
     "shortName": "Leases - Lease Cash Flow and Supplemental Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274015 - Disclosure - Leases - Lease Weighted Average (Details)",
     "role": "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails",
     "shortName": "Leases - Lease Weighted Average (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284016 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)",
     "role": "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i3be748d3389b4043bbf41058de1b56a6_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314017 - Disclosure - Affiliated Companies - Schedule of Investments (Details)",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails",
     "shortName": "Affiliated Companies - Schedule of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i3be748d3389b4043bbf41058de1b56a6_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324018 - Disclosure - Affiliated Companies - Narrative (Details)",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
     "shortName": "Affiliated Companies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i4d99a299ac9b4d1c83a488c5da492713_D20191101-20191101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354019 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i2c002af1ee644b9c8cd78b9164f93d0f_I20190401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364020 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374021 - Disclosure - Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible Assets by Major Class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i89754d8eff0a4a21b0723157da2cda70_I20171231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - CONSOLIDATED STATEMENT OF EQUITY",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i89754d8eff0a4a21b0723157da2cda70_I20171231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404022 - Disclosure - Other Current Liabilities (Details)",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails",
     "shortName": "Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434023 - Disclosure - Debt - Schedule of Debt (Details)",
     "role": "http://www.westpharma.com/role/DebtScheduleofDebtDetails",
     "shortName": "Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444024 - Disclosure - Debt - Narrative (Details)",
     "role": "http://www.westpharma.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "if9b19f87e2fa4bd7b7446c6d36467a3b_I20121231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "wst:DebtInstrumentNumberOfTranches",
      "reportCount": 1,
      "unique": true,
      "unitRef": "tranche",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474025 - Disclosure - Derivative Financial Instruments - Narrative (Details)",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
     "shortName": "Derivative Financial Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i69dfa7633a364a67bca000079fe4bfb7_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i897b04b0d4e34a368ecdaa5308ccf498_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484026 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
     "shortName": "Derivative Financial Instruments - Foreign Exchange Rate Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i897b04b0d4e34a368ecdaa5308ccf498_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494027 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
     "shortName": "Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524028 - Disclosure - Fair Value Measurements - Fair Value of Assets and Liabilities (Details)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Fair Value of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534029 - Disclosure - Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "if5b68aa1ac4341fcb7f0d0dd71671e3f_I20181231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544030 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Other Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574031 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "ia95e3548123544be897471a0d9dc1c0b_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584032 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i2fadb2a71cac4c68a8087322aebf7865_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614033 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624034 - Disclosure - Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
     "shortName": "Stock-Based Compensation - Allocation of Share-based Compensation Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634035 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
     "shortName": "Stock-Based Compensation - Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i2dbee5d17b2041f18a82faf7a164c68f_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644036 - Disclosure - Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
     "shortName": "Stock-Based Compensation - Stock Appreciation Rights Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "ie536733ecf0f49159c3492b03170fa5e_I20171231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "ibae2919783b045ffaef7c87dc7aa860f_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654037 - Disclosure - Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
     "shortName": "Stock-Based Compensation - Nonvested Performance-based Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "if03468ad1c7345619b7c14865b28e6f4_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684038 - Disclosure - Benefit Plans - Narrative (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
     "shortName": "Benefit Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694039 - Disclosure - Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704040 - Disclosure - Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
     "shortName": "Benefit Plans - Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714041 - Disclosure - Benefit Plans - Amounts Recognized in Balance Sheet (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
     "shortName": "Benefit Plans - Amounts Recognized in Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "if4075113bb61471da80f2c6ac352be97_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "wst:AssetsDefinedBenefitPlansNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "if4075113bb61471da80f2c6ac352be97_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724042 - Disclosure - Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
     "shortName": "Benefit Plans - Amounts Recognized in Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "if4075113bb61471da80f2c6ac352be97_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734043 - Disclosure - Benefit Plans - Expected Benefit Payments (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
     "shortName": "Benefit Plans - Expected Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744044 - Disclosure - Benefit Plans - Assumptions Used (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
     "shortName": "Benefit Plans - Assumptions Used (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "id8ae62fcca1d41dca69fc6c8a125055d_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754045 - Disclosure - Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails",
     "shortName": "Benefit Plans - Weighted Average Interest Crediting Rating by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i4c81dd52c38d4046959394fe7cf2404e_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764046 - Disclosure - Benefit Plans - Allocation of Plan Assets (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
     "shortName": "Benefit Plans - Allocation of Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794047 - Disclosure - Other Expense (Income) - Schedule of Other (Income) Expense (Details)",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails",
     "shortName": "Other Expense (Income) - Schedule of Other (Income) Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804048 - Disclosure - Other Expense (Income) - Narrative (Details)",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
     "shortName": "Other Expense (Income) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "wst:DevelopmentAndLicensingIncome",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i124cb2fa8c124903a808a37113465670_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "wst:DevelopmentAndLicensingIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814049 - Disclosure - Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)",
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails",
     "shortName": "Other Expense (Income) - Schedule of Restructuring and Related Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i23e32d9c6ce54b18abbf607406fce66b_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRestructuring",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i0230c88584154e91a07b322788cd39a8_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844050 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "i5453ad25e23d488d8f67da586cc0b187_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854051 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20201231.htm",
      "contextRef": "iac1e5371f0134eb9995482f7560ead18_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - wst-20201231.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - wst-20201231.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 154,
   "tag": {
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SGD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Singapore, Dollars",
        "terseLabel": "SGD"
       }
      }
     },
     "localname": "SGD",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r859",
      "r860",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r859",
      "r860",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continents of North and South America.",
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r214",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r234",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r214",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r234",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r156",
      "r167",
      "r271",
      "r546",
      "r547",
      "r548",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r156",
      "r167",
      "r271",
      "r546",
      "r547",
      "r548",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r156",
      "r167",
      "r271",
      "r546",
      "r547",
      "r548",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Non-Employee Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EnergyAxis": {
     "auth_ref": [
      "r864",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of energy source.",
        "label": "Energy [Axis]",
        "terseLabel": "Energy [Axis]"
       }
      }
     },
     "localname": "EnergyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EnergyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combustible material used to power engines, power plants or reactors. Examples include, but are not limited to, fuel and oil.",
        "label": "Energy [Domain]",
        "terseLabel": "Energy [Domain]"
       }
      }
     },
     "localname": "EnergyDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Equity Method Investee, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r245",
      "r385",
      "r390",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r496",
      "r502",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r765",
      "r819",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails",
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r496",
      "r502",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r765",
      "r819",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r245",
      "r385",
      "r390",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r241",
      "r385",
      "r388",
      "r766",
      "r818",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r241",
      "r385",
      "r388",
      "r766",
      "r818",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r432",
      "r496",
      "r502",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r765",
      "r819",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails",
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r432",
      "r496",
      "r502",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r765",
      "r819",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails",
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r497",
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Equity Method Investee, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r151",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule of Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r242",
      "r243",
      "r385",
      "r389",
      "r821",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r242",
      "r243",
      "r385",
      "r389",
      "r821",
      "r841",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r868",
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r345",
      "r497",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r247",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual with Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r151",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r740",
      "r742",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance.",
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r163",
      "r268",
      "r269",
      "r270",
      "r271",
      "r274",
      "r275",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r594",
      "r595",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r24",
      "r248",
      "r249"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r9",
      "r49",
      "r555"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrual for Taxes Other than Income Taxes, Current",
        "terseLabel": "Accrued taxes other than income"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r17",
      "r779",
      "r801"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r49"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r17",
      "r19",
      "r781",
      "r800"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued Sales Commission",
        "terseLabel": "Accrued commissions, rebates and royalties"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r71",
      "r78",
      "r81",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined benefit pension and other postretirement plans",
        "verboseLabel": "Amortization of Defined Benefit Pension and Other Postretirement Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r43",
      "r315"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r66",
      "r78",
      "r81",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "(Losses) gains on derivatives",
        "verboseLabel": "Gains (losses) on derivatives"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r78",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Change in equity affiliate investment AOCI"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r75",
      "r77",
      "r78",
      "r804",
      "r831",
      "r835"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r74",
      "r78",
      "r81",
      "r153",
      "r154",
      "r155",
      "r632",
      "r826",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r65",
      "r78",
      "r81",
      "r632",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired finite-lived intangible assets, weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25",
      "r550"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in Excess of Par Value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r123",
      "r307"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r163",
      "r268",
      "r269",
      "r270",
      "r271",
      "r274",
      "r275",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r592",
      "r593",
      "r594",
      "r595",
      "r768",
      "r769",
      "r770",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r505",
      "r538",
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r31",
      "r254",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r123",
      "r299",
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization of Acquisition-related Intangible Assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization of Acquisition-related Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.",
        "label": "Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total recognized in net periodic benefit cost and OCI"
       }
      }
     },
     "localname": "AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive options excluded from computation of diluted net income per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r123",
      "r312"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset-related charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r134",
      "r222",
      "r229",
      "r236",
      "r264",
      "r628",
      "r633",
      "r692",
      "r777",
      "r799"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r62",
      "r134",
      "r264",
      "r628",
      "r633",
      "r692"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r677"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r507",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r491",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r491",
      "r498",
      "r614",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business acquisition, transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r122",
      "r625"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 5.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, estimated outcome, high"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "auth_ref": [
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "terseLabel": "Contingent consideration, estimated outcome, low"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r620",
      "r621",
      "r623"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business acquisition, recognized intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r616",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business acquisition, recognized inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r616",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business acquisition, recognized property, plant, and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business acquisition, recognized goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r128",
      "r129",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r39",
      "r125"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash, including cash equivalents at end of period",
        "periodStartLabel": "Cash, including cash equivalents at beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r126",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r119",
      "r697"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "negatedLabel": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "negatedTerseLabel": "Derivative (gain) loss on hedged item, fair value hedges"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r56",
      "r344",
      "r786",
      "r808"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r340",
      "r342",
      "r343",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityMember": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading in a derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity [Member]",
        "terseLabel": "Commodity call options"
       }
      }
     },
     "localname": "CommodityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommodityOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option contract in which the underlying asset is a commodity.",
        "label": "Commodity Option [Member]",
        "terseLabel": "Commodity call options"
       }
      }
     },
     "localname": "CommodityOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.25 per share; 200 million shares authorized; shares issued: 75.3 million in 2020 and 2019; shares outstanding: 74.0 million and 74.1 million in 2020 and 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r87",
      "r95",
      "r790",
      "r814"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r94",
      "r105",
      "r789",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r204",
      "r205",
      "r245",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r204",
      "r205",
      "r245",
      "r690",
      "r691",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r204",
      "r205",
      "r245",
      "r690",
      "r691",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r204",
      "r205",
      "r245",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of net sales"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r204",
      "r205",
      "r245",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Change in Contract with Customer, Asset and Liability"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r372",
      "r374",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Contract assets, December 31, 2020",
        "periodStartLabel": "Contract assets, December 31, 2019"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r372",
      "r373",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "negatedPeriodEndLabel": "Deferred income, December 31, 2020",
        "negatedPeriodStartLabel": "Deferred income, December 31, 2019",
        "terseLabel": "Contract with customer, liability",
        "verboseLabel": "Deferred income"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.",
        "label": "Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized",
        "terseLabel": "Change in deferred income - (increase) decrease"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r372",
      "r373",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred income, current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r372",
      "r373",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred income, noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r238",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and Unallocated"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r99",
      "r766"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedTerseLabel": "Cost of goods and services sold",
        "terseLabel": "Cost of goods and services sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods and services sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r433",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r588",
      "r601"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r139",
      "r588"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r588",
      "r601",
      "r603"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Current income tax provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r588",
      "r601"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r201",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer contracts"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r778",
      "r783",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r18",
      "r360",
      "r783",
      "r797"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r709",
      "r711"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r53",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "verboseLabel": "Debt instrument, maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r54",
      "r136",
      "r365",
      "r366",
      "r367",
      "r368",
      "r708",
      "r709",
      "r711",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.",
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]",
        "terseLabel": "Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "verboseLabel": "Deferred compensation benefits"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.",
        "label": "Deferred Compensation, Share-based Payments [Member]",
        "terseLabel": "Deferred Compensation, Share-based Payments"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.",
        "label": "Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r589",
      "r601"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r563",
      "r564"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r135",
      "r589",
      "r601",
      "r602",
      "r603"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Deferred income tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r20",
      "r21",
      "r579",
      "r780",
      "r796"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r563",
      "r564"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r581"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax (liability) asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r581"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Operating loss carryforwards, foreign"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Operating loss carryforwards, state and local"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r584",
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Pension and deferred compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r564",
      "r581"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax (liability) asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r586"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "terseLabel": "Tax on undistributed earnings of subsidiaries"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r72",
      "r78",
      "r453"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r78",
      "r453"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Net actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r78",
      "r453"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r422",
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial gains (losses)",
        "verboseLabel": "Actuarial (loss) gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r408",
      "r448",
      "r476",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Amortization of actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r408",
      "r449",
      "r477",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "negatedTerseLabel": "Prior service credit",
        "terseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]",
        "terseLabel": "Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r15",
      "r406",
      "r407",
      "r430",
      "r482",
      "r776",
      "r798"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r457",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Weighted-average interest crediting rating used to determine net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r410"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedPeriodEndLabel": "Balance",
        "negatedPeriodStartLabel": "Balance"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r417",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "negatedTerseLabel": "Participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r460",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashMember": {
     "auth_ref": [
      "r433",
      "r435",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r424",
      "r433",
      "r435",
      "r480",
      "r482",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanCurtailments": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment",
        "negatedLabel": "Curtailment gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDebtSecurityMember": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Debt Security [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanDebtSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r433",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 6.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2026 to 2030"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 1.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 5.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 4.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 3.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 2.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r443",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Expected contribution to the plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r408",
      "r447",
      "r475",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r421",
      "r433",
      "r435",
      "r436",
      "r482"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r406",
      "r430",
      "r482"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year",
        "terseLabel": "Assumed healthcare cost trend rate, benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r408",
      "r413",
      "r446",
      "r474",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedTerseLabel": "Interest cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r444",
      "r472",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Net periodic benefit cost:"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r426",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r432",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target allocation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r409",
      "r451",
      "r479"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "negatedTerseLabel": "Pension settlement charge"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r409",
      "r451",
      "r479"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedLabel": "Settlement loss",
        "terseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r411",
      "r445",
      "r473",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "negatedTerseLabel": "Service cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "terseLabel": "Settlement loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlement loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Ultimate healthcare cost trend rate, benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Weighted average asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Weighted average assumptions used in benefit obligations:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Weighted average assumptions used in net periodic benefit cost:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r466",
      "r467",
      "r470",
      "r471",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "verboseLabel": "401 (k) plan contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r123",
      "r313"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r123",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r63",
      "r64",
      "r689"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Commodity call options"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAveragePriceRiskOptionStrikePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average strike price on the group of price risk option contracts such as put options or call options.",
        "label": "Derivative, Average Price Risk Option Strike Price",
        "terseLabel": "Derivative, average price risk option strike price"
       }
      }
     },
     "localname": "DerivativeAveragePriceRiskOptionStrikePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": {
     "auth_ref": [
      "r651",
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings",
        "terseLabel": "Gain recognized in earnings"
       }
      }
     },
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r645",
      "r647",
      "r654",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "verboseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r643",
      "r645",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r643",
      "r645",
      "r654",
      "r662",
      "r663",
      "r668",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r652",
      "r655"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative instruments not designated as hedging instruments, gain (loss), net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Short term derivative instruments"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNonmonetaryNotionalAmount": {
     "auth_ref": [
      "r637",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal number of units used to calculate payment on derivative.",
        "label": "Derivative, Nonmonetary Notional Amount",
        "terseLabel": "Derivative, nonmonetary notional amount outstanding"
       }
      }
     },
     "localname": "DerivativeNonmonetaryNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeNonmonetaryNotionalAmountVolume": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal volume used to calculate payments on a derivative instrument.",
        "label": "Derivative, Nonmonetary Notional Amount, Volume",
        "terseLabel": "Derivative, nonmonetary notional amount, volume"
       }
      }
     },
     "localname": "DerivativeNonmonetaryNotionalAmountVolume",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "volumeItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r637",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r636",
      "r638",
      "r639",
      "r643",
      "r644",
      "r648",
      "r654",
      "r665",
      "r667",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative contract term"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r141",
      "r636",
      "r638",
      "r643",
      "r644",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.",
        "label": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]",
        "terseLabel": "Difference Between Revenue Guidance in Effect Before and After Topic 606"
       }
      }
     },
     "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r385",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r9",
      "r49"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends declared, not paid",
        "verboseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.",
        "label": "Domestic Line of Credit [Member]",
        "terseLabel": "Domestic Line of Credit"
       }
      }
     },
     "localname": "DomesticLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r490",
      "r494",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromAffiliates": {
     "auth_ref": [
      "r140",
      "r729",
      "r730",
      "r810"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Due from Affiliates",
        "terseLabel": "Amount receivable from affiliates"
       }
      }
     },
     "localname": "DueFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrentAndNoncurrent": {
     "auth_ref": [
      "r140",
      "r729",
      "r731",
      "r785",
      "r809",
      "r839"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Due to Affiliate",
        "terseLabel": "Amount due and payable to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, Middle East, Africa"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r96",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r176",
      "r178",
      "r183",
      "r184",
      "r185",
      "r189",
      "r190",
      "r791",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r96",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r178",
      "r183",
      "r184",
      "r185",
      "r189",
      "r190",
      "r791",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r697"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOnFutureEarningsAmount": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The quantified amount of the future effect on earnings.",
        "label": "Effect on Future Earnings, Amount",
        "terseLabel": "Effect on future earnings, amount"
       }
      }
     },
     "localname": "EffectOnFutureEarningsAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r566",
      "r605"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r566",
      "r605"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Impact of 2017 Tax Act"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r566",
      "r605"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Tax on international operations other than U.S. tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r566",
      "r605"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r566",
      "r605"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Adjustments to reserves for unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r553",
      "r566"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "Excess tax benefits on share-based payments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r566",
      "r605"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax effect"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r566",
      "r605"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "U.S. research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unrecognized compensation expense for all nonvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Severance and benefits"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalCostsPolicy": {
     "auth_ref": [
      "r131",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.",
        "label": "Environmental Costs, Policy [Policy Text Block]",
        "terseLabel": "Environmental Remediation and Compliance Costs"
       }
      }
     },
     "localname": "EnvironmentalCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.",
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]",
        "terseLabel": "Type of Deferred Compensation, All Types [Domain]"
       }
      }
     },
     "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r160",
      "r170",
      "r172",
      "r196",
      "r271",
      "r364",
      "r369",
      "r546",
      "r547",
      "r548",
      "r594",
      "r595",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r826",
      "r827",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r92",
      "r118",
      "r123",
      "r811"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends received from affiliated companies"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r40",
      "r223",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Affiliated Companies"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompanies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r482",
      "r678",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value.",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]"
       }
      }
     },
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedges"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Pension plan assets in the fair value hierarchy"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r433",
      "r435",
      "r440",
      "r482",
      "r678",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r433",
      "r435",
      "r440",
      "r482",
      "r678",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r482",
      "r678",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Level 3 Fair Value Measurements [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r682",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Changes in Level 3 Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r435",
      "r676",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Pension plan assets measured at NAV"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r683"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Increase in fair value recorded in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r682"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r482",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r714",
      "r726"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r258",
      "r259",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r306"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r300",
      "r302",
      "r306",
      "r309",
      "r767",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation gains (losses)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r306",
      "r774"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r300",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r306",
      "r767"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign currency contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign currency contracts and swaps"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyGainLossMember": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing foreign currency gain (loss).",
        "label": "Foreign Currency Gain (Loss) [Member]",
        "terseLabel": "Other expense (income)"
       }
      }
     },
     "localname": "ForeignCurrencyGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r693",
      "r694",
      "r695",
      "r696"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 3.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Foreign exchange transaction gains"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionLossBeforeTax": {
     "auth_ref": [
      "r695",
      "r696"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 2.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.",
        "label": "Foreign Currency Transaction Loss, before Tax",
        "terseLabel": "Argentina currency devaluation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r433",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency hedge contracts",
        "verboseLabel": "Foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward",
        "verboseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.",
        "label": "Foreign Line of Credit [Member]",
        "terseLabel": "Foreign Line of Credit"
       }
      }
     },
     "localname": "ForeignLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r490",
      "r494",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "International plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet": {
     "auth_ref": [
      "r651",
      "r673"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net",
        "negatedLabel": "Derivative (gain) loss on amount excluded from effectiveness testing, fair value hedges"
       }
      }
     },
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r645"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gain (loss) on derivative instruments, net, pretax"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "terseLabel": "Gain (loss) on disposition of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r649"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "negatedTotalLabel": "Derivative (gain) loss recognized in income, fair value hedges"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Fixed asset impairments and sale of equipment, net"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "terseLabel": "Gain on restructuring-related sale of assets"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedTerseLabel": "Corporate general costs"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r290",
      "r291",
      "r775"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r293"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill recorded due to acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r296",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r292",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment losses"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r98",
      "r134",
      "r222",
      "r228",
      "r232",
      "r235",
      "r238",
      "r264",
      "r692"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r643",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r311",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r138",
      "r604"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r138",
      "r604"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r138",
      "r222",
      "r228",
      "r232",
      "r235",
      "r238"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r92",
      "r123",
      "r219",
      "r261",
      "r787",
      "r811"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net income of affiliated companies"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedTerseLabel": "Equity in undistributed earnings of affiliates, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r571",
      "r576",
      "r578",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r567",
      "r577",
      "r583",
      "r599",
      "r606",
      "r610",
      "r611",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r171",
      "r172",
      "r220",
      "r565",
      "r600",
      "r609",
      "r816"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "terseLabel": "Income tax expense",
        "totalLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r131",
      "r561",
      "r562",
      "r577",
      "r578",
      "r582",
      "r590",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r560",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "negatedTerseLabel": "Tax benefit from impact of tax law changes enacted",
        "terseLabel": "Tax benefit for impact of tax law changes enacted"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "negatedTerseLabel": "Tax benefit from stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Increase in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedTerseLabel": "Decrease (increase) in other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Changes in other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "verboseLabel": "Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r185"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of equity awards, based on the treasury stock method (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Axis]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Domain]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceClaimsMember": {
     "auth_ref": [
      "r349",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A demand for payment of a policy benefit because of the occurrence of an insured event, such as the death or disability of the insured; the maturity of an endowment; the incurrence of hospital or medical bills; the destruction or damage of property and related deaths or injuries; defects in, liens on, or challenges to the title to real estate; or the occurrence of a surety loss; and the costs to process claims.",
        "label": "Insurance Claims [Member]",
        "terseLabel": "Insurance Claims"
       }
      }
     },
     "localname": "InsuranceClaimsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r298",
      "r304"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r707"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r90",
      "r216",
      "r706",
      "r710",
      "r792"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r103",
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r115",
      "r120",
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid, net of amounts capitalized"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r49"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r214",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r234",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment sales elimination"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r288"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r59"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r60",
      "r131",
      "r192",
      "r286",
      "r287",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r35",
      "r288"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r34",
      "r288"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r101",
      "r103"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in affiliated companies"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r725",
      "r727"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Operating lease liability payments due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r726"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed lease interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r48",
      "r134",
      "r230",
      "r264",
      "r629",
      "r633",
      "r634",
      "r692"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r134",
      "r264",
      "r692",
      "r784",
      "r806"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r51",
      "r134",
      "r264",
      "r629",
      "r633",
      "r634",
      "r692"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r677"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r18",
      "r783",
      "r797"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Letters of credit supporting the reimbursement of workers' compensation and other claims",
        "verboseLabel": "Outstanding amount"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of credit facility, current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of credit facility, unused commitment level"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Long"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r18",
      "r361",
      "r783",
      "r803"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Aggregate annual maturities of long-term debt [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Less: current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r143",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r143",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r143",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r143",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r143",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r143",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r54",
      "r355",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit, Noncurrent",
        "terseLabel": "Line of credit, noncurrent"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r54",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average of the coupon interest rate"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrual for insurance obligations"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyReceivable": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.",
        "label": "Loss Contingency, Receivable",
        "terseLabel": "Amount reimbursable by the insurance company"
       }
      }
     },
     "localname": "LossContingencyReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual funds"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r119",
      "r121",
      "r124"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r82",
      "r85",
      "r93",
      "r124",
      "r134",
      "r159",
      "r165",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r182",
      "r222",
      "r228",
      "r232",
      "r235",
      "r238",
      "r264",
      "r692",
      "r788",
      "r812"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r157",
      "r158",
      "r161",
      "r162",
      "r173",
      "r174",
      "r175",
      "r272",
      "r273",
      "r395",
      "r396",
      "r398",
      "r399",
      "r549",
      "r596",
      "r597",
      "r598",
      "r771",
      "r772",
      "r773",
      "r830",
      "r831",
      "r832",
      "r833",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r156",
      "r159",
      "r160",
      "r161",
      "r163",
      "r164",
      "r167",
      "r189",
      "r268",
      "r269",
      "r270",
      "r271",
      "r274",
      "r275",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r592",
      "r593",
      "r594",
      "r595",
      "r768",
      "r769",
      "r770",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense/(income), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r78",
      "r89"
     ],
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r222",
      "r228",
      "r232",
      "r235",
      "r238"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Profit",
        "totalLabel": "Operating profit"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r718",
      "r727"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r714"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r714"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r714"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r715",
      "r721"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r713"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r724",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r723",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r712"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionMember": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).",
        "label": "Options Held [Member]",
        "terseLabel": "Commodity Call Options"
       }
      }
     },
     "localname": "OptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r123",
      "r317"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 7.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Fixed asset impairments and sale of equipment, net"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service credit arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "negatedTerseLabel": "Prior service cost arising during period, net of tax of $0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r70",
      "r75",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Net actuarial loss arising during period, net of tax of $(0.7), $(0.3), and $(0.2)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "terseLabel": "Net actuarial gain (loss) arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r626",
      "r627",
      "r631"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r75",
      "r79",
      "r80",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": {
     "auth_ref": [
      "r75",
      "r79",
      "r80",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Less: amortization of prior service credit, net of tax of $(0.1), $(0.1) and $(0.5)."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Less: amortization of prior service credit, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r67",
      "r68",
      "r75"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net gain (loss) on equity affiliate accumulated other comprehensive income, net of tax of $0, $0, and $(0.1)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r67",
      "r68",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "terseLabel": "Net gain (loss) on investment securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "terseLabel": "Net (loss) gain on derivatives, net of tax of $(0.6), $(0.2), and $1.5"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "terseLabel": "Net gain (loss) on derivatives, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r66",
      "r75",
      "r646",
      "r650",
      "r671"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Cash flow hedges, amount of gain (loss) recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax": {
     "auth_ref": [
      "r653"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax",
        "negatedLabel": "Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r656"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Fair value and net investment hedges, amount of gain (loss) recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r657"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r83",
      "r86",
      "r89",
      "r94",
      "r364",
      "r698",
      "r703",
      "r704",
      "r789",
      "r813"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r83",
      "r86",
      "r626",
      "r627",
      "r631"
     ],
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r72",
      "r75",
      "r452",
      "r482"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "totalLabel": "Total recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": {
     "auth_ref": [
      "r76",
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax",
        "terseLabel": "Prior service credit arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r70",
      "r75",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "negatedTerseLabel": "Net loss (gain) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r75",
      "r79",
      "r80",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Amortization of actuarial (loss) gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r75",
      "r79",
      "r80",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Less: amortization of actuarial (gain) loss, net of tax of $0, $0, and $0.3"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "negatedTerseLabel": "Less: amortization of actuarial loss, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the liabilities, classified as other, for deferred compensation arrangements payable after one year or the operating cycle, if longer.",
        "label": "Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r817"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other expense (income)"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r402",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "verboseLabel": "Other Expense (Income)"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r49"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other nonoperating (income) expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 6.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other items"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r405",
      "r406",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other retirement benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r782",
      "r802"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for retirement benefits, classified as other.",
        "label": "Liability, Other Retirement Benefits",
        "terseLabel": "Accrued retirement plans (excluding pension)"
       }
      }
     },
     "localname": "OtherPostretirementBenefitsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r123",
      "r326",
      "r332",
      "r338"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other charges"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other charges"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r128",
      "r129",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Given",
        "terseLabel": "Purchase of investment in affiliated companies, treasury stock"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r49",
      "r354"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "negatedTerseLabel": "Contingent consideration payments in excess of acquisition-date liability"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r106",
      "r109",
      "r142"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Shares purchased under share repurchase programs"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r117",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividend payments"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r107",
      "r622"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedTerseLabel": "Acquisition of business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Purchase of investment in affiliated companies",
        "terseLabel": "Purchase in investment in affiliated companies in cash"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "terseLabel": "Capital Expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r432",
      "r434",
      "r440",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r482",
      "r484",
      "r487",
      "r489",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "verboseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r17",
      "r406",
      "r407",
      "r430",
      "r482"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities",
        "verboseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r407",
      "r430",
      "r782",
      "r802"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Liability, Defined Benefit Plan",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19",
      "r406",
      "r407",
      "r430",
      "r482"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities",
        "verboseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r131",
      "r466",
      "r485",
      "r486",
      "r489",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r404",
      "r406",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r489",
      "r490",
      "r498",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension benefits"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r460",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding in 2020 and 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.",
        "label": "Proceeds from Issuance of Other Long-term Debt",
        "terseLabel": "Issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r110",
      "r541"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from stock-based compensation awards"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Borrowings under revolving credit agreements"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Employee stock purchase plan contributions"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r43",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r321",
      "r843",
      "r844",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r42",
      "r314"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r316",
      "r807"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r131",
      "r316",
      "r843",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r13",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r13",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]",
        "terseLabel": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Quarterly Operating and Per Share Data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r78",
      "r89"
     ],
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTerseLabel": "Amounts reclassified out"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Schedule of Reclassification out of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r227",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r113",
      "r137"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayments under revolving credit agreements"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Debt issuance cost"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r557",
      "r855"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r131",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r327",
      "r329",
      "r336",
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and related cost, cumulative cost incurred"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r327",
      "r329",
      "r336",
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "verboseLabel": "Restructuring and related cost, expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r327",
      "r329",
      "r336",
      "r339"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 1.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Total restructuring and related charges",
        "totalLabel": "Total restructuring and related charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r123",
      "r326",
      "r332",
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "negatedTerseLabel": "Restructuring and severance related charges",
        "terseLabel": "Restructuring and severance related charges",
        "verboseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r328",
      "r334"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring , ending balance",
        "periodStartLabel": "Restructuring beginning balance",
        "terseLabel": "Restructuring and severance related charges"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r326",
      "r333"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedLabel": "Non-cash asset write-downs",
        "terseLabel": "Non-cash restructuring charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r369",
      "r550",
      "r805",
      "r830",
      "r835"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r160",
      "r170",
      "r172",
      "r271",
      "r546",
      "r547",
      "r548",
      "r594",
      "r595",
      "r826",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees": {
     "auth_ref": [
      "r732"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consolidated retained earnings that represent undistributed (not yet received) earnings from 50% or less owned persons accounted for by the equity method (equity method investees).",
        "label": "Retained Earnings, Undistributed Earnings from Equity Method Investees",
        "terseLabel": "Unremitted income of affiliated companies"
       }
      }
     },
     "localname": "RetainedEarningsUndistributedEarningsFromEquityMethodInvestees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r463",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r490",
      "r494",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r463",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r490",
      "r494",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r498",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r457",
      "r458",
      "r460",
      "r463",
      "r467",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r498",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r213",
      "r214",
      "r227",
      "r233",
      "r234",
      "r241",
      "r242",
      "r245",
      "r384",
      "r385",
      "r766"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Proprietary Products",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r387",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition and Deferred Revenue [Abstract]",
        "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAndDeferredRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r91",
      "r134",
      "r213",
      "r214",
      "r227",
      "r233",
      "r234",
      "r241",
      "r242",
      "r245",
      "r264",
      "r692",
      "r793"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Proprietary Products"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r722",
      "r727"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r204",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r78",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Components of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Allocation of Share-based Compensation Costs by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Obligations, Net of Current Maturities"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r466",
      "r467",
      "r470",
      "r471",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails",
      "http://www.westpharma.com/role/BenefitPlansWeightedAverageInterestCreditingRatingbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r645",
      "r654",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r636",
      "r638",
      "r639",
      "r643",
      "r644",
      "r648",
      "r654",
      "r665",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Foreign Currency Contracts"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Basic to Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of Sales by Significant Product Group"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r1",
      "r134",
      "r263",
      "r264",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r300",
      "r305",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r36",
      "r37",
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Summary of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-based Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-based Share Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r652",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r43",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Quarterly Financial Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r330",
      "r331",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r328",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Obligations"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r97",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Sales and Long-Lived Assets, by Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r91",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r222",
      "r225",
      "r231",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r222",
      "r225",
      "r231",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r507",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Appreciation Rights Award Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r513",
      "r526",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r576",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r209",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r245",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r209",
      "r211",
      "r212",
      "r222",
      "r226",
      "r232",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241",
      "r244",
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Items [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Other acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r123",
      "r326",
      "r332",
      "r338"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "netLabel": "Severance Costs",
        "verboseLabel": "Severance and post-employment benefits"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "negatedTerseLabel": "Stock-based compensation expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted at target level (in shares)",
        "verboseLabel": "Granted at target level (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted at target level (in dollars per share)",
        "verboseLabel": "Granted at target level (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending (in shares)",
        "periodStartLabel": "Outstanding, beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Non-vested PSU Awards [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, ending (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Average remaining term of shares issued at conversion"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested and converted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested and converted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Stock volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Limitation on payroll deductions of employee's base salary, percent"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-option equity instruments exercised by participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r514",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending (in shares)",
        "periodStartLabel": "Outstanding, beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "SARs Activity [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under the 2016 Plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Options exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of total options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r515",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, ending (in shares)",
        "periodStartLabel": "Options outstanding, beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options Activity [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, ending (in dollars per share)",
        "periodStartLabel": "Options outstanding, beginning (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Stock Options, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r531"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of total options vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r504",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r131",
      "r507",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Awards, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r532",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Grant date fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of current market price for sales to eligible employees"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Short"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r719",
      "r727"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Estimated increase (decrease) in the liability for unrecognized tax benefits"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r209",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r245",
      "r296",
      "r319",
      "r329",
      "r339",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r58",
      "r153",
      "r154",
      "r155",
      "r160",
      "r170",
      "r172",
      "r196",
      "r271",
      "r364",
      "r369",
      "r546",
      "r547",
      "r548",
      "r594",
      "r595",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r826",
      "r827",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r196",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r22",
      "r23",
      "r364",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Purchases of shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r22",
      "r23",
      "r364",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Activity related to stock-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r364",
      "r369",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r58",
      "r364",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Purchase of investment in affiliated companies"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r22",
      "r23",
      "r369",
      "r506",
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Activity related to stock-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock repurchase program, shares authorized (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r28",
      "r29",
      "r134",
      "r256",
      "r264",
      "r692"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary of Investment Holdings [Line Items]",
        "terseLabel": "Summary of Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsTable": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The summary of investment holding table is used for any listing of investment in a summary form. Table lists the 50 largest investments and any other investment the value of which exceeded one percent of net asset value of the registrant as of the close of the period.",
        "label": "Summary of Investment Holdings [Table]",
        "terseLabel": "Summary of Investment Holdings [Table]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)",
        "terseLabel": "Measurement period adjustment, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase (decrease) in effective tax rate for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Increase (Decrease) in Effective Tax Rate",
        "terseLabel": "Net impact to the 2018 effective tax rate, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense",
        "terseLabel": "Transition toll tax"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ToolsDiesAndMoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale.",
        "label": "Tools, Dies and Molds [Member]",
        "terseLabel": "Molds and dies"
       }
      }
     },
     "localname": "ToolsDiesAndMoldsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount": {
     "auth_ref": [
      "r747"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount",
        "terseLabel": "Sales of certain accounts receivable"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r258",
      "r259",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Forward treasury locks"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Shares purchased under share repurchase program, average cost per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r57",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r57",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, at cost (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r23",
      "r364",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Shares purchased under share repurchase program (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r57",
      "r370",
      "r371"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost (1.3 million and 1.2 million shares in 2020 and 2019)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r364",
      "r369",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Shares purchased under share repurchase program",
        "terseLabel": "Shares purchased under share repurchase program"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r163",
      "r268",
      "r269",
      "r270",
      "r271",
      "r274",
      "r275",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r592",
      "r593",
      "r594",
      "r595",
      "r768",
      "r769",
      "r770",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Less: unamortized debt issuance costs",
        "verboseLabel": "Unamortized debt issuance costs remaining"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r558",
      "r612",
      "r795",
      "r837"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r559",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1",
        "terseLabel": "Total gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails",
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued liabilities for interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase due to current year position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase due to prior year position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r575"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Reduction for expiration of statute of limitations/audits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Outstanding unconditional contractual commitments due to be paid in 2021"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).",
        "label": "Unrecorded Unconditional Purchase Obligation",
        "terseLabel": "Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r206",
      "r207",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r144",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r720",
      "r727"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r177",
      "r185"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares assuming dilution (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r176",
      "r185"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_AccruedSalariesWagesAndBenefitsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Salaries, Wages, and Benefits, Current",
        "label": "Accrued Salaries, Wages, and Benefits, Current",
        "terseLabel": "Accrued salaries, wages and benefits"
       }
      }
     },
     "localname": "AccruedSalariesWagesAndBenefitsCurrent",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect",
        "label": "Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect",
        "terseLabel": "Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AluplastSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aluplast S.A. de C.V. [Member]",
        "label": "Aluplast S.A. de C.V. [Member]",
        "terseLabel": "Aluplast S.A. de C.V."
       }
      }
     },
     "localname": "AluplastSADeCVMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_AmortizationExpenseImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Expense, Impact On Diluted Earnings Per Share",
        "label": "Amortization Expense, Impact On Diluted Earnings Per Share",
        "terseLabel": "Amortization expense (in dollars per share)"
       }
      }
     },
     "localname": "AmortizationExpenseImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_AssetRelatedChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset-Related Charges [Member]",
        "label": "Asset-Related Charges [Member]",
        "terseLabel": "Asset-related charges"
       }
      }
     },
     "localname": "AssetRelatedChargesMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_AssetsDefinedBenefitPlansNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent",
        "label": "Assets, Defined Benefit Plans, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsDefinedBenefitPlansNoncurrent",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award Types Other than Stock Options and Stock Appreciation Rights [Member]",
        "label": "Award Types Other than Stock Options and Stock Appreciation Rights [Member]",
        "terseLabel": "Award Types Other than Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_BiologicsCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biologics Customers [Member]",
        "label": "Biologics Customers [Member]",
        "terseLabel": "Biologics"
       }
      }
     },
     "localname": "BiologicsCustomersMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_BrazilTaxRecovery": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 8.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brazil Tax Recovery",
        "label": "Brazil Tax Recovery",
        "negatedLabel": "Brazil tax recovery",
        "netLabel": "Tax recovery",
        "terseLabel": "Tax recovery"
       }
      }
     },
     "localname": "BrazilTaxRecovery",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_BusinessCombinationContingentConsiderationMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Measurement Input",
        "label": "Business Combination, Contingent Consideration, Measurement Input",
        "terseLabel": "Business combination, contingent consideration, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationMeasurementInput",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_CashSettledPSUAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash-Settled PSU Awards",
        "label": "Cash-Settled PSU Awards [Member]",
        "terseLabel": "Cash-Settled PSU Awards"
       }
      }
     },
     "localname": "CashSettledPSUAwardsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_CashSettledStockAppreciationRightsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of cash-settled stock appreciation rights outstanding.",
        "label": "Cash-Settled Stock Appreciation Rights, Outstanding",
        "terseLabel": "Cash-settled SARs, outstanding (in shares)"
       }
      }
     },
     "localname": "CashSettledStockAppreciationRightsOutstanding",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ComputerHardwareAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Hardware and Software [Member]",
        "label": "Computer Hardware and Software [Member]",
        "terseLabel": "Computer hardware and software"
       }
      }
     },
     "localname": "ComputerHardwareAndSoftwareMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Arrangements, Range Of Outcomes, Payable Period",
        "label": "Contingent Consideration Arrangements, Range Of Outcomes, Payable Period",
        "terseLabel": "Contingent consideration, payable period"
       }
      }
     },
     "localname": "ContingentConsiderationArrangementsRangeOfOutcomesPayablePeriod",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_ContractManufacturedCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract-Manufactured Customers [Member]",
        "label": "Contract-Manufactured Customers [Member]",
        "terseLabel": "Contract-Manufactured Products"
       }
      }
     },
     "localname": "ContractManufacturedCustomersMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContractManufacturedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Manufactured Products [Member]",
        "label": "Contract Manufactured Products [Member]",
        "terseLabel": "Contract-Manufactured Products",
        "verboseLabel": "Contract-Manufactured Products"
       }
      }
     },
     "localname": "ContractManufacturedProductsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContractWithCustomerAssetIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Increase (Decrease)",
        "label": "Contract With Customer, Asset, Increase (Decrease)",
        "terseLabel": "Change in contract assets - increase (decrease)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetIncreaseDecrease",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset [Roll Forward]",
        "label": "Contract With Customer, Asset [Roll Forward]",
        "terseLabel": "Contract With Customer, Asset [Roll Forward]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetRollForward",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments",
        "label": "Contract With Customer, Liability, Increase (Decrease) Due To Additional Cash Payments",
        "terseLabel": "Cash payments received in advance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ContractWithCustomerLiabilityRecognitionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Recognition Period",
        "label": "Contract With Customer, Liability, Recognition Period",
        "terseLabel": "Contract with customer liability recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRecognitionPeriod",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Revenue Recognized During The Period",
        "label": "Contract With Customer, Liability, Revenue Recognized During The Period",
        "terseLabel": "Revenue recognized during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedDuringThePeriod",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability [Roll Forward]",
        "label": "Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Contract With Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRollForward",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_CostInvestmentImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost investment impairment",
        "label": "Cost investment impairment",
        "negatedTerseLabel": "Cost investment impairment"
       }
      }
     },
     "localname": "CostInvestmentImpairment",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_CreditAvailableForIssuanceOfLettersOfCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "this refers to Credit available for the issuance of letters of credit",
        "label": "Credit available for the issuance of letters of credit",
        "terseLabel": "Credit available for the issuance of letters of credit"
       }
      }
     },
     "localname": "CreditAvailableForIssuanceOfLettersOfCredit",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_CreditFacilityIsAvailableForSwingLineLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This refers to credit facility is available for swing-line loans",
        "label": "Credit facility is available for swing-line loans",
        "terseLabel": "Credit facility is available for swing-line loans"
       }
      }
     },
     "localname": "CreditFacilityIsAvailableForSwingLineLoans",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DaikyoSeikoLtdDaikyoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Daikyo Seiko, Ltd. (Daikyo) [Member]",
        "label": "Daikyo Seiko, Ltd. (Daikyo) [Member]",
        "terseLabel": "Daikyo"
       }
      }
     },
     "localname": "DaikyoSeikoLtdDaikyoMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails",
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_DebtInstrumentNumberOfTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Tranches",
        "label": "Debt Instrument, Number Of Tranches",
        "terseLabel": "Number Tranches"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfTranches",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualConversionUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Arrangement With Individual, Conversion Unit",
        "label": "Deferred Compensation Arrangement With Individual, Conversion Unit",
        "terseLabel": "Deferred compensation conversion unit (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualConversionUnit",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualNumberOfPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Arrangement With Individual, Number Of Plans",
        "label": "Deferred Compensation Arrangement With Individual, Number Of Plans",
        "terseLabel": "Number of deferred compensation plans"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualNumberOfPlans",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Arrangement With Individual, Share Equivalents Balance",
        "label": "Deferred Compensation Arrangement With Individual, Share Equivalents Balance",
        "terseLabel": "Number of deferred stock units (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualShareEquivalentsBalance",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Federal, State and Local Income Tax Expense (Benefit)",
        "label": "Deferred Federal, State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Federal and state"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DeferredStockUnitsPayableInCash": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Stock Units Payable In Cash",
        "label": "Deferred Stock Units Payable In Cash",
        "terseLabel": "Number of deferred stock units payable in cash (in shares)"
       }
      }
     },
     "localname": "DeferredStockUnitsPayableInCash",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges",
        "terseLabel": "Restructuring and impairment charges"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets",
        "label": "Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets",
        "terseLabel": "Percentage of global plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_DefinedBenefitPlanExpectedFutureBenefitPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Expected Future Benefit Payments",
        "label": "Defined Benefit Plan, Expected Future Benefit Payments",
        "totalLabel": "Total benefit payments expected"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPayments",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost",
        "terseLabel": "Assumed healthcare cost trend rate, net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums",
        "label": "Defined Benefit Plan, Plan Assets, Contributions By Employer, Net Of Premiums",
        "terseLabel": "Employer contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByEmployerNetOfPremiums",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost",
        "terseLabel": "Ultimate healthcare cost trend rate, net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_DevelopmentAndLicensingIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": 4.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.",
        "label": "Development And Licensing Income",
        "negatedTerseLabel": "Development and licensing income",
        "terseLabel": "Development and licensing income"
       }
      }
     },
     "localname": "DevelopmentAndLicensingIncome",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign-Derived Intangible Income Deductions (FDII), Percent",
        "label": "Effective Income Tax Rate Reconciliation, Foreign-Derived Intangible Income Deductions (FDII), Percent",
        "terseLabel": "Foreign-Derived Intangible Income Deductions (FDII)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionsFDIIPercent",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation Of Foreign Earnings, Net Of Foreign Tax Credits, Percent",
        "terseLabel": "U.S. tax on international earnings, net of foreign tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarningsNetOfForeignTaxCreditsPercent",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Undistributed Earnings Of Subsidiaries, Percentage",
        "terseLabel": "Tax on undistributed earnings of subsidiaries"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUndistributedEarningsOfSubsidiariesPercentage",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EmployeeStockPurchasePlanEsppMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan (ESPP) [Member]",
        "label": "Employee Stock Purchase Plan (ESPP) [Member]",
        "terseLabel": "Employee Stock Purchase Plan (ESPP)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanEsppMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ExpirationPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration Period [Axis]",
        "label": "Expiration Period [Axis]",
        "terseLabel": "Expiration Period [Axis]"
       }
      }
     },
     "localname": "ExpirationPeriodAxis",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ExpirationPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Expiration Period [Axis]",
        "label": "Expiration Period [Domain]",
        "terseLabel": "Expiration Period [Domain]"
       }
      }
     },
     "localname": "ExpirationPeriodDomain",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_FixedAssetImpairmentFromRestructuring": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Asset Impairment From Restructuring",
        "label": "Fixed Asset Impairment From Restructuring",
        "terseLabel": "Fixed assets restructuring plan"
       }
      }
     },
     "localname": "FixedAssetImpairmentFromRestructuring",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Asset Impairment From Restructuring, Impact On Diluted Earnings Per Share",
        "label": "Fixed Asset Impairment From Restructuring, Impact On Diluted Earnings Per Share",
        "terseLabel": "Fixed assets restructuring plan (in dollars per share)"
       }
      }
     },
     "localname": "FixedAssetImpairmentFromRestructuringImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Charges From Devaluation Of Argentina Currency",
        "label": "Foreign Currency Charges From Devaluation Of Argentina Currency",
        "terseLabel": "Devaluation of Argentina"
       }
      }
     },
     "localname": "ForeignCurrencyChargesFromDevaluationOfArgentinaCurrency",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Charges From Devaluation Of Argentina Currency, Impact On Diluted Earnings Per Share",
        "label": "Foreign Currency Charges From Devaluation Of Argentina Currency, Impact On Diluted Earnings Per Share",
        "terseLabel": "Devaluation of Argentina diluted share (in dollars per share)"
       }
      }
     },
     "localname": "ForeignCurrencyChargesFromDevaluationOfArgentinaCurrencyImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign currency-denominated debt designated as a hedge of our net investments in foreign operations.",
        "label": "Foreign Currency, Denominated Debt [Member]",
        "terseLabel": "Foreign currency-denominated debt"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_GainLossOnArgentinaCurrencyDevaluation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Argentina Currency Devaluation",
        "label": "Gain (Loss) On Argentina Currency Devaluation",
        "terseLabel": "Argentina currency devaluation"
       }
      }
     },
     "localname": "GainLossOnArgentinaCurrencyDevaluation",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_GenericsCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generics Customers [Member]",
        "label": "Generics Customers [Member]",
        "terseLabel": "Generics"
       }
      }
     },
     "localname": "GenericsCustomersMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_HighValueProductComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High-Value Components [Member]",
        "label": "High-Value Product Components [Member]",
        "terseLabel": "High-Value Product Components"
       }
      }
     },
     "localname": "HighValueProductComponentsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_HighValueProductDeliveryDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High Value Product Delivery Devices Member",
        "label": "High Value Product Delivery Devices [Member]",
        "terseLabel": "High-Value Product Delivery Devices"
       }
      }
     },
     "localname": "HighValueProductDeliveryDevicesMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_IWPharmaGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I&amp;W Pharma Group LLC",
        "label": "I&amp;W Pharma Group LLC [Member]",
        "terseLabel": "I&amp;W Pharma Group LLC"
       }
      }
     },
     "localname": "IWPharmaGroupLLCMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_IncentiveStockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive Stock Awards [Member]",
        "label": "Incentive Stock Awards [Member]",
        "terseLabel": "Incentive Stock Awards",
        "verboseLabel": "Annual Incentive Plan"
       }
      }
     },
     "localname": "IncentiveStockAwardsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Benefit From Change In Enacted Tax Rate, Impact On Diluted Earnings Per Share",
        "label": "Income Tax Benefit From Change In Enacted Tax Rate, Impact On Diluted Earnings Per Share",
        "terseLabel": "Tax benefit for impact of tax law changes enacted (in dollars per share)"
       }
      }
     },
     "localname": "IncomeTaxBenefitFromChangeInEnactedTaxRateImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_IncomeTaxBenefitFromStockBasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Benefit From Stock-Based Compensation",
        "label": "Income Tax Benefit From Stock-Based Compensation",
        "terseLabel": "Tax benefit from stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxBenefitFromStockBasedCompensation",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Benefit From Stock-Based Compensation, Impact On Diluted Earnings Per Share",
        "label": "Income Tax Benefit From Stock-Based Compensation, Impact On Diluted Earnings Per Share",
        "terseLabel": "Tax benefit from stock-based compensation (in dollars per share)"
       }
      }
     },
     "localname": "IncomeTaxBenefitFromStockBasedCompensationImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Matters, Contingencies and Legal Costs [Policy Text Block]",
        "label": "Legal Matters, Contingencies and Legal Costs [Policy Text Block]",
        "terseLabel": "Litigation"
       }
      }
     },
     "localname": "LegalMattersContingenciesAndLegalCostsPolicyTextBlock",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "lessee, lease Cash Flow and Supplemental information [Table Text Block]",
        "label": "lessee, lease Cash Flow and Supplemental information [Table Text Block]",
        "terseLabel": "Cash Flow and Supplemental information"
       }
      }
     },
     "localname": "LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_LesseeOperatingLeaseOptionToTerminateTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Option To Terminate, Term",
        "label": "Lessee, Operating Lease, Option To Terminate, Term",
        "terseLabel": "Lease, operating lease, terminate term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToTerminateTerm",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAdoptionofASC842Details"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_LineOfCreditFacilityAdditionalBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility Additional Borrowing Capacity",
        "label": "Line Of Credit Facility Additional Borrowing Capacity",
        "terseLabel": "Line of credit facility, additional borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityAdditionalBorrowingCapacity",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_NetSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net sales member",
        "label": "Net Sales [Member]",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "NetSalesMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_NotesPayableAndOtherDebtCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Payable and Other Debt, Current",
        "label": "Notes Payable and Other Debt, Current",
        "terseLabel": "Notes payable and other current debt"
       }
      }
     },
     "localname": "NotesPayableAndOtherDebtCurrent",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement Gain (Loss), Before Tax",
        "negatedTerseLabel": "Settlement loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanSettlementGainLossBeforeTax",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax",
        "terseLabel": "Settlement effects arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.",
        "label": "Other Comprehensive Loss, Defined Benefit Plans Settlement Effects, Net Of Tax",
        "negatedTerseLabel": "Settlement effects arising during period, net of tax of $0.9, $0.8, and $0"
       }
      }
     },
     "localname": "OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetOfTax",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-European Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_OtherCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Liabilities [Abstract]",
        "label": "Other Current Liabilities [Abstract]",
        "terseLabel": "Other Current Liabilities [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesAbstract",
     "nsuri": "http://www.westpharma.com/20201231",
     "xbrltype": "stringItemType"
    },
    "wst_OtherEuropeCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Europe Countries [Member]",
        "label": "Other Europe Countries [Member]",
        "terseLabel": "Other European countries"
       }
      }
     },
     "localname": "OtherEuropeCountriesMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandLonglivedAssetsbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_OtherExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Expense (Income) [Abstract]",
        "label": "Other Expense (Income) [Abstract]",
        "terseLabel": "Other Expense (Income) [Abstract]"
       }
      }
     },
     "localname": "OtherExpenseIncomeAbstract",
     "nsuri": "http://www.westpharma.com/20201231",
     "xbrltype": "stringItemType"
    },
    "wst_OtherFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Financial Instruments [Abstract]",
        "terseLabel": "Other Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "OtherFinancialInstrumentsAbstract",
     "nsuri": "http://www.westpharma.com/20201231",
     "xbrltype": "stringItemType"
    },
    "wst_OtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Income (Expense)",
        "negatedTerseLabel": "Other expense (income)",
        "negatedTotalLabel": "Total other expense"
       }
      }
     },
     "localname": "OtherIncomeExpense",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherMutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Mutual Funds",
        "label": "Other Mutual Funds [Member]",
        "terseLabel": "Other mutual funds"
       }
      }
     },
     "localname": "OtherMutualFundsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PatentsAndLicensingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and Licensing [Member]",
        "label": "Patents and Licensing [Member]",
        "terseLabel": "Patents and licensing"
       }
      }
     },
     "localname": "PatentsAndLicensingMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PaymentOfExciseTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Of Excise Taxes",
        "label": "Payment Of Excise Taxes",
        "terseLabel": "Payment of excise taxes"
       }
      }
     },
     "localname": "PaymentOfExciseTaxes",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_PaymentOfExciseTaxesImpactOnDilutedEarningsShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Of Excise Taxes, Impact On Diluted Earnings Share",
        "label": "Payment Of Excise Taxes, Impact On Diluted Earnings Share",
        "terseLabel": "Payment of excise taxes (in dollars per share)"
       }
      }
     },
     "localname": "PaymentOfExciseTaxesImpactOnDilutedEarningsShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Intangible Assets, Impact On Diluted Earnings Per Share",
        "label": "Payments to Acquire Intangible Assets, Impact On Diluted Earnings Per Share",
        "terseLabel": "Intangible assets (in dollars per share)"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssetsImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_PensionAndOtherPostretirementBenefitExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.",
        "label": "Pension And Other Postretirement Benefit Expense, Net",
        "terseLabel": "Pension and other retirement plans, net"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitExpenseNet",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_PensionSettlementAndRelatedCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension Settlement And Related Charges",
        "label": "Pension Settlement And Related Charges",
        "terseLabel": "Pension settlement and related charges"
       }
      }
     },
     "localname": "PensionSettlementAndRelatedCharges",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension Settlement And Related Charges, Impact On Diluted Earnings Per Share",
        "label": "Pension Settlement And Related Charges, Impact On Diluted Earnings Per Share",
        "terseLabel": "Pension settlement and related charges (in dollars per share)"
       }
      }
     },
     "localname": "PensionSettlementAndRelatedChargesImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-vesting Shares or Units Dividend Equivalents [Member]",
        "label": "Performance-vesting Shares or Units Dividend Equivalents [Member]",
        "terseLabel": "Performance-vesting Shares or Units Dividend Equivalents"
       }
      }
     },
     "localname": "PerformanceVestingSharesOrUnitsDividendEquivalentsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharma Customers [Member]",
        "label": "Pharma Customers [Member]",
        "terseLabel": "Pharma"
       }
      }
     },
     "localname": "PharmaCustomersMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaRubberSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharma Rubber S.A. de C.V. [Member]",
        "label": "Pharma Rubber S.A. de C.V. [Member]",
        "terseLabel": "Pharma Rubber S.A. de C.V."
       }
      }
     },
     "localname": "PharmaRubberSADeCVMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaTapSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharma Tap S.A de C.V. [Member]",
        "label": "Pharma Tap S.A de C.V. [Member]",
        "terseLabel": "Pharma Tap S.A. de C.V."
       }
      }
     },
     "localname": "PharmaTapSADeCVMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ProbabilitiesOfSuccessfulExecutionOfAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probabilities of Successful Execution of Agreement [Member]",
        "label": "Probabilities of Successful Execution of Agreement [Member]",
        "terseLabel": "Probabilities of Successful Execution of Agreement"
       }
      }
     },
     "localname": "ProbabilitiesOfSuccessfulExecutionOfAgreementMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ProbabilitiesOfSuccessfulFDAApprovalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probabilities of Successful FDA Approval [Member]",
        "label": "Probabilities of Successful FDA Approval [Member]",
        "terseLabel": "Probabilities of Successful FDA Approval"
       }
      }
     },
     "localname": "ProbabilitiesOfSuccessfulFDAApprovalMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ProprietaryProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proprietary Products [Member]",
        "label": "Proprietary Products [Member]",
        "terseLabel": "Proprietary Products"
       }
      }
     },
     "localname": "ProprietaryProductsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ProvisionForProductReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for Product Returns",
        "label": "Provision for Product Returns",
        "terseLabel": "Provision for product returns"
       }
      }
     },
     "localname": "ProvisionForProductReturns",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueVoluntaryRecallDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases and Royalty Payments from Equity Method Investees",
        "label": "Purchases and Royalty Payments from Equity Method Investees",
        "terseLabel": "Purchases and royalty payments made to affiliates"
       }
      }
     },
     "localname": "PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_RatioOfDebtToEBITDA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio of debt to EBITDA",
        "label": "Ratio of debt to EBITDA",
        "terseLabel": "Ratio of debt to EBITDA"
       }
      }
     },
     "localname": "RatioOfDebtToEBITDA",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "wst_ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction In Number Of Shares Available For Grant For Each Award Granted",
        "label": "Reduction In Number Of Shares Available For Grant For Each Award Granted",
        "terseLabel": "Number of shares reduced for each award granted (in shares)"
       }
      }
     },
     "localname": "ReductionInNumberOfSharesAvailableForGrantForEachAwardGranted",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_RestructuringAndRelatedActivitiesPeriodOfImplementation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Related Activities, Period Of Implementation",
        "label": "Restructuring And Related Activities, Period Of Implementation",
        "terseLabel": "Restructuring and related activities, period of implementation"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesPeriodOfImplementation",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_RestructuringAndSeveranceRelatedCharges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Severance Related Charges",
        "label": "Restructuring And Severance Related Charges",
        "terseLabel": "Restructuring and severance related charges"
       }
      }
     },
     "localname": "RestructuringAndSeveranceRelatedCharges",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Severance Related Charges, Impact On Diluted Earnings Per Share",
        "label": "Restructuring And Severance Related Charges, Impact On Diluted Earnings Per Share",
        "terseLabel": "Restructuring and severance related charges (in dollars per share)"
       }
      }
     },
     "localname": "RestructuringAndSeveranceRelatedChargesImpactOnDilutedEarningsPerShare",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/QuarterlyOperatingandPerShareDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_RevolvingCreditFacilityDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Due 2024",
        "label": "Revolving Credit Facility, Due 2024 [Member]",
        "terseLabel": "Revolving credit facility, due 2024"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDue2024Member",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SalesProjectionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Projections [Member]",
        "label": "Sales Projections [Member]",
        "terseLabel": "Sales Projections"
       }
      }
     },
     "localname": "SalesProjectionsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SalesToEquityMethodInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales to Equity Method Investees",
        "label": "Sales to Equity Method Investees",
        "terseLabel": "Sales to affiliates"
       }
      }
     },
     "localname": "SalesToEquityMethodInvestees",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]",
        "label": "Schedule Of Changes In Fair Value Of Plan Assets, Projected Benefit Obligations And Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule Of Intangible Assets By Major Class [Line Items]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule Of Intangible Assets By Major Class [Table]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table Text Block]",
        "label": "Schedule Of Intangible Assets By Major Class [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets by Major Class"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Other Income and Expense, by Component [Table Text Block]",
        "label": "Schedule Of Other Income And Expense, By Component [Table Text Block]",
        "terseLabel": "Schedule of Other Expense (Income)"
       }
      }
     },
     "localname": "ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_SeniorBNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior B Notes Due 2024 [Member]",
        "label": "Senior B Notes Due 2024 [Member]",
        "terseLabel": "Series B notes, due July 5, 2024 (3.82%)"
       }
      }
     },
     "localname": "SeniorBNotesDue2024Member",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SeniorCNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior C Notes Due 2027 [Member]",
        "label": "Senior C Notes Due 2027 [Member]",
        "terseLabel": "Series C notes, due July 5, 2027 (4.02%)"
       }
      }
     },
     "localname": "SeniorCNotesDue2027Member",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior A Notes Due 2022 [Member]",
        "label": "Senior A Notes Due 2022 [Member]",
        "terseLabel": "Series A notes, due July 5, 2022 (3.67%)"
       }
      }
     },
     "localname": "SeniorNotesDue2022Member",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage",
        "terseLabel": "Actual payout range"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Conversion Rate",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Conversion Rate",
        "terseLabel": "Conversion rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRate",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target",
        "terseLabel": "Adjustments above/(below) target (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value",
        "terseLabel": "Adjustments above/(below) target (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting",
        "verboseLabel": "Number of shares to be issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount",
        "terseLabel": "Limitation on payroll deductions of employee's base salary, amount"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year",
        "terseLabel": "Maximum number of shares per employee, per year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]",
        "terseLabel": "SARs, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_SmartDoseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SmartDose [Member]",
        "label": "SmartDose [Member]",
        "terseLabel": "SmartDose"
       }
      }
     },
     "localname": "SmartDoseMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SouthKoreaDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "South Korea Distributor",
        "label": "South Korea Distributor [Member]",
        "terseLabel": "South Korea Distributor"
       }
      }
     },
     "localname": "SouthKoreaDistributorMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StandardPackagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard Packaging [Member]",
        "label": "Standard Packaging [Member]",
        "terseLabel": "Standard Packaging"
       }
      }
     },
     "localname": "StandardPackagingMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockOptionAndAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option and Appreciation Rights [Member]",
        "label": "Stock Option and Appreciation Rights [Member]",
        "terseLabel": "Stock option and appreciation rights"
       }
      }
     },
     "localname": "StockOptionAndAppreciationRightsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockSettledPSUAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock-Settled PSU Awards",
        "label": "Stock-Settled PSU Awards [Member]",
        "terseLabel": "Stock-settled PSU awards"
       }
      }
     },
     "localname": "StockSettledPSUAwardsMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockSettledStockAppreciationRightsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock-settled stock appreciation rights outstanding.",
        "label": "Stock-Settled Stock Appreciation Rights, Outstanding",
        "terseLabel": "Stock-settled SARs, outstanding (in shares)"
       }
      }
     },
     "localname": "StockSettledStockAppreciationRightsOutstanding",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_TermLoanDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Due 2024",
        "label": "Term Loan Due 2024 [Member]",
        "terseLabel": "Term Loan, due December 31, 2024 (1.13%)"
       }
      }
     },
     "localname": "TermLoanDue2024Member",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_The2018RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2018 Restructuring Plan",
        "label": "The 2018 Restructuring Plan [Member]",
        "terseLabel": "2018 Restructuring Plan"
       }
      }
     },
     "localname": "The2018RestructuringPlanMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_The2020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2020 Restructuring Plan",
        "label": "The 2020 Restructuring Plan [Member]",
        "terseLabel": "2020 Restructuring Plan",
        "verboseLabel": "2020 Restructuring Plan"
       }
      }
     },
     "localname": "The2020RestructuringPlanMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_WeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Weighted average shares outstanding: [Abstract]",
        "verboseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_WestCompanyMexicoSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The West Company Mexico, S.A. de C.V. [Member]",
        "label": "The West Company Mexico, S.A. de C.V. [Member]",
        "terseLabel": "The West Company Mexico, S.A. de C.V."
       }
      }
     },
     "localname": "WestCompanyMexicoSADeCVMember",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year 2021",
        "label": "Year 2021 [Member]",
        "terseLabel": "Year 2021"
       }
      }
     },
     "localname": "Year2021Member",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_YearAfter2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year After 2021",
        "label": "Year After 2021 [Member]",
        "terseLabel": "Year After 2021"
       }
      }
     },
     "localname": "YearAfter2021Member",
     "nsuri": "http://www.westpharma.com/20201231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e639-108305"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13185-110859"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13231-110859"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6571209&loc=d3e13669-110860"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/subtopic&trid=2175709"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7656903&loc=SL6757497-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28200-109314"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(f))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(g))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121636179&loc=d3e34841-113949"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121607252&loc=SL5864739-113975"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061172-113977"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117332851&loc=SL7495116-110257"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498357-110258"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=120604989&loc=d3e56071-112765"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=6462270&loc=d3e57205-112772"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB Topic 5.W)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04.12(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r856": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r857": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r858": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r859": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r860": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r861": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r862": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r863": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r864": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1204",
   "Subparagraph": "(1)"
  },
  "r865": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1204",
   "Subparagraph": "(2)"
  },
  "r866": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r867": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r868": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r869": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r870": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>134
<FILENAME>0000105770-21-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000105770-21-000008-xbrl.zip
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M)#?D>Y0K*DOW6OC5JRO(4K_Y:AZT_@502P,$%     @ *H974JK&!+ET P
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M4()DX7NJ*H$^@9NU #:!.6G4@I4(NT>L1[)2*TC6:+#WA@;J14BSFMZB4C
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M)HOU97@B"-S_ZR"06"9+Q-C#9173-N '<SPV:\]EF8%0@F[A>ZIJ@3Z!F[4
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MH]<M'-+>+<O_R,3ORHZ0OWNR@C 7YY@D!R GE).82NIGBZ%.V_ZANI49N>V
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M"(P-4/G[LQ[CGPJ1MS2#P9Q]KB'X'B"SPS$UUTNIR7PT=#G(BP.1IR$N/%+
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M+]Q')YV-"P#:3;0+N%RI=$4+_&)D2GY2%4LO'>!#?'_W?$CH#G.H%APLOGO
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M5GZS7*Q6%\9QMEM:5^NQ2_IU:\<=ST[?]S57W_%L?LN^V-<O7W'][:K9[P[
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M[W'OW/F!XY^>'^_FLBWUK%X53)>S<.JYM\8.&L+4_?C.HKVEK14^] ZC1+8
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M<J&F I*90NE1)&+-Q)[ITT#K$GI\7PI:G<PW1A>QA0R>@GE,RRFI:Y684IM
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M[ZG;[DK1X.$<&X&P7,?S.3<)[%&;F@%SL#*4+X]NU5'MYA!R+<W@I]>N#U=
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MNL+D8>A[ 2<QYQ$P/;,<T_$]2FRR :BUG[%\+(;TZ^YL.LH+&-HB(#F>PM(
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MDSR\EY@E.T'@/(28O:>DO!<8^0P/QH>7=^0,<B-G/+CLB_-B3*=P-\P43$+
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MYK1_XL :N%_2P/S+CYC%0B?JNE[@= D1=C>*F=/U?$I92*EE"P!AKF,:?PC
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MD&FXY<U*Q\&@P?J3S*-L5-"MP@RVCK&T@B^&9Q]=D'_*TUDVI87,("S*ER7
METL[N'_%/K>(3>RNB)@  !F# 2]<T76LR"6.Y7DF]5&2K*DLWSS)<C42,M9X
M2;S\8OUJC  *H4SA!DW36K"T)4XD] 7PS$4ALR!<6J"IPOHH</!G# HP./R:
MG<E+)X5@0GI.+=N055%*XQ=X'EAP1CEC(Z,<Y9@O525%3T=TNCSV*UI>EXOR
M9CV'7P'E9=SXQ59SC, .A-^C<Y@!7B\OA9MP%/HY6.J@E(.0@Z3EU A-@]-Y
M>:O4W)1_'UW"Z2HVJCX$.H:F=#I[88(.D.K)U5].9)JAS6"Q(N9AD;"@&SF
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M4HD:.YJK <BFB5[/ED/F )07R^5=_Z+P]8[Q,952N?;62T^[W3%^</[RLZ$
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M4S_)%@IOZO@7Z1)K=V5HE;G"AV.D4"JXW"6UEQ6>H-M =*[YJ!8.+5HA$IO
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MS]QN0[7<;6!Y"]X2N2<35>O8>$P_G4RE3+@I8K M=*IIZ*.NZA'+O7MPO5-
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M55[>*O0BHAD^2R,"I="TZ-!F;B24/,9,'CRCDHB+S2,4[5/*+K3H:LB@#70
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M<J6,1^@&!Q;CN#R\BB*1I^?<P4>M*0KP2\30#=(:UE\OT^H]Z=J_M*@T]K<
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MM A!TTK(7>&8$$>\)@681'WC"=$A*QR'S] TSI-F&F'254"]/Q8!-2\4C3D
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M\R/#.9F,,"H&$IF)W.>:?#QQ8,'">-O+@ TY+/QGT!N,5BT)N"X0%</ACNJ
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M/$_+ Q?O$RXGS 0Q9R  PN0V9NC$/4\R7I$;'QQ?<:R][N)^<3CT>FA\%,[
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M'$24=BH8Z'SSG,E#3-!6F0PJ-7\*V],ZC[Q[#KHQ M7CHOHSIM8,?Y0E]0G
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MVO574M@.@EK-?M?L:FJM2ZUVW6QI:JU+K6;'/-/46O=:ZW?,IK[4-O*8.-[
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M0;=RPBB@B*^\R$+0D>#.!?DXD)*5WZ&<N'!KNJ$O*0"#!' :(S8)N8KVA!2
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M1^H+=G'S^_7E::.?]-_"?N>/3C2K!+>5NL4@Y[M5+097<&#?[&09L&_VMLF
MW9TPX%0N[\F)QC"S"<Q'F1[<C&&8M9XKPFZRJ50Y.$O.AEK'SG/.689S$"M
MY9RGL3,8*\ULYWMMK6:(+#]87H81PL@??#M]$%UO)]@43NET2WVYX''L*_C(
M"AXH.T<T"[/82M'J,M_P$'>0%*X/CF=Y \=RC2\L "$!7QHPXRZ>3/!:#-F
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MD5UW9-]XY=<Y0U'7T^]J_>5.NN[K$F3-R(?!R ?>OEHS\K$PLJZD/]QZYRV
MJ!Y>N;-FK)<7S^V'L<I'B",LI+>F%%[_+T9VA5EWF,W73QIF>Q$&81E1!JM-
M[+K9U\0^:&(?-DT[G16^C<-4FPY[4RF+KOE>MT\_& >T0RE^Q]9$?8DFHWM
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M$[_2=-2]T7]7[%D1%[Q=J>-J G;0MO^%8ZCJD/BPK3N\-$=9,^J8O=L'(^P
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M14*DG$O0;W2KNY)^L!B*HAZ57H:;,%)O*KLIPR'>M)(1IJ>K<XB!AG/U''Z
M=!P/SOL \F)LCYL*RE1'95TH83;+:)Y2_=HB&?,18H_*AQ\"[HZ-# >;)CB+
MW>)$(NQ%CLGT"E[Z*AFV*W_"([Q[ W*A .1N/.H6+="5O "ZPO/^ 9L\&.FV
MZ5U^G2O24F2JVIS#[W&:Q:,>9H/&L"A &5U/H&0$V"!\QQ@Q@)3@V$LN*[(%
MBS]65)7 N@;99B1U3BJK9*6JPN1L;I6GS<1UUVG3L9Z U&ZS?RF&:F9/SQH,
M<X^U=%:9RXWL=LPZ=B:+1Y0M!0M>UJI[?*.1K5OT$#_\68XWWC2^>GJ*"N>I
M%KNU9M.,)T_KN,4"D0>X7S,,B:F=\FKM8;?UPJW:F=1_\YTRK&F\T:5M5YD%
MU0?CS2S/)NIGS)B[:JI9UFRJIH8,E9=IXS,&:JQ7PW4S]1_W&( Q'0@U..)<
M']-U49XKF9"/DB2-4]R9<J";EA)<:N>J6B\X4%]*40G0LMQ+/CVC^1N.<Y@N
M3]5,&><344WJD+.1W@>N#_6:GQ?"NNAIG]=/J>HB>7GTS8[-Y8@;@3T8-Z")
M7N?8)SK''O=PM3"$9_V"MNU*RRZ+&-0'+]3<Y\'3G8%'ZQNHJ*""H 9M5"N8
M4>5@S0YV]@:BQ5=4!4!.JG/J2W?+C,(*H-W-WTW%R%AR:JQRPU2]!N3?18;%
MYZM!4.C ES#S_P=/NPJKY@[;%!ECQ20DJ/^96G5!U"A$:+-1KVHJ3$.__EN[
M]1F4G('2H9&UXZ%2PW*0+RG@%E?X H9%H=\,=%VB0E]29D@<HQL)C,6\V'=E
MB(U4@:J9O;)M:_>1.4R->-=NU(W"<7.FLR[-L;>F=3>UR\"M]6S578K@27[>
M!/Q[/\KR$:_-WZ(P#NH+8,?"S\KSK.M_*3ERGDG9T^H>0)VN'0.860B/'@?S
M'_Z/YAO 4II?2%$7(\,A,ZY5R720%]I@ 2:Q1'6A\;6N''M:.1_P*D";,,HH
MJR:CC$]\KS9KM#*$#I-J%6B%]Q787%^D\05.OK2^4+2!P:140YR/*KNC2W/"
M$[]#>^7'20MK+U6^-65D-GPI:N<:,\%U7\L20.&-$Z;SC-&4HP,D:UYXR/*Q
MU1<.*H!WG)>]-L6E;B6]SZJT32IQTU%/5O9$J>I6!H9V-U5Z1WTN0 *#<ZF.
M6^^W%H5:TLPMB@1'!I(,-YD+H%MT,*!4$B)#L51ZHG(IE5"MU0&M:T?* BBD
M6JE0ZV,L)9X^\6B4PWIQQ,9\9]9OQ(7F,=#[J"OK*DLXCJ*: 7##>4&(]ZOE
M\_PN8;PUO(1Y\GN600_4,$U+J@86?",KG%@G-4UM D[,ZD:?CWIHM/Z2FF?C
MB=7&C=4V.&B^%536:AU[6/GG2_[6\DW9Z!QO6F$M>&%:^$OZ-53<DTVG2FY-
M5^9YI")<6$K1TA2]:!4NYK8#UUUZ8:N@[3S"J+;5=L/EEPP+VY[C;\RHCGVW
M';ACP; %"D[-?=2F&UJ<ZGTIK ] <_OKIO5>.?86J5"U22& VUYW[6PP([!Q
M5J#: I5GUGS)[[0K!EYLMVXDSY[7ZNT6:3EJW;D2S2_K:W[JW(6^MV@O'-@+
M=\Y>3/=>W>Z].!YD4G-%N2.KK#FX"K7;*CQ#*DQP3"=^%/>;UW;O,*,9QBM2
M&W'4MR>W#R:NG: O&YT/M6%FBLP]JR)SMAVTV9H6F3-D^&S(D-F&"M?F,)XM
M%?I>&0AHJ'#EA_%LJ= R4+@V9_%LB5#EF] _UY00GT/-!Q54]U)6 :BC/N\-
M8'HZECO"\'",38BE#OJ>[X:@B^W+3,9</P+%2C<K+ ?U##9X7<HD;^?V,F]=
M:H%LY_[:#FM;9H,?T5AR5KF_S\;1?%2&!ZKH]2K.?I#GI$I"R:_YU28ZG^D<
MY_.=..>NA2S6CW.<M2DPLIW[ZR\,3&9[%[HRN*^7S.SOW<C7H,-C*M[W=:\9
MQ\7=-OA$!W6K)*J)&_)GYJ,(%B_&:TR0120179B7S?XNLK_APFTQS/XN5-)^
M84W*[.\BAI:_2A_;LW%1G*@T,ZS4I.MM-6LH;*!7PGF>7@E_E7KQ]F^OM<H.
M4]N_O?:ZM+W8SNU=7-$VV[N(HK+RZK]/Z)-8F9YRIBL]#69GOVZ@IL(6#=XO
M3JZ(SRFR:1V@&S$88>ILN=)G&\6U_ U:;^!AX>*%QY>^1X\1CF@HW5#ZV,YX
MSGW#Q0RA&T+?($*WW7M[%0VE&TK?*$J_]_V$H71#Z9M$Z79PWV#+U5/Z/;H+
ME:LJ7D^05%_904F_J2HB_XK@7U941JV1./_TK_]S;%^\ML-P'TZ:E?6PS/$0
M"^BIVGRZE/908F%_^+$LIM\L#*:J!&+][&XJL[Q9%A?+>JK*W%7)@Z25\>NJ
MS)<N*H;= E1ARO/!0!3E*%67A[I*HVI;\G9O[_UN4:/Q:E81A;*P6":3KJXL
M5E0&Q^%ZL-<WJL8O/(J4JFH?EEU;X/VRZ/'2'+VY3#%64%.WYQA<ZO<4I3KK
M0FE<UZY4U<0'64\YCT:9WH%RI^?W=YHBWIU-IWFZ=C3_!DO.IC^E(%@%LW$'
MB:'2NW5M5:S57)6GO,J N-,K;$O0T^7;-0'#,'C JF6(9IZA*G%"9%]UYE!=
M-JHAZV*4?<50B&]Z%BI,6Q4^+=M9P,!(+N=S7JVH&SE/M_F0N@1U]28UZ-A<
MFD'A27>@HJW*=V?I#^5"'&N#-K9^8 #@M,GE%\.,OS9ONDN[-R6C8B>7QGSN
M5]-OC0G=63M"_RBOL/"J.JT88$K[BTG9PDB7R#V70%Q%(R+X2Q_[.<!Y*_"-
M041C">!*0C2&*:H58\7<HD[Q=UG3=U'[.)?=+E9$5UU=A.ZK4@XZJ$+^8#N
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M!6?Y3%,/4<UVG$:_U%M:-M7"V6J'K89<QLX;/U6'G:KUA!B!CJS8L"]V=9]
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M'6B$E^, ?6FI0\V!VVFI60G4*?&Y"4==ZL#J-FI!#-Q=  "+6[N[<6=!59G
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MO!J"3H^I/#YJPX""D!()4F4)/>7E:R9[9:P%OJ\XB@KM"J=4^>OTG2$O@RK
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M8JI#?I(TRX>%SZOUOX"(Z5#?/A7)=<TU]7B<#0"Q^H->&K>J&&OUC!CE0]A
MG!(8Y]\!4L=<G+F^#*M'502+T >GW%A#,_4/(Q.J "P 7R6:TFG>+;ZDMAQ6
M@(O32YA'V\HU)XM*!+@'2E3HJXAJP\HKT4).3 WQEW*O*>U@W&NH++QJXH7+
M,-7YZ@ARO4%6N!1O=+BZ0KY2=C1T%#AL[8TNHXR:&*?3)Y02H@;!OTQ"+>[Q
M+1-YX":NEZ8S6W5H*#*%\%40BH4ML+1 ^J/,::[:L&J55(G0L6N=,IRAN-=)
MFZEW@*?)J*N'*X/X?J3R^ND-*I-B<#>7;;B&+MNGM@(.02,>W$C9*M):5ZSD
M?Y;U10G>B!=7;*-^\8N .?:;>:[-[.U2+JM@?Z7NM/HCO*-6X*FOBQ$2,R7U
MD,D4T[1DL0=X)S0 'D>' I!GJGUQ8]5CIC.]P?3KYWB+,S-KOIB8UHY!Q_@!
MLA L6-X=7L0(.55ZIXHM42_%.B%C$]*CHC83277?#/8F,KIHM][?]E*N)$PO
M+>3;H*]$#=[\<YV1,+EN#3KSEEYDH/[-01*"M% 7_K:OKZX+=V=I3!;24LEZ
M)>(;7E(=RZ-Q;-YISJA"4"^I2*DHO G5^8XE8C02,,K+++7!#4%:$0EF!0(6
ME>KRF3;N9XU5X?D,0U-_#@86UZDB@(L76L&M2AKDK9?7*CBBK@CS1Z4'-RZ;
M$W72!5WHVS^4O*B4]O0%="1+6JHBSJJSA!5<#THO10]/H,KP:&K_:;]2"K1/
M6^]\Z9E2WL"+"3>,=BV6SK3:6LD*[;8(/QFKXX!YH*4/OWIYD:@ ,^AA5MS5
M!9Z/U@DK@ZEQ]H# NT71&G5IWDA/!;44[T*5MP>$-U=4J_849J*8NRSW5&2R
MZ%#"=""*6&B%+E>BM"/+F2EE3M>XJ&]'M1M**^0*C8J:$==UMD5QW5Y[V*OM
MTM[#PFAM7D\T]FK,Y&E<T(X-5&V$WFZ58C'AQ;K[T?3EPJ2B#P9YOC\L"F!4
M9%/X'2:<=Y\4RS>*A-5NSKSR<Y851<:66A@\>'XZ*$0=60Q*4U%\J8X# JK(
MY 62L:J0I(#R);IA_\#-5*,KR^I<921@)-= )9AI4S+* >FD*DE2:X&JI!H&
M L&RBV">PA(KLMT75;56=/%:6ZW?Y<W8T3Z:\?E9-@,3 ,)0W[UI49?HR"B=
MY)#I+&W%Q^I=<PFWGG3K6LVY9/PIY(IN,&QLO,[+;I'+=I<IC".>?IF0M[[,
M'GL9>M"J+Q0:R?B@%6@5+N>F,QQ3C@MI.!;3A&%2RG5>S$")T0*&REN_N9GS
M13B>58?$[>HL]TRCW@O6C):;,XP=ZEG,>G-=QV9>\2 U Z]MWR7-?VQJ7MN[
MP\S6BP_G.-PU*)WQGW+U6G;%G56)KI]2A6#JF@BU6Z,49@*>RE40:%],U$#"
M.B5=>9[FW2+$>$Q'%K+($QM[4WF5/2-K0/:Y0G],<AV!"+Q1+]!B#UV]^#:\
M7E/6,5 >)A$4Y?9 "QIDJ)W.DC#*FXPE513[CR-7E5 [87-74GIVT(I6%^=/
M6*MZN/9\/ 90?5C).7W9U"@46-C_*E*\O,L$-37FZCY@-$R;KDLM\2<VI%6D
M;V0Y[Y8/S=J>=NL?G>$[:(2EY;HG?7%NN)A&2$LSTD[%T&EGW'R'%CKW\/JN
M##'00?;3PVLUMW)HH'L6;9RSB_*W(CA">8IG3 Z#-&O;0"G%5:9S[7N%+Z@M
MUM2XV]0KRGN5,OQ!Z06I2'5%"%44I' @HQ%YHZ]3QKW"XYRP6Y>/*.R7R:IE
MRH?3R ,OE?S:H5,MN;%251NSY+RZ)IJV5+1,+Z*I5&#&Y2@?UA7_X"N5NM8O
M(^1!F]&:=Q%FFN8-G^&:H>N<K# 5]%O[O,<J1 WQZF$<@!K@4TC^6>GUNGXB
M(A,J2$#B1),X01(GFL1AJR\&Q9WT+$3)ZM1R[1F?,);'RE?!+]^ENKJ80 ?]
M=Q6;K]!%Z44;<3*SJ]>9XG5/7+PNP-IU94;4>ZUTUC6>3D>]'N(<?'9:5VAL
M7B*]+VI(K+KDG9JNHB%J:.BI:2C8>8WS:Y#%*98+00ULU72Q6R5?_K9DC"I2
M)ZK:4&E?73=JW:2(E&_PP(PZ*KLJ,DB["\3@2OEWZJ?R<DNTW3GK$Q"P.=Z9
M1Z.ATGANT#>D1UJT0E0J_K/S^Y-SZ<[J#:"SP^.6O]?6MIO^[X=/>YVSH[.]
MLZ-_#E5)(_C#N_+W@Z/3_7<GIY\^8KFCOTX^G;6.]S[^S^%9Z^/1Z?]L@NA#
M>WG0/Q_@V5>J8,-] C(>_?&CO%DT+$OS[WDC<J0[0N?5C!+>NY7O6AMI\4V=
M)Y15%8H*;X.NK=_K#03JDRI'J2JHCV^L--*XB&0LO* S_3Z[DZ$KLWQ 9X,B
MZ*;P]A<1 <7RKN6X([;1Q:!1ZKP>MU'TO-Z;\4KJ^36_PF"GJX9OJMB@:E_J
M9+*B&(*J6CD17;-;?G>ZHKK$Z B%-%E][[X[EJJN@56;LGB^H.OI+*2B14%=
MB@YSA55TYLUOUSP9Y:C3P'0 <!'PV&[M@?U4#S01+U[GNLZ+%^?#9N"3N46^
M$XLSZ]G?(M^F^+PI&'"_1*C#DA,_ @YL H:?ZA3!T1 O>$I7BKX]C,O(9F1.
ME[6]?Y7NHC$N0[^M3HW1%;VM=NN?-"L:+RCO2!G849>5*<&D#N?368O(TD)B
M[%6_O "IKYSBF]H?%.NF)OTR'DNE5)67)H!?GTX/U+3'9EI'%S5!97@Q&)U?
M3!4]JL*@IW.YZ@65'I0R?67&W!,PTPN4G5Q&[8!1$'NCW248Q*:!LW*'-%\^
M\8IFGGB<UD(OQ9@^-> YHBZ():G#P"9$:C.U5U\>Z5C-7.].KH)>44;N+EPB
M3_O3E Z@S'S%&>JL9\MS)47&I"9F<)0>OQDR#L:\D +_5%;*;B;6#3)=U%#)
MZ!Y\Z0*;?DP(A4J$J9(06*2:5+-3XK?TC'4'>'^^"1Q=UD]68J/DA_F[B"YL
MM =TS:NQ! *UN?EN8QN5V['8,D5.#>UM2ADIKG+OLJ^W5EU0Y#7[9F1W9A"U
M9LY;"$<UN3E]>]#R++M125I55K"=NG[Y1ISW9,C.].'G4@6A3C/_7"*H]-^*
M!IKZ)%:[N%(1Y3@-O'Q0[)7KQD7](FY#L^88?"M-'&!M$*?J345EPX;G7'DJ
MZ[N ,8:>0+Z)U:3R-V1455QNUCF>OR4J8+349=4U.D8NE$B#T8XZ7J-ZNPIO
MT&&V]0788NHEV!  D&73.T\U?M'5]BM-4C6] ])2!79>E3_\B4DZ77[S*NTK
M E%?FFQO-QQ<U3I7V])Z%S:YJ]OQ%1^WU4<3K?KT9Z[3=@)_[L=6VY[[V6W#
M M<%EG.O86__##A\G2;[VV&].PVK>A,61P<T@.3TGQUG9Z*ET*M-Z)[Y$KBI
M@-N\:C=4;L M:[-P93L/>]2[RXYI^VM%>S9ED*@].P4H&MNJC:2'V6LK3:D%
M2&$S#NU](4P>A\8W8P_ +-NZ<ST<98-%F'&ZY6T<2YDDDTUKUX1+9Z/V;0=)
M?[_4AW6 7K]&QZZ_<)_C17?B 0V[[T.$<Z'G&9ZNRO.E?V[  3_#PV%AFZ[I
MR6RD5C9[E[_(_AWP?@/)Q]^U0U;&.,^AH,>#X070=@/WEM&R(^@3;>Q&[Q:E
MO]$AG@"2MD(W/7W[(-UT TF'5=U\%Y6!&ZIA;N 94?>^)L(*E,0-W-^5;J^"
MU7\KK_O:7Q9U!C_4[<C8M5IQFY9BB:_^97%EK>]GBFI,=;EVE=#;[!59I;6!
M1IVI>E1E(K3JMZ#[1[[AL0[VG[C&0?>)F@JHF$59$=*XC-)W>8V!,7=4W4F5
MUT5]50NR#!U240CE+0V.?25QE\<NZG'=//U^,RCRH:ON=$4L$694MHHL3-6D
MH @N4'>$5;Y!45JT2M:<E:FI$E?&*L%/K.;E59;JB^K&LN$]?^AT$5U9\\YO
M2OLJYSP=JDJ?H[X*X2HWHRP7^$.WA\&BT'6H69'&5UW=E\=<W_'7=4_Q@_%-
M+T]$KW13;DU73_LER8_=UO+Y-]>3U[1\\J+V87?UR YI/O_UF$.KFJ4,&IOG
M6&N9I#AUZK8[\]1G[#XV^5-=+6!?U7:1X8"4/Y>[0X $="S11'0#AFFV7B*=
M%*W_9GQ>M@%43/4BM";2>:ORPI.GK:_49^(>DE,3U"9".TO:G359.'*<@/MG
M6"861T5 Q,L7@=\.QF;WQV]:M7_J5W4"IE]5%@96)>^K'1T/<ZW*[S8R"C,I
MB0HQ4'%=[X[^.OG8NNIB>["6OC+?G>@/ H.HL[K/*X I9[UBS>A[ZBX"Z/NV
M2,6C<@<^X@XTHQ.??IX[KUOK7EI S;(1_58Q':92=&NPU\5F5&1>'7Q3"P4A
MHZ*BH:J8DJ0_BY(_& U?)&HV8][;NC9S_=TB=+M2=L[PDW<#7J0U2:70[.VV
M_E*_[R/;RX4+-SS?Z&;[644WS^\JU2@DJ\.-5+Z<ZCJ&5#<.GQC%!2_KXVFK
M:B1U&/]+U91)Z )^=:D11<J8$U3T902"_F-& ^6Y85#3-\#K%QCEN&W7"I8>
M%.2U+6?Y$4QFU,<9%30H_VX17(N,ZK=]GSW"#H1W#.3;HGNLER]:]XPW6[=@
ME#E>1HO:V[@HNHV+<K9Q46P;%^5NW:+.L%:C4F>W;FG[98TCK/VS2+CE9BSO
M#2;H3"]M(X7T;2' 6 TM&KZZP_G=*9#G#K&T9IQM'^<YA#^HY%V!]F_6O&^X
M"Q_=8_EK") O:/LNFM7] Q3,&(:"MGFU"Z-DHOXW,Y)"S6&=X7(/<V//)QSQ
M+5)YZ.]%![,W9,WIP&[;SK^6L=Q[ 849XVG'V"Y5:+8AH2[3U)79G4V)31&D
M9HQ''N,W_%'>*_4'J@#B+:\U3][W27,$*W]R([U*CV\7+RZ<-TL5?,%HVUK
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M5/:6</ZYB0X&/][1CS^^.,<C<7GXX^O;\/*D=^Q\?7MD=\Z.?GT]Z'[O_/I
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MV/-![%D;#VZ8!&$040)P&1 6.P&)N/!)$"6>+3F/!+>1/:=O( Q[;@U[+MT
M,.SY(/:DC4K7D>.J(M<^AAZ%7DPX30(BI./#H5DR<1BRYX.SG=?O^F$SM'L=
M<K3J2X<-A*=%XA<>0;O_ 8>'"5;:0]&1IB;#0A@UEHY@"2N)>$B8$"YAH-B1
M, PX ='!I.7!AZZ-5Z33&'7W( 83S[S&[/D(VKUASP>R9Z,2$G6Y'4<A$:ZT
M"./2)9$'W!HF<1 SRGC,Z<YK9T9M,\.>6\&>CZ#=&_9\('O6&K[K^)$7Q@GA
MKBL)8Y02+FV+6)XGP 0/(S=4(8#3E<Q7PI[/P76OLPI@JP=5;%&56E#F&AAW
M_F9I_.I,.XTC-?&1]R[(=K8W/$ZMGPK"]KXEL67'O@P)9Q*SHR)*HLB)26)[
M/H]=-_$%YAC,</";&.:UY=6GU?XG8I@-SSX*SW;V*Y[U[=!W(PQH]A/XCPW6
M.N<N*!W2EHS9-! Q\*QEVJ=L'..NU# P#+M<AJV%;"B]2"0)(X'G4C3B'<(]
M.R")(R(WCKD3"+'SVIM1.& E0O9992!H(F]%,AEDLK@0: WYS]77+3*Y"$N[
M+RCC&,O&EFE_!/M7!#H.^OE?ZO3U<V=X]L=I?Y"EPYORIFBO+\9'.?S?$7Q\
M+(<7 U%[5$R@Y&(H>3AFBB0L\L(0VS=00>#D$\)#QR6@G=JA%"%0 Q92M>S'
M#Y7<5%_H,PZ#?H1K#(,:ZXH:#6,HBE@48/ZU[=@.6$2,D3"Q+>)0P6PF$L=V
M5?Z$_?CM7PQP;")P/,(%BP&.M06.6MVP?9\Z;AP2QGR+L C0(XH]03S7EHZ,
ML2EWK#,S-J;'S'.XWCFJ+#23F['!UAC 7N%8^DOVI>FJLRB4'34M)]OU+<$B
MBW@!!2B+(Y<$@>41QD,[MF*PJERZ\]J?58G&>(2WAE,?R0(RG/I03FU8*\"F
M#N4T)%38#.-%$L+CQ"823LKE+'8H-JMT0U/2;9LY]9%,#L.I#^;4ADR-8CP8
M1B(F\<Z&)6 >4)]8D>L%J@DE!D:P68'1)GGC,?E,F\*MM-_JRS*#HS5(6CQ)
MTF[*AQ*7WH.)I:N_PME &%MQ9H=Q>BP;U8Z;EH)O)0[S$TJXG<2$>2$G 0>;
MP:<@@3CS+19BMH=OTCVVE6<?^9[$\.QR>+9A,[A)9 5V3(G#+&R")2T2,C\@
M=FQ+5]K,M2*.6:33M=\,RVX%RS[R#85AV26Q;"UF 6!]']UP$HP%PEQ.2>3)
MB @KLFR'>YZ;@)GOSRCIMLEI(9L1\-61#\K[_HV3XW??>T!0U]KMY(M%3=P[
M+GZ]D7N5]A'0KBG*=T^ _M"T@T*:V*[-(^))4*Q #Y8D=&*/L,1S7>S"%UG)
MSFN'>4NK;+4>L6:/A5[/'<"V%\.6;B\:#'L(AC73@&()0$5#$GA8.3AT0,D,
MN,0V!X$GDL2*5$-"9C\\@&51\C<P9F!LO6!LZ3:T@;$'P5BMBL$F>U@!G202
MS&06^HP$(@Z(0ZTHB9PHLE0 [S*:&SP5C!7V=#F1DF9=!5++]H\]T1B-37-@
M6\1@%'7EU*Z963[2+)]#:&?MF6E=2>">"Y[)5X\:W?FP#5P_@3@;#\V6;<R6
M/8SG-SD/]R^>I_%CQ&L\^/)H[;;J[OK^K"6N-SO>IM*_E]DIRH3E>EGII&9_
MR+,^[%9>ODY19J7A6T;#OX.&'S>=K0(KC+J.2S!3#S1\(4CH8J9-("R6@!G&
MG&3G-6M[R\K06Z-K;(,^6XX^#_2/&O1Y%/1IN$EI(#PG9@Z1KN\3)KR(!)9/
MB1_YC'''=2,JL((J75::GT$?@SY/A3X/=&L:]'D<]*EU'\>*?<L6#O'B!'4?
M9H/N8PG"0V9%U,%#\;! ;/#@A!\3#W0_KCM(NZ.A%"L.!IKP VXU,B^X^JT#
M[<<V6 N*-K"]$&R?-TU61T2^Q7R/6+X/=FLL*>&6'Q.L#$&Y:P-P8RVJMOL(
M5^NW,</F7*S?<K'Q+#%M^V'ML2UA VOW@[6&+9Q8%A..FY PE#8&"C'"90"F
M<1A$H>#"%:&VA9=5.OCN_&"0S2#;NB+;8UO9!MGNB6R-C!O?#SP_\<&P]D!A
M\VU* B^11'!;)IR&,6<)VMG^LM+U'Q_9GE<4T09,<<-G^1Q"B#ZK7Z1H<9@5
M/Y<ZB"AO#4;#?,C[:AWK$NMAPF/,EIF(H@V,*'K SJTWY<Y5C36*/G9V8PG>
M>QJ[.Z->)+.31*G(^4F-X..74B;D_@[*\N58I?TH3N"DN$LB] "PV+9(9-DQ
M\4/A<)>Z5A)$.Z]]9T;$O>&G1^.GI6?:&7YZ3'YJNM5<X7(G 7ZB/" ,<)&$
M$?PJ:>RR(''=*(F!G]B,JHZ&GQZ-GY:>\F7XZ5'YJ2&?9.1C_TEBV7C[)D$T
M!1@PFD2.Y'82A,SF=Y%/)H[AZ>V.PC&AMV+*R;.0UVR;P.BIE.6""J8PR<#1
M0G T5EX]L6EHN8P1-PHCPJ*8$\X\BX34BAESPL#S$([<&1UF##>N)3<^E:IM
MN'%)W-A0M@,I6>C1@,0VV*W,]SU0#@*/>'!((K9]EGA4<>/T38_AQK7DQJ=2
MU TW+HL;:]D8!YR%<2 (CX$E66@+$EBA2^(H$<S%Z#GFWH4;?Z.JBS2_ZO(;
M_+Z\G?F>QY-FNQ;?KG\/.0 J_"O2'Z__2_U'$V"4_;LFQO+#<K@&SL82V[,]
M/:12A-2S"]GBL:YL?P.@U>H/AC Z0%D+)I/"S,XSWFU=\6R(U?"'\#B K*IM
MHFKB)VF?]^,4'@'8&TI5XK4]=]7%JWT*<[L:Y"DR[*M,=ODP_2'_O$[%\**$
M^L:W"L%FU5_A$<P 0'?N5]9E>YDSOA?-_^)TE5R(?1&Y+EAPH?"9Q\(H<$/*
M;6K#7X5KTV^>O5-^Z:(*W+@"$42B3/+OA">PPE>\>\UO\IU_CVU$+^V3YJY/
M;MA\8IV@Y\?;.7_FSNV?=$Y/WAT=[)T='K1.S^"?X\/.V6GKY$UK_^3X_<?#
M_S[LG![]<]@ZZL#OAZTIFEO-@7^6^;#U'E2!'H_E2&E.K5.9_4ACF>^VCOIQ
M&_A*M$Y'49Z*E&<IO#H99(JQ;B3/\I;L"^"K QE+5"_TK:]C[[;0?L?_VJ$:
M 566-5GSR[3?@F&[V(/RCSES^@T<]GAV#I1:<+JG8Y$05VL,4%HL+*G+KW+Y
MJOSASQ*7T[Z:F/K2I-(*NF]!^&'8#IP0:;^0<L7P!5NT%5M,Q&KISSS:=BPZ
M]V.K;<_][+9A;:OMV?Z]AKW],^]Q)LM<;W,FZ]&[3>@W:L\F12K=.4KDED5I
MB;E6RT+P6V!1=["F-VW]=OC,UQ\\[ YF UM2S2\IOT 8Y_.J1+KP^C?4X?5<
MB\+3X]/"EW7YB1Y?QM=?+[]V.V<?G,[EQVZ''KE?SS[<'*-OJW?H?+T\MK^>
MB>^U+^O0^G)Y3#OT[\NOO8_?3\X^7N#<CC]_L;_\^N1^??OIY\G;+];QV2=W
MRI=U]C$]_O7%^=+K]+Z^_>!VWAY:)Y^/?GZ]_.>R<];]_O7LD'V]_/ 3?DZ.
M3PL_UJEU_4W$24!#:A$["3S"W" F >P]B8!R/)M;OF?92RH)_U3]P)^HBH@!
ML6<'8L^C*ORF@-BO"L1D: L!IT)BB>5&I)T0+CQ.I$LC.*/$XKZUI)KP!L0,
MB&TVB#V/FO"; F)V!6*A&TCN."%A,<66/)8%FIB,"(V%\!W0S+@42ZH(_U0@
M]AQR[TZ&%S)3O9<S>2'[>?I#EN6\7W:!(?[851V;\7**_UQ*%MY&Q$*L5SJ8
MV;(URJ"C;>JN.5._&63P:[\5C[),]N.;UC"#T? >&&0K%Y>CHEOHW,/:SO:M
MJ_3W*)S=;\*L5CJ*H]HO3NH,#TI/;Z\OSNICVZM.#?25D^2,_WP_R-0'PV&6
M1B-U,W<V>,]AF*'18A;18FX:_B0W9+%GA1:QT:G$(N&2P/=C$OI^XG+A!G$$
MIABSV@^NM;-^=6<-]S^:H\1P_QIS?^V(85[$.(T3$OO"(8R%@H3<ED3X;BPM
M*EUF,2P@N"P+QC#_4S'_$W=NSV'!\).!@0V"@=J5X41^)&@0$S]&&!"132*'
MNR3F#G Y#V/'PX)[X8P[I<WO!+\!YLV!3.!OHA7)/OPT;%TA+Z%ETQ>M@?)G
M7 WR82:'::9"9EM777C;VI00VMHQGCIJI!'A6 Q!\/E7=J#FM K2?)^E@ZR5
MZY!4V(1\V.)9FF/HMQAE^,\5##P03:\:_O-B';53=(B_U[P%<D@]]7Z,L?[2
M#/@>V:OQ\Q&,-/BAG@ 1=9@D,C;2:!%IU $I5$HC&*<K__OCS=?/XBJB#--^
MTLZO+^S+V7=8TY>?G8,WL$9<ZR$]>=N!??KK^_';-Y?'EUAN<<\].8-UGWVY
MZ?PZMX[WOG$_"/U("O3+1X2YKDW"V T)6+I<1$[BAF&RGIX20XW;2(VQS8/(
M(MQ- L(XUHR@-B>VS]S(HS3AKK?:VT%#C<^'&A,:,1I22H0E$L)H$!'XS2,!
MLZ7K!5' 9+CS>E8YH-__82SWYWG8W$\K1))!UN-#&.OG\-4OF0T$SR_NRLR%
M0=%@4["OE2I7)!?M VOG^YD4Z7!/JW,'2IM[KY2YTA@W?+P8']=N=]L)+$\(
M1J3GQR 'O(!PFUDH!Z@0">,LYGC#",*!_FF<;]L+!$NP;0P0;!P0-$(A?8\%
M+&+$MB)*0!0 $ 0V-F)C,I&N*QPF#!!L*A \L1?>\/P:\WSM;I<\<%S?"XG@
M 2<L"26)/(L2R^&)DTC?L5S@>:OM;(2W?8N<F9@A!SL]XAE6H,!HP#LZ,Q?A
M\R6H_@O>MDTS? XK_01?QLNT7U*\Y6D?[?L9W&X8?4%&3^=;Z_"<#>^Y^7K0
M^0Z6>J]S<,2^OCVDG;=OTJ^]H^O.P07,Z1,[_O7WI+5.3\!:CSQ7@E9  B<$
MV/ "AP124N(Q3TH[LGR/1@@;TSD3?^PN1J)+4$H-B3XW$G6 1+V$44MBXV 1
M.F#6NB'\9$DB@MA.(IK$;AS.D6R[ZC9S(3)]^K@%0Z8;3Z:L<_V-NHXG(P>L
MK,23A+F@>W&?<A( Q-K43X1T%)+>%N[P.\?FEELKFZ7%&)OE?@Q8.RPCG_,D
MH0#E41 3%GB<1)9CD2!F04A9P&CH8N<Z]\XVR^-Y(19P-FPYEVZ6(F>X]'Y<
M6GL3@3F3T$;#@#)L",YLPJV $\&CQ$+-*';HSFM[1CSOTW/I_<.U;O,5SHCT
MVT*^WBS-U_#U_?BZ]AC:5A*&-'9)R!BVPDHD":/ (Z!L<=!< =G9/--_T8ZQ
M*XG/W;ZXR%,Y''9U,*Y4,2]W=26N(A+M.A_>&O<S@_GK]>F0'F/Q+H'E;^9;
MO,<'__2^H!_PK//]Y.#H9^?ML77\]LWWXU^'UU\NOUB=S_]<?#G[8!U?3EF\
M=N?\F^N%7DA=2K 2,&&^C$B81"%AM@02"B+*?0\!9%HQV%U-J*XAR6TF27I\
M_8T)VT5W(8G"""Q*SQ(D]")&/"?PG<1E++;4+=ATNYK"5;B*NU5#EEM-EIWK
M;XX;4]OA%K&=*"#,<1GA'"PJBX?2L[ET@))FQT2:B,>G=1C.YL6[<J$Q2N['
M=[5+D$46CV5L$R$#09C@$>&^PT@2 ]Q:KF.[7H N09,\O,5LO7P/HV'K5;!U
M[4-TF8B"4,;$D6&,?01CPCT>D]B.8QHSYH4^1[9>5FE&P]9KR-9+4)AO"TLV
M/+X*'F\D_"=10B/7(KYC>X116Y"(!G@!;L5A)!Q)V5JF'SR?4,1W,L]?M0KO
MNJYC-D@:P8DOSWG:_T/%**Z%"_$NZ8,?9=SE>9XF< ;CU3W>9(/>WLG^T9T3
M#-\,,D"!\L[!8,%B6'"R/]]\[IR=6\>_/L"\/[&O9U]P'+?S&?;D(&:=7W_W
MCG\=.6!"7QY_?C/E:#S9^T9IZ+I^:!'/CWW";(RJ"2-&A!/YS!)@$[!XEOF\
M(C>C(5M#MNB,#!B(/>I%1%H6D&TD'1)%TB,RBMTH$* )V]YLLEV!*W+!JUM#
MP]M/P\[QAV\QT)+/T&8+*-[LA!BBY7G$\6C(?#?V)9#2S.!;$]2X3=J0,8_N
MQY>U9U,*1ATF@7\X:#),-8[V/8M8DB;4XXRS@"$G3==$-<&.&QWL:+AW8[FW
M=F &H1<&(G*)18. ,-<'[K6Y:OL>),#7MHSLWT7WFR#(Y^"B7"=%VO#]_?B^
MT9"%1I''/>!V&KC ]SP$&RZ.21Q&":6!16/+P>#G!U<R-Y&2C^_IO!JO*ZF*
M$6Q8VK6*AFXLZ\%0,5FC09=H,)BQ(&;<4D\-UO2]\_GCY?'EWB]X-[S_8_?D
M[#M:X=WCLX^77W[]!7O2[74^=Z:]2.??(E^XT@LX22P?] WFQR2(0TH<WXG\
MT F%&P9S[(:US] VU/R<J!G]29$7V&&8^(2'#B- 98($MA\185EQ)*-$NG8\
MAYHW(9?;$/1S(FAVO/<ME)@O$S$223LD+(A]$M$(],6(R<0#]3&@' EZ1@YK
M^UF&=QK]"AC8&&;WX^+:G9I(21,1<>*X;J@C_;E/7>+Z7F)[;NQ[U)[#=R:8
M;!NP86NU58,-]\.&1OU+*@63040B5?_2=FP22A$0&0H[\2T'Y')DL&&+L6%K
M%7^##??#AMJA*ZS M7GL$,>G$6$Q&* ABVSB>$GL^(XCN</0H;LFV/ ;7ZY(
M\ZLNO\%YRMOA9).??.H6XG,=VK9JZ[7"0J(8H%NT%&\!!,K_':7#FQ9/DK2;
M\J%L\3@>]49=^+%LXC6K*?G&!/?N_>!I%]OQ 2:> MZ=RGB4I<-4FA"Q15OS
M(?Z5X2C[H?7U_UU8<>^?/O\<CD[@O<K9?'E^ WMB=0X^N">?W\#^Q-;QVR-8
MQW=8 [RK]S7]?[\.KT_.OMLP'JZ5=<Z.OP6VY?MQ$A'/HXPPBS$2Q*Y+)&>.
MY0M&.7,W+#S7$-[:$][ET3=F<RZ2@)$XQ% ,2X8D\H($_N/Y41!X@8L-+^8&
MV&Z 1FG(<-W)\-?Q-QYZ,7.83ZS(L;#Z24C T/0)M1ES610'@$J_B^Q;W /\
M+.)QUD3;F&X9;)AO4>8KG;=[WVR?RD!R2B+J>X0)(4D4NJ Y1*[P73]PW"">
M'4NWNI@:$VFW?CG^#^E19/C]L?G]IN)W+W&#,.",6-REA#E11 +N2>()SZ8\
MLFS/=9>6&&QXWOAE#9\_'9]W:KDNO<BUF!<2QXUM,,=<GP08"N%8(@YCT(,M
M.2]2[5F'R:[<JU@X%)5S$1A8P$@_^!!X:+H,P/I';^R#%O"F.[C^;RG.955
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MVFX\(2&E"8E\SD,OH5XHXIW7GNW.R$A>71K&$]VI&/A9K\4M #\6=:PX"-R
MV2Z3H<TM/W(H]8,@%D[(%?S<Z2+8P,_RX:?N_.%;06(Q : 3R80P+[))$ I.
M'-_RPYBQF'-KYS5SPH<W;%V_++#-4>CVXAB6,\Q;F8PE,$'4U37I[V*VWR,E
M;K.A9UF:3[GI'ZL][\AA83X:Q%D <3K[#86'A8['(PDX8WL^-HC&5M&V0^!O
MH>]2WW=\3X?N38>@+(/<MZ7:Y!K+;,,XRV.<6E1S%@*>"8<D(5:%E2"E0RS
M(A(_<'V+1584 N/8X<-CM]:O:.3FB.JC_@\@\P%>A]X+KGZ?KK'9(+,LZ5SN
M\PU@BP&514"EV174#L,XB)V(4$^&A-&8D8!R2BB/N>7&B>>X'$"%VLN2QEM:
M?&6-I;%AE/LS2BU]F2N$G]B,L#CAA$62DBBBH,5ZKD^E0Z67N#NOJ>.V?6,H
MKXZ_BMHI8W=\QDA^1#&L-GQ/[;/1\.^!,6GS+L"V FJ)D AJQ83YW"+<BGT2
MN9+1).*A[\N=UZX]HWJ!L8PW0A8;;GDHMS0D<L*CP&(AB?P8&]HG'@E :25Q
M ,?+7#PL;^>UM[Q:'VMD#J^W$#X;#'EW&4)X/!=BX=BJS<:<^TOH9I^G_J@G
M!L/B\RE'G4&B^R)1\PX_=NT@M@&$;*;ZN 0."9(X(&$L/>ZZ,@RP )F]Z_C.
M#.M@U6;TQI3[62NY;GCL*7BLEO:QQUS;C@3Q(LS XT%$(F9+T(UC&C$O -TX
M0!ZSW&!I%OCZU?)9IVJF=V7']]G@"N9SL]NZZG+4!_I"A21>83K=0^P6HQ8\
MDEI0GMA[/*^]OC@L3^MM-LAS@V$+8-A)\^I;QCRQ;<=&^)+P'S\DW$\HB2SA
M4M]CF-^]\YKN6LZL:+]5F_A&3WA4/<$PW3*9KE8<(M^B<8#%_P*.%4$QUDV
MAAX*ZOE2.DXD(E0< CJKT>*:5@5]%FZ$=S+/7V'^_J@WZJI\?"&O,N >U05
MZ1&\AQ4S?ZD_F-OV%3D1Z@,Z:)P/_-R51;N&O<8QS<4Y W&+0%SS$I^*T(OA
M_T3$$B"..H!NW.(DBG@4^A8#H/.5;112<XV_.:J#8;-U8+-:DP@]UX^HG9#8
MHPEA"6<D""P7^UO&MB\IC3U[YW486*9CREKY&!X<*6\<#0^)$)B+1"8>:<'$
MG;.]9@U<3[(XM&V+>(X;$A9;'@DBWR%.DE@R]&W.$X0CYLRH@6M\"9NO$!B^
M6B9?U352 ^E:CL^P0W 08:2?10+J^,!<B9-@EDI 09L.G.7%V1MWP5)"_X ;
M0/7MG[>ZDN>RI?:%#!(R@E\>'H1@Y/SO8IO*_7^'V_\1)W.2?,JEN@ U@+00
M(!V.]UL6"0\ @;PHQ+! QR6!S0/"J15Y%I5>0$'0>X&Q[3=5E!O662KK--J!
MN8!@-A7$$3[HR)S&!,O4$Y_[GA"2.V#*[[SVE^#Y-Q;[XFER^5!5U&VE_19/
MDK2;*B>_+M=[W_0Y$[=_]_2Y8O^/^GOE[N?-:JZ /H-8_16LB[\':7_X#SP^
MRJ2YC5P,DHZ:TIQR-^ 6%V"Q!ZIUC4<B:KO$CIGK"Q9Z# .9J,V6%2IHHOQ7
MD7%G>.O)>*L6]Y$7@>ENQR02TD8&2TA@"8=0-[8B&;M"1!@D&-*'APB:G(#%
MV/#M8""NTV[7F."/*-3+3388LA"&C'43YY;#F0LV HV]".1S*$CD6 F)?3<
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MR"O!$:SE'E1Q62 (KB";(AOR3AM>EW<L?7I20W6/4=UH^XX+>)'\$6I26%B
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M+NI- IFV7(.7=3>?X1(\&@<87#FPE(,0<6W=76TW7X-LLX2:F)J8;JF8%E&
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MW/X^M[A<,\TE0?;,@%*60YU>"TJGG!2S.23L'6[OP^S%GW 71Y$>#)Y2I+U
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M7;,W^T&>IX5]B4F>7(H@DK-0G/-B;PK,8&,4(K$4R<7.WM1J:1LL;IY#N\K
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M!W4>5TOG7'LZYS@$M#5Z642RE5],Z@BTV><:*YH].Y9.(ZF%2.K9O.,@BM_
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MXS): /&N@/C:P_\-Q$L \:EK@%D$9DWQYHU#4*J&$XE;('0.)4GF0@&Q;TF
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M)1@6T"D&'KWUVDBEA5I;YU:=4X31NJ3O G"7'FIHP%T=<.<:FQ()<M$ T\J
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M,%*Y&##<@0\^U0UT)A#9V@Y;A]=<Q7YIV+^+V%^=Z]*POT+LSZ^@D-&[8@&
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MUA_%UBF9,;#5YUA?Z!(*.M68-Z@.^89K\</@63>?_SU5*=]PXO< &UHKAD"
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M0H95&9M#+_"+OY2H[1#KX"1,A@/C_*XK ._KF53C)#K?Y5A[%0^9=]T/$06
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M*KE6TUY14^2D:BON<JJ\?+093,]W('=/J>O(5JE.7D)KG3]P?>QWB=2*U%_
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M>\'2-5KD98RDM>!_U((WR]P$+/@_*A/^STYEPM]?XZ='JKG=X@(]'G9]"TZ
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M2(EH<CH,B RL(G$:9(&B@08A #(@7.- KV  D +]ZCKN6]%C[A=X:X'K S9
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MD3I^]H)3O@6T?/$\5V4A5<,;7ROBDJ(N-,>HDJ<F<*0KQ$J'_8G]![_)&;
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M'5?(@1T%V3)!ZN"8DV9EC5T3JU]437RB&[JOZ8[MC-Q 9U)VW(@0BIM@-2"
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MUBGBP7EDK(J(@(@GZKU-6&>"=U.QTY> :)4$W"0!HKZ_%Z@+QHB()-,)<9U
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M\\NP/<>D[E +XZ7-GYA+\W\+I;*WKK"I' RZYV77ZW=9W]!U^5]-_M5<A5_
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MJ$#G7J#CIT%'Z2"<#0H1D8M+VAB0L<(AP@,.U+FH/%E98^KA-[Z6B-\\Y![
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M\DFYD+@RWON5-7X]._2?#X//%YA,L=X> :D"^'PP7/YZ\DL( @] Q!<YW_E
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M W*-+%.:.>D3<23W<[XY:KV<'+G:])LVO5G?<\8:P0Q#TAB7-SV?: +S49(
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MBUXD,:Q[/^J,BG[/F^?M22[%T/&;4XR=D\:&S_UM\_M%O?EQCT?%F3(4=,.
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MH0@UE$&%G+AR/SCNV/X^P,,87V61N?<$RC;>[JG=;N9$BK>L;HWU/6M$,+#
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M_%54G'W>2JK<I.\79[]4$6/GD H0.SC>^!^JKT8@)+9&&,.G_ZV>T0V0 ($
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M^&4OZO#)X<=^AE]HM?ILY8V[_E(3UCTU 0M+&N/3=MDW.EB/=-K+G7GQ>_D
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MGQSBS#U,'GPE[WY-#G]O<GBZZ.3PMY.]3_S>K=0+RTJV\&9$&O>F--V39VG
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M&IE'F<C"$.P\<$A$#87+ 86SU-(0FA)/-OG N7!8<P>:DB)C6'A#?-UB^L(
M<&L(@,P+S91Q" <(Y7D4'#FF&3+6::H9<2'1R:?L]YO<5:-@C8*+]. ORQ^L
MLQZ/"(J?AZ (VYPXM@[9)#WB7@ED O6(<NJ)MDF#$<R@R&M0K$%Q"4%QICKK
M9_,-:S!\1##T0S ,/,@@@D8L,(TX]Q8YD<!#) XG'X77U+VR$'E94Z-+S_XW
MF2TW]PF/J*T?1)G;?_I[4V@NGBUX (?F'$]8Z@6M%[1>T%>UH(MI01[/<+Y
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M1:.4=Q;[P!0S6O-<V@"PE9SSG@2MB;ES8#&%_' $074Y^(,1Z,=X7L DRDS
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M<44L7N7(C<+78[XV7FDK''&8<,Z]-$X83T320FE.B2^2>:DX^/T5!SMN-$_
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M&B!IDDD+&U"@R2 0?PXY8@GR.C#IF1->YR#%35I\<,O#WG,8I\\0O.:Q01>
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MG3W BRO[LP#V^,&GW 4H"U N7%..AH64"ZTK3+EG&' 3,-%P1IPSV-*[<;+
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M(6:H05P*C'*Y&4042\%2K0(&+8:;36,6Y*-9(B]U 8*EMV4*$#PJ$$S,&6-
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MNITR+K=R85FXL"2!I<J%!W%AP@^*PJ'&$P-1$ 5""%):E5$(,G"A(T/; ;E
M&5VW#_*$:DSI"8?(K<Q&SY*X/Q=/NQ+M7D2[-$J.4:HTL0R2)!*$\0E\R3>V
M$>4B"Y.RHT@TNBYJM&B)T; D'E!%PX/1,':"HM3*)<_!"<% 4!/0V$';AQ)#
MLI4Z9"41#6J=530L,1J6Q FJ:'@H&B;\(*VCI-X)T$)1](,T 8^F)(C@A9)*
M<]'$@_@Z2LQ\H&$5 D*WZAWQC3[Y=]G\6?'Z3,*%,B[2@*(N%;5>!RJ,DIZ9
MI+*8WJ)^7E!8ZS,? L)+8]NB53HJF4&*,G"72P&(/ O"9UPP42XL\0A"QM:U
MG549PMR4>\]P+WFU<5*;T:PT3L8NEQ<DTDP(&*L+1 (#EY(&I632G!N3F9M9
M,YJ*DR7%26U&L\HXF>P>(4HQ0%3@A';HG.D -N32<3Y*XJ4U+-J9-:-Y*IR,
M/+DKC:6I&+9E?6B+Q(G3YWB"L7=2^KQ>/?\[]%I<GN]<HO%QYX,M6J/)%JVF
M]K*U61K0_UI:I?]5>J3?H?GFHG34K!U55_SZ:T?5NW54?=P^97-WL^X\X/?V
MU[^@%O;-\YONY[6S9["DK\QQ:A:[LM:5I:Y9Z:J1?2<C^_/D%B#'AR]E2F -
ME6AD$S2W'?,0<+'UV@>J6%[;L*QMR*(T:'NB^>>5G2O+SOMM451V+@4[Q_N=
MQ!!IC+,0.<L@A-)@N4X04PPY*>>])&L;6K6G9--6=E9VKB0[[]<<N+)S&=@Y
ML;GK@]$J:%WZBQ,0V0>P'O^1W"<3K"2>I[4-)=K<+ H[5R%)IS8&OJ^[_;#J
MA2?DW^5&?A6",^Z/?MH L 'ARP_&$)I)B! #<2"<D."8M>"C=BZ)1+@+:QM4
MZS:_XRSE6JZYB)1X8"%#I<0246+K@A(I.8Y28, ($TI/O PH$ FRU%$([O'_
M26D(RMOBP9MTE1+S3XD'UC142BP1)=Y=4$)1[:RE"F2,JB3S1K J.M!)>"J(
MU\RB1V5)6\@Y@L0JQ'!KT^!Y\9Z>K7U?1=^,T??WI!L5J)/,\PBR:7^5* ''
M(P%)@V<Y6^:U7MM +XK,:@;F'.VU5UH\EA=5:;%$M)APIXR5A-,,@2ND138,
MG-8>N E",.=XL'1MP_"V>7#-4Z7%_--B5MY4I<42T6+"K5*:&^TY!,DT""H2
MH&084"9X7&0$S11M"XZTN%XK_GRT6(585.T@O-R!J,N-_RKE9DRYLTD/2@4M
MA)(.@K9(.>$C>.,2D"A*&19*BBS=<C1OSZQRLVXQSS$E%B<052GQV)08>TY6
MVA@8E\!E2=JQV8%11H!7U$>>@_8Q-)/IVK*&JU> $HL3B*J4>&Q*C#VFS*PV
MFE&(S"(E&&-@ K,@.+$D*\-,I&L;EK?)/$6K5R$0M:J=AI?:31H]U)-^&E2N
MS9AK7R=])&>BM5XJT#P*$#0X])&" 6(]M>57&W*Q?D1;\#G:"JH;QROO(U5$
M/"HBMB:V4=#<$4Z"Y)RBZ6,S&.$-I$04%29(0]7:AK)M4D-+*T"(Q?&/*B$>
ME1 3SE&2:"ID"IK(!"(+!U81!MH9([)*//* A#!M]> LO1I.>M+^PP_>$IJ[
M.W+[LM9IE[AT-+]?V^1:N;H$"">3?B 3B'"2,WI_2H-(7H.GU(%&R]]$&0,*
M1ADZH]HS:TLX1[O@%7-+CKG:&&J5,3?V92E/26BF09:F4$(C\$J#!O A*>IR
M3L38&76&JI2KE*LMG"KEGHQR8W^<.4Z9M1*D5Q&$]PF,MZ7*5EOON* Y\AGU
M<)IUL/*?Q\YW$_XW=KYLG)_<-DI3OQ,V_K?YX_#,?/^?&Q=GV?S]XL4GU%16
M-+51AD$KN?XA>M9X<]"5'OO7K0-WUOI2.IGF?N^@=:-:'XYZJU^V6P3J-"&6
M*&6%T=J(&%WT.26:3-;Z-O-!9Y#)_3(<G[@N_J5W<HSL*7UT46LO=!38@BKI
MWK_W23CXZ]"]MR=O#M[1[0-\SZ>?#_8^O9+;FV_)[M>_.GMXO+V=K=-RG.VO
MW4]O-K?XO[^^Y5L['S\0QH*F+(&52: YX01:$CH")=$&ZAQM1G5>-R7^NW7<
MNZ,DH)F*+!>*4HX>NP@^YJ!RRDD28[P351*>3Q(^O?V0;+8A2@DD"02M#+S(
MA 3F@^%&Y:R$*-V>I\E"+[<06NG@J-L[2^E__LLPJG\:C.IH2S)XN?'MULY^
M:N72"?U+62#+IV[:TFMU!BU?GEP+Q0J78$10_W,Z;ATA1)L/]D[ZPP\W/8_P
M#1^;9NNQ-%LOJ>?X^7X*O8^'2$'\?F3;WT5(\+-(\.8#1ZG?#*8X#,W/G5Y<
M;[FFG ,_@*^T<)E'T2N_C7HJH<"$7J%N^8+#\H=<WGB^0S^\OM/S+O!NU 5^
MXL1N>>T?1]V<XDD?5Z3F9,\0S8-648OU5O'SFE,HIE#K%*_M'TN=2;%JW0KN
MK\CO3M\@TKUQA$82(7%E0$1/P7O/(04BK XD>:%N[%ZT?B]A6IR8>Q6F6PO3
MWUN;KS\$&YS(5(!2F8%0UH*Q1D'6*5GE/;/<W]CDIJ'4?>1I<2*T59[N(D^?
M/VB4&1K1P(S1HKVIH@>G90:CG"WCG[DUXJ9V*.NXI ^.$O[R)77/VJW7AZ%[
M4IRVB56X$;FFFP>,5FT7]COI2_.4&R,@'#</?[".2_7H#[C$CJR(&]?DTTZW
M>U[/]DW3]\E'>SYN@>NKY@:EN-,KN=K#Z5EO\M!??#T8G!1?]]U1[["\BD]B
ME>7[#,_U@S&<:$49R& 5+KZX MN T%2XZFI:(!J:QOWKVEZOV&H-A:?(ET]H
MP@Y.B@%<#%:TKL_MR7XZ<)W#QC!,_8-B2/[OI3V&&9AY$S*'NA!>H"%ZVD,M
M2(=/!]8W)\>#8U1FO- K5/WC_ ;\@A=:;AVZ<SMX*P:K)W)X+'3A';/"HKOF
MC(\@DO& 2Z, 7#6S-EE$ZMG:1N]PZ$5<W9%JW[ %-5?[4]<=Q^ &^S?XC<C.
MWKV=Q\:)0S=Q=#@4752XYEOC^9L3KC!XD(0+2^L_)ZZ/:CC^NK!?)!_/XW#B
M6YHO;K=>XO'*$G;2;5S'<JQR&:WA930+5$ZNK&+K-U[?\(1":9H<<5$ZWB]?
M5%2GU>T=?H0&"=V.\YUNY[B#/ND=GNXW*"*%Y"XRF1B/PIAHLM)HB!D5 O'4
M3-_$NT**L)_B23>]R1=;Z+^//?"&#^]P#1V\+,L[HF&GK"P[> 8_=_$6KIQJ
M?S[=WGSW@0I!92BS6J6PQ?J6X*CDP EB/'B/CAXNM G7W".\U8C2M/;<6MKK
M=GNGS>I4'F!K<'* VH<'&5Q5C=X8\#=)^XN[L>G\>O$+/W8.8;@W_T(-9S@.
MS^;2G$*\+UUW-$@OSG_X*78&1UUW]J)SV%Q=\Z&K6_['O:.?3COQ>+]$N=ID
M&.D:)>&-CC]ZN=V\="4 ,7Q-LK8T\L:729O>^-JW#DMYVQ!^K\-^^S5%[O?)
MY3I9?:O#WG*DY1(. JR#(%?\^E=Z$.0-B]@WYD#>I31CQ:>/VQBI\YSXLB$H
MO8F1,?2PH_4L.2&G9[_5Z>./F1G2D]OOMS_O??K7YZV=E_)-,6?97P>[GW;%
M]L[NZ9N=;G=K\R7=^K2]?_&9\\R03Y_I+OOC8.O@;=D4%-MX_+WW>YUM/,_M
M3WBL]^].MS;+-;Q"4_C5Y&!$RZ5WCD>(3;6G"27?EZ.S2[W,)**J.+&V0=>M
M>7"KBP4;[E5A<EN8$&>M]L8Q*8U( 1U:HVPDD1-A(PUD>I)9A<F2P&0\*9 :
MD74,'"2N+R""9N #,^")<M$JE7)D!29RREYMA4F%21.J9#D'60CBDF#".1U\
ML,YE(QR+44P?G%=ALAPPF1B=)TU@7DD*ADA6.I(:L-EQT%)R7&&X4"DUEHE>
M&)BL0GUI'9UW=^:57E$Z6"ZX="*3Y-'Z)B%X110QRLC;9W(^=8)&!=R= /=Z
MTO5R.1.O3(8DB ?A<T#4>0J*$IL"*=9S7MO0O'8B76[MESH1YB,/+GDAT=CA
M00=B?+96$A+4=Y+]JO8OD/:/?:7  DG66\@\2Q!2H/:S3"#;*((ET3I5QC.0
M![=;K]H_U]H?8_2&6*I8\"(K[IA141KIM;%)V>^E9E;M7QSMGW!N5.#61:O!
MV%SJ\9@%'UP %KV,)#%KM5K;D&J>:HY7(?Q49]A=NAT_/+T?,\"+_G]K\.SC
M9BK=[D2WK4G/)CM+"6(,A*,.1#02G @&:$B2:L<M=7)MPUYO#OAC[0NX)"B8
MA5-34;"H*!B[.4Y&M&M,0+]&61#4,G"6:\!GKHVPEHC2")!-<7,J"Y:%!;-P
M<2H+%I0%$TZ/#BKX*!4^Y50B.J8T(6$1T1 RX5FK$,W:!K_N\SP+"E8A6%-G
MRSV'B_,\TV JN>Y$KK>3#@U#PQ47* X\);1B!(G@,I<00L@Q\QPI02M&3IF[
M?7MTU7W:^=;\10K35,U_F.:/_9?HC*%&>."L:#XC!CQC')(UG*2,#]YE]%_H
M]>S8JOG+HOF+%**IFO\@S9_P5KQRS%*J(>#J#J)L7WCM%629K PL1:+BVH:E
M#W%7:G2F#G:;RVRRR53:KZG?BVZP_^1C6BK'[LFQ=Y.^"R><9:\I)$4S""4<
M^#*LB;&$MHM)PI4YE4V/0?;3' UCJ5NQ\YEJ5M&PX&@8.S>$*T%D9F ]E2 "
M*5.:2JPF.JHMUXZ4YF$5#:N AEDX.14-BXV&">^'B!BUT01BD 8$\Q(LSQQ,
M3$GPZ(0-;A[1L I1F]OT2/C&!+>[;.Z,2J)&K7\X/I38.RF=?\ZO<K6+%6D0
M4A#/E/=:..NLLB&%+'5 W5&,/J0/92U6G&]<[DXZ68IQ16WBD',);4?&P1J.
MX$2R,6F9MEZN;;!U2F=5S3,[S5R@O>:*H]K5I>+H)AQ-%!<E5SHB4PC)6A \
M6_ \$%#6!4N"H<;R&75UJ3BJ.*I]82J.KN%HPIED7B7EDH%4)B,)@R:2=]*"
M(SXSKB57>E9]8>8&1U-FE]5^J\O7PG2A3G:F_5878:?DO--]:]3JOM54L+;*
M")%6F2'2:H:(W*')Z*)T#JV=8U?\^FOGV#MUCGW<GFQS=Z]N/R7YSM>_H [,
M-T8HWVM3I8Y0?D0?ANU^^AD_\_)T]^N_.EL[G\GV)GYZYZW<_K1[NKWYFFT?
M;)WN[;SC>[]<]6'V.EN_E>/^_&GKX/7P^P[V]K<W/S/T8<C6IUVV^_5G/*?X
M^4JCW)!%8HZ@8FAJ0' AP!CK@$E5ZAM33*K4-/,V,XO2CFY&8?3*SLK.&]AY
MOQV@RLZE8.=$7V"NO"[][;CW$H3RHI1/,0B21*(XU2P@.[5MB\K.RL[*S@<T
M0J[L7 9V3K9!3HX1[PB$$#,(IS@XD0UD;Z@+S$FF3!F V6;7![S.*3M7(4>K
MMD&^)_8>6+U21U4O"00OM4K6@CF>*!J05! 0)%.P)I7.R<)[$9*02J]M4$O:
M>E8)#0N:DK :D'A@'4N%Q/) 8NQE,LJ2,C9 2)2"$%: (0P5)&L?HQ*2"K24
M*&%M62&Q I!X8$5+A<320&+"G>+:&,^Y _2AT9TRUH-#^Q*8T<&XH!(5I>VZ
M;2LQ1XQ8A?AM;;T\+Z[3LS57K.2;+?DN-66V-"BJ% -*HP;!- 'TG1SDF*/D
MA*9<FC)KT19\CNKY:JGOG+M0%1;+ XNQ+Y49CT8$"9PS!0*7%323+ 7)DZ8Q
M2\)E,Y^B;6>UZUQA,<>PF)4K56&Q-+"8\*E2H)Q*1P!7#P&"HF7A>!! E;9*
MQJ")]VL;@K;E/%D6JQ"%JOV=ESL$=;G;8X7<;"%WJ06TB)X%&@R8D$N%OU+@
MJ.* 8F(L0UGA"2TBJGF;U8&=*P")Q0E!54@\,B0FND43&K16%+0T!BTA[L$'
M(\'K'+-'<9'6U1#4ZD!B<4)0%1*/"XD)=RE[09U7$3)/)1O:T#(2RX.VQD>3
M56(^-Y4DI$[_K/VEYY1L#_>1YJ)9Y$D_#2KL9@N[2]VGC;#"ZZA!EJD9(D@'
MGFH-0G 2?<XBVS"/?23K5O+<^DT5',L+CHG>U#I[S;T%224#0=!*LHHR8+B<
M)&-80!FIX%@A<#S<EZK@6%IP3$X9%4DY:PQ0+Q <B4JT.+($7&LBLYHH+^82
M'*L0CWI@Y^H';RK-W0VY?4'LM$M<.L;?KY]VK7E=?(1?[J:MF)64(;V-+T,7
M<P+K$@&3K7,TT,AE7-N@G+3I@S,*YF\;O5)NR2E7.TJM,.7&'JZ7U#MO-03T
M<T'PB!XN=P8RQ\6NS P0TLRHHU2%7(5<;?U4(?=$D)OPQ@V3)B?G(%&*]ER@
M&5PF";B267 58T !F$WKIUD'.R\W[QZ=W#8*4[\3AK\7@>\<GC0B>:F#]TAY
M-$/M.NH-.N4-+_JIB^_\DL;=MXMF37QJU/";C#_B_*#7/3F^^2/7^M ^/2!8
M.2<U[K<[O%L3_^[WQUUT/R;P_>0^HQ#@R;YPW5-W-EC[Y^7VYYU#F+R!5Z_]
MYA[JMVBS?N6I#?59LT1<#LK01(3&1=DGIB)G)DE+3-DN&A_T$>YL<\07G6-\
MCN'2O=93[_6K@Z-N[RREUI_'O?"Y]?M)/^PC_5J_=]WAM9[RWVPX_SRR\CZU
MD/6]5B_GU&_A]W_K@EH_E)TZ1GYZ]>?OOS<_TI]^7&^=[G?"?NNHW_O2B7AF
MN==O(=Y; \0T'K?5.^GC:G1PT"L75XYYW&LEU)).::*?1E\W*,UY;ES9#D=3
M'RXM:EYRKXB@0D56VH&:& @:<<)Z2:1-X3:CE:>L;_[[ZYN_NKZ=WZ7?D4;I
M3?ZEN=KF!N*"7%APL6H!6]!E:^_?^R0<_'7HWMN3-P?OZ/8!ON?3SP=[GU[)
M[3*YXNM?G3T\WM[.UFDYSO;7[J<WFUMEE*' _WY@6@JELP-J10)AJ0!7&A!F
M996(1'E9QIN:ZQ5,_UUDJ,A3..GW\5:V#ES_<SI&><-[W4(I*:]UW>"X==QW
M9;%I17=6/I,<2N5_3EP?X=8]&TIX>?FHR:IJM_ !]GO=+HI$/&F^"F6PCX?J
M')2LDR*E=Y/'+*)03JG 71#9)EQ:A4[&$9^$#8%]8_[<C,RL+?=WY^#DX%R%
M_SSQ@]#O-!;6'VA#K;(0[IYN;084PB@$M1X,T@*$IP:<E0*\D,Q%$Y+AZ.5-
M:=YV(83GO&I"%OJG0:NPH*#.]<_66X>]XX9N?X>$$O2/;UGJ,Q$><HOA/ \J
M\_J.1+T\0)OO>.%-\H>(%9[;!R<XUYQJ8%QF$-%I,#X0\#(8K<ISC+J(U3J9
MDD78ZASBNHM\.D3$X6T\C*[?.DNNWVZ]QE?0?BYO6Y]8*0^0;T72_,E9ZZ"'
MR#I&1^IF6$T=!S6+Q?/QYT*-Q&\X].E-;MXTP"7U7!Y76?+PG#]_<(@&].<E
M*,(\""TMF"#0"V/<)B,M59*449=3!6\H&*UXTBR+C0Q>7B-;/\RA4,V"9S<*
M%/ZXBZJWTG*U_2E\D-S%D+D VLB50[O->UPW;?)*"8-^F QHK7U3KE"&&H[]
MV+[P(@8H0#$-W8/B0[1.$^)K#H7L@ES%AG\]&)RDN-FHR3 E?R@W%ZMB8^B?
MNP#H)PU667[.MG8^?N!2IV+.@)&E94'0%GPQM!1/1N.SP2<3US:X6A?V>FNG
MD0"MWU$PHD]16<E(UDZ(F)TC)BNI0S!9"$:_D\Q8!>/1!:,L6%)(%7P$JA-'
M-] %,-IG<"II'[QUE*&I).DZM]>+LL[)4DJH[R8;.N#W)L$08E0$$HRQ7'IG
M=+3"R^R_DZ]69>.Q96-[<^N#MC0DJS-8@A:-8(*A8Y8U2&0(*B[)O S*E7)=
ME1W.&V3C?/>IK#R#5ED!UEM%W1NA*<]VO85O.TJA[/YVS]JME\<764[#/6Y.
MUT>?*T&*-%RCW-%1OX>V SH]W;,["M\#-@8>W\2^; J]_.(ZW;+3_FNOW\1>
M5EDH\7T?/UAB!8H/FM11,0269F"4-L Y55Q%;3A)N)*M:\O7&;T>-[E@UOF=
M;22T@W1PAR%=L8?:<[)E?,=-\,V$;D,_Q=:D[#4[QD-6_Y$&Q_U.*+MJC9BU
M&LD;S,G%?G-__,U)'W5R='EA\O*.FLOK'(;N240^M$HZY=L3O&.Y@V^]^98T
MS[^\^6*G?;/31QSU^FCQ#,5AN*&.4@3G3G\KGK^G\?Z;,VJY;K>%QSIR_>/1
M]E2G;.$?XDDT&9T(NF.'5]0?M%L[*&$7UY'/=Q%\:@7\P_E^IQMNT$/ZSTGG
M2]F*.&ZA@UFV>!"3S5;/X-+[C_<[@_-W-'NG%WU-\+[@ZQ=?.-SW+Y0<;IC%
M\WW;7.9^CC9TOY3P;KF0N]%54.UU8#1&ZH7VQ@L2N0@!114]A<3NZ ^@H(2"
MVM,>2F@ZG/0ZSY_I#81]WSG>?WV(DMJ)^ 1^:6[% -_R#D]_E3$JRLYKR$%J
MP1+@4FO0(8BXMA/+@(?HJ#*,IH0.0>\PW0#0J8&DR<W_T:9_^7VTY]]NX2(V
M709/NL?G2_F1ZQ1I;11F'36@VW&^T^T<GR&CRWY<..FZT>P(U%W7: $>%(]_
M@*H56_ZL=5 .=]0]*QLGY?N'T8%R-B.)/[M9UJ]=4YE14?:9$9OG,8Q^.NKU
MCR=#%Y<V!J]<X3!UNU''CZ.Y%Z/[%,NDW=%WCC!QD%(Y\'J#Z?*1V"FH]B=#
M'3Y?O/!#DR?9G,#01#H=?\L=W7B7F*46UT^/UE[.+F4=T!X/VCFC2)Z/#<@[
M=HM>834/9_@=']#S9EDE!4A? H(35EKT>(@RNVRDB&C(EYX;Z_C*=4V?*LDH
M8PA6U,S3\_G1C< -I;G1J0ME^F; Y8;4J ?*86U,/I>R^&;GY0=\KB+)3"!Y
MZT"@$P96"P'2*LMRY$FF9DZ):+/K[F2[]6<'S4G7[YZ55:'88O^Y,.YN-@@;
MXVY*<L.UY(AP81Z,X#H^SHVF$QIA#8J_X:[>#.%R=E=$/T3I"<.#196%C-I1
M-*6X%(D2G0WSM_-+9V4PG3NBJ[X7@N>SL_O!.YUB$!RD<Q:$9QQ,"A+03"(B
M<Y*]1GOI^+3W#8I.<5?V4Q?7>;3=T;6[NZD]&X&Y.:QS)WEI*/KJPE,9_.RZ
MQ:->9<FA6YM;'Z0W O^7D7.^-'DHB3:).+2T$Z&2.9HI8H]+LV[LE.#--/"L
MC]S<8H+.I\0TNZG%T1K@DEIV65X?_M(4%*^R,'S]^"$9$A4SZ&PYDQ CN/RY
M( @PYWEBP3,3T1Y3ZTQ/"<,,O1=<C'RZY";-RR[531LW5/[WVL9E%VD8XGZH
MRX)F XT"S0F#=D2T/E#"<TE5C9%KZJO+LF JPK8VWWV(27'-2UL+;7"E54R"
M,8H#=]18H3ECR950MV93 E+]\<[F<)OBW/L^ON:PP*P<EH=)8758YE(2M[^^
M^I RM\3[!-3GC+!6L620E4(T%G+*,;M0TL@(:?/K&8I-NL50!DL&XH7G,0XP
MH"RH9@>ZW=H\YR&U#^"ALNA%6:<B"U(X2[WE^+MFZ&E9CH;'; /NE8>/+H5\
M>_/U!Y4YC80[T*7-#SY+#3YF#3E)SI02N+SF4N^]SLF4:-<S /&!8EB!.(^B
M*+8VT7IUFF>ARG/3$H&(=JQQ-( VAA#FC8G,HRA2U>93$@+N!T3S " &8A//
M/A"&+HZ1T;DD\6]6I"1E5GRV6285B(\MA:].W^Q\IEL[K]C6UT#*_K9)PE!.
M%3C.%2 +"1BB'1"%2[<*3!A7&L_+=2NF[&\_ QP?*)(5CG,OEMN;+S]H3TR0
M4D(@JHSD1HET6GOPNG1G8Y&HA*"TJJWUPSBYLW]5*/$-@PM![EP)[U\NU1I&
M'B^%.2=".24"B9_OI]#[>(B.?FRY02O]760,/_ME="ZE2GPB$CHG.Q%WS)=Y
M.0R^OCXLI8&=+XM3+?JND8F)^''GXA+*_O)ZDXO2"9TCUPP.[8_VC7SO\*0D
M?X^DPAV7M)0"@2;VD?KEUU;N'+K#T,&#?NPA>\[+2O$#9ZV EYJZ*33552@A
MJ7PC?B9U"D2&R2Z]_D2T^FI8O=UZ?;E^:WBX 9Y?@ZAQK'M]^(T-G4MA[$?\
MJD/$\P2[QQ<]$:=LI1(?*N=7"GF&^M0$@TH$/Y?S:>["^3EVFO30H4)-/=Z@
M$?4KZ0#_>ZGN_3+I>?!$TM+--3HAN7+4IJBD=4%8ZC2=NB]P-8X33_I7XC@/
M!G_SSU]#M1VRG:X<L3_B^;S^$(G@-A$&UL62^ZP8.(,VK?.N9"(;83A?VVAD
MI<E>O=KF8/T\C!A+Q==0,"84KK6/P"QU80>N24B+G<$P9-DDIN!OYYT,QLEB
MDR+9GN#1I%PWB![<IU+C7A+Y.)6QU>:]M:CB>6Q]"-2BZ1 =*&LCBBI38#,O
M\VF=Y$)+95(H0:0;JW_N6KQ!)3KFC*"DT"P$-39H&7C4R1)I?/Y>)^KJ.LV;
M&+&MS;<?3)E$*$0&$;(%(0C:I<@"=&ZLL\RKK$1"=VF=?Z.,[.[%'DRF$).3
M6@0K@A!6&^:\HN@!>8825=WPA9.EG8\?9"2!,N6!).%*1D0&8YD&FAA/*N/2
M$DIJV;K\ABQU#F]3$7)U'<SC9M%WSYE8I$7P8N1*%;K+3G:36,%HLC+0!,SR
MA#!C!@POT4)%O.#:!F+CVL9<K8A5<)Z!5DT4Q<=L<P@:(G$>1&01S?R0P27*
M$_&<T""_*2S/L^Q5@7D6@=G9_< ]FD=*1PBX*H!P@H*-02)L:.:"VHRK7A/\
MO7%QZX6F0U*\Y2IWJ3#I?)_M\@;<#;MNMRCAF5:F,70GRU[?BWMM93]P):U;
MV?,H^[+46,8<?1 \ F52HJ^ G+0Z! @FTTAM]-(W4175%M^,\YU'[2X4X#YB
M]L!UMXK97(I9@UA)C&$Q@\K&ET[VZ(T&1R!ZPHU+(00F2G&*:M,IV9 WB-F(
ML/>1M <NV%72YE+2WFR&#X9J= ^, ,XS+N9!E:)QEH!D?- 1G[-,YJ:IHC<*
MFKD2[9K:]/:;0:/APP@:@2H9CS9JH83U1EKF**/XUX@+[ <JY-H3AIJFQ\BV
M>\>I1>6+89'+J/OP-\(?4I2>1:A2>&'"F#*[54<GC0J!>&KT5.O@LO[\CBI3
M%.8P-O+_>P_U(1UW^D/=28<I=XX'FYU!Z/8&)_VT@]_]<Q<-G&<6\NW-=^="
MOK_]=:^SB_[J;LF@^?2:;+-M%,QWI[L['\7>3G<?CT&V?MO^O/WG52%_Q;</
M_O5I^^M?^/\?S[8^O>6[;$ML[_R\_V9SO_OF_:]XOF]/=]E;VM3Z[7S\P)Q#
MD(;&8BW=I 4!SY0&KJGB)A'B?1@2#R44:5%VTY2(IMAK(48B3%1.(8:%80H-
M7BL$OC\A.HY*,^4^<F1C=-='O02N]WV>_Y#I]";'W[\/E^\;Q95!$IE#%KA:
M9.^",:&,;E0:1=[9M8U?1F'44?#S7?O/]C"D7AI1'S9?[;JMP8D?=&+']3MX
MA8,C1/NP1'I8RCRZV4=#/1B6#%TI-CY-YT&HUD'GL*Q$^'%WO'_^X6&%VWE,
MMSF+H0Z-=G*/W%G+M9IZYF$@:C^Y[O%^&'8/&(P^/_Q(''Z^::Y9RNXF>@4?
MQE$$*R8\VUC6K';KY\E3N!:)#KU>/W8.FV+NIJ)T*\5.\[VG^PDOMC<8E**]
M=NN\)?+Y[7$7-Z@\DZ8X^E*YW_G%7IQG.;M]? C=L^$%7)QWNU7:20A"?_C\
MX_#SDT<<Q=CNTC7T7M ;6Q @[[#1O3F\";],G''1RE_PH?UQX3)>K/QJY:#X
M5KQYB4NG4<I)#N@X*$#]1B]>FI+,;6ACV<E8,A95>TKJ+,*G6YYWD:E;N"]7
MO6/TGPQ-@2@4!<ZYLX;F9)B6QF0;O^>V5%&8I2C(-V\_!.NUSU)#)@2=VF02
M&&,L!.^(B"I&.TP5;*OOB<)M7(RK3BRU')\ZL3DJ0:PS%JU.JFR,C#N4Q>^X
M%E4:9B@-^+VG'XC0D5$1P+A<4IFY!"-E!AV3])GHTHEN;4.UIQ1V7!$&<Y$T
MU$^E]S2N/#>O*.<NZJEK?BX[@+VRS]<T[\$U,0U&&X"39L.XT+V(W;72]YMM
MA9*QAP?ZET-;IW_6HJ,=R!]*/^RCXV'CJV*.E,2F81^ASN''']M3/)D[&78K
M.^A#D_D9]#'5S/VNV7K%S'54FA"TCC$(H:DU7NJLN RXNAE+^'S-_ACYBXV6
M-!YCZX\+=_'"&+V#*#^N=_MGV$_QI)O>Y.UT[LT61@]V2KWT:CNS6Q^B*3$Y
MI="%C1&$0S0[K01$E9@DSE$6S%7G]/F<RIVF@\@!LKQX/H6YAR7-NMF=0]$Y
MAW-QJ!KI[#72Z48MW"8B/+@FO/GE]:C%97&<NMW>Z>#%_?A[X/H?D2(CH*IF
MQ%PSMFF,VGY,_3(BJNN.!NG%^0\_E>3$KCM[T3ELKK7YT-6A4,>]HS&4VF0(
MIM&(YM'Q1R^WFY>NC*@:OB9XVW)VX\ND36]\[5N'U6UN^;V.^NW7%+G?)^NY
MUG-=IG,UMSKJ=X:VWS3]\N*M5%Y[[Y19ET.+;ZXF0IX;(OZJS7'SC-#EO1E#
M2VR\<3_]KGQ'5FX[T'"NAZ#^\(^ROH_<Q\&/MY"*&R][M'+C&ORBC'%$_Z@3
M6^=7L%CR4>SC1[\5-ZK5JMUK:NN]?K)[;1YRK^OMK)BHF%B%>VWN8@G-I\%S
M;4.NN;;MFS9!7MQ&NF8D1'>1M_J5*_R5=W9!0DAIP5R0/U/_2^G]4)3PUK/C
MIUPG:2W"U?[C09<X>6G]<M2YNK8[!)^C<4FQ'(*C4= 8G+(YJ& <99)(&6^1
ME3(UPCP*6I3@\DBN2OQBX2/+N^__-=C;Z<G=G2WR9N<MW_WZBNZ^?T>VV);<
M??_KIZVO;\G>SBNR]]NOW:W-73SRZ#/__M>^/XC=-Y^Z^_@>N;T9/VWM_+6_
MM_/VZ^Y7_([W6U^W-__H;NW\\1F/=[K]:?O@WU^WCK?^)'__W\ZKXZV7'Q+/
MB>0R"KD9;A0= T>E T<,H50QJ63)B)X2E1XE9#Y W@LE[RCW=S+=KGSE5817
M^BPI?72VL51H:F6B8)$;Q7,9!J2XRSQ2>XM$J$J?1Z3/V05]/*-><4,A44Y*
MDXDRH$%F4$PHZPC%)UB2Y=K7BS$J?2I]YI,^3FF664I1D2"DTB84'CE&=!:!
M6G>+Q+M*G\>CS_;8]C'<"I,4!Y0=6FIT"!@J-4B+)A!Q+!'!2C78E%3=BI^*
MG_G$3TI<:!\2XRP(9[2E+E-'7& Y)DV_-\WJ:M[OU]3OQ6:.1H72(T)I;!))
M)GF4D@"Q7I;QV!R,B!F"CLZPD"PQZ)#]SW\91ME/E4N52PO"I6ABS$)$(J5
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M!F8RD];J'#PO^OK@B'#5U_G5UQG$,*J^/J:^CM=7(6024KC2Y*CH:Y9@:4B
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M"L0*Q'FZ\'EMYE>!^*1 ',<ZH[',!:\A2\U*MP,)7I@(D0BF1-#>13K=9:Y
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M3J+A! JJK2>!)8]D)8'X) /)5JL<F**)YB*[7[MIOE 8STKLL,+XZ6$\\3D
MG<.H B<N^W*PTS!BJ6*$@M/>,XUA%R\P?DB#\PKC!8;Q_;,B%<9SAO%4BB1I
M\ R4)3H%2Z2SL72VLL0F)RQ$'B)7*V_H->VM*HQ?!(SO'_17&,\;QI/5F$;(
M7(E,+*.!R, 5L=8GXBAGGM*470H+!.,EJ_YY:'C_?-OS/(?P?HJ":CKRGF3T
M:3K"1_]?1B\,\4)B:*"\)S9+20P77EAFT>5 GT+Q!\DAU$Y;"PSE>87X%<HS
M@?)4E4@R3CJ(1.-<$FFM)BYR0 MCB&:G,L[QRAOYL$/_%<H+#.5YA?D5RK.
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M5U7:FR?M37P^;BG5W"B2E"BRD!D(R!R1 #$<SAE,]ACXFE7Z#&CO)]G+LXH
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MWT>_&V^+=(_*51J7]-79%6/:[^WTX7 7UY.2I>QW\)/I51/.A=0? @ZGUZ1
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M7/K=M[G& \GXU#N<H]#0"XF8WTUH:%;,J0H-/=#0O)C]F^(F':Q55C(EDV-
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M.2/V_*P@(E"3L)DP,(Q(75(;DD1K029@D2DI%%Q==EBK"UX$6!^FDU %Z_S
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M[DE1$Z#)$I%*859,/IEK>K"T$(F=,KVX< M_3%9=& \L+H<.#,= &.ZU!U>
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M[9L0^B.\RLR\X>_7SV;M[7C2*G'=BKAFE/2"CYZ;$(F4MC@X^(?+/):R01O
M4= LE-JA%QAMJ=B^OZ&!ML,!E-2/[\-7)ZG?BS#8JXA?0,1/F2J9EO:B!DT5
MUX0T$G$^"L*9 Y#"A!3X"J+;<L;_M4"H7[;XQA\(CH+;8JB<9;:4I!?\?9.C
M50,=3Q'HN,!>;Z<F!)EJDI5<">IV!#6C\&6#U6B1*.)TL4MRD?W)5)&L.??:
M1.ZD:X0':_/C%XSAAPQ^5 P_#(;/C0Q>]'R,"@1Q+(@$GH@7Y2S%R9BH=AQB
M6GG-U:I>( PO6T!D:[B7^C7B\?B)(V7<*[O<BEUV9G)$,LV9H86@LBEU2U(2
M\)J2:'5BRC@92G]%1N_/+C5JL;CX?+BDBHK/N^#S?/=/E.NHA2)E\(EDUI'2
MT9@$FZS)+B8':,&[^^L/U?#"G8'V%W0FI5[0Z?2.H!N630SM-IU.'\P6.)N&
M-Z>S4(GG5L0S(WPFE*32^$C0$-#E&#81ZZPG06N1%)5:A-QT/63W;VY:HP:+
M"-0',PHJ4.\/U',+P?DD@3%%DE&*2(U_ (*TM"/6$),TSH4&J)<S+)\$J,O0
MD7"[-X3.546T]PD1+'$+U0>S&3;32VE[\EC<,R.)9'RPV>5,/"_G"U$$XFWF
MQ AA$MH('/]>>:WDW*('SZ415,7UTYH8%==WP/548H/18&W,!%>H(-+YTC53
M9Y*HH]I*ZB/HE==2/!]<+Y4P2[$WICIUO+I)X?6].E3?I,SZSI[8@]SDLAU0
M_=$O%=S#XU]:AQWH#G]I<F'2_XW:AR47K)Y</:+E.=4[Z716_BAS\J8;WYU.
M2-V\;K5YS?9\!A4!#&=$*B6)%)83!\82H2EZRBH))@3N7OR*T%4]TWHQR'T
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M%F8HTAPK%*V3*6(?G+W!-/DH@'\)_I:<MW>YW-+,OS*I8Y']*W4!I^)>6;&
MK6KUMGKACSY,67$-+T$7R0X4IIVSE*" ?8XV)AA9&T$9<3BX@"E():+D!SU_
M0#]&T%8!]+)UC9Q(+93@%#.40M7(.T1DI57(>$($2RYZG982A5D O=* ?HS
MK0+H9>L2.7@K<1Q!OD+PMP! XPQHEG*I%FT=YB3FQGCT.?;>7&EEH@K>RKD?
M=N"/&K87 #V?8J=?-;._4XS6B[&'/(86,?/+_C59N\).B['3X;S^H"B/PIB
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M(YB<4>6T!EX 2FJ/+D4 9D?FC+*N=ZG DAS&7B:O]0805 Z:RY->;4T?)Y&
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MHZ]IUY4<VW>=]F%%LK6<-"6T.<])CBT#;7H0XR00^,_Z5X/,W)GU*VS*]8O
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M+XXX_!(WRG'S@*AD*E52!X$1QYHC35U" . $(@8+VMJUS?,XZ']YR"V:\?$
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MB8=CGC&2S>/"(8-C0,I%%B25$N=&PE2P$H;UG+'));%.Z20\EEQ[Z90P/MF
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M P/(Q/AK>>.]<3?T1Y//7UB+OP__.<*^^T_/OC?CW>/?NT"![6:WU6EU_^G
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M,4"B*8X[\+Y#UX,9Z(#IA._=\;""X#"R'WL1_R-SCO.UVH6V&-5*5H.1*.9
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M)9!U:\O8*NU"8AIT!23Y/Z-0R4I/NVZFRY ATEC4_8Z+*6I84\K#.F@59 4
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MR&4"7##A!9(9YO ;E:E(34YYS%D2=][3VP!0 T#/+&S> -!M 6@:./=IRBR
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MF6-T/H,?^O& "TN=T1YX1]B610A%FIL,*:D9)GDJN53!#[V<-[H\-.2:\]X
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ML,J^J-H6OMW;6)ML'1^,.JX:B]"WLI7,&[<Z/6$EOJ(_&B:=HEL,XT"L7&M
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M>!YY5VK879UFM-6R6F'R.-4"?NL-!_U.IP'D9\F*G[?,SV#R94%O0'G9IR^
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MS<!',S(NEOB5N?UN#X^I$,^UW;&^NV(7S!5B<X4QEB7$)FJ,L'X7I9-EF&M
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MF(+]':#I]?G:79H]MQLG%G#'V9>PQ\>/,9\8[KH\4U!8;C^ZAV\9%=T?O;"
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M3E?/47K)\ARGY;&<E=-//%@"-JMHTGU)>NE?/P&2DBB)HK@ U%56]:EV:J&
M+Q8 $8% Q+__[V^?1C]\@6XZG(S_\B/[$_WQ!QC'21J./_SEQ]_>OR3VQ__]
M'__V;__^/PCY?S^_>_W#\TF<?X+Q[(=G'?@9I!^^#F<??_@]P?0?/^1N\NF'
MWR?=/X9?/"'_L?BC9Y//W[OAAX^S'SCE[/9ONS][2SU+5I'$.2<R2T:"=YE8
M*;70,;-LP__Z\&=F).=&.L*$ /P8".*H8R1%"S1+%951BT%'P_$__ES^"7X*
M/R!QX^GBV[_\^'$V^_SGGW[Z^O7KG[Z%;O2G2??A)TZI^.GRTS^N/O[MSN>_
MBL6GF7/NI\5OKSXZ'6[Z( [+?OI_O[Z^B!_ADR?#\73FQ[%,,!W^>;KXX>M)
M]+,%SQ_$]<.]GRC?D<N/D?(CPC@1[$_?ING'__BW'WY8LJ.;C. =Y!_*?W][
M]^HF8IC./G_TW2?_ISCY]%/YR$_/)J@0"';QQ[/OG^$O/TZ'GSZ/X/)G'SO(
M?_GQZW2&<W+*^'+&_[G\NY^N)XY^%.>C!9VO\?O57Y<Y#L$ WV8P3I#69]B;
MM/,W%^>O7ST_>__B^<5[_/?7%V_>7YR_?/7FV?FO+PZA>?N E9BQ!^HK+I69
M+^<>3>*-#XV*]DVN^#OR 4:+GP[F4_+!^\^#5[@)?(+7D^GT):[J9Y/Q;#B>
MXZ9P_AFZ!0W3GR%/.EA^[KW_!M-?A^-)-YQ]?S6>08=4G(W3S5%>_-<<?_TK
MS#Y.\#=?\"-E)YD.5+#&:<:(X[@1R"@ML4'@;N"8-#8*:1B_*885OQ:K(?MI
M6"R)%?2?BGQ^@M%L>OF3A<0(9:N5\3\?@<:E(APNCA6D\8?KV08A&IN=1SY9
M)?$?X,2%'(AARK/H* 0-+=BV <M-\M8T_:R+/TRZ!!V>+3_^\!7*2; Z9I;
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M3AUB8-0:Q8B)$64FHB8VZ4B 9SR*F***^S^4G?^XAO#AVGIW]^^GDE2T6%;
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M]M702B%.HL[/_/3CR]'DZU\A?8 KARC/H+MSSH[+[=AEV(RFA M0DRPT6J3
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MWAZCEJ&X%5L3\@^VHNX;J1$K6EE6=R8ZQI>X9ZA&+&D9X/U]X=%#.OL"G?\
M;^:? G0EP7 TQY\N*[*=SV?3XLW@CC;0C'LJ9"DE".6AK;#$:\F(,HHE"LYJ
MV^3%XIXXCPWFW#/=G7E*W#X.@G ,I)(DJ2B(M Y(<$P3J@TDG4P4;2[M]T+9
MI]!Q2ZV['05J)\JZ^2$EN]>/5K5>%^#.9LO,WK(COI]<OV]>/<HZ0[ML_ &6
MCP"=3I"%"X0EDXGTU))%V,QF2#D$:5EN\@#E>.A]BE*?4B]/+/3&T<L;C[7\
M>O7$_<_7^\>J<\#NB+6&U7'O5 >;8P^-V)A%K<RS>R>\]Q>+VFV'&W%'3MB8
MS0=0W50*%4(;NX_=F+?M QJO2XK@(3Q:_6$=!FQ"48^Z@S>P&W]>D])66]-R
M]!O!;2OYX0MA^W@U.;(3YGHL6OQ;>O <RYL[ ]5DRG:4E=SJJTD&3G@;#/<D
M!F>(#,P37]KV9C!<. ,^A2;)1%<(CG5.KG*<KVFR- OP3A$)Y0D^!$4LFL(D
MYQC!.AVY;.)LW(72)Z?V,)G?=@N.9'?%,F>3;K9HR':%@\OH(D,?QYG2)5T'
M4SKZ,>*HHQ:LCZY-A^>[4/KD,]81^Y'LKB;VO_EN6,[1:Q@L,71D/2<TZ$"D
MY8ZX4L3%J&QU0!"9-:F:?@=)GW*4Z@C].&8W]NC73TL__?AR-/FZ2$G^C*?X
M,FSQ:IPGW9)==4[\G:>I;P\<1F%EV^E6^*D*4^\9LSH'=\%>CUV_^E*AKUQ/
M3_+-$[-*6L,!D]1DZ.'453-?IU. S5-_ORQW_GP. T=E-,*6,H@BETQ;05PR
M:)IH2&  ++=->C#O"O#8XW#7>?X3?/?^ZV3@3(Q,*4D$&%7JT&;<OR4CS"JF
MI&=20"-K?R^<_3*;&^C:[9.VI1RKV5Z[@GR#J_S]5QA]@5\GX]G'Z4 )C[Z
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M;+U-R'768B5=WSIV Y7?G98:;%Q$K,N6-YZN8M4'\&O#('48\Q"Z-APXN.W
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M<$ZB$LEE'Y.@36X 'L#5IP.]HM[<WK%J2J?:.;L"50IU0[G#Q3_8 "THHYT
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MQ/6J)W-]7B![-I[.?L79V3@/+'B9!*DQ)$]FFB;_SR?4S/@DA"Z6_M=>8=:
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MPR&I?UYC9N>'YG[QU@<G?^7PE]A'98H5M.B'D+63,4JO)09MP:>4K-^+_06
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MM1K.E3O,=<HE**:"R$Q;ZQF@Y<Q($90,VD1LH@P;,'T/ULA.\K^K&K9WU:C
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M71D:]R+>!G[3SY?#\SP<G=(@%U^^O/@X&7^:6T.+(E^UD!?HF)BP-;$ :_M
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M:631-PUN[2[7'@V Y7S(+C".-*-^*P;6)&/O(KZ&&?4YBPB>#$H/H79<$<#
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M-,63.)U'R :91V>A8O>D[MJ(FBCM,BL&0"5OE$Q-D@#W 7W$FG8P+AO4,=F
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MQZ$#^PIY!?%[QR)O^D*U,O?5%G<2I_/BA8/ E= B([-&U*X7Y!I#THX5H=%
MT"JYV&K[6 _K.-2A1]&O2+':.SIY$]XUN"%.W^%'^#+O0/FFO)T,1VGX$<Y?
MCE[CG[,/G_'\$_XZ'LW.I@.?O5=H:06+B?3:ERJ8VN4FZ"*XR[4F8VO%V1KU
MPUP@Z$L'-JA76_X:7='L#/Z_$"8?/H\''*4SD2:C\]8Q;0$88!',V1 <1U'
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M*@#4FR-*T3 ]!H;& Z)W7D"7%:!3">5OKWW*%N<> NS10?F&XEI+N^#HN[7
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M:O]J.,=@<O4@Z 8E7.ZB6O0 [X#K #58[P![&(.L#_+NU8<])'^0A6%Q!R0
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M#*T2JX#;@+XP;9UMPC_S@$RGAI)]7#'27B*O1'.Z),IY&9#&#E0I&KS0KDY
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M8$#>CYITU-++)=%#VEQ?O?KZ=9GC?*/-^_FGS^O5NXOU:HWGE1%PYEV4684
MMFS.#E?'60D!-HG"O<G)9MLA)^SUI2<#K;;N&)"4HPJZD:Z[I$B22FDS<,'(
M'L9'<(+LD5T2.NED#><=@-/O6T\*.0T=TH";8N](X,^+9?Q,/_QS2:'RNT+_
M^LOB<B(A;::Q#@$,F067"P=$1CNJUG4PI5,4&A2FHF?6QFF%A8^J=#(XGA@Z
M&G!K[&W8?^#?\R\77VYRQ8NPBLOYU\WBQG6>)86"MOT,(DD'BAM%&G(),L?L
M?1#%AR8S&%HI=)J8/S8R!N0,V9Q)C71Z]65Q06LY6:$R6EK+%.N0N96 $)T#
M&Y$SEEEAW'<)*II*>3) GIC#M]0X#N]^/U"]G\LZ="1=ZSOC!8W+/()P=?B8
M%A8"Z@*BCGPM3BN#D]R^=VIT,K"?%C:VH'[OTMX0"WJG5O3+_\ZXG E74E%H
M@;LZX*9H R&0KC$&*RTWA@4QPA[^F)PG ^?).7T+H@^NVVTR@K>KU45.;RZ6
M-Q=QE_+>G$&;M.$ZH:B]I3/%7$[*&1#<4_)@HZUSF3A$J5&[R(-.3?K*]Y3W
M9$ [IE^WX''OFEA=;&]RR<OE3H/5R2QOS]/\VSQ=U(K?^;>\K.]&_B)7SDPT
M,@5?.STBG0S6AAH/:>"<5E+P26E3.FR>!XAP,A ;TU5;(':\BM5E _\/)J;+
MF5X?/^/YNTUXOMHT(*W>7E?FI"HI%*W)I-F"<K4/26&FD%WDY +M[7=+!$>.
M9'LJ>#*(GS1RMBR1@^GOQU+TG[G>QN?TBO8'_)0W?_B&DMS?<+[\+SR[R#,=
MA<E**>""=@P5) (61O%1MBZ5Z+CT3WH-/6J!ET7V)+"W914>5%3L=<!>9QF7
M(9PIF?'L)%B4#)3G$CP3'JPTQA3M4]!LZ%#H)PE.!K(C.FH+OO:N//86>V.[
MNKR^X5E=6+\@R1_SS#'FF!4&5(R5@2-X\-*:6D$*I1@K=8I#(VV'+"^8:^F\
M+>C;N_YW6X%- EJ3@A49J+;UOSVO;1^S@EI:^@](3_NM$K3SAD(".F6%S=FH
M6!Y[4=?A:TX2,T.8? L<CE,<^Y%9;NI[/F='<;, K3" THE!0&\A!IZRUD;[
MT.6=SD#BG!2\CN'"+<\8CE?7>C3Z_&VQ+'E. >=-EL==REZ: %E["8KV8W#>
M&)!1BQA+"9$UF=<[HHXGLP:FCI\M:^7@AVX?XN><+L[R57GC(:U7N]2^I/AB
M$F52E=-+%E]),!(X(SUP%T-]VN\=:T(9,I@&8\U&.3:ZC^+QZ8Q'Z1MVWU:>
M#%+9N=^5K1^S(?3'8K4CH")3F6Q2&;NCCV #Q>DRY$PY88M5T%BO8[$.'@FL
M]\=,3@8TS;CJ-B+?MN=/Q9\-,_UJMQ[7DTDZ:-*>^' (58XU3V9"2-M*L'<T
MF$P;^$D%;H7@X-#:>AVCP27,(**)6"M L33II9@ZX!\=CG,2>.^#CB:#FNY+
M=M^85PQSRJ3DF8P@72!9&5KP@E)XFY+56<G$6)/WFWV$/!;QW_A@Z!")#.+)
M ;EZ5LOU['VUT&8%)E^,,+) \IGB+J\S);B,A BVH$_:IMAE8Z0/O04E^MU=
M&/WTK:<9KNYO^ ')1&Z$N )A%S%Z1(3=<3#\3O%X&'> !^[Z\ #S#7B"W!5'
M1XS)E0Q83 )%6QF@TAP8"\4PF0+M-$_&BSMBD^&=V,=J SOO'V2I+Q=?K@5A
M3EGE%002B8Z>'"M[FP,G<\X<,1O3A=>OD_M^^N;Q#NR#;+\8PG #'Z577>A7
M@@0M=7U  =SS.D%F,S+;"; \*A$,,YBZ/ ?NYL';W_P$/;BWX09>@Q_GZQH2
M_(@5-QL+*U(E[QW$:$F@5 524D+2AE1,FC3K4CGJY,FM$IQND'2X0P9DDMHJ
M4$U\W^>SC3U6G^=?/RY^/5]3 G*50G01=>B@JJ>,XP=> WCU(8PT<$GK?>81
MD64I&'2)M"6&2M93:5QE890DAA2T8":9+K6*IX.>!P*^XX*GCR<&!LV;^3)'
M^N.K8S(*S#&C BTIO-F\'4)9Z)@4OC#C9<QWN[;VQ\3/7SUN@-'40XM!S-MB
M"LCF[*2_O$$WK\,,8M; 1:*@5A@+0:D(3&0NG>(4TS:91O23%*<9A1SND&/0
M .XTQ \USE/MB_X#;X8+=M&I946PA5+'J0T>@)6^#4YC.;I!K:.);BPFE+$$
M$,%EVOVM!CH-. CE Q<\)$1VVN!]I,XW<>SV\6]+MOG:UWW9*G@][@FM+SS4
MWEFO:Z-7@I"QEC-M4E$%Q]O,X=HIT02;09L[?!?!]4'>&G@XQHVN/WI.;\FW
M(@OL8%&\OA[+-O**!6,9!3&<@ERO98!4ER./S-G<A7SJ0#%.&%UC.['%T;M=
MN ^OWG^X'O<LT+ID,UB%!I31$7R0"D3DB2OO,T/7Y!Q]3+(3!EX;[PU84:XK
M8R?;R:^KKU^OVQTBR[(H#Z74&=.,9T#.(OU6,!^]RB*K#EM8AZ\Z8;2T<$:#
ML0SO\VJ]G,?UU5NY*Z%*X!RST>#J(SD5E /TE:W)*^LPV62E;K'];)7FA$$T
MG)<&O 6IR'Y[7EEUY]\NH7TYF^1**E-4R%P%X-$5REGH/VB" ^%$"9'S'.Z2
M6&S=779_PPGC84#3#SQ/X#8-^9\?_OI)+!&T#\RP^LR1HBW-/:"P @SS(4EN
M?/:=^%IW?\6)0V(HX^^<%3#*'.179QN(T:\6EU?-X>[?J,..5D//G>WYM0VG
MTAYB@#LS:Z5E6:/G 5U1J)5+/ 3)&0O"&&MW#0WN*<'1)]H*Q%1T=A0WR3ID
M,\6ZX640W!@"N(R4RQWENK'Y1-LK3^6T791?_ZZ_S#,A<S#)2' A473I'26Z
MQ1<P1C"G,P;;9N1O-_$FN&T/B[E[5:SAO=:@^#E<Q<_PJ&O+'U@,I$BF8\C3
M"0<\"::-XK09-9GA>8I/G0_!Y7$\/I6GSC_77*)BPJ!&B*CKY4UE[$090/M*
M-A]01-MDI/<S*_;W L*#Q?X^#GDJ==(N.KT4^_L7^WMA98R"Z3Z.?BH@3MH9
M'6NO?ZDGCK417.246B:1/4/%/#\.7>EDP-NKV#\Y[/;Q[X"8O;G1N*SFD5P[
MZWB&<^F8*H00M!0H2PDA> N:<\4T>;&H+G>-W;YM@ME*<Z_>O60:UB4-<I<_
M\[(LEE\JZ>/&,M=B.1^4U2I"1HN5 %*!0U&@>%I:WD8=VQ14=\ASPE@:TE,#
M[SJWIK#>O495@M(G%CUD3@*IJ!WX%"1@E-)C9BD@=MAI=G_#"2-B0-,/7$V_
MA=&KT<V74'VWW)"*OJDM\?D\W2*<O7Z-S#"2Q@(<D[Q6=1&"S@FR8L&ER(HO
M74H>^W[_B8-I%+<-6(SOVBM@K&.DNX'H):T$7\>*"%H)11D9(]>&5LI+X\8
M !K:&0W>(/0B. G:%:<4!X&*9$TL0K"%@\DJ.8?*%M<D^IDV5<UD(-?<ISN+
M_:,4=G]JS8QKVGW7WX>NXC[T'0U+MIU5NU.?Y:$('8WDV685@W%<%UE,4#P*
M.H-P1WWVH:\[>C%6FFQ##<R2L*HB/U=Z?02"/6.:LR)=FV+/T8NQVTOE'>:6
M__KWU_ER\Y>O6(Y%25DJIH V"DF+VF=P:=,!$CSCG@G$-MS 0VDPP5U\6.0.
M-K/^(-^WJ/KN:\>;&4*O5JN++Y>;T_OYZE^_+7-^>[[.%'BO-W3W%%27HDH
M&8VO3X,9'9)T;&DT+LJ0C)#3ZM;HJMEI@GXR6#E&O:2/@K6MH_;N_M>BOIH_
MHS/[4D5?8O1<@S:!@0IYHR("3^B3L5(IU:3)>@3=7A;$D?$RX#U84Q6OKV(V
M"FJC!0]D=F-$ E6;5KT0 K+F.GE26JKT9!;$;<U>EL-1L=+@V<S>4=]#"G[,
MRR]\9AR*5 EO-:WIFM<7RNOIMT6&Z*5CJ$.[-*J)2J<)_^.CHP7SR6#]84HJ
M9)33@&5<@)+10PA%@\]!,)8QEMR$!_X46T,/PO)1/#[-UE"==.(I1."8:H=.
MY;92DH'0-HHB#7.Y33?]\VH-[06$!UM#^SCDJ735=='II36T?VMH+ZR,T5ZW
MCZ.?"HA3*5ALEB $8IULJ< C1C!2!N6E9X6UX:]X,N#MU1HZ.>SV\>^H/%"F
M*"\XI81">,H+C8C@-V,BF=;9"I&5: *\Y\X#U<OAG7F@^GAK9\ECO!KV_:;7
M2[.UK&EW_,[6->Y]5+]3\_:T=UE,.I<8E:083W*5?4*F@N5*F(=JWAV__N@U
M<)49+Y@)P3S6EW@J@Z<?@+,!B_2<!6PRU?(YU<!K$E!'$(#7.8 J$0$S&A"\
M1%F<CI:WN1DXZ1IX'^2VJX'W\?V4:N!_+*XF5]^?;'VQ7JWQ/,W//[U?G)W]
MMEC6OS\KR.A\DV3N("4INF% 3 Q,%J*$++DS<E(;15\-3W,13 X[4ZJ-=U+T
MCXNK9T18^QH+E*A2Y7_GE/%X!M8'CU9+[].T:H$]E'M"2Z,M-D==07L ZVDL
MGO^@?[O.:9:]-9G%",57.CAK&(18.&2IE)%%J%*:S"-MI]++0AEMH>P#HBDU
MF>S6[->_\S+.Z:_/:HE4&[)QJ@-)E,P<0JG= QF=+8+\X?&)+) ;I5Z6R&A+
M9#\@M6H^&58W,GG)\_7%,J]FEBNO1)T;R!,%P<I;<"%$R%F7P*,(.CV5<^26
M6B\+9;2%LB^8CC&I9XB0DDN?7) !I+>5=K52;'*'8(WR*59VYT[CX::P8![)
M57J2>#3;@VL;P97QA>.IOKBD'9B">N4U@G?>$_9EB3I8S?*=1'$[!<@(LCZA
M+>BP*Y%).G]@:H"VB^^?N18Y<GKU+2_Q4[X./?Y<SF.^O?.'Y!0C/8'VH  *
MG0+G)0>AG27G6"^P$P'.%)1Y61Z3AL_ ? ?',\ LYB@$(UV+5QR4$Q%(\P)%
M;:K.CJ,]TI'148/Q5LH3A>HD%EHOG W-G];HAFCU]JI2]Z#BQ6FN@^<04=DZ
M7DE!X'0L%ZSWJYATD%UX2HZJQ,L:.^H::X2VL8/ G:U6CU\S=5.>1XS)<P>L
MQKU*&TZY)]DB,2=<JJ3/>I  L+4B+\MMP.4V*=1-/VZ\=5_527LG2W&%,3"Z
M$K62YN 25Q"%EBF@$"CD<8ZWGIJ\++JCGG$M<3?PO*\C1M%:!/(2I=1,*7*8
M\'7 &>FO"\KB1"X^A2>4K4TFP*C7: _#+6$JUFN(5M7Q<CR0X4T!(X2S(:@@
M["!1?#L57FZ4)@B52;]*MAZ#8:Z B%%2+F$-&9_<$%ETR5<./]&F]GF"KY(/
M:K8\BL>G^2HY^Y28205<#6:4$F3'$I"6(?U T!$979-^^6?V*KD7$!Y\E=S'
M(4_E06<7G5Y>)?=_E=P+*V.\[-S'T4\%Q,J5*+A&",CIQ!',DI;U/XPSJ805
M/AVG 7 RX.WU*GERV.WCWQ:8W?Y2\<.K]Q^N)W8KEXW*9*=8JH"9@PO:@N7:
M,,IJI?5M7OT\)MD$,Z7F +B+R$&]=]S7RI31?:._3';[,0DAU+_4]+UROV]M
M^&+Y /7OO%F.% $J5KQ&;I3)WBEK$V/:YL"5%&K'F^5^ AS]U;+T+/,L);A:
M-U-)"UHVEH'PT4A*W07WQV'K:/9J^: ;0?+?!9[13Q87:W)PI)_CISP+PJ,H
M.D$*A=?-QP/&S, '0Q95@:-J>E&Y7:P)[NS# G*02_H!7#K@<^2#5+E_3;W^
MG)<?/^/5)=\/0L%%'8YSV4EYE3ZOWJY6%S4;_NOKXOQJ=,Z,E)7*:@=TP)$1
M)(O@<YWHALD::8-1A;?$]= *O:R(R<-H2@\O'S7$[C+0^USA03]_O3A?+W&S
MQU0:S]7,*\93+ )2L094UAZ\B J<\B+I:&QTTWICT\(*)[,0)VG]7AB<TE//
M1XUQ$WW?KOO70)X;8X Y2<D;5[5++&K0D5-:R(KQ=EJ$&WNI^;*DIH.B*;W\
M[*[MU<L:&U1A6EDPR!2HHAPXF>FWGD5$D6+2T^+?Z*OA$UHI(T!U_%6U!\Z>
M5%3X<P/S+%I3I!<"0F ,E(D9D-5Y!2BCMX8%89M01X^EX,MR.LIR.@!E4WD/
M^:B.K]+_7*S6FS]Z%1;?\B_Y;/'OC[C\E-<S[@SSP0FP2E'H(+T#E.A FA*9
MT%F1BXYZ-_& \"]+9LN2>1I0>E*AW7]M''.S1RA#R%?1 OHZ#*)H!R%C@H16
MARB4R7Q:4_AZ*OBRK(YR$AV LBGQ?CRJYU73_BU5BR%WT*8!F6E?.4O)'UES
MX-H6GTKB7/"GM:#NZ?BRIHZRI@[#VLZAWU-<5G?S0F.24#$%4#5^5<(E<,HY
M.IQS2JEXI]VTN-H.NW^8I"ONW"1O<HTWN,XW4\INKR OF4 3$FCD""I%!]X)
M"]IG4UMKI;'VB3JLCQV>T$[Y9"Y@F^'P204>W<TQ8\9BUJR E-[4X$N#2\H!
ME]):LH9AY8F%^-V5?T(+< HK8(*KN1=\G_"=\..&L,J)P#4#'EFMT";:EX6F
MF,ASHR6%062HI[6.>UK@93%/<S&W!/)SN)=^W")>,$/)G *1+26<)7 (44O(
MTH7("Q.EE*E>7+\LVR;+=KK^[(76)WPW_K@AI! 8K3:0C"Z@;"H0R)L0%<\N
ML^C+T[X\?UG:3_1$;@GD)Y4FWR+5>=P*RDL>?-20;:AS55&#9T6"22:GDK-3
M^FE>W7=2_V4M3W,M-X/PTZP(/&Z#Z)/V"2UX7Q\BL^0 ?6&0N2S!)V=2%D]K
M&>][WW5,[AR)TJ%4&@27&92TY \M$@05K;$N%=WHMN($N7,.NK$_BL>/S9VS
M6JYG[ZM>&^H"H5+Q6#Q@J0F-P4!"LPA1\LP,>EMX%ZS2A]["*?WN+D9_^M:G
MSY'3R^&+0PT_X-WNC1!73_F[B-&#SJ8[#H:G6WB<>>8 #]SUX0'F:^A-8PTW
M3G.PR010,2/MAN@A!L-"T#D$T>6QPC2\N(."97@G]K':P,[[!UGJR\67*T%R
MB=PD3,#JT"H*WS0X6:-P-#8P+J7P@[GOIV\>+P$ZR/:+(0PWX//TC2#X]RU!
M= R$2"7 LEC;DB1"*(R B98+IY2500WFP=O?_ 0]N+?A&I0Z?^9S\BB3RR51
M*LD2**<#>&L,%.VT51J+5%V\>.I$@OL$28<[Y!@O=/>A:.JBTPN18'\BP5Y8
M&8.,;1]'/QDB0>6R4B* 9G0"*%;;A4-@8+RF%6YSD.XXKV,G ]Y>1(*3PVX?
M_PX\N>GM>24?FG_+EWQT5<;5=<C!A(Y*9S!TA%R^[G/,1+ 9)<4BP?J[#PVV
M]@SL_H8)%@2:>V\QN.F')H*JPGS(Z_49&>##7S^)I;2RR8<"P2;2- 8)SI/.
M*((@&85)OM/SQ]U?<>*0&,KX V\2KW'U>8=4A--0'&;(!I&B3^4AB%B%#"$&
MY9V+C[$[/OP-)XZ(@4S?(%Q_GU?KY;Q2<FU0>R64XYEKQQE@I/U*1=3@E*RS
MP:TOG'O,KDE2MU6:$\;.<%X:L,&J7DA\G*]KUOOV/,V_S=,%GFU"LF)9-J;2
MLT4"-(5D532>P5*HQG@QMK N,\T[W>ALE> T[P&&<4AKA/QSOO[\/I]M[+'Z
M//_Z<?$KQ4WK[U?+HXNH0Q=7>LHX?@%F *\^A)$&+AGXSK^OR%H65[B*$/WF
M:C35]@YAP(OL=4D^,I&?%7H>*/P<%SQ]/#$P:-[,ESG2'U\=DTDS3B>E!2X$
MI6%""G!9:H@AA^ D#U)W:;_MA(F?OWK<0D-3#RT&,>^ 6>[UT?LFE[Q<[CQN
MJPU^6.3>R4NG<8W6WI6M'U/7B]5%9Q\59>TND95L+=F4 BE%JV5D09DN,4WO
M4+BQ7J<9*4T1- T:I2\[!3<BW[;G#Y6N:5U7N_6XVB2Z:-*R\C*<*L>IMTP*
M:8M)P:1!W69 C;+C6.@@A!)]H>2:%<!$V;LWI@B%3*38I#UXZH!_I$9S(GCO
M@XX&.-\FV7UC7@5H7C+N2R5*9<:!TMS4RT4.)C@M$2U:8<:*8'8).?X=W['
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M<;V!_K2O_D%9U6]D-CS[[XS+6>&V=E4BN+JCJD(K(WBG 9VS,7'->6Q"U3*
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MH^"+Y> ",&\H=L[6@?.5(C4P*Y.4Q8N1:"LFQC!W!.CLZY=1^J-^XC0K)>N
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M=-3 DXL48@H)7C%3"0.M#9PI-=:9V$?L%QB/X>_)/H/2T@3NC07&Q"9/$90
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M[@<[NXWWC0ENC9X>&740#7<L2;A[2L[$FU)W5RS/,]KX#F:6?.F>\@J''(M
MNW#. H85-&RWL?+&XSB7L\_:"P:G]SYW,-O31S,X=)S)^$L8G(<!^*8DH+DU
MT'CB9M@N;;(KETV-E[WC?I-OPP/%<J[.DGF)*^ZH09W,V7V-V;)5L;?Z"L4.
M8 ._03M1WF8TCA7I"B7J%2B7/-C&S1@L!D;5'8;?8  )7^U'UN@*CLM;GQP\
M)YHRQNQ?MP<,EVY=;VANB%;D#1]F5HT6LZ5($#"@JOV:CEN!LP6QAAQ%'.QB
M 'M7AJ%<IH-'1V6O5[26>]_=JU\D,E&M=?&=1,GC7I;C&YGF8R+05A;JYEXZ
MW5^R8G?GLO/'*,7PH,ZB>%.NZCP.X^AJI!1Q< ';B35"PL$'S[XA;OI,PJ=V
MS^JWW?EX=]XIJ5=^.Y^_&P$:83I1A]Z :(H&,F#"2..>5P'HW^/TV$7I3=)9
MDE?ZG&*N^AVC6 [Y!,LP#LJ\8W?PU_50B@M]$":-QJ]L3H<N5G;"8\D->9PI
M'2%7DDH2*MQ"?0QM[F<YVBK4CK(Z+FA_>!UGK^QNL5?09G)SHS'_&TII9 DJ
M* IF;HI<"%.J::MWO/9H#P>$8Z.P8"D3:V]O;S=OJ:2DVMN=/*ZRT?)<+_*O
M*C.' 7BFX[ (#-&6/Q;'_PIR%6*:<JF%]#%5N")]@7:@\]*;]/.Q"AFCSU^*
M<#K?EWOT<VA!@GVGM/>#CAM9 :PCUD_2^7EI^4:G_$D2IU*LQY"R:%=7U.ZK
MDQ()+U[]2-%G2;\_D6H\:+S$+O<.21M%-/^P85^ 4\7[2:)O0Q@ 55B)/)]E
M1HK.N<, .)42$#9#@FI3_3?U"QW'+P]PL.^\$/&,<^_;8W*L&XF%<F(G.$JD
MD(UI6;^($0.HQO26G_QN!B81X*PK,RX1>-Q:69SFYO6$<R06 T%U\\C8JT*]
MZM7U(H<M4I.'L^EYJI'2HL2!"BP\?KW%T%6Z]!Y7MW^IF6<XP:'G4)*,Q%-3
M-J;#>!MVO!)5J)* [DPRI//N 5?S5Z2/#:]OEL?$J?NJ?QTKL'!K;/0<J%7@
M]D#F4Q,2V_AT(BPHA^GS(8%K"1!FDT%$-XH;U%G@CS]::WQT#'FDS!.E-B([
M7CO(;W7OU8J!#>ZF"%377K+35+G>\=17QBA98I?[1>6M6W6&%KHTTX]JL8HG
MJ]N-7(?'MEFD.?+YO\#($> XL1GQZU$5%!!&V)L_4?+4DZ2#3T/AT94MWB2A
M7F/),?7RC6WENB"%UHAS]6G[%Y)')C\XI$EPT#\4,CF9:1L^L(!B_X])W<J'
M:*)_R5HNY3SU:B.:#VF4WA%RVHHPYS1CKEZ0*;%N/Q W]_A6@*C^VDJP22ZW
MFQZE^$ZQ5Z"?G\)$CI^<DT7;>%&40\>46J.V\85P4S,WDXVGSU=<[,G)&-;>
MU$.9_,8R],L1A15F/-JWS:#<#F4;5CKXE5CC &F/H[]M.Y;>39YY$)U!@/.L
MBA-6><D6/Q)4C$P\;J?-GSHXK0&_^VK)_:([UUTV/N,HB 94P]V.!2[RK[DO
M(&8I^(MIO8N58=D_Q%OKRXLE/\X<ZZKRR]3&!K7?SFS@^A1IDALSK[<[8.LR
M[;AB=W=Y-ZG(7N1[SWE/Q<2CYD57RU3PX8;B -A_GI:!]DQ)Q!#-4N)Q_-1
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MN)<!<)\</)-SV4=<F9I *=.Z&TY])]95*7^A6\PX<^6NI3CU&N3.0*H%&/@
MVK0?HH:.#F2EZ'KYZ*'Y5R;$K<9"_K"26A^I>"S.X: O_VA_\4]1I1V_WO=W
M*,,0,U5$MSMCW> SZ>2[T%6VJ3RT.OA5&]T!!/FA#JC3%=A_ZWI]U9A)PNPG
MEX\)8>^;[L^^;3V;?3%-VGL<CE_6G$KID9:'!-5 _P7LVKL%[M5R"7Q#?*W/
MN:^G7R>59 18'COZW5K;Q[;)6OERMUS#=0NIMF6Y[9NA:H:E5_-61E2D9RXH
MU+S;KZBDVN=H02GQKO[L'RWW3$\#^,>CAD.H@^AV23C^68C?6W0L78C(']_B
M3SD>9(RSSK,2<B3YQ>D98E@0SK%)2Q3+X #R!/F:^>G8Z5ECUUC9U)8ZVMU7
M.+X@@PYI?N=(8E:4[ISZE8$O<[Q'>PZSC* ?D)D:6P?UBH_#4M#$8&Q<F\ G
M=+L^56?!RK[K*#?8@2.TY1BG/[<(YAQS"YM&<!:9?__"T:<L5M7P>-#0>Q4-
M&JSV(GBHEWX]*P.%"I#&)-\XM'$JGMM<+T=#D:PB_7X5&7[QZ=XO1W@*K-K#
M%"*D&RMK///YOW:2Q\:,^'^UYZ"8RC<RHYB@YF\'-5B >J223IOVYT&KQR?U
M? X[EY ?)![Q^M%8\'2"NUDXV9Q9?ZHH^7SDK<J7<*_-1/1K]!HW=)%X$-HF
MH*728P#7DI1Z7'A)OHTE[7<>$.:.4BX,&=D&JW<8C-^(L0U,V_C(GBY]7UCQ
M#Q^>DS\S=BL)UIR@?8]3T(@18J$<?JE6D).UHOAZ>H]D@$\%1]^[K_/EEB53
MUE=G+D\<:BTS6=*K.<WCKI54'.+3NW\Y'J [HF_!DN'\=(6@&CKG5XJ="_4X
M::)ML,+A$]6$E!)OI!7ZW+/I ?5H<KKZKEVZKVO\1S5#87[QXO!@DY-5'JE_
MI+R"XS_#XC \VPA0PW[-\.45L,8JN?_<1( $[?ZQ<[;,7A-WP?")2Z%OGL],
MO+_&TW7FY7&[OOUZE,&#286?3OGY&6?<(DWW57JF[$EE5NZHYD$6\44&E.DR
M217/%=->V9-%M0992*\>#7!'6^Q-C#Y_6";BD8E&=W=K;DM6H'^1[>FHI4Q3
M:.^]GF8-,,UC3 #T83H,RHY._."QF]8)Z4A'X@QX<772[E17B5/$&LS3F#6M
MS^3KQM;.@Q>Q6IAMC)*+VK8]G4^1]J1-E3X-)YJCXQ"\=&#9?Q4ETV!EZ#+Z
MXX&NF/SXLYKF>(+#M4OO,CZHR14H*\P)7!3L:%N$N%4.5"(M=C>)KH="6]46
MJ@OS>G-MX,4,V$NH*%DL/SB,Y"R8EY\IKB6+^Y:Z!R@U7&B;<\O^<FQ3YI+)
MU:[UGS%%Z/8N#)?>YG0@.>97"@@:)5SY4;Z B-[R.JH4;W2#V#?QR,HUN-BH
MVE+FLHHG(?,2.T^_9"1S[>).NC71.D(W%[7:'6(/E<L^YW]<^WZ^X772027)
MVUNLG^;8SX=P-;_PRO;]M15>,>9^8:FVO^( 7R.[##Y<FX,E1. X[!&&>%N4
M*HPP 1U?T3\T67=B61RF03>"9GPV Z"+]A03=X]=.$^LSQ+>;FWMGG\H-29X
MJR5H_R<S[4(=4QG/QT\%)K_Z@8K\"6VB2 B\$:^,%?0>DNJ2$PB#@(4??MGH
M0<G-]5<K\P^>IVM?/J<Y-(_:/I#MK_#VR@MNX[<<L"&-^=P27*T5VHWGR[RK
M.IMG1/!=GH7)8_NO;QWYDK*V#J><HCBO':*5O=M"C2[QZ_1_7,]I6A\\O)P-
M4*6@U9)!FH/!I5#@#,/JV9Z5!&V:Y>&Z[% J*<?SI,XH6EGUQJK+J_FV5VE-
M)8-GJ2\&AH00;^!B=)D@H05T!\V_!RN(]"@.0IO5C"IYMUYP&I.K:X@,OH7R
MDI<ULW9:_@91!0DZ;R+M,0-PUP251=<&*)?HG9A:NX;"J94VK8A.(? HX8NG
MZ/G:YJA[UQKJE=>D3<-/":1>B+;8 ^]75/MF#<HH4??!"/94P11R)0E!W3M+
MY[(E<*/YI[R:UJ -KX)J4N;R\[Z=Z%W4SMJJ[AM;]Y#$@S)N#;>JA>4"0&N<
MDS+SSWY0C, __9W."3$VUD^T%VU0QFBW.TB]M !C1;J3^$HJ@^R[R2[*$S_*
MN/LJ]"1RFNUR:]\1**<%VP-USVY^4;]@.IS;^"@%]0_",("KV8%X 'Z>UVZ6
MSKE).>PM+0IZ^)'.=W;53T1/[-SK?JC!DMV;<7_02'_D2&+IHX-NTP?''9G@
MM7DR1(\(JJ/&*[H*\7E.:6MBFT_ZBHC6!Y_/^,V3^#5?=CGVAT[:9I+#M>=[
M7B46:;_ND]EFL6'_S+]^C&30@:F#Z*FX5RGH1[Z3MMEM+[T?Y,?G^'C5#AC;
M)7.7'ZMMO,=]E7)'OK[41^6)K*OT_#G_E ]84-EZW9FH0\!2)5(IBM0]H/\B
MVSC5"H\5_=!VJ*ZFZFG!L+O RLW,'1V?K<7L2VCMPPF^0<.?> OU:/:.4P[+
M$[;+30\>'W+NWF]>OI"H>B!Y3Y0DT_JE%L,%- ]H=H[>1\3$W IHMM8JHAS,
M]7QDUMI4/P9<WSGVC9F83N?K 3.(F]T(HH7U=')GI[3A\+;8MD;HN;$ \-4]
MY>?>.:>'E9(V]JI)#<<$G%P,^\#FCZA#[*'Z$[O1-Q!<X,YQ4F8< ^#(K8SP
M44IP;AB[1F&Q2W56]C+"SSLD[9&LO]U\[D[\YK^@C"."I+DP&0/'/\(1SQ]3
MZY(V'%'WK:3#CE35-X^Y)5L^U,>\G.U>*CNDV>9U+>[.'RTO6AV8=X.AG!,/
MEG2&#%(%!H\3R>F53I=QW^BZ$XOCMYZ]L<L<+FKRDA-4/F+5UQX=$I&***FU
M83+9]_^3@6R XB6(5D^UHK#1^YWLNZUY<([+,.(CI-F0D5HI1%MK*":5D:_\
M-KKLCW952:H7<$1DV,GR)$GC^S-\+Y"/C*"]7R M%] PT)G<.MFF%,1\"6Q>
M/*;6,V%\:+0V)T7-,M[*]96>&G<_M_>-V)RR4.5LN2]OW1J[5  3%N:U7;7O
MHV0:K;$%L3@XBQJD<ZY3#OYZ%<=8&O7119.XD>+UH'(^"-N1*3[0&UM9M\?J
M>8:W\(_47HEN+O7-:$VEV?(,IL[%1EHE [AI/6- Y_S5./\V5(E21KJ^!CM)
MG5WS:E5$C\@6L]*@&[S2_7:3VY:-(N-%-34=O:PM3)\*JKQ82UG;T^^&/2@V
M03J2#*&JYRMT"9!6AF)"ZH*S) ;@ #[%HY.SNWLC[EDY=V7K/_7P?P86OG-\
MI51''ZQ_:%4WRYD?&LP2K7W@>GJ<\")H03F-](?R2 Q]' LSAE&%:?EUZ.B\
M/:!H92^^7-.&.)'P?&YN-4_9(3$[JGMX3*-BG[-38S)+0ZSLHZ=7/B\) \:3
M!6V^T!4NH6:;<.N+%*5NDAJ!+<*]"%SMF%<:H\)(<F=&+1]DSUX9O;'ERV,8
MY[HO_EKNI3CE&A:%^ VX^="_./=\&TDD[OD@V9EVYG 1()48W&T"5;PIT?!O
M>NRT[>/B%^W\J(K&^QE _AAL9QQ&? *ZT2-LT+B+3,4F-QA A]M"RB[O"0;P
MP/;_BOU?L?\K]G_%_E\0NY0$=QZY9^_Y8Q7\<EWL:DQ^/O=%6Q-@'S3NP&!(
M-:(<(>MA[UOXC%SGC&E#/O)TGA5/4*!SW??\<7>*[LX-WC=O785?C91=%SX4
M7G3(B5I!2V[1H1Q'MTNAO7 Q."XZ-_4DIAM=H]23DC*O (:64 ]-+*5!A<>>
MFS8X7'GK7%2G2+!&KH;C5SO\WK43@=_5MC7)L;1LX[WTL7G>*B*\1T/"YDW]
MR+WF!QXF+<-UE(&#.V?'KO+)-C<T56>J%&08M'&]8=%BV6M>>926"\?_@69%
M,8-?-!/$-QH)_))@@]7$O?Y!7N]YK8D-/[XHZ=) ]>_EKP3/#'7JO,J[W' F
MW"M,]HG:+4"$ =QB * B=LV,$H0\,M'"2[&$-D#Q\>OC/E*B7<O%)T0J2RP:
MN/W]0D0'XD_C(]Z4,GNSG;](OX)\,$0_=AG:)47AUS23&( T]4(@01FU%S5&
M%Q]KL2"$=GSP,U+S*5\11^6\?#^09F=I/_KDB%+()[5,A;(?>?R@?,.:NS<I
MH0>]?ZT6+C:+[;)RL;+O==E7"SXM/[6P'K)KO5TSMWQG3J-N\.GP8JJX(DMX
MI*#:G-$#8M9"5K=FM#BF'1&+8AG91G-Z'[5<#L'$^*F/ERO57)^ZJK7(I$\$
M>@YI)7(!H &=.WU! T'8A&H43NH^8N3=_G)KROEENLI6^>"FD-6PJT'@:&*
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M3X1[SXF>"]OOF"_WU:SIZ8@,.]_KLQP*%\/XO\Q@"RM!W4TZQQS$]#Y@/2$
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MRM2S$_"I^3WA9X6,&^Z+&U[;1UO8^_V@8]"'^Q^/$MHDH3H?#K\*%0<1V.K
M6 ;@MQGOA*P.:EX\1NE^-H=P+TDY6?\T)MNQ[=:G.<[KM[Z&G/#%_S'$OB:2
M4>R5+9+E\^Q;$U(_\_[]9=;B\EI7N6AYFY?QA5$V$ P!X6OQRLR_.6KJGQJ+
M_]W?^#32I'-N,@!Y:SL&4+7IR !&TEV67?ZJ._1GLZKJWVF0O&"^]G==UM^;
MG>7Q__241_^_XOW?#C58%W9+=)@!K/Y@ -\4Z__-YW]'T* 'OJ7NP@ FF9TN
M_6MC*)\[^[>.I\WR;\\L_JZKY ;"Z"<@8$^NX7:%;_WS\S:[[G]SNHL2A"]1
M6@T22ADL5%I\FRQJ8EYKRQW!Z:EM631U;DH\NEAV[[03T3_NH'P<I^3+3-]X
M3V82@L['#*8N(D"U':J(_P*<*H#%GVO0&C*2*#,33="\10^(L7V3>/FFP5GV
M]X1^Z[,\6_+>D2O>.[B%F$X_5JH$Z)./E /O/.M^'A3:L:M1D?%L>8@_;69D
M7B%>N;>Z0)FJ1G*F\[+0$I&(13/P&:1C,"T_<B8K'G5@U;[).FK;\L>'+*Y)
MN.=X'1 BI#<Q=8IGKT^)2PKBS=B_1-GO72"[8UG4Y!WL]I+H=[V_;O]*?NVN
M3,#R&K-0C<=0JD@74F[FPP6:BD#E/<.?'"8'5R4]\_>,F&_TQ8GOV=AX^>QI
MF+$M49/.94'1I :3YK(ZYN3.D^ Q1I:OO,7;<A<&)'I=V,9UC^@UZDXK.E=6
MU:VW>-W^]LA"K>.51QR3=J\8#[L:9%$H[9'Q4=04KCHJ[R'E4%#GN1%C^2#N
MWB;-Y!:NI@E4.[ITV5X:J=]P>%GB#SPF*Z2WF3O-^ &T/9NB<%@6!N"MN1^^
MAJ5<".)"1.-J,9WH>!=ETG4,W[U2-ES=W,#+]CO&3^^D-529\3T+YF8UG.2[
MW=?F"M"8P&X2>J'RUWNQE5TP"6.MH*;)$\2&J-K2.HU ^U:E_KKZ.$O#O4PW
M#N_GRJ_1XLI/8QH@XM9A1.LNB!+E/:4X.2-/5-> P65!1W'==O-*$YS5#2GF
M>?\/>V\"3U7;[H]OR9QDGNW*6$)DJ R;)"21BA"[,A,2(K:]BC*$1$DT[$JB
M3)G+M&UC*O-,[$&E#%F[LJWLP7]YGO><1^^IYYSWG/>\[_G]/V^?3S[V7JZU
M[G7?U_2]KNN^[H& [.J,+N[NXK3I=Q8B16>,Y46I*0S1D\ZT;F8RWL?0Y=9K
M,)NLW*@AR;P@L."ZE1I5E!(N%6BIIOWBR-,%@3Q5O5>#W%U?<7.%E+I3 +1I
MGB%<3 N/#K,6IBQ>J></1[=0W;:$Y51F<#2-/?]X-">:<R.XU_U$-]<G(@$8
M.TP[#RU0/M:RD6R$?0='WT]<TNG0L*":7ZI0$YH\W/MZ:U1UK^&>";'J"SON
M>\5O-U6(I'U/>&&DA1U#EE4U%$M;@F.M+)6!HEH3OP>R@8=[:M7(:E;.+_JT
M&UJ,QL+D<($[G!H<CZN^$C^?3 L8IJ]LN8@FAS<=@?3HMMA&O'2M[(>6HA:Z
M[2>6\-="%OU31+]2+XO(/L\C?^1[A%#B1^Y Q@9<BQ.^->4JOG)Q3F!R2U94
MH!WS:2B:C\=3,OQ;G=B$:B0?YMZY-I$<XX\\;A>O&R.!</E6UGHH@S2G01%O
M(HH<\XL0JSHI2DLI\ FS,JR8*\^3V_4PE<=AGQWW1E*,4_IWXC*"\RW4=K2:
MF<'29@BZJ737"[/Z77> N3'D +LA*\O[-5?'!4ZDN71\N8KP:,O!QO\>$/U)
MUDAUJGA8XQC^&;0KW\3__O'CQ0QEJ?:OF^4EZ59!'9&!#(5J/)-7'+_8V\W9
M(IH">SKJQ;"]OCS/_%8.-%KEPWKU 6PLH]00IP\=@SDM;7H9\4T%5FY$*_,?
M:']05LC5?^=X3W1(1]IEMP49'']#>ONRI2<#<?,39,OE8.8&NV*KGO$#F;&T
MB#WJCT?T_# TMI)_%NWJK,(/URHR_8I\52FW\W/ \=?Z8_L*$1YO[PNWWU]?
M=*4-!D49#K#6WK/(6G)"D14'8 MB"]NC^INP&2D (,M08$E$ YC/R68)N:!9
ME_F(]$_>L#G[AQ.6,&"/9E,4DH6W845[_W"3-T,Z'?NBS*W3;/C?MKJ]V!;_
MYL6UN8\J[/D/2V"0N.H!*7_<'';[5)&K'O###6$G[9] N=H!-/UA_<R;JVFY
MP??'3?1BU1_8Q\>HEI*C.A A4JO,]C%[5_D!NTX%-(_K=D&5=9)GPF?L?F2E
M_TQ,_B<B]K]&*_=#>NU5N,/Q?O^03_)Q36$[8H+EQ?<=7^.<2W8"_D$2AKZ(
M T/-YZ2I?+119GG]>H @C/+,+SO_Y.W,X.ZX*Z3+"4F^0]FO2Z[XUSYU'K54
MZ[_$>*!^J&NI'N6-\ID?+6[$E0;.?IW4&#U,*8[[/%>+(A4+')^N3I0\Y'0T
M@>?884/W5%IK3$WUU04(!^O9%PQN*)/N@QTC2J!(E<ARKUCE@5#IY'-+;8UE
M:YF]OHO9;^K29-\^=7:R%"TXX7ZZVH/49HQ\CBNMFIT$%VE[F'<,1.F:#-6R
M+R'(M>'GQBR?G;KH"FQ!G"?*NJ<OOIJJ>=E6%[;PWUXZMM4.D,.6G^J80M3_
M@N#X#J8_G9@6VNWB?7WT\O'8&TEZ52)L$?]6LZ#.?&H03#=EZ'8;:$RB1[Z2
MF,04LXS$E58 0XVC+LSDBH7!6%J5I>IHW6S)WCXS?:<W\EJ;KNU]*1%0?)FQ
MB:X-?:5-,1\9\3..=2\CO#J\&F@X3I1WL114XPJE4.+G_ ,?5T8=MN4CSUB<
MRIS*Z+QY;)1\1X'[V8845=U1YJZ5AC$H?PU(KX;%0Z<4CP12)K%=R-+T-WBA
M!30;=)$A+(2Q&'2[ZH+UTX\M_ZZN(^C[H"C+2'&-'!;(T.D8 PA"BGTH4A)Q
M'?QT(&:"HP(,;.WBL"8+)"@-':/*# T63C*U6F%?*,U-F]HB4Z.N]C4 <TF+
MRVSK=N+C$%NN%J1X/1OC..P])+"&T&6+S;@$Y!H#$_!K W+-0DV*Y(PN5N-%
MJ5^'<_/$_I;<D3'%1U_91;._EUF=M;AJ^GZ;,^&<!8N'P0-UP>[Z.^83P-M&
M&*,-L5,$XN^Q063*)>I\K!I#.<Q-MO4VQ>>!YK2]WJG/%$&1,"&%PRUG=TBQ
M;[4X\O0\SK_'&+D#-OI*^%,"@E@"OG0O>KV1_/2@'DN?ZG4E%"7!V%??.Y(U
M:!UH=[LC<],V-F^*R3JVEQS-^F!-9<KC?R&QOS,2.X83-I(/WP'?O.DN0.EJ
M]C\KNZ.))=%35.$2;'>'K.:O1O'Q3*]+%TPA&R.OP%(?-C^'H\R+C3&VPYQD
MQNIB87,HN 2I@9N%E.2MA#*U-_[![WR<SDL2=KA\OO6$P#G(WC.SX,#B::*+
M0Z8LGJ]T888A,ZU6_MWK903WXQB9B,X':_RE8G.W[' =CZ!8Q:7?D$G?DW]'
MI;@%@#9J-.$D <))%*D<+[J,()7@9;YML8G#B.8;L(1+:VU[FO*Z)*OZ_/=A
M'>BRER(39!(."!!\69?S_BUZ\B_0_W^&U40AZF\;WXE#>(YEA'N@ ): 7*?#
M@VXA2LZG+^3[R913/]KW/M"<0]^2OEV\5:>-:!$@7(=M\,UZ?/NA3X;48%F>
MJ8^7%WM76&BPB@4Y0:1,7Y-\!&&I?($#T,>!!SLT8,<FF@ZKEE8Y=69M+?JD
MSE0C$*,7Y"LG'?W9H'EC>2JYN_ *[OF7-VG3Z^/D0X+5L2>-D<^0H!ENF/,U
MBZ<,7M)9$#D[%9G;(I[POHPU1OW6<S&SHJ;"X;E=4]R&B[*E52&5INBCJ]_]
M;RP 83,+QHG5JS.T(6&0?@AZ0HUL/>?$%??MT;ZZ_OEWFT1J"H(>7N"SE*_9
MK.#-5U/]--83\=V\ 0]M49[%4Z?:SJ'Y0I*MFEDR5/62 M^EL#CM0-EPZ2/=
M[P;?];EG!M2W#E52<YH>FB@4\Y;<4UC[6L9].T)NP0PS0C\*$%SP)!RRQ"8E
MI0D]BIH<Z=&QD!H//>Q%3K8Y5-F[CGQ -2K(RW^;[@%R3[IGR*FBXN1'.E$"
M#\(3C:GF<04,9W)=0)]M;X7TSL^S.JKZEV_RW3Z_8;>5S)7]U5K7"!<):P6-
MQ56*TP&O8D@-SQ#Z2BN"%CWHFMA.8H5U;J)!8%Y'J.S-Y,?A;O9C&B.3:8ZW
MCAL^;!"TTPO<WO[LPO:#^Z)L)I7G2NCZ&%YJ.8Z_-I"2[#33+%8M.+A@*-TX
M(=1?47-WQX%UA^>J@C[1ONH4<*0WUCX(NT7TG$LI9Q_X6(!?&TXD$(48LCF,
M/5 D)9$_<,_@[.;ZGH5D]4]>E765Z>QMVG:;MGY\9;)69H.?W;\D^^\HV=B3
M &$0!]IV06Z!D+(LL8'(X8=;*;CZY DN7/BMX.KI2L'5<#-U=&D9\=@]:O0;
M#M(39_%,+2/6P]]$>T*']U,]XVAH&889'X4H];V$<LSC13+VM>?(>TSB(:%2
MN;6%FLCPH0^B[<N(^'B ]'Z@ZC"S&-0GG;ZUTY^6$7$P(ZB+KJZQ(-[FZ><U
M_SZ(*=&]6NPX5X?A?JRR^^F+_[:S])\2)*,[T/*H77,"X)@QB$\&O+IB%K&&
M8JX:<2QA-)]/&$UW:,A)>G1<H=AWL;1%V%IDSF][TLM8$^&-)ZOKQ<&XV;[)
MKC$<[1JD1W4S9>)T<.RC& GFPUH_REPD!75%OJ*B/FMDP=I8(ZYPTQ6O>^C=
MCFY^L6>N;6[88U PYLT^!MO8<I10"&YDAL733G5HNB?%O%'K/.FBWSHA,S#+
M,)[@!M^(4WUXHJ0+)XK/\UE+6VQR5'@^.:_M*TDY_BHMW(I<?YU^&,8_&#W0
MG,632ATE6O48F(%Q-F#7!48PQ<KQ41J_[D[YLEM=,I$NZIA;CR]7SFD>L!)X
MSC8G36M@/@U%RH9/D16[&,+2%*[1D,)]'X8($YNO-R\)0Y'-]IGNT9_];M8X
M%DP&Q:5I;/8YQ,.F$/1^:!,81U9NG8<4T QA?7)5 VZDC';Z!315$*[K75AK
M=1\*;K9?,GBL7Y.86+=OZ:7KFC+NS\K UH%,R=0;XAP'C0WZ:*+,$OSIE)%%
M6B.XC& (J[)X@T#E!BF'! -K\DQ-<0Q2A"7J9+!;^8K_[":AX\/:0BI^?GDG
M#F^R%3SW6!?A=GX3O.["4+X#U$,=HDTP'S \=M@43J,K#N:33VYKTI#+>#C6
M$G@R\'KG,.5&GBS;MC-:?N,AZ-AEQ(9EQ.G 46=RX)PYU8L&#-9+?02X#]OC
MP:*X2>DZ(Y? 0P,5?/*G>E_+7FYY(S;X;,QR)Z^GC\?-(Z>NQ8N\;F (0\)4
M'+Q8=#M6]STER ?D:D8*&K!3FUIX)HGKG*&#GUOUD_6:^_:X]1<$M(PW;U;Y
MK&"1>^6=IS;GD6M/CGQ%["R&=*=:=Q<.P18FEY0HN>\RB*,]I.(N&R#YSMZL
M=K+F>'ON8^3:M,^!-\ZPJQNJ?MM3OW)LCC6V66XS,P9PCZ^7P9@/% 0RPBA=
M(M-832@Y*J=,IR!K(D?OMM:>8VMZFJ,EV*_QQ8>1P_R1!WZ/^G6AG[F6 "?!
M8/OH,>/G+]#009WK'_;NVT&[.9E%(_X!\(KE?U)DR_DK)%Y1 JNL/T'QSB(_
MT YZ70[MV#=T,&TG1B]XIYZ69HA'@V(U5G1@\,=]0FR_!L*G#QE+_!((#[:(
ML/T)B/['T?XBSE=4]$-%/?NO(/CPPPN:OX3@A;"/_4OP_H^A]-MQ?$A'<D%6
MU]) +UCRZKM2>:T/IE7WX=?[(32(^'6 L5+E_KJ?!QC]3EU!_$ED\A]"F$UQ
MB3S\HCO@_NTF<=O\O2;I(V?J/U3[KJK:MM(0G'[B):1QJ5B"^P;GNN<&H4^
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MUIYYHV.!_K7"@8^VP A(HIHJDH)/F8SCHM^7VP)K.L)S(N@H,!9]I!\@9>/
MHS5^+D:?FEX_LJ'X'VXN=0[;JB99.">_9+[)"<&,8SX 2"4HT*IXQ*LK9C)P
MK@N</P@;]5'MNWHN+G:L;4!$;UOG'>R6SO6JY,!189: +CP>?\;.K]_F+Q!Y
MZ^4Q%G4I1F:]G[H_+F'PM,'W'8U3K+IE1.,35A< >G,QA'+)Q:EYC%"H#?8!
M$AP24HP&HYP,E6VNRZ4ZF4\5 3.P*G"B9],B5DHY5B(Y@ >P&;A(+*EJLE;_
M CL  _,A(OVAW-1/89$?.E'S]=[L7YQLH%UN++[;]&"+021X,!!2DAK^5+4W
MON)V(-\T5C[R3/BZP/UC(_>G"E+==GX:1Y''T&"8.$-$8 >K#U=I0.0+B9P(
M"!G#R;7D9#<"ET;#S^J93T)*6X%:DV)B.,.9;.%V[.' W("H\5%7!/O]-7=7
MQ5>-D0E(=CRI?3ZF(R]%&#N,JK)),G",#%:^"_B1QL5D=Y;=>U!4+/7I??OT
MA)/PO;8L>AP-!L Q_C!,197E1<];,I._I8A."[+A#T&7HX(*)>,_#RZJ^\<Q
M.$4[H@I_$<E%G(WHFBVDZ_CA.72 D?I%DMZE;%"L+K?N:B%9VI"3SX\O7N+$
MDUC%H\?/F*I+6JQ[M(&;Y8(GE>'! (<Y83H7MG>W6=5L+JDPDH)LLHF?V&B-
M:DC)'=/I8-T&=F"RC@X?6L1/W9GBV_Q$V4^5EU4(_&<'C6JS@5R,#:HL;E%P
MGL5S$ORL 4NBY!R,6C<P0JGK<54. ]T\_@R=@$FUW!'-Z?&<YS(O]PTTNTTQ
M%?]$X_WW].3?F6H'2PVC"&. 2?+C*C!X$AD-.X""$+HY G-S]T3"4V.%Z,]<
M$EN;2CZ:KM-Z]MM,VP.D<C08@(9G>BVV1\H=5]H670&;)Q0?:^-,^TE2YJR:
MTP>Z57WFU0[UK][T<<R+3C&SPW<+"E27*E>K]66$2'AVT^(]9$U%Q<"I\W*;
M!46^6".P4;!8L $DV,]:#Y!N$OE)T!@U;<B&*M"&$O*Y[UM=S::&CRU\9^ML
M4^K&.$;Q:=,2K B2^+Z,L,S?_"='DAYARS'S_%6JP5CJB'W@3Y,<?Q/9V66$
M&-YG?J2/I'Q9D4IL$TAFB8.QB>O#IN\I#CXHC=GHY7T^TR303.9>XP7]IZI?
MB:TP1M:8G9KL.#O5@ 8/XD>&*'%S&A0)Q>T5;1<-]-2NQOAM9TG?M5\0VGGD
MSBDSRPU+2Y- (PKV$^:9%5C@"JH\K+%K1+51#PWL@:).&#A0BK<Q/SZNNY-H
M<?O9S>'HW7,+B!D\Z0-:IH-$A#9GM+[VEV^I='+-S_]4[9%^PT&O?5U&JE'Q
M*75RO";G/MW'F*?O4N^I0K3B&=BDIS VZ+-X$K+]TC FS,?(%G0Y,CG ?U05
M+\$X2TWNK#KSBO3YR*4;529I^W';JH/B7G8 \H"0#AHQ<\]H8 %WN7X]'ER,
M4R]^E[&ON\+:/U0UD>_<Z4<:(<\:E+?N)+Y7"GK9I<V6@.[C8@B.L;@+R2EC
M*!;/;1"@X.;ZZ$<P$=1]B?G0B;L:9&XH)3@WW,VF3XCB/2>H5AAM09A+$Q__
ML%Z&K4&40<2H#6)EH3"*>F(1PQE4@_4N0\<KSURW@CRGX2+EOI1<?:><[]Q)
MW,OQ[N?)\6LGN=8"#O>$8 4\-ET*F>Z'@NFP"TV U]"''S#K"1F&I5J 'VBL
MK!?NZ1U4&=SI%DWY[-6\_\I3'I,+NVVY^O!E $,(8/%4T!6XE9@XX!0^;DET
M[MD:?D]K3OUQLZ!EA$V5JS]A&8%/_Z:(#<6-MK'6BT*=*,I;5A.RK(UPZS&]
MF(JFY'3%>UR.LN@Y9'+Z+->!A2)]BL,E%.FQ9NL0NA)@R%B#&:2ZBY*U/1@N
M<-&R%.$&:2SX#(939V*,D7D54RCQ9<1I@9$=M"A'Z<FV.4-PD>"Y$=-,=4@J
M"*')C7FE6QH-=V#U,389+&[^1Q8S=+^5[$'];LS9S*MCR3(,Q_X%0UU/UCO=
M4=DGW 7A#=>N1EPI ;,I @QI*DDL&7!#0QN+6S62TF)8B4_U"*IUGATIAQ0R
MI!::1"19FW/3=MX7>/%?1U_L+&0B-9(2]QGO7@S)Z\V93UHO(Z@S3\/+&L^Q
MQ/K4@WO2IK_8OUI&E-NZ]3Z?1[#&4>!AE9!BR!SO!D ;E>/J93[V(C;U&_A1
M'?;VG+*Q7@J]8Q0HUS9:5;4R!''@G2%UAF8%F7@HOS62Z Z]"QRZA)QG/DL\
M=Y+5)<*6LXS@9X/!GQS&"TD- $@X8AD\&W]9A[M=\8I_68?@JYDS>W'/B SQ
MPY3IVRE7 ="QBQ]:TW)1+T*Y42!ZT-U-9A:/!XP,(N:,%K( 4B:PTJY0'E7>
MQ9 1I#K-P4# Q0_,)D0X7#)X!EQ6K!*J8D]N=E_(L8'T,E@\^93O8L"H&V6J
MM2OY+'NF I1/S3U:JX6SIZN.Q3#RV-\8J0($(Q0I?8+_*YK%"RMRCDX(-_DB
M3CQ+H#EP-&*TL:.+JF OUB&<9_!>-*%8'\2UX*$=>)K?0%\3GL=H0[@R1:X&
MN=VG&FCJ"&S-$+Z&_=(>R=]\()CX9KXE:@K,9O%PP"CE#*3V'G41=1)Y:>+T
M6HF 4#Q?R]/.N'XKC-*9J*]92\J$K#!"<9R4;7>]G+?3_\?>N\=#V;Y[PU,J
M9#.R#YE244E3V16:J20D2;*/J83LFLHVIAF;[#<3BCMB%)(DV4ZRF1B;"A'9
MC9B-4#:9B<:5N6:\EWNM]_G=][WNW_JL]UGK7<_SO)_WCSX??3C/ZSR/Z]A\
MO]=YG,<A&77E0.(1A3,) ]M22#M.Y1,+8;A-;)Y@(Z_(Z[4]N)WRT@J4RN?>
M;2S'B7D-,DU(=P+"B,?3.]1'&R<V:/[Z"-D9 W>4GR]8/<>PP6M!ON1YHR@Q
M%F70KRMAX&?<)&1/IOBI]?'V=#H<7Y+_TJY#NB3_?/95A[;[V0G353#Q/]PM
MYBZ"?9X Z,Y3$>QSQ)'*=G0-&30R@$-[:O;B/X#B23>X9P7V.PFVJ/J=!,\=
M,H("G_L"NO_%*._6R*MPPL'[_(O02@I<]P"C)= /B'HDLRR>(HZNP.D6A$0Y
M("2-3%4?^>WQ>>W[^G[?9VT3E5*=@U0"=RCN_O;/N3;JG'3,)M,5V :KJ\BG
M[U:_D]N*9.Q(.GB!T)S!?#=]@%])HUR"*#ZBPBH&S<A:@;TD15 NDP"7ZR%]
M BG*'!HHII03*AN'N5WGOJ_ !$? ;V #R1MBQP-Z<]FO1JM@MW?^E\0IVV2T
M<V^@_=7%&6#RRN:+L7EY8N?_]4#D%G'N&,\!MX>?JD,4!:CCKM78_!"?EMR#
M4=3!L9V?]IW0"]7N]@O<H:]P</^(BJ7.IJ,N"<^JFROWPP8GEL)1</  FPRN
M'F5CYE;5:8I3OYNCW$;?8N3IQ1FDYDKVVXV?^E0O*E_TE,S-+10W>4P^D(K=
M4A7KF;.CN#),W73VOZI=, P>C68PK!(1XD:;5F#BB?E .TL^L7"4RO,!4?U%
MU91/K 2S $"C3MO5H')M#6=\\AY3]J[HNH1E'O<W?A6D&/-#"TR/3 Z52P0:
MW)AE(CX&7;F914"*A==W/R76-\<\Y,[ZFR*/+R;AED:DD^1OI)*LGRW7I!;,
M+/O2].H*1\:&/ZMW)%J\DC>;P)RT6[>?J[.&8Y58A8S D*U 62KW-O\9Q1VM
M>#57,Y8QFAE_A5/6@A5Q;0TNLG2[_:0AYT4"]I*67&<;R]__2\GAB*VI#T]X
MQKUK_L_FD6HM:T#&&41TD\\L&#+V\5N[+G*,MC6U+3_/]BQ,M?EQOXZ$V(4P
M+]U2^5[.\^_KN,F!OA6*.[?LL'PS=RE]0?*J$(L$;-6?97+@C.!9+(N8@) #
M-6[E00M102&!6)9M6T3QB.*UQ1&_DPX# YM3PP_4DLD)-ILGQ%L=-H@+?];Y
MUR)'\-4^K575),:+YPO.)Z<$,J57W._*K, 0Z@T=?\A^VO0W-=O7H?\V(<+2
M!&;\MVD]YS_]:<B5D'WO/[CL.9G1JX[VO>>>+YS<7_?GRBA*F/_4 _Z30QS&
MT$ BF\=$W\'B"!R+=B=T3-46 Z3VV8%J_AE-0XOS@L7TT^_CCKR375/TMW/;
M3UBMYG()!T$N[##!X\8MIM7PXPY;8(05HJ^F%VD9$Z\254G_$%VP162_\1Y]
M]*&R9.=Q.+AEM8 J;2TR&J7\&H"S2;8(]7R//L"CV<?CZ^0/R^7DY8HTY5GF
MHVLW$WO#49X0DR.N\BI5PC4D;3N&?W>1*#)#@*,4<48<\8%S(<;GJ_6R8BJ?
M.M<:WWIJ^@EV\E+XQ%FIJ7TGZ9U*?!"(@OSD.9=OE(J,NA<A&"ZED6/:KGOL
M]I-C-XI,W?-<S81T:DY?>(=^L.V0\Y/4\_M_L2 X",D'<%^!T1 ")81@,U(@
M2X]#,]T)S<?XL2LP$7NN/Y\RQ^/^4L5<F'K('Z7H!2T<5:WER>-I&+:-WYYV
M$_X=@IL5S:>=MH$TCI1IE\QDTC?2+VPOG.C8H]TR\';P )+SFCHHSK.X,CA#
MH6(!;4U6>RM6"DFD8"G ;O7\%],5XW,](3X6I+.O,A\^]#9(JFL('<FMY:*O
M$)K64A@1&,D5&",#(<D"NCFY?:N\!"/UC1=XVP660:?:?3](NYVN6DISCNB\
MXW?A)(K0ZP0#6?Q<"N/3/+#=\TT$-K@,E!K$JTW+ [L)'*%6[0^*R]4-1<-S
M#\-T3MB/D-93KM"'_;G8OI-$'DKPP74#VY*269[/+HO6VJM?QCNI^*GVB+EO
MVBVCP;R/1Z568'^7""2G*[L&_D^RV6RL_V=&79AJH:1@U@G$AE9@WKC+ )6)
M%1WQ&^42I8%(6K-1Z/><3Y<;W8'5!$$!9,WZ.,5;:AP,*"OT9O#'=K\?X':=
M98['MVA!5\+U6^ NH1GZ/Q+ * :K7Y71;"?,ZCGJ+O 6&]U4\UHWM[@XI*S-
M&@/T63D8=W@RS4CO7S^0O:D>C#/.51QY;VB?1&@RHS!F*)&8#=!^)$S/\E-0
M8J#Y)R,,:YV/U3J TD:!%_49&:6!C>YOPIZ8[W/5\9N1;H]L#;Y;V[T0R#LF
M@+#)%F@[\PGZ*S E"A3+$Y;I2?4VQ7?W5><$_7R2?G''<S-XAZQ%>LV.C7&2
M<D=9X>@ZI+AW(YQ3%+.X E,$SDRW6_=6^RB6Z70=[_-I]<?N$4XY?XFJJ;EA
M7> ZV_D_[/&>%;"-#*HX\TP)38;U/@7@!N ;.J%1 U1ZG>SKB]MYQ6[!KJ?0
MR)A_?\I@0NR2Q*/ I)CWOA>#\>->%/;-3% &8=J8>)*?5XV.IPCKBCY4<\#9
M )8E#H?\P;T]U(/(3R]5%]<LE?V3M^<JRDX4;&R O/$'8'["A%W"_0%8/[O0
M3=0\@U4>'AG3Y]=UJ5FLP%(&&[RRGCPH=3!Y]I66I!!4^>+K-;\GCMOOAI;L
MW@H!/^1_J4[]QT?]VW1<GX$_W))4[UOD;7@9GKW+?/\+\Z30C=E_R$O\8TFI
MM8B_S4!\\L)J'-%.C$174J(F@ C./&LI!J?PB$K2MN.<J5T?W7CT0\^"0>18
MPN$CT;  ^M\Z=)P8"P,<0C/T6[I"9YBK#6&"N9Y ">\,D#!FLRX3#6$FW=R(
M53)?Z@21>=G?R?Q4V>F>%5BT"^3&Q? T"KH5D4(2AQB2R.AMOAB3^_!OZ3PO
M>!S11@S_QV)C[X#_]V++_"YA[VI7&77FD1^G6%W"R &9 HC;\@QQIP=?-"(@
M\](GN)/B(9HU'U<ZL=_<GPTAQIN.7^4KX<S7_676VR/,VW:<3Y4,7>S.!;H%
MHGQ(8R3YD480!!4+%FRTX%DXX,X!\6N%LR_P"U [(*?\S!(\85HH/ZSF>9?B
M<??IF^X7\%;(@1L,"D0'V6@JMU&4?Q>U-B2_+>.ZLUR/AIY=K@1[I*U!6C/'
MK.6]8;2%?]L9B$E"\T<;0E(0^A<I)-'%T/]#"O<:-3GV&?A%&]</)@660Q:^
MQ[8$+?\DB4!.@XX%-)!4 @0?FB?XA3K=TF H)Z?>PYFBC,-S3K^>@:$\NNKK
M_-9=_!+..7 6M71!<-.;Q+Z^!,H%<^F-Z<;\--QNX9CG'FZ(8?P&G/(GD, 2
MVRS:Y/A"=WUU[_NR6]MWB,N\;36!M')=(^34W@@^ZQ_P052A9UO'B<H[*O;>
M'<,/(*K.U]!$?+\8 /Y4_'GN1=73'I[""[)KEJ,X^0(Q[=5S7GZ2UE; ZQ;O
M-" WOS>\NJ]>AOVA@^<QJ?]!?MBOZM6$@_)'S,6I&I_WJ_7ZUD?QJU#[OU;.
M$,H]P4V\M@P\XE@&D,@[.1/D*MSKES_G_^5,EVZG1DV;W=:I+251_!PT(Y)"
M5HAXOKYP?H[#0$8L!WSTK>]!N],C0X-2 QA)""!W5 @_I>)AV?*SVYN+E" T
MO4*SSVC.78,KXOO.X:R GV5O@M7)G"(6/O_9>TR=(BODDN_RP?W</'B\X BA
MR;AQIW?W7@S9%%0YS/9D^F5_<<&A^"F@@D9<F0/IUV7=R^G=?KM4I%%GA[N%
M=,&O@TNB@="^FR"1W=9_PP_C^O<0KA#7 _[-JKOZE,]P-I 877NO^M.=RM>S
MTF:L]G^68O@1QMP_593OZ82/=X-'VU=@CB8KL$X-R/:?P< U93/95,1+)"BW
MQ$U@C^6,6\4CV"Z&+OI46G^2?HT=1AB_T<NNW J[1U3:(5 TY\F>MV^*:3=%
M=-FN$&388+0"\Z7I#H)&2QTCVNUD@>P+_ZIQ] \E.5XM6YF!H<*'LQGSL?@U
M./F>:SIEHH"-I26:NNS^H300-Y!1G',W_L5$AJ>ML'>,?_7QI\U/84*L.$CW
MQN"1KGIN-WAG!'1$M7YK%!+$.824C:MP'!"V%F%FK!^090<<GG'I;NX&],D"
MD6YVS/E:]OPLG,$_Y6Z8BU6P"'[Q0+G80RFI;_>.A20W6F/GX_!#F!A$Q?QL
M-_O4SEA&^^P< R/R6%PMQ*U9SVZ-:9[4B5<O^O[AVHJ?YHD0_C9#.BL!%ONW
MJ=G_<T/$-0TUM<<-AY(+G$T>7D%F[)>T]/F#WY;+_M-MY_\D2$9I^EP5W>_\
M6.;3XS59M_\7U$FT\TS">:TJQ.9ZB*S!Y;VRY).+CGM\TKWM(3!T=G9HMT]S
MW/@86;O5?M+T=P3N0VC2@9AD4#V[Z(U%@\5X<(+6DAJ5J2!/.VAF:%Y\NM#%
M2C$L9,HU- '&/U7V< 7F1P0TT:LIB:)SEP[PB]%>.4(F_>.).%?9\M_H/MI7
MW&^X7U-UEW@C.5V^T+&F"Z\-IY$$DI J1TY3AM$0R5\[BA,';)YQ5,E/?C4B
M*M)&7YL%FD=A7,6EE6>-W:Y,'ACY2AG*%(@S^/<%JMZ;<"?Y%(&N#TFAWD2'
M?K6AIZJXL$\GYG[*E/1[E='1G,_S"UL_G/FBLV8"K8IFS);15F#<!DX]'49A
M)!->/JDM]B8[6F"E?)8-IY?SDA[>>E?D)!\SA!3NS'+,A^6\/Y#5#! @,UN]
MN7B9P'B*UZP$WJV6]>/75"/@#E6-.)3\;?/ Y..?51VW54=DGNF+$AI0^Z+R
M/7%P"<- SH[PT((._(9$9M'L.-N-ZBK2<[E)R3,F(.3Y>&IX^P.-C+SW4W6U
M>T/3?&KRX,F42QA@*P&4$1*(+N_]2;E#J:S.C#.R]:S.;%<],E+B'7FLUR$I
M85LU(2SD\5+7[723[:]/QI@K[GG:<> 0[.S:P;8@C"*!D7.3T'0#BQ<C4TN%
M!$J[49*FH;G[]8JYQ/);^4$Y% &^\8/=M6Q!YXVZBR-0=)YS@_;CMNK.\.T(
M.'AL')Z(K@X./UGTZ)N]PG7@>$?K@+_W<E)Y6V=-C]..&+O4H76(?6LNI0GK
M@O&K2=NG*%=GL,!N->C'LY*U=2P8$(X[,S/Y,OI>HR0I]_'0B(P/61 "5JWA
MUW_$9%,V4AAD-%EX+HJ]9 'D\X2@8;*-6X$.:NBLNJ5&JZH>D)X?$M3F;G<E
MV"XHN\LV('#;F9L%UT->Q/*"!9(8  K 6^EK\>\)&Q9_X:&7V5;T/"36-CQ(
M[,OZZIN&4SUGA;]*R/T"T8P'%+8](5&XDY]/8-3A=Y579?(]$ME$)NI^WB_8
M3]&PVDGLY8[4HQ )O+$"<R.J@/1J^SEEG@F(179U8F0$NM,RU&U'CEI85<YA
M3(0CVJX*31,32>2BV6-L<3.*,L$7$8.22=L:[ Q$M=O)5TH;[KUY:@OQY3J>
M?9= =_4J/85!'%/L)\88[>2=<0%FG*;>?6Q$A&C:]A=F(SZ'^-6G=_-UBD97
M&2Z%08</R;_31<;186C/LO6EKX5C9EB!_<DM^2HQ]OT3J1T!3<(:9*<FDD#L
M%Q1\/ #D30BT$#RP<A> J?.)WT,L&)Y4S8X%]4/*2F(A<Z17BFGAJ@3&*\QF
ME+H'<MA>(-+ LPFA7&^MR6?-BSH#SF=>'4FX,/K^EROI@/5BOD )+9#4 5K;
MJ01  _Z&&/5M=\LYG -0JU=_61AX$'#^PC+#GY9%8=LA@=T*;6Q[[FI10 6<
M7=J 6UQ@60H4^4#%EV5>2@-N>RO@7.O*[FH=4 ^207HC6AKGR#,7?$##=+ZM
MP/KA:X'C2ZT&U16D7]_XC^WZ/Q->!F7!T@6*XZM0CA,U":RVF@P$;K$_C-D(
MT@O![8#&>H$]KSCPF=E.(I\A6F8 0&YI73?_7N/FHS0B*$L1B(UP.LZ>JWL1
M@)$#;U>RVS(/;0=\+XL,'XEL/'-=VS6&P(C&&P+UC<%SM=#<6'YAH_JO*+ZV
M<0_HJ!"]:$%RX>KM"EELB8)E+:(C">RC%&#["NR-\[U/]3MYHH"^7:/] N(L
MI]X_),9KYX?3=Z;/G1'R?/A4\<B!HPB2DEX9Y!WNXM0XY[-,F^##9%M^7OV5
MLM>35*JJ/$<A>=_WSP\WJ/],+KBS^,M9):#L$6J3X!.]:N)9JQ^T"XBB15W=
M5R_J\4;,+YAEW@.NU9):#*Y(47_ [U<.UEW&,%9@0H F<S)6(<9H#5,":=P'
M87J;HJ_+N* >4\'LC:?6P,9/>?#).H%D"@!AS/5$()KMS"3.:?%P@#)S)RD*
M1#Z?-@@B%8&(VD_[)*-UEVEW P]CX?-*-E>E]:-/>UO?3Z@JCP'/E\VY"<2L
M><8X)#\#S?B-)(?7 [WX.<]1>T/LK5[VS5938FFY)5S%P!!LM:&%])/Q=[^U
MN.FKN;LGO;R:Z64<BQF/'6]/6&W%KA@B&'?EY^+%@,PWR^M;)DW8 LKXJ^I!
M\KHO[5N:AYQJFCX&E[R$7?,PNBLLZ" )X=4%O?0J^TB!$*C4HRMAU3*VBR-1
MG9'N57AP+Z\CLE?3['U\N9"9R[#U6GD/VW7$Z2F;U5)\A";3 )YH0-GJC9$P
MU!XQK[,E(P"=^2*1I?A9]4/E'<D#*7"\SX]8@<1Y?AG:#;Y&,-8HR<]J5!4T
MT4C@7FQ<4&AI*;T-*0-:$:VS+2('3]=10GQGM_?FF;EESC[60WFE3[U+O7?+
M<_E*'AS";(D4-E9XCL)1[-)/HGC1AV-9NIVDL+,<[&QT_M4E_Z!?+P)J'.T'
M8V9<)9X1FBH1;&B5,8.]/NC*F%*>(7!\H@"Y+Y_-8UD1Z]&X.?X7&R,N)S=6
M^7C2=<VER008*-^'OHP%#.NX095FC1OQO5G=<1/AEZSB&O=[N:J9P^;(3B]/
M3M4X;Q^HHX@*: 1V2/";+P[XO82FPS@)S@:1]OE)ZR+=E@3#?"^GBCR-GF;\
M?9[+L:WBZ4<1]U172VLL$YJLZQ74'/&]=&@C[2)I:&"YOQ'1&E:<)U0L=3OJ
MJM 8+HSCX@R)\Q/A97<4<KR7<+5L.(J;#-B@W^_#M!/$C.*8.]82^B^\VZ9X
M^,,;LSG,8Z456!OFCJJL^-@NH)19JK.K0YD?-*8B[JD1EO)Y4*9,0$>_+(K6
MA\M"*Q8-&(V%\Q]Q$*=CO3X<IA]JWP%O"T>YLXF@"A1=UZ$XB07R)+)$X;T/
MAQ/MV7:U5V5RY[7N$G^XN18QD8 6$90V;*LCE$/H-!\M<FGL(+H:]/,I$A"\
M0SC 8 X.QW^*9GPF)5KIT*L0;9AAY3;MPZ@KRS7YS#FGZ[>^'#IXZ%I]I(C&
MI\%6C*I $MIE9NZAA>^!1 2(ZL&JZ"][AAM9EU(KGP11KW:OF49///C6'@KC
M^_Y>:4,!6(%AP:V$:GHS'TL8%;SE<'/\2469![I"]>Z77EW^F4?I^>GC,R3Z
M)JLW,%5TN5B-\ALA@50^!2J58X.-")7SH%PL"W7_J65:AOT*;..U>JMK=Z11
M)K?EU6D'WAY,"YVLU[;CWR=X8F*#>[WI%4LMYX&.,-*BUT]2N*H1^U.:?S-\
MUN=-^)>Y#V-0'!4F-$&1C_$\$\,VIPPUX;?BCO3-SC=N#^FS\5-X8T?FS$?2
MK#>GA?VR$3CM$"6+@N<LI-"[?0GJ&%6"KQ6MB)O'^=G>L@*CB7'O<((3 SL>
M=#Y9<AA43W^W8\IW]ZL=(NB80_W6IAMAK(9$[@R;,+>M#'>H!^<RCAA&L,KN
M&!UA=CP8K^=LH 2S?+I$<[^TE(N@:QYMZ/JMQ71YX.#$FLW'2/=W"?WT%X@H
M0PARDZ"'4+X$69 DOAM= V_+L6A%K,>9WY;/OA'&&C7_[L'&I>D-S6][=2_3
MV?:RT9#YKO*,@(WOC04](9D"23@@P=%V?;T*PM:-\A\(]@CZ&M7(]YIV=D.
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M$KP(E#"Q,3-OWN1.:Q:/^<0*I3EV)J<OR!Q5%6/" ?TR@1C$!]=?YIB06HF
M)L2/LV\QM\B^W[>5W=#UPSNXAO'CA%)@OCKI4NT9?4V%<_BK\8IE?<0A>X'$
M-"1/9_R;.7<6 H;OY@J0'/?< 2LET.1*?UG&L5ZSU![GD4.'J<8;]0_M]6'2
M52"Q!*!]YS=C45K0R#P\%;,N@/S6FC'57^]?ZLS'W0\[?*!-[^?A,L-L[D?^
M [SA&3;.&WKO,02?[J2;&6I3I_@Y*#@]!#7FENLVLCY5/"=%.96>!>-/<*9:
M*#$0T*@R9EG%TZ5TT!+?BG,&E[DE$@_%4BA&SY^A#7[YC"-!A7&!"(=]T+.2
MXSDWP\@Y]\WYLE/(/J_Z8SO2 D30E=L?7M-(,9LJEOM5SD#&H-EF^:7(!-QJ
M=\IU?'+C82"BG"B/LV#;%=W"!GZ;/#*9MW6J;+_])_J&%=C5>=H\\\1N+$^2
MT%0JU+QI;F1]ZWPR#LG<8)TDGVJW=NJ)V0?G0?5PB+0 A#MH6:MABAL6V#D(
MQ6S[3L17&@UW6-#ZT7UQ!6;9<->OV]7M6W>U!JA# E6<.6_=F%:@3#HCMLGG
M%N73*'@9*-W7H/;H@TKKX\?W?2_.'6XZ='BR (%8O=Z'4/5G8@"-J=EYAA:X
MB]/>ZM-@T[&$G?VR&3RR"U(1"(X)[P^9]6Q%5V-F'S&.C)I&UL-+O:.UO_'S
MJ(?R-A"H:PE-6($>?H&[>@.OYYM I#Q3@#(ZS+9A2CQ47(&]"$T>5[[7CKWW
M>QZ4!O<H$#[CS[NX>OQ6A6PO5HQY10;R.2D"9SLC=SM-=.7LF4,N[4))?13F
MR&HY,J32%W"5SX#>-7?1+F@H %4*8HMNX>NNB2=O TUE$< V; M6,6T%ID1@
M5"-J]&H0#^:,T!S4%OD!M\\Z9YWU.P1OMY.-S@HSD:!*!Y,R;,B]SG_EQK^S
M G/##%<VY\+82]3;&]JLI$:]#(+FC&T_S?OEUZD&?BF<2MLU5U@CMOEF'>WD
MX9U!@FN#TP10!8)5ZRYQL*#,PKAZ(N\D#CE@Y#^.CFG<WY=7W8_#C!_QMG0^
M6S' VJ M,=&WR_!*].6K#UY*OI,BE, $#F>%IY= Y=7*FQ6?(.F32%+U)CQM
MW(W$-E4-P(MU&^4\+P%@FU_O?5W*3WD=?49+JV]RV.BXU8&3"@'6%,1A[/!J
M[<!7D&$<1^D2D5QHIDA%T(T2<VWK $K7YS4A\G*R%5B]_[-.A5D#MWA=DELO
M90^:\8'T^R5KA&"03&&?G9<!KDU3WPC6?BRKZI:8SMPDYV+O6!<W\O;NU'R!
M7J_5Y'Z&42I2(PA=^ P&\C"KY>#?8Q#=X'F"$L6C>YAG0>)C0+5<E4:.7:6O
MR%1(@Z;'K*'?UE >$1+-(8#,(<H(1BAL!P+-@K7KAB#S,6#3(B_8]/%%Y2=S
M]\O)]V?"5=P&*,=VY<%34&*$)@J=;3H?0<YWZ"%<FM\XLYR.?H J&I]ZQ9&M
M[!@[J70O?>OE6[_.B_^ E9742[#GF2LPZA91(R1[\,UK_=BJMY3^;S35!W(%
MHFV'4G;:JH39*;26T9RY-X'UWMA& Y# MHI\)/:J@]4MY_CMO<+F#]=V'$OX
MY</"0H:RZFD!G^(56+,AEG?92Z#5/YI ^X:&+VXQ=LF8X.24-SR$;T+;"XV%
MHT8>4] $YB^T/&HW:3OWV.HA-_Z3J@&\]44IBR3:Q/3;,_5P;69P6HW]IWN*
MBWDXR$5&W17HK<#>H?FQ!$]BI-U"(#8!+7T--/5?F\NX.EU>&=&CJCV8 ..O
MS;N;5RD%4TG'D$CL>2R@16BSGL3W0&C;EIUSCS(#'F'[,/C1&9TIN(:3$UUO
MYOMO+_<2 7TDUP0(Q]%I\]Q,_N-&P\V2U_P:-4 /2D8_W_9R)0_5,BNK+P0%
MI3[,9@HCG_!28?;[3N)X\%P^FTK5EYJZ'5,R'K;C]:%I>7KGP@7>GG3,H1DZ
M^Z8G*/U]RC:;BED#.G*$QN4KA?QN;V>:-O/M;>Z1W>W3%!_CN'N^A V6@JLW
M4 \0FG;C8;\.@MK\<+RB\0TL48WGP&YQ*OQT)=AQ_DYOU'=EW45\%'-.J/GU
M!2=$C([A$;WW:^+VSFJE*>:K)L3!$.%Y\)8R &D*RK9SL_C/**M%*N1P,D6$
MIIV->C@40'BZ KND5\Z1874/+1[6J;(,MLJ0X6>YFC\YV)EJ''VI\L-8B#%I
M2II"I@-[T+,'5F#P7?P[H#]/%GJMD(^Y@Q3(6,UVK^;=H:OP[=PCYWI_S[L#
M?L\,7$V\VS?*JQVI$AAX$]ANW=S T9PRT&B)0)L\\!UR?YK)#SW1/Y0FP]':
M:$9DHQ#PBZ,OV-C*+FI"5,+;2P@QJ,.-@E$!E=,U&)TWD'YZ^)&WM&7V[F&W
M[,X(]SO7MGO=.S1A0C"EL&?+@+T>-0069+M1T?4VUY7C-T3QC@!AIW<$,-JW
M^QV:G^D*@8/2XP()",?'^@A&<S?PJRG,^A484V=U%[]?\0-LZ<-T7YY'9O"E
M%1@"04O_%8;JGR24^(WH<>JN\_%Y\' TLXM4HU>[ MO>#2J$<>^]&A54\M9:
M&EJ\FVG/E/&;0L28AD+JNTZ<:/>K/A!R1 G\VL"[^)^58-@/K6Y^94J/?R3U
M\-?^Y34F,-R:%9C4%T%;*$G5D)]/\$+(>LY#4CW&Z;!.)[S ->1<1\___H$8
M(EW)M(C1<<+P?,N8.I9U.XQ%CKNR][95)B[G![Y@D+YX5K@E"PXJKWH(*_:(
MIA?])3+F"^TFBE[JG7E[H9L4\ L,N]%;YR<D$(F'_B:>W6,-J8 !2OI=U0W^
M(P8OK'%HJMN^VW4%YK2<D0#C2 @)1#.A/QQCOX#'0&"+M"[@AX%N9G..VO:1
MUR/P8[_LL7GX3D*E9S1D@\U:D*01EB/)E&&!3&7LEE#?I%!2Y^ -$YA]GTZR
MADF-?"CJ =9+I$VM)L+-.B*B.=P MJ<5@L&3PN"65IX9> B (-JZ:(Y&$UP&
M,]6"EC<Z5O -KUB>',/ER1?Z%'_^0"V[ETJ+>[=%E;4-M 4?V2_]^F,Q>8$>
MFA%.JK*G$H?M!6)";.-Q=&NIQ:S3>DH<4J=D9'+KSA)O)[^Q![*],LTM::-M
MW]N_/RZ?PPQW_=.JSW\\"/MW3K;^>=NQ-?^L YCNW]=S1?S>,FH%=@6>0JK1
MGWWD"8E7=7]?%3%>=2WG>^)XV=H7U:27F.E0VW:21.D'@Y-3AS0FQLJ_-W\A
MD@B,5!)YO@E-ZVB#\Y""3V-K,YGD.0TVG9698.2H0<WQ/D:>"_;W?GG!ZLF%
M*Z6SUM2GKL>;SORD/CR(_ W?SW]FY,\S!O5ZC)#CF.$%!I].-,E,7&W?/MA,
M<^$G5_\<B.&2S35I#;/E)_I,#)TZMQ_<=O?$6\5K9='@-IX.L,"=XA>@)$"'
MGA689Y?G&RYI _IJF1)0YPH067%S?M@G-;=MSHHQ9\PN/YC*_)#A0&,^W"'R
M4HJHJ4>#+6( I,3]TM:RV5O^.AM[C_%NX?1#,*_3=6FD'HB>3#]' H?&6T-;
M5F!K&V&";JDSWQ[C7/G/ZC<S"0JM285C&8/2GX_4I40[.6R]#%]W\J1$,)WM
M0(^D5)';:PF>+MK<8'Y.8)E2$76>YM^,D#*R#[[TXBO7>L3+X I9XGH<<O[B
MK6N2B[2$0C.-?2*M06BV+7:(VD8@$V93BZZ2Q-/HYD R ZOP=0P%^,O7'GR^
M?^:U;Z-OT"!\4Z#U#NR1VH"]3]TEQ=8WP3@(8)]"DJY5%*%:>%:34]<TYNLT
MBZF6)#'1!O3YQLS2XW[(.3:*G:9KE?EH5V,XA(^;1$';$O J,,/#XGL$!Q\4
M#?Q$THILV2\S+F42+3[ZL<@OR>^F?&^<.B\9GG%HL^XHZ H(<_P%&S5X+OAN
MNC1^!TZ$(TSMAN'$!KX;>3X?!AHGWY7I8F5N:<J3/'TSTCO%[8B375KOU [#
M[Y5CUP]O!S38&N-H"+QR"_F/C"S9?0QX'$HM1'@\-D&FO5&1S,X930I6PL8_
MN=->[#":6!=WPOJS6:J5W-O.J^+%V\X53\)N8-A^W4F!SF7#A'&K)OF#R6),
M])S).'IC"$I^0BN@*DOLU5P/5W3G9_HNQH8+H?9?HW'=D'%G\>.,3'@;!.\V
MX0X!Q!('.C#?FKO[$^C&4>)9>/@XZC:<PNI=N?-R?7[\NOW"6Q6DYIN_TU"_
M_4LCKES*Q8;+ BICLG1]3<2-FQ3V0Q^-SK@DSSFM=MTY"CL-(CZ+NR#CH5NX
MFOY=H6UQ F >2%B611+F"_,%TBX80;08G??-YU_[0&1"(/S1\27!LA.#X&TE
M(_BTFV<8\HYRA;C^&Y&S]ZH,Y.'D&W?C')3G*!K95?R@J&@M\@VQ=-=2$QA!
MB"!5P*D?0PVJ UG8[GB$0RUJFT'>I0!L4NG4KY':!:,N7N6'V<GRF9_YO]\Y
M6"<$A?4^_!"";-^*H6&9\Z!,P@CU-2(9YQ-6[.7D0F[!BIO&;6&GFU%H.*M=
MJ@&O&!U[[USWF8 /SPM$CD !Y1J_6*:E K>9GZ@[4\B.C=O9\W.A='HY*/F+
M]R;"\PATU;6+"^]OO&IML+_Y)9FZ51I2,R2:D8"I:0?E0OM:5=7Y#ZQB%I,1
MS3+&V*<AL:W+R5VESS-O1C;3Y,GDG"_WMHY1K]K:67:*Y6$K<-#>-Z01FLQ1
MB&GSXIG<]8 MJW93A(E5?%9I5O&6ID2K^#='&GU3)BF.$-RF$8=MN'7\6,K%
MQ/GA,"Z5G^'7J.+S&IE4AESDG^S#]"&A:+N=7+<1HF</GN_S;.'(_9#DUR88
M7J^KJ4$;/Q7ZM<A> J7\N47LD:; <0J@1FJBQ\F,7'J<;<M_8G3&8==TMNJ$
MV[LEE_K%,D>V_JP6Q ]VB7*1@*X,]_K@G1/2&D#Y$]?-1V""WDC7G#.S40G\
MBL?AZ+T@?-5HY-B$J^PB4"F,<623VR^3]BB!-G!<A>Q7WG[E>7[9CA68P:(#
M@5&"8)]W4=I1/4!@T!'Q&=,)F[;W-NZ^.GBJ(%#H,DPVZ,C,HFH"#%R&4,0'
MP;#!C>XX"B,*4_7\%.IRP) O5K+I$_.">X-"<;X 4<W1MYQJH;.-NT<N;ZVG
M<.V;#\U?AY_VK55."4T9]5F4A^8!T.SKQ"A?PA</2"]L\#3:;I5#_:@UI[.5
M*W+($N]4^I0%DD?YZ;.QX'E,!7%.HT#?,BNSR7G1L*ZLHRYUC'+\:1Z\6P'"
M" \IC =VVX/C)H'L@EU?&@O910Y'I0()&:.-UF-Q:,8W+* V<J8FE#AG$E;T
M873;)Q1BAJ,2FN:K%WZ["Q][/MBNAOQ2MW2NRO_$"BST\-F#N6#40#CZ-R)@
M0!=L].-!CV@RW0H(W>!M!=UJ.-[ B9 2@?2:#3G!UP9(/H*W/_2U.@^0LF?[
MW&#\#S=22>W3? ZT*I;18>:<)&$X;<:DY_GSB=<H'=[IC)IB94LR3_@:*^]:
MVQGM/G6*T%.AGU,""1M^?;TQ3YY$5+*/(EPF)E$V_R0H$,7X"1U,TV@3T  [
M3*C^,;A0E5 3O^V5M;+42'WMH5\^/\<((]T"L29.?!!NM1"'-A#,Y#^/E:=-
MM2$2N3^^J"9Q]40TB%N:W'+[V5A0$;)X?0ANW+023,TL+8>C#W\!X! )5P9]
M(+>Q^GEI#6#.#MI,&:3A$,#)P!K;(];N ^[B12K75%+R"[4%*K=85A"&^H:H
M7H&!LB7<"N"W"X2"KSTX4TOXR>Q!/;L;(.7.0TG-Q6L),, '8L525@)1.#OH
MB[>!/BB3?7P0:S&?N]2N;Z^Z]1:][O6T]ND[N8Q=JOT_D51T#%VL<>,WTA!E
M->GVB$RS75@0/YUJ(%=XQV%Q9.VN=B&R]^+&74*(?_BPJW_R7T./PR$?P]S9
MOP+[>K9A!=:80?R'YRM-^'\TLE*WR]^:9-UW)9T:?."W[Q9JVONN&(9N_)L>
M1?\QWXK^X^3_TF3G?^' 9ZB=@]6&.1NF1>L/!&ZL.K'9)5/LN\^3/W5//5_!
M47V6<4,-.,4)CS]ZL2.JW2GS#\^S^&/VZW_/._DO&WF/_:+V*>U;KRD\YKOG
MALF3^Y)>K2-;-5?]9="?VUG^;_U"_S)P0BNPRP1G$QC0J%SK&7:U/T^\[M[:
M6ZOUPT3WE4&[B9[G+U;]F[8[?_@=H=FB9 76\PCZ_6VM?VV\\P>@80KN>$WA
M;U2@+/4.M/YE;+7/J7YLH.B6?57F<\=?&)\ZJ3R2T/!_;!6]WT\?X@E?D)!O
M'/P&B<32]R___W<&_B./O*KD'PU$CBKHS/\2;H*,S/[7QJQ'?VA2_$];$_U[
MG89*_WE'HW_::6CH[UNJ_,V__[\-[#]O0/+?TK;D7UJ7#"9!"+, HXC?"@;5
M ]:\S3@%=E%\ %T4Q&!C&Y&#]=AQP^2=^ZI?+3KGG&&]_Z@U>RWGG-1=S5&S
M Y/RR6IW90Z&>3;-TR@G.66SY-L\*]PEMNT\-1$#WW+;R*U@9NG&&9KVU\'!
M#/OG'G?N96WEGGNGDKC$NN*[=L3T#9IM739DS,WE)Z[ ?$OA@HVKF>?O!C M
M!F5$U(YVPCAA>,;EE6@A0')(//F)3*>=<<1W!' 3@]"T#%O?^_R/R[%,!2(:
MLC5@'Q&4B10T3QWGV,?@D./*\8ND+8"=<DV?KI_R^>K7COMFU=/V;WR98WP
M=BMN!;9?>7C76OBP#W<24L(4,!@8+0",6=W@IA68,X!A2%AZYF+C7+<"E$(7
M<Z]KVVYM13X9:?&0?M^L<T!>U=&_MM$XM_("OQ:_#3S&?RS8*NBBE].;MB#:
M0S.;70P^6,49D.-P'LNZ]PR2/UOJUJ1>Y0R/*B?F;_R5IBW"BL*=^M#96;R
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MV'6"C:)/COO-"M A<M8/:X6I!U7-W\T<11S]Z"KVU^F(@#V=?78%MGP(N9;
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M8*T"Y*#O8H.F167:O,VGGV+W8\9ZQW21.RK,ONQ1>[K7X2YL7=:OD2;5#>7
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M$_J\J>FF!8Y:X&#OV9*<DV:4']LKY;#71VDH\FCN:9_2;#L&#F39)T$J[$J
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MQ78IUG', K0%NZ9>PY%IXS[G7""+OT%[ !UE@-S*7!]/I!T?>V1QCRX5IIB
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M%YLG+#11KT6=[4+_>L'/-LW?4%S>_41U\WR(<D.QD,K9JHZ-]."U+0@?EF#
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M;%O<.V</:":Z7TSR<;^]5_H7:&XBA-;-.HZR#OLP[]-#M#=04(J2IT8]@%W
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M(RM+DU&8I_ID9XUHG*?MB4<E&X\\!U1ZA[\+[6G\4)'@=)2MSA..9K+[,5+
M.GN[6+0.1@2U?OES*3!+32EB8I.;Z#Y^DR\9M5DW'BT09+^OF^FDE:HBB4\Z
M)R\^3MQ#2, #QZ19)P%QMOWV*CIT.-.\#Z/<DD85O-=D58T^R$Q\ICKB/>&9
M,5E]@ZZ5M9%^LW:/"U7"+JI ..NHK]\OZ%PP 2O-4P O]L*37Y":L?U/]J@.
M>S+TT_4G5*U;DYM%Q=Q>9JE_$X7]GM_)7_<PMH+_,T^#8Q,*'$CBR&+)T/>A
M2<3"(O%N.!%A,]5D3A+V7IF6S]W42O[3FQ@3<FJ"+F5N>=/EF^ZWC-T90]6E
M47$CS]ERJ%?#V_MEG'CC>&D+H^"[WY9ZL DXR5(@F-':HXA(7C=:#7:O]EVH
M"-Y)=%#(_17HE]QGKL*P*?(]Y#[LCR5<Y,B_YD2"+C;%>[\%$>Y4N/E[ 3"]
MR/3/X)QE_C+B&BSJPH=R$3^K&RVO@F%+27N]&^QAA[?8I 5?$*YY"[+VA*;M
M 94 ;%E54Q$I14\E-=IOEOL'3,F[P=8*=5RR$;<"^+]@R:G0YNG>]2S\'LPA
MWB>L:J<G/!D=P8:AKTQAH$%=!SH);Z>K0P[X-7S14H\W[%=0J<\+<"B\/$U\
M\D_C%F37!DK_TB1O'YCF-5\V^=FE!!2P+P(9G>JW,73NDR?SRZRWHS8VT0L&
M0DI%87.X\:#_#RR#^I\\@22 6$YB.&)G$:#),AQX,DET1W);J"[]>G &O_?X
MDD20A^8PI"S8/?6-LR5?]F3QK5U?;^R)69#A ZR@G+W+C&K4*OL4$M#.2Q9/
M1'.V(-?T>Y(%-I[@.ECXUKT;OADD__[H.2+> TO&81GGD+-(GM SQG&+G9AA
MU=V/$/6Y8>$UP6;IU%A;C_:Y5KK\A1 O>J;L)1<CY?W:!]Y-_5]W6E4;P/)6
M&PLU$K5WFR-Y#(8>LR%HKUQZ$Z,LC31&(7A"*NR#'#V& 5H'D*0B4I%BG1I7
M?]5R=,C(M+N3B;ACZF(NFFWPZU&#>JQ^N=OV/O8'NG!UDLPZCDP>:P\03JMQ
MH QDPH/6!9;SRU(P+6:,MLDOGH&FMGOC?G[%4,>]70\:%HOV[+OF)+#@R>+C
M9C37S8+^=85KQ8K][$E17\;[6(C8%>AV1W=%/55Q.Z/U&Q^[M/X;/3^(CU[P
M#F2#_(\ IKM7<;.1(?M0KCV+^DS=O,0R*<#V%!!/XR(NCW=:T,R]AQ'MSVJN
M9(?_&MIOH,5X,S@Z#A7KTN18 !T4;70,H[4_WS_YCL/SM*>ZS;&J3#W=LIS%
M:-WO0ONEZAH"2DZ=5-<.3@;FV#<Q@[C&K)1'!*R2Q0D@IF>3,"%6:I(7$>E-
MG7IO,A$#"TL,CKDRNROZ5.]NN*D@1%6!L<';?7!;W1VXP+:Q9SN@CW-QW\?^
M'C0.:+[.&$E*7O<%N13K@7-TMA?VNA#FDX=ISX "\I )7X[QH=U_<"DDQMFL
MF3D:E&Y,V8+,0:G0^QQ$#%.K.T4#H\"$0:4Y5D&;%V]'=UV+9! P#_N44DI=
MK"VK:R_&=;JV!Q _95-U]T_TJD(G0^K6].G%;^N[&@O\$JGR3H,:-TNJB@_N
M/*(A<5+V*U0&NZW>H4405[1GT&BF]&>,T6[,OI34KA0J7&%VUFN'2C&\/=_:
MQ[18S[+_8N87OK7/O6]./53SJ2@Z&7783K4DQWX#-@7MTT_T%@ FP00%+MBE
MC;JKZ]F#.31VLRD#ZY!O:]W1^#:E*'__!ROM:Y$*SGO]]\6/^'(DN*5X?P31
MU^HMTW1M"0QC7; )NJ:DMS?*O+>E_7'D+V6*1G"TLLT\],D;%,PUQ!)JBOD(
M9YQ!S/*SSBD>AHK?&558-2F4>^I IFL-P"6;8Z/.,>;NG>K"^<6$:S:7I"K$
M#2O[..V]!VA9$)@T\C;T^E+ZIKNQ&1CQ+/>QFS?WM;EUC1V6]EBPVC\L,-G)
M:' ("9-)K5,>,[-+?UG%?]F_'PMZX9HT^SCJ9VC"%@2*OT%*5!5A:G9*CH:]
M!' #<B:FV;;[?V80#Y:Z.@U_T+A]7/:'A3I 8)2#,5GD&S!'):4HJN:1?Q@U
M?2EGVA17]HD^B+Q9E!M9,+,OO>K@GG-BE,PFOB&.-#>;)X868N;6,^$]+<3^
M1IHH9DA$!=F/T9NNC?!RCCGFL#=$+B;/5[3=T##99U8A,E X[[KO<R:6I0R(
M,A]1K0?ZN&?TI5 Q?8J9B>UZ';4 M&]C4_-38UF5H6;-W*R#0H%3QS\WL3'R
M3ZFFEO3"Y^16N@X#RDI.<\;&;4&D_XS<]5)THTT=#BFYUO[&0 _H9$?O&);(
M/GE-[Z59>J5Z?BFSCO66FX_U/^$R>A*88Q9;,5A%6#]=>@LN)N)Y5GV_92[]
ME>6H2H,4_Z?WIQ_<^VB@S5\.N#,:*:,$:-)=>#?B@;?(1*<YI4Y\IK0PXU6@
M2[=.C)W\JT-9O3G1/O8:.8ZADX[\O8KB:48Z<!F4IV?3EZ81FRGS OCYB9\N
M 7HO(_;D#.R7JDTOD7C_\.1.19J%&682VHA<ZRD[6<,;PZO"M,B>2KDB NMI
MQC.'U2*U((+/GMRV.Z8PV >)^N(J3R$1]<GPM"XYTP%Q88X7@U=*_G8ZG!JC
M<N[XC3,FW=4'G)TJI=3VB.T.6W4C[<"';#_!>-G15K]=PS0PE!_XY6E@301L
M>UN(20\M!<6N1 K?.DE8DN%;_E>!*)?MK8NI6%&>,$K<&2AB1@UXN"9VFA?/
M/?M[(MCCG4-,<,! 9-2^/2\@9CF6"@<:MG<V$:7)Z_1+C!@;@,T0[*]'I76K
MJMGCK*=>-N?+M+N5YPCZV6<K\VF<XSO$SY?]\.0^E0+9;[BF+0B]D7V0UV]F
M\JP6,X%7^A,J9%NS(NGV8VJZ]M<"<E3]P<7$1=GHTG^2=[Z6:!O<YUKYF<]:
MMAM]AUL.-IHUFW?VS20&CO9C;#R8<&DSV80I]I=DSP==V'-=)R#\^^7!.+$/
MD\^5J??,VW4&.Y78D9B!Q1-?J"!2)6Y! K+VM-09<VL>>PC0@:8O^3'/8%41
M;&6*%I?&J&D4321TO[@[\M]VES@%W2W$O5IN5>ROB<QEM3R$31L.S;C1+AW^
MB+@"T6*\%/I1=P (9*-X?5B%KGWSG . +?L2P-^[J-WPY%47XV<\M<JS:L[?
M=698XV@;ZD/HXY_\@IG-JT:0\];1H71Q=C!O"-^06$?!B?$^XY2:0D6#"@VF
MZ$99(LOR>K\6@URC#'=?M:NAN#ZN?)A@$#+3F>L'><BW<O%_4H/X?_4AFT3#
MIN!%NQ0\"+%,=:I8$N6'7LG1.<?:H,]$C4^[SE0^>7R4_X7P?)T.MW)[E_TL
MG#7WV:A.!#.Y!=GQ!ZX2N*E"6U@VR?]Z=CG8L*P_@MB3T^FTJXYCG+0&YDRV
M.N"<@!BC ^69V_Z;<TCX%J0G#D[.P/_)"DW:@@""IEL0Y6*>LB08DD*V("4Q
M:/ 7[X_C@6^06+XMB.A5]N$MR-@0!SS;/32P!<F<I@AR5 >8OA3_/G'@.A9P
MP4EQX%1],)'O]F>1UG2OB^ ;UWG=L_BAR-D.7]JQ3Q.9B7B0SE((4(8-:=.V
MM0=,^?E!]\ETI0ER5$AL/EX_Z0V)8TCB&"#6-L"@!C;;?7X+(N3/T8#..+7'
M=JR19A9MN!_#&^G2OM#?GS\+@C"XCB4\PLE9R*'U01M\N@5)R&/J]_!4V%$<
M-9P/;V'J2A/;9I2^P(9->[&CRL)>W%18T6$DXOWQY#'Q&7&6";<-3BF"4VK
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M?%KICS*#RA,X)RB(/3^8RXLBG_]PX8C01>M=>2'*3@7OT01?ONB]2^_\.6X
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MNCR%1K;303KUUK7W.1PI4OP,6?;1(YLLZ!/78^)[10C:N &!QRTT<;?TRH/
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M-O]W#HK9OTW^DXN?O$NB^>__.2^2V?P]!U%GY"R,+LQW)E!0/PD4;.&Y CU
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M7I?;ZV/'BY@&29@E K*04(AP$D$2XA F"46$I(&B0JOEW_%AYD9W6RF;EM!
M+M??*Z#-#=;;ORRU I;I="= -B.T\=!Y)JT=:HV$VT/@#ALZG\? )=6<&&E2
M.CFO[7/*N'#U"._I<&?^R_7G+UT@*R%Q1D2*8<BX8H@D"R F7#E+:<R"+)$H
M2NR=I7,CSHTL3@>I?E)"FQ8X- ?<POUQ!:-O;^<"@AZ.?1O#X]Q].3OH]-Z*
M"09'G1.C&UVT@C[1%_-:.4=W@BMG]X/X4;\K*D:6.M7M1#-:@:50;)1 ++,8
MHCB7D(HP@D&**%;_2E(RHC6T$QGG1FR=]--WBG9C\?,\.1,[>F;6XSG#9[H.
M@][HNG"/5A:TVC9IQ)ZZ2[LQ]YANTY.;_46[3T]I_I$=J9T:QJI#M9N17[!C
MM5/HSG>P=CO4L(7*D2I[']:UT#U,FA8F"Q2G69XA"F,22(B"7+D"*8T@(AF-
M BH29%;DW73 V<WFS@N*7H3<;*7B$DC/T^G14I\_:>3^#+3,X'<O/7-,$7*Y
M5KDXYJ1+%5,$GJ]4C.\;V(9OO;K]*LJ[-X+6OY)Z4S8=P#Z+^V[S18?"BQ4K
M[LGR9J6I[ZLRD5CD0<[B4 J8!XA!E,84YHJ&( U$F,F0Q(@(&RH:)L;<"$J]
MB+%EY[YA\)O1DG]0/9.55@!J#8!6X0IT2CQV1P(;<1UV!!P%E].N@<,DF;:S
MX"BT#KH/CGN:_2;-9\$W31_QF]6'C=[P^2C;B.7U RF6.LE'.7U-41?UW[>$
M?6M2P)M?"+Z@>1++F#,8I:'ROS F,"=Q!'&8H4CB(!;8N-W.*$GFQH"M!CK#
ML.V- TJM7;<:$TIX0)J3$[>M^,.ZZ(RSW>5-E<DLXID^MWHH/P]TEODH^T*D
M6V5TM+TK^Z5_T@JU]<1 I])4EC'?_YC,0A/M<GBWE-4FAA-TSVQ5C'O^9!L2
M3F#8WW9P\\ !+>G$JEB7K_6RH7JS$<H>6=_81"I?/9$9C$D4*C>>1Y D'$$4
M9SP+:)HGR/BH[,E1YC9'?1&E3I5\#59:U"O -P+\VV;Y")(KH*4&/Z&_!-'_
M;=/6[23 ER<;)[#YCFXV,BK$&BF!$K,%RO[,Z6FD+!J+N4!LJN9?0Y&S:\EU
M"9%S;;-.WCM=:ZM+XC]I/W7QXJ%)^?^Y*92W^JY8%;5X7SP(?J->C]5MH7BY
MK6WPK.3C;Y60F^7[0HH%SS/)XH# C& ,D1 88IJ&:E&01%$2IH$,K"HSCA%F
M;G3;ZP)DHPQ<:FU L54'D*[AQO>^%"WI2M%N&IW 4BEEF_\_PI9F>RM36<@S
MLV^-\V[?.#M-MMU0#NH$M^J ]^>,,^"HP7A4W1Y&&"'/Q,<5QB-W>*#!P3,'
M;DL+]7CQ-!_P?4%HL2SJQSXQ4-&_#LM]_2Z6#^+7]:K^5BTPR3&+J(0R12E$
M>81@SJ($1HGR9<.$YRCB5AO3 P69&PNK%SRTW)H>:@+#S>D)@/6]/=VH< 4.
MLH:W>ESI4R94@$^DX-VF]<>5RRWKD2 ZW;0>*LNTV]8C$3O8N![[O&'\^+54
M VW*QR:/L=M$Z-AZ@4.)4,XXC!@+($J2'&+"B"X3'B$42)K+P(8"SXPU-Y;K
M-LSNU?.^-6>,-BO>]]$ I>A_K^L*WY;DSG[[V01_,_YSA*IGBNNE;.L8=>>W
M=*OI3E1W5&: ATNV.C?<I(1DH/=SSC&Y9>*N5ETAI+VF-NT.YP+%H0@BC)0#
M)I0_%B0"YC*.81)BR;!,XS2))VQ1=4I.FT]NPGY372&Q]>F^4X/8R[V9 XPC
M*0()4Q%0B)CD, _45T>"(,'*_E2@<++.4>Z,/$$;J&,FWFL'-1/[FLUI+VHQ
MWWO@X[LS;?LO/>G]U6HZ@PY+EXPPBW9))X7\8_0^NH2QLT9&%P?RNR_35.Q6
MW]Z"I$@*F0;J1=!QQ3"FD.:8PXR'E*&,21P:11B'"C"W%8KZ'I"??9@MY&[W
M7X8 .<=]%ZW#]!LOS]%[B0V7K0RSW&AYCM#0#9:#YXRM*KAMY-85-E>N8#=L
MH7L(ZQ68X!]7GP7;E+J\A:+@HFK*@^V.#V".HR1  4P"02#*@PR21/TD,1-!
M2%&48JO=:*?2S8T:]^L3=K7Z=06]/;U KQ@@M4EWR@DL;.@8OY3=?#O%>R;;
MV>/JHOGT\?A>0]"HV)5'!%Y.GWB!WT\Y11<"OE#-18?8GB[,Z'*083/$V[O[
MY?I1B"]M.[KC'OJV36CCC%=?US59[O]='Q?\L*[_+FHEZ?IV5?Q3\$4<")'+
M+(0)SC.]5X9@GD4$8L1YE..<Y"Q9/(B2KDWG"V^RVG#0OL3^J.BW5;F5[DDQ
M-R!^Z)]%DX).EDNPZO5M<]$MCPSZ,[_95#(+DTZXUW*T2MQ6OWYKI3D$KC0"
MCZ(&.YW43'2G:S*ZFTJ\P^]R6O$G[*13C'?,GT\W_@<<6N%./[A/F)5Y3H)4
M0!DQM;8@1$!,PA3*(!-A%H=1F&.[NG:[A\]M::!PO5MS7;WSM6;P;G/+MG+=
M'GAF7#L4$L_TV,<,_J=8<@^%I8YI[;8NW=[S)ZY&=ZC980VZ(]<,^UP_B.][
M-8'+]4K]R$1[GK%\_4U/9S>K_2N:$XY+\;Y8B9M:W%4+(40HF<CT1\T@PG&F
M9D690(12A$,B4V97F6ZT1',C!J40V*^#_40EH#/O&Z5 L7IZ6:<7^%UK!AK5
M+&N,CS>N&0=-:C+/Q#6)M:SYSAG"+DERO%"3,JLS#)_3L;L'3YP1\ROY4=QM
M[IX>]/LDRMZW7!":$>VGP9@% J*,I)#J#6(LTB@(XR0*$JLS(]XDG1OG=_*"
MU?.SYO?J7Z(3^@62)RY:W',2A4L[SC^9HG\+=A4'NN1/I3'H59Y!5H6I56:1
M77%1V#]&EH4IYLZR+8P''%@9;E.6:J@OM2Y)M^+OU=NZ_$I^O&TW-KL*=(LD
MCF40IP*&A.1J0HDRF(LHAT'"49HE81@'TJH\G,FH<YL<&FDMB\ 9H6M&WLXQ
M\TS$G;R@$;B-UVF1@9(9=$*#GSJQ3\^C]N7@;&!R6A/.:.!I"\/98'%0'<[J
MYH%G3<B/UZ7@1?V:E.6C7)>:\=I]]460(4922F# J(0H)\I_U>>@"1>!S"G.
M.;%*<#@SUMR81G\BK)$5L#UA+<^1G,'6C'$<(>:99S18K9A@7T[W\1D#.)P>
M(SDSW+3'2"[K?7",Q."688SQ22$L%#&U7;&;</V"THR11!(HFE[4+*(0XRR&
M,A4XE6D@L\BJL^&1,>;&$%L1VT9C5R#^2P#NBN52KW2Z-2O9U-_6I8X-_3<0
M]+\LFJY)S72\=RY ;XOIU[#Y?12$N1W5'#.*&<6,A-HSM>Q0[LZH=3E(;>LI
M=\QR!@67C')LF$F9Y(R>SQGDW*7V9:KTEMU'V5+2.\*:!,]KKOZA/A>R?+4N
MR_5W]1F\)NI%4']:I A31B(!8Q*R-@!*@H#"C.8\"5@N66)TSG7 V'-CFF9?
M?"U[?T1V&EP!LM4!T%X)Y:ZT6IB7;;(US7E>\0RX9[YIL/XH>W>F%Q[LI =;
M\<%K[U";U\WR"/E$U;3<0F]58FL@>&<*;]D^<;)R7 -5W2_2-?01 ]-B="^
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MN=&H_D#7*[#9%QF(3EC-KM6&5@4OB'W_LP'V,0X#>D3=?VAPEVF\)_X5>*(
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M;_D+R#II,7]IC)').[NCXTT*OI)G&_C[L*Z[$"*_KK<W[-@"L32DE&<PSXF
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MM)[[@R.?9N\"OA>W9/DKJ375O%ZOZF)U*U:L/0?4_.WUNJJKYY7R22Q3%)
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MT/TI%H=>FA5*3ITULY&G]=FLT#APW>SN'D95[]:E*&Y7;W^P;^KE$;I;FR;
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M?X3WP&PFG*5E/<^OC4*0:HW OM9@3^VFHM3>=9WJH-']"K3:[S=[!>U&0:T
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M+$WXK^##;DQ5A%!+D. %O9^RTG:/-UQ.K^WJCGGK@P+7-*>54HXHN9SSZU^
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M^SKSMOEW:KHQ?MRL'S9KN:/;IX\;XTBDJXJ2_K%9[1_D,D3:YJ09@Q(9VS/
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MC:YAY<PF76#XI(ZSXTS*$UV:OB2%SFO[,4#9VUP_YJD*VJ@S.F6<A9('B:8
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M?]) <B)BG#DU>^H>;FX?Z[%2UZH\(UX=3P'<ON$K*-M]U_ZP&_E;/\)62KH
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MMA>C!$,6A4S_2E <!3RA=@>278/,C0.^:-M=%N &K(VH"R"TZ?=_]JLG$"^
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M.AUEVFRJBUJ>Y%-=OK+?Q]U8.9_DMNRF^VFSROG35_EC]ZN6\%]+E?*8ATD
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M4):Y<=A1'>.A.^JS (^5V$YY83XFZ[J?;L(I&)GR6N@_4Z7M#M*[M%(;<*=
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MM=Z8HECY/$Z34*8Q@YPK9L9N"FF4F.LD&8:*L20D3M/UY::F-FD?JB09Z4G
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M$VA?_"!=2]*^TCMAQ_?3[>F!YPKC2B4BV_!H!@[.EO]H^OWX=R^^4(( :A3
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MMQ+%#Q\?]>N^,2NF=P]T<R]S/?JIXD$2P%C1"**8F>5,K& 8(A&P.$N$6Y2
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MK/#RFG73WN*X63=6WI]DW=A]JV/6#=VL-(?E7^2FJ%IQNUCNME+,XTCO'8-
MP"33JSLD,P;U@D] )K,D#@BC4>:D,WJAG:DMWBJSBI(RHJQE!Y[DIBPOXUA=
MYA*T=LSB ;"!*:6VT&B[E25F9J"RTF/.23L,7C-*+C0U;KY(N[\GV2!7/MXW
MM*D.5#6*GN]_Z1&XHLNZT)4YT#(9@47\57G$]?;YGW)]OZ%/#PM.-4R2YL6B
MZ!"'$X<HTUO% ":"*8@P2B%&DD"584R#1(1!X,0KPYDZ-6IJ!OH4YXK%3%[D
MSY;!D;5.#GL&3== X5O7L"KO+X =^TVC6P<FT&:/5FZ6BLJUG_L"?VY]/5+
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MPX;:9*IB1,.$9/.?<L/6UEIR'4UQ&7]-@P9<+I7&%L6'7(7@NO:''9^-@?'
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ML3(W&#>;1:ZWVK?%AKN\C=8?O%/?Z:\Y51&+)!60)"0U51PII()QF 91FM
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MV@W\,VTXC?I]2\.]VGL3P=-FK1:.&_]S( H29!(G 4PI91!E 88LCA1D1/%
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MC3$7KA7<Y;4@<$<UF[-8V_&&-P0'YHZ3<(JO-7K:6-_5\ZQ &43WYFR#KZ.
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MB.D=:I9 S%0,8\6P5"J2*HW=-!BZ&3(U$N]<PKQK1UB&?XP []#1(MH%:'P
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MXV)A9W$Y7P'L_"/Z\=M7\[SBX=MJ^9(+W>)K55!L(Z!_;61&R@G<3,4Q38-
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M]CQS><]5D+R@]_<K4TVBK'C]7;[(Q;/\DB_DY[5\+&8BC+,0Q5C/DAB%",L
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M&<QDFNFADB6<T8!2Y'3&S;+=J8U_S6IX52BPJ1WUI[8<-*;;Q-$7=87=5&@
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MM-MGK.XS4UNI/&)E5 S^Q^S35D)@N@&S%&&T=-12-Q7^HA^N\H6^HKFU_*K
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M?>NXM*?&>,=9W8.3=K(YP;(OVUN)^=[1GS-!4Q(EB,!(F)1$$A"SOR.A3).
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MARF288D$#F"JA(2(QRG,,!=0!2K@(68A4TZ+D%V-38TEC&6.2A1=4-H1@B^
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M2$P"N_F58[M3(Y3**D ;VX$.P\#Z08*\]L"$\_/*AU*/O;S>7N35I4NZF6A
MH >FI"EA;*]X.Q#6(TG3KA]RDQ*C#*3K)?#<!4XZLCV [!!\=7G::,JL/5QL
M2ZCVN=U]="B+>Y0K@U+</-#5O2R:HR:<J2A* \@SFNH98!I"PKD>&EA(4CT!
M9 Q;'37I;&5JS%\:"E>5I8!7IMJ3SFDTS].X%XP&)NT*GMI(4%MY/@W5 2=[
M*O:"UTC$VQ,W)T8]BT<'?YZ^=S2V/&M^FQO/7^PK0;_^YRV;Y_>U5-QBF_!6
M2<9]HZMUSO,GNEC/,D+", T8%!FE$ 540BJS%.(L#!&A#$N5]<@QN]BPJ6:1
M;2TL_M?_1Z(P_8^JNE'CR*6G ES[SV[B/TYWO.7Y@N:GK4-78,>EC5AHRZLA
MSR'T!'C8PPJN1KWQB8:>&)X_]M#WP>[QZ@<S>UF=+"OP]WS]\'DA3'[R,YU_
M?39CPJTRS1<SCGF&$BJ@CEY-03D=RV8XHE#$&6<\%"DBU@%M?S.F%O%6QIGI
MG:A]VE6+>S)&VT=V%_3/^1!Y'-2'Y]L*YI/%88P?8.O(%:C[Z%:5C#M.;]@'
MXN/TRDB1^H"]XQ3-7PYJ1[A_P<-'FP]<#D![PN#A:>YCU>>_?]-SDT?ZE]7R
M^>G+EYMZBAN%01S'4D(LI-E0UU,$$N$89B1D499&+"'8=APZWL34QIC/_XL^
M/OW'WT%E*RB-!=I:>R([ >7Y(>-R@ 8>#DYATV-5Y01(]DQ^.5@CL;3S"^7$
MO=TP=/#JB1M'X\QNP]M\>.9*=Z[[J)3DZ\UIC#OZTVBJ?)?&ZO+,K7X?OLLG
MJF<%M1)_G<+TD:X6^>*^* ]@;-*:?E8+V\4WJ=\8/2T/B2(L9>:<@PH@XF$
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MBE%&.'91WWIC=ZR^TO%ENXR8TUR;#M[=4U/JXZAFEQO%O=7[8L>A4^[^M],
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MAI(X(XSC,$4NB@RV#3L1S@CJ#-M*F'-C\D::X14\U4;KF?/I7?_+.L&.BH:
M=F!:JDR^:M49+:UNY=Q>F>0*)L$WFI]>C7#F(5>H?'*2==NC\I,K(OM<Y7S_
M9>HQ>IYUK1M<%^7T;4:B&)<KAD)0#C4U"4AEDL$($QX'+.&2.M6'.M[,U(*@
MTJA^PC![^-D1S.6H#$PG.V(PE8F:6SI1ZJT#<QR$(11@]EIZ$^V7X]Z>4GTY
M<77O34BC=6E68^I9>Y3$*8E#"K,T01!E+-43'T(A9Y01JJD B]!Q_W&WA:E]
MZ#LRMN#)K$LY;S[N86B][]@?F>&W'$NAVC*;?)#=QN.N>]YHW&MD[#W&XSX>
MV5X\<6%/V>IE833FZ%S6Q=2V!:,%2RGA1$*9FE6-#.NYAHPC/?40BB!&D8B<
M4AM/-S6UK_S'0_[T9&)@DT;\5_V?_Y^\=VUR&]>R!?\*/O3$N"*$:A($'^AO
MZ5>U[_@X/;;K5$S4!P6>F;PE2WE%*<N>7S\ 'Q(S]0(H@,FZTQVGG':2Q-X+
MY,)K[[47YB_&?L>O_0RZ=I^]'\P"?_]UQ/5*@=]6*]&$:'^5Z\>2R[#%&2]C
MXU6S^G1KX\I57_3Z0*GZ\AWNI;W>TO*OGZNOLOQK]7$CFK^U QI&.%,TS6',
MA5X"1+F>%# N(64)DT@(+.QV0\\W,S7.:&RS+\=T!L#SU. /EM!K@-HL4%LY
M ]K.7\&KYM]^N3Q+<,'+OBR5']Q&*C=U%7Y.59\NPW*FFM.9FT>KTG39@7[U
M)8NK?0EBZL77]GNMEU/];L1VZ()O%_6^S">Y^=R6^6JO-SS]AY[<W6^DN'F4
M:VI2BC5UR6K3G 4891VZD?,\2K,\SU*8LKHFHD@AT8LMF!,6,1'G45%<J9L9
MPNRI$79G,Z2-T:!LK0:\,QNT6Z';JLD!%%)?\5UC=;I*V[6"G4%>&.M-I8F]
M!N$WJ8Z$6/6<!K_7TF][M^O"BYWCN_N,ZS.P>Y]:[T'G/MCY#PP (55#0W98
M6''1():_L 9IR-ZX+%4:M/5AX^,^ZLO4XCJ1#E57.'Q;/I9"+D5UNWY;5IMU
MR;:U)W,]]\@9R2.8(*D7%X5>5Y",8)@)3A')TP(K.2 B^7K+K'AM_.#B-FFP
M7(+M4G3V:E*3=+W4G5J9=3M5JBZ69E*JVXJBHO/2;3SST,%V8]5(_37../0D
M\K<I5'@RU[.I_:M[:.>7_@+!$\_\#3#^4/8Y>'BP:M2!P1^*STG?XY.O.A%J
M(F'XSV]KNJPHKY]\LQ3U7Q?U*OE@^U,54M*$(HASLTG$J(*D,,(C,E,Q0DPO
M89S4.P=;,K5E27>8TGD">K8/.FH:T#E.1U)A(1_IZ.HIVJT7]59VWP_0;F<'
MW=:^&M8 QV(#C'F)X[/AF)TX9KOB@<,(53]9R.]T_5>7E8H4DDB) F8R,IOI
MA8)4%05,$H1HIN>\1>(43_.\@:G1W]X^-[([ ,Z.PZZ!(S U[4T+<*9^RF^?
MW''0QJB4<,K#YU_ZR>N&?<!=@)TFD"_2)'WP39V:-,^D2DF$<YAP/=?!+,H@
MC2(,DYS3)$XXBV32+5SM/N5330U8B0;^J-_0ZGX7G>OV79_$T^[[O@JC<;[S
MSL0ZZ/^)D?X^]TLP^/SL3[8UZN=_R>/G-'#Q>C<Z$+*<OVV/">O90JU3UPB>
MSQDJ1)P7"$8RSR"FF1[34<H@1TAI&H@DPU92B^<:F=JXWMD)]H:V8OQV?' 6
MT/-<X NFT*<1[@A9\X -!'L.J#H2J"3_]6[U^)_Z]N;[US\\_^S//GJ43][&
MN>YSM[K678+K6[DQ E\?EO6^Z98N:M$HC$G$,Y5!1)#9V2 (LDPE$$D<8XPC
M'L6)K0+7T1:F]I'71IK-R;V9S@)<QZ$\_X5[ 2CT=-X=&R?YK;/^7ZN^=?SA
MHXEOG?6MK[UU_D)/99);?='=T9G1>M_JJ4*;<F.V"+K:XDPQE(I(P)RD.<0Q
ME["(I(!$416I7&8HRH9DPPRP96I<T;GR7U?64W;H#>LPB#$P#A_;T"3@M(=+
M)@^G=02\:EWYI2O38;P!>W>"E(;W &O0HLX.YKQLS6=WW"Z6A![P2/>(X7??
M'Q:KGU+6]>P_Z_?\GE:RKJE:/3QT\BHXDS0AFB4SH?F21+G1&Q-0"B:0B"*<
M"6D;.FS1WM0XL3,9U#:#SN@FL>;5NZ^?/_]B'S!K@_=Y1@R 8F#6LP!P0.BQ
M#9+V,<B>$1TI&-D+LDY!R0XXG8E.MGG*:&'*#B[UXY5=;O.O+WG32&XU^OOB
M?VZ;L (3<'!S^^:#M7S7^]7:Q)VMR]6ZS0XR06=-=%D=HF#T U/$]*Q88DAK
MC0M""T@S%,,4<XFR.$LC:K5BGIA?4QMGC$3 ?P': \ L3!^,#Z!J4[>:(.A=
M0-A&SQ_U'__Q*OHUUO/&YL_Z@-S\F/[RJS^!RC%?.+LEP42LG=! >TS \E4#
MRB^M9-'QZ.K:PUU^8)TY^*KQ4K]57R1?T*HJ5<G;RB\[0)NP. -IIY8TFL#E
M"_3P6(*78[HV&0',%^A/%T',ES!O8/0?+=>F-(\V_F&[J3[*1[E [7PXCF+!
M<8IA(3&'&*>I'M,Y@U'"];\(AI1=]0F+MJ8WNFK; '(,UCN#I=T@Y0FAP .'
ML;(N[25GH#%T!EK 0DA'7,;$:[3<F>;&C8>[[/=!Q)O%+0,K:=UK0FM?Y30O
MA$A$!GG*$<0%DI A+&"21K'"JE T=]H0[SU[:C10F^98ZZJ'E-U'/]#_P!]Y
M;56 S_F(MUYK3_4>/VZ!J4._#JI(';G$?0^VJTKQ1[FY?Z-G%GK*L=YIPWW1
MG_QR*_4D?'6W-!K;C:CVMWO99(O-]<C-4:K'=%$DD5Z=YRDLDCR"B*<BCK/(
M!*[8[LY>9<G4/O767B.!VQK<%6_0<S2G @[7=]+E+=W1H _,,IT?P#@".D^>
M*%9V';-WIZN6H!UJ$WG'ZAC['>+1.FBDO>/0'>6TK>P%W#,;SM<]?[2M:"\P
M]#>I_3QPH(9RVTXIJ]TT]FU9\<6JVJ[E[OQ?I30F,2]@3C&%."<,%CQ*(,4Q
M51*AK,!.:H5VS4YML.I9[1A[80FSW<S5/WB!AYN>P3.P7\:"O=%!XB;<</(J
MCVS7\KCBR$YH'$@CN]T]4%&QD84?$J"$,$T880@*&FF"P@1#@I"".$$Y3^(L
M+9134NQP4Z9&6JTGCH1U15?8D=@X (>>1S=.3"92['I0O>H^#K=F7%W(JU$[
MT(V\_HF^9-2.*];L>1,)ADF$],3.Y-;%"D,J"@6S**-$4,P5=9K8N1HP-;;\
M=$J=S#W8UJTC[%@S)+R!N?+XH?9)5;#=V7:HD-I!.(95\KI@PPMK<MDA=%E=
MR_(YUZ4<F!-B3;G-4?!ZK5_$^IC7++'W*0Y?[^E:OJ:5%%T.X^N?WW2[M^KH
M8TPVC5[NTIRA!/*(Y7IV&4>P2.,"B@13C%1<<#ZH2$<@>Z=&K\;:6H*IB['O
M&^R4\#16AUOS\E2Z,3"--U))L#8?]%RL9OWTK%T-[QFXJLL'YTH$[H@0^12A
M3'Z1G(O ^)_*RPC=[%45,/6$_^N&+@5=B^KW!T$W$D5Q%B?ML74D<CT7SU*8
M4<;TT,(32!#3KPLCC.%<882MS@B=6IW: +$W&NRL!HW9P-@-XV10><P+V-NQ
MO'=$ W.U!9@!0@V<4 I0*/-"PR]1,=,.BQ.E,RUO=@]I: ,BO\K-9E'3Y,U2
M?)$+HVKS1E/DG:SF19KJ&6W.8<J5A#AG!#)*!<QCAA!7,9:)==S"Y>:F1D:M
MQ:#:F5R'[:\;HP%OK+8_!;< _'(,@E\8 S-0A^#>6J#-!:V]X$T !.V#!?PB
M.5)$P)6(.AWXVP-TYE3?XB&C'=W;.]0_GW>XRUW_Y,WV>ZTM_BC?*25YNS5R
MJV[$ZF&W",TBPF52<%@P&4,L8P*IP#$D>4Y9+E!.$BO9(]L&IT;$>YM!8_2L
MW30T"\O.<&>]%"OHSQ-R"$"#GUEYP-))7\4%H&OE5JS:&DU]Q<7SOAB+TWT#
MS]KKW?7WE-=11F]7WVFYG%.24,X(AQS7]<<DTM,]33M)%B4Y%32+(J?=S6.-
M3(Y;:AM!9R3XLS'3<1OR*)R6)^%7@A2:+USQ<3^U/@. U_/H8^V,>])\QM.#
M,^1SUP[[YC_)O_=KRL_KU5+_R)O=6SVET7.9I9[+?%CVKRF7O'Q8R&JO<,X$
ME2C+,"0$91#'"8(T*02D2'*9(_TKZA1IX\.HJ7&*]@D<VWQQXQ0OW67'06-W
MP@MN?)D5?..0*>W2NW+G$O@SB#J]3XQ]TJ(7NT:E49](/J==K\\>1M/_VFZV
M=/%^NQ3M[C3/<E2(-(,44PIQE@K(HBR#41J)M, 8YY&3ML?S!J9&GXU]0&V=
MJR@=0&='?]< $IC*6BR,;0'VZD\Y[I-?#MH8E2M.>?C\NS]YW;!O^%U;)$RO
MW+KCQI+/.65I@B6!,4,88IXH_4D7L9X[%9+%<2H0=2H_>K25J7W-M5'@E1YL
MQ6JQH.O*!-B!RMAKJ<EV'E2[3_QJJ )_YYU]9C,&U!;.0&VCOX_]+ 0^O_CC
M#8WZV9_U]?FW?_[BH:G[^D',!!F<B$EX_7-_21N'</.WGJCNTBMZ52A-_#!O
MRAY^C^>LP (G$8=1;G(=HH1#RG,)"1<D%E$1HT2Y*0&$,G5J5-09!Q:E.EU-
M=NS^M".P:?128!:L/8"U"T_CQ'I^ O83]*]K?06ULT_RRWH.S\"N[XW//H45
M0G>+7YV&8-:.+/L0&O5#%8G@+080H'RDI;YV(=^OUE_I0GZ5?+NND_B,@A\S
MV_TJ3F$BDPQBH2>BK" %C#')"L4$*A(G19G!EDQMF#!)"7=43UA?+>JZLII_
MREU54%#M3)\9;4>/ZHUG>\MNE!BE#P(/ K52X5O)-N!K#^J=]5"MUM#8/P._
MU9U4%__MM WWNF^S$74.;9 =39GPK#'3T1*TP<Q)_<_J@>[%J-XM-^7FY_MR
M(3]M&R6N),=9RF.HD%[*XZ3 D)*B@!+G1K(/T[2P6L4?>_C4J+"Q#Q@#06.A
M?=&I ^#.4]BU<(1>H-LCX51<ZI3+5Q25.GCD:,6D3CG3+R)U\IK!P?5KLW.W
M6NO/7%8U0WR[I\M=\JVLVG3<><18DK!<3W/TYPLQ(RED.3(?;D)DGLN"Q\0Q
MPMZRZ:E]UK7E>BVT,3:"52U)O-&6ZWF.,=TYQ-ZV!^PF,6%P#7_FN*Y/+5:U
MP+*&]78/ZUX@P$QE6N.]AMP[ N8Y[MZV];&#[QU1.1*![_H$7WG[>\$GO1HQ
M\UPSQ7F[E=]6NL6-GNG41Y+SA/$XRD4,TTPPB N>0U*D&11,)M(H#A)-:6VI
MVF_7I/';V6/U/3XMH/OM90+YF^#]:Y/Z+7O)CO:"@C[M)/\G2SF@/02;%>CY
M&#+SWPWDL H EK:\L!* &V*7%0$<GS>PO/@Y^?=#FZJ>XM4G#50[@<EDSN*(
M&($43;68YX6>3!8,)AD1BDE,,D7GCW+-5K94Z\4N%PKH6Q>><DVX53._?'CB
M62>NXEK4W$LOBI1C;L9*D3,*L:0<$BXC6"@5Q_J7B/%DP*@Y7E>./X3N#02+
MO=DOT7EV@^GHGU7@D;6G^'IBD-U9[6^P] JBSY'3CV&C#J->L7P^IOI]N*\U
M3._$ZW=S<$87O$YK6=X=UP#ZHLGL5O7/U_1":RUI)>><42212J"(<P(QP@P6
MTH1 BBA+*%6%$,5U.F7^C)W:9H^QU"1W\?Z!>MD:>^T*R&,?#UTEO4S/O<A*
MJN<J^+T.DM@[>WJ9-0/=*_ DIN+#I5? P^+*?]^$78!YM/>%%VG^D;^\D O0
MYL"@B$98<WGWT3SL#UG>W>MY\HU>^M [^46:7*KNETT,5IJ2*$%)!+F($,3Z
MKY"H@D,5ZV&'1TF4)V[E,QT-F-J8T5D,:&,R6'<V@X4Q&FS.15'YZ1/+B(>
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M55Q%,D<8HH(@B&,E(9,T@[EV+,J2N$B%583WD6=/[0/?F>=0R_L96I?WD:_
M(/2JI;-LP.;Q<QP<BHD/QV.L*M[VN+A5R3[N^;GRU,_N&*\N]'%3GQ1D/G')
MT&D'7TM:R;>R^?.#*>UF=INK+Y++\K'>1,@PI91I+M*+'*ZI"1/(,OU3E*HX
MDUFA\E3,EW75&/'-93)RN6VKUY0TK^F!!2$'XL9D$YU/6Z/!>F>UZXS%H@]L
M)S">(!UK/M/"^*HS^!>#:&<S^'(9T0$3''N(_,YW+-H=>?ICC\3A;,CAWJ$:
M&?IK-L/.K6HJ2MXLQ9$ZD[LH[43(&/'"5&U/"<0$Y9 9O2^:9[DD1424F[Z/
M8_N3FV1UYIO-T:?E8AO#!RO^N':,Y1YT.+A#S^=\(#U ZV(07GYU+MQ,&%GC
M8A ^A_H6PQXS5,],^[;43S(S[2]E]=<W_9Q6=P^G":?"%![ 9A9&TAP6*!$P
M3^,X4X1SAI6;?MG)MJ;&94],!<968(QU5#6T =F.JSQ!%YB7!J,V0)/L(AY^
M-<A.-S>RYMA%OP\UQB[?XKZ9I"=?ZZT47^F"FC"A/^A=+:7>"=$UJHN;.8US
M)$Q]S:20B9XG91$LI)10")[':4Q$;"<A9M_DU)BDM1I4K=DS\+<QO-;^9ZWI
M]KLQEK!?WJSR#V9@;NEP_+K#L;9Y5@/9F3UK)58MB\<X(&J_[>4?V9%VPSPA
M[+13Y@;6F0TTRP>-MJ_FYEA_N\WQSH%U]MJB?;?+7?;Y?TNA6]*+Z=7=LJGP
M]XZNE^7RKIHG*2Y$FC!(>*I9G*,$D@@IR'"41I&0,B_VVW&K#5W8S0>=C!BR
M+[<S)>0A^[I\U!^F7GJ]NJ,F<WFA/3([<ZT'9GNIK&?L,Z",9,:C\1/<UXXZ
MUM]SZC2[B:7_/ABI_MZ^&"G0<\V]& EHS =?GO1 YX''$GQ#@/-:@L_)@'%+
M\ W!YJ $WZ"'#*/#VP=IYL?+NX]F:U&WL.Q.73_)S5SJ>2H2BD&1205QD1:0
ML=04\,DB'BN3Q^P4$W&VM:G-7VL;AP5&G$?5CI^\8168CW9V@L;0&3"F=F$3
M,Z"M]<<]5J#XY)KS#8[*+5:^/^<2NYN&<4<O%EY/TVIUVOO50M]?-?I \P(5
M,A(*PXB03),&BV%!)(:24DT=,LH4Y?.-_;3I4H-.##+"%*F>AO63..H%16.K
M&Z%<A-J.4WP"&)A6'%%S9A);*'R2R<4V1^436P2>4XKU?0,"M<S#&@DQ_>B;
MAP>]FBC;[;N[^TV7P1FK@L8)S: LA.85@A6DHLA@0J3DDN=9FEL=/]HW.;6Y
M26TU6#TTA03UYT%[AH-U;;E#I),=[)?WUOR#&?P\T>!XN\>Q;S-HC!X2.F8'
MJ$-$F7=@QPHT\P*P6PR:$U;G0M/L'C1>Q)J38T\"V=SN'#@=U$O6-ZNEF6PV
M9:<^EDOY82._5_,LT[RL4 P9C_0ZDB0$,H$8C#%6N(@S5! GM<7334V-J(VE
MX(FIX$]C+*BM=3Q-/8.PY?S/"VZA9WX#(7.? EY$P^OD[W1KXT[[+GI],.&[
M?,<PQFCCV/1SOV[TV$#7HOK]0="-U$2,(]*.DA$G22Z(@A'G>K:7B0(RFA>0
M(LR2%$L>F56D/7E8M3HU'MD;#796@\9L8.S62VPW+K'#WHY6O",:_D3U$I@!
MTGV<4/+)/'8-CTI"3E@\YR.WFP=3T_;[MJYTULK"',2A&5K\)#>WZAO],8_U
M#"=B!88,&[U/S"DL6$QAEBG!TPCG"CE5J'9L?X)TU9D/5K4\$7\2K&F."IWY
MRJE#K)DK%,SA.6R'<">4=20<MCDHK'?A3<BL]L$KH0T!SS.U.9DP-LD-P><(
MW0UZS. L)?U _9R]YL,W^6/S6COVUURAA,:"YU"D>6(2)QFD19Y!R@6149Y(
MQ)6;JO&YYER^MG%4C=N/2IOK&L%P%E8[KO(%56!BVF/44X0!?QI306VKUPSJ
MRY!X3BPZW=[8"447/3^22'3Y'O=-^_\N[^[K((56 O2M7&AB6O]\*Q]+OE==
M+ BGJ4AA)#,]0<H*!$D2&767-,Z$S"7)F>V>O56+4YL2&:-A$ZC3:<]V=H/6
M</L-9CO,+V_8>T<R,+D8>\%Y$ =LUUN^P=:[]=Y1'6FSW@;=QG@_._5..)W9
MJ+=[SFC[]$YN];?IW6YT9^IG=9B:PL&WVTUEEM&F DF71I@7F"/,]!"8I5RO
M9A.IYWD%@RRE/(M3D9""VLWS7)J=WGQO5P6.ME7@FJ+F8+4WWK(DDA/\EWD[
M!*2!J=L&2^<\62=8[0D\!+PC<3B$1@E:_JK_"YXT">2/LMI4M?C]YKZL@%S4
MR9:_ @C]T+DK:F<8W?I1HY&ZJW-]7G>^=]C2_??E/OA>S_*[O(DOTHPEIBK?
M%UEM%V;?]+UV[2-]J.2MNGEX6)3<: B8]-OM1O_3Q_)[V;PSU3R*(J)$3&">
MFY/;(D\A(YE>^U-<I)+S.)6J2X"P6_$'L-+J,WR:(1%XX-AY4W]N\L=#V::&
MKA2H&@_,CXN]#_])M\(Z(2YDC]MM1KQ4+XXS5O6]JW<R]DE@^Y[=>=C42ZQ]
M-)VZ]Q)\W7=USU%_^Q\!>\'GMDD(,T?=;0F(\_--FI!-^4@1>;/2 QI)>)YS
M+""B7(\%49%!EJ413'&6R#Q'24Z=XGD.FYC:[LT^RV%1IX5P;>,U.2$UC'94
M>QTX@9GR6?;'#+PY!\R5^1Y]W\,E>=2MO&!F1]_+\^D<3ZX<]G&_WE;E4IKX
MGN^L7#8A@?LL,Z'7!Z4J#;'<5)7<5#?\?VW+M12_K5;B[W*QN%F*?CAX5>GU
MAC Y3A'"*9$YA2F/$,1<(4A$'$.B,">28D2HDX)*(#NG1C.=FX :!ZK2^#GK
MY]3>M0ZY<4^H7K8CL GT76 6W'5;S\59/Q&W[R5HW 2=GS/0>=H(#O0S7UIO
M/6?1!>X0G]0<RM11^3TPWL\'B=#-#11>T#/9-35/OQ'?RV59U<(\C[)-1YPG
MA&8B3E*HHH)!+",.BRA/((]S,ZG$.8WX .73"\T.V#H80_3TS6K]L%J;>,2[
MQOYZPNFJFG !<3OV]@'@2,H(+51UFLD36[ML9(\B"':H>)4]N-#DN$('=OX?
M2!M8WC:TKDPG2?)AJ9]<[WU7G9K"ZY]&1$%/G;_(1;,NOB\?;GZ4U9S2C!*<
MYI 65)C83:)_XA@RQHLLE1$BS&FN.LR,J4U%6S-!WT[PI['4,6ME8*_8L5-X
MK$-'- R >4!IFFM0\ENL9I E(Y>ON0:MPX(V5SW-9]W1W4DHSR*<*LX@%0F'
MF.K5.8L%A2J7>9Q2245F%8QEU]S4F&U78G-#?X#%WE[+HWQ+C&WYRQ=R@7GJ
M=%W2W]8F82^$[K(=..&KE+Z,JK*=]W:U2KV=, LS92O95J^#.@6J6_5^M9;E
MW?+KEE6E*&OQOKD4-)6(YC#6?T*<TA@2S"BD44SB+"8I1D[24?9-3XUNGE@.
M9&NZ.1-4C?&@ZEGO>@!LW2&VY[HA8 Y^7-M'^%T/X=9N\-4&X0''KZY@^3U5
MM6Y]Y,-25U0.ST"=GS#P:-/DTWR19EK&-]NU;L8<J53S3.8L2G(.4RZ4J3TJ
M8$'2&$8%+O0,B>81<EH1GFAG:DS5Y)'Q>[IV5N@\A:3E$>?U^(0^YZRA>6)B
M?=3ID4TN@.#UP/-$4^.>>I[W]^#H\\+E _-\EQO-)8NM69]]W17:??>#+[9"
M"A-B8=+MMDTDQ:WJR.BS7-=1?#??32;RG.4D3DQ!P:+(*,01CV 1HPPJ(3*B
MBB+-,ZN"@EZMFAJ[])UJI:LJ(%N?FA@JOO?*C-[UU?IW2[EIE83!@_X*Z\!A
M\*I<MB'$OSAF$GOI<CMB&[TC ]/@DS[<.P3>/>G&-T^[<3<ATVZ!VJ\9:#SS
MF(OL$VBO&<I>#!LW;]DGE@?9S%X?/K#T3Z,DO\N';$\?VEB[>403F>8)ASD3
M!&*49Y#)+(8Q0HI'+*9($!?9TO/-.='T"**EK;4=X9H]LH?UZK&L='\X%O\Y
M#[,=@_H#+S U=KCU\I^[TM&O6FM/#U3N98"L8/%:">A\B^,6 [+R_J >D-U=
M7I,ONN*-3\-V/Z_+U5I36KDRUWY>-8%>U9QPO>[,.8%YE#"(,TXA$86 1,:4
M%#BE/"_<-LVN-VIJT\A=(5.QU>RTTN2DS08_)5V#A]9F+TD4;CUGN[LV;G\$
MWW<[F2:QZZ5G61*U4Z#QJKYEYU?PK(A!*(^0!N%FUQ3R'@8A:9GH,.S9(W!V
M.WH<^?9QGG.!> *+3$J(A:"0TLAD0Q"<"B$8IUDPUCYIUM1YF[?SI;&8^W3_
M!>!N+[TR/?;NYK@3XN^+2+\8@Y^V;+H<?A'-JUC\\M.'\?C[<EENY,?RT11&
MVNAWO.R"FW^OI-HN/I9*SO,D3A)<1#"C2L^M259 5F1*][*269ZIB$5.9SHV
MC4Z-@]]5F_)[+1FXK6T$"VUD?1)=.P.-W(BI&M:Y V@=(>[&RE:]8<>YOC$.
MS*B-N;"V%^P-;A(^9J"Q&1BC_9&E"T0^J="JW5&)S@6)YS3F=.\PDFJ*HYC-
MS=52DV!;!)L3I43!&)0F !D;>7Q2Y$I/)=,$\2*1#%F5"3[;RN1HJ#82[*P<
M6%S\.*)VS'(U3H&IQ!TB9^8X"X%/JCC>T*C<<-;7YV1P_N(K(DU.*+?>/-)R
M8?*QWJ_67^FB=RQR(_[GMMJ8B.&=KG$>YTF4T )R3C'$189@D? <JH*B2+(L
MRE.WDHR>#)L:QQC!X[NZ5.JB*Y4JFV^**E4N2I-;12^H5'?5:Y>->+(Y"M%_
M_$<TJ_]GTHS^XU7T:^QX_NSM5;!CNI?HX,#D>/OFPPR\E6S3.X*>@9TS4*W6
MT+@S [UBN;K#E'[QP-ZSN@>]*F+[QMI[S(\/V\8/$O*(Z-&H(I_/=U=E?+=3
MAVH6QNT\)L^Q(L+,#%5,(6:IV5^,N/XK204VREO<BNA/-S$URMY;V6TPN<T+
MSX!YGBK]0!1Z1A@.'7MAQ.M1&DD&L<.FUE\[ IVG!+O+F)P1.3QQXVB2AN<-
M[PL87KARV)3X*[^78KN0M\H<Q',]"6MW#S_3GW62W#?#O;WB S)CE,4*1B1*
M($ZE@E0* B/!,XDH*O(L=IGY.K8_-;;LS*\C[%H'NBU\T+G@-C-U[1&["6A
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MT/,8L)^@?UWK=5-$V"CRUHX;[?;6=:-'U3@_ _N7Q7.>_Y@=Y7-?=12[1]V
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M+^%\-O\^8DP&$R@&5AHIEY%%W"0S(\R+"" ]92KV6J9S]>INL&@^;;F_.)M
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M3$N;KVURT@:=&.-E$FEI4LFR(%:G0 "D+,<2V>P:FU1W'>S'RK#WPAM>$4=
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MO6YJ550S(.86\^7HY88EY.!USA"7'V ^GJ73?))F7]:J6H<?-+(8$0J,.70
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MLJ?,STY">LKQ;)_]!D%66J>6&/CW\?+S2W0*9Q<POXJ+1<G[6;!$&XUQ,5-
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MO9 :=TC&P1$901#'LBP5RHDZ9-%UNDC8#3;W43%<6-.3=F=]BWI@O)Q<E*,
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MT-.5==A'\X^MP_'R'CGW[MK 73,2EI]>7LR_U=2P.M;NIIOHJUF9T]ZLZGG
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MTU<R[0].;*&,].OB4Z,Q"4]2M=N]*CLW5 VGB5Y@M8$-V@*H1/%@O&'$AC1
M06L!)J.7F0668A,CM86>W:!T=G?T0TB_WV2E%Q@O#WC.6_VS@1[M'I,P4/..
M^N%-K1>2T3PI"\Z+.EJJSCQVKH!5AHN<)3F^3>SP9G*.=V/N?_7N'5I':;.R
M2)!GLK;4<\1E8!!#8%)'\LC$";@<.25@0"0\]EN.E_N [RY-#,/!R47W_O&
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M5Z8JX_5V:3F1:!1)CX%#XT$IFZ *#NC@0F%SB0YW:;:U^XH]N3['H:BAI+O
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MZ^XL 3K]BJM".X.Q (H8*I/DQYC,P&<1<O)92M&FEO80:L>M!>D*H/OJ[KP
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M!R#;,N%5."^+=@PXUD['16<(/F:2C726>4L;M$FFXWF-UMU+U[N-UMU'\!W
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M'I!CPT0A$3%#.](JX)9BRL*T=;9)F] G:.HD_AX%88>HI5.$R1M6G"Z9>\>
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M23]%T*&I"L\0=49@LN0*>J?L8%;BAY5'UOPA>IL/(<2QM1_^ND>X)6LGLC'
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M"L"2$""L0DI"C'@?IF"YIPH-1 VX/GVDMHH"4Z%R()$UUJ-^Q:&94"I&]+M
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M.H6I5M(R^_VBN\'RZY^/8^GB'UT]IR+<\2C*^RF>;7DU& %O'0O4!)^30&M
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M/.+GS28C:;(1@@)S FF+)(#7F8)*(AKCA,ZFBK?7YY"-STH:VP6L)M\&L#M
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M4FT L0/TE7-+$DV<@RG/?D64Z XZ38#9H#C3@5%K)JDA#K-HHUY+?Q,NSL@
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MD)J$VNYMB7/<IQPHV)@M"&82.)XD<!>L"IPJ$ZLT!I_4:*M>PNXZVJH/YQM
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MT(EYQXVT5([T$N6L1P+VP6.=D8!]!-U 6>6) 62)QZ H1^_-XE4IN$2.LJ#
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MD@Y<+J6V(RTE"6.L/DUWSA_IZC>]:M3\@R.4T1>V[JZ0HJ2Q7CA )NJH'1$
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M-UI*]RSQ92:]JIW]S,DJQA%I:87:H\EI<$$$D-(Z*462_GZ6TJ/WB$/>U1=
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MZ_>K99EO9B$P1NYM!&MJ)9NP%H*5#@27]"<9=<W;%*W>TC!U(^O&@#I4VAT
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M)#DD)FY$WC#4GN?=1@\:[2!>OCDHJ*TA%W%^<=4%B,2Q^$3^\IL%,;O-OOM
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M:65S7S(P,C N:'1M4$L! A0#%     @ *H974JK&!+ET P  0 L  !0
M         ( !\@8  &5X,C-C;VYS96YT7S(P,C N:'1M4$L! A0#%     @
M*H974G1$5VY%!P  ,"(  !X              ( !F H  &5X,S$Q8V5O,S R
M8V5R=&EF:6-A=&EO;E\R+FAT;5!+ 0(4 Q0    ( "J&5U)?(=P11P<  $ B
M   >              "  1D2  !E>#,Q,F-F;S,P,F-E<G1I9FEC871I;VY?
M,BYH=&U02P$"% ,4    "  JAE=2W'*6TO8#  "(#0  '@
M@ &<&0  97@S,C%C96\Y,#9C97)T:69I8V%T:6]N7S(N:'1M4$L! A0#%
M  @ *H974I#,:M@#!   RPT  !X              ( !SAT  &5X,S(R8V9O
M.3 V8V5R=&EF:6-A=&EO;E\R+FAT;5!+ 0(4 Q0    ( "J&5U)J\U:'L1T
M %ZH   >              "  0TB  !E>#0T9&5S8W)I<'1I;VYO9G)E9VES
M=&5R92YH=&U02P$"% ,4    "  JAE=2Q*+V%]J)! #C5C< $
M    @ 'Z/P  =W-T+3(P,C Q,C,Q+FAT;5!+ 0(4 Q0    ( "J&5U+@D>N'
MKAT  .E= 0 0              "  0+*! !W<W0M,C R,#$R,S$N>'-D4$L!
M A0#%     @ *H974L$/\!19/P  ?+," !0              ( !WN<$ '=S
M="TR,#(P,3(S,5]C86PN>&UL4$L! A0#%     @ *H974M^QA,Y'S   OQX)
M !0              ( !:2<% '=S="TR,#(P,3(S,5]D968N>&UL4$L! A0#
M%     @ *H974A"$6CU)*P$ 184! !,              ( !XO,% '=S="TR
M,#(P,3(S,5]G,2YJ<&=02P$"% ,4    "  JAE=22C+R^@_A 0!;W!, %
M            @ %<'P< =W-T+3(P,C Q,C,Q7VQA8BYX;6Q02P$"% ,4
M"  JAE=2BO)(_V<C 0"5K@T %               @ &=  D =W-T+3(P,C Q
A,C,Q7W!R92YX;6Q02P4&      X #@#0 P  -B0*

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
